PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Irie, R; Suzuki, M; Yamamoto, M; Takano, N; Suga, Y; Hori, M; Kamagata, K; Takayama, M; Yoshida, M; Sato, S; Hamasaki, N; Oishi, H; Aoki, S				Irie, R.; Suzuki, M.; Yamamoto, M.; Takano, N.; Suga, Y.; Hori, M.; Kamagata, K.; Takayama, M.; Yoshida, M.; Sato, S.; Hamasaki, N.; Oishi, H.; Aoki, S.			Assessing Blood Flow in an Intracranial Stent: A Feasibility Study of MR Angiography Using a Silent Scan after Stent-Assisted Coil Embolization for Anterior Circulation Aneurysms	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; FOLLOW-UP; CEREBRAL ANEURYSMS; ENTERPRISE STENT; ECHO TIME; OCCLUSION	BACKGROUND AND PURPOSE: Blood flow in an intracranial stent cannot be visualized with 3D time-of-flight MR angiography owing to magnetic susceptibility and radiofrequency shielding. As a novel follow-up tool after stent-assisted coil embolization, we applied MRA by using a Silent Scan algorithm that contains an ultrashort TE combined with an arterial spin-labeling technique (Silent MRA). The purpose of this study was to determine whether Silent MRA could visualize flow in an intracranial stent placed in the anterior circulation. MATERIALS AND METHODS: Nine patients treated with stent-assisted coil embolization for anterior circulation aneurysms underwent MRAs (Silent MRA and TOE MFtA) and x-ray digital subtraction angibgraphy. MRAs were performed in the same session on a 3T unit. TWO neuroradiologists independently reviewed the MRA images and subjectively scored flow in a stent as 1 (not visible) to 4 (excellent) by referring to the latest x-ray digital subtraction angiography image as a criterion standard. RESULTS: Both observers gave MRA higher scores than TOE MRA for flow in a stent in all cases. The mean score for Silent MRA was 3.44 0.53, and for TOF MRA, it was 1.44 +/- 0.46 (P < .001). CONCLUSIONS: Silent MRA was able to visualize flow in an intracranial stent more effectively than TOE MRA. Silent MRA might be useful for follow-up imaging after stent-assisted coil embolization, though these study results may be only preliminary due to some limitations.	[Irie, R.; Suzuki, M.; Takano, N.; Hori, M.; Kamagata, K.; Takayama, M.; Yoshida, M.; Sato, S.; Hamasaki, N.; Aoki, S.] Juntendo Univ Hosp, Dept Radiol, Tokyo 1138431, Japan; [Yamamoto, M.; Suga, Y.; Oishi, H.] Juntendo Univ Hosp, Dept Neurosurg, Tokyo 1138431, Japan; [Oishi, H.] Juntendo Univ, Sch Med, Dept Neuroendovasc Therapy, Tokyo 113, Japan	Irie, R (reprint author), Juntendo Univ Hosp, Dept Radiol, Bunkyo Ku, 3-1-3 Hongo, Tokyo 1138431, Japan.	ririe@juntendo.ac.jp					Alibek S, 2014, DIAGN INTERV RADIOL, V20, P360, DOI 10.5152/dir.2014.13458; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Robson MD, 2003, J COMPUT ASSIST TOMO, V27, P825, DOI 10.1097/00004728-200311000-00001; Ferns SP, 2009, STROKE, V40, pE523, DOI 10.1161/STROKEAHA.109.553099; Cho WS, 2014, ACTA RADIOL, V55, P604, DOI 10.1177/0284185113502335; Mocco J, 2011, NEUROSURGERY, V69, P908, DOI 10.1227/NEU.0b013e318228490c; BERGIN CJ, 1991, RADIOLOGY, V179, P777; Chan CF, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-17; Cho YD, 2014, KOREAN J RADIOL, V15, P161, DOI 10.3348/kjr.2014.15.1.161; Choi Jin Woo, 2011, Neurointervention, V6, P71, DOI 10.5469/neuroint.2011.6.2.71; Gonner F, 1998, AM J NEURORADIOL, V19, P1324; Gonner F, 2002, NEURORADIOLOGY, V44, P755, DOI 10.1007/s00234-002-0825-8; Kanaan H, 2010, NEUROSURGERY, V67, P1523, DOI 10.1227/NEU.0b013e3181f8d194; Kanaan H, 2010, NEUROSURGERY, V67, P1532; Lavoie P, 2012, STROKE, V43, P740, DOI 10.1161/STROKEAHA.111.635300; Mine B, 2014, J NEURORADIOLOGY, V41, P322, DOI 10.1016/j.neurad.2014.01.001; Mizuki K, 2014, P JOINT ANN M INT SO; Mocco J, 2011, NEUROSURGERY, V69, P913; Schaafsma JD, 2010, RADIOLOGY, V256, P209, DOI 10.1148/radiol.10091528; Takayama K, 2011, J COMPUT ASSIST TOMO, V35, P568, DOI 10.1097/RCT.0b013e31822bd498; Wu HM, 2013, MAGN RESON MED, V69, P708, DOI 10.1002/mrm.24298	21	0	0	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	MAY	2015	36	5					967	970		10.3174/ajnr.A4199		4	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CI5VU	WOS:000354828700029		
J	Yuguchi, T; Sasao, E; Ishibashi, M; Nishiyama, T				Yuguchi, Takashi; Sasao, Eiji; Ishibashi, Masayuki; Nishiyama, Tadao			Hydrothermal chloritization processes from biotite in the Toki granite, Central Japan: Temporal variations of of the compositions of hydrothermal fluids associated with chloritization	AMERICAN MINERALOGIST			English	Article						Chloritization; fluorine-bearing biotite; hydrothermal fluid; tetrahedral aluminum in chlorite; singular value decomposition (SVD) analysis	METAMORPHIC MINERAL ASSEMBLAGES; CHLORITE; ROCKS; PLUTON; MODEL	This paper describes the biotite chloritization process with a focus on mass transfer in the Toki granitic pluton, Central Japan, and also depicts the temporal variations in chemical characteristics of hydrothermal fluid associated with chloritization during the sub-solidus cooling of the pluton. Singular value decomposition (SVD) analysis results in chloritization reaction equations for eight mineral assemblages, leading to the quantitative assessment of mass transfer between the reactant and product minerals, and inflow and outflow of components through the hydrothermal fluid. The matrices for SVD analysis consist of arbitrary combinations of molar volume and closure component in the reactant and product minerals. The eight reactions represent the temporal variations of chemical characteristics of the hydrothermal fluid associated with chloritization: the progress of chloritization results in gradual increase of silicon, potassium, and chlorine and gradual decrease of calcium and sodium in the hydrothermal fluid with temperature decrease. The biotite chloritization involves two essential formation mechanisms: chlorite formation (CF) mechanism 1, small volume decrease from biotite to chlorite and large inflow of metallic ions such as Al3+, Fe2+, Mn2+, and Mg2+ from the hydrothermal fluid, and CF mechanism 2, large volume decrease and large outflow of the metallic ions into hydrothermal fluid. Chlorite produced with CF mechanism 1 dominates over that of CF mechanism 2, resulting in the gradual decrease of the metallic components in the hydrothermal fluid with chloritization progress. The chloritization reactions also give the temporal variations in physicochemical parameter of the hydrothermal fluid: a gradual decrease of pH and a gradual increase of redox potential in the hydrothermal fluid as chloritization proceeds. The combination of continuous reactions based on compositional variations in chlorite together with corresponding continuous AV variations gives an indication of the temporal variations in rates of decreasing and increasing concentration of chemical components in the hydrothermal fluid associated with chloritization. The biotite chloritization and resultant temporal variations of chemical and physicochemical characteristics in hydrothermal fluid act as a trigger for the successive dissolution precipitation process of a granitic rock.	[Yuguchi, Takashi; Sasao, Eiji; Ishibashi, Masayuki] Japan Atom Energy Agcy, Sect Decommissioning & Radioact Waste Management, Geosci Res Dept, Mizunami Underground Res Lab, Gifu 5096132, Japan; [Nishiyama, Tadao] Kumamoto Univ, Grad Sch Sci & Technol, Sch Sci, Dept Earth & Environm Sci,Chuo Ku, Kumamoto 8608555, Japan	Yuguchi, T (reprint author), Japan Atom Energy Agcy, Sect Decommissioning & Radioact Waste Management, Geosci Res Dept, Mizunami Underground Res Lab, 1-64 Yamanouchi, Gifu 5096132, Japan.	yuguchi.takashi@jaea.go.jp					Adachi M., 1998, J METAMORPH GEOL, V16, P27; Amouric M., 1984, AM MINERAL, V69, P869; DECARITAT P, 1993, CLAY CLAY MINER, V41, P219, DOI 10.1346/CCMN.1993.0410210; Nishimoto S, 2010, LITHOS, V115, P153, DOI 10.1016/j.lithos.2009.11.015; Vidal O, 2001, AM J SCI, V301, P557, DOI 10.2475/ajs.301.6.557; NAKAJIMA T, 1994, LITHOS, V33, P51, DOI 10.1016/0024-4937(94)90053-1; KRANIDIOTIS P, 1987, ECON GEOL, V82, P1898; EGGLETON RA, 1985, AM MINERAL, V70, P902; CATHELINEAU M, 1988, CLAY MINER, V23, P471, DOI 10.1180/claymin.1988.023.4.13; CATHELINEAU M, 1985, CONTRIB MINERAL PETR, V91, P235, DOI 10.1007/BF00413350; FERRY JM, 1979, CONTRIB MINERAL PETR, V68, P125, DOI 10.1007/BF00371895; FISHER GW, 1989, CONTRIB MINERAL PETR, V102, P69, DOI 10.1007/BF01160191; FISHER GW, 1993, AM MINERAL, V78, P1257; GILKES RJ, 1979, CLAY CLAY MINER, V27, P349, DOI 10.1346/CCMN.1979.0270505; Gresens R. L., 1967, CHEM GEOL, V2, P47, DOI DOI 10.1016/0009-2541(67)90004-6; Hey M.H., 1954, MINERAL MAG, V30, P277, DOI DOI 10.1180/MINMAG.1954.030.224.01; Ishihara S., 2007, B GEOL SURV JPN, V58, P323; Ishihara S, 1969, REPORTS GEOLOGICAL S, V232, P113; Itoigawa J, 1974, B MIZUNAMI FOSSIL MU, V1, P9; Itoigawa J., 1980, MONOGR MIZUNAMI FOSS, V1, P1; Japan Nuclear Cycle Development Institute, 2000, TN74002003007 JNC TO; Japan Nuclear Cycle Development Institute, 2002, TN74102003001 JNC TO; Jowett EC, 1991, GAC MAC SEG JOINT AN, V16, pA62; Kogure T, 2000, AM MINERAL, V85, P1202; LANG HM, 1991, CAN MINERAL, V29, P655; Lang HM, 2004, AM MINERAL, V89, P20; Maeda H., 2008, J MMIJ, V124, P694, DOI 10.2473/journalofmmij.124.694; Nishimoto S., 2008, J JAPAN SOC ENG GEOL, V49, P94; PARNEIX JC, 1985, CHEM GEOL, V51, P89, DOI 10.1016/0009-2541(85)90089-0; PARRY WT, 1982, CLAY CLAY MINER, V30, P81, DOI 10.1346/CCMN.1982.0300201; POZZUOLI A, 1992, CLAY MINER, V27, P175, DOI 10.1180/claymin.1992.027.2.03; SANO H, 1992, PALAEOGEOGR PALAEOCL, V96, P41, DOI 10.1016/0031-0182(92)90058-D; SHIBATA K, 1979, GEOCHEM J, V13, P113; Shigeno M, 2012, EUR J MINERAL, V24, P289, DOI 10.1127/0935-1221/2012/0024-2195; SHIKAZONO N, 1987, CAN MINERAL, V25, P465; Sonehara T, 2007, J VOLCANOL GEOTH RES, V167, P57, DOI 10.1016/j.jvolgeores.2007.05.012; Suzuki K., 1998, J EARTH PLANETARY SC, V45, P17; Tadashi M., 1975, J JAPANESE ASS MINER, V70, P413; Todo Collaborative Research Group, 1999, EARTH SCI, V53, P291; Umeda K., 2012, JAPANESE MAGAZINE MI, V41, P39; VEBLEN DR, 1983, AM MINERAL, V68, P1160; WALSHE JL, 1986, ECON GEOL, V81, P681; WHITNEY DL, 1995, CONTRIB MINERAL PETR, V120, P404, DOI 10.1007/BF00306517; Wilamowski A, 2002, CHEM GEOL, V182, P529, DOI 10.1016/S0009-2541(01)00344-8; Yuguchi T, 2013, J MINER PETROL SCI, V108, P1, DOI 10.2465/jmps.120801b; Yuguchi T., 2010, JAPANESE MAGAZINE MI, V39, P50; Yuguchi T, 2011, AM MINERAL, V96, P308, DOI 10.2138/am.2011.3445; Yuguchi T, 2011, J MINER PETROL SCI, V106, P130, DOI 10.2465/jmps.100129b; Yuguchi T, 2011, J MINER PETROL SCI, V106, P61, DOI 10.2465/jmps.100129a; Yuguchi T, 2011, CONTRIB MINERAL PETR, V162, P1063, DOI 10.1007/s00410-011-0640-5	50	0	0	MINERALOGICAL SOC AMER	CHANTILLY	3635 CONCORDE PKWY STE 500, CHANTILLY, VA 20151-1125 USA	0003-004X	1945-3027		AM MINERAL	Am. Miner.	MAY-JUN	2015	100	5-6					1134	1152		10.2138/am-2015-5126		19	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	CI3RS	WOS:000354665700016		
J	Nakatsuka, A; Kuribayashi, S; Nakayama, N; Fukui, H; Arima, H; Yoneda, A; Yoshiasa, A				Nakatsuka, Akihiko; Kuribayashi, Shoichi; Nakayama, Noriaki; Fukui, Hiroshi; Arima, Hiroshi; Yoneda, Akira; Yoshiasa, Akira			Temperature dependence of crystal structure of CaGeO3 high-pressure perovskite phase and experimental determination of its Debye temperatures studied by low- and high-temperature single-crystal X-ray diffraction	AMERICAN MINERALOGIST			English	Article						CaGeO3; perovskite; single-crystal X-ray diffraction; phase transition; thermal expansion; Debye temperature; one particle potential	DARWIN TRANSFER EQUATIONS; MGSIO3 PEROVSKITE; GDFEO3-TYPE PEROVSKITES; SPHERICAL CRYSTALS; POWDER DIFFRACTION; CATIO3 PEROVSKITE; THERMAL-EXPANSION; HEAT-CAPACITY; TRANSITION; EXTINCTION	Single-crystal X-ray diffraction study of CaGeO3 perovskite has been conducted over the temperature range of 98 to 1048 K. The crystal begins to deteriorate at a temperature above about 900 K and completely amorphizes by 980 K. The diffraction-intensity distribution and the structure refinements indicate that the Pbnm structure is kept until the occurrence of amorphization. The obtained unit-cell parameters, unit-cell volumes, bond lengths, and displacement parameters increase monotonously with increasing temperature. Thus, no evidence for the existence of the Cmcm high-temperature phase, previously suggested above 520 K, is observed. The Ge-O bond lengths show much smaller thermal expansions than the Ca-O bond lengths; the former ranges between 0.42(2) x 10(-5) K-1 and 0.57(2) x 10(-5) K-1 and the latter between 1.58(4) x 10(-5) K-1 and 3.96(6) x 10(-5) K-1. The Debye temperatures and static disorder components for each constituent atom were determined by applying the Debye model to the temperature dependence of mean square displacements (MSDs) of the atoms. Consequently, no significant static disorder components can be detected in each atom. The Debye temperatures averaged over all directions, obtained from the Debye model fitting to Ue, yield the harmonic one particle potential coefficients of 4.76(2) eV angstrom(-2) for Ca, 11.0(1) eV angstrom(-2) for Ge, 5.02(2) eV angstrom(-2) for O1, and 5.33(5) eV angstrom(-2) for O2. These values become larger in order of Ca < O1 <O2 << Ge, which shows that the one particle potential of Ge is much narrower than that of Ca. This relationship between Ca and Ge is consistent reasonably with bonding stiffness expected from the thermal expansion coefficients of the bond lengths. The anisotropies of MSDs are remarkable in O1 and O2 atoms as a consequence of the strong interaction with adjacent Ge atoms, forming the rigid bonds with these O atoms. In comparison of the three Pbnm orthorhombic perovskites of CaGeO3, CaTiO3, and MgSiO3, all of these have the BO6 octahedra more rigid than the AO(12) polyhedra (A = Ca or Mg; B = Ge, Ti, or Si) and the tilt angles of BO6 octahedra are the largest in MgSiO3 perovskite. These observations indicate that if MgSiO(3)perovskite under high pressures undergoes the same sequence of the high-temperature phase transitions as CaTiO3 perovskite, the phase boundaries have positive Clapeyron slopes and the phase transition temperatures should become further much higher than those (1512K for the Pbnm to I4/mcm transition and 1635 K for the I4/mcm to Pm (3) over barm transition) observed in CaTiO3 perovskite at ambient pressure. This leads to the conclusion that the high-temperature phase transition to a perovskite phase with different symmetry under high pressures previously suggested in MgSiO3 perovskite is unlikely.	[Nakatsuka, Akihiko; Kuribayashi, Shoichi; Nakayama, Noriaki] Yamaguchi Univ, Grad Sch Sci & Engn, Ube, Yamaguchi 7558611, Japan; [Fukui, Hiroshi] Univ Hyogo, Grad Sch Mat Sci, Ako 6781297, Japan; [Arima, Hiroshi] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Yoneda, Akira] Okayama Univ, Inst Study Earths Interior, Misasa, Tottori 6820193, Japan; [Yoshiasa, Akira] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan	Nakatsuka, A (reprint author), Yamaguchi Univ, Grad Sch Sci & Engn, Ube, Yamaguchi 7558611, Japan.	tuka@yamaguchi-u.ac.jp			Photon Factory BL-10A, High Energy Accelerator Research Organization, Tsukuba, Japan [2010G608]	This work was partly performed under the research project (no. 2010G608) at Photon Factory BL-10A, High Energy Accelerator Research Organization, Tsukuba, Japan. We thank H. Tsukamoto, K. Tsutsui, and Y. Ueno of Yamaguchi University for their experimental assistance.	Kennedy BJ, 1999, J PHYS-CONDENS MAT, V11, P1479, DOI 10.1088/0953-8984/11/6/012; ALLMANN R, 1975, MONATSH CHEM, V106, P779, DOI 10.1007/BF00902183; BECKER PJ, 1974, ACTA CRYSTALLOGR A, VA 30, P129, DOI 10.1107/S0567739474000337; Wang D, 2011, ACTA CRYSTALLOGR B, V67, P302, DOI 10.1107/S0108768111018313; MCMILLAN P, 1988, PHYS CHEM MINER, V16, P21; Ali R, 2005, J SOLID STATE CHEM, V178, P2867, DOI 10.1016/j.jssc.2005.06.027; ANDERSON OL, 1966, PHYS REV, V144, P553, DOI 10.1103/PhysRev.144.553; LIU X, 1993, PHYS CHEM MINER, V20, P171; Campbell BJ, 2006, J APPL CRYSTALLOGR, V39, P607, DOI 10.1107/S0021889806014075607; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; Dekura H, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.025904; Yashima M, 2009, SOLID STATE IONICS, V180, P120, DOI 10.1016/j.ssi.2008.11.019; Zhao J, 2004, ACTA CRYSTALLOGR B, V60, P263, DOI 10.1107/S0108768104004276; BROWN ID, 1985, ACTA CRYSTALLOGR B, V41, P244, DOI 10.1107/S0108768185002063; TOKONAMI M, 1965, ACTA CRYSTALLOGR, V19, P486, DOI 10.1107/S0365110X65003729; Tsuchiya T, 2004, EARTH PLANET SC LETT, V224, P241, DOI 10.1016/j.epsl.2004.05.017; SUSAKI J, 1985, GEOPHYS RES LETT, V12, P729, DOI 10.1029/GL012i010p00729; Angel RJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.025503; GLAZER AM, 1975, ACTA CRYSTALLOGR A, V31, P756, DOI 10.1107/S0567739475001635; SASAKI S, 1983, AM MINERAL, V68, P1189; BECKER PJ, 1974, ACTA CRYSTALLOGR A, VA 30, P148, DOI 10.1107/S0567739474000349; DURBEN DJ, 1991, PHYS CHEM MINER, V18, P215; Fei Y., 1995, AGU REFERENCE SHELF, P29; GLAZER AM, 1972, ACTA CRYSTALLOGR B, VB 28, P3384, DOI 10.1107/S0567740872007976; GUYOT F, 1993, PHYS CHEM MINER, V20, P141; HORIUCHI H, 1987, AM MINERAL, V72, P357; KUDOH Y, 1987, PHYS CHEM MINER, V14, P350, DOI 10.1007/BF00309809; Liu W, 2008, AM MINERAL, V93, P745, DOI 10.2138/am.2008.2428; Liu W, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.024107; LIU X, 1991, PHYS CHEM MINER, V18, P224; MADON M, 1989, PHYS CHEM MINER, V16, P320; Nakatsuka A, 2011, AM MINERAL, V96, P1593, DOI 10.2138/am.2011.3714; PREWITT CT, 1969, SCIENCE, V163, P386, DOI 10.1126/science.163.3865.386; RINGWOOD AE, 1967, EARTH PLANET SC LETT, V2, P106, DOI 10.1016/0012-821X(67)90109-4; ROSS NL, 1989, PHYS CHEM MINER, V16, P415; Sasaki S., 1987, RADY FORTRAN PROGRAM; Shim SH, 2001, SCIENCE, V293, P2437, DOI 10.1126/science.1061235; Sugahara M, 2006, AM MINERAL, V91, P533, DOI 10.2138/am.2006.1980; Suzuki I., 1979, J PHYS EARTH, V27, P63; WANG YB, 1991, SCIENCE, V251, P410, DOI 10.1126/science.251.4992.410; Wentzcovitch R. M., 2004, PHYS REV LETT, V92; Willis B. T. M., 1975, THERMAL VIBRATIONS C; Wilson A. J. C., 1992, INT TABLES CRYSTALLO; Yoshiasa A, 2005, Z ANORG ALLG CHEM, V631, P502, DOI 10.1002/zaac.200400358	44	0	0	MINERALOGICAL SOC AMER	CHANTILLY	3635 CONCORDE PKWY STE 500, CHANTILLY, VA 20151-1125 USA	0003-004X	1945-3027		AM MINERAL	Am. Miner.	MAY-JUN	2015	100	5-6					1190	1202		10.2138/am-2015-4945		13	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	CI3RS	WOS:000354665700021		
J	Kaneko, S; Miyahara, M; Ohtani, E; Arai, T; Hirao, N; Sato, K				Kaneko, Shohei; Miyahara, Masaaki; Ohtani, Eiji; Arai, Tomoko; Hirao, Naohisa; Sato, Kazuhisa			Discovery of stishovite in Apollo 15299 sample	AMERICAN MINERALOGIST			English	Article						Apollo; stishovite; Imbrium impact; Procellarum terrane	SHOCKED LUNAR METEORITE; HIGH-PRESSURE; COESITE; SURFACE; SIO2	High-pressure polymorphs recovered in terrestrial craters are evidence of meteoroid impact events on the Earth's surface. Despite countless impact craters on the Moon, high-pressure polymorphs have not been reported to date in returned Apollo samples. On the other hand, recent studies report that the high-pressure polymorphs of silica, coesite, and stishovite occur in shocked lunar meteorites. We investigated regolith breccia 15299, which was returned by the Apollo 15 mission, using the combined techniques of focused ion beam (FIB), synchrotron X-ray diffraction (XRD), and transmission electron microscopy (TEM). The regolith breccia 15299 studied here consists of a mafic impact melt breccia with millimeter-sized, coarse-grained, low-Ti basalt clasts. The mafic melt breccia consists of fragments of minerals (olivine, pyroxene, plagioclase, silica, and ilmenite) and glass. Several quartz, tridymite, and cristobalite grains of 10-100 mu m across occur in the mafic impact melt breccia. Vesicular melt veins of less than similar to 200 mu m wide cut across the mafic melt breccia matrix and mineral fragments. Some silica grains are entrained in the melt veins. One of the silica grains entrained in the melt veins consist of stishovite [a = 4.190(1), c = 2.674(1) angstrom, V = 46.95 angstrom(3), space group P4(2)/mnm] along with tridymite and silica glass. This is the first report of high-pressure polymorphs from returned lunar samples. TEM images show that the stishovite is needle-like in habit, and up to similar to 400 nm in size. Considering the lithologies and shock features of 15299, it is inferred that the stishovite possibly formed by the Imbrium impact or subsequent local impact event(s) in the Procellarum KREEP Terrane (PKT) of the nearside of the Moon.	[Kaneko, Shohei; Miyahara, Masaaki; Ohtani, Eiji] Tohoku Univ, Grad Sch Sci, Dept Earth & Planetary Mat Sci, Sendai, Miyagi 9808578, Japan; [Miyahara, Masaaki] Hiroshima Univ, Grad Sch Sci, Dept Earth & Planetary Syst Sci, Higashihiroshima 7398526, Japan; [Ohtani, Eiji] Russian Acad Sci, Siberian Branch, VS Sobolev Inst Geol & Mineral, Novosibirsk 630090, Russia; [Arai, Tomoko] Chiba Inst Technol, Planetary Explorat Res Ctr, Chiba 2750016, Japan; [Hirao, Naohisa] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan; [Sato, Kazuhisa] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan	Miyahara, M (reprint author), Tohoku Univ, Grad Sch Sci, Dept Earth & Planetary Mat Sci, Sendai, Miyagi 9808578, Japan.	miyahara@hiroshima-u.ac.jp	Sato, Kazuhisa/C-1510-2011	Sato, Kazuhisa/0000-0001-9078-2541	MEXT [22000002, 26800277]; Ministry of Education and Science of Russian Federation [14.B25.31.0032]; Nanotechnology Platform Program of the MEXT, Japan	We are grateful to the Johnson Space Center of NASA for providing us a chance to study Apollo samples. We thank Sasaki S. for useful discussion about a dynamic event on the Moon. This study was supported by a grant-in-aid for Scientific Research, No. 22000002 and No. 26800277 by MEXT to E.O. and MM., respectively. This work was partly supported by the Ministry of Education and Science of Russian Federation, Project No 14.B25.31.0032 and by the Nanotechnology Platform Program of the MEXT, Japan. Synchrotron X-ray diffraction analyses of the samples were made with the approval nos. 2011A0028, 2011B0028, 2012A0028, 2012B1062, 2013A1496, 2013B0104, and 2014A0104. This work was conducted as a part of Tohoku University's Global COE program entitled "Global Education and Research Center for Earth and Planetary Dynamics." Two anonymous reviewers and Ian Swainson improved an earlier version of this manuscript.	AKAOGI M, 1984, PHYS EARTH PLANET IN, V36, P124, DOI 10.1016/0031-9201(84)90013-X; Ohtani E, 2011, P NATL ACAD SCI USA, V108, P463, DOI 10.1073/pnas.1009338108; CHAO ECT, 1962, J GEOPHYS RES, V67, P419, DOI 10.1029/JZ067i001p00419; MARTINI JEJ, 1978, NATURE, V272, P715, DOI 10.1038/272715a0; Langenhorst F, 2000, EARTH PLANET SC LETT, V184, P37, DOI 10.1016/S0012-821X(00)00317-4; ZHANG JZ, 1993, J GEOPHYS RES-SOL EA, V98, P19785, DOI 10.1029/93JB02218; Jolliff BL, 2000, J GEOPHYS RES-PLANET, V105, P4197, DOI 10.1029/1999JE001103; Beck P, 2004, EARTH PLANET SC LETT, V219, P1, DOI 10.1016/S0012-821X(03)00695-2; Biren M. B., 2013, EARTH PLANET SC LETT, V303, P310; El Goresy A, 2013, GEOCHIM COSMOCHIM AC, V101, P233, DOI 10.1016/j.gca.2012.10.002; McKay D. S., 1983, P 14 LUN SCI C, P481; McKay D. S., 1989, P 19 LUN PLAN SCI C, P19; Miyahara M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2733; Miyahara M, 2014, P NATL ACAD SCI USA, V111, P10939, DOI [10.1073/pnas.1404247111, 10.1073/pnas.1404247111/-/DCSupplemental]; Norman MD, 2010, GEOCHIM COSMOCHIM AC, V74, P763, DOI 10.1016/j.gca.2009.10.024; Papike J.J., 1991, LUNAR SOURCEBOOK, P121; Statile V., 2008, CONTRIB MINERAL PETR, V155, P457; Swann G. A., 1972, SP289 NASA REP; Taylor S. R., 1973, GEOCHIM COSM SUPPL, V2, P1445	19	0	0	MINERALOGICAL SOC AMER	CHANTILLY	3635 CONCORDE PKWY STE 500, CHANTILLY, VA 20151-1125 USA	0003-004X	1945-3027		AM MINERAL	Am. Miner.	MAY-JUN	2015	100	5-6					1308	1311		10.2138/am-2015-5290		4	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	CI3RS	WOS:000354665700032		
J	Fujii, T; Yajima, R; Morita, H; Hirakata, T; Miyamoto, T; Fujisawa, T; Tsutsumi, S; Ynagita, Y; Iijima, M; Kuwano, H				Fujii, Takaaki; Yajima, Reina; Morita, Hiroki; Hirakata, Tomoko; Miyamoto, Takeshi; Fujisawa, Tomomi; Tsutsumi, Soichi; Ynagita, Yasuhiro; Iijima, Misa; Kuwano, Hiroyuki			Impact of Vascular Invasion of a Primary Tumor as a Strong Risk Factor for Disease Recurrence in Patients with Node-Positive Breast Cancer	AMERICAN SURGEON			English	Article							BLOOD-VESSEL INVASION; LYMPHOVASCULAR INVASION; GALECTIN-3 EXPRESSION; PROGNOSTIC VALUE; CLINICAL-TRIALS; METASTASIS; CARCINOMA	The presence of lymph node metastasis is considered to be the most significant indicator of prognosis. However, in some cases with node-positive breast cancer, cancer cell dissemination is localized to the lymphatic systems. It is, therefore, important to develop selection criteria for strong adjuvant therapy in patients with node-positive breast cancer. This study was undertaken to evaluate the presence of vascular invasion that may reflect systemic disease as a predictor of disease recurrence in node-positive breast cancer. We retrospectively evaluated the cases of 134 consecutive female patients with breast cancer with lymph node metastasis who underwent radical breast operations. We examined the relationship between recurrence and clinicopathological factors, particularly vascular invasion. The presence of vascular invasion was found to be significant in a univariate analysis. The presence of vascular invasion was the independent risk factor in a multivariate analysis. Among the 66 patients without vascular invasion, four (6.1%) had disease recurrence. On the other hand, among the 68 patients with vascular invasion, 15 (22.1%) had a recurrence. It is interesting to note that despite the presence of lymph node metastasis, the group without vascular invasion had few patients with distant metastases. Our results suggest that the presence of vascular invasion could be an indicator of high biological aggressiveness and may be a strong prognostic factor for node-positive breast cancer.	[Fujii, Takaaki; Yajima, Reina; Morita, Hiroki; Tsutsumi, Soichi; Kuwano, Hiroyuki] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gumma 3718511, Japan; [Hirakata, Tomoko; Miyamoto, Takeshi; Fujisawa, Tomomi; Ynagita, Yasuhiro] Gunma Prefectural Canc Ctr, Dept Breast Oncol, Ota, Gunma, Japan; [Iijima, Misa] Gunma Prefectural Canc Ctr, Dept Pathol, Ota, Gunma, Japan	Fujii, T (reprint author), Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	taka.jifu@gmail.com			Japanese Ministry of Education, Culture, Sports, Science, and Technology	We thank Saitoh Y, Yano T, Matsui Y, Ishida A, and Ishikubo A for their secretarial assistance. This work was supported in part by Grants-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (TF).	Achen MG, 2009, ANN NY ACAD SCI, V1131, P225; Taghian A, 2004, J CLIN ONCOL, V22, P4247, DOI 10.1200/JCO.2004.01.042; Rakha EA, 2012, CANCER-AM CANCER SOC, V118, P3670, DOI 10.1002/cncr.26711; Fujii T, 2014, ANTICANCER RES, V34, P1255; Lee AHS, 2006, EUR J CANCER, V42, P357, DOI 10.1016/j.ejca.2005.10.021; Braun M, 2008, BREAST CANCER RES TR, V112, P503, DOI 10.1007/s10549-007-9875-2; Colleoni M, 2007, ANN ONCOL, V18, P1632, DOI 10.1093/annonc/mdm268; Cornwell LB, 2011, AM SURGEON, V77, P874; Tsuboi K, 2007, ANTICANCER RES, V27, P2289; DAVIS BW, 1985, HUM PATHOL, V16, P1212, DOI 10.1016/S0046-8177(85)80033-2; Ejlertsen B, 2009, J NATL CANCER I, V101, P729, DOI 10.1093/jnci/djp090; Fujii T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-216; Fujii T, 2010, WORLD J SURG, V34, P544, DOI 10.1007/s00268-009-0389-4; LAURIA R, 1995, CANCER, V76, P1772, DOI 10.1002/1097-0142(19951115)76:10<1772::AID-CNCR2820761014>3.0.CO;2-O; LEE AKC, 1990, J CLIN ONCOL, V8, P1457; Okada K, 2006, ANTICANCER RES, V26, P1369; Royton D, 2009, J PATHOL, V217, P608; Song YJ, 2011, J BREAST CANCER, V14, P198, DOI 10.4048/jbc.2011.14.3.198; Sundquist M, 2000, EUR J SURG ONCOL, V26, P357, DOI 10.1053/ejso.1999.0898; Woo CS, 2002, AM J SURG, V184, P337, DOI 10.1016/S0002-9610(02)00950-9; Woodward WA, 2003, J CLIN ONCOL, V21, P3244, DOI 10.1200/JCO.2003.03.052; Yamaki S, 2013, SURG TODAY, V43, P901, DOI 10.1007/s00595-012-0378-3	22	0	0	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	MAY	2015	81	5					523	526				4	Surgery	Surgery	CI6TS	WOS:000354895700037		
J	Takasugi, N; Goto, H; Kuwahara, T; Verrier, RL				Takasugi, Nobuhiro; Goto, Hiroko; Kuwahara, Takashi; Verrier, Richard L.			Sudden Paradoxical QT-Interval Prolongation Exacerbating T-Wave Alternans in a Patient with Type 3 Long QT Syndrome	ANNALS OF NONINVASIVE ELECTROCARDIOLOGY			English	Article						congenital long QT syndrome; QT interval; RR interval; T-wave alternans		We report a case with type 3 congenital long QT syndrome, who exhibited a sudden paradoxical QT-interval prolongation during a progressive increase in heart rate, which exacerbated T-wave alternans.	[Takasugi, Nobuhiro] Gifu Univ Hosp, Gifu 5011194, Japan; [Goto, Hiroko; Kuwahara, Takashi] Gifu Prefectural Gen Med Ctr, Gifu, Japan; [Verrier, Richard L.] Harvard Univ, Sch Med, Boston, MA USA; [Verrier, Richard L.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Takasugi, N (reprint author), Gifu Univ Hosp, Div Cardiovasc Med, 1-1 Yanagido, Gifu 5011194, Japan.	konezumi@ccn3.aitai.ne.jp					Goto H, 2013, J CARDIOVASC ELECTR, V24, P1183, DOI 10.1111/jce.12169; Goto H, 2014, J CARDIOVASC ELECTR, V25, P657, DOI 10.1111/jce.12354; ROSENBAUM MB, 1991, J AM COLL CARDIOL, V18, P1363	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1082-720X	1542-474X		ANN NONINVAS ELECTRO	Ann. Noninvasive Electrocardiol.	MAY	2015	20	3					290	291		10.1111/anec.12188		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CI6NU	WOS:000354877600009		
J	Kuma, S; Ishida, M; Nakamura, Y; Okazaki, J				Kuma, Sosei; Ishida, Masaru; Nakamura, Yoshitaka; Okazaki, Jin			Prearterial External Iliac Vein as a Rare Anomaly of the Iliac Vein	ANNALS OF VASCULAR SURGERY			English	Article							AORTOILIAC SURGERY	The coexistence of a retroperitoneal venous anomaly requires special consideration during open aortoiliac surgery. Anomalies of the external iliac vein are rare, and no anomalies of the right external iliac vein, which passes ventral to the external iliac artery, have been reported in the English literature to the best of our knowledge. We herein report the first case of Leriche syndrome combined with a prearterial external iliac vein treated with bypass surgery and a synthetic bifurcated graft.	[Kuma, Sosei; Ishida, Masaru; Okazaki, Jin] Kokura Mem Hosp, Dept Vasc Surg, Kitakyushu, Fukuoka 8028555, Japan; [Nakamura, Yoshitaka] Kokura Mem Hosp, Dept Radiol Technol, Kitakyushu, Fukuoka 8028555, Japan	Kuma, S (reprint author), Kokura Mem Hosp, Dept Vasc Surg, Kokurakita Ku, 3-2-1 Asano, Kitakyushu, Fukuoka 8028555, Japan.	kumasosei@yahoo.co.jp		Kuma, Sosei/0000-0001-7291-2912			Aljabri B, 2001, ANN VASC SURG, V15, P615, DOI 10.1007/s10016-001-0095-7; BALDRIDGE ED, 1987, ARCH SURG-CHICAGO, V122, P1184; EDWARDS EDWARD A., 1951, ANGIOLOGY, V2, P85, DOI 10.1177/000331975100200201; Lee BB, 2012, PHLEBOLYMPHOLOGY, V19, P170; LOTZ PR, 1982, AM J ROENTGENOL, V138, P735; OHARA PJ, 1993, J VASC SURG, V17, P940; Saxena AK, 2009, PEDIATR RADIOL, V39, P1242, DOI 10.1007/s00247-009-1366-7; Shin M, 2014, SURG RADIOL ANAT; Shindo S, 2000, ANN VASC SURG, V14, P393, DOI 10.1007/s100169910071; Yahyayev A, 2013, PHLEBOLOGY, V28, P162, DOI 10.1258/phleb.2011.011080	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0890-5096	1615-5947		ANN VASC SURG	Ann. Vasc. Surg.	MAY	2015	29	4								10.1016/j.avsg.2014.09.036		3	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CH6DD	WOS:000354125300030		
J	Murakami, T; Kawatani, Y; Nakamura, Y; Hori, T				Murakami, Takashi; Kawatani, Yohei; Nakamura, Yoshitsugu; Hori, Takaki			Transapical Endovascular Aortic Aneurysm Repair in a Patient with Shaggy Aorta Syndrome	ANNALS OF VASCULAR SURGERY			English	Article							STENT-GRAFT; DEPLOYMENT	We report a case of a 68-year-old man with a large saccular aneurysm (70 mm) of the aortic arch. Although abundant atherosclerotic plaques or mural thrombi are generally considered to be a contraindication for endovascular repair, the patient's multiple comorbidities and anatomic limitations with a patent internal thoracic artery graft adjacent to the aneurysm made him unfit for open repair. Transapical deployment of the endograft through the less-diseased ascending aorta, with a concomitant chimney graft and carotidecarotid bypass, was performed, without evident stroke or embolism.	[Murakami, Takashi] Osaka City Univ, Dept Cardiovasc Surg, Grad Sch Med, Osaka 5458585, Japan; [Kawatani, Yohei; Nakamura, Yoshitsugu; Hori, Takaki] Chibanishi Gen Hosp, Dept Cardiovasc Surg, Chiba, Japan	Murakami, T (reprint author), Osaka City Univ, Dept Cardiovasc Surg, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	takashimurakami24@hotmail.com					Kolbel T, 2013, ANN THORAC SURG, V95, P694, DOI 10.1016/j.athoracsur.2012.06.055; Szeto WY, 2010, ANN THORAC SURG, V89, P616, DOI 10.1016/j.athoracsur.2009.06.090; Murphy EH, 2012, ANN VASC SURG, V26, P55, DOI 10.1016/j.avsg.2011.08.009; Kappert U, 2012, ANN THORAC SURG, V93, P2063, DOI 10.1016/j.athoracsur.2011.10.069; Uthoff H, 2012, ANN THORAC SURG, V93, P1735, DOI 10.1016/j.athoracsur.2011.12.004; MacDonald S, 2009, J VASC SURG, V49, P759, DOI 10.1016/j.jvs.2008.09.045; Kazmier F J, 1993, Heart Dis Stroke, V2, P131; Shiiya N, 2001, ANN THORAC SURG, V72, P401	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0890-5096	1615-5947		ANN VASC SURG	Ann. Vasc. Surg.	MAY	2015	29	4								10.1016/j.avsg.2014.11.017		3	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CH6DD	WOS:000354125300040		
J	Suetsugu, A; Snyder, CS; Moriwaki, H; Saji, S; Bouvet, M; Hoffman, RM				Suetsugu, Atsushi; Snyder, Cynthia S.; Moriwaki, Hisataka; Saji, Shigetoyo; Bouvet, Michael; Hoffman, Robert M.			Imaging the Interaction of Pancreatic Cancer and Stellate Cells in the Tumor Microenvironment during Metastasis	ANTICANCER RESEARCH			English	Article						Pancreatic cancer; dual color cells; GFP; RFP; stellate cells; interaction; CFP nude mouse; color-coded fluorescence imaging	FLUORESCENT-PROTEIN EXPRESSION; NUDE-MOUSE; IN-VIVO; FIBROBLASTS; GROWTH; HOST; IDENTIFICATION; ANGIOGENESIS; MACROPHAGES; DYNAMICS	Background/Aim: Pancreatic stellate cells are involved in fibrosis of pancreatic cancer termed desmoplasia, which may contribute to both pancreatic cancer growth and metastasis, as well as to drug resistance. A better understanding of pancreatic cancer-cell interactions with stellate cells is therefore critical to our ability to develop effective anti-metastatic therapeutics for pancreatic cancer. Materials and Methods: The human pancreatic cancer cell line XPA-1 was engineered to express green fluorescent protein (GFP) in the nucleus and red fluorescent protein (RFP) in the cytoplasm. Pancreatic stellate cells were engineered to express RFP. The pancreatic cancer cells and stellate cells were co-cultured and their interaction was imaged in vitro. The pancreatic cancer cells and stellate cells were then co-injected in the spleen of transgenic cyan fluorescent protein (CFP) nude mice and imaged in liver, lung and diaphragm metastasis. Results: The interaction of the pancreatic cancer cells expressing GFP in the nucleus and RFP in the cytoplasm and stellate cells expressing RFP was first imaged in vitro. The intimate relationship between the two cell types could be seen. Three hours after splenic co-injection, dual-color pancreatic cancer cells and pancreatic stellate cells were found distributed in the host liver. By 28 days after splenic co-injection of the pancreatic cancer and stellate cells, liver metastases were observed in host CFP nude mice. Metastases were also observed in the lung and diaphragm. Stellate cells were observed along with the pancreatic cancer cells at all metastatic sites suggesting that stellate cells may be necessary for metastasis. With high-resolution intravital imaging afforded by the Olympus FV1000 confocal microscope, the interaction of the dual-colored pancreatic cancer cells and the RFP-expressing pancreatic stellate cells could be clearly imaged in the liver and other metastases, further suggesting that stellate cells participate in metastasis formation. Conclusion: Pancreatic cancer cells and stellate stem cells form a very close relationship and accompany each other to distant metastatic sties. Our hypothesis is that pancreatic stellate cells form a niche for metastasis of pancreatic cancer.	[Suetsugu, Atsushi; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA 92111 USA; [Suetsugu, Atsushi; Snyder, Cynthia S.; Bouvet, Michael; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Suetsugu, Atsushi; Moriwaki, Hisataka; Saji, Shigetoyo] Gifu Univ, Grad Sch Med, Gifu, Japan	Hoffman, RM (reprint author), AntiCancer Inc, 7917 Ostrow St, San Diego, CA 92111 USA.	all@anticancer.com			National Cancer Institute [CA132971]	This study was supported in part by National Cancer Institute grant CA132971.	Uchugonova A, 2011, J CELL BIOCHEM, V112, P2046, DOI 10.1002/jcb.23122; Hoffman RM, 2006, NAT PROTOC, V1, P775, DOI 10.1038/nprot.2006.109; Yamamoto N, 2004, CANCER RES, V64, P4251, DOI 10.1158/0008-5472.CAN-04-0643; FOLKMAN J, 1986, CANCER RES, V46, P467; Suetsugu A, 2012, ANTICANCER RES, V32, P31; Anderberg C, 2009, CELL CYCLE, V8, P1461; Ostman A, 2009, CURR OPIN GENET DEV, V19, P67, DOI 10.1016/j.gde.2009.01.003; Bouvet M, 2006, CANCER RES, V66, P11293, DOI 10.1158/0008-5472.CAN-06-2662; Bachem MG, 2008, LANGENBECK ARCH SURG, V393, P891, DOI 10.1007/s00423-008-0279-5; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Suetsugu A, 2011, J CELL BIOCHEM, V112, P949, DOI 10.1002/jcb.23011; Menen RS, 2012, IN VIVO, V26, P565; Xu ZH, 2010, AM J PATHOL, V177, P2585, DOI 10.2353/ajpath.2010.090899; Yang M, 2004, CANCER RES, V64, P8651, DOI 10.1158/0008-5472.CAN-04-3118; Egeblad M, 2008, DIS MODEL MECH, V1, P155, DOI 10.1242/dmm.000596; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Duda DG, 2010, P NATL ACAD SCI USA, V107, P21677, DOI 10.1073/pnas.1016234107; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Yang M, 2003, P NATL ACAD SCI USA, V100, P14259, DOI 10.1073/pnas.2436101100; Kimura H, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3526356; Apte MV, 1998, GUT, V43, P128; Lu J, 2014, BRIT J CANCER, V110, P409, DOI 10.1038/bjc.2013.706; Yang M, 2009, J CELL BIOCHEM, V106, P279, DOI 10.1002/jcb.21999; Rasanen K, 2010, EXP CELL RES, V316, P2713, DOI 10.1016/j.yexcr.2010.04.032; Schneiderhan W, 2007, J CELL SCI, V120, P512, DOI 10.1242/jcs.03347; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; FOLKMAN J, 1990, J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Hiroshima Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103382; Nyberg P, 2008, FRONT BIOSCI, V13, P6537, DOI 10.2741/3173; Tran Cao Hop S, 2009, JOP, V10, P152; Tran Cao Hop S, 2009, J Cell Biochem, V107, P328, DOI 10.1002/jcb.22128	38	2	2	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAY	2015	35	5					2545	2551				7	Oncology	Oncology	CH8DU	WOS:000354267200009		
J	Suetsugu, A; Jiang, P; Yang, M; Yamamoto, N; Moriwaki, H; Saji, S; Hoffman, RM				Suetsugu, Atsushi; Jiang, Ping; Yang, Meng; Yamamoto, Norio; Moriwaki, Hisataka; Saji, Shigetoyo; Hoffman, Robert M.			The Use of Living Cancer Cells Expressing Green Fluorescent Protein in the Nucleus and Red Fluorescence Protein in the Cytoplasm for Real-time Confocal Imaging of Chromosome and Cytoplasmic Dynamics During Mitosis	ANTICANCER RESEARCH			English	Article						Cancer cells; GFP; histone-H2B; fusion; nuclear labeling; RFP; retrovirus; cytoplasmic labeling; mitosis; chromosomes	LIVE MICE; IN-VIVO; CELLULAR-DYNAMICS; TUMOR-CELLS; DEFORMATION; BRAIN; MOUSE; GFP; TRAFFICKING; METASTASIS	Background/Aim: A library of dual-color fluorescent cancer cells with green fluorescent protein (GFP), linked to histone H2B, expressed in the nucleus and red fluorescent protein (RFP) expressed in the cytoplasm was previously genetically engineered. The aim of the current study was to use the dual-color cancer cells to visualize chromosome and cytoplasmic dynamics during mitosis. Materials and Methods: Using an Olympus FV1000 confocal microscope, a library of dual-color cells from the major cancer types was cultured on plastic. The cells were imaged by confocal microscopy to demonstrate chromosome and cytoplasmic dynamics during mitosis. Results: Nuclear GFP expression enabled visualization of chromosomes behavior, whereas simultaneous cytoplasmic RFP expression enabled visualization of cytoplasmic behavior during mitosis. Thus, total cellular dynamics can be visualized at high resolution, including individual chromosomes in some cases, in living dual-color cells in real time. Conclusion: Dual-color cancer cells expressing H2B-GFP in the nucleus and RFP in the cytoplasm provide unique tools for visualizing subcellular nuclear and cytoplasm dynamics, including the behavior of individual chromosomes during mitosis. The dual-color cells can be used to evaluate chromosomal loss or gain in real time during treatment with a variety of agents or as the cells are selected for increased or decreased malignancy in culture or in vivo. The dual color cells will be a useful tool to discover and evaluate novel strategies for killing cancer cells.	[Suetsugu, Atsushi; Jiang, Ping; Yang, Meng; Yamamoto, Norio; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA 92111 USA; [Suetsugu, Atsushi; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Suetsugu, Atsushi; Moriwaki, Hisataka; Saji, Shigetoyo] Gifu Univ, Grad Sch Med, Dept Gastroenterol, Gifu, Japan; [Yang, Meng] AntiCanc Biotech Beijing Co Ltd, Beijing, Peoples R China; [Yamamoto, Norio] Kanazawa Univ, Dept Community Tramatol & Orthopaed, Kanazawa, Ishikawa, Japan	Hoffman, RM (reprint author), AntiCancer Inc, 7917 Ostrow St, San Diego, CA 92111 USA.	all@anticancer.com					Amoh Y, 2012, J CELL BIOCHEM, V113, P465, DOI 10.1002/jcb.23370; Hoffman RM, 2006, NAT PROTOC, V1, P775, DOI 10.1038/nprot.2006.109; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Kimura H, 2010, J CELL BIOCHEM, V109, P58, DOI 10.1002/jcb.22379; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Yamamoto N, 2004, CANCER RES, V64, P4251, DOI 10.1158/0008-5472.CAN-04-0643; Hayashi K, 2007, CANCER RES, V67, P8223, DOI 10.1158/0008-5472.CAN-07-1237; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927; Zhao M, 2005, P NATL ACAD SCI USA, V102, P755, DOI 10.1073/pnas.0408422102; Bouvet M, 2006, CANCER RES, V66, P11293, DOI 10.1158/0008-5472.CAN-06-2662; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Yang M, 2007, CANCER RES, V67, P5195, DOI 10.1158/0008-5472.CAN-06-4590; Tsuji K, 2006, CANCER RES, V66, P303, DOI 10.1158/0008-5472.CAN-05-2958; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; Momiyama M, 2013, J CELL BIOCHEM, V114, P428, DOI 10.1002/jcb.24381; Momiyama M, 2013, ANTICANCER RES, V33, P1367; Yang M, 2003, P NATL ACAD SCI USA, V100, P14259, DOI 10.1073/pnas.2436101100; Hayashi K, 2011, ANTICANCER RES, V31, P3665; Hiroshima Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103382; Hu MX, 2012, ANTICANCER RES, V32, P2509; Jiang P, 2006, CELL CYCLE, V5, P1198, DOI 10.4161/cc.5.11.2795; Momiyama M, 2013, ANTICANCER RES, V33, P103; Yamauchi K, 2005, CANCER RES, V65, P4246, DOI 10.1158/0008-5472.CAN-05-0069; Yamauchi K, 2012, ANTICANCER RES, V32, P39	26	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAY	2015	35	5					2553	2557				5	Oncology	Oncology	CH8DU	WOS:000354267200010		
J	Saeki, N; Ono, H; Sakamoto, H; Yoshida, T				Saeki, Norihisa; Ono, Hiroe; Sakamoto, Hiromi; Yoshida, Teruhiko			Down-regulation of Immune-related Genes by PSCA in Gallbladder Cancer Cells Implanted into Mice	ANTICANCER RESEARCH			English	Article						Prostate stem cell antigen; GPI-anchored protein; intracellular signaling; gallbladder cancer; tumor suppressor	LIPOCALIN 2; GASTRIC-CARCINOMA; PROSTATE-CANCER; ANTIGEN; EXPRESSION; PROTEIN; TUMORS; ESTABLISHMENT; PROGRESSION; METASTASIS	Background/Aim: In previous work, we found that prostate stem cell antigen (PSCA) gene, encoding a glycosylphosphatidylinositol-anchored protein, is a presumable tumor suppressor in gastric cancer and gallbladder cancer (GBC). The introduction of PSCA cDNA into GBC cell lines significantly suppressed tumorigenecity of cells in mice. The PSCA protein is thought to be involved in some form of intracellular signaling that remains to be elucidated. Materials and Methods: Using microarrays, we conducted gene-expression profiling on tumors generated by a GBC cell line TGBC-1TKB, with and without expression of PSCA, which was implanted into mice. Genes whose expression was down-regulated by PSCA were selected, and their down-regulation was confirmed by real-time PCR. Results: We identified several immune-related genes down-regulated by PSCA, including interleukin 8 (IL8), IL1 receptor antagonist (IL1RN) and S100 calcium-binding proteins A8 (S100A8) and A9 (S100A9). Conclusion: PSCA signaling may suppress tumor growth in vivo by modulating immunological characteristics of GBC cells.	[Saeki, Norihisa; Ono, Hiroe; Sakamoto, Hiromi; Yoshida, Teruhiko] Natl Canc Ctr, Div Genet, Chuo Ku, Tokyo 1040045, Japan	Saeki, N (reprint author), Natl Canc Ctr, Div Genet, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	nsaeki@ncc.go.jp			JST; JSPS KAKENHI [23501327]	This work was supported by a JST grant for the Personalized Medicine Project and by JSPS KAKENHI (no. 23501327). We thank Ms. Misuzu Okuyama for technical support.	Adams S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112945; Amara N, 2001, CANCER RES, V61, P4660; Reiter RE, 1998, P NATL ACAD SCI USA, V95, P1735, DOI 10.1073/pnas.95.4.1735; Argani P, 2001, CANCER RES, V61, P4320; Zhao PC, 2014, J LEUKOCYTE BIOL, V95, P521, DOI 10.1189/jlb.0613331; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Cao DF, 2005, INT J GYNECOL PATHOL, V24, P67, DOI 10.1097/01.pgp.0000139648.17750.35; Wang T, 2014, ONCOTARGET, V5, P3611; Scott A, 2011, BIOCHEM SOC T, V39, P1437, DOI 10.1042/BST0391437; Rodvold JJ, 2012, CANCER LETT, V316, P132, DOI 10.1016/j.canlet.2011.11.002; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Saeki N, 2010, CLIN CANCER RES, V16, P3533, DOI 10.1158/1078-0432.CCR-09-3169; Cascon A, 2012, CANCER RES, V72, P3119, DOI 10.1158/0008-5472.CAN-11-3891; Rabionet R, 2000, HUM MUTAT, V16, P190, DOI 10.1002/1098-1004(200009)16:3<190::AID-HUMU2>3.0.CO;2-I; Srikrishna G, 2012, J INNATE IMMUN, V4, P31, DOI 10.1159/000330095; Singh J, 2008, INT IMMUNOPHARMACOL, V8, P300, DOI 10.1016/j.intimp.2007.08.015; Moore ML, 2008, PROSTATE, V68, P139, DOI 10.1002/pros.20686; Numata S, 2013, J INVEST DERMATOL, V133, P1785, DOI 10.1038/jid.2013.65; Baumann M, 2013, BLOOD, V121, P3900, DOI 10.1182/blood-2012-09-455022; Berard JL, 2012, GLIA, V60, P1145, DOI 10.1002/glia.22342; Champliaud MF, 2000, GENOMICS, V70, P264, DOI 10.1006/geno.2000.6390; Elsamman EM, 2006, BJU INT, V98, P668, DOI 10.1111/j.1464-410X.2006.06350.x; Feng HC, 2008, HISTOPATHOLOGY, V52, P167, DOI 10.1111/j.1365-2559.2007.02925.x; Gales D, 2013, ISRN ONCOL; Ghosh M, 2004, INT J ONCOL, V24, P1189; Iizuka N, 1999, CANCER LETT, V142, P179, DOI 10.1016/S0304-3835(99)00162-7; Inanc M, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0801-7; Jiang HF, 2012, J CANCER RES CLIN, V138, P1, DOI 10.1007/s00432-011-1062-5; Kawaguchi T, 2010, JPN J CLIN ONCOL, V40, P319, DOI 10.1093/jjco/hyp181; Koike N, 1998, INT J ONCOL, V13, P1269; KOYAMA S, 1980, GANN, V71, P574; Koyama S, 2004, DIGEST DIS SCI, V49, P1621, DOI 10.1023/B:DDAS.0000043375.35611.dd; Labidi-Galy SI, 2015, ONCOGENE, V34, P299, DOI 10.1038/onc.2013.562; Marra E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-129; Naude PJW, 2012, FASEB J, V26, P2811, DOI 10.1096/fj.11-202457; Ono H, 2012, GENE CHROMOSOME CANC, V51, P30, DOI 10.1002/gcc.20928; Ono Hiroe, 2013, J Carcinog, V12, P4, DOI 10.4103/1477-3163.109030; Ostrand-Rosenberg S, 2010, CANCER IMMUNOL IMMUN, V59, P1593, DOI 10.1007/s00262-010-0855-8; Sharom FJ, 2004, SUB CELL BIOCHEM, V37, P285; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046017	41	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAY	2015	35	5					2619	2625				7	Oncology	Oncology	CH8DU	WOS:000354267200018		
J	Ohashi, T; Yoshimasu, T; Oura, S; Kokawa, Y; Kawago, M; Hirai, Y; Miyasaka, M; Aoishi, Y; Kiyoi, M; Nishiguchi, H; Honda, M; Okamura, Y				Ohashi, Takuya; Yoshimasu, Tatsuya; Oura, Shoji; Kokawa, Yozo; Kawago, Mitsumasa; Hirai, Yoshimitsu; Miyasaka, Miwako; Aoishi, Yuka; Kiyoi, Megumi; Nishiguchi, Haruka; Honda, Mariko; Okamura, Yoshitaka			Class III Beta-tubulin Expression in Non-small Cell Lung Cancer: A Predictive Factor for Paclitaxel Response	ANTICANCER RESEARCH			English	Article						Histoculture drug response assay; paclitaxel; predictive factor; non-small cell lung cancer; chemotherapy; class III beta-tubulin	VINORELBINE PLUS CISPLATIN; ADJUVANT CHEMOTHERAPY; TUMOR-CELLS; ASSAY; TRIAL; ASSOCIATION; SENSITIVITY; MUTATIONS; DOCETAXEL; SURVIVAL	Aim: In order to clarify whether class III betatubulin (TUBB3) is a predictive marker for paclitaxel (PTX) chemotherapy, chemosensitivity was examined using an in vitro drug sensitivity assay. Patients and Methods: Twelve specimens from non-small cell lung cancer (NSCLC) patients were obtained for dose-response curve analysis and measurement of the half-maximal effective dose (ED50) of PTX using the histoculture drug response assay (HDRA). Forty-one specimens were evaluated using the HDRA and the inhibition ratio (IR) at a concentration of 25 mu g/ml PTX (IR25) was measured. TUBB3 expression was evaluated by H-score in immunohistochemical staining. Results: The ED50 of PTX was 24.5 +/- 8.06 mu g/ml. The median H-score was significantly higher (p=0.0076) in the high effective dose (HE)-group (ED50 >25 mu g/ml) than in the low effective (LE)-group (ED50 <= 25 mu g/ml). The mean IR25 was 53.8 +/- 26.6%. The median H-score for the high-inhibition ratio (HI)-group (IR25 >50%) was significantly higher (p=0.0337) than the low-inhibition ratio (LI)-group (IR25 <= 50%). Conclusion: High TUBB3 expression in NSCLC appeared to correlate with lower PTX sensitivity.	[Ohashi, Takuya; Yoshimasu, Tatsuya; Oura, Shoji; Kokawa, Yozo; Kawago, Mitsumasa; Hirai, Yoshimitsu; Miyasaka, Miwako; Aoishi, Yuka; Kiyoi, Megumi; Nishiguchi, Haruka; Honda, Mariko; Okamura, Yoshitaka] Wakayama Med Univ, Dept Thorac & Cardiovasc Surg, Wakayama 6418509, Japan	Ohashi, T (reprint author), Wakayama Med Univ, Dept Thorac & Cardiovasc Surg, 811-1 Kimiidera, Wakayama 6418509, Japan.	t-ohashi@wakayama-med.ac.jp					Akaike H., 1973, 2 INT S INF THEOR, P267; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Goffin J, 2010, J THORAC ONCOL, V5, P260, DOI 10.1097/JTO.0b013e3181c6f035; Zhang HL, 2012, LUNG CANCER, V77, P9, DOI 10.1016/j.lungcan.2012.01.005; Seve P, 2005, MOL CANCER THER, V4, P2001, DOI 10.1158/1535-7163.MCT-05-0244; FURUKAWA T, 1995, CLIN CANCER RES, V1, P305; Narvi E, 2013, BRIT J CANCER, V108, P82, DOI 10.1038/bjc.2012.553; Arriagada R, 2010, J CLIN ONCOL, V28, P35, DOI 10.1200/JCO.2009.23.2272; Yoshimasu T, 2007, J THORAC CARDIOV SUR, V133, P303, DOI 10.1016/j.jtcvs.2006.06.030; Strauss GM, 2008, J CLIN ONCOL, V26, P5043, DOI 10.1200/JCO.2008.16.4855; Hayashi Y, 2009, INTERNAL MED, V48, P203, DOI 10.2169/internalmedicine.48.1659; Douillard JY, 2006, LANCET ONCOL, V7, P719, DOI 10.1016/S1470-2045(06)70804-X; Kubota T, 1995, CLIN CANCER RES, V1, P1537; Butts CA, 2010, J CLIN ONCOL, V28, P29, DOI 10.1200/JCO.2009.24.0333; Yoshimasu T, 2011, J THORAC ONCOL, V6, P1658, DOI 10.1097/JTO.0b013e318221f71a; Kang CH, 2010, LUNG CANCER, V68, P478, DOI 10.1016/j.lungcan.2009.07.004; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623; Kato H, 2004, NEW ENGL J MED, V350, P1713, DOI 10.1056/NEJMoa032792; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nr1317; Seve P, 2007, CLIN CANCER RES, V13, P994, DOI 10.1158/1078-0432.CCR-06-1503; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351; Bernard-Marty Chantal, 2002, Clin Breast Cancer, V3, P341, DOI 10.3816/CBC.2002.n.037; Bunn PA, 1998, CLIN CANCER RES, V4, P1087; Burkhart C.A., 2001, BIOCHIM BIOPHYS ACTA, V1471, P1; Demer JL, 2010, INVEST OPHTH VIS SCI, V51, P4600, DOI 10.1167/iovs.10-5438; Hirai Yoshimitsu, 2009, Gan To Kagaku Ryoho, V36, P611; Hirai Y, 2011, ANTICANCER RES, V31, P999; Hirai Yoshimitsu, 2012, Gan To Kagaku Ryoho, V39, P381; Kaira K, 2013, INT J CLIN ONCOL, V18, P371, DOI 10.1007/s10147-012-0386-8; Le Chevalier T, 2010, ANN ONCOL, V21, P196, DOI 10.1093/annonc/mdq376; Ohie S, 2005, METH MOLEC MED, V110, P79; Scagliotti GV, 2005, CLIN CANCER RES, V11, p5011S, DOI 10.1158/1078-0432.CCR-05-9009; W. H. Organization, 2014, CANC FACT SHEET; Yoshimasu Tatsuya, 2005, Gan To Kagaku Ryoho, V32, P497; Yoshimasu Tatsuya, 2007, Breast Cancer, V14, P401, DOI 10.2325/jbcs.14.401	35	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAY	2015	35	5					2669	2674				6	Oncology	Oncology	CH8DU	WOS:000354267200025		
J	Kobashigawa, S; Morikawa, K; Mori, H; Kashino, G				Kobashigawa, Shinko; Morikawa, Keiko; Mori, Hiromu; Kashino, Genro			Gemcitabine Induces Radiosensitization Through Inhibition of RAD51-dependent Repair for DNA Double-strand Breaks	ANTICANCER RESEARCH			English	Article						Radiosensitization; gemcitabine; homologous recombination; RAD51	HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; RAD51 PROTEIN; PANCREATIC-CANCER; CARCINOMA; 2,2-DIFLUORODEOXYCYTIDINE; SENSITIZATION; CHEMOTHERAPY; RADIATION; KINASE	Background/Aim: Gemcitabine (GEM) is used in clinical chemo-radiotherapy; however, the mechanism that contributes to enhanced radiosensitivity by GEM is not fully-understood. We evaluated the effect of GEM on radiosensitization in pancreatic cancer cell lines. Materials and Methods: Pancreatic cell lines PK-59 and PK-45p were used. A total of 5 mu M GEM for 4 h were administered pre- or post-gamma irradiation. Results: Enhanced cell killing effects by GEM in radiotherapy were observed for pre-treatment but not post-treatment GEM. We focused on the dynamics of RAD51 and phospho-H2AX foci after irradiation. Significantly higher numbers of phospho-H2AX foci were observed in GEM pre-treated cells than in untreated cells after irradiation. We also found inhibition of the formation and degradation of RAD51 foci by GEM pre-treatment. The radiosensitizing effect of GEM was suppressed by knockdown of RAD51. Conclusion: RAD51-dependent homologous recombination is one of the key targets in the GEM-induced radiosensitizing effect.	[Kobashigawa, Shinko; Mori, Hiromu] Oita Univ, Sch Med, Dept Radiol, Oita 87011, Japan; [Morikawa, Keiko] Junshin Gakuen Univ, Fac Hlth Sci, Dept Radiol Sci, Fukuoka, Japan; [Kashino, Genro] Oita Univ, Sch Med, Adv Mol Imaging Ctr, Oita 87011, Japan	Kashino, G (reprint author), Oita Univ, Sch Med, Adv Mol Imaging Ctr, Oita 87011, Japan.	kashino@oita-u.ac.jp			 [24791317]	This study was supported by a Grant-in-Aid for Scientific Research, Japan (no. 24791317).	Arnaudeau C, 1999, J MOL BIOL, V289, P1231, DOI 10.1006/jmbi.1999.2856; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Gospodinov A, 2013, DNA REPAIR, V12, P800, DOI 10.1016/j.dnarep.2013.07.006; Wachters FM, 2003, INT J RADIAT ONCOL, V57, P553, DOI 10.1016/s0360-3016(03)00503-0; Daboussi F, 2002, CELL SIGNAL, V14, P969, DOI 10.1016/S0898-6568(02)00052-9; Vispe S, 1998, NUCLEIC ACIDS RES, V26, P2859, DOI 10.1093/nar/26.12.2859; HUANG P, 1991, CANCER RES, V51, P6110; Benson FE, 1998, NATURE, V391, P401; Karran P, 2000, CURR OPIN GENET DEV, V10, P144, DOI 10.1016/S0959-437X(00)00069-1; Oh SY, 2010, INVEST NEW DRUG, V28, P343, DOI 10.1007/s10637-009-9265-1; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Kanaar R, 1998, TRENDS CELL BIOL, V8, P483, DOI 10.1016/S0962-8924(98)01383-X; Storniolo AM, 1999, CANCER, V85, P1261, DOI 10.1002/(SICI)1097-0142(19990315)85:6<1261::AID-CNCR7>3.0.CO;2-T; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Milas L, 1999, CANCER RES, V59, P107; Lawrence TS, 1996, INT J RADIAT ONCOL, V34, P867, DOI 10.1016/0360-3016(95)02134-5; Lambert S, 2000, EMBO J, V19, P3090, DOI 10.1093/emboj/19.12.3090; HEINEMANN V, 1990, MOL PHARMACOL, V38, P567; BOUFFARD DY, 1993, BIOCHEM PHARMACOL, V45, P1857, DOI 10.1016/0006-2952(93)90444-2; Maacke H, 2000, ONCOGENE, V19, P2791, DOI 10.1038/sj.onc.1203578; Van Rompay AR, 1999, MOL PHARMACOL, V56, P562; Huang YY, 1999, MOL CELL BIOL, V19, P2986; Burris HA, 1997, J CLIN ONCOL, V15, P2403; Joschko M A, 1997, Radiat Oncol Investig, V5, P62, DOI 10.1002/(SICI)1520-6823(1997)5:2<62::AID-ROI4>3.0.CO;2-H; Oh SY, 2011, INVEST NEW DRUG, V29, P1066, DOI 10.1007/s10637-010-9417-3; SHEWACH DS, 1994, CANCER RES, V54, P3218; Yamauchi M, 2005, BIOCHEM BIOPH RES CO, V330, P483, DOI 10.1016/j.bbrc.2004.11.174; Yong KJ, 2013, INT J RADIAT ONCOL, V85, P1119, DOI 10.1016/j.ijrobp.2012.09.015	28	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAY	2015	35	5					2731	2737				7	Oncology	Oncology	CH8DU	WOS:000354267200033		
J	Emoto, M; Yano, K; Choijamts, B; Sakai, S; Hirasawa, S; Wakamori, S; Aizawa, M; Nabeshima, K; Tachibana, K; Kanomata, N				Emoto, Makoto; Yano, Kyoko; Choijamts, Batsuren; Sakai, Shinnosuke; Hirasawa, Shun; Wakamori, Shinnosuke; Aizawa, Mamoru; Nabeshima, Kazuki; Tachibana, Katsuro; Kanomata, Nobuhiro			Azaspirene Analogs Inhibit the Growth of Human Uterine Carcinosarcoma In Vitro and In Vivo	ANTICANCER RESEARCH			English	Article						Uterine carcinosarcoma; azaspirene; anti-angiogenic therapy	ANTI-ANGIOGENIC AGENT; MICROVESSEL DENSITY; TUBE FORMATION; TNP-470; XENOGRAFTS; IRRADIATION; ULTRASOUND; EXPRESSION; UTERUS; VEGF	Uterine carcinosarcoma is a highly aggressive gynecological neoplasm that responds poorly to conventional chemotherapy and radiotherapy. Recent studies have shown high angiogenic activities of this tumor, hence anti-angiogenic approaches are expected to provide new treatment strategies for this tumor. In previous work, azaspirene was isolated from Neosartorya sp. fungi, and in vitro anti-angiogenic activities were shown. In the present study, the anti-angiogenic effects of azaspirene analogs, synthetic molecules with a shorter ethyl group replacing a hexadienyl side-chain of the natural compound, were assessed in vitro using human umbilical vein endothelial cells (HUVECs) co-cultured with FU-MMT-3 human uterine carcinosarcoma cells. The anti-tumor and anti-angiogenic effects of these analogs were also evaluated in vivo using FU-MMT-3 xenografted tumors in nude mice. The azaspirene analogs inhibited the tube formation of HUVECs induced by FU-MMT-3 cells in vitro and significantly suppressed tumor growth in vivo compared to the untreated group (control). A significant reduction of the microvessel density in tumors was observed, in comparison to the control. No apparent toxicity, including body loss, was observed in any mice treated in this study. These azaspirene analogs may be effective against uterine carcinosarcoma, possibly acting via potent antiangiogenic effects.	[Emoto, Makoto; Choijamts, Batsuren] Int Univ Hlth & Welf, Dept Hlth & Welf, Fukuoka 8140001, Japan; [Yano, Kyoko; Nabeshima, Kazuki] Fukuoka Univ, Dept Pathol, Fac Med, Jonan Ku, Fukuoka 81401, Japan; [Tachibana, Katsuro] Fukuoka Univ, Dept Anat, Fac Med, Jonan Ku, Fukuoka 81401, Japan; [Sakai, Shinnosuke; Hirasawa, Shun; Wakamori, Shinnosuke; Kanomata, Nobuhiro] Waseda Univ, Sch Adv Sci & Engn, Dept Chem & Biochem, Shinjuku Ku, Tokyo, Japan; [Aizawa, Mamoru] Meiji Univ, Sch Sci & Technol, Dept Appl Chem, Kawasaki, Kanagawa, Japan; [Emoto, Makoto] Fukuoka Sanno Hosp, Div Gynecol Prevent Med, Sawara Ku, Fukuoka, Japan	Emoto, M (reprint author), Int Univ Hlth & Welf, Div Gynecol Prevent Med, Fukuoka Sanno Hosp, Sawara Ku, 3-6-45 Momochihama, Fukuoka 8140001, Japan.	emoto1209@gmail.com	Kanomata, Nobuhiro/A-4948-2011	Kanomata, Nobuhiro/0000-0002-5266-9756	Ministry of Education, Culture, Sports, Science and Technology of Japan [11671164, 20300182]	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 11671164 and No. 20300182).	Cimbaluk D, 2007, GYNECOL ONCOL, V105, P138, DOI 10.1016/j.ygyno.2006.11.001; Hayashi Y, 2002, J AM CHEM SOC, V124, P12078, DOI 10.1021/ja0276826; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Powell MA, 2010, J CLIN ONCOL, V28, P2727, DOI 10.1200/JCO.2009.26.8326; Raspollini MR, 2005, GYNECOL ONCOL, V96, P159, DOI 10.1016/j.ygyno.2004.09.050; Emoto M, 2003, GYNECOL ONCOL, V89, P88, DOI 10.1016/S0090-8258(02)00155-5; Sartori E, 1997, GYNECOL ONCOL, V67, P70, DOI 10.1006/gyno.1997.4827; Asami Y, 2008, CANCER SCI, V99, P1853, DOI 10.1111/j.1349-7006.2008.00890.x; Asami Y, 2002, ORG LETT, V4, P2845, DOI 10.1021/ol020104+; Brooks Sandra E., 2004, Gynecologic Oncology, V93, P204, DOI 10.1016/j.ygyno.2003.12.029; Choijamts B, 2011, CANCER SCI, V102, P452, DOI 10.1111/j.1349-7006.2010.01807.x; Emoto M, 1999, HUM PATHOL, V30, P1232, DOI 10.1016/S0046-8177(99)90043-6; Emoto M, 2007, CANCER SCI, V98, P929, DOI 10.1111/j.1349-7006.00474.x; Emoto M, 2010, CANCER SCI, V101, P984, DOI 10.1111/j.1349-7006.2009.01479.x; Emoto M, 2004, GYNECOL ONCOL, V95, P474, DOI 10.1016/j.ygyno.2004.08.042; Emoto M, 1997, VIRCHOWS ARCH, V431, P249, DOI 10.1007/s004280050096; Kanomata S, 2010, ISCD 22 PB, VPB-47; Kempson R L, 1970, Hum Pathol, V1, P331; McMeekin DS, 2012, GYNECOL ONCOL, V127, P356, DOI 10.1016/j.ygyno.2012.07.095; Miura S, 2004, CANCER LETT, V203, P45, DOI 10.1016/j.canlet.2003.08.020; Miura S, 2005, CANCER LETT, V220, P49, DOI 10.1016/j.canlet.2004.06.048; Naganuma Y, 2011, CANCER SCI, V102, P1545, DOI 10.1111/j.1349-7006.2011.01998.x	22	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAY	2015	35	5					2739	2746				8	Oncology	Oncology	CH8DU	WOS:000354267200034		
J	Toiyama, Y; Inoue, Y; Shimura, T; Fujikawa, H; Saigusa, S; Hiro, J; Kobayashi, M; Ohi, M; Araki, T; Tanaka, K; Mohri, Y; Kusunoki, M				Toiyama, Yuji; Inoue, Yasuhiro; Shimura, Tadanobu; Fujikawa, Hiroyuki; Saigusa, Susumu; Hiro, Jyunichiro; Kobayashi, Minako; Ohi, Masaki; Araki, Toshimitsu; Tanaka, Koji; Mohri, Yasuhiko; Kusunoki, Masato			Serum Angiopoietin-like Protein 2 Improves Preoperative Detection of Lymph Node Metastasis in Colorectal Cancer	ANTICANCER RESEARCH			English	Article						ANGPTL2; C-reactive protein; CEA; lymph node metastasis; colorectal cancer	ADVANCED RECTAL-CANCER; POSTOPERATIVE CHEMORADIOTHERAPY; METAANALYSIS; CT; CARCINOMA; PET/CT; COLONOGRAPHY; TOMOGRAPHY; DIAGNOSIS; ACCURACY	Aim: We investigated whether serum markers and clinical factors could be used to preoperatively predict lymph node (LN) metastasis in colorectal cancer (CRC). Patients and Methods: The present study enrolled 157 curative CRC patients for whom preoperative serum carcinoembryonic antigen (CEA), systemic inflammatory markers (C-reactive protein (CRP) and angiopoietin-like protein 2 (ANGPTL2)) and objective preoperative clinical factors were available as indicators of pathological LN status. Results: Specific clinical factors, including gender, tumor size, histopathology of biopsy sample and tumor morphology, were significantly correlated with LN metastases. Additionally, CEA, CRP and ANGPTL2 levels were also predictive factors for LN status. Multivariate analysis revealed that clinical factors, including gender, histopathology, tumor morphology and ANGPTL2, were identified as independent predictive factors for LN metastases. A combination of clinical factors reached high predictive accuracy of LN metastases and, combined with clinical factors, ANGPTL2 further improved the accuracy. Conclusion: Serum ANGPTL2 improves preoperative detection of LN metastasis in CRC.	[Toiyama, Yuji; Inoue, Yasuhiro; Shimura, Tadanobu; Fujikawa, Hiroyuki; Saigusa, Susumu; Hiro, Jyunichiro; Kobayashi, Minako; Ohi, Masaki; Araki, Toshimitsu; Tanaka, Koji; Mohri, Yasuhiko; Kusunoki, Masato] Mie Univ, Grad Sch Med, Dept Gastrointestinal & Pediat Surg, Div Reparat Med,Inst Life Sci, Tsu, Mie 5148507, Japan	Toiyama, Y (reprint author), Mie Univ, Grad Sch Med, Dept Gastrointestinal & Pediat Surg, Div Reparat Med,Inst Life Sci, Tsu, Mie 5148507, Japan.	ytoi0725@clin.medic.mie-u.ac.jp					Bipat S, 2004, RADIOLOGY, V232, P773, DOI 10.1148/radiol.2323031368; Zerhouni EA, 1996, RADIOLOGY, V200, P443; SCHNALL MD, 1994, RADIOLOGY, V190, P709; van der Paardt MP, 2013, RADIOLOGY, V269, P101, DOI 10.1148/radiol.13122833; Koike Y, 2008, J SURG ONCOL, V98, P540, DOI 10.1002/jso.21154; Cserni G, 2002, J CLIN PATHOL, V55, P386; Ishii Y, 2010, EJSO-EUR J SURG ONC, V36, P1061, DOI 10.1016/j.ejso.2010.05.017; Sauer R, 2012, J CLIN ONCOL, V30, P1926, DOI 10.1200/JCO.2011.40.1836; Monig SP, 1999, ANN SURG ONCOL, V6, P579, DOI 10.1007/s10434-999-0579-1; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Puli SR, 2009, ANN SURG ONCOL, V16, P1255, DOI 10.1245/s10434-009-0337-4; Hasegawa J, 2014, CANCER CHEMOTH PHARM, V73, P1079, DOI 10.1007/s00280-014-2417-9; Cipe G, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-49; Elmas N, 2002, EUR J RADIOL, V42, P206, DOI 10.1016/S0720-048X(02)00036-0; Glasgow SC, 2012, J GASTROINTEST SURG, V16, P1019, DOI 10.1007/s11605-012-1827-4; Heriot AG, 1999, BRIT J SURG, V86, P17; Iyer RB, 2002, AM J ROENTGENOL, V179, P3; Kijima S, 2014, WORLD J GASTROENTERO, V20, P16964, DOI 10.3748/wjg.v20.i45.16964; Miao YM, 2000, GUT, V47, P832, DOI 10.1136/gut.47.6.832; Shin SS, 2008, ABDOM IMAGING, V33, P270, DOI 10.1007/s00261-007-9262-9; Toiyama Y, 2014, CLIN CANCER RES, V20, P6175, DOI 10.1158/1078-0432.CCR-14-0007; Veit-Haibach P, 2006, JAMA-J AM MED ASSOC, V296, P2590, DOI 10.1001/jama.296.21.2590	23	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAY	2015	35	5					2849	2856				8	Oncology	Oncology	CH8DU	WOS:000354267200046		
J	Uchihara, T; Yamashita, YI; Hualin, W; Takeishi, K; Itoh, S; Harimoto, N; Yoshizumi, T; Aishima, S; Shirabe, K; Baba, H; Maehara, Y				Uchihara, Tomoyuki; Yamashita, Yo-Ichi; Hualin, Wang; Takeishi, Kazuki; Itoh, Shinji; Harimoto, Norihumi; Yoshizumi, Tomoharu; Aishima, Shinichi; Shirabe, Ken; Baba, Hideo; Maehara, Yoshihiko			Recurrence 11 Years After Complete Response to Gemcitabine, 5-Fluorouracil, and Cisplatin Chemotherapy Followed by Radiotherapy in a Patient with Advanced Pancreatic Cancer: a Case Report	ANTICANCER RESEARCH			English	Article						Pancreatic cancer; complete response; recurrence; case report	BILIARY TREE CANCERS; THERAPY; SURVIVAL; GFP	A 63-year-old man diagnosed with locally advanced pancreatic ductal adenocarcinoma (PDAC; stage IIa) was treated with chemotherapy (gemcitabine, 5-fluorouracil and cisplatin) followed by radiotherapy. He had complete response by imaging and relapse-free survival for 11 years. However, he subsequently presented with local tumor recurrence and underwent pancreaticoduodenectomy followed by chemotherapy; a partial response was achieved. As in liver metastasis of colonic cancer, complete response by imaging in PDAC may not mean pathological complete response. We would propose the importance of adjuvant surgery for a patient with PDAC with complete response by imaging after chemoradiotherapy.	[Uchihara, Tomoyuki; Yamashita, Yo-Ichi; Hualin, Wang; Takeishi, Kazuki; Itoh, Shinji; Harimoto, Norihumi; Yoshizumi, Tomoharu; Shirabe, Ken; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan; [Hualin, Wang] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Pathol Sci, Fukuoka 812, Japan; [Uchihara, Tomoyuki; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto 8608556, Japan; [Aishima, Shinichi] Saga Univ, Fac Med, Dept Pathol & Microbiol, Saga 840, Japan	Uchihara, T (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, 1-1-1 Honjo, Kumamoto 8608556, Japan.	tomoyuki.u.mikawa1@gmail.com					Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Martin ST, 2012, BRIT J SURG, V99, P918, DOI 10.1002/bjs.8702; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; VILMANN P, 1992, GASTROINTEST ENDOSC, V38, P172, DOI 10.1016/S0016-5107(92)70385-X; Benoist S, 2006, J CLIN ONCOL, V24, P3939, DOI 10.1200/JCO.2006.05.8727; Conroy T, 2013, CURR ONCOL REP, V15, P182, DOI 10.1007/s11912-012-0290-4; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Bochatay Laurent, 2014, Rev Med Suisse, V10, P1582; Chun YS, 2011, ANN SURG ONCOL, V18, P3601, DOI 10.1245/s10434-011-2086-4; Gresham GK, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-471; Opendro SS, 2014, J HEPATO-BIL-PAN SCI, V21, P695, DOI 10.1002/jhbp.119; Sobin L, 2009, INT UNION CANC TNM C; Wang HM, 2012, ANN DIAGN PATHOL, V16, P427, DOI 10.1016/j.anndiagpath.2012.04.002; Yamashita Y, 2010, JPN J CLIN ONCOL, V40, P24, DOI 10.1093/jjco/hyp119; Yamashita YI, 2006, ANTICANCER RES, V26, P771; Yanagimoto H, 2014, J HEPATO-BIL-PAN SCI, V21, P761, DOI 10.1002/jhbp.130	16	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAY	2015	35	5					2867	2871				5	Oncology	Oncology	CH8DU	WOS:000354267200049		
J	Yajima, A; Uesawa, Y; Ogawa, C; Yatabe, M; Kondo, N; Saito, S; Suzuki, Y; Atsuda, K; Kagaya, H				Yajima, Airi; Uesawa, Yoshihiro; Ogawa, Chiaki; Yatabe, Megumi; Kondo, Naoki; Saito, Shinichiro; Suzuki, Yoshihiko; Atsuda, Kouichiro; Kagaya, Hajime			Construction of a Model for Predicting Creatinine Clearance in Japanese Patients Treated with Cisplatin Therapy	ANTICANCER RESEARCH			English	Article						Head and neck cancer; serum albumin; creatinine clearance; renal function; cisplatin	GLOMERULAR-FILTRATION-RATE; SERUM CREATININE; EQUATION; KIDNEY	Background/ Aim: There exist various useful predictive models, such as the Cockcroft-Gault model, for estimating creatinine clearance (CLcr). However, the prediction of renal function is difficult in patients with cancer treated with cisplatin. Therefore, we attempted to construct a new model for predicting CLcr in such patients. Patients and Methods: Japanese patients with head and neck cancer who had received cisplatin-based chemotherapy were used as subjects. A multiple regression equation was constructed as a model for predicting CLcr values based on background and laboratory data. Results: A model for predicting CLcr, which included body surface area, serum creatinine and albumin, was constructed. The model exhibited good performance prior to cisplatin therapy. In addition, it performed better than previously reported models after cisplatin therapy. Conclusion: The predictive model constructed in the present study displayed excellent potential and was useful for estimating the renal function of patients treated with cisplatin therapy.	[Yajima, Airi; Atsuda, Kouichiro] Kitasato Univ, Sch Pharm, Dept Pharm Practice & Sci 1, Minato Ku, Tokyo, Japan; [Yajima, Airi; Uesawa, Yoshihiro; Kagaya, Hajime] Meiji Pharmaceut Univ, Dept Clin Pharmaceut, Tokyo 2048588, Japan; [Ogawa, Chiaki; Yatabe, Megumi; Kondo, Naoki; Suzuki, Yoshihiko] Tokyo Med Ctr, Natl Hosp Org, Dept Pharmaceut, Meguro Ku, Tokyo, Japan; [Saito, Shinichiro] Natl Canc Ctr Hosp East, Dept Pharmaceut, Kashiwa, Chiba, Japan; [Atsuda, Kouichiro] Kitasato Univ Hosp, Dept Pharm, Minami Ku, Sagamihara, Kanagawa, Japan	Uesawa, Y (reprint author), Meiji Pharmaceut Univ, Dept Clin Pharmaceut, 2-522-1 Noshio, Tokyo 2048588, Japan.	uesawa@mypharm.ac.jp					Smith HW, 1938, J CLIN INVEST, V17, P263, DOI 10.1172/JCI100950; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Levey AS, 2006, ANN INTERN MED, V145, P247; Levey AS, 1999, ANN INTERN MED, V130, P461; Burton ME, 2005, APPL PHARMACOKINETIC; Dowling TC, 1999, PHARMACOTHERAPY, V19, P943, DOI 10.1592/phco.19.11.943.31576; Gottschalk EM, 2004, CLIN CHEM, V50, pA27; Horio M, 1997, CLIN EXP NEPHROL, V11, P110, DOI 10.1007/BF02479909; Japanese Society of Nephrology, 2009, CLIN EXPT NEPHROL, V13, P537; JELLIFFE RW, 1973, ANN INTERN MED, V79, P604; KASISKE BL, 1986, ARCH PATHOL LAB MED, V110, P55; Katja T, 2012, LUNG CANCER, V76, P397; MAWER GE, 1972, LANCET, V1, P12; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID; Rocco MV, 1996, AM J NEPHROL, V16, P138, DOI 10.1159/000168985; Yajima A, 2013, PHARMAZIE, V68, P777, DOI 10.1691/ph.2013.3572; Yasuda H, 1980, MED BIOL, V101, P83	17	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAY	2015	35	5					2909	2914				6	Oncology	Oncology	CH8DU	WOS:000354267200055		
J	Ochiai, T; Ishii, H; Yamamoto, Y; Morimura, R; Ikoma, H; Otsuji, E				Ochiai, Toshiya; Ishii, Hiromichi; Yamamoto, Yusuke; Morimura, Ryo; Ikoma, Hisashi; Otsuji, Eigo			Significance of Hepatectomy for AJCC/UICC T3 Hepatocellular Carcinoma	ANTICANCER RESEARCH			English	Article						Hepatocellular carcinoma; UICC; stage; surgery	JAPAN; CLASSIFICATION	Background: It is difficult to treat the American Joint Committee on Cancer (AJCC)/International Union against Cancer (UICC) T3 hepatocellular carcinoma (HCC), curatively. Patients and Methods: We compared the clinicopathology of T3 group (n=44: T3a 25, T3b 19) with that of the T1 (n=257) or T2 group (n=120) and evaluated favorable conditions of hepatectomy for T3 HCC patients. Results: The T3 group had significantly higher hepatitis B surface antigen (HBsAg)-positive rates and better liver function. Infiltrative large tumors located beyond one sub-segment with intrahepatic metastasis were significantly more common. Significantly, more non-curative large hepatectomies with transarterial embolization were performed. There was no significant difference between T3 and 2 groups in 5-year disease-free survival (DFS) and survival (S). Tumor size more than 55 mm and serum albumin less than 3.5 g/dl were risk factors of hepatectomy for T3 HCC patients by multivariate analysis. Conclusion: Surgeons should resect AJCC/UICC T3 HCC lesions if the patient is able to tolerate surgery.	[Ochiai, Toshiya; Ishii, Hiromichi] Kyoto Prefectural Univ Med, Med Ctr N, Dept Surg, Yosano, Kyoto 6292261, Japan; [Ochiai, Toshiya; Yamamoto, Yusuke; Morimura, Ryo; Ikoma, Hisashi; Otsuji, Eigo] Kyoto Prefectural Univ Med, Div Digest Surg, Dept Surg, Yosano, Kyoto 6292261, Japan	Ochiai, T (reprint author), Kyoto Prefectural Univ Med, Med Ctr N, Dept Surg, 481 Otokoyama, Yosano, Kyoto 6292261, Japan.	tochiai@koto.kpu-m.ac.jp					American Joint Committee on Cancer, 2010, AJCC CANC STAGING MA; Vauthey JN, 2002, J CLIN ONCOL, V20, P1527, DOI 10.1200/JCO.20.6.1527; MAKUUCHI M, 1985, SURG GYNECOL OBSTET, V161, P346; Kudo M, 2003, J GASTROENTEROL, V38, P207, DOI 10.1007/s005350300038; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Zhong JH, 2014, ANN SURG, V260, P329, DOI 10.1097/SLA.0000000000000236; Guglielmi A, 2014, WORLD J GASTROENTERO, V20, P7525, DOI 10.3748/wjg.v20.i24.7525; Tsoulfas G, 2012, ANZ J SURG, V82, P510, DOI 10.1111/j.1445-2197.2012.06079.x; MAKUUCHI M, 1993, SEMIN SURG ONCOL, V9, P298, DOI 10.1002/ssu.2980090404; Makuuchi M, 2008, HEPATOL RES, V38, P37, DOI 10.1111/j.1872-034X.2007.00216.x; Shi J, 2011, J HEPATO-BIL-PAN SCI, V18, P74, DOI 10.1007/s00534-010-0314-0; Chok KSH, 2014, WORLD J SURG, V38, P490, DOI 10.1007/s00268-013-2290-4; Torzilli G, 2008, ARCH SURG-CHICAGO, V143, P1082, DOI 10.1001/archsurg.143.11.1082; Inoue Y, 2009, SURGERY, V145, P9, DOI 10.1016/j.surg.2008.09.005; Llovet Josep M, 2004, Liver Transpl, V10, pS115, DOI 10.1002/lt.20034; Minagawa M, 2007, ANN SURG, V245, P909, DOI 10.1097/01.sla.0000254368.65878.da; Pons F, 2005, INT HEPATOPANCREATOB, V7, P35; Shimada K, 2008, LANGENBECK ARCH SURG, V393, P521, DOI 10.1007/s00423-007-0264-4; Sobin LH, 2010, TNM CLASSIFICATION M, V7th, P110; Yang T, 2012, J CANCER RES CLIN, V138, P1121, DOI 10.1007/s00432-012-1188-0; Zhong JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068193	21	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAY	2015	35	5					2921	2928				8	Oncology	Oncology	CH8DU	WOS:000354267200057		
J	Jo, T; Horio, K; Shigematsu, K				Jo, Tatsuro; Horio, Kensuke; Shigematsu, Kazuto			Impact of Nagasaki Atomic Bomb Exposure on Myelodysplastic Syndrome Patients Who Are Treated with Azacitidine	ANTICANCER RESEARCH			English	Article						Atomic bomb; high-dose radiation exposure; myelodysplastic syndrome; azacitidine; hypomethylating agents	NUCLEAR TEST-SITE; CANCER INCIDENCE; POINT MUTATIONS; SCORING SYSTEM; RADIATION; SURVIVORS; LEUKEMIA	Background/Aim: High-dose radiation exposure greatly increases the risk of myelodysplastic syndromes (MDS), however the clinical characteristics of MDS among atomic bomb survivors have not been thoroughly investigated to date. We designed this study to identify these characteristics. Patients and Methods: We retrospectively evaluated data from 13 atomic bomb survivors with MDS and 15 elderly patients with de novo MDS who were diagnosed between April 2011 and April 2013 at the Nagasaki Genbaku Hospital. All patients were treated with azacitidine (AZA; a hypomethylating agent) and overall survival rates were estimated. Results: No clear difference was observed in the clinical response to AZA between the two groups. However, atomic bomb survivors had a survival disadvantage, independent of their karyotype. Conclusion: Minute genetic alterations caused by exposure to atomic radiation can adversely affect the response to AZA, even 66 years after the exposure. Further studies are required to clarify the mechanisms underlying this phenomenon.	[Jo, Tatsuro; Horio, Kensuke] Japanese Red Cross Nagasaki Genbaku Hosp, Dept Hematol, Nagasaki 8528511, Japan; [Shigematsu, Kazuto] Japanese Red Cross Nagasaki Genbaku Hosp, Dept Pathol, Nagasaki 8528511, Japan	Jo, T (reprint author), Japanese Red Cross Nagasaki Genbaku Hosp, Dept Hematol, 3-15 Mori Machi, Nagasaki 8528511, Japan.	firetj@nagasaki-med.jrc.or.jp					Abylkassimova Z, 2000, ANN EPIDEMIOL, V10, P479; Uchida T, 2011, CANCER SCI, V102, P1680, DOI 10.1111/j.1349-7006.2011.01993.x; Zharlyganova D, 2008, J RADIAT RES, V49, P549, DOI 10.1269/jrr.08040; Iwanaga M, 2011, J CLIN ONCOL, V29, P428, DOI 10.1200/JCO.2010.31.3080; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Greenberg P, 1997, BLOOD, V89, P2079; BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x; Cheson BD, 2006, BLOOD, V108, P419, DOI 10.1182/blood-2005-10-4149; Bally C, 2013, LEUKEMIA RES, V37, P637, DOI 10.1016/j.leukres.2013.02.014; Bauer S, 2005, RADIAT RES, V164, P409, DOI 10.1667/RR3423.1; Gusev BI, 1998, RADIAT ENVIRON BIOPH, V37, P209, DOI 10.1007/s004110050119; Imamura N, 2002, LEUKEMIA, V16, P154, DOI 10.1038/sj.leu.2402277; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Swerdlow SH, 2008, WHO CLASSIFICATION T, P87; THOMPSON DE, 1994, RADIAT RES, V137, pS17, DOI 10.2307/3578892; Tsushima H, 2012, INT J HEMATOL, V95, P232, DOI 10.1007/s12185-012-1002-4; Zhumadilov Z, 2000, J RADIAT RES, V41, P35, DOI 10.1269/jrr.41.35	18	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAY	2015	35	5					2929	2933				5	Oncology	Oncology	CH8DU	WOS:000354267200058		
J	Yano, Y; Otsuka, T; Hirano, H; Uenami, T; Satomi, A; Kuroyama, M; Niinaka, M; Yoneda, T; Kimura, H; Mori, M; Yamaguchi, T; Yokota, S				Yano, Yukihiro; Otsuka, Tomoyuki; Hirano, Hiroshi; Uenami, Takeshi; Satomi, Akitoshi; Kuroyama, Muneyoshi; Niinaka, Manabu; Yoneda, Tsutomu; Kimura, Hiromi; Mori, Masahide; Yamaguchi, Toshihiko; Yokota, Soichiro			Nuclear Survivin Expression in Small Cell Lung Cancer	ANTICANCER RESEARCH			English	Article						Small cell lung cancer; survivin; nucleus; labeling index; immunohistochemistry	CARCINOMA	Background/Aim: Little evidence exists regarding a relationship between survivin expression and prognosis in small cell lung cancer (SCLC). We investigated the relationship between survivin expression, clinical characteristics and prognosis in SCLC patients. Materials and Methods: We retrospectively reviewed medical records of study patients and analyzed their tumor sections using nuclear survivin labeling index (LI). Results: A significant correlation between nuclear survivin LI and clinical stage was found (p=0.012). In multivariate analysis, a significant association was found between survival and clinical stage (hazard ratio (HR)=2.09; 95 % confidence interval (CI)=1.08-4.31; p=0.027) but not between survival and nuclear survivin LI (HR=0.96; 95 % CI=0.91-1.02; p=0.2). Conclusion: We did not find any positive relationship between nuclear survivin expression and survival in SCLC patients. Conversely, we found a positive relationship between clinical stage and nuclear survivin LI, which is considered to be useful in deciding treatment strategies.	[Yano, Yukihiro; Uenami, Takeshi; Satomi, Akitoshi; Kuroyama, Muneyoshi; Niinaka, Manabu; Yoneda, Tsutomu; Kimura, Hiromi; Mori, Masahide; Yamaguchi, Toshihiko; Yokota, Soichiro] Toneyama Natl Hosp, Natl Hosp Org, Dept Thorac Oncol, Toyonaka, Osaka 5608522, Japan; [Hirano, Hiroshi] Toneyama Natl Hosp, Natl Hosp Org, Dept Lab Med, Toyonaka, Osaka 5608522, Japan; [Otsuka, Tomoyuki] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka, Japan	Yano, Y (reprint author), Toneyama Natl Hosp, Natl Hosp Org, Dept Thorac Oncol, 5-1-1 Toneyama, Toyonaka, Osaka 5608522, Japan.	yanoy@toneyama.go.jp					Tamm I, 1998, CANCER RES, V58, P5315; Stauber RH, 2007, CANCER RES, V67, P5999, DOI 10.1158/0008-5472.CAN-07-0494; Leslie M, 2011, SCIENCE, V334, P1047, DOI 10.1126/science.334.6059.1047; Rosato A, 2013, LUNG CANCER, V79, P180, DOI 10.1016/j.lungcan.2012.11.004; Li FZ, 2005, INT J CANCER, V114, P509, DOI 10.1002/ijc.20768; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Chen P, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0775-5; Halasova E, 2013, ADV EXP MED BIOL, V756, P15, DOI 10.1007/978-94-007-4549-0_3; Huang LN, 2013, MOL BIOL REP, V40, P917, DOI 10.1007/s11033-012-2132-8; Sun PL, 2013, VIRCHOWS ARCH, V463, P427, DOI 10.1007/s00428-013-1462-9; Wang M, 2012, EXP THER MED, V3, P983, DOI 10.3892/etm.2012.512	11	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAY	2015	35	5					2935	2939				5	Oncology	Oncology	CH8DU	WOS:000354267200059		
J	Nabeki, B; Ishigami, S; Uchikado, Y; Sasaki, K; Kita, Y; Okumura, H; Arigami, T; Kijima, Y; Kurahara, H; Maemura, K; Natsugoe, S				Nabeki, Bunpei; Ishigami, Sumiya; Uchikado, Yasuto; Sasaki, Ken; Kita, Yoshiaki; Okumura, Hiroshi; Arigami, Takaaki; Kijima, Yuko; Kurahara, Hiroshi; Maemura, Kosei; Natsugoe, Shoji			Interleukin-32 Expression and Treg Infiltration in Esophageal Squamous Cell Carcinoma	ANTICANCER RESEARCH			English	Article						IL32; esophageal carcinoma; regulatory T-cell; immunsuppressive; survival	REGULATORY T-CELLS; NF-KAPPA-B; MAP-KINASE PATHWAYS; GASTRIC-CANCER; IL-32; IL-32-ALPHA; SUPPRESSION; DISEASE; MARKER	Background/Aim: Interleukin-32 (IL32) has been newly-identified as a proinflammatory cytokine. In the present study, we aimed to clarify the clinical role of IL32-positive cells in esophageal squamous cell cancer (ESCC) and regulatory T-cell (Treg) infiltration in the stroma. A total of 179 patients with ESCC who underwent surgical resection from 1990 to 2004 were eligible for this study. The expression of IL32 and the degree of stromal infiltration by Tregs were examined simultaneously. The association between each factor and the clinicopathological features was analyzed. Sixty and 74 out of 179 patients with ESCC were regarded as having IL32-positive tumors and many Tregs (high-Treg group), respectively. The IL32-positive and high-Treg groups had significantly deeper tumor invasion than did the IL32-negative and low-Treg groups (p<0.05, for both groups). The multivariate analysis indicated that a combination of IL32 expression and presence of Tregs was one of the poor independent factors (p<0.05). IL32 expression and Treg infiltration in ESCC play an important synergistic role in tumor growth and invasion. The combination of IL32 positivity and degree of infiltration of Treg is a useful prognostic marker in ESCC.	[Nabeki, Bunpei; Ishigami, Sumiya; Uchikado, Yasuto; Sasaki, Ken; Kita, Yoshiaki; Okumura, Hiroshi; Arigami, Takaaki; Kijima, Yuko; Kurahara, Hiroshi; Maemura, Kosei; Natsugoe, Shoji] Kagoshima Univ, Grad Sch Med Sci, Dept Digest Surg Breast & Thyroid Surg, Kagoshima 8908520, Japan	Ishigami, S (reprint author), Kagoshima Univ, Grad Sch Med, Digest Surg, Dept Surg Oncol, Sakuragaoka 8-35-1, Kagoshima 8908520, Japan.	ishiga@m.kufm.kagoshima-u.ac.jp					Yamaguchi T, 2011, SEMIN IMMUNOL, V23, P424, DOI 10.1016/j.smim.2011.10.002; Deans DAC, 2006, BRIT J CANCER, V95, P1568, DOI 10.1038/sj.bjc.6603446; Aoki M, 2011, BRIT J CANCER, V104, P714, DOI 10.1038/sj.bjc.6606075; Smith AJ, 2011, J IMMUNOL, V186, P6576, DOI 10.4049/jimmunol.1100277; Chen MF, 2012, J MOL MED, V90, P89, DOI 10.1007/s00109-011-0809-4; Hata K, 2002, AM J PHYSIOL-GASTR L, V282, pG1035, DOI 10.1152/ajpgi.00494.2001; Motoyama S, 2009, ANN SURG ONCOL, V16, P2479, DOI 10.1245/s10434-009-0525-2; Shioya M, 2007, CLIN EXP IMMUNOL, V149, P480, DOI 10.1111/j.1365-2249.2007.03439.x; Heinhuis B, 2012, CYTOKINE, V60, P321, DOI 10.1016/j.cyto.2012.07.010; Deng XQ, 2012, EXP LUNG RES, V38, P295, DOI 10.3109/01902148.2012.689924; Kang YH, 2012, CANCER LETT, V318, P226, DOI 10.1016/j.canlet.2011.12.023; Ando N, 2003, J CLIN ONCOL, V21, P4592, DOI 10.1200/JCO.2003.12.095; Watanabe MAE, 2010, CANCER METAST REV, V29, P569, DOI 10.1007/s10555-010-9247-y; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Tateno T, 2009, ANN SURG ONCOL, V16, P440, DOI 10.1245/s10434-008-0237-z; Raghavan S, 2011, EXPERT REV GASTROENT, V5, P489, DOI [10.1586/egh.11.44, 10.1586/EGH.11.44]; Felaco P, 2009, J BIOL REG HOMEOS AG, V23, P141; Ishigami S, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0472-4; Kobori A, 2010, WORLD J GASTROENTERO, V16, P2355, DOI 10.3748/wjg.v16.i19.2355; Lee HJ, 2012, ONCOL LETT, V3, P490, DOI 10.3892/ol.2011.511; Natsugoe S, 2004, J GASTROINTEST SURG, V8, P631, DOI 10.1016/j.gassur.2004.02.004; Nishida A, 2009, J BIOL CHEM, V284, P17868, DOI 10.1074/jbc.M900368200; Nishimaki Tadashi, 2004, Ann Thorac Cardiovasc Surg, V10, P324; Seo EH, 2008, J MICROBIOL BIOTECHN, V18, P1606; Sobin LH, 2010, TNM CLASSIFICATION M; Sorrentino C, 2009, AM J RESP CRIT CARE, V180, P769, DOI 10.1164/rccm.200903-0400OC; Tanchot C, 2013, Cancer Microenviron, V6, P147, DOI 10.1007/s12307-012-0122-y; Yasui W, 2001, Gastric Cancer, V4, P113, DOI 10.1007/PL00011733; Yousif NG, 2013, CYTOKINE, V61, P223, DOI 10.1016/j.cyto.2012.09.022	29	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAY	2015	35	5					2941	2947				7	Oncology	Oncology	CH8DU	WOS:000354267200060		
J	Katsube, T; Murayama, M; Yamaguchi, K; Usuda, A; Shimazaki, A; Asaka, S; Konnno, S; Miyaki, A; Usui, T; Yokomizo, H; Shiozawa, S; Yoshimatsu, K; Shimakawa, T; Naritaka, Y				Katsube, Takao; Murayama, Minoru; Yamaguchi, Kentaro; Usuda, Atsuko; Shimazaki, Asako; Asaka, Shinichi; Konnno, Soich; Miyaki, Akira; Usui, Takebumi; Yokomizo, Hazime; Shiozawa, Schunichi; Yoshimatsu, Kazuhiko; Shimakawa, Takeshi; Naritaka, Yoshihiko			Additional Surgery After Non-curative Resection of ESD for Early Gastric Cancer	ANTICANCER RESEARCH			English	Article						Non-curative resection; ESD; early gastric cancer	ENDOSCOPIC SUBMUCOSAL DISSECTION; LONG-TERM OUTCOMES; LYMPH-NODE METASTASIS; SINGLE-CENTER	Aim: The appropriate additional surgery after noncurative resection of Endoscopic Mucosal Resection (ESD) for early gastric cancer is herein discussed. Patients and Methods: Data on 54 patients after non-curative resection of ESD were evaluated. These patients were broadly classified according to the risk of lymph node metastasis with lesions into group A (without risk) (n=26) and group B (with risk) (n=28). Their treatment results were evaluated. Results: The incidence of residual lesion was 7.7% in group A and 14.3% in group B. Risk factors were piecemeal resection, involvement of the horizontal margin (HM1) or unclear involvement of the horizontal margin (HMX) and with ulceration. Lymph node metastasis was detected in one patient with lymphatic invasion, total diameter of 3 cm or more and submucosal invasion over 0.5 mm (SM2). The 5-year survival rate was 93% and none of the patients died of gastric cancer. Conclusion: Follow-up observation was reasonable in group A. Patients who are judged as having undergone piecemeal resection, HM1 or HMX and with ulceration, should be treated by additional surgery and patients judged with SM2 or total diameter of 3 cm or more or lymphatic invasion should be treated by additional surgery with lymphadectomy in groupB.	[Katsube, Takao; Murayama, Minoru; Yamaguchi, Kentaro; Usuda, Atsuko; Shimazaki, Asako; Asaka, Shinichi; Konnno, Soich; Miyaki, Akira; Usui, Takebumi; Yokomizo, Hazime; Shiozawa, Schunichi; Yoshimatsu, Kazuhiko; Shimakawa, Takeshi; Naritaka, Yoshihiko] Tokyo Womens Med Univ, Med Ctr East, Dept Surg, Tokyo 1168567, Japan	Katsube, T (reprint author), Tokyo Womens Med Univ, Med Ctr East, Dept Surg, 2-1-10 Nisiogu Arakawa Ku, Tokyo 1168567, Japan.	katsusu@dnh.twmu.ac.jp					Abe N, 2012, GASTRIC CANCER, V15, P70, DOI 10.1007/s10120-011-0067-8; Kosaka T, 2014, DIGEST ENDOSC, V26, P183, DOI 10.1111/den.12099; Oda I, 2008, BRIT J SURG, V95, P1495, DOI 10.1002/bjs.6305; Oda I, 2014, DIGEST ENDOSC, V26, P214, DOI 10.1111/den.12141; Son SY, 2013, SURG ENDOSC, V27, P3247, DOI 10.1007/s00464-013-2901-z; Numata N, 2015, GASTRIC CANCER, V18, P332, DOI 10.1007/s10120-014-0368-9; Kusano C, 2011, AM J GASTROENTEROL, V106, P1064, DOI 10.1038/ajg.2011.49; Kim H, 2011, ONCOL REP, V25, P1589, DOI 10.3892/or.2011.1242; Tanabe S, 2014, GASTRIC CANCER, V17, P130, DOI 10.1007/s10120-013-0241-2; Nonaka S, 2011, GASTRIC CANCER, V14, P56, DOI 10.1007/s10120-011-0008-6; Gotoda T, 2000, GASTRIC CANCER, V3, P219, DOI 10.1007/PL00011720; Hoteya S, 2014, GASTRIC CANCER, V17, P697, DOI 10.1007/s10120-013-0325-z; Japanese Gastric Cancer Association, 2014, GASTRIC CANCER, V14, P113; Katsube T, 2009, ANTICANCER RES, V29, P4271; Sasako Mitsuru, 1993, Stomach and Intestine, V28, P139; Toyokawa T, 2014, JPN J GASTROENTEROL, V47, P561; Tsujimoto H, 2012, EXP THER MED, V4, P507, DOI 10.3892/etm.2012.630; Yahagi N, 2004, DIGEST ENDOSC, V16, P34, DOI 10.1111/j.1443-1661.2004.00313.x	18	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAY	2015	35	5					2969	2974				6	Oncology	Oncology	CH8DU	WOS:000354267200063		
J	Tamura, S; Takeno, A; Taniguchi, H; Katsura, Y; Ohmura, Y; Kagawa, Y; Sakisaka, H; Takeda, Y; Kato, T				Tamura, Shigeyuki; Takeno, Atsushi; Taniguchi, Hirokazu; Katsura, Yoshiteru; Ohmura, Yoshiaki; Kagawa, Yoshinori; Sakisaka, Hideki; Takeda, Yutaka; Kato, Takeshi			Induction Chemotherapy Using FAP for Patients with Stage II/III Squamous Cell Carcinoma of the Esophagus	ANTICANCER RESEARCH			English	Article						Induction chemotherapy; metastatic esophageal cancer; adriamycin; cisplatin; fluorouracil; combination chemotherapy	RANDOMIZED CLINICAL-TRIALS; NEOADJUVANT CHEMOTHERAPY; PREOPERATIVE CHEMOTHERAPY; PHASE-II; NECK-CANCER; CISPLATIN; FLUOROURACIL; DOCETAXEL; METAANALYSIS; SURGERY	Background: The aim of this study were to evaluate the feasibility and efficacy of chemotherapy using fluorouracil, adriamycin, and cisplatin (FAP) in patients with clinical stage II/III squamous cell carcinoma of the esophagus (SCCE). Patients and Methods: Forty patients were enrolled in the study. They received 30 mg/m(2) adriamycin and 70 mg/m(2) cisplatin on day 1, and 700 mg/m(2) 5-fluorouracil on days 1-5 every four weeks. Following two courses of chemotherapy, eligible patients underwent esophagectomy. Results: Twentyone patients (53%) achieved partial response, and 27 patients underwent surgical resection (resection rate: 68%). Grade 3/4 toxicities developed: 7 patients (18%) with leukopenia, 23 (58%) with neutropenia. The three and five-year survival rates were 55% and 48%. Patients with surgical resection had better prognosis than those without resection, with a three-year survival rate of 68% vs. 25%. Conclusion: FAP is effective and feasible and surgery may provide additional benefit for SCCE patients with FAP.	[Tamura, Shigeyuki; Takeno, Atsushi; Taniguchi, Hirokazu; Katsura, Yoshiteru; Ohmura, Yoshiaki; Kagawa, Yoshinori; Sakisaka, Hideki; Takeda, Yutaka; Kato, Takeshi] Kansai Rosai Hosp, Dept Surg, Amagasaki, Hyogo 6608511, Japan	Tamura, S (reprint author), Kansai Rosai Hosp, Dept Surg, Amagasaki, Hyogo 6608511, Japan.	stamura@kanrou.net					Yanagawa M, 2012, J NUCL MED, V53, P872, DOI 10.2967/jnumed.111.098699; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; NYGAARD K, 1992, WORLD J SURG, V16, P1104; Xu XH, 2012, ASIAN PAC J CANCER P, V13, P103, DOI 10.7314/APJCP.2012.13.1.103; Ajani JA, 2005, J CLIN ONCOL, V23, P5660, DOI 10.1200/JCO.2005.17.376; Therasse P, 2006, EUR J CANCER, V42, P1031, DOI 10.1016/j.ejca.2006.01.026; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028; Boonstra JJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-181; Watanabe M, 2011, DIGESTION, V83, P146, DOI 10.1159/000321797; [Anonymous], 1999, NAT CANC I COMM TERM; Ancona E, 2001, CANCER, V91, P2165, DOI 10.1002/1097-0142(20010601)91:11<2165::AID-CNCR1245>3.0.CO;2-H; Yamasaki M, 2011, ONCOLOGY-BASEL, V80, P307, DOI 10.1159/000329806; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Ando N, 2003, J CLIN ONCOL, V21, P4592, DOI 10.1200/JCO.2003.12.095; Ozawa S, 2012, ESOPHAGUS-TOKYO, V9, P75, DOI 10.1007/s10388-012-0327-7; Bleiberg H, 1997, EUR J CANCER, V33, P1216, DOI 10.1016/S0959-8049(97)00088-9; Kranzfelder M, 2011, BRIT J SURG, V98, P768, DOI 10.1002/bjs.7455; DEBESI P, 1986, CANCER TREAT REP, V70, P909; Japan Esophageal Society, 2009, ESOPHAGUS, V6, P1; Japan Esophageal Society, 2009, ESOPHAGUS, V6, P71; Kaklamanos IG, 2003, ANN SURG ONCOL, V10, P754, DOI 10.1245/ASO.2003.03.078; Kies MS, 1987, CANCER, V60, P215; Law S, 1997, J THORAC CARDIOV SUR, V114, P210, DOI 10.1016/S0022-5223(97)70147-8; MAIPANG T, 1994, J SURG ONCOL, V56, P191, DOI 10.1002/jso.2930560314; Multhaner R, 2003, COCHRANE DB SYST REV, V4; NEUHAUS P, 1992, ARCH SURG-CHICAGO, V127, P1446; Shimakawa T, 2008, ANTICANCER RES, V28, P2321; Urschel JD, 2002, AM J SURG, V183, P273	29	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAY	2015	35	5					2975	2982				8	Oncology	Oncology	CH8DU	WOS:000354267200064		
J	Kazama, S; Kitayama, J; Hiyoshi, M; Taketomi, Y; Murakami, M; Nishikawa, T; Tanaka, T; Tanaka, J; Kiyomatsu, T; Kawai, K; Hata, K; Yamaguchi, H; Nozawa, H; Ishihara, S; Sunami, E; Watanabe, T				Kazama, Shinsuke; Kitayama, Joji; Hiyoshi, Masaya; Taketomi, Yoshitaka; Murakami, Makoto; Nishikawa, Takeshi; Tanaka, Toshiaki; Tanaka, Junichiro; Kiyomatsu, Tomomichi; Kawai, Kazushige; Hata, Keisuke; Yamaguchi, Hironori; Nozawa, Hiroaki; Ishihara, Soichiro; Sunami, Eiji; Watanabe, Toshiaki			Phospholipase A2 Group III and Group X Have Opposing Associations with Prognosis in Colorectal Cancer	ANTICANCER RESEARCH			English	Article						Phospholipase A2; colorectal cancer; immunohistochemistry; lymph node metastasis	A(2) ENZYMES; SECRETORY PHOSPHOLIPASE-A2; PROLONGED SURVIVAL; GASTRIC-CANCER; KNOCKOUT MICE; EXPRESSION; GENE; ADENOCARCINOMA; CARCINOMA; CELLS	Background: Although secretory phospholipase A2 (sPLA2) has been shown to be involved in various biological processes, its specific roles in sub-types of cancer development remain to be elucidated. Materials and Methods: We examined the expression of sPLA2 group III (GIII) in 142 patients with colorectal cancer using immunohistochemistry, and its correlation with clinicopathological features and outcomes. In addition, we examined the co-expression of sPLA2GIII and sPLA2GX using serial tissue sections to clarify the roles of both proteins in colorectal carcinogenesis. Results: In 66 cases, diffuse staining of sPLA2GIII was seen; this was defined as the group with high expression. High expression was associated with a significantly higher rate of lymph node metastasis (p=0.02) and poorer survival (p=0.03) compared with low expression. Patients with low sPLA2GIII and high sPLA2GX expression had a significantly higher survival rate than those with high sPLA2GIII and low sPLA2GX expression (p=0.038). Conclusion: sPLA2GIII expression may be used as a risk factor for lymph node metastasis and a prognostic marker in colorectal cancer. In addition, sPLA2GIII and sPLA2GX may play opposing roles in colorectal carcinogenesis.	[Kazama, Shinsuke; Kitayama, Joji; Hiyoshi, Masaya; Nishikawa, Takeshi; Tanaka, Toshiaki; Tanaka, Junichiro; Kiyomatsu, Tomomichi; Kawai, Kazushige; Hata, Keisuke; Yamaguchi, Hironori; Nozawa, Hiroaki; Ishihara, Soichiro; Sunami, Eiji; Watanabe, Toshiaki] Univ Tokyo, Fac Med, Dept Surg, Div Surg Oncol,Bunkyo Ku, Tokyo 1138655, Japan; [Taketomi, Yoshitaka; Murakami, Makoto] Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Setagaya Ku, Tokyo 113, Japan	Kazama, S (reprint author), Univ Tokyo, Fac Med, Dept Surg, Div Surg Oncol,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kaz-tky@umin.ac.jp					Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Murakami M, 2011, J BIOCHEM, V150, P233, DOI 10.1093/jb/mvr088; Mounier CM, 2008, BRIT J CANCER, V98, P587, DOI 10.1038/sj.bjc.6604184; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Jiang JZ, 2002, AM J PATHOL, V160, P667, DOI 10.1016/S0002-9440(10)64886-9; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Yamamoto K, 2011, J BIOL CHEM, V286, P11616, DOI 10.1074/jbc.M110.206714; Nevalainen TJ, 2008, BBA-MOL CELL BIOL L, V1781, P1, DOI 10.1016/j.bbalip.2007.12.001; Iacopetta B, 2002, INT J CANCER, V101, P403, DOI 10.1002/ijc.10635; Sved P, 2004, CANCER RES, V64, P6934, DOI 10.1158/0008-5472.CAN-03-3018; Masuda S, 2004, BBA-MOL CELL BIOL L, V1686, P61, DOI 10.1016/j.bbalip.2004.08.017; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Leung SY, 2002, P NATL ACAD SCI USA, V99, P16203, DOI 10.1073/pnas.212646299; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Murakami M, 2010, BIOCHIMIE, V92, P561, DOI 10.1016/j.biochi.2010.03.015; Sato H, 2011, J BIOL CHEM, V286, P11632, DOI 10.1074/jbc.M110.206755; Ivandic B, 1999, ARTERIOSCL THROM VAS, V19, P1284; Aggarwal A, 2006, CANCER RES, V66, P232, DOI 10.1158/0008-5472.CAN-05-2232; Guan M, 2011, HEPATOLOGY, V53, P458, DOI 10.1002/hep.24066; YAMASHITA SI, 1994, BRIT J CANCER, V69, P1166, DOI 10.1038/bjc.1994.229; Graff JR, 2001, CLIN CANCER RES, V7, P3857; Grass DS, 1996, J CLIN INVEST, V97, P2233, DOI 10.1172/JCI118664; VADAS P, 1986, LAB INVEST, V55, P391; Bhalla A, 2013, CLIN LAB MED, V33, P835, DOI 10.1016/j.cll.2013.10.001; Birkenkamp-Demtroder K, 2005, GUT, V54, P374, DOI 10.1136/gut.2003.036848; Boilard E, 2010, EMBO MOL MED, V2, P172, DOI 10.1002/emmm.201000072; Buhmeida A, 2009, ANN ONCOL, V20, P1230, DOI 10.1093/annonc/mdn783; Fujioka D, 2008, CIRCULATION, V117, P2977, DOI 10.1161/CIRCULATIONAHA.107.743997; Hiyoshi M, 2013, ONCOL LETT, V5, P533, DOI 10.3892/ol.2012.1067; Ishikawa Y, 2005, HISTOPATHOLOGY, V47, P257, DOI 10.1111/j.1365-2559.2005.02227.x; Kashiwagi M, 1999, GUT, V45, P605; Krause W F, 2001, Clin Colorectal Cancer, V1, P47, DOI 10.3816/CCC.2001.n.005; Laye JP, 2003, DRUG DISCOV TODAY, V8, P710, DOI 10.1016/S1359-6446(03)02754-5; Li X, 2010, FASEB J, V24, P4313, DOI 10.1096/fj.10-154716; Masuda S, 2005, BIOCHEM J, V387, P27, DOI 10.1042/BJ20041307; Morioka Y, 2000, FEBS LETT, V487, P262, DOI 10.1016/S0014-5793(00)02350-4; Murakami M, 2005, J BIOL CHEM, V280, P24987, DOI 10.1074/jbc.M502088200; Ohtsuki M, 2006, J BIOL CHEM, V281, P36420, DOI 10.1074/jbc.M607975200; Sobin LH, 2009, TNM CLASSIFICATION M; Takaku K, 2000, J BIOL CHEM, V275, P34013; Toomey DP, 2009, SURG-J R COLL SURG E, V7, P174; Xing XF, 2011, HISTOPATHOLOGY, V59, P198, DOI 10.1111/j.1365-2559.2011.03913.x	42	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAY	2015	35	5					2983	2990				8	Oncology	Oncology	CH8DU	WOS:000354267200065		
J	Doi, K; Beppu, T; Ishiko, T; Chikamoto, A; Hayashi, H; Imai, K; Nitta, H; Baba, Y; Masuda, T; Okabe, K; Kuramoto, M; Kudo, K; Ogata, K; Ohchi, T; Takamori, H; Kikuchi, K; Baba, H				Doi, Koichi; Beppu, Toru; Ishiko, Takatoshi; Chikamoto, Akira; Hayashi, Hiromitsu; Imai, Katsunori; Nitta, Hidetoshi; Baba, Yoshifumi; Masuda, Toshiro; Okabe, Kazutoshi; Kuramoto, Masafumi; Kudo, Keisuke; Ogata, Kenichi; Ohchi, Tetsufumi; Takamori, Hiroshi; Kikuchi, Ken; Baba, Hideo			Endoscopic Radiofrequency Ablation in Elderly Patients with Hepatocellular Carcinoma	ANTICANCER RESEARCH			English	Article						Endoscopic radiofrequency ablation; elderly patients; hepatocellular carcinoma	MICROWAVE COAGULATION THERAPY; INTERSTITIAL THERMAL ABLATION; HEPATIC RESECTION; LAPAROSCOPIC RADIOFREQUENCY; CIRRHOTIC-PATIENTS; LOCAL RECURRENCE; LIVER-CIRRHOSIS; RISK-FACTORS; EFFICACY; CANCER	Background: The number of elderly patients with hepatocellular carcinoma (HCC) has increased in Japan. Patients and Methods: A total of 280 patients with HCC treated with endoscopic radiofrequency ablation (ERFA) were enrolled in the present study. The patients were divided into two groups, an elderly group (=70 years) and a non-elderly group (<70 years) and their clinical and survival data were compared. Results: The cumulative overall survival rates in the elderly and non-elderly groups were equivalent: 73% and 70% at three years and 57% and 52% at five years, respectively (p=0.900). The disease-free survival rates were 21% and 23% at three years and 17% and 14% at five years, respectively (p=0.628). No significant effects were observed between the two groups due to any of the covariates in the survival analysis (all p-values for interaction >= 0.19). The complication rates were also comparable: 5.1% in the elderly group and 8.6% in the non-elderly group. Conclusion: ERFA is safe and provides excellent therapeutic effects in elderly as well as non-elderly patients with HCC.	[Doi, Koichi; Beppu, Toru; Ishiko, Takatoshi; Chikamoto, Akira; Hayashi, Hiromitsu; Imai, Katsunori; Nitta, Hidetoshi; Baba, Yoshifumi; Masuda, Toshiro; Okabe, Kazutoshi; Kuramoto, Masafumi; Takamori, Hiroshi; Baba, Hideo] Kumamoto Univ, Grad Sch Life Sci, Dept Surg Gastroenterol, Kumamoto 8608556, Japan; [Kikuchi, Ken] Kumamoto Univ, Grad Sch Social & Cultural Sci, Med Qual Management Ctr, Kumamoto 8608556, Japan; [Beppu, Toru] Kumamoto Univ Hosp, Dept Multidisciplinary Treatment Gastroenterol Ca, Kumamoto, Japan; [Kudo, Keisuke; Ogata, Kenichi; Ohchi, Tetsufumi] Miyazaki Prefectural Nobeoka Hosp, Dept Surg, Miyazaki, Japan	Baba, H (reprint author), Kumamoto Univ, Grad Sch Life Sci, Dept Surg Gastroenterol, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hdobaba@kumamoto-u.ac.jp					Abe T, 2000, ENDOSCOPY, V32, P598; Allgaier HP, 1999, LANCET, V353, P1676, DOI 10.1016/S0140-6736(99)00368-2; Ferrero A, 2005, WORLD J SURG, V29, P1101, DOI 10.1007/s00268-005-7768-2; Umemura T, 2007, HEPATOL RES, V37, pS95, DOI 10.1111/j.1872-034X.2007.00169.x; COLAPINTO ND, 1985, CAN J SURG, V28, P323; Tateishi R, 2005, CANCER, V103, P1201, DOI 10.1002/cncr.20892; Spampinato MG, 2013, SURG ENDOSC, V27, P1881, DOI 10.1007/s00464-012-2687-4; Berber E, 2005, SURG ENDOSC, V19, P710, DOI 10.1007/s00464-004-8815-z; Llovet JM, 2001, HEPATOLOGY, V33, P1124, DOI 10.1053/jhep.2001.24233; Livraghi T, 2005, BRIT J SURG, V92, P856, DOI 10.1002/bjs.4986; Takahashi H, 2010, HEPATOL RES, V40, P997, DOI 10.1111/j.1872-034X.2010.00713.x; Kondo K, 2008, WORLD J SURG, V32, P2223, DOI 10.1007/s00268-008-9688-4; Hori T, 2003, J GASTROENTEROL, V38, P977, DOI 10.1007/s00535-003-1181-0; BARLOW AP, 1989, ANN ROY COLL SURG, V71, P110; Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8; Podnos YD, 2001, AM SURGEON, V67, P1181; Nanashima A, 2011, J SURG ONCOL, V104, P284, DOI 10.1002/jso.21932; Beppu T, 2007, THERMAL MED, V23, P63, DOI 10.3191/thermalmedicine.23.63; Curley SA, 2000, ANN SURG, V232, P381, DOI 10.1097/00000658-200009000-00010; FORTNER JG, 1990, ANN SURG, V211, P141, DOI 10.1097/00000658-199002000-00005; Hiraoka A, 2010, J GASTROEN HEPATOL, V25, P403, DOI 10.1111/j.1440-1746.2009.06037.x; Hiraoka A, 2008, HEPATO-GASTROENTEROL, V55, P2171; Imai K, 2013, HEPATOL RES, V43, P853, DOI 10.1111/hepr.12035; Imamura J, 2008, AM J GASTROENTEROL, V103, P3057, DOI 10.1111/j.1572-0241.2008.02153.x; Kono M, 2014, DIGEST DIS, V32, P670, DOI 10.1159/000367999; Masuda T, 2007, THERMAL MED, V23, P123, DOI 10.3191/thermalmed.23.123; Montorsi M, 2001, SURG ENDOSC-ULTRAS, V15, P141, DOI 10.1007/s004640000242; Sakaguchi H, 2009, HEPATOL RES, V39, P47, DOI 10.1111/j.1872-034X.2008.00410.x; Santambrogio R, 2003, SURG ENDOSC, V17, P1826, DOI 10.1007/s00464-002-8960-1; Seki S, 2000, ENDOSCOPY, V32, P591; Tesche LJ, 2010, SURG LAPARO ENDO PER, V20, P404, DOI 10.1097/SLE.0b013e3181fd619b	31	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAY	2015	35	5					3033	3040				8	Oncology	Oncology	CH8DU	WOS:000354267200072		
J	Takeishi, K; Maeda, T; Tsujita, E; Yamashita, YI; Harada, N; Itoh, S; Harimoto, N; Ikegami, T; Yoshizumi, T; Shirabe, K; Maehara, Y				Takeishi, Kazuki; Maeda, Takashi; Tsujita, Eiji; Yamashita, Yo-Ichi; Harada, Noboru; Itoh, Shinji; Harimoto, Norifumi; Ikegami, Toru; Yoshizumi, Tomoharu; Shirabe, Ken; Maehara, Yoshihiko			Predictors of Intrahepatic Multiple Recurrences After Curative Hepatectomy for Hepatocellular Carcinoma	ANTICANCER RESEARCH			English	Article						Hepatocellular carcinoma; multiple recurrences; hepatectomy	PORTAL VENOUS INVASION; MULTIVARIATE ANALYSES; REPEAT HEPATECTOMY; PROGNOSTIC-FACTORS; RESECTION; EXPERIENCE; JAPAN; LIVER; SUBSEGMENTECTOMY; UNIVARIATE	Background/Aim: Survival of patients with multiple recurrences (MR) of hepatocellular carcinoma (HCC) is very poor as recurrent tumors are usually aggressive and not amenable to curative resection. The present study aimed to investigate retrospectively predictors of intrahepatic MR of HCC after hepatectomy. Patients and Methods: We reviewed 416 patients who underwent hepatectomy and developed intrahepatic recurrence during the follow-up period. According to the recurrence pattern, the patients were divided into two groups: 83 who had four or more recurrent lesions in the remnant liver were defined as the MR group and the others who constituted the control group. Results: Multivariate analysis showed that micro-intrahepatic metastasis, a-fetoprotein and tumor size were independent risk factors for MR after hepatectomy. The combination of these three independent factors was significantly associated with MR. The recurrence rates within 1 year after hepatectomy of MR and control groups were 53.0% and 27.6%, respectively (p=0.0001). The 5-year overall survival rate of the MR group was 39%, which was significantly less than that of the control group (68%, p<0.0001). Conclusions: MR of HCC was associated with an earlier recurrence and poorer survival after hepatectomy. The combination of three independent factors for MR might help predict MR occurrence during the follow-up period.	[Takeishi, Kazuki; Yamashita, Yo-Ichi; Itoh, Shinji; Harimoto, Norifumi; Ikegami, Toru; Yoshizumi, Tomoharu; Shirabe, Ken; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan; [Takeishi, Kazuki; Maeda, Takashi; Tsujita, Eiji; Yamashita, Yo-Ichi; Harada, Noboru] Hiroshima Red Cross Hosp, Dept Surg, Hiroshima, Japan; [Takeishi, Kazuki; Maeda, Takashi; Tsujita, Eiji; Yamashita, Yo-Ichi; Harada, Noboru] Atom Bomb Survivors Hosp, Hiroshima, Japan	Takeishi, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ktake@surg2.med.kyushu-u.ac.jp					Chan ACY, 2013, ANN SURG, V257, P686, DOI 10.1097/SLA.0b013e3182822c02; MAKUUCHI M, 1985, SURG GYNECOL OBSTET, V161, P346; Eguchi S, 2008, SURGERY, V143, P469, DOI 10.1016/j.surg.2007.12.003; Yoshizumi T, 2013, HEPATOL RES, V43, P709, DOI 10.1111/hepr.12016; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Takeishi K, 2011, WORLD J SURG, V35, P1063, DOI 10.1007/s00268-011-1017-7; Adachi E, 1996, CANCER, V77, P2022, DOI 10.1002/(SICI)1097-0142(19960515)77:10<2022::AID-CNCR9>3.0.CO;2-S; Shimada M, 1996, GASTROENTEROLOGY, V111, P720, DOI 10.1053/gast.1996.v111.pm8780578; Hasegawa K, 2005, ANN SURG, V242, P252, DOI 10.1097/01.sla.0000171307.37401.db; Yamashita Y, 2007, J AM COLL SURGEONS, V205, P19, DOI 10.1016/j.jamcollsurg.2007.01.069; Poon D, 2009, LANCET ONCOL, V10, P1111, DOI 10.1016/S1470-2045(09)70241-4; Thelen A, 2013, BRIT J SURG, V100, P130, DOI 10.1002/bjs.8962; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; SHIRABE K, 1991, HEPATOLOGY, V14, P802, DOI 10.1002/hep.1840140510; Taketomi A, 2010, ANN SURG ONCOL, V17, P2740, DOI 10.1245/s10434-010-1076-2; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Kiyosawa K, 2004, GASTROENTEROLOGY, V127, pS17, DOI 10.1053/j.gastro.2004.09.012; Makuuchi M, 2008, HEPATOL RES, V38, P37, DOI 10.1111/j.1872-034X.2007.00216.x; MAKUUCHI M, 1987, SURG GYNECOL OBSTET, V164, P155; Hagiwara S, 2006, J GASTROENTEROL, V41, P1214, DOI 10.1007/s00535-006-1950-7; KANEMATSU T, 1989, HEPATOLOGY, V10, P98, DOI 10.1002/hep.1840100119; Kim BW, 2006, WORLD J GASTROENTERO, V12, P99; Liver Cancer Study Group of Japan, 2003, GEN RUL CLIN PATH ST, V2nd; MATSUMATA T, 1989, HEPATOLOGY, V9, P457, DOI 10.1002/hep.1840090320; SHIJO H, 1991, JPN J CLIN ONCOL, V21, P94; Sonoyama T, 2003, HEPATO-GASTROENTEROL, V50, P1078; Tsujita E, 2012, AM SURGEON, V78, P419; Tung-Ping PR, 2000, ANN SURG, V232, P10, DOI DOI 10.1097/00000658-200007000-00003]; Yamashita Y, 2013, SURGERY, V154, P1038, DOI 10.1016/j.surg.2013.04.046	29	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAY	2015	35	5					3061	3066				6	Oncology	Oncology	CH8DU	WOS:000354267200076		
J	Miyazaki, A; Miyake, H; Harada, KI; Fujisawa, M				Miyazaki, Akira; Miyake, Hideaki; Harada, Ken-Ichi; Fujisawa, Masato			No Significant Correlation of Clinical Outcomes Between First- and Second-line Tyrosine Kinase Inhibitors in Patients with Metastatic Renal Cell Carcinoma	ANTICANCER RESEARCH			English	Article						Tyrosine kinase inhibitor; metastatic renal cell carcinoma; first-line; second-line; objective response; progression-free survival	VEGF-TARGETED THERAPY; INTERFERON-ALPHA; EXPANDED-ACCESS; SUNITINIB; EFFICACY; SAFETY; SORAFENIB; SURVIVAL; AGENTS; TRIAL	Aim: To identify patients with metastatic renal cell carcinoma (mRCC) who received tyrosine kinase inhibitors (TKIs) in both first- and second-line settings in order to investigate the association of oncological outcomes between the two lines of therapy. Patients with Methods: The study included 76 consecutive patients with mRCC treated with second-line TKI therapy after the failure of first-line TKI therapy. The association of oncological outcomes between first-and second-line therapies was analyzed in these 76 patients. Results: In this series, the objective response rates (ORRs) to first-and second-line TKI therapies were 10.5% and 25.0%, respectively. The ORR to second-line TKI therapy was not significantly different among patients achieving a complete or partial response, stable disease and progressive disease to first-line TKI therapy (37.5%, 21.6% and 29.4%, respectively; p=0.34). The median durations of progression-free survival (PFS) with first-and second-line TKI therapies were 7.9 and 8.1 months, respectively, and there was no significant correlation between them (p=0.78). Out of the examined factors, the pre-treatment C-reactive protein level, number of metastatic sites and Memorial Sloan-Kettering Cancer Center risk classification model, but not the response to first-line TKI therapy, were independently associated with PFS on second-line TKI therapy, based on multivariate analysis. Conclusion: The clinical response to second-line TKI therapy is not dependent on that to first-line TKI therapy in patients with mRCC; therefore, it may not be necessary to switch to an alternative agent with a mechanism different from TKIs as second-line therapy, even if patients do not respond to first-line TKI therapy.	[Miyazaki, Akira; Miyake, Hideaki; Harada, Ken-Ichi; Fujisawa, Masato] Kobe Univ, Grad Sch Med, Div Urol, Kobe, Hyogo 6500017, Japan	Miyake, H (reprint author), Kobe Univ, Grad Sch Med, Div Urol, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	hideakimiyake@hotmail.com					Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Al-Marrawi MY, 2013, TARGET ONCOL, V8, P203, DOI 10.1007/s11523-012-0252-7; Figlin R, 2012, J UROLOGY, V188, P707, DOI 10.1016/j.juro.2012.04.108; Parton M, 2006, J CLIN ONCOL, V24, P5584, DOI 10.1200/JCO.2006.08.1638; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Gore ME, 2009, LANCET ONCOL, V10, P757, DOI 10.1016/S1470-2045(09)70162-7; Oudard S, 2012, CANCER TREAT REV, V38, P981, DOI 10.1016/j.ctrv.2011.12.009; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2002, J CLIN ONCOL, V20, P289, DOI 10.1200/JCO.20.1.289; Sakai I, 2014, INT J CLIN ONCOL, V19, P674, DOI 10.1007/s10147-013-0612-z; Harshman LC, 2012, LANCET ONCOL, V13, P927, DOI 10.1016/S1470-2045(12)70285-1; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Beck J, 2011, ANN ONCOL, V22, P1812, DOI 10.1093/annonc/mdq651; Busch J, 2011, EUR UROL, V60, P1163, DOI 10.1016/j.eururo.2011.07.037; Calvo E, 2013, CANCER TREAT REV, V39, P366, DOI 10.1016/j.ctrv.2012.06.010; Choueiri TK, 2010, BJU INT, V105, P1247, DOI 10.1111/j.1464-410X.2009.08972.x; Edge SB, 2009, AJCC CANC STAGING MA, V7th, P479; Miyake H, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0978-4; Motzer RJ, 2013, NEW ENGL J MED, V369, P722, DOI 10.1056/NEJMoa1303989; Patard JJ, 2011, EUR UROL, V60, P684; Porta C, 2010, EUR J CLIN MED ONCOL, V2, P1; Rini BI, 2012, LANCET, V378, P1931, DOI DOI 10.1016/S0140-6736(11)61613-9; Wada Y, 2012, INT J UROL, V19, P284, DOI 10.1111/j.1442-2042.2012.02962.x	24	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAY	2015	35	5					3067	3073				7	Oncology	Oncology	CH8DU	WOS:000354267200077		
J	Takeshita, J; Masago, K; Kato, R; Otsuka, K; Okuda, C; Hata, A; Kaji, R; Fujita, S; Takayama, K; Kokubo, M; Katakami, N				Takeshita, Jumpei; Masago, Katsuhiro; Kato, Ryoji; Otsuka, Kyoko; Okuda, Chiyuki; Hata, Akito; Kaji, Reiko; Fujita, Shiro; Takayama, Kenji; Kokubo, Masaki; Katakami, Nobuyuki			A New Strategy for Metachronous Primary Lung Cancer: Stereotactic Body Radiation Therapy with Concurrent Chemotherapy	ANTICANCER RESEARCH			English	Article						Non-small cell lung cancer; stage I; metachronous; platinum doublets; inoperable	SURGICAL-TREATMENT; LOCAL RECURRENCE; ONCOLOGY-GROUP; RADIOTHERAPY; 2ND; TUMORS; CRITERIA	Background/Aim: Patients with malignant lung cancer often develop a solitary pulmonary nodule after treatment of the initial cancer. In those cases, it is difficult to distinguish primary lung cancer (PLC) from lung metastasis. Therefore, both local therapy for a single lung lesions and systemic therapy for micrometastases are needed. This retrospective study aimed to evaluate the safety and tolerability of concurrent stereotactic body radiation therapy (SBRT) and chemotherapy in patients with metachronous PLC. Patients and Methods: We reviewed the records of 10 patients with metachronous PLC treated with SBRT and concurrent chemotherapy with curative intent from 2007 to 2013. The delivered radiation dose was 48 Gy in four fractions. Results: All patients received SBRT with concurrent chemotherapy on schedule. Complete response rate was 90%. Safety profile of this treatment was compatible with that of traditional chemoradiotherapy. Conclusion: Our study showed good feasibility and safety for SBRT with concurrent chemoradiotherapy.	[Takeshita, Jumpei; Masago, Katsuhiro; Kato, Ryoji; Otsuka, Kyoko; Okuda, Chiyuki; Hata, Akito; Kaji, Reiko; Fujita, Shiro; Katakami, Nobuyuki] Inst Biomed Res & Innovat, Div Integrated Oncol, Kobe, Hyogo 6500047, Japan; [Takayama, Kenji; Kokubo, Masaki] Inst Biomed Res & Innovat, Div Radiat Oncol, Kobe, Hyogo 6500047, Japan; [Kokubo, Masaki] Kobe City Med Ctr Gen Hosp, Dept Radiat Oncol, Kobe, Hyogo, Japan	Takeshita, J (reprint author), Inst Biomed Res & Innovat, Div Integrated Oncol, Chuo Ku, 2-2 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	jumpeinr2tfm3@fbri.org					Chang JY, 2013, CANCER-AM CANCER SOC, V119, P3402, DOI 10.1002/cncr.28217; MARTINI N, 1995, J THORAC CARDIOV SUR, V109, P120, DOI 10.1016/S0022-5223(95)70427-2; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Zatloukal P, 2004, LUNG CANCER-J IASLC, V46, P87, DOI 10.1016/j.lungcan.2004.03.004; Yamamoto N, 2010, J CLIN ONCOL, V28, P3739, DOI 10.1200/JCO.2009.24.5050; Johnson BE, 1998, J NATL CANCER I, V90, P1335, DOI 10.1093/jnci/90.18.1335; Neri S, 2010, J THORAC ONCOL, V5, P2003, DOI 10.1097/JTO.0b013e3181f8a785; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Hamaji M, 2013, J THORAC CARDIOV SUR, V145, P683, DOI 10.1016/j.jtcvs.2012.12.051; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Rea F, 2001, EUR J CARDIO-THORAC, V20, P489, DOI 10.1016/S1010-7940(01)00858-2; Griffioen GHMJ, 2013, RADIOTHER ONCOL, V107, P403, DOI 10.1016/j.radonc.2013.04.026; Onishi H, 2007, J THORAC ONCOL, V2, P94, DOI 10.1097/JTO.0b013e318074de34; Pastorino U, 1997, J THORAC CARDIOV SUR, V113, P37, DOI 10.1016/S0022-5223(97)70397-0; Prisadov Georgi Cv, 2010, Folia Med (Plovdiv), V52, P23; Ulhoa-Cintra A, 2012, J CLIN ONCOL, V30	16	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAY	2015	35	5					3103	3107				5	Oncology	Oncology	CH8DU	WOS:000354267200082		
J	Chang, WH; Ota, H; Maeda, T				Chang, Wen Hsin; Ota, Hiroyuki; Maeda, Tatsuro			Achieving low parasitic resistance in Ge p-channel metal-oxide-semiconductor field-effect transistors by ion implantation after germanidation	APPLIED PHYSICS EXPRESS			English	Article							ELECTRICAL PERFORMANCE; GATE STACK; SCHOTTKY; TECHNOLOGY; CONTACT; BARRIER; MOSFETS	The parasitic resistance (R-para) of Ge p-channel metal-oxide-semiconductor field-effect transistors (p-MOSFETs) fabricated by ion implantation after germanidation (IAG) has been investigated by varying the drive-in annealing temperature. The lowest R-para of 835 Omega mu m was achieved after 450 degrees C drive-in annealing for 1 min. Boron segregation between NiGe and Ge induced by drive-in annealing has advantages in forming an abrupt metallic source/drain (S/D) junction and contributes to the decrease in R-para. The appropriate process window for fabricating Ge p-MOSFETs by IAG was also given. IAG, a pathway for introducing a Ge channel into CMOS technology beyond the 10nm node, was proved to be effective for reducing R-para. (C) 2015 The Japan Society of Applied Physics	[Chang, Wen Hsin; Ota, Hiroyuki; Maeda, Tatsuro] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058562, Japan	Chang, WH (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058562, Japan.	wh-chang@aist.go.jp					Zhang R, 2013, IEEE T ELECTRON DEV, V60, P927, DOI 10.1109/TED.2013.2238942; Yamamoto K, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4821546; Zhang R, 2012, IEEE T ELECTRON DEV, V59, P335, DOI 10.1109/TED.2011.2176495; Morii K, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.04C050; Prabhakaran K, 2000, APPL PHYS LETT, V76, P2244, DOI 10.1063/1.126309; Xie RL, 2009, IEEE T ELECTRON DEV, V56, P1330, DOI 10.1109/TED.2009.2019420; Oxland R, 2012, IEEE ELECTR DEVICE L, V33, P501, DOI 10.1109/LED.2012.2185919; Lieten RR, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.101301; Brunco DP, 2008, J ELECTROCHEM SOC, V155, pH552, DOI 10.1149/1.2919115; Burchhart T, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/43/435704; Feng J, 2008, IEEE ELECTR DEVICE L, V29, P805, DOI 10.1109/LED.2008.2000613; Guo Y, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3378878; Hosoi T, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4900442; Husain MK, 2008, MAT SCI SEMICON PROC, V11, P305, DOI 10.1016/j.mssp.2008.11.007; Ikeda K., 2013, IEDM, P637; Koike M, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.021301; Li R, 2008, JPN J APPL PHYS, V47, P2548, DOI 10.1143/JJAP.47.2548; Li R, 2006, THIN SOLID FILMS, V504, P28, DOI 10.1016/j.tsf.2005.09.033; Li ZQ, 2012, IEEE ELECTR DEVICE L, V33, P1687, DOI 10.1109/LED.2012.2220954; Li ZQ, 2013, IEEE ELECTR DEVICE L, V34, P596, DOI 10.1109/LED.2013.2252458; Nishimura T, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2789701; Oka H, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4893152; Wu H, 2015, VISUAL COMPUT, V31, P367, DOI 10.1007/s00371-014-0931-8; Yamamoto K, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.051301; Yamauchi T, 2007, INT EL DEVICES MEET, P963, DOI 10.1109/IEDM.2007.4419113	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	MAY	2015	8	5							054201	10.7567/APEX.8.054201		4	Physics, Applied	Physics	CI7RV	WOS:000354963000023		
J	Harada, T; Hashimoto, H; Tanaka, Y; Amano, T; Watanabe, T; Kinoshita, H				Harada, Tetsuo; Hashimoto, Hiraku; Tanaka, Yusuke; Amano, Tsuyoshi; Watanabe, Takeo; Kinoshita, Hiroo			Quantitative phase imaging of a small phase structure on an extreme-ultraviolet mask by coherent diffraction imaging	APPLIED PHYSICS EXPRESS			English	Article							MICROSCOPY; RETRIEVAL	Extreme-ultraviolet (EUV) lithography poses a number of challenges. One of which is the production of a defect-free mask. To observe the phase defects on an EUV mask in a quantitative phase image, we have developed a micro-coherent EUV scatterometry microscope at the NewSUBARU synchrotron facility. This microscope focused coherent EUV on a 140-nm-diameter defect and recorded the diffraction. The intensity and phase images of the defect are reconstructed by the coherent diffraction imaging method of ptychography. Phase defects with a 30 nm spatial resolution were reconstructed. This quantitative phase imaging method should help improve EUV masks. (C) 2015 The Japan Society of Applied Physics	[Harada, Tetsuo; Hashimoto, Hiraku; Tanaka, Yusuke; Watanabe, Takeo; Kinoshita, Hiroo] Univ Hyogo, Ctr EUV Lithog, Lab Adv Sci & Technol Ind, Kamigori, Hyogo 6781205, Japan; [Amano, Tsuyoshi] EUVL Infrastruct Dev Ctr, Tsukuba, Ibaraki 3058569, Japan	Harada, T (reprint author), Univ Hyogo, Ctr EUV Lithog, Lab Adv Sci & Technol Ind, Kamigori, Hyogo 6781205, Japan.	harada@lasti.u-hyogo.ac.jp			New Energy and Industrial Technology Development Organization (NEDO), Japan	This work is a recontracted study from the EUVL Infrastructure Development Center (EIDEC). EIDEC programs are supported by the New Energy and Industrial Technology Development Organization (NEDO), Japan.	Miao JW, 1999, NATURE, V400, P342, DOI 10.1038/22498; Miao J, 1998, J OPT SOC AM A, V15, P1662, DOI 10.1364/JOSAA.15.001662; Rodenburg JM, 2004, APPL PHYS LETT, V85, P4795, DOI 10.1063/1.1823034; Thibault P, 2008, SCIENCE, V321, P379, DOI 10.1126/science.1158573; Harada T, 2013, J VAC SCI TECHNOL B, V31, DOI 10.1116/1.4826249; Harada T, 2013, PROC SPIE, V8701, DOI 10.1117/12.2027283; Harada T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.06FB08; Harada T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.06GB02; Humphry MJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1733; Kwon HJ, 2011, PROC SPIE, V8166, DOI 10.1117/12.897165; Mochi I, 2011, PROC SPIE, V7969, DOI 10.1117/12.881652; Nagata Y, 2013, PROC SPIE, V8849, DOI 10.1117/12.2023880; Tanaka Y, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.06JC03	13	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	MAY	2015	8	5							055202	10.7567/APEX.8.055202		3	Physics, Applied	Physics	CI7RV	WOS:000354963000028		
J	Iwai, A; Nakamura, Y; Bambina, A; Sakai, O				Iwai, Akinori; Nakamura, Yoshihiro; Bambina, Alexandre; Sakai, Osamu			Experimental observation and model analysis of second-harmonic generation in a plasma-metamaterial composite	APPLIED PHYSICS EXPRESS			English	Article								We observed enhanced second-harmonic-wave generation in a plasma-metamaterial composite, the intensity of which was much stronger than that in plasma with a similar level of electron density. We clarified that this specific intense second-harmonic-wave generation was derived from additional nonlinearity based on the electric connection between a plasma with a density gradient and metamaterials using an equivalent circuit model. (C) 2015 The Japan Society of Applied Physics	[Iwai, Akinori; Nakamura, Yoshihiro; Sakai, Osamu] Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6158510, Japan; [Bambina, Alexandre; Sakai, Osamu] Univ Shiga Prefecture, Dept Elect Syst Engn, Hikone, Shiga 5228533, Japan	Iwai, A (reprint author), Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6158510, Japan.				Ministry of Education, Culture, Sports, Science and Technology; Casio Science Promotion Foundation	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology and by the Casio Science Promotion Foundation.	Kanazawa T, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3610471; PORKOLAB M, 1985, PHYS REV LETT, V54, P434, DOI 10.1103/PhysRevLett.54.434; YASAKA Y, 1993, PLASMA PHYS CONTR F, V35, P379, DOI 10.1088/0741-3335/35/3/007; Baena JD, 2005, IEEE T MICROW THEORY, V53, P1451, DOI 10.1109/TMTT.2005.845211; Iza F, 2008, PLASMA PROCESS POLYM, V5, P322, DOI 10.1002/ppap.200700162; Shadrivov IV, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2999634; Sakai O, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/1/013001; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Godyak VA, 1999, PHYS REV LETT, V83, P1610, DOI 10.1103/PhysRevLett.83.1610; Iwai A., ENHANCED GENER UNPUB; Lieberman M. A., 1994, PRINCIPLES PLASMA DI; Moisan M, 1992, MICROWAVE EXCITED PL; Naito T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.066003; Nakamura Y, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.03DB04; Nakamura Y, 2014, PLASMA SOURCES SCI T, V23, DOI 10.1088/0963-0252/23/6/064009; Pendry JB, 1999, IEEE T MICROW THEORY, V47, P2075, DOI 10.1109/22.798002; Rose A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.063902; Sakai O., 2013, PLASMA FUSION RES, V8; Sakai O, 1996, JPN J APPL PHYS 1, V35, P4056, DOI 10.1143/JJAP.35.4056; SAKURAI T, 1983, IEEE T ELECTRON DEV, V30, P183, DOI 10.1109/T-ED.1983.21093; Shadrivov IV, 2005, RADIO SCI, V40, DOI 10.1029/2004RS003191; Tachibana K, 2010, PURE APPL CHEM, V82, P1189, DOI 10.1351/PAC-CON-09-10-09; Takahashi E., 2002, Physical Review E (Statistical, Nonlinear, and Soft Matter Physics), V65, DOI 10.1103/PhysRevE.65.016402	23	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	MAY	2015	8	5							056201	10.7567/APEX.8.056201		4	Physics, Applied	Physics	CI7RV	WOS:000354963000031		
J	Kabuyanagi, S; Nishiumura, T; Yajima, T; Toriumi, A				Kabuyanagi, Shoichi; Nishiumura, Tomonori; Yajima, Takeaki; Toriumi, Akira			Nondestructive characterization of oxide/germanium interface by direct-gap photoluminescence analysis	APPLIED PHYSICS EXPRESS			English	Article							GERMANIUM	We demonstrate that direct-gap photoluminescence (PL) analysis is useful for the nondestructive, fast, and in-line characterization of the oxide/germanium (Ge) interface without making actual devices. The fact that Ge has a quasi-direct gap enables us to utilize direct-gap PL intensity as a good indicator for interface quality estimation. We experimentally confirm the validity of the present analysis, by comparing PL spectra with capacitance-voltage characteristics. The impact of the band bending at the interface on PL intensity is also discussed. Furthermore, the effect of forming gas annealing at oxide/Ge interfaces is discussed by taking advantage of the present method. (C) 2015 The Japan Society of Applied Physics	[Kabuyanagi, Shoichi; Nishiumura, Tomonori; Yajima, Takeaki; Toriumi, Akira] Univ Tokyo, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Kabuyanagi, Shoichi; Nishiumura, Tomonori; Yajima, Takeaki; Toriumi, Akira] Japan Sci & Technol Agcy JST, CREST, Bunkyo Ku, Tokyo 1138656, Japan	Kabuyanagi, S (reprint author), Univ Tokyo, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan.	kabuyanagi@adam.t.u-tokyo.ac.jp					ASPNES DE, 1983, PHYS REV B, V27, P985, DOI 10.1103/PhysRevB.27.985; VANDRIEL HM, 1976, SOLID STATE COMMUN, V20, P837, DOI 10.1016/0038-1098(76)91286-2; Houssa M, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2944892; Nguyen QT, 2007, SOLID STATE ELECTRON, V51, P1172, DOI 10.1016/j.sse.2007.07.015; Lu CM, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4868032; Othonos A, 1998, J APPL PHYS, V83, P1789, DOI 10.1063/1.367411; Chikata Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.021101; Kabuyanagi S., 2014, SOL STAT DEV MAT, P680; Kim J. G., 2014, ECS SOLID STATE LETT, V3, pN11; Lee C. H., 2013, IEDM, P40; Lee CH, 2009, ECS TRANSACTIONS, V19, P165, DOI 10.1149/1.3118942; Lu C., 2014, MRS SPRING M; Hashemi FSM, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4812334; Passlack M, 1997, IEEE T ELECTRON DEV, V44, P214, DOI 10.1109/16.557709; Rommel M, 2005, MICROELECTRON ENG, V80, P50, DOI 10.1016/j.mee.2005.04.042; Sze S. M., 1981, PHYSICS SEMICONDUCTO, V2nd, P13; Tu LW, 1999, APPL PHYS LETT, V75, P2038, DOI 10.1063/1.124908; Van de Walle CG, 2008, THIN SOLID FILMS, V517, P144, DOI 10.1016/j.tsf.2008.08.071	18	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	MAY	2015	8	5							051301	10.7567/APEX.8.051301		3	Physics, Applied	Physics	CI7RV	WOS:000354963000006		
J	Kobayashi, H; Tokita, Y				Kobayashi, Hajime; Tokita, Yuichi			Modeling of hole transport across grain boundaries in organic semiconductors for mesoscale simulations	APPLIED PHYSICS EXPRESS			English	Article							CHARGE-TRANSPORT; PENTACENE; MOBILITY; PARAMETERS	Mesoscale carrier transport simulations for organic semiconductors with heterogeneous polycrystalline structures are very challenging because the charge transfer rates across the grain boundaries are unknown. To overcome this difficulty, we studied the process of hole transport across pentacene grain boundaries using large-scale quantum mechanics calculations. In this paper, we propose a simplified model for determining the hole transfer rates, which were found to be reduced considerably by hole barriers that were generated near the grain boundaries. By using this model, mesoscale simulations, such as the kinetic Monte Carlo method, can be applied to heterogeneous polycrystalline structures. (C) 2015 The Japan Society of Applied Physics	[Kobayashi, Hajime; Tokita, Yuichi] Sony Corp, Adv Mat Labs, Atsugi, Kanagawa 2430014, Japan	Kobayashi, H (reprint author), Sony Corp, Adv Mat Labs, Atsugi, Kanagawa 2430014, Japan.	HajimeA.Kobayashi@jp.sony.com					Jurchescu OD, 2004, APPL PHYS LETT, V84, P3061, DOI 10.1063/1.1704874; Kelley TW, 2001, J PHYS CHEM B, V105, P4538, DOI 10.1021/jp004519t; Kirkpatrick J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.227402; Shuai ZG, 2014, CHEM SOC REV, V43, P2662, DOI 10.1039/c3cs60319a; [Anonymous], 2009, GAUSS 09 REV D 01; Kang JH, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1900944; Vehoff T, 2010, J AM CHEM SOC, V132, P11702, DOI 10.1021/ja104380c; MARCUS RA, 1993, REV MOD PHYS, V65, P599, DOI 10.1103/RevModPhys.65.599; Kalb WL, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.035327; May F, 2012, J AM CHEM SOC, V134, P13818, DOI 10.1021/ja305310r; Yamada T, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2940593; Deng WQ, 2004, J PHYS CHEM B, V108, P8614, DOI 10.1021/jp0495848; Kobayashi H, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4812389; Coropceanu V, 2007, CHEM REV, V107, P926, DOI 10.1021/cr050140x; Valeev EF, 2006, J AM CHEM SOC, V128, P9882, DOI 10.1021/ja061827h; Horowitz G, 2000, ADV MATER, V12, P1046, DOI 10.1002/1521-4095(200007)12:14<1046::AID-ADMA1046>3.0.CO;2-W; BASSLER H, 1982, PHYS REV B, V26, P3105, DOI 10.1103/PhysRevB.26.3105; Lang DV, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.086802; Mattheus CC, 2001, ACTA CRYSTALLOGR C, V57, P939, DOI 10.1107/S010827010100703X; Olthof S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.176601; Verlaak S, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.115127	21	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	MAY	2015	8	5							051602	10.7567/APEX.8.051602		4	Physics, Applied	Physics	CI7RV	WOS:000354963000009		
J	Krockenberger, Y; Horio, M; Irie, H; Fujimori, A; Yamamoto, H				Krockenberger, Yoshiharu; Horio, Masafumi; Irie, Hiroshi; Fujimori, Atsushi; Yamamoto, Hideki			As-grown superconducting Pr2CuO4 under thermodynamic constraints	APPLIED PHYSICS EXPRESS			English	Article							CRYSTAL NEUTRON-DIFFRACTION; COPPER OXIDES; ELECTRON; STATE; FILMS; ND	Pr2CuO4 and other cuprates with square-planar coordinated copper require an annealing procedure for the induction of superconductivity. While this annealing procedure has prevented the origin of superconductivity in cuprates from being understood, it has been assumed that the antiferromagnetic insulating state is common among cuprate superconductors in their undoped state. Here, we show that appropriate synthesis conditions allow for the growth of as-grown superconducting Pr2CuO4 thin films by molecular beam epitaxy. The fact that Pr2CuO4 can be a superconductor in its as-grown state shows that thermodynamic rather than doping mechanisms are responsible for the different electronic ground state in electron-doped cuprates. (C) 2015 The Japan Society of Applied Physics	[Krockenberger, Yoshiharu; Horio, Masafumi; Irie, Hiroshi; Yamamoto, Hideki] NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan; [Horio, Masafumi; Fujimori, Atsushi] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Krockenberger, Y (reprint author), NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan.	yoshiharu.k@lab.ntt.co.jp	Irie, Hiroshi/E-8147-2010	Irie, Hiroshi/0000-0002-3524-7463			Weber C, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.125107; BRINKMANN M, 1995, PHYS REV LETT, V74, P4927, DOI 10.1103/PhysRevLett.74.4927; Adachi T, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.063713; Halcrow MA, 2013, CHEM SOC REV, V42, P1784, DOI 10.1039/c2cs35253b; TAKAGI H, 1989, PHYS REV LETT, V62, P1197, DOI 10.1103/PhysRevLett.62.1197; PETROV AN, 1988, J SOLID STATE CHEM, V77, P1, DOI 10.1016/0022-4596(88)90083-7; Sebastian SE, 2014, NATURE, V511, P61, DOI 10.1038/nature13326; Fujita M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.147003; Ikeda A, 2011, PHYSICA C, V471, P686, DOI 10.1016/j.physc.2011.05.027; Kang HJ, 2007, NAT MATER, V6, P224, DOI 10.1038/nmat1847; Kang HJ, 2003, NATURE, V423, P522, DOI 10.1038/nature01641; Krockenberger Y, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.184502; Krockenberger Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02235; Lee WS, 2014, NAT PHYS, V10, P883, DOI 10.1038/NPHYS3117; Li SL, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.014520; NAITO M, 1995, APPL PHYS LETT, V67, P2557, DOI 10.1063/1.114431; RADAELLI PG, 1994, PHYS REV B, V49, P15322, DOI 10.1103/PhysRevB.49.15322; SCHMIDTW.RD, 1974, J CRYST GROWTH, V23, P113, DOI 10.1016/0022-0248(74)90110-9; Schultz AJ, 1996, PHYS REV B, V53, P5157, DOI 10.1103/PhysRevB.53.5157; Song D, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.144520; Takagi H, 2007, NAT MATER, V6, P179, DOI 10.1038/nmat1855; THURSTON TR, 1990, PHYS REV LETT, V65, P263, DOI 10.1103/PhysRevLett.65.263; UZUMAKI T, 1991, JPN J APPL PHYS 2, V30, pL981, DOI 10.1143/JJAP.30.L981; Wakimoto S, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.172501; Wordenweber R, 1999, SUPERCOND SCI TECH, V12, pR86, DOI 10.1088/0953-2048/12/6/202; Yamamoto H, 2011, SOLID STATE COMMUN, V151, P771, DOI 10.1016/j.ssc.2011.03.006	26	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	MAY	2015	8	5							053101	10.7567/APEX.8.053101		4	Physics, Applied	Physics	CI7RV	WOS:000354963000020		
J	Miyoshi, M; Fujita, S; Egawa, T				Miyoshi, Makoto; Fujita, Shu; Egawa, Takashi			Numerical and experimental analyses of two-dimensional electron mobility in AI(In,Ga)N/AIGaN heterostructures	APPLIED PHYSICS EXPRESS			English	Article							ALGAN CHANNEL HEMTS; EPITAXIAL ALN/SAPPHIRE TEMPLATES; DISLOCATION SCATTERING; GAS; PERFORMANCE; LAYERS; ENHANCEMENT; TRANSISTORS; QUALITY; ALN	Two-dimensional electron mobilities in AlGaN-channel nitride heterostructures were numerically and experimentally analyzed. The calculation and experimental results indicated that mobility for InAlN/AlGaN heterostructures grown by metalorganic chemical vapor deposition was limited by interface roughness scattering as well as alloy disorder scattering. The mobility limits for AlGaN-channel heterostructures with a two-dimensional electron gas (2DEG) density of 3 x 10(13)/cm(2) were estimated to be, for instance, 249 cm(2)V(-1) s(-1) for an Al0.3Ga0.7N channel and 192 cm(2) V-1 s(-1) for an Al0.5Ga0.5N channel. The calculated values showed no major disagreement with the results reported on AlGaN-channel heterostructures. (C) 2015 The Japan Society of Applied Physics	[Miyoshi, Makoto; Fujita, Shu; Egawa, Takashi] Nagoya Inst Technol, Res Ctr Nano Devices & Adv Mat, Nagoya, Aichi 4668555, Japan; [Miyoshi, Makoto; Egawa, Takashi] Nagoya Inst Technol, Innovat Ctr Multibusiness Nitride Semicond, Nagoya, Aichi 4668555, Japan	Miyoshi, M (reprint author), Nagoya Inst Technol, Res Ctr Nano Devices & Adv Mat, Nagoya, Aichi 4668555, Japan.	miyoshi.makoto@nitech.ac.jp			Super Cluster Program of the Japan Science and Technology (JST) Agency	This work was partially supported by the Super Cluster Program of the Japan Science and Technology (JST) Agency.	Chung JW, 2010, IEEE ELECTR DEVICE L, V31, P195, DOI 10.1109/LED.2009.2038935; Ridley BK, 2000, PHYS REV B, V61, P16862, DOI 10.1103/PhysRevB.61.16862; Lin SC, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.031003; Raman A, 2008, JPN J APPL PHYS, V47, P3359, DOI 10.1143/JJAP.47.3359; GELMONT BL, 1995, J APPL PHYS, V77, P657, DOI 10.1063/1.359051; Hsu L, 1997, PHYS REV B, V56, P1520, DOI 10.1103/PhysRevB.56.1520; Nanjo T, 2009, ELECTRON LETT, V45, P424, DOI 10.1049/el.2009.0129; Foutz BE, 1999, J APPL PHYS, V85, P7727, DOI 10.1063/1.370577; Miyoshi M, 2005, J APPL PHYS, V98, DOI 10.1063/1.2060946; Hashimoto S, 2010, PHYS STATUS SOLIDI C, V7, DOI 10.1002/pssc.200983440; WALUKIEWICZ W, 1984, PHYS REV B, V30, P4571, DOI 10.1103/PhysRevB.30.4571; Zanato D, 2004, SEMICOND SCI TECH, V19, P427, DOI 10.1088/0268-1242/19/3/024; Jena D, 2000, APPL PHYS LETT, V76, P1707, DOI 10.1063/1.126143; HIRAKAWA K, 1986, PHYS REV B, V33, P8291, DOI 10.1103/PhysRevB.33.8291; Hashimoto S, 2012, PHYS STATUS SOLIDI C, V9, DOI 10.1002/pssc.201100289; Romanov AE, 2006, J APPL PHYS, V100, DOI 10.1063/1.2218385; Egawa T., 2012, IEDM; Goldberg Y., 2001, PROPERTIES ADV SEMIC, V31; Hashimoto S, 2012, PHYS STATUS SOLIDI A, V209, P501, DOI 10.1002/pssa.201100379; Hatano M, 2012, IEICE T ELECTRON, VE95C, P1332, DOI 10.1587/transele.E95.C.1332; Hatano M., 2010, IEEE INT C COMP SEM, P101; HUTSON AR, 1961, J APPL PHYS, V32, P2287, DOI 10.1063/1.1777061; Jeon CM, 2004, IEEE ELECTR DEVICE L, V25, P120, DOI 10.1109/LED.2004.824246; Kikkawa T., 2013, ECS T, V50, P323; Liu J, 2004, IEEE INTERNATIONAL ELECTRON DEVICES MEETING 2004, TECHNICAL DIGEST, P811; Liu J, 2005, IEEE ELECTR DEVICE L, V26, P145, DOI 10.1109/LED.2005.843218; Miyoshi M, 2015, APPL PHYS EXPRESS, V8, DOI 10.7567/APEX.8.021001; Nanjo T, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2949087; Nanjo T, 2007, INT EL DEVICES MEET, P397, DOI 10.1109/IEDM.2007.4418956; Nanjo T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.011101; Sakai M, 2002, J CRYST GROWTH, V244, P6, DOI 10.1016/S0022-0248(02)01573-7; Shur M, 2012, SPRINGER SERIES MAT, V156, P83; STERN F, 1972, PHYS REV B, V5, P4891, DOI 10.1103/PhysRevB.5.4891; Tokuda H, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.121003; Wu CI, 1999, APPL PHYS LETT, V74, P546, DOI 10.1063/1.123140	35	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	MAY	2015	8	5							051003	10.7567/APEX.8.051003		4	Physics, Applied	Physics	CI7RV	WOS:000354963000003		
J	Morimoto, T; Okazaki, T				Morimoto, Takahiro; Okazaki, Toshiya			Optical resonance in far-infrared spectra of multiwalled carbon nanotubes	APPLIED PHYSICS EXPRESS			English	Article							ELECTRONIC-STRUCTURE; ABSORPTION-SPECTRA; SPECTROSCOPY	We have studied the plasmon resonance behaviors of various multiwalled carbon nanotubes (MWCNTs) using far-infrared (FIR) spectroscopy. MWCNTs having high crystallinity showed clear FIR peak structures, the same as those observed in single-walled carbon nanotubes (SWCNTs). However, the FIR peak structures in defective MWCNTs were severely suppressed. The observed FIR peak positions apparently depend on the inverse of the MWCNT length. These results are consistent with the one-dimensional plasmon resonance model, which is sensitive to the geometrical structure of a CNT channel and the disturbance of the plasmon motion in the channels. (C) 2015 The Japan Society of Applied Physics	[Morimoto, Takahiro; Okazaki, Toshiya] Technol Res Assoc Single Wall Carbon Nanotubes TA, Tsukuba, Ibaraki 3058565, Japan; [Okazaki, Toshiya] Natl Inst Adv Ind Sci & Technol, Nanotube Res Ctr, Tsukuba, Ibaraki 3058565, Japan	Okazaki, T (reprint author), Technol Res Assoc Single Wall Carbon Nanotubes TA, Tsukuba, Ibaraki 3058565, Japan.	toshi.okazaki@aist.go.jp					Ouyang M, 2001, SCIENCE, V292, P702, DOI 10.1126/science.1058853; Landi BJ, 2005, J PHYS CHEM B, V109, P9952, DOI 10.1021/jp044990c; Dillon AC, 1999, ADV MATER, V11, P1354, DOI 10.1002/(SICI)1521-4095(199911)11:16<1354::AID-ADMA1354>3.0.CO;2-N; EKLUND PC, 1995, CARBON, V33, P959, DOI 10.1016/0008-6223(95)00035-C; Kane CL, 1997, PHYS REV LETT, V78, P1932, DOI 10.1103/PhysRevLett.78.1932; Pekker A, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.075475; Zhang Q, 2013, NANO LETT, V13, P5991, DOI 10.1021/nl403175g; Akima N, 2006, ADV MATER, V18, P1166, DOI 10.1002/adma.200502505; Itkis ME, 2002, NANO LETT, V2, P155, DOI 10.1021/nl0156639; Kataura H, 1999, SYNTHETIC MET, V103, P2555, DOI 10.1016/S0379-6779(98)00278-1; Mintmire JW, 1998, PHYS REV LETT, V81, P2506, DOI 10.1103/PhysRevLett.81.2506; HAMADA N, 1992, PHYS REV LETT, V68, P1579, DOI 10.1103/PhysRevLett.68.1579; Borondics F, 2006, PHYS REV B, V74, DOI 10.1103/PhysREvB.74.045431; Dresselhaus M. S., 2001, TOPICS APPL PHYS, V80; Ichida M, 2011, SOLID STATE COMMUN, V151, P1696, DOI 10.1016/j.ssc.2011.07.046; Jorio A., 2008, TOPICS APPL PHYS, V111; Kampfrath T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.267403; Lauret JS, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.057404; IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0; Morimoto T, 2014, ACS NANO, V8, P9897, DOI 10.1021/nn505430s; Nakanishi T, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.114708; Ren L, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.161401; Shuba MV, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.165435; Slepyan GY, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.205423; Ugawa A., 1999, Physical Review B (Condensed Matter), V60, DOI 10.1103/PhysRevB.60.R11305	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	MAY	2015	8	5							055101	10.7567/APEX.8.055101		4	Physics, Applied	Physics	CI7RV	WOS:000354963000025		
J	Oka, T; Ina, T; Ueno, Y; Nishii, J				Oka, Tohru; Ina, Tsutomu; Ueno, Yukihisa; Nishii, Junya			1.8m Omega.cm(2) vertical GaN-based trench metal-oxide-semiconductor field-effect transistors on a free-standing GaN substrate for 1.2-kV-class operation	APPLIED PHYSICS EXPRESS			English	Article								In this paper, we report on 1.2-kV-class vertical GaN-based trench metal-oxide-semiconductor field-effect transistors (MOSFETs) on a free-standing GaN substrate with a low specific on-resistance. A redesigned epitaxial layer structure following our previous work with a regular hexagonal trench gate layout enables us to reduce the specific on-resistance to as low as 1.8m Omega.cm(2) while obtaining a sufficient blocking voltage for 1.2-kV-class operation. Normally-off operation with a threshold voltage of 3.5V is also demonstrated. To the best of our knowledge, this is the first report on vertical GaN-based MOSFETs with a specific on-resistance of less than 2m Omega.cm(2). (C) 2015 The Japan Society of Applied Physics	[Oka, Tohru; Ina, Tsutomu; Ueno, Yukihisa; Nishii, Junya] TOYODA GOSEI Co Ltd, Res & Dev Headquarters, Ama, Aichi 4901207, Japan	Oka, T (reprint author), TOYODA GOSEI Co Ltd, Res & Dev Headquarters, Ama, Aichi 4901207, Japan.	tg28708@toyoda-gosei.co.jp					Dora Y, 2006, IEEE ELECTR DEVICE L, V27, P713, DOI 10.1109/LED.2006.881020; Tipirneni N, 2006, IEEE ELECTR DEVICE L, V27, P716, DOI 10.1109/LED.2006.881084; Nie H, 2014, IEEE ELECTR DEVICE L, V35, P939, DOI 10.1109/LED.2014.2339197; Okada M, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.054201; Kodama M, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.021104; Kanechika M, 2007, JPN J APPL PHYS 2, V46, pL503, DOI 10.1143/JJAP.46.L503; NAKAMURA S, 1992, JPN J APPL PHYS 1, V31, P1258, DOI 10.1143/JJAP.31.1258; Srivastava P, 2011, IEEE ELECTR DEVICE L, V32, P30, DOI 10.1109/LED.2010.2089493; Oka T, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.021002; Look DC, 2003, APPL PHYS LETT, V83, P3525, DOI 10.1063/1.1623009; Hilt O, 2011, PROC INT SYMP POWER, P239, DOI 10.1109/ISPSD.2011.5890835; Chowdhury S, 2012, IEEE ELECTR DEVICE L, V33, P41, DOI 10.1109/LED.2011.2173456; Egawa T., 2012, IEDM, P613; Hwang I, 2012, PROC INT SYMP POWER, P41; Ikeda N, 2011, PROC INT SYMP POWER, P284, DOI 10.1109/ISPSD.2011.5890846; Kachi T., 2007, IEEE COMP SEM IC S, P13; Lee W, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2535899; Nakamura T., 2011, IEDM, P599; Otake H, 2007, JPN J APPL PHYS 2, V46, pL599, DOI 10.1143/JJAP.46.L599; Otake H, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.011105; Sze S.M., 1981, PHYS SEMICONDUCTOR D, P442; Uemoto Y, 2007, INT EL DEVICES MEET, P861, DOI 10.1109/IEDM.2007.4419085; Umeda H., 2010, IEDM, P480	23	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	MAY	2015	8	5							054101	10.7567/APEX.8.054101		3	Physics, Applied	Physics	CI7RV	WOS:000354963000022		
J	Onuma, T; Sugiura, Y; Yamaguchi, T; Honda, T; Higashiwaki, M				Onuma, Takeyoshi; Sugiura, Yohei; Yamaguchi, Tomohiro; Honda, Tohru; Higashiwaki, Masataka			Impacts of AlOx formation on emission properties of AlN/GaN heterostructures	APPLIED PHYSICS EXPRESS			English	Article							2-DIMENSIONAL ELECTRON-GAS; POLARIZATION	The effects of AlOx formation on the emission properties of AlN/GaN heterostructures are comparatively investigated using steady-state and time-resolved photoluminescence (PL) measurements. By analyzing the excitation power and temperature-dependent PL spectra, PL at around 3.45-3.46 eV is attributed to the two-dimensional electron-gas (2DEG)-related emission. Simultaneous changes in the emission energies and lifetimes are observed by forming a crystallized AlOx layer. The results demonstrate a possibility of controlling the surface states by changing the surface oxide structure. (C) 2015 The Japan Society of Applied Physics	[Onuma, Takeyoshi] Tokyo Natl Coll Technol, Dept Liberal Arts, Hachioji, Tokyo 1930997, Japan; [Onuma, Takeyoshi; Sugiura, Yohei; Yamaguchi, Tomohiro; Honda, Tohru] Kogakuin Univ, Grad Sch Engn, Dept Informat & Commun Engn, Hachioji, Tokyo 1920015, Japan; [Onuma, Takeyoshi; Higashiwaki, Masataka] Natl Inst Informat & Commun Technol, Koganei, Tokyo 1848795, Japan	Onuma, T (reprint author), Tokyo Natl Coll Technol, Dept Liberal Arts, Hachioji, Tokyo 1930997, Japan.	onuma@tokyo-ct.ac.jp	Higashiwaki, Masataka/D-2073-2014		Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [25390071, 25289093, 25420341, 25706020]	This work was supported in part by Grants-in-Aid for Scientific Research Nos. 25390071, 25289093, 25420341, and 25706020 from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT).	Kwack HS, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2000334; Bergman JP, 1996, APPL PHYS LETT, V69, P3456, DOI 10.1063/1.117250; Higashiwaki M, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3522649; Kwon HK, 1999, APPL PHYS LETT, V75, P2788, DOI 10.1063/1.125150; Ambacher O, 1999, J APPL PHYS, V85, P3222, DOI 10.1063/1.369664; Ibbetson JP, 2000, APPL PHYS LETT, V77, P250, DOI 10.1063/1.126940; Higashiwaki M, 2010, J APPL PHYS, V108, DOI 10.1063/1.3481412; Zheng ZW, 2000, PHYS REV B, V62, pR7739, DOI 10.1103/PhysRevB.62.R7739; ASPNES DE, 1973, SURF SCI, V37, P418, DOI 10.1016/0039-6028(73)90337-3; Chichibu S, 1996, APPL PHYS LETT, V68, P3766, DOI 10.1063/1.116000; PASHLEY MD, 1989, PHYS REV B, V40, P10481, DOI 10.1103/PhysRevB.40.10481; Okumura H, 2006, JPN J APPL PHYS 1, V45, P7565, DOI 10.1143/JJAP.45.7565; Bernardini F, 1997, PHYS REV B, V56, P10024; Chichibu SF, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.045501; Kim TW, 2004, SOLID STATE COMMUN, V132, P67, DOI 10.1016/j.ssc.2004.06.039; Miao MS, 2010, J APPL PHYS, V107, DOI 10.1063/1.3431391; Sugiura Y, 2014, J CRYST GROWTH, V405, P64, DOI 10.1016/j.jcrysgro.2014.07.055; Wang T., 2001, Physical Review B (Condensed Matter and Materials Physics), V63, DOI 10.1103/PhysRevB.63.205320	18	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	MAY	2015	8	5							052401	10.7567/APEX.8.052401		3	Physics, Applied	Physics	CI7RV	WOS:000354963000012		
J	Oshima, Y; Vllora, EG; Shimamura, K				Oshima, Yuichi; Vllora, Encarnacion G.; Shimamura, Kiyoshi			Halide vapor phase epitaxy of twin-free alpha-Ga2O3 on sapphire (0001) substrates	APPLIED PHYSICS EXPRESS			English	Article							BETA-GA2O3 SINGLE-CRYSTALS; MOLECULAR-BEAM EPITAXY; THIN-FILMS; GROWTH; ABSORPTION; WAFERS; EDGE; GAN	The halide vapor phase epitaxy of alpha-Ga2O3 is demonstrated for the first time. The films are twin-free and heteroepitaxially grown on sapphire (0001) substrates using gallium chloride and oxygen as precursors. X-ray omega-2 theta and pole figure measurements reveal that the film is single-crystalline (0001) alpha-Ga2O3 with no detectable formation of beta-Ga2O3. The optical bandgap is determined to be 5.16 eV based on the transmittance spectrum. The growth rate monotonically increases with the partial pressures of the raw material gases, reaching approximately 150 mu m/h, which is over two orders of magnitude larger than those of conventional vapor phase epitaxial growth techniques, such as mist CVD or MBE. (C) 2015 The Japan Society of Applied Physics	[Oshima, Yuichi; Vllora, Encarnacion G.; Shimamura, Kiyoshi] Natl Inst Mat Sci, Opt Single Crystals Grp, Tsukuba, Ibaraki 3050044, Japan	Oshima, Y (reprint author), Natl Inst Mat Sci, Opt Single Crystals Grp, Tsukuba, Ibaraki 3050044, Japan.	OSHIMA.Yuichi@nims.go.jp			Japan Society for the Promotion of Science (JSPS) [25420307]	This work was partly supported by a Grant-in-Aid for Scientific Research (C) No. 25420307 from the Japan Society for the Promotion of Science (JSPS).	Akaiwa K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.070203; ROY R, 1952, J AM CHEM SOC, V74, P719, DOI 10.1021/ja01123a039; Kaneko K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.020201; Higashiwaki M, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4821858; Aida H, 2008, JPN J APPL PHYS, V47, P8506, DOI 10.1143/JJAP.47.8506; Shinohara D, 2008, JPN J APPL PHYS, V47, P7311, DOI 10.1143/JJAP.47.73111; Shimamura K, 2005, JPN J APPL PHYS 2, V44, pL7, DOI 10.1143/JJAP.44.L7; Kumaran R, 2010, OPT LETT, V35, P3793, DOI 10.1364/OL.35.003793; Villora EG, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2164407; Fujita S, 2014, J CRYST GROWTH, V401, P588, DOI 10.1016/j.jcrysgro.2014.02.032; Galazka Z, 2014, J CRYST GROWTH, V404, P184, DOI 10.1016/j.jcrysgro.2014.07.021; Villora EG, 2004, J CRYST GROWTH, V270, P420, DOI 10.1016/j.jcrysgro.2004.06.027; Kawaharamura T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.040207; Oshima T, 2008, THIN SOLID FILMS, V516, P5768, DOI [10.1016/j.tsf.2007.10.045, 10.1016/j.tsf2007.10.045]; Higashiwaki M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3674287; Oshima T, 2007, JPN J APPL PHYS 1, V46, P7217, DOI 10.1143/JJAP.46.7217; BANS VS, 1973, J PHYS CHEM SOLIDS, V34, P1119, DOI 10.1016/S0022-3697(73)80020-4; MATSUMOT.T, 1974, JPN J APPL PHYS, V13, P1578, DOI 10.1143/JJAP.13.1578; Murakami H, 2015, APPL PHYS EXPRESS, V8, DOI 10.7567/APEX.8.015503; Nomura K, 2014, J CRYST GROWTH, V405, P19, DOI 10.1016/j.jcrysgro.2014.06.051; Oshima T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.011202; Oshima Y, 2003, JPN J APPL PHYS 2, V42, pL1, DOI 10.1143/JJAP.42.L1; Oshima Y., 2015, CRYST GROWTH, V410, P53; Sasaki K, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.035502; Suzuki N, 2007, PHYS STATUS SOLIDI C, V4, P2310, DOI 10.1002/pssc.200674884; TIETJEN JJ, 1966, J ELECTROCHEM SOC, V113, P724, DOI 10.1149/1.2424100; TIPPINS HH, 1965, PHYS REV, V140, pA316, DOI 10.1103/PhysRev.140.A316; Villora EG, 2014, PROC SPIE, V8987, DOI 10.1117/12.2039305; Villora EG, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2919728	29	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	MAY	2015	8	5							055501	10.7567/APEX.8.055501		4	Physics, Applied	Physics	CI7RV	WOS:000354963000029		
J	Qu, C; Yoshimura, M; Takahashi, Y; Mori, Y				Qu, Chen; Yoshimura, Masashi; Takahashi, Yoshinori; Mori, Yusuke			Highly efficient 355nm UV generation with non-collinear phase-matching by a prism-coupled device based on CsLiB6O10	APPLIED PHYSICS EXPRESS			English	Article							II 2ND-HARMONIC GENERATION; SOLID-STATE LASERS; KTIOPO4; CRYSTAL; LIB3O5; LIGHT; POWER; NM	We report 355nm third-harmonic generation (THG) of UV light using CsLiB6O10 (CLBO). To compensate for the walk-off angle in THG by Type II CLBO, we designed a prism-coupled device that takes advantage of non-collinear phase-matching. This new device, equipped with a Nd:YVO4 laser source, achieved THG with 1.86W at 47.6% conversion efficiency from the second-harmonic input. This result marks a 1.43-fold improvement over a conventional CLBO crystal, thus validating the effectiveness of the design for walk-off compensation in Type II THG. This is also the first time THG has been achieved using CLBO. (C) 2015 The Japan Society of Applied Physics	[Qu, Chen; Yoshimura, Masashi; Takahashi, Yoshinori; Mori, Yusuke] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan	Yoshimura, M (reprint author), Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan.	yoshi@eei.eng.osaka-u.ac.jp	Yoshimura, Masashi/N-7222-2013; Mori, Yusuke/C-3302-2014		JST-CREST; JSPS KAKENHI [26286064]	The optical contact technique and CLBO cutting and polishing in the experiment are provided by Kogakugiken Corporation. The work is supported by JST-CREST and JSPS KAKENHI Grant Number 26286064.	Yan XP, 2014, J OPTICS-UK, V16, DOI 10.1088/2040-8978/16/4/045201; ROBERTS DA, 1992, IEEE J QUANTUM ELECT, V28, P2057, DOI 10.1109/3.159516; KATO K, 1994, IEEE J QUANTUM ELECT, V30, P2950, DOI 10.1109/3.362711; Sasaki T, 2000, MAT SCI ENG R, V30, P1, DOI 10.1016/S0927-796X(00)00025-5; BOYD GD, 1968, J APPL PHYS, V39, P3597, DOI 10.1063/1.1656831; ASAUMI K, 1992, APPL PHYS B-PHOTO, V54, P265, DOI 10.1007/BF00325191; Asaumi K, 1998, APPL OPTICS, V37, P555, DOI 10.1364/AO.37.000555; Bovatsek JM, 2010, PROC SPIE, V7585, DOI 10.1117/12.845298; Chen C., 2012, NONLINEAR OPTICAL BO; Chen CT, 2001, CHINESE PHYS LETT, V18, P1081, DOI 10.1088/0256-307X/18/8/327; Deki K., 1997, C LAS EL CLEO; Endert H, 1999, J LASER APPL, V11, P1; Hodgson N, 2003, P SOC PHOTO-OPT INS, V4977, P281, DOI 10.1117/12.479574; Hoffman H. J., 2007, US Patent, Patent No. 7292387; Katsura T., 2007, EUR C LAS EL CLEO EU; Kitano H, 2003, OPT LETT, V28, P263, DOI 10.1364/OL.28.000263; Nishioka M., 2003, C LAS EL CLEO; QIU P, 1988, APPL PHYS B-PHOTO, V45, P225, DOI 10.1007/BF00687150; Shoji I, 2001, J OPT SOC AM B, V18, P302, DOI 10.1364/JOSAB.18.000302; Smith A. V., SNLO NONLINEAR OPTIC; Umemura N, 1999, OSA TRENDS OPT PHOTO, V26, P715; Wang CX, 2006, P SOC PHOTO-OPT INS, V6100, P10019, DOI 10.1117/12.659288; WU BC, 1989, OPT LETT, V14, P1080, DOI 10.1364/OL.14.001080; Zhu P, 2013, OPT LETT, V38, P4716, DOI 10.1364/OL.38.004716; ZONDY JJ, 1994, J OPT SOC AM B, V11, P2368, DOI 10.1364/JOSAB.11.002368	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	MAY	2015	8	5							052601	10.7567/APEX.8.052601		4	Physics, Applied	Physics	CI7RV	WOS:000354963000015		
J	Skowronski, W; Nozaki, T; Shiota, Y; Tamaru, S; Yakushiji, K; Kubota, H; Fukushima, A; Yuasa, S; Suzuki, Y				Skowronski, Witold; Nozaki, Takayuki; Shiota, Yoichi; Tamaru, Shingo; Yakushiji, Kay; Kubota, Hitoshi; Fukushima, Akio; Yuasa, Shinji; Suzuki, Yoshishige			Perpendicular magnetic anisotropy of Ir/CoFeB/MgO trilayer system tuned by electric fields	APPLIED PHYSICS EXPRESS			English	Article							MGO	The perpendicular magnetic anisotropy of an Ir/CoFeB/MgO trilayer was investigated after annealing at temperatures ranging from 200 to 350 degrees C. In the trilayer system annealed at 300 degrees C, we measured an interface anisotropy energy of 1.9mJ/m(2). Further annealing led to mixing of the buffer and ferromagnet, degrading the properties of the latter. In addition, we show the dependence of the magnetic anisotropy on the bias voltage. The presented system is important for the development of perpendicular magnetic tunnel junctions for storage applications. (C) 2015 The Japan Society of Applied Physics	[Skowronski, Witold; Nozaki, Takayuki; Shiota, Yoichi; Tamaru, Shingo; Yakushiji, Kay; Kubota, Hitoshi; Fukushima, Akio; Yuasa, Shinji; Suzuki, Yoshishige] Natl Inst Adv Ind Sci & Technol, Spintron Res Ctr, Tsukuba, Ibaraki 3058568, Japan; [Skowronski, Witold] AGH Univ Sci & Technol, Dept Elect, PL-30059 Krakow, Poland; [Suzuki, Yoshishige] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan	Skowronski, W (reprint author), Natl Inst Adv Ind Sci & Technol, Spintron Res Ctr, Tsukuba, Ibaraki 3058568, Japan.	skowron@agh.edu.pl	SUZUKI, Yoshishige/D-2652-2013; Shiota, Yoichi/G-8440-2013		Strategic AIST integrated RD program; IMPULSE: Initiative for Most Power-efficient Ultra-Large-Scale data Exploration; ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan); Foundation for Polish Science (FNP) scholarship under the START Programme	We thank E. Usuda, Y. Sato, and M. Sekine for assistance with the experiment and T. Yorozu for a fruitful discussion. This work was partly supported by the Strategic AIST integrated R&D program, "IMPULSE: Initiative for Most Power-efficient Ultra-Large-Scale data Exploration" and the ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan). W.S. acknowledges a Foundation for Polish Science (FNP) scholarship under the START Programme.	Worledge DC, 2014, J APPL PHYS, V115, DOI 10.1063/1.4870169; Fujisaki Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.040001; Ma QL, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4754118; Cheng TI, 2012, J APPL PHYS, V112, DOI 10.1063/1.4742195; CARCIA PF, 1985, APPL PHYS LETT, V47, P178, DOI 10.1063/1.96254; Maruyama T, 2009, NAT NANOTECHNOL, V4, P158, DOI [10.1038/nnano.2008.406, 10.1038/NNANO.2008.406]; Nozaki T, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3279157; Ikeda S, 2010, NAT MATER, V9, P721, DOI [10.1038/nmat2804, 10.1038/NMAT2804]; Zhang RJ, 2001, PHYS REV LETT, V86, P2665, DOI 10.1103/PhysRevLett.86.2665; Skowronski W, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4893463; Miura Y, 2013, J APPL PHYS, V113, DOI 10.1063/1.4811685; Mangin S, 2006, NAT MATER, V5, P210, DOI 10.1038/nmat1595; Rajanikanth A, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4817268; Sinha J, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4811269; Weisheit M, 2007, SCIENCE, V315, P349, DOI 10.1126/science.1136629; Odkhuu D, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.184405; Yoda H, 2010, CURR APPL PHYS, V10, pE87, DOI 10.1016/j.cap.2009.12.021; Bauer U, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4712620; Cui B, 2013, J ALLOY COMPD, V559, P112, DOI 10.1016/j.jallcom.2013.01.093; Goncalves AM, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4826927; Kubota H, 2012, J APPL PHYS, V111, DOI 10.1063/1.3679393; Lambert CH, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4798291; Liu T, 2012, AIP ADV, V2, DOI 10.1063/1.4748337; Nakayama M, 2008, J APPL PHYS, V103, DOI 10.1063/1.2838335; Nozaki Takayuki, 2012, Nature Physics, V8, DOI 10.1038/nphys2298; Oh YW, 2014, J APPL PHYS, V115, DOI 10.1063/1.4864047; Okabayashi J, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4896290; Przewoznik, 2013, J APPL PHYS, V114; Sato H, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4736727; Shinjo T., 1979, J PHYS, V40, pC2; Shiota Y, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.043005; Skowronski W, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.094419; Tiusan C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.106602; Yakata S, 2009, J APPL PHYS, V105, DOI 10.1063/1.3057974; Yamanouchi M, 2011, J APPL PHYS, V109, DOI 10.1063/1.3554204; Yuasa S., 2013, IEDM, P3	36	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	MAY	2015	8	5							053003	10.7567/APEX.8.053003		4	Physics, Applied	Physics	CI7RV	WOS:000354963000019		
J	Takayanagi, R; Fujii, T; Asamitsu, A				Takayanagi, Ryohei; Fujii, Takenori; Asamitsu, Atsushi			Simultaneous control of thermoelectric properties in p- and n-type materials by electric double-layer gating: New design for thermoelectric device	APPLIED PHYSICS EXPRESS			English	Article							FIELD; SUPERCONDUCTIVITY; INSULATOR; TRANSISTORS; OXIDES; METAL	We report a novel design of a thermoelectric device that can control the thermoelectric properties of p- and n-type materials simultaneously by electric double-layer gating. Here, p-type Cu2O and n-type ZnO were used as the positive and negative electrodes of the electric double-layer capacitor structure. When a gate voltage was applied between the two electrodes, holes and electrons accumulated on the surfaces of Cu2O and ZnO, respectively. The thermopower was measured by applying a thermal gradient along the accumulated layer on the electrodes. We demonstrate here that the accumulated layers worked as a p-n pair of the thermoelectric device. (C) 2015 The Japan Society of Applied Physics	[Takayanagi, Ryohei; Asamitsu, Atsushi] Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; [Fujii, Takenori; Asamitsu, Atsushi] Univ Tokyo, Cryogen Res Ctr, Bunkyo Ku, Tokyo 1130032, Japan	Fujii, T (reprint author), Univ Tokyo, Cryogen Res Ctr, Bunkyo Ku, Tokyo 1130032, Japan.	fujii@crc.u-tokyo.ac.jp					Mahan GD, 1998, SOLID STATE PHYS, V51, P81; Shimotani H, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2939006; Yuan HT, 2011, NANO LETT, V11, P2601, DOI 10.1021/nl201561u; Ahn CH, 2003, NATURE, V424, P1015, DOI 10.1038/nature01878; Taniguchi K, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4740268; Shimotani H, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2772781; Zhao LD, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3485050; Zhang YJ, 2012, NANO LETT, V12, P1136, DOI 10.1021/nl2021575; Yuan HT, 2013, NAT PHYS, V9, P563, DOI 10.1038/NPHYS2691; Ueno K, 2008, NAT MATER, V7, P855, DOI 10.1038/nmat2298; Ito T, 1998, J MATER SCI, V33, P3555, DOI 10.1023/A:1004690809547; Yuan HT, 2009, ADV FUNCT MATER, V19, P1046, DOI 10.1002/adfm.200801633; Pearton SJ, 2003, J APPL PHYS, V93, P1, DOI 10.1063/1.1517164; Ohtaki M, 1996, J APPL PHYS, V79, P1816, DOI 10.1063/1.360976; Zhang YJ, 2013, NANO LETT, V13, P3023, DOI 10.1021/nl400902v; Kotz R, 2000, ELECTROCHIM ACTA, V45, P2483, DOI 10.1016/S0013-4686(00)00354-6; Ye JT, 2010, NAT MATER, V9, P125, DOI [10.1038/nmat2587, 10.1038/NMAT2587]; Ueno K, 2011, NAT NANOTECHNOL, V6, P408, DOI [10.1038/nnano.2011.78, 10.1038/NNANO.2011.78]; GLOVER RE, 1960, PHYS REV LETT, V5, P248, DOI 10.1103/PhysRevLett.5.248; Inoue IH, 2005, SEMICOND SCI TECH, V20, pS112, DOI 10.1088/0268-1242/20/4/013; Ohta H, 2013, J MATER SCI, V48, P2797, DOI 10.1007/s10853-012-6856-6; Ohta H, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1112; Takayanagi R, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.111101	23	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	MAY	2015	8	5							051101	10.7567/APEX.8.051101		4	Physics, Applied	Physics	CI7RV	WOS:000354963000004		
J	Tanaka, H; Sawada, E; Azuma, K; Kuroda, S				Tanaka, Hisaaki; Sawada, Eishi; Azuma, Kenjiro; Kuroda, Shin-ichi			Direct probing of gate-bias stress effect in organic transistors by electron spin resonance spectroscopy	APPLIED PHYSICS EXPRESS			English	Article							FIELD-EFFECT TRANSISTORS; STABILITY	The origin of gate-bias stress effect in organic field-effect transistors of poly(9,9-dioctylfluorene-co-bithiophene) has been studied by the direct observation of charge carriers using electron spin resonance. Stressed devices exhibited a remarkable decrease in polaron concentration, demonstrating the formation of nonmagnetic trap charges. The observed spin-charge relation excludes the formation of nonmagnetic bipolarons, which suggests that the trap charges are not in semiconducting layers but in the gate dielectrics. The results are consistent with the previously proposed migration of protons into dielectrics, produced by oxygen/water redox reactions. The suppression of the stress effect by adopting a topgate device geometry, sealing water vapor, further supports the mechanism. (C) 2015 The Japan Society of Applied Physics	[Tanaka, Hisaaki; Sawada, Eishi; Azuma, Kenjiro; Kuroda, Shin-ichi] Nagoya Univ, Dept Appl Phys, Nagoya, Aichi 4648603, Japan	Tanaka, H (reprint author), Nagoya Univ, Dept Appl Phys, Nagoya, Aichi 4648603, Japan.	htanaka@nuap.nagoya-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25287073, 24654087, 26400315]; Murata Science Foundation	The authors are grateful to Professor M. Matsushita and Professor K. Awaga for their help with the fabrication of parylene dielectric layers. This work was partially supported by Grants-in-Aid for Scientific Research (Nos. 25287073, 24654087, and 26400315) from the Japan Society for the Promotion of Science (JSPS), and by the Murata Science Foundation.	Chen Y, 2012, ADV MATER, V24, P2679, DOI 10.1002/adma.201200455; Watanabe S, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3421538; Marumoto K, 2005, J PHYS SOC JPN, V74, P3066, DOI 10.1143/JPSJ.74.3066; Gholamrezaie F, 2012, SMALL, V8, P241, DOI 10.1002/smll.201101467; Pattison LR, 2006, MACROMOLECULES, V39, P2225, DOI 10.1021/ma0521912; Holliday S, 2014, CHEM MATER, V26, P647, DOI 10.1021/cm402421p; Mathijssen SGJ, 2010, ADV MATER, V22, P5105, DOI 10.1002/adma.201001865; Lee WH, 2014, ADV MATER, V26, P1660, DOI 10.1002/adma.201304665; Sirringhaus H, 2009, ADV MATER, V21, P3859, DOI 10.1002/adma.200901136; Zilker SJ, 2001, APPL PHYS LETT, V79, P1124, DOI 10.1063/1.1394718; Sirringhaus H, 2000, APPL PHYS LETT, V77, P406, DOI 10.1063/1.126991; Sharma A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.075322; Bobbert PA, 2012, ADV MATER, V24, P1146, DOI 10.1002/adma.201104580; Sirringhaus H, 2005, ADV MATER, V17, P2411, DOI 10.1002/adma.200501152; Tanaka H, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3100193; Kumaki D, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2890853; Gomes HL, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2178410; Endo T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.121601; Kalb WL, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2709894; Kinoshita Y, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4890962; Lee B, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.085302; Marumoto K, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.256603; Pietro R. D., 2012, ADV MATER, V24, P3367; Richards T, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2825584; Salleo A, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.235324; Sharma A, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3275807; Street R. A., 2003, PHYS REV B, V68; Tanaka H, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.045309; Tanaka H, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.081306; Tanaka H, 2014, ADV MATER, V26, P2376, DOI 10.1002/adma.201304691; Wang SD, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2844857; Yasuda T, 2003, JPN J APPL PHYS 1, V42, P6614, DOI 10.1143/JJAP.42.6614	32	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	MAY	2015	8	5							051603	10.7567/APEX.8.051603		4	Physics, Applied	Physics	CI7RV	WOS:000354963000010		
J	Uedono, A; Kurihara, K; Yoshihara, N; Nagao, S; Ishibashi, S				Uedono, Akira; Kurihara, Kaori; Yoshihara, Nakaaki; Nagao, Satoshi; Ishibashi, Shoji			Vacancies in InxGa1-xN/GaN multiple quantum wells fabricated on m-plane GaN probed by a monoenergetic positron beam	APPLIED PHYSICS EXPRESS			English	Article								Vacancy-type defects in InxGa1-xN/GaN multiple-quantum-well (MQW) structures fabricated on m-plane GaN by metal-organic chemical vapor deposition have been studied using a monoenergetic positron beam. Through measurements of Doppler broadening spectra of the annihilation radiation, the vacancy-type defects in MQW structures were probed. The positron trapping rate of defects decreased under photon illumination, which is attributed to the emission of electrons from those defects and/or the suppression of the positron diffusion by optically active defects. The energy level of the defects was close to the energy of photoluminescence emissions. The relationship between the energy width of the photoluminescence line and the defects is discussed. (C) 2015 The Japan Society of Applied Physics	[Uedono, Akira; Yoshihara, Nakaaki] Univ Tsukuba, Fac Pure & Appl Sci, Div Appl Phys, Tsukuba, Ibaraki 3058573, Japan; [Kurihara, Kaori; Nagao, Satoshi] Mitsubishi Chem Corp, Ushiku, Ibaraki 3001295, Japan; [Ishibashi, Shoji] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan	Uedono, A (reprint author), Univ Tsukuba, Fac Pure & Appl Sci, Div Appl Phys, Tsukuba, Ibaraki 3058573, Japan.	uedono.akira.gb@u.tsukuba.ac.jp					Huang Y, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3605253; Tuomisto F, 2013, REV MOD PHYS, V85, P1583, DOI 10.1103/RevModPhys.85.1583; ZUNGER A, 1990, PHYS REV LETT, V65, P353, DOI 10.1103/PhysRevLett.65.353; MILLER DAB, 1985, PHYS REV B, V32, P1043, DOI 10.1103/PhysRevB.32.1043; Fujito K, 2009, J CRYST GROWTH, V311, P3011, DOI 10.1016/j.jcrysgro.2009.01.046; Kelchner KM, 2013, J CRYST GROWTH, V382, P80, DOI 10.1016/j.jcrysgro.2013.08.013; VANVEEN A, 1995, APPL SURF SCI, V85, P216, DOI 10.1016/0169-4332(94)00334-3; Uedono A, 2007, J APPL PHYS, V102, DOI 10.1063/1.2798586; Van de Walle CG, 2004, J APPL PHYS, V95, P3851, DOI 10.1063/1.1682673; Ishibashi S, 2014, J PHYS CONF SER, V505, DOI 10.1088/1742-6596/505/1/012010; Chichibu SF, 2012, SEMICOND SCI TECH, V27, DOI 10.1088/0268-1242/27/2/024008; Krause-Rehberg R., 1999, SPRINGER SERIES SOLI, V127; Maki JM, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/36/364216; Maki JM, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.217403; Marcinkevicius S, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4794904; McNamara JD, 2014, PHYS STATUS SOLIDI C, V11, P726, DOI 10.1002/pssc.201300553; Nakamura S, 2000, INTRO NITRIDE SEMICO; Uedono A, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.121001; Uedono A, 2013, J APPL PHYS, V114, DOI 10.1063/1.4830033; Uedono A, 2013, J APPL PHYS, V114, DOI 10.1063/1.4818720; Uedono A, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4866966; Uedono A, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4892834; Uedono A, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.08JJ02; Uedono A, 2009, J APPL PHYS, V105, DOI 10.1063/1.3075907	24	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	MAY	2015	8	5							051002	10.7567/APEX.8.051002		4	Physics, Applied	Physics	CI7RV	WOS:000354963000002		
J	Ukhtary, MS; Hasdeo, EH; Nugraha, ART; Saito, R				Ukhtary, M. Shoufie; Hasdeo, Eddwi H.; Nugraha, Ahmad R. T.; Saito, Riichiro			Fermi energy-dependence of electromagnetic wave absorption in graphene	APPLIED PHYSICS EXPRESS			English	Article							TRANSISTORS	Undoped graphene is known to absorb 2.3% of visible light at a normal angle of incidence. In this paper, we theoretically demonstrate that the absorption of 10-100 GHz of an electromagnetic wave can be tuned from nearly 0 to 100% by varying the Fermi energy of graphene when the angle of incidence of the electromagnetic wave is kept within total internal reflection geometry. We calculate the absorption probability of the electromagnetic wave as a function of the Fermi energy of graphene and the angle of incidence of the wave. These results open up possibilities for the development of simple electromagnetic wave-switching devices operated by gate voltage. (C) 2015 The Japan Society of Applied Physics	[Ukhtary, M. Shoufie; Hasdeo, Eddwi H.; Nugraha, Ahmad R. T.; Saito, Riichiro] Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan	Ukhtary, MS (reprint author), Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan.		Nugraha, Ahmad Ridwan Tresna/A-5363-2011; Saito, Riichiro/B-1132-2008	Nugraha, Ahmad Ridwan Tresna/0000-0002-5108-1467; 	MEXT scholarship; Interdepartmental Doctoral Degree Program of Tohoku University; MEXT [25286005, 25107005]	M.S.U. and E.H. acknowledge the support of a MEXT scholarship. A.R.T.N. acknowledges the support of the Interdepartmental Doctoral Degree Program of Tohoku University, and R.S. acknowledges MEXT Grants Nos. 25286005 and 25107005. We are all grateful to Professor J. Kono (Rice University) for fruitful discussions which stimulated this work.	Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Piper JR, 2014, ACS PHOTONICS, V1, P347, DOI 10.1021/ph400090p; Hwang EH, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.205418; Ferreira A, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.235410; Lin YM, 2009, NANO LETT, V9, P422, DOI 10.1021/nl803316h; Schwierz F, 2010, NAT NANOTECHNOL, V5, P487, DOI [10.1038/nnano.2010.89, 10.1038/NNANO.2010.89]; Nikitin AY, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.081405; Koppens FHL, 2011, NANO LETT, V11, P3370, DOI 10.1021/nl201771h; Jablan M, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.245435; Bruss H., 2004, MANY BODY QUANTUM TH; Thongrattanasiri S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.047401; Wunsch B, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/12/318	13	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	MAY	2015	8	5							055102	10.7567/APEX.8.055102		4	Physics, Applied	Physics	CI7RV	WOS:000354963000026		
J	Zheng, YJ; Kawashima, T; Satoh, N; Sekine, T; Kan, H				Zheng, Yujin; Kawashima, Toshiyuki; Satoh, Nakahiro; Sekine, Takashi; Kan, Hirofumi			Narrow-bandwidth and stable-wavelength operation of spatial beam-combining high-power laser-diode stack configuration using a single volume Bragg grating	APPLIED PHYSICS EXPRESS			English	Article							ARRAY	The spectral bandwidth was effectively suppressed and the wavelength was locked for two high-power laser-diode (LD) stacks with an external-cavity configuration that consisted of a stripe mirror and volume Bragg grating. During operation at a drive current of 100 A, the bandwidth was reduced from 2.59 to 0.31nm (8.4-fold reduction), and a peak power output of 581W was achieved. The power spectral density of the combined beam was increased to 1874W/nm from 279W/nm. The high-power-density external-cavity LD stack source showed a narrow spectral bandwidth and stable spectrum over the entire current range. (C) 2015 The Japan Society of Applied Physics	[Zheng, Yujin; Kawashima, Toshiyuki; Satoh, Nakahiro; Sekine, Takashi; Kan, Hirofumi] Hamamatsu Photon KK, Power Laser Dev Sect, Hamamatsu, Shizuoka 4311202, Japan	Zheng, YJ (reprint author), Hamamatsu Photon KK, Power Laser Dev Sect, Hamamatsu, Shizuoka 4311202, Japan.	y-zheng@crl.hpk.co.jp					Meng LS, 2006, OPT EXPRESS, V14, P10469, DOI 10.1364/OE.14.010469; Zheng YJ, 2005, OPT LETT, V30, P2424, DOI 10.1364/OL.30.002424; Kracht D, 2005, OPT EXPRESS, V13, P10140, DOI 10.1364/OPEX.13.010140; Volodin BL, 2004, OPT LETT, V29, P1891, DOI 10.1364/OL.29.001891; Zheng YJ, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.032501; Krupke WF, 2003, OPT LETT, V28, P2336, DOI 10.1364/OL.28.002336; Feeler R., 1997, [No title captured], Patent No. 9230977; Levy J, 2012, PROC SPIE, V8241, DOI 10.1117/12.909276; Ohashi H, 2004, OPT ENG, V43, P2206, DOI 10.1117/1.1789151; Paboeuf D, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3036896; Pavel N, 2010, OPT LETT, V35, P1617, DOI 10.1364/OL.35.001617; Zheng YJ, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.092702	12	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	MAY	2015	8	5							052701	10.7567/APEX.8.052701		4	Physics, Applied	Physics	CI7RV	WOS:000354963000016		
J	Ishizaka, N; Tanigawa, J; Suzuki, S				Ishizaka, Nobukazu; Tanigawa, Jun; Suzuki, Shuji			Sudden Cardiac Death Due To IgG4-Related Disease	ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE			English	Letter							G4-RELATED CORONARY PERIARTERITIS; ARTERY		[Ishizaka, Nobukazu; Tanigawa, Jun; Suzuki, Shuji] Osaka Med Coll, Dept Cardiol, Osaka, Japan	Ishizaka, N (reprint author), Osaka Med Coll, Dept Cardiol, Osaka, Japan.						Grabner R, 2009, J EXP MED, V206, P233, DOI 10.1084/jem.20080752; Tanigawa J, 2012, HUM PATHOL, V43, P1131, DOI 10.1016/j.humpath.2011.09.019; Urabe Y, 2012, CIRC-CARDIOVASC IMAG, V5, P685, DOI 10.1161/CIRCIMAGING.112.975946; Matsumoto Y, 2008, HUM PATHOL, V39, P975, DOI 10.1016/j.humpath.2007.10.023; Patel NR, 2014, ARCH PATHOL LAB MED, V138, P833, DOI 10.5858/arpa.2012-0614-CR	5	0	0	COLL AMER PATHOLOGISTS	NORTHFIELD	C/O KIMBERLY GACKI, 325 WAUKEGAN RD, NORTHFIELD, IL 60093-2750 USA	0003-9985	1543-2165		ARCH PATHOL LAB MED	Arch. Pathol. Lab. Med.	MAY	2015	139	5					571	571		10.5858/arpa.2014-0325-LE		1	Medical Laboratory Technology; Medicine, Research & Experimental; Pathology	Medical Laboratory Technology; Research & Experimental Medicine; Pathology	CI6EL	WOS:000354851400002		
J	Odaka, K				Odaka, Konosuke			World Economic Performance-past, present and future: essays in celebration of the life and work of Angus Maddison	ASIAN-PACIFIC ECONOMIC LITERATURE			English	Review									Hitotsubashi Univ, Inst Econ Res, Tokyo, Japan	Odaka, K (reprint author), Hitotsubashi Univ, Inst Econ Res, Tokyo, Japan.						Bosworth B., 2006, SOURCES GROWTH INDIA; Maddison A., 2001, WORLD EC MILLENNIAL	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0818-9935	1467-8411		ASIAN-PAC ECON LIT	Asian-Pac Econ. Lit.	MAY	2015	29	1					186	193		10.1111/apel.12097		8	Economics	Business & Economics	CI4NJ	WOS:000354726600011		
J	Asanuma, S				Asanuma, Shinji			Fiscal Sustainability & Competitiveness in Europe and Asia	ASIAN-PACIFIC ECONOMIC LITERATURE			English	Book Review									[Asanuma, Shinji] Hitotsubashi Univ, Tokyo, Japan	Asanuma, S (reprint author), Hitotsubashi Univ, Tokyo, Japan.						Reinhart CM, 2010, AM ECON REV, V100, P573, DOI 10.1257/aer.100.2.573; Herndon Thomas, 2013, WORKING PAPER SERIES, V322; RAJAN RS, 2014, FISCAL SUSTAINABILIT	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0818-9935	1467-8411		ASIAN-PAC ECON LIT	Asian-Pac Econ. Lit.	MAY	2015	29	1					194	195		10.1111/apel.12107		2	Economics	Business & Economics	CI4NJ	WOS:000354726600012		
J	Takigawa, A; Tachibana, S; Nagahara, H; Ozawa, K				Takigawa, Aki; Tachibana, Shogo; Nagahara, Hiroko; Ozawa, Kazuhito			EVAPORATION AND CONDENSATION KINETICS OF CORUNDUM: THE ORIGIN OF THE 13 mu m FEATURE OF OXYGEN-RICH AGB STARS	ASTROPHYSICAL JOURNAL SUPPLEMENT SERIES			English	Article						dust, extinction; meteorites, meteors, meteoroids; stars: AGB and post-AGB; stars: mass-loss; stars: winds, outflows	HABIT CONTROLLING FACTOR; IRAS LRS OBSERVATIONS; GIANT BRANCH STARS; DUST FORMATION; ATTACHMENT ENERGY; PRESOLAR AL2O3; SOLAR NEBULA; ISOTOPIC FRACTIONATION; CIRCUMSTELLAR DUST; SURFACE RELAXATION	Corundum is predicted to be the most abundant refractory circumstellar dust and has been suggested as a candidate emitting the 13 mu m feature in infrared spectra of oxygen-rich asymptotic giant branch stars. Crystalline dust has morphologies reflecting the anisotropic crystal structure and formation conditions or processes. and may emit characteristic infrared features. In this study, evaporation and condensation experiments of corundum along different crystallographic orientations were performed in vacuum to determine key kinetic parameters controlling morphological anisotropy: evaporation and condensation coefficients (alpha(e) and alpha(c)), the degrees of kinetic hindrance on evaporation and condensation. Plausible shapes of corundum condensates were estimated from the experimental results to evaluate the infrared features of corundum condensates. The evaporation coefficients of corundum are 0.02-0.2 at 1600-1785 degrees C, which increase with temperature and show notable anisotropy. The order of ae along the crystallographic c, a, and m. axes is alpha(m)(e) >> alpha(e) (a) > alpha(c)(e) irrespective of temperature. The obtained condensation coefficients along the c, a, and m. axes at 1575 degrees C and a supersaturation ratio of similar to 4 are 0.04-0.06, 0.06-0.08, and 0.1-0.2, respectively. The morphology of condensed circumstellar corundum expected from our experiments is oblate and slightly flattened to the c. axis. and is consistent with the fact that no presolar corundum with eccentric shapes has been found. The mass absorption coefficient of oblate corundum slightly flattened to the c. axis shows a peak at 13 mu m without any accompanying strong peaks. These results strongly indicate that corundum condensed anisotropically in circumstellar environments is a carrier of the unidentified 13 mu m feature around oxygen-rich evolved stars.	[Takigawa, Aki] Kyoto Univ, Grad Sch Sci, Div Earth & Planetary Sci, Kyoto 6068502, Japan; [Tachibana, Shogo] Hokkaido Univ, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan; [Nagahara, Hiroko; Ozawa, Kazuhito] Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan	Takigawa, A (reprint author), Kyoto Univ, Grad Sch Sci, Div Earth & Planetary Sci, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	takigawa@kueps.kyoto-u.ac.jp; tachi@ep.sci.hokudai.ac.jp; hiroko@eps.s.u-tokyo.ac.jp; ozawa@eps.s.u-tokyo.ac.jp			 [12J02495]	We are grateful to Aya Okubo for her help in condensation experiments. We also appreciate constructive and helpful comments from an anonymous reviewer. This work was supported by Grant-in-Aid for JSPS Fellows (12J02495) (AT).	Akulenok E. M., 1974, Soviet Physics - Crystallography, V18; SANTELER DJ, 1986, J VAC SCI TECHNOL A, V4, P338, DOI 10.1116/1.573923; Knapp GR, 1998, ASTROPHYS J SUPPL S, V117, P209, DOI 10.1086/313111; Begemann B, 1997, ASTROPHYS J, V476, P199, DOI 10.1086/303597; GROSSMAN L, 1972, GEOCHIM COSMOCHIM AC, V36, P597, DOI 10.1016/0016-7037(72)90078-6; Nittler LR, 2008, ASTROPHYS J, V682, P1450, DOI 10.1086/589430; MACKRODT WC, 1987, J CRYST GROWTH, V80, P441, DOI 10.1016/0022-0248(87)90093-5; HUTCHEON ID, 1994, ASTROPHYS J, V425, pL97, DOI 10.1086/187319; HARTMAN P, 1980, J CRYST GROWTH, V49, P145, DOI 10.1016/0022-0248(80)90075-5; Posch T, 1999, ASTRON ASTROPHYS, V352, P609; NITTLER LR, 1994, NATURE, V370, P443, DOI 10.1038/370443a0; Speck AK, 2000, ASTRON ASTROPHYS SUP, V146, P437, DOI 10.1051/aas:2000274; Floss C, 2009, GEOCHIM COSMOCHIM AC, V73, P2415, DOI 10.1016/j.gca.2009.01.033; Nittler LR, 1997, ASTROPHYS J, V483, P475, DOI 10.1086/304234; HARTMAN P, 1980, J CRYST GROWTH, V49, P157, DOI 10.1016/0022-0248(80)90076-7; BARKER AS, 1963, PHYS REV, V132, P1474, DOI 10.1103/PhysRev.132.1474; Bernatowicz TJ, 1996, ASTROPHYS J, V472, P760, DOI 10.1086/178105; Bohren C. F., 1983, ABSORPTION SCATTERIN; Bose M, 2010, ASTROPHYS J, V714, P1624, DOI 10.1088/0004-637X/714/2/1624; CHASE AB, 1970, J AM CERAM SOC, V53, P343, DOI 10.1111/j.1151-2916.1970.tb12121.x; Ebel D. S., 2006, METEORITES EARLY SOL, P253; Ferrarotti AS, 2002, ASTRON ASTROPHYS, V382, P256, DOI 10.1051/0004-6361:20011580; FRANKE W, 1981, CRYST RES TECHNOL, V16, P1229; Gail HP, 2004, ASTRON ASTROPHYS, V413, P571, DOI 10.1051/0004-6361:20031554; Gyngard F, 2010, ASTROPHYS J, V717, P107, DOI 10.1088/0004-637X/717/1/107; HARTMAN P, 1980, J CRYST GROWTH, V49, P166, DOI 10.1016/0022-0248(80)90077-9; HARTMAN P, 1989, J CRYST GROWTH, V96, P667, DOI 10.1016/0022-0248(89)90065-1; Hofner S, 2008, ASTRON ASTROPHYS, V491, pL1, DOI 10.1051/0004-6361:200810641; HUSS GR, 1994, ASTROPHYS J, V430, pL81, DOI 10.1086/187443; Little-Marenin I. R., 1986, INTERSTELLAR PROCESS, P137; Makide K, 2009, ASTROPHYS J, V706, P142, DOI 10.1088/0004-637X/706/1/142; Nagahara H, 1996, GEOCHIM COSMOCHIM AC, V60, P1445, DOI 10.1016/0016-7037(96)00014-2; ONAKA T, 1989, ASTRON ASTROPHYS SUP, V81, P261; ONAKA T, 1989, ASTRON ASTROPHYS, V218, P169; Ozawa K, 2012, AM MINERAL, V97, P80, DOI 10.2138/am.2012.3750; Ozawa K, 2000, GEOCHIM COSMOCHIM AC, V64, P939, DOI 10.1016/S0016-7037(99)00353-1; Ozawa K., 1996, LPS, V27, P989; Paule R. C., 1967, CHARACTERIZATION HIG; Pollock M., 1961, T BRIT CERAMIC SOC, V16, P684; Rohl AL, 1995, MINERAL MAG, V59, P607, DOI 10.1180/minmag.1995.059.397.04; SASAMOTO T, 1971, KOG KAGAKU ZASSHI, V74, P832; SEDLMAYR E, 1995, SPACE SCI REV, V73, P211, DOI 10.1007/BF00751238; Sloan GC, 1996, ASTROPHYS J, V463, P310, DOI 10.1086/177243; Sloan GC, 1998, ASTROPHYS J SUPPL S, V119, P141, DOI 10.1086/313156; Sloan GC, 2003, ASTROPHYS J, V594, P483, DOI 10.1086/376857; Stroud R. M., 2007, LUN PLAN SCI C, VXXXVIII, P2203; Stroud RM, 2004, SCIENCE, V305, P1455, DOI 10.1126/science.1101099; Tachibana S, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/16; Takigawa A, 2009, ASTROPHYS J LETT, V707, pL97, DOI 10.1088/0004-637X/707/1/L97; Takigawa A, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/2/149; Takigawa A, 2014, GEOCHIM COSMOCHIM AC, V124, P309, DOI 10.1016/j.gca.2013.09.013; Tasker P. W., 1984, ADV CERAM, V10, P13; Toppani A, 2006, GEOCHIM COSMOCHIM AC, V70, P5035, DOI 10.1016/j.gca.2006.05.020; Tropf W. J., 1991, HDB OPTICAL CONSTANT, VII, P883; Tsuchiyama A, 1999, GEOCHIM COSMOCHIM AC, V63, P2451, DOI 10.1016/S0016-7037(99)00190-8; WATANABE K, 1977, J CRYST GROWTH, V41, P1, DOI 10.1016/0022-0248(77)90087-2; Woitke P, 2006, ASTRON ASTROPHYS, V460, pL9, DOI 10.1051/0004-6361:20066322; WOOD JA, 1993, GEOCHIM COSMOCHIM AC, V57, P2377, DOI 10.1016/0016-7037(93)90575-H; Yamada M, 2006, PLANET SPACE SCI, V54, P1096, DOI 10.1016/j.pss.2006.05.020; Zeidler S, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201220459	60	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0067-0049	1538-4365		ASTROPHYS J SUPPL S	Astrophys. J. Suppl. Ser.	MAY	2015	218	1							2	10.1088/0067-0049/218/1/2		16	Astronomy & Astrophysics	Astronomy & Astrophysics	CI8DN	WOS:000354999200002		
J	Shinfuku, N				Shinfuku, N.			TREATMENT OF SCHIZOPHRENIA IN ASIA: REALITIES AND CHALLENGES	AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY			English	Meeting Abstract									[Shinfuku, N.] Kobe Univ, Sch Med, Kobe, Hyogo 650, Japan; [Shinfuku, N.] Asian Federat Psychiat Assoc, Taipei, Taiwan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0004-8674	1440-1614		AUST NZ J PSYCHIAT	Aust. N. Z. J. Psych.	MAY	2015	49			1			86	87				2	Psychiatry	Psychiatry	CI0OU	WOS:000354437500217		
J	Fukuchi, N				Fukuchi, N.			CHILD PSYCHOEDUCATION AFTER THE GREAT EAST JAPAN EARTHQUAKE	AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY			English	Meeting Abstract									[Fukuchi, N.] Japanese Soc Psychiat & Neurol, Tokyo, Japan; [Fukuchi, N.] Miyagi Disaster Mental Hlth Care Ctr, Sendai, Miyagi, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0004-8674	1440-1614		AUST NZ J PSYCHIAT	Aust. N. Z. J. Psych.	MAY	2015	49			1			87	87				1	Psychiatry	Psychiatry	CI0OU	WOS:000354437500218		
J	Koeda, M; Fleming, D; Okubo, Y; Belin, P				Koeda, M.; Fleming, D.; Okubo, Y.; Belin, P.			CEREBRAL RESPONSE TO NONVERBAL AFFECTIVE VOCALIZATIONS AND CROSS-CULTURAL DIFFERENCES BY ASIAN AND CAUCASIAN LISTENERS: AN FMRI STUDY	AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY			English	Meeting Abstract									[Koeda, M.; Okubo, Y.] Nippon Med Sch, Dept Neuropsychiat, Tokyo 113, Japan; [Fleming, D.] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Belin, P.] Aix Marseille Univ, Fac Med, Marseille, France								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0004-8674	1440-1614		AUST NZ J PSYCHIAT	Aust. N. Z. J. Psych.	MAY	2015	49			1			87	87				1	Psychiatry	Psychiatry	CI0OU	WOS:000354437500219		
J	Jang, JH; Chun, JN; Godo, S; Wu, GY; Shimokawa, H; Jin, CZ; Jeon, JH; Kim, SJ; Jin, ZH; Zhang, YH				Jang, Ji Hyun; Chun, Jung Nyeo; Godo, Shigeo; Wu, Guangyu; Shimokawa, Hiroaki; Jin, Chun Zi; Jeon, Ju Hong; Kim, Sung Joon; Jin, Zhe Hu; Zhang, Yin Hua			ROS and endothelial nitric oxide synthase (eNOS)-dependent trafficking of angiotensin II type 2 receptor begets neuronal NOS in cardiac myocytes	BASIC RESEARCH IN CARDIOLOGY			English	Article						Angiotensin II; Angiotensin type 2 receptor; eNOS; nNOS; Cardiac myocyte	LEFT-VENTRICULAR MYOCYTES; SPONTANEOUSLY HYPERTENSIVE-RATS; HEART-FAILURE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; DEFICIENT MICE; RENIN; ACTIVATION; EXPRESSION; PRESSURE	Angiotensin II (Ang II), a potent precursor of hypertrophy and heart failure, upregulates neuronal nitric oxide synthase (nNOS or NOS1) in the myocardium. Here, we investigate the involvement of type 1 and 2 angiotensin receptors (AT1R and AT2R) and molecular mechanisms mediating Ang II-upregulation of nNOS. Our results showed that pre-treatment of left ventricular (LV) myocytes with antagonists of AT1R or AT2R (losartan, PD123319) and ROS scavengers (apocynin, tiron or PEG-catalase) blocked Ang II-upregulation of nNOS. Surface biotinylation or immunocytochemistry experiments demonstrated that AT1R expression in plasma membrane was progressively decreased (internalization), whereas AT2R was increased (membrane trafficking) by Ang II. Inhibition of AT1R or ROS scavengers prevented Ang II-induced translocation of AT2R to plasma membrane, suggesting an alignment of AT1R-ROS-AT2R. Furthermore, Ang II increased eNOS-Ser(1177) but decreased eNOS-Thr(495), indicating concomitant activation of eNOS. Intriguingly, ROS scavengers but not AT2R antagonist prevented Ang II-activation of eNOS. NOS inhibitor (L-NG-Nitroarginine Methyl Ester, L-NAME) or eNOS gene deletion (eNOS(-/-)) abolished Ang II-induced membrane trafficking of AT2R, nNOS protein expression and activity. Mechanistically, S-nitrosation of AT2R was increased by sodium nitroprusside (SNP), a NO donor. Site-specific mutagenesis analysis reveals that C-terminal cysteine 349 in AT2R is essential in AT2R translocation to plasma membrane. Taken together, we demonstrate, for the first time, that Ang II upregulates nNOS protein expression and activity via AT1R/ROS/eNOS-dependent S-nitrosation and membrane translocation of AT2R. Our results suggest a novel crosstalk between AT1R and AT2R in regulating nNOS via eNOS in the myocardium under pathogenic stimuli.	[Jang, Ji Hyun; Chun, Jung Nyeo; Jeon, Ju Hong; Kim, Sung Joon; Zhang, Yin Hua] Seoul Natl Univ, Dept Physiol & Biomed Sci, Hypoxia Res Inst, Inst Human Environm Interface Biol,Coll Med, Seoul 110799, South Korea; [Jin, Chun Zi; Jin, Zhe Hu; Zhang, Yin Hua] Yanbian Univ Hosp, Yanji, Peoples R China; [Godo, Shigeo; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan; [Wu, Guangyu] Georgia Regents Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA USA	Jin, ZH (reprint author), Yanbian Univ Hosp, Yanji, Peoples R China.	Jinzh_621@163.com; yinzhang@snu.ac.kr			Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2013068067]; Brain Korea 21 Graduate Programme of the Korean Ministry of Education, Science and Technology, Seoul National University Hospital; Korean Society of Hypertension; SK Telecom Research Fund [3420130290]; National Natural Science Foundation of China (NSFC) [31460265]; National Institutes of Health [R01GM076167]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2013068067); by the Brain Korea 21 Graduate Programme of the Korean Ministry of Education, Science and Technology, Seoul National University Hospital, the Korean Society of Hypertension (2013), SK Telecom Research Fund (no. 3420130290) and from the National Natural Science Foundation of China (NSFC, 31460265). National Institutes of Health grant R01GM076167.	Oyamada S, 2010, BASIC RES CARDIOL, V105, P513, DOI 10.1007/s00395-010-0093-4; Zhang YH, 2008, CIRC RES, V102, P242, DOI 10.1161/CIRCRESAHA.107.164798; Dias-Peixoto MF, 2008, HYPERTENSION, V52, P542, DOI 10.1161/HYPERTENSIONAHA.108.114280; Zhang YH, 2009, BBA-BIOENERGETICS, V1787, P811, DOI 10.1016/j.bbabio.2009.03.020; Jin CZ, 2013, J MOL CELL CARDIOL, V60, P107, DOI 10.1016/j.yjmcc.2013.04.017; Zhang XP, 2011, J BIOL CHEM, V286, P20525, DOI 10.1074/jbc.M111.222034; Gao J, 2011, AM J HYPERTENS, V24, P724, DOI 10.1038/ajh.2011.33; Schmieder RE, 2007, LANCET, V369, P1208, DOI 10.1016/S0140-6736(07)60242-6; Barouch LA, 2002, NATURE, V416, P337; Costa MA, 2010, AM J PHYSIOL-HEART C, V299, pH1205, DOI 10.1152/ajpheart.00850.2009; Sears CE, 2003, CIRC RES, V92, pE52, DOI 10.1161/01.RES.0000064585.95749.6D; Jalowy A, 1998, J AM COLL CARDIOL, V32, P1787, DOI 10.1016/S0735-1097(98)00441-0; Xu KY, 1999, P NATL ACAD SCI USA, V96, P657, DOI 10.1073/pnas.96.2.657; Cat AND, 2013, ANTIOXID REDOX SIGN, V19, P1110, DOI 10.1089/ars.2012.4641; Takimoto E, 2005, J CLIN INVEST, V115, P1221, DOI 10.1172/JCI200521968; Paliege A, 2006, AM J PHYSIOL-REG I, V290, pR694, DOI 10.1152/ajpregu.00219.2005; Jin CZ, 2012, J MOL CELL CARDIOL, V52, P1274, DOI 10.1016/j.yjmcc.2012.03.013; Padia SH, 2013, PFLUG ARCH EUR J PHY, V465, P99, DOI 10.1007/s00424-012-1146-3; Zhang YH, 2014, J PHYSIOL-LONDON, V592, P3189, DOI 10.1113/jphysiol.2013.270306; Chow BSM, 2014, KIDNEY INT, V86, P75, DOI 10.1038/ki.2013.518; Heusch G, 2000, CIRC RES, V87, P146; Cai H, 2002, J BIOL CHEM, V277, P48311, DOI 10.1074/jbc.M208884200; Jones ES, 2008, PHARMACOL THERAPEUT, V120, P292, DOI 10.1016/j.pharmthera.2008.08.009; Ladurner A, 2012, FREE RADICAL BIO MED, V52, P2082, DOI 10.1016/j.freeradbiomed.2012.03.022; Copp SW, 2012, J PHYSIOL-LONDON, V590, P3585, DOI 10.1113/jphysiol.2012.235929; Bendall JK, 2004, CIRCULATION, V110, P2368, DOI 10.1161/01.CIR.0000145160.04084.AC; Brede M, 2003, HYPERTENSION, V42, P1177, DOI 10.1161/01.HYP.0000100445.80029.8E; Burkard N, 2010, CIRCULATION, V122, P1588, DOI 10.1161/CIRCULATIONAHA.109.933630; Damy T, 2004, LANCET, V363, P1365, DOI 10.1016/S0140-6736(04)16048-0; Gao J, 2014, AM J HYPERTENS, V27, P1248, DOI 10.1093/ajh/hpu044; Heusch G, 2011, J AM COLL CARDIOL, V57, P310, DOI 10.1016/j.jacc.2010.06.057; Huang A, 2002, AM J PHYSIOL-HEART C, V282, pH429; Huisamen B, 2011, MOL CELL BIOCHEM, V349, P21, DOI 10.1007/s11010-010-0656-6; Kellogg DL, 2008, J PHYSIOL-LONDON, V586, P847, DOI 10.1113/jphysiol.2007.144642; Kinugawa S, 2005, CIRC RES, V96, P355, DOI 10.1161/01.RES.0000155331.09458.A7; Patel KP, 2013, ANTIOXID REDOX SIGN, V19, P1121, DOI 10.1089/ars.2012.4614; Post H, 2001, AM J PHYSIOL-HEART C, V281, pH2392; Ritter Oliver, 2003, FASEB Journal, V17, P283; Sartoretto JL, 2011, P NATL ACAD SCI USA, V108, P15792, DOI 10.1073/pnas.1111331108; Tambascia RC, 2001, HYPERTENSION, V37, P1423; Unger T, 2002, AM J CARDIOL, V89, p3A; Varagic J, 2002, J MOL CELL CARDIOL, V34, P1435, DOI 10.1006/jmcc.2002.2075; Wiemer G, 2001, HYPERTENSION, V38, P1367, DOI 10.1161/hy1101.096115; Zhang YH, 2012, J MOL CELL CARDIOL, V52, P341, DOI 10.1016/j.yjmcc.2011.09.006	44	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0300-8428	1435-1803		BASIC RES CARDIOL	Basic Res. Cardiol.	MAY	2015	110	3							21	10.1007/s00395-015-0477-6		15	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CI2WC	WOS:000354607300001		
J	Hisamatsu, Y; Shibuya, A; Suzuki, N; Suzuki, T; Abe, R; Aoki, S				Hisamatsu, Yosuke; Shibuya, Ai; Suzuki, Nozomi; Suzuki, Toshihiro; Abe, Ryo; Aoki, Shin			Design and Synthesis of Amphiphilic and Luminescent Tris-Cyclometalated Iridium(III) Complexes Containing Cationic Peptides as Inducers and Detectors of Cell Death via a Calcium-Dependent Pathway	BIOCONJUGATE CHEMISTRY			English	Article							NEGATIVELY CHARGED PHOSPHATIDYLSERINE; HOST-DEFENSE PEPTIDES; ANTIMICROBIAL PEPTIDES; POLYAMINE TRANSPORTER; LIVING CELLS; ALPHA-2-ADRENERGIC RECEPTORS; PHOTOCHEMICAL PROPERTIES; COMPETITIVE ANTAGONIST; PHOSPHORESCENT SENSOR; MUSCARINIC RECEPTORS	Cationic amphiphilic peptides have the potential to function as agents for the treatment of microbial infections and cancer therapy. The cationic and hydrophobic parts of these molecules allow them to associate strongly with negatively charged bacterial or cancer cell membranes, thus exerting antimicrobial and anticancer activities through membrane disruption. Meanwhile, cydometalated iridium(III) complexes such as fac-Ir(ppy)(3) (ppy = 2-phenylpyridine) and fac-Ir(tpy)(3) (tpy = 2-(4'-tolyOpyridine) possess C-3-symmetric structures and excellent photophysical properties as phosphorescence materials, which make them important candidates for use in biological applications such as chemosensors, biolabeling, living cell staining, in vivo tumor imaging, and anticancer agents. We recently reported on some regioselective substitution reactions of Ir(tpy)(3) and Ir(ppy)(3) at the 5'-position (p-position with respect to the C-Ir bond) on the 2-phenylpyridine ligands and their subsequent conversions to a variety of functional groups. We report here on the design and synthesis of amphiphilic and luminescent tris-cydometalated Ir complexes in which cationic peptides are attached through alkyl chain linkers that work as inducers and detectors of cell death. Ir complexes containing cationic peptides such as a KKGG sequence and alkyl chain linkers of adequate length (C6 and C8) exhibit considerable cytotoxicity against cancer cells such as Jurkat, Molt-4, HeLa-S3, and A549 cells, and that dead cells are well stained with these Ir complexes. Furthermore, an Ir complex in which the KKGG peptide is attached through a C6 linker displayed lower cytotoxicity against normal mouse lymphocytes. Mechanistic studies suggest that Ir complexes containing the KKGG peptide interact with anionic molecules on the cell surface and/or membrane receptors to trigger the Ca2+ dependent pathway and intracellular Ca2+ response, resulting in necrosis accompanied by membrane disruption.	[Hisamatsu, Yosuke; Shibuya, Ai; Suzuki, Nozomi; Aoki, Shin] Tokyo Univ Sci, Fac Pharmaceut Sci, Noda, Chiba 2788510, Japan; [Suzuki, Toshihiro; Abe, Ryo] Tokyo Univ Sci, Res Inst Biomed Sci, Noda, Chiba 2788510, Japan; [Aoki, Shin] Tokyo Univ Sci, Div Med Sci Engn Corp, Res Inst Sci & Technol, Noda, Chiba 2788510, Japan	Aoki, S (reprint author), Tokyo Univ Sci, Fac Pharmaceut Sci, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	shinaoki@rs.noda.tus.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [22890200, 24890256, 26860016, 19659026, 22390005, 24659085]; Uehara Memorial Foundation; High-Tech Research Center Project for Private Universities (MEXT)	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (No. 22890200, 24890256, and 26860016 for Y.H., and No. 19659026, 22390005, and 24659085 for S.A.), the Uehara Memorial Foundation for Y.H. and High-Tech Research Center Project for Private Universities (matching fund subsidy from MEXT). We thank Prof. Dr. Takeshi Inukai (Department of Pediatrics, School of Medicine, University of Yamanashi), Prof. Dr. Ko Okumura and Prof. Dr. Hideo Yagita (Department of Immunology, School of Medicine, Juntendo University) for the helpful discussion. We also thank Prof. Dr. Akinori Morita (Department of Radiological Science, Institute of Health Biosciences, University of Tokushima) for providing Bcl-2 overexpressed Molt-4 cells and wild-type Molt-4 cells and useful suggestion. We thank Dr. Yuuki Obata (Research Institute for Biomedical Sciences, Tokyo University of Science) for providing filipin, cytochalasin D and useful discussion. We thank Dr. Mitsutoshi Tsukimoto (Faculty of Pharmaceutical Sciences, Tokyo University of Science) for providing A549 cells, RPMI 1640-based buffer, and useful suggestion. We appreciate the aid of Mrs. Fukiko Hasegawa (Faculty of Pharmaceutical Sciences, Tokyo University of Science) for measurement of mass spectra.	AFFOLTER H, 1985, EUR J PHARMACOL, V108, P157, DOI 10.1016/0014-2999(85)90720-4; Xiong LQ, 2010, INORG CHEM, V49, P6402, DOI 10.1021/ic902266x; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; Zhang SJ, 2010, CANCER RES, V70, P4490, DOI 10.1158/0008-5472.CAN-09-3948; Sinthuvanich C, 2012, J AM CHEM SOC, V134, P6210, DOI 10.1021/ja210569f; Schmittel M, 2007, INORG CHEM, V46, P9139, DOI 10.1021/ic700413v; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; Herzig S, 2013, NAT CELL BIOL, V15, P1398, DOI 10.1038/ncb2891; Koren K, 2012, CHEMBIOCHEM, V13, P1184, DOI 10.1002/cbic.201200083; Dolan C, 2013, J INORG BIOCHEM, V119, P65, DOI 10.1016/j.jinorgbio.2012.11.001; Sakata K, 2000, BIOCHEM J, V347, P297, DOI 10.1042/0264-6021:3470297; Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014; Khalil IA, 2006, J BIOL CHEM, V281, P3544, DOI 10.1074/jbc.M503202200; Triggle DJ, 2007, BIOCHEM PHARMACOL, V74, P1, DOI 10.1016/j.bcp.2007.01.016; You Y, 2013, CURR OPIN CHEM BIOL, V17, P699, DOI 10.1016/j.cbpa.2013.05.023; Cao R, 2013, J MED CHEM, V56, P3636, DOI 10.1021/jm4001665; UTSUGI T, 1991, CANCER RES, V51, P3062; DEDEIAN K, 1991, INORG CHEM, V30, P1685, DOI 10.1021/ic00008a003; Schroder-Borm H, 2005, FEBS LETT, V579, P6128, DOI 10.1016/j.febslet.2005.09.084; Liu LH, 2009, NAT NANOTECHNOL, V4, P457, DOI [10.1038/nnano.2009.153, 10.1038/NNANO.2009.153]; Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2; Jambrina E, 2003, J BIOL CHEM, V278, P14134, DOI 10.1074/jbc.M211388200; WAELBROECK M, 1984, BIOCHEM BIOPH RES CO, V121, P340; Yin LM, 2012, J BIOL CHEM, V287, P7738, DOI 10.1074/jbc.M111.303602; Ru JX, 2014, INORG CHEM, V53, P11498, DOI 10.1021/ic501417s; Iwasaki T, 2009, PEPTIDES, V30, P660, DOI 10.1016/j.peptides.2008.12.019; Kass GEN, 1999, ENVIRON HEALTH PERSP, V107, P25, DOI 10.2307/3434469; Lo KKW, 2011, NEW J CHEM, V35, P265, DOI 10.1039/c0nj00478b; Drose S, 1997, J EXP BIOL, V200, P1; Nakase I, 2013, MOL BIOSYST, V9, P855, DOI 10.1039/c2mb25467k; Floryk D, 1999, BIOSCIENCE REP, V19, P27, DOI 10.1023/A:1020193906974; Findlay B, 2010, ANTIMICROB AGENTS CH, V54, P4049, DOI 10.1128/AAC.00530-10; Nakagawa A, 2014, INORG CHEM, V53, P409, DOI 10.1021/ic402387b; Zhou YY, 2013, CHEM COMMUN, V49, P3230, DOI 10.1039/c3cc40845k; Liu Z, 2014, ACCOUNTS CHEM RES, V47, P1174, DOI 10.1021/ar400266c; Li SPY, 2012, CHEM-EUR J, V18, P13342, DOI 10.1002/chem.201200979; Flamigni L, 2007, TOP CURR CHEM, V281, P143, DOI 10.1007/128_2007_131; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; Yoshihara T, 2012, ANGEW CHEM INT EDIT, V51, P4148, DOI 10.1002/anie.201107557; Das J, 2011, CHEM REV, V111, P4405, DOI 10.1021/cr1002722; Lee PK, 2011, INORG CHEM, V50, P8570, DOI 10.1021/ic201153d; Li CY, 2011, J AM CHEM SOC, V133, P11231, DOI 10.1021/ja202344c; Lee PK, 2011, DALTON T, V40, P2180, DOI 10.1039/c0dt00501k; Wu YQ, 2011, INORG CHEM, V50, P7412, DOI 10.1021/ic102082k; Ma XC, 2014, J AM CHEM SOC, V136, P17734, DOI 10.1021/ja511656q; Woo H, 2013, J AM CHEM SOC, V135, P4771, DOI 10.1021/ja3123202; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Harris F, 2013, MED RES REV, V33, P190, DOI 10.1002/med.20252; Slee EA, 1996, BIOCHEM J, V315, P21; Lowry MS, 2006, CHEM-EUR J, V12, P7970, DOI 10.1002/chem.200600618; Schweizer F, 2009, EUR J PHARMACOL, V625, P190, DOI 10.1016/j.ejphar.2009.08.043; Zhao Q, 2010, ORGANOMETALLICS, V29, P1085, DOI 10.1021/om900691r; Bernardi P, 1999, PHYSIOL REV, V79, P1127; Zhang Y, 2008, BIOMED MICRODEVICES, V10, P321, DOI 10.1007/s10544-007-9139-2; Brandel J, 2010, CHEM COMMUN, V46, P3958, DOI 10.1039/c002401e; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Gonzalez A, 2000, J BIOL CHEM, V275, P38680, DOI 10.1074/jbc.M005667200; Cinelli MA, 2009, BIOORGAN MED CHEM, V17, P7145, DOI 10.1016/j.bmc.2009.08.066; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Zhao Q, 2011, CHEM SOC REV, V40, P2508, DOI 10.1039/c0cs00114g; Ho ML, 2006, ORG BIOMOL CHEM, V4, P98, DOI 10.1039/b511943j; Lo KKW, 2014, RSC ADV, V4, P10560, DOI 10.1039/c3ra47611a; Riedl S, 2011, BBA-BIOMEMBRANES, V1808, P2638, DOI 10.1016/j.bbamem.2011.07.026; Lo KKW, 2010, COORDIN CHEM REV, V254, P2603, DOI 10.1016/j.ccr.2010.01.014; Liu Z, 2011, INORG CHEM, V50, P5777, DOI 10.1021/ic200607j; Miyoshi N, 2004, CANCER RES, V64, P2134, DOI 10.1158/0008-5472.CAN-03-2296; Evans RC, 2006, COORDIN CHEM REV, V250, P2093, DOI 10.1016/j.ccr.2006.02.007; You Y, 2011, J AM CHEM SOC, V133, P11488, DOI 10.1021/ja204997c; Dong Z, 2006, ANNU REV PATHOL-MECH, V1, P405, DOI 10.1146/annurev.pathol.1.110304.100218; Chen YQ, 2010, PEPTIDES, V31, P1504, DOI 10.1016/j.peptides.2010.05.010; Zhao QA, 2010, CHEM SOC REV, V39, P3007, DOI 10.1039/b915340c; Kimura T, 2013, CANCER RES, V73, P3, DOI 10.1158/0008-5472.CAN-12-2464; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Novohradsky V, 2014, METALLOMICS, V6, P682, DOI 10.1039/c3mt00341h; KAKINUMA Y, 1988, EUR J BIOCHEM, V176, P409, DOI 10.1111/j.1432-1033.1988.tb14297.x; Paredes-Gamero EJ, 2012, MOL PHARMACEUT, V9, P2686, DOI 10.1021/mp300251j; Zhi DF, 2013, BIOCONJUGATE CHEM, V24, P487, DOI 10.1021/bc300381s; Lau JSY, 2009, INORG CHEM, V48, P708, DOI 10.1021/ic801818x; Simoni E, 2010, J MED CHEM, V53, P7264, DOI 10.1021/jm100637k; Aoki S, 2011, INORG CHEM, V50, P806, DOI 10.1021/ic101164g; Babcock DF, 1997, J CELL BIOL, V136, P833, DOI 10.1083/jcb.136.4.833; You Y, 2011, J AM CHEM SOC, V133, P18328, DOI 10.1021/ja207163r; Cantekin S, 2012, CHEM SOC REV, V41, P6125, DOI 10.1039/c2cs35156k; Kosuge M, 2008, BIOCONJUGATE CHEM, V19, P656, DOI 10.1021/bc700289w; Chi Y, 2010, CHEM SOC REV, V39, P638, DOI 10.1039/b916237b; Ulbricht C, 2009, ADV MATER, V21, P4418, DOI 10.1002/adma.200803537; Murphy L, 2010, CHEM COMMUN, V46, P8743, DOI 10.1039/c0cc03705b; Moscho A, 1996, P NATL ACAD SCI USA, V93, P11443, DOI 10.1073/pnas.93.21.11443; Shiu HY, 2014, CHEM COMMUN, V50, P4375, DOI 10.1039/c3cc48376b; Zhang KY, 2010, INORG CHEM, V49, P5432, DOI 10.1021/ic902443e; Wang XB, 2011, CHEM-EUR J, V17, P8028, DOI 10.1002/chem.201100568; Minois N, 2011, AGING-US, V3, P716; Tamayo AB, 2003, J AM CHEM SOC, V125, P7377, DOI 10.1021/ja034537z; Standley SM, 2010, CANCER RES, V70, P3020, DOI 10.1158/0008-5472.CAN-09-3267; Hartinger CG, 2012, ORGANOMETALLICS, V31, P5677, DOI 10.1021/om300373t; Zhang KY, 2010, INORG CHEM, V49, P2530, DOI 10.1021/ic902465b; Riedl S, 2011, CHEM PHYS LIPIDS, V164, P766, DOI 10.1016/j.chemphyslip.2011.09.004; Farinola GM, 2011, CHEM SOC REV, V40, P3467, DOI 10.1039/c0cs00204f; Leung SK, 2010, INORG CHEM, V49, P4984, DOI 10.1021/ic100092d; Baggaley E, 2012, COORDIN CHEM REV, V256, P1762, DOI 10.1016/j.ccr.2012.03.018; AUGUET M, 1986, GEN PHARMACOL, V17, P133, DOI 10.1016/0306-3623(86)90129-1; CATTERALL WA, 1992, TRENDS PHARMACOL SCI, V13, P256, DOI 10.1016/0165-6147(92)90079-L; Chen CX, 2010, BIOMACROMOLECULES, V11, P402, DOI 10.1021/bm901130u; Cullis PM, 1999, CHEM BIOL, V6, P717, DOI 10.1016/S1074-5521(00)80019-8; DE BERNARDO S, 1974, ARCH BIOCHEM BIOPHYS, V163, P390, DOI 10.1016/0003-9861(74)90490-1; Dodo K, 2005, BIOORG MED CHEM LETT, V15, P3114, DOI 10.1016/j.bmcl.2005.04.016; Dort M., 2014, CURR OPIN CHEM BIOL, V19, P76; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; FELDMAN RD, 1985, CIRCULATION, V72, P547; Gardner RA, 2004, J MED CHEM, V47, P6055, DOI 10.1021/jm0497040; Gaspar D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00294; Gaspar D, 2015, BBA-MOL CELL RES, V1853, P308, DOI 10.1016/j.bbamcr.2014.11.006; Gaspar D, 2012, BIOCHEMISTRY-US, V51, P6263, DOI 10.1021/bi300836r; Guerchais V, 2011, COORDIN CHEM REV, V255, P2448, DOI 10.1016/j.ccr.2011.04.006; Gunter TE, 2009, BBA-BIOENERGETICS, V1787, P1291, DOI 10.1016/j.bbabio.2008.12.011; HARROW JAC, 1976, BIOCHEM PHARMACOL, V25, P897, DOI 10.1016/0006-2952(76)90311-7; Hisamatsu Y, 2011, EUR J INORG CHEM, P5360, DOI 10.1002/ejic.201100755; Hisamatsu Y., UNPUB; Hockerman GH, 1997, ANNU REV PHARMACOL, V37, P361, DOI 10.1146/annurev.pharmtox.37.1.361; Hondroulis E, 2014, THERANOSTICS, V4, P919, DOI 10.7150/thno.8575; Jaouen G, 2006, BIOORGANOMETALLICS: BIOMOLECULES, LABELING, MEDICINE, P1; Kando A., INORG CHEM IN PRESS; KARLISH SJD, 1979, NATURE, V282, P333, DOI 10.1038/282333a0; Kuil J, 2011, CHEMBIOCHEM, V12, P1896, DOI 10.1002/cbic.201100271; Liu ZG, 2007, CHEMBIOCHEM, V8, P2063, DOI 10.1002/cbic.200700502; Lott R. S., 1979, J CHEM SOC CHEM COMM, V11, P493; Madani Fatemeh, 2011, Journal of Biophysics, DOI 10.1155/2011/414729; Marquez M, 2004, ANTICANCER RES, V24, P1347; Monney A., 2012, COORDIN CHEM REV, V257, P2420; Morita A, 2006, CELL DEATH DIFFER, V13, P499, DOI 10.1038/sj.cdd.4401768; Moromizato S, 2012, INORG CHEM, V51, P12697, DOI 10.1021/ic301310q; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MOTULSKY HJ, 1984, CIRC RES, V55, P376; MOTULSKY HJ, 1983, CIRC RES, V52, P226; Murov S. L., 1992, HDB PHOTOCHEMISTRY, V2nd; Muth A, 2013, J MED CHEM, V56, P5819, DOI 10.1021/jm400496a; Newcomb CJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4321; Paredes-Gamero EJ, 2012, BBA-GEN SUBJECTS, V1820, P1062, DOI 10.1016/j.bbagen.2012.02.015; Phanstiel O 4th, 2007, Amino Acids, V33, P305, DOI 10.1007/s00726-007-0527-y; SCHREIBER G, 1985, J CARDIOVASC PHARM, V7, P390, DOI 10.1097/00005344-198503000-00026; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shibata K, 1998, CIRCULATION, V97, P1227; Sun VZ, 2011, BIOMACROMOLECULES, V12, P10, DOI 10.1021/bm101036f; VANDRIESSCHE W, 1984, J PHYSIOL-LONDON, V356, P79; Vanlangenakker N., 2008, CUR MOL MED, V8, P2071; Wang Guangshun, 2014, Pharmaceuticals (Basel), V7, P545, DOI 10.3390/ph7050545; Yoshihara T., 2012, P SOC PHOTO-OPT INS, V8233	148	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	MAY	2015	26	5					857	879		10.1021/acs.bioconjchem.5b00095		23	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CI8XB	WOS:000355053900010		
J	Shima, F; Akagi, T; Akashi, M				Shima, Fumiaki; Akagi, Takami; Akashi, Mitsuru			Effect of Hydrophobic Side Chains in the Induction of Immune Responses by Nanoparticle Adjuvants Consisting of Amphiphilic Poly(gamma-glutamic acid)	BIOCONJUGATE CHEMISTRY			English	Article							DENDRITIC CELLS; CROSS-PRESENTATION; VACCINE ADJUVANTS; ANTIGEN; DELIVERY; PH; DISRUPTION; POLYMERS; INNATE	The new generation vaccines are safe but,poorly immunogenic, and thus they require the use of adjuvants. Adjuvants that can control the balance and induction level of cellular and humoral immunities are urgently required for the treatment of and/or protection from infectious diseases and cancers. However, there are no adjuvants which can achieve these requirements. In this study, amphiphilic poly(gamma-glutamic-acid) (gamma-PGA) with various kinds of hydrophobic amino acid ethyl esters (AAE) was synthesized (gamma-PGA-AAE) and used to prepare antigen-encapsulated nanoparticles (NPs). gamma-PGA-graft-Leu (gamma-PGA-Leu, where Leu = leucine ethyl ester), gamma-PGA-graft-Phe (gamma-PGA-Phe, where Phe = phenylalanine ethyl ester), and gamma-PGA-graft-Tip (gamma-PGA-Trp, where Trp = tryptophan ethyl ester) formed monodispersed NPs that encapsulated ovalbumin (OVA). The type and the induction level of the antigen-specific cellular and humoral immunities could be controlled by the kinds of hydrophobic segments and vaccine formulation (encapsulation or mixture) used. When OVA was encapsulated into NPs, the cellular immunity was dominantly induced, while humoral immunity was dominant when OVA was mixed with NPs. These results are a first report to demonstrate that the balance and induction level of cellular and humoral immunities could be controlled by modifying compositions of NPs and vaccine formulation. Our results suggest that gamma-PGA-AAE NPs can provide safe and efficient nanoparticle-based vaccine adjuvants, and the results also provide guidelines in the rational design of amphiphilic polymers as vaccine adjuvants which can control the balance of immune responses.	[Shima, Fumiaki; Akagi, Takami; Akashi, Mitsuru] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan	Akashi, M (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.	akashi@chem.eng.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [23225004]	This work was supported by a Research Fellow of the Japan Society for the Promotion of Science and a Grant-in-Aid for Scientific Research (5) from the Ministry of Education, Culture, Sports, Science, and Technology (23225004).	Tran KK, 2009, BIOMATERIALS, V30, P1356, DOI 10.1016/j.biomaterials.2008.11.034; Jones RA, 2003, BIOCHEM J, V372, P65, DOI 10.1042/BJ20021945; Shima F, 2013, BIOMATERIALS, V34, P9709, DOI 10.1016/j.biomaterials.2013.08.064; Foged C, 2002, PHARMACEUT RES, V19, P229, DOI 10.1023/A:1014474414097; Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604; Uto T, 2007, J IMMUNOL, V178, P2979; Murthy N, 1999, J CONTROL RELEASE, V61, P137, DOI 10.1016/S0168-3659(99)00114-5; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Liu Y, 2013, J MATER CHEM B, V1, P3888, DOI 10.1039/c3tb20383b; Uto T, 2011, BIOMATERIALS, V32, P5206, DOI 10.1016/j.biomaterials.2011.03.052; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; O'Hagan DT, 2003, NAT REV DRUG DISCOV, V2, P727, DOI 10.1038/nrd1176; Mbow ML, 2010, CURR OPIN IMMUNOL, V22, P411, DOI 10.1016/j.coi.2010.04.004; KREUTER J, 1988, VACCINE, V6, P253, DOI 10.1016/0264-410X(88)90220-4; Akagi T, 2011, BIOMATERIALS, V32, P4959, DOI 10.1016/j.biomaterials.2011.03.049; Chiu YL, 2010, J CONTROL RELEASE, V146, P152, DOI 10.1016/j.jconrel.2010.05.023; Shima F, 2013, ACTA BIOMATER, V9, P8894, DOI 10.1016/j.actbio.2013.06.010; Yi AK, 2001, INT IMMUNOL, V13, P1391, DOI 10.1093/intimm/13.11.1391; Kim H, 2009, MACROMOL BIOSCI, V9, P842, DOI 10.1002/mabi.200800367; Moon JJ, 2012, ADV MATER, V24, P3724, DOI 10.1002/adma.201200446; Csizmadia F, 1997, J PHARM SCI, V86, P865, DOI 10.1021/js960177k; Shima F, 2013, BIOCONJUGATE CHEM, V24, P926, DOI 10.1021/bc300611b; Peek LJ, 2008, ADV DRUG DELIVER REV, V60, P915, DOI 10.1016/j.addr.2007.05.017; Li WJ, 2004, ADV DRUG DELIVER REV, V56, P967, DOI 10.1016/j.addr.2003.10.041; Kanchan V, 2007, BIOMATERIALS, V28, P5344, DOI 10.1016/j.biomaterials.2007.08.015; Moyano DF, 2012, J AM CHEM SOC, V134, P3965, DOI 10.1021/ja2108905; Lacey M. H., 2011, MOL PHARM, V8, P153; Lacey M. H., 2010, J CONTROL RELEASE, V142, P180; Lee TY, 2009, CANCER IMMUNOL IMMUN, V58, P1783, DOI 10.1007/s00262-009-0689-4; Ohmori N, 1998, BIOCHEM BIOPH RES CO, V245, P259, DOI 10.1006/bbrc.1998.8408; Shima F, 2014, COLLOID POLYM SCI, V292, P2663, DOI 10.1007/s00396-014-3303-z; Shima F., 2013, J BIOMAT SCI-POLYM E, V25, P203; Shima F, 2014, BIOMATER SCI-UK, V2, P1419, DOI 10.1039/c4bm00140k; Swartz MA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003763; Tayar N. E., 1992, J CHEM SOC P2, V2, P79; Uto T, 2011, IMMUNOL LETT, V140, P36, DOI 10.1016/j.imlet.2011.06.002; Uto Tomofumi, 2013, Results Immunol, V3, P1, DOI 10.1016/j.rinim.2012.11.002	38	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	MAY	2015	26	5					890	898		10.1021/acs.bioconjchem.5b00106		9	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CI8XB	WOS:000355053900012		
J	Huang, T; Miura, M; Nobukawa, S; Yamaguchi, M				Huang, Tong; Miura, Motohiro; Nobukawa, Shogo; Yamaguchi, Masayuki			Chain Packing and Its Anomalous Effect on Mechanical Toughness for Poly(lactic acid)	BIOMACROMOLECULES			English	Article							POLY(METHYL METHACRYLATE); GLASSY-POLYMERS; POLY(L-LACTIDE); POLYCARBONATE; LOCALIZATION; ENTANGLEMENT; DEFORMATION; POLYLACTIDE; PERFORMANCE; RELAXATION	The effect of chain packing on tensile properties was studied employing amorphous poly(lactic add) PIA. It Was found that the samples cooled in the, temperature range from 60 to 80 degrees C, that is, slightly higher than the glass transition temperature T-g, Showed ductile behavior with a low brittle ductile transition temperattre. Furthermore, the Samples obtained by prolonged cooling at SO degrees C also showed ductile behavior, whereas a shorter cooling time at the same temperature provided a, brittle product Even for the samples quenched at 40 degrees C, they showed ductile behavior after the exposure to postproCessing annealing operation at 60 degrees C; that is, the strain at break is larger than 3. This is an anomalous phenomenon for a glassy polymer. The dynamic mechanical analysis and thermal characterization revealed that the ductile samples show slightly higher Tg than the brittle ones, presumably due to high packing density of polymer chains. Moreover, it was found from infrared spectroscopy that the ductile samples show strong absorbance at 1267 cm(-1), ascribed to high energy gauche gauche gg conformers:Following the classic Robertson's descriptions, of plastic flow, it is Concluded that the increase in the gauche gauche gg conformers, which shows the conformation change under a low stress level, reduces the critical onset stress for shear yielding. The results demonstrated that the mechanical toughness of PLA can be controlled by the cooling conditions during processing and the postprocessing annealing Operation.	[Huang, Tong; Miura, Motohiro; Nobukawa, Shogo; Yamaguchi, Masayuki] Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi, Ishikawa 9231292, Japan	Yamaguchi, M (reprint author), Japan Adv Inst Sci & Technol, Sch Mat Sci, 1-1 Asahidai, Nomi, Ishikawa 9231292, Japan.	m_yama@jaist.ac.jp					ALLEN G, 1973, J MATER SCI, V8, P1449, DOI 10.1007/BF00551669; Edgar KJ, 2001, PROG POLYM SCI, V26, P1605, DOI 10.1016/S0079-6700(01)00027-2; GRIJPMA DW, 1994, COLLOID POLYM SCI, V272, P1068, DOI 10.1007/BF00652375; Lee HN, 2010, MACROMOLECULES, V43, P5863, DOI 10.1021/ma.1006649; Malmgren T, 2006, J THERM ANAL CALORIM, V83, P35, DOI 10.1007/s10973-005-7066-0; Zhang CM, 2013, MATER DESIGN, V45, P198, DOI 10.1016/j.matdes.2012.09.024; Rasal RM, 2010, PROG POLYM SCI, V35, P338, DOI 10.1016/j.progpolymsci.2009.12.003; Anderson KS, 2008, POLYM REV, V48, P85, DOI 10.1080/15583720701834216; van Melick HGH, 2003, POLYMER, V44, P3579, DOI 10.1016/S0032-3861(03)00089-2; Meijer HEH, 2005, PROG POLYM SCI, V30, P915, DOI 10.1016/j.progpolymsci.2005.06.009; Liu HZ, 2011, J POLYM SCI POL PHYS, V49, P1051, DOI 10.1002/polb.22283; Lim LT, 2008, PROG POLYM SCI, V33, P820, DOI 10.1016/j.progpolymsci.2008.05.004; Deblieck RAC, 2011, POLYMER, V52, P2979, DOI 10.1016/j.polymer.2011.03.055; Zhao QN, 2013, POLYM TEST, V32, P299, DOI 10.1016/j.polymertesting.2012.11.012; ARGON AS, 1977, POLYM ENG SCI, V17, P174, DOI 10.1002/pen.760170306; Park JW, 2004, BIOMACROMOLECULES, V5, P1557, DOI 10.1021/bm0499051; Auras R, 2004, MACROMOL BIOSCI, V4, P835, DOI 10.1002/mabi.200400043; Wang SF, 2005, BIOMACROMOLECULES, V6, P3067, DOI 10.1021/bm050378v; Saeidlou S, 2012, PROG POLYM SCI, V37, P1657, DOI 10.1016/j.progpolymsci.2012.07.005; Pan PJ, 2007, MACROMOLECULES, V40, P9664, DOI 10.1021/ma071737c; Kister G, 1998, POLYMER, V39, P267, DOI 10.1016/S0032-3861(97)00229-2; Argon A.S., 2013, PHYS DEFORMATION FRA; Auras R., 2010, POLYLACTIC ACID SYNT; Cheng SW, 2013, POLYMER, V54, P3363, DOI 10.1016/j.polymer.2013.04.036; GROHENS Y, 1997, J POLYM, V38, P5913; Hadac J, 2007, J NON-CRYST SOLIDS, V353, P2681, DOI 10.1016/j.jnoncrysol.2007.05.017; Ito M, 2010, J APPL POLYM SCI, V115, P1454, DOI 10.1002/app.31292; Jimenez A., 2014, POLYLACTIC ACID SCI; Kambour R. P., 1972, POLYM SCI, P688; Kambour R. P., 1973, Journal of Polymer Science, Macromolecular Reviews, V7, DOI 10.1002/pol.1973.230070101; Kausch H.-H., 1987, POLYM FRACTURE; Kinloch AJ, 1983, FRACTURE BEHAV POLYM; Koeing J. L., 1977, J POLYM SCI PP, V15, P1379; Kowalczyk M, 2012, J APPL POLYM SCI, V124, P4579, DOI 10.1002/app.35489; Meaurio E, 2006, MACROMOLECULES, V39, P9291, DOI 10.1021/ma061890r; Meaurio W., 2006, J PHYS CHEM B, V110, P5790; NARISAWA I, 1991, MAKROMOL CHEM-M SYMP, V41, P87, DOI 10.1002/masy.19910410109; OGURA K, 1971, MACROMOLECULES, V4, P79, DOI 10.1021/ma60019a017; OREILLY JM, 1981, MACROMOLECULES, V14, P602, DOI 10.1021/ma50004a029; Pan P., 2008, J CHEM PHYS, V129; Pan P., 2007, MACROMOLECULES, V40, P6869; Robertson R E., 1968, APPL POLYMER S, V7, P201; STEARNE JM, 1969, J MATER SCI, V4, P1088, DOI 10.1007/BF00549849; VINCENT PI, 1960, POLYMER, V1, P425, DOI 10.1016/0032-3861(60)90059-8; VLEESHOUWERS S, 1994, THERMOCHIM ACTA, V238, P371, DOI 10.1016/S0040-6031(94)85220-0; Ward I.M., 1993, INTRO MECH PROPERTIE; Zhang Y, 2004, MACROMOLECULES, V37, P2532, DOI 10.1021/ma035709f	47	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1525-7797	1526-4602		BIOMACROMOLECULES	Biomacromolecules	MAY	2015	16	5					1660	1666		10.1021/acs.biomac.5b00293		7	Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	CI1KS	WOS:000354503700024		
J	Belkacem, AN; Shin, D; Kambara, H; Yoshimura, N; Koike, Y				Belkacem, Abdelkader Nasreddine; Shin, Duk; Kambara, Hiroyuki; Yoshimura, Natsue; Koike, Yasuharu			Online classification algorithm for eye-movement-based communication systems using two temporal EEG sensors (vol 16, pg 40, 2015)	BIOMEDICAL SIGNAL PROCESSING AND CONTROL			English	Correction									[Belkacem, Abdelkader Nasreddine] Tokyo Inst Technol, Dept Informat Proc, Yokohama, Kanagawa 2268503, Japan; [Shin, Duk; Kambara, Hiroyuki; Yoshimura, Natsue; Koike, Yasuharu] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan; [Koike, Yasuharu] Tokyo Inst Technol, Solut Sci Res Lab, Yokohama, Kanagawa 2268503, Japan	Belkacem, AN (reprint author), Tokyo Inst Technol, Dept Informat Proc, Yokohama, Kanagawa 2268503, Japan.	belkacem011@hotmail.com	Belkacem, Abdelkader Nasreddin/E-4569-2014	Belkacem, Abdelkader Nasreddin/0000-0002-3024-4167			Belkacem AN, 2015, BIOMED SIGNAL PROCES, V16, P40, DOI 10.1016/j.bspc.2014.10.005	1	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1746-8094	1746-8108		BIOMED SIGNAL PROCES	Biomed. Signal Process. Control	MAY	2015	19						137	137		10.1016/j.bspc.2015.01.006		1	Engineering, Biomedical; Medical Laboratory Technology	Engineering; Medical Laboratory Technology	CI8TQ	WOS:000355045000016		
J	Halpern, W; Prell, R; Chihaya, Y; Arima, A; Nijem, I; Tarrant, J; O'Mahoney, J; Kaur, S				Halpern, W.; Prell, R.; Chihaya, Y.; Arima, A.; Nijem, I; Tarrant, J.; O'Mahoney, J.; Kaur, S.			A Study for Effects of Onartuzumab on Embryo-Fetal and Pre- and Postnatal Development When Administered Intravenously Once Weekly for up to 23 Weeks to Pregnant Cynomolgus Monkeys (Enhanced Design)	BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY			English	Meeting Abstract									[Halpern, W.; Prell, R.; Nijem, I; Tarrant, J.; O'Mahoney, J.; Kaur, S.] Genentech Inc, San Francisco, CA 94080 USA; [Chihaya, Y.; Arima, A.] SNBL Ltd, Kagoshima, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1542-0752	1542-0760		BIRTH DEFECTS RES A	Birth Defects Res. Part A-Clin. Mol. Teratol.	MAY	2015	103	5				27	389	389				1	Developmental Biology; Toxicology	Developmental Biology; Toxicology	CI4SD	WOS:000354742400076		
J	Helms, MC; Grabocka, E; Martz, MK; Suzuki, N; Wedegaertner, PB				Helms, M. C.; Grabocka, E.; Martz, M. K.; Suzuki, N.; Wedegaertner, P. B.			Mitotic-Dependent Phosphorylation of LARG by Cdk1	BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY			English	Meeting Abstract									[Helms, M. C.; Grabocka, E.; Martz, M. K.; Wedegaertner, P. B.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Suzuki, N.] Univ Tokyo, Meguro Ku, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1542-0752	1542-0760		BIRTH DEFECTS RES A	Birth Defects Res. Part A-Clin. Mol. Teratol.	MAY	2015	103	5				P14	409	409				1	Developmental Biology; Toxicology	Developmental Biology; Toxicology	CI4SD	WOS:000354742400114		
J	Shiga, T; Shimbo, T; Yoshizawa, A; Hinoshita, F				Shiga, T.; Shimbo, T.; Yoshizawa, A.; Hinoshita, F.			Diseases Affecting Thalidomide Embryopathy at around 50 Years of Age	BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY			English	Meeting Abstract									[Shiga, T.; Yoshizawa, A.; Hinoshita, F.] Natl Ctr Global Hlth & Med, Shinjuku Ku, Tokyo, Japan; [Shimbo, T.] Ohta Nishinouchi Hosp, Koriyama, Fukushima, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1542-0752	1542-0760		BIRTH DEFECTS RES A	Birth Defects Res. Part A-Clin. Mol. Teratol.	MAY	2015	103	5				P24	414	414				1	Developmental Biology; Toxicology	Developmental Biology; Toxicology	CI4SD	WOS:000354742400124		
J	Parajuli, RP; Umezaki, M; Fujiwara, T; Watanabe, C				Parajuli, R. P.; Umezaki, M.; Fujiwara, T.; Watanabe, C.			Impact of In Utero Exposure of Lead (Pb), Arsenic (As), and Zinc (Zn) on the Neurodevelopment of Young Children from Birth to 36 Months of Age: A Birth Cohort Study in Chitwan Valley, Nepal	BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY			English	Meeting Abstract									[Parajuli, R. P.] McGill Univ, Environm Hlth Sci Lab, Montreal, PQ, Canada; [Umezaki, M.; Watanabe, C.] Univ Tokyo, Dept Human Ecol, Sch Int Hlth, Grad Sch Med,Bunkyo Ku, Tokyo, Japan; [Fujiwara, T.] Natl Res Inst Child Hlth & Dev, Dept Social Med, Setagaya Ku, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1542-0752	1542-0760		BIRTH DEFECTS RES A	Birth Defects Res. Part A-Clin. Mol. Teratol.	MAY	2015	103	5				P51	427	427				1	Developmental Biology; Toxicology	Developmental Biology; Toxicology	CI4SD	WOS:000354742400151		
J	Akiyama, Y; Iizuka, A; Kume, A; Komiyama, M; Urakami, K; Ashizawa, T; Miyata, H; Omiya, M; Kusuhara, M; Yamaguchi, K				Akiyama, Yasuto; Iizuka, Akira; Kume, Akiko; Komiyama, Masaru; Urakami, Kenichi; Ashizawa, Tadashi; Miyata, Haruo; Omiya, Maho; Kusuhara, Masatoshi; Yamaguchi, Ken			Effect of STAT3 Inhibition on the Metabolic Switch in a Highly STAT3-activated Lymphoma Cell Line	CANCER GENOMICS & PROTEOMICS			English	Article						STAT3; shRNA; Warburg effect; cancer metabolomics; proteomics	ATP-CITRATE LYASE; 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE; GLUTAMINE-METABOLISM; MITOCHONDRIAL STAT3; BREAST-CANCER; GROWTH; PHOSPHORYLATION; IDENTIFICATION; TRANSFORMATION; GLYCOLYSIS	Background: Signal transducer and activator of transcription (STAT) 3 is involved in a metabolic shift in cancer cells, the Warburg effect through its pro-oncogenic activity. To develop efficient STAT3 inhibitors against cancer cells, novel proteomic and metabolic target molecules need to be explored using multi-omics approaches in the context of STAT3 gene inhibition-mediated tumor growth suppression. Materials and Methods: We found that short hairpin (sh) RNA-mediated STAT3 inhibition suppressed tumor growth in a highly STAT3-activated lymphoma cell line, SCC-3 cells, and we investigated the effect of STAT3 inhibition on metabolic switching using 2-dimensional differential gel electrophoresis and capillary electrophoresistime of flight-mass spectrometry. Results: We identified latexin as a proteomic marker candidate and metabolic enzymes including fructose-bisphosphate aldolase A (ALDOA) as a metabolic marker candidate for STAT3-targeting therapy using STAT3-specific shRNA gene transduction. In particular, latexin expression was upregulated in four STAT3-activated cancer cell lines including SCC-3 transduced with STAT3-specific shRNA. The upregulation of latexin was identified in SCC-3 tumors transplanted to nude mice after treatment with STAT3 inhibitor. Conclusion: Our results suggest that STAT3 inactivation reverses the glycolytic shift by down-regulating key enzymes and that it induces up-regulation of latexin as a tumor-suppressor molecule, which partially results in cancer cell apoptosis and tumor growth suppression.	[Akiyama, Yasuto; Iizuka, Akira; Kume, Akiko; Komiyama, Masaru; Ashizawa, Tadashi; Miyata, Haruo; Omiya, Maho] Shizuoka Canc Ctr Res Inst, Div Immunotherapy, Nagaizumi, Shizuoka 4118777, Japan; [Urakami, Kenichi] Shizuoka Canc Ctr Res Inst, Canc Diagnost Div, Nagaizumi, Shizuoka 4118777, Japan; [Kusuhara, Masatoshi] Shizuoka Canc Ctr Res Inst, Reg Resources Div, Nagaizumi, Shizuoka 4118777, Japan; [Yamaguchi, Ken] Shizuoka Canc Ctr Hosp, Off President, Nagaizumi, Shizuoka, Japan	Akiyama, Y (reprint author), Shizuoka Canc Ctr Res Inst, Div Immunotherapy, 1007 Shimonagakubo, Nagaizumi, Shizuoka 4118777, Japan.	y.akiyama@scchr.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by a grant from the regional innovation strategy support program of the Ministry of Education, Culture, Sports, Science and Technology, Japan	Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Chang HY, 2012, CANCER RES, V72, P4696, DOI 10.1158/0008-5472.CAN-12-0567; Demaria M, 2010, AGING-US, V2, P823; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Jiang S, 2012, EMBO J, V31, P1985, DOI 10.1038/emboj.2012.45; Zaidi N, 2012, CANCER RES, V72, P3709, DOI 10.1158/0008-5472.CAN-11-4112; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Mitsunaga K, 2012, J CELL PHYSIOL, V227, P1138, DOI 10.1002/jcp.22834; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Marie SKN, 2011, CLINICS, V66, P33, DOI 10.1590/S1807-59322011001300005; Akiyama Y, 2012, CANCER IMMUNOL IMMUN, V61, P2311, DOI 10.1007/s00262-012-1298-1; Liu DB, 2012, ACTA PHARMACOL SIN, V33, P682, DOI 10.1038/aps.2012.18; Xu RH, 2005, CANCER RES, V65, P613; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Ashizawa T, 2011, INT J ONCOL, V38, P1245, DOI 10.3892/ijo.2011.957; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Bai JW, 2012, ONCOL REP, V28, P714, DOI 10.3892/or.2012.1806; Darnell JE, 2010, AGING-US, V2, P890; Dawson NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068830; Harada Y, CANC LETT, V319, P83; Li Y, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-121; Liu Q, 2013, CARCINOGENESIS, V34, P1728, DOI 10.1093/carcin/bgt125; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044979; Lu ZJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-16; Pan J, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-211; Ryu YM, 2013, CANCER PREV RES, V6, P349, DOI 10.1158/1940-6207.CAPR-12-0389; Sarafian TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009532; Takikawa M, 2006, ONCOL REP, V16, P705; Urakami K, 2013, BIOMED RES-TOKYO, V34, P221	35	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	1109-6535	1790-6245		CANCER GENOM PROTEOM	Cancer Genomics Proteomics	MAY-JUN	2015	12	3					133	142				10	Oncology; Genetics & Heredity	Oncology; Genetics & Heredity	CI1CZ	WOS:000354480000004		
J	Manabe, A; Kawasaki, H; Shimada, H; Kato, I; Kodama, Y; Sato, A; Matsumoto, K; Kato, K; Yabe, H; Kudo, K; Kato, M; Saito, T; Saito, AM; Tsurusawa, M; Horibe, K				Manabe, Atsushi; Kawasaki, Hirohide; Shimada, Hiroyuki; Kato, Itaru; Kodama, Yuichi; Sato, Atsushi; Matsumoto, Kimikazu; Kato, Keisuke; Yabe, Hiromasa; Kudo, Kazuko; Kato, Motohiro; Saito, Tomohiro; Saito, Akiko M.; Tsurusawa, Masahito; Horibe, Keizo			Imatinib use immediately before stem cell transplantation in children with Philadelphia chromosome-positive acute lymphoblastic leukemia: Results from Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Study Ph(+)ALL04	CANCER MEDICINE			English	Article						Ph plus ALL; children; imatinib; HSCT; MRD	MINIMAL RESIDUAL DISEASE; TOTAL-BODY IRRADIATION; TYROSINE KINASE; COMPLETE REMISSION; IMPROVES; CHEMOTHERAPY; COMBINATION; CHILDHOOD; INHIBITOR; 1ST	Incorporation of imatinib into chemotherapeutic regimens has improved the prognosis of children with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph(+)ALL). We investigated a role of imatinib immediately before hematopoietic stem cell transplantation (HSCT). Children with Ph(+)ALL were enrolled on JPLSG Ph(+)ALL 04 Study within 1week of initiation of treatment for ALL. Treatment regimen consisted of Induction phase, Consolidation phase, Reinduction phase, 2weeks of imatinib monotherapy phase, and HSCT phase (Etoposide+CY+TBI conditioning). Minimal residual disease (MRD), the amount of BCR-ABL transcripts, was measured with the real-time PCR method. The study was registered in UMIN-CTR: UMIN ID C000000290. Forty-two patients were registered and 36 patients (86%) achieved complete remission (CR). Eight of 17 patients (47%) who had detectable MRD at the beginning of imatinib monotherapy phase showed disappearance or decrease in MRD after imatinib treatment. Consequently, 26 patients received HSCT in the first CR and all the patients had engraftment and no patients died because of complications of HSCT. The 4-year event-free survival rates and overall survival rates among all the 42 patients were 54.1 +/- 7.8% and 78.1 +/- 6.5%, respectively. Four of six patients who did achieve CR and three of six who relapsed before HSCT were salvaged with imatinib-containing chemotherapy and subsequently treated with HSCT. The survival rate was excellent in this study although all patients received HSCT. A longer use of imatinib concurrently with chemotherapy should eliminate HSCT in a subset of patients with a rapid clearance of the disease.	[Manabe, Atsushi] St Lukes Int Hosp, Dept Pediat, Tokyo 1048560, Japan; [Kawasaki, Hirohide] Kansai Med Univ, Hirakata Hosp, Dept Pediat, Osaka, Japan; [Shimada, Hiroyuki] Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan; [Kato, Itaru] Kyoto Univ, Grad Sch Med, Pediat, Kyoto, Japan; [Kodama, Yuichi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pediat, Kagoshima 890, Japan; [Sato, Atsushi] Miyagi Childrens Hosp, Dept Hematol & Oncol, Sendai, Miyagi, Japan; [Matsumoto, Kimikazu] Natl Res Inst Child Hlth & Dev, Tokyo, Japan; [Kato, Keisuke] Ibaraki Childrens Hosp, Dept Pediat, Mito, Ibaraki, Japan; [Yabe, Hiromasa] Tokai Univ, Dept Pediat, Isehara, Kanagawa, Japan; [Kudo, Kazuko] Shizuoka Childrens Hosp, Dept Hematol Oncol, Shizuoka, Japan; [Kato, Motohiro] Univ Tokyo, Dept Pediat, Tokyo, Japan; [Saito, Tomohiro] Natl Res Inst Child Hlth & Dev, MPH Dept Hlth Policy, Tokyo, Japan; [Saito, Akiko M.] Natl Hosp Org, Nagoya Med Ctr, Clin Res Ctr, MPH Lab Clin Epidemiol & Hlth Serv Res, Aichi, Japan; [Tsurusawa, Masahito] Aichi Med Univ, Dept Pediat, Nagakute, Aichi 48011, Japan; [Horibe, Keizo] Natl Hosp Org, Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan	Manabe, A (reprint author), St Lukes Int Hosp, Dept Pediat, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	manabe-luke@umin.ac.jp			Ministry of Health, Labour and Welfare; Children's Cancer Association of Japan	This study was supported by a grant from the Ministry of Health, Labour and Welfare and a grant from the Children's Cancer Association of Japan.	Bunin N, 2003, BONE MARROW TRANSPL, V32, P543, DOI 10.1038/sj.bmt.1704198; Schultz KR, 2009, J CLIN ONCOL, V27, P5175, DOI 10.1200/JCO.2008.21.2514; Lee S, 2009, CANCER, V115, P561, DOI 10.1002/cncr.24026; van der Veer A, 2014, BLOOD, V123, P1691, DOI 10.1182/blood-2013-06-509794; Biondi A, 2012, LANCET ONCOL, V13, P936, DOI 10.1016/S1470-2045(12)70377-7; Thomas DA, 2004, BLOOD, V103, P4396, DOI 10.1182/blood-2003-08-2958; Manabe A, 2008, HAEMATOL-HEMATOL J, V93, P1155, DOI 10.3324/haematol.12365; Jeha S, 2014, CANCER-AM CANCER SOC, V120, P1514, DOI 10.1002/cncr.28598; Schultz KR, 2014, LEUKEMIA, V28, P1467, DOI [10.1038/leu.2014.30, 10.1038/1eu.2014.30]; Leung W, 2012, BLOOD, V120, P468, DOI 10.1182/blood-2012-02-409813; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; Towatari M, 2004, BLOOD, V104, P3507, DOI 10.1182/blood-2004-04-1389; Eckert C, 2013, J CLIN ONCOL, V31, P2736, DOI 10.1200/JCO.2012.48.5680; Mizuta S, 2011, LEUKEMIA, V25, P41, DOI 10.1038/leu.2010.228; Arico M, 2010, J CLIN ONCOL, V28, P4755, DOI 10.1200/JCO.2010.30.1325; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Rives S, 2011, BRIT J HAEMATOL, V154, P600, DOI 10.1111/j.1365-2141.2011.08783.x; SIMON R, 1989, CONTROL CLIN TRIALS, V10, P1, DOI 10.1016/0197-2456(89)90015-9; Soverini S, 2013, BLOOD, V122, P1634, DOI 10.1182/blood-2013-03-487728; VansDongen JJ, 1998, LANCET, V352, P1731; Yabe H, 2011, BONE MARROW TRANSPL, V46, pS270; Zaliova M, 2009, LEUKEMIA, V23, P944, DOI 10.1038/leu.2008.386	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7634			CANCER MED-US	Cancer Med.	MAY	2015	4	5					682	689		10.1002/cam4.383		8	Oncology	Oncology	CI0AJ	WOS:000354397700006		
J	Koyama, T; Ogawara, K; Kasamatsu, A; Okamoto, A; Kasama, H; Minakawa, Y; Shimada, K; Yokoe, H; Shiiba, M; Tanzawa, H; Uzawa, K				Koyama, Tomoyoshi; Ogawara, Katsunori; Kasamatsu, Atsushi; Okamoto, Atsushi; Kasama, Hiroki; Minakawa, Yasuyuki; Shimada, Ken; Yokoe, Hidetaka; Shiiba, Masashi; Tanzawa, Hideki; Uzawa, Katsuhiro			ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer	CANCER MEDICINE			English	Article						Angiopoietin-like 3; extracellular signal-regulated MAP Kinases; head and neck; squamous cell carcinoma; survival	SQUAMOUS-CELL CARCINOMA; CYCLIN D1; IN-VIVO; SIGNALING PATHWAYS; KINASE PATHWAY; PROTEIN; EXPRESSION; GROWTH; MAPK; PROLIFERATION	Angiopoietin-like 3 (ANGPTL3), which is involved in new blood vessel growth and stimulation of mitogen-activated protein kinase (MAPK), is expressed aberrantly in several types of human cancers. However, little is known about the relevance of ANGPTL3 in the behavior of oral squamous cell carcinoma (OSCC). In this study, we evaluated ANGPTL3 mRNA and protein in OSCC-derived cell lines (n=8) and primary OSCCs (n=109) and assessed the effect of ANGPTL3 on the biology and function of OSCCs in vitro and in vivo. Significant (P<0.05) ANGPTL3 upregulation was detected in the cell lines and most primary OSCCs (60%) compared with the normal counterparts. The ANGPTL3 expression level was correlated closely (P<0.05) with tumoral size. In patients with T3/T4 tumors, the overall survival rate with an ANGPTL3-positive tumor was significantly (P<0.05) lower than that of ANGPTL3-negative cases. In vitro, cellular growth in ANGPTL3 knockdown cells significantly (P<0.05) decreased with inactivated extracellular regulated kinase (ERK) and cell-cycle arrest at the G1 phase resulting from upregulation of the cyclin-dependent kinase inhibitors, including p21(Cip1) and p27(Kip1). We also observed a marked (P<0.05) reduction in the growth in ANGPTL3 knockdown-cell xenografts with decreased levels of phosphorylated ERK relative to control-cell xenografts. The current data indicated that ANGPTL3 may play a role in OSCCs via MAPK signaling cascades, making it a potentially useful diagnostic/therapeutic target for use in patients with OSCC.	[Koyama, Tomoyoshi; Okamoto, Atsushi; Kasama, Hiroki; Tanzawa, Hideki; Uzawa, Katsuhiro] Chiba Univ, Grad Sch Med, Dept Oral Sci, Chuo Ku, Chiba 2608670, Japan; [Ogawara, Katsunori; Kasamatsu, Atsushi; Minakawa, Yasuyuki; Shimada, Ken; Tanzawa, Hideki; Uzawa, Katsuhiro] Chiba Univ Hosp, Dept Dent & Oral Maxillofacial Surg, Chuo Ku, Chiba 2608670, Japan; [Yokoe, Hidetaka] Natl Def Med Coll, Dept Oral & Maxillofacial Surg, Res Inst, Tokorozawa, Saitama 3598513, Japan; [Shiiba, Masashi] Chiba Univ, Grad Sch Med, Dept Clin Oncol, Chuo Ku, Chiba 2608670, Japan	Uzawa, K (reprint author), Chiba Univ, Grad Sch Med, Dept Oral Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	uzawak@faculty.chiba-u.jp					Perisanidis C, 2012, J ORAL PATHOL MED, V41, P40, DOI 10.1111/j.1600-0714.2011.01071.x; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Yu HB, 2011, HEPATO-GASTROENTEROL, V58, P1742, DOI 10.5754/hge10647; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; TAM SW, 1994, ONCOGENE, V9, P2663; Viglietto G, 2002, CELL CYCLE, V1, P394, DOI 10.4161/cc.1.6.263; Orton RJ, 2005, BIOCHEM J, V392, P249, DOI 10.1042/BJ20050908; ALBANESE C, 1995, J BIOL CHEM, V270, P23589; Ono M, 2003, J BIOL CHEM, V278, P41804, DOI 10.1074/jbc.M302861200; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; MARSHALL CJ, 1991, CELL, V64, P313, DOI 10.1016/0092-8674(91)90641-B; Giancotti FG, 2000, NAT CELL BIOL, V2, pE13, DOI 10.1038/71397; Lavoie JN, 1996, J BIOL CHEM, V271, P20608; Mebratu Y, 2009, CELL CYCLE, V8, P1168; Camenisch G, 2002, J BIOL CHEM, V277, P17281, DOI 10.1074/jbc.M109768200; Wey JS, 2005, BRIT J CANCER, V93, P233, DOI 10.1038/sj.jbc.6602663; Coolican SA, 1997, J BIOL CHEM, V272, P6653; Squires MS, 2002, BIOCHEM J, V366, P673, DOI 10.1042/BJ20020372; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; MUSGROVE EA, 1994, P NATL ACAD SCI USA, V91, P8022, DOI 10.1073/pnas.91.17.8022; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Baba T., 2013, MOL CARCINO IN PRESS; Bhatt KV, 2005, ONCOGENE, V24, P3459, DOI 10.1038/sj.onc.1208544; Broxmeyer HE, 2012, BLOOD CELL MOL DIS, V48, P25, DOI 10.1016/j.bcmd.2011.09.004; Diaz-Rodriguez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027583; Ferrero M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028602; Greulich H, 1998, J BIOL CHEM, V273, P13280, DOI 10.1074/jbc.273.21.13280; Iyoda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014082; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kisielewska J, 2009, DEV BIOL, V334, P383, DOI 10.1016/j.ydbio.2009.07.043; Li Y., 2014, J DRUG TARGET, V22, P679; McCubrey JA, 2007, ADV ENZYME REGUL, V47, P64, DOI 10.1016/j.advenzreg.2006.12.013; Mountzios G, 2008, CLIN CANCER RES, V14, P4096, DOI 10.1158/1078-0432.CCR-07-4150; Shimizu F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083187; Shimizu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045510; Shrestha Y, 2012, ONCOGENE, V31, P3397, DOI 10.1038/onc.2011.515; Uchida F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056381; Uzawa K, 2012, ONCOTARGET, V3, P670; Yu H., 2010, HEPATO-GASTROENTEROL, V58, P1742	41	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7634			CANCER MED-US	Cancer Med.	MAY	2015	4	5					759	769		10.1002/cam4.418		11	Oncology	Oncology	CI0AJ	WOS:000354397700013		
J	Saitoh, M				Saitoh, Masao			Epithelial-mesenchymal transition is regulated at post-transcriptional levels by transforming growth factor- signaling during tumor progression	CANCER SCIENCE			English	Review						Cancer biology; EMT; signal transduction; Smad; TGF-beta	TGF-BETA; BREAST-CANCER; TRANSCRIPTION FACTOR; DNA METHYLATION; CARCINOMA-CELLS; ZEB PROTEINS; SNAIL; SMAD; DELTA-EF1; EMT	Transforming growth factor (TGF)- acts as a tumor suppressor during cancer initiation, but as a tumor promoter during tumor progression. It has become increasingly clear that TGF- plays fundamental roles in multiple steps of tumor progression, including epithelial-mesenchymal transition (EMT). The EMT, first described by developmental biologists at the beginning of the 1980s, plays crucial roles in appropriate embryonic development, but also functions in adults during wound healing, organ fibrosis, and tumor progression. During EMT, epithelial cells lose their epithelial polarity and acquire mesenchymal phenotypes, endowing them with migratory and invasive properties. Many secreted polypeptides are implicated in this process, and act in a sequential or cooperative manner. TGF- induces EMT by propagating intracellular signaling pathways and activating transcriptional factors. Here, I discuss new insights into the molecular mechanisms underlying induction of EMT by TGF- in cooperation with Ras or growth factors, along with the signals that induce EMT through transcriptional and post-transcriptional regulation.	[Saitoh, Masao] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Biochem, Ctr Med Educ & Sci,Chuo Ku, Yamanashi 4093898, Japan	Saitoh, M (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Biochem, Chuo Ku, 1110 Shimokato, Yamanashi 4093898, Japan.	msaitoh-ind@umin.ac.jp			Japan Society for the Promotion of Science; Astellas Foundation for Research on Metabolic Disorders; Kobayashi Foundation for Cancer Research	Japan Society for the Promotion of Science; Astellas Foundation for Research on Metabolic Disorders; Kobayashi Foundation for Cancer Research.	Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Tanaka Y, 2013, CANCER BIOL THER, V14, P13, DOI 10.4161/cbt.22625; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Horiguchi K, 2012, ONCOGENE, V31, P3190, DOI 10.1038/onc.2011.493; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Matsuzaki K, 2013, CYTOKINE GROWTH F R, V24, P385, DOI 10.1016/j.cytogfr.2013.06.002; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Fiegen D, 2004, J BIOL CHEM, V279, P4743, DOI 10.1074/jbc.M310281200; Kawata M, 2012, J BIOCHEM, V151, P205, DOI 10.1093/jb/mvr136; Wrana JL, 2000, CYTOKINE GROWTH F R, V11, P5, DOI 10.1016/S1359-6101(99)00024-6; Kawataki T, 2007, EXP CELL RES, V313, P3819, DOI 10.1016/j.yexcr.2007.07.038; Zheng HQ, 2014, CANCER CELL, V26, P358, DOI 10.1016/j.ccr.2014.07.022; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Inman GJ, 2011, CURR OPIN GENET DEV, V21, P93, DOI 10.1016/j.gde.2010.12.004; Hur K, 2013, GUT, V62, P1315, DOI 10.1136/gutjnl-2011-301846; Ehata S, 2007, CANCER RES, V67, P9694, DOI 10.1158/0008-5472.CAN-07-1522; Lamouille S, 2013, CURR OPIN CELL BIOL, V25, P200, DOI 10.1016/j.ceb.2013.01.008; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Hay ED, 1995, ACTA ANAT, V154, P8; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; GREENBURG G, 1982, J CELL BIOL, V95, P333, DOI 10.1083/jcb.95.1.333; Shirakihara T, 2011, EMBO J, V30, P783, DOI 10.1038/emboj.2010.351; SPORN MB, 1992, J CELL BIOL, V119, P1017, DOI 10.1083/jcb.119.5.1017; Zhang HF, 2014, CURR PHARM DESIGN, V20, P1896; Massague J, 2003, GENE DEV, V17, P2993, DOI 10.1101/gad.1167003; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Behnsawy HM, 2013, BJU INT, V111, P30, DOI 10.1111/j.1464-410X.2012.11551.x; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Saitoh M, 2012, J BIOCHEM, V151, P563, DOI 10.1093/jb/mvs040; Goncalves V, 2009, HUM MOL GENET, V18, P3696, DOI 10.1093/hmg/ddp317; Lin YW, 2014, CURR PHARM DESIGN, V20, P1698; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Nishimura G, 2006, DEV CELL, V11, P93, DOI 10.1016/j.devcel.2006.05.011; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Postigo AA, 2003, EMBO J, V22, P2453, DOI 10.1093/emboj/cdg226; Motizuki M, 2013, J BIOL CHEM, V288, P18911, DOI 10.1074/jbc.M113.480996; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; Postigo AA, 2003, EMBO J, V22, P2443, DOI 10.1093/emboj/cdg225; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Miyazono K, 2009, P JPN ACAD B-PHYS, V85, P314, DOI 10.2183/pjab.85.314; Derynck R, 2008, THE TGF FAMILY; Espada J, 2011, NUCLEIC ACIDS RES, V39, P9194, DOI 10.1093/nar/gkr658; Fukagawa A, 2015, CANCER MED-US, V4, P125, DOI 10.1002/cam4.347; FUNAHASHI J, 1993, DEVELOPMENT, V119, P433; Ishii H, 2014, J BIOL CHEM, V289, P27386, DOI 10.1074/jbc.M114.589432; Kamaraju Anil K., 2005, Journal of Biological Chemistry, V280, P1024; Kumar MS, 2014, NATURE, V505, P212, DOI 10.1038/nature12785; Nakano A, 2009, J BIOL CHEM, V284, P6109, DOI 10.1074/jbc.M804659200; Shirakihara T, 2013, CANCER SCI, V104, P1189, DOI 10.1111/cas.12220; Tobin NP, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-417	58	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	MAY	2015	106	5					481	488		10.1111/cas.12630		8	Oncology	Oncology	CI6QM	WOS:000354885700001		
J	Tanaka, K; Kumano, K; Ueno, H				Tanaka, Kiyomichi; Kumano, Keiki; Ueno, Hiroo			Intracellular signals of lung cancer cells as possible therapeutic targets	CANCER SCIENCE			English	Review						Lung cancer; lung cancer stem cells; lung stem cells; molecularly targeted therapy; survival signals	STEM-CELLS; K-RAS; GEFITINIB RESISTANCE; ABERRANT METHYLATION; DNA METHYLATION; NOTCH PATHWAY; SELF-RENEWAL; MOUSE MODEL; ADENOCARCINOMA; SOX2	In recent years, several molecularly targeted therapies have been developed as part of lung cancer treatment; they have produced dramatically good results. However, among the many oncogenes that have been identified to be involved in the development of lung cancers, a number of oncogenes are not covered by these advanced therapies. For the treatment of lung cancers, which is a group of heterogeneous diseases, persistent effort in developing individual therapies based on the respective causal genes is important. In addition, for the development of a novel therapy, identification of the lung epithelial stem cells and the origin cells of lung cancer, and understanding about candidate cancer stem cells in lung cancer tissues, their intracellular signaling pathways, and the mechanism of dysregulation of the pathways in cancer cells are extremely important. However, the development of drug resistance by cancer cells, despite the use of molecularly targeted drugs for the causal genes, thus obstructing treatment, is a well-known phenomenon. In this article, we discuss major causal genes of lung cancers and intracellular signaling pathways involving those genes, and review studies on origin and stem cells of lung cancers, as well as the possibility of developing molecularly targeted therapies based on these studies.	[Tanaka, Kiyomichi; Kumano, Keiki; Ueno, Hiroo] Kansai Med Univ, Dept Stem Cell Pathol, Hirakata, Osaka 5731010, Japan	Ueno, H (reprint author), Kansai Med Univ, Dept Stem Cell Pathol, 2-5-1 Shin Machi, Hirakata, Osaka 5731010, Japan.	hueno@hirakata.kmu.ac.jp			Kansai Medical University; Funding Program for Next Generation World-Leading Researchers; Mochida Memorial Foundation; Naito Memorial Foundation; Cell Science Research Foundation; Uehara Memorial Foundation; Mitsubishi Foundation; Yasuda Memorial Foundation; Takeda Science Foundation	Kansai Medical University; Grant-in-Aid for Scientific Research; Funding Program for Next Generation World-Leading Researchers; The Mochida Memorial Foundation; The Naito Memorial Foundation; The Cell Science Research Foundation; The Uehara Memorial Foundation; The Mitsubishi Foundation; The Yasuda Memorial Foundation; The Takeda Science Foundation.	Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Hashimoto S, 2012, J CELL SCI, V125, P932, DOI 10.1242/jcs.092734; Xing YM, 2012, STEM CELLS, V30, P946, DOI 10.1002/stem.1059; Hassan KA, 2013, CLIN CANCER RES, V19, P1972, DOI 10.1158/1078-0432.CCR-12-0370; Licciulli S, 2013, CANCER RES, V73, P5974, DOI 10.1158/0008-5472.CAN-13-1384; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Sutherland KD, 2014, P NATL ACAD SCI USA, V111, P4952, DOI 10.1073/pnas.1319963111; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; Dakir ELH, 2008, CARCINOGENESIS, V29, P2377, DOI 10.1093/carcin/bgn190; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Song H, 2012, P NATL ACAD SCI USA, V109, P17531, DOI 10.1073/pnas.1207238109; Tanaka T, 2013, NAT CELL BIOL, V15, P511, DOI 10.1038/ncb2719; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Casas-Selves M, 2012, CANCER RES, V72, P4154, DOI 10.1158/0008-5472.CAN-11-2848; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Allen TD, 2011, CANCER RES, V71, P6010, DOI 10.1158/0008-5472.CAN-11-0595; Xu X, 2014, GENE DEV, V28, P1929, DOI 10.1101/gad.243717.114; Teng Y, 2010, BIOCHEM BIOPH RES CO, V392, P373, DOI 10.1016/j.bbrc.2010.01.028; Rauch TA, 2008, P NATL ACAD SCI USA, V105, P252, DOI 10.1073/pnas.0710735105; You L, 2004, ONCOGENE, V23, P6170, DOI 10.1038/sj.onc.1207844; Sriuranpong V, 2001, CANCER RES, V61, P3200; Xie M, 2013, EUR J CANCER, V49, P3559, DOI 10.1016/j.ejca.2013.07.007; Ceteci F, 2007, CANCER CELL, V12, P145, DOI 10.1016/j.ccr.2007.06.014; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Baumgart A, 2015, ONCOGENE, V34, P578, DOI 10.1038/onc.2013.592; Osada H, 2011, CANCER SCI, V102, P9, DOI 10.1111/j.1349-7006.2010.01707.x; Chou YT, 2013, STEM CELLS, V31, P2607, DOI 10.1002/stem.1518; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Reynolds SD, 2008, STEM CELLS, V26, P1337, DOI 10.1634/stemcells.2008-0053; Nakatsugawa M, 2011, LAB INVEST, V91, P1796, DOI 10.1038/labinvest.2011.140; Konishi J, 2010, ONCOGENE, V29, P589, DOI 10.1038/onc.2009.366; Sriuranpong V, 2002, MOL CELL BIOL, V22, P3129, DOI 10.1128/MCB.22.9.3129-3139.2002; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Xi SC, 2013, J CLIN INVEST, V123, P1241, DOI 10.1172/JCI61271; Pacheco-Pinedo EC, 2011, J CLIN INVEST, V121, P1935, DOI 10.1172/JCI44871; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Xiang R, 2011, BRIT J CANCER, V104, P1410, DOI 10.1038/bjc.2011.94; Westhoff B, 2009, P NATL ACAD SCI USA, V106, P22293, DOI 10.1073/pnas.0907781106; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Ushijima T, 2007, J BIOCHEM MOL BIOL, V40, P142; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Red-Horse K, 2010, NATURE, V464, P549, DOI 10.1038/nature08873; Belinsky SA, 2004, NAT REV CANCER, V4, P707, DOI 10.1038/nrc1432; Kasinski AL, 2012, CANCER RES, V72, P5576, DOI 10.1158/0008-5472.CAN-12-2001; Ito T, 2000, DEVELOPMENT, V127, P3913; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Kim S, 2008, J BIOL CHEM, V283, P18158, DOI 10.1074/jbc.M800186200; Maraver A, 2012, CANCER CELL, V22, P222, DOI 10.1016/j.ccr.2012.06.014; Meuwissen R, 2005, GENE DEV, V19, P643, DOI 10.1101/gad.1284505; Ceteci F, 2012, NEOPLASIA, V14, P1164, DOI 10.1593/neo.121088; Chen SF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031864, 10.1371/journal.pone.0049275]; Dang TP, 2003, ONCOGENE, V22, P1988, DOI 10.1038/sj.onc.1206230; Ghosh MC, 2013, AM J PHYSIOL-LUNG C, V24, P222; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Ho JN, 2010, CANCER SCI, V101, P1417, DOI 10.1111/j.1349-7006.2010.01552.x; Komai Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06175; Kuang SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061807; Lee JM, 2013, MOL CANCER RES, V11, P43, DOI 10.1158/1541-7786.MCR-12-0355; Lin LP, 2010, CANCER RES, V70, P632, DOI 10.1158/0008-5472.CAN-09-3293; Ochoa CE, 2010, CANC PREV RES, V4, P51; Otsubo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016617; Reddy R, 2004, AM J PHYSIOL-LUNG C, V286, P658; Shan L, 2007, AM J PHYSIOL-LUNG C, V292, P500; Singh S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-73; Smith MK, 2012, AM J PHYSIOL-LUNG C, V302, P1580; Sunday ME, 1999, ONCOGENE, V18, P4336, DOI 10.1038/sj.onc.1202810; SUTHERLAND K, 2011, TLS TIMES LIT S 0422, P19; Suzuki M, 2007, CLIN CANCER RES, V13, P6087, DOI 10.1158/1078-0432.CCR-07-0591; Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112; Xi SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013764; Yanai H, 2013, J GASTROENTEROL, V48, P423, DOI 10.1007/s00535-012-0736-3; Zhao D., 2014, ONCOGENE, DOI [10.1038/onc.2014.257, DOI 10.1038/ONC.2014.257]; Zheng YY, 2013, CANCER CELL, V24, P59, DOI 10.1016/j.ccr.2013.05.021; Zuo W, 2015, NATURE, V517, P616, DOI 10.1038/nature13903	79	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	MAY	2015	106	5					489	496		10.1111/cas.12643		8	Oncology	Oncology	CI6QM	WOS:000354885700002		
J	Kenmotsu, H; Tanigawara, Y				Kenmotsu, Hirotsugu; Tanigawara, Yusuke			Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose	CANCER SCIENCE			English	Review						Docetaxel; ethnic difference; pharmacodynamics; pharmacokinetics; toxicity	CELL LUNG-CANCER; PHASE-III TRIAL; METASTATIC BREAST-CANCER; PROSPECTIVE RANDOMIZED-TRIAL; PLATINUM-BASED CHEMOTHERAPY; GENOME-WIDE ASSOCIATION; 2ND-LINE TREATMENT; POPULATION PHARMACOKINETICS; INTRAVENOUS-INFUSION; UNBOUND DOCETAXEL	Docetaxel (Taxotere((R))) has been one of the most important chemotherapeutic drugs for cancer treatment since 1996. Although a large number of clinical studies have been conducted in various cancer fields, there is a discrepancy in the standard dose between Japan and Western countries. This article reviews the pharmacokinetic, pharmacodynamic and toxicological profiles of docetaxel, and explains why there exists an ethnic difference in dose, and further discusses which direction we should go forward to solve this problem. The original recommended dose was 100mg/m(2) every 3weeks in US and European populations, while a Japanese phaseI study suggested the recommended dose as 60mg/m(2) every 3weeks. A prospective population pharmacokinetic analysis of docetaxel conducted in both the USA/Europe and Japan, indicated an absence of ethnic difference in the pharmacokinetics. Both analyses demonstrated that docetaxel clearance is related to 1-acid glycoprotein level, hepatic function, age and body surface area. The relationship was observed between increasing docetaxel dose and increased tumor response rates across the dose range of 60 to 100mg/m(2). The area under the serum concentration time curve (AUC) of docetaxel at the first cycle was significantly related to time to progression. Hematological toxicities were well correlated with the AUC of docetaxel, and severe hematological toxicities were more frequently observed in Japanese patients treated with 60mg/m(2), compared to the US/European patients treated with 75-100mg/m(2) dose. The Japanese population seems more susceptible to the toxicity of docetaxel. A docetaxel dose of 75mg/m(2) is now standard not only in global trials but also in recent Japanese trials. Although the optimal dose of docetaxel is still unclear, we need to continue to seek the appropriate dose of docetaxel depending on patient status and the goals of chemotherapy.	[Kenmotsu, Hirotsugu; Tanigawara, Yusuke] Keio Univ Sch Med, Dept Clin Pharmacokinet & Pharmacodynam, Tokyo 1608582, Japan; [Kenmotsu, Hirotsugu] Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan	Tanigawara, Y (reprint author), Keio Univ Sch Med, Dept Clin Pharmacokinet & Pharmacodynam, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	tanigawara-yusuke@umin.ac.jp					Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Harvey V, 2006, J CLIN ONCOL, V24, P4963, DOI 10.1200/JCO.2005.05.0294; Yamamoto N, 2005, J CLIN ONCOL, V23, P1061, DOI 10.1200/JCO.2005.11.036; Urien S, 1996, INVEST NEW DRUG, V14, P147; Engels FK, 2004, CLIN PHARMACOL THER, V75, P448, DOI 10.1016/j.clpt.2004.01.001; Loos WJ, 2003, CLIN PHARMACOL THER, V74, P364, DOI 10.1097/S0009-9236(03)00222-4; Herbst RS, 2010, LANCET ONCOL, V11, P619, DOI 10.1016/S1470-2045(10)70132-7; Maruyama R, 2008, J CLIN ONCOL, V26, P4244, DOI 10.1200/JCO.2007.15.0185; Bosch TM, 2006, CLIN CANCER RES, V12, P5786, DOI 10.1158/1078-0432.CCR-05-2649; Ramlau R, 2012, J CLIN ONCOL, V30, P3640, DOI 10.1200/JCO.2012.42.6932; Kawaguchi T, 2014, J CLIN ONCOL, V32, P1902, DOI 10.1200/JCO.2013.52.4694; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095; Fossella FV, 2000, J CLIN ONCOL, V18, P2354; Bruno R, 2001, INVEST NEW DRUG, V19, P163, DOI 10.1023/A:1010687017717; Tran A, 2006, CLIN PHARMACOL THER, V79, P570, DOI 10.1016/j.clpt.2006.02.003; Engels FK, 2011, CLIN CANCER RES, V17, P353, DOI 10.1158/1078-0432.CCR-10-1636; Goh BC, 2002, J CLIN ONCOL, V20, P3683, DOI 10.1200/JCO.2002.01.025; Winther D, 2007, SUPPORT CARE CANCER, V15, P1191, DOI 10.1007/s00520-007-0232-0; Camps C, 2006, ANN ONCOL, V17, P467, DOI 10.1093/annonc/mdj115; Minami H, 2004, J CLIN ONCOL, V22, P2901, DOI 10.1200/jco.2004.10.163; Ramlau R, 2006, J CLIN ONCOL, V24, P2800, DOI 10.1200/JCO.2005.03.6491; Clarke SJ, 1999, CLIN PHARMACOKINET, V36, P99, DOI 10.2165/00003088-199936020-00002; Cui YH, 2001, MOL PHARMACOL, V60, P934; Kiyotani K, 2008, CANCER SCI, V99, P967, DOI 10.1111/j.1349-7006.2008.00765.x; Low SK, 2013, CANCER SCI, V104, P1074, DOI 10.1111/cas.12186; Jones SE, 2005, J CLIN ONCOL, V23, P5542, DOI 10.1200/JCO.2005.02.027; Baker SD, 2005, CLIN PHARMACOL THER, V77, P43, DOI 10.1016/j.clpt.2004.09.005; Krzakowski M, 2010, J CLIN ONCOL, V28, P2167, DOI 10.1200/JCO.2009.23.4146; Lee DH, 2010, CLIN CANCER RES, V16, P1307, DOI 10.1158/1078-0432.CCR-09-1903; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Hong J, 2007, JPN J CLIN ONCOL, V37, P424, DOI 10.1093/jjco/hym042; Nabholtz JM, 1999, J CLIN ONCOL, V17, P1413; Sissung TM, 2008, CLIN CANCER RES, V14, P4543, DOI 10.1158/1078-0432.CCR-07-4230; Schuette W, 2005, J CLIN ONCOL, V23, P8389, DOI 10.1200/JCO.2005.02.3739; Smorenburg CH, 2003, EUR J CANCER, V39, P196, DOI 10.1016/S0959-8049(02)00611-1; Bruno R, 1996, J PHARMACOKINET BIOP, V24, P153, DOI 10.1007/BF02353487; Minami H, 2006, CANCER SCI, V97, P235, DOI 10.1111/j.1349-7006.2006.00166.x; Bruno R, 1998, J CLIN ONCOL, V16, P187; Hor SY, 2008, PHARMACOGENOMICS J, V8, P139, DOI 10.1038/sj.tpj.6500478; Gridelli C, 2004, BRIT J CANCER, V91, P1996, DOI 10.1038/sj.bjc.6602241; Yamamoto N, 2000, J CLIN ONCOL, V18, P2301; BRUNO R, 1993, CANCER SURV, V17, P305; Baker SD, 2006, CLIN PHARMACOKINET, V45, P235, DOI 10.2165/00003088-200645030-00002; Uchiyama T, 2012, CANCER CHEMOTH PHARM, V69, P1617, DOI 10.1007/s00280-012-1872-4; Hirth J, 2000, CLIN CANCER RES, V6, P1255; Shou MG, 1998, PHARMACOGENETICS, V8, P391, DOI 10.1097/00008571-199810000-00004; Yano R, 2013, INT J CLIN ONCOL, V18, P96, DOI 10.1007/s10147-011-0349-5; Baker SD, 2004, CLIN CANCER RES, V10, P1976, DOI 10.1158/1078-0432.CCR-0842-03; Baker SD, 2009, CLIN PHARMACOL THER, V85, P155, DOI 10.1038/clpt.2008.95; Bruno R, 2003, CLIN CANCER RES, V9, P1077; Bruno R, 2012, CPT Pharmacometrics Syst Pharmacol, V1, pe19, DOI 10.1038/psp.2012.20; BURRIS H, 1993, J CLIN ONCOL, V11, P950; Eckmann Karen, 2014, J Oncol Pharm Pract, V20, P120, DOI 10.1177/1078155213480536; EXTRA JM, 1993, CANCER RES, V53, P1037; Frances N, 2011, CANCER CHEMOTH PHARM, V68, P1413, DOI 10.1007/s00280-011-1628-6; Garassino MC, 2013, LANCET ONCOL, V14, P981, DOI 10.1016/S1470-2045(13)70310-3; Goncalves A, 2003, CLIN CANCER RES, V9, P102; Hooker AC, 2008, CLIN PHARMACOL THER, V84, P111, DOI 10.1038/sj.clpt.6100476; Lewis LD, 2007, CLIN CANCER RES, V13, P3302, DOI 10.1158/1078-0432.CCR-06-2345; McLeod HL, 1998, CANCER CHEMOTH PHARM, V42, P155, DOI 10.1007/s002800050799; Mencoboni M, 2006, CHEMOTHERAPY, V52, P147, DOI 10.1159/000092903; Minami H, 2009, CANCER SCI, V100, P144, DOI 10.1111/j.1349-7006.2009.00992.x; Nakamura S, 2012, CLIN BREAST CANCER, V12, P49, DOI 10.1016/j.clbc.2011.10.002; Niu NF, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-422; Paz-Ares L, 2008, BRIT J CANCER, V98, P1608, DOI 10.1038/sj.bjc.6604372; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Puisset F, 2007, BRIT J CANCER, V97, P290, DOI 10.1038/sj.bjc.6603872; Reck M, 2014, LANCET ONCOL, V15, P143, DOI 10.1016/S1470-2045(13)70586-2; RINGEL I, 1991, J NATL CANCER I, V83, P288, DOI 10.1093/jnci/83.4.288; Rosing H, 2000, CANCER CHEMOTH PHARM, V45, P213, DOI 10.1007/s002800050032; Rudek MA, 2004, EUR J CANCER, V40, P1170, DOI 10.1016/j.ejca.2003.12.026; Salminen E, 1999, J CLIN ONCOL, V17, P1127; Taguchi T, 1994, Gan To Kagaku Ryoho, V21, P1997; Takeda K, 2009, ANN ONCOL, V20, P835, DOI 10.1093/annonc/mdn705; Tanigawara Y, 1996, P AN M AM SOC CLIN, V15, p479a; tensTije AJ, 2005, J CLIN ONCOL, V23, P1070; vansZuylen L, 2000, CLIN CANCER RES, V6, P2598; vansZuylen L, 2002, EUR J CANCER, V38, P1090; Veyrat-Follet C, 2000, CLIN PHARMACOL THER, V68, P677, DOI 10.1067/mcp.2000.111948; Yamada K, 2014, JPN J CLIN ONCOL, V44, P338, DOI 10.1093/jjco/hyt236; Zamboni WC, 2000, J CLIN ONCOL, V18, P3288	82	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	MAY	2015	106	5					497	504		10.1111/cas.12647		8	Oncology	Oncology	CI6QM	WOS:000354885700003		
J	Nishimura, Y; Tomita, Y; Yuno, A; Yoshitake, Y; Shinohara, M				Nishimura, Yasuharu; Tomita, Yusuke; Yuno, Akira; Yoshitake, Yoshihiro; Shinohara, Masanori			Cancer immunotherapy using novel tumor-associated antigenic peptides identified by genome-wide cDNA microarray analyses	CANCER SCIENCE			English	Review						Cancer immunotherapy; cDNA microarray analysis; CTL epitope; helper T-cell epitope; tumor-associated antigen	ADVANCED ESOPHAGEAL CANCER; CYTOTOXIC T-LYMPHOCYTES; II CLINICAL-TRIAL; GENE-EXPRESSION; TESTIS ANTIGENS; LUNG-CANCER; CELL RESPONSE; HLA-DR; VACCINATION; CD4(+)	Recent genome-wide cDNA microarray analysis of gene expression profiles in comprehensive tumor types coupled with isolation of cancer tissues by laser-microbeam microdissection have revealed ideal tumor-associated antigens (TAAs) that are frequently overexpressed in various cancers including head and neck squamous cell cancer (HNSCC) and lung cancer, but not in most normal tissues except for testis, placenta, and fetal organs. Preclinical studies using HLA-transgenic mice and human T cells in vitro showed that TAA-derived CTL-epitope short peptides (SPs) are highly immunogenic and induce HLA-A2 or -A24-restricted CTLs. Based on the accumulated evidence, we carried out a phase II clinical trial of the TAA-SP vaccine in advanced 37 HNSCC patients. This study showed a significant induction of TAA-specific CTLs in the majority of patients without serious adverse effects. Importantly, clinical responses including a complete response were observed in this study. Another phase II clinical trial of therapeutic TAA-SP vaccine, designed to evaluate the ability of prevention of recurrence, is ongoing in HNSCC patients who have received curative operations. Further studies in human preclinical studies and in vivo studies using HLA class I transgenic mice showed TAA-derived long peptides (TAA-LPs) have the capacity to induce not only promiscuous HLA class II-restricted CD4(+) T helper type 1 cells but also tumor-specific CTLs through a cross-presentation mechanism. Moreover, we observed an augmentation of TAA-LP-specific T helper type 1 cell responses and tumor antigen-spreading in HNSCC patients vaccinated with TAA-SPs. This accumulated evidence suggests that therapeutic TAA-SPs and LPs vaccines may provide a promising cancer immunotherapy.	[Nishimura, Yasuharu; Tomita, Yusuke; Yuno, Akira] Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Kumamoto 8608556, Japan; [Tomita, Yusuke] Kumamoto Univ, Dept Resp Med, Grad Sch Med Sci, Kumamoto 8608556, Japan; [Yuno, Akira; Yoshitake, Yoshihiro; Shinohara, Masanori] Kumamoto Univ, Grad Sch Med Sci, Dept Oral & Maxillofacial Surg, Kumamoto 8608556, Japan; [Yoshitake, Yoshihiro; Shinohara, Masanori] Itoh Maxillofacial Hosp, Kumamoto, Japan	Nishimura, Y (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Chuo Ku, Honjo 1-1-1, Kumamoto 8608556, Japan.	mxnishim@kumamoto-u.ac.jp			Japan Society for Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, Japan; OncoTherapy Science, Inc.	Japan Society for Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, Japan; OncoTherapy Science, Inc.	Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Hailemichael Y, 2013, NAT MED, V19, P465, DOI 10.1038/nm.3105; Harao M, 2008, INT J CANCER, V123, P2616, DOI 10.1002/ijc.23823; Tomita Y, 2014, INT J CANCER, V134, P352, DOI 10.1002/ijc.28376; Kyte JA, 2011, CLIN CANCER RES, V17, P4568, DOI 10.1158/1078-0432.CCR-11-0184; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Ishikawa N, 2007, CANCER RES, V67, P11601, DOI 10.1158/0008-5472.CAN-07-3243; Imai K, 2008, CLIN CANCER RES, V14, P6487, DOI 10.1158/1078-0432.CCR-08-1086; Yokomine K, 2010, INT J CANCER, V126, P2153, DOI 10.1002/ijc.24836; Tomita Y, 2013, CLIN CANCER RES, V19, P4508, DOI 10.1158/1078-0432.CCR-13-0197; Okabe H, 2001, CANCER RES, V61, P2129; Iwahashi M, 2010, CANCER SCI, V101, P2510, DOI 10.1111/j.1349-7006.2010.01732.x; Saito S, 2000, TISSUE ANTIGENS, V56, P522, DOI 10.1034/j.1399-0039.2000.560606.x; Corbiere V, 2011, CANCER RES, V71, P1253, DOI 10.1158/0008-5472.CAN-10-2693; Aarntzen EHJG, 2013, CANCER RES, V73, P19, DOI 10.1158/0008-5472.CAN-12-1127; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Hayama S, 2006, CANCER RES, V66, P10339, DOI 10.1158/0008-5472.CAN-06-2137; Bos R, 2010, CANCER RES, V70, P8368, DOI 10.1158/0008-5472.CAN-10-1322; Nakamura T, 2004, ONCOGENE, V23, P2385, DOI 10.1038/sj.onc.1207392; Weide B, 2012, J CLIN ONCOL, V30, P1835, DOI 10.1200/JCO.2011.40.2271; Walter S, 2012, NAT MED, V18, P1254, DOI 10.1038/nm.2883; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Ribas A, 2003, TRENDS IMMUNOL, V24, P58, DOI 10.1016/S1471-4906(02)00029-7; Church SE, 2014, EUR J IMMUNOL, V44, P69, DOI 10.1002/eji.201343718; Melief CJM, 2008, NAT REV CANCER, V8, P351, DOI 10.1038/nrc2373; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Widenmeyer M, 2012, INT J CANCER, V131, P140, DOI 10.1002/ijc.26365; Godet Y, 2012, CLIN CANCER RES, V18, P2943, DOI 10.1158/1078-0432.CCR-11-3185; Komori H, 2006, CLIN CANCER RES, V12, P2689, DOI 10.1158/1078-0432.CCR-05-2267; Brunsvig PF, 2011, CLIN CANCER RES, V17, P6847, DOI 10.1158/1078-0432.CCR-11-1385; Couzin-Frankel J, 2013, SCIENCE, V342, P1432, DOI 10.1126/science.342.6165.1432; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Saito-Hisaminato A, 2002, DNA RES, V9, P35, DOI 10.1093/dnares/9.2.35; Firat H, 1999, EUR J IMMUNOL, V29, P3112, DOI 10.1002/(SICI)1521-4141(199910)29:10<3112::AID-IMMU3112>3.0.CO;2-Q; Imai K, 2011, BRIT J CANCER, V104, P300, DOI 10.1038/sj.bjc.6606052; Inoue M, 2010, INT J CANCER, V127, P1393, DOI 10.1002/ijc.25160; Jung KO, 2012, J VIROL, V86, P7616, DOI 10.1128/JVI.00166-12; Kono K, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-141; Kono K, 2009, CANCER SCI, V100, P1502, DOI 10.1111/j.1349-7006.2009.01200.x; Martorelli D, 2010, INT REV IMMUNOL, V29, P371, DOI 10.3109/08830185.2010.489658; Melief CJM, 2013, CLIN CANCER RES, V19, P4295, DOI 10.1158/1078-0432.CCR-13-1432; Osawa R, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/848042; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Suda T, 2007, CANCER SCI, V98, P1803, DOI 10.1111/j.1349-7006.2007.00603.x; Suzuki H, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-97; Tomita Y, 2014, ONCOIMMUNOLOGY, V3; Tomita Y, 2011, CANCER SCI, V102, P697, DOI 10.1111/j.1349-7006.2011.01865.x; Tomita Y, 2011, CANCER SCI, V102, P71, DOI 10.1111/j.1349-7006.2010.01780.x; Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Yamabuki T, 2006, INT J ONCOL, V28, P1375; Yoshitake Y, 2004, CLIN CANCER RES, V10, P6437, DOI 10.1158/1078-0432.CCR-04-0841; Yoshitake Y, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1022307; Yoshitake Y, 2015, CLIN CANCER RES, V21, P312, DOI 10.1158/1078-0432.CCR-14-0202	57	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	MAY	2015	106	5					505	511		10.1111/cas.12650		7	Oncology	Oncology	CI6QM	WOS:000354885700004		
J	Akagi, JI; Toyoda, T; Cho, YM; Mizuta, Y; Nohmi, T; Nishikawa, A; Ogawa, K				Akagi, Jun-ichi; Toyoda, Takeshi; Cho, Young-Man; Mizuta, Yasuko; Nohmi, Takehiko; Nishikawa, Akiyoshi; Ogawa, Kumiko			Validation study of the combined repeated-dose toxicity and genotoxicity assay using gpt delta rats	CANCER SCIENCE			English	Article						Genotoxicity; gpt delta; mutation; reduction of animal use; repeated-dose toxicity	GLUTATHIONE-S-TRANSFERASE; MOUSE-LIVER TUMORS; N-NITROSODIETHYLAMINE; LUNG-TUMORS; DI(2-ETHYLHEXYL)PHTHALATE; HEPATOCARCINOGENS; 6-THIOGUANINE; MUTAGENESIS; PHTHALATE	Transgenic rodents carrying reporter genes to detect organ-specific invivo genetic alterations are useful for risk assessment of genotoxicity that causes cancer. Thus, the Organization for Economic Co-operation and Development has established the guideline for genotoxicity tests using transgenic animals, which may be combined with repeated-dose toxicity studies. Here, we provide evidence to support equivalence of gpt delta and wild type (WT) rats in terms of toxicological responses to a genotoxic hepatocarcinogen, N-nitrosodiethylamine (DEN), and a non-genotoxic hepatocarcinogen, di(2-ethylhexyl)phthalate (DEHP). gpt delta rats treated with DEHP showed similar increases in liver and kidney weights, serum albumin, albumin/globulin ratios, and incidence of diffuse hepatocyte hypertrophy compared to WT F344 and Sprague-Dawley (SD) rats. DEN-treated gpt delta rats showed equivalent increases in the number and area of precancerous GST-P-positive foci in the liver compared to WT rats. The liversofDEN-treated gpt delta rats also showed increased frequencies of gpt and Spi(-) mutations; such changes were not observed in DEHP-treated gpt delta rats. These results indicated that gpt delta rats (both F344 and SD backgrounds) showed comparable DEHP-induced toxicity and DEN-induced genotoxicity to those observed in WT rats. With regard to the administration period, the general toxicity of 1.2% DEHP was evident throughout the experimental period, and the genotoxicity of 10p.p.m. DEN could be detected after 2weeks of administration and further increased at 4weeks. These results suggested that combined assays using gpt delta rats could detect both general toxicity and genotoxicity by the canonical 4-week administration protocol. Therefore, this assay using gpt delta rats would be applicable for risk assessment including early detection of genotoxic carcinogens and ultimately serve to reduce cancer risks in humans from environmental chemicals.	[Akagi, Jun-ichi; Toyoda, Takeshi; Cho, Young-Man; Mizuta, Yasuko; Ogawa, Kumiko] Natl Inst Hlth Sci, Div Pathol, Tokyo 1588501, Japan; [Nohmi, Takehiko; Nishikawa, Akiyoshi] Natl Inst Hlth Sci, Biol Safety Res Ctr, Tokyo 1588501, Japan; [Nohmi, Takehiko] Natl Inst Biomed Innovat, Ctr Innovat Drug Discovery & Dev, Tokyo, Japan	Ogawa, K (reprint author), Natl Inst Hlth Sci, Div Pathol, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	ogawa93@nihs.go.jp			Food Safety Commission of Japan [1104]	Food Safety Commission of Japan (1104).	Nohmi T, 1996, ENVIRON MOL MUTAGEN, V28, P465, DOI 10.1002/(SICI)1098-2280(1996)28:4<465::AID-EM24>3.0.CO;2-C; Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252; Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6; Boerrigter M.E, 2004, J CARCINOG, V3, P7, DOI 10.1186/1477-3163-3-7; Caldwell JC, MUTAT RES, V751, P82; CHEN B, 1993, CARCINOGENESIS, V14, P1603, DOI 10.1093/carcin/14.8.1603; Hayashi H, 2003, ENVIRON MOL MUTAGEN, V41, P253, DOI 10.1002/em.10152; IARC, 2000, IARC MON EV CARC RIS; IARC, 1977, IARC MON EV CARC RIS; Kanki K, 2005, MOL CARCINOGEN, V42, P9, DOI 10.1002/mc.20061; KLUWE WM, 1982, ENVIRON HEALTH PERSP, V45, P129, DOI 10.2307/3429396; Nohmi T, 2000, MUTAT RES-FUND MOL M, V455, P191, DOI 10.1016/S0027-5107(00)00077-4; NTP (National Toxicology Program), 2006, NTP PUBL; NTP (National Toxicology Program), 1982, NTP PUBL; OECD, 2008, OECD GUID TEST CHEM; OECD, 2013, OECD GUID TEST CHEM; RAO MS, 1986, CANCER RES, V46, P5287; RUMSBY PC, 1991, CARCINOGENESIS, V12, P2331, DOI 10.1093/carcin/12.12.2331; SWENBERG JA, 1991, CANCER RES, V51, P6409; TATEMATSU M, 1987, TOXICOL PATHOL, V15, P60; YOU M, 1992, CARCINOGENESIS, V13, P1583, DOI 10.1093/carcin/13.9.1583	21	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	MAY	2015	106	5					529	541		10.1111/cas.12634		13	Oncology	Oncology	CI6QM	WOS:000354885700007		
J	Konishi, H; Shirabe, K; Nakagawara, H; Harimoto, N; Yamashita, YI; Ikegami, T; Yoshizumi, T; Soejima, Y; Oda, Y; Maehara, Y				Konishi, Hideyuki; Shirabe, Ken; Nakagawara, Hidekazu; Harimoto, Norifumi; Yamashita, Yo-Ichi; Ikegami, Toru; Yoshizumi, Tomoharu; Soejima, Yuji; Oda, Yoshinao; Maehara, Yoshihiko			Suppression of silent information regulator 1 activity in noncancerous tissues of hepatocellular carcinoma: Possible association with non-B non-C hepatitis pathogenesis	CANCER SCIENCE			English	Article						Nicotinamide adenine dinucleotide; nicotinamide phosphoribosyltransferase; non-alcoholic steatohepatitis; non-B non-C hepatitis; silent information regulator 1	FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; SIRT1 DEACETYLASE; PROTEIN SIR2; MOUSE MODEL; METABOLISM; MICE; TRANSCRIPTION; ACETYLATION; STEATOSIS	Silent information regulator 1 (SIRT1) is a nicotinamide adenine dinucleotide (NAD(+))-dependent protein deacetylase. In mice, mSirt1 deficiency causes the onset of fatty liver via regulation of the hepatic nutrient metabolism pathway. In this study, we demonstrate SIRT1 expression, activity and NAD(+) regulation using noncancerous liver tissue specimens from hepatocellular carcinoma patients with non-B non-C (NBNC) hepatitis. SIRT1 expression levels were higher in NBNC patients than in healthy donors, while SIRT1 histone H3K9 deacetylation activity was suppressed in NBNC patients. In the liver of hepatitis patients, decreased NAD(+) amounts and its regulatory enzyme nicotinamide phosphoribosyltransferase expression levels were observed, and this led to inhibition of SIRT1 activity. SIRT1 expression was associated with HIF1 protein accumulation in both the NBNC liver and liver cancer cell lines. These results may indicate that the NBNC hepatitis liver is exposed to hypoxic conditions. In HepG2 cells, hypoxia induced inflammatory chemokines, such as CXCL10 and MCP-1. These inductions were suppressed in rich NAD(+) condition, and by SIRT1 activator treatment. In conclusion, hepatic SIRT1 activity was repressed in NBNC patients, and normalization of NAD(+) amounts and activation of SIRT1 could improve the inflammatory condition in the liver of NBNC hepatitis patients.	[Konishi, Hideyuki; Shirabe, Ken; Nakagawara, Hidekazu; Harimoto, Norifumi; Yamashita, Yo-Ichi; Ikegami, Toru; Yoshizumi, Tomoharu; Soejima, Yuji; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan; [Konishi, Hideyuki] Chugai Pharmaceut Co Ltd, Gotemba Res Labs, Shizuoka, Japan; [Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 8128582, Japan	Shirabe, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	kshirabe@surg2.med.kyushu-u.ac.jp			JSPS KAKENHI [25861197]; Ministry of Health, Labour and Welfare, Japan [H23-kannen-003]	JSPS KAKENHI Grant Number 25861197, and a Grant-in-Aid from the Ministry of Health, Labour and Welfare, Japan (H23-kannen-003).	Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Scaglioni F, 2011, DIGEST DIS, V29, P202, DOI 10.1159/000323886; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Dominguez M, 2009, GASTROENTEROLOGY, V136, P1639, DOI 10.1053/j.gastro.2009.01.056; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Zhang T, 2009, J BIOL CHEM, V284, P20408, DOI 10.1074/jbc.M109.016469; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Fujii M, 2013, MED MOL MORPHOL, V46, P141, DOI 10.1007/s00795-013-0016-1; Nath B, 2011, HEPATOLOGY, V53, P1526, DOI 10.1002/hep.24256; Imai S, 2000, NATURE, V403, P795; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen R, 2011, J BIOL CHEM, V286, P13869, DOI 10.1074/jbc.M110.175414; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191; Savransky V, 2007, AM J PHYSIOL-GASTR L, V293, pG871, DOI 10.1152/ajpgi.00145.2007; Suter MA, 2012, FASEB J, V26, P5106, DOI 10.1096/fj.12-212878; Ajmo JM, 2008, AM J PHYSIOL-GASTR L, V295, pG833, DOI 10.1152/ajpgi.90358.2008; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Escande C, 2013, DIABETES, V62, P1084, DOI 10.2337/db12-1139; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JC126498; Lin HC, 2012, CANCER PREV RES, V5, P952, DOI 10.1158/1940-6207.CAPR-12-0001; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Dahl TB, 2010, J CLIN ENDOCR METAB, V95, P3039, DOI 10.1210/jc.2009-2148; Hintermann E, 2010, J AUTOIMMUN, V35, P424, DOI 10.1016/j.jaut.2010.09.003; Minor RK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00070; Okanoue T, 2011, J GASTROEN HEPATOL, V26, P153, DOI 10.1111/j.1440-1746.2010.06547.x; Sun LJ, 2013, HEPATOL RES, V43, P1343, DOI 10.1111/hepr.12089; Yu JW, 2013, INT J INFECT DIS, V17, P539	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	MAY	2015	106	5					542	549		10.1111/cas.12653		8	Oncology	Oncology	CI6QM	WOS:000354885700008		
J	Yoshimaru, T; Komatsu, M; Miyoshi, Y; Honda, J; Sasa, M; Katagiri, T				Yoshimaru, Tetsuro; Komatsu, Masato; Miyoshi, Yasuo; Honda, Junko; Sasa, Mitsunori; Katagiri, Toyomasa			Therapeutic advances in BIG3-PHB2 inhibition targeting the crosstalk between estrogen and growth factors in breast cancer	CANCER SCIENCE			English	Article						Crosstalk; estrogen; growth factor; PHB2; tamoxifen-resistance	SURGICAL ADJUVANT BREAST; RECEPTOR-ALPHA; TAMOXIFEN RESISTANCE; IGF-1 RECEPTOR; PROTEIN-KINASE; ER-ALPHA; PHOSPHORYLATION; CELLS; ACTIVATION; EXPRESSION	Our previous studies demonstrated that specific inhibition of the BIG3-PHB2 complex, which is a critical modulator in estrogen (E2) signaling, using ERAP, a dominant negative peptide inhibitor, leads to suppression of E2-dependent estrogen receptor (ER) alpha activation through the reactivation of the tumor suppressive activity of PHB2. Here, we report that ERAP has significant suppressive effects against synergistic activation caused by the crosstalk between E2 and growth factors associated with intrinsic or acquired resistance to anti-estrogen tamoxifen in breast cancer cells. Intrinsic PHB2 released from BIG3 by ERAP effectively disrupted each interaction of membrane-associated ER and insulin-like growth factor 1 receptor beta (IGF-1R), EGFR, PI3K or human epidermal growth factor 2 (HER2) in the presence of E2 and the growth factors IGF or EGF, followed by inhibited the activation of IGF-1R, EGFR or HER2, and reduced Akt, MAPK and ER phosphorylation levels, resulting in significant suppression of proliferation of ER-positive breast cancer cells invitro and invivo. More importantly, combined treatment with ERAP and tamoxifen led to a synergistic suppression of signaling that was activated by crosstalk between E2 and growth factors or HER2 amplification. Taken together, our findings suggest that the specific inhibition of BIG3-PHB2 is a novel potential therapeutic approach for the treatment of tamoxifen-resistant breast cancers activated by the crosstalk between E2 and growth factor signaling, especially in premenopausal women.	[Yoshimaru, Tetsuro; Komatsu, Masato; Katagiri, Toyomasa] Univ Tokushima, Inst Genome Res, Div Genome Med, Tokushima 7708503, Japan; [Miyoshi, Yasuo] Hyogo Coll Med, Dept Surg, Div Breast & Endocrine, Nishinomiya, Hyogo, Japan; [Honda, Junko] Natl Hosp Org Higashitokushima Med Ctr, Dept Surg, Tokushima, Japan; [Sasa, Mitsunori] Tokushima Breast Care Clin, Dept Surg, Tokushima, Japan	Katagiri, T (reprint author), Univ Tokushima, Inst Genome Res, Div Genome Med, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	tkatagi@genome.tokushima-u.ac.jp			Relay for Life, Ministry of Education, Culture, Science, and Technology of Japan [251347212, 26461948]; IMSUT Joint Research Project, Cancer Research Institute, Kanazawa University; Tokushima Breast Care Clinic	Relay for Life, Ministry of Education, Culture, Science, and Technology of Japan (251347212)(26461948), IMSUT Joint Research Project, Cancer Research Institute, Kanazawa University and Tokushima Breast Care Clinic.	Shimizu C, 2004, HUM PATHOL, V35, P1537, DOI 10.1016/j.humpath.2004.09.005; Berry DA, 2000, J CLIN ONCOL, V18, P3471; Filardo EJ, 2002, J STEROID BIOCHEM, V80, P231, DOI 10.1016/S0960-0760(01)00190-X; Joel PB, 1998, MOL CELL BIOL, V18, P1978; Kahlert S, 2000, J BIOL CHEM, V275, P18447, DOI 10.1074/jbc.M910345199; Dowsett M, 2006, ANN ONCOL, V17, P818, DOI 10.1093/annonc/mdl016; Ali S, 2000, J MAMMARY GLAND BIOL, V5, P271, DOI 10.1023/A:1009594727358; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Fan P, 2007, CANCER RES, V67, P1352, DOI 10.1158/0008-5472.CAN-06-1020; Osborne CK, 2005, J CLIN ONCOL, V23, P1616, DOI 10.1200/JCO.2005.10.036; Jordan VC, 2003, NAT REV DRUG DISCOV, V2, P205, DOI 10.1038/nrd1031; Bostner J, 2010, CLIN CANCER RES, V16, P1624, DOI 10.1158/1078-0432.CCR-09-1733; Knowlden JM, 2005, ENDOCRINOLOGY, V146, P4609, DOI 10.1210/en.2005-0247; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Clarke R, 2001, PHARMACOL REV, V53, P25; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Chen DS, 2000, MOL CELL, V6, P127, DOI 10.1016/S1097-2765(00)00014-9; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; Migliaccio A, 2005, CANCER RES, V65, P10585, DOI 10.1158/0008-5472.CAN-05-0912; Chen DS, 1999, MOL CELL BIOL, V19, P1002; Sun M, 2001, CANCER RES, V61, P5985; Gee JM, 2005, ENDOCR-RELAT CANCER, V12, pS99, DOI 10.1677/erc.1.01005; Baserga R, 2003, INT J CANCER, V107, P873, DOI 10.1002/ijc.11487; Murphy LC, 2011, ENDOCR-RELAT CANCER, V18, pR1, DOI 10.1677/ERC-10-0070; Fisher B, 2001, J NATL CANCER I, V93, P684, DOI 10.1093/jnci/93.9.684; Rogatsky I, 1999, J BIOL CHEM, V274, P22296, DOI 10.1074/jbc.274.32.22296; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Nicholson RI, 2005, BREAST CANCER RES TR, V93, pS3, DOI 10.1007/s10549-005-9036-4; Wang RA, 2002, EMBO J, V21, P5437, DOI 10.1093/emboj/cdf543; Arnold SF, 1997, MOL ENDOCRINOL, V11, P48, DOI 10.1210/me.11.1.48; Cheskis BJ, 2004, J CELL BIOCHEM, V93, P20, DOI 10.1002/jcb.20180; Chung YL, 2002, INT J CANCER, V97, P306, DOI 10.1002/ijc.1614; De Laurentiis M, 2005, CLIN CANCER RES, V11, P4741, DOI 10.1158/1078-0432.CCR-04-2569; desLeeuw R, 2013, ONCOGENE, V32, P3543; Fisher B, 2005, J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Frederic T, 2013, CHEM BIOL, V20, P316; Kim JW, 2009, CANCER SCI, V100, P1468, DOI 10.1111/j.1349-7006.2009.01209.x; Kurebayashi J, 1996, BRIT J CANCER, V74, P200, DOI 10.1038/bjc.1996.338; Kurebayashi Junichi, 2004, Breast Cancer, V11, P38, DOI 10.1007/BF02968000; Lannigan D. A., 2008, STEROIDS, V68, P1; Macedo LF, 2008, CANCER, V112, P679, DOI 10.1002/cncr.23191; Nicholson RI, 2001, EUR J CANCER, V37, pS9; Nicholson RI, 2002, ANN NY ACAD SCI, V963, P104; Pietras Richard J, 2003, Breast J, V9, P361, DOI 10.1046/j.1524-4741.2003.09510.x; Santen R. J., 2004, CLIN CANCER RES, V10, P337; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Song RX, 2004, P NATL ACAD SCI USA, V101, P2076, DOI 10.1073/pnas.0308334100; Song RXD, 2005, TRENDS ENDOCRIN MET, V16, P347, DOI 10.1016/j.tem.2005.06.010; Wang LJ, 2013, ONCOL REP, V29, P1563, DOI 10.3892/or.2013.2245; Yoshimaru T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3443; Yoshimaru T, 2014, SCI REP-UK, V4, DOI 10.1038/srep07355	51	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	MAY	2015	106	5					550	558		10.1111/cas.12654		9	Oncology	Oncology	CI6QM	WOS:000354885700009		
J	Ishijima, N; Kanki, K; Shimizu, H; Shiota, G				Ishijima, Naoki; Kanki, Keita; Shimizu, Hiroki; Shiota, Goshi			Activation of AMP-activated protein kinase by retinoic acid sensitizes hepatocellular carcinoma cells to apoptosis induced by sorafenib	CANCER SCIENCE			English	Article						AMPK; combination therapy; hepatocellular carcinoma; retinoic acid; sorafenib	PANCREATIC-CANCER CELLS; LACTATE-DEHYDROGENASE; SERUM RETINOL; OXIDATIVE STRESS; RECEPTOR-ALPHA; METABOLISM; RISK; INHIBITION; CAROTENOIDS; PATHWAY	To improve the outcome of cancer chemotherapy, strategies to enhance the efficacy of anticancer drugs are required. Sorafenib is the only drug to prolong overall survival of the patients with hepatocellular carcinoma (HCC), however, the outcome is still not satisfactory. Retinoids, vitamin A derivatives, have been known to exhibit inhibitory effects on various cancers including HCC. In this study, we investigated the effects of combined treatment using sorafenib and retinoids including all-trans retinoic acid (ATRA), NIK-333, and Am80 on HCC cells. Cell viability assays in six HCC cell lines, HepG2, PLC/PRF/5, HuH6, HLE, HLF, and Hep3B, revealed that 5 and 10M ATRA, concentrations that do not exert cytotoxic effects, enhanced the cytotoxicity of sorafenib, being much more effective than NIK-333 and Am80. We found that ATRA induced AMP-activated protein kinase activation, which was followed by reduced intracellular ATP level. Gene expression analysis revealed that ATRA decreased the expression of glycolytic genes such as GLUT-1 and LDHA. In the combination treatment using ATRA and sorafenib, increased apoptosis, followed by the activation of p38 MAPK and JNK, the upregulation and translocation of Bax to mitochondria, and the activation of caspase-3, was observed. Suppression of AMP-activated protein kinase by siRNA restored the viability of the cells treated with ATRA and sorafenib. Our results thus indicate that ATRA is useful for enhancing the cytotoxicity of sorafenib against HCC cells by regulating the energy metabolism of HCC cells.	[Ishijima, Naoki; Kanki, Keita; Shimizu, Hiroki; Shiota, Goshi] Tottori Univ, Grad Sch Med, Dept Genet Med & Regenerat Therapeut, Div Mol & Genet Med, Yonago, Tottori 6838504, Japan	Shiota, G (reprint author), Tottori Univ, Grad Sch Med, Dept Genet Med & Regenerat Therapeut, Div Mol & Genet Med, Nishi Cho 36-1, Yonago, Tottori 6838504, Japan.	gshiota@med.tottori-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan.	Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Xi X, 2001, J BIOL CHEM, V276, P41029, DOI 10.1074/jbc.M102824200; Sheng SL, 2012, FEBS J, V279, P3898, DOI 10.1111/j.1742-4658.2012.08748.x; Cardaci S, 2012, J CELL SCI, V125, P2115, DOI 10.1242/jcs.095216; Weinberg F, 2009, ANN NY ACAD SCI, V1177, P66, DOI 10.1111/j.1749-6632.2009.05039.x; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Kitamura K, 2011, J HEPATOL, V55, P846, DOI 10.1016/j.jhep.2011.01.038; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Amann T, 2009, AM J PATHOL, V174, P1544, DOI 10.2353/ajpath.2009.080596; Liu Y, 2012, MOL CANCER THER, V11, P1672, DOI 10.1158/1535-7163.MCT-12-0131; Schenk JM, 2009, CANCER EPIDEM BIOMAR, V18, P1227, DOI 10.1158/1055-9965.EPI-08-0984; Gonda K, 2008, BIOCHEM BIOPH RES CO, V370, P629, DOI 10.1016/j.bbrc.2008.04.008; Zhang W, 2008, LEUKEMIA, V22, P808, DOI 10.1038/sj.leu.2405098; Muto Y, 1999, NEW ENGL J MED, V340, P1046, DOI 10.1056/NEJM199904013401315; Michaud DS, 2000, AM J CLIN NUTR, V72, P990; Capano M, 2006, BIOCHEM J, V395, P57, DOI 10.1042/BJ20051654; Miao P, 2013, IUBMB LIFE, V65, P904, DOI 10.1002/iub.1216; Kuhajda FP, 2008, INT J OBESITY, V32, pS36, DOI 10.1038/ijo.2008.121; Nakagawa T, 2009, CANCER LETT, V273, P250, DOI 10.1016/j.canlet.2008.08.004; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Pettersson F, 2002, BRIT J CANCER, V87, P555, DOI 10.1038/sj.bjc.6600496; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chi SW, 2014, BMB REP, V47, P167, DOI 10.5483/BMBRep.2014.47.3.261; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Kurosu T, 2009, CANCER RES, V69, P3927, DOI 10.1158/0008-5472.CAN-08-2978; Larsson SC, 2007, AM J CLIN NUTR, V85, P497; Liedtke C, 2007, APOPTOSIS, V12, P2259, DOI 10.1007/s10495-007-0145-x; Pettersson F, 2001, PANCREAS, V23, P273, DOI 10.1097/00006676-200110000-00008; Shimizu M, 2009, CANCER SCI, V100, P369, DOI 10.1111/j.1349-7006.2008.01045.x; Shimizu M, 2011, CANCER PREV RES, V4, P128, DOI 10.1158/1940-6207.CAPR-10-0163; TAKAGI K, 1988, J CANCER RES CLIN, V114, P221, DOI 10.1007/BF00405825; Toniolo P, 2001, AM J EPIDEMIOL, V153, P1142, DOI 10.1093/aje/153.12.1142; Tsuchiya H, 2012, HEPATOLOGY, V56, P1319, DOI 10.1002/hep.25798; Tsuchiya H, 2009, GASTROENTEROLOGY, V136, P341, DOI 10.1053/j.gastro.2008.09.027; Vander Heiden MG, 2009, SCIENCE, V324, P1029, DOI DOI 10.1126/SCIENCE.1160809; WALD N, 1986, BRIT J CANCER, V54, P957, DOI 10.1038/bjc.1986.267; Yanagitani A, 2004, HEPATOLOGY, V40, P366, DOI 10.1002/hep.20335; Yuan JM, 2006, JNCI-J NATL CANCER I, V98, P482, DOI 10.1093/jnci/djj104	44	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	MAY	2015	106	5					567	575		10.1111/cas.12633		9	Oncology	Oncology	CI6QM	WOS:000354885700011		
J	Nakashima, S; Kobayashi, S; Nagano, H; Tomokuni, A; Tomimaru, Y; Asaoka, T; Hama, N; Wada, H; Kawamoto, K; Marubashi, S; Eguchi, H; Doki, Y; Mori, M				Nakashima, Shinsuke; Kobayashi, Shogo; Nagano, Hiroaki; Tomokuni, Akira; Tomimaru, Yoshito; Asaoka, Tadafumi; Hama, Naoki; Wada, Hiroshi; Kawamoto, Koichi; Marubashi, Shigeru; Eguchi, Hidetoshi; Doki, Yuichiro; Mori, Masaki			BRCA/Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer	CANCER SCIENCE			English	Article						BRCA2; CD24; FANCD2; Fanconi anemia; RAD51c	CELL LUNG-CANCER; STEM-CELLS; DNA-REPAIR; CHOLANGIOCARCINOMA CELLS; H2AX PHOSPHORYLATION; CHEMOTHERAPY; CISPLATIN; BRCA1; RAD51; BREAST	The BRCA/Fanconi anemia (FA) pathway plays a key role in the repair of DNA double strand breaks. We focused on this pathway to clarify chemoresistance mechanisms in biliary tract cancer (BTC). We also investigated changes in the CD24(+)/44(+) population that may be involved in chemoresistance, as this population likely includes cancer stem cells. We used three BTC cell lines to establish gemcitabine (GEM)-resistant (GR) cells and evaluated the expression of BRCA/FA pathway components, chemoresistance, and the effect of BRCA/FA pathway inhibition on the CD24(+)/44(+) population. FANCD2 and CD24 expression were evaluated in 108 resected BTC specimens. GR cells highly expressed the BRCA/FA components. The BRCA/FA pathway was upregulated by GEM and cisplatin (CDDP) exposure. Inhibition using siRNA and RAD51 inhibitor sensitized GR cells to GEM or CDDP. The CD24(+)/44(+) population was increased in GR and parent BTC cells treated with GEM or CDDP and highly expressed BRCA/FA genes. FANCD2 was related to CD24 expression in resected BTC specimens. Inhibition of the BRCA/FA pathway under GEM reduced the CD24(+)/44(+) population in MzChA1-GR cells. Thus, high expression of the BRCA/FA pathway is one mechanism of chemoresistance against GEM and/or CDDP and is related to the CD24(+)/44(+) population in BTC.	[Nakashima, Shinsuke; Kobayashi, Shogo; Nagano, Hiroaki; Tomokuni, Akira; Tomimaru, Yoshito; Asaoka, Tadafumi; Hama, Naoki; Wada, Hiroshi; Kawamoto, Koichi; Marubashi, Shigeru; Eguchi, Hidetoshi; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Dept Surg, Grad Sch Med, Suita, Osaka 5650871, Japan; [Kobayashi, Shogo] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka, Japan	Nagano, H (reprint author), Osaka Univ, Dept Surg, Yamadaoka 2-2 E2, Suita, Osaka 5650871, Japan.	hnagano@gesurg.med.osaka-u.ac.jp			Mitsui Life Social Welfare Foundation	Mitsui Life Social Welfare Foundation and Grant-in-Aid for Scientific Research(C).	Alli Elizabeth, 2011, BMC Pharmacology, V11, P7, DOI 10.1186/1471-2210-11-7; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Zhu AX, 2011, HEPATOLOGY, V53, P695, DOI 10.1002/hep.24145; MURAKAMI T, 1987, HEPATOLOGY, V7, P551, DOI 10.1002/hep.1840070322; Maugeri-Sacca M, 2012, MOL CANCER THER, V11, P1627, DOI 10.1158/1535-7163.MCT-11-1040; Kobayashi S, 2011, J SURG ONCOL, V104, P499, DOI 10.1002/jso.21971; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Xu TP, 2013, GENE, V526, P265, DOI 10.1016/j.gene.2013.05.021; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Parsels LA, 2009, MOL CANCER THER, V8, P45, DOI 10.1158/1535-7163.MCT-08-0662; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Teng DHF, 1996, NAT GENET, V13, P241, DOI 10.1038/ng0696-241; Masters JR, 2001, P NATL ACAD SCI USA, V98, P8012, DOI 10.1073/pnas.121616198; Nagaria P, 2013, BBA-GEN SUBJECTS, V1830, P2345, DOI 10.1016/j.bbagen.2012.09.001; Okusaka T, 2010, BRIT J CANCER, V103, P469, DOI 10.1038/sj.bjc.6605779; Taron M, 2004, HUM MOL GENET, V13, P2443, DOI 10.1093/hmg/ddh260; Iwahashi S, 2013, SURG TODAY, V43, P654, DOI 10.1007/s00595-012-0437-9; HUANG P, 1991, CANCER RES, V51, P6110; Yamada D, 2013, EUR J CANCER, V49, P1725, DOI 10.1016/j.ejca.2012.12.002; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Deb S, 2014, BRIT J CANCER, V110, P1606, DOI 10.1038/bjc.2014.31; Ewald B, 2007, MOL CANCER THER, V6, P1239, DOI 10.1158/1535-7163.MCT-06-0633; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Takenaka T, 2007, INT J CANCER, V121, P895, DOI 10.1002/ijc.22738; Shi CJ, 2011, WORLD J GASTROENTERO, V17, P2965, DOI 10.3748/wjg.v17.i24.2965; Kobayashi S, 2005, GASTROENTEROLOGY, V128, P2054, DOI 10.1053/j.gastro.2005.03.010; Huang F, 2011, ACS CHEM BIOL, V6, P628, DOI 10.1021/cb100428c; KNUTH A, 1985, J HEPATOL, V1, P579, DOI 10.1016/S0168-8278(85)80002-7; Fan S, 2006, BRIT J CANCER, V94, P407, DOI 10.1038/sj.bjc.6602935; Lim JJ, 2014, NEOPLASIA, V16, P343, DOI 10.1016/j.neo.2014.04.003; Vencken PMLH, 2011, ANN ONCOL, V22, P1346, DOI 10.1093/annonc/mdq628; Maacke H, 2000, ONCOGENE, V19, P2791, DOI 10.1038/sj.onc.1203578; Santarpia L, 2013, ONCOLOGIST, V18, P1063, DOI 10.1634/theoncologist.2013-0163; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Birkbak NJ, 2013, PLOS ONE, V8; Chan IW, 2013, FOLIA NEUROPATHOL, V51, P275, DOI 10.5114/fn.2013.39716; DesDosso S, 2013, CANCER CHEMOTH PHARM, V72, P159; Ferrer Miriam, 2005, Clin Lung Cancer, V6, P250, DOI 10.3816/CLC.2005.n.005; Ji M, 2013, ONKOLOGIE, V36, P335, DOI 10.1159/000351260; Kim K, 2013, WORLD J GASTROENTERO, V19, P1438, DOI 10.3748/wjg.v19.i9.1438; Kim YS, 2013, ANTICANCER RES, V33, P4469; Kobayashi S, 2013, INT J SURG, V11, P145, DOI 10.1016/j.ijsu.2012.12.006; Kokuryo T, 2012, J HEPATO-BIL-PAN SCI, V19, P606, DOI 10.1007/s00534-012-0542-6; Li YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044254; Morine Y, 2012, SURG TODAY, V42, P147, DOI 10.1007/s00595-011-0057-9; Oh SY, 2011, INVEST NEW DRUG, V29, P1066, DOI 10.1007/s10637-010-9417-3; Sasaki T, 2012, INVEST NEW DRUG, V30, P708, DOI 10.1007/s10637-010-9553-9; Sasaki T, 2013, CHEMOTHERAPY, V59, P106, DOI 10.1159/000354209; Shi CJ, 2010, CANCER BIOL THER, V10, P1183, DOI 10.4161/cbt.10.11.13664; SHIMIZU Y, 1992, INT J CANCER, V52, P252, DOI 10.1002/ijc.2910520217; Wang M, 2011, INT J CANCER, V128, P72, DOI 10.1002/ijc.25317	52	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	MAY	2015	106	5					584	591		10.1111/cas.12652		8	Oncology	Oncology	CI6QM	WOS:000354885700013		
J	Kobayashi, S; Watanabe, E; Ishigaki, T; Ohno, N; Yuji, K; Nakano, K; Yamochi, T; Watanabe, N; Tojo, A; Watanabe, T; Uchimaru, K				Kobayashi, Seiichiro; Watanabe, Eri; Ishigaki, Tomohiro; Ohno, Nobuhiro; Yuji, Koichiro; Nakano, Kazumi; Yamochi, Tadanori; Watanabe, Nobukazu; Tojo, Arinobu; Watanabe, Toshiki; Uchimaru, Kaoru			Advanced human T-cell leukemia virus type 1 carriersand early-stage indolent adult T-cell leukemia-lymphoma are indistinguishable based on CADM1 positivity in flow cytometry	CANCER SCIENCE			English	Article						Adult T-cell leukemia-lymphoma; CADM1 protein; CD7 antigen; flow cytometry; HTLV-1	I-INFECTED CELLS; HTLV-I; CLONAL EXPANSION; CLINICAL ENTITY; PROVIRUS; LEUKEMIA/LYMPHOMA; INTEGRATION; DISEASE; EXPRESSION; JAPAN	We previously reported that the cell adhesion molecule 1 (CADM1) versus CD7 plot in flow cytometry reflects disease progression in human T-cell leukemia virus type 1 (HTLV-1) infection. In CD4(+) cells from peripheral blood, CADM1(-)CD7(+) (P), CADM1(+)CD7(dim) (D) and CADM1(+)CD7(-) (N) subpopulations are observed. The D and N subpopulations increase as asymptomatic HTLV-1 carriers (AC) progress to indolent adult T-cell leukemia-lymphoma (ATL) and the N subpopulation then expands in aggressive ATL. In the present study we examined whether the analysis can estimate the risk of developing ATL in advanced AC. Peripheral blood samples from AC (N=41) and indolent ATL patients (N=19) were analyzed by flow cytometry using the CADM1 versus CD7 plot for CD4(+) cells and inverse long PCR (clonality analysis) of FACS-sorted subpopulations. Almost all AC with a high HTLV-1 proviral load (>4copies/100 cells) had a CADM1(+) (D+N) frequency of >10%. AC with 25%<CADM1(+)50% contained expanded clones similar to smoldering-type ATL. In many patients in the 25%<CADM1(+)50% group, the proportion of abnormal lymphocytes was distributed around the 5% line, which divides AC and smoldering-type ATL in Shimoyama's classification. In conclusion, the CADM1 versus CD7 plot is useful for selection of putative high-risk AC. The characteristics of some AC and smoldering ATL are said to be similar; however, long-term follow up is required and the clinical outcome (e.g. rate of transformation) of these cases should be used to determine whether to include them in the same clinical category.	[Kobayashi, Seiichiro; Tojo, Arinobu] Univ Tokyo, Inst Med Sci, Div Mol Therapy, Tokyo, Japan; [Watanabe, Eri; Ishigaki, Tomohiro; Watanabe, Nobukazu] Univ Tokyo, Inst Med Sci, Lab Diagnost Med, Tokyo, Japan; [Ohno, Nobuhiro; Tojo, Arinobu; Uchimaru, Kaoru] Univ Tokyo, Inst Med Sci, Res Hosp, Dept Hematol Oncol, Tokyo, Japan; [Yuji, Koichiro] Univ Tokyo, Inst Med Sci, Project Div Int Adv Med Res, Tokyo, Japan; [Nakano, Kazumi; Yamochi, Tadanori; Watanabe, Toshiki] Univ Tokyo, Grad Sch Frontier Sci, Tokyo, Japan	Uchimaru, K (reprint author), 4-6-1 Shirokanedai,Minato Ku, Tokyo 1088639, Japan.	uchimaru@ims.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22591028, 23390250]; Ministry of Health, Labor and Welfare of Japan [H26-sink-oujitsuyuoka-ippan-013]	Ministry of Education, Culture, Sports, Science and Technology of Japan (22591028, 23390250), Ministry of Health, Labor and Welfare of Japan (H26-sink-oujitsuyuoka-ippan-013).	MURPHY EL, 1989, INT J CANCER, V43, P250, DOI 10.1002/ijc.2910430214; Cook LB, 2012, BLOOD, V120, P3488, DOI 10.1182/blood-2012-07-445593; Hisada M, 1998, BLOOD, V92, P3557; Tsukasaki K, 2009, J CLIN ONCOL, V27, P453, DOI 10.1200/JCO.2008.18.2428; Yamagishi M, 2012, CANCER CELL, V21, P121, DOI 10.1016/j.ccr.2011.12.015; OSAME M, 1986, LANCET, V1, P1031; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; WATTEL E, 1995, J VIROL, V69, P2863; YOSHIDA M, 1984, P NATL ACAD SCI-BIOL, V81, P2534, DOI 10.1073/pnas.81.8.2534; Ishida T, 2012, J CLIN ONCOL, V30, P837, DOI 10.1200/JCO.2011.37.3472; MOCHIZUKI M, 1992, JPN J CANCER RES, V83, P236; SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x; Iwanaga M, 2010, BLOOD, V116, P1211, DOI 10.1182/blood-2009-12-257410; Yamaguchi K, 2002, INT J HEMATOL, V76, P240; Gillet NA, 2011, BLOOD, V117, P3113, DOI 10.1182/blood-2010-10-312926; Sasaki H, 2005, BLOOD, V105, P1204, DOI 10.1182/blood-2004-03-1222; Cook LB, 2014, BLOOD, V123, P3925, DOI 10.1182/blood-2014-02-553602; Firouzi S, 2014, GENOME MED, V6, DOI 10.1186/gm568; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Iwanaga M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00322; Kamihira S, 2012, INT J HEMATOL, V95, P399, DOI 10.1007/s12185-012-1020-2; Kobayashi S, 2014, CLIN CANCER RES, V20, P2851, DOI 10.1158/1078-0432.CCR-13-3169; Kobayashi S, 2013, PLOS ONE, V8; Nakahata S, 2012, LEUKEMIA, V26, P1238, DOI 10.1038/leu.2011.379; Sasaki D, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-81; Tian YM, 2011, CANCER SCI, V102, P569, DOI 10.1111/j.1349-7006.2010.01833.x; Tsukasaki K, 1999, BRIT J HAEMATOL, V105, P369, DOI 10.1111/j.1365-2141.1999.01323.x	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	MAY	2015	106	5					598	603		10.1111/cas.12639		6	Oncology	Oncology	CI6QM	WOS:000354885700015		
J	Takahashi, N; Yamada, Y; Furuta, K; Nagashima, K; Kubo, A; Sasaki, Y; Shoji, H; Honma, Y; Iwasa, S; Okita, N; Takashima, A; Kato, K; Hamaguchi, T; Shimada, Y				Takahashi, Naoki; Yamada, Yasuhide; Furuta, Koh; Nagashima, Kengo; Kubo, Akiko; Sasaki, Yusuke; Shoji, Hirokazu; Honma, Yoshitaka; Iwasa, Satoru; Okita, Natsuko; Takashima, Atsuo; Kato, Ken; Hamaguchi, Tetsuya; Shimada, Yasuhiro			Association between serum ligands and the skin toxicity of anti-epidermal growth factor receptor antibody in metastatic colorectal cancer	CANCER SCIENCE			English	Article						Colorectal cancer; EGFR; KRAS; ligands; skin toxicity	HUMAN KERATINOCYTES; FAMILY-MEMBERS; CETUXIMAB; EPIREGULIN; RASH; AMPHIREGULIN; CHEMOTHERAPY; EXPRESSION; RESISTANCE; INDUCTION	Skin toxicity is a known clinical signature used to predict the prognosis of anti-epidermal growth factor receptor (EGFR) antibody treatment in metastatic colorectal cancer (mCRC). There are no biological markers to predict skin toxicity before anti-EGFR antibody treatment in mCRC patients. Between August 2008 and August 2011, pretreatment serum samples were obtained from KRAS wild-type (WT) patients who received anti-EGFR antibody treatment. Serum levels of ligands were measured by ELISA. A total of 103 KRASWT patients were enrolled in the study. Progression-free survival and overall survival of patients with a high grade (grade 2-3) of skin toxicity were significantly longer than those with a low grade (grade 0-1) of skin toxicity (median progression-free survival, 6.4months vs 2.4months, P<0.001; median overall survival, 14.6months vs 7.1months, P=0.006). There were significant differences in distribution of serum levels of epiregulin (EREG), amphiregulin (AREG), and hepatocyte growth factor (HGF) between groups of low/high grade of skin toxicity (P<0.048, P<0.012, P<0.012, respectively). In addition, serum levels of HGF, EREG, and AREG were inversely proportional to grades of skin toxicity as determined by the Cochran-Armitage test (P=0.019, P=0.047, P=0.021, respectively). Our study indicated that serum levels such as HGF, EREG, and AREG may be significant markers to predict the grade of skin toxicity and the prognosis of anti-EGFR antibody treatment, which contribute to improvement of the management of skin toxicity and survival time in mCRC patients.	[Takahashi, Naoki; Yamada, Yasuhide; Sasaki, Yusuke; Shoji, Hirokazu; Honma, Yoshitaka; Iwasa, Satoru; Okita, Natsuko; Takashima, Atsuo; Kato, Ken; Hamaguchi, Tetsuya; Shimada, Yasuhiro] Natl Canc Ctr, Div Gastrointestinal Oncol, Tokyo 1040045, Japan; [Furuta, Koh] Natl Canc Ctr, Div Clin Labs, Tokyo 1040045, Japan; [Nagashima, Kengo] Chiba Univ Hosp, Clin Res Ctr, Chiba, Japan; [Kubo, Akiko] Natl Canc Ctr, Div Pharm, Tokyo 1040045, Japan; [Shimada, Yasuhiro] Kochi Hlth Sci Ctr, Div Med Oncol, Kouch, Japan	Yamada, Y (reprint author), Natl Canc Ctr, Gastrointestinal Oncol Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	yayamada@ncc.go.jp	Nagashima, Kengo/I-1726-2013	Nagashima, Kengo/0000-0003-4529-9045	The Princess Takamatsu Cancer Research Fund	The Princess Takamatsu Cancer Research Fund.	Spix JK, 2007, EXP CELL RES, V313, P3319, DOI 10.1016/j.yexcr.2007.06.006; Pastore S, 2014, ARCH TOXICOL, V88, P1189, DOI 10.1007/s00204-014-1244-4; Gatzemeier U, 2011, LANCET ONCOL, V12, P30, DOI 10.1016/S1470-2045(10)70278-3; Wacker B, 2007, CLIN CANCER RES, V13, P3913, DOI 10.1158/1078-0432.CCR-06-2610; Nanba D, 2013, J DERMATOL SCI, V72, P81, DOI 10.1016/j.jdermsci.2013.05.009; PIEPKORN M, 1995, J INVEST DERMATOL, V105, P802, DOI 10.1111/1523-1747.ep12326567; Morita S, 2007, MOL VIS, V13, P2119; Shirakata Y, 2000, J BIOL CHEM, V275, P5748, DOI 10.1074/jbc.275.8.5748; Perez-Soler R, 2005, ONCOLOGIST, V10, P345, DOI 10.1634/theoncologist.10-5-345; Yang ZY, 2013, INT J CANCER, V133, P1914, DOI 10.1002/ijc.28153; Van Cutsem E, 2012, J CLIN ONCOL, V30, P2861, DOI 10.1200/JCO.2011.40.9243; Takahashi N, 2014, BRIT J CANCER, V110, P2716, DOI 10.1038/bjc.2014.230; Bardelli A, 2013, CANCER DISCOV, V3, P658, DOI 10.1158/2159-8290.CD-12-0558; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Van Cutsem E, 2014, CLIN CANCER RES, V20, P4240, DOI 10.1158/1078-0432.CCR-13-2752; Rittie L, 2006, J INVEST DERMATOL, V126, P732, DOI 10.1038/sj.jid.5700202; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; Scartozzi M, 2010, INT J CANCER, V127, P1941, DOI 10.1002/ijc.25193; Xu KP, 2007, INVEST OPHTH VIS SCI, V48, P2242, DOI 10.1167/iovs.06-0560; Loupakis F, 2010, BRIT J CANCER, V101, P715; Yarden Y., 2001, EJC SUPPL, V37, P3, DOI 10.1016/S0959-8049(01)00230-1	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	MAY	2015	106	5					604	610		10.1111/cas.12642		7	Oncology	Oncology	CI6QM	WOS:000354885700016		
J	Okusaka, T; Aramaki, T; Inaba, Y; Nakamura, S; Morimoto, M; Moriguchi, M; Sato, T; Ikawa, Y; Ikeda, M; Furuse, J				Okusaka, Takuji; Aramaki, Takeshi; Inaba, Yoshitaka; Nakamura, Shinichiro; Morimoto, Manabu; Moriguchi, Michihisa; Sato, Takashi; Ikawa, Yuta; Ikeda, Masafumi; Furuse, Junji			Phase I study of tivantinib in Japanese patients with advanced hepatocellular carcinoma: Distinctive pharmacokinetic profiles from other solid tumors	CANCER SCIENCE			English	Article						c-Met inhibitor; CYP2C19 polymorphisms; hepatocellular carcinoma; phase I study; tivantinib	MET INHIBITOR TIVANTINIB; ARQ 197; THERAPY; CANCER; TRIAL	A c-Met inhibitor tivantinib is a candidate anticancer agent for patients with hepatocellular carcinoma (HCC), and CYP2C19 is the key metabolic enzyme for tivantinib. Previous Japanese phase I studies in patients with solid tumors (except HCC) recommend 360mg twice daily (BID) and 240mg BID for CYP2C19 extensive metabolizers (EM) and poor metabolizers (PM), respectively. In this study, Japanese patients with HCC in whom sorafenib treatment has failed were enrolled to evaluate the safety, tolerability and pharmacokinetics of oral tivantinib as a single agent. The dose was escalated separately in EM and PM, from 120mg BID to 240mg BID, in both capsule and tablet formulations. A total of 28 patients (EM: 21, PM: 7) received tivantinib. At a dose of 120mg BID, dose-limiting toxicities (DLT) did not develop in 12 EM (capsule: 6, tablet: 6) and 7 PM (capsule: 4, tablet: 3) during the DLT-observation period (for 29days after first dosing). At this dose, the pharmacokinetic profiles of tivantinib (AUC(0-12) and C-max) did not remarkably differ between EM and PM. When treated with 240mg BID, 5 of 9 EM (capsule: 4 of 6, tablet: 1 of 3) developed neutropenia-related DLT accompanying plasma tivantinib concentration higher than expected from the previous studies. Consequently, PM did not receive 240mg BID. In conclusion, 120mg BID of tivantinib is recommended among Japanese patients with HCC regardless of CYP2C19 phenotype. This would be one of the first manuscripts demonstrating that the recommended dose of an anti-cancer agent for patients with hepatocellular carcinoma (HCC) could be distinct from its recommended dose for patients with other solid tumors.	[Okusaka, Takuji] Natl Canc Ctr, Div Dept Hepatobiliary & Pancreat Oncol, Chuo Ku, Tokyo, Japan; [Aramaki, Takeshi; Moriguchi, Michihisa] Shizuoka Canc Ctr, Div Intervent Radiol, Shizuoka, Japan; [Inaba, Yoshitaka] Aichi Canc Ctr Hosp, Dept Diagnost & Intervent Radiol, Nagoya, Aichi 464, Japan; [Nakamura, Shinichiro] Okayama Univ Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama, Japan; [Morimoto, Manabu] Kanagawa Canc Ctr, Div Hepatobiliary & Pancreat Oncol, Yokohama, Kanagawa 2410815, Japan; [Sato, Takashi; Ikawa, Yuta] Kyowa Hakko Kirin Co Ltd, R&D Div, Chiyoda Ku, Tokyo, Japan; [Ikeda, Masafumi] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan; [Furuse, Junji] Kyorin Univ Sch Med, Dept Med Oncol, Mitaka, Tokyo, Japan	Okusaka, T (reprint author), Natl Canc Ctr, Div Dept Hepatobiliary & Pancreat Oncol, 1-1 Tsukiji 5 chome, Tokyo, Japan.	tokusaka@ncc.go.jp			Kyowa Hakko Kirin Co., Ltd.	This work was supported by Kyowa Hakko Kirin Co., Ltd.	Yamamoto N, 2013, BRIT J CANCER, V109, P2803, DOI 10.1038/bjc.2013.588; Cohen RB, 2012, INVEST NEW DRUG, V30, P2066, DOI 10.1007/s10637-012-9796-8; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fornaro L, 2014, FUTURE ONCOL, V10, P285, DOI [10.2217/fon.13.181, 10.2217/FON.13.181]; Kondo S, 2013, INT J CLIN ONCOL, V18, P207, DOI 10.1007/s10147-011-0361-9; Marrero JA, 2005, HEPATOLOGY, V41, P707, DOI 10.1002/hep.20636; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2012, CLIN CANCER RES, V18, P2290, DOI 10.1158/1078-0432.CCR-11-2175; Yamamoto N, 2013, ANN ONCOL, V24, P1653, DOI 10.1093/annonc/mdt014; Kang YK, 2014, INVEST NEW DRUG, V32, P355, DOI 10.1007/s10637-013-0057-2; Adjei AA, 2011, ONCOLOGIST, V16, P788, DOI 10.1634/theoncologist.2010-0380; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Santoro A, 2013, LANCET ONCOL, V14, P55, DOI 10.1016/S1470-2045(12)70490-4; Frye RF, 2006, CLIN PHARMACOL THER, V80, P235, DOI 10.1016/j.clpt.2006.05.006; Azuma K, 2014, J CLIN ONCOL, V32, p5s; Kubota T, 2001, XENOBIO METAB DISPOS, V16, P69	16	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	MAY	2015	106	5					611	617		10.1111/cas.12644		7	Oncology	Oncology	CI6QM	WOS:000354885700017		
J	Shinohara, N; Obara, W; Tatsugami, K; Naito, S; Kamba, T; Takahashi, M; Murai, S; Abe, T; Oba, K; Naito, S				Shinohara, Nobuo; Obara, Wataru; Tatsugami, Katsunori; Naito, Sei; Kamba, Tomomi; Takahashi, Masayuki; Murai, Sachiyo; Abe, Takashige; Oba, Koji; Naito, Seiji			Prognosis of Japanese patients with previously untreated metastatic renal cell carcinoma in the era of molecular-targeted therapy	CANCER SCIENCE			English	Article						Metastasis; molecular-targeted therapy; prognosis; renal cell carcinoma; risk classification	INTERFERON-ALPHA; KIDNEY CANCER; SURVIVAL; SUNITINIB; MODEL; CLASSIFICATION; VALIDATION	A multicenter cooperative study was conducted to clarify the prognosis of Japanese patients with metastatic renal cell carcinoma in the era of molecular-targeted therapy and the clinical usefulness of the Japanese metastatic renal cancer (JMRC) prognostic classification. Of 389 consecutive patients for whom treatment was started between 2008 and 2010 at 23 hospitals in Japan, 357 patients who received vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFR-TKI) or cytokine as initial systemic therapy were the subject of the present study. Patients were classified into three prognostic groups according to the JMRC prognostic classification. The endpoints were progression-free survival (PFS) and overall survival (OS) after the start of the initial treatment. The median PFS and OS for the entire cohort of 357 patients were 9.1 and 27.2months, respectively. VEGFR-TKI were selected for patients with multiple organ metastases, those with liver metastasis, and those with bone metastasis. The median PFS and OS were 11.0 and 23.2months and 5.4 and 38.2months in the VEGFR-TKI group and the cytokines group, respectively. The JMRC prognostic classification was useful as a prognostic model for PFS and OS (c-indexes: 0.613 and 0.630 in patients who initially received VEGFR-TKI and 0.647 and 0.642 in patients who received cytokines, respectively). The present study showed for the first time the prognosis of Japanese patients with metastatic renal cell carcinoma in the era of molecular-targeted therapy. The JMRC prognostic classification may be clinically useful as a prognostic model.	[Shinohara, Nobuo; Murai, Sachiyo; Abe, Takashige] Hokkaido Univ Grad Sch Med, Dept Renal & Genitourinary Surg, Sapporo, Hokkaido 0608638, Japan; [Obara, Wataru] Iwate Med Univ, Dept Urol, Morioka, Iwate 020, Japan; [Tatsugami, Katsunori; Naito, Seiji] Kyushu Univ, Grad Sch Med Sci, Dept Urol, Fukuoka 812, Japan; [Naito, Sei] Yamagata Univ, Grad Sch Med, Dept Urol, Yamagata 990, Japan; [Kamba, Tomomi] Kyoto Univ, Grad Sch Med, Dept Urol, Kyoto, Japan; [Takahashi, Masayuki] Univ Tokushima, Grad Sch Med, Dept Urol, Tokushima 770, Japan; [Oba, Koji] Univ Tokyo, Dept Biotat, Sch Publ Hlth, Tokyo, Japan	Shinohara, N (reprint author), Hokkaido Univ Grad Sch Med, Dept Renal & Genitourinary Surg, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	nobuo-s@med.hokudai.ac.jp					Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Rini BI, 2008, J CLIN ONCOL, V26, P5422, DOI 10.1200/JCO.2008.16.9847; Shinohara N, 2013, UROL ONCOL-SEMIN ORI, V31, P1276, DOI 10.1016/j.urolonc.2011.08.009; Naito S, 2010, EUR UROL, V57, P317, DOI 10.1016/j.eururo.2008.12.026; Mckay RR, 2014, EUR UROL, V65, P577, DOI 10.1016/j.eururo.2013.08.012; Choueiri TK, 2007, CANCER, V110, P543, DOI 10.1002/cncr.22827; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Wahlgren T, 2013, BRIT J CANCER, V108, P1541, DOI 10.1038/bjc.2013.119; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Negrier S, 2002, ANN ONCOL, V13, P1460, DOI 10.1093/annonc/mdf257; Manola J, 2011, CLIN CANCER RES, V17, P5443, DOI 10.1158/1078-0432.CCR-11-0553; Heng DYC, 2013, LANCET ONCOL, V14, P141, DOI 10.1016/S1470-2045(12)70559-4; Shinohara N, 2012, CANCER SCI, V103, P1695, DOI 10.1111/j.1349-7006.2012.02351.x; Tomita Y, 2010, JPN J CLIN ONCOL, V40, P1166, DOI 10.1093/jjco/hyq146; Motzer RJ, 2011, J NATL COMPR CANC NE, V9, P960; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Motzer RJ, 2002, J CLIN ONCOL, V20, P289, DOI 10.1200/JCO.20.1.289; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Motzer RJ, 2008, CANCER, V113, P1552, DOI 10.1002/cncr.23776; Bamias A, 2013, BRIT J CANCER, V109, P332, DOI 10.1038/bjc.2013.341; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Karakiewicz PI, 2011, EUR UROL, V60, P48, DOI 10.1016/j.eururo.2010.12.011; Sobin LH, 2009, TNM CLASSIFICATION M	23	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	MAY	2015	106	5					618	626		10.1111/cas.12646		9	Oncology	Oncology	CI6QM	WOS:000354885700018		
J	Yamamoto, Y; Hyodo, I; Koga, Y; Tsumura, R; Sato, R; Obonai, T; Fuchigami, H; Furuya, F; Yasunaga, M; Harada, M; Kato, Y; Ohtsu, A; Matsumura, Y				Yamamoto, Yoshiyuki; Hyodo, Ichinosuke; Koga, Yoshikatsu; Tsumura, Ryo; Sato, Ryuta; Obonai, Toshihumi; Fuchigami, Hirobumi; Furuya, Fumiaki; Yasunaga, Masahiro; Harada, Mitsunori; Kato, Yasuki; Ohtsu, Atsushi; Matsumura, Yasuhiro			Enhanced antitumor effect of anti-tissue factor antibody-conjugated epirubicin-incorporating micelles in xenograft models	CANCER SCIENCE			English	Article						Antibody drug conjugate; drug delivery system; epirubicin; polymeric micelles; tissue factor	TISSUE FACTOR; IN-VIVO; POLYMERIC MICELLES; GASTRIC-CANCER; SOLID TUMORS; PHASE-II; NANOPARTICLE FORMULATION; BRENTUXIMAB VEDOTIN; IMMUNOMICELLES; PACLITAXEL	For the creation of a successful antibody-drug conjugate (ADC), both scientific and clinical evidence has indicated that highly toxic anticancer agents (ACA) should be conjugated to a monoclonal antibody (mAb) to administer a reasonable amount of ADC to patients without compromising the affinity of the mAb. For ordinary ACA, the conjugation of a mAb to ACA-loaded micellar nanoparticles is clinically applicable. Tissue factor (TF) is often overexpressed in various cancer cells and tumor vascular endothelium. Accordingly, anti-TF-NC-6300, consisting of epirubicin-incorporating micelles (NC-6300) conjugated with the F(ab')(2) of anti-TF mAb was developed. The invitro and invivo efficacy and pharmacokinetics of anti-TF-NC-6300 were compared to NC-6300 using two human pancreatic cancer cell lines, BxPC3 (high TF expression) and SUIT2 (low TF expression), and a gastric cancer cell line, 44As3 (high TF expression). The intracellular uptake of epirubicin was faster and greater in BxPC3 cells treated with anti-TF-NC-6300, compared with NC-6300. Anti-TF-NC-6300 showed a superior antitumor activity in BxPC3 and 44As3 xenografts, compared with NC-6300, while the activities of both micelles were similar in the SUIT2 xenograft. A higher tumor accumulation of anti-TF-NC-6300 compared to NC-6300 was seen, regardless of the TF expression levels. However, anti-TF-NC-6300 appeared to be localized to the tumor cells with high TF expression. These results indicated that the enhanced antitumor effect of anti-TF-NC6300 may be independent of the tumor accumulation but may depend on the selective intratumor localization and the preferential internalization of anti-TF-NC-6300 into high TF tumor cells.	[Yamamoto, Yoshiyuki; Koga, Yoshikatsu; Tsumura, Ryo; Sato, Ryuta; Obonai, Toshihumi; Fuchigami, Hirobumi; Furuya, Fumiaki; Yasunaga, Masahiro; Matsumura, Yasuhiro] Natl Canc Ctr Hosp East, Div Dev Therapeut, Res Ctr Innovat Oncol, Kashiwa, Chiba 2778577, Japan; [Yamamoto, Yoshiyuki; Hyodo, Ichinosuke] Univ Tsukuba, Inst Clin Med, Grad Sch Comprehens Human Sci, Dept Gastroenterol & Hepatol, Tsukuba, Ibaraki 305, Japan; [Harada, Mitsunori; Kato, Yasuki] NanoCarrier Co Ltd, Div Res, Kashiwa, Chiba, Japan; [Ohtsu, Atsushi] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Tokyo 104, Japan	Matsumura, Y (reprint author), Natl Canc Ctr Hosp East, Div Dev Therapeut, Res Ctr Innovat Oncol, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	yhmatsum@east.ncc.go.jp			Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program), the National Cancer Center Research and Development Fund [26-A-14]	This work was supported by the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program), the National Cancer Center Research and Development Fund (26-A-14).	Younes A, 2012, J CLIN ONCOL, V30, P2183, DOI 10.1200/JCO.2011.38.0410; Yamamoto Y, 2014, INT J CANCER, V135, P214, DOI 10.1002/ijc.28651; Li W, 2012, BIOMATERIALS, V33, P5349, DOI 10.1016/j.biomaterials.2012.04.016; Bartlett DW, 2007, P NATL ACAD SCI USA, V104, P15549, DOI 10.1073/pnas.0707461104; Uchino H, 2005, BRIT J CANCER, V93, P678, DOI 10.1038/sj.bjc.6602772; Choi CHJ, 2010, P NATL ACAD SCI USA, V107, P1235, DOI 10.1073/pnas.0914140107; Taylor RM, 2012, INT J NANOMED, V7, P4341, DOI 10.2147/IJN.S34381; Zhao J, 2013, BIOMATERIALS, V34, P3411, DOI 10.1016/j.biomaterials.2013.01.009; Liao CD, 2011, EUR J RADIOL, V80, P699, DOI 10.1016/j.ejrad.2010.08.005; Kato K, 2012, INVEST NEW DRUG, V30, P1621, DOI 10.1007/s10637-011-9709-2; Hamaguchi T, 2007, BRIT J CANCER, V97, P170, DOI 10.1038/sj.bjc.6603855; van den Berg YW, 2012, BLOOD, V119, P924, DOI 10.1182/blood-2011-06-317685; KATAOKA K, 1993, J CONTROL RELEASE, V24, P119; Yasunaga M, 2011, BIOCONJUGATE CHEM, V22, P1776, DOI 10.1021/bc200158j; Saito Y, 2011, EUR J CANCER, V47, P2230, DOI 10.1016/j.ejca.2011.04.028; Harada M, 2011, CANCER SCI, V102, P192, DOI 10.1111/j.1349-7006.2010.01745.x; Collins BE, 2006, J IMMUNOL, V177, P2994; Heng HHQ, 2009, J CELL PHYSIOL, V220, P538, DOI 10.1002/jcp.21799; Takahashi A, 2013, CANCER SCI, V104, P920, DOI 10.1111/cas.12153; Pirollo KF, 2008, TRENDS BIOTECHNOL, V26, P552, DOI 10.1016/j.tibtech.2008.06.007; Pro B, 2012, J CLIN ONCOL, V30, P2190, DOI 10.1200/JCO.2011.38.0402; Torchilin VP, 2003, P NATL ACAD SCI USA, V100, P6039, DOI 10.1073/pnas.0931428100; Burke PJ, 2009, BIOCONJUGATE CHEM, V20, P1242, DOI 10.1021/bc9001097; Mamot C, 2005, CANCER RES, V65, P11631, DOI 10.1158/0008-5472.CAN-05-1093; Plummer R, 2011, BRIT J CANCER, V104, P593, DOI 10.1038/bjc.2011.6; Song HB, 2012, ONCOL REP, V28, P2057, DOI 10.3892/or.2012.2048; Hamaguchi T, 2005, BRIT J CANCER, V92, P1240, DOI 10.1038/sj.bjc.6602479; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Sawant RR, 2012, ADV DRUG DELIVER REV, V64, P1436, DOI 10.1016/j.addr.2012.08.003; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Kirpotin DB, 2006, CANCER RES, V66, P6732, DOI 10.1158/0008-5472.CAN-05-4199; Junutula JR, 2008, NAT BIOTECHNOL, V26, P925, DOI 10.1038/nbt.1480; Nishiyama N, 2003, CANCER RES, V63, P8977; Matsumura Y, 2012, ADV DRUG DELIVER REV, V64, P710, DOI 10.1016/j.addr.2011.12.010; Colman RW, 2006, HEMOSTASIS THROMBOSI, V5th; Coyne CP, 2011, BIOORGAN MED CHEM, V19, P67, DOI 10.1016/j.bmc.2010.11.046; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Hayden EC, 2008, NATURE, V455, P148, DOI 10.1038/455148a; Hisada Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02604; Jin C, 2010, BIOMACROMOLECULES, V11, P2422, DOI 10.1021/bm1005992; KOENDERS PG, 1992, BRIT J CANCER, V65, P189, DOI 10.1038/bjc.1992.39; Kothari H, 2013, J THROMB HAEMOST, V11, P1353, DOI 10.1111/jth.12272; Messersmith W, 2005, CANCER BIOL THER, V4, P1381; Schmidt MM, 2008, CANCER IMMUNOL IMMUN, V57, P1879, DOI 10.1007/s00262-008-0518-1; Yue J, 2012, MACROMOL BIOSCI, V12, P1209, DOI 10.1002/mabi.201200037	45	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	MAY	2015	106	5					627	634		10.1111/cas.12645		8	Oncology	Oncology	CI6QM	WOS:000354885700019		
J	Zhou, XP; Koizumi, Y; Zhang, MX; Natsui, M; Koyota, S; Yamada, M; Kondo, Y; Hamada, F; Sugiyama, T				Zhou, Xiaoping; Koizumi, Yukio; Zhang, Muxin; Natsui, Miyuki; Koyota, Souichi; Yamada, Manabu; Kondo, Yoshihiko; Hamada, Fumio; Sugiyama, Toshihiro			Cadmium-coordinated supramolecule suppresses tumor growth of T-cell leukemia in mice	CANCER SCIENCE			English	Article						Cadmium; leukemia; supramolecule; T-cell receptor; thiacalixarene	CHELATING-AGENTS; ANTICANCER AGENT; EPITHIO GROUPS; PHASE-I; COMPLEXES; APOPTOSIS; CULTURES; RECEPTOR; THIACALIXARENE; PROTEASOME	Cadmium is a toxic pollutant with occupational and environmental significance, due to its diverse toxic effects. Supramolecules that conjugate and decontaminate toxic metals have potential for use in treatment of cadmium intoxication. In addition, metal-coordinating ability has been postulated to contribute to the cytotoxic effects of anti-tumor agents such as cisplatin or bleomycin. Thiacalixarenes, cyclic oligomers of p-alkylphenol bridged by sulfur atoms, are supramolecules known to have potent coordinating ability to metal ions. In this study, we show that cadmium-coordinated thiacalix[4]arene tetrasulfate (TC4ATS-Cd) exhibits an anti-proliferative effect against T-cell leukemia cells. Cadmium exhibited cytotoxicity with IC50 values ranging from 36 to 129M against epithelia-derived cancer cell lines, while TC4ATS-Cd elicited no significant cytotoxicity (IC50>947M). However, a number of T-cell leukemia cell lines exhibited marked sensitivity to TC4ATS-Cd. In Jurkat cells, toxicity of TC4ATS-Cd occurred with an IC50 of 6.9M, which is comparable to that of 6.5M observed for cadmium alone. TC4ATS-Cd induced apoptotic cell death through activation of caspase-3 in Jurkat cells. In a xenograft model, TC4ATS-Cd (13mg/kg) treatment significantly suppressed the tumor growth of Jurkat cells in mice. In addition, TC4ATS-Cd-treated mice exhibited significantly less cadmium accumulation in liver and kidney compared to equimolar cadmium-treated mice. These results suggest that cadmium-coordinated supramolecules may have therapeutic potential for treatment of T-cell leukemia.	[Zhou, Xiaoping; Koizumi, Yukio; Zhang, Muxin; Natsui, Miyuki; Koyota, Souichi; Sugiyama, Toshihiro] Akita Univ Grad Sch Med, Dept Biochem, Akita 0108543, Japan; [Zhou, Xiaoping] Akita Univ, Venture Business Lab, Akita 010, Japan; [Yamada, Manabu] Akita Univ, Grad Sch Engn & Resource Sci, Res Ctr Engn Sci, Akita 010, Japan; [Kondo, Yoshihiko] Akita Univ, Grad Sch Engn & Resource Sci, Dept Life Sci, Akita 010, Japan; [Hamada, Fumio] Akita Univ, Grad Sch Engn & Resource Sci, Appl Chem, Akita 010, Japan	Koizumi, Y (reprint author), Akita Univ Grad Sch Med, Dept Biochem, 1-1-1 Hondo, Akita 0108543, Japan.	ykoizumi@med.akita-u.ac.jp			JSPS KAKENHI Grant [22700913, 24701019, 25640087]; Tokyo Biochemical Research Foundation	This work was supported by JSPS KAKENHI Grant Numbers 22700913, 24701019, 25640087, and by The Tokyo Biochemical Research Foundation.	MIRABELLI CK, 1986, J MED CHEM, V29, P218, DOI 10.1021/jm00152a009; Ikeda A, 1997, CHEM REV, V97, P1713, DOI 10.1021/cr960385x; Paclet MH, 2006, J INCL PHENOM MACRO, V55, P353, DOI 10.1007/s10847-006-9107-0; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Daniel KG, 2004, BIOCHEM PHARMACOL, V67, P1139, DOI 10.1016/j.bcp.2003.10.031; Coleman AW, 2008, NEW J CHEM, V32, P780, DOI 10.1039/b718962a; SUTTON BM, 1972, J MED CHEM, V15, P1095, DOI 10.1021/jm00281a001; Rademaker-Lakhai JM, 2004, CLIN CANCER RES, V10, P3717, DOI 10.1158/1078-0432.CCR-03-0746; Milacic V, 2008, TOXICOL APPL PHARM, V231, P24, DOI 10.1016/j.taap.2008.03.009; Gulisano M, 2009, J NEUROSCI RES, V87, P228, DOI 10.1002/jnr.21830; Ronconi L, 2005, INORG CHEM, V44, P1867, DOI 10.1021/ic048260v; Iki N, 1998, CHEM LETT, P625, DOI 10.1246/cl.1998.625; Guo DS, 2008, J INCL PHENOM MACRO, V62, P1, DOI 10.1007/s10847-008-9452-2; BERGER MR, 1989, ANTICANCER RES, V9, P761; Perret F, 2011, CHEM COMMUN, V47, P7303, DOI 10.1039/c1cc11541c; Da Silva E, 2004, INT J PHARM, V273, P57, DOI 10.1016/j.ijpharm.2003.12.008; Milacic V, 2006, CANCER RES, V66, P10478, DOI 10.1158/0008-5472.CAN-06-3017; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Xu CY, 1996, TOXICOLOGY, V107, P1, DOI 10.1016/0300-483X(95)03195-L; Kumagai H, 1997, TETRAHEDRON LETT, V38, P3971, DOI 10.1016/S0040-4039(97)00792-2; Flora SJS, 2010, INT J ENV RES PUB HE, V7, P2745, DOI 10.3390/ijerph7072745; Li YS, 2012, ENVIRON POLLUT, V167, P93, DOI 10.1016/j.envpol.2012.03.042; Hartinger CG, 2008, CHEM BIODIVERS, V5, P2140, DOI 10.1002/cbdv.200890195; Inaba T, 2005, TOXICOL LETT, V159, P192, DOI 10.1016/j.toxlet.2005.05.011; Aydin HH, 2003, BIOL TRACE ELEM RES, V95, P139, DOI 10.1385/BTER:95:2:139; Bjelogrlic S, 2010, J INORG BIOCHEM, V104, P673, DOI 10.1016/j.jinorgbio.2010.02.009; Coleman AW, 2007, International Patent, Patent No. [O/ 2007/ 119027, 1190272007]; Coleman AW, International Patent, Patent No. [C07F 09/ 12, 07F0912]; Coleman AW, International Patent, Patent No. [PCT A61P 35/ 00, 61P3500]; Coleman AW, International Patent, Patent No. [A61K 31/ 6615, 61316615]; ENGSTROM B, 1984, ENVIRON HEALTH PERSP, V54, P219, DOI 10.2307/3429810; HAZENMARTIN DJ, 1989, IN VITRO CELL DEV B, V25, P784; Iki N, 1998, B CHEM SOC JPN, V71, P1597, DOI 10.1246/bcsj.71.1597; Iki N, 1999, CHEM LETT, P219; International Agency for Research on Cancer, 1993, IARC MON EV CARC RIS, V58, P119; International Programme on Chemical Safety, 1992, ENV HLTH CRIT; Iwamoto KS, 1999, MOL CARCINOGEN, V25, P113, DOI 10.1002/(SICI)1098-2744(199906)25:2<113::AID-MC6>3.0.CO;2-D; Mestroni G, International Patent PCT, Patent No. [WO 98/ 00431, 9800431]; Mestroni G, International Patent, Patent No. [PCT A61K 31/ 28, 61K3128]; Mestroni G, International Patent, Patent No. [PCT C07F 15/ 00, 07F1500]; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; TSUCHIYA K, 1976, Keio Journal of Medicine, V25, P83; Zhukalin M, 2007, BIOMETALS, V20, P61, DOI 10.1007/s10534-006-9015-1	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	MAY	2015	106	5					635	641		10.1111/cas.12651		7	Oncology	Oncology	CI6QM	WOS:000354885700020		
J	Nakamura, R; Oyama, T; Tajiri, R; Mizokami, A; Namiki, M; Nakamoto, M; Ooi, A				Nakamura, Ritsuko; Oyama, Takeru; Tajiri, Ryosuke; Mizokami, Atsushi; Namiki, Mikio; Nakamoto, Masaru; Ooi, Akishi			Expression and regulatory effects on cancer cell behavior of NELL1 and NELL2 in human renal cell carcinoma	CANCER SCIENCE			English	Article						Cell migration; methylation; NELL1; NELL2; renal cell carcinoma	TUMOR-SUPPRESSOR GENE; EGF-LIKE REPEATS; PROMOTER HYPERMETHYLATION; CPG ISLAND; CLEAR-CELL; RAT-BRAIN; METHYLATION; ADHESION; RASSF1A; PROTEIN	Neural epidermal growth factor-like like (NELL) 1 and 2 constitute a family of multimeric and multimodular extracellular glycoproteins. Although the osteogenic effects of NELL1 and functions of NELL2 in neural development have been reported, their expression and functions in cancer are largely unknown. In this study, we examined expression of NELL1 and NELL2 in renal cell carcinoma (RCC) using clinical specimens and cell lines. We show that, whereas NELL1 and NELL2 proteins are strongly expressed in renal tubules in non-cancerous areas of RCC specimens, their expression is significantly downregulated in cancerous areas. Silencing of NELL1 and NELL2 mRNA expression was also detected in RCC cell lines. Analysis of NELL1/2 promoter methylation status indicated that the CpG islands in the NELL1 and NELL2 genes are hypermethylated in RCC cell lines. NELL1 and NELL2 bind to RCC cells, suggesting that these cells express a receptor for NELL1 and NELL2 that can transduce signals. Furthermore, we found that both NELL1 and NELL2 inhibit RCC cell migration, and NELL1 further inhibits RCC cell adhesion. These results suggest that silencing of NELL gene expression by promoter hypermethylation plays roles in RCC progression by affecting cancer cell behavior.	[Nakamura, Ritsuko; Oyama, Takeru; Tajiri, Ryosuke; Ooi, Akishi] Kanazawa Univ Grad Sch Med Sci, Dept Mol & Cellular Pathol, Kanazawa, Ishikawa 9208640, Japan; [Mizokami, Atsushi; Namiki, Mikio] Kanazawa Univ Grad Sch Med Sci, Integrat Canc Therapy & Urol, Kanazawa, Ishikawa, Japan; [Nakamoto, Masaru] Univ Aberdeen, Sch Med Sci, Aberdeen Dev Biol Grp, Aberdeen, Scotland	Nakamura, R (reprint author), Kanazawa Univ Grad Sch Med Sci, Dept Mol & Cellular Pathol, 13-1 Takaramachi, Kanazawa, Ishikawa 9208640, Japan.	rnakamura@staff.kanazawa-u.ac.jp		Nakamoto, Masaru/0000-0001-9356-1189			Truong T, 2007, J BONE MINER RES, V22, P7, DOI 10.1359/JBMR.061012; GREGER V, 1989, HUM GENET, V83, P155, DOI 10.1007/BF00286709; Aghaloo T, 2006, AM J PATHOL, V169, P903, DOI 10.2353/ajpath.2006.051210; Matsuoka H, 2005, J BIOL CHEM, V280, P29355, DOI 10.1074/jbc.M500010200; Morrissey C, 2001, CANCER RES, V61, P7277; Kim DH, 2013, DNA CELL BIOL, V32, P517, DOI 10.1089/dna.2013.1974; Zhang YW, 2000, P NATL ACAD SCI USA, V97, P10549, DOI 10.1073/pnas.180309597; Slovak ML, 2011, CLIN CANCER RES, V17, P3443, DOI 10.1158/1078-0432.CCR-10-1071; Osman I, 2006, CLIN CANCER RES, V12, P3374, DOI 10.1158/1078-0432.CCR-05-2081; Shen J, 2012, J CELL BIOCHEM, V113, P3620, DOI 10.1002/jcb.24253; Klug M, 2006, EPIGENETICS, V1, P127; Xue J, 2011, BONE, V48, P485, DOI 10.1016/j.bone.2010.10.166; Zhang XL, 2002, J CLIN INVEST, V110, P861, DOI 10.1172/JCI200215375; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Lukas J, 1996, MOL CELL BIOL, V16, P1047; Hasebe A, 2012, FEBS LETT, V586, P2500, DOI 10.1016/j.febslet.2012.06.014; Dulaimi E, 2004, CLIN CANCER RES, V10, P3972, DOI 10.1158/1078-0432.CCR-04-0175; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V265, P79, DOI 10.1006/bbrc.1999.1638; Yoon JH, 2001, INT J CANCER, V94, P212, DOI 10.1002/ijc.1466; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Nakamura R, 2012, J BIOL CHEM, V287, P3282, DOI 10.1074/jbc.M111.281485; Dreijerink K, 2001, P NATL ACAD SCI USA, V98, P7504, DOI 10.1073/pnas.131216298; Jiang YL, 2009, MOL CELL NEUROSCI, V41, P113, DOI 10.1016/j.mcn.2009.02.006; Ting K, 1999, J BONE MINER RES, V14, P80, DOI 10.1359/jbmr.1999.14.1.80; Watanabe TK, 1996, GENOMICS, V38, P273, DOI 10.1006/geno.1996.0628; Schmidt L, 1999, ONCOGENE, V18, P2343, DOI 10.1038/sj.onc.1202547; Witt H, 2011, CANCER CELL, V20, P143, DOI 10.1016/j.ccr.2011.07.007; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19; Howlader N, 2013, SEER CANC STAT REV 1; Jin Z, 2007, ONCOGENE, V26, P6332, DOI 10.1038/sj.onc.1210461; Kim H, 2002, J NEUROCHEM, V83, P1389, DOI 10.1046/j.1471-4159.2002.01245.x; Maeda K, 2001, NEUROL MED-CHIR, V41, P582, DOI 10.2176/nmc.41.582; MATSUHASHI S, 1995, DEV DYNAM, V203, P212; Mori Y, 2006, GASTROENTEROLOGY, V131, P797, DOI 10.1053/j.gastro.2006.06.006; Nakamoto C, 2014, MOL BIOL CELL, V25, P234, DOI 10.1091/mbc.E13-08-0453; Oyasu M, 2000, MOL BRAIN RES, V76, P151, DOI 10.1016/S0169-328X(99)00342-3; Shah US, 2004, J CELL BIOCHEM, V91, P161, DOI 10.1002/jcb.10739; Wang JD, 2005, ONCOGENE, V24, P5637, DOI 10.1038/sj.onc.1208720; Yamada D, 2006, INT J CANCER, V118, P916, DOI 10.1002/ijc.21450	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	MAY	2015	106	5					656	664		10.1111/cas.12649		9	Oncology	Oncology	CI6QM	WOS:000354885700023		
J	Yamanoi, K; Arai, E; Tian, Y; Takahashi, Y; Miyata, S; Sasaki, H; Chiwaki, F; Ichikawa, H; Sakamoto, H; Kushima, R; Katai, H; Yoshida, T; Sakamoto, M; Kanai, Y				Yamanoi, Kazuhiro; Arai, Eri; Tian, Ying; Takahashi, Yoriko; Miyata, Sayaka; Sasaki, Hiroki; Chiwaki, Fumiko; Ichikawa, Hitoshi; Sakamoto, Hiromi; Kushima, Ryoji; Katai, Hitoshi; Yoshida, Teruhiko; Sakamoto, Michiie; Kanai, Yae			Epigenetic clustering of gastric carcinomas based on DNA methylation profiles at the precancerous stage: its correlation with tumor aggressiveness and patient outcome	CARCINOGENESIS			English	Article							RENAL-CELL CARCINOMAS; PROMOTER METHYLATION; SOMATIC MUTATIONS; COLLAGEN-XXIII; CANCER CELLS; GENOME; GENES; ACTIVATION; EXPRESSION; PROTEIN	Single-CpG resolution genome-wide DNA methylation analysis indicated that distinct DNA methylation profiles are established during field cancerization in gastric mucosae, and such profiles at the precancerous stage are inherited by gastric cancers, thus determining tumor aggressiveness and patient outcome.The aim of this study was to clarify the significance of DNA methylation alterations during gastric carcinogenesis. Single-CpG resolution genome-wide DNA methylation analysis using the Infinium assay was performed on 109 samples of non-cancerous gastric mucosa (N) and 105 samples of tumorous tissue (T). DNA methylation alterations in T samples relative to N samples were evident for 3861 probes. Since N can be at the precancerous stage according to the field cancerization concept, unsupervised hierarchical clustering based on DNA methylation levels was performed on N samples (beta(N)) using the 3861 probes. This divided the 109 patients into three clusters: A (n = 20), B1 (n = 20), and B2 (n = 69). Gastric carcinomas belonging to Cluster B1 showed tumor aggressiveness more frequently than those belonging to Clusters A and B2. The recurrence-free and overall survival rates of patients in Cluster B1 were lower than those of patients in Clusters A and B2. Sixty hallmark genes for which beta(N) characterized the epigenetic clustering were identified. We then focused on DNA methylation levels in T samples (beta(T)) of the 60 hallmark genes. In 48 of them, including the ADAM23, OLFM4, AMER2, GPSM1, CCL28, DTX1 and COL23A1 genes, beta(T) was again significantly correlated with tumor aggressiveness, and the recurrence-free and/or overall survival rates. Multivariate analyses revealed that beta(T) was a significant prognostic factor, being independent of clinicopathological parameters. These data indicate that DNA methylation profiles at the precancerous stage may be inherited by gastric carcinomas themselves, thus determining tumor aggressiveness and patient outcome.	[Yamanoi, Kazuhiro; Arai, Eri; Tian, Ying; Kanai, Yae] Natl Canc Ctr, Div Mol Pathol, Res Inst, Tokyo 1040045, Japan; [Yamanoi, Kazuhiro; Sakamoto, Michiie] Keio Univ, Dept Pathol, Sch Med, Tokyo 1608582, Japan; [Takahashi, Yoriko; Miyata, Sayaka] Mitsui Knowledge Ind Co Ltd, Biosci Dept, Business Dev Div, Tokyo 1056215, Japan; [Sasaki, Hiroki; Chiwaki, Fumiko] Natl Canc Ctr, Dept Translat Oncol, Res Inst, Tokyo 1040045, Japan; [Ichikawa, Hitoshi; Sakamoto, Hiromi; Yoshida, Teruhiko] Natl Canc Ctr, Div Genet, Res Inst, Tokyo 1040045, Japan; [Kushima, Ryoji] Natl Canc Ctr, Dept Pathol, Tokyo 1040045, Japan; [Kushima, Ryoji] Natl Canc Ctr, Clin Labs, Div Pathol, Tokyo 1040045, Japan; [Katai, Hitoshi] Natl Canc Ctr, Dept Gastr Surg, Tokyo 1040045, Japan	Arai, E (reprint author), Natl Canc Ctr, Div Mol Pathol, Res Inst, Tokyo 1040045, Japan.	earai@ncc.go.jp	Sakamoto, Michiie/N-2917-2015		National Institute of Biomedical Innovation (NiBio) [10-41, 10-42]; Japan Society for the Promotion of Science (JSPS) [23390096, 25460487]; National Cancer Center Research and Development Fund [26-A-1]; Applied Research for Innovative Treatment of Cancer [H26-019]	National Institute of Biomedical Innovation (NiBio), 10-41, 10-42; Japan Society for the Promotion of Science (JSPS) (23390096, 25460487); National Cancer Center Research and Development Fund (26-A-1); the Applied Research for Innovative Treatment of Cancer (H26-019).	Matsusaka K, 2011, CANCER RES, V71, P7187, DOI 10.1158/0008-5472.CAN-11-1349; YOSHIURA K, 1995, P NATL ACAD SCI USA, V92, P7416, DOI 10.1073/pnas.92.16.7416; Marx AH, 2009, HUM PATHOL, V40, P769, DOI 10.1016/j.humpath.2008.11.014; Banyard J, 2007, CLIN CANCER RES, V13, P2634, DOI 10.1178/1078-0432.CCR-06-2163; Arai E, 2009, CARCINOGENESIS, V30, P214, DOI 10.1093/carcin/bgn268; Spivey KA, 2010, CANCER EPIDEM BIOMAR, V19, P1362, DOI 10.1158/1055-9965.EPI-09-1095; Tahara T, 2013, CANCER PREV RES, V6, P1093, DOI 10.1158/1940-6207.CAPR-13-0034; Kanai Y, 2010, CANCER SCI, V101, P36, DOI 10.1111/j.1349-7006.2009.01383.x; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Sato T, 2014, INT J CANCER, V135, P319, DOI 10.1002/ijc.28684; Clements WM, 2002, CANCER RES, V62, P3503; Kim JG, 2013, CANCER LETT, V330, P33, DOI 10.1016/j.canlet.2012.11.022; Corso G, 2013, J CLIN ONCOL, V31, P868, DOI 10.1200/JCO.2012.44.4612; Ramachandran K, 2012, EPIGENOMICS-UK, V4, P243, DOI [10.2217/epi.12.12, 10.2217/EPI.12.12]; Park J, 2004, ONCOGENE, V23, P3474, DOI 10.1038/sj.onc.1207470; Oster B, 2011, INT J CANCER, V129, P2855, DOI 10.1002/ijc.25951; Matsuda T, 2009, JPN J CLIN ONCOL, V39, P850, DOI 10.1093/jjco/hyp106; Arai E, 2012, CARCINOGENESIS, V33, P1487, DOI 10.1093/carcin/bgs177; Lu B, 2014, WORLD J GASTROENTERO, V20, P5660, DOI 10.3748/wjg.v20.i19.5660; Li VSW, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-29; Fenoglio-Preiser CM, 2003, HUM MUTAT, V21, P258, DOI 10.1002/humu.10180; Etoh T, 2004, AM J PATHOL, V164, P689, DOI 10.1016/S0002-9440(10)63156-2; Kobayashi D, 2007, CANCER SCI, V98, P334, DOI 10.1111/j.1349-7006.2007.00397.x; Nishiyama N, 2010, CANCER SCI, V101, P231, DOI 10.1111/j.1349-7006.2009.01330.x; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Ushijima T, 2012, CLIN CANCER RES, V18, P923, DOI 10.1158/1078-0432.CCR-11-2011; Peng DF, 2006, CARCINOGENESIS, V27, P1160, DOI 10.1093/carcin/bgi361; Bethge N, 2014, EPIGENETICS-US, V9, P428, DOI 10.4161/epi.27554; Nojima M, 2007, ONCOGENE, V26, P4699, DOI 10.1038/sj.onc.1210259; Arai E, 2010, EPIGENOMICS-UK, V2, P467, DOI [10.2217/epi.10.16, 10.2217/EPI.10.16]; Ashktorab H, 2013, EPIGENETICS-US, V8, P807, DOI 10.4161/epi.25497; Cheng Y, 2014, ONCOL LETT, V7, P1021, DOI 10.3892/ol.2014.1838; Fléjou Jean-François, 2011, Ann Pathol, V31, pS27, DOI 10.1016/j.annpat.2011.08.001; Guo Q, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0695-4; Hu CY, 2011, INT J EXP PATHOL, V92, P333, DOI 10.1111/j.1365-2613.2011.00766.x; Huber RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057793; Jemel A., 2007, CA CANC J CLIN, V57, P43; Nagashio R, 2011, INT J CANCER, V129, P1170, DOI 10.1002/ijc.26061; Pfister AS, 2012, J BIOL CHEM, V287, P1734, DOI 10.1074/jbc.M111.308650; Richter TM, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-29; Sato T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059444; Shao S, 2014, INT J HEMATOL, V99, P57, DOI 10.1007/s12185-013-1484-8; Shull AY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058731; Sobin LH, 2009, TNM CLASSIFICATION M; Verbisck NV, 2009, CANCER RES, V69, P5546, DOI 10.1158/0008-5472.CAN-08-2976; Waki T, 2003, CANCER SCI, V94, P360, DOI 10.1111/j.1349-7006.2003.tb01447.x	50	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0143-3334	1460-2180		CARCINOGENESIS	Carcinogenesis	MAY	2015	36	5					509	520		10.1093/carcin/bgv013		12	Oncology	Oncology	CI4TK	WOS:000354746400001		
J	Inayama, M; Suzuki, Y; Yamada, S; Kurita, T; Yamamura, H; Ohya, S; Giles, WR; Imaizumi, Y				Inayama, Munenori; Suzuki, Yoshiaki; Yamada, Satoshi; Kurita, Takashi; Yamamura, Hisao; Ohya, Susumu; Giles, Wayne R.; Imaizumi, Yuji			Orail-Orai2 complex is involved in store-operated calcium entry in chondrocyte cell lines	CELL CALCIUM			English	Article						Chondrocyte; Orai1; Orai2; Store-operated calcium entry (SOCE); Stromal interaction molecule 1 (STIM1); Total internal reflection fluorescence (TIRF) microscopy	HUMAN ARTICULAR CHONDROCYTES; PROTEIN-KINASE-C; CRAC CHANNEL; CA2+ ENTRY; IN-VITRO; FUNCTIONAL-CHARACTERIZATION; MEMBRANE HYPERPOLARIZATION; OSTEOARTHRITIC CARTILAGE; CHONDROGENIC CELLS; RHEUMATOID LESION	Ca2+ influx via store-operated Ca2+ entry (SOCE) plays critical roles in many essential cellular functions. The Ca2+ release-activated Ca2+ (CRAC) channel complex, consisting of Oral and STIM, is one of the major components of store-operated Ca2+ (SOC) channels. Our previous study demonstrated that histamine can cause sustained Ca2+ entry through SOC channels in OUMS-27 cells derived from human chondrosarcoma. This SOCE was increased by low- and decreased by high-concentrations of 2-aminoethoxydiphenyl borate. Quantitative reverse transcription PCR and Western blot analyses revealed abundant expressions of Orai1 Orai2 and STIM1. Introduction of dominant negative mutant of Orai1, or siOrai1 knockdown significantly attenuated SOCE. Following histamine application, single molecule imaging using total internal reflection fluorescence (TIRF) microscopy demonstrated punctate Orai1-STIM1 complex formation in plasma membrane. In contrast, knockdown or over-expression of Orai2 resulted in an increase or a decrease in SOCE, respectively. Finally, TIRF imaging revealed direct coupling between Orai1 and Orai2, and suggested that Orai2 reduces Orai1 function by formation of a hetero-tetramer. These results provide substantial evidence that Orai1, Orai2 and STIM1 form functional CRAC channels in OUMS-27 cells and that these complexes are responsible for sustained Ca2+ entry in response to agonist stimulation. (C) 2015 Elsevier Ltd. All rights reserved.	[Inayama, Munenori; Suzuki, Yoshiaki; Yamada, Satoshi; Kurita, Takashi; Yamamura, Hisao; Ohya, Susumu; Imaizumi, Yuji] Nagoya City Univ, Dept Mol & Cellular Pharmacol, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4678603, Japan; [Ohya, Susumu] Kyoto Pharmaceut Univ, Div Pathol Sci, Dept Pharmacol, Kyoto 6078414, Japan; [Giles, Wayne R.] Univ Calgary, Fac Kinesiol, Calgary, AB T2N 1N4, Canada	Imaizumi, Y (reprint author), Nagoya City Univ, Dept Mol & Cellular Pharmacol, Grad Sch Pharmaceut Sci, Mizuho Ku, 3-1 Tanabedori, Nagoya, Aichi 4678603, Japan.	yimaizum@phar.nagoya-cu.ac.jp			JSPS KAKENHI [26293021, 26860059]; Nakatomi Foundation; CIHR	This work was supported by JSPS KAKENHI Grant Numbers, 26293021; to Y.I.,26860059; to Y.S. and by theNakatomi Foundation to H.Y. Dr. W. Giles holds an Alberta Innovates - Health Solutions Scientist Award, and CIHR funding.	Wu QQ, 2000, EXP CELL RES, V256, P383, DOI 10.1006/excr.2000.4847; Loeser RF, 2003, J BIOL CHEM, V278, P24577, DOI 10.1074/jbc.M304530200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Gross SA, 2007, J BIOL CHEM, V282, P19375, DOI 10.1074/jbc.M701962200; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Demuro A, 2011, P NATL ACAD SCI USA, V108, P17832, DOI 10.1073/pnas.1114814108; Maruyama Y, 2009, J BIOL CHEM, V284, P13676, DOI 10.1074/jbc.M900812200; TETLOW LC, 1995, ANN RHEUM DIS, V54, P896, DOI 10.1136/ard.54.11.896; Phan MN, 2009, ARTHRITIS RHEUM, V60, P3028, DOI 10.1002/art.24799; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Huang WC, 2011, CELL CALCIUM, V50, P27, DOI 10.1016/j.ceca.2011.04.004; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Lee KP, 2009, P NATL ACAD SCI USA, V106, P14687, DOI 10.1073/pnas.0904664106; Matta C, 2008, CELL CALCIUM, V44, P310, DOI 10.1016/j.ceca.2007.12.010; Mignen O, 2009, J PHYSIOL-LONDON, V587, P4181, DOI 10.1113/jphysiol.2009.174193; Takahashi Y, 2007, BIOCHEM BIOPH RES CO, V356, P45, DOI 10.1016/j.bbrc.2007.02.107; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Frischauf I, 2011, J BIOL CHEM, V286, P8577, DOI 10.1074/jbc.M110.187179; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; Suzuki Y, 2013, J BIOL CHEM, V288, P36750, DOI 10.1074/jbc.M113.511485; Derler I, 2013, CELL CALCIUM, V53, P139, DOI 10.1016/j.ceca.2012.11.005; Woolley DE, 2000, ARTHRITIS RES, V2, P65, DOI 10.1186/ar70; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1093/jcb.200502019; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Barrett-Jolley R, 2010, FRONT PHYSIOL, V1, P1; Fodor J, 2013, CELL CALCIUM, V54, P1, DOI 10.1016/j.ceca.2013.03.003; FUKUDA K, 1991, AM J PHYSIOL, V261, pC413; Funabashi K, 2010, AM J PHYSIOL-CELL PH, V298, pC786, DOI 10.1152/ajpcell.00469.2009; Funabashi K, 2010, J PHARMACOL SCI, V113, P94, DOI 10.1254/jphs.10026SC; Kito H., 2015, BIOCH BIOPH IN PRESS; Lewis R, 2011, CELL PHYSIOL BIOCHEM, V28, P1111, DOI 10.1159/000335847; Ohba T, 2013, J PHARMACOL EXP THER, V347, P145, DOI 10.1124/jpet.113.205138; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Raizman I, 2010, CELL CALCIUM, V48, P232, DOI 10.1016/j.ceca.2010.09.006; Rao GK, 2006, J LEUKOCYTE BIOL, V79, P202, DOI 10.1189/jlb.0505274; Sohen S., 2001, PATHOPHYSIOLOGY, V8, P93, DOI 10.1016/S0928-4680(01)00066-9; TAYLOR DJ, 1986, ARTHRITIS RHEUM, V29, P160, DOI 10.1002/art.1780290202; Tetlow LC, 2002, ANN RHEUM DIS, V61, P737, DOI 10.1136/ard.61.8.737; Tetlow LC, 2003, ANN RHEUM DIS, V62, P991, DOI 10.1136/ard.62.10.991; Tetlow LC, 2005, RHEUMATOL INT, V26, P173, DOI 10.1007/s00296-005-0622-x; Thompson JL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01961; Yamamura H, 2012, AM J PHYSIOL-CELL PH, V302, pC1257, DOI 10.1152/ajpcell.00191.2011; Yoo SA, 2007, ARTHRITIS RHEUM, V56, P2299, DOI 10.1002/art.22731	52	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0143-4160	1532-1991		CELL CALCIUM	Cell Calcium	MAY	2015	57	5-6					337	347		10.1016/j.ceca.2015.02.005		11	Cell Biology	Cell Biology	CI8TT	WOS:000355045300002		
J	Imai, N; Miyake, N; Saito, Y; Kojima, E; Ikawa, M; Manaka, S; Shiina, M; Ogata, K; Matsumoto, N				Imai, N.; Miyake, N.; Saito, Y.; Kojima, E.; Ikawa, M.; Manaka, S.; Shiina, M.; Ogata, K.; Matsumoto, N.			A pedigree of paroxysmal extreme pain disorder with short-lasting, unilateral headaches and ipsilateral facial flushing caused by a novel SCN9A mutation	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Imai, N.] Japanese Red Cross Shizuoka Hosp, Dept Neurol, Shizuoka, Japan; [Miyake, N.; Matsumoto, N.] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 232, Japan; [Saito, Y.; Kojima, E.] Natl Ctr Neurol & Psychiat, Dept Child Neurol, Tokyo, Japan; [Ikawa, M.] Shizuoka Shimizu Municipal Hosp, Dept Oral Surg, Shizuoka, Japan; [Manaka, S.] Manaka Hosp, Dept Neurosurg, Odawara, Japan; [Shiina, M.; Ogata, K.] Yokohama City Univ, Dept Biochem, Grad Sch Med, Yokohama, Kanagawa 232, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		OR05	6	7				2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400012		
J	Shimohata, K; Shimohata, T; Motigi, R; Miyashita, K				Shimohata, K.; Shimohata, T.; Motigi, R.; Miyashita, K.			Clinical features of headache in children and adolescents at an outpatient pain clinic in Japan	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Shimohata, K.] Kameda Daiichi Hosp, Dept Anesthesiol, Niigata, Japan; [Shimohata, T.] Niigata Univ, Inst Brain, Dept Neurol, Niigata, Japan; [Motigi, R.; Miyashita, K.] Takasaki Pain Clin, Dept Anesthesiol, Takasaki, Gumma, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO033	30	31				2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400064		
J	Suzuki, A; Tatsumoto, M; Suzuki, T; Hirata, K				Suzuki, A.; Tatsumoto, M.; Suzuki, T.; Hirata, K.			Are blue-light blocking eyeglasses beneficial to migraine patients?	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Suzuki, A.; Tatsumoto, M.; Hirata, K.] Dokkyo Med Univ, Neurol, Mibu, Tochigi, Japan; [Suzuki, T.] Ind Res Inst Shizuoka Prefecture, Mech Engn, Shizuoka, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO044	36	36				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400075		
J	Kitamura, E; Hamada, J; Kanazawa, N; Nishiyama, K				Kitamura, E.; Hamada, J.; Kanazawa, N.; Nishiyama, K.			The migraine prophylactic effect of candesartan and telmisartan on rat CSD model	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Kitamura, E.; Hamada, J.; Kanazawa, N.; Nishiyama, K.] Kitasato Univ, Sch Med, Neurol, Sagamihara, Kanagawa 228, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO047	37	37				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400078		
J	Kayama, Y; Shibata, M; Takizawa, T; Shimizu, T; Toriumi, H; Ebine, T; Ko, A; Suzuki, N				Kayama, Y.; Shibata, M.; Takizawa, T.; Shimizu, T.; Toriumi, H.; Ebine, T.; Ko, A.; Suzuki, N.			Regulation of TRPM8 expression by inflammatory mediators: implications for novel migraine therapy	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Kayama, Y.; Shibata, M.; Takizawa, T.; Shimizu, T.; Toriumi, H.; Ebine, T.; Ko, A.; Suzuki, N.] Keio Univ, Sch Med, Neurol, Keio, Japan			Shimizu, Toshihiko/M-4870-2013; Suzuki, Norihiro/J-5125-2013					0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO063	44	45				2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400093		
J	Mitsufuji, T; Yamamoto, T; Miyake, A; Ito, Y; Isobe, H; Tamura, N; Araki, N				Mitsufuji, T.; Yamamoto, T.; Miyake, A.; Ito, Y.; Isobe, H.; Tamura, N.; Araki, N.			Yokukansan and lomelizine was effective in the case of MOH	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Mitsufuji, T.; Yamamoto, T.; Miyake, A.; Ito, Y.; Tamura, N.; Araki, N.] Saitama Med Univ, Sch Med, Neurol, Moroyama, Saitama, Japan; [Isobe, H.] Saitama Med Univ, Sch Med, Japanese Herbal Med, Moroyama, Saitama, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO094	60	61				2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400123		
J	Shibata, Y				Shibata, Y.			Yokukannsannka-chinpihange(chinese herbal medicine) as the treatment for tension-type headache	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Shibata, Y.] Univ Tsukuba, Neurosurg, Ibaraki, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO107	67	67				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400136		
J	Koh, A; Shimizu, T; Mamoru, S; Takizawa, T; Kayama, Y; Ebine, T; Toriumi, H; Suzuki, N				Koh, A.; Shimizu, T.; Mamoru, S.; Takizawa, T.; Kayama, Y.; Ebine, T.; Toriumi, H.; Suzuki, N.			Distribution of the calcitonin gene-related peptide receptors in the sphenopalatine ganglion of the rat	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Koh, A.; Shimizu, T.; Mamoru, S.; Takizawa, T.; Kayama, Y.; Ebine, T.; Toriumi, H.; Suzuki, N.] Keio Univ, Sch Med, Neurol, Tokyo, Japan			Shimizu, Toshihiko/M-4870-2013; Suzuki, Norihiro/J-5125-2013					0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO121	74	74				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400149		
J	Kaji, Y; Hirata, K				Kaji, Y.; Hirata, K.			The study of validity of duloxetine/mirtazapine to chronic primary headache with depressive state	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Kaji, Y.; Hirata, K.] Dokkyo Med Univ, Dept Neurol, Mibu, Tochigi, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO166	95	96				2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400192		
J	Ikeda, K; Hanashiro, S; Takazawa, T; Kawase, Y; Sawada, M; Yanagihashi, M; Ishikawa, Y; Miura, K; Hirayama, T; Kano, O; Kawabe, K; Iwasaki, Y				Ikeda, K.; Hanashiro, S.; Takazawa, T.; Kawase, Y.; Sawada, M.; Yanagihashi, M.; Ishikawa, Y.; Miura, K.; Hirayama, T.; Kano, O.; Kawabe, K.; Iwasaki, Y.			The prevalence and the clinical profile of primary exercise headache on japanese physical check-up	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Ikeda, K.; Hanashiro, S.; Takazawa, T.; Kawase, Y.; Sawada, M.; Yanagihashi, M.; Ishikawa, Y.; Miura, K.; Hirayama, T.; Kano, O.; Kawabe, K.; Iwasaki, Y.] Toho Univ, Omori Med Ctr, Neurol, Tokyo, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO185	104	105				2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400209		
J	Igarashi, S; Sekiya, K; Shimbo, J; Sato, A; Sasaki, O; Yamazaki, M; Okamoto, K				Igarashi, S.; Sekiya, K.; Shimbo, J.; Sato, A.; Sasaki, O.; Yamazaki, M.; Okamoto, K.			Characterization of japanese cases of reversible cerebral vasoconstriction syndrome (RCVS)	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Igarashi, S.; Sekiya, K.; Shimbo, J.; Sato, A.] Niigata City Gen Hosp, Neurol, Niigata, Japan; [Sasaki, O.] Niigata City Gen Hosp, Neurosurg, Niigata, Japan; [Yamazaki, M.] Toukamachi Hosp, Neurol, Toukamachi, Japan; [Okamoto, K.] Niigata Univ, Brain Reserch Instutute, Neurosurg, Niigata, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO219	122	123				2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400242		
J	Kitamura, T; Kitamura, T; Sato, S; Tateyama, K; Morita, A; Adachi, K; Takumi, I				Kitamura, T.; Kitamura, T.; Sato, S.; Tateyama, K.; Morita, A.; Adachi, K.; Takumi, I.			The best treatment of chronic subdural hematoma caused by intracranial hypotension	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Kitamura, T.; Kitamura, T.; Sato, S.; Tateyama, K.; Morita, A.; Adachi, K.; Takumi, I.] Nippon Med Sch, Grad Sch Med, Neurol Surg, Tokyo 113, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO257	140	141				2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400279		
J	Watanabe, Y; Igarashi, H; Takashima, R; Hirata, K				Watanabe, Y.; Igarashi, H.; Takashima, R.; Hirata, K.			Survey regarding awareness of the disease name for medication-overuse headaches	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Watanabe, Y.; Takashima, R.; Hirata, K.] Dokkyo Med Univ, Neurol, Mibu, Tochigi, Japan; [Igarashi, H.] Fujitsu Clin, Neurol, Tokyo, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO266	144	144				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400288		
J	Shimizu, T; Arakawa, I				Shimizu, T.; Arakawa, I.			A longitudinal observation survey on factors that affect duration of prophylactic medications for migraine in Japan setting	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Shimizu, T.] Tokyo Womens Med Univ, Sch Med, Dept Neurosurgy, Tokyo, Japan; [Arakawa, I.] Teikyo Heisei Univ, Fac Pharmaceut Sci, Tokyo, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO273	147	147				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400294		
J	Okuma, H; Kodera, Y; Yasuda, T; Tokuoka, K; Nogawa, S; Kitagwa, Y				Okuma, H.; Kodera, Y.; Yasuda, T.; Tokuoka, K.; Nogawa, S.; Kitagwa, Y.			Examination of fluctuations in the atmospheric pressure related to migraine	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Okuma, H.; Kodera, Y.; Yasuda, T.; Tokuoka, K.; Nogawa, S.; Kitagwa, Y.] Tokai Univ, Hachioji Hosp, Neurol, Tokyo 151, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO292	156	156				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400312		
J	Shibata, Y; Kuniyasu, R				Shibata, Y.; Kuniyasu, R.			Prevalence and knowledge of headaches among Japanese hospital workers	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Shibata, Y.] Univ Tsukuba, Neurosurg, Ibaraki, Japan; [Kuniyasu, R.] Mito Kyodo Gen Hosp, Headache Clin, Ibaraki, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO300	160	160				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400320		
J	Unno, Y; Iwashita, T				Unno, Y.; Iwashita, T.			Trend of patients at a headache clinic	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Unno, Y.] Kawakita Gen Hosp, Neurol, Tokyo, Japan; [Iwashita, T.] Inagi Municipal Hosp, Neurol, Tokyo, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO303	161	162				2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400323		
J	Takeshima, T; Kikui, S				Takeshima, T.; Kikui, S.			Prevalence of restless leg (RLS) syndrome and association of chronic migraine and obesity in a Japan regional headache center	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Takeshima, T.; Kikui, S.] Tominaga Hosp, Headache Ctr Neurol, Osaka, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO304	162	162				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400324		
J	Ishibashi, Y; Kudo, M; Yonezawa, H; Yonekura, Y; Sakata, K; Kobayashi, S; Ogawa, A; Terayama, Y				Ishibashi, Y.; Kudo, M.; Yonezawa, H.; Yonekura, Y.; Sakata, K.; Kobayashi, S.; Ogawa, A.; Terayama, Y.			Study of headache after the great east Japan earthquake in iwate coast area (1) report of 2012	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Ishibashi, Y.; Kudo, M.; Yonezawa, H.; Terayama, Y.] Iwate Med Univ, Neurol & Gerontol, Morioka, Iwate 020, Japan; [Yonekura, Y.; Sakata, K.] Iwate Med Univ, Hyg & Prevent Med, Morioka, Iwate 020, Japan; [Kobayashi, S.] Iwate Med Univ, Plast Surg, Morioka, Iwate 020, Japan; [Ogawa, A.] Iwate Med Univ, Neurosurg, Morioka, Iwate 020, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO321	170	170				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400340		
J	Kudo, M; Ishibashi, Y; Yonezawa, H; Yonekura, Y; Sakata, K; Kobayashi, S; Ogawa, A; Terayama, Y				Kudo, M.; Ishibashi, Y.; Yonezawa, H.; Yonekura, Y.; Sakata, K.; Kobayashi, S.; Ogawa, A.; Terayama, Y.			Study of headache after the great east Japan earthquake in iwate coast area (2) comparison between migraine group and non-migraine group	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Kudo, M.; Ishibashi, Y.; Yonezawa, H.] Iwate Med Univ, Dept Internal Med, Morioka, Iwate 020, Japan; [Yonekura, Y.; Sakata, K.] Iwate Med Univ, Dept Hyg & Prevent Med, Morioka, Iwate 020, Japan; [Kobayashi, S.] Iwate Med Univ, Dept Plast Surg, Morioka, Iwate 020, Japan; [Ogawa, A.] Iwate Med Univ, Dept Nurosurg, Morioka, Iwate 020, Japan; [Terayama, Y.] Iwate Med Univ, Dept Neurol & Gerontol, Morioka, Iwate 020, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO322	171	171				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400341		
J	Sakai, F; Asano, Y; Chijiwa, K; Saisho, Y; Maruki, Y				Sakai, F.; Asano, Y.; Chijiwa, K.; Saisho, Y.; Maruki, Y.			Outcome of a headache center, integrating western-eastern medicine in Asia	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Sakai, F.; Asano, Y.; Chijiwa, K.; Saisho, Y.; Maruki, Y.] Saitama Int Headache Ctr, Saitama Neuropsychiat Inst, Saitama, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO331	175	175				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400350		
J	Kanki, R; Komiyama, M; Ishiguro, T; Terada, A; Nakano, S				Kanki, R.; Komiyama, M.; Ishiguro, T.; Terada, A.; Nakano, S.			The effect of embolization of pulmonary arteriovenous malformations on migraine among patients with hereditary hemorrhagic telangiectasia	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Kanki, R.; Nakano, S.] Osaka City Gen Hosp, Neurol, Osaka, Japan; [Komiyama, M.; Ishiguro, T.] Osaka City Gen Hosp, Neurointervent, Osaka, Japan; [Terada, A.] Osaka City Gen Hosp, Neurosurg, Osaka, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO337	178	179				2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400356		
J	Ebine, T; Toriumi, H; Takizawa, T; Kayama, Y; Shibata, M; Shimizu, T; Suzuki, N				Ebine, T.; Toriumi, H.; Takizawa, T.; Kayama, Y.; Shibata, M.; Shimizu, T.; Suzuki, N.			Influence of the natural estrous cycle on the threshold for potassium induced cortical spreading depression in mice	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Ebine, T.; Toriumi, H.; Takizawa, T.; Kayama, Y.; Shibata, M.; Shimizu, T.; Suzuki, N.] Keio Univ, Sch Med, Neurol, Tokyo, Japan			Shimizu, Toshihiko/M-4870-2013; Suzuki, Norihiro/J-5125-2013					0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO354	188	188				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400372		
J	Shimohata, K; Shimohata, T; Motegi, R; Miyashita, K				Shimohata, K.; Shimohata, T.; Motegi, R.; Miyashita, K.			Clinical features of headache in children and adolescents at an outpatient pain clinic in Japan	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Shimohata, K.] Kameda Daiichi Hosp, Deapartment Anesthesiol, Niigata, Japan; [Shimohata, T.] Niigata Univ, Brain Res Inst, Deapartment Neurol, Niigata, Japan; [Motegi, R.; Miyashita, K.] Takasaki Pain Clin, Deapartment Anesthesiol, Takasaki, Gumma, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO363	192	192				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400381		
J	Hikita, T; Ogita, K; Amakata, K; Kaneko, S; Nakamoto, N; Kodama, H				Hikita, T.; Ogita, K.; Amakata, K.; Kaneko, S.; Nakamoto, N.; Kodama, H.			Correlation between characteristics of cyclic vomiting syndrome and levels of adrenocorticotropic hormone and/or antidiuretic hormone	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Hikita, T.; Ogita, K.; Amakata, K.; Kaneko, S.; Kodama, H.] Teikyo Univ, Sch Med, Dept Pediat, Tokyo 173, Japan; [Nakamoto, N.] Mejiro Univ, Dept Occupat Therapy, Fac Hlth Sci, Saitama, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO378	199	199				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400396		
J	Hikita, T; Ogita, K; Amakata, K; Kaneko, S; Nakamoto, N; Kodama, H				Hikita, T.; Ogita, K.; Amakata, K.; Kaneko, S.; Nakamoto, N.; Kodama, H.			A study on treatment options and prognosis of cyclic vomiting syndrome	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Hikita, T.; Ogita, K.; Amakata, K.; Kaneko, S.; Nakamoto, N.; Kodama, H.] Teikyo Univ, Sch Med, Dept Pediat, Tokyo 173, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO379	199	200				2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400397		
J	Tatsumoto, M; Yamakawa, M; Okajima, K; Hirata, K				Tatsumoto, M.; Yamakawa, M.; Okajima, K.; Hirata, K.			Contribution of intrinsically photosensitive retinal Ganglion cells in the photophobia of migraine patients	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Tatsumoto, M.; Hirata, K.] Dokkyo Med Univ, Neurol, Mibu, Tochigi, Japan; [Yamakawa, M.] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 240, Japan; [Okajima, K.] Yokohama Natl Univ, Fac Environm & Informat Sci, Yokohama, Kanagawa 240, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO398	208	208				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400416		
J	Takizawa, T; Shibata, M; Kayama, Y; Shimizu, T; Toriumi, H; Ebine, T; Koh, A; Suzuki, N				Takizawa, T.; Shibata, M.; Kayama, Y.; Shimizu, T.; Toriumi, H.; Ebine, T.; Koh, A.; Suzuki, N.			Microglial activation by multiple inductions of cortical spreading depression	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Takizawa, T.; Shibata, M.; Kayama, Y.; Shimizu, T.; Toriumi, H.; Ebine, T.; Koh, A.; Suzuki, N.] Keio Univ, Sch Med, Dept Neurol, Tokyo, Japan			Shimizu, Toshihiko/M-4870-2013; Suzuki, Norihiro/J-5125-2013					0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO403	210	210				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400421		
J	Shibata, Y; Matsushita, A; Matsumura, A				Shibata, Y.; Matsushita, A.; Matsumura, A.			Diffusion tensor imaging analysis for patients suffering from migraine using tract-based spatial statistics	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Shibata, Y.; Matsumura, A.] Univ Tsukuba, Neurosurg, Ibaraki, Japan; [Matsushita, A.] Univ Tsukuba, Ctr Cybern Res, Ibaraki, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO411	213	214				2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400429		
J	Kowa, H; Takigawa, H; Nakano, T; Nakashima, K				Kowa, H.; Takigawa, H.; Nakano, T.; Nakashima, K.			Eicosapentaenoic acid/arachidonic acid ratio is associated with migraine chronification	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Kowa, H.; Takigawa, H.; Nakashima, K.] Tottori Univ, Fac Med, Dept Brain & Neurosci, Yonago, Tottori 683, Japan; [Nakano, T.] Tottori Univ, Fac Med, Div Med Educ, Yonago, Tottori 683, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO434	226	226				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400449		
J	Kikuchi, T; Yamaguchi, S; Araki, N; Matsuda, H; Honda, N; Mimura, T				Kikuchi, T.; Yamaguchi, S.; Araki, N.; Matsuda, H.; Honda, N.; Mimura, T.			Effect of acupuncture stimulation on cerebral blood flow using arterial spin labeling MRI in patients with migraine (2)	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Kikuchi, T.; Yamaguchi, S.] Saitama Med Univ, Ctr Oriental & Integrated Med, Hidaka, Saitama, Japan; [Araki, N.] Saitama Med Univ, Dept Neurol, Hidaka, Saitama, Japan; [Matsuda, H.] NCNP, Integrat Brain Imaging Ctr, Tokyo, Japan; [Honda, N.] Saitama Med Ctr, Dept Radiol, Hidaka, Saitama, Japan; [Mimura, T.] Saitama Med Univ, Ctr Oriental & Integrated Med, Hidaka, Saitama, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO466	243	243				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400480		
J	Takigawa, H; Kowa, H; Nakano, T; Nakashima, K				Takigawa, H.; Kowa, H.; Nakano, T.; Nakashima, K.			Genetic polymorphisms of the interleikin-6 receptor-183G/A in the patients with chronic headache	CEPHALALGIA			English	Meeting Abstract	International Headache Congress of the International-Headache-Society	MAY 14-17, 2015	Valencia, SPAIN	Int Headache Soc					[Takigawa, H.; Kowa, H.; Nakashima, K.] Tottori Univ, Fac Med, Dept Brain & Neurosci, Div Neurolofy, Yonago, Tottori 683, Japan; [Nakano, T.] Tottori Univ, Fac Med, Div Med Educ, Yonago, Tottori 683, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2015	35			6		PO506	263	264				2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI2FC	WOS:000354559400519		
J	Shinkai, Y; Abiko, Y; Ida, T; Miura, T; Kakehashi, H; Ishii, I; Nishida, M; Sawa, T; Akaike, T; Kumagai, Y				Shinkai, Yasuhiro; Abiko, Yumi; Ida, Tomoaki; Miura, Takashi; Kakehashi, Hidenao; Ishii, Isao; Nishida, Motohiro; Sawa, Tomohiro; Akaike, Takaaki; Kumagai, Yoshito			Reactive Sulfur Species-Mediated Activation of the Keap1-Nrf2 Pathway by 1,2-Naphthoquinone through Sulfenic Acids Formation under Oxidative Stress	CHEMICAL RESEARCH IN TOXICOLOGY			English	Article							DIESEL EXHAUST PARTICLES; GROWTH-FACTOR RECEPTOR; COVALENT MODIFICATION; REDOX REGULATION; MOLECULAR-MECHANISMS; CHEMICAL BIOLOGY; PROTEIN; CYSTEINE; CELLS; SULFHYDRATION	Sulfhydration by a hydrogen sulfide anion and electrophile thiolation by reactive sulfur species (RSS) such as persulfides/polysulfides (e.g., R-S-SH/R-S-S-n-H(R)) are unique reactions in electrophilic signaling. Using 1,2-dihydroxynaphthalene-4-thioacetate (1,2-NQH(2)-SAc) as a precursor to 1,2-dihydroxynaphthalene-4-thiol (1,2-NQH(2)-SH) and a generator of reactive oxygen species (ROS), we demonstrate that protein thiols can be modified by a reactive sulfenic acid to form disulfide adducts that undergo rapid cleavage in the presence of glutathione (GSH). As expected, 1,2-NQH(2)-SAc is rapidly hydrolyzed and partially oxidized to yield 1,2-NQ-SH, resulting in a redox cycling reaction that produces ROS through a chemical disproportionation reaction. The sulfenic acid forms of 1,2-NQ-SH and 1,2-NQH2-SH were detected by derivatization experiments with dimedone. 1,2-NQH(2)-SOH modified Keap1 at Cys171 to produce a Keap1-S-S-1,2-NQH(2) adduct. Subsequent exposure of A431 cells to 1,2-NQ or 1,2-NQH(2)-SAc caused an extensive chemical modification of cellular proteins in both cases. Protein adduction by 1,2-NQ through a thio ether (C-S-C) bond slowly declined through a GSH-dependent S-transarylation reaction, whereas that originating from 1,2-NQH2-SAc through a disulfide (C-S-S-C) bond was rapidly restored to the free protein thiol in the cells. Under these conditions, 1,2-NQH(2)-SAc activated Nrf(2) and upregulated its target genes, which were enhanced by pretreatment with buthionine sulfoximine (BSO), to deplete cellular GSH. Pretreatment of catalase conjugated with poly(ethylene glycol) suppressed Nrf2 activation by 1,2-NQH(2)-SAc. These results suggest that RSS-mediated reversible electrophilic signaling takes place through sulfenic acids formation under oxidative stress.	[Shinkai, Yasuhiro; Abiko, Yumi; Miura, Takashi; Kakehashi, Hidenao; Kumagai, Yoshito] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Shinkai, Yasuhiro; Abiko, Yumi; Kumagai, Yoshito] Univ Tsukuba, Fac Med, Environm Biol Lab, Tsukuba, Ibaraki 3058575, Japan; [Ida, Tomoaki; Akaike, Takaaki] Tohoku Univ, Environm Hlth Sci Lab, Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Ishii, Isao] Keio Univ, Grad Sch Pharmaceut Sci, Dept Biochem, Minato Ku, Tokyo 1058512, Japan; [Nishida, Motohiro] Okazaki Inst Integrat Biosci, Div Cardiocirculatory Signaling, Okazaki, Aichi 4448787, Japan; [Sawa, Tomohiro] Kumamoto Univ, Grad Sch Med Sci, Dept Microbiol, Kumamoto 8608556, Japan	Kumagai, Y (reprint author), Univ Tsukuba, Grad Sch Comprehens Human Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	yk-em-tu@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [25220103]	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan no. 25220103 to Y.K.).	Dalle-Donne I, 2008, ANTIOXID REDOX SIGN, V10, P445, DOI 10.1089/ars.2007.1716; Blair IA, 2006, CURR DRUG METAB, V7, P853, DOI 10.2174/138920006779010601; Sawa T, 2007, NAT CHEM BIOL, V3, P727, DOI 10.1038/nchembio.2007.33; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Roos G, 2011, FREE RADICAL BIO MED, V51, P314, DOI 10.1016/j.freeradbiomed.2011.04.031; Hughes MN, 2009, FREE RADICAL BIO MED, V47, P1346, DOI 10.1016/j.freeradbiomed.2009.09.018; Kumagai Y, 2002, CHEM RES TOXICOL, V15, P483, DOI 10.1021/tx0100993; Mansuy D, 2011, ARCH BIOCHEM BIOPHYS, V507, P174, DOI 10.1016/j.abb.2010.09.015; Cho AK, 2004, AEROSOL SCI TECH, V38, P68, DOI 10.1080/02786820390229471; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Miura T, 2010, J TOXICOL SCI, V35, P843, DOI 10.2131/jts.35.843; Allen EMG, 2012, ANTIOXID REDOX SIGN, V17, P1748, DOI 10.1089/ars.2012.4644; Nishida M, 2012, NAT CHEM BIOL, V8, P714, DOI [10.1038/nchembio.1018, 10.1038/NCHEMBIO.1018]; Paul BD, 2012, NAT REV MOL CELL BIO, V13, P499, DOI 10.1038/nrm3391; Ono K, 2014, FREE RADICAL BIO MED, V77, P82, DOI 10.1016/j.freeradbiomed.2014.09.007; Kettenhofen NJ, 2010, CHEM RES TOXICOL, V23, P1633, DOI 10.1021/tx100237w; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Paulsen CE, 2013, CHEM REV, V113, P4633, DOI 10.1021/cr300163e; Truong TH, 2012, BIOCHEMISTRY-US, V51, P9954, DOI 10.1021/bi301441e; Iwamoto N, 2007, J BIOL CHEM, V282, P33396, DOI 10.1074/jbc.M705224200; Kumagai Y, 2012, ANNU REV PHARMACOL, V52, P221, DOI 10.1146/annurev-pharmtox-010611-134517; Miura T, 2011, CHEM RES TOXICOL, V24, P559, DOI 10.1021/tx100427p; Miura T, 2011, CHEM RES TOXICOL, V24, P1836, DOI 10.1021/tx200025y; Hu CQ, 2011, CHEM RES TOXICOL, V24, P515, DOI 10.1021/tx100389r; Koike S, 2013, FEBS LETT, V587, P3548, DOI 10.1016/j.febslet.2013.09.013; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Endo A, 2007, BIOCHEM BIOPH RES CO, V361, P243, DOI 10.1016/j.bbrc.2007.07.024; Ida T, 2014, P NATL ACAD SCI USA, V111, P7606, DOI 10.1073/pnas.1321232111; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; Rudolph TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.290re7; Sun Y, 2006, TOXICOL APPL PHARM, V214, P55, DOI 10.1016/j.taap.2006.01.005; Taguchi K, 2007, FREE RADICAL BIO MED, V43, P789, DOI 10.1016/j.freeradbiomed.2007.05.021; Takayama N., 2012, J TOXICOL SCI, V36, P817; Toyama T, 2014, CHEM-BIOL INTERACT, V214, P41, DOI 10.1016/j.cbi.2014.02.008; Vignaud C, 2004, J CHROMATOGR A, V1031, P125, DOI 10.1016/j.chroma.2003.10.136; Yoshida E, 2011, CHEM RES TOXICOL, V24, P1633, DOI 10.1021/tx200394g	38	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0893-228X	1520-5010		CHEM RES TOXICOL	Chem. Res. Toxicol.	MAY	2015	28	5					838	847		10.1021/tx500416y		10	Chemistry, Medicinal; Chemistry, Multidisciplinary; Toxicology	Pharmacology & Pharmacy; Chemistry; Toxicology	CI6XM	WOS:000354907500002		
J	Oki, M; Saka, H; Ando, M; Tsuboi, R; Nakahata, M; Oka, S; Kogure, Y; Kitagawa, C				Oki, Masahide; Saka, Hideo; Ando, Masahiko; Tsuboi, Rie; Nakahata, Masashi; Oka, Saori; Kogure, Yoshihito; Kitagawa, Chiyoe			Transbronchial vs Transesophageal Needle Aspiration Using an Ultrasound Bronchoscope for the Diagnosis of Mediastinal Lesions A Randomized Study	CHEST			English	Article							LINEAR ENDOBRONCHIAL ULTRASOUND; CELL LUNG-CANCER; ENDOSCOPIC ULTRASOUND; LYMPH-NODES; SARCOIDOSIS; ENDOSONOGRAPHY; SATISFACTION; METAANALYSIS; TRIAL	BACKGROUND: The purpose of this study was to compare the tolerance, efficacy, and safety of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) with transesophageal endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) with an endobronchial ultrasound scope for the first pathologic diagnosis of lesions accessible by both procedures. METHODS: Patients who had lesions accessible by both EBUS-TBNA and EUS-FNA were enrolled and were randomized to undergo either procedure. Patients quantified tolerance, and operators charted the quality of examination using a 100-mm visual analog scale (VAS). RESULTS: A specific diagnosis was made in 50 of 55 patients (91%) in the EBUS-TBNA group and in 48 of 55 patients (87%) in the EUS-FNA group (P = .76). Compared with EBUS-TBNA, EUS-FNA was associated with a shorter duration of procedure (median, 15.3 min vs 11.3 min; P < .001), lower doses of IV midazolam (mean, 4.4 mg vs 4 mg; P = .02) and intraairway lidocaine (mean, 303 mg vs 189 mg; P < .001), less frequent oxygen desaturations (23 of 55 vs two of 55, P < .001), and higher operator satisfaction (P < .001). There was no significant difference in patient tolerance according to the patients' VAS. Lymph node infection occurred in one patient in the EBUS-TBNA group and in two patients in the EUS-FNA group. CONCLUSIONS: Both EBUS-TBNA and EUS-FNA provide high accuracy with good tolerance, although the occurrence of infectious complications should be monitored carefully. EUS-FNA has the advantage of comparable tolerance with fewer doses of anesthetics and sedatives, a shorter procedure time, and fewer oxygen desaturations during the procedure.	[Oki, Masahide; Saka, Hideo; Tsuboi, Rie; Nakahata, Masashi; Oka, Saori; Kogure, Yoshihito; Kitagawa, Chiyoe] Nagoya Med Ctr, Dept Resp Med, Nagoya, Aichi 4600001, Japan; [Ando, Masahiko] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan	Oki, M (reprint author), Nagoya Med Ctr, Dept Resp Med, Naka Ku, 4-1-1 Sannomaru, Nagoya, Aichi 4600001, Japan.	masahideo@aol.com					Annema JT, 2010, CHEST, V138, P765, DOI 10.1378/chest.10-0955; Navani N, 2012, AM J RESP CRIT CARE, V185, P1316, DOI 10.1164/rccm.201202-0294OC; Tanner NT, 2013, CHEST, V143, P423, DOI 10.1378/chest.12-0212; Annema JT, 2005, EUR RESPIR J, V25, P405, DOI 10.1183/09031936.05.00098404; Kang HJ, 2014, THORAX, V69, P261, DOI 10.1136/thoraxjnl-2013-203881; Wahidi MM, 2014, CHEST, V145, P574, DOI 10.1378/chest.13-0701; Micames CG, 2007, CHEST, V131, P539, DOI 10.1378/chest.06-1437; Oki M, 2012, J THORAC CARDIOV SUR, V143, P1324, DOI 10.1016/j.jtcvs.2012.01.040; Kennedy CC, 2013, CHEST, V144, P183, DOI 10.1378/chest.12-1786; Varela-Lema L, 2009, EUR RESPIR J, V33, P1156, DOI 10.1183/09031936.00097908; Davoudi M, 2012, AM J RESP CRIT CARE, V186, P773, DOI 10.1164/rccm.201111-1968OC; Oki M, 2013, RESPIRATION, V85, P137, DOI 10.1159/000345207; von Bartheld MB, 2013, JAMA-J AM MED ASSOC, V309, P2457, DOI 10.1001/jama.2013.5823; Hwangbo B, 2010, CHEST, V138, P795, DOI 10.1378/chest.09-2100; Herth FJF, 2010, CHEST, V138, P790, DOI 10.1378/chest.09-2149; Singh P, 2007, AM J RESP CRIT CARE, V175, P345, DOI 10.1164/rccm.200606-851OC; Asano F, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-50; Lamb CR, 2010, CHEST, V137, P195, DOI 10.1378/chest.09-0494; Lechtzin N, 2002, AM J RESP CRIT CARE, V166, P1326, DOI 10.1164/rccm.200203-231OC; Mehta AC, 2002, AM J RESP CRIT CARE, V166, P1306, DOI 10.1164/rccm.200208-895IE; Oguri Tomoyo, 2012, Respir Investig, V50, P162, DOI 10.1016/j.resinv.2012.08.006; Oki M, 2014, CARDIOVASC SURG, V148, P1169; Oki M, 2013, RESPIRATION, V85, P486, DOI 10.1159/000346987; Silvestri GA, 2013, CHEST S, V143, p211S; Tanaka S, 2006, J JPN SOC BRONCHOL, V28, P417; Wang KP, 2011, CHEST, V140, P271, DOI 10.1378/chest.11-0171	26	5	5	AMER COLL CHEST PHYSICIANS	GLENVIEW	2595 PATRIOT BLVD, GLENVIEW, IL 60026 USA	0012-3692			CHEST	Chest	MAY	2015	147	5					1259	1266		10.1378/chest.14-1283		8	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	CI2VW	WOS:000354606600030		
J	Hara, M; Hayashi, K; Hikoso, S; Sakata, Y; Kitamura, T				Hara, Masahiko; Hayashi, Kenichi; Hikoso, Shungo; Sakata, Yasushi; Kitamura, Tetsuhisa			Different Impacts of Time From Collapse to First Cardiopulmonary Resuscitation on Outcomes After Witnessed Out-of-Hospital Cardiac Arrest in Adults	CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES			English	Article						cardiopulmonary resuscitation; out-of-hospital cardiac arrest; ventricular fibrillation	AMERICAN-HEART-ASSOCIATION; EMERGENCY CARDIOVASCULAR CARE; STROKE-FOUNDATION; TASK-FORCE; SURVIVAL; PROFESSIONALS; GUIDELINES; STATEMENT; COMMITTEE; COUNCIL	Background-It is well known that cardiopulmonary resuscitation (CPR) should be attempted as early as possible after out-of-hospital cardiac arrest (OHCA). However, it is unclear about the impact of time to CPR on OHCA outcome by first documented rhythm (pulseless ventricular tachycardia/ventricular fibrillation [pVT/VF], pulseless electric activity [PEA], and asystole). Methods and Results-We enrolled 257 354 adult witnessed OHCA patients between 2007 and 2012 from a prospective nationwide population-based cohort database in Japan. We evaluated relationships between time from collapse to first CPR and neurologically favorable 1-month survival defined as Glasgow-Pittsburg cerebral performance category 1 or 2 by first documented rhythm after witnessed OHCA. We used logistic model for the estimation of prognosis. The number of OHCA patients with pVT/VF, PEA, and asystole were 38 661, 96 906, and 121 787, respectively. The overall neurologically favorable 1-month survival rates were 21.3% in patients with pVT/VF, 2.7% PEA, and 0.6% asystole. The proportion of asystole increased as the time from collapse to CPR delayed, whereas those of pVT/VF and PEA decreased (trend P< 0.001). Estimated incidences of end-point after OHCA became lower as first CPR delayed irrespective of type of first documented rhythm, but were different by the rhythm. The average percentage point decreases in neurologically favorable 1-month survival probability for each incremental minute of CPR delay were 8.3%, 4.4%, and 6.4% for patients with pVT/VF, PEA, and asystole, respectively. Conclusions-The OHCA outcome differed by time to first CPR and first documented rhythm. Shortening of time to first CPR is crucial for improving the OHCA outcome.	[Hara, Masahiko; Hikoso, Shungo; Sakata, Yasushi] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; [Hayashi, Kenichi] Osaka Univ, Grad Sch Med, Dept Publ Hlth, Suita, Osaka 5650871, Japan; [Hikoso, Shungo] Osaka Univ, Grad Sch Med, Dept Med Therapeut Heart Failure, Suita, Osaka 5650871, Japan; [Kitamura, Tetsuhisa] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Div Environm Med & Populat Sci, Suita, Osaka 5650871, Japan	Hara, M (reprint author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	masahikohara@cardiology.med.osaka-u.ac.jp; lucky_unatan@yahoo.co.jp					Wissenberg M, 2013, JAMA-J AM MED ASSOC, V310, P1377, DOI 10.1001/jama.2013.278483; Kamarainen A, 2008, RESUSCITATION, V76, P360, DOI 10.1016/j.resuscitation.2007.08.015; CUMMINS RO, 1991, CIRCULATION, V84, P960; Semeraro F, 2011, RESUSCITATION, V82, P436, DOI 10.1016/j.resuscitation.2010.11.023; Field JM, 2010, CIRCULATION, V122, pS640, DOI 10.1161/CIRCULATIONAHA.110.970889; Kitamura T, 2012, CIRCULATION, V126, P2834, DOI 10.1161/CIRCULATIONAHA.112.109496; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Stiell IG, 2004, NEW ENGL J MED, V351, P647, DOI 10.1056/NEJMoa040325; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Sasson C, 2013, CIRCULATION, V127, P1342, DOI 10.1161/CIR.0b013e318288b4dd; Kitamura T, 2010, NEW ENGL J MED, V362, P994, DOI 10.1056/NEJMoa0906644; Iwami T, 2009, CIRCULATION, V119, P728, DOI 10.1161/CIRCULATIONAHA.108.802058; Rea TD, 2003, CIRCULATION, V107, P2780, DOI 10.1161/01.CIR.0000070950.17208.2A; Hernandez-Orallo J, 2012, J MACH LEARN RES, V13, P2813; Skrifvars MB, 2010, RESUSCITATION, V81, P679, DOI 10.1016/j.resuscitation.2010.01.033; Sayre MR, 2008, CIRCULATION, V117, P2162, DOI 10.1161/CIRCULATIONAHA.107.189380; BECKER LB, 1993, NEW ENGL J MED, V329, P600, DOI 10.1056/NEJM199308263290902; Chan PS, 2014, CIRCULATION, V130, P1876, DOI 10.1161/CIRCULATIONAHA.114.009711; Engdahl J, 2000, AM J CARDIOL, V86, P610, DOI 10.1016/S0002-9149(00)01037-7; Japan Resuscitation Council CPR Guidelines Committee, 2011, 2010 JAP GUID EM CAR, V1st; Koike S, 2011, CRIT CARE, V15, DOI 10.1186/cc10219; Rickard J, 2011, HEART RHYTHM, V8, P1895, DOI 10.1016/j.hrthm.2011.07.030; Tilmann G, 2007, J AM STAT ASSOC, V102, P359	23	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1941-7705	1941-7713		CIRC-CARDIOVASC QUAL	Circ.-Cardiovasc. Qual. Outcomes	MAY	2015	8	3					277	284		10.1161/CIRCOUTCOMES.115.001864		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CI4SO	WOS:000354743900009		
J	Kihara, N; Niida, Y; Takabatake, D; Kaida, H; Shibayama, A; Miyagawa, Y				Kihara, Naoto; Niida, Yasuo; Takabatake, Daisuke; Kaida, Hideki; Shibayama, Atsushi; Miyagawa, Yoshinori			Large-scale experiments on tsunami-induced pressure on a vertical tide wall	COASTAL ENGINEERING			English	Article						Tsunami; Large-scale experiment; Hydrodynamic pressure; Impact pressure	DAM-BREAK; HYDRAULIC RESISTANCE; WATER IMPACT; PART 1; FORCES; SURGES; WEDGE; BORES	Large-scale experiments on the pressure exerted on a tide wall due to the impact, reflection, and overflow of tsunami inundation flow were carried out to investigate the characteristics of the pressure and the flow in front of the tide wall in the bore impact, initial reflection, and quasi-steady-state phases. The Central Research Institute of Electric Power Industry (CRIEPI)'s Large-scale Tsunami Physical Simulator, in which large and long tsunami inundation flows can be reproduced, was used in the experiments. In the impact phase, two types of short-duration pressures with durations in the ranges of 10(-3) to 10(-2)s and 10(-1) to 1 s were observed. The latter pressure can be partially predicted by Cumberbatch's theory (1960). For cases of tsunami bore with high impact speeds, the theory obviously overestimates the impact force. For cases of tsunami bore with low impact speeds, the forces predicted by the theory agreed reasonably well only with the forces measured just after the bore impact. By contrast, the forces predicted by the modified solution of the theory agreed well with the measured forces for these cases. In the initial reflection phase, pressure greater than the hydrostatic pressure at the depth of the incident bore was exerted at heights above the depth of the bore. The most likely cause of this is the collapse of the water column. In the quasi-steady-state phase, the pressures were almost equal to the hydrostatic pressure upstream of the wall. The pressure and the flow reached the quasi-steady state within a few seconds after the bore impacted the wall. (C) 2015 Elsevier B.V. All rights reserved.	[Kihara, Naoto; Takabatake, Daisuke; Kaida, Hideki; Shibayama, Atsushi; Miyagawa, Yoshinori] Cent Res Inst Elect Power Ind, Civil Engn Res Lab, Abiko, Chiba 2701194, Japan; [Niida, Yasuo] Cent Res Inst Elect Power Ind, Environm Sci Res Lab, Abiko, Chiba 2701194, Japan	Kihara, N (reprint author), Cent Res Inst Elect Power Ind, Civil Engn Res Lab, 1646 Abiko, Abiko, Chiba 2701194, Japan.	kihara@criepi.denken.or.jp; niida@criepi.denken.or.jp; tdaisuke@criepi.denken.or.jp; h-kaida@criepi.denken.or.jp; atushi@criepi.denken.or.jp; miyagawa@criepi.denken.or.jp					Amason H., 2005, THESIS U WASHINGTON; Amason H., 2009, J DISASTER RES, V4, P391; Lugni C, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2399077; Chanson H, 2006, COAST ENG J, V48, P355, DOI 10.1142/S0578563406001477; Palermo D, 2009, CAN J CIVIL ENG, V36, P1804, DOI 10.1139/L09-104; Bredmose H, 2009, J FLUID MECH, V641, P389, DOI 10.1017/S0022112009991571; Bullock GN, 2007, COAST ENG, V54, P602, DOI 10.1016/j.coastaleng.2006.12.002; Hogg AJ, 2004, J FLUID MECH, V501, P179, DOI 10.1017/S0022112003007468; Mei XM, 1999, APPL OCEAN RES, V21, P1; Scolan YM, 2001, J FLUID MECH, V440, P293; Nouri Y, 2010, COAST ENG J, V52, P43, DOI 10.1142/S0578563410002117; YEH HH, 1989, J FLUID MECH, V206, P563, DOI 10.1017/S0022112089002417; Mori N, 2012, COAST ENG J, V54, DOI 10.1142/S0578563412500015; Oliver JM, 2007, J FLUID MECH, V572, P59, DOI 10.1017/S002211200600276X; Arikawa T., 2005, ANN J COAST ENG JSCE, V52, P746; Arikawa T., 2006, ANN J COAST ENG JSCE, V53, P796; Asakura R., 2000, P COASTAL ENG JSCE, V47, P911; Asakura R., 2002, P INT COST ENG C ICC, V28, P1191; Celata GP, 2006, EXP THERM FLUID SCI, V31, P37, DOI 10.1016/j.expthermflusci.2005.08.006; Chanson H., 1996, AIR BUBBLE ENTRAINME; Chanson H, 2009, J HYDRAUL RES, V47, P41, DOI 10.3826/jhr.2009.2865; Cross R. H, 1967, J WATERWAYS HARBORS, V93, P201; CUMBERBATCH E, 1960, J FLUID MECH, V7, P353, DOI 10.1017/S002211206000013X; DRESSLER RF, 1952, J RES NAT BUR STAND, V49, P217, DOI 10.6028/jres.049.021; Federal Emergency Management Agency (FEMA), 2000, FEMA PUBL; Fukui Y., 1963, COASTAL ENG JAPAN, V6, P67; Kihara N., 2012, N12010 CRIEPI; Lukkunaprasit P., 2009, J DISASTER RES, V1, P410; Nakamura S., 1973, B DISASTER PREVENTIO, V23, P47; Nandasena NAK, 2012, COAST ENG, V67, P1, DOI 10.1016/j.coastaleng.2012.03.009; Ota K., 2013, J JSCE B2, V69, P1471; Palermo D., 2013, INT J TSUNAMI SOC, V32, P58; RAMSDEN JD, 1990, J WATERW PORT C-ASCE, V116, P592, DOI 10.1061/(ASCE)0733-950X(1990)116:5(592); Ramsden JD, 1996, J WATERW PORT C-ASCE, V122, P134, DOI 10.1061/(ASCE)0733-950X(1996)122:3(134); Ramsden J.D., 1993, THESIS CALTECH; Ritter A., 1892, Z VEREINES DTSCH ING, V36, P947; SVENDSEN IA, 1984, J FLUID MECH, V148, P73, DOI 10.1017/S0022112084002251; Takabatake D., 2013, J JSCE B2, V69, P851; Takabatake D., 2014, P COAST ENG C ICCE20; von Karman T, 1929, 321 NACA TN; Wagner H., 1932, NACA TRANSLATION; WHITHAM GB, 1955, PROC R SOC LON SER-A, V227, P399, DOI 10.1098/rspa.1955.0019; Yeh H, 2006, J WATERW PORT C-ASCE, V132, P496, DOI 10.1061/(ASCE)0733-950X(2006)132:6(496); Yettou EM, 2006, FLUID DYN RES, V38, P47, DOI 10.1016/j.fluiddyn.2005.09.003	44	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-3839	1872-7379		COAST ENG	Coast. Eng.	MAY	2015	99						46	63		10.1016/j.coastaleng.2015.02.009		18	Engineering, Civil; Engineering, Ocean	Engineering	CI8SZ	WOS:000355043300006		
J	Suzuki, T; Hosoya, T; Sasaki, J				Suzuki, Takayuki; Hosoya, Taku; Sasaki, Jun			Estimating wave height using the difference in percentile coastal sound level	COASTAL ENGINEERING			English	Article						Wave height estimation; Percentile sound level; Sound level	AMBIENT NOISE; SURF ZONE; BREAKING	This study investigated the correlation between sound level and wave height using field experiments conducted from July 14, 2009, to November 2, 2009, at the Hasaki coast in lbaraki, Japan. We modeled wave height using the observed data from the first half of the study period to calibrate our model, and validated it using wave height from the latter half of the study period. Based on our results, we propose a model for estimating wave height using sound level and differences in sound level. The model predicted wave height with good accuracy (R = 0.87), and accurately described wave heights during the validation time period (R = 0.87). By comparing field data and each of the parameters utilized, it is clear that percentile sound level is a more accurate parameter for estimating wave height. (C) 2015 Elsevier B.V. All rights reserved.	[Suzuki, Takayuki] Yokohama Natl Univ, Fac Urban Innovat, Yokohama, Kanagawa 2408501, Japan; [Hosoya, Taku] Sugumogu LLC, Setagaya Ku, Tokyo 1570064, Japan; [Sasaki, Jun] Univ Tokyo, Dept Sociocultural Environm Studies, Kashiwa, Chiba 2778563, Japan	Suzuki, T (reprint author), Yokohama Natl Univ, Fac Urban Innovat, Tokiwadai 79-5, Yokohama, Kanagawa 2408501, Japan.	suzuki-t@ynu.ac.jp; hosoya@sugumogu.com; jsasaki@k.u-tokyo.ac.jp		Suzuki, Takayuki/0000-0001-7989-2088	Kawai Foundation for Sound Technology and Music; Maeda Engineering Foundation; JSPS KAKENHI Grant [26709034]	The authors thank all the staff members at HORS for conducting the field surveys. They also thank the Coastal Sediments and Processes Research Group, Port and Airport Research Institute for allowing the use of the beach topography data, wave data, and wind data. This research was partially supported by Kawai Foundation for Sound Technology and Music, The Maeda Engineering Foundation, and JSPS KAKENHI Grant Number 26709034.	Deane GB, 1997, J ACOUST SOC AM, V102, P2671, DOI 10.1121/1.420321; Means SL, 2002, J ACOUST SOC AM, V112, P481, DOI 10.1121/1.1491256; Bass SJ, 2013, J COASTAL RES, P1721, DOI 10.2112/SI65-291.1; Bass SJ, 1997, IEEE J OCEANIC ENG, V22, P411, DOI 10.1109/48.611130; Grates M., 2006, GEOPHYS RES LETT, V33; Katoh K., 1990, REP PHRI, V29, P37; Kuriyama Y, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000899; Murakami H., 1996, P 25 INT C COAST ENG, P275; Nadaoka K., 1991, COAST ENG JPN, V34, P117; Nadaoka K., 1991, COAST ENG JPN, V34, P105; Wilson B.W., 1965, DEUT HYDROGR Z, V18, P114, DOI 10.1007/BF02333333	11	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-3839	1872-7379		COAST ENG	Coast. Eng.	MAY	2015	99						73	81		10.1016/j.coastaleng.2015.02.010		9	Engineering, Civil; Engineering, Ocean	Engineering	CI8SZ	WOS:000355043300008		
J	Chida, M; Hsieh, ML				Chida, Masataka; Hsieh, Ming-Lun			On the anticyclotomic Iwasawa main conjecture for modular forms	COMPOSITIO MATHEMATICA			English	Article						Iwasawa main conjecture; modular forms	ELLIPTIC-CURVES; REPRESENTATIONS	We generalize the work of Bertolini and Darmon on the anticyclotomic main conjecture for elliptic curves to modular forms of higher weight.	[Chida, Masataka] Kyoto Univ, Dept Math, Sakyo Ku, Kyoto 6068502, Japan; [Hsieh, Ming-Lun] Natl Taiwan Univ, Dept Math, Taipei 10617, Taiwan	Chida, M (reprint author), Kyoto Univ, Dept Math, Sakyo Ku, Oiwake Cho, Kyoto 6068502, Japan.	chida@math.kyoto-u.ac.jp; mlhsieh@math.ntu.edu.tw		HSIEH, MING-LUN/0000-0002-7329-5167	Hakubi project of Kyoto University; National Science Council [101-2115-M-002-010-MY2];  [23740015]	The first author is partly supported by Grant-in-Aid for Young Scientists (B) No. 23740015 and Hakubi project of Kyoto University. The second author is partially supported by National Science Council grant 101-2115-M-002-010-MY2.	DIAMOND F, 1994, INVENT MATH, V115, P435, DOI 10.1007/BF01231768; HIDA H, 1988, ANN MATH, V128, P295, DOI 10.2307/1971444; Nekovar J, 2012, CAN J MATH, V64, P588, DOI 10.4153/CJM-2011-077-6; Skinner C, 2014, INVENT MATH, V195, P1, DOI 10.1007/s00222-013-0448-1; RIBET KA, 1990, INVENT MATH, V100, P431, DOI 10.1007/BF01231195; BERTOLINI M, 1994, DUKE MATH J, V76, P75, DOI 10.1215/S0012-7094-94-07604-7; BLOCH S., 1990, GROTHENDIECK FESTSCH, VI, P333; Bosch S., 1990, ERGEBNISSE MATH IHRE, V21; Boutot J.-F., 1992, ASTERISQUE, V7, P45; Caerednik I. V., 1976, MAT SBORNIK, V100, P165; Caerednik I. V., 1976, PREPRINT, V100, P165; CARAYOL H, 1986, ANN SCI ECOLE NORM S, V19, P409; Chida M., 2012, ARXIV12042427; Chida M., 2013, PREPRINT; Bertolini M, 2005, ANN MATH, V162, P1; Drinfeld V. G., 1976, FUNCT ANAL APPL, V10, P29; Greenberg R, 1999, LECT NOTES MATH, V1716, P51; Ihara B., 1999, CONT MATH, V245, P15; Longo M, 2011, MANUSCRIPTA MATH, V135, P273, DOI 10.1007/s00229-010-0409-6; Nekovar J., 2006, ASTERISQUE, V310; Pollack R, 2011, COMPOS MATH, V147, P1353, DOI 10.1112/S0010437X11005318; Ribet KA, 1997, PAC J MATH, P277; Rubin K., 2000, ANN MATH STUDIES, V147; Vatsal V, 2003, DUKE MATH J, V116, P219, DOI 10.1215/S0012-7094-03-11622-1	24	1	1	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0010-437X	1570-5846		COMPOS MATH	Compos. Math.	MAY	2015	151	5					863	897		10.1112/S0010437X14007787		35	Mathematics	Mathematics	CI5JZ	WOS:000354793200003		
J	Voraphab, I; Hanboonsong, Y; Kobori, Y; Ikeda, H; Osawa, T				Voraphab, Itsarapong; Hanboonsong, Yupa; Kobori, Youichi; Ikeda, Hiroaki; Osawa, Takeshi			Insect species recorded in sugarcane fields of Khon Kaen Province, Thailand, over three seasons in 2012	ECOLOGICAL RESEARCH			English	Editorial Material						Agricultural ecosystem; Decomposer; Herbivore; Parasitoid; Pollinator; Predator		The diversity of insect species in cultivated fields provides a number of ecosystem benefits, including natural pest control and pollination. However, current knowledge of the insect fauna in agricultural landscapes is extremely limited when compared with information available for other ecosystems, such as forests and rivers. Here, we present data on insect diversity, including functional feeding group diversity, in sugarcane fields of Khon Kaen Province, Thailand. Sugarcane is a major Thai crop. We collected insects using light trap systems located in 16 sugarcane field plots. Each light trap was deployed in an individual 0.16 ha plot. Trapping was conducted over three seasons, including both dry and rainy periods, in March, June, and October of 2012. On each trapping day, we collected insects in the evening from 18:00 to 19:30. The traps yielded a total of 98,423 individuals including 143 species belonging to 26 families. We classified collections into five functional feeding groups: herbivores, predators, decomposers, parasitoids, and pollinators. The dominant functional species were herbivores, followed in rank order by predators; most individuals in the traps were predatory species. We assembled an insect fauna data set that will be useful in the study of southeast Asian agricultural ecosystems and provided the data in the Darwin Core Archive format.	[Voraphab, Itsarapong; Hanboonsong, Yupa] Khon Kaen Univ, Div Entomol, Fac Agr, Khon Kaen 40002, Thailand; [Kobori, Youichi] Japan Int Res Ctr Agr Sci, Ishigaki, Japan; [Ikeda, Hiroaki; Osawa, Takeshi] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 305, Japan; [Osawa, Takeshi] Japan Node Global Biodivers Informat Facil, Tsukuba, Ibaraki, Japan	Osawa, T (reprint author), Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 305, Japan.	arosawa@gmail.com						0	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0912-3814	1440-1703		ECOL RES	Ecol. Res.	MAY	2015	30	3					415	415		10.1007/s11284-015-1252-8		1	Ecology	Environmental Sciences & Ecology	CI5RW	WOS:000354817700001		
J	Murakami, Y; Sugawara, H; Takahashi, H; Hayashi, F				Murakami, Yuki; Sugawara, Hirotaka; Takahashi, Hiroo; Hayashi, Fumio			Population genetic structure and distribution patterns of sexual and asexual gecko species in the Ogasawara Islands	ECOLOGICAL RESEARCH			English	Article						Genetic diversity; Island biogeography; Microsatellite DNA; Parthenogenesis; Reproductive cost	LEPIDODACTYLUS-LUGUBRIS; MICROSATELLITE MARKERS; HEMIDACTYLUS; SOFTWARE; ECOLOGY; LIZARDS; WINDOWS; LINUX	Asexual reproduction lacks genetic diversity but is predicted to be advantageous for dispersal and for increasing abundance relative to sexual reproduction. The oceanic Ogasawara Islands are inhabited by two gecko species, the asexual (parthenogenetic) all-female Lepidodactylus lugubris and the sexually reproductive Hemidactylus frenatus. This situation offers a unique opportunity to examine the relationships among sexuality and the abundance, distribution, and genetic diversity of the two species. A total of 445 geckos were collected across nine islands, and the population genetic structure of both species was estimated using microsatellite markers. Lepidodactylus lugubris was collected on all nine islands and consisted of two widely distributed clones: one diploid and the other triploid. In contrast, H. frenatus was limited to four islands and exhibited variation in population genetic structure among islands, with some bottleneck effects. Successful dispersal may be more frequent in L. lugubris than in H. frenatus; therefore, the asexual reproductive strategy of L. lugubris appears to have contributed to its dispersal success and increased abundance among the small oceanic islands. However, the absence of H. frenatus on islands not inhabited by humans may be partially explained by their different microhabitat preferences, as H. frenatus collection sites were relatively more confined to artificial substrates in towns and along roadways compared to L. lugubris. Moreover, the colonization histories of these two geckos have not yet been assessed; therefore, further study is needed to confirm the effects of sexuality on the population dynamics of these species.	[Murakami, Yuki; Sugawara, Hirotaka; Hayashi, Fumio] Tokyo Metropolitan Univ, Dept Biol, Hachioji, Tokyo 1920397, Japan; [Takahashi, Hiroo] Japan Wildlife Res Ctr, Sumida Ku, Tokyo 1308606, Japan	Murakami, Y (reprint author), Tokyo Metropolitan Univ, Dept Biol, Minamiosawa 1-1, Hachioji, Tokyo 1920397, Japan.	murakami-yuhki@ed.tmu.ac.jp; fhayashi@tmu.ac.jp					OTA H, 1994, ECOL RES, V9, P121, DOI 10.1007/BF02347487; Simon JC, 2003, BIOL J LINN SOC, V79, P151, DOI 10.1046/j.1095-8312.2003.00175.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Pritchard JK, 2000, GENETICS, V155, P945; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Goudet J, 1995, J HERED, V86, P485; Li JJ, 2007, MOL ECOL NOTES, V7, P674, DOI 10.1111/j.1471-8286.2006.01674.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Neaves WB, 2011, TRENDS GENET, V27, P81, DOI 10.1016/j.tig.2010.12.002; BOLGER DT, 1994, OECOLOGIA, V100, P397, DOI 10.1007/BF00317861; COLE CJ, 1984, SCI AM, V250, P94; HANLEY KA, 1994, EVOL ECOL, V8, P438, DOI 10.1007/BF01238194; Hayashi F, 2009, ZOOL SCI, V26, P543, DOI 10.2108/zsj.26.543; Horikoshi Kazuo, 2008, Ogasawara Research, V33, P129; Ineich I., 1992, B COLL SCI U RYUKYUS, V53, P31; Ineich I, 1999, TROPICAL ISLAND HERP, P199; Maynard Smith J., 1978, EVOLUTION SEX; MORITZ C, 1993, BIOL J LINN SOC, V48, P113, DOI 10.1111/j.1095-8312.1993.tb00882.x; Newbery Brock, 2007, P59; Okada Y, 1930, B BIOGEOGR SOC JAPAN, V1, P187; Owusu KA, 2012, CONSERV GENET RESOUR, V4, P563, DOI 10.1007/s12686-011-9592-3; RADTKEY RR, 1995, P ROY SOC B-BIOL SCI, V259, P145, DOI 10.1098/rspb.1995.0022; Short KH, 2008, ANIM BEHAV, V76, P429, DOI 10.1016/j.anbehav.2008.04.008; Takada E, 2011, KEYS ILLUSTRATED MAN; WEIR B.S., 1984, EVOLUTION, V38, P1350; Wilmhoff CD, 2003, MOL ECOL NOTES, V3, P400, DOI 10.1046/j.1471-8286.2003.00459.x; Yamashiro S, 2000, ZOOL SCI, V17, P1013, DOI 10.2108/zsj.17.1013; Yamashiro Saiko, 2005, Current Herpetology, V24, P95, DOI 10.3105/1345-5834(2005)24[95:OTCTOL]2.0.CO;2	31	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0912-3814	1440-1703		ECOL RES	Ecol. Res.	MAY	2015	30	3					471	478		10.1007/s11284-015-1246-6		8	Ecology	Environmental Sciences & Ecology	CI5RW	WOS:000354817700007		
J	Kimura, MT; Novkovic, B				Kimura, Masahito T.; Novkovic, Biljana			Local adaptation and ecological fitting in host use of the Drosophila parasitoid Leptopilina japonica	ECOLOGICAL RESEARCH			English	Article						Allopatric; Host acceptance; Host suitability; Sympatric; Taxonomic effect	DIPTERA DROSOPHILIDAE; CENTRAL JAPAN; FRUGIVOROUS DROSOPHILIDS; SUBTROPICAL ISLAND; IRIOMOTE-JIMA; ASSOCIATIONS; HYMENOPTERA; FLIES; DIVERSITY; ABUNDANCE	Local adaptation and ecological fitting are the major processes by which organisms colonize and persist in novel environments and form novel associations with unfamiliar species. In this study, we assessed the role of these two processes in the formation of associations between the parasitoid Leptopilina japonica and various host Drosophila species using laboratory populations from three different localities. Each L. japonica population was highly virulent to some Drosophila species from its original locality, meaning they used these Drosophila species as major hosts. However, major host species at a given locality were usually less successfully parasitized by parasitoid populations from different localities. These results indicate that the investigated parasitoid populations showed local adaptation in host use. We also observed cases in which unfamiliar Drosophila species were successfully parasitized or allopatric Drosophila populations were more successfully parasitized. These findings suggest that L. japonica can form novel associations with some Drosophila species in novel environments without undergoing adaptive changes, a phenomenon called ecological fitting. In this study, L. japonica also usually appeared to have oviposited well in D. melanogaster species group members irrespective of their suitability as hosts. This result suggests that the parasitoid makes oviposition decisions based on characteristics common to the drosophilids in this species group.	[Kimura, Masahito T.; Novkovic, Biljana] Hokkaido Univ, Grad Sch Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan	Kimura, MT (reprint author), Hokkaido Univ, Grad Sch Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan.	mtk@ees.hokudai.ac.jp			Ministry of Education, Science, Sports, Culture and Technology of Japan [23370005]	We thank H. Mitsui, M. J. Toda, M. Kondo, M. B. Lakim, S.-C. Tsaur and N. Kasuya for providing us with laboratory populations of parasitoid and Drosophila species and for their help with collections. This study was partly supported by a Grant-in-Aid from the Ministry of Education, Science, Sports, Culture and Technology of Japan (No. 23370005).	Kasuya N, 2013, APPL ENTOMOL ZOOL, V48, P87, DOI 10.1007/s13355-012-0156-0; KUROKAWA H, 1967, JPN J GENET, V42, P109, DOI 10.1266/jjg.42.109; Kimura MT, 2014, ENVIRON ENTOMOL, V43, P123, DOI 10.1603/EN13141; Mitsui H, 2010, EUR J ENTOMOL, V107, P535; Lapchin L, 2002, AM NAT, V160, P245, DOI 10.1086/341020; Kraaijeveld AR, 2001, EVOL ECOL RES, V3, P107; Kimura MT, 2012, J NAT HIST, V46, P1947, DOI 10.1080/00222933.2012.707239; Kimura MT, 2004, OECOLOGIA, V140, P442, DOI 10.1007/s00442-004-1605-4; Novkovic B, 2012, EUR J ENTOMOL, V109, P517; Agosta SJ, 2006, OIKOS, V114, P556, DOI 10.1111/j.2006.0030-1299.15025.x; Mitsui H, 2010, ENTOMOL SCI, V13, P60, DOI 10.1111/j.1479-8298.2010.00372.x; Novkovic B, 2011, ENTOMOL SCI, V14, P333, DOI 10.1111/j.1479-8298.2011.00459.x; Mitsui H, 2007, J NAT HIST, V41, P1731, DOI 10.1080/00222930701504797; JANZEN DH, 1985, OIKOS, V45, P308, DOI 10.2307/3565565; Kasuya N, 2013, ENTOMOL SCI, V16, P227, DOI 10.1111/j.1479-8298.2012.00544.x; Agosta SJ, 2008, ECOL LETT, V11, P1123, DOI 10.1111/j.1461-0248.2008.01237.x; VET LEM, 1985, OIKOS, V44, P487, DOI 10.2307/3565790; Dubuffet A, 2006, PHYSIOL ENTOMOL, V31, P170, DOI 10.1111/j.1365-3032.2006.00505.x; Beppu Katsura, 2000, Memoirs of the National Science Museum (Tokyo), V36, P409; Cameron PJ, 2006, BIOL CONTROL, V39, P375, DOI 10.1016/j.biocontrol.2006.06.008; Development Core Team R., 2012, R LANG ENV STAT COMP; Futuyma DJ, 2013, EVOLUTION; Gilbert P, 2010, EVOL ECOL RES, V12, P873; Harvey JA, 2012, J EVOLUTION BIOL, V25, P2139, DOI 10.1111/j.1420-9101.2012.02596.x; Hawkins B.A., 1994, PATTERN PROCESS HOST; Hirai Yoshiyuki, 2000, Entomological Science, V3, P273; Kaufman LV, 2010, ENVIRON ENTOMOL, V39, P430, DOI 10.1603/EN09083; KIMURA M T, 1987, Kontyu, V55, P429; KIMURA M T, 1977, Kontyu, V45, P571; Kondo M, 2008, ENTOMOL SCI, V11, P7, DOI 10.1111/j.1479-8298.2007.00250.x; Sasaki A, 1999, P ROY SOC B-BIOL SCI, V266, P455; Schulter D, 2000, ECOLOGY ADAPTIVE RAD; Sheehan William, 1994, P90; Thompson J, 2005, GEOGRAPHIC MOSAIC CO; Wilkinson DM, 2004, J BIOGEOGR, V31, P1, DOI 10.1111/j.1365-2699.2004.01216.x	35	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0912-3814	1440-1703		ECOL RES	Ecol. Res.	MAY	2015	30	3					499	505		10.1007/s11284-015-1244-8		7	Ecology	Environmental Sciences & Ecology	CI5RW	WOS:000354817700010		
J	Bao, GS; Suetsugu, K; Wang, HS; Yao, X; Liu, L; Ou, J; Li, CJ				Bao, Gensheng; Suetsugu, Kenji; Wang, Hongsheng; Yao, Xiang; Liu, Li; Ou, Jing; Li, Chunjie			Effects of the hemiparasitic plant Pedicularis kansuensis on plant community structure in a degraded grassland	ECOLOGICAL RESEARCH			English	Article						Host selectivity; Haustoria; Host range; Community structure; Orobanchaceae	RHINANTHUS-MINOR L; PARASITIC PLANTS; FUNCTIONAL-ROLE; NATURAL COMMUNITIES; ROOT HEMIPARASITES; HOST SELECTIVITY; L. OROBANCHACEAE; FOOD-WEB; SCROPHULARIACEAE; ECOSYSTEM	Species-rich grasslands have high conservation value because they support diverse floral and faunal assemblages. Alpine grassland is an important and characteristic ecosystem of the Qinghai-Tibet Plateau, but ca. 30 % has been severely degraded by the combined effects of climate change, human activity, overgrazing and rodent damage. One potential method to restore grassland diversity involves using hemiparasitic plants to modify the competitive relationships among neighboring species. A possible candidate is Pedicularis kansuensis, a hemiparasitic plant found in grasslands throughout the Qinghai-Tibet Plateau, but more information on its host associations and its effects on surrounding vegetation is required to assess its suitability. Thus, we examined host associations of P. kansuensis by direct root excavation at a selected site on the Qinghai-Tibet Plateau and found that haustoria formation is non-randomly distributed among host species, with preferential bias for members of Poaceae, Rosaceae and Fabaceae. We also found that aboveground biomass of grasses and legumes was higher in quadrats from which the parasite had been removed than in intact controls, while the biomass of sedges and forbs was unaffected by parasite removal. However, removal significantly decreased plant species richness and Shannon-Wiener diversity. These results suggest that P. kansuensis modifies the competitive balance in grassland communities of the Qinghai-Tibet Plateau, allowing for colonization by subordinate species and thereby enhancing species diversity and contributing to restoration of these degraded grasslands.	[Bao, Gensheng; Yao, Xiang; Liu, Li; Li, Chunjie] Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730020, Peoples R China; [Bao, Gensheng; Wang, Hongsheng] Qinghai Acad Anim Sci & Vet Med, Grassland Inst, Xining 810003, Qinghai, Peoples R China; [Suetsugu, Kenji] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan; [Ou, Jing] Qinghai Univ, Dept Biol, Xining 810016, Qinghai, Peoples R China	Li, CJ (reprint author), Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, POB 61, Lanzhou 730020, Peoples R China.	baogsh12@lzu.edu.cn; chunjie@lzu.edu.cn			National Key Basic Research Program (973) of China [2014CB138702]; Natural Science Foundation of China [31372366]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13019]; Special Fund for Agro-Scientific Research in the Public Interest [201203041]	We wish to thank Dr. Jakub Tesitel and an anonymous reviewer for their constructive comments on an earlier version of the manuscript. Prof. Steve W. Adkins, Chunping Zhang and Chunhui Zhang helped revise the manuscript, Minglong Yuan and Hui Song gave inspiring advice on the manuscript, and Mr. Huiqiang Li assisted with sampling. The research was financially supported by the National Key Basic Research Program (973) of China (2014CB138702), the Natural Science Foundation of China (31372366), the Program for Changjiang Scholars and Innovative Research Team in University (IRT13019) and the Special Fund for Agro-Scientific Research in the Public Interest (201203041).	Westbury DB, 2004, J ECOL, V92, P906, DOI 10.1111/j.0022-0477.2004.00929.x; Ree RH, 2005, INT J PLANT SCI, V166, P595, DOI 10.1086/430191; Yu WB, 2011, J SYST EVOL, V49, P425, DOI 10.1111/j.1759-6831.2011.00154.x; Spasojevic MJ, 2011, OECOLOGIA, V165, P193, DOI 10.1007/s00442-010-1726-x; Fisher JP, 2013, NEW PHYTOL, V198, P222, DOI 10.1111/nph.12144; Suetsugu K, 2008, ANN BOT-LONDON, V102, P49, DOI 10.1093/aob/mcn065; Press MC, 2005, NEW PHYTOL, V166, P737, DOI 10.1111/j.1469-8137.2005.01358.x; Lafferty KD, 2006, P NATL ACAD SCI USA, V103, P11211, DOI 10.1073/pnas.0604755103; Borowicz VA, 2012, OECOLOGIA, V169, P783, DOI 10.1007/s00442-011-2222-7; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; Pywell RF, 2004, J APPL ECOL, V41, P880, DOI 10.1111/j.0021-8901.2004.00940.x; Yang YH, 2010, GLOBAL ECOL BIOGEOGR, V19, P268, DOI 10.1111/j.1466-8238.2009.00502.x; Hellstrom K, 2011, BASIC APPL ECOL, V12, P235, DOI 10.1016/j.baae.2011.02.010; Decleer K, 2013, J NAT CONSERV, V21, P65, DOI 10.1016/j.jnc.2012.10.004; CHUANG TI, 1971, AM J BOT, V58, P218, DOI 10.2307/2441157; GIBSON CC, 1992, OECOLOGIA, V89, P62, DOI 10.1007/BF00319016; GIBSON CC, 1991, OECOLOGIA, V86, P81, DOI 10.1007/BF00317393; Bullock JM, 2005, FOLIA GEOBOT, V40, P273, DOI 10.1007/BF02803240; Sato T, 2011, ECOLOGY, V92, P201, DOI 10.1890/09-1565.1; Quested HM, 2003, OECOLOGIA, V135, P606, DOI 10.1007/s00442-003-1225-4; Quested HM, 2003, ECOLOGY, V84, P3209, DOI 10.1890/02-0426; Marvier MA, 1998, ECOLOGY, V79, P2616, DOI 10.1890/0012-9658(1998)079[2616:PIOHCP]2.0.CO;2; Ameloot E, 2005, FOLIA GEOBOT, V40, P289, DOI 10.1007/BF02803241; Bardgett RD, 2006, NATURE, V439, P969, DOI 10.1038/nature04197; Ren GH, 2013, ENVIRON EARTH SCI, V69, P235, DOI 10.1007/s12665-012-1951-1; Cameron DD, 2005, FOLIA GEOBOT, V40, P217, DOI 10.1007/BF02803236; Yang MX, 2004, COLD REG SCI TECHNOL, V39, P47, DOI 10.1016/j.coldregions.2004.01.002; Pennings SC, 1996, ECOLOGY, V77, P1410, DOI 10.2307/2265538; Sato T, 2012, ECOL LETT, V15, P786, DOI 10.1111/j.1461-0248.2012.01798.x; Watling JR, 2001, PLANT BIOLOGY, V3, P244, DOI 10.1055/s-2001-15195; Davies DM, 1997, BIOL CONSERV, V82, P87, DOI 10.1016/S0006-3207(97)00010-4; Ren YQ, 2010, FOLIA GEOBOT, V45, P443, DOI 10.1007/s12224-010-9081-6; Cameron DD, 2007, NEW PHYTOL, V174, P412, DOI 10.1111/j.1469-8137.2007.02013.x; Cameron DD, 2006, ANN BOT-LONDON, V98, P1289, DOI 10.1093/aob/mcl218; GAUSLAA Y, 1990, HOLARCTIC ECOL, V13, P112; GIBSON CC, 1989, OECOLOGIA, V78, P401, DOI 10.1007/BF00379116; Graves J. D., 1995, PARASITIC PLANTS; Hedberg AM, 2005, J TORREY BOT SOC, V132, P401, DOI 10.3159/1095-5674(2005)132[401:IBAHPP]2.0.CO;2; Huang Xin-ya, 2011, Shengtaixue Zazhi, V30, P1838; Irving LJ, 2009, ADV BOT RES, V50, P87, DOI 10.1016/S0065-2296(08)00803-3; Jiang F, 2008, J EXP BOT, V59, P917, DOI 10.1093/jxb/ern015; Kuijt J., 1969, BIOL PARASITIC FLOWE; Li X, 2011, LAND DEGRAD DEV, V24, P72, DOI DOI 10.1002/LDR.1108; MALCOLM WM, 1966, ECOLOGY, V47, P179, DOI 10.2307/1933763; Marvier MA, 1997, CONSERV BIOL, V11, P839, DOI 10.1046/j.1523-1739.1997.96223.x; Mill R. R., 2001, Edinburgh Journal of Botany, V58, P57; Musselman L. J., 1995, P1; MUSSELMAN LJ, 1977, PLANT SYST EVOL, V127, P45, DOI 10.1007/BF00988018; Pate J. S., 1995, P80; PIEHL MA, 1963, AM J BOT, V50, P978, DOI 10.2307/2439904; Press MC, 1998, OIKOS, V82, P609, DOI 10.2307/3546383; Qiu Z, 2006, GRASSLAND TURF, V5, P26; Reed J, 2012, PURS J UNDERGRAD RES, V3, P8; Rumer S, 2007, FLORA, V202, P194, DOI 10.1016/j.flora.2006.07.002; Shang Z. H., 2007, FRONTIERS AGR CHINA, V1, P197, DOI [10.1007/s11703-007-0034-7, DOI 10.1007/S11703-007-0034-7]; Song Z, 2006, CHINESE J AGR RESOUR, V27, P21; Suetsugu K, 2012, BOT J LINN SOC, V170, P69, DOI 10.1111/j.1095-8339.2012.01263.x; Tesitel J, 2011, NEW PHYTOL, V192, P188, DOI 10.1111/j.1469-8137.2011.03777.x; Tesitel J, 2013, OECOLOGIA, V172, P933, DOI 10.1007/s00442-012-2566-7; Van Hoveln MD, 2011, BOTANY, V89, P537, DOI [10.1139/B11-045, 10.1139/b11-045]; Wang G, 2001, J DESERT RES, V21, P101; Wang H, 2003, PLANT SYST EVOL, V237, P1, DOI 10.1007/s00606-002-0188-y; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Yang H, 1998, FLORA CHINA SCROPHUL, P156; Zhe C, 2010, ECOL ENV SCI, V19, P2800; Zhou Huakun, 2005, Grassland Science, V51, P191, DOI 10.1111/j.1744-697X.2005.00028.x; [周华坤 Zhou Huakun], 2003, [生态学杂志, Chinese Journal of Ecology], V22, P51	67	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0912-3814	1440-1703		ECOL RES	Ecol. Res.	MAY	2015	30	3					507	515		10.1007/s11284-015-1248-4		9	Ecology	Environmental Sciences & Ecology	CI5RW	WOS:000354817700011		
J	Fujita, N; Koda, R				Fujita, Noboru; Koda, Ryosuke			Capitulum and rosette leaf avoidance from grazing by large herbivores in Taraxacum	ECOLOGICAL RESEARCH			English	Article						Scape; Livestock; Pasture; Rural habitat; Urban habitat	SEED DISPERSAL; MEDITERRANEAN GRASSLAND; PLANT TOLERANCE; LAND-USE; HEIGHT; POLLINATION; WIND; DISTANCE; COLOR; COMMUNITIES	Plants defense against herbivore damage is achieved through resistance and tolerance, of which resistance is composed of avoidance and antibiosis. Plants have developed various adaptations that facilitate escape from herbivory. We hypothesized that post-anthesis prostrate scapes in Taraxacum is an adaptation for avoidance of capitulum grazing by large herbivores. To test this hypothesis, we divided flowering into the following four stages based on the external appearance of the capitulum: green bud, yellow corolla, brown corolla, and white pappus stages. We conducted an experiment in natural pasture in Mongolia to artificially raise capitula and rosette leaves of T. collinum. We measured the natural height of capitula and rosette leaves of the Mongolian pasture and urban species, T. collinum and T. ceratophorum, respectively, and of the Japanese rural and exotic urban species, T. japonicum and T. officinale, respectively. We investigated natural grazing by livestock in the field of the capitula and rosette leaves of the two Mongolian species. In Mongolia, naturally short capitula at the green bud and brown corolla stages and rosette leaves of T. collinum were not grazed. However, artificially raised capitula and rosette leaves of T. collinum and the naturally high capitula and leaves of T. ceratophorum were grazed. Short capitulum and leaf height was shown to be effective for avoidance of livestock grazing in Mongolia. In Japan, T. japonicum and T. officinale showed similar scape behavior to T. collinum and T. ceratophorum, respectively. We discuss the reasons for the capitulum behavior differences in Japan.	[Fujita, Noboru; Koda, Ryosuke] Natl Inst Humanities, Res Inst Humanity & Nat, Kita Ku, Kyoto 6038047, Japan	Fujita, N (reprint author), Ctr Restorat Reg Nat, Kita Ku, 28-5 Koyama Horiike Cho, Kyoto 6038145, Japan.	fujitanb@ae.auone-net.jp			research project "Collapse and Restoration of Ecosystem Networks with Human Activity" of the Research Institute for Humanity and Nature; 21st Century Center of Excellence program of the Center for Ecological Research, Kyoto University; JSPS KAKENHI [26850106]	We are grateful to Dr. R. Tsujino and Dr. T. Seyama for their helpful suggestions and comments. This study was financially supported in part by the research project "Collapse and Restoration of Ecosystem Networks with Human Activity" of the Research Institute for Humanity and Nature, by the 21st Century Center of Excellence program of the Center for Ecological Research, Kyoto University, and by JSPS KAKENHI Grant Number 26850106.	Agren J, 2006, OECOLOGIA, V150, P225, DOI 10.1007/s00442-006-0509-x; NOYMEIR I, 1989, J ECOL, V77, P290, DOI 10.2307/2260930; DIAZ S, 1992, J VEG SCI, V3, P689, DOI 10.2307/3235837; Tiffin P, 2000, AM NAT, V155, P128, DOI 10.1086/303301; Soons MB, 2004, ECOLOGY, V85, P3056, DOI 10.1890/03-0522; Milchunas DG, 2002, OIKOS, V99, P113, DOI 10.1034/j.1600-0706.2002.990112.x; SHELDON JC, 1973, NEW PHYTOL, V72, P665, DOI 10.1111/j.1469-8137.1973.tb04415.x; Nathan R, 2002, NATURE, V418, P409, DOI 10.1038/nature00844; HATTORI M, 1992, PHYTOCHEMISTRY, V31, P4001, DOI 10.1016/S0031-9422(00)97572-1; Fornoni J, 2011, FUNCT ECOL, V25, P399, DOI 10.1111/j.1365-2435.2010.01805.x; Evju M, 2009, OECOLOGIA, V161, P77, DOI 10.1007/s00442-009-1358-1; Agrawal AA, 2011, FUNCT ECOL, V25, P420, DOI 10.1111/j.1365-2435.2010.01796.x; Thomson FJ, 2011, J ECOL, V99, P1299, DOI 10.1111/j.1365-2745.2011.01867.x; Uematsu Y, 2010, AGR ECOSYST ENVIRON, V135, P304, DOI 10.1016/j.agee.2009.10.010; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Nunez-Farfan J, 2007, ANNU REV ECOL EVOL S, V38, P541, DOI 10.1146/annurev.ecolsys.38.091206.095822; THINES G, 1977, BRIT VET J, V133, P97; Cingolani AM, 2005, J APPL ECOL, V42, P50, DOI 10.1111/j.1365-2664.2004.00978.x; Dickson CR, 2006, PLANT SYST EVOL, V262, P65, DOI 10.1007/s00606-006-0472-3; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; REES SB, 1985, PHYTOCHEMISTRY, V24, P2225; HAINSWORTH FR, 1984, OECOLOGIA, V63, P405; OKUBO A, 1989, ECOLOGY, V70, P329, DOI 10.2307/1937537; LAUNCHBAUGH KL, 1993, OIKOS, V66, P501, DOI 10.2307/3544945; Diaz S, 2001, J APPL ECOL, V38, P497, DOI 10.1046/j.1365-2664.2001.00635.x; TOTLAND O, 1993, CAN J BOT, V71, P1072; Bakker J.P., 1983, VEGETATIO, V55, P153, DOI DOI 10.1007/BF00045017; Briske D.D., 1991, GRAZING MANAGEMENT E, P85; Carlassare M, 2003, AGRON J, V95, P844; CLIFFORD PE, 1991, AM BIOL TEACH, V53, P290; DABROWSKA B, 1981, BEHAV PROCESS, V6, P1, DOI 10.1016/0376-6357(81)90011-5; Donnelly SE, 1998, AM J BOT, V85, P1618, DOI 10.2307/2446490; Fernandez-Gimenez ME, 1999, GEOGR REV, V89, P315, DOI 10.2307/216154; Fujita N, 2013, MONGOLIAN ECOSYSTEM, P131; GILBERT BJ, 1986, J DAIRY SCI, V69, P825; Hirayama K, 1972, THE DANDELION; HUNTER RF, 1962, J ECOL, V50, P651, DOI 10.2307/2257476; Kono M, 2009, JAPANESE HIST HUMAN, V2, P96; Lavoral S, 1999, J VEG SCI, V10, P661, DOI 10.2307/3237081; MCKITRICK MC, 1993, ANNU REV ECOL SYST, V24, P307; MCNAUGHTON SJ, 1984, AM NAT, V124, P863, DOI 10.1086/284321; MITCHLEY J, 1988, J ECOL, V76, P341, DOI 10.2307/2260597; Morita T, 1995, FLORA JAPAN B, V3b, P7; MORITA T, 1990, Plant Species Biology, V5, P167, DOI 10.1111/j.1442-1984.1990.tb00201.x; OGAWA K, 1991, ECOL RES, V6, P233, DOI 10.1007/BF02347125; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; R Development Core Team, 2012, R LANG ENV STAT COMP; REGEHR DL, 1976, ECOLOGY, V57, P1297, DOI 10.2307/1935054; RICHARDS AJ, 1970, NEW PHYTOL, V69, P761, DOI 10.1111/j.1469-8137.1970.tb02461.x; SALA OE, 1986, VEGETATIO, V67, P27; Shibaike H, 2002, J PLANT RES, V115, P321, DOI 10.1007/s10265-002-0045-7; Takakura K, 2009, BIOL INVASIONS, V11, P973, DOI 10.1007/s10530-008-9309-z; vanDorp D, 1996, CAN J BOT, V74, P1956; Watanabe Mikio, 1997, Journal of Japanese Botany, V72, P51; Zotz G, 2000, PLANT BIOLOGY, V2, P653, DOI 10.1055/s-2000-16639	55	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0912-3814	1440-1703		ECOL RES	Ecol. Res.	MAY	2015	30	3					517	525		10.1007/s11284-015-1249-3		9	Ecology	Environmental Sciences & Ecology	CI5RW	WOS:000354817700012		
J	Chikaraishi, Y; Steffan, SA; Takano, Y; Ohkouchi, N				Chikaraishi, Yoshito; Steffan, Shawn A.; Takano, Yoshinori; Ohkouchi, Naohiko			Diet quality influences isotopic discrimination among amino acids in an aquatic vertebrate	ECOLOGY AND EVOLUTION			English	Article						Amino acids; diet quality; food web; nitrogen isotopic composition; trophic discrimination factor	TROPHIC POSITION; FOOD WEBS; NITROGEN; FRACTIONATION; DELTA-N-15; ENRICHMENT; PLANKTON; ECOLOGY	Stable nitrogen isotopic composition of amino acids (N-15(AA)) has recently been employed as a powerful tool in ecological food web studies, particularly for estimating the trophic position (TP) of animal species in food webs. However, the validity of these estimates depends on the consistency of the trophic discrimination factor (TDF; = N-15(AA) at each shift of trophic level) among a suite of amino acids within the tissues of consumer species. In this study, we determined the TDF values of amino acids in tadpoles (the Japanese toad, Bufo japonicus) reared exclusively on one of three diets that differed in nutritional quality. The diets were commercial fish-food pellets (plant and animal biomass), bloodworms (animal biomass), and boiled white rice (plant carbohydrate), representing a balanced, protein-rich, and protein-poor diet, respectively. The TDF values of two source amino acids (Src-AAs), methionine and phenylalanine, were close to zero (0.3-0.5 parts per thousand) among the three diets, typifying the values reported in the literature (similar to 0.5 parts per thousand and similar to 0.4 parts per thousand, respectively). However, TDF values of trophic amino acids (Tr-AAs) including alanine, valine, leucine, isoleucine, and glutamic acid varied by diet: for example, the glutamic acid TDF was similar to the standard value (similar to 8.0 parts per thousand) when tadpoles were fed either the commercial pellets (8.0 parts per thousand) or bloodworms (7.9 parts per thousand), but when they were fed boiled rice, the TDF was significantly reduced (0.6 parts per thousand). These results suggest that a profound lack of dietary protein may alter the TDF values of glutamic acid (and other Tr-AAs and glycine) within consumer species, but not the two Src-AAs (i.e., methionine and phenylalanine). Knowledge of how a nutritionally poor diet can influence the TDF of Tr- and Src-AAs will allow amino acid isotopic analyses to better estimate TP among free-roaming animals.	[Chikaraishi, Yoshito; Takano, Yoshinori; Ohkouchi, Naohiko] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan; [Steffan, Shawn A.] Univ Wisconsin, Dept Entomol, Vegetable Crops Res Unit, USDA,ARS, Madison, WI 53706 USA	Chikaraishi, Y (reprint author), Japan Agcy Marine Earth Sci & Technol, 2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan.	ychikaraishi@jamstec.go.jp			JSPS; USDA-ARS	This work was supported by Grant-in-Aid for Scientific Research of the JSPS to YC, YT, and NO, and USDA-ARS appropriated funds to SAS.	McClelland JW, 2002, ECOLOGY, V83, P2173, DOI 10.1890/0012-9658(2002)083[2173:TRATNI]2.0.CO;2; Maeda T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042024; Robbins CT, 2005, OECOLOGIA, V144, P534, DOI 10.1007/s00442-005-0021-8; Hoen DK, 2014, J EXP MAR BIOL ECOL, V453, P76, DOI 10.1016/j.jembe.2014.01.006; Chikaraishi Y, 2007, MAR ECOL PROG SER, V342, P85, DOI 10.3354/meps342085; Kochevenko A, 2012, MOL PLANT, V5, P366, DOI 10.1093/mp/ssr108; McCarthy MD, 2007, GEOCHIM COSMOCHIM AC, V71, P4727, DOI 10.1016/j.gca.2007.06.061; Ogawa NO, 2013, ECOL RES, V28, P697, DOI 10.1007/s11284-012-0967-z; Popp BN, 2007, TERR ECOL SER, V1, P173; Dale JJ, 2011, MAR ECOL PROG SER, V433, P221, DOI 10.3354/meps09171; Lorrain A, 2009, MAR ECOL PROG SER, V391, P293, DOI 10.3354/meps08215; Germain LR, 2013, MAR ECOL PROG SER, V482, P265, DOI 10.3354/meps10257; Ohkouchi N, 2013, MAR BIOL, V160, P773, DOI 10.1007/s00227-012-2132-1; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; Hannides CCS, 2009, LIMNOL OCEANOGR, V54, P50, DOI 10.4319/lo.2009.54.1.0050; Chikaraishi Y, 2014, ECOL EVOL, V4, P2423, DOI 10.1002/ece3.1103; Vander Zanden HB, 2013, MAR ECOL PROG SER, V476, P237, DOI 10.3354/meps10185; Miller MJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0826; Decima M, 2013, LIMNOL OCEANOGR, V58, P624, DOI 10.4319/lo.2013.58.2.0624; Sherwood OA, 2011, P NATL ACAD SCI USA, V108, P1011, DOI 10.1073/pnas.1004904108; Bender D. A., 2002, INTRO NUTR METABOLIS; Bradley CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085818; Chikaraishi Y, 2011, ECOL RES, V26, P835, DOI 10.1007/s11284-011-0844-1; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740; Chikaraishi Y, 2010, EARTH LIFE ISOTOPES, P37; Hutson S. M., 2005, J NUTR, V135, P15575; Mahmud T, 2005, CHEMBIOCHEM, V6, P322, DOI 10.1002/cbic.2004.00261; Miura K., 2012, RES ORGANIC GEOCHEMI, V28, P13; Ohkouchi N., 2015, PROG EARTH PLANET SC, V2, DOI [10.1186/s40645-015-0032-y, DOI 10.1186/S40645-015-0032-Y]; Ruiz-Cooley RI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059651; Sato R, 2014, BUNSEKI KAGAKU, V63, P399; Seminoff JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037403; Steffan SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076152; Tsahar E, 2008, J EXP BIOL, V211, P459, DOI 10.1242/jeb.013219	34	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7758			ECOL EVOL	Ecol. Evol.	MAY	2015	5	10					2048	2059		10.1002/ece3.1491		12	Ecology	Environmental Sciences & Ecology	CI5QC	WOS:000354812500010		
J	Kadowaki, K; Inouye, BD				Kadowaki, Kohmei; Inouye, Brian D.			Habitat configuration affects spatial pattern of beta diversity of insect communities breeding in oyster mushrooms	ECOSPHERE			English	Article						aggregation; fungivore; habitat arrangement; Pleurotus ostreatus; predator-mediated coexistence; spatial autocorrelation; spatial heterogeneity	MYCOPHAGOUS FLY COMMUNITIES; SPECIES-DIVERSITY; COEXISTENCE; COMPETITION; AGGREGATION; RESOURCE; DROSOPHILA; DISPERSAL; PREDATION; DYNAMICS	Theory predicts that spatial structure can mediate interactions that affect species diversity in a patchy environment. A rarely considered effect of spatial structure on biodiversity is the interplay of spatial habitat arrangement with species interactions at multiple spatial scales. We investigated how spatial habitat arrangement and predation mediate the assembly of the larval communities of fungivorous insects breeding in the oyster mushroom, Pleurotus ostreatus (Jacq. ex Fr.) P.Kumm in a North American woodland. In a two-way factorial design, we varied the spatial arrangement of mushroom clumps ('clustered', 'patchy', and 'uniform'; 3 levels) crossed with predator exclusion (access allowed or not; 2 levels) to study their joint effects on patterns of alpha, beta and gamma diversity of the fungivorous insect communities. Partitioning diversity into these three components suggested that neither spatial nor predation treatments significantly affected alpha, beta and gamma diversity. We found that an intermediate inter-clump distance (i.e., the 'patchy' treatment) increased spatial autocorrelation in insect community composition within experimental blocks, particularly in the mushrooms to which predators had access. The spatial structuring in b diversity indicates that the arrangement of mushroom clumps can structure beta diversity of fungivorous larval communities through direct effects on the species themselves (e.g., increased aggregation and habitat choice of ovipositing females of fungivorous insects), as well as effects mediated through the presence and behavior of predators (e.g., spatially structured selective foraging by predators acting as a filter on which species were in the clumps). The naturally patchy nature of mushroom fruiting may transform the spatial pattern of beta diversity by altering the behavior of ovipositing females, or by weakening the negative effect of larval competition.	[Kadowaki, Kohmei] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto 6068501, Japan; [Kadowaki, Kohmei; Inouye, Brian D.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	Kadowaki, K (reprint author), Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto 6068501, Japan.	kinokomushi@gmail.com			NSF [DEB-0816838]; JSPS	Comments on the manuscript were provided by T. E. Miller, J. M. Gaillard, and two anonymous reviewers. We thank B. Grenat for providing mushrooms, T. McDevitt-Galles and B. Spiesman for helping with fieldwork, P. E. Skelly and G. J. Steck for examining specimens. Taxonomic assistance was provided by B. V. Brown, K. T. Eldredge, Z. H. Falin, W. L. Grogan Jr., W. E. Hall, D. Houle, F. C. James, P. H. Kerr, S. A. Marshall, G. J. Steck, K. van der Linde, and J. R. Wiley. This work was supported by NSF grant DEB-0816838 to B. D. Inouye. During the final preparation of the manuscript, K. Kadowaki was funded by a JSPS postdoctoral fellowship (PD).	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Kneitel JM, 2003, AM NAT, V162, P165, DOI 10.1086/376585; ATKINSON WD, 1984, AM NAT, V124, P336, DOI 10.1086/284277; JAENIKE J, 1991, J ANIM ECOL, V60, P913, DOI 10.2307/5421; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1111/j.1442-9993.2001.01070.pp.x; Chesson P, 2008, NATURE, V456, P235, DOI 10.1038/nature07248; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2; Cadotte MW, 2006, AM NAT, V167, P913, DOI 10.1086/504850; HUFFAKER C. B., 1958, HILGARDIA, V27, P343; Kauserud H, 2008, P NATL ACAD SCI USA, V105, P3811, DOI 10.1073/pnas.0709037105; Mouquet N, 2003, AM NAT, V162, P544, DOI 10.1086/378857; Wertheim B, 2000, J ANIM ECOL, V69, P335, DOI 10.1046/j.1365-2656.2000.00396.x; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Hart SP, 2009, ECOLOGY, V90, P1485, DOI 10.1890/08-1813.1; Shurin JB, 2001, AM NAT, V158, P624, DOI 10.1086/323589; SHMIDA A, 1984, VEGETATIO, V58, P29; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Cline AR, 2005, SOUTHEAST NAT, V4, P409, DOI 10.1656/1528-7092(2005)004[0409:CAWTOM]2.0.CO;2; Fader JE, 2013, ECOLOGY, V94, P478, DOI 10.1890/12-0123.1; Heard SB, 1998, OIKOS, V81, P187, DOI 10.2307/3546480; Heard SB, 1997, AM NAT, V150, P744, DOI 10.1086/286092; Holt RD, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P68; Holyoak M, 1996, ECOLOGY, V77, P1867, DOI 10.2307/2265790; Inouye BD, 2005, OECOLOGIA, V145, P188, DOI 10.1007/s00442-005-0059-7; Kadowaki K, 2011, OIKOS, V120, P776, DOI 10.1111/j.1600-0706.2011.19302.x; Kadowaki K, 2010, EUR J ENTOMOL, V107, P89; Kadowaki K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042651; KAREIVA P, 1987, NATURE, V326, P388, DOI 10.1038/326388a0; LEWIS GP, 1992, OIKOS, V64, P553, DOI 10.2307/3545175; Oksanen J., 2013, VEGAN COMMUNITY ECOL; R Core Team, 2013, R LANG ENV STAT COMP; Sarkar D, 2008, USE R, P1; SHORROCKS B, 1979, J ANIM ECOL, V48, P899, DOI 10.2307/4202; Spiesman B. J., 2012, THESIS FLORIDA STATE; Srivastava DS, 2006, OECOLOGIA, V149, P493, DOI 10.1007/s00442-006-0467-3; Takahashi KH, 2006, J ANIM ECOL, V75, P266, DOI 10.1111/j.1365-2656.2006.01043.x; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; WORTHEN WB, 1994, OIKOS, V69, P277, DOI 10.2307/3546148; WORTHEN WB, 1989, OIKOS, V54, P145, DOI 10.2307/3565260; WORTHEN WB, 1990, AM MIDL NAT, V124, P12, DOI 10.2307/2426075; WORTHEN WB, 1989, ECOL ENTOMOL, V14, P117, DOI 10.1111/j.1365-2311.1989.tb00761.x; Worthen WB, 1996, OECOLOGIA, V107, P257, DOI 10.1007/BF00327910	42	0	0	ECOLOGICAL SOC AMER	WASHINGTON	1990 M STREET NW, STE 700, WASHINGTON, DC 20036 USA	2150-8925			ECOSPHERE	Ecosphere	MAY	2015	6	5							72	10.1890/ES14-00327.1		12	Ecology	Environmental Sciences & Ecology	CI5FA	WOS:000354777800001		
J	Kyotani, T				Kyotani, Takashi			Carbon-Old and Simple but New and Complex Materials	ELECTROCHEMISTRY			English	Editorial Material									Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 980, Japan	Kyotani, T (reprint author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 980, Japan.							0	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	MAY	2015	83	5					318	318				1	Electrochemistry	Electrochemistry	CI5XK	WOS:000354832900002		
J	Ozaki, J; Imashiro, Y				Ozaki, Jun-ichi; Imashiro, Yasuo			Carbon Alloy Catalysts for Polymer Electrolyte Fuel Cells: Exploration of Materials and Understanding of Mechanisms	ELECTROCHEMISTRY			English	Article						Carbon Alloy Catalysts; Oxygen Reduction Reaction; Cathode Catalysts; Polymer Electrolyte Fuel Cells	OXYGEN REDUCTION ACTIVITY; ELECTROCATALYTIC ACTIVITY; NITROGEN; CARBONIZATION; FERROCENE; IRON; PHTHALOCYANINES; ENHANCEMENT; ALCOHOL); CATHODE	The launch of the fuel cell vehicle (FCV) in December 2014 has moved our society into the era of hydrogen energy. Expectations for, and demands on, this technology will first increase steadily and then explosively. Owing to the scarcity of available natural resources and considering costs, the development of cathodes using non-platinum catalysts is an important issue to be addressed for the stable and secure provision of FCVs. We have been developing carbon alloy catalysts, such as nanoshell-containing carbon and boron nitrogen (BN)-doped carbon catalysts, where catalytic activities originate from the carbon surface and not from surface metal complexes. First, we discuss the discovery of carbon materials exhibiting electrocatalytic activity followed by their application to ORR. Second, we provide experimental evidence for ORR activity originating from warped graphitic layers. Next, we describe useful methods to obtain highly active carbon alloy catalysts. Finally, we report a notable single cell performance of 0.65 W/cm(2) using air as the oxidant. (C) The Electrochemical Society of Japan, All rights reserved.	[Ozaki, Jun-ichi] Gunma Univ, Grad Sch Sci & Technol, Kiryu, Gunma 3768515, Japan; [Imashiro, Yasuo] Nissinbo Holdings Inc, R&D Ctr, Midori Ku, Chiba 2670056, Japan	Ozaki, J (reprint author), Gunma Univ, Grad Sch Sci & Technol, 1-5-1 Tenjin Cho, Kiryu, Gunma 3768515, Japan.	jozaki@gunma-u.ac.jp					Acosta M, 2006, J POWER SOURCES, V159, P1123, DOI 10.1016/j.jpowsour.2005.12.068; LADOUCEUR M, 1993, J ELECTROCHEM SOC, V140, P1974, DOI 10.1149/1.2220748; Jaouen F, 2011, ENERG ENVIRON SCI, V4, P114, DOI 10.1039/c0ee00011f; Gong KP, 2009, SCIENCE, V323, P760, DOI 10.1126/science.1168049; Ozaki J, 2007, CARBON, V45, P1847, DOI 10.1016/j.carbon.2007.04.031; Singh D, 2014, J CATAL, V317, P30, DOI 10.1016/j.jcat.2014.05.025; Lefevre M, 2005, J PHYS CHEM B, V109, P16718, DOI 10.1021/jp0529265; Lalande G, 1997, ELECTROCHIM ACTA, V42, P1379, DOI 10.1016/S0013-4686(96)00361-1; Ikeda T, 2010, J PHYS CHEM C, V114, P8933, DOI 10.1021/jp100045e; Ozaki J, 2010, ELECTROCHIM ACTA, V55, P1864, DOI 10.1016/j.electacta.2009.10.037; Ozaki J, 2006, CARBON, V44, P3358, DOI 10.1016/j.carbon.2006.08.022; OYA A, 1982, J MATER SCI, V17, P309, DOI 10.1007/BF00591464; Zhang P, 2014, ENERG ENVIRON SCI, V7, P442, DOI 10.1039/c3ee42799d; Tritsaris GA, 2011, ELECTROCHIM ACTA, V56, P9783, DOI 10.1016/j.electacta.2011.08.045; Charreteur F, 2008, ELECTROCHIM ACTA, V53, P2925, DOI 10.1016/j.electacta.2007.11.002; Kannari N, 2012, CARBON, V50, P2941, DOI 10.1016/j.carbon.2012.02.063; Jacob T, 2006, FUEL CELLS, V6, P159, DOI 10.1002/fuce.200500201; Bailey L. D., 1994, J MATER RES, V9, P3203; Bran M., 2002, ELECTROANAL CHEM, V535, P113; Chung HT, 2014, INT J HYDROGEN ENERG, V39, P15887, DOI 10.1016/j.ijhydene.2014.05.137; Cote R, 1998, J ELECTROCHEM SOC, V145, P2411; Fujimoto H., 1999, TANSO, V1999, P83; Kannari N., TANSO UNPUB; Kannari N., CARBON UNPUB; Kannari N., 2011, TANSO, V2011, P102; Kinoshita K., 1988, CARBON ELECTROCHEMIC; Kishimoto T., 2014, P 41 ANN M CARB SOC, V1B05; Ko R., 2014, APPL CATAL A-GEN, V477, P102; Kobayashi R, 2009, CHEM LETT, V38, P396, DOI 10.1246/cl.2009.396; Lalande G, 1997, CHEM MATER, V9, P784, DOI 10.1021/cm960479n; Maie T., 2014, TANSO, V2014, P159; Male T., UNPUB; Mate T., 2013, CARB 2013 RIO JAN BR, P398; Nariduka K., 2013, 40 ANN M CARB SOC JA, VIA09; Otani S., 1997, TANSO JIMON JITOU; Otani S., 1976, SUMI KAGAKU TO SONO; Ozaki J., 2013, CARB 2013 RIO JAN BR, P391; Ozaki J, 1998, CHEM LETT, P573, DOI 10.1246/cl.1998.573; Ozaki J, 1998, CHEM MATER, V10, P3386, DOI 10.1021/cm980081m; Ozaki J., 2007, TANSO, V2007, P153; Ozaki J, 1994, TANSO, V165, P268; Ozaki J, 1998, CARBON, V36, P131, DOI 10.1016/S0008-6223(97)00165-6; OZAKI J, 1995, J APPL PHYS, V77, P4459, DOI 10.1063/1.359475; Ozaki JI, 2006, CARBON, V44, P1324, DOI 10.1016/j.carbon.2005.12.026; Ozaki JI, 2006, J APPL ELECTROCHEM, V36, P239, DOI 10.1007/s10800-005-9054-2; Takigatni M., 2014, TANSO, V267; Tanabe Y, 2000, CARBON, V38, P329, DOI 10.1016/S0008-6223(99)00147-5	47	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	MAY	2015	83	5					319	325		10.5796/electrochemistry.83.319		7	Electrochemistry	Electrochemistry	CI5XK	WOS:000354832900003		
J	Asaka, K; Akabe, S; Matsuufia, H; Uchiyama, S				Asaka, Koichi; Akabe, Syuhei; Matsuufia, Hiroaki; Uchiyama, Shunichi			Nitrogen-Doped Glassy Carbon Electrodes Prepared by Stepwise Electrolysis for Hydrogen Peroxide Determination	ELECTROCHEMISTRY			English	Article						Nitrogen-Doped Glassy Carbon Electrode; Electrochemically Modification; Electrocatalytic Activity; Hydrogen Peroxide Determination	DIAMOND ELECTRODES; ELECTROCHEMISTRY; REDUCTION; OXIDASE; SENSOR; OXYGEN; ACID	An amperometric determination based on flow injection analysis (FIA) of hydrogen peroxide was first developed using nitrogen-doped glassy carbon electrodes prepared by stepwise electrolysis as the working electrode. A glassy carbon electrode was covalently modified by electrochemical oxidation/reduction procedures. The electrocatalytic activity for the electrode oxidation of hydrogen peroxide has successfully been applied to the FIA of hydrogen peroxide. The typical current vs. time curve was obtained by the repetitive measurement of 20 mu M hydrogen peroxide and when flow rate is 2.0 ml/min, the measurement of hydrogen peroxide was finished completely in a short time (10 sec.). (C) The Electrochemical Society of Japan, All rights reserved.	[Asaka, Koichi; Akabe, Syuhei; Matsuufia, Hiroaki; Uchiyama, Shunichi] Saitama Inst Technol, Grad Sch Engn, Dept Appl Chem, Fukaya, Saitama 3690293, Japan; [Matsuufia, Hiroaki] Saitama Inst Technol, Fac Engn, Dept Life Sci & Green Chem, Fukaya, Saitama 3690293, Japan	Matsuufia, H (reprint author), Saitama Inst Technol, Grad Sch Engn, Dept Appl Chem, 1690 Fusaiji, Fukaya, Saitama 3690293, Japan.	matsuura@sit.ac.jp					Niwa O, 1998, ANAL CHEM, V70, P1126, DOI 10.1021/ac970257o; McCreery RL, 2008, CHEM REV, V108, P2646, DOI 10.1021/cr068076m; Tang YF, 2009, J AM CHEM SOC, V131, P13200, DOI 10.1021/ja904595t; Wang Y, 2010, ACS NANO, V4, P1790, DOI 10.1021/nn100315s; Yano T, 1998, J ELECTROCHEM SOC, V145, P1870, DOI 10.1149/1.1838569; Xu JS, 1998, ANAL CHEM, V70, P3146, DOI 10.1021/ac9800661; Kanazawa A, 2014, LANGMUIR, V30, P5297, DOI 10.1021/la4044667; MURRAY RW, 1984, ELECTROANAL CHEM, V13, P191; Goran JM, 2011, ANAL CHEM, V83, P8123, DOI 10.1021/ac2016272; JENKINS GM, 1971, NATURE, V231, P175, DOI 10.1038/231175a0; LUNDBACK H, 1983, ANAL CHIM ACTA, V155, P47, DOI 10.1016/S0003-2670(00)85578-6; Matsuura H, 2013, J ENVIRON SCI-CHINA, V25, P1077, DOI 10.1016/S1001-0742(12)60130-2; McCreery R.L., 1991, ELECTROANALYTICAL CH, V17, P221; Niwa O, 2005, B CHEM SOC JPN, V78, P555, DOI 10.1246/bcsj.78.555; HENDJI AN, 1993, SENSOR ACTUAT B-CHEM, V15, P127; Uchiyama S, 2007, J ELECTROCHEM SOC, V154, pF31, DOI 10.1149/1.2402127; Uchiyama S, 2013, ELECTROCHIM ACTA, V88, P251, DOI 10.1016/j.electacta.2012.10.090; Watanabe H, 2009, ELECTROCHIM ACTA, V54, P1362, DOI 10.1016/j.electacta.2008.09.020; Zhang S, 2001, BIOSENS BIOELECTRON, V16, P1119, DOI 10.1016/S0956-5663(01)00240-8	19	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	MAY	2015	83	5					326	328		10.5796/electrochemistry.83.326		3	Electrochemistry	Electrochemistry	CI5XK	WOS:000354832900004		
J	Shitanda, I; Nakafuji, H; Tsujimura, S; Hoshi, Y; Itagaki, M				Shitanda, Isao; Nakafuji, Hiroki; Tsujimura, Seiya; Hoshi, Yoshinao; Itagaki, Masayuki			Electrochemical Impedance Study of Screen-printed Branch Structure Porous Carbon Electrode using MgO-templated Carbon and MgO Particle and its Application for Bilirubin Oxidase-immobilized Biocathode	ELECTROCHEMISTRY			English	Article						Screen-printing; Electrochemical Impedance Spectroscopy; Porous Carbon; Biofuel Cell	FRUCTOSE/DIOXYGEN BIOFUEL CELL; REDUCTION; BIOELECTROCATALYSIS; IMPROVEMENT; STABILITY; DIOXYGEN; ENZYMES	A porous carbon electrode with a branch structure composed of macropores and mesopores was prepared using MgO-templated carbon and MgO particles by screen-printing. The electrode characteristics were investigated using electrochemical impedance spectroscopy. Loci of the straight line with angles at 22.5 degrees and 45 degrees were observed in the high- and mid-frequency ranges, respectively. A partial semicircle appeared in the low-frequency range. The impedance analysis revealed that almost the entire charge-transfer reaction occurred only at the mesopore interface of the electrode. The current density of the bilirubin oxidase (BOD)-immobilized branch structure carbon electrode was 1.3 times higher than that of the BUD-immobilized non-branch structure carbon electrode. (C) The Electrochemical Society of Japan, All rights reserved.	[Shitanda, Isao; Nakafuji, Hiroki; Hoshi, Yoshinao; Itagaki, Masayuki] Tokyo Univ Sci, Fac Sci & Technol, Dept Pure & Appl Chem, Noda, Chiba 2788510, Japan; [Shitanda, Isao; Hoshi, Yoshinao; Itagaki, Masayuki] Tokyo Univ Sci, Res Inst Sci & Technol, Noda, Chiba 2788510, Japan; [Tsujimura, Seiya] Univ Tsukuba, Fac Pure & Appl Sci, Div Mat Sci, Tsukuba, Ibaraki 3055358, Japan	Shitanda, I (reprint author), Tokyo Univ Sci, Fac Sci & Technol, Dept Pure & Appl Chem, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	shitanda@rs.noda.tus.ac.jp			JSPS KAKENHI [70434024]; Tokyo Ohka Foundation	This work was partially supported by JSPS KAKENHI 70434024 Grant (I. Shitanda) and the Tokyo Ohka Foundation (I. Shitanda and M. Itagaki).	Asano I, 2012, ELECTROCHEMISTRY, V80, P324, DOI 10.5796/electrochemistry.80.324; Vamvakaki V, 2007, BIOSENS BIOELECTRON, V22, P2650, DOI 10.1016/j.bios.2006.10.040; Kumar CV, 2000, J AM CHEM SOC, V122, P830, DOI 10.1021/ja993310u; Chen T, 2001, J AM CHEM SOC, V123, P8630, DOI 10.1021/ja0163164; Takahashi H, 2000, CHEM MATER, V12, P3301, DOI 10.1021/cm000487a; So K, 2014, PHYS CHEM CHEM PHYS, V16, P4823, DOI 10.1039/c3cp54888k; Mano N, 2003, J AM CHEM SOC, V125, P6588, DOI 10.1021/ja0346328; Zloczewska A, 2013, J POWER SOURCES, V228, P104, DOI 10.1016/j.jpowsour.2012.11.081; Shitanda I, 2013, CHEM LETT, V42, P1369, DOI 10.1246/cl.130681; Tsujimura S, 2001, J ELECTROANAL CHEM, V496, P69, DOI 10.1016/S0022-0728(00)00239-4; Lopez RJ, 2014, CHEMELECTROCHEM, V1, P241, DOI 10.1002/celc.201300085; Kamitaka Y, 2007, PHYS CHEM CHEM PHYS, V9, P1793, DOI 10.1039/b617650j; Katz E, 1999, J ELECTROANAL CHEM, V479, P64, DOI 10.1016/S0022-0728(99)00425-8; Tsujimura S, 2004, ELECTROCHEMISTRY, V72, P437; Itagaki M, 2010, ELECTROCHIM ACTA, V55, P6255, DOI 10.1016/j.electacta.2009.10.016; Morishita T., 2005, CARBON, V219, P226; Shitanda, 2013, CHEM COMMUN, V49, P11110; Shitanda I., UNPUB; Shitanda I, 2009, ELECTROCHIM ACTA, V54, P4933, DOI 10.1016/j.electacta.2009.04.005; Tsujimura S, 2010, ELECTROCHEM COMMUN, V12, P446, DOI 10.1016/j.elecom.2010.01.016; Zhou X., 2001, BIOCHEMISTRY-US, V40, P1289	21	2	2	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	MAY	2015	83	5					329	331		10.5796/electrochemistry.83.329		3	Electrochemistry	Electrochemistry	CI5XK	WOS:000354832900005		
J	Shiba, S; Inoue, J; Kato, D; Yoshioka, K; Niwa, O				Shiba, Shunsuke; Inoue, Junji; Kato, Dai; Yoshioka, Kyoko; Niwa, Osamu			Graphene Modified Electrode for the Direct Electron Transfer of Bilirubin Oxidase	ELECTROCHEMISTRY			English	Article						Graphene; Direct Electron Transfer; Bilirubin Oxidase; Nanocarbon	CARBON; SENSORS; ENZYME	We fabricated graphene modified glassy carbon (Gr/GC) electrodes to enhance the direct electron transfer (DET) of bilirubin oxidase (BOD) by casting graphene-dispersed solutions with different concentrations. With a concentration of 2 mu g mu L-1, a large increase was observed in the reduction current at the BOD-modified Gr/GC electrode, and the value was 74 times that of a BOD-modified GC electrode (unmodified with graphene). Moreover, with graphene modification the capacitance increase was much less than with other carbon materials including carbon black and graphite powder. These results demonstrate that a graphene nanostructure is suitable for achieving the efficient DET of BOD. (C) The Electrochemical Society of Japan, All rights reserved.	[Shiba, Shunsuke; Niwa, Osamu] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan; [Shiba, Shunsuke; Inoue, Junji; Kato, Dai; Yoshioka, Kyoko; Niwa, Osamu] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058566, Japan	Kato, D (reprint author), Natl Inst Adv Ind Sci & Technol, 1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	dai.kato@aist.go.jp; niwa.o@aist.go.jp					Zhai YP, 2011, ADV MATER, V23, P4828, DOI 10.1002/adma.201100984; Graf D, 2007, NANO LETT, V7, P238, DOI 10.1021/nl061702a; Zhang XH, 2014, BIOSENS BIOELECTRON, V52, P281, DOI 10.1016/j.bios.2013.07.022; Tang LH, 2009, ADV FUNCT MATER, V19, P2782, DOI 10.1002/adfm.200900377; Hallam PM, 2011, ELECTROCHEM COMMUN, V13, P8, DOI 10.1016/j.elecom.2010.10.030; Mano N, 2013, BIOSENS BIOELECTRON, V50, P478, DOI 10.1016/j.bios.2013.07.014; Goh MS, 2010, ELECTROCHEM COMMUN, V12, P1375, DOI 10.1016/j.elecom.2010.07.024; Katz E, 2004, CHEMPHYSCHEM, V5, P1085, DOI 10.1002/cphc.200400193; Kang XH, 2009, BIOSENS BIOELECTRON, V25, P901, DOI 10.1016/j.bios.2009.09.004; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Tsujimura S, 2004, ELECTROCHEMISTRY, V72, P437; Shao YY, 2010, ELECTROANAL, V22, P1027, DOI 10.1002/elan.200900571; Martins MVA, 2014, PHYS CHEM CHEM PHYS, V16, P17426, DOI 10.1039/c4cp00452c; SOUKUP L, 1992, MAT SCI ENG B-SOLID, V11, P355, DOI 10.1016/0921-5107(92)90240-A; Tsujimura S, 2010, ELECTROCHEM COMMUN, V12, P446, DOI 10.1016/j.elecom.2010.01.016; Ueda A, 2011, J AM CHEM SOC, V133, P4840, DOI 10.1021/ja108614d; Xue Q, 2013, ANAL SCI, V29, P611; Yoshioka K, 2013, ANAL CHEM, V85, P9996, DOI 10.1021/ac402661w	18	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	MAY	2015	83	5					332	334		10.5796/electrochemistry.83.332		3	Electrochemistry	Electrochemistry	CI5XK	WOS:000354832900006		
J	Shitanda, I; Tswimura, S; Yanai, H; Hoshi, Y; Itagaki, M				Shitanda, Isao; Tswimura, Seiya; Yanai, Hiroki; Hoshi, Yoshinao; Itagaki, Masayuki			Electrochemical Impedance Simulation of Branch Structure Porous Carbon Electrode Using Transmission Line Model	ELECTROCHEMISTRY			English	Article						Branch Structure Electrode; Mesopore; Macropore; Electrochemical Impedance Spectroscopy Simulation	DOUBLE-LAYER CAPACITOR; ORGANIC AEROGELS; INTERFACE	Impedance simulation was performed for analysis of a branch structure porous carbon electrode composed of macropores and mesopores. Theoretical equations were derived by introducing a new branch structure transmission line model, in which the charge-transfer reactions in the pores are considered. The loci of the straight line with angles at 22.5 degrees and semicircle were observed in the high and low frequency ranges. It was found that the charge-transfer resistance in the mesopore interface had no influence on the loci of the straight line. (C) The Electrochemical Society of Japan, All rights reserved.	[Shitanda, Isao; Yanai, Hiroki; Hoshi, Yoshinao; Itagaki, Masayuki] Tokyo Univ Sci, Fac Sci & Technol, Dept Pure & Appl Chem, Noda, Chiba 2788510, Japan; [Shitanda, Isao; Hoshi, Yoshinao; Itagaki, Masayuki] Tokyo Univ Sci, Res Inst Sci & Technol, Noda, Chiba 2788510, Japan; [Tswimura, Seiya] Univ Tsukuba, Fac Pure & Appl Sci, Div Mat Sci, Tsukuba, Ibaraki 3055358, Japan	Shitanda, I (reprint author), Tokyo Univ Sci, Fac Sci & Technol, Dept Pure & Appl Chem, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	shitanda@rs.noda.tus.ac.jp			JSPS KAKENHI [70434024]; Tokyo Ohka Foundation; Noguchi Institute	This work was partially supported by JSPS KAKENHI 70434024 Grant (to Shitanda), the Tokyo Ohka Foundation (to Shitanda and Itagaki) and Noguchi Institute (to Tsujimura).	PEKALA RW, 1989, J MATER SCI, V24, P3221, DOI 10.1007/BF01139044; PEKALA RW, 1993, MACROMOLECULES, V26, P5487, DOI 10.1021/ma00072a029; PEKALA RW, 1992, J NON-CRYST SOLIDS, V145, P90, DOI 10.1016/S0022-3093(05)80436-3; Tamon H, 2000, CARBON, V38, P1099, DOI 10.1016/S0008-6223(99)00235-3; KAPLAN T, 1987, PHYS REV B, V35, P5379, DOI 10.1103/PhysRevB.35.5379; Eikerling M, 2005, J ELECTROCHEM SOC, V152, pE24, DOI 10.1149/1.1825379; Cisse Haba T., 2007, CHAOS SOLITON FRACT, V33, P36; de Levie R., 1963, ELECTROCHIM ACTA, V8, P751, DOI 10.1016/0013-4686(63)80042-0; Itagaki M, 2007, J POWER SOURCES, V164, P415, DOI 10.1016/j.jpowsour.2006.09.077; Itagaki M, 2010, ELECTROCHIM ACTA, V55, P6255, DOI 10.1016/j.electacta.2009.10.016; Lewandowski A, 2003, SOLID STATE IONICS, V161, P243, DOI 10.1016/S0167-2738(03)00275-3; Ramus-Serment C, 2002, CHAOS SOLITON FRACT, V14, P479, DOI 10.1016/S0960-0779(01)00223-5; Shitanda I., 2013, P EIS2013, pP01; Tsujimura S, 2010, ELECTROCHEM COMMUN, V12, P446, DOI 10.1016/j.elecom.2010.01.016; WANG JC, 1988, ELECTROCHIM ACTA, V33, P707, DOI 10.1016/0013-4686(88)80071-9; West WC, 2008, J ELECTROCHEM SOC, V155, pA716, DOI 10.1149/1.2961044	16	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	MAY	2015	83	5					335	338		10.5796/electrochemistry.83.335		4	Electrochemistry	Electrochemistry	CI5XK	WOS:000354832900007		
J	Kodera, F; Takada, H; Nishimura, H; Akinaga, Y; Miyakoshi, A; Umeda, M				Kodera, Fumihiro; Takada, Haruki; Nishimura, Hajime; Akinaga, Yutaka; Miyakoshi, Akihiko; Umeda, Minoru			Electro-Catalytic Oxygen Reduction Activity of Graphene-Covered Nickel Particles Prepared by Microwave-assisted Catalytic Decomposition	ELECTROCHEMISTRY			English	Article						Methane Gas; Microwave Decomposition; Graphene-covered Nickel Particle; Oxygen Reduction	FUEL-CELLS; POROUS-MICROELECTRODE; CATHODE CATALYST; CARBON; PERFORMANCE; HYDROGEN; METHANOL; IRON; ELECTROCATALYSTS	A new electrode catalyst prepared using methane gas by microwave-assisted catalytic decomposition has been developed. The prepared catalyst has a graphene-covered nickel particle (GCNP) structure. GCNPs were fabricated as a powder microelectrode. Oxygen reduction activity was evaluated using an electrochemical potential sweep method. This activity was evaluated by comparing the oxygen reduction reaction (ORR) at the GCNP and commercially available Pt/C. The ORR at the GCNP was found to be similar to that of Pt/C in neutral solution. In acidic solution, the GCNP exhibited higher corrosion resistance than a nickel particle. The result was due to the prepared graphene. (C) The Electrochemical Society of Japan, All rights reserved.	[Kodera, Fumihiro; Takada, Haruki; Nishimura, Hajime; Akinaga, Yutaka; Miyakoshi, Akihiko] Asahikawa Coll, Natl Inst Technol, Dept Chem Mat, Asahikawa, Hokkaido 0718142, Japan; [Umeda, Minoru] Nagaoka Univ Technol, Fac Engn, Dept Mat Sci & Technol, Nagaoka, Niigata 9402188, Japan	Kodera, F (reprint author), Asahikawa Coll, Natl Inst Technol, Dept Chem Mat, 2-2-1-6 Shunkodai, Asahikawa, Hokkaido 0718142, Japan.	kodera@asahikawa-nct.ac.jp			Nagaoka University of Technology	This work was supported by a Grant-in-Aid (2014) from the Nagaoka University of Technology.	Gasteiger HA, 2004, J POWER SOURCES, V127, P162, DOI 10.1016/j.jpowsour.2003.09.013; Gong KP, 2009, SCIENCE, V323, P760, DOI 10.1126/science.1168049; Kou R, 2011, J AM CHEM SOC, V133, P2541, DOI 10.1021/ja107719u; Lidstrom P, 2001, TETRAHEDRON, V57, P9225, DOI 10.1016/S0040-4020(01)00906-1; Fidalgo B, 2008, INT J HYDROGEN ENERG, V33, P4337, DOI 10.1016/j.ijhydene.2008.05.056; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Hayes BL, 2004, ALDRICHIM ACTA, V37, P66; Umeda M, 2003, ELECTROCHIM ACTA, V48, P1367, DOI 10.1016/S0013-4686(03)00002-1; Lefevre M, 2009, SCIENCE, V324, P71, DOI 10.1126/science.1170051; Dominguez A, 2007, INT J HYDROGEN ENERG, V32, P4792, DOI 10.1016/j.ijhydene.2007.07.041; Chisaka M, 2013, ELECTROCHIM ACTA, V113, P735, DOI 10.1016/j.electacta.2013.06.048; Ferrari AC, 2013, NAT NANOTECHNOL, V8, P235, DOI 10.1038/nnano.2013.46; Zhang LP, 2011, J PHYS CHEM C, V115, P11170, DOI 10.1021/jp201991j; Aravind SSJ, 2012, ACS APPL MATER INTER, V4, P3805, DOI 10.1021/am301187h; Wu G, 2011, SCIENCE, V332, P443, DOI 10.1126/science.1200832; Sharma S, 2010, J PHYS CHEM C, V114, P19459, DOI 10.1021/jp107872z; Gahleitner G, 2013, INT J HYDROGEN ENERG, V38, P2039, DOI 10.1016/j.ijhydene.2012.12.010; Qu LT, 2010, ACS NANO, V4, P1321, DOI 10.1021/nn901850u; Menendez JA, 2010, FUEL PROCESS TECHNOL, V91, P1, DOI 10.1016/j.fuproc.2009.08.021; Bard A. J., 2000, ELECTROCHEMICAL METH, V2nd, P226; Borghei M, 2014, INT J HYDROGEN ENERG, V39, P12749, DOI 10.1016/j.ijhydene.2014.06.105; Kodera F, 2007, J POWER SOURCES, V172, P698, DOI 10.1016/j.jpowsour.2007.05.016; Liew K. B., 2014, INT J HYDROGEN ENERG, V39, P4870; Miyakoshi A., 2014, CHEM ENG, V59, P596; Bockris JOM, 2013, INT J HYDROGEN ENERG, V38, P2579, DOI 10.1016/j.ijhydene.2012.12.026; Pourbaix M., 1966, ATLAS ELECTROCHEMICA; Proietti E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1427; Radev I, 2013, INT J HYDROGEN ENERG, V38, P7133, DOI 10.1016/j.ijhydene.2013.04.014; Reith F, 2014, EARTH-SCI REV, V131, P1, DOI 10.1016/j.earscirev.2014.01.003; Sakai T, 2011, ELECTROCHEMISTRY, V79, P349	30	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	MAY	2015	83	5					339	341		10.5796/electrochemistry.83.339		3	Electrochemistry	Electrochemistry	CI5XK	WOS:000354832900008		
J	Kawakita, I; Shinoda, YH; Sakamoto, Y				Kawakita, In; Shinoda, Yasuo Hashimoto; Sakamoto, Yukihiro			Electrochemically Catalytic Activity of Boron-doped Diamond for I-/I-0 Redox Couple	ELECTROCHEMISTRY			English	Article						Boron-doped Diamond; Iodide/Iodine; Electrocatalyst	SENSITIZED SOLAR-CELLS; ELECTRODES; ADHESION; FILMS; STEEL	Boron-doped diamond (BDD) is promising as electrocatalyst for alternative material to platinum (Pt) because of its superior chemical stability. Electrochemically catalytic activity of BDD on the redox couple of I-/I-0 was studied by using the electrochemical method. It showed the parabolic dependence on the doping level of boron in diamond and the maximum value was 0.94 mu A/cm(2) in terms of the exchanging current density. This value is slightly higher than graphite and smaller than Pt. Additional surface modification of BDD could improve the catalytic activity. (C) The Electrochemical Society of Japan, All rights reserved.	[Kawakita, In; Shinoda, Yasuo Hashimoto] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Shinoda, Yasuo Hashimoto; Sakamoto, Yukihiro] Chiba Inst Technol, Narashino, Chiba 2750016, Japan	Kawakita, I (reprint author), Natl Inst Mat Sci, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	KAWAKITA.Jin@nims.go.jp					Olsen E, 2000, SOL ENERG MAT SOL C, V63, P267, DOI 10.1016/S0927-0248(00)00033-7; Suzuki K, 2003, CHEM LETT, V32, P28, DOI 10.1246/cl.2003.28; Kraft A, 2007, INT J ELECTROCHEM SC, V2, P355; Imoto K, 2003, SOL ENERG MAT SOL C, V79, P459, DOI 10.1016/S0927-0248(03)00021-7; Buijnsters JG, 2004, DIAM RELAT MATER, V13, P848, DOI 10.1016/j.diamond.2003.11.012; Fryda M, 2003, DIAM RELAT MATER, V12, P1950, DOI 10.1016/S0925-9635(03)00261-9; Fujishima A., 2005, DIAMOND ELECTROCHEMI; Haenni W, 2004, SEMICONDUCT SEMIMET, V77, P149; NESLADEK M, 1994, DIAM RELAT MATER, V3, P98, DOI 10.1016/0925-9635(94)90038-8; Sakamoto Y., P 8 PAC RIM INT C AD; Sedaka N., 1989, JINZO DAIMOND GIJUTS, P294; Torrengo S, 2009, DIAM RELAT MATER, V18, P804, DOI 10.1016/j.diamond.2009.02.003	12	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	MAY	2015	83	5					342	344		10.5796/electrochemistry.83.342		3	Electrochemistry	Electrochemistry	CI5XK	WOS:000354832900009		
J	Matsuo, Y; Hashiguchi, K; Ueda, K; Muramatsu, Y				Matsuo, Yoshiaki; Hashiguchi, Katsuki; Ueda, Koji; Muramatsu, Yasuji			Electrochemical Intercalation of Sodium Ions into Thermally Reduced Graphite Oxide	ELECTROCHEMISTRY			English	Article						Sodium Ion Battery; Graphite Oxide; Intercalation; Soft X-ray Absorption	RAY-ABSORPTION-SPECTROSCOPY; GRAPHENE OXIDE; HIGH-CAPACITY; NEGATIVE ELECTRODES; ANODE MATERIALS; THIN-FILMS; BATTERIES; CARBON; NANOCOMPOSITES	The structure of carbon obtained from the thermal reduction of graphite oxide at 900 degrees C after electrochemical storage sodium ions was investigated. X-ray diffraction measurement of the carbon sample after charged to various potentials indicated that sodium ions are stored between the layers of carbon below 0.3V vs. Na/Na+ though the interlayer spacing of it was similar to that of graphite. The lower LUMO energy as revealed from the broad pi* peak in the region of CK observed in soft X-ray absorption measurement was responsible for the intercalation of a large amount of sodium ions into the present carbon material. (C) The Electrochemical Society of Japan, All rights reserved.	[Matsuo, Yoshiaki; Hashiguchi, Katsuki; Ueda, Koji; Muramatsu, Yasuji] Univ Hyogo, Himeji, Hyogo 6712280, Japan	Matsuo, Y (reprint author), Univ Hyogo, 2167 Shosha, Himeji, Hyogo 6712280, Japan.	ymatsuo@eng.u-hyogo.ac.jp					Ganguly A, 2011, J PHYS CHEM C, V115, P17009, DOI 10.1021/jp203741y; Bagri A, 2010, NAT CHEM, V2, P581, DOI [10.1038/nchem.686, 10.1038/NCHEM.686]; Su DW, 2013, CHEM COMMUN, V49, P3131, DOI 10.1039/c3cc40448j; Alcantara R, 2002, J ELECTROCHEM SOC, V149, pA201, DOI 10.1149/1.1431963; Lee V, 2009, CHEM MATER, V21, P3905, DOI 10.1021/cm901554p; Matsuo Y, 2014, J POWER SOURCES, V263, P158, DOI 10.1016/j.jpowsour.2014.04.038; Saxena S, 2010, J PHYS CHEM LETT, V1, P3433, DOI 10.1021/jz1014339; Thorne JS, 2013, ELECTROCHIM ACTA, V112, P133, DOI 10.1016/j.electacta.2013.08.120; Baggetto L, 2013, ELECTROCHEM COMMUN, V27, P168, DOI 10.1016/j.elecom.2012.11.030; Stevens DA, 2000, J ELECTROCHEM SOC, V147, P1271, DOI 10.1149/1.1393348; Datta MK, 2013, J POWER SOURCES, V225, P316, DOI 10.1016/j.jpowsour.2012.10.014; Pacile D, 2011, CARBON, V49, P966, DOI 10.1016/j.carbon.2010.09.063; Alcantara R, 2001, ELECTROCHEM COMMUN, V3, P639, DOI 10.1016/S1388-2481(01)00244-2; Zhan D, 2011, CARBON, V49, P1362, DOI 10.1016/j.carbon.2010.12.002; Lopez MC, 2013, ELECTROCHEM COMMUN, V27, P152, DOI 10.1016/j.elecom.2012.11.029; Wu L, 2013, ELECTROCHIM ACTA, V87, P41, DOI 10.1016/j.electacta.2012.08.103; Komaba S, 2011, ADV FUNCT MATER, V21, P3859, DOI 10.1002/adfm.201100854; Sun Q, 2011, ELECTROCHEM COMMUN, V13, P1462, DOI 10.1016/j.elecom.2011.09.020; ASHER RC, 1959, J INORG NUCL CHEM, V10, P238, DOI 10.1016/0022-1902(59)80118-4; Brodie M. B. C., 1860, ANN CHIM PHYS, V59, P466; Chuang C. H., 2014, SCI REPORTS, V4, P1; Jeong HK, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/67004; Jeong HK, 2008, CHEM PHYS LETT, V460, P499, DOI 10.1016/j.cplett.2008.06.042; Kawaguchi M., 2010, J ELECTROCHEM SOC, V157, P13; Lee V, 2012, J VAC SCI TECHNOL B, V30, DOI 10.1116/1.4766325; METROT A, 1980, SYNTHETIC MET, V1, P363, DOI 10.1016/0379-6779(80)90071-5; Ponrouch A, 2013, ELECTROCHEM COMMUN, V27, P85, DOI 10.1016/j.elecom.2012.10.038	27	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	MAY	2015	83	5					345	347		10.5796/electrochemistry.83.345		3	Electrochemistry	Electrochemistry	CI5XK	WOS:000354832900010		
J	Tenmyo, H; Asano, T; Jo, Y; Yoshii, K; Tsuda, T; Maruyama, J; Uyama, H; Kuwabata, S				Tenmyo, Hiroshi; Asano, Taisuke; Jo, Yungwoo; Yoshii, Kazuki; Tsuda, Tetsuya; Maruyama, Jun; Uyama, Hiroshi; Kuwabata, Susumu			Double Layer Capacitance Properties of Monodisperse Carbon Particles with High Porosity Derived from Polyacrylonitrile Synthesized by Dispersion Polymerization	ELECTROCHEMISTRY			English	Article						Electric Double Layer Capacitor; Polyacrylonitrile; Monodisperse Carbon Particle; Porous Carbon Material	NANOPARTICLES; SPHERES; FABRICATION; CATALYST; STORAGE	Polyacrylonitrile-derived carbon particles with uniform size and high porosity were synthesized and their capacitor properties were investigated. The carbon particles were simply prepared just by carbonizing and activating monodisperse polyacrylonitrile particles which were synthesized by polymerization of acrylonitrile in the mixture of methanol and N,N-dimethylformamide. The electrochemical measurements revealed that the carbon particles electrode maintained large specific capacitance even at high charge-discharge current densities. (C) The Electrochemical Society of Japan, All rights reserved.	[Tenmyo, Hiroshi; Asano, Taisuke; Jo, Yungwoo; Yoshii, Kazuki; Tsuda, Tetsuya; Uyama, Hiroshi; Kuwabata, Susumu] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan; [Maruyama, Jun] Osaka Municipal Tech Res Inst, Environm Technol Res Div, Joto Ku, Osaka 5368553, Japan	Kuwabata, S (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan.	kuwabata@chem.eng.osaka-u.ac.jp	Tsuda, Tetsuya/F-7234-2014	Tsuda, Tetsuya/0000-0001-9462-8066			Zhai YP, 2011, ADV MATER, V23, P4828, DOI 10.1002/adma.201100984; Ikeda S, 2006, ANGEW CHEM INT EDIT, V45, P7063, DOI 10.1002/anie.200602700; Kim Y, 2012, LANGMUIR, V28, P10543, DOI 10.1021/la3021468; Yu LH, 2013, CARBON, V61, P245, DOI 10.1016/j.carbon.2013.05.001; Yang ZX, 2007, J AM CHEM SOC, V129, P1673, DOI 10.1021/ja067149g; Pelekani C, 2000, CARBON, V38, P1423, DOI 10.1016/S0008-6223(99)00261-4; Cheng JL, 2014, CHEM ENG J, V242, P285, DOI 10.1016/j.cej.2013.12.089; Friedel B, 2006, SMALL, V2, P859, DOI 10.1002/smll.200500516; Li WR, 2007, CARBON, V45, P1757, DOI 10.1016/j.carbon.2007.05.004; Jiang DE, 2009, NANO LETT, V9, P4019, DOI 10.1021/nl9021946; Li FB, 2006, CARBON, V44, P128, DOI 10.1016/j.carbon.2005.06.049; Hao GP, 2010, ADV MATER, V22, P853, DOI 10.1002/adma.200903765; Burket CL, 2006, CARBON, V44, P2957, DOI 10.1016/j.carbon.2006.05.029; Fuertes AB, 2008, J PHYS CHEM C, V112, P3648, DOI 10.1021/jp711248h; Jiang XP, 2014, CHEM LETT, V43, P1023, DOI 10.1246/cl.140188; Jo Y., UNPUB; Takahashi K., 1992, Jpn. Kokai Tolckyo Koho, Patent No. [JPO4261404A, 04261404]; Tanaka S, 2012, J PHYS CHEM C, V116, P26791, DOI 10.1021/jp308415s; WANG S, 2014, J MATER CHEM A, V2, P4406; Woo SW, 2008, J MATER CHEM, V18, P1674, DOI 10.1039/b717996k	20	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	MAY	2015	83	5					348	350		10.5796/electrochemistry.83.348		3	Electrochemistry	Electrochemistry	CI5XK	WOS:000354832900011		
J	Dobashi, A; Shu, Y; Hasegawa, T; Maruyama, J; Iwasaki, S; Shen, YH; Uyama, H				Dobashi, Ayumi; Shu, Yu; Hasegawa, Takahiro; Maruyama, Jun; Iwasaki, Satoshi; Shen, Yehua; Uyama, Hiroshi			Preparation of Activated Carbon by KOH Activation from Amygdalus Pedunculata Shell and its Application for Electric Double-layer Capacitor	ELECTROCHEMISTRY			English	Article						Activated Carbon; Biomass; Electric Double-Layer Capacitor	SURFACE-AREA; PERFORMANCE; SUPERCAPACITORS; ELECTROLYTE; ADSORPTION	Activated carbon was prepared from Amygdalus pedunculata shell by carbonization and KOH activation. A. pedunculata is a good candidate plant for desert greening in China. By choosing the activation conditions, the activated carbon with the microporous structure and the large surface area (2900 m(2)g(-1)) was obtained. The resulting activated carbon exhibited the good electrochemical capacitive behavior. The present activated carbon from A. pedunculata is a promising electrode material for high-performance electric double-layer capacitor. (C) The Electrochemical Society of Japan, All rights reserved.	[Dobashi, Ayumi; Shu, Yu; Uyama, Hiroshi] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan; [Shu, Yu; Shen, Yehua] Northwestern Polytech Univ, Coll Chem & Mat Sci, Xian 710069, Shaanxi Provinc, Peoples R China; [Hasegawa, Takahiro; Maruyama, Jun; Iwasaki, Satoshi] Osaka Municipal Tech Res Inst, Environm Technol Res Div, Joto Ku, Osaka 5368553, Japan	Uyama, H (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan.	uyama@chem.eng.osaka-u.ac.jp					Chen MD, 2013, J SOLID STATE ELECTR, V17, P1005, DOI 10.1007/s10008-012-1946-6; Jiang L, 2013, CARBON, V56, P146, DOI 10.1016/j.carbon.2012.12.085; Simon P, 2013, ACCOUNTS CHEM RES, V46, P1094, DOI 10.1021/ar200306b; Senthilkumar ST, 2013, ACS APPL MATER INTER, V5, P10541, DOI 10.1021/am402162b; He XJ, 2013, J POWER SOURCES, V240, P109, DOI 10.1016/j.jpowsour.2013.03.174; MARSH H, 1982, CARBON, V20, P419, DOI 10.1016/0008-6223(82)90042-2; Chu JM, 2013, BIORESOURCE TECHNOL, V134, P374, DOI 10.1016/j.biortech.2012.12.089; Dutta S, 2014, ENERG ENVIRON SCI, V7, P3574, DOI 10.1039/c4ee01075b; Wei L, 2012, NANO ENERGY, V1, P552, DOI 10.1016/j.nanoen.2012.05.002; Kalyani P, 2013, INT J HYDROGEN ENERG, V38, P4034, DOI 10.1016/j.ijhydene.2013.01.048; Bhatnagar A, 2013, CHEM ENG J, V219, P499, DOI 10.1016/j.cej.2012.12.038; Wang GP, 2012, CHEM SOC REV, V41, P797, DOI 10.1039/c1cs15060j; Saleh TA, 2014, ADV COLLOID INTERFAC, V211, P93, DOI 10.1016/j.cis.2014.06.006; Galinski M, 2013, J POWER SOURCES, V228, P83, DOI 10.1016/j.jpowsour.2012.11.048; Cuna A, 2014, J ELECTROCHEM SOC, V161, pA1806, DOI 10.1149/2.0391412jes; Otowa T., 1996, HYOMEN, V34, P130; Otowa T., 1990, KAGAKU TO KOGYO, V64, P331; Van J., 2014, ADV ENERGY MATER, V4; Zang XM, 2013, ASIAN J CHEM, V25, P9485; Zhang ST, 2014, J MATER CHEM A, V2, P15889, DOI 10.1039/c4ta03503h	20	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	MAY	2015	83	5					351	353		10.5796/electrochemistry.83.351		3	Electrochemistry	Electrochemistry	CI5XK	WOS:000354832900012		
J	Egashira, M				Egashira, Minato			Effect of Cation Mixing on Utility of Iron in Iron/Carbon Nano-Fiber Composite Electrode	ELECTROCHEMISTRY			English	Article						Alkaline Secondary Battery; Iron Negative Electrode; Carbon Nano-fiber; Ferrous Ion	AIR BATTERY; CARBON COMPOSITE; FE/C COMPOSITE; BEHAVIOR; ANODE	Iron/carbon nano-fiber composite electrodes on the basis of Fe3+ but containing Fe2+ or Ni2+ ions have been prepared via sol-gel precipitation. The influence of the Fe2+ doping on the nano-structure and the utility of iron in alkaline electrolyte has been confirmed. The mixing of Fe2+ in composite provides larger iron oxide particles with high crystallinity, and changes the specific capacity of composite electrode. The specific capacity of the composite electrode introducing Fe2+:Fe3+ at 4:1 increases about 1.4 times compared with analogue having only Fe3+. In contrast, the doping of Ni2+ in the composite reduces the iron utility. (C) The Electrochemical Society of Japan, All rights reserved.	Nihon Univ, Coll Bioresource Sci, Fujisawa, Kanagawa 2520880, Japan	Egashira, M (reprint author), Nihon Univ, Coll Bioresource Sci, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	egashira.minato@nihon-u.ac.jp			JSPS KAKENHI [25410250]	This work has been supported by JSPS KAKENHI Grant No. 25410250. The VGCF (TM)-X sample was kindly provided by Showa Denko Co. Ltd., Japan.	Hang BT, 2008, J POWER SOURCES, V178, P393, DOI 10.1016/j.jpowsour.2007.12.012; OJEFORS L, 1978, J POWER SOURCES, V2, P287, DOI 10.1016/0378-7753(78)85019-8; Hang BT, 2006, J POWER SOURCES, V155, P461, DOI 10.1016/j.jpowsour.2005.04.010; VIJAYAMOHANAN K, 1991, J POWER SOURCES, V34, P269, DOI 10.1016/0378-7753(91)80093-D; Kao CY, 2011, J POWER SOURCES, V196, P5746, DOI 10.1016/j.jpowsour.2010.12.076; Huang KC, 2007, ELECTROCHEM COMMUN, V9, P1907, DOI 10.1016/j.elecom.2007.05.001; Egashira M, 2014, ELECTROCHEMISTRY, V82, P273, DOI 10.5796/electrochemistry.82.273; Egashira M, 2008, J POWER SOURCES, V183, P399, DOI 10.1016/j.jpowsour.2008.05.009; Urbaniak J, 2010, J SOLID STATE ELECTR, V14, P1629, DOI 10.1007/s10008-010-1004-1; Hang BT, 2005, ELECTROCHEM SOLID ST, V8, pA476, DOI 10.1149/1.1999914; Kao CY, 2010, J POWER SOURCES, V195, P2399, DOI 10.1016/j.jpowsour.2009.08.008; Hang BT, 2005, J POWER SOURCES, V143, P256, DOI 10.1016/j.jpwsour.2004.11.044; BLURTON KF, 1979, J POWER SOURCES, V4, P263, DOI 10.1016/0378-7753(79)80001-4; Egashira M., ELECTROCHEMIST UNPUB; MAITI HS, 1984, PHYS STATUS SOLIDI A, V84, P631, DOI 10.1002/pssa.2210840236; RAJENDRAN S, 1994, J MATER SCI, V29, P5673, DOI 10.1007/BF00349963; Scrosati B., 1997, MODERN BATTERIES, P292	17	1	1	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	MAY	2015	83	5					354	356		10.5796/electrochemistry.83.354		3	Electrochemistry	Electrochemistry	CI5XK	WOS:000354832900013		
J	Wahyuni, WT; Ivandini, TA; Jiwanti, PK; Saepudin, E; Gunlazuardi, J; Einaga, Y				Wahyuni, Wulan Tri; Ivandini, Tribidasari A.; Jiwanti, Prastika K.; Saepudin, Endang; Gunlazuardi, Jarnuzi; Einaga, Yasuaki			Electrochemical Behavior of Zanamivir at Gold-Modified Boron-Doped Diamond Electrodes for an Application in Neuraminidase Sensing	ELECTROCHEMISTRY			English	Article						Neuraminidase; Zanamivir; Cyclic Voltammetry; Gold-modified Diamond	INFLUENZA-VIRUS; RAPID DETECTION; VOLTAMMETRIC DETERMINATION; ESCHERICHIA-COLI; ASSAY; HEMAGGLUTININ; INHIBITORS; CLONING; GENE	This study emphasizes the electrochemical detection of Neuraminidase (NA) based on NA inhibition by Zanamivir. The detection method was developed based on the difference of electrochemical responses of Zanamivir in the presence and the absence of NA in phosphate buffer solution (pH 5.5). Gold and gold-modified boron-doped diamond was used as the working electrode and the measurement was conducted using cyclic voltammetry method. A linear calibration curve of Zanamivir was observed in the concentration range of 5 x 10(-6)-1 x 10(-4) mol/L (R-2 = 0.991), with the estimated limit of detection (LOD) of 1.49 X 10(-6) mol/L. The presence of NA increases the peak current of gold oxidation and reduction with linear calibration curves were monitored in the concentration range of 0-15 mU (R-2 = 0.996). An estimated LOD of 0.25 mU NA and an excellent reproducibility of the detection with an RSD of 1.18% can be achieved. Application of a real sample was successfully demonstrated for NA detection in the presence of mucin, suggested that the method is promising for pharmaceutical or medical application. (C) The Electrochemical Society of Japan, All rights reserved.	[Wahyuni, Wulan Tri; Ivandini, Tribidasari A.; Jiwanti, Prastika K.; Saepudin, Endang; Gunlazuardi, Jarnuzi] Univ Indonesia, Fac Math & Nat Sci, Dept Chem, Jakarta 16424, Indonesia; [Einaga, Yasuaki] Keio Univ, Fac Sci & Technol, Dept Chem, Yokohama, Kanagawa 2238522, Japan; [Einaga, Yasuaki] JST CREST ACCEL, Yokohama, Kanagawa 2238522, Japan	Einaga, Y (reprint author), Keio Univ, Fac Sci & Technol, Dept Chem, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	ivandini.tri@ui.ac.id; einaga@chem.keio.ac.jp			PUPT BOPTN University of Indonesia [2786/H2.R12/HKP.05.00/2013]	This work was partly granted by, PUPT BOPTN University of Indonesia with the Contract No. 2786/H2.R12/HKP.05.00/2013.	Ivandini TA, 2012, ANAL CHEM, V84, P9825, DOI 10.1021/ac302090y; Rismetov B, 2014, DIAM RELAT MATER, V48, P88, DOI 10.1016/j.diamond.2014.07.003; DuVall SH, 1999, ANAL CHEM, V71, P4594, DOI 10.1021/ac990399d; VIMR ER, 1985, J BACTERIOL, V164, P845; Turgeon N, 2011, AEROSOL SCI TECH, V45, P183, DOI 10.1080/02786826.2010.530624; Ushizawa K, 1998, DIAM RELAT MATER, V7, P1719, DOI 10.1016/S0925-9635(98)00296-9; Samson M, 2013, ANTIVIR RES, V98, P174, DOI 10.1016/j.antiviral.2013.03.014; Kastelic S, 2013, VET MICROBIOL, V162, P707, DOI 10.1016/j.vetmic.2012.09.018; Williams TL, 2012, VACCINE, V30, P2475, DOI 10.1016/j.vaccine.2011.12.056; Takayama I, 2013, J VIROL METHODS, V188, P73, DOI 10.1016/j.jviromet.2012.12.005; [Anonymous], PROD SPEC NEUR CLOST; Honda K, 2000, J ELECTROCHEM SOC, V147, P659, DOI 10.1149/1.1393249; Toghill KE, 2010, ELECTROANAL, V22, P1947, DOI 10.1002/elan.201000072; BERRY AM, 1988, GENE, V71, P299, DOI 10.1016/0378-1119(88)90046-7; Chien CH, 1997, ENZYME MICROB TECH, V20, P277, DOI 10.1016/S0141-0229(96)00129-9; Chiku M., 2008, J ELECTROANAL CHEM, V612, P2001; Coles MP, 2006, DALTON T, P985, DOI 10.1039/b515490a; Fujishima A., 2005, DIAMOND ELECTROCHEMI; Gerentes L, 1998, J VIROL METHODS, V73, P185, DOI 10.1016/S0166-0934(98)00056-1; Gue X., 2015, SENSOR ACTUAT B-CHEM, V206, P721; Li Y, 2013, J VIROL METHODS, V194, P194, DOI 10.1016/j.jviromet.2013.08.021; Ivandini TA, 2013, ELECTROCATALYSIS-US, V4, P367, DOI 10.1007/s12678-013-0169-7; lvandini T. A., 2010, J ELECTROANAL CHEM, V645, P85; Moryama T., 1967, J BACTERIOL, V94, P1565; Ouattara L, 2003, NEW DIAM FRONT C TEC, V13, P97; Pourbaix M., 1974, ATLAS ELECTROCHEMICA; RAMACHANDRAN M, 2012, ASIAN PAC J TROP DIS, V2, P426, DOI DOI 10.1016/S2222-1808(12)60094-2; REUTERVING CO, 1987, DIABETES METAB, V13, P457; Skrzypek S, 2010, ELECTROANAL, V22, P2339, DOI 10.1002/elan.201000163; Skrzypek S, 2012, CENT EUR J CHEM, V10, P977, DOI 10.2478/s11532-012-0043-0; Wang QN, 2005, VET MICROBIOL, V107, P265, DOI 10.1016/j.vetmic.2005.01.022; Welty J. R., 1984, FUNDAMENTALS MOMENTU, VThird, P803; Yang W, 2012, CARBOHYD RES, V359, P92, DOI 10.1016/j.carres.2012.06.009; Ye DJ, 2012, EUR J MED CHEM, V54, P764, DOI 10.1016/j.ejmech.2012.06.033; Zhang F, 2012, DIAGN MICR INFEC DIS, V74, P263, DOI 10.1016/j.diagmicrobio.2012.07.011	35	1	1	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	MAY	2015	83	5					357	362		10.5796/electrochemistry.83.357		6	Electrochemistry	Electrochemistry	CI5XK	WOS:000354832900014		
J	Kotani, A; Nagami, K; Mino, C; Sugawara, Y; Takahashi, K; Kusu, F; Hakamata, H				Kotani, Akira; Nagami, Kota; Mino, Chika; Sugawara, Yasuhito; Takahashi, Kouji; Kusu, Fumiyo; Hakamata, Hideki			Determination of Nobiletin in Rat Plasma after Ingestion of Citrus depressa Juice by Capillary Liquid Chromatography with Electrochemical Detection Using Boron-doped Diamond Electrode	ELECTROCHEMISTRY			English	Article						Boron-doped Diamond; Capillary Liquid Chromatography; Nobiletin; Pharmacokinetics	MASS-SPECTROMETRY; POLYMETHOXYLATED FLAVONES; ANODIC-OXIDATION; HAMSTERS; TANGERETIN; SERUM; MICE	Voltammetric detection using a boron doped diamond (BDD) electrode coupled with capillary liquid chromatography (CLC) was developed for determining nobiletin, one of the polymethoxyflavones (PMFs), in plasma samples. CLC with electrochemical detection (CLC-ECD) was performed using a capillary octadecylsilica (ODS) column, water-acetonitrile-phosphoric acid (65:35:0.5, v/v/v), as a mobile phase, and an applied potential at +1.45 V vs. Ag/AgCl. Chromatographic peak heights were found linearly related to the amounts of nobiletin injected from 0.48 pg to 0.40 ng (r = 0.999). The detection limit (S/N = 3) was 0.13 pg. The concentrations of nobiletin in rat plasma after oral ingestion of 5.0 mL kg(-1) Citrus depressa juice, corresponding to 0.17 mg kg(-1) nobiletin, were determined to obtain a concentration-time profile of nobiletin by the present CLC-ECD method, which required only 30 mu L of plasma sample for each time point. Based on the concentration-time profile of nobiletin in the rat plasma, the pharmacokinetic parameters of maximum drug concentration (C-max), maximum drug concentration time (t(max)), and area under the concentration-time curve (AUC(0-3h)) were obtained. (C) The Electrochemical Society of Japan, All rights reserved.	[Kotani, Akira; Nagami, Kota; Mino, Chika; Sugawara, Yasuhito; Takahashi, Kouji; Kusu, Fumiyo; Hakamata, Hideki] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Analyt Chem, Hachioji, Tokyo 1920392, Japan	Kotani, A (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Analyt Chem, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	kotani@toyaku.ac.jp					Akachi T, 2010, J NUTR SCI VITAMINOL, V56, P60, DOI 10.3177/jnsv.56.60; Swain GM, 1998, MRS BULL, V23, P56; Koga N, 2007, BIOL PHARM BULL, V30, P2317, DOI 10.1248/bpb.30.2317; Li TX, 2013, BIOMED CHROMATOGR, V27, P1041, DOI 10.1002/bmc.2904; Chen QY, 1997, J ELECTROCHEM SOC, V144, P3806, DOI 10.1149/1.1838096; Li RW, 2006, LIFE SCI, V79, P365, DOI 10.1016/j.lfs.2006.01.023; Einaga Y, 2010, J APPL ELECTROCHEM, V40, P1807, DOI 10.1007/s10800-010-0112-z; Zheng JK, 2013, MOL NUTR FOOD RES, V57, P1999, DOI 10.1002/mnfr.201300211; ROCKLIN RD, 1994, J CHROMATOGR A, V671, P109, DOI 10.1016/0021-9673(94)80228-9; Manthey JA, 2011, J AGR FOOD CHEM, V59, P145, DOI 10.1021/jf1033224; DOLSON MG, 1981, J AM CHEM SOC, V103, P2361, DOI 10.1021/ja00399a037; Kurowska EA, 2004, J AGR FOOD CHEM, V52, P2879, DOI 10.1021/jf035354z; Sumi T, 2012, ANGEW CHEM INT EDIT, V51, P5443, DOI 10.1002/anie.201200878; Kotani A, 2007, ANAL SCI, V23, P157, DOI 10.2116/analsci.23.157; Duan L, 2014, J CHROMATOGR A, V1339, P118, DOI 10.1016/j.chroma.2014.02.091; Onozuka H, 2008, J PHARMACOL EXP THER, V326, P739, DOI 10.1124/jpet.108.140293; Liu RH, 2007, J PHARMACEUT BIOMED, V43, P1007, DOI 10.1016/j.jpba.2006.09.031; Roza JM, 2007, ALTERN THER HEALTH M, V13, P44; Murakami A, 2000, CANCER RES, V60, P5059; Granger MC, 1999, ANAL CHIM ACTA, V397, P145, DOI 10.1016/S0003-2670(99)00400-6; Lin YS, 2012, J AGR FOOD CHEM, V60, P12082, DOI 10.1021/jf303896q; Bouamrane F., 1996, J ELECTROANAL CHEM, V405, P95, DOI 10.1016/0022-0728(95)04388-8; Dong M. W., 2005, MODERN HPLC PRACTICI, P66; Einaga Y., 2009, ELECTROCHEMISTRY, V77, P341; Feng XW, 2012, ANAL METHODS-UK, V4, P3748, DOI 10.1039/c2ay25562f; Kawaii S, 1999, J AGR FOOD CHEM, V47, P3565, DOI 10.1021/jf990153+; KISSINGER PT, 1981, LIFE SCI, V28, P455, DOI 10.1016/0024-3205(81)90138-7; Kohno H, 2001, LIFE SCI, V69, P901, DOI 10.1016/S0024-3205(01)01169-9; Kondo T, 2014, ANAL CHEM, V86, P8066, DOI 10.1021/ac500919k; Kumar A, 2012, BIOMED CHROMATOGR, V26, P1464, DOI 10.1002/bmc.2717; Saigusa D, 2011, ANAL BIOANAL CHEM, V400, P3635, DOI 10.1007/s00216-011-5031-2	31	1	1	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	MAY	2015	83	5					363	367		10.5796/electrochemistry.83.363		5	Electrochemistry	Electrochemistry	CI5XK	WOS:000354832900015		
J	Inoue, M; Nagai, K; Shironita, S; Abe, T; Umeda, M				Inoue, Mitsuhiro; Nagai, Kazuhiro; Shironita, Sayoko; Abe, Takayuki; Umeda, Minoru			Post-annealing Effects on Reaction Selectivity of Methanol Oxidation at Carbon-based Platinum Co-sputtered Electrocatalyst	ELECTROCHEMISTRY			English	Article						Carbon-platinum Co-sputtered Anode Catalyst; Direct Methanol Fuel Cells; Methanol Oxidation Reaction Selectivity; Post-annealing Effect	FUEL-CELL DMFC; OXYGEN REDUCTION; POROUS MICROELECTRODE; COMPOSITE MEMBRANES; ACID-MEDIA; PT-CO; ELECTRODE; CATALYST; ELECTROOXIDATION; NANOFLOWERS	A carbon with Pt (C-Pt) catalyst was prepared by a co-sputtering technique. Pt4f peaks of the prepared sample were observed at higher binding energies than those of a Pt sputtered sample. These Pt4f peaks shifted to the low binding energies with an increase in a post-annealing temperature, whereas the C1s peak position was unchanged. For the C-Pt catalyst as sputter-deposited, the methanol oxidation performance was enhanced by the presence of O-2. This O-2-enhnaced methanol oxidation was suppressed by the post-annealing at 160 degrees C, while the reaction selectivity of the methanol oxidation was retained. (C) The Electrochemical Society of Japan, All rights reserved.	[Inoue, Mitsuhiro; Abe, Takayuki] Toyama Univ, Hydrogen Isotope Res Ctr, Toyama 9308555, Japan; [Nagai, Kazuhiro; Shironita, Sayoko; Umeda, Minoru] Nagaoka Univ Technol, Fac Engn, Dept Mat Sci & Technol, Nagaoka, Niigata 9402188, Japan	Umeda, M (reprint author), Nagaoka Univ Technol, Fac Engn, Dept Mat Sci & Technol, 1603-1 Kamitomioka, Nagaoka, Niigata 9402188, Japan.	mumeda@vos.nagaokaut.ac.jp			JSPS KAKENHI [24350091]; Hydrogen Isotope Research Center, University of Toyama [HRC2014-04]	The present work was supported by JSPS KAKENHI Grant Numbers 24350091. A part of this work was supported by joint research program of the Hydrogen Isotope Research Center, University of Toyama (HRC2014-04).	Franceschini EA, 2011, J POWER SOURCES, V196, P1723, DOI 10.1016/j.jpowsour.2010.10.016; Ahmadi R, 2012, J CATAL, V292, P81, DOI 10.1016/j.jcat.2012.05.001; Colmenares L, 2007, J APPL ELECTROCHEM, V37, P1413, DOI 10.1007/s10800-007-9353-x; Zhuo Y, 2014, ANAL CHEM, V86, P1053, DOI 10.1021/ac403019e; Fu GT, 2013, J PHYS CHEM C, V117, P9826, DOI 10.1021/jp400502y; Corpuz AR, 2012, J POWER SOURCES, V217, P142, DOI 10.1016/j.jpowsour.2012.06.012; Justin P, 2014, APPL CATAL B-ENVIRON, V144, P767, DOI 10.1016/j.apcatb.2013.08.024; Wakisaka M, 2006, J PHYS CHEM B, V110, P23489, DOI 10.1021/jp0653510; Kamarudin SK, 2009, INT J HYDROGEN ENERG, V34, P6902, DOI 10.1016/j.ijhydene.2009.06.013; Ainla A, 2007, SOLID STATE IONICS, V178, P581, DOI 10.1016/j.ssi.2007.01.014; Bauer F, 2005, J POWER SOURCES, V145, P101, DOI 10.1016/j.jpowsour.2005.01.063; Antolini E, 2006, APPL CATAL B-ENVIRON, V63, P137, DOI 10.1016/j.apcatb.2005.09.014; Bard A. J., 2001, ELECTROCHEMICAL METH, V2nd, P570; Inoue M, 2013, INT J HYDROGEN ENERG, V38, P8992, DOI 10.1016/j.ijhydene.2013.05.006; Inoue M, 2011, ELECTROCHEMISTRY, V79, P329; Kucernak A, 2003, CHEM ENG J, V93, P81, DOI 10.1016/S1385-8947(02)00111-0; Lamy C., 2009, ELECTROCATALYSIS DIR; Ma L, 2014, THIN SOLID FILMS, V556, P460, DOI 10.1016/j.tsf.2014.01.048; Papageorgopoulos DC, 2007, ELECTROCHIM ACTA, V52, P4982, DOI 10.1016/j.electacta.2007.01.076; Sakai T, 2011, ELECTROCHEMISTRY, V79, P349; Shironita S, 2014, ELECTROCHIM ACTA, V128, P265, DOI 10.1016/j.electacta.2013.10.139; Umeda M, 2010, PHYS CHEM CHEM PHYS, V12, P7041, DOI 10.1039/b926115j; Umeda M., 2013, ELECTROCHIM ACTA, V101, P142; Umeda M, 2011, J RENEW SUSTAIN ENER, V3, DOI 10.1063/1.3608911; Vielstich W, 2001, J ELECTROCHEM SOC, V148, pA502, DOI 10.1149/1.1366619; Yang CC, 2009, J POWER SOURCES, V188, P30, DOI 10.1016/j.jpowsour.2008.11.098; Zhao XS, 2012, J POWER SOURCES, V201, P37, DOI 10.1016/j.jpowsour.2011.10.098; Zheng JN, 2014, ELECTROCHIM ACTA, V137, P431, DOI 10.1016/j.electacta.2014.06.052	28	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	MAY	2015	83	5					368	371		10.5796/electrochemistry.83.368		4	Electrochemistry	Electrochemistry	CI5XK	WOS:000354832900016		
J	Funabashi, H; Murata, K; Tsujimura, S				Funabashi, Hiroto; Murata, Kazuki; Tsujimura, Seiya			Effect of Pore Size of MgO-templated Carbon on the Direct Electrochemistry of D-fructose Dehydrogenase	ELECTROCHEMISTRY			English	Article						D-fructose Dehydrogenase; MgO-template Carbon; Direct Electron Transfer	DIRECT ELECTRON-TRANSFER; BIOFUEL CELLS; IMMOBILIZED ENZYMES; CRYOGEL ELECTRODES; GLUCOSE-DEHYDROGENASE; CATALYTIC ACTIVITY; MESOPOROUS SILICA; OXYGEN REDUCTION; PERFORMANCE; STABILITY	MgO-templated porous carbon (MgOC) was developed for c-fructose dehydrogenase (FDH) electrodes. MgOCs with an average pore diameter ranging from 10 to 100 nm were used in this study. FDH adsorbed on a MgOCs electrode exhibited significant catalytic currents for c-fructose-oxidation without a redox mediator. When the pore size of MgOCs was much larger than the size of FDH, a sufficient amount of FDH was adsorbed in the mesopore on and even inside the MgOCs structure. In contrast, when the pore size of MgOCs was comparable to the size of FDH, the catalytic current depended only on the amount of enzyme adsorbed in mesopores formed at the surface of the carbon particles; however, an enhanced thermal stability of FDH was observed. Thus, FDH was stabilized through encaging in carbon mesopores with a size comparable to that of the enzyme. (C) The Electrochemical Society of Japan, All rights reserved.	[Funabashi, Hiroto; Murata, Kazuki; Tsujimura, Seiya] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan	Tsujimura, S (reprint author), Univ Tsukuba, Fac Pure & Appl Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058573, Japan.	seiya@ims.tsukuba.ac.jp			Kato Foundation for the Promotion of Science and the Sumitomo Foundation; Sumitomo Foundation	The MgO-templated carbon and PVDF were donated by Toyo Tanso Co., Ltd. and Kureha Corp., respectively. The DLS measurements of FDH with FDLS 3000 and FE-SEM with SU-8020 were carried out at the OPEN FACILITY, Research Facility Center for Science and Technology, University of Tsukuba. This work was partially supported by a grant from the Kato Foundation for the Promotion of Science and the Sumitomo Foundation.	Miyake T, 2011, J AM CHEM SOC, V133, P5129, DOI 10.1021/ja111517e; Murata K, 2014, CHEM LETT, V43, P928, DOI 10.1246/cl.140189; Tsujimura S, 2007, FUEL CELLS, V7, P463, DOI 10.1002/fuce.200700032; Holzinger M, 2012, ELECTROCHIM ACTA, V82, P179, DOI 10.1016/j.electacta.2011.12.135; Shitanda I, 2015, ELECTROCHEMISTRY, V83, P329, DOI 10.5796/electrochemistry.83.329; Tsujimura S, 2014, J AM CHEM SOC, V136, P14432, DOI 10.1021/ja5053736; Takahashi H, 2000, CHEM MATER, V12, P3301, DOI 10.1021/cm000487a; Morishita T, 2010, CARBON, V48, P2690, DOI 10.1016/j.carbon.2010.03.064; Kim J, 2006, BIOTECHNOL ADV, V24, P296, DOI 10.1016/j.biotechadv.2005.11.006; Tominaga M, 2009, BIOSENS BIOELECTRON, V24, P1184, DOI 10.1016/j.bios.2008.07.002; Flexer V, 2011, ANAL CHEM, V83, P5721, DOI 10.1021/ac200981r; Bayne L, 2013, CHEM SOC REV, V42, P9000, DOI 10.1039/c3cs60270b; Kamitaka Y, 2007, PHYS CHEM CHEM PHYS, V9, P1793, DOI 10.1039/b617650j; Takahashi H, 2001, MICROPOR MESOPOR MAT, V44, P755, DOI 10.1016/S1387-1811(01)00257-8; Kamitaka Y, 2007, CHEM LETT, V36, P218, DOI 10.1246/cl.2007.218; Shitanda I, 2013, CHEM COMMUN, V49, P11110, DOI 10.1039/c3cc46644b; Gao F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1000; Hamano Y, 2012, BIOELECTROCHEMISTRY, V88, P114, DOI 10.1016/j.bioelechem.2012.07.005; Hamano Y, 2014, MATER LETT, V128, P191, DOI 10.1016/j.matlet.2014.04.125; Poulpiquet A.D., 2014, ELECTROCHEMICAL ACTA, V126, P104; Suraniti E, 2013, J ELECTROCHEM SOC, V160, pG79, DOI 10.1149/2.072306jes; Tsujimura S, 2010, ELECTROCHEM COMMUN, V12, P446, DOI 10.1016/j.elecom.2010.01.016; Tsujimura S, 2014, ELECTROCHIM ACTA, V117, P263, DOI 10.1016/j.electacta.2013.11.131; Zebda A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1365	24	2	2	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	MAY	2015	83	5					372	375		10.5796/electrochemistry.83.372		4	Electrochemistry	Electrochemistry	CI5XK	WOS:000354832900017		
J	Ohtsuka, M; Kitamura, F				Ohtsuka, Misako; Kitamura, Fusao			On the Formal Redox Potential of Oxygen Reduction Reaction at Iron Phthalocyanine/Graphene Composite Electrode in Alkaline Media	ELECTROCHEMISTRY			English	Article						Graphene; Iron Phthalocyanine; Oxygen Reduction Reaction; Electronic Structure	ELECTROCATALYTIC ACTIVITY; GRAPHENE NANOSHEETS; FUEL-CELL; GRAPHITE; SURFACE; OXIDE; MOLECULES; FILMS	The redox reaction of iron phthalocyanine (FePc) combined with electrochemically-reduced graphene oxide (ER-GO) was investigated as a function of FePc fraction. A FePc/ER-GO/GC electrode was fabricated and the redox response of Fe3+/2+ couple was analyzed by cyclic voltammetry. The formal potential was observed to change with the FePc fraction, and the most positive value was obtained at the full monolayer coverage. The onset potential of oxygen reduction reaction at the fabricated electrode shifted linearly with the formal potential of FePc. Such a coverage-dependent potential shift was explained in terms of the electronic interaction between FePc and substrate graphene surface based on the X-ray photoelectron spectroscopy as well as the theoretical DFT calculation of a model adsorption system. (C) The Electrochemical Society of Japan, All rights reserved.	[Ohtsuka, Misako; Kitamura, Fusao] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, Midori Ku, Yokohama, Kanagawa 2268502, Japan	Kitamura, F (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268502, Japan.	kitamura@echem.titech.ac.jp					Dong GF, 2012, PHYS CHEM CHEM PHYS, V14, P2557, DOI 10.1039/c2cp23718k; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Yoo E, 2009, NANO LETT, V9, P2255, DOI 10.1021/nl900397t; Delley B, 2000, J CHEM PHYS, V113, P7756, DOI 10.1063/1.1316015; Schmid M, 2011, J PHYS CHEM C, V115, P17028, DOI 10.1021/jp204524s; ZAGAL J, 1992, J ELECTROANAL CHEM, V339, P13, DOI 10.1016/0022-0728(92)80442-7; Jiang YY, 2013, ACS CATAL, V3, P1263, DOI 10.1021/cs4001927; Cook PL, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3257621; Kovtyukhova NI, 1999, CHEM MATER, V11, P771, DOI 10.1021/cm981085u; Taniguchi T, 2013, PART PART SYST CHAR, V30, P1063, DOI 10.1002/ppsc.201300177; Schmid M, 2012, SURF SCI, V606, P945, DOI 10.1016/j.susc.2012.02.012; DELLEY B, 1990, J CHEM PHYS, V92, P508, DOI 10.1063/1.458452; Zhang K, 2010, CHEM MATER, V22, P1392, DOI 10.1021/cm902876u; Erickson K, 2010, ADV MATER, V22, P4467, DOI 10.1002/adma.201000732; Luo ZQ, 2011, J MATER CHEM, V21, P8038, DOI 10.1039/c1jm10845j; Park S, 2009, NAT NANOTECHNOL, V4, P217, DOI [10.1038/nnano.2009.58, 10.1038/NNANO.2009.58]; Yue ZR, 1999, CARBON, V37, P1785, DOI 10.1016/S0008-6223(99)00047-0; PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048; Hirata M, 2004, CARBON, V42, P2929, DOI 10.1016/j.carbon.2004.07.003; Yang DQ, 2009, J PHYS CHEM C, V113, P6418, DOI 10.1021/jp810171e; Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451; Qu LT, 2010, ACS NANO, V4, P1321, DOI 10.1021/nn901850u; PULAY P, 1980, CHEM PHYS LETT, V73, P393, DOI 10.1016/0009-2614(80)80396-4; Chen RR, 2009, J PHYS CHEM C, V113, P20689, DOI 10.1021/jp906408y; Steele BCH, 2001, NATURE, V414, P345, DOI 10.1038/35104620; Wilson NR, 2009, ACS NANO, V3, P2547, DOI 10.1021/nn900694t; Choi SM, 2011, CARBON, V49, P904, DOI 10.1016/j.carbon.2010.10.055; De Arco LG, 2010, ACS NANO, V4, P2865, DOI 10.1021/nn901587x; Dong L., 2011, CARBON, V48, P5158; Dryer D.R., 2010, CHEM SOC REV, V39, P228; Isvoranu C, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3563636; Tang B. L., 2009, ADV FUNCT MATER, V19, P2782; Yang J, 2014, J POWER SOURCES, V245, P277, DOI 10.1016/j.jpowsour.2013.06.143	33	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	MAY	2015	83	5					376	380		10.5796/electrochemistry.83.376		5	Electrochemistry	Electrochemistry	CI5XK	WOS:000354832900018		
J	Shimizu, Y; Suda, Y; Takikawa, H; Ue, H; Shimizu, K; Umeda, Y				Shimizu, Yoshiaki; Suda, Yoshiyuki; Takikawa, Hirofumi; Ue, Hitoshi; Shimizu, Kazuki; Umeda, Yoshito			Effective Utilization of Carbon Nanocoil-supported PtRu Anode Catalyst by Applying Anode Microporous Layer for Improved Direct Methanol Fuel Cell Performance	ELECTROCHEMISTRY			English	Article						Microporous Layer; Carbon Nanocoil; Carbon Nanoballoon; Carbon Loading	GAS-DIFFUSION LAYER; MICRO-POROUS LAYER; PORTABLE APPLICATIONS; OPERATING-CONDITIONS; WATER CROSSOVER; DMFC; MEMBRANE; TRANSPORT; PEMFC; MANAGEMENT	The application of a microporous layer (MPL) between the gas diffusion layer and the catalyst layer (CL) plays a crucial role in the performance of the direct methanol fuel cell (DMFC). To this end, this study investigates the effects of carbon loading and the nature of the carbon material used in the anode MPL on the performance of DMFC using transmission and scanning electron microscopy, polarization technique, and electrochemical impedance spectroscopy (EIS). DMFC was indigenously fabricated using 30 wt% PtRu catalyst supported on carbon nanocoil and commercial Pt catalyst as the anode CL and the cathode CL, respectively. Carbon nanoballoon (CNB) and Vulcan XC-72R (Vulcan) were used as the anode MPL. According to polarization studies, a membrane electrode assembly (MEA) with CNB and Vulcan MPLs (loading of 1.5 mg cm(-2)) shows higher power density. This is 1.3 and 1.8 times higher than that without the anode MPL when methanol concentration was 0.5M (M = mol dm(-3)), respectively. Electrochemical impedance spectra (EIS) results indicate that the MEAs with the anode MPLs have lower high-frequency resistance and charge transfer resistance when compared to those without the anode MPL. Thus, it can be realized that the anode MPL plays a significant role in the effective utilization of CNC-supported PtRu anode catalyst, thereby improving DMFC performance. (C) The Electrochemical Society of Japan, All rights reserved.	[Shimizu, Yoshiaki; Suda, Yoshiyuki; Takikawa, Hirofumi] Toyohashi Univ Technol, Dept Elect & Elect Informat Engn, Tempaku Ku, Toyohashi, Aichi 4418580, Japan; [Ue, Hitoshi] Tokai Carbon Co Ltd, Fuji Res Lab, Shizuoka 4101431, Japan; [Shimizu, Kazuki] Shonan Plast Mfg Co Ltd, Hiratsuka, Kanagawa 2540807, Japan; [Umeda, Yoshito] Toho Gas Co Ltd, Corp Res Dept, Nagoya, Aichi 4568511, Japan	Suda, Y (reprint author), Toyohashi Univ Technol, Dept Elect & Elect Informat Engn, Tempaku Ku, 1-1 Hibarigaoka, Toyohashi, Aichi 4418580, Japan.	suda@ee.tut.ac.jp			EIIRIS Project from Toyohashi University of Technology (TUT); JSPS KAKENHI [24360108, 25630110]	This work has been partly supported by the EIIRIS Project from Toyohashi University of Technology (TUT); JSPS KAKENHI Grant Number 24360108 and 25630110.	Yang H, 2005, J POWER SOURCES, V139, P79, DOI 10.1016/j.jpowsour.2004.05.033; Blum A, 2003, J POWER SOURCES, V117, P22, DOI 10.1016/S0378-7753(03)00310-0; Dyer CK, 2002, J POWER SOURCES, V106, P31, DOI 10.1016/S0378-7753(01)01069-2; Yoshitake T, 2002, PHYSICA B, V323, P124, DOI 10.1016/S0921-4526(02)00871-2; Ge SH, 2003, J POWER SOURCES, V124, P1, DOI 10.1016/S0378-7753(03)00584-6; Schultz T, 2006, J MEMBRANE SCI, V276, P272, DOI 10.1016/j.memsci.2005.10.001; Yokota M, 2011, J NANOSCI NANOTECHNO, V11, P2344, DOI 10.1166/jnn.2011.3126; Pasaogullari U, 2004, ELECTROCHIM ACTA, V49, P4359, DOI 10.1016/j.electacta.2004.04.027; Zhang J, 2007, J POWER SOURCES, V168, P453, DOI 10.1016/j.jpowsour.2007.03.027; Suda Y, 2014, AIP CONF PROC, V1585, P77, DOI 10.1063/1.4866623; Nam JH, 2003, INT J HEAT MASS TRAN, V46, P4595, DOI 10.1016/S0017-9310(03)00305-3; Liu FQ, 2006, J ELECTROCHEM SOC, V153, pA543, DOI 10.1149/1.2161636; Liu FQ, 2008, ELECTROCHIM ACTA, V53, P5517, DOI 10.1016/j.electacta.2008.03.011; Song KY, 2007, ELECTROCHIM ACTA, V53, P637, DOI 10.1016/j.electacta.2007.07.044; Jewett G, 2007, J POWER SOURCES, V168, P434, DOI 10.1016/j.jpowsour.2007.03.052; Park GG, 2004, J POWER SOURCES, V131, P182, DOI 10.1016/j.jpowsour.2003.12.037; Hyun MS, 2008, CATAL TODAY, V132, P138, DOI 10.1016/j.cattod.2007.12.034; Zhao TS, 2009, PROG ENERG COMBUST, V35, P275, DOI 10.1016/j.pecs.2009.01.001; Qi ZG, 2002, J POWER SOURCES, V109, P38; Kamarudin SK, 2007, J POWER SOURCES, V163, P743, DOI 10.1016/j.jpowsour.2006.09.081; Jeong SU, 2006, J POWER SOURCES, V159, P1089, DOI 10.1016/j.jpowsour.2006.12.046; Park JY, 2008, J POWER SOURCES, V178, P181, DOI 10.1016/j.jpowsour.2007.12.021; Chen R, 2006, J POWER SOURCES, V157, P351, DOI 10.1016/j.jpowsour.2005.07.073; Gogel V, 2004, J POWER SOURCES, V127, P172, DOI 10.1016/j.jpowsour.2003.09.035; Hosokawa Y., 2007, RES LETT MAT SCI, V2007; Ikeda T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.01AF13; Kim H, 2006, J POWER SOURCES, V162, P497, DOI 10.1016/j.jpowsour.2006.07.025; Lu GQ, 2004, J POWER SOURCES, V134, P33, DOI 10.1016/j.jpowsour.2004.01.055; Mennola T, 2004, J APPL ELECTROCHEM, V34, P31, DOI 10.1023/B:JACH.0000005610.11433.aa; Niwa H., 2006, SMART PROCESS TECHNO, V1, P57; Pivovar BS, 2006, POLYMER, V47, P4194, DOI 10.1016/j.polymer.2006.02.071; Wan NF, 2007, J POWER SOURCES, V163, P725, DOI 10.1016/j.jpowsour.2006.09.057; Wu QX, 2009, J POWER SOURCES, V191, P304, DOI 10.1016/j.jpowsour.2009.01.099; Xu C, 2007, J POWER SOURCES, V171, P268, DOI 10.1016/j.jpowsour.2007.07.028; Xu C, 2007, J POWER SOURCES, V168, P143, DOI 10.1016/j.jpowsour.2007.03.023; Yang SH, 2010, J POWER SOURCES, V195, P3536, DOI 10.1016/j.jpowsour.2009.12.043; Yi JS, 1998, J ELECTROCHEM SOC, V145, P1149, DOI 10.1149/1.1838431	37	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	MAY	2015	83	5					381	385		10.5796/electrochemistry.83.381		5	Electrochemistry	Electrochemistry	CI5XK	WOS:000354832900019		
J	Onodera, S; Kato, N; Ito, T; Ito, T; Tachibana, K; Nishina, T				Onodera, Shinya; Kato, Naoki; Ito, Tomoyuki; Ito, Tomohiro; Tachibana, Kazuhiro; Nishina, Tatsuo			The Effect of Dispersion Degree of Positive Electrodes Containing Carbon Nanotubes with Identical Composition on Contact Resistance in Lithium Ion Secondary Batteries	ELECTROCHEMISTRY			English	Article						Contact Resistance; Electric Susceptibility; Carbon Nanotubes; Dispersant	ALUMINUM	In this study the formula for expressing contact resistance R-c between the aluminum (Al) current collector and positive electrode composite in lithium secondary batteries is derived as follows: (1) R-c, is proportional to the thickness of the Al oxide film and apparent electric susceptibility of the composite X-e. (2) R-c decreases when the active material is coated with Carbon Nanotubes (CNT) due to the reduction of X-e. (3) X-e can be formulated by the contribution ratio C-i of the component i of the composite, with C-i determined by the dispersed condition of the composite. (C) The Electrochemical Society of Japan, All rights reserved.	[Onodera, Shinya; Kato, Naoki; Ito, Tomoyuki; Ito, Tomohiro; Tachibana, Kazuhiro; Nishina, Tatsuo] Yamagata Univ, Dept Chem & Chem Engn, Grad Sch Sci & Engn, Yonezawa, Yamagata 9928510, Japan	Onodera, S (reprint author), Yamagata Univ, Dept Chem & Chem Engn, Grad Sch Sci & Engn, 4-3-16 Jonan, Yonezawa, Yamagata 9928510, Japan.	tyt73646@st.yamagata-u.ac.jp					Honda C., 2013, 54 BATT S JAP, P185; Honda C, 2014, ELECTROCHEMISTRY, V82, P328, DOI 10.5796/electrochemistry.82.328; Ito T., 2014, FALL M EL SOC JAP, V2P09, P251; Ito T., 2013, 80 ANN M EL SOC JAP, V3A12, P32; Onodera S., 2013, 30 C AN RES SOC HIR, P107; Tachibana K, 2001, ELECTROCHEMISTRY, V69, P670	6	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	MAY	2015	83	5					386	388		10.5796/electrochemistry.83.386		3	Electrochemistry	Electrochemistry	CI5XK	WOS:000354832900020		
J	Luong, TT; Tran, BT; Ho, YT; Wei, TW; Wu, YH; Yen, TC; Wei, LL; Maa, JS; Chang, EY				Luong, Tien-Tung; Binh Tinh Tran; Ho, Yen-Teng; Wei, Ting-Wei; Wu, Yue-Han; Yen, Tzu-Chun; Wei, Lin-Lung; Maa, Jer-Shen; Chang, Edward Yi			2H-Silicon Carbide Epitaxial Growth on c-Plane Sapphire Substrate Using an AlN Buffer Layer and Effects of Surface Pre-Treatments	ELECTRONIC MATERIALS LETTERS			English	Article						AlN buffer; hydrogen pre-treatment; carbonization; XRD phi-scan; 2H-SiC	SILICON-CARBIDE; FILMS; GAN; CVD; RECONSTRUCTION; OPTIMIZATION; HYDROGEN; MODEL; EELS; AES	The effects of surface pre-treatments and the role of an AN buffer layer for 2H-SiC growth on c-plane sapphire substrates by thermal CVD are investigated. While the crystallinity of SiC directly grown on sapphire substrate always degrades with a hydrogen pre-treatment but improves by optimizing carbonization, the crystallinity of SiC grown on sapphire substrate using an AN buffer grown by MOCVD improves with sufficient time of exposure to the H pre-treatment but always deteriorates with carbonization. Detailed microstructural analysis by phi-scan x-ray diffraction reveals that SiC film grown on sapphire substrate consists of crystalline domains with two different crystallographic orientations which are rotated relative to each other along the [111] axis by 60 degrees. A highly oriented hexagonal 2H-SiC film is obtained on low-cost c-plane sapphire substrate by using an AN buffer. 2H-SiC is unambiguously determined not only by phi-scan x-ray diffraction but also by high-resolution transmission electron microscopy. The growth relationship between 2H-SiC and 2H-AlN are coherent due to the favorable bonding of C and Al between SiC and AlN.	[Luong, Tien-Tung; Ho, Yen-Teng; Wu, Yue-Han; Yen, Tzu-Chun; Wei, Lin-Lung; Chang, Edward Yi] Natl Chiao Tung Univ, Dept Mat Sci & Engn, Hsinchu 30010, Taiwan; [Binh Tinh Tran] RIKEN, Adv Sci Inst, Wako, Saitama 3510198, Japan; [Ho, Yen-Teng; Maa, Jer-Shen] Natl Chiao Tung Univ, Coll Photon, Tainan 71150, Taiwan; [Chang, Edward Yi] Natl Chiao Tung Univ, Dept Elect Engn, Hsinchu 30010, Taiwan	Chang, EY (reprint author), Natl Chiao Tung Univ, Dept Mat Sci & Engn, 1001 Univ Rd, Hsinchu 30010, Taiwan.	edc@mail.nctu.edu.tw			NCTU-UCB I-RiCE program, Ministry of Science and Technology, Taiwan [MOST 103-2911-I-009-302]	This work was sponsored by the NCTU-UCB I-RiCE program, Ministry of Science and Technology, Taiwan, under Grant No. MOST 103-2911-I-009-302.	Schoner A, 2006, CHEM VAPOR DEPOS, V12, P523, DOI 10.1002/cvde.200606467; Perova TS, 2010, NANOSCALE RES LETT, V5, P1507, DOI 10.1007/s11671-010-9670-6; Knaup JM, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.115323; Mahmood A, 2003, DIAM RELAT MATER, V12, P1315, DOI 10.1016/S0925-9635(03)00076-1; Severino A, 2007, J APPL PHYS, V102, DOI 10.1063/1.2756620; Persson C, 1996, PHYS REV B, V54, P10257, DOI 10.1103/PhysRevB.54.10257; Ouerghi A, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4734396; Nilsson HE, 1999, J APPL PHYS, V86, P6230, DOI 10.1063/1.371677; Wang XG, 2000, PHYS REV LETT, V84, P3650, DOI 10.1103/PhysRevLett.84.3650; Choyke WJ, 1997, MRS BULL, V22, P25; Daulton TL, 2003, GEOCHIM COSMOCHIM AC, V67, P4743, DOI 10.1016/S0016-7037(03)00272-2; Wasyluk J, 2010, MATER SCI FORUM, V645-648, P359, DOI 10.4028/www.scientific.net/MSF.645-648.359; BECOURT N, 1993, PHYSICA B, V185, P79, DOI 10.1016/0921-4526(93)90217-T; Bertilsson K, 2002, DIAM RELAT MATER, V11, P1254, DOI 10.1016/S0925-9635(01)00550-7; Bosi M, 2013, J CRYST GROWTH, V383, P84, DOI 10.1016/j.jcrysgro.2013.08.005; Feenstra RM, 2005, J VAC SCI TECHNOL B, V23, P1174, DOI 10.1116/1.1881612; Nguyen NG, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.085502; Han JC, 2009, OPT LASER TECHNOL, V41, P339, DOI 10.1016/j.optlastec.2008.05.026; Hwang J, 2013, J CRYST GROWTH, V366, P26, DOI 10.1016/j.jcrysgro.2012.12.136; Hwang JH, 2010, J CRYST GROWTH, V312, P3219, DOI 10.1016/j.jcrysgro.2010.07.046; Komiyama J, 2008, J CRYST GROWTH, V310, P96, DOI 10.1016/j.jcrysgro.2007.10.017; Kusumori T, 2004, APPL PHYS LETT, V84, P1272, DOI 10.1063/1.1649797; LAMBRECHT WRL, 1990, PHYS REV B, V41, P2948, DOI 10.1103/PhysRevB.41.2948; Li JC, 2010, THIN SOLID FILMS, V518, P1658, DOI 10.1016/j.tsf.2009.11.088; Luo MC, 2003, J CRYST GROWTH, V249, P1, DOI 10.1016/S0022-0248(02)02019-5; McArdle TJ, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3575202; Miao MS, 2010, J APPL PHYS, V107, DOI 10.1063/1.3431391; Nakagawa Y, 2013, J CRYST GROWTH, V371, P23, DOI 10.1016/j.jcrysgro.2013.01.042; Neugebauer J, 2001, PHYS STATUS SOLIDI B, V227, P93, DOI 10.1002/1521-3951(200109)227:1<93::AID-PSSB93>3.0.CO;2-Y; Park MH, 2012, MAT SCI SEMICON PROC, V15, P6, DOI 10.1016/j.mssp.2011.04.007; Park Y, 2008, J CRYST GROWTH, V310, P2724, DOI 10.1016/j.jcrysgro.2008.02.010; Qin Z, 2006, THIN SOLID FILMS, V515, P580, DOI 10.1016/j.tsf.2005.12.173; Saw KG, 2004, J MATER SCI, V39, P2911, DOI 10.1023/B:JMSC.0000021479.20164.f8; STAN MA, 1994, APPL PHYS LETT, V64, P2667, DOI 10.1063/1.111486; Stara I, 1997, APPL SURF SCI, V115, P46, DOI 10.1016/S0169-4332(96)00582-X; Suzuki H, 2007, JPN J APPL PHYS 1, V46, P5112, DOI 10.1143/JJAP.46.5112; Tepesch PD, 2000, PHYS STATUS SOLIDI B, V217, P377, DOI 10.1002/(SICI)1521-3951(200001)217:1<377::AID-PSSB377>3.0.CO;2-B; Tsuda M, 2003, APPL SURF SCI, V216, P585, DOI 10.1016/S0169-4332(03)00449-5; Uchida K, 2012, AIP ADV, V2, DOI 10.1063/1.4769082; Nose T, 2007, JPN J APPL PHYS 1, V46, P1114, DOI [10.1143/JJAP.46.1114, 10.1143/JJAP.46.11141]; Wang SW, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.026101; Xue QZ, 1999, APPL PHYS LETT, V74, P2468, DOI 10.1063/1.123883; Ye H, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.033302; Zheng HW, 2006, J ALLOY COMPD, V426, P290, DOI 10.1016/j.jallcom.2006.01.094; Zheng JC, 2001, APPL PHYS LETT, V79, P1643, DOI 10.1063/1.1402162	45	0	0	KOREAN INST METALS MATERIALS	SEOUL	KIM BLDG 6TH FLOOR, SEOCHO-DAERO 56 GIL 38, SEOCHO-GU, SEOUL 137-881, SOUTH KOREA	1738-8090	2093-6788		ELECTRON MATER LETT	Electron. Mater. Lett.	MAY	2015	11	3					352	359		10.1007/s13391-015-4208-9		8	Materials Science, Multidisciplinary	Materials Science	CI5VO	WOS:000354828100004		
J	Sujan, GK; Haseeb, ASMA; Amalina, MA; Nishikawa, H				Sujan, G. K.; Haseeb, A. S. M. A.; Amalina, M. A.; Nishikawa, Hiroshi			Ball Shear Strength and Fracture Modes of Lead-Free Solder Joints Prepared Using Nickel Nanoparticle Doped Flux	ELECTRONIC MATERIALS LETTERS			English	Article						Lead-free solder; nanoparticle doped flux; intermetallic compounds; ball shear test; fractography	INTERFACIAL INTERMETALLIC COMPOUNDS; COPPER SUBSTRATE; SN-3.5AG SOLDER; CU; GROWTH; REFLOW; IMPACT	Miniaturization and the need for the replacement of lead (Pb) based solders in microelectronic devices raise concerns over their reliability in the recent years. Particularly, the rapid growth of interfacial intermetallic compound (MC) layers in Pb free solders can lead to brittle fracture. A novel nanoparticle doped fluxing method was used to prepare ball grid array solder joints between Sn-3.0Ag-0.5Cu solder balls and Cu pads. In this method, nickel nanoparticles were mixed with a water soluble flux prior to its use. The shear strength and fracture modes of the resulting solder joints were investigated as a function of aging time. Results showed that MC layer growth was suppressed in solder joints prepared with 0.1 wt. % Ni doped flux. The average shear strength was marginally higher for solder joints prepared using 0.1 wt. % Ni doped flux compared with the joints prepared with undoped flux. Samples prepared using Ni doped flux showed a better resistant against brittle fracture for up to 30 days of aging.	[Sujan, G. K.; Haseeb, A. S. M. A.; Amalina, M. A.] Univ Malaya, Dept Mech Engn, Kuala Lumpur 50603, Malaysia; [Nishikawa, Hiroshi] Osaka Univ, Joining & Welding Res Inst, Osaka 5670047, Japan	Haseeb, ASMA (reprint author), Univ Malaya, Dept Mech Engn, Kuala Lumpur 50603, Malaysia.	haseeb@um.edu.my	Engineering, Faculty /I-7935-2015; HASEEB,  A S Md Abdul/B-8081-2010	Engineering, Faculty /0000-0002-4848-7052; HASEEB,  A S Md Abdul/0000-0003-2129-1903	High Impact Research grant (UM.C/HIR/MOHE/ENG/26) [D000026-16001]; University of Malaya Research grant (UMRG) [RP021-2012D]	The authors acknowledge the financial support of High Impact Research grant (UM.C/HIR/MOHE/ENG/26, Grant No. D000026-16001) and University of Malaya Research grant (UMRG, Grant No. RP021-2012D).	Haseeb ASMA, 2011, INTERMETALLICS, V19, P707, DOI 10.1016/j.intermet.2011.01.009; Fouzder T, 2010, MICROELECTRON RELIAB, V50, P2051, DOI 10.1016/j.microrel.2010.06.013; FREAR DR, 1994, METALL MATER TRANS A, V25, P1509, DOI 10.1007/BF02665483; Tay SL, 2013, INTERMETALLICS, V33, P8, DOI 10.1016/j.intermet.2012.09.016; Fouzder T, 2011, J ALLOY COMPD, V509, P1885, DOI 10.1016/j.jallcom.2010.10.081; Kumar S, 2011, ELECTRON MATER LETT, V7, P365, DOI 10.1007/s13391-011-0160-5; Haseeb ASMA, 2014, INTERMETALLICS, V54, P86, DOI 10.1016/j.intermet.2014.05.011; Wang JX, 2014, MICROELECTRON RELIAB, V54, P1583, DOI 10.1016/j.microrel.2014.03.007; El-Daly AA, 2014, MATER DESIGN, V55, P309, DOI 10.1016/j.matdes.2013.10.009; Gao F, 2006, MAT SCI ENG A-STRUCT, V420, P39, DOI 10.1016/j.msea.2006.01.032; Gao F, 2010, J ELECTRON MATER, V39, P426, DOI 10.1007/s11664-010-1093-8; Haseeb A. S. M. A., 2013, Patent Application No. P1, Patent No. 2013000584; Sujan GK, 2014, MATER CHARACT, V97, P199, DOI 10.1016/j.matchar.2014.10.002; Tang Y, 2013, J ALLOY COMPD, V554, P195, DOI 10.1016/j.jallcom.2012.12.019; Yang CR, 2014, MICROELECTRON RELIAB, V54, P435, DOI 10.1016/j.microrel.2013.10.005; Yoon JW, 2009, J ALLOY COMPD, V486, P142, DOI 10.1016/j.jallcom.2009.06.159; Zhang L, 2014, ELECTRON MATER LETT, V10, P645, DOI 10.1007/s13391-014-3190-y	17	0	0	KOREAN INST METALS MATERIALS	SEOUL	KIM BLDG 6TH FLOOR, SEOCHO-DAERO 56 GIL 38, SEOCHO-GU, SEOUL 137-881, SOUTH KOREA	1738-8090	2093-6788		ELECTRON MATER LETT	Electron. Mater. Lett.	MAY	2015	11	3					452	456		10.1007/s13391-015-4377-6		5	Materials Science, Multidisciplinary	Materials Science	CI5VO	WOS:000354828100019		
J	Fujiwara, T; Okamoto, H; Ohnishi, Y; Fukuoka, T; Ichimaru, K				Fujiwara, Takashi; Okamoto, Hiroshi; Ohnishi, Yasuhiro; Fukuoka, Toshio; Ichimaru, Kazuyuki			Diagnostic accuracy of lateral neck radiography in ruling out supraglottitis: a prospective observational study	EMERGENCY MEDICINE JOURNAL			English	Article							ACUTE EPIGLOTTITIS; ADULT EPIGLOTTITIS; VALLECULA SIGN; PARAMETERS	Objective To assess the diagnostic accuracy of lateral neck radiographs (LNR) for acute supraglottitis in adults. Design A single centre prospective observational study. Setting Emergency department at Kurashiki Central Hospital, Japan. Participants Adult patients who underwent LNR to detect supraglottitis. Main outcome measures Presence of supraglottitis, based on nasopharyngeal laryngoscopy or a follow-up telephone call, 7-30 days after the visit. Results 140 patients had LNR during the study period. 35 patients were excluded from further analysis because of lack of consent. Of the 105 eligible patients, 21 patients (20%) were given the diagnosis of supraglottitis: 17 of 29 with a radiographic abnormality, and 4 of 76 patients without a radiographic abnormality. Three of the four cases where LNR was negative was grade 1, and all cases of grade 3 or higher had abnormal LNR. Sensitivity and specificity (95% CI) of LNR for supraglottitis were 81.0% (64.2 to 97.7) and 85.7% (78.2 to 93.2), respectively. The positive predictive value of LNR was 58.6% (40.7 to 76.5) and the negative predictive value was 94.7% (89.7 to 99.8). The positive likelihood ratio of LNR was 5.67 (3.27 to 9.82) and the negative likelihood ratio was 0.22 (0.10 to 0.51). Conclusions LNR showed only moderate sensitivity and specificity for supraglottitis and would miss some cases of supraglottitis if the pre-test probability is high. LNR was very sensitive for grade 3 or higher supraglottitis, but would miss milder cases.	[Fujiwara, Takashi] Ehime Univ, Dept Otolaryngol Head & Neck Surg, Toon City, Ehime 7910295, Japan; [Okamoto, Hiroshi] Kurashiki Cent Hosp, Dept Emergency Med, Kurashiki, Okayama, Japan; [Ohnishi, Yasuhiro] Kurashiki Cent Hosp, Dept Radiol, Kurashiki, Okayama, Japan; [Fukuoka, Toshio] Kurashiki Cent Hosp, Dept Emergency Med, Kurashiki, Okayama, Japan; [Ichimaru, Kazuyuki] Kokura Mem Hosp, Dept Otolaryngol Head & Neck Surg, Kitakyushu, Fukuoka, Japan	Fujiwara, T (reprint author), Ehime Univ, Dept Otolaryngol Head & Neck Surg, Toon City, Ehime 7910295, Japan.	t.fujiwarabi@gmail.com					Katori H, 2005, J LARYNGOL OTOL, V119, P967; FRANTZ TD, 1994, JAMA-J AM MED ASSOC, V272, P1358, DOI 10.1001/jama.272.17.1358; Briem B, 2009, AURIS NASUS LARYNX, V36, P46, DOI 10.1016/j.anl.2008.03.012; Guldfred LA, 2008, J LARYNGOL OTOL, V122, P818, DOI 10.1017/S0022215107000473; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Ducic Y, 1997, ANN EMERG MED, V30, P1, DOI 10.1016/S0196-0644(97)70102-1; Frumkin K, 1998, ANN EMERG MED, V31, P139; HARRIS R D, 1970, Journal of the Canadian Association of Radiologists, V21, P270; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P389, DOI 10.1001/jama.271.5.389; Rafei K, 2006, PEDIATR CLIN N AM, V53, P215, DOI 10.1016/j.pcl.2005.10.001; ROTHROCK SG, 1990, ANN EMERG MED, V19, P978, DOI 10.1016/S0196-0644(05)82557-0; SCHABEL SI, 1977, RADIOLOGY, V122, P601; SCHUMAKER HM, 1984, ANN EMERG MED, V13, P588, DOI 10.1016/S0196-0644(84)80279-6; SHEIKH KH, 1989, WESTERN J MED, V151, P520; Yong MG, 2001, YONSEI MED J, V42, P367	15	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	MAY	2015	32	5					348	352		10.1136/emermed-2013-203340		5	Emergency Medicine	Emergency Medicine	CI5ET	WOS:000354777000005		
J	Sekine, K; Tojo, K; Bae, YJ				Sekine, Kazuki; Tojo, Koji; Bae, Yeon Jae			Distribution and genetic characteristics of Ephoron shigae (Ephemeroptera: Polymitarcyidae) in Korea	ENTOMOLOGICAL RESEARCH			English	Article						bisex population; burrowing mayfly; COI gene; dispersal; Ephoron shigae; Korean population	JAPAN EPHEMEROPTERA; GENUS EPHORON; LIFE-CYCLE; POPULATION; INSECTA	Ephoron shigae is distributed in Far East Russia, Korea and Japan, where it inhabits rivers, streams and lakes. Although this mayfly is a geographically parthenogenetic species, unisex populations have been observed only in Japan. We aimed to answer the following three questions: (i) whether there is a unisex population of E.shigae in Korea; (ii) whether migration and gene flow exists between E.shigae populations in Korea and Japan; and (3) whether E.shigae populations are fragmented in Korea because of mountains running to the north and south. We observed 20 populations across Korea and investigated the sex ratio in 12 populations. Our results showed that all the populations were bisex, and we believe that there is no unisex population of E.shigae in Korea. In addition, we examined the genetic structure of E.shigae in Korea by using the COI gene. The results showed that the Korean populations were clearly divergent from the Japanese populations; the level of genetic distance between the Korean and Japanese populations was interspecific rather than intraspecific. Therefore, parthenogenetic populations of E.shigae probably belong to unisex populations that originated in Japan, while the individuals would have not migrated to Korea. The Korean populations did not show clear fragmentation by geographic barrier, although this mayfly with extremely short adult stage (up to 2h) could be a comparatively strong disperser across Korea.	[Sekine, Kazuki; Bae, Yeon Jae] Korea Univ, Plus Ecoleader Educ Ctr BK21, Seoul, South Korea; [Sekine, Kazuki; Bae, Yeon Jae] Korea Univ, Coll Life Sci & Biotechnol, Korean Entomol Inst, Seoul 136713, South Korea; [Tojo, Koji] Shinshu Univ, Fac Sci, Dept Biol, Matsumoto, Nagano 390, Japan; [Tojo, Koji] Shinshu Univ, Inst Mt Sci, Matsumoto, Nagano 390, Japan; [Bae, Yeon Jae] Korea Univ, Coll Life Sci & Biotechnol, Div Environm Sci & Ecol Engn, Seoul 136713, South Korea	Bae, YJ (reprint author), Korea Univ, Coll Life Sci & Biotechnol, Div Environm Sci & Ecol Engn, 145 Anam Ro, Seoul 136713, South Korea.	yjbae@korea.ac.kr			BK21 Plus program - National Research Foundation of Korea (NRF) [21A20130012270]	This study was supported by the BK21 Plus program in 2014 (Project no. 21A20130012270), funded by the National Research Foundation of Korea (NRF). We thank Drs. M. J. Baek, J. M. Hwang, D. G. Kim, R. Kuranishi, K. I. Suh, and T. Suzuki, and Mr/Ms H. M. Baek, C. J. C. Uy, J. I. Jo, S. W. Jung, H. J. Kang, Y. Kato, K. Kobayashi, R. Saito, and H. J. Song for providing useful information in sampling and preparation of specimens.	BRITTAIN JE, 1982, ANNU REV ENTOMOL, V27, P119, DOI 10.1146/annurev.en.27.010182.001003; Sekine K, 2013, BIOL J LINN SOC, V109, P181, DOI 10.1111/bij.12033; Truett GE, 2000, BIOTECHNIQUES, V29, P52; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ishiwata S, 1996, CAN ENTOMOL, V128, P551; Tojo K, 2006, LIMNOLOGY, V7, P31, DOI 10.1007/s10201-006-0163-3; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Sekine K, 2010, BIOL J LINN SOC, V99, P335; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47; Bae YJ, 2011, TECHNOLOGY UTILIZATI, P1; Bae YJ, 2010, INSECT FAUNA KOREA; Sekine Kazuki, 2007, Japanese Journal of Limnology, V68, P253, DOI 10.3739/rikusui.68.253; Sekine K, 2006, FUKUSHIMASEIBUTSU, V49, P5; Sekine K, 2013, JAPANESE J LIMNOLOGY, V74, P73; Watanabe NC, 2000, AQUAT INSECT, V22, P108, DOI 10.1076/0165-0424(200004)22:2;1-P;FT108; Watanabe Naoshi C., 1997, Japanese Journal of Limnology, V58, P15; Watanabe Naoshi C., 1998, Japanese Journal of Limnology, V59, P199; Webb JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038063; YOON I B, 1985, Entomological Research Bulletin, V11, P93	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1738-2297	1748-5967		ENTOMOL RES	Entomol. Res.	MAY	2015	45	3					150	157		10.1111/1748-5967.12107		8	Entomology	Entomology	CI8EC	WOS:000355001100004		
J	Terasaki, M; Abe, R; Makino, M; Tatarazako, N				Terasaki, Masanori; Abe, Ryoko; Makino, Masakazu; Tatarazako, Norihisa			Chronic toxicity of parabens and their chlorinated by-products in Ceriodaphnia dubia	ENVIRONMENTAL TOXICOLOGY			English	Article						chlorinated by-products; Ceriodaphnia dubia; chronic toxicity; multivariate analyses; preliminary risk assessment	TROUT ONCORHYNCHUS-MYKISS; ESTROGENIC ACTIVITY; DAPHNIA-MAGNA; IN-VITRO; AQUATIC INVERTEBRATES; WASTE-WATER; PHARMACEUTICALS; ESTERS; VIVO; FOOD	The chronic toxicity of 12 compounds of parabens and their chlorinated by-products was investigated using 7-day Ceriodaphnia dubia test under static renewal condition in order to generate information on how to disinfect by-products of preservatives that are discharged in aquatic systems. The mortality and inhibition of reproduction tended to increase with increasing hydrophobicity and decreased with the degree of chlorination of parabens. The EC50 values for mortality, offspring number, and first brood production ranged between 0.30-3.1, 0.047-12, and 1.3-6.3 mg L-1, respectively. For the number of neonates, the most sensitive endpoint, the no-observed-effect concentration (NOEC) and lowest-observed-effect concentration (LOEC) values ranged from 0.63 to 10 mg L-1 and from 1.2 to 19 mg L-1, respectively. Methylparaben (MP), benzylparaben (BnP), and dichlorinated BnP (Cl2BnP) elicited a significant decrease in offspring numbers even at their lowest concentration tested; the NOEC for these compounds was determined to be less than the lowest test concentration (1.3, 0.04, and 0.63 mg L-1 for MP, BnP, and Cl2BnP, respectively). Propylparaben (PP), chlorinated PP, isopropylparaben (iPP), and chlorinated iPP exhibited nonmonotonic concentration-dependent response; their NOEC and LOEC values could not be determined. The multivariate approach involving principal component analysis and hierarchical cluster analysis revealed four groups that corresponded to the toxicological profiles of parabens. Our results suggested that disinfection of parabens by chlorination could reduce aquatic toxicity of original compounds. The findings obtained in our study together with the data available on paraben concentrations in aquatic systems can be used to perform preliminary risk assessment by comparing the predicted environmental concentration (PEC) with the predicted no-effect concentration (PNEC) for the marine aquatic environment. The calculated PEC/PNEC ratios ranged from 0.0012 to 0.2, with the highest value observed in MP. This suggested that there are negligible environmental risks for aquatic organisms at current use levels. (c) 2013 Wiley Periodicals, Inc. Environ Toxicol 30: 664-673, 2015.	[Terasaki, Masanori; Makino, Masakazu] Univ Shizuoka, Inst Environm Sci, Suruga Ku, Shizuoka 4228526, Japan; [Abe, Ryoko; Tatarazako, Norihisa] Natl Inst Environm Studies, Res Ctr Environm Risk, Tsukuba, Ibaraki 3058506, Japan	Terasaki, M (reprint author), Univ Shizuoka, Inst Environm Sci, Suruga Ku, Yada 52-1, Shizuoka 4228526, Japan.	terasaki@u-shizuoka-ken.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [24750148]	Contract grant sponsor: Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.; Contract grant number: 24750148.	Alslev B, 2005, AQUAT TOXICOL, V72, P295, DOI 10.1016/j.aquatox.2005.01.005; Terasaki M, 2009, J APPL TOXICOL, V29, P242, DOI 10.1002/jat.1402; Ma S, 2013, ENVIRON SCI-PROC IMP, V15, P145, DOI 10.1039/c2em30637a; Oetken M, 2005, ARCH ENVIRON CON TOX, V49, P353, DOI 10.1007/s00244-004-0211-0; Benijts T, 2004, ANAL CHEM, V76, P704, DOI 10.1021/ac035062x; Terasaki M, 2008, INT J ENVIRON AN CH, V88, P911, DOI 10.1080/03067310802272663; Bjerregaard P, 2003, COMP BIOCHEM PHYS C, V136, P309, DOI 10.1016/j.cca.2003.10.004; Yamamoto H, 2011, SCI TOTAL ENVIRON, V410, P102, DOI 10.1016/j.scitotenv.2011.09.040; Kamaya Y, 2005, CHEMOSPHERE, V59, P255, DOI 10.1016/j.chemosphere.2004.11.003; Canosa P, 2006, ANAL CHIM ACTA, V575, P106, DOI 10.1016/j.aca.2006.05.068; Gonzalez-Marino I, 2011, WATER RES, V45, P6770, DOI 10.1016/j.watres.2011.10.027; Terasaki M, 2009, J HEALTH SCI, V55, P631; Golden R, 2005, CRIT REV TOXICOL, V35, P435, DOI 10.1080/10408440490920104; Nentwig G, 2007, ARCH ENVIRON CON TOX, V52, P163, DOI 10.1007/s00244-005-7190-7; Soni MG, 2005, FOOD CHEM TOXICOL, V43, P985, DOI 10.1016/j.fct.2005.01.020; Routledge EJ, 1998, TOXICOL APPL PHARM, V153, P12, DOI 10.1006/taap.1998.8544; Darbre PD, 2002, J APPL TOXICOL, V22, P219, DOI 10.1002/jat.860; Tulp HC, 2009, ENVIRON SCI TECHNOL, V43, P9189, DOI 10.1021/es902272j; Kusk KO, 2011, ENVIRON TOXICOL CHEM, V30, P413, DOI 10.1002/etc.385; Dobbins LL, 2009, ENVIRON TOXICOL CHEM, V28, P2744, DOI 10.1897/08-523.1; Miller D, 2001, ENVIRON HEALTH PERSP, V109, P133, DOI 10.2307/3434765; Terasaki M, 2012, ENVIRON CHEM LETT, V10, P401, DOI 10.1007/s10311-012-0367-1; Terasaki M, 2009, ENVIRON TOXICOL CHEM, V28, P204, DOI 10.1897/08-225.1; Environment Canada, 2007, BIOL TEST METHOD TES; Harmon SM, 2003, ARCH ENVIRON CON TOX, V45, P79, DOI 10.1007/s00244-002-0116-8; Jukosky JA, 2008, B ENVIRON CONTAM TOX, V81, P230, DOI 10.1007/s00128-008-9462-1; Madsen T., 2001, ENV HLTH ASSESSMENT; R Core Team, 2013, LANG ENV STAT COMP; Steinberg D. C., 2010, COSMET TOILETRIES, V125, P46; SUNDERAM RIM, 1994, ARCH ENVIRON CON TOX, V27, P541; U. S. Environmental Protection Agency, EST PROGR INT EPI SU	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1520-4081	1522-7278		ENVIRON TOXICOL	Environ. Toxicol.	MAY-JUN	2015	30	6					664	673		10.1002/tox.21944		10	Environmental Sciences; Toxicology; Water Resources	Environmental Sciences & Ecology; Toxicology; Water Resources	CI3JO	WOS:000354644200006		
J	Kwan, P; Cabral-Lim, L; D'Souza, W; Jain, S; Lee, BI; Liao, WP; Lim, SH; Otsuki, T; Tan, CT; Wantanabe, M				Kwan, Patrick; Cabral-Lim, Leonor; D'Souza, Wendyl; Jain, Satish; Lee, Byung-In; Liao, Weiping; Lim, Shih-Hui; Otsuki, Taisuke; Tan, Chong-Tin; Wantanabe, Masako		CAOA Res Task Force	Research priorities in epilepsy for the Asia-Oceanian region	EPILEPSIA			English	Article						Epilepsy; Research priorities; Asia; Oceania; International League Against Epilepsy	QUALITY-OF-LIFE; SURGERY; JAPAN; CHINA	The Asia-Oceanian region is the most populous region in the world. Although there has been substantial economic development and improvement in health services in recent years, epilepsy remains generally an underrecognized and understudied condition. To help promote research in the region, the Commission on Asian and Oceanian Affairs (CAOA) of the International League Against Epilepsy (ILAE) appointed the Research Task Force (RTF) to facilitate the development of research priorities for the region. Research that focuses on issues that are unique or of particular importance in the Asia-Oceanian region is encouraged, and that captures the impact of the dynamic socioeconomic changes taking place in the region is emphasized. Based on these considerations, we propose research dimensions as priorities within the Asia-Oceanian region. These are studies (1) that would lead to fuller appreciation of the health burden of epilepsy, particularly the treatment gap; (2) that would lead to better understanding of the causes of epilepsy; (3) that would alleviate the psychosocial consequences of epilepsy; (4) that would develop better therapies and improved therapeutic outcomes; and (5) that would improve the research infrastructure.	[Kwan, Patrick] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Parkville, Vic 3052, Australia; [Kwan, Patrick] Univ Melbourne, Dept Neurol, Royal Melbourne Hosp, Parkville, Vic 3052, Australia; [Cabral-Lim, Leonor] Univ Philippines, Hlth Sci Ctr, Philippine Gen Hosp, Dept Neurosci,Coll Med, Manila, Philippines; [D'Souza, Wendyl] Univ Melbourne, St Vincents Hosp Melbourne, Dept Med, Fitzroy, Vic 3065, Australia; [Jain, Satish] Indian Epilepsy Ctr, New Delhi, India; [Jain, Satish] Asian Inst Med Sci, Faridabad, India; [Lee, Byung-In] Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Liao, Weiping] Guangzhou Med Univ, Inst Neurosci, Key Lab Neurogenet & Channelopathies Guangdong Pr, Guangzhou, Guangdong, Peoples R China; [Liao, Weiping] Guangzhou Med Univ, Affiliated Hosp 2, Key Lab Neurogenet & Channelopathies Guangdong Pr, Guangzhou, Guangdong, Peoples R China; [Liao, Weiping] Minist Educ China, Guangzhou, Guangdong, Peoples R China; [Lim, Shih-Hui] Duke Natl Univ Singapore, Grad Sch Med, Singapore Gen Hosp, Natl Neurosci Inst, Singapore, Singapore; [Otsuki, Taisuke] Natl Ctr Neurol & Psychiat, Dept Neurosurg, Tokyo, Japan; [Tan, Chong-Tin] Univ Malaya, Div Neurol, Kuala Lumpur, Malaysia; [Wantanabe, Masako] Natl Ctr Neurol & Psychiat, Dept Psychiat, Tokyo, Japan	Kwan, P (reprint author), Royal Melbourne Hosp, Dept Neurol, Parkville, Vic 3050, Australia.	patrick.kwan@unimelb.edu.au			Eisai; GlaxoSmithKline; UCB Pharma; Novartis Pharmaceuticals; Pfizer Pharmaceuticals; Sanofi-Synthelabo; GlaxoSmithKline Neurology Australia; SciGen; Novartis; Pfizer	This report was written by experts selected by the International League Against Epilepsy (ILAE) and was approved for publication by the ILAE. Opinions expressed by the authors, however, do not necessarily represent the policy or position of the ILAE. P. Kwan has received honoraria for speaking from Eisai, GlaxoSmithKline, and UCB Pharma, and has served on scientific advisory boards for Eisai and GlaxoSmithKline; his institution has received research funding from Eisai, GlaxoSmithKline, and UCB Pharma. W. D'Souza has received travel, investigator-initiated, speaker honoraria and has served on scientific advisory boards from UCB Pharma; educational grants from Novartis Pharmaceuticals, Pfizer Pharmaceuticals, and Sanofi-Synthelabo; educational, travel, and fellowship grants from GlaxoSmithKline Neurology Australia, has served on scientific advisory boards and received honoraria from SciGen Pharmaceuticals. His institute has received research funding from GlaxoSmithKline, SciGen, Pfizer, Novartis, and UCB Pharma. All the other authors have no conflict of interest to disclose. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.	Lim YJ, 2009, EPILEPSY RES, V87, P107, DOI 10.1016/j.eplepsyres.2009.08.014; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Jacoby A, 2008, EPILEPSY BEHAV, V12, P286, DOI 10.1016/j.yebeh.2007.10.006; Haneef Z, 2010, NEUROLOGY, V75, P699, DOI 10.1212/WNL.0b013e3181eee457; Kumlien E, 2010, SEIZURE-EUR J EPILEP, V19, P253, DOI 10.1016/j.seizure.2010.02.001; Englot DJ, 2012, NEUROLOGY, V78, P1200, DOI 10.1212/WNL.0b013e318250d7ea; Erba G, 2012, EPILEPSIA, V53, P35, DOI 10.1111/j.1528-1167.2011.03282.x; Arida RM, 2010, EPILEPSY BEHAV, V17, P432, DOI 10.1016/j.yebeh.2010.01.013; [Anonymous], 2002, EPILEPSIA S6, V43, P43; Asadi-Pooya AA, 2007, EPILEPSY BEHAV, V11, P450, DOI 10.1016/j.yebeh.2007.07.004; Sirven JI, 2003, NEUROLOGY, V61, P576; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Jette N, 2012, NEUROLOGY, V79, P1084; Lundgren T, 2008, EPILEPSY BEHAV, V13, P102, DOI 10.1016/j.yebeh.2008.02.009; Wang WZ, 2008, B WORLD HEALTH ORGAN, V86, P964, DOI 10.2471/BLT.07.047050; Cramer JA, 1998, EPILEPSIA, V39, P81, DOI 10.1111/j.1528-1157.1998.tb01278.x; Asawavichienjinda Thanin, 2005, Journal of the Medical Association of Thailand, V88, P1782; Baulac M., 2008, EPILEPSIA, V50, P571, DOI DOI 10.1111/J.1528-1167.2008.01811.X; Bergin P, 2007, EPILEPSIA, V48, P1418; Birbeck G, 2006, Psychol Health Med, V11, P364, DOI 10.1080/13548500600595343; Hu Yin, 2009, Zhejiang Da Xue Xue Bao Yi Xue Ban, V38, P605; Huang WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032960; Husain M, 2002, J Clin Forensic Med, V9, P61, DOI 10.1054/jcfm.2002.0562; Inoue Y, 2004, EPILEPSIA, V45, P1630, DOI 10.1111/j.0013-9580.2004.t01-1-17304.x; Anney RJL, 2014, LANCET NEUROL, V13, P893, DOI 10.1016/S1474-4422(14)70171-1; Kelly MS, 2009, EPILEPSIA, V50, P571; Kugoh T, 1998, CLIN THER, V20, pA48, DOI 10.1016/S0149-2918(98)80024-6; Lim SH, 2005, EPILEPSIA, V46, P48, DOI 10.1111/j.0013-9580.2005.461014.x; Locharernkul Chaichon, 2007, Journal of the Medical Association of Thailand, V90, P587; Mac TL, 2007, LANCET NEUROL, V6, P533; Rajshekhar V, 2003, ACTA TROP, V87, P53, DOI 10.1016/S0001-706X(03)00055-X; Seino M, 2001, NEUROL J SE ASIA, V6, P1; Somerville ER, 2010, MED J AUSTRALIA, V192, P342; STANAWAY L, 1983, NEW ZEAL MED J, V96, P525; Tran DS, 2006, NEUROEPIDEMIOLOGY, V26, P199, DOI 10.1159/000092407; Yoo HJ, 2002, J KOREAN EPILEPSY SO, V6, P45	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	MAY	2015	56	5					667	673		10.1111/epi.12957		7	Clinical Neurology	Neurosciences & Neurology	CI3IP	WOS:000354641700006		
J	Wilson, SJ; Baxendale, S; Barr, W; Hamed, S; Langfitt, J; Samson, S; Watanabe, M; Baker, GA; Helmstaedter, C; Hermann, BP; Smith, ML				Wilson, Sarah J.; Baxendale, Sallie; Barr, William; Hamed, Sherifa; Langfitt, John; Samson, Severine; Watanabe, Masako; Baker, Gus A.; Helmstaedter, Christoph; Hermann, Bruce P.; Smith, Mary-Lou			Indications and expectations for neuropsychological assessment in routine epilepsy care: Report of the ILAE Neuropsychology Task Force, Diagnostic Methods Commission, 2013-2017	EPILEPSIA			English	Article						Epilepsy; Neuropsychology; Training; Minimum standards; Adult; Pediatric	TEMPORAL-LOBE EPILEPSY; COGNITIVE-BEHAVIORAL THERAPY; STATUS EPILEPTICUS; SUICIDAL IDEATION; FOCAL EPILEPSY; CHILDREN; REHABILITATION; SURGERY; MEMORY; INTERVENTION	The International League Against Epilepsy (ILAE) Diagnostic Methods Commission charged the Neuropsychology Task Force with the job of developing a set of recommendations to address the following questions: (1) What is the role of a neuropsychological assessment? (2) Who should do a neuropsychological assessment? (3) When should people with epilepsy be referred for a neuropsychological assessment? and (4) What should be expected from a neuropsychological assessment? The recommendations have been broadly written for health care clinicians in established epilepsy settings as well as those setting up new services. They are based on a detailed survey of neuropsychological assessment practices across international epilepsy centers, and formal ranking of specific recommendations for advancing clinical epilepsy care generated by specialist epilepsy neuropsychologists from around the world. They also incorporate the latest research findings to establish minimum standards for training and practice, reflecting the many roles of neuropsychological assessment in the routine care of children and adults with epilepsy. The recommendations endorse routine screening of cognition, mood, and behavior in new-onset epilepsy, and describe the range of situations when more detailed, formal neuropsychological assessment is indicated. They identify a core set of cognitive and psychological domains that should be assessed to provide an objective account of an individual's cognitive, emotional, and psychosocial functioning, including factors likely contributing to deficits identified on qualitative and quantitative examination. The recommendations also endorse routine provision of feedback to patients, families, and clinicians about the implications of the assessment results, including specific clinical recommendations of what can be done to improve a patient's cognitive or psychosocial functioning and alleviate the distress of any difficulties identified. By canvassing the breadth and depth of scope of neuropsychological assessment, this report demonstrates the pivotal role played by this noninvasive and minimally resource intensive investigation in the care of people with epilepsy.	[Wilson, Sarah J.] Univ Melbourne, Melbourne Sch Psychol Sci, Parkville, Vic 3010, Australia; [Wilson, Sarah J.] Austin Hlth, Comprehens Epilepsy Program, Melbourne, Vic, Australia; [Baxendale, Sallie] NIHR Univ Coll London Hosp Biomed Res Ctr, UCL Inst Neurol, Dept Clin & Expt Epilepsy, London, England; [Barr, William] NYU, Sch Med, Dept Neurol, New York, NY USA; [Barr, William] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Hamed, Sherifa] Assiut Univ Hosp, Dept Neurol & Psychiat, Assiut, Egypt; [Langfitt, John] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Langfitt, John] Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA; [Samson, Severine] Hop La Pitie Salpetriere, Epilepsy Unit, Paris, France; [Samson, Severine] Univ Lille Nord France, Neuropsychol & Auditory Cognit, Lille, France; [Watanabe, Masako] Natl Ctr Neurol Psychiat, Dept Psychiat, Tokyo, Japan; [Baker, Gus A.] Walton Ctr Neurol & Neurosurg, Univ Dept Neurosci, Liverpool, Merseyside, England; [Helmstaedter, Christoph] Univ Bonn, Dept Epileptol, Bonn, Germany; [Hermann, Bruce P.] Univ Wisconsin, Dept Neurol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Smith, Mary-Lou] Univ Toronto Mississauga, Dept Psychol, Toronto, ON, Canada; [Smith, Mary-Lou] Hosp Sick Children, Neurosci & Mental Hlth Program, Toronto, ON M5G 1X8, Canada	Wilson, SJ (reprint author), Univ Melbourne, Melbourne Sch Psychol Sci, 12th Floor,Redmond Barry Bldg, Parkville, Vic 3010, Australia.	sarahw@unimelb.edu.au		Wilson, Professor Sarah/0000-0002-2678-1576			Tinuper P, 1998, J NEUROL NEUROSUR PS, V64, P231, DOI 10.1136/jnnp.64.2.231; Wagner JL, 2011, SEIZURE-EUR J EPILEP, V20, P462, DOI 10.1016/j.seizure.2011.02.010; Jackson DC, 2013, J PEDIATR-US, V162, P1047, DOI 10.1016/j.jpeds.2012.10.046; Hermann BP, 1996, EPILEPSIA, V37, P942, DOI 10.1111/j.1528-1157.1996.tb00531.x; Helmstaedter C, 2009, BRAIN, V132, P2822, DOI 10.1093/brain/awp182; Velissaris SL, 2007, EPILEPSY BEHAV, V10, P223, DOI 10.1016/j.yebeh.2006.12.008; Jones-Gotman M, 2010, EPILEPSY BEHAV, V18, P3, DOI 10.1016/j.yebeh.2010.02.019; Baker GA, 2011, EPILEPSIA, V52, P1084, DOI 10.1111/j.1528-1167.2011.03043.x; Thorbecke R, 2014, EPILEPSIA, V55, P725, DOI 10.1111/epi.12573; Blume WT, 2006, EPILEPSIA, V47, P71, DOI 10.1111/j.1528-1167.2006.00665.x; Witt JA, 2012, J NEUROL, V259, P1727, DOI 10.1007/s00415-012-6526-2; Neligan A, 2011, EPILEPSY RES, V93, P1, DOI 10.1016/j.eplepsyres.2010.09.003; Velissaris SL, 2012, EPILEPSIA, V53, P1774, DOI 10.1111/j.1528-1167.2012.03658.x; Butler CR, 2008, BRAIN, V131, P2243, DOI 10.1093/brain/awn127; Helmstaedter C, 2008, EPILEPSY BEHAV, V12, P402, DOI 10.1016/j.yebeh.2007.11.010; Baxendale S, 2010, EPILEPSIA, V51, P2225, DOI 10.1111/j.1528-1167.2010.02710.x; Overvliet GM, 2011, EPILEPSY BEHAV, V22, P527, DOI 10.1016/j.yebeh.2011.08.012; Engelberts NHJ, 2002, EPILEPSIA, V43, P587, DOI 10.1046/j.1528-1157.2002.29401.x; Blocher JB, 2013, EPILEPSY BEHAV, V27, P70, DOI 10.1016/j.yebeh.2012.12.014; Caplan R, 2008, EPILEPSIA, V49, P1838, DOI 10.1111/j.1528-1167.2008.01680.x; Loring DW, 2011, EPILEPSIA, V52, P1186, DOI 10.1111/j.1528-1167.2011.03018.x; Witt JA, 2014, ACTA NEUROL SCAND, V130, P172, DOI 10.1111/ane.12260; Calamia M, 2013, CLIN NEUROPSYCHOL, V27, P1077, DOI 10.1080/13854046.2013.809795; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Wilson SJ, 2014, EPILEPSY BEHAV, V41, P307, DOI 10.1016/j.yebeh.2014.09.011; Djordjevic J, 2011, PROGR EPILEPTIC DISO, V11, P13; Gascoigne MB, 2014, NEUROPSYCHOLOGIA, V59, P93, DOI 10.1016/j.neuropsychologia.2014.04.012; Giovagnoli AR., 2011, PROGR EPILEPTIC DISO, V11, P263; Gorske TT, 2009, COLLABORATIVE THERAPEUTIC NEUROPSYCHOLOGICAL ASSESSMENT, P1, DOI 10.1007/978-0-387-75426-0; Helmstaedter C, 2011, PROGR EPILEPTIC DISO, V11; Helmstaedter C, 2007, EPILEPSIA, V48, P85, DOI 10.1111/j.1528-1167.2007.01360.x; Helmstaedter Christoph, 2012, Handb Clin Neurol, V107, P437, DOI 10.1016/B978-0-444-52898-8.00036-7; Hermann B, 2008, EPILEPSIA, V49, P731, DOI 10.1111/j.1528-1167.2007.01435.x; Hesdorffer DC, 2013, EPILEPSIA, V54, P879, DOI 10.1111/epi.12128; Jones JE, 2013, EPILEPSY BEHAV, V29, P521, DOI 10.1016/j.yebeh.2013.09.020; Kerr EN, 2013, EPILEPSIA, V54, P27; Loughman A, 2014, NEUROSCI BIOBEHAV R, V43, P20, DOI 10.1016/j.neubiorev.2014.02.012; Rayner G, 2010, EPILEPSY BEHAV, V19, P359, DOI 10.1016/j.yebeh.2010.07.019; Strub RL, 2000, MENTAL STATUS EXAMIN; Taylor J, 2009, EPILEPSIA, V51, P48; Walker ER, 2010, EPILEPSY BEHAV, V19, P239, DOI 10.1016/j.yebeh.2010.07.032; Wiebe S, 2002, J NEUROL NEUROSUR PS, V73, P2116; Wilson SJ, 2010, SEIZURE-EUR J EPILEP, V19, P659, DOI 10.1016/j.seizure.2010.10.028	43	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	MAY	2015	56	5					674	681		10.1111/epi.12962		8	Clinical Neurology	Neurosciences & Neurology	CI3IP	WOS:000354641700007		
J	Honda, H				Honda, Hirotada			SMALL-TIME SOLVABILITY OF PRIMITIVE EQUATIONS FOR THE OCEAN WITH SPATIALLY-VARYING VERTICAL MIXING	ESAIM-MATHEMATICAL MODELLING AND NUMERICAL ANALYSIS-MODELISATION MATHEMATIQUE ET ANALYSE NUMERIQUE			English	Article						Primitive equations; Sobolev-Slobodetskii space; strong solution	LARGE-SCALE OCEAN; NAVIER-STOKES EQUATIONS; FREE-SURFACE METHOD; HYDROSTATIC APPROXIMATION; ATMOSPHERE; MODELS; REGULARITY; EXISTENCE; DYNAMICS; WAVES	The small-time existence of a strong solution to the free surface problem of primitive equations for the ocean with variable turbulent viscosity terms is shown in this paper. In this model, the turbulent viscosity coefficients, which include the Richardson number depending on unknown variables, are explicitly formulated. In addition, following the formulation of practical models, the kinematic condition is assumed on the free ocean surface. As in preceding works, we consider the problem in the three-dimensional strip-like region, and assume the f-approximation. Under some conditions on the initial and boundary data and the topography of the bottom of the ocean, we construct a strong local-in-time solution in Sobolev-Slobodetskii spaces. The boundedness of the temperature and salinity is also shown in the present paper.	Keio Univ, Dept Math, Yokohama, Kanagawa 2238522, Japan	Honda, H (reprint author), Keio Univ, Dept Math, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	t.asc2904@gmail.com					KILLWORTH PD, 1991, J PHYS OCEANOGR, V21, P1333, DOI 10.1175/1520-0485(1991)021<1333:TDOAFS>2.0.CO;2; LIONS JL, 1992, NONLINEARITY, V5, P1007, DOI 10.1088/0951-7715/5/5/002; Hu CB, 2003, DISCRETE CONT DYN S, V9, P97; PACANOWSKI RC, 1981, J PHYS OCEANOGR, V11, P1443, DOI 10.1175/1520-0485(1981)011<1443:POVMIN>2.0.CO;2; DUKOWICZ JK, 1994, J GEOPHYS RES-OCEANS, V99, P7991, DOI 10.1029/93JC03455; Azerad P, 2001, SIAM J MATH ANAL, V33, P847; LIONS JL, 1992, NONLINEARITY, V5, P237, DOI 10.1088/0951-7715/5/2/001; Griffies SM, 2001, MON WEATHER REV, V129, P1081, DOI 10.1175/1520-0493(2001)129<1081:TCWAEF>2.0.CO;2; BEALE JT, 1984, ARCH RATION MECH AN, V84, P307; Beron-Vera FJ, 1999, OCEAN MODEL, V1, P111, DOI 10.1016/S1463-5003(00)00003-2; BESSON O, 1992, ESAIM-MATH MODEL NUM, V26, P855; Bjerknes V., 1904, METEOROL Z, V21, P1; BLECK R, 1986, J GEOPHYS RES-OCEANS, V91, P7611, DOI 10.1029/JC091iC06p07611; Blumberg AF, 1987, 3 DIMENSIONAL COASTA, DOI [10.1029/CO004p0001, DOI 10.1029/C0004P0001]; Bresch D, 2004, SIAM J MATH ANAL, V36, P796, DOI 10.1137/S0036141003422242; Bryan K., 1972, Journal of Physical Oceanography, V2, DOI 10.1175/1520-0485(1972)002<0510:AAEOSF>2.0.CO;2; Bryan K., 1969, J COMPUT PHYS, V135, P154; Cao CS, 2007, ANN MATH, V166, P245; Cox M.D., 1984, 1 GFDL OC GROUP, V1; Crowley W. P., 1968, Journal of Computational Physics, V3, DOI 10.1016/0021-9991(68)90009-0; Crowley W. P., 1970, Journal of Computational Physics, V5, DOI 10.1016/0021-9991(70)90057-4; Griffies S., 2004, FUNDAMENTALS OCEAN C; Guillen-Gonzalez F., 2005, BANACH CTR, V70, P85; Guillen-Gonzalez F, 2002, NONLINEAR ANAL-THEOR, V50, P621, DOI 10.1016/S0362-546X(01)00773-8; Guillen-Gonzlaez F., 2001, DIFFERENTIAL INTEGRA, V14, P1381; Hasumi H., 2000, 13 CCSR; Honda H., 2011, THESIS KEIO U JAPAN; Honda H, 2012, TOKYO J MATH, V35, P97; Honda H., 2009, SURIKAISEKI KENKYUSH, V1631, P12; Honda H., 2010, ADV MATH SCI APPL, V20, P547; Jones J. H., 1973, Journal of Physical Oceanography, V3, DOI 10.1175/1520-0485(1973)003<0286:VMITEU>2.0.CO;2; KRAUS EB, 1967, TELLUS, V19, P98; Ladyzenskaja O.A., 1968, TRANSL MATH MONOGR, V23; Lions J. L., 1993, Computational Mechanics Advances, V1; Lions J. L., 1993, Computational Mechanics Advances, V1; Lions JL, 2000, NONLINEAR ANAL-THEOR, V40, P439, DOI 10.1016/S0362-546X(00)85026-9; LIONS JL, 1995, J MATH PURE APPL, V74, P105; LIONS JL, 1994, CR ACAD SCI I-MATH, V318, P1165; Richardson LF, 1922, WEATHER PREDICTION N; Semtner A. J., 1974, UCLA DEP METEOROLOGY, V8, P99; Solonnikov V. A., 1965, T MATEM I VA STEKLOV, V83, P3; Solonnikov V. A., 1965, P STEKLOV I MATH, V83, p[3, 1]; Solonnikov V. A., 1991, CONSTANTIN CARATHEOD, P1270; Solonnikov V. A., 1992, ST PETERSB MATH J, V3, P189; Tanaka N., 2003, J MATH FLUID MECH, V5, P303, DOI 10.1007/s00021-003-0078-2; Tanaka N., 1995, JAPAN J MATH, V21, P1; TANI A, 1995, ARCH RATION MECH AN, V130, P303, DOI 10.1007/BF00375142; Temam R., 2004, HDB MATH FLUID DYNAM, VIII, P535; UNESCO, 1980, UNESCO TECHNICAL PAP, V36; Washington W. M., 1986, INTRO 3 DIMENSIONAL; Wloka J., 1982, PARTIELLE DIFFERENTI; Ziane M, 1997, NONLINEAR ANAL-THEOR, V28, P289, DOI 10.1016/0362-546X(95)00154-N; Ziane M, 1995, APPL ANAL, V58, P263, DOI 10.1080/00036819508840376	53	0	0	EDP SCIENCES S A	LES ULIS CEDEX A	17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A, FRANCE	0764-583X	1290-3841		ESAIM-MATH MODEL NUM	ESAIM-Math. Model. Numer. Anal.-Model. Math. Anal. Numer.	MAY-JUN	2015	49	3					875	919		10.1051/m2an/2014061		45	Mathematics, Applied	Mathematics	CI5KG	WOS:000354794100012		
J	Takigawa, M; Kuwahara, T; Takahashi, A; Okubo, K; Takahashi, Y; Nakashima, E; Yamao, K; Watari, Y; Nakajima, J; Takagi, K; Fujino, T; Kimura, S; Hikita, H; Hirao, K; Isobe, M				Takigawa, Masateru; Kuwahara, Taishi; Takahashi, Atsushi; Okubo, Kenji; Takahashi, Yoshihide; Nakashima, Emiko; Yamao, Kazuya; Watari, Yuji; Nakajima, Jun; Takagi, Katsumasa; Fujino, Tadashi; Kimura, Shigeki; Hikita, Hiroyuki; Hirao, Kenzo; Isobe, Mitsuaki			Simultaneous isolation of superior and inferior pulmonary veins on both the left and right sides could yield better outcomes in patients with paroxysmal atrial fibrillation	EUROPACE			English	Article						Atrial fibrillation; Catheter ablation; Pulmonary vein isolation; Pulmonary vein potentials; Recurrence; Carina; Reconnection	DOUBLE-LASSO TECHNIQUE; CATHETER ABLATION; RADIOFREQUENCY ABLATION; VENA-CAVA; CARINA; INITIATION; ISTHMUS; POINT	Aims This study investigated whether disappearance patterns of pulmonary vein (PV) potentials (PVPs) during PV isolation (PVI) affect the outcome of catheter ablation (CA) in patients with paroxysmal atrial fibrillation (PAF). Methods and Results Extensive PVI was performed in 1149 PAF patients (age, 61 +/- 10 years). Clinical and demographic characteristics, ablation data, and follow-up outcomeswere prospectively collected. During an initial CA, simultaneous disappearance of superior and inferior PVPs in both right and left PVs was observed in 464 (40.4%) patients (Group S). Atrial fibrillation-recurrence free rates at 1, 3, and 5 years after the initial CA in Group S were 78.9, 71.9, and 68.1%, respectively, which were higher than those in Group Non-S (P = 0.004). However, those were similar after the final CA between both groups. The incidence of PV-left atrium (LA) electrical reconnection was significantly lower in Group S than in Group Non-S in the second (Group S, 65.6% vs. Group Non-S, 82.1%; P = 0.004) and third (Group S, 8.3% vs. Group Non-S, 47.6%; P = 0.03) CAs. Furthermore, the reconnections more frequently occurred on the side of PVs where simultaneous PVP elimination had not been achieved at the initial CA. Simultaneous disappearance of superior and inferior PVPs in both right and left PVs independently reduced the risk of AF recurrence after the initial CA by 26%. Conclusions The simultaneous disappearance of superior and inferior PVPs in both right and left PVs is associated with less frequent PV-left atrium reconnection and may yield a better clinical outcome after the initial CA.	[Takigawa, Masateru; Kuwahara, Taishi; Takahashi, Atsushi; Okubo, Kenji; Takahashi, Yoshihide; Nakashima, Emiko; Yamao, Kazuya; Watari, Yuji; Nakajima, Jun; Takagi, Katsumasa; Fujino, Tadashi; Kimura, Shigeki; Hikita, Hiroyuki] Yokosuka Kyosai Hosp, Cardiovasc Ctr, Yokosuka, Kanagawa 2388558, Japan; [Takigawa, Masateru; Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan; [Hirao, Kenzo] Tokyo Med & Dent Univ, Heart Rhythm Ctr, Tokyo, Japan	Takigawa, M (reprint author), Yokosuka Kyosai Hosp, Cardiovasc Ctr, 1-16 Yonegahama St, Yokosuka, Kanagawa 2388558, Japan.	teru.takigawa@gmail.com					Miller MA, 2012, EUROPACE, V14, P653, DOI 10.1093/europace/eus048; Tsai CF, 2000, CIRCULATION, V102, P67; Takigawa M, 2013, INT J CARDIOL, V168, P1984, DOI 10.1016/j.ijcard.2012.12.101; Bhargava M, 2009, HEART RHYTHM, V6, P1403, DOI 10.1016/j.hrthm.2009.06.014; Jais P, 2004, CIRCULATION, V110, P2996, DOI 10.1161/01.CIR.0000146917.75041.58; Hachiya H, 2007, J CARDIOVASC ELECTR, V18, P392, DOI 10.1111/j.1540-8167.2006.00753.x; Calkins H, 2012, EUROPACE, V14, P528, DOI 10.1093/europace/eus027; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Ouyang FF, 2004, CIRCULATION, V110, P2090, DOI 10.1161/01.CIR.0000144459.37455.EE; Themistoclakis S, 2008, HEART RHYTHM, V5, P679, DOI 10.1016/j.hrthm.2008.01.031; Lin WS, 2003, CIRCULATION, V107, P3176, DOI 10.1161/01.CIR.0000074206.52056.2D; Hocini M, 2005, CIRCULATION, V112, P3688, DOI 10.1161/CIRCULATIONAHA.105.541052; Miyazaki S, 2007, CIRC J, V71, P1922, DOI 10.1253/circj.71.1922; Higuchi K, 2010, HEART RHYTHM, V7, P1186, DOI 10.1016/j.hrthm.2010.05.017; Kuwahara T, 2009, J CARDIOVASC ELECTR, V20, P1, DOI 10.1111/j.1540-8167.2008.01280.x; Takigawa M, 2014, CIRC-ARRHYTHMIA ELEC, V7, P267, DOI 10.1161/CIRCEP.113.000471; Takigawa M, 2013, EUROPACE, V15, P33, DOI 10.1093/europace/eus243; Udyavar AR, 2008, J CARDIOVASC ELECTR, V19, P593, DOI 10.1111/j.1540-8167.2008.01182.x; Valles E, 2008, J AM COLL CARDIOL, V52, P1413, DOI 10.1016/j.jacc.2008.07.025; Winkle RA, 2011, AM HEART J, V162, P193, DOI 10.1016/j.ahj.2011.04.013	20	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1099-5129	1532-2092		EUROPACE	Europace	MAY 1	2015	17	5					732	740		10.1093/europace/euu372		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CI0SW	WOS:000354449300009		
J	Ritter, P; Duray, GZ; Zhang, S; Narasimhan, C; Soejima, K; Omar, R; Laager, V; Stromberg, K; Williams, E; Reynolds, D				Ritter, Philippe; Duray, Gabor Z.; Zhang, Shu; Narasimhan, Calambur; Soejima, Kyoko; Omar, Razali; Laager, Verla; Stromberg, Kurt; Williams, Eric; Reynolds, Dwight		Micra Transcatheter Pacing Study G	The rationale and design of the Micra Transcatheter Pacing Study: safety and efficacy of a novel miniaturized pacemaker	EUROPACE			English	Article						Pacemaker; Transcatheter pacing system; Miniaturization; Delivery catheter; Leadless pacemaker	SINUS-NODE DISEASE; MULTICENTER; COHORT; RATES; RISK	Aims Recent advances in miniaturization technologies and battery chemistries have made it possible to develop a pacemaker small enough to implant within the heart while still aiming to provide similar battery longevity to conventional pacemakers. The Micra Transcatheter Pacing System is a miniaturized single-chamber pacemaker system that is delivered via catheter through the femoral vein. The pacemaker is implanted directly inside the right ventricle of the heart, eliminating the need for a device pocket and insertion of a pacing lead, thereby potentially avoiding some of the complications associated with traditional pacing systems. Methods and results The Micra Transcatheter Pacing Study is currently undergoing evaluation in a prospective, multi-site, single-arm study. Approximately 720 patients will be implanted at up to 70 centres around the world. The study is designed to have a continuously growing body of evidence and data analyses are planned at various time points. The primary safety and efficacy objectives at 6-month post-implant are to demonstrate that (i) the percentage of Micra patients free from major complications related to the Micra system or implant procedure is significantly higher than 83% and (ii) the percentage of Micra patients with both low and stable thresholds is significantly higher than 80%. The safety performance benchmark is based on a reference dataset of 977 subjects from 6 recent pacemaker studies. Conclusions The Micra Transcatheter Pacing Study will assess the safety and efficacy of a miniaturized, totally endocardial pacemaker in patients with an indication for implantation of a single-chamber ventricular pacemaker.	[Ritter, Philippe] Univ Bordeaux, CHU, Dept Cardiac Pacing & Electrophysiol, F-33604 Pessac, France; [Ritter, Philippe] Univ Bordeaux, CHU, Inst Rythmol & Modelisat Cardiaque LIRYC, INSERM,U1045, F-33604 Pessac, France; [Duray, Gabor Z.] Hungarian Def Forces, Med Ctr, Clin Electrophysiol Dept Cardiol, Budapest, Hungary; [Zhang, Shu] Fuwai Hosp, Clin EP Lab, Beijing, Peoples R China; [Zhang, Shu] Fuwai Hosp, Arrhythmia Ctr, Beijing, Peoples R China; [Narasimhan, Calambur] CARE Hosp & CARE Fdn, Dept Cardiol, Div Electrophysiol, Hyderabad, Andhra Pradesh, India; [Soejima, Kyoko] Kyorin Univ Hosp, Dept Cardiol, Tokyo, Japan; [Omar, Razali] Natl Heart Inst, Electrophysiol & Pacing Unit, Kuala Lumpur, Malaysia; [Laager, Verla; Stromberg, Kurt; Williams, Eric] Medtronic, Mounds View, MN USA; [Reynolds, Dwight] Univ Oklahoma, Hlth Sci Ctr, Cardiovasc Sect, OU Med Ctr, Oklahoma City, OK USA	Ritter, P (reprint author), Univ Bordeaux, CHU, Dept Cardiac Pacing & Electrophysiol, Ave Magellan, F-33604 Pessac, France.	ritterph@free.fr			Medtronic Bakken Research Center BV, Maastricht, NL, Europe; Medtronic Inc., Minneapolis, MN, USA	This work was supported by Medtronic Bakken Research Center BV, Maastricht, NL, Europe and Medtronic Inc., Minneapolis, MN, USA.	Schwitter J, 2013, HEART RHYTHM, V10, P864, DOI 10.1016/j.hrthm.2013.02.019; Poole JE, 2010, CIRCULATION, V122, P1553, DOI 10.1161/CIRCULATIONAHA.110.976076; Kirkfeldt RE, 2014, EUR HEART J, V35, P1186, DOI 10.1093/eurheartj/eht511; Wilkoff BL, 2011, HEART RHYTHM, V8, P65, DOI 10.1016/j.hrthm.2010.10.002; Gillis AM, 2006, PACE, V29, P697, DOI 10.1111/j.1540-8159.2006.00422.x; Coates S, 2000, PACE, V23, P1273, DOI 10.1111/j.1540-8159.2000.tb00943.x; Connolly SJ, 2000, NEW ENGL J MED, V342, P1385, DOI 10.1056/NEJM200005113421902; Johansen JB, 2011, EUR HEART J, V32, P991, DOI 10.1093/eurheartj/ehq497; Gammage MD, 2006, PACE, V29, P858, DOI 10.1111/j.1540-8159.2006.00452.x; Bonner M, 2013, EUR HEART J, V34, DOI 10.1093/eurheartj/eht308.1918; Bonner MD, 2014, HEART RHYTHM, V11, pS19; Bonner MD, 2014, HEART RHYTHM, V11, pS342; Eggen MD, HRS 2013; HWANG IK, 1990, STAT MED, V9, P1439, DOI 10.1002/sim.4780091207; Mallela Venkateswara Sarma, 2004, Indian Pacing Electrophysiol J, V4, P201; Medtronic Inc, 2005, CAPSUREFIX NOV 5076; SPICKLER J W, 1970, Journal of Electrocardiology, V3, P325, DOI 10.1016/S0022-0736(70)80059-0; Sweeney MO, 2007, NEW ENGL J MED, V357, P1000, DOI 10.1056/NEJMoa071880; Wilkoff BL, 1989, J ELECTROPHYSIOL, V3, P176	19	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1099-5129	1532-2092		EUROPACE	Europace	MAY 1	2015	17	5					807	813		10.1093/europace/euv026		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CI0SW	WOS:000354449300020		
J	Intarasirisawat, R; Benjakul, S; Vissessanguan, W; Maqsood, S; Osako, K				Intarasirisawat, Rossawan; Benjakul, Soottawat; Vissessanguan, Wonnop; Maqsood, Sajid; Osako, Kazufumi			Skipjack roe protein hydrolysate combined with tannic acid increases the stability of fish oil upon microencapsulation	EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY			English	Article						Katsuwonus pelamis; Microcapsule; Oxidized tannic acid; Protein hydrolysate; Roe; Tannic acid	POLYUNSATURATED FATTY-ACIDS; WATER EMULSION PROPERTIES; OXIDATIVE STABILITY; FUNCTIONAL-PROPERTIES; LIPID OXIDATION; WALL MATERIALS; SPRAY; ENCAPSULATION; PRODUCTS; IMPACT	Microencapsulation of fish oil was achieved by spray drying the micro-emulsion, in which skipjack roe protein hydrolysate (SRPH: degree of hydrolysis, 5%) was used as the wall material in the absence or presence of tannic acid (TA) or oxidized tannic acid (OTA). Microcapsule using SRPH had a lower encapsulation efficiency (EE) than those having sodium caseinate-whey protein concentrate (Ca-WPC) as the wall materials (p<0.05). The incorporation of TA or OTA in combination with SRPH yielded spherical encapsulated fish oil with higher EE but lower particle size (p<0.05) than achieved with SRPH alone. Furthermore, the addition of TA retarded lipid oxidation of microcapsule more effectively as indicated by lower peroxide value and thiobarbituric acid reactive substances (TBARS) value during storage at 30 degrees C for 4 weeks, compared with those using only SRPH (p<0.05). Nevertheless, OTA in conjunction with SRPH yielded the higher EE than TA. Therefore, SRPH could serve as an alternative wall material for microencapsulation of fish oil, especially with the aid of TA or OTA.	[Intarasirisawat, Rossawan; Benjakul, Soottawat] Prince Songkla Univ, Fac Agroind, Dept Food Technol, Hat Yai 90112, Songkhla, Thailand; [Vissessanguan, Wonnop] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand; [Maqsood, Sajid] UAE Univ, Fac Food & Agr, Dept Food Sci, Al Ain, U Arab Emirates; [Osako, Kazufumi] Tokyo Univ Marine Sci & Technol, Dept Food Sci & Technol, Tokyo, Japan	Benjakul, S (reprint author), Prince Songkla Univ, Fac Agroind, Dept Food Technol, Hat Yai 90112, Songkhla, Thailand.	soottawat.b@psu.ac.th	OSAKO, Kazufumi/O-1978-2014		Higher Education Research Promotion; National Research University Project of Thailand, Office of the Higher Education Commission	This work was supported by the Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission. The TRF Distinguished Research Professor Grant and Prince of Songkla University were also acknowledged.	Aberkane L., 2013, FOOD BIOPROCESS TECH, P1; Carneiro HCF, 2013, J FOOD ENG, V115, P443, DOI 10.1016/j.jfoodeng.2012.03.033; Walton DE, 1999, CHEM ENG RES DES, V77, P21, DOI 10.1205/026387699525846; Jafari SM, 2008, FOOD RES INT, V41, P172, DOI 10.1016/j.foodres.2007.11.002; Bae EK, 2008, J MICROENCAPSUL, V25, P549, DOI 10.1080/02652040802075682; Serfert Y, 2009, FOOD CHEM, V113, P1106, DOI 10.1016/j.foodchem.2008.08.079; Drusch S, 2006, FOOD RES INT, V39, P807, DOI 10.1016/j.foodres.2006.03.003; Chabanon G, 2007, PROCESS BIOCHEM, V42, P1419, DOI 10.1016/j.procbio.2007.07.009; Klaypradit W, 2008, LWT-FOOD SCI TECHNOL, V41, P1133, DOI 10.1016/j.lwt.2007.06.014; Wang RX, 2011, FOOD RES INT, V44, P2735, DOI 10.1016/j.foodres.2011.06.013; Maqsood S, 2010, FOOD CHEM, V119, P123, DOI 10.1016/j.foodchem.2009.06.004; Anwar SH, 2011, J FOOD ENG, V105, P367, DOI 10.1016/j.jfoodeng.2011.02.047; Drusch S, 2007, J AGR FOOD CHEM, V55, P11044, DOI 10.1021/jf072536a; Gharsallaoui A, 2007, FOOD RES INT, V40, P1107, DOI 10.1016/j.foodres.2007.07.004; Intarasirisawat R, 2014, FOOD HYDROCOLLOID, V41, P146, DOI 10.1016/j.foodhyd.2014.03.034; Alamilla-Beltran L, 2005, J FOOD ENG, V67, P179, DOI 10.1016/j.jfoodeng.2004.05.063; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Quispe-Condori S, 2011, LWT-FOOD SCI TECHNOL, V44, P1880, DOI 10.1016/j.lwt.2011.01.005; Chaiyasit W, 2007, CRIT REV FOOD SCI, V47, P299, DOI 10.1080/10408390600754248; Tonon RV, 2011, FOOD RES INT, V44, P282, DOI 10.1016/j.foodres.2010.10.018; Benjakul S, 1997, J AGR FOOD CHEM, V45, P3423, DOI 10.1021/jf970294g; Kagami Y, 2003, J FOOD SCI, V68, P2248, DOI 10.1111/j.1365-2621.2003.tb05755.x; Castellani O, 2006, FOOD HYDROCOLLOID, V20, P35, DOI 10.1016/j.foodhyd.2005.02.010; Augustin MA, 2006, J FOOD SCI, V71, pE25; Aewsiri T, 2009, FOOD CHEM, V117, P160, DOI 10.1016/j.foodchem.2009.03.092; Klinkesorn U, 2005, J AGR FOOD CHEM, V53, P8365, DOI 10.1021/jf050761r; Iglesias J, 2008, J CHROMATOGR A, V1192, P9, DOI 10.1016/j.chroma.2008.03.028; Ortiz SEM, 2009, LWT-FOOD SCI TECHNOL, V42, P919, DOI 10.1016/j.lwt.2008.12.004; Intarasirisawat R, 2012, FOOD CHEM, V135, P3039, DOI 10.1016/j.foodchem.2012.06.076; Aghbashlo M, 2013, FOOD BIOPROCESS TECH, V6, P1561, DOI 10.1007/s11947-012-0796-7; Venkateshwarlu G, 2004, J AGR FOOD CHEM, V52, P311, DOI 10.1021/jf034833v; Ritter JCS, 2012, LIPIDS, V47, P1169, DOI 10.1007/s11745-012-3733-7; Kolanowski W, 2006, EUR FOOD RES TECHNOL, V222, P336, DOI 10.1007/s00217-005-0111-1; AOAC, 1984, AOAC OFF AN METH; Buege J A, 1978, Methods Enzymol, V52, P302; Bottcher S., 2014, FOOD CHEM; Daimer K, 2009, FOOD HYDROCOLLOID, V23, P1366, DOI 10.1016/j.foodhyd.2008.10.002; Dlugogorski B. Z., 2012, IND ENG CHEM RES, V51, P5653; Garg ML, 2006, J FOOD SCI, V71, pR66, DOI 10.1111/j.1750-3841.2006.00033.x; Shahidi F., 1995, ACS SYM SER, P139; Song SQ, 2011, FOOD CHEM, V124, P203, DOI 10.1016/j.foodchem.2010.06.010; Steel R.G., 1980, PRINCIPLES PROCEDURE; Takeungwongtrakul S., 2013, INT AQUAT RES, V5, P14, DOI DOI 10.1186/2008-6970-5-14; Tan LH, 2009, J MICROENCAPSUL, V26, P263, DOI 10.1080/02652040802305519; Venkatesan P, 2009, J PHARM SCI RES, V1, P26; Wan YT, 2011, J FOOD SCI, V76, pE348, DOI 10.1111/j.1750-3841.2011.02111.x; Yin HX, 2010, J FOOD SCI, V75, pE163, DOI 10.1111/j.1750-3841.2010.01532.x	47	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1438-7697	1438-9312		EUR J LIPID SCI TECH	Eur. J. Lipid Sci. Technol.	MAY	2015	117	5					646	656		10.1002/ejlt.201400247		11	Food Science & Technology; Nutrition & Dietetics	Food Science & Technology; Nutrition & Dietetics	CH8EP	WOS:000354269400009		
J	Beppu, F; Konno, K; Kawamatsu, T; Nagai, T; Yoshinaga, K; Mizobe, H; Kojima, K; Watanabe, H; Gotoh, N				Beppu, Fumiaki; Konno, Kaoru; Kawamatsu, Takashi; Nagai, Toshiharu; Yoshinaga, Kazuaki; Mizobe, Hoyo; Kojima, Koichi; Watanabe, Hiroyuki; Gotoh, Naohiro			Comparison of catabolic rates of C-13-labeled palmitic acid bound to the alpha and beta positions of triacylglycerol using CO2 expired from mice	EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY			English	Article						C-13-labeled carbon dioxide; Binding position; Catabolism; Fatty acid; Triacylglycerol	STEREOSELECTIVE HYDROLYSIS; EICOSANOID PRODUCTION; LYMPH CHYLOMICRONS; PANCREATIC LIPASES; LIPID-METABOLISM; FATTY-ACIDS; FISH OILS; ABSORPTION; SEAL; ACCUMULATION	We investigated the catabolic rate of C-13-labeled palmitic acid (*P) bound to alpha (sn-1) or beta (sn-2) position of triacylglycerol (TAG) using isotope-ratio mass spectrometry. Specifically, we measured the C-13-to-C-12 ratio in CO2 expired from mice. After 30-75 min, *P bound to the alpha position was catabolized faster than that bound to the beta position. Thereafter, the catabolic rate of *P bound to the beta position increased and surpassed that bound to the alpha position. This indicated that binding position affected the catabolic rate of *P, possibly due to the different specificities of pancreatic lipase, lipoprotein lipase, and hepatic lipase. Next, we measured the catabolic rate of *P bound to TAG in combination with one of three unsaturated fatty acids (oleic acid, linoleic acid, or alpha-linolenic acid). When *P was bound to the beta position and Ln was bound to the alpha position, the catabolism of TAG was significantly higher than for other TAGs. This result suggests that fatty acid structure might affect the catabolism of counterpart fatty acids in TAG.	[Beppu, Fumiaki; Konno, Kaoru; Kawamatsu, Takashi; Gotoh, Naohiro] Tokyo Univ Marine Sci & Technol, Dept Food Sci & Technol, Minato Ku, Tokyo 1088477, Japan; [Nagai, Toshiharu; Yoshinaga, Kazuaki; Mizobe, Hoyo; Kojima, Koichi] Tsukishima Foods Ind Co Ltd, Edogawa Ku, Tokyo 1348520, Japan; [Watanabe, Hiroyuki] Kochi Univ, Dept Hlth Sci, Kochi, Kochi 7810111, Japan	Gotoh, N (reprint author), Tokyo Univ Marine Sci & Technol, Dept Food Sci & Technol, Minato Ku, 4-5-7 Konan, Tokyo 1088477, Japan.	ngotoh@kaiyodai.ac.jp	BEPPU, Fumiaki/O-1986-2014; GOTOH, Naohiro/O-1975-2014				Shibata R, 2012, EUR J LIPID SCI TECH, V114, P1340, DOI 10.1002/ejlt.201200164; ROGALSKA E, 1990, J BIOL CHEM, V265, P20271; Carriere F, 1997, BIOORGAN MED CHEM, V5, P429, DOI 10.1016/S0968-0896(96)00251-9; JENSEN RG, 1990, J DAIRY SCI, V73, P223; CHRISTIE WW, 1972, COMP BIOCHEM PHYSIOL, V41, P297, DOI 10.1016/0305-0491(72)90032-6; Yoshida H, 1999, J NUTR SCI VITAMINOL, V45, P411; Bender D. A., 2006, HARPERS ILLUSTRATED, V27th, P145; Botham K. M., 2006, HARPERS ILLUSTRATED, V27th, P187; Botham K. M., 2006, HARPERS ILLUSTRATED, V27th, P217; Botham K. M., 2006, BT HARPERS ILLUSTRAT, V27th, P209; Botham KM, 2006, HARPERS ILLUSTRATED, P121; BROCKERH.H, 1966, J LIPID RES, V7, P62; Chardigny JM, 2003, J NUTR, V133, P4212; CHRISTENSEN MS, 1995, NUTR RES, V15, P359, DOI 10.1016/0271-5317(95)00004-6; Couedelo L, 2012, J NUTR, V142, P70, DOI 10.3945/jn.111.146290; El- Maghrabi R. M., 1978, J BIOL CHEM, V253, P974; ELMAGHRABI R, 1978, BIOCHEM BIOPH RES CO, V81, P82, DOI 10.1016/0006-291X(78)91633-9; FILER LJ, 1969, J NUTR, V99, P293; Fujimoto K, 1998, FOOD SCI TECHNOL INT, V4, P140; Gotoh N, 2010, J OLEO SCI, V59, P71, DOI 10.5650/jos.59.71; Ikeda I, 1998, LIPIDS, V33, P897, DOI 10.1007/s11745-998-0286-7; ITABASHI Y, 1993, J AM OIL CHEM SOC, V70, P1177, DOI 10.1007/BF02564223; Leyton J., 1997, BR J NUTR, V51, P383; Maki K. C., 2002, AM J CLIN NUTR, V76, P130; MATTSON FH, 1956, J BIOL CHEM, V219, P735; MURATA M, 1994, BIOSCI BIOTECH BIOCH, V58, P1416; Nagao T, 2000, J NUTR, V130, P792; VANTRAPPEN GR, 1989, GASTROENTEROLOGY, V96, P1126; Yoshida H, 1996, BIOSCI BIOTECH BIOCH, V60, P1293	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1438-7697	1438-9312		EUR J LIPID SCI TECH	Eur. J. Lipid Sci. Technol.	MAY	2015	117	5					718	723		10.1002/ejlt.201400326		6	Food Science & Technology; Nutrition & Dietetics	Food Science & Technology; Nutrition & Dietetics	CH8EP	WOS:000354269400016		
J	Kimura, A; Imbe, H				Kimura, Akihisa; Imbe, Hiroki			Anatomically structured burst spiking of thalamic reticular nucleus cells: implications for distinct modulations of sensory processing in lemniscal and non-lemniscal thalamocortical loop circuitries	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						auditory input; juxtacellular labeling; rat; topography; unit discharge	MEDIAL GENICULATE-BODY; DORSAL LATERAL GENICULATE; AUDITORY THALAMUS; RESPONSE PROPERTIES; AXONAL PROJECTIONS; VENTRAL DIVISION; GATING FUNCTION; NEURONS; RAT; CORTEX	The thalamic reticular nucleus (TRN) occupies a highly strategic position to modulate sensory processing in the thalamocortical loop circuitries. It has been shown that TRN visual cells projecting to first- and higher-order thalamic nuclei have distinct levels of burst spiking, suggesting the possibility that the TRN exerts differential influences on information processing in first- and higher-order thalamic nuclei that compose the lemniscal and non-lemniscal sensory systems, respectively. To determine whether this possibility could extend across sensory modalities, the present study examined activities of TRN auditory cells projecting to the ventral and dorsal divisions (first- and higher-order auditory thalamic nuclei) of the medial geniculate nucleus (TRN-MGV and TRN-MGD cells) in anesthetized rats, using juxta-cellular recording and labeling techniques. Burst spiking of TRN-MGV cells consisted of larger numbers of spikes with shorter inter-spike intervals as compared with that of TRN-MGD cells in auditory response evoked by noise burst stimuli. Similar distinctions, although not statistically significant, were observed in spontaneous activity. Furthermore, the features of burst spiking varied in association with the topographies of cell body and terminal field locations. These features of burst spiking are similar to those observed in the two types of TRN visual cells. First- and higher-order thalamic nuclei are known to have distinct levels of burst spiking across sensory modalities. Taken together, it is suggested that the distinctions in burst spiking in the TRN, in conjunction with those in thalamic nuclei, could constitute distinct circuitries for lemniscal and non-lemniscal sensory processing in the thalamocortical loop.	[Kimura, Akihisa; Imbe, Hiroki] Wakayama Med Univ, Dept Physiol, Wakayama 6418509, Japan	Kimura, A (reprint author), Wakayama Med Univ, Dept Physiol, Wakayama Kimiidera 811-1, Wakayama 6418509, Japan.	akimura@wakayama-med.ac.jp			Japan Society for the Promotion of Science [23500397]	We are grateful to T. Tsujinaka for her assistance with histology. This work was supported by a Grant-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science (23500397) to A.K. The authors declare no competing financial interests.	Varela C, 2007, J NEUROPHYSIOL, V98, P3538, DOI 10.1152/jn.00578.2007; BORDI F, 1994, EXP BRAIN RES, V98, P261, DOI 10.1007/BF00228414; Komura Y, 2001, NATURE, V412, P546, DOI 10.1038/35087595; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Yu XJ, 2009, NAT NEUROSCI, V12, P1165, DOI 10.1038/nn.2373; Kimura A, 2012, J COMP NEUROL, V520, P1457, DOI 10.1002/cne.22805; Mehta AK, 1999, BRAIN RES REV, V29, P196, DOI 10.1016/S0165-0173(98)00052-6; Varela C, 2009, CEREB CORTEX, V19, P1776, DOI 10.1093/cercor/bhn208; Ramcharan EJ, 2005, P NATL ACAD SCI USA, V102, P12236, DOI 10.1073/pnas.0502843102; Sherman SM, 2012, CURR OPIN NEUROBIOL, V22, P575, DOI 10.1016/j.conb.2012.03.005; SHOSAKU A, 1983, EXP BRAIN RES, V49, P432; Huguenard JR, 2007, TRENDS NEUROSCI, V30, P350, DOI 10.1016/j.tins.2007.05.007; Kimura A, 2003, NEUROSCIENCE, V117, P1003, DOI 10.1016/S0306-4522(02)00949-1; LU SM, 1992, J NEUROPHYSIOL, V68, P2185; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Kimura A, 2007, EUR J NEUROSCI, V26, P3524, DOI 10.1111/j.1460-9568.2007.05925.x; Halassa MM, 2011, NAT NEUROSCI, V14, P1118, DOI 10.1038/nn.2880; Wan X, 2003, NEUROSCIENCE, V121, P947, DOI 10.1016/S0306-4522(03)00592-X; Bartlett EL, 1999, J NEUROPHYSIOL, V81, P1999; Lee SH, 2007, J PHYSIOL-LONDON, V582, P195, DOI 10.1113/jphysiol.2007.134254; Winer JA, 1996, P NATL ACAD SCI USA, V93, P3083, DOI 10.1073/pnas.93.7.3083; Kimura A, 2005, NEUROSCIENCE, V135, P1325, DOI 10.1016/j.neuroscience.2005.06.089; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; FRENCH CR, 1985, EXP BRAIN RES, V57, P471; Jones EG, 2009, ANN NY ACAD SCI, V1157, P10, DOI 10.1111/j.1749-6632.2009.04534.x; Wolfart J, 2005, NAT NEUROSCI, V8, P1760, DOI 10.1038/nn1591; Zaman T, 2011, NEURON, V70, P95, DOI 10.1016/j.neuron.2011.02.042; Pinault D, 2004, BRAIN RES REV, V46, P1, DOI 10.1016/j.brainresrev.2004.04.008; Swadlow HA, 2001, NAT NEUROSCI, V4, P402, DOI 10.1038/86054; Landisman CE, 2002, J NEUROSCI, V22, P1002; He JF, 2002, J NEUROPHYSIOL, V88, P2152, DOI 10.1152/jn.00091.2002; Sun YG, 2012, J NEUROSCI, V32, P7782, DOI 10.1523/JNEUROSCI.0839-12.2012; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Kimura A, 2014, EUR J NEUROSCI, V39, P1405, DOI 10.1111/ejn.12545; Antunes FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014071; Cappe C, 2009, HEARING RES, V258, P28, DOI 10.1016/j.heares.2009.04.017; Cotillon-Williams N, 2003, J NEUROPHYSIOL, V89, P1968, DOI 10.1152/jn.00728.2002; Cotillon-Williams N, 2008, J NEUROPHYSIOL, V99, P1137, DOI 10.1152/jn.01159.2007; DOMICH L, 1986, J PHYSIOL-LONDON, V379, P429; Donishi T, 2011, NEUROSCIENCE, V174, P200, DOI 10.1016/j.neuroscience.2010.11.041; Fitzgibbon T, 2007, VISUAL NEUROSCI, V24, P857, DOI 10.1017/S0952523807070770; Hartings JA, 2003, J NEUROSCI, V23, P5264; Kim U, 1997, SCIENCE, V278, P130, DOI 10.1126/science.278.5335.130; Kimura A, 2009, EUR J NEUROSCI, V30, P783, DOI 10.1111/j.1460-9568.2009.06880.x; Kimura A, 2012, NEUROSCIENCE, V226, P208, DOI 10.1016/j.neuroscience.2012.09.016; Massaux A, 2004, J NEUROPHYSIOL, V91, P2117, DOI 10.1152/jn.00970.2003; Massaux A, 2003, EXP BRAIN RES, V153, P573, DOI 10.1007/s00221-003-1516-3; Paxinos G., 1997, RAT BRAIN STEREOTAXI; Pinault D, 2003, J PHYSIOL-LONDON, V552, P881, DOI 10.1113/jphysiol.2003.146573; RODRIGUESDAGAEFF C, 1989, HEARING RES, V39, P103, DOI 10.1016/0378-5955(89)90085-3; ROUILLER EM, 1990, HEARING RES, V49, P249, DOI 10.1016/0378-5955(90)90107-Z; SHOSAKU A, 1989, PROG NEUROBIOL, V32, P77, DOI 10.1016/0301-0082(89)90011-7; Sohal VS, 2003, J NEUROSCI, V23, P8978; STERIADE M, 1987, J NEUROPHYSIOL, V57, P260; SUMITOMO I, 1989, BRAIN RES, V482, P34, DOI 10.1016/0006-8993(89)90539-8; Wei HY, 2011, J NEUROSCI, V31, P17287, DOI 10.1523/JNEUROSCI.6431-10.2011	56	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	MAY	2015	41	10					1276	1293		10.1111/ejn.12874		18	Neurosciences	Neurosciences & Neurology	CI3KK	WOS:000354646400002		
J	Nakamura, H; Hioki, H; Furuta, T; Kaneko, T				Nakamura, Hisashi; Hioki, Hiroyuki; Furuta, Takahiro; Kaneko, Takeshi			Different cortical projections from three subdivisions of the rat lateral posterior thalamic nucleus: a single-neuron tracing study with viral vectors	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						axonal arborisation; extrageniculate pathway; lateral posterior nucleus of the thalamus; Sindbis virus; single-neuron labeling	VISUAL-CORTEX; ALBINO-RAT; FUNCTIONAL SPECIALIZATION; RETINOTOPIC ORGANIZATION; POSTRHINAL CORTICES; PERIRHINAL CORTEX; PARIETAL CORTEX; BARREL CORTEX; HOODED RAT; IN-VIVO	The lateral posterior thalamic nucleus (LP) is one of the components of the extrageniculate pathway in the rat visual system, and is cytoarchitecturally divided into three subdivisions - lateral (LPl), rostromedial (LPrm), and caudomedial (LPcm) portions. To clarify the differences in the dendritic fields and axonal arborisations among the three subdivisions, we applied a single-neuron labeling technique with viral vectors to LP neurons. The proximal dendrites of LPl neurons were more numerous than those of LPrm and LPcm neurons, and LPrm neurons tended to have wider dendritic fields than LPl neurons. We then analysed the axonal arborisations of LP neurons by reconstructing the axon fibers in the cortex. The LPl, LPrm and LPcm were different from one another in terms of the projection targets - the main target cortical regions of LPl and LPrm neurons were the secondary and primary visual areas, whereas those of LPcm neurons were the postrhinal and temporal association areas. Furthermore, the principal target cortical layers of LPl neurons in the visual areas were middle layers, but that of LPrm neurons was layer 1. This indicates that LPl and LPrm neurons can be categorised into the core and matrix types of thalamic neurons, respectively, in the visual areas. In addition, LPl neurons formed multiple axonal clusters within the visual areas, whereas the fibers of LPrm neurons were widely and diffusely distributed. It is therefore presumed that these two types of neurons play different roles in visual information processing by dual thalamocortical innervation of the visual areas.	[Nakamura, Hisashi; Hioki, Hiroyuki; Furuta, Takahiro; Kaneko, Takeshi] Kyoto Univ, Grad Sch Med, Dept Morphol Brain Sci, Kyoto 6068501, Japan	Hioki, H (reprint author), Kyoto Univ, Grad Sch Med, Dept Morphol Brain Sci, Kyoto 6068501, Japan.	hioki@mbs.med.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [25123709, 22110007, 23115101, 24500408, 25250006]; Japan Society for the Promotion of Science (JSPS)	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas 'Neural Diversity and Neocortical Organisation (25123709 to H. Hioki), 'Foundation of Synapse and Neurocircuit Pathology' (22110007 to H. Hioki), and 'Mesoscopic Neurocircuitry' (23115101 to T. Kaneko), and Grants-in-Aid for Scientific Research (24500408 to H. Hioki; 24500408 to T. Furuta; 25250006 to T. Kaneko) from The Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Japan Society for the Promotion of Science (JSPS).	AHMED AKMF, 1995, BRAIN RES, V674, P275, DOI 10.1016/0006-8993(94)01452-N; SHOLL DA, 1953, J ANAT, V87, P387; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; Rubio-Garrido P, 2009, CEREB CORTEX, V19, P2380, DOI 10.1093/cercor/bhn259; Hioki H, 2003, NEUROSCIENCE, V117, P1, DOI 10.1016/S0306-4522(02)00943-0; Bucci DJ, 2002, BEHAV NEUROSCI, V116, P479, DOI 10.1037//0735-7044.116.3.479; Hioki H, 2010, J COMP NEUROL, V518, P668, DOI 10.1002/cne.22237; Rubio-Garrido P, 2007, NEUROSCIENCE, V149, P242, DOI 10.1016/j.neuroscience.2007.07.036; KOLB B, 1994, CEREB CORTEX, V4, P664, DOI 10.1093/cercor/4.6.664; Tamamaki N, 2000, NEUROSCI RES, V38, P231, DOI 10.1016/S0168-0102(00)00176-0; Bucci DJ, 2000, BEHAV NEUROSCI, V114, P882; Kuramoto E, 2009, CEREB CORTEX, V19, P2065, DOI 10.1093/cercor/bhn231; Noseda R, 2011, J NEUROSCI, V31, P14204, DOI 10.1523/JNEUROSCI.3285-11.2011; Clasca F, 2012, EUR J NEUROSCI, V35, P1524, DOI 10.1111/j.1460-9568.2012.08033.x; Jones EG, 1998, NEUROSCIENCE, V85, P331, DOI 10.1016/S0306-4522(97)00581-2; HERKENHAM M, 1980, SCIENCE, V207, P532, DOI 10.1126/science.7352263; Sherman SM, 2007, CURR OPIN NEUROBIOL, V17, P417, DOI 10.1016/j.conb.2007.07.003; Noseda R, 2010, NAT NEUROSCI, V13, P239, DOI 10.1038/nn.2475; Sherman SM, 2012, CURR OPIN NEUROBIOL, V22, P575, DOI 10.1016/j.conb.2012.03.005; Marshel JH, 2011, NEURON, V72, P1040, DOI 10.1016/j.neuron.2011.12.004; Shi CJ, 2001, J NEUROSCI, V21, P9844; Agster KL, 2009, HIPPOCAMPUS, V19, P1159, DOI 10.1002/hipo.20578; DIAMOND IT, 1969, SCIENCE, V164, P251, DOI 10.1126/science.164.3877.251; Fujiyama F, 2011, EUR J NEUROSCI, V33, P668, DOI 10.1111/j.1460-9568.2010.07564.x; Furtak SC, 2007, HIPPOCAMPUS, V17, P709, DOI 10.1002/hipo.20314; Andermann ML, 2011, NEURON, V72, P1025, DOI 10.1016/j.neuron.2011.11.013; Ohno S, 2012, CEREB CORTEX, V22, P2840, DOI 10.1093/cercor/bhr356; Jones EG, 2001, TRENDS NEUROSCI, V24, P595, DOI 10.1016/S0166-2236(00)01922-6; Furuta T, 2001, J HISTOCHEM CYTOCHEM, V49, P1497; Furuta T, 2009, J NEUROSCI, V29, P4089, DOI 10.1523/JNEUROSCI.5393-08.2009; REEP RL, 1994, EXP BRAIN RES, V100, P67; BOURASSA J, 1995, NEUROSCIENCE, V66, P253, DOI 10.1016/0306-4522(95)00009-8; Kamishina H, 2009, BRAIN RES, V1264, P39, DOI 10.1016/j.brainres.2009.01.024; Tanaka YR, 2011, J NEUROSCI, V31, P18223, DOI 10.1523/JNEUROSCI.3139-11.2011; COOGAN TA, 1993, J NEUROSCI, V13, P3749; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; Bucci DJ, 2004, BEHAV NEUROSCI, V118, P1117, DOI 10.1037/0735-7044.118.5.1117; Burwell RD, 2004, J NEUROSCI, V24, P11023, DOI 10.1523/JNEUROSCI.3781-04.2004; CHANDLER HC, 1992, NEUROSCI LETT, V143, P237, DOI 10.1016/0304-3940(92)90273-A; DIAMOND IT, 1976, FED PROC, V35, P60; ESPINOZA SG, 1983, BRAIN RES, V272, P137, DOI 10.1016/0006-8993(83)90370-0; Funaki S, 1998, Neurobiology (Bp), V6, P273; GOODMAN DC, 1973, BRAIN BEHAV EVOLUT, V8, P27, DOI 10.1159/000124346; HICKS RR, 1991, BRAIN RES, V568, P325, DOI 10.1016/0006-8993(91)91420-6; Hioki H, 2013, J NEUROSCI, V33, P544, DOI 10.1523/JNEUROSCI.2255-12.2013; HUGHES HC, 1977, J COMP NEUROL, V175, P311, DOI 10.1002/cne.901750306; Jones EG, 2007, THALAMUS; Kamishina H, 2008, BRAIN RES, V1204, P24, DOI 10.1016/j.brainres.2008.01.094; Koshimizu Y, 2013, J COMP NEUROL, V521, P2125, DOI 10.1002/cne.23277; Kuramoto E, 2015, CEREB CORTEX, V25, P221, DOI 10.1093/cercor/bht216; MASON R, 1981, NEUROSCI LETT, V25, P107, DOI 10.1016/0304-3940(81)90316-5; Masterson SP, 2009, J COMP NEUROL, V515, P647, DOI 10.1002/cne.22077; McDonald AJ, 1996, NEUROSCIENCE, V71, P37, DOI 10.1016/0306-4522(95)00416-5; MEYER PM, 1986, BEHAV NEUROSCI, V100, P845, DOI 10.1037//0735-7044.100.6.845; MONTERO VM, 1973, BRAIN RES, V53, P197, DOI 10.1016/0006-8993(73)90780-4; MONTERO VM, 1993, EXP BRAIN RES, V94, P1; Nishino E, 2008, J NEUROSCI, V28, P7153, DOI 10.1523/JNEUROSCI.4398-07.2008; OLAVARRIA J, 1979, BRAIN RES, V173, P137, DOI 10.1016/0006-8993(79)91101-6; PARNAVELAS JG, 1981, EXP BRAIN RES, V41, P184; PERRY VH, 1980, NEUROSCIENCE, V5, P915, DOI 10.1016/0306-4522(80)90160-8; Reep RL, 1999, BRAIN RES, V841, P43, DOI 10.1016/S0006-8993(99)01779-5; SANDERSON KJ, 1991, EXP BRAIN RES, V85, P324; SCHNEIDE.GE, 1969, SCIENCE, V163, P895, DOI 10.1126/science.163.3870.895; SCHOBER W, 1981, Z MIKROSK ANAT FORSC, V95, P827; SERIZAWA M, 1994, ARCH HISTOL CYTOL, V57, P493, DOI 10.1679/aohc.57.493; Sherman S.M., 2006, EXPLORING THALAMUS I; SUKEKAWA K, 1988, BRAIN BEHAV EVOLUT, V32, P246, DOI 10.1159/000116552; Swanson LW, 2004, BRAIN MAPS STRUCTURE; TAKAHASHI T, 1985, J COMP NEUROL, V231, P281, DOI 10.1002/cne.902310302; Tohmi M, 2014, CURR BIOL, V24, P587, DOI 10.1016/j.cub.2014.01.061; vansGroen T., 1992, J COMP NEUROL, V315, P200; Varela C, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00069; Watson C, 2007, RAT BRAIN STEREOTAXI; WORTWEIN G, 1994, ACTA NEUROBIOL EXP, V54, P365; YAMADORI T, 1977, Okajimas Folia Anatomica Japonica, V54, P229; Zilles K., 1985, CORTEX RAT STEREOTAX	77	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	MAY	2015	41	10					1294	1310		10.1111/ejn.12882		17	Neurosciences	Neurosciences & Neurology	CI3KK	WOS:000354646400003		
J	Shiraki, T; Iida, O; Takahara, M; Soga, Y; Yamauchi, Y; Hirano, K; Kawasaki, D; Fujihara, M; Utsunomiya, M; Tazaki, J; Yamaoka, T; Shintani, Y; Suematsu, N; Suzuki, K; Miyashita, Y; Tsuchiya, T; Uematsu, M				Shiraki, T.; Iida, O.; Takahara, M.; Soga, Y.; Yamauchi, Y.; Hirano, K.; Kawasaki, D.; Fujihara, M.; Utsunomiya, M.; Tazaki, J.; Yamaoka, T.; Shintani, Y.; Suematsu, N.; Suzuki, K.; Miyashita, Y.; Tsuchiya, T.; Uematsu, M.			Predictors of Delayed Wound Healing after Endovascular Therapy of Isolated Infrapopliteal Lesions Underlying Critical Limb Ischemia in Patients with High Prevalence of Diabetes Mellitus and Hemodialysis	EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY			English	Article						Critical limb ischemia; Endovascular therapy; Angiosome concept; Wound healing; Risk factor stratification	PERIPHERAL ARTERIAL-DISEASE; INFRAINGUINAL BYPASS; TASK-FORCE; REVASCULARIZATION; ANGIOPLASTY; FOOT; METAANALYSIS; GUIDELINES; OUTCOMES; UTILITY	Objectives: Acceptable limb salvage rates underlie the widespread use of endovascular therapy (EVT) for patients with critical limb ischemia (CLI) secondary to isolated infrapopliteal lesions; however, post-EVT delayed wound healing remains a challenge. Predictors of delayed wound healing and their use in risk stratification of EVT in patients with CLI due to isolated infrapopliteal lesions are explored. Methods: This was a retrospective multicenter study. 871 consecutive critically ischemic limbs were studied. There was tissue loss in 734 patients (age: 71 +/- 10 years old; 71% male) who had undergone EVT between April 2004 and December 2012. The wound healing rate after EVT was estimated by the Kaplan-Meier method. The association between baseline characteristics and delayed wound healing was assessed by the Cox proportional hazard model. Results: Diabetes mellitus and regular dialysis were present in 75% (553/734) and 64% (476/734) of patients, respectively; 67% of limbs (585/871) had Rutherford class 5 CLI; 8% (67/871) of wounds were located in the heel only; 25% (219/871) of limbs had Rutherford 6 (involving not only the heel); and 42% (354/871) of wounds were complicated by infection. The rate of freedom from major amputation at 1 year reached 88%, whereas the wound healing rate was 67%. Median time to wound healing was 146 days. By multivariate analysis, non-ambulatory status (hazard ratio [HR], 1.58; 95% confidence interval [Cl] 1.31-1.91) serum albumin <3 g/dL (HR 1.42; 95% Cl 1.08-1.86), Rutherford 6 (not only heel) (HR 1.68; 95% Cl 1.33-2.14), wound infection (HR 1.24; 95% Cl 1.03-1.50), EVT not based on angiosome concept (HR 1.28; 95% Cl 1.06-1.55), and below the ankle (BTA) 0 vessel runoff after EVT (HR 1.45; 95% Cl 1.14-1.86) were independent predictors of delayed wound healing. Conclusions: Non-ambulatory status, low albumin level, Rutherford 6 (not only heel), wound infection, indirect intervention, and poor BTA runoff were independent predictors for delayed wound healing after EVT in patients with CLI secondary to infrapopliteal lesions, and their use in risk stratification allows estimation of the wound healing rate. (C) 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.	[Shiraki, T.; Iida, O.; Uematsu, M.] Kansai Rosai Hosp, Cardiovasc Ctr, Amagasaki, Hyogo 6608511, Japan; [Takahara, M.] Osaka Univ, Grad Sch Med, Dept Metab Med, Osaka, Japan; [Soga, Y.] Kokura Mem Hosp, Dept Cardiol, Kitakyushu, Fukuoka, Japan; [Yamauchi, Y.] Kikuna Mem Hosp, Dept Cardiol, Yokohama, Kanagawa, Japan; [Hirano, K.] Yokohama City Eastern Hosp, Dept Cardiol, Yokohama, Kanagawa, Japan; [Kawasaki, D.] Hyogo Coll Med, Dept Internal Med, Cardiovasc Div, Nishinomiya, Hyogo 6638501, Japan; [Fujihara, M.] Kishiwada Tokushukai Hosp, Dept Cardiol, Kishiwada, Japan; [Utsunomiya, M.] Toho Univ, Ohashi Med Ctr, Div Cardiovasc Med, Tokyo, Japan; [Tazaki, J.] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan; [Yamaoka, T.] Matsuyama Red Cross Hosp, Dept Vasc Surg, Matsuyama, Ehime, Japan; [Shintani, Y.] Shin Koga Hosp, Dept Cardiol, Kurume, Fukuoka, Japan; [Suematsu, N.] Fukuoka Red Cross Hosp, Dept Cardiol, Fukuoka, Japan; [Suzuki, K.] Sendai Kosei Hosp, Dept Cardiol, Sendai, Miyagi, Japan; [Miyashita, Y.] Shinshu Univ, Dept Adv PAD Therapeut, Matsumoto, Nagano 390, Japan; [Tsuchiya, T.] Kanazawa Med Univ Hosp, Div Transcatheter Cardiovasc Therapeut, Uchinada, Ishikawa, Japan	Shiraki, T (reprint author), Kansai Rosai Hosp, Cardiovasc Ctr, 3-1-69 Inabasou, Amagasaki, Hyogo 6608511, Japan.	shiraki.tatsuya@gail.com		Shiraki, Tatsuya/0000-0003-1901-1642			Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Kawarada O, 2012, CATHETER CARDIO INTE, V80, P861, DOI 10.1002/ccd.24370; Biancari F, 2014, EUR J VASC ENDOVASC, V47, P517, DOI 10.1016/j.ejvs.2013.12.010; Iida O, 2013, CIRC-CARDIOVASC INTE, V6, P68, DOI 10.1161/CIRCINTERVENTIONS.112.975318; Pickwell KM, 2013, DIABETES-METAB RES, V29, P377, DOI 10.1002/dmrr.2400; Palena LM, 2014, CATHETER CARDIO INTE, V83, P123, DOI 10.1002/ccd.24992; HIATT WR, 1995, CIRCULATION, V91, P1472; Iida O, 2012, J VASC SURG, V55, P363, DOI 10.1016/j.jvs.2011.08.014; Azuma N, 2012, EUR J VASC ENDOVASC, V43, P322, DOI 10.1016/j.ejvs.2011.12.001; Rocha-Singh KJ, 2012, CATHETER CARDIO INTE, V80, P1042, DOI 10.1002/ccd.24485; Marso SP, 2006, J AM COLL CARDIOL, V47, P921, DOI 10.1016/j.jacc.2005.09.065; Liistro F, 2013, CIRCULATION, V128, P615, DOI 10.1161/CIRCULATIONAHA.113.001811; Yamada T, 2008, J VASC SURG, V47, P318, DOI 10.1016/j.jvs.2007.10.045; Anderson JL, 2013, CIRCULATION, V127, P1425, DOI 10.1161/CIR.0b013e31828b82aa; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Romiti M, 2008, J VASC SURG, V47, P975, DOI 10.1016/j.jvs.2008.01.005; Tendera M, 2011, EUR HEART J, V32, P2851, DOI 10.1093/eurheartj/ehr211; Attinger CE, 2006, PLAST RECONSTR SURG, V117, P261; Chung J, 2006, J VASC SURG, V43, P1183, DOI 10.1016/j.jvs.2005.12.068; lida O, 2012, EUR J VASC ENDOVASC, V44, P425; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS1, DOI DOI 10.1016/S1078-5884(07)00246-8.PUBMED:17161778; Soderstrom M, 2009, J VASC SURG, V49, P932, DOI 10.1016/j.jvs.2008.11.045; TAYLOR GI, 1987, BRIT J PLAST SURG, V40, P113, DOI 10.1016/0007-1226(87)90185-8; Zeller T, 2014, J AM COLL CARDIOL, V64, P1568, DOI 10.1016/j.jacc.2014.06.1198	24	1	1	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1078-5884	1532-2165		EUR J VASC ENDOVASC	Eur. J. Vasc. Endovasc. Surg.	MAY	2015	49	5					565	573		10.1016/j.ejvs.2015.01.017		9	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CI8QK	WOS:000355036600014		
J	Sata, H; Shibayama, H; Maeda, I; Habuchi, Y; Nakatani, E; Fukushima, K; Fujita, J; Ezoe, S; Tadokoro, S; Maeda, T; Mizuki, M; Kosugi, S; Nakagawa, M; Ueda, S; Iida, M; Tokumine, Y; Azenishi, Y; Mitsui, H; Oritani, K; Kanakura, Y				Sata, Hiroshi; Shibayama, Hirohiko; Maeda, Ikuhiro; Habuchi, Yoko; Nakatani, Eiji; Fukushima, Kentaro; Fujita, Jiro; Ezoe, Sachiko; Tadokoro, Seiji; Maeda, Tetsuo; Mizuki, Masao; Kosugi, Satoru; Nakagawa, Masashi; Ueda, Shuji; Iida, Masato; Tokumine, Yukihiro; Azenishi, Yasuhiko; Mitsui, Hideki; Oritani, Kenji; Kanakura, Yuzuru			Quantitative polymerase chain reaction analysis with allele-specific oligonucleotide primers for individual IgH VDJ regions to evaluate tumor burden in myeloma patients	EXPERIMENTAL HEMATOLOGY			English	Article							MINIMAL RESIDUAL DISEASE; HIGH-DOSE THERAPY; MULTIPLE-MYELOMA; STEM-CELL; BONE-MARROW; PERIPHERAL-BLOOD; NUCLEIC-ACIDS; PCR PRIMERS; IMMUNOGLOBULIN; CANCER	Quantitative polymerase chain reaction (PCR) with patient-specific, allele-specific oligonucleotide (ASO) primers for individual immunoglobulin H VDJ region (ASO-PCR) amplification was performed using several sources of clinical material, including mRNA from peripheral blood cells (PBMNCs), whole bone marrow cells (BMMNCs), and the CD20(+)CD38(-) B-cell population in bone marrow, as well as cell-free DNA from the sera of patients with multiple myeloma (MM). We designed the ASO primers and produced sufficient PCR fragments to evaluate tumor burden in 20 of 30 bone marrow samples at diagnosis. Polymerase chain reaction amplification efficiency depended on primer sequences because the production of ASO-PCR fragments did not correlate with serum M-protein levels. However, the ASO-PCR levels in BMMNCs showed statistically significant correlations with those in PBMNCs and CD20(+)CD38(-) B-cells. The good association between the BMMNC and PBMNC data indicated that PBMNCs could be a suitable source for monitoring minimal residual disease (MRD). In the case of cell-free DNA, ASO-PCR levels showed a unique pattern and remained high even after treatment. Because the sequence information for each ASO-PCR product was identical to the original, the cell-free DNA might also be useful for evaluating MRD. Moreover, the ASO-PCR products were clearly detected in 17 of 22 mRNA samples from CD20(+)CD38(-) populations, suggesting that MM clones might exist in relatively earlier stages of B cells than in plasma cells. Thus, ASO-PCR analysis using various clinical materials is useful for detecting MRD in MM patients as well as for clarifying MM pathogenesis. Copyright (C) 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.	[Sata, Hiroshi; Shibayama, Hirohiko; Habuchi, Yoko; Fukushima, Kentaro; Fujita, Jiro; Ezoe, Sachiko; Tadokoro, Seiji; Maeda, Tetsuo; Mizuki, Masao; Oritani, Kenji; Kanakura, Yuzuru] Osaka Univ, Dept Hematol & Oncol, Grad Sch Med, Suita, Osaka 5650871, Japan; [Maeda, Ikuhiro] Osaka Univ Hosp, Cent Lab Clin Investigat, Suita, Osaka, Japan; [Nakatani, Eiji] Translat Res Informat Ctr, Dept Stat Anal, Kobe, Hyogo, Japan; [Kosugi, Satoru] Toyonaka City Hosp, Dept Internal Med, Toyonaka, Osaka, Japan; [Nakagawa, Masashi] Nissay Hosp, Dept Hematol & Oncol, Osaka, Japan; [Ueda, Shuji] Hyogo Prefectural Nishinomiya Hosp, Dept Internal Med, Nishinomiya, Hyogo, Japan; [Iida, Masato] Kawasaki Hosp, Dept Hematol, Kobe, Hyogo, Japan; [Tokumine, Yukihiro] Itami City Hosp, Dept Hematol, Itami, Hyogo, Japan; [Azenishi, Yasuhiko] Minoh City Hosp, Dept Internal Med, Mino, Japan; [Mitsui, Hideki] Otemae Hosp, Dept Hematol, Osaka, Japan	Sata, H (reprint author), Osaka Univ, Dept Hematol & Oncol, Grad Sch Med, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	hiro@bldon.med.osaka-u.ac.jp			Mitsui Life Social Welfare Foundation	We thank Noriko Kobayashi, Yoshiyasu Ogawa, and Masaaki Kihara at LSI Medience Corporation for their assistance with ASO primer design. This work was supported in part by medical research funding from the Mitsui Life Social Welfare Foundation.	Chanan-Khan AA, 2010, J CLIN ONCOL, V28, P2612, DOI 10.1200/JCO.2009.25.4250; Gonzalez-Masia JA, 2013, ONCOTARGETS THER, V6, P819, DOI 10.2147/OTT.S44668; Sarasquete ME, 2005, HAEMATOL-HEMATOL J, V90, P1365; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Ladetto M, 2000, BIOL BLOOD MARROW TR, V6, P241, DOI 10.1016/S1083-8791(00)70006-1; Watanabe R, 2013, INT J HEMATOL, V97, P333, DOI 10.1007/s12185-013-1294-z; Harousseau JL, 2009, BLOOD, V114, P3139, DOI 10.1182/blood-2009-03-201053; Martinez-Lopez J, 2014, BLOOD, V123, P3073, DOI 10.1182/blood-2014-01-550020; Gay F, 2011, BLOOD, V117, P3025, DOI 10.1182/blood-2010-09-307645; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; Ferrero S, 2011, HEMATOL ONCOL, V29, P167, DOI 10.1002/hon.989; Billadeau D, 1997, LEUKEMIA, V11, P1565, DOI 10.1038/sj.leu.2400773; Cremer FW, 2000, BONE MARROW TRANSPL, V26, P851, DOI 10.1038/sj.bmt.1702628; Cremer FW, 1997, ANN ONCOL, V8, P633, DOI 10.1023/A:1008286803199; Dune BG, 2006, LEUKEMIA, V20, P1467, DOI DOI 10.1038/SJ.LEU.2404284; Fenk Roland, 2004, Hematology, V9, P17, DOI 10.1080/10245330310001638965; Kellner J, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-91; Kiel K, 1999, BONE MARROW TRANSPL, V23, P1019, DOI 10.1038/sj.bmt.1701767; Korthals M, 2013, BIOL BLOOD MARROW TR, V19, P1109, DOI 10.1016/j.bbmt.2013.04.025; Novella E, 2002, HAEMATOLOGICA, V87, P1157; ORITANI K, 1990, BRIT J HAEMATOL, V75, P10, DOI 10.1111/j.1365-2141.1990.tb02610.x; Paino T, 2012, HAEMATOL-HEMATOL J, V97, P1110, DOI 10.3324/haematol.2011.057372; Paiva B, 2011, LEUKEMIA, V25, P697, DOI 10.1038/leu.2010.320; Takamatsu H, 2013, EXP HEMATOL, V41, P894, DOI 10.1016/j.exphem.2013.05.004; Zane M, 2013, BIOMED PHARMACOTHER, V67, P723, DOI 10.1016/j.biopha.2013.06.007	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	MAY	2015	43	5					374	381		10.1016/j.exphem.2015.01.002		8	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CI8ZT	WOS:000355060900004		
J	Kawabata, H; Uchiyama, T; Sakamoto, S; Kanda, J; Oishi, S; Fujii, N; Tomosugi, N; Kadowaki, N; Takaori-Kondo, A				Kawabata, Hiroshi; Uchiyama, Tatsuki; Sakamoto, Soichiro; Kanda, Junya; Oishi, Shinya; Fujii, Nobutaka; Tomosugi, Naohisa; Kadowaki, Norimitsu; Takaori-Kondo, Akifumi			A HAMP promoter bioassay system for identifying chemical compounds that modulate hepcidin expression	EXPERIMENTAL HEMATOLOGY			English	Article							HEREDITARY HEMOCHROMATOSIS PROTEIN; ANTIMICROBIAL PEPTIDE HEPCIDIN; TRANSFERRIN RECEPTOR 2; IRON-OVERLOAD; SERUM HEPCIDIN; JUVENILE HEMOCHROMATOSIS; SMALL MOLECULES; ANEMIA; INFLAMMATION; MICE	Hepcidin is the central regulator of systemic iron homeostasis; dysregulation of hepcidin expression causes various iron metabolic disorders, including hereditary hemochromatosis and anemia of inflammation. To identify molecules that modulate hepcidin expression, we developed a bioassay system for hepcidin gene (HAMP) promoter activity by stable transfection of Hep3B hepatoma cells with an expression plasmid in which EGFP was linked to a 2.5kb human HAMP promoter. Interleukin 6, bone morphogenetic protein 6 (BMP-6), and oncostatin M, well-characterized stimulators of the HAMP promoter, strongly enhanced the green fluorescence intensity of these cells. Dorsomorphin, heparin, and cobalt chloride, known inhibitors of hepcidin expression, significantly suppressed green fluorescence intensity, and these inhibitory effects were more prominent when the cells were stimulated with BMP-6. Employing this system, we screened 1,280 biologically active small molecules and found several candidate inhibitors of hepcidin expression. Apomorphine, benzamil, etoposide, CGS-15943, kenpaullone, and rutaecarpine (all at 10 mu mol/L) significantly inhibited hepcidin mRNA expression by Hep3B cells without affecting cell viability. CGS-15943 was the strongest suppressor of BMP-6-induced hepcidin-25 secretion in these cells. We conclude that our newly developed hepcidin promoter bioassay system is useful for identifying and evaluating compounds that modulate hepcidin expression. Copyright (C) 2015 Published by Elsevier Inc. on behalf of ISEH - International Society for Experimental Hematology.	[Kawabata, Hiroshi; Uchiyama, Tatsuki; Sakamoto, Soichiro; Kadowaki, Norimitsu; Takaori-Kondo, Akifumi] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto 6068507, Japan; [Kanda, Junya] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Saitama, Japan; [Oishi, Shinya; Fujii, Nobutaka] Kyoto Univ, Grad Sch Pharmaceut Sci, Lab Bioorgan Med Chem & Chemogen, Kyoto, Japan; [Tomosugi, Naohisa] Kanazawa Med Univ, Med Res Inst, Div Adv Med, Uchinada, Ishikawa 92002, Japan	Kawabata, H (reprint author), Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Sakyo Ku, 54 Shogo In, Kyoto 6068507, Japan.	hkawabat@kuhp.kyoto-u.ac.jp			Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan;  [26461400]	We thank Professor Norio Komatsu (Juntendo University) for kindly providing us with valuable UT7/EPO cells. This work was supported in part by Grant-in-Aids for Scientific Research (26461400) and Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Preza GC, 2011, J CLIN INVEST, V121, P4880, DOI 10.1172/JCI57693; Casanovas G, 2009, J MOL MED-JMM, V87, P471, DOI 10.1007/s00109-009-0447-2; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Shalev H, 2013, EUR J HAEMATOL, V90, P31, DOI 10.1111/ejh.12027; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; Bridle KR, 2003, LANCET, V361, P669, DOI 10.1016/S0140-6736(03)12602-5; Kawabata H, 2005, BLOOD, V105, P376, DOI 10.1182/blood-2004-04-1416; Goswami T, 2006, J BIOL CHEM, V281, P28494, DOI 10.1074/jbc.C600197200; Camaschella C, 2000, NAT GENET, V25, P14; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Guo SL, 2013, J CLIN INVEST, V123, P1531, DOI 10.1172/JCI66969; Papanikolaou G, 2005, BLOOD, V105, P4103, DOI 10.1182/blood-2004-12-4844; Theurl I, 2011, BLOOD, V118, P4977, DOI 10.1182/blood-2011-03-345066; Lee PL, 2009, ANNU REV PATHOL-MECH, V4, P489, DOI 10.1146/annurev.pathol.4.110807.092205; Gehrke SG, 2003, BLOOD, V102, P371, DOI 10.1182/blood-2002-11-3610; Muckenthaler M, 2003, NAT GENET, V34, P102, DOI 10.1038/ng1152; Armitage AE, 2011, BLOOD, V118, P4129, DOI 10.1182/blood-2011-04-351957; Zhen AW, 2013, HEPATOLOGY, V58, P1315, DOI 10.1002/hep.26490; Casanovas G, 2013, HAEMATOLOGICA, V98, P444, DOI 10.3324/haematol.2012.069807; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Ramos E, 2012, BLOOD, V120, P3829, DOI 10.1182/blood-2012-07-440743; Smith CL, 2013, J IMMUNOL, V191, P1845, DOI 10.4049/jimmunol.1202716; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Tomosugi N, 2006, BLOOD, V108, P1381, DOI 10.1182/blood-2005-10-4043; Wallace DF, 2005, GUT, V54, P980, DOI 10.1136/gut.2004.062018; Gao JW, 2009, CELL METAB, V9, P217, DOI 10.1016/j.cmet.2009.01.010; KOMATSU N, 1993, BLOOD, V82, P456; Steinbicker AU, 2011, BLOOD, V117, P4915, DOI 10.1182/blood-2010-10-313064; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Song SNJ, 2010, BLOOD, V116, P3627, DOI 10.1182/blood-2010-03-271791; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Kanda J, 2009, INT J HEMATOL, V90, P545, DOI 10.1007/s12185-009-0443-x; Braliou GG, 2008, J HEPATOL, V48, P801, DOI 10.1016/j.jhep.2007.12.021; Camaschella C, 2013, NEW ENGL J MED, V368, P2325, DOI 10.1056/NEJMcibr1304338; Chung B, 2010, FASEB J, V24, P2093, DOI 10.1096/fj.09-152561; Dzikaite V, 2006, J HEPATOL, V44, P544, DOI 10.1016/j.jhep.2005.07.028; Fujiwara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075568; Fung E, 2013, MOL PHARMACOL, V83, P681, DOI 10.1124/mol.112.083428; Gaun V, 2014, BLOOD CELL MOL DIS, V53, P231, DOI 10.1016/j.bcmd.2014.06.002; Kanda J, 2008, HAEMATOL-HEMATOL J, V93, P1550, DOI 10.3324/haematol.12399; Kawabata H, 2012, INTERNAL MED, V51, P917, DOI 10.2169/internalmedicine.51.6978; Poli M, 2011, BLOOD, V117, P997, DOI 10.1182/blood-2010-06-289082; Poli Maura, 2010, Haematologica, V95, P1832, DOI 10.3324/haematol.2010.027003; Santini V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023109; Song SNJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4323; Subramony JA, 2006, MOL PHARMACEUT, V3, P380, DOI 10.1021/mp060012c; Tsuchiya H, 2009, GASTROENTEROLOGY, V136, P341, DOI 10.1053/j.gastro.2008.09.027; UBEDA A, 1993, FREE RADICAL BIO MED, V15, P159, DOI 10.1016/0891-5849(93)90055-Y; Falzacappa MVV, 2008, J MOL MED-JMM, V86, P531, DOI 10.1007/s00109-008-0313-7; Volke M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007875; von Drygalski A, 2013, JPEN-PARENTER ENTER, V37, P599, DOI 10.1177/0148607112459648; Youdim M. B. H., 2000, Journal of Neural Transmission Supplement, V58, P83; Yu Paul B, 2008, Nat Chem Biol, V4, P33, DOI 10.1038/nchembio.2007.54	62	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	MAY	2015	43	5					404	413		10.1016/j.exphem.2015.01.005		10	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CI8ZT	WOS:000355060900007		
J	Kummalue, T; Inoue, T; Miura, Y; Narusawa, M; Inoue, H; Komatsu, N; Wanachiwanawin, W; Sugiyama, D; Tani, K				Kummalue, Tanawan; Inoue, Tomoko; Miura, Yoshie; Narusawa, Megumi; Inoue, Hiroyuki; Komatsu, Norio; Wanachiwanawin, Wanchai; Sugiyama, Daisuke; Tani, Kenzaburo			Ribosomal protein L11-and retinol dehydrogenase 11-induced erythroid proliferation without erythropoietin in UT-7/Epo erythroleukemic cells	EXPERIMENTAL HEMATOLOGY			English	Article							DIAMOND-BLACKFAN ANEMIA; CYCLIN D1; HEMATOPOIETIC-CELLS; IN-VIVO; STAT5; SURVIVAL; ACID; TRANSLATION; INHIBITION; MECHANISM	Erythropoiesis is the process of proliferation, differentiation, and maturation of erythroid cells. Understanding these steps will help to elucidate the basis of specific diseases associated with abnormal production of red blood cells. In this study, we continued our efforts to identify genes involved in erythroid proliferation. Lentivirally transduced UT-7/Epo erythroleukemic cells expressing ribosomal protein L11 (RPL11) or retinol dehydrogenase 11 (RDH11) could proliferate in the absence of erythropoietin, and their cell-cycle profiles revealed G(0)/G(1) prolongation and low percentages of apoptosis. RPL11-expressing cells proliferated more rapidly than the RDH11-expressing cells. The antiapoptotic proteins BCL-XL and BCL-2 were expressed in both cell lines. Unlike the parental UT-7/Epo cells, the expression of hemoglobins (Hbs) in the transduced cells had switched from adult to fetal type. Several signal transduction pathways, including STAT5, were highly activated in transduced cells; furthermore, expression of the downstream target genes of STAT5, such as CCND1, was upregulated in the transduced cells. Taken together, the data indicate that RPL11 and RDH11 accelerate erythroid cell proliferation by upregulating the STAT5 signaling pathway with phosphorylation of Lyn and cyclic AMP response element-binding protein (CREB). Copyright (C) 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.	[Kummalue, Tanawan] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Clin Pathol, Bangkok 10700, Thailand; [Inoue, Tomoko; Miura, Yoshie; Narusawa, Megumi; Inoue, Hiroyuki; Tani, Kenzaburo] Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Div Mol & Clin Genet, Fukuoka 812, Japan; [Inoue, Tomoko; Sugiyama, Daisuke] Kyushu Univ, Fac Med Sci, Dept Res & Dev Next Generat Med, Fukuoka 812, Japan; [Inoue, Hiroyuki; Tani, Kenzaburo] Kyushu Univ Hosp, Dept Adv Mol & Cell Therapy, Fukuoka 812, Japan; [Komatsu, Norio] Juntendo Univ, Sch Med, Dept Hematol, Tokyo 113, Japan; [Wanachiwanawin, Wanchai] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Med,Div Hematol, Bangkok 10700, Thailand	Tani, K (reprint author), Kyushu Univ, Med Inst Bioregulat, Dept Adv Mol & Cell Therapy, Dept Mol Genet,Div Mol & Clin Genet,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	taniken@bioreg.kyushu-u.ac.jp			Project for Realization of Regenerative Medicine from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) in Japan [08008010]; Japan Society for the Promotion of Science (JSPS) [NRCT-11031]	We are thankful to Ms. Michiko Ushijima for administrative assistance. This work was supported by grants from the Project for Realization of Regenerative Medicine (K.T., 08008010) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) in Japan. TK received a grant from the Japan Society for the Promotion of Science (JSPS; grant no. NRCT-11031).	Horos R, 2012, BLOOD, V119, P262, DOI 10.1182/blood-2011-06-358200; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; Basham B, 2008, NUCLEIC ACIDS RES, V36, P3802, DOI 10.1093/nar/gkn271; Liden M, 2006, J BIOL CHEM, V281, P13001, DOI 10.1074/jbc.R500027200; Robledo S, 2008, RNA, V14, P1918, DOI 10.1261/rna.1132008; Vlachos A, 2008, BRIT J HAEMATOL, V142, P859, DOI 10.1111/j.1365-2141.2008.07269.x; Xiao WB, 2010, BLOOD, V116, P6003, DOI 10.1182/blood-2010-05-283937; Stacey DW, 2003, CURR OPIN CELL BIOL, V15, P158, DOI 10.1016/S0955-0674(03)00008-5; Teng T, 2013, MOL CELL BIOL, V33, P4660, DOI 10.1128/MCB.01174-13; Itzykson R, 2009, LEUKEMIA, V23, P673, DOI 10.1038/leu.2008.362; Sankaran VG, 2011, P NATL ACAD SCI USA, V108, P1519, DOI 10.1073/pnas.1018384108; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; Menegola Elena, 2006, Birth Defects Research, V78, P345, DOI 10.1002/bdrc.20082; KOMATSU N, 1993, BLOOD, V82, P456; Erickson-Miller CL, 2000, STEM CELLS, V18, P366, DOI 10.1634/stemcells.18-5-366; Noy N, 2010, ANNU REV NUTR, V30, P201, DOI 10.1146/annurev.nutr.28.061807.155509; Boer AK, 2003, EXP HEMATOL, V31, P512, DOI 10.1016/S0301-472X(03)00075-4; de Groot Rolf P., 2000, Molecular Cell Biology Research Communications, V3, P299, DOI 10.1006/mcbr.2000.0231; DOUER D, 1982, J CLIN INVEST, V69, P1039, DOI 10.1172/JCI110507; Gabbianelli M, 2010, HAEMATOL-HEMATOL J, V95, P1253, DOI 10.3324/haematol.2009.018259; Hamadi A, 2010, J ONCOL, V2010; Ingley E, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-21; Inoue T, 2011, STEM CELL REV REP, V7, P43, DOI 10.1007/s12015-010-9140-7; Koulnis M, 2012, BLOOD, V119, P1228, DOI 10.1182/blood-2011-07-365346; Kurita R, 2008, MOL CELL BIOCHEM, V319, P181, DOI 10.1007/s11010-008-9891-5; Lulli V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060436; Moniz H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.88; Sankaran V, 2013, COLD SPRING HARB PER, V3, P1; Schepers Hein, 2012, JAKSTAT, V1, P13, DOI 10.4161/jkst.19316; Stegeman H, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-133; Uchida M, 2007, INT J HEMATOL, V86, P315, DOI 10.1532/IJH97.07093; Zhang ZJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-896	33	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	MAY	2015	43	5					414	423		10.1016/j.exphem.2015.01.006		10	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CI8ZT	WOS:000355060900008		
J	Fujiwara, T; Kawachi, M; Sato, Y; Mori, H; Kutsuna, N; Hasezawa, S; Maeshima, M				Fujiwara, Takashi; Kawachi, Miki; Sato, Yori; Mori, Haruki; Kutsuna, Natsumaro; Hasezawa, Seiichiro; Maeshima, Masayoshi			A high molecular mass zinc transporter MTP12 forms a functional heteromeric complex with MTP5 in the Golgi in Arabidopsis thaliana	FEBS JOURNAL			English	Article						Arabidopsis; cation diffusion facilitator; Golgi; MTP; zinc	TRANSIENT GENE-EXPRESSION; VACUOLAR MEMBRANE ZINC; HISTIDINE-RICH LOOP; SACCHAROMYCES-CEREVISIAE; SECRETORY PATHWAY; ALKALINE-PHOSPHATASES; METAL HOMEOSTASIS; BINARY VECTOR; PLANT-CELLS; PROTEIN	Zinc (Zn) is an essential micronutrient required for plant growth and development. In Arabidopsis thaliana, several families of Zn transporters engaged in Zn import, export and intracellular compartmentalization play important roles in Zn homeostasis. We describe a novel Zn transporter, A. thaliana metal tolerance protein 12 (AtMTP12), which belongs to the cation diffusion facilitator family. AtMTP12 is predicted to consist of 798 amino acids and have 14 transmembrane segments. The expression of AtMTP12 in suspension-cultured cells was not affected by Zn deficiency or excess. Heterologous expression in a mutant of budding yeast (Saccharomyces cerevisiae) that lacks Msc2p, an orthologue of AtMTP12, revealed that AtMTP12 complements the growth phenotype of the msc2 mutant when AtMTP5t1, one of the splicing variants of AtMTP5, is coexpressed. Transient expression of AtMTP12-fused green fluorescent protein in A. thaliana mesophyll protoplasts demonstrated that AtMTP12 is localized to the Golgi apparatus. Moreover, AtMTP12 and AtMTP5t1 interact in the Golgi, as determined by a bimolecular fluorescence complementation assay. These results suggest that AtMTP12 forms a functional complex with AtMTP5t1 to transport Zn into the Golgi.	[Fujiwara, Takashi; Kawachi, Miki; Sato, Yori; Mori, Haruki; Maeshima, Masayoshi] Nagoya Univ, Grad Sch Bioagr Sci, Lab Cell Dynam, Nagoya, Aichi 4648601, Japan; [Kutsuna, Natsumaro; Hasezawa, Seiichiro] Univ Tokyo, Dept Integrated Biosci, Tokyo 1138654, Japan; [Kutsuna, Natsumaro] LPixel Inc, Bunkyo Ku, Tokyo, Japan	Maeshima, M (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Lab Cell Dynam, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	maeshima@agr.nagoya-u.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan [50724499, 24770038, 25650093, 26252011]; Steel Foundation for Environmental Protection Technology [2010-29]	We are grateful to Dr Takashi Ueda (The University of Tokyo, Japan) for valuable discussions and providing cDNAs encoding intracellular markers (cis-Golgi, trans-Golgi, TGN, and early endosome). We also thank Dr David Eide (University of Wisconsin-Madison, USA), Dr Tsuyoshi Nakagawa (Shimane University, Japan) and Dr Ikuko Hara-Nishimura (Kyoto University, Japan) for providing S. cerevisiae strains (DY150 and DY150 msc2), bimolecular fluorescence complementation vectors (pGWnY, pGWcY, and pnYGW), and cDNA encoding an ER marker, respectively. TF received Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists. This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan to TF (50724499) NK (24770038) and MM (25650093 and 26252011) and from the Steel Foundation for Environmental Protection Technology (2010-29) to M. M.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Peiter E, 2007, P NATL ACAD SCI USA, V104, P8532, DOI 10.1073/pnas.0609507104; Li LT, 2001, J BIOL CHEM, V276, P5036, DOI 10.1074/jbc.M008969200; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Uemura T, 2004, CELL STRUCT FUNCT, V29, P49, DOI 10.1247/csf.29.49; Ellis CD, 2005, J BIOL CHEM, V280, P28811, DOI 10.1074/jbc.M505500200; Verret F, 2004, FEBS LETT, V576, P306, DOI 10.1016/j.febslet.2004.09.023; Delhaize E, 2007, PLANT J, V51, P198, DOI 10.1111/j.1365-313X.2007.03138.x; Drager DB, 2004, PLANT J, V39, P425, DOI 10.1111/j.1365-313X.2004.02143.x; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Ellis CD, 2004, J CELL BIOL, V166, P325, DOI 10.1083/jcb.200401157; KAMIZONO A, 1989, MOL GEN GENET, V219, P161; Kirschke CP, 2003, J BIOL CHEM, V278, P4096, DOI 10.1074/jbc.M207644200; Sinclair SA, 2007, NEW PHYTOL, V174, P39, DOI 10.1111/j.1469-8137.2007.02030.x; Kawachi M, 2008, J BIOL CHEM, V283, P8374, DOI 10.1074/jbc.M707646200; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Milner MJ, 2013, J EXP BOT, V64, P369, DOI 10.1093/jxb/ers315; Morel M, 2009, PLANT PHYSIOL, V149, P894, DOI 10.1104/pp.108.130294; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; Chen PY, 2003, MOL BREEDING, V11, P287, DOI 10.1023/A:1023475710642; SHEN WJ, 1989, NUCLEIC ACIDS RES, V17, P8385; Gupta S, 2014, NATURE, V512, P101, DOI 10.1038/nature13382; CONKLIN DS, 1992, MOL CELL BIOL, V12, P3678; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Lin YF, 2009, NEW PHYTOL, V182, P392, DOI 10.1111/j.1469-8137.2009.02766.x; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; AXELOS M, 1992, PLANT PHYSIOL BIOCH, V30, P123; Hino T, 2011, BIOSCI BIOTECH BIOCH, V75, P1848, DOI 10.1271/bbb.110331; Ueda T, 2004, PLANT J, V40, P783, DOI 10.1111/j.1365-313X.2004.02249.x; Korshunova YO, 1999, PLANT MOL BIOL, V40, P37, DOI 10.1023/A:1026438615520; Becher M, 2004, PLANT J, V37, P251, DOI 10.1046/j.1365-313X.2003.01959.x; Hussain D, 2004, PLANT CELL, V16, P1327, DOI 10.1105/tpc.020487; Sinclair SA, 2012, BBA-MOL CELL RES, V1823, P1553, DOI 10.1016/j.bbamcr.2012.05.016; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Akada R, 2000, BIOTECHNIQUES, V28, P668; Arrivault S, 2006, PLANT J, V46, P861, DOI 10.1111/j.1365-313X.2006.02746.x; Kobae Y, 2004, PLANT CELL PHYSIOL, V45, P1749, DOI 10.1093/pcp/pci015; Chaumont F, 2014, PLANT PHYSIOL, V164, P1600, DOI 10.1104/pp.113.233791; Vert G, 2009, PLANTA, V229, P1171, DOI 10.1007/s00425-009-0904-8; Vert G, 2001, PLANT J, V26, P181, DOI 10.1046/j.1365-313x.2001.01018.x; Ito Y, 2012, MOL BIOL CELL, V23, P3203, DOI 10.1091/mbc.E12-01-0034; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; Desbrosses-Fonrouge AG, 2005, FEBS LETT, V579, P4165, DOI 10.1016/j.febslet.2005.06.046; Fang Y, 2008, MOL BIOL CELL, V19, P1295, DOI 10.1091/mbc.E07-08-0805; Ferrando A, 2000, PLANT J, V22, P553, DOI 10.1046/j.1365-313x.2000.00763.x; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; Huang LP, 2002, J BIOL CHEM, V277, P26389, DOI 10.1074/jbc.M200462200; Kawachi M, 2012, FEBS J, V279, P2339, DOI 10.1111/j.1742-4658.2012.08613.x; Kawachi M, 2009, PLANT CELL PHYSIOL, V50, P1156, DOI 10.1093/pcp/pcp067; Kramer U, 2006, TOP CURR GENET, V14, P215; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Muller-Taubenberger A, 2007, APPL MICROBIOL BIOT, V77, P1, DOI 10.1007/s00253-007-1131-5; NAGATA T, 1981, MOL GEN GENET, V184, P161; Rose M.D., 1990, METHODS YEAST GENETI; Tamura K, 2005, PLANT CELL, V17, P1764, DOI 10.1105/tpc.105.031930; TANAKA K, 1990, MOL CELL BIOL, V10, P4303; Tanaka N, 2013, FEBS OPEN BIO, V3, P218, DOI 10.1016/j.fob.2013.04.004; Winter D., 2007, PLOS ONE, V2, pe718, DOI DOI 10.1371/J0URNAL.P0NE.0000718	59	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	MAY	2015	282	10					1965	1979		10.1111/febs.13252		15	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CI5PG	WOS:000354809700010		
J	Liu, JK; Hyde, KD; Jones, EBG; Ariyawansa, HA; Bhat, DJ; Boonmee, S; Maharachchikumbura, SSN; McKenzie, EHC; Phookamsak, R; Phukhamsakda, C; Shenoy, BD; Abdel-Wahab, MA; Buyck, B; Chen, J; Chethana, KWT; Singtripop, C; Dai, DQ; Dai, YC; Daranagama, DA; Dissanayake, AJ; Doilom, M; D'souza, MJ; Fan, XL; Goonasekara, ID; Hirayama, K; Hongsanan, S; Jayasiri, SC; Jayawardena, RS; Karunarathna, SC; Li, WJ; Mapook, A; Norphanphoun, C; Pang, KL; Perera, RH; Persoh, D; Pinruan, U; Senanayake, IC; Somrithipol, S; Suetrong, S; Tanaka, K; Thambugala, KM; Tian, Q; Tibpromma, S; Udayanga, D; Wijayawardene, NN; Wanasinghe, D; Wisitrassameewong, K; Zeng, XY; Abdel-Aziz, FA; Adamck, S; Bahkali, AH; Boonyuen, N; Bulgakov, T; Callac, P; Chomnunti, P; Greiner, K; Hashimoto, A; Hofstetter, V; Kang, JC; Lewis, D; Li, XH; Liu, XZ; Liu, ZY; Matsumura, M; Mortimer, PE; Rambold, G; Randrianjohany, E; Sato, G; Sri-Indrasutdhi, V; Tian, CM; Verbeken, A; von Brackel, W; Wang, Y; Wen, TC; Xu, JC; Yan, JY; Zhao, RL; Camporesi, E				Liu, Jian Kui; Hyde, Kevin D.; Jones, E. B. Gareth; Ariyawansa, Hiran A.; Bhat, Darbhe J.; Boonmee, Saranyaphat; Maharachchikumbura, Sajeewa S. N.; McKenzie, Eric H. C.; Phookamsak, Rungtiwa; Phukhamsakda, Chayanard; Shenoy, Belle Damodara; Abdel-Wahab, Mohamed A.; Buyck, Bart; Chen, Jie; Chethana, K. W. Thilini; Singtripop, Chonticha; Dai, Dong Qin; Dai, Yu Cheng; Daranagama, Dinushani A.; Dissanayake, Asha J.; Doilom, Mingkwan; D'souza, Melvina J.; Fan, Xin Lei; Goonasekara, Ishani D.; Hirayama, Kazuyuki; Hongsanan, Sinang; Jayasiri, Subashini C.; Jayawardena, Ruvishika S.; Karunarathna, Samantha C.; Li, Wen Jing; Mapook, Ausana; Norphanphoun, Chada; Pang, Ka Lai; Perera, Rekhani H.; Persoh, Derek; Pinruan, Umpava; Senanayake, Indunil C.; Somrithipol, Sayanh; Suetrong, Satinee; Tanaka, Kazuaki; Thambugala, Kasun M.; Tian, Qing; Tibpromma, Saowaluck; Udayanga, Danushka; Wijayawardene, Nalin N.; Wanasinghe, Dhanuska; Wisitrassameewong, Komsit; Zeng, Xiang Yu; Abdel-Aziz, Faten A.; Adamck, Slavomir; Bahkali, Ali H.; Boonyuen, Nattawut; Bulgakov, Timur; Callac, Philippe; Chomnunti, Putarak; Greiner, Katrin; Hashimoto, Akira; Hofstetter, Valerie; Kang, Ji Chuan; Lewis, David; Li, Xing Hong; Liu, Xing Zhong; Liu, Zuo Yi; Matsumura, Misato; Mortimer, Peter E.; Rambold, Gerhard; Randrianjohany, Emile; Sato, Genki; Sri-Indrasutdhi, Veera; Tian, Cheng Ming; Verbeken, Annemieke; von Brackel, Wolfgang; Wang, Yong; Wen, Ting Chi; Xu, Jian Chu; Yan, Ji Ye; Zhao, Rui Lin; Camporesi, Erio			Fungal diversity notes 1-110: taxonomic and phylogenetic contributions to fungal species	FUNGAL DIVERSITY			English	Article						Ascomycota; Basidiomycota; Global Taxonomy Initiative; Phylogeny; Taxonomy	RIBOSOMAL DNA-SEQUENCES; MOLECULAR PHYLOGENY; NORTH-AMERICA; SP NOV.; ALLIED GENERA; FRESH-WATER; SENSU-LATO; CANTHARELLUS CANTHARELLALES; NATURAL CLASSIFICATION; MULTILOCUS PHYLOGENY	This paper is a compilation of notes on 110 fungal taxa, including one new family, 10 new genera, and 76 new species, representing a wide taxonomic and geographic range. The new family, Paradictyoarthriniaceae is introduced based on its distinct lineage in Dothideomycetes and its unique morphology. The family is sister to Biatriosporaceae and Roussoellaceae. The new genera are Allophaeosphaeria (Phaeosphaeriaceae), Amphibambusa (Amphisphaeriaceae), Brunneomycosphaerella (Capnodiales genera incertae cedis), Chaetocapnodium (Capnodiaceae), Flammeascoma (Anteagloniaceae), Multiseptospora (Pleosporales genera incertae cedis), Neogaeumannomyces (Magnaporthaceae), Palmiascoma (Bambusicolaceae), Paralecia (Squamarinaceae) and Sarimanas (Melanommataceae). The newly described species are the Ascomycota Aliquandostipite manochii, Allophaeosphaeria dactylidis, A. muriformia, Alternaria cesenica, Amphibambusa bambusicola, Amphisphaeria sorbi, Annulohypoxylon thailandicum, Atrotorquata spartii, Brunneomycosphaerella laburni, Byssosphaeria musae, Camarosporium aborescentis, C. aureum, C. frutexensis, Chaetocapnodium siamensis, Chaetothyrium agathis, Colletotrichum sedi, Conicomyces pseudotransvaalensis, Cytospora berberidis, C. sibiraeae, Diaporthe thunbergiicola, Diatrype palmicola, Dictyosporium aquaticum, D. meiosporum, D. thailandicum, Didymella cirsii, Dinemasporium nelloi, Flammeascoma bambusae, Kalmusia italica, K. spartii, Keissleriella sparticola, Lauriomyces synnematicus, Leptosphaeria ebuli, Lophiostoma pseudodictyosporium, L. ravennicum, Lophiotrema eburnoides, Montagnula graminicola, Multiseptospora thailandica, Myrothecium macrosporum, Natantispora unipolaris, Neogaeumannomyces bambusicola, Neosetophoma clematidis, N. italica, Oxydothis atypica, Palmiascoma gregariascomum, Paraconiothyrium nelloi, P. thysanolaenae, Paradictyoarthrinium tectonicola, Paralecia pratorum, Paraphaeosphaeria spartii, Pestalotiopsis digitalis, P. dracontomelon, P. italiana, Phaeoisaria pseudoclematidis, Phragmocapnias philippinensis, Pseudocamarosporium cotinae, Pseudocercospora tamarindi, Pseudotrichia rubriostiolata, P. thailandica, Psiloglonium multiseptatum, Saagaromyces mangrovei, Sarimanas pseudofluviatile, S. shirakamiense, Tothia spartii, Trichomerium siamensis, Wojnowicia dactylidicola, W. dactylidis and W. lonicerae. The Basidiomycota Agaricus flavicentrus, A. hanthanaensis, A. parvibicolor, A. sodalis, Cantharellus luteostipitatus, Lactarius atrobrunneus, L. politus, Phylloporia dependens and Russula cortinarioides are also introduced. Epitypifications or reference specimens are designated for Hapalocystis berkeleyi, Meliola tamarindi, Pallidocercospora acaciigena, Phaeosphaeria musae, Plenodomus agnitus, Psiloglonium colihuae, P. sasicola and Zasmidium musae while notes and/or new sequence data are provided for Annulohypoxylon leptascum, A. nitens, A. stygium, Biscogniauxia marginata, Fasciatispora nypae, Hypoxylon fendleri, H. monticulosum, Leptosphaeria doliolum, Microsphaeropsis olivacea, Neomicrothyrium, Paraleptosphaeria nitschkei, Phoma medicaginis and Saccotheciaceae. A full description of each species is provided with light micrographs (or drawings). Molecular data is provided for 90 taxa and used to generate phylogenetic trees to establish a natural classification for species.	[Liu, Jian Kui; Hyde, Kevin D.; Maharachchikumbura, Sajeewa S. N.; Thambugala, Kasun M.; Liu, Zuo Yi] Guizhou Acad Agr Sci, Guizhou Key Lab Agr Biotechnol, Guiyang 550006, Guizhou, Peoples R China; [Hyde, Kevin D.; Ariyawansa, Hiran A.; Maharachchikumbura, Sajeewa S. N.; Phookamsak, Rungtiwa; Phukhamsakda, Chayanard; Singtripop, Chonticha; Dai, Dong Qin; Daranagama, Dinushani A.; Doilom, Mingkwan; D'souza, Melvina J.; Hongsanan, Sinang; Jayawardena, Ruvishika S.; Karunarathna, Samantha C.; Li, Wen Jing; Mapook, Ausana; Perera, Rekhani H.; Senanayake, Indunil C.; Thambugala, Kasun M.; Tian, Qing; Udayanga, Danushka; Wijayawardene, Nalin N.; Wanasinghe, Dhanuska; Chomnunti, Putarak; Mortimer, Peter E.] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming 650201, Yunnan, Peoples R China; [Liu, Jian Kui; Hyde, Kevin D.; Ariyawansa, Hiran A.; Boonmee, Saranyaphat; Maharachchikumbura, Sajeewa S. N.; Phookamsak, Rungtiwa; Phukhamsakda, Chayanard; Chen, Jie; Chethana, K. W. Thilini; Singtripop, Chonticha; Dai, Dong Qin; Daranagama, Dinushani A.; Dissanayake, Asha J.; Doilom, Mingkwan; D'souza, Melvina J.; Goonasekara, Ishani D.; Hongsanan, Sinang; Jayasiri, Subashini C.; Jayawardena, Ruvishika S.; Karunarathna, Samantha C.; Li, Wen Jing; Mapook, Ausana; Norphanphoun, Chada; Perera, Rekhani H.; Senanayake, Indunil C.; Thambugala, Kasun M.; Tian, Qing; Tibpromma, Saowaluck; Udayanga, Danushka; Wijayawardene, Nalin N.; Wanasinghe, Dhanuska; Wisitrassameewong, Komsit; Zeng, Xiang Yu; Chomnunti, Putarak] Mae Fah Luang Univ, Inst Excellence Fungal Res, Chiang Rai 57100, Thailand; [Liu, Jian Kui; Hyde, Kevin D.; Ariyawansa, Hiran A.; Boonmee, Saranyaphat; Maharachchikumbura, Sajeewa S. N.; Phookamsak, Rungtiwa; Phukhamsakda, Chayanard; Chen, Jie; Chethana, K. W. Thilini; Singtripop, Chonticha; Dai, Dong Qin; Daranagama, Dinushani A.; Dissanayake, Asha J.; Doilom, Mingkwan; D'souza, Melvina J.; Goonasekara, Ishani D.; Hongsanan, Sinang; Jayasiri, Subashini C.; Jayawardena, Ruvishika S.; Karunarathna, Samantha C.; Li, Wen Jing; Mapook, Ausana; Norphanphoun, Chada; Perera, Rekhani H.; Senanayake, Indunil C.; Thambugala, Kasun M.; Tian, Qing; Tibpromma, Saowaluck; Udayanga, Danushka; Wijayawardene, Nalin N.; Wanasinghe, Dhanuska; Wisitrassameewong, Komsit; Zeng, Xiang Yu; Chomnunti, Putarak] Mae Fah Luang Univ, Sch Sci, Chiang Rai 57100, Thailand; [Jones, E. B. Gareth] King Saudi Univ, Dept Bot & Microbiol, Riyadh, Saudi Arabia; [McKenzie, Eric H. C.] Manaaki Whenua Landcare Res, Auckland, New Zealand; [Bhat, Darbhe J.] Goa Univ, Dept Bot, Bambolim, Goa, India; [Bhat, Darbhe J.] Azad Housing Soc, Curca, Goa Velha, India; [Buyck, Bart] Museum Natl Hist Nat, Dept Systemat & Evolut, UMR 7205, F-75231 Paris, France; [Dai, Yu Cheng] Beijing Forestry Univ, Inst Microbiol, Beijing 100083, Peoples R China; [Dai, Yu Cheng] Beijing Forestry Univ, Beijing Key Lab Forest Pest Control, Beijing 100083, Peoples R China; [Chethana, K. W. Thilini; Dissanayake, Asha J.; Jayawardena, Ruvishika S.; Li, Xing Hong; Yan, Ji Ye] Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing 10097, Peoples R China; [Fan, Xin Lei; Tian, Cheng Ming] Beijing Forestry Univ, Minist Educ, Key Lab Silviculture & Conservat, Beijing 100083, Peoples R China; [Greiner, Katrin; Rambold, Gerhard] Univ Bayreuth, Mycol, D-95440 Bayreuth, Germany; [Hashimoto, Akira] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 0208550, Japan; [Hirayama, Kazuyuki] Aomori Prefectural Agr & Forestry Res Ctr, Apple Expt Stn, Kuroishi, Aomori 0360332, Japan; [Hofstetter, Valerie] Agroscope Changins Wadenswil Res Stn ACW, Dept Plant Protect, CH-1260 Nyon, Switzerland; [Jones, E. B. Gareth; Abdel-Wahab, Mohamed A.; Bahkali, Ali H.] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 1145, Saudi Arabia; [Abdel-Wahab, Mohamed A.; Abdel-Aziz, Faten A.] Sohag Univ, Dept Bot, Fac Sci, Sohag, Egypt; [Adamck, Slavomir] Slovak Acad Sci, Inst Bot, Bratislava 84523, Slovakia; [Lewis, David] Hirosaki Univ, Newton, TX 75966 USA; [Tanaka, Kazuaki; Hashimoto, Akira; Matsumura, Misato; Sato, Genki] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori 0368561, Japan; [von Brackel, Wolfgang] Inst Vegetat Studies & Landscape Ecol, D-91334 Hemhofen, Germany; [Pang, Ka Lai] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung 20224, Taiwan; [Pang, Ka Lai] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung 20224, Taiwan; [Persoh, Derek] Ruhr Univ Bochum, Geobot, D-44780 Bochum, Germany; [Randrianjohany, Emile] CNRE, LME, Antananarivo, Madagascar; [Shenoy, Belle Damodara] CSIR Natl Inst Oceanog, Panaji 403004, Goa, India; [Pinruan, Umpava; Somrithipol, Sayanh] Natl Sci & Technol Dev Agcy, BIOTEC, Microbe Interact Lab, Khlong Luang 12120, Pathum Thani, Thailand; [Suetrong, Satinee; Boonyuen, Nattawut; Sri-Indrasutdhi, Veera] Natl Sci & Technol Dev Agcy, BIOTEC, Fungal Biodivers Lab, Khlong Luang 12120, Pathum Thani, Thailand; [Verbeken, Annemieke] Univ Ghent, Dept Biol, Res Grp Mycol, B-9000 Ghent, Belgium; [Wijayawardene, Nalin N.; Wang, Yong] Guizhou Univ, Coll Agr, Dept Plant Pathol, Guiyang 550025, Peoples R China; [Kang, Ji Chuan; Wen, Ting Chi] Guizhou Univ, Minist Educ, Engn & Res Ctr Southwest Bio Pharmaceut Resource, Guiyang 550025, Guizhou, Peoples R China; [Xu, Jian Chu] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing 100101, Peoples R China; [Camporesi, Erio] AMB Grp Micol Forlivese Antonio Cicognani, Forli, Italy; [Camporesi, Erio] AMB Circolo Micol Giovanni Carini, Brescia, Italy; [Camporesi, Erio] Soc Nat Romagna, Bagnacavallo, RA, Italy; [Bulgakov, Timur] Southern Fed Univ, Acad Biol & Biotechnol, Dept Biol Sci, Rostov Na Donu 344090, Russia; [Liu, Xing Zhong; Zhao, Rui Lin] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing 100101, Peoples R China; [Callac, Philippe] INRA, Mycol & Food Safety Res Unit, Bordeaux, France	Liu, ZY (reprint author), Guizhou Acad Agr Sci, Guizhou Key Lab Agr Biotechnol, Guiyang 550006, Guizhou, Peoples R China.	gzliuzuoyi@163.com			Chinese Academy of Sciences [KSCX2-EW-Z-9]; Japan Society for the Promotion of Science (JSPS) [25440199]; Distinguished Scientist Fellowship Program (DSFP), King Saud University, Saudi Arabia; NSTIP strategic technologies program in the Kingdom of Saudi Arabia [12-BIO2840-02]; ATM "Emergences" from the National museum of natural history, Paris; ATM research program "Etat et structure phylogenetique de la biodiversite actuelle et fossile" of the Paris' Museum; national Slovak Project [VEGA 02/0075/14]; Indo-Thailand bilateral programme [THAI-1205]; joint doctorate program of the "Bijzonder Onderzoeksfonds Gent University" (BOF), Gent University; Biodiversity and Training Program [BRT R 149009]; Interaction Laboratory (BMIT), National Center for Genetic Engineering and Biotechnology (BIOTEC) Khlong Luang, Pathum Thani, Thailand; Thailand Research Fund [BRG 5580009]; National Natural Science Foundation of China [31000013, 31360014, 31470152]	The research was supported by 1) Chinese Academy of Sciences (Project No. KSCX2-EW-Z-9). K. Tanaka would like to thank the Japan Society for the Promotion of Science (JSPS, 25440199) for financial support. This project was supported by the Distinguished Scientist Fellowship Program (DSFP), King Saud University, Saudi Arabia. This project was also supported by NSTIP strategic technologies program, number (12-BIO2840-02) in the Kingdom of Saudi Arabia. B. Buyck and V. Hofstetter acknowledge the ATM "Emergences" (Dirs. P. Janvier & S. Peigne) from the National museum of natural history, Paris, for financial support related to sequencing as well as travel expenses in Madagascar. Overseas travel of B. Buyck was funded by the ATM research program "Etat et structure phylogenetique de la biodiversite actuelle et fossile" of the Paris' Museum. (director Ph. Janvier); S. Adamcik acknowledges funding by his national Slovak Project VEGA 02/0075/14. B.D. Shenoy acknowledges funding to visit Mae Fah Luang University, Chiang Rai under Indo-Thailand bilateral programme (THAI-1205). The Lewis family is warmly thanked for their generous hospitality, offering excellent and very agreeable working and field condition. K. Wisitrassameewong and A. Verbeken were financially supported by the joint doctorate program of the "Bijzonder Onderzoeksfonds Gent University" (BOF), Gent University. This research was also financial supported by The Biodiversity and Training Program (BRT R 149009) and Interaction Laboratory (BMIT), National Center for Genetic Engineering and Biotechnology (BIOTEC) Khlong Luang, Pathum Thani 12120, Thailand. Thanks are extended to the Thailand Research Fund grant (BRG 5580009) under the research grant entitled "Taxonomy, Phylogeny and Biochemistry of Thai Basidiomycetes" for financial support. J. Chen and R. L. Zhao would like to thank the National Natural Science Foundation of China (Project ID: 31000013, 31360014 and 31470152). Uwe Braun, Walter Jaklitsch, Tom May, Marc Stadler and Jo Taylor, are thanks for commenting on some parts of the manuscript. Shaun Pennycook is thanked for checking and suggesting corrections to most of the Latin names.	Adamcik S., 2014, CRYPTOG MYCOLOG, V35, P291; Adams G.C., 2005, STUD MYCOL, V52, P1; AMANO N, 1983, T MYCOL SOC JPN, V24, P283; Zhao RL, 2011, FUNGAL DIVERS, V51, P279, DOI 10.1007/s13225-011-0136-7; Hawksworth DL, 1997, PHYTOPATHOLOGY, V87, P888, DOI 10.1094/PHYTO.1997.87.9.888; CALLAN BE, 1986, CAN J BOT, V64, P842; Crous PW, 2009, STUD MYCOL, P17, DOI 10.3114/sim.2009.64.02; Udayanga D, 2012, CRYPTOGAMIE MYCOL, V33, P295; Suetrong S, 2011, FUNGAL DIVERS, V51, P163, DOI 10.1007/s13225-011-0138-5; Chomnunti P, 2012, FUNGAL DIVERS, V56, P63, DOI 10.1007/s13225-012-0197-2; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Crous PW, 2009, PERSOONIA, V22, P139, DOI 10.3767/003158509X461701; BARR ME, 1975, MYCOLOGIA, V67, P187, DOI 10.2307/3758246; Zhang Y, 2011, FUNGAL DIVERS, V51, P249, DOI 10.1007/s13225-011-0141-x; BARR ME, 1982, MYCOTAXON, V15, P349; Lorenzo LE, 1998, MYCOL RES, V102, P1101, DOI 10.1017/S0953756297006072; Wong PTW, 2012, AUSTRALAS PLANT PATH, V41, P321, DOI 10.1007/s13313-012-0118-6; BARR ME, 1990, MYCOTAXON, V39, P43; SPIELMAN LJ, 1985, CAN J BOT, V63, P1355; Tanaka K, 2010, BOTANY, V88, P1057, DOI 10.1139/B10-078; Ruiz RFC, 2002, CRYPTOGAMIE MYCOL, V23, P9; Damm U, 2009, FUNGAL DIVERS, V39, P45; Buyck B, 2012, CRYPTOGAMIE MYCOL, V33, P167; SHEARER CA, 1990, MYCOLOGIA, V82, P496, DOI 10.2307/3760021; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Reblova M, 2011, STUD MYCOL, P163, DOI 10.3114/sim.2011.68.07; Zhang N, 2006, MYCOLOGIA, V98, P1076, DOI 10.3852/mycologia.98.6.1076; Hirayama K, 2010, MYCOLOGIA, V102, P729, DOI 10.3852/09-230; Crous PW, 2007, STUD MYCOL, P1, DOI 10.3114/sim.2007.58.01; Aveskamp MM, 2008, FUNGAL DIVERS, V31, P1; Zhao RL, 2012, MYCOTAXON, V122, P187, DOI 10.5248/122.187; Wedin M, 2009, MOL PHYLOGENET EVOL, V53, P862, DOI 10.1016/j.ympev.2009.08.013; Somrithipol S, 2007, NOVA HEDWIGIA, V84, P479, DOI 10.1127/0029-5035/2007/0084-0479; GLAWE DA, 1984, MYCOTAXON, V20, P401; Zhou LW, 2013, MYCOTAXON, V124, P361, DOI 10.5248/124.361; Adams GC, 2006, AUSTRALAS PLANT PATH, V35, P521, DOI 10.1071/AP06058; Phillips AJL, 2008, PERSOONIA, V21, P29, DOI 10.3767/003158508X340742; Udayanga D, 2011, FUNGAL DIVERS, V50, P189, DOI 10.1007/s13225-011-0126-9; WALKER J, 1972, T BRIT MYCOL SOC, V58, P427; Miadlikowska J, 2006, MYCOLOGIA, V98, P1088, DOI 10.3852/mycologia.98.6.1088; De Gruyter J, 2009, MYCOL RES, V113, P508, DOI 10.1016/j.mycres.2009.01.002; Hyde KD, 2013, FUNGAL DIVERS, V63, P1, DOI 10.1007/s13225-013-0263-4; Dai YC, 2012, MYCOSCIENCE, V53, P49, DOI 10.1007/s10267-011-0134-3; Pinho DB, 2012, MYCOTAXON, V122, P333, DOI 10.5248/122.333; BARR ME, 1979, MYCOLOGIA, V71, P935, DOI 10.2307/3759283; Crous PW, 2013, STUD MYCOL, P37, DOI 10.3114/sim0005; Rossman Amy Y., 2007, Mycoscience, V48, P135, DOI 10.1007/s10267-007-0347-7; Boehm EWA, 2009, MYCOL RES, V113, P461, DOI 10.1016/j.mycres.2008.12.001; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Kaiser WJ, 2008, PLANT DIS, V92, P1365, DOI 10.1094/PDIS-92-9-1365A; Hirayama K, 2011, MYCOSCIENCE, V52, P401, DOI 10.1007/s10267-011-0126-3; Crous PW, 2004, STUD MYCOL, P19; Thongkantha S, 2009, FUNGAL DIVERS, V34, P157; Alves A, 2004, MYCOLOGIA, V96, P598, DOI 10.2307/3762177; [Anonymous], 2004, FUNG DIVERS RES SER; Chacon S, 2013, MYCOLOGIA, V105, P681, DOI 10.3852/12-131; Andersen HL, 2005, MYCOL RES, V109, P21, DOI 10.1017/S0953756204001625; Inderbitzin P, 2001, AM J BOT, V88, P52, DOI 10.2307/2657126; Chomnunti P, 2014, FUNGAL DIVERS, V66, P1, DOI 10.1007/s13225-014-0278-5; Buyck B, 2014, CRYPTOGAMIE MYCOL, V35, P23, DOI 10.7872/crym.v35.iss1.2014.23; Aveskamp MM, 2010, STUD MYCOL, P1, DOI 10.3114/sim.2010.65.01; Jones EBG, 2009, FUNGAL DIVERS, V35, P1; Damm U, 2008, PERSOONIA, V20, P9, DOI 10.3767/003158508X286842; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Zhang Y, 2009, PERSOONIA, V23, P48, DOI 10.3767/003158509X472187; Zhang Y, 2009, FUNGAL DIVERS, V38, P225; Castlebury LA, 2002, MYCOLOGIA, V94, P1017, DOI 10.2307/3761867; Quaedvlieg W, 2013, STUD MYCOL, P307, DOI 10.3114/sim0017; SHOEMAKER RA, 1989, CAN J BOT, V67, P1500; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Schmit JP, 2007, BIODIVERS CONSERV, V16, P99, DOI 10.1007/s10531-006-9129-3; Kirschner R, 2013, MYCOL PROG, V12, P29, DOI 10.1007/s11557-012-0812-3; Chomnunti P, 2011, FUNGAL DIVERS, V51, P103, DOI 10.1007/s13225-011-0145-6; Liu JK, 2012, FUNGAL DIVERS, V57, P149, DOI 10.1007/s13225-012-0207-4; Hyde KD, 2000, BIODIVERS CONSERV, V9, P393, DOI 10.1023/A:1008911121774; BARR ME, 1984, MYCOTAXON, V20, P1; Fan XL, 2014, MYCOSCIENCE, V55, P252, DOI 10.1016/j.myc.2013.10.001; Schoch CL, 2006, MYCOLOGIA, V98, P1041, DOI 10.3852/mycologia.98.6.1041; Liew ECY, 2000, MOL PHYLOGENET EVOL, V16, P392, DOI 10.1006/mpev.2000.0801; Rivera-Orduna FN, 2011, FUNGAL DIVERS, V47, P65, DOI 10.1007/s13225-010-0045-1; Buyck B, 2008, FUNGAL DIVERS, V28, P15; Vasilyeva LN, 2005, FUNGAL DIVERS, V19, P189; Mugambi GK, 2009, STUD MYCOL, P103, DOI 10.3114/sim.2009.64.05; Wagner T, 2002, MYCOLOGIA, V94, P998, DOI 10.2307/3761866; Acero FJ, 2004, MYCOLOGIA, V96, P249, DOI 10.2307/3762061; Schoch CL, 2009, STUD MYCOL, P1, DOI 10.3114/sim.2009.64.01; de Gruyter J, 2010, MYCOLOGIA, V102, P1066, DOI 10.3852/09-240; Lebel T, 2012, MYCOLOGIA, V104, P496, DOI 10.3852/11-092; Cai L, 2009, FUNGAL DIVERS, V39, P183; Hyde KD, 2001, FUNGAL DIVERS, V7, P35; Trouillas FP, 2011, FUNGAL DIVERS, V49, P203, DOI 10.1007/s13225-011-0094-0; Dai YC, 2010, FUNGAL DIVERS, V45, P131, DOI 10.1007/s13225-010-0066-9; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Kruys A, 2006, MYCOL RES, V110, P527, DOI 10.1016/j.mycres.2006.03.002; Buyck B, 2013, CRYPTOGAMIE MYCOL, V34, P259, DOI 10.7872/crym.v34.iss2.2013.259; Luo J, 2013, MYCOLOGIA, V105, P1019, DOI 10.3852/12-359; Chomnunti P, 2012, MYCOLOGIA, V104, P382, DOI 10.3852/11-066; Huhndorf SM, 2008, MYCOLOGIA, V100, P940, DOI 10.3852/08-037; Xu J, 2010, FUNGAL DIVERS, V44, P15, DOI 10.1007/s13225-010-0055-z; Lawrey JD, 2003, BRYOLOGIST, V106, P80, DOI 10.1639/0007-2745(2003)106[0080:LFIEAB]2.0.CO;2; Wu HX, 2011, FUNGAL DIVERS, V51, P189, DOI 10.1007/s13225-011-0143-8; Buyck B, 2013, CRYPTOGAMIE MYCOL, V34, P29; Verkley GJM, 2014, PERSOONIA, V32, P25, DOI 10.3767/003158514X679191; Zhou LW, 2012, MYCOLOGIA, V104, P211, DOI 10.3852/11-093; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Cannon PF, 2012, STUD MYCOL, P181, DOI 10.3114/sim0014; Zhang Y, 2009, STUD MYCOL, P85, DOI 10.3114/sim.2009.64.04; Frohlich J, 1999, BIODIVERS CONSERV, V8, P977, DOI 10.1023/A:1008895913857; Adams GC, 2002, MYCOLOGIA, V94, P947, DOI 10.2307/3761863; HYDE KD, 1995, MYCOL RES, V99, P291, DOI 10.1016/S0953-7562(09)80902-7; Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Arzanlou M, 2008, PERSOONIA, V20, P19, DOI 10.3767/003158508X302212; Eyssartier G, 1998, BELG J BOT, V131, P139; Wang HK, 2007, MYCOL RES, V111, P1268, DOI 10.1016/j.mycres.2007.08.014; BARR ME, 1993, MYCOTAXON, V49, P129; Kodsueb R, 2006, MYCOLOGIA, V98, P571, DOI 10.3852/mycologia.98.4.571; Liu JK, 2011, FUNGAL DIVERS, V51, P135, DOI 10.1007/s13225-011-0142-9; Crous PW, 2012, PERSOONIA, V28, P126, DOI 10.3767/003158512X652624; de Gruyter J, 2013, STUD MYCOL, P1, DOI 10.3114/sim0004; Murata N, 2014, J GEN PLANT PATHOL, V80, P66, DOI 10.1007/s10327-013-0477-z; Phillips AJL, 2013, STUD MYCOL, P51, DOI 10.3114/sim0021; Suetrong S, 2009, STUD MYCOL, P155, DOI 10.3114/sim.2009.64.09; Buyck B, 2014, FUNGAL DIVERS, V64, P101, DOI 10.1007/s13225-013-0272-3; Alves A, 2006, FUNGAL DIVERS, V23, P1; Frohlich J, 2000, MYCOL RES, V104, P1202, DOI 10.1017/S095375620000263X; Aptroot A., 1995, STUDIES MYCOLOGY, V37, P1; Aptroot A, 1991, BIBLIOTHECA LICHENOL, V44, P1; Ariyawansa HA, 2014, FUNGAL DIVERS, V69, P57, DOI 10.1007/s13225-014-0315-4; Ariyawansa HA, 2014, FUNGAL DIVERS, V68, P69, DOI 10.1007/s13225-014-0305-6; Barr ME, 1978, MYCOL MEM, V7, P1; BARR ME, 1968, CAN J BOTANY, V46, P799; BARR M E, 1989, Sydowia, V41, P25; Barr ME, 1987, PRODOMUS CLASS LOCUL; BAS C, 1991, GENETICS AND BREEDING OF AGARICUS, P21; BATISTA A. CHAVES, 1963, QUADERNO 1ST BOT UNIV LAB CRITTOGAM PAVIA, V31, P1; BATISTA A. CHAVES, 1962, SYDOWIA ANN MYCOLOGICI SUPPL, V3, P1; Bendiksby M, 2013, TAXON, V62, P940; BERBEE ML, 1992, BIOSYSTEMS, V28, P117, DOI 10.1016/0303-2647(92)90014-P; BILLS GF, 1984, MYCOTAXON, V21, P491; Boehm EWA, 2009, FAMILY HYSTERIACEAE; Bonorden HF, 1864, ABHANDLUNGEN NATURFO, V8, P1; Budziszewska J, 2011, MYCOTAXON, V115, P457, DOI 10.5248/115.457; Buyck B, 2004, CRYPTOGAMIE MYCOL, V25, P3; Buyck B, 2015, FUNGAL DIVERS, V70, P189, DOI 10.1007/s13225-014-0314-5; Buyck B, 2010, TAXON, V59, P295; Buyck B, 2005, B MICOL BRESADOLA, V46, P57; Buyck B, 2015, FUNGAL DIVERS, V64, P101; Cai L, 2003, SYDOWIA, V55, P129; Cai L, 2003, CRYPTOGAMIE MYCOL, V24, P3; Calatayud V, 2001, MYCOL RES, V105, P634, DOI 10.1017/S0953756201003963; Cannon P. F., 1994, Systema Ascomycetum, V13, P25; Cappelli A, 1984, AGARICUS; Chen J, 2012, CRYPTOGAMIE MYCOL, V33, P145; Chesters CGC, 1970, MYCOL PAP, V120, P1; Ciferri, 1958, MAN MIC MED, V1, P178; Corda ACI, 1831, STURM NURNBERG, V12, P33; Corda ACI, 1836, WEITENWEBER BEITRAGE; Crous PW, 2006, STUD MYCOL, P235; Crous PW, 2003, CBS BIODIVERSITY SER, V1, P1; Dai DQ, 2014, CRYPTOGAMIE MYCOL, V35, P63, DOI 10.7872/crym.v35.iss1.2014.63; Dai DQ, 2014, PHYTOTAXA, V176, P18; Dai DQ, 2012, MYCOLOGIE, V33, P363; de Gruyter J, 2012, STUD MYCOL, V75, P1; De Notaris G, 1963, COMMENT SOC CRITTOG, V1, P177; Doweld AB, 2012, TAXON, V61, P681; Ellis MB, 1963, V MYCOL PAP, V93, P1; Ellis M. B., 1976, More dematiaceous hyphomycetes.; Ellis MB, 1971, DEMATIACEOUS HYPHOMY; Ellwood SR, 2006, PHYTOPATHOLOGY, V96, P1330, DOI 10.1094/PHYTO-96-1330; Eriksson O., 1986, SYSTEMA ASCOMYCETUM, V5, P185; ERIKSSON O E, 1991, Systema Ascomycetum, V9, P39; Eriksson O.E., 2006, MYCONET, V12, P1; FARR DF, 1995, MYCOLOGIA, V87, P518, DOI 10.2307/3760770; Farr DF, 1995, FUNGI PLANTS PLANT P; Fries E., 1823, SYSTEMA MYCOLOGICUM, V2; Fu CH, 2013, MYCOLOGIA, V105, P861, DOI 10.3852/12-346; Geiser DM, 2006, MYCOLOGIA, V98, P1053, DOI 10.3852/mycologia.98.6.1053; GLAWE DA, 1985, MYCOLOGIA, V77, P880; Goh Teik-Khiang, 1999, Fungal Diversity, V2, P65; HAFELLNER J., 1984, NOVA HEDWIGIA S, V79, P241; Hall T., 2004, BIOEDIT V 7 0 1; Hansford GC, 1946, MYCOL PAP, V15, P1; Hashimoto A, 2015, MYCOLOGIA, V107, P383, DOI 10.3852/14-171; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641; Hawksworth DL, 1995, AINSWORTH BISBYS DIC; HERTEL H, 1988, PLANT SYST EVOL, V158, P289; Hohnel F, 1919, SBER AKAD WISS WI MN, V128, P535; Holm L., 1988, SYMB BOT UPSAL, V28, P1; HUGHES S. J., 1958, CANADIAN JOUR BOT, V36, P727; HUGHES S J, 1972, New Zealand Journal of Botany, V10, P225; Hyde KD, 2009, FUNGAL DIVERS, V39, P1; Hyde KD, 2014, FUNGAL DIVERS, V67, P21, DOI 10.1007/s13225-014-0298-1; ILLINGWORTH CA, 1991, EXP MYCOL, V15, P65, DOI 10.1016/0147-5975(91)90008-2; Illman WM, 1984, CAN J BOT, V63, P419; Jaklitsch WM, 2004, STUD MYCOL, P229; Ju YM, 2004, MYCOLOGIA, V96, P154, DOI 10.2307/3761997; Ju Y-M, 1996, MYCOL MEM, V20, P1; Justavino DR, 2014, FUNGAL DIVERS, V70, P73; Kang Ji-Chuan, 1999, Fungal Diversity, V2, P135; Kang Ji-Chuan, 1998, Fungal Diversity, V1, P147; Kang JC, 1999, MYCOL RES, V103, P1621, DOI 10.1017/S0953756299001264; Kerrigan RW, 2006, MYCOLOGIA, V97, P1292; Khan S. N., 1988, Indian Journal of Forestry, V11, P188; Kirk PM, 2008, AINSWORTH BISBYS DIC; Kirk PM, 2001, AINSWORTH BISBYS DIC; Kohlmeyer Jan, 1993, Systema Ascomycetum, V12, P7; KOHLMEYER J, 1984, Marine Ecology, V5, P329, DOI 10.1111/j.1439-0485.1984.tb00130.x; Lamprecht Sandra C, 2011, IMA Fungus, V2, P13, DOI 10.5598/imafungus.2011.02.01.03; Leveille JH, 1846, ANN SCI NAT BOT 3, V5, P249; Lindau G, 1896, NATURLICHE PFLANZE 1, V1, P265; Liu JK, 2014, PHYTOTAXA, V181, P1; Locqum M, 1984, MYCOLOGIE GEN STRUCT; Lohman ML, 1931, PAPERS MICHIGAN ACAD, V13, P141; LOHMAN MARION L., 1934, PAPERS MICHIGAN ACAD SCI ARTS AND LETT, V19, P133; LOHMAN MARION, 1933, MYCOLOGIA [NEW YORK], V25, P34, DOI 10.2307/3754128; Lohman ML., 1933, PAPERS MICHIGAN ACAD, V17, P229; Lumbsch H. T., 2010, MYCONET, V14, P1, DOI DOI 10.3158/1557.1; Maharachchikumbura SSN, 2014, STUD MYCOL, P121, DOI 10.1016/j.simyco.2014.09.005; Maharachchikumbura SSN, 2013, TROP PLANT PATHOL, V38, P227, DOI [10.1590/S1982-56762013005000002, http://dx.doi.org/10.1590/s1982-56762013005000002]; Maharachchikumbura SSN, 2012, FUNGAL DIVERS, V56, P95, DOI 10.1007/s13225-012-0198-1; Maharachchikumbura SSN, 2011, FUNGAL DIVERS, V50, P167, DOI 10.1007/s13225-011-0125-x; Matsushima T, 1996, MATSUSHIMA MYCOLOGIC, V9, P1; McNeill J, 2012, TAXON, V60, P1507; Mel'nik VA, 2012, MYCOSPHERE, V3, P957, DOI 10.5943/mycosphere/3/6/10; Miadlikowska J, 2014, MOL PHYLOGENET EVOL, V79, P132, DOI 10.1016/j.ympev.2014.04.003; MULLER E., 1950, BER SCHWEIZ BOT GES, V60, P329; Munk A, 1957, MYCOL PAP, V17, P1; MUNK ANDERS, 1953, DANSK BOT ARK, V15, P1; Nag Raj TR, 1993, COELOMYCETOUS ANAMOR; Niessl G, 1872, VERH NATURF VEREINS, V10, P153; Nimis P. L., 1987, STUDIA GEOBOTANIC S1, V7, P1; Nitschke T, 1869, GRUNDZUGE SYSTEMS PY, V26, P70; Pang Ka-Lai, 2003, Mycological Progress, V2, P29, DOI 10.1007/s11557-006-0041-8; Parra LA, 2013, FUNGI EUROPAEI A, V1A; Parra LA, 2008, AGARICUS 1; Peck CH, 1906, B NEW YORK STATE MUS, V105, P36; Peck CH, 1903, B NEW YORK MORPH MUS, V67, P3; Peck CH, 1898, B TORREY BOT CLUB, V25, P368; Persoh Derek, 2004, Mycological Progress, V3, P103, DOI 10.1007/s11557-006-0081-0; Petrak F, 1923, CURR ANN MYCOLOGICI, V21, P182; PETRINI L E, 1986, Mycologia Helvetica, V1, P501; Phookamsak R, 2014, FUNGAL DIVERS, V68, P159, DOI 10.1007/s13225-014-0308-3; Prabhugaonkar A, 2011, MYCOSPHERE, V2, P463; Preston NC, 1948, T BR MYCOL SOC, V26, P158; Raja Huzefa A., 2007, Mycoscience, V48, P395, DOI 10.1007/s10267-007-0375-3; Raja HA, 2005, MYCOTAXON, V91, P207; Rambold G., 1992, BIBLIOTHECA LICHENOL, V48, P1; Rambold G, 2001, LIAS LIGHT DATABASE; Rappaz F., 1987, Mycologia Helvetica, V2, P285; Reblova M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063547; Rehm H., 1912, ANN MYCOL, V10, P389; Saccardo PA, 1892, SYLLOGE FUNGORUM, V10, P1; Saccardo PA, 1925, SYLLOGE FUNGORUM, VXXIV, P940; Saccardo PA, 1913, SYLLOGE FUNGORUM, VXXII, P185; Saccardo PA, 1883, SYLLOGE FUNGORUM, V2, P815; Saccardo PA, 1884, SYLLOGE FUNGORUM, V3; SCHULZER S., 1870, VERHANDLUNGEN ZOOLOG, V20, P635; Seifert K, 2011, CBS BIODIVERSITY SER, V9, P1, DOI DOI 10.3767/003158511X617435; Seifert KA, 1999, MYCOTAXON, V71, P301; Shao S-C, 2014, CRYPTOGAM MYCOL, V35, P281; SHEARER CA, 1980, BOT MAR, V23, P607; SINCLAIR RC, 1983, MYCOLOGIA, V75, P1100, DOI 10.2307/3792667; Singer R., 1932, BEIH BOT CENTRALBL, V49, P205; SINGER R., 1939, BULL TRIMESTR SOC MYCOL FRANCE, V55, P233; Singer R, 1986, AGARICALES MODERN TA, P981; Singer R., 1951, LILLOA, V22, P5; Singer R., 1943, MYCOLOGIA, V35, P142, DOI 10.2307/3754706; SINGER R., 1926, HEDWIGIA, V66, P163; Sipman HJM, 2001, MYCOL RES, V105, P1433, DOI 10.1017/S0953756201004932; Sitzungsberichte Akademie K, 1909, WIEN MATH NATURWIS 1, V118, P329; Sivanesan A., 1984, The bitunicate ascomycetes and their anamorphs.; SIVANESAN A, 1990, MYCOL RES, V94, P566; Somrithipol S, 2007, MYCOLOGIA, V99, P792, DOI 10.3852/mycologia.99.5.792; Spegazzini C, 1910, ANAL MUS NAC BUENOS, V20, P329; Sutton BC, 1980, COELOMYCETES FUNGI I; Suwannasai N, 2005, MYCOTAXON, V94, P303; Swofford D. L., 2002, PAUP PHYLOGENETIC AN; Sydow H, 1912, ANN MYCOL, V10, P77; Sydow H, 1917, ANN MYCOL, V15, P389; Tanaka Kazuaki, 2005, Mycoscience, V46, P114, DOI 10.1007/s10267-004-0223-7; Tanaka Kazuki, 2003, Mycoscience, V44, P115, DOI 10.1007/s10267-003-0092-5; Tanaka Kazuaki, 2003, Mycoscience, V44, P173; Tanaka Kazuaki, 2003, Mycoscience, V44, P85, DOI 10.1007/s10267-002-0085-9; Thambugala KM, 2014, FUNGAL DIVERS, V68, P105, DOI 10.1007/s13225-014-0303-8; Triebel D, 2005, LIAS NAMES DATABASE; Trouillas FP, 2010, MYCOSPHERE, V1, P183; Tsui CKM, 2006, FUNGAL DIVERS, V21, P157; Tulasne C, 1861, SELECTA FUNGORUM CAR; Tulloch M, 1972, MYCOL PAP, V130, P1; Udayanga D, 2014, FUNGAL BIOL IN PRESS; Ueker FA, 1988, MYCOLOGIA MEMOIR, V13, P1; Van Ryckegem G, 2001, NOVA HEDWIGIA, V73, P161; Verkley GJM, 2004, STUD MYCOL, P323; Von Hohnel F, 1910, SITSUNGSBER KAISE MN, V119, P618; von Hohnel F, 1909, SITZUNGSBERICHT 1 MN, V118, P275; Wehmeyer LE, 1933, GENUS DIAPORTHE NITS; WEHMEYER LEWIS E., 1941, UNIV MICHIGAN STUD SCI SER, V14, P1; WHALLEY AJS, 1985, T BRIT MYCOL SOC, V85, P385; Whitton RS, 2012, FUNGAL DIVERS RES SE, V21; Wijayawardene NN, 2013, CRYPTOGAMIE MYCOL, V34, P357, DOI 10.7872/crym.v34.iss2.2013.357; Wijayawardene N.N., 2012, MYCOSPHERE, V3, P157; Wijayawardene NN, 2014, FUNGAL DIVERS, V69, P1, DOI 10.1007/s13225-014-0309-2; Winter G, 1887, RABENHORST KRYPTOGAM, V1, P1; Wisitrassameewong K, 2014, PHYTOTAXA, V158, P23; Woudenberg JHC, 2013, STUD MYCOL, P171, DOI 10.3114/sim0015; Xu J, 2014, J CHEM PHARM RES, V6, P893; Yamazaki M., 2014, Japanese Journal of Phytopathology, V80, P11, DOI 10.3186/jjphytopath.80.11; Yuan Zi-Qing, 1994, Sydowia, V46, P162; Zhang Y, 2014, PHYTOTAXA, V176, P64; Zhang Y, 2012, MYCOLOGIA, V40, P107; Zhang Y, 2012, FUNGAL DIVERS, V53, P1, DOI 10.1007/s13225-011-0117-x	311	15	15	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1560-2745	1878-9129		FUNGAL DIVERS	Fungal Divers.	MAY	2015	72	1					1	197		10.1007/s13225-015-0324-y		197	Mycology	Mycology	CI4JJ	WOS:000354714200001		
J	Yanagisawa, K				Yanagisawa, Katsuhiko			GM1 ganglioside and Alzheimer's disease	GLYCOCONJUGATE JOURNAL			English	Review						Alzheimer's disease; Amyloid beta-protein; Ganglioside; GM1-ganglioside-bound A beta (GA beta); Seed; Conformational transition	AMYLOID BETA-PROTEIN; ENDOCYTIC PATHWAY ABNORMALITIES; FIBRIL FORMATION; ENDOGENOUS SEED; LIPID-MEMBRANE; APOE-GENOTYPE; MECHANISM; CHOLESTEROL; PEPTIDE; BINDING	Assembly and deposition of amyloid -protein (A) is an invariable and fundamental event in the pathological process of Alzheimer's disease (AD). To decipher the AD pathogenesis and also to develop disease-modifying drugs for AD, clarification of the molecular mechanism underlying the A assembly into amyloid fibrils in the brain has been a crucial issue. GM1-ganglioside-bound A (GA), with unique molecular characteristics such as having an altered conformation and the capability to accelerate A assembly, was discovered in an autopsied brain showing early pathological changes of AD in 1995. On the basis of these findings, it was hypothesized that GA is an endogenous seed for amyloid fibril formation in the AD brain. A body of evidence that supports this GA hypothesis has been growing over this past 20 years. In this article, seminal GA studies that have been carried out to date, including recent ones using unique animal models, are reviewed.	Natl Ctr Geriatr & Gerontol, Ctr Dev Adv Med Dementia, Dept Alzheimers Dis Res, Obu 4748511, Japan	Yanagisawa, K (reprint author), Natl Ctr Geriatr & Gerontol, Ctr Dev Adv Med Dementia, Dept Alzheimers Dis Res, Morioka 7-430, Obu 4748511, Japan.	katuhiko@ncgg.go.jp			National Center for Geriatrics and Gerontology [25-19]	This work was supported by the Research Funding of the Longevity Sciences (25-19) from the National Center for Geriatrics and Gerontology.	Fukunaga S, 2012, BIOCHEMISTRY-US, V51, P8125, DOI 10.1021/bi300839u; Yuyama K, 2010, NEUROSCI LETT, V481, P168, DOI 10.1016/j.neulet.2010.06.080; Hong S, 2014, NEURON, V82, P308, DOI 10.1016/j.neuron.2014.02.027; Matsubara T, 2013, LANGMUIR, V29, P2258, DOI 10.1021/la3038999; Kakio A, 2001, J BIOL CHEM, V276, P24985, DOI 10.1074/jbc.M100252200; McLaurin J, 1998, J BIOL CHEM, V273, P4506, DOI 10.1074/jbc.273.8.4506; Yanagisawa K, 2007, BBA-BIOMEMBRANES, V1768, P1943, DOI 10.1016/j.bbamem.2007.01.018; Fezoui Y, 2002, J BIOL CHEM, V277, P36948, DOI 10.1074/jbc.M204168200; JARRETT JT, 1992, BIOCHEMISTRY-US, V31, P12345, DOI 10.1021/bi00164a008; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Mori K, 2012, J PHYS CHEM B, V116, P5111, DOI 10.1021/jp207881k; Utsumi M, 2009, GLYCOCONJUGATE J, V26, P999, DOI 10.1007/s10719-008-9216-7; Keilani S, 2012, J NEUROSCI, V32, P5223, DOI 10.1523/JNEUROSCI.4860-11.2012; Ariga T, 2008, J LIPID RES, V49, P1157, DOI 10.1194/jlr.R800007-JLR200; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Williamson MP, 2006, BIOCHEM J, V397, P483, DOI 10.1042/BJ20060293; Hoshino T, 2013, J PHYS CHEM B, V117, P8085, DOI 10.1021/jp4029062; Okada T, 2008, J MOL BIOL, V382, P1066, DOI 10.1016/j.jmb.2008.07.072; Matsuzaki K, 2010, BBA-MOL CELL BIOL L, V1801, P868, DOI 10.1016/j.bbalip.2010.01.008; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00120; Yagi-Utsumi M, 2010, FEBS LETT, V584, P831, DOI 10.1016/j.febslet.2010.01.005; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Esler WP, 2000, BIOCHEMISTRY-US, V39, P6288, DOI 10.1021/bi992933h; Ikeda K, 2011, BIOCHEMISTRY-US, V50, P6433, DOI 10.1021/bi200771m; Knight EM, 2015, MOL PSYCHIATR, V20, P109, DOI 10.1038/mp.2014.135; Manna M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071308; Oikawa N., 2015, PLOS ONE; Oikawa N, 2014, J NEUROSCI RES, V92, P641, DOI 10.1002/jnr.23341; Okabayashi S., 2015, PLOS ONE; Yagi-Utsumi M, 2011, INT J ALZHEIMERS DIS, DOI [10.4061/2011/925073, DOI 10.4061/2011/925073]; Yuyama K, 2009, J NEUROCHEM, V109, P1250, DOI 10.1111/j.1471-4159.2009.06046.x; Yuyama K, 2006, FEBS LETT, V580, P6972, DOI 10.1016/j.febslet.2006.11.072	34	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0282-0080	1573-4986		GLYCOCONJUGATE J	Glycoconjugate J.	MAY	2015	32	3-4					87	91		10.1007/s10719-015-9579-5		5	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CI5SR	WOS:000354820300002		
J	Yagi-Utsumi, M; Kato, K				Yagi-Utsumi, Maho; Kato, Koichi			Structural and dynamic views of GM1 ganglioside	GLYCOCONJUGATE JOURNAL			English	Review						Ganglioside GM1; Nuclearmagnetic resonance spectroscopy; Molecular dynamics simulation; Amyloid beta; alpha-synuclein; Bicelle	SOLUTION NMR-SPECTROSCOPY; MOLECULAR-DYNAMICS; ALPHA-SYNUCLEIN; OLIGOSACCHARIDE CHAIN; PHOSPHOLIPID-BINDING; MASS-SPECTROMETRY; LIPID-MEMBRANE; AMYLOID-BETA; SURFACE; GLYCOSPHINGOLIPIDS	The ganglioside GM1 mediates various physiological and pathological processes mainly through the formation of GM1 clusters on cell surfaces. Therefore, detailed characterization of conformational properties of the glycan moiety of GM1 and the structures and interactions of this glycosphingolipid in membrane environments is necessary for better understanding of the clustering-coupled functional promotion. Nuclear magnetic resonance (NMR) spectroscopy has provided conformational information of GM1 in solution as well as in membrane-like environments. Recently, sophisticated paramagnetism-assisted NMR approaches combined with molecular dynamics simulations have enabled the quantitative exploration of conformational spaces of a series of gangliosides, including GM1, taking into account their minor conformations. NMR techniques have also been successfully applied to investigations of the dynamic interactions of GM1 clusters with amyloidogenic proteins such as amyloid beta and alpha-synuclein associated with neurodegenerative disorders. Further integration of experimental and computational approaches will open up new possibilities to provide structural views of the more complicated heterogeneous systems exemplified by microdomains involving GM1.	[Yagi-Utsumi, Maho; Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan; [Yagi-Utsumi, Maho; Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Yagi-Utsumi, Maho; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Kato, Koichi] Ochanomizu Univ, Glycosci Inst, Bunkyo Ku, Tokyo 1128610, Japan	Kato, K (reprint author), Natl Inst Nat Sci, Inst Mol Sci, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan.	kkatonmr@ims.ac.jp			JSPS/MEXT KAKENHI [25102001, 25102008]; National Center for Geriatrics and Gerontology [2519]; Nanotechnology Platform Program of MEXT; Okazaki ORION project;  [26560451]	This study was partly supported by a JSPS/MEXT KAKENHI Grant-in-Aid for Scientific Research on Innovation Areas (25102001 and 25102008), Grant-in-Aid for Challenging Exploratory Research (26560451), Research Funding for Longevity Sciences (2519) from the National Center for Geriatrics and Gerontology, the Nanotechnology Platform Program of MEXT, and the Okazaki ORION project. We thank Drs. Hisashi Okumura, Satoru G. Itoh, and Takumi Yamaguchi for the useful discussion.	ACQUOTTI D, 1990, J AM CHEM SOC, V112, P7772, DOI 10.1021/ja00177a043; DeMarco ML, 2010, J AM CHEM SOC, V132, P1334, DOI 10.1021/ja907518x; Mao YL, 2010, BBA-BIOMEMBRANES, V1798, P1090, DOI 10.1016/j.bbamem.2010.03.003; Ichikawa N, 2009, J CELL SCI, V122, P289, DOI 10.1242/jcs.030338; Michel V, 2007, BIOL CELL, V99, P129, DOI 10.1042/BC20060051; Zhang Y, 2013, CHEM LETT, V42, P1455, DOI 10.1246/cl.130789; Kopitz J, 1998, J BIOL CHEM, V273, P11205, DOI 10.1074/jbc.273.18.11205; Mori K, 2012, J PHYS CHEM B, V116, P5111, DOI 10.1021/jp207881k; Utsumi M, 2009, GLYCOCONJUGATE J, V26, P999, DOI 10.1007/s10719-008-9216-7; Ariga T, 2008, J LIPID RES, V49, P1157, DOI 10.1194/jlr.R800007-JLR200; Sonnino S, 2009, GLYCOCONJUGATE J, V26, P615, DOI 10.1007/s10719-008-9215-8; Neu U, 2008, P NATL ACAD SCI USA, V105, P5219, DOI 10.1073/pnas.0710301105; Hoshino T, 2013, J PHYS CHEM B, V117, P8085, DOI 10.1021/jp4029062; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Zhang Y, 2012, MOLECULES, V17, P6658, DOI 10.3390/molecules17066658; Matsuzaki K, 2010, BBA-MOL CELL BIOL L, V1801, P868, DOI 10.1016/j.bbalip.2010.01.008; Sonnino S, 2000, BBA-REV BIOMEMBRANES, V1469, P63, DOI 10.1016/S0005-2736(00)00210-8; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00120; Bodner CR, 2010, BIOCHEMISTRY-US, V49, P862, DOI 10.1021/bi901723p; Canales A, 2013, ANGEW CHEM INT EDIT, V52, P13789, DOI 10.1002/anie.201307845; Fantini J, 2011, J MOL BIOL, V408, P654, DOI 10.1016/j.jmb.2011.03.009; Yagi-Utsumi M, 2010, FEBS LETT, V584, P831, DOI 10.1016/j.febslet.2010.01.005; Yamamoto S, 2012, CHEM COMMUN, V48, P4752, DOI 10.1039/c2cc30353a; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Lozano MM, 2013, J AM CHEM SOC, V135, P5620, DOI 10.1021/ja310831m; Yasuda T, 2014, BIOPHYS J, V106, P631, DOI 10.1016/j.bpj.2013.12.034; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Botto L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098344; Brocca P, 1998, BIOPHYS J, V74, P309; Brocca P, 2000, GLYCOCONJUGATE J, V17, P283, DOI 10.1023/A:1007161319700; Erdelyi M, 2011, CHEM-EUR J, V17, P9368, DOI 10.1002/chem.201100854; HOLMGREN J, 1975, P NATL ACAD SCI USA, V72, P2520, DOI 10.1073/pnas.72.7.2520; Khatun UL, 2014, GLYCOCONJUGATE J, V31, P435, DOI 10.1007/s10719-014-9554-6; Khatun UL, 2012, BIOPHYS CHEM, V168, P48, DOI 10.1016/j.bpc.2012.06.003; KOERNER TAW, 1983, BIOCHEMISTRY-US, V22, P2676, DOI 10.1021/bi00280a014; Ng NM, 2013, STRUCTURE, V21, P2003, DOI 10.1016/j.str.2013.08.024; Patel RY, 2007, BBA-BIOMEMBRANES, V1768, P1628, DOI 10.1016/j.bbamem.2007.02.020; POPPE L, 1994, BIOPHYS J, V66, P1642; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; SCARSDALE JN, 1990, BIOCHEMISTRY-US, V29, P9843, DOI 10.1021/bi00494a014; SILLERUD LO, 1982, BIOCHEMISTRY-US, V21, P1260, DOI 10.1021/bi00535a024; Sugiura Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003232; Thudichum J. L. W., 1884, TREATISE CHEM CONSTI; Vyas KA, 2001, BIOL CHEM, V382, P241, DOI 10.1515/BC.2001.031; Yagi-Utsumi M., 2011, INT J ALZHEIMERS DIS, V2011, DOI DOI 10.4061/2011/925073; Yamaguchi T, 2013, CHEM COMMUN, V49, P1235, DOI 10.1039/c2cc38016a; Yamaguchi T., 2014, GLYCOSCI BIOL MED, V1, P137, DOI [10.1007/978-4-431-54841-6101, DOI 10.1007/978-4-431-54841-6101]; Yamaguchi Yoshiki, 2014, Adv Neurobiol, V9, P165, DOI 10.1007/978-1-4939-1154-7_8; Yuki N, 2005, CURR OPIN IMMUNOL, V17, P577, DOI 10.1016/j.coi.2005.09.004; Zhang Y, 2015, ADV EXP MED BIOL, V842, P217, DOI 10.1007/978-3-319-11280-0_14	51	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0282-0080	1573-4986		GLYCOCONJUGATE J	Glycoconjugate J.	MAY	2015	32	3-4					105	112		10.1007/s10719-015-9587-5		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CI5SR	WOS:000354820300004		
J	Ichimiya, T; Maeda, M; Sakamura, S; Kanazawa, M; Nishihara, S; Kimura, Y				Ichimiya, Tomomi; Maeda, Megumi; Sakamura, Shou; Kanazawa, Masato; Nishihara, Shoko; Kimura, Yoshinobu			Identification of beta 1,3-galactosyltransferases responsible for biosynthesis of insect complex-type N-glycans containing a T-antigen unit in the honeybee	GLYCOCONJUGATE JOURNAL			English	Article						Insect beta 1,3-galactosyltransferase; Insect N-glycan; N-glycan biosynthesis; Thomsen-Friedenreich antigen; Apismellifera	LINKED CARBOHYDRATE CHAINS; DROSOPHILA-MELANOGASTER; APIS-MELLIFERA; O-GLYCAN; CLONING; FAMILY; GALACTOSAMINE; GLYCOPROTEIN; SYNTHASE; CELLS	Honeybees (Apis mellifera) produce unique complex-type N-glycans bearing a Gal beta 1-3GalNAc (T-antigen) unit, and honeybee-specific N-glycans are linked to royal jelly glycoproteins. In this study, we identified two novel honeybee beta 1,3-galactosyltransferase (beta 1,3-GalT) genes responsible for biosynthesis of the T-antigen in insect N-glycans. The products of the two putative beta 1,3-GalT genes (beta 1,3-GalT1 and beta 1,3-GalT2), which were expressed in Sf21 insect cells, transferred galactose (Gal) residues to GalNAc2GlcNAc2Man3GlcNAc2-PA to form the Gal beta 1-3GalNAc unit, indicating that the identified genes were involved in biosynthesis of the beta 1-3 Gal-containing N-glycan. Therefore, using biochemistry and molecular biology techniques, we revealed a unique N-glycan biosynthesis mechanism in the cephalic region of honeybees, which has not previously been found in other animal or plant cells.	[Ichimiya, Tomomi; Nishihara, Shoko] Soka Univ, Fac Engn, Dept Bioinformat, Tokyo, Japan; [Maeda, Megumi; Kimura, Yoshinobu] Okayama Univ, Grad Sch Environm & Life Sci, Dept Biofunct Chem, Okayama 7008530, Japan; [Maeda, Megumi; Sakamura, Shou; Kanazawa, Masato; Kimura, Yoshinobu] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Biofunct Chem, Okayama 7008530, Japan	Nishihara, S (reprint author), Soka Univ, Fac Engn, Dept Bioinformat, 1-236 Tangi Cho, Tokyo, Japan.	shoko@soka.ac.jp; yosh8mar@cc.okayama-u.ac.jp					Yoshida H, 2008, GLYCOBIOLOGY, V18, P1094, DOI 10.1093/glycob/cwn094; Amado M, 1998, J BIOL CHEM, V273, P12770, DOI 10.1074/jbc.273.21.12770; Schmitzova J, 1998, CELL MOL LIFE SCI, V54, P1020, DOI 10.1007/s000180050229; Togayachi A, 2010, METHOD ENZYMOL, V479, P185, DOI 10.1016/S0076-6879(10)79011-X; Muller R, 2005, FEBS J, V272, P4295, DOI 10.1111/j.1742-4658.2005.04838.x; WONGMADDEN ST, 1995, GLYCOBIOLOGY, V5, P19, DOI 10.1093/glycob/5.1.19; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Ju TZ, 2006, GLYCOBIOLOGY, V16, P947, DOI 10.1093/glycob/cwl008; Kimura Y, 2007, BIOSCI BIOTECH BIOCH, V71, P1111, DOI 10.1271/bbb.70081; Kimura Y, 2010, BIOSCI BIOTECH BIOCH, V74, P2148, DOI 10.1271/bbb.100472; Kimura Y, 2006, BIOSCI BIOTECH BIOCH, V70, P2583, DOI 10.1271/bbb.60331; Kolbinger F, 1998, J BIOL CHEM, V273, P433, DOI 10.1074/jbc.273.1.433; Kucharski R, 1998, NATURWISSENSCHAFTEN, V85, P343, DOI 10.1007/s001140050512; Kudo T, 2002, J BIOL CHEM, V277, P47724, DOI 10.1074/jbc.M205839200; Lommerse JPM, 1997, EUR J BIOCHEM, V249, P195, DOI 10.1111/j.1432-1033.1997.00195.x; Takemae H, 2003, J BIOL CHEM, V278, P15571, DOI 10.1074/jbc.M301123200; Togayachi A, 2007, TRENDS GLYCOSCI GLYC, V19, P29, DOI 10.4052/tigg.19.29; Ueyama M, 2008, J BIOL CHEM, V283, P6076, DOI 10.1074/jbc.M709189200; VANKUIK JA, 1987, EUR J BIOCHEM, V169, P399	19	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0282-0080	1573-4986		GLYCOCONJUGATE J	Glycoconjugate J.	MAY	2015	32	3-4					141	151		10.1007/s10719-015-9585-7		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CI5SR	WOS:000354820300008		
J	Nishida, M; Murata, K; Oshima, K; Itoh, C; Kitaguchi, K; Kanamaru, Y; Yabe, T				Nishida, Mitsutaka; Murata, Kazuma; Oshima, Kazuya; Itoh, Chihiro; Kitaguchi, Kohji; Kanamaru, Yoshihiro; Yabe, Tomio			Pectin from Prunus domestica L. induces proliferation of IEC-6 cells through the alteration of cell-surface heparan sulfate on differentiated Caco-2 cells in co-culture	GLYCOCONJUGATE JOURNAL			English	Article						Differentiated Caco-2 cell; Heparan sulfate; IEC-6 cell; Pectin; Wnt3a	INTESTINAL EPITHELIAL-CELLS; DIETARY FIBER; WNT PROTEINS; PROTEOGLYCANS; MICROFLORA; EXPRESSION; MORPHOLOGY	Dietary fiber intake provides various physiological and metabolic effects for human health. Pectin, a water-soluble dietary fiber, induces morphological changes of the small intestine in vivo. However, the molecular mechanisms underlying pectin-derived morphological alterations have not been elucidated. Previously, we found that pectin purified from Prunus domestica L. altered the sulfated structure of cell-surface heparan sulfate (HS) on differentiated Caco-2 cells via fibronectin and alpha 5 beta 1 integrin. In this study, we investigated the biological significance of the effect of pectin on HS in differentiated Caco-2 cells. An in vitro intestinal epithelium model was constructed by co-culture of differentiated Caco-2 cells and rat IEC-6 cells, which were used as models of intestinal epithelium and intestinal crypt cells, respectively. We found that pectin-treated differentiated Caco-2 cells promoted growth of IEC-6 cells. Real-time RT-PCR analysis and western blotting showed that relative mRNA and protein expression levels of Wnt3a were upregulated by pectin treatment in differentiated Caco-2 cells. Analysis by surface plasmon resonance spectroscopy demonstrated that pectin-induced structural alteration of HS markedly decreased the interaction with Wnt3a. However, depression in the secretion of Wnt3a from Caco-2 cells by anti-Wnt3a antibody did not affect the proliferation of IEC-6 cells in co-culture system. These observations indicated that pectin altered the sulfated structure of cell-surface HS to promote secretion of Wnt3a from differentiated Caco-2 cells and Wnt3a indirectly stimulated the proliferation of IEC-6 cells.	[Nishida, Mitsutaka; Kitaguchi, Kohji; Kanamaru, Yoshihiro; Yabe, Tomio] Gifu Univ, United Grad Sch Agr Sci, Gifu 5011193, Japan; [Murata, Kazuma; Oshima, Kazuya; Itoh, Chihiro; Kitaguchi, Kohji; Kanamaru, Yoshihiro; Yabe, Tomio] Gifu Univ, Fac Appl Biol Sci, Dept Appl Life Sci, Gifu 5011193, Japan	Yabe, T (reprint author), Gifu Univ, United Grad Sch Agr Sci, 1-1 Yanagido, Gifu 5011193, Japan.	yabet@gifu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [23580163]	We thank the members of the Division of Genomics Research, Life Science Research Center, Gifu University, for their support in conducting the experiments and thank Miki Corporation (Hyogo, Japan) for providing the concentrated prune juice. This work was supported by Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (C) Grant Number 23580163.	Liu L, 2012, AM J PHYSIOL-CELL PH, V302, pC277, DOI 10.1152/ajpcell.00341.2011; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Witze ES, 2008, SCIENCE, V320, P365, DOI 10.1126/science.1151250; Fuerer C, 2010, DEV DYNAM, V239, P184, DOI 10.1002/dvdy.22067; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Mertens G, 1996, J CELL BIOL, V132, P487, DOI 10.1083/jcb.132.3.487; Brown L, 1999, AM J CLIN NUTR, V69, P30; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Frese MA, 2009, J BIOL CHEM, V284, P28033, DOI 10.1074/jbc.M109.035808; Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x; Langhout DJ, 1999, BRIT POULTRY SCI, V40, P340; Lamanna WC, 2008, J BIOL CHEM, V283, P27724, DOI 10.1074/jbc.M802130200; Habuchi O, 2000, BBA-GEN SUBJECTS, V1474, P115, DOI 10.1016/S0304-4165(00)00016-7; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Babyatsky M.W., 1999, TXB GASTROENTEROLOGY, P547; McCullough JS, 1998, GUT, V42, P799; Nishida M, 2014, BIOSCI BIOTECH BIOCH, V78, P635, DOI 10.1080/09168451.2014.891937; Ouko L, 2004, J BIOL CHEM, V279, P26707, DOI 10.1074/jbc.M402877200; SIMONASSMANN P, 1989, J CELL BIOL, V109, P1837, DOI 10.1083/jcb.109.4.1837; TASMANJONES C, 1982, DIGEST DIS SCI, V27, P519, DOI 10.1007/BF01296731; Yamamoto S, 2013, AM J PHYSIOL-GASTR L, V305, pG241, DOI 10.1152/ajpgi.00480.2012	24	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0282-0080	1573-4986		GLYCOCONJUGATE J	Glycoconjugate J.	MAY	2015	32	3-4					153	159		10.1007/s10719-015-9588-4		7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CI5SR	WOS:000354820300009		
J	Kang, SH; Jung, HS; Lee, SJ; Park, CI; Lim, SM; Park, H; Kim, BS; Na, KH; Han, GJ; Bae, JW; Park, HJ; Bang, KC; Park, BT; Hwang, HS; Jung, IS; Kim, JI; Oh, DB; Kim, DI; Yagi, H; Kato, K; Kim, DK; Kim, HH				Kang, Seung Hoon; Jung, Hahn Sun; Lee, Song Jae; Park, Cheon Ik; Lim, Sang Min; Park, Heajin; Kim, Byung Sun; Na, Kwang Heum; Han, Gyeong Jin; Bae, Jae Woo; Park, Hyun Joo; Bang, Keuk Chan; Park, Byung Tae; Hwang, Hye Seong; Jung, In-Soo; Kim, Jae Il; Oh, Doo Byung; Kim, Dong Il; Yagi, Hirokazu; Kato, Koichi; Kim, Dae Kyong; Kim, Ha Hyung			Glycan structure and serum half-life of recombinant CTLA4Ig, an immunosuppressive agent, expressed in suspension-cultured rice cells with coexpression of human beta 1,4-galactosyltransferase and human CTLA4Ig	GLYCOCONJUGATE JOURNAL			English	Article						Plant cell culture; CTLA4Ig; Human beta 1,4-galactosyltransferase; N-glycan; Half-life; Clearance	N-LINKED OLIGOSACCHARIDES; MONOCLONAL-ANTIBODY; GLYCOSYLATION PATTERNS; THERAPEUTIC PROTEIN; TRANSGENIC PLANTS; FC GLYCANS; IGG; GLYCOPROTEINS; CARBOHYDRATE; GALACTOSE	Human cytotoxic T-lymphocyte antigen 4-immunoglobulin (hCTLA4Ig) is an immunosuppressive therapeutic, and recently produced rice cell-derived hCTLA4Ig (hCTLA4Ig(P)) reportedly exhibits in vitro immunosuppressive activities equivalent to those of Chinese hamster ovary cell-derived hCTLA4Ig (hCTLA4Ig(M)). However, limitations of hCTLA4Ig(P) include shortened in vivo half-life as well as the presence of nonhuman N-glycans containing (beta 1-2)-xylose and alpha 1,3-fucose, which cause immunogenic reactions in humans. In the present study, human beta 1,4-galactose-extended hCTLA4Ig(P) (hCTLA4Ig(P)-Gal) was expressed through the coexpression of human beta 1,4-galactosyltransferase (hGalT) and hCTLA4Ig in an attempt to overcome these unfavorable effects. The results indicated that both encoding hGalT and hCTLA4Ig were successfully coexpressed, and the analysis of N-glycan and its relative abundance in purified hCTLA4Ig(P)-Gal indicated that not only were the two glycans containing (beta 1-4)-galactose newly extended, but also glycans containing both beta 1,2-xylose and alpha 1,3-fucose were markedly reduced and high-mannose-type glycans were increased compared to those of hCTLA4Ig(P), respectively. Unlike hCTLA4Ig(P), hCTLA4Ig(P)-Gal was effective as an acceptor via (beta 1-4)-galactose for in vitro sialylation. Additionally, the serum half-life of intravenously injected hCTLA4Ig(P)-Gal in Sprague-Dawley rats was 1.9 times longer than that of hCTLA4Ig(P), and the clearance pattern of hCTLA4Ig(P)-Gal was close to that for hCTLA4Ig(M). These results indicate that the coexpression with hGalT and hCTLA4Ig(P) is useful for both reducing glycan immunogens and increasing in vivo stability. This is the first report of hCTLA4Ig as an effective therapeutics candidate in glycoengineered rice cells.	[Kang, Seung Hoon; Jung, Hahn Sun; Lee, Song Jae; Park, Cheon Ik; Lim, Sang Min] Boryung Pharmaceut Co Ltd, Boryung Cent Res Inst, Ansan 425839, Kyungki Do, South Korea; [Park, Heajin; Kim, Byung Sun; Na, Kwang Heum; Han, Gyeong Jin; Bae, Jae Woo; Park, Hyun Joo; Bang, Keuk Chan; Park, Byung Tae; Hwang, Hye Seong; Kim, Ha Hyung] Chung Ang Univ, Coll Pharm, Biotherapeut & Glyc Lab, Seoul 156756, South Korea; [Jung, In-Soo] Korea Univ, Coll Life Sci & Biotechnol, Seoul 136701, South Korea; [Kim, Jae Il] Gwangju Inst Sci & Technol, Sch Life Sci, Gwangju 500712, South Korea; [Oh, Doo Byung] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea; [Kim, Dong Il] Inha Univ, Dept Biol Engn, Inchon 4022751, South Korea; [Yagi, Hirokazu; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan; [Kim, Dae Kyong] Chung Ang Univ, Coll Pharm, Dept Environm & Hlth Chem, Seoul 156756, South Korea	Kim, DK (reprint author), Chung Ang Univ, Coll Pharm, Dept Environm & Hlth Chem, 84 Heukseok Ro, Seoul 156756, South Korea.	proteinlab@hanmail.net; hahyung@cau.ac.kr			National Research Foundation of Korea, Republic of Korea [2013M3A9B6075896]; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), Japan; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [24249002]	This study was supported by a grant (no. 2013M3A9B6075896) from the National Research Foundation of Korea, Republic of Korea. This work was also supported, in part, by the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), Japan, and by Grants-in-Aid for Scientific Research (A) (no. 24249002) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654; Chen M, 2005, MED RES REV, V25, P343, DOI 10.1002/med.20022; Bakker H, 2001, P NATL ACAD SCI USA, V98, P2899, DOI 10.1073/pnas.031419998; Goetze AM, 2011, GLYCOBIOLOGY, V21, P949, DOI 10.1093/glycob/cwr027; Fujiyama K, 2001, BIOCHEM BIOPH RES CO, V289, P553, DOI 10.1006/bbrc.2001.6006; Boyd PN, 1995, MOL IMMUNOL, V32, P1311, DOI 10.1016/0161-5890(95)00118-2; Gomord V, 2010, PLANT BIOTECHNOL J, V8, P564, DOI 10.1111/j.1467-7652.2009.00497.x; Byrne B, 2007, DRUG DISCOV TODAY, V12, P319, DOI 10.1016/j.druidis.2007.02.010; Takahashi N, 2003, TRENDS GLYCOSCI GLYC, V15, P235; Raju TS, 2008, CURR OPIN IMMUNOL, V20, P471, DOI 10.1016/j.coi.2008.06.007; Wright A, 1998, J IMMUNOL, V160, P3393; Matsumiya S, 2007, J MOL BIOL, V368, P767, DOI 10.1016/j.jmb.2007.02.034; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; Li HJ, 2006, NAT BIOTECHNOL, V24, P210, DOI 10.1038/nbt1178; Saint-Jore-Dupas C, 2007, TRENDS BIOTECHNOL, V25, P317, DOI 10.1016/j.tibtech.2007.04.008; Palacpac NQ, 1999, P NATL ACAD SCI USA, V96, P4692, DOI 10.1073/pnas.96.8.4692; Bosch D, 2013, CURR PHARM DESIGN, V19, P5503; Ko KS, 2003, P NATL ACAD SCI USA, V100, P8013, DOI 10.1073/pnas.0832472100; Schahs M, 2007, PLANT BIOTECHNOL J, V5, P657, DOI 10.1111/j.1467-7652.2007.00273.x; Vezina LP, 2009, PLANT BIOTECHNOL J, V7, P442, DOI 10.1111/j.1467-7652.2009.00414.x; WATZELE G, 1990, NUCLEIC ACIDS RES, V18, P7174, DOI 10.1093/nar/18.23.7174; Lee SJ, 2007, PROTEIN EXPRES PURIF, V51, P293, DOI 10.1016/j.pep.2006.08.019; JOHNSON KD, 1987, PLANT PHYSIOL, V84, P1301, DOI 10.1104/pp.84.4.1301; Mizushima T, 2011, GENES CELLS, V16, P1071, DOI 10.1111/j.1365-2443.2011.01552.x; Dong X, 1999, J IMMUNOL, V163, P5427; NAKAGAWA H, 1995, ANAL BIOCHEM, V226, P130, DOI 10.1006/abio.1995.1200; Gawlitzek M, 2000, BIOTECHNOL BIOENG, V68, P637, DOI 10.1002/(SICI)1097-0290(20000620)68:6<637::AID-BIT6>3.0.CO;2-C; Becerra-Arteaga A, 2007, BIOTECHNOL BIOENG, V97, P1585, DOI 10.1002/bit.21344; Chrispeels M. J., 1996, Transgenic plants: a production system for industrial and pharmaceutical proteins., P99; Fujiyama K, 2007, BIOCHEM BIOPH RES CO, V358, P85, DOI 10.1016/j.bbrc.2007.04.054; Hwang HS, 2014, GLYCOCONJUGATE J, V31, P41, DOI 10.1007/s10719-013-9498-2; JENKINS N, 1994, ENZYME MICROB TECH, V16, P354, DOI 10.1016/0141-0229(94)90149-X; Jung HS, 2006, BIOTECHNOL LETT, V28, P2039, DOI 10.1007/s10529-006-9191-7; Lerouge P., 2000, Current Pharmaceutical Biotechnology, V1, P347, DOI 10.2174/1389201003378843; Metzler WJ, 1997, NAT STRUCT BIOL, V4, P527, DOI 10.1038/nsb0797-527; NARIMATSU H, 1994, MICROBIOL IMMUNOL, V38, P489; Palacpac NQ, 1999, BIOSCI BIOTECH BIOCH, V63, P35, DOI 10.1271/bbb.63.35; Robert J.P., 1995, METHODS, V8, P116; Terada R, 2004, PLANT CELL REP, V22, P653, DOI 10.1007/s00299-003-0752-0; THOMPSON JA, 1986, PLANT SCI, V47, P123, DOI 10.1016/0168-9452(86)90059-2; Wilson IBH, 1998, GLYCOBIOLOGY, V8, P651, DOI 10.1093/glycob/8.7.651; Wise AA, 2006, METH MOL B, V343, P43; Wright A, 1997, TRENDS BIOTECHNOL, V15, P26, DOI 10.1016/S0167-7799(96)10062-7	44	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0282-0080	1573-4986		GLYCOCONJUGATE J	Glycoconjugate J.	MAY	2015	32	3-4					161	172		10.1007/s10719-015-9590-x		12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CI5SR	WOS:000354820300010		
J	Dworski, S; Berger, A; Furlonger, C; Moreau, JM; Yoshimitsu, M; Trentadue, J; Au, BCY; Paige, CJ; Medin, JA				Dworski, Shaalee; Berger, Alexandra; Furlonger, Caren; Moreau, Joshua M.; Yoshimitsu, Makoto; Trentadue, Jessa; Au, Bryan C. Y.; Paige, Christopher J.; Medin, Jeffrey A.			Markedly perturbed hematopoiesis in acid ceramidase deficient mice	HAEMATOLOGICA			English	Letter						hematopoiesis; acid ceramidase deficient mice; histiocytosis; organ architecture; Farber disease	FARBER-DISEASE; LIPOGRANULOMATOSIS; CELLS		[Dworski, Shaalee; Medin, Jeffrey A.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Berger, Alexandra; Furlonger, Caren; Trentadue, Jessa; Au, Bryan C. Y.; Paige, Christopher J.; Medin, Jeffrey A.] Univ Hlth Network, Toronto, ON, Canada; [Moreau, Joshua M.; Paige, Christopher J.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A1, Canada; [Yoshimitsu, Makoto] Kagoshima Univ, Grad Sch Med & Dent Sci, Ctr Chron Viral Dis, Div Hematol & Immunol, Kagoshima 890, Japan; [Paige, Christopher J.; Medin, Jeffrey A.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada	Medin, JA (reprint author), Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada.	jmedin@uhnres.utoronto.ca					Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Bikman BT, 2012, CELL MOL LIFE SCI, V69, P2135, DOI 10.1007/s00018-012-0917-5; Alayoubi AM, 2013, EMBO MOL MED, V5, P827, DOI 10.1002/emmm.201202301; Mielke MM, 2012, NEUROLOGY, V79, P633, DOI 10.1212/WNL.0b013e318264e380; ANTONARAKIS SE, 1984, J PEDIATR-US, V104, P406, DOI 10.1016/S0022-3476(84)81106-3; BURCK U, 1985, EUR J PEDIATR, V143, P203, DOI 10.1007/BF00442139; FUJIWAKI T, 1992, Acta Paediatrica Japonica, V34, P72; Jarisch A, 2014, EUR J PEDIATR, V173, P1399, DOI 10.1007/s00431-013-2098-0; Kanzaki S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012105; Kattner E, 1997, EUR J PEDIATR, V156, P292, DOI 10.1007/s004310050603; Levade T, 2009, ACID CERAMIDASE DEFI; Mondal RK, 2009, INDIAN PEDIATR, V46, P175; Pacheco Chris D., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S146239940800080X; Sharma P, 2009, EUR J HISTOCHEM, V53, P183; van Lijnschoten G, 2000, PEDIATR DEVEL PATHOL, V3, P597, DOI 10.1007/s100240010107	15	0	0	FERRATA STORTI FOUNDATION	PAVIA	VIA GIUSEPPE BELLI 4, 27100 PAVIA, ITALY	0390-6078			HAEMATOLOGICA	Haematologica	MAY	2015	100	5								10.3324/haematol.2014.108530		4	Hematology	Hematology	CI5IE	WOS:000354788000001		
J	Palmer, J; Chai, XY; Martin, PJ; Weisdorf, D; Inamoto, Y; Pidala, J; Jagasia, M; Pavletic, S; Cutler, C; Vogelsang, G; Arai, S; Flowers, MED; Lee, SJ				Palmer, Jeanne; Chai, Xiaoyu; Martin, Paul J.; Weisdorf, Daniel; Inamoto, Yoshihiro; Pidala, Joseph; Jagasia, Madan; Pavletic, Steven; Cutler, Corey; Vogelsang, Georgia; Arai, Sally; Flowers, Mary E. D.; Lee, Stephanie J.			Failure-free survival in a prospective cohort of patients with chronic graft-versus-host disease	HAEMATOLOGICA			English	Article							STEM-CELL TRANSPLANTATION; LONG-TERM SURVIVAL; CHRONIC GVHD; SYSTEMIC TREATMENT; LATE DEATHS; CONSORTIUM; PROGNOSIS; SEVERITY; CRITERIA; OUTCOMES	Failure-free survival, defined as the absence of relapse, non-relapse mortality or addition of another systemic therapy, has been proposed as a potential endpoint for clinical trials, but its use has only been reported for single-center studies. We measured failure-free survival in a prospective observational cohort of patients (n= 575) with both newly diagnosed and existing chronic graft-versus-host disease from nine centers. Failure was observed in 389 (68%) patients during the observation period. The median follow up of all patients was 30.9 months, and the median failure-free survival was 9.8 months (63% at 6 months, 45% at 1 year, and 29% at 2 years). Of the variables measured at enrollment, ten were associated with shorter failure-free survival: higher National Institutes of Health 0-3 skin score, higher National Institutes of Health 0-3 gastrointestinal score, worse range of motion summary score, lower forced vital capacity (%), bronchiolitis obliterans syndrome, worse quality of life, moderate to severe hepatic dysfunction, absence of treatment for gastric acid, female donor for male recipient, and prior grade II-IV acute graft-versus-host disease. Addition of a new systemic treatment, the major cause of failure, was associated with an increased risk of subsequent non-relapse mortality (hazard ratio= 2.06, 95% confidence interval: 1.29-3.32; P< 0.003) and decreased survival (hazard ratio= 1.51, 95% confidence interval: 1.04-2.18; P< 0.03). These results show that fewer than half of patients on systemic treatment will be failure-free survivors at 1 year, and fewer than a third will reach 2 years without experiencing failure. Better treatments are needed for chronic graft-versus-host disease.	[Palmer, Jeanne] Mayo Clin Phoenix, Div Hematol Oncol, Phoenix, AZ 85054 USA; [Chai, Xiaoyu; Martin, Paul J.; Inamoto, Yoshihiro; Flowers, Mary E. D.; Lee, Stephanie J.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Weisdorf, Daniel] Univ Minnesota, Blood & Marrow Transplant Program, Minneapolis, MN USA; [Inamoto, Yoshihiro] Natl Canc Ctr, Div Hematopoiet Stem Cell Transplantat, Tokyo, Japan; [Pidala, Joseph] Univ S Florida, H Lee Moffitt Canc Ctr, Blood & Marrow Transplantat, Tampa, FL 33682 USA; [Jagasia, Madan] Vanderbilt Univ, Med Ctr, Hematol & Stem Cell Transplant Program, Nashville, TN USA; [Pavletic, Steven] NCI, NIH, Bethesda, MD 20892 USA; [Cutler, Corey] Dana Farber Canc Inst, Hematol Malignancies, Boston, MA 02115 USA; [Vogelsang, Georgia] Johns Hopkins Univ Hosp, Div Oncol, Baltimore, MD 21287 USA; [Arai, Sally] Stanford Univ, Med Ctr, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA	Palmer, J (reprint author), Mayo Clin Phoenix, Div Hematol Oncol, Phoenix, AZ 85054 USA.	palmer.jeanne@mayo.edu			Chronic GVHD Consortium, National Institutes of Health Rare Disease Clinical Research Network [U54 CA163438];  [CA118953]	The Chronic GVHD Consortium (U54 CA163438) is a part of the National Institutes of Health Rare Disease Clinical Research Network, supported through a collaboration between the Office of Rare Diseases Research, NCATS, and the National Cancer Institute. This work was also supported by CA118953	Inamoto Y, 2013, BLOOD, V121, P2340, DOI 10.1182/blood-2012-11-465583; Socie G, 1999, NEW ENGL J MED, V341, P14, DOI 10.1056/NEJM199907013410103; Williams KM, 2009, JAMA-J AM MED ASSOC, V302, P306, DOI 10.1001/jama.2009.1018; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Socie G, 2003, BLOOD, V101, P3373, DOI 10.1182/blood-2002-07-2231; Inamoto Y, 2013, BLOOD, V121, P5098, DOI 10.1182/blood-2012-10-464198; Lee SJ, 2003, BIOL BLOOD MARROW TR, V9, P215, DOI 10.1053/bbmt.2003.50026; Socie G, 2011, BLOOD, V117, P6375, DOI 10.1182/blood-2011-01-329821; Pidala J, 2011, HAEMATOL-HEMATOL J, V96, P1678, DOI 10.3324/haematol.2011.049841; Fraser CJ, 2006, BLOOD, V108, P2867, DOI 10.1182/blood-2006-02-003954; Baird K, 2013, BIOL BLOOD MARROW TR, V19, P632, DOI 10.1016/j.bbmt.2013.01.013; Wingard JR, 2011, J CLIN ONCOL, V29, P2230, DOI 10.1200/JCO.2010.33.7212; Arora M, 2011, BLOOD, V117, P6714, DOI 10.1182/blood-2010-12-323824; Lee SJ, 2006, BONE MARROW TRANSPL, V38, P305, DOI 10.1038/sj.bmt.1705434; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Chien Jason W, 2010, Biol Blood Marrow Transplant, V16, pS106, DOI 10.1016/j.bbmt.2009.11.002; Chronic GC, 2011, BIOL BLOOD MARROW TR, V17, P1114; Flowers MED, 2008, BIOL BLOOD MARROW TR, V14, P1380, DOI 10.1016/j.bbmt.2008.09.017; Inamoto Y, 2014, BLOOD, V124, P1363, DOI 10.1182/blood-2014-03-563544; Jacobsohn DA, 2012, BLOOD, V120, P2545, DOI 10.1182/blood-2012-04-424135; Kim DH, 2007, BONE MARROW TRANSPL, V40, P779, DOI 10.1038/sj.bmt.1705806; Pidala J, 2013, BIOL BLOOD MARROW TR, V19, P784, DOI 10.1016/j.bbmt.2013.02.001; Socie Gerard, 2010, Biol Blood Marrow Transplant, V16, pS146, DOI 10.1016/j.bbmt.2009.10.013	23	0	0	FERRATA STORTI FOUNDATION	PAVIA	VIA GIUSEPPE BELLI 4, 27100 PAVIA, ITALY	0390-6078			HAEMATOLOGICA	Haematologica	MAY	2015	100	5					690	695		10.3324/haematol.2014.117283		6	Hematology	Hematology	CI5IE	WOS:000354788000035		
J	Velasquez, CV; Roman, AD; Lan, NTP; Huy, NT; Mercado, ES; Espino, FE; Perez, MLM; Huong, VTQ; Thuy, TT; Timm, VD; Nga, CTP; Ha, TTN; Bilar, JM; Bajaro, JDP; Baello, BQ; Kikuchi, M; Yasunami, M; Morita, K; Watanabe, N; Karbwang, J; Hirayama, K				Velasquez, Clara Vasquez; Roman, Arthur Dessi; Lan, Nguyen Thi Phuong; Huy, Nguyen Tien; Mercado, Edelwisa Segubre; Espino, Fe. Esperanza; Perez, Ma Lucila M.; Huong, Vu Thi Que; Thuy, Tran Thi; Timm, Vo Dinh; Nga, Cao Thi Phi; Ha, Tran Thi Ngoc; Bilar, Josie M.; Bajaro, Jemimah Dawn. P.; Baello, Benilda Q.; Kikuchi, Mihoko; Yasunami, Michio; Morita, Kouichi; Watanabe, Naohiro; Karbwang, Juntra; Hirayama, Kenji			Alpha tryptase allele of Tryptase 1 (TPSAB1) gene associated with Dengue Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS) in Vietnam and Philippines	HUMAN IMMUNOLOGY			English	Article						Chymase (CMA1); Tryptase 1 (TPSAB1); Single nucleotide polymorphism (SNP); Dengue Hemorrhagic Fever (DHF); Dengue Shock Syndrome (DSS)	MAST-CELL CHYMASE; ATOPIC-DERMATITIS; PROMOTER REGION; ASTHMA; ECZEMA; POPULATION; INFECTION; HAPLOTYPE; VARIANTS; LUNG	We previously reported, significantly higher levels of Chymase and Tryptase in early stage plasma of DSS patients prior to the occurrence of shock suggesting a possible role of mast cells in dengue pathogenesis. To further investigate, we analyzed CMA1 promoter SNP (rs1800875) and TPSAB1 gene alleles, which encode the Human Chymase and alpha- and beta- tryptase 1 enzymes respectively, for susceptibility to Dengue Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS) in patients from hospitals in Vietnam (Ho Chi Minh City and Vinh Long) and the Philippines. While the CMA1 promoter SNP (rs1800875) was not associated with DHF/DSS, the homozygous form of alpha-tryptase allele was associated with DSS patients in Vinh Long and the Philippines (OR = 3.52, p < 0.0001; OR = 3.37, p < 0.0001, respectively) and with DHF in Ho Chi Minh City (OR = 2.54, p = 0.0084). Also, a statistically significant association was observed when DHF and DSS were combined in Vinh Long (OR = 1.5, p = 0.034) and the Philippines (OR = 2.36, p = 0.0004); in Ho Chi Minh City when DHF and DSS were combine an association was observed, but it was not statistically significant (OR = 1.5, p = 0.0505). Therefore, the alpha-tryptase might have a possible effect on the susceptibility to severe form of Dengue infection. (C) 2015 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.	[Velasquez, Clara Vasquez; Roman, Arthur Dessi; Kikuchi, Mihoko; Yasunami, Michio; Hirayama, Kenji] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Immunogenet, Nagasaki 8528523, Japan; [Velasquez, Clara Vasquez; Roman, Arthur Dessi; Huy, Nguyen Tien; Kikuchi, Mihoko; Yasunami, Michio; Morita, Kouichi; Hirayama, Kenji] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528523, Japan; [Lan, Nguyen Thi Phuong] Inst Pasteur, Immunol & Mol Biol, Ho Chi Minh City, Vietnam; [Huy, Nguyen Tien; Karbwang, Juntra] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Clin Prod Dev, Nagasaki 8528523, Japan; [Mercado, Edelwisa Segubre] Res Inst Trop Med, Mol Biol Lab, Muntinlupa, Philippines; [Espino, Fe. Esperanza] Res Inst Trop Med, Dept Med, Muntinlupa, Philippines; [Perez, Ma Lucila M.; Bilar, Josie M.; Bajaro, Jemimah Dawn. P.; Baello, Benilda Q.] Off Res Dev, Philippine Childrens Med Ctr, Quezon City, Philippines; [Huong, Vu Thi Que; Ha, Tran Thi Ngoc] Inst Pasteur, Arbovirus Lab, Ho Chi Minh City, Vietnam; [Thuy, Tran Thi] Hosp 2, Ho Chi Minh City, Vietnam; [Timm, Vo Dinh; Nga, Cao Thi Phi] Ctr Prevent Med, Ho Chi Minh City, Vinh Long Provi, Vietnam; [Morita, Kouichi] Nagasaki Univ, Dept Virol, Inst Trop Med NEKKEN, Nagasaki 8528523, Japan; [Watanabe, Naohiro] Jikei Univ, Dept Trop Med, Sch Med, Tokyo, Japan	Hirayama, K (reprint author), Nagasaki Univ, Inst Trop Med NEKKEN, Dept Immunogenet, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	hiraken@nagasaki-u.ac.jp		Hirayama, Kenji/0000-0001-9467-1777	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT Japan; Joint Japan/World Bank Graduate Program Scholarship	CV is a recipient of the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) PhD fellowship. This work is partly supported by J-GRID Project from MEXT Japan. ADR is a recipient of the Joint Japan/World Bank Graduate Program Scholarship.	Akin C, 2007, CLIN IMMUNOL, V123, P268, DOI 10.1016/j.clim.2007.02.007; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545; St John AL, 2011, P NATL ACAD SCI USA, V108, P9190, DOI 10.1073/pnas.1105079108; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Mao XQ, 1996, LANCET, V348, P581, DOI 10.1016/S0140-6736(95)10244-2; Huang CF, 2001, J BIOL CHEM, V276, P26276, DOI 10.1074/jbc.M102356200; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480; Abdelmotelb AM, 2014, CLIN EXP ALLERGY, V44, P822, DOI 10.1111/cea.12259; Caughey GH, 2000, J IMMUNOL, V164, P6566; Voehringer D, 2013, NAT REV IMMUNOL, V13, P362, DOI 10.1038/nri3427; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; Avirutnan P, 2013, ELIFE, V2; Chugunova E., 2004, BIOL FUNCTIONAL MAST, P51; Forrest S, 1999, J ALLERGY CLIN IMMUN, V104, P1066; Furuta T, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001505; Hallgren J, 2006, FEBS J, V273, P1871, DOI 10.1111/j.1742-4658.2006.05211.x; Hossny EM, 2008, J INVEST ALLERG CLIN, V18, P376; Iwanaga T, 2004, CLIN EXP ALLERGY, V34, P1037, DOI 10.1111/j.1365-2222.2004.02000.x; Lan NTP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000304; Lancaster AK, 2007, TISSUE ANTIGENS, V69, P192, DOI 10.1111/j.1399-0039.2006.00769.x; Mao XQ, 1998, HUM HERED, V48, P38, DOI 10.1159/000022782; Min HK, 2004, J ALLERGY CLIN IMMUN, V114, P48, DOI 10.1016/j.jaci.2004.04.008; Pallaoro M, 1999, J BIOL CHEM, V274, P3355, DOI 10.1074/jbc.274.6.3355; Pascale E, 2001, HUM HERED, V51, P177, DOI 10.1159/000053339; Soto D, 2002, CLIN EXP ALLERGY, V32, P1000, DOI 10.1046/j.1365-2222.2002.01416.x; St John AL, 2013, ELIFE, V2, DOI 10.7554/eLife.00481; Tanaka, 1999, CLIN EXP ALLERGY, V29, P800; Trivedi NN, 2009, J ALLERGY CLIN IMMUN, V124, P1099, DOI 10.1016/j.jaci.2009.07.026; World Health Organisation (WHO), 1997, DENG HAEM FEV DIAGN, V2nd, P1; World Health Organization (WHO), 2005, DENG HEM FEV DENG SH, P34	31	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0198-8859	1879-1166		HUM IMMUNOL	Hum. Immunol.	MAY	2015	76	5					318	323		10.1016/j.humimm.2015.03.009		6	Immunology	Immunology	CH6KL	WOS:000354145400003		
J	Kurotaki, YK; Hatanaka, Y; Kamimura, S; Oikawa, M; Inoue, H; Ogonuki, N; Inoue, K; Ogura, A				Kurotaki, Yoko Kakino; Hatanaka, Yuki; Kamimura, Satoshi; Oikawa, Mami; Inoue, Hiroki; Ogonuki, Narumi; Inoue, Kimiko; Ogura, Atsuo			Impaired active DNA demethylation in zygotes generated by round spermatid injection	HUMAN REPRODUCTION			English	Article						DNA demethylation; ROSI; mouse; Tet3	1-CELL MOUSE EMBRYOS; SPERMATOGENIC CELLS; MAMMALIAN ZYGOTE; PATERNAL GENOME; REPORTER MOUSE; RABBIT OOCYTES; REPLICATION; MICROINSEMINATION; METHYLATION; FERTILIZATION	STUDY QUESTION: Is the poor development of embryos generated from round spermatid injection (ROSI) in humans and animals associated with abnormal active DNA demethylation? SUMMARY ANSWER: A significant proportion of ROSI-derived embryos failed to undergo active DNA demethylation. WHAT IS KNOWN ALREADY: Active DNA demethylation is initiated by the conversion of 5-methylcytosine (5mC) to 5-hydroxycytosine (5hmC) by the Tet3 enzyme. Active demethylation proceeds in a more pronounced manner in the male pronucleus than in the female one. PARTICIPANTS/MATERIALS, SETTING, METHODS: Mouse zygotes generated by ICSI or ROSI were analyzed for active DNA methylation by quantification of 5mC and 5hmC using specific antibodies. Some ROSI-derived embryos were subjected to time-lapse imaging for DNA methylation levels and were transferred into recipient pseudo-pregnant female mice. MAIN RESULTS AND THE ROLE OF CHANCE: In ICSI-derived embryos, the male: female pronucleus (M/F) ratio of 5mC immunostaining intensity was decreased while that of 5hmC was increased. However, a significant proportion of ROSI-derived embryos showed unchanged M/F ratios for 5mC and 5hmC even at the late zygotic period, indicating that they failed to undergo asymmetric active DNA demethylation. Consistent with this, some ROSI-derived embryos did not show preferential localization of Tet3 to the male pronucleus. ROSI-derived embryos were classified into 'demethylated' or 'non-demethylated' groups by time-lapse imaging and transferred into recipient female mice separately. More normal-sized fetuses were retrieved from the 'demethylated' group than 'non-demethylated' group at Day 11.5 of pregnancy. LIMITATIONS, REASONS FOR CAUTION: A causal relationship between impaired active DNA demethylation and the poor developmental ability of ROSI-derived embryos remains to be determined. WIDER IMPLICATIONS OF THE FINDINGS: We identified two types of ROSI-derived embryos in terms of the degree of active DNA demethylation. Induction of normal DNA demethylation at the zygotic stage might help in the technical improvement of ROSI.	[Kurotaki, Yoko Kakino; Hatanaka, Yuki; Kamimura, Satoshi; Oikawa, Mami; Inoue, Hiroki; Ogonuki, Narumi; Inoue, Kimiko; Ogura, Atsuo] RIKEN, BioResource Ctr, Tsukuba, Ibaraki 3050074, Japan; [Kurotaki, Yoko Kakino; Kamimura, Satoshi; Inoue, Kimiko; Ogura, Atsuo] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Inoue, Hiroki] Tohoku Univ, Grad Sch Agr Sci, Lab Anim Reprod & Dev, Sendai, Miyagi 980, Japan; [Ogura, Atsuo] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 113, Japan	Ogura, A (reprint author), RIKEN, BioResource Ctr, 3-1-1 Koyadai, Tsukuba, Ibaraki 3050074, Japan.	ogura@rtc.riken.go.jp	Ogura, Atsuo/J-3916-2014	Ogura, Atsuo/0000-0003-0447-1988	Ministry of Education, Culture, Sports, Science and Technology of Japan; RIKEN Epigenetics Program	The work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by the RIKEN Epigenetics Program. The authors have no competing interests to declare.	ALFONSO PJ, 1993, BIOL REPROD, V48, P522, DOI 10.1095/biolreprod48.3.522; Tachibana M, 2009, MOL REPROD DEV, V76, P270, DOI 10.1002/mrd.20951; McLay DW, 2003, REPRODUCTION, V125, P625, DOI 10.1530/rep.0.1250625; Sousa M, 2002, HUM REPROD, V17, P161, DOI 10.1093/humrep/17.1.161; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Abe T, 2013, DEV GROWTH DIFFER, V55, P390, DOI 10.1111/dgd.12062; Shirakata Y, 2014, J REPROD DEVELOP, V60, P383, DOI 10.1262/jrd.2014-018; QUINN P, 1985, FERTIL STERIL, V44, P493; KIMURA Y, 1995, DEVELOPMENT, V121, P2397; Hazzouri M, 2000, EUR J CELL BIOL, V79, P950, DOI 10.1078/0171-9335-00123; Lin CJ, 2014, DEV CELL, V30, P268, DOI 10.1016/j.devcel.2014.06.022; CHATOT CL, 1989, J REPROD FERTIL, V86, P679; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Ueda J, 2014, STEM CELL REP, V2, P910, DOI 10.1016/j.stemcr.2014.05.008; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Tesarik J, 1996, HUM REPROD, V11, P772; Adenot PG, 1997, DEVELOPMENT, V124, P4615; Ogura A, 1998, P NATL ACAD SCI USA, V95, P5611, DOI 10.1073/pnas.95.10.5611; Kishigami S, 2006, DEV BIOL, V289, P195, DOI 10.1016/j.ydbio.2005.10.026; Yamagata K, 2005, GENESIS, V43, P71, DOI 10.1002/gene.20158; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; OGURA A, 1994, P NATL ACAD SCI USA, V91, P7460, DOI 10.1073/pnas.91.16.7460; OGURA A, 1993, BIOL REPROD, V48, P219, DOI 10.1095/biolreprod48.2.219; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Guo F, 2014, CELL STEM CELL, V15, P447, DOI 10.1016/j.stem.2014.08.003; Hatanaka Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060205; Hirabayashi M, 2009, MOL REPROD DEV, V76, P573, DOI 10.1002/mrd.20984; Kamimura Satoshi, 2014, Biol Reprod, V91, P120, DOI 10.1095/biolreprod.114.120451; Kaufman MH., 1992, ATLAS MOUSE DEV, P385; Ogonuki N, 2005, MOL REPROD DEV, V72, P411, DOI 10.1002/mrd.20363; Ogonuki N, 2003, HUM REPROD, V18, P1273, DOI 10.1093/humrep/dep212; Ogonuki N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011062; Ogura A, 2005, INT REV CYTOL, V246, P189, DOI 10.1016/S0074-7696(05)46005-2; Ohta H, 2009, BIOL REPROD, V80, P511, DOI 10.1095/biolreprod.108.073270; Shen L, 2014, CELL STEM CELL, V15, P459, DOI 10.1016/j.stem.2014.09.002; TESARIK JN, 1995, NEW ENGL J MED, V333, P525, DOI 10.1056/NEJM199508243330819; Xu GL, 2014, BMB REP, V47, P609, DOI 10.5483/BMBRep.2014.47.11.223; Yamagata K, 2009, HUM REPROD, V24, P2490, DOI 10.1093/humrep/dep236; Yamazaki T, 2007, DEV BIOL, V304, P409, DOI 10.1016/j.ydbio.2006.12.046; Yanagimachi R, 2005, REPROD BIOMED ONLINE, V10, P247	42	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0268-1161	1460-2350		HUM REPROD	Hum. Reprod.	MAY	2015	30	5					1178	1187		10.1093/humrep/dev039		10	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CI5JQ	WOS:000354792100018		
J	Abrao, MS; Petraglia, F; Falcone, T; Keckstein, J; Osuga, Y; Chapron, C				Abrao, Mauricio Simoes; Petraglia, Felice; Falcone, Tommaso; Keckstein, Joerg; Osuga, Yutaka; Chapron, Charles			Deep endometriosis infiltrating the recto-sigmoid: critical factors to consider before management	HUMAN REPRODUCTION UPDATE			English	Review						deep endometriosis; ultrasound; MRI; minimally invasive surgery; recurrence	LAPAROSCOPIC COLORECTAL RESECTION; QUALITY-OF-LIFE; TERM-FOLLOW-UP; RECTOVAGINAL ENDOMETRIOSIS; PELVIC ENDOMETRIOSIS; SURGICAL-MANAGEMENT; BOWEL RESECTION; RECTAL ENDOMETRIOSIS; SYMPTOMATIC ENDOMETRIOSIS; REPRODUCTIVE-PERFORMANCE	BACKGROUND: Deep endometriosis invading the bowel constitutes a major challenge for the gynecologist. In addition to the greater impact on pain, the high incidence of surgical morbidity involved with bowel endometriosis poses a therapeutic dilemma for the surgeon. Intestinal involvement by deep endometriotic nodules has been estimated to occur in 8-12% of women with endometriosis. Individual and clinical factors, pre-operative morphologic characteristics from imaging, surgical considerations and impact on quality of life are critical variables that should be considered in determining the best therapeutic strategy for a patient with deep endometriosis involving the sigmoid and/or the rectum. Pre-operative planning is fundamental for defining the optimal therapeutic strategy; patient counseling of treatment options, and when surgery is indicated, involvement of a multidisciplinary surgical team is required. METHODS: The PubMed and Cochrane database were searched for all original and review articles published in English, French and Italian, until June 2014. Search terms included 'deep endometriosis', 'surgical and clinical approach', 'bowel disease', 'quality of life', 'management of deep endometriosis'. Special attention was paid to articles comparing features of discoid and segmental resection. RESULTS: The rationale for the best therapeutic options for patients with deep endometriosis has been shown and an evidence-based treatment algorithm for determining when and which surgical intervention may be required is proposed. In deciding the best treatment option for patients with deep endometriosis involving the sigmoid and rectum, it is important to understand how the different clinical factors and pre-operative morphologic imaging affect the algorithm. Surgery is not indicated in all patients with deep endometriosis, but, when surgery is chosen, a complete resection by the most appropriate surgical team is required in order to achieve the best patient outcome. CONCLUSION: In women with deep endometriosis, surgery is the therapy of choice for symptomatic patients when deep lesions do not improve with a medical treatment.	[Abrao, Mauricio Simoes] Univ Sao Paulo, Dept Obstet & Gynecol, Endometriosis Div, Sao Paulo, Brazil; [Petraglia, Felice] Univ Siena, Dept Mol & Dev Med, Obstet & Gynecol, I-53100 Siena, Italy; [Falcone, Tommaso] Cleveland Clin, Obstet Gynecol & Womens Hlth Inst, Cleveland, OH 44106 USA; [Keckstein, Joerg] Villach Hosp, Ctr Endometriosis, Dept Obstet & Gynecol, Villach, Austria; [Osuga, Yutaka] Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo 113, Japan; [Chapron, Charles] Ctr Hosp Univ CHU Cochin, Univ Paris Descartes, Grp Hosp Univ GHU Ouest,Sorbonne Paris Cite, AP HP,Dept Gynecol Obstet & Reprod Med 2,Fac Med, F-75679 Paris, France; [Chapron, Charles] Univ Paris 05, Inst Cochin, Sorbonne Paris Cite, CNRS,UMR 8104, Paris, France; [Chapron, Charles] Univ Paris 05, Inst Cochin, INSERM, Unite Rech,U1016, Paris, France	Abrao, MS (reprint author), Rua Sao Sebastiao 550, BR-04708001 Sao Paulo, SP, Brazil.	msabrao@mac.com					Acien P, 2013, ISRN OBSTET GYNECOL, V17; Acién Pedro, 2013, Int J Womens Health, V5, P449, DOI 10.2147/IJWH.S46519; Ahmad G, 2008, COCHRANE DB SYST REV; Anaf V, 2004, HUM REPROD, V19, P996, DOI 10.1093/humrep/deh150; Maas K, 1999, LANCET, V354, P772, DOI 10.1016/S0140-6736(05)76009-8; Possover M, 2005, J AM COLL SURGEONS, V201, P913, DOI 10.1016/j.jamcollsurg.2005.07.006; Remorgida V, 2005, HUM REPROD, V20, P2317, DOI 10.1093/humrep/dei047; Noel JC, 2010, FERTIL STERIL, V93, P1774, DOI 10.1016/j.fertnstert.2008.12.114; Abrao MS, 2007, HUM REPROD, V22, P3092, DOI 10.1093/humrep/dem187; Beck DE, 2003, DIS COLON RECTUM, V46, P1310, DOI 10.1097/01.DCR.0000089117.62296.E4; Ford J, 2004, BJOG-INT J OBSTET GY, V111, P353, DOI 10.1111/.1471-0528.2004.00093.x; Meuleman C, 2011, HUM REPROD UPDATE, V17, P311, DOI 10.1093/humupd/dmq057; Somigliana E, 2007, FERTIL STERIL, V87, P1287, DOI 10.1016/j.fertnstert.2006.11.090; Kavallaris A, 2003, HUM REPROD, V18, P1323, DOI 10.1093/humrep/deg251; Benbara A, 2008, GYNECOL OBSTET FERTI, V36, P1191, DOI 10.1016/j.gyobfe.2008.09.016; Darai E, 2007, SURG ENDOSC, V21, P1572, DOI 10.1007/s00464-006-9160-1; Seracchioli R, 2009, HUM REPROD, V24, P2729, DOI 10.1093/humrep/dep259; Bianchi PHM, 2009, J MINIM INVAS GYN, V16, P174, DOI 10.1016/j.jmig.2008.12.009; Chapron C, 2003, HUM REPROD, V18, P157, DOI 10.1093/humrep/deg009; Fedele L, 2004, AM J OBSTET GYNECOL, V190, P1020, DOI 10.1016/j.ajog.2003.10.698; Trencheva K, 2013, ANN SURG, V257, P108, DOI 10.1097/SLA.0b013e318262a6cd; Chapron C, 1998, HUM REPROD, V13, P2266, DOI 10.1093/humrep/13.8.2266; Vignali M, 2005, J MINIM INVAS GYN L, V12, P508, DOI 10.1016/j.jmig.2005.06.016; Razzi S, 2007, FERTIL STERIL, V88, P789, DOI 10.1016/j.fertnstert.2006.12.077; Vercellini P, 2010, REPROD BIOMED ONLINE, V21, P259, DOI 10.1016/j.rbmo.2010.04.018; Fourquet J, 2011, FERTIL STERIL, V96, P107, DOI 10.1016/j.fertnstert.2011.04.095; Koninckx PR, 2012, FERTIL STERIL, V98, P564, DOI 10.1016/j.fertnstert.2012.07.1061; Guerriero S, 2008, HUM REPROD, V23, P2452, DOI 10.1093/humrep/den293; Ferrero S, 2010, HUM REPROD, V25, P94, DOI 10.1093/humrep/dep361; Fauconnier A, 2005, HUM REPROD UPDATE, V11, P595, DOI 10.1093/humupd/dmi029; Dousset B, 2010, ANN SURG, V251, P887, DOI 10.1097/SLA.0b013e3181d9722d; Donnez J, 2010, HUM REPROD, V25, P1949, DOI 10.1093/humrep/deq135; Roman H, 2014, COLORECTAL DIS, V16, pO253, DOI 10.1111/codi.12605; Thomassin I, 2004, AM J OBSTET GYNECOL, V190, P1264, DOI 10.1016/j.ajog.2003.12.004; BAILEY HR, 1994, DIS COLON RECTUM, V37, P747; Keckstein J, 2005, MINIM INVASIV THER, V14, P160, DOI 10.1080/14017430510035916; Dubernard G, 2006, HUM REPROD, V21, P1243, DOI 10.1093/humrep/dei491; Vercellini P, 2009, ACTA OBSTET GYN SCAN, V88, P1074, DOI 10.1080/00016340903214973; Vercellini P, 2012, REPROD BIOMED ONLINE, V24, P389, DOI 10.1016/j.rbmo.2012.01.003; Pagidas K, 1996, FERTIL STERIL, V65, P791; Abrao MS, 2006, FERTIL STERIL, V86, P543, DOI 10.1016/j.fertnstert.2006.02.102; Hudelist G, 2009, HUM REPROD, V24, P1012, DOI 10.1093/humrep/dep014; Ferrero S, 2009, FERTIL STERIL, V92, P41, DOI 10.1016/j.fertnstert.2008.04.070; Darai E, 2008, GYNECOL OBSTET FERTI, V36, P1214, DOI 10.1016/j.gyobfe.2008.09.010; Littman E, 2005, FERTIL STERIL, V84, P1574, DOI 10.1016/j.fertnstert.2005.02.059; Ruffo G, 2012, SURG ENDOSC, V26, P1035, DOI 10.1007/s00464-011-1991-8; de Ziegler D, 2010, LANCET, V376, P730, DOI 10.1016/S0140-6736(10)60490-4; Roman H, 2011, HUM REPROD, V26, P274, DOI 10.1093/humrep/deq332; Vercellini P, 2006, HUM REPROD, V21, P2679, DOI 10.1093/humrep/del230; Roman H, 2010, HUM REPROD, V25, P890, DOI 10.1093/humrep/dep407; Remorgida V, 2007, OBSTET GYNECOL SURV, V62, P461, DOI 10.1097/01.ogx.0000268688.55653.5c; Piketty M, 2009, HUM REPROD, V24, P602, DOI 10.1093/humrep/den405; Chapron C, 2004, ANN NY ACAD SCI, V1034, P326, DOI 10.1196/annals.1335.035; Goncalves MOD, 2010, HUM REPROD, V25, P665, DOI 10.1093/humrep/dep433; Brouwer R, 2007, ANZ J SURG, V77, P562, DOI 10.1111/j.1445-2197.2007.04153.x; Haggag H, 2011, CURR OPIN OBSTET GYN, V23, P278, DOI 10.1097/GCO.0b013e328348a25b; Anaf V, 2000, HUM REPROD, V15, P1744, DOI 10.1093/humrep/15.8.1744; Abrao MS, 2008, J MINIM INVAS GYN, V15, P280, DOI 10.1016/j.jmig.2008.01.006; Chapron C, 2010, HUM REPROD, V25, P884, DOI 10.1093/humrep/deq017; Possover M, 2000, OBSTET GYNECOL, V96, P304, DOI 10.1016/S0029-7844(00)00839-5; Sampson JA, 1927, AM J OBSTET GYNECOL, V14, P422; Garry R, 2000, BRIT J OBSTET GYNAEC, V107, P44, DOI 10.1111/j.1471-0528.2000.tb11578.x; Bridoux V, 2012, HUM REPROD, V27, P418, DOI 10.1093/humrep/der422; Armengol-Debeir L, 2011, HUM REPROD, V26, P2330, DOI 10.1093/humrep/der190; Meuleman C, 2009, REPROD BIOMED ONLINE, V18, P282; Chapron C, 2006, HUM REPROD, V21, P1839, DOI 10.1093/humrep/del079; Roman H, 2014, FERTIL STERIL, V102, pE7, DOI 10.1016/j.fertnstert.2014.04.038; Noel JC, 2008, FERTIL STERIL, V89, P1069, DOI 10.1016/j.fertnsterl.2007.05.011; Duepree HJ, 2002, J AM COLL SURGEONS, V195, P754, DOI 10.1016/S1072-7515(02)01341-8; Ruffo G, 2010, SURG ENDOSC, V24, P63, DOI 10.1007/s00464-009-0517-0; Meuleman C, 2014, ANN SURG, V259, P522, DOI 10.1097/SLA.0b013e31828dfc5c; Abrao MS, 2003, INT J GYNECOL OBSTET, V82, P31, DOI 10.1016/S0020-7292(03)00079-1; Darai E, 2007, CURR OPIN OBSTET GYN, V19, P308, DOI 10.1097/GCO.0b013e328216f6bc; Carmona F, 2009, FERTIL STERIL, V92, P868, DOI 10.1016/j.fertnstert.2008.07.1738; CORONADO C, 1990, FERTIL STERIL, V53, P411; Minelli L, 2009, ARCH SURG-CHICAGO, V144, P234, DOI 10.1001/archsurg.2008.555; Vercellini P, 2009, HUM REPROD UPDATE, V15, P177, DOI 10.1093/humupd/dmn062; Mechsner S, 2010, FERTIL STERIL, V94, P457, DOI 10.1016/j.fertnstert.2009.03.097; Fanfani F, 2010, FERTIL STERIL, V94, P444, DOI 10.1016/j.fertnstert.2009.03.066; Lazzeri L, 2014, REPROD SCI, V21, P1027, DOI 10.1177/1933719114522520; Redwine DB, 2001, FERTIL STERIL, V76, P358, DOI 10.1016/S0015-0282(01)01913-6; Roman H, 2013, FERTIL STERIL, V99, P1695, DOI 10.1016/j.fertnstert.2013.01.131; Tran KTC, 1996, EUR J SURG, V162, P139; Roman H, 2012, HUM REPROD, V27, P3440, DOI 10.1093/humrep/des322; Exacoustos C, 2014, FERTIL STERIL, V102, P143, DOI 10.1016/j.fertnstert.2014.03.043; Ballester M, 2012, HUM REPROD, V27, P1043, DOI 10.1093/humrep/des012; Jerby BL, 1999, SURG ENDOSC-ULTRAS, V13, P1125, DOI 10.1007/s004649901187; Chapron C, 2009, FERTIL STERIL, V92, P453, DOI 10.1016/j.fertnstert.2008.06.003; Landi S, 2006, HUM REPROD, V21, P774, DOI 10.1093/humrep/dei324; Bachmann R, 2014, ARCH GYNECOL OBSTET, V290, P919, DOI 10.1007/s00404-014-3257-x; Bassi MA, J MINIM INVASIVE GYN, V18, P730; Berlanda N, 2013, SEMIN REPROD MED, V31, P133, DOI 10.1055/s-0032-1333478; Berlanda N, 2010, CURR OPIN OBSTET GYN, V22, P320, DOI 10.1097/GCO.0b013e32833bea15; Borghese B, 2014, J GYNECOL OBST BIO R, V43, P12, DOI 10.1016/j.jgyn.2012.11.009; Campagnacci R, 2005, SURG ENDOSC, V19, P662, DOI 10.1007/s00464-004-8710-7; Chapron C, 2012, HUM REPROD, V27, P702, DOI 10.1093/humrep/der462; De Cicco C, 2011, BJOG-INT J OBSTET GY, V118, P285, DOI 10.1111/j.1471-0528.2010.02744.x; Cohen J, 2014, Minerva Ginecol, V66, P575; Darai E, 2005, AM J OBSTET GYNECOL, V192, P394, DOI 10.1016/j.ajog.2004.08.033; de Almeida Amélia, 2014, Surg Technol Int, V24, P243; De Ziegler D, 2011, Minerva Ginecol, V63, P365; Di Donato N, 2014, MINIM INVASIVE SURG, V2014; Dubernard G, 2008, HUM REPROD, V23, P846, DOI 10.1093/humrep/den026; ENDORE - WCE Sao Paolo, 2014, FUNCT OUTC SURG MAN; English James, 2014, Gastroenterol Rep (Oxf), V2, P288, DOI 10.1093/gastro/gou055; Ferrero S, 2009, J REPROD MED, V54, P366; Jacobson TZ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001300.pub2; Jess T, 2012, GUT, V61, P1279, DOI 10.1136/gutjnl-2011-301095; Kamergorodsky G, 2009, FERTIL STERIL, V92, P2074, DOI 10.1016/j.fertnstert.2009.05.086; Laas E, 2014, J MINIM INVAS GYN, V4650, P308; Li Hua-jun, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P13; Mabrouk M, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-98; Mangler M, 2008, INT J GYNECOL OBSTET, V103, P59, DOI 10.1016/j.ijgo.2008.06.009; Moawad Nash S, 2013, Int J Womens Health, V5, P753, DOI 10.2147/IJWH.S37846; Moawad NS, 2011, JSLS-J SOC LAPAROEND, V15, P331, DOI 10.4293/108680811X13125733356431; Mohr Catherine, 2005, JSLS, V9, P16; Nirgianakis K, 2014, ACTA OBSTET GYN SCAN, V93, P1262, DOI 10.1111/aogs.12490; Oliveira MAP, 2014, J MINIM INVAS GYN, V21, P136, DOI 10.1016/j.jmig.2013.07.022; Panebianco V, 1994, Minerva Chir, V49, P215; Pereira RMA, 2009, J MINIM INVAS GYN, V16, P472, DOI 10.1016/j.jmig.2009.04.004; Practice Committee of the American Society for Reproductive Medicine, 2006, FERTIL STERIL, V86, pS156; Pronio Annamaria, 2007, Chir Ital, V59, P599; Reich H, 1997, Surg Technol Int, V6, P199; Rocha ALL, 2012, EXPERT OPIN INV DRUG, V21, P905, DOI 10.1517/13543784.2012.683783; Roman Horace, 2014, J Minim Invasive Gynecol, V21, P730, DOI 10.1016/j.jmig.2014.03.003; Seracchioli R, 2007, BJOG-INT J OBSTET GY, V114, P889, DOI 10.1111/j.1471-0528.2007.01363.x; Sibiude J, 2014, OBSTET GYNECOL, V124, P709, DOI 10.1097/AOG.0000000000000464; Tuttlies F, 2005, Zentralbl Gynakol, V127, P275, DOI 10.1055/s-2005-836904; van Dijk LJEW, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-7; Vercellini P, 2009, EUR J OBSTET GYN R B, V146, P15, DOI 10.1016/j.ejogrb.2009.05.007; Wills HJ, 2008, AUST NZ J OBSTET GYN, V48, P292, DOI 10.1111/j.1479-828X.2008.00871.x; Zanardi R, 2003, ABDOM IMAGING, V28, P733, DOI 10.1007/s00261-003-0005-2	132	6	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1355-4786	1460-2369		HUM REPROD UPDATE	Hum. Reprod. Update	MAY-JUN	2015	21	3					329	339		10.1093/humupd/dmv003		11	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CI5JW	WOS:000354792800004		
J	Sacchi, C; Bhasin, K; Kadowaki, N; Vong, F				Sacchi, Claudio; Bhasin, Kul; Kadowaki, Naoto; Vong, Fred			TECHNOLOGIES AND APPLICATIONS OF FUTURE SATELLITE NETWORKING	IEEE COMMUNICATIONS MAGAZINE			English	Editorial Material									[Sacchi, Claudio] Univ Trento, Fac Engn, Trento, Italy; [Bhasin, Kul] NASA Glenn Res Ctr, Cleveland, OH USA; [Bhasin, Kul] Space Commun Projects NASA GRC, San Diego, CA USA; [Bhasin, Kul] AIAA, San Diego, CA USA; [Bhasin, Kul] SPIE, Bellingham, WA USA; [Kadowaki, Naoto] Strateg Planning Dept NICT, Koganei, Tokyo, Japan; [Kadowaki, Naoto] Wireless Network Res Inst NICT, Yokosuka, Kanagawa, Japan; [Vong, Fred] Asia Satellite Telecommun Co Ltd, Engn, Hong Kong, Hong Kong, Peoples R China	Sacchi, C (reprint author), Univ Trento, Dept Comp Sci & Informat Engn, Trento, Italy.	sacchi@disi.unitn.it						0	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0163-6804	1558-1896		IEEE COMMUN MAG	IEEE Commun. Mag.	MAY	2015	53	5					154	155				2	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CI1CV	WOS:000354479400018		
J	Wang, YK; Tobayashi, S; Lorenz, RD				Wang, Yukai; Tobayashi, Shunsuke; Lorenz, Robert D.			A Low-Switching-Frequency Flux Observer and Torque Model of Deadbeat-Direct Torque and Flux Control on Induction Machine Drives	IEEE TRANSACTIONS ON INDUSTRY APPLICATIONS			English	Article						Deadbeat-direct torque and flux control (DB-DTFC); flux observer; low-switching-frequency (SF) operation	DESIGN; STATOR; MOTOR	This paper presents a digital implementation of deadbeat-direct torque and flux control (DB-DTFC) for induction machines at low switching frequencies (SFs). For high SFs, existing discrete-time flux observers and Volt-second-based inverse torque models used for DB-DTFC achieve acceptable flux estimation accuracy and fast torque response. However, the flux estimate is less accurate when the SF is reduced and the DB-DTFC performance degrades. This paper develops a more suitable flux observer and Volt-second-based inverse torque model that minimizes flux estimation error and improves torque control for DB-DTFC. Simulation and experimental results are provided to evaluate the performance of the proposed observer and torque model at very low SFs. Consequently, digital implementation of low-SF DB-DTFC on high-power induction machines is feasible.	[Wang, Yukai; Lorenz, Robert D.] Univ Wisconsin, Wisconsin Elect Machines & Power Elect Consortium, Madison, WI 53706 USA; [Tobayashi, Shunsuke] Toshiba Mitsubishi Elect Ind Syst Corp, Fuchu, Tokyo 1040031, Japan	Wang, YK (reprint author), Univ Wisconsin, Wisconsin Elect Machines & Power Elect Consortium, Madison, WI 53706 USA.	ywang289@wisc.edu; TOBAYASHI.shunsuke@tmeic.co.jp; lorenz@engr.wisc.edu			Toshiba Mitsubishi-Electric Industrial Systems Corporation, Fuchu, Japan	This work was supported by Toshiba Mitsubishi-Electric Industrial Systems Corporation, Fuchu, Japan.	Kenny BH, 2003, IEEE T IND APPL, V39, P1093, DOI 10.1109/TIA.2003.813727; Xu W, 2014, IEEE T IND APPL, V50, P1053, DOI 10.1109/TIA.2013.2272052; Rehman HU, 2002, IEEE T POWER ELECTR, V17, P1041, DOI 10.1109/TPEL.2002.805579; West NT, 2009, IEEE T IND APPL, V45, P729, DOI 10.1109/TIA.2009.2013567; Bojoi R, 2006, IEEE IND APPLIC SOC, P1253; Habetler TG, 1998, IEEE T POWER ELECTR, V13, P125, DOI 10.1109/63.654966; Diao LJ, 2013, IEEE T POWER ELECTR, V28, P4803, DOI 10.1109/TPEL.2012.2235149; BOTTURA CP, 1993, IEEE T IND APPL, V29, P349, DOI 10.1109/28.216543; Depenbrock M., 1988, IEEE Transactions on Power Electronics, V3, DOI 10.1109/63.17963; HABETLER TG, 1992, IEEE T IND APPL, V28, P1045, DOI 10.1109/28.158828; Harnefors L, 2001, IEEE T IND ELECTRON, V48, P383, DOI 10.1109/41.915417; Heinbokel B. E., 2009, P EPE, P1; JANSEN PL, 1994, IEEE T IND APPL, V30, P101, DOI 10.1109/28.273627; Lipo T. A., 1996, VECTOR CONTROL DYNAM; Lorenz R. D., 2008, PROC OPTIM ELECT ELE, P19; Nilsen R., P IEEE POWER ELECT S, V1, P242; Obermann T., 2010, P ICEMS INCH S KOR O, P742; Orlowska-Kowalsa T., 1989, IEEE P D, V136, P323; TAKAHASHI I, 1986, IEEE T IND APPL, V22, P820, DOI 10.1109/TIA.1986.4504799; Vershese G., 1988, IEEE T IND ELECTRON, V35, P85; Zell C, 1996, PROCEEDINGS OF THE 1996 IEEE INTERNATIONAL CONFERENCE ON CONTROL APPLICATIONS, P1102, DOI 10.1109/CCA.1996.559086	21	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-9994	1939-9367		IEEE T IND APPL	IEEE Trans. Ind. Appl.	MAY-JUN	2015	51	3					2255	2267		10.1109/TIA.2014.2365628		13	Engineering, Multidisciplinary; Engineering, Electrical & Electronic	Engineering	CI7LJ	WOS:000354944600035		
J	Ishibashi, T; Okamoto, M; Hiraki, E; Tanaka, T; Hashizume, T; Kikuta, D; Kachi, T				Ishibashi, Takaharu; Okamoto, Masayuki; Hiraki, Eiji; Tanaka, Toshihiko; Hashizume, Tamotsu; Kikuta, Daigo; Kachi, Tetsu			Experimental Validation of Normally-On GaN HEMT and Its Gate Drive Circuit	IEEE TRANSACTIONS ON INDUSTRY APPLICATIONS			English	Article						Current collapse phenomena; GaN-based high-electron-mobility transistor (GaN HEMT); gate driver; normally-on; switching characteristics	WIDE BANDGAP SEMICONDUCTORS; POWER DEVICES	Wide-bandgap semiconductors such as silicon carbide (SiC) and gallium nitride (GaN) are promising materials for next-generation power devices. We have fabricated a normally on GaN-based high-electron-mobility transistor (GaN HEMT) for power electronic converters. In this paper, the current collapse phenomena, which are distinctive characteristics of GaN devices, are evaluated in detail for several voltages with two switching frequencies. We also evaluate a gate drive circuit that we previously proposed for the normally on GaN HEMT with a single positive voltage source. We construct and test prototype circuits for a boost-type dc-dc converter and a single-phase full-bridge inverter with a gate drive circuit. The problems to be solved for the normally on GaN HEMT, which has a (static) voltage rating of over 600 V, are clarified on the basis of the experimental results.	[Ishibashi, Takaharu; Tanaka, Toshihiko] Yamaguchi Univ, Grad Sch Sci & Engn, Ube, Yamaguchi 7558611, Japan; [Ishibashi, Takaharu; Okamoto, Masayuki; Hiraki, Eiji; Tanaka, Toshihiko; Hashizume, Tamotsu; Kikuta, Daigo; Kachi, Tetsu] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo 1020076, Japan; [Okamoto, Masayuki] Ube Natl Coll Technol, Ube, Yamaguchi 7558555, Japan; [Hiraki, Eiji] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Hashizume, Tamotsu] Hokkaido Univ, Res Ctr Integrated Quantum Elect, Sapporo, Hokkaido 0600808, Japan; [Kikuta, Daigo; Kachi, Tetsu] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan	Ishibashi, T (reprint author), Yamaguchi Univ, Grad Sch Sci & Engn, Ube, Yamaguchi 7558611, Japan.	s006vk@yamaguchi-u.ac.jp; mokamoto@ube-k.ac.jp; hiraki@okayama-u.ac.jp; totanaka@yamaguchi-u.ac.jp; hashi@rciqe.hokudai.ac.jp; e1356@mosk.tytlabs.co.jp; kachi@mosk.tylabs.co.jp	Hashizume, Tamotsu/A-6539-2012				Hudgins JL, 2003, IEEE T POWER ELECTR, V18, P907, DOI 10.1109/TPEL.2003.810840; [Anonymous], 2004, JEC24062004; Hudgins JL, 2002, IEEE POWER ELECTRON, P1747; International Rectifier Datasheets IR2011, DAT IR2011; Kaminski N., 2009, P IEEE POW EL APPL, P1; Kanamura M., 2010, I ELECT ENG JPN T EL, V130, P929; Khanna R, 2012, 2012 IEEE ENERGY CONVERSION CONGRESS AND EXPOSITION (ECCE), P1489, DOI 10.1109/ECCE.2012.6342638; Lidow A., 2011, P IEEE 2011 EN CONV, P1; Ohno Y., 2002, CURRENT COLLAPSE GAN, P19; Okamoto M, 2011, 2011 IEEE ENERGY CONVERSION CONGRESS AND EXPOSITION (ECCE), P1795, DOI 10.1109/ECCE.2011.6064002; Okamoto M., 2012, P RCIQE INT WORKSH G, P11; Ozpineci B., 2003, P EUR C EPE TOUL FRA, P1; Saito W., 2007, P INT C COMP SEM MAN, P209; Tokura N., 2011, IEEJ T IA, V131, P1, DOI 10.1541/ieejias.131.1; TOSHIBA Corporation, DAT TK2Q60D; Yoshida S., 1999, MONTHLY PUBLICATION, V68, P787; Zhang NQ, 2003, IEEE POWER ELECTRON, P233; Zhou Y., 2012, P IEEE 2012 EN CONV, P1615	18	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-9994	1939-9367		IEEE T IND APPL	IEEE Trans. Ind. Appl.	MAY-JUN	2015	51	3					2415	2422		10.1109/TIA.2014.2369818		8	Engineering, Multidisciplinary; Engineering, Electrical & Electronic	Engineering	CI7LJ	WOS:000354944600051		
J	Kuroki, T; Nakayama, K; Nakamura, D; Onji, T; Okubo, M				Kuroki, Tomoyuki; Nakayama, Ken; Nakamura, Daisuke; Onji, Takeshi; Okubo, Masaaki			Nonthermal Plasma Hybrid Process for Preparation of Organic Electroluminescence Fluoropolymer Film Devices	IEEE TRANSACTIONS ON INDUSTRY APPLICATIONS			English	Article						Fluoropolymer films; graft polymerization; nonthermal plasma (NTP); organic light-emitting diodes (OLEDs); surface treatment	LIGHT-EMITTING DEVICES; FLUOROCARBON POLYMER-FILMS; GRAFT-POLYMERIZATION; SURFACE MODIFICATION; GLOW-DISCHARGE; POLY(TETRAFLUOROETHYLENE); ADHESION; FABRICS	In this paper, organic electroluminescence fluoropolymer film devices, i.e., organic light-emitting diodes (OLEDs) comprising polychlorotrifluoroethylene (PCTFE) films treated by an atmospheric-pressure nonthermal plasma (NTP) graft-polymerization process, are investigated. PCTFE films can provide a long lifetime for OLEDs because of their excellent gas barrier properties; however, they are difficult to laminate, owing to low adhesiveness. The surfaces of PCTFE films are treated by an atmospheric-pressure NTP-graft-polymerization process to improve their adhesiveness, and then, indium tin oxide and a luminous layer are deposited on the treated PCTFE films. As a result, OLEDs comprising PCTFE films are successfully demonstrated.	[Kuroki, Tomoyuki; Nakayama, Ken; Nakamura, Daisuke; Okubo, Masaaki] Osaka Prefecture Univ, Grad Sch Engn, Dept Mech Engn, Sakai, Osaka 5998531, Japan; [Onji, Takeshi] Technol Res Inst Osaka Prefecture, Izumi 5941157, Japan	Kuroki, T (reprint author), Osaka Prefecture Univ, Grad Sch Engn, Dept Mech Engn, Sakai, Osaka 5998531, Japan.	kuroki@me.osakafu-u.ac.jp; onji@tri-osaka.jp; mokubo@me.osakafu-u.ac.jp					BURROWS PE, 1994, APPL PHYS LETT, V65, P2922, DOI 10.1063/1.112532; Janghouri M, 2013, J LUMIN, V140, P7, DOI 10.1016/j.jlumin.2013.02.018; D'Andrade BW, 2004, ADV MATER, V16, P1585, DOI 10.1002/adma.200400684; WROBEL AM, 1978, POLYMER, V19, P908, DOI 10.1016/0032-3861(78)90197-0; Sarani A, 2012, SURF COAT TECH, V206, P2226, DOI 10.1016/j.surfcoat.2011.09.070; [Anonymous], 2003, TECHNICAL DOCUMENT N; Iriyama Y, 2002, J PHOTOPOLYM SCI TEC, V15, P299, DOI 10.2494/photopolymer.15.299; Salapare HS, 2013, J COLLOID INTERF SCI, V396, P287, DOI 10.1016/j.jcis.2012.12.072; Borcia C, 2009, IEEE T PLASMA SCI, V37, P941, DOI 10.1109/TPS.2009.2014637; Borra JP, 2012, PLASMA PROCESS POLYM, V9, P1104, DOI 10.1002/ppap.201100210; Cernakova L, 2005, PLASMA CHEM PLASMA P, V25, P427, DOI 10.1007/s11090-004-3137-4; INAGAKI N, 1981, J APPL POLYM SCI, V26, P3333, DOI 10.1002/app.1981.070261014; Kim Kwan-Do, 2012, Transactions on Electrical and Electronic Materials, V13, P93, DOI 10.4313/TEEM.2012.13.2.93; Konig U, 2002, COLLOID SURFACE B, V24, P63, DOI 10.1016/S0927-7765(01)00247-8; Kuroki T, 2014, IEEE T IND APPL, V50, P45, DOI 10.1109/TIA.2013.2271742; Lappan U, 1999, POLYMER, V40, P4087, DOI 10.1016/S0032-3861(98)00647-8; Okubo M, 2008, J PHOTOPOLYM SCI TEC, V21, P219, DOI 10.2494/photopolymer.21.219; Okubo M, 2010, IEEE T IND APPL, V46, P1715, DOI 10.1109/TIA.2010.2057492; Okubo M, 2008, J ELECTROSTAT, V66, P381, DOI 10.1016/j.elstat.2008.03.003; Okubo M, 2008, THIN SOLID FILMS, V516, P6592, DOI 10.1016/j.tsf.2007.11.033; Roth J. R., 2001, IND PLASMA ENG APPL, P383; Sun HY, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2208270; Teng HX, 2012, APPL SCI-BASEL, V2, P496, DOI 10.3390/app2020496	23	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-9994	1939-9367		IEEE T IND APPL	IEEE Trans. Ind. Appl.	MAY-JUN	2015	51	3					2497	2503		10.1109/TIA.2014.2365111		7	Engineering, Multidisciplinary; Engineering, Electrical & Electronic	Engineering	CI7LJ	WOS:000354944600059		
J	Pistohl, T; Joshi, D; Ganesh, G; Jackson, A; Nazarpour, K				Pistohl, Tobias; Joshi, Deepak; Ganesh, Gowrishankar; Jackson, Andrew; Nazarpour, Kianoush			Artificial Proprioceptive Feedback for Myoelectric Control	IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING			English	Article						Electromyogram signal; proprioceptive feedback; sensorimotor integration	MACHINE-INTERFACE CONTROL; FOREARM PROSTHESES; SENSORY FEEDBACK; HAND; VIBROTACTILE; ADAPTATION; INFORMATION; SENSATION; AMPUTEES; TASK	The typical control of myoelectric interfaces, whether in laboratory settings or real-life prosthetic applications, largely relies on visual feedback because proprioceptive signals from the controlling muscles are either not available or very noisy. We conducted a set of experiments to test whether artificial proprioceptive feedback, delivered noninvasively to another limb, can improve control of a two-dimensional myoelectrically-controlled computer interface. In these experiments, participants were required to reach a target with a visual cursor that was controlled by electromyogram signals recorded from muscles of the left hand, while they were provided with an additional proprioceptive feedback on their right arm by moving it with a robotic manipulandum. Provision of additional artificial proprioceptive feedback improved the angular accuracy of their movements when compared to using visual feedback alone but did not increase the overall accuracy quantified with the average distance between the cursor and the target. The advantages conferred by proprioception were present only when the proprioceptive feedback had similar orientation to the visual feedback in the task space and not when it was mirrored, demonstrating the importance of congruency in feedback modalities for multi-sensory integration. Our results reveal the ability of the human motor system to learn new inter-limb sensory-motor associations; the motor system can utilize task-related sensory feedback, even when it is available on a limb distinct from the one being actuated. In addition, the proposed task structure provides a flexible test paradigm by which the effectiveness of various sensory feedback and multi-sensory integration for myoelectric prosthesis control can be evaluated.	[Pistohl, Tobias; Jackson, Andrew; Nazarpour, Kianoush] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Joshi, Deepak] Graph Era Univ, Dept Elect & Elect Engn, Dehra Dun 248002, Uttar Pradesh, India; [Ganesh, Gowrishankar] CNRS AIST JRL Joint Robot Lab, UMI3218, CRT, Intelligent Syst Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Ganesh, Gowrishankar] Ctr Informat & Neural Networks CINET NICT, Osaka 5650871, Japan; [Nazarpour, Kianoush] Newcastle Univ, Sch Elect & Elect Engn, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Pistohl, T (reprint author), Univ Freiburg, Bernstein Ctr Freiburg, D-79085 Freiburg, Germany.	kianoush.nazarpour@ncl.ac.uk		Jackson, Andrew/0000-0001-8701-6387	Leverhulme Trust [RPG-128]; Wellcome Trust [086561]; Medical Research Council, U.K. [G0802195]	Manuscript received May 23, 2014; revised July 23, 2014; accepted August 27, 2014. Date of publication September 09, 2014; date of current version May 06, 2015. This work was supported by The Leverhulme Trust (RPG-128). The work of A. Jackson was supported by a Wellcome Trust Career Development Fellow (086561). The work of K. Nazarpour was supported by The Medical Research Council, U.K. (G0802195).	Nazarpour K, 2012, J NEUROSCI, V32, P12349, DOI 10.1523/JNEUROSCI.5481-11.2012; Brown LE, 2003, J NEUROPHYSIOL, V90, P3105, DOI 10.1152/jn.00013.2003; Marasco PD, 2011, BRAIN, V134, P747, DOI 10.1093/brain/awq361; Suminski AJ, 2010, J NEUROSCI, V30, P16777, DOI 10.1523/JNEUROSCI.3967-10.2010; Williams I, 2013, IEEE T BIOMED CIRC S, V7, P129, DOI 10.1109/TBCAS.2013.2256906; Witteveen HJB, 2012, IEEE T BIO-MED ENG, V59, P2219, DOI 10.1109/TBME.2012.2200678; Pipereit K, 2006, EXP BRAIN RES, V174, P45, DOI 10.1007/s00221-006-0417-7; Pistohl T, 2013, ANN BIOMED ENG, V41, P2687, DOI 10.1007/s10439-013-0876-5; Witteveen HJB, 2014, IEEE T NEUR SYS REH, V22, P53, DOI 10.1109/TNSRE.2013.2267394; Panarese A, 2009, IEEE T NEUR SYS REH, V17, P560, DOI 10.1109/TNSRE.2009.2021689; HARRIS CS, 1963, SCIENCE, V140, P812, DOI 10.1126/science.140.3568.812; Dhillon GS, 2005, IEEE T NEUR SYS REH, V13, P468, DOI 10.1109/TNSRE.2005.856072; Farina D, 2014, IEEE T NEUR SYS REH, V22, P797, DOI 10.1109/TNSRE.2014.2305111; Radhakrishnan SM, 2008, J NEUROPHYSIOL, V100, P2397, DOI 10.1152/jn.90614.2008; Antfolk C, 2013, IEEE T NEUR SYS REH, V21, P112, DOI 10.1109/TNSRE.2012.2217989; Antuvan CW, 2014, IEEE T NEUR SYS REH, V22, P820, DOI 10.1109/TNSRE.2014.2302212; Howard IS, 2009, J NEUROSCI METH, V181, P199, DOI 10.1016/j.jneumeth.2009.05.005; Scheidt RA, 2005, J NEUROPHYSIOL, V93, P3200, DOI 10.1152/jn.00947.2004; Wheeler J, 2010, IEEE T NEUR SYS REH, V18, P58, DOI 10.1109/TNSRE.2009.2039602; Blank A., 2010, ACM T APPL PERCEPT, V7; Cipriani C., 2007, IEEE T BIOMED ENG, V56, P2739; Cipriani C, 2014, IEEE T NEUR SYS REH, V22, P828, DOI 10.1109/TNSRE.2014.2301234; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P582; Hebert JS, 2014, IEEE T NEUR SYS REH, V22, P765, DOI 10.1109/TNSRE.2013.2294907; Makin JG, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003035; Mann R. W., 1968, P I MECH ENG, V183, P86; Mon-Williams S. M., 1997, P BIOL SCI, V264, P1007; Pistohl T., 2013, P IEEE EMBC, P1595; Ramos-Murguialday A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047048; Saunders I, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-60; Sherrington C. S., 1906, INTEGRATIVE ACTION N; Thorp EB, 2014, IEEE T NEUR SYS REH, V22, P62, DOI 10.1109/TNSRE.2013.2273177; TILLERY SIH, 1991, J NEUROSCI, V11, P770	33	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1534-4320	1558-0210		IEEE T NEUR SYS REH	IEEE Trans. Neural Syst. Rehabil. Eng.	MAY	2015	23	3					498	507		10.1109/TNSRE.2014.2355856		10	Engineering, Biomedical; Rehabilitation	Engineering; Rehabilitation	CI0YW	WOS:000354467200018		
J	Kadota, M; Tanaka, S				Kadota, Michio; Tanaka, Shuji			Ultra-Wideband Ladder Filter Using SH0 Plate Wave in Thin LiNbO3 Plate and Its Application to Tunable Filter	IEEE TRANSACTIONS ON ULTRASONICS FERROELECTRICS AND FREQUENCY CONTROL			English	Article								A cognitive radio terminal using vacant frequency bands of digital TV (DTV) channels, i.e., TV white space, strongly requires a compact tunable filter covering a wide frequency range of the DTV band (470 to 710 MHz in Japan). In this study, a T-type ladder filter using ultra-wideband shear horizontal mode plate wave resonators was fabricated, and a low peak insertion loss of 0.8 dB and an ultra-large 6 dB bandwidth of 240 MHz (41%) were measured in the DTV band. In addition, bandpass filters with different center frequencies of 502 and 653 MHz at 6 dB attenuation were numerically synthesized based on the same T-type ladder filter in conjunction with band rejection filters with different frequencies. The results suggest that the combination of the wideband T-type ladder filter and the band rejection filters connected with variable capacitors enables a tunable filter with large tunability of frequency and bandwidth as well as large rejection at the adjacent channels of an available TV white space.	[Kadota, Michio; Tanaka, Shuji] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 9808579, Japan	Kadota, M (reprint author), Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 9808579, Japan.	mkadota@mems.mech.tohoku.ac.jp			Ministry of Internal Affairs and Communications of Japan	We thank Mr. Y. Kuratani and Mr. T. Kimura at Murata Manufacturing Co., Ltd., for useful discussion, and Dr. Y. Hori and Mr. T. Tai at NGK Insulators, Ltd., for their support. This research was supported by the Ministry of Internal Affairs and Communications of Japan under the Strategic Information and Communications R & D Promotion Programme (SCOPE).	Kadota M, 2010, IEEE T ULTRASON FERR, V57, P2564, DOI 10.1109/TUFFC.2010.1722; [Anonymous], 2013, 80211AF2013 IEEE; Kadota M, 2005, JPN J APPL PHYS 1, V44, P4285, DOI 10.1143/JJAP.44.4285; Kadota M, 2013, IEEE T ULTRASON FERR, V60, P2129, DOI 10.1109/TUFFC.2013.2803; Hirano H, 2014, 2014 IEEE INTERNATIONAL ULTRASONICS SYMPOSIUM (IUS), P803, DOI 10.1109/ULTSYM.2014.0197; Harada H., 2008, IEICE B, V91, P1320; Kadota M, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.07HD26; Kadota M., 2015, 139 M 150 COMM AC WA, P10; Kadota M, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.07KD03; Kadota M., 2011, P IEEE ULTR S, P559; Kadota M, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.07HD04; Kadota M., 2013, P IEEE ULTRASON S, P1668; Kadota M, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.07HD11; Kadota M., 2011, IEEJ T, V131, P1108; Kadota M., 2012, 2012 AUT M C DIV I E, P5; Komatsu T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.07HD24; Matsumura T., 2013, IEICE T A, V96, P292	17	2	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0885-3010	1525-8955		IEEE T ULTRASON FERR	IEEE Trans. Ultrason. Ferroelectr. Freq. Control	MAY	2015	62	5					939	946		10.1109/TUFFC.2014.006845		8	Acoustics; Engineering, Electrical & Electronic	Acoustics; Engineering	CI0UV	WOS:000354455100014		
J	Yang, B; Chen, Y; Cai, Y; Jiang, XH				Yang, Bin; Chen, Yin; Cai, Ying; Jiang, Xiaohong			Packet Delivery Ratio/Cost in MANETs With Erasure Coding and Packet Replication	IEEE TRANSACTIONS ON VEHICULAR TECHNOLOGY			English	Article						Ad hoc networks; erasure coding; packet replication; routing protocol	DELAY TOLERANT NETWORKS; HOC MOBILE NETWORKS; LARGE-SCALE MANETS; WIRELESS NETWORKS; CAPACITY; SELFISHNESS; TRADEOFFS; IMPACT; WALK	This paper studies the performance of a general two-hop relay (2HR)-(x, w, f) packet delivery scheme that combines both erasure coding and packet replication techniques in mobile ad hoc networks (MANETs). Under this packet delivery scheme, a group of x packets is first encoded into w(w >= x) coded packets using erasure coding, and each coded packet is then replicated to at most f distinct relay nodes that can help to forward the coded packets to its destination node. The original packets can be recovered when x distinct coded packets reach the destination node. To understand the packet delivery process under the 2HR-(x, w, f) scheme, we develop a multidimensional Markov chain framework, and based on this analytical expressions on the packet delivery ratio and corresponding expected packet delivery cost are further derived. Finally, extensive simulation and numerical studies are conducted to illustrate the efficiency of the developed theoretical models and to illustrate our findings. Our results indicate that the replication parameter f should be carefully selected in order to obtain a high packet-delivery-ratio performance while maintaining a relatively low delivery cost.	[Yang, Bin; Chen, Yin; Jiang, Xiaohong] Future Univ Hakodate, Sch Syst Informat Sci, Hakodate, Hokkaido 0418655, Japan; [Yang, Bin] Chuzhou Univ, Sch Comp & Informat Engn, Chuzhou 239012, Peoples R China; [Cai, Ying] Beijing Informat Sci & Technol Univ, Beijing Key Lab Internet Culture & Digital Dissem, Beijing 100101, Peoples R China; [Cai, Ying] Chinese Acad Sci, State Key Lab Informat Secur, Inst Informat Engn, Beijing 100093, Peoples R China	Yang, B (reprint author), Future Univ Hakodate, Sch Syst Informat Sci, Hakodate, Hokkaido 0418655, Japan.	yangbinchi@gmail.com; ychen1986@gmail.com; ycai@bistu.edu.cn; jiang@fun.ac.jp			JSPS of Japan [24300026]; NSF of China [61472057]; Anhui Education Department [KJ2014A179]; NSF of Chuzhou University [2012kj002Z]; Talented Team of Computer System Architecture	This work was supported in part by the JSPS of Japan Grant 24300026, the NSF of China Grant 61472057, Anhui Education Department Grant KJ2014A179, the NSF of Chuzhou University Grant 2012kj002Z, and the Talented Team of Computer System Architecture. The review of this paper was coordinated by Prof. C. Zhang.	Altman E, 2013, IEEE T WIREL COMMUN, V12, P725, DOI 10.1109/TWC.2012.122212.120196; Altman E., 2010, P IEEE INFOCOM, P1; Gupta P, 2000, IEEE T INFORM THEORY, V46, P388, DOI 10.1109/18.825799; Li Y, 2014, IEEE T INTELL TRANSP, V15, P318, DOI 10.1109/TITS.2013.2281104; Cai Y, 2014, WIREL NETW, V20, P525, DOI 10.1007/s11276-013-0617-6; Altman E, 2011, IEEE ACM T NETWORK, V19, P1, DOI 10.1109/TNET.2010.2091968; Panichpapiboon S, 2012, IEEE COMMUN SURV TUT, V14, P784, DOI 10.1109/SURV.2011.070711.00131; Zhang C, 2009, IEEE J SEL AREA COMM, V27, P662, DOI 10.1109/JSAC.2009.090608; [Anonymous], 2013, 2013 IEEEC INT C; Li Y, 2011, IEEE T VEH TECHNOL, V60, P2224, DOI 10.1109/TVT.2011.2149552; Zhang C, 2009, IEEE INFOCOM SER, P199, DOI 10.1109/INFCOM.2009.5061922; Lee K, 2012, IEEE ACM T NETWORK, V20, P515, DOI 10.1109/TNET.2011.2172984; Li P, 2012, IEEE T MOBILE COMPUT, V11, P2073, DOI 10.1109/TMC.2011.239; Goldsmith A, 2011, IEEE COMMUN MAG, V49, P195, DOI 10.1109/MCOM.2011.5762818; Li P, 2012, IEEE T MOBILE COMPUT, V11, P427, DOI 10.1109/TMC.2011.54; Kong ZN, 2012, IEEE T INFORM THEORY, V58, P6894, DOI 10.1109/TIT.2012.2208573; Neely MJ, 2005, IEEE T INFORM THEORY, V51, P1917, DOI 10.1109/TIT.2005.847717; Chen Y, 2013, AD HOC NETW, V11, P1122, DOI 10.1016/j.adhoc.2012.12.003; Haenggi M., 2009, INTERFERENCE LARGE W; James A, 2013, IEEE T VEH TECHNOL, V62, P4379, DOI 10.1109/TVT.2013.2265279; Li Y, 2010, IEEE COMMUN LETT, V14, P1026, DOI 10.1109/LCOMM.2010.093010.100492; Liu J., 20130201 TOH U; Liu JJ, 2011, IEEE T WIREL COMMUN, V10, P2738, DOI 10.1109/TWC.2011.062111.101976; Pellegrini F. D., 2013, P WIOPT, P580; Yang B., 2014, 20140629 FUT U HAK; Yang B, 2013, 2013 IEEE/CIC INTERNATIONAL CONFERENCE ON COMMUNICATIONS IN CHINA (ICCC), P651	26	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9545	1939-9359		IEEE T VEH TECHNOL	IEEE Trans. Veh. Technol.	MAY	2015	64	5					2062	2070		10.1109/TVT.2014.2362355		9	Engineering, Electrical & Electronic; Telecommunications; Transportation Science & Technology	Engineering; Telecommunications; Transportation	CI1AR	WOS:000354472800033		
J	Sugiura, S; Hanzo, L				Sugiura, Shinya; Hanzo, Lajos			Frequency-Domain-Equalization-Aided Iterative Detection of Faster-than-Nyquist Signaling	IEEE TRANSACTIONS ON VEHICULAR TECHNOLOGY			English	Article						Extrinsic information transfer (EXIT) chart; faster-than-Nyquist signaling (FTNS); frequency-domain equalization (FDE); iterative detection; single-carrier transmission; soft-output detection; turbo coding	BAND WIRELESS SYSTEMS; CONCATENATED CODES; MIMO CHANNELS; INFORMATION; CHART; DESIGN	A reduced-complexity three-stage-concatenated faster-than-Nyquist signaling (FTNS)-based transceiver architecture is proposed, which operates with the aid of soft decision (SoD) frequency-domain equalization (FDE) at the receiver. More specifically, the decoding algorithm conceived allows us to attain near-capacity performance as an explicit benefit of iterative detection, which is capable of eliminating the intersymbol interference imposed by FTNS. The proposed SoD FDE-aided FTNS detector has low decoding complexity that linearly increases upon increasing the FTNS block length and, hence, is particularly beneficial for practical long-dispersion scenarios. Furthermore, extrinsic information transfer charts are utilized for designing a near-capacity three-stage-concatenated turbo FTNS system, which exhibits an explicit turbo cliff in the low-signal-to-noise-ratio region, hence outperforming its conventional two-stage-concatenated FTNS counterpart.	[Sugiura, Shinya] Tokyo Univ Agr & Technol, Dept Comp & Informat Sci, Tokyo 1838538, Japan; [Hanzo, Lajos] Univ Southampton, Sch Elect & Comp Sci, Southampton SO17 1BJ, Hants, England	Sugiura, S (reprint author), Tokyo Univ Agr & Technol, Dept Comp & Informat Sci, Tokyo 1838538, Japan.	sugiura@ieee.org; lh@ecs.soton.ac.uk	Sugiura, Shinya/A-5358-2013		Adaptable and Seamless Technology Transfer Program (A-STEP) from the Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science (JSPS) [KAKENHI 26630170]	This work was supported in part by the Adaptable and Seamless Technology Transfer Program (A-STEP) from the Japan Science and Technology Agency (JST) and in part by a Grant-in-Aid for Scientific Research under Grant KAKENHI 26630170 from the Japan Society for the Promotion of Science (JSPS). The review of this paper was coordinated by Prof. S.-H. Leung.	Anderson J. B., 2012, Proceedings of the 2012 IEEE International Symposium on Information Theory - ISIT, DOI 10.1109/ISIT.2012.6283937; Ng B, 2007, IEEE T WIREL COMMUN, V6, P759, DOI 10.1109/TWC.2007.05439; Kansanen K, 2007, IEEE T WIREL COMMUN, V6, P59, DOI 10.1109/TWC.2007.05172; Prlja A, 2012, IEEE T COMMUN, V60, P2591, DOI 10.1109/TCOMM.2012.070912.110296; Benedetto S, 1998, IEEE T INFORM THEORY, V44, P909, DOI 10.1109/18.669119; El-Hajjar M, 2014, IEEE COMMUN SURV TUT, V16, P127, DOI 10.1109/SURV.2013.050813.00137; Rusek F, 2008, IEEE T COMMUN, V56, P808, DOI 10.1109/TCOMM.2008.060075; Rusek F, 2009, IEEE T COMMUN, V57, P1329, DOI 10.1109/TCOMM.2009.05.070224; MAZO JE, 1975, AT&T TECH J, V54, P1451; Liu SM, 2004, IEEE T SIGNAL PROCES, V52, P721, DOI 10.1109/TSP.2003.822376; Anderson JB, 2013, P IEEE, V101, P1817, DOI 10.1109/JPROC.2012.2233451; Falconer D, 2002, IEEE COMMUN MAG, V40, P58, DOI 10.1109/35.995852; ten Brink S, 2001, IEEE T COMMUN, V49, P1727, DOI 10.1109/26.957394; Colavolpe G, 2011, OPT EXPRESS, V19, P26600, DOI 10.1364/OE.19.026600; Brannstrom F, 2005, IEEE T INFORM THEORY, V51, P3354, DOI 10.1109/TIT.2005.853312; Ashikhmin A, 2004, IEEE T INFORM THEORY, V50, P2657, DOI 10.1109/TIT.2004.836693; Sugiura S, 2012, IEEE COMMUN SURV TUT, V14, P421, DOI 10.1109/SURV.2011.032511.00136; ten Brink S, 2000, AEU-INT J ELECTRON C, V54, P389; Prlja A, 2008, 2008 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY PROCEEDINGS, VOLS 1-6, P464, DOI 10.1109/ISIT.2008.4595029; Schreckenbach F, 2006, EUR T TELECOMMUN, V17, P269, DOI 10.1002/ett.1107; Esch J, 2013, P IEEE, V101, P1815, DOI 10.1109/JPROC.2013.2266459; Hanzo L., 2009, NEAR CAPACITY MULTIF; Liveris AD, 2003, IEEE T COMMUN, V51, P1502, DOI 10.1109/TCOMM.2003.816943; McGuire M., 2010, P IEEE GLOB TEL C, P1; Rusek F, 2009, IEEE T WIREL COMMUN, V8, P1118, DOI 10.1109/TWC.2009.080193; Sugiura S., 2002, IEEE COMMUN MAG, V40, P58; Tuchler M, 2002, IEEE T SIGNAL PROCES, V50, P673, DOI 10.1109/78.984761; Xu L, 2008, IEEE T WIREL COMMUN, V7, P2039, DOI 10.1109/TWC.2008.070071	28	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9545	1939-9359		IEEE T VEH TECHNOL	IEEE Trans. Veh. Technol.	MAY	2015	64	5					2122	2128		10.1109/TVT.2014.2336984		8	Engineering, Electrical & Electronic; Telecommunications; Transportation Science & Technology	Engineering; Telecommunications; Transportation	CI1AR	WOS:000354472800039		
J	Hashiguchi, M; Kashiwakura, Y; Kojima, H; Kobayashi, A; Kanno, Y; Kobata, T				Hashiguchi, Masaaki; Kashiwakura, Yuji; Kojima, Hidefumi; Kobayashi, Ayano; Kanno, Yumiko; Kobata, Tetsuji			Peyer's patch innate lymphoid cells regulate commensal bacteria expansion	IMMUNOLOGY LETTERS			English	Article						Peyer's patch; Innate lymphoid cell; Commensal bacteria; IL-22	ROR-GAMMA-T; ARYL-HYDROCARBON RECEPTOR; EPITHELIAL-CELLS; NKP46(+) CELLS; GUT MICROBIOTA; INTERLEUKIN-22; DRIVES; INFLAMMATION; HOMEOSTASIS; TISSUES	Anatomical containment of commensal bacteria in the intestinal mucosa is promoted by innate lymphoid cells (ILCs). However, the mechanism by which ILCs regulate bacterial localization to specific regions remains unknown. Here we show that Peyer's patch (PP) ILCs robustly produce IL-22 and IFN-gamma in the absence of exogenous stimuli. Antibiotic treatment of mice decreased both IL-22(+) and IFN-gamma(+) cells in PPs. Blockade of both IL-2 and IL-23 signaling in vitro lowered IL-22 and IFN-gamma production. PP ILCs induced mRNA expression of the antibacterial proteins RegIII beta and RegIII gamma in intestinal epithelial cells. Furthermore, in vivo depletion of ILCs rather than T cells altered bacterial composition and allowed bacterial proliferation in PPs. Collectively, our results show that ILCs regulate the expansion of commensal bacteria in PPs. (C) 2015 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.	[Hashiguchi, Masaaki; Kashiwakura, Yuji; Kojima, Hidefumi; Kobayashi, Ayano; Kanno, Yumiko; Kobata, Tetsuji] Dokkyo Med Univ, Sch Med, Dept Immunol, Mibu, Tochigi 3210293, Japan	Hashiguchi, M (reprint author), Dokkyo Med Univ, Sch Med, Dept Immunol, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan.	mhashi@dokkyomed.ac.jp			Japan Society for the Promotion of Science [24580196]; Minato Seki Foundation	We are grateful to Drs. Hiroyuki Hosokawa and Toshinori Nakayama (Chiba University) for providing reagents; Ms. Yasuko Nonaka for cell sorting; Mr. Takashi Namatame for DNA sequencing; Dr. Masahiko Itoh for information on epithelial cell preparation; the staff of the Laboratory Animal Research Center, Dokkyo Medical University, for maintenance of mice; and Ms. Yoshie Nitta for secretarial assistance. This study was supported by a Grant-in-aid from the Japan Society for the Promotion of Science (24580196) and by a grant from the Minato Seki Foundation.	Ikutani M, 2012, J IMMUNOL, V188, P703, DOI 10.4049/jimmunol.1101270; Serafini N, 2014, J EXP MED, V211, P199, DOI 10.1084/jem.20131038; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Van Maele L, 2014, J INFECT DIS, V210, P493, DOI 10.1093/infdis/jiu106; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Roulis M, 2011, P NATL ACAD SCI USA, V108, P5396, DOI 10.1073/pnas.1007811108; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Alam MS, 2010, P NATL ACAD SCI USA, V107, P5943, DOI 10.1073/pnas.0911755107; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Weiss GA, 2014, BRIT J NUTR, V111, P1602, DOI 10.1017/S0007114513004200; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Reynders A, 2011, EMBO J, V30, P2934, DOI 10.1038/emboj.2011.201; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Hashiguchi M, 2011, IMMUNOL LETT, V141, P109, DOI 10.1016/j.imlet.2011.09.001; Eken A, 2014, MUCOSAL IMMUNOL, V7, P143, DOI 10.1038/mi.2013.33; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Hwang YY, 2013, ADV EXP MED BIOL, V785, P9, DOI 10.1007/978-1-4614-6217-0_2; Fujihashi K, 2001, P NATL ACAD SCI USA, V98, P3310, DOI 10.1073/pnas.061412598; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Kuraoka M, 2004, EUR J IMMUNOL, V34, P1920, DOI 10.1002/eji.200324696; Mabbott NA, 2013, MUCOSAL IMMUNOL, V6, P666, DOI 10.1038/mi.2013.30; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Littman DR, 2011, CELL HOST MICROBE, V10, P311, DOI 10.1016/j.chom.2011.10.004; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Obata T, 2010, P NATL ACAD SCI USA, V107, P7419, DOI 10.1073/pnas.1001061107; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Zenewicz LA, 2008, EUR J IMMUNOL, V38, P3265, DOI 10.1002/eji.200838655; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Kirchberger S, 2013, J EXP MED, V210, P917, DOI 10.1084/jem.20122308; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Hill DA, 2010, ANNU REV IMMUNOL, V28, P623, DOI 10.1146/annurev-immunol-030409-101330; Debard N, 1999, SEMIN IMMUNOL, V11, P183, DOI 10.1006/smim.1999.0174; MCCLELLAND DBL, 1976, SCAND J IMMUNOL, V5, P909, DOI 10.1111/j.1365-3083.1976.tb03041.x; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288	44	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-2478	1879-0542		IMMUNOL LETT	Immunol. Lett.	MAY	2015	165	1					1	9		10.1016/j.imlet.2015.03.002		9	Immunology	Immunology	CI8PY	WOS:000355035400001		
J	Aoyagi, M; Hiraguri, T; Ueno, T				Aoyagi, M.; Hiraguri, T.; Ueno, T.			Observation of powder and particles in a container by pulsed thermography	INSIGHT			English	Article							CRACK DETECTION; CONDUCTION; EXCITATION	We propose a technique for observing a granular substance, such as a powder or particles, in a container, where the characteristics of a transient decrease in temperature on the surface of the container are monitored by thermography following momentary heating of the surface of the container by a light flash. This technique is a type of non-destructive inspection employing pulsed thermography. We investigate the observation of polypropylene balls and ceramic balls in a polyvinyl chloride container and an aluminium container, and also demonstrate the observation technique using copper powder and wheat flour in a copper container and a paper container in addition to the containers described above. The proposed technique is successful in observing the polypropylene balls, ceramic balls, copper powder and wheat flour in the polyvinyl chloride and paper containers. However, the technique cannot clearly observe any of the substances in an aluminium or copper container because of the rapid homogenisation of the surface temperature distribution on the metal container by facile heat diffusion in the plane direction within the metal plate. We expect this non-contact observation technique to be useful for material control, product inspection and product analysis in manufacturing.	[Aoyagi, M.; Hiraguri, T.; Ueno, T.] Nippon Inst Technol, Dept Elect & Elect Engn, Saitama 3458501, Japan	Aoyagi, M (reprint author), Nippon Inst Technol, Dept Elect & Elect Engn, 4-1 Gakuendai, Saitama 3458501, Japan.	aoyagi_minoru@yahoo.co.jp; hira@nit.ac.jp; ueno@nit.ac.jp					Burrows SE, 2011, NDT&E INT, V44, P589, DOI 10.1016/j.ndteint.2011.06.001; Oswald-Tranta B, 2007, NONDESTRUCT TEST EVA, V22, P137, DOI 10.1080/10589750701448225; Aoyagi M, 2014, INSIGHT NONDESTRUCTI, V56, P1; Aoyagi M, 2013, INSIGHT, V55, P10, DOI 10.1784/insi.2012.55.1.10; Bejan A., 2003, HEAT TRANSFER HDB; Bently JP, 1995, PRINCIPLES MEASUREME; Doeblin E. O., 1990, MEASUREMENT SYSTEM A, V4<SUP>th</SUP>; Holman J. P., 2009, HEAT TRANSFER; Li T, 2011, NDT&E INT, V44, P216, DOI 10.1016/j.ndteint.2010.08.006; Liptak B G, 2003, PROCESS MEASUREMENT; Mizu T, 2009, FOOD SCI TECHNOL RES, V15, P217, DOI 10.3136/fstr.15.217; Rantala J, 1998, NDT&E INT, V31, P43, DOI 10.1016/S0963-8695(97)00021-2; Reynolds W N, 1985, CAN J PHYS, V64, P1150; Shepard SM, 2006, INSIGHT, V48, P298, DOI 10.1784/insi.2006.48.5.298; Zenzinger G, 2007, NONDESTRUCT TEST EVA, V22, P101, DOI 10.1080/10589750701447920	15	0	0	BRITISH INST NON-DESTRUCTIVE TESTING	NORTHAMPTON	1 SPENCER PARADE, NORTHAMPTON NN1 5AA, NORTHANTS, ENGLAND	1354-2575	1754-4904		INSIGHT	Insight	MAY	2015	57	5					269	275		10.1784/insi.2015.57.5.269		7	Instruments & Instrumentation; Materials Science, Characterization & Testing	Instruments & Instrumentation; Materials Science	CI6LH	WOS:000354870200006		
J	Fischer, S; Itoh, M; Inagaki, T				Fischer, Sandrine; Itoh, Makoto; Inagaki, Toshiyuki			Screening Prototype Features in Terms of Intuitive Use: Design Considerations and Proof of Concept	INTERACTING WITH COMPUTERS			English	Article						Intuitive use; Interaction design theory, concepts, and paradigms; Quantitative methods; User studies; Graphical user interfaces	HUMAN COGNITIVE ARCHITECTURE; MENTAL-MODEL; KNOWLEDGE; INFORMATION; TEXT; INSTRUCTION; PERFORMANCE; EXPERTISE; METAPHORS; EVOLUTION	Graphical interface use involves schemata operations that range from transfer to induction. The former apply existing knowledge, such as prior schemata, and are effortless, preconscious and intuitive. The latter, which consist in constructing new schemata, are resource-consuming and thus detrimental to intuitive use (IU). A quantitative method is proposed to manipulate and screen schemata operations at the level of an interface's states and features. Relevance for the design cycle of innovative interfaces is critically reviewed, and integration with existing intuitive-use design frameworks is proposed. These considerations are built upon instructional design studies suggesting that assessment should precede and inform the application of design techniques geared toward IU.	[Fischer, Sandrine; Itoh, Makoto; Inagaki, Toshiyuki] Univ Tsukuba, Dept Risk Engn, Lab Cognit Syst Sci, Adv Res Lab, Tsukuba, Ibaraki 3058573, Japan	Fischer, S (reprint author), Univ Tsukuba, Dept Risk Engn, Lab Cognit Syst Sci, Adv Res Lab, B 0826,1-1-1 Tennoudai, Tsukuba, Ibaraki 3058573, Japan.	fischer@css.risk.tsukuba.ac.jp			G-COE Cybernics Program in the University of Tsukuba	The present research was supported by the G-COE Cybernics Program in the University of Tsukuba.	Yeung AS, 1998, CONTEMP EDUC PSYCHOL, V23, P1, DOI 10.1006/ceps.1997.0951; Camp G, 2001, COMPUT HUM BEHAV, V17, P575, DOI 10.1016/S0747-5632(01)00028-0; Gentner D, 2003, J EDUC PSYCHOL, V95, P393, DOI 10.1037/0022-0663.95.2.393; Chalmers PA, 2003, COMPUT HUM BEHAV, V19, P593, DOI 10.1016/S0747-5632(02)00086-9; Gentner D, 1998, COGNITION, V65, P263, DOI 10.1016/S0010-0277(98)00002-X; Borgman CL, 1999, INT J HUM-COMPUT ST, V51, P435, DOI 10.1006/ijhc.1985.0318; Kelley K, 2012, PSYCHOL METHODS, V17, P137, DOI 10.1037/a0028086; GICK ML, 1980, COGNITIVE PSYCHOL, V12, P306, DOI 10.1016/0010-0285(80)90013-4; van Merrienboer JJG, 2005, EDUC PSYCHOL REV, V17, P147, DOI 10.1007/s10648-005-3951-0; Kalyuga S, 2007, EDUC PSYCHOL REV, V19, P509, DOI 10.1007/s10648-007-9054-3; Ozgungor S, 2004, J EDUC PSYCHOL, V96, P437, DOI 10.1037/0022-0663.96.3.437; CHI MTH, 1981, COGNITIVE SCI, V5, P121, DOI 10.1207/s15516709cog0502_2; McNamara DS, 1996, COGNITION INSTRUCT, V14, P1, DOI 10.1207/s1532690xci1401_1; Kalyuga S, 2000, J EDUC PSYCHOL, V92, P126, DOI 10.1037/0022-0663.92.1.126; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; GICK ML, 1983, COGNITIVE PSYCHOL, V15, P1, DOI 10.1016/0010-0285(83)90002-6; McNamara DS, 2004, J EXP PSYCHOL LEARN, V30, P465, DOI 10.1037/0278-7393.30.2.465; Pollock E, 2002, LEARN INSTR, V12, P61, DOI 10.1016/S0959-4752(01)00016-0; Sweller J, 2003, PSYCHOL LEARN MOTIV, V43, P215, DOI 10.1016/S0079-7421(03)01015-6; Mugge R, 2012, APPL ERGON, V43, P1081, DOI 10.1016/j.apergo.2012.03.009; Sweller J, 2004, INSTR SCI, V32, P9, DOI 10.1023/B:TRUC.0000021808.72598.4d; McNamara DS, 2001, CAN J EXP PSYCHOL, V55, P51, DOI 10.1037/h0087352; HINTZMAN DL, 1986, PSYCHOL REV, V93, P411, DOI 10.1037//0033-295X.93.4.411; REBER AS, 1989, J EXP PSYCHOL GEN, V118, P219, DOI 10.1037//0096-3445.118.3.219; Blackler A., 2004, DES 2004 8 INT DES C; Blackler A., 2007, MMI INTERAKT, V1, pS36; Blackler A, 2010, APPL ERGON, V41, P72, DOI 10.1016/j.apergo.2009.04.010; Blackler A., 2011, IASDR2011 4 WORLD C; Blackler A., 2014, INT J DES SCI TECHNO, V20, P7; Blackler A., 2007, DEV TESTING METHODOL; Blackler A.L., 2008, INTUITIVE INTERACTIO; Ceret E, 2013, INFORM SOFTWARE TECH, V55, P795, DOI 10.1016/j.infsof.2012.11.002; Chalmers P.A., 2003, MEMORY, V11, P233; Chi M. T. H., 1982, ADV PSYCHOL HUMAN IN, V1, P7; Cohen J., 1988, STAT POWER ANAL BEHA; Epstein S., 1999, DUAL PROCESS THEORIE; Fischer S, 2010, ETUDE DIAGNOSTIQUE I; Fischer S., 2014, EUR J AUTOM, V48, P319; Fischer S., 2009, P 1 INT C AUT US INT, P35, DOI 10.1145/1620509.1620516; Fischer S, 2015, APPL ERGON, V46, P8, DOI 10.1016/j.apergo.2014.05.010; FURNAS GW, 1987, COMMUN ACM, V30, P964, DOI 10.1145/32206.32212; Gudur R.R., 2013, LECT NOTES COMPUTER, V2013, P564; Hammond K. R., 1996, HUMAN JUDGMENT SOCIA; Hsu YC, 2005, INTERACT COMPUT, V17, P367, DOI 10.1016/j.intcom.2005.01.006; Hsu YC, 2006, INTERACT COMPUT, V18, P770, DOI 10.1016/j.intcom.2005.10.008; Hurtienne J, 2013, UNIVERSAL ACCESS INF, V12, P297, DOI 10.1007/s10209-013-0296-1; Hurtienne J., 2009, IMAGE SCHEMAS DESIGN; HYDE TS, 1973, J VERB LEARN VERB BE, V12, P471, DOI 10.1016/S0022-5371(73)80027-1; Lawry S., 2010, DES RES SOC INT C 20; Loeffler D., 2013, P 27 INT BCS HUM COM; MAYER RE, 1976, J EDUC PSYCHOL, V68, P143, DOI 10.1037//0022-0663.68.2.143; Mayer R.E, 1999, DOCUMENT DESIGN, V1, P7, DOI 10.1075/dd.1.1.02may; MAYER RE, 1980, J EDUC PSYCHOL, V72, P770; Mayer R.E., 2001, MULTIMEDIA LEARNING; McGough James J, 2009, Psychiatry (Edgmont), V6, P21; McNamara D.S., 1996, DISCOURSE PROCESS, V22, P246; Mohs C., 2006, INTUITIVITAT DEFINIE, P215; Naito M., 2004, JPN J PERSON, V13, P67, DOI [10.2132/personality.13.67, DOI 10.2132/PERSONALITY.13.67]; Naumann A., 2010, MOBILEHCI 10 LISB, P401; O'Brien M.A., 2012, ACM T ACCESSIBLE COM, V4; O'Brien M.A., 2010, HFATR1001 GEORG I TE; PEPER RJ, 1986, J EDUC PSYCHOL, V78, P34, DOI 10.1037/0022-0663.78.1.34; Posner M.I., 1975, ATT COGN CONTR INF P; RAUTERBERG M, 1993, ERGONOMICS, V36, P1369, DOI 10.1080/00140139308968006; Reber A.S., 1967, J VERB LEARN VERB BE, V6, P863; Reddy G.R., 2009, P IASDR 2009 RIG REL, P209; Rumelhart D.E., 1977, REPRESENTATION KNOWL, P99; Rumelhart D.E., 1978, ACCRETION TUNING RES, P37; Sweller J, 2003, ED PSYCH, V38, P23; Van Merrienboer J. J. G., 1997, TRAINING COMPLEX COG	70	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0953-5438	1873-7951		INTERACT COMPUT	Interact. Comput.	MAY	2015	27	3			SI		256	270		10.1093/iwc/iwv002		15	Computer Science, Cybernetics; Ergonomics	Computer Science; Engineering	CI4BQ	WOS:000354691800004		
J	Tanaka, H; Minatoya, K; Sasaki, H; Seike, Y; Itonaga, T; Oda, T; Kobayashi, J				Tanaka, Hiroshi; Minatoya, Kenji; Sasaki, Hiroaki; Seike, Yoshimasa; Itonaga, Tatsuya; Oda, Tatsuya; Kobayashi, Junjiro			Recent thoraco-abdominal aortic repair outcomes using moderate-to-deep hypothermia combined with targeted reconstruction of the Adamkiewicz artery	INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY			English	Article						Thoraco-abdominal aorta; Hypothermia; Spinal cord protection	MAGNETIC-RESONANCE ANGIOGRAPHY; CIRCULATORY ARREST; PREOPERATIVE DEMONSTRATION; ANEURYSM REPAIR; PROTECTION; PERFUSION; MORTALITY; SAFETY	OBJECTIVES: We retrospectively reviewed the surgical results of thoraco-abdominal aortic repair using moderate-to-deep hypothermia combined with targeted reconstruction of the Adamkiewicz artery (AKA). METHODS: Between 2006 and 2014, 100 patients underwent thoraco-abdominal aortic aneurysm repair using moderate-to-deep hypothermia. Their mean age was 58 +/- 15 years and 76 (76%) were men. Their aortic pathologies included acute dissection (5), chronic dissection (74), degeneration (20) and infection (1). Thirty-four had connective tissue disorders and 5 had emergency operations. The degrees of repair were Crawford extent I for 11, II for 76 and III for 13. Seven had concomitant arch repair. Preoperative magnetic resonance angiography or computed tomographic angiography was performed to detect the AKA in 95. We used deep hypothermia (18 degrees C) for those requiring open proximal aortic anastomosis for cerebral protection and moderate hypothermia (25 degrees C) for those not requiring open proximal aortic anastomosis. RESULTS: Two patients had spinal cord injuries and 4 had a stroke. For those in whom the AKA was identified (90%), all had targeted artery reconstruction. The mean pairs of reconstructed intercostal arteries were 1.5 +/- 0.7. There were 5 in-hospital deaths for which the causes were lung bleeding (2), infection (2) and iliac aneurysm rupture (1). Temporary dialysis for new-onset renal failure was required for 9. The mean postoperative mechanical ventilation period was 1.7 +/- 1.9 days. Six required a tracheostomy due to respiratory failure. CONCLUSIONS: Moderate-to-deep hypothermia combined with targeted reconstruction of the AKA provided satisfactory outcomes with thoraco-abdominal aortic repair, particularly for spinal cord protection.	[Tanaka, Hiroshi; Minatoya, Kenji; Sasaki, Hiroaki; Seike, Yoshimasa; Itonaga, Tatsuya; Oda, Tatsuya; Kobayashi, Junjiro] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan	Tanaka, H (reprint author), Natl Cerebral & Cardiovasc Ctr, 5-7-1 Fujishirodai, Suita, Osaka, Japan.	hirtanak@hsp.ncvc.go.jp	Kobayashi, Junjiro/J-8547-2015				Adamkiewicz AA, 1882, SITZ AKAD WISS WI MN, V85, P101; Andersen Nicholas D, 2014, Ann Cardiothorac Surg, V3, P264, DOI 10.3978/j.issn.2225-319X.2014.05.07; Kawaharada N, 2002, EUR J CARDIO-THORAC, V21, P970, DOI 10.1016/S1010-7940(02)00097-0; Etz CD, 2011, J THORAC CARDIOV SUR, V141, P1020, DOI 10.1016/j.jtcvs.2010.06.023; Rigberg DA, 2006, J VASC SURG, V43, P217, DOI 10.1016/j.jvs.2005.10.070; Etz CD, 2009, EUR J CARDIO-THORAC, V36, P946, DOI 10.1016/j.ejcts.2009.05.046; Massoni CB, 2014, J VASC SURG, V59, P1265, DOI 10.1016/j.jvs.2013.11.064; Yamada N, 2000, EUR J CARDIO-THORAC, V18, P104, DOI 10.1016/S1010-7940(00)00412-7; Yoshioka K, 2006, RADIOGRAPHICS, V26, pS63, DOI 10.1148/rg.26si065506; Kouchoukos NT, 2013, J THORAC CARDIOV SUR, V145, pS139, DOI 10.1016/j.jtcvs.2012.11.077; ROHRER MJ, 1992, CRIT CARE MED, V20, P1402, DOI 10.1097/00003246-199210000-00007; Ogino H, 2006, ANN THORAC SURG, V82, P592, DOI 10.1016/j.athoracsur.2006.03.041; Kamiya H, 2007, J THORAC CARDIOV SUR, V133, P501, DOI 10.1016/j.jtcvs.2006.09.045; Safi HJ, 2003, ANN SURG, V238, P372, DOI 10.1097/01.sla.0000086664.90571.7a; Yoshioka K, 2010, EUR J CARDIO-THORAC, V37, P1234, DOI 10.1016/j.ejcts.2009.11.044; Coselli JS, 2010, J THORAC CARDIOV SUR, V140, pS147, DOI 10.1016/j.jtcvs.2010.07.038; Coselli JS, 2007, ANN THORAC SURG, V83, pS862, DOI 10.1016/j.athoracsur.2006.10.088; Fehrenbacher JW, 2010, J THORAC CARDIOV SUR, V140, pS154, DOI 10.1016/j.jtcvs.2010.08.054; Kouchoukos NT, 2001, ANN THORAC SURG, V72, P699, DOI 10.1016/S0003-4975(01)02800-4; Masuda M, 2014, GEN THORAC CARDIOVAS, V62, P734; Mazzeffi Michael, 2012, Ann Card Anaesth, V15, P266, DOI 10.4103/0971-9784.101855; Tanaka H, 2014, INTERACT CARDIOV TH, V19, P205, DOI 10.1093/icvts/ivu148; Zhao H, 2007, J NEUROSURG, V107, P636, DOI 10.3171/JNS-07/09/0636	23	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1569-9293	1569-9285		INTERACT CARDIOV TH	Interact Cardiovasc. Thorac. Surg.	MAY	2015	20	5					605	610		10.1093/icvts/ivv013		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CI5LO	WOS:000354798000007		
J	Maniwa, T; Kondo, H; Mori, K; Sato, T; Teramukai, S; Ebina, M; Kishi, K; Watanabe, A; Sugiyama, Y; Date, H				Maniwa, Tomohiro; Kondo, Haruhiko; Mori, Keita; Sato, Toshihiko; Teramukai, Satoshi; Ebina, Masahito; Kishi, Kazuma; Watanabe, Atsushi; Sugiyama, Yukihiko; Date, Hiroshi			Outcomes in surgically managed non-small-cell lung cancer patients with evidence of interstitial pneumonia identified on preoperative radiology or incidentally on postoperative histology	INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY			English	Article						Lung cancer; Interstitial lung disease; Acute exacerbation	IDIOPATHIC PULMONARY-FIBROSIS; ACUTE EXACERBATION; DISEASE; RESECTION; ABNORMALITIES; PREDICTION; IMPACT	OBJECTIVES: Although some interstitial pneumonia (IP) cases are not detected on computed tomography (CT) before surgery, they are confirmed by pathological diagnosis after pulmonary resection. In the present study, we aimed to investigate patients who underwent pulmonary resection for non-small-cell lung cancer (NSCLC) and subsequently showed pathological findings of IP but no apparent interstitial changes on CT. METHODS: We retrospectively analysed 1688 patients with NSCLC who underwent pulmonary resection and presented with a radiological or pathological diagnosis of IP in 64 institutions between January 2000 and December 2009. We compared 135 patients without radiological findings but with pathological findings of IP (Group A) with 1553 patients with radiological findings of IP (Group B). RESULTS: The percent vital capacity and predicted diffusing capacity for carbon monoxide were higher in Group A than in Group B. Although there was no significant difference in the occurrence of acute exacerbation (AE) between both groups, the mortality after AE in Group A was significantly lower than that in Group B. The overall survival rates of patients in Groups A and B at 5 years were 59.1 and 40.9%, respectively (P = 0.0031). CONCLUSIONS: The mortality after AE in patients with only pathological findings of IP was significantly lower than in those with radiological findings of IP. Moreover, the patients with only pathological findings of IP had a better prognosis than those with radiological findings of IP. Thus, our findings suggest that patients with pathological findings of IP and without radiological abnormality had early-stage IP.	[Maniwa, Tomohiro] Shizuoka Canc Ctr, Dept Thorac Surg, Nagaizumi, Shizuoka, Japan; [Kondo, Haruhiko] Kyorin Univ, Sch Med, Dept Thorac Surg, Tokyo, Japan; [Mori, Keita] Shizuoka Canc Ctr, Clin Trial Coordinat Off, Shizuoka, Japan; [Sato, Toshihiko; Date, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Thorac Surg, Kyoto, Japan; [Teramukai, Satoshi] Kyoto Prefectural Univ Med, Dept Biostat, Kyoto, Japan; [Ebina, Masahito] Tohoku Pharmaceut Univ Hosp, Resp Ctr, Dept Resp Med, Sendai, Miyagi, Japan; [Kishi, Kazuma] Toranomon Gen Hosp, Resp Ctr, Dept Resp Med, Tokyo, Japan; [Watanabe, Atsushi] Sapporo Med Univ, Sch Med & Hosp, Dept Thorac Surg, Sapporo, Hokkaido, Japan; [Sugiyama, Yukihiko] Jichi Med Univ, Dept Pulm Med, Shimotsuke, Tochigi, Japan	Maniwa, T (reprint author), Shizuoka Canc Ctr, Dept Thorac Surg, 1007 Shimonagakubo, Nagaizumi, Shizuoka, Japan.	to.maniwa@scchr.jp					Doyle TJ, 2012, AM J RESP CRIT CARE, V185, P756, DOI 10.1164/rccm.201109-1618OC; Kumar P, 2003, J THORAC CARDIOV SUR, V125, P1321, DOI 10.1016/S0022-5223(03)00028-X; Hyzy R, 2007, CHEST, V132, P1652, DOI 10.1378/chest.07-0299; Park JS, 2011, THORAC CARDIOV SURG, V59, P148, DOI 10.1055/s-0030-1250644; Washko GR, 2011, NEW ENGL J MED, V364, P897, DOI 10.1056/NEJMoa1007285; Tsushima K, 2010, RESP MED, V104, P1712, DOI 10.1016/j.rmed.2010.05.014; Sato T, 2014, J THORAC CARDIOV SUR, V147, P1604, DOI 10.1016/j.jtcvs.2013.09.050; Lederer DJ, 2009, AM J RESP CRIT CARE, V180, P407, DOI 10.1164/rccm.200812-1966OC; Watanabe A, 2008, J THORAC CARDIOV SUR, V136, P1357, DOI 10.1016/j.jtcvs.2008.07.016; Ohnishi H, 2002, AM J RESP CRIT CARE, V165, P378; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Doyle TJ, 2012, AM J RESP CRIT CARE, V185, P1147, DOI 10.1164/rccm.201108-1420PP; Chiyo M, 2003, J THORAC CARDIOV SUR, V126, P1141, DOI 10.1016/S0022-5223(03)00791-8; Fujimoto D, 2013, LUNG CANCER, V80, P159, DOI 10.1016/j.lungcan.2013.01.017; Kashiwabara K, 2006, CHEST, V129, P402, DOI 10.1378/chest.129.2.402; Kohno N, 1994, Int J Cancer Suppl, V8, P81; Maniwa T, 2013, SURG TODAY, V43, P408, DOI 10.1007/s00595-012-0428-x; Muraoka M, 2006, EUR J CARDIO-THORAC, V30, P657, DOI 10.1016/j.ejcts.2006.06.020; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Saito H, 2011, EUR J CARDIO-THORAC, V39, P190, DOI 10.1016/j.ejcts.2010.05.017; The Japanese Respiratory Society, 2011, ID INT PNEUM DIAGN T; Wells AU, 1997, AM J RESP CRIT CARE, V155, P1367; Yamashita M, 2009, HUM PATHOL, V40, P542, DOI 10.1016/j.humpath.2008.06.031; Yoshimura K, 1984, Nihon Kyobu Shikkan Gakkai Zasshi, V22, P1012	24	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1569-9293	1569-9285		INTERACT CARDIOV TH	Interact Cardiovasc. Thorac. Surg.	MAY	2015	20	5					641	646		10.1093/icvts/ivv021		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CI5LO	WOS:000354798000013		
J	Suda, T; Tochii, D; Tochii, S; Takagi, Y				Suda, Takashi; Tochii, Daisuke; Tochii, Sachiko; Takagi, Yasushi			Trans-subxiphoid robotic thymectomy	INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY			English	Article						Thymectomy; Minimally invasive surgery; Thoracoscopy/Video assisted thoracic surgery; Robotics		Minimally invasive surgery has replaced median sternotomy for resectable anterior mediastinal masses and is performed by various approaches. We developed a new minimally invasive surgical procedure by combining the subxiphoid approach performed through a midline camera port with the use of a robotic surgery system (Intuitive Surgical, Sunnyvale, CA, USA). A 3-cm transverse incision was made 1 cm below the xiphoid process. Then, a port designed for single-port surgery was inserted. Through this port, CO2 gas was injected at 8 mmHg. The thymus was then detached from the back of the sternum. A 1-cm skin incision was made bilaterally in the sixth intercostal space, followed by insertion of a port for the robotic system. A camera port was inserted into the subxiphoid port, to which the camera scope was mounted, and thymectomy was performed. We have performed the operation in 3 patients. In our experience, this procedure provides a good operative view in the neck region and makes verification of the phrenic nerve easy. Furthermore, with the da Vinci surgical system, which enables surgical manipulation from a correct angle due to the multijoint robotic arms, trans-subxiphoid robotic thymectomy may be a promising new thymectomy procedure.	[Suda, Takashi; Tochii, Daisuke; Tochii, Sachiko; Takagi, Yasushi] Fujita Hlth Univ, Sch Med, Div Thorac & Cardiovasc Surg, Toyoake, Aichi 4701192, Japan	Suda, T (reprint author), Fujita Hlth Univ, Sch Med, Div Thorac & Cardiovasc Surg, 1-98 Dengakugakubo Kutsukake, Toyoake, Aichi 4701192, Japan.	suda@fujita-hu.ac.jp					Suda T, 2012, ANN THORAC SURG, V93, P334, DOI 10.1016/j.athoracsur.2011.08.047; Cerfolio RJ, 2012, J THORAC CARDIOV SUR, V143, P1138, DOI 10.1016/j.jtcvs.2011.12.021; Detterbeck Frank C, 2012, Innovations (Phila), V7, P161, DOI 10.1097/IMI.0b013e31826145b1; Pennathur A, 2011, J THORAC CARDIOV SUR, V141, P694, DOI 10.1016/j.jtcvs.2010.09.003; Suda Takashi, 2014, Gen Thorac Cardiovasc Surg, V62, P570, DOI 10.1007/s11748-013-0337-y	5	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1569-9293	1569-9285		INTERACT CARDIOV TH	Interact Cardiovasc. Thorac. Surg.	MAY	2015	20	5					669	671		10.1093/icvts/ivv001		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CI5LO	WOS:000354798000022		
J	Hasegawa, T; Oshima, Y; Bitoh, Y; Iwaki, R				Hasegawa, Tomomi; Oshima, Yoshihiro; Bitoh, Yuko; Iwaki, Ryuma			The left anterior extrapleural approach for innominate artery transection in a patient with tracheostomy and a neurological disorder	INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY			English	Article						Left anterior extrapleural approach; Innominate artery transection; Neurological disorder		Although innominate artery transection for innominate artery compression of the trachea is recently used for prevention of life-threatening complications (e.g. massive bleeding and obstructive apnoea) in patients with neurological disorders, pre-existing tracheostomy poses a risk of mediastinal infection with sternotomy. We successfully performed innominate artery transection on such a patient via the left anterior extrapleural approach without sternotomy after confirming the anatomical configuration on three-dimensional multidetector row computed tomography angiography.	[Hasegawa, Tomomi; Oshima, Yoshihiro; Iwaki, Ryuma] Kobe Childrens Hosp, Dept Cardiovasc Surg, Kobe, Hyogo 6540081, Japan; [Bitoh, Yuko] Kobe Childrens Hosp, Dept Pediat Surg, Kobe, Hyogo 6540081, Japan	Hasegawa, T (reprint author), Kobe Childrens Hosp, Dept Cardiovasc Surg, Suma Ku, 1-1-1 Takakuradai, Kobe, Hyogo 6540081, Japan.	tohasegawa_kch@hp.pref.hyogo.jp					Gummert JF, 2002, THORAC CARDIOV SURG, V50, P87, DOI 10.1055/s-2002-26691; Hasegawa T, 2014, EUR J CARDIO-THORAC, V45, P305, DOI 10.1093/ejcts/ezt346; Hasegawa T, 2010, J PEDIATR SURG, V45, pE1, DOI 10.1016/j.jpedsurg.2010.04.003; Olak J, 1996, Chest Surg Clin N Am, V6, P31; YAO JKY, 1969, J CARDIOVASC SURG, V10, P273	5	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1569-9293	1569-9285		INTERACT CARDIOV TH	Interact Cardiovasc. Thorac. Surg.	MAY	2015	20	5					685	686		10.1093/icvts/ivv008		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CI5LO	WOS:000354798000032		
J	Guo, SQ				Guo, Shuqi			Reactive Hot-Pressing and Flexural Strength of ZrB2-ZrCx-Zr-Based Cermets with SiC Additives	INTERNATIONAL JOURNAL OF APPLIED CERAMIC TECHNOLOGY			English	Article							MECHANICAL-PROPERTIES; ZIRCONIUM DIBORIDE; COMPOSITES; OXIDATION; DENSIFICATION; CARBIDE; ZRB2	In this study, ZrB2-ZrCx-Zr cermets with 20 vol% SiC additives were prepared via reactive hot-pressing of Zr+B4C+SiC powder mixtures. Relative density exceeding 95% was obtained for the sintered cermets with 10 vol% excess Zr and without excess Zr. The resulting cermets composed of ZrB2, ZrCx, and SiC primary phases and zirconium silicide secondary phase. The presence of excess Zr improved densification of cermets as well as promoted formation of zirconium silicide. However, excess Zr led to the lowered room temperature flexural strength. The room temperature flexural strength of cermets was in the range of 384.2-409.2MPa.	Natl Inst Mat Sci, Hybrid Mat Unit, Tsukuba, Ibaraki 3050047, Japan	Guo, SQ (reprint author), Natl Inst Mat Sci, Hybrid Mat Unit, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.	guo.shuqi@nims.go.jp			Japan Society for the Promotion of Science (JSPS) [25420722]	This work was partially supported by a Grant-in Aid C (No. 25420722) for Scientific Research from the Japan Society for the Promotion of Science (JSPS).	TRIPP WC, 1973, AM CERAM SOC BULL, V52, P612; Paul A, 2012, AM CERAM SOC BULL, V91, P22; Guo SQ, 2009, J EUR CERAM SOC, V29, P787, DOI 10.1016/j.jeurceramsoc.2008.06.037; Bellosi A, 2006, INT J APPL CERAM TEC, V3, P32, DOI 10.1111/j.1744-7402.2006.02060.x; Rangaraj L, 2010, J EUR CERAM SOC, V30, P129, DOI 10.1016/j.jeurceramsoc.2009.08.003; KURIAKOSE AK, 1964, J ELECTROCHEM SOC, V111, P827, DOI 10.1149/1.2426263; Guo SQ, 2014, J EUR CERAM SOC, V34, P621, DOI 10.1016/j.jeurceramsoc.2013.09.002; Upadhya K, 1997, AM CERAM SOC BULL, V76, P51; Monteverde F, 2006, APPL PHYS A-MATER, V82, P329, DOI 10.1007/s00339-005-3327-9; BERKOWIT.JB, 1966, J ELECTROCHEM SOC, V113, P908, DOI 10.1149/1.2424154; Claar T.D., 1989, CERAM ENG SCI P, V10, P599, DOI 10.1002/9780470310557.ch5; Guo S.Q., 2012, SCRIPTA MATER, V67, P474; Johnson W.B., 1989, CERAM ENG SCI P, V10, P588, DOI 10.1002/9780470310557.ch4; Ondik H. M., 1998, PHASE DIAGRAMS ZIRCO, P423; Rangaraj L, 2010, J EUR CERAM SOC, V30, P3263, DOI 10.1016/j.jeurceramsoc.2010.05.030; Rangaraj L, 2008, METALL MATER TRANS A, V39A, P1496, DOI 10.1007/s11661-008-9500-y; Rezaie A, 2006, J AM CERAM SOC, V89, P3240, DOI 10.1111/j.1551-2916.2006.01229.x; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293; Wuchina E, 2007, Electrochemical Society Interface, V16	19	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1546-542X	1744-7402		INT J APPL CERAM TEC	Int. J. Appl. Ceram. Technol.	MAY-JUN	2015	12			2	SI		E152	E158		10.1111/ijac.12271		7	Materials Science, Ceramics	Materials Science	CI2BU	WOS:000354550500021		
J	Gotoda, H; Pradas, M; Kalliadasis, S				Gotoda, Hiroshi; Pradas, Marc; Kalliadasis, Serafim			Nonlinear Forecasting of the Generalized Kuramoto-Sivashinsky Equation	INTERNATIONAL JOURNAL OF BIFURCATION AND CHAOS			English	Article						Spatiotemporal chaos; nonlinear forecasting; pattern formation	SOLITARY PULSES; SPATIOTEMPORAL CHAOS; DISSIPATIVE MEDIA; FALLING FILM; TIME-SERIES; DYNAMICS; SYSTEMS; INSTABILITY; PREDICTION; WAVES	The emergence of pattern formation and chaotic dynamics is studied in the one-dimensional (1D) generalized Kuramoto-Sivashinsky (gKS) equation by means of a time-series analysis, in particular, a nonlinear forecasting method which is based on concepts from chaos theory and appropriate statistical methods. We analyze two types of temporal signals, a local one and a global one, finding in both cases that the dynamical state of the gKS solution undergoes a transition from high-dimensional chaos to periodic pulsed oscillations through low-dimensional deterministic chaos while increasing the control parameter of the system. Our results demonstrate that the proposed nonlinear forecasting methodology allows to elucidate the dynamics of the system in terms of its predictability properties.	[Pradas, Marc; Kalliadasis, Serafim] Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, London SW7 2AZ, England; [Gotoda, Hiroshi] Ritsumeikan Univ, Dept Mech Engn, Kusatsu, Shiga 5258577, Japan	Gotoda, H (reprint author), Ritsumeikan Univ, Dept Mech Engn, Kusatsu, Shiga 5258577, Japan.	s.kalliadasis@imperial.ac.uk			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); JGC-S Scholarship Foundation; European Research Council (ERC) [247031]	We thank Prof. G. A. Pavliotis and Prof. D. T. Papageorgiou for useful comments and suggestions. H. Gotoda thanks the Department of Chemical Engineering of Imperial College for hospitality during a sabbatical visit. He was partially supported by a "Grant-in-Aid for Young Scientists (A)" from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)" and from the JGC-S Scholarship Foundation. We acknowledge financial support from European Research Council (ERC) Advanced Grant No. 247031.	Knobloch E, 2008, NONLINEARITY, V21, pT45, DOI 10.1088/0951-7715/21/4/T02; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; Munkel M, 1996, PHYSICA D, V98, P156, DOI 10.1016/0167-2789(96)00095-4; SMYRLIS YS, 1991, P NATL ACAD SCI USA, V88, P11129, DOI 10.1073/pnas.88.24.11129; Gotoda H, 2011, CHAOS, V21, DOI 10.1063/1.3563577; Krumscheid S, 2013, MULTISCALE MODEL SIM, V11, P442, DOI 10.1137/110854485; Pradas M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.060602; Hanias MP, 2010, CHAOS, V20, DOI 10.1063/1.3293133; Gotoda H, 2012, CHAOS, V22, DOI 10.1063/1.4731267; Houghton SM, 2010, PHYS LETT A, V374, P2030, DOI 10.1016/j.physleta.2010.02.078; Kassam AK, 2005, SIAM J SCI COMPUT, V26, P1214, DOI 10.1137/S1064827502410633; KURAMOTO Y, 1976, PROG THEOR PHYS, V55, P356, DOI 10.1143/PTP.55.356; Gotoda H, 2012, CHAOS, V22, DOI 10.1063/1.4766589; Pradas M, 2012, EUR J APPL MATH, V23, P563, DOI 10.1017/S0956792512000125; ABARBANEL HDI, 1993, REV MOD PHYS, V65, P1331, DOI 10.1103/RevModPhys.65.1331; LAQUEY RE, 1975, PHYS REV LETT, V34, P391, DOI 10.1103/PhysRevLett.34.391; Gotoda H, 2013, J APPL PHYS, V113, DOI 10.1063/1.4795264; SIVASHINSKY GI, 1980, PROG THEOR PHYS, V63, P2112, DOI 10.1143/PTP.63.2112; Schmuck M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.244101; Rempel EL, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056217; Kalliadasis S, 2003, J FLUID MECH, V492, P303, DOI 10.1017/S0022112003005809; Duprat C, 2011, CHEM ENG PROCESS, V50, P519, DOI 10.1016/j.cep.2010.10.004; HOOPER AP, 1985, PHYS FLUIDS, V28, P37, DOI 10.1063/1.865160; VERGASSOLA M, 1993, J PHYS A-MATH GEN, V26, P6093, DOI 10.1088/0305-4470/26/22/012; Elder KR, 1997, PHYS REV E, V56, P1631, DOI 10.1103/PhysRevE.56.1631; TSONIS AA, 1992, NATURE, V358, P217, DOI 10.1038/358217a0; CASDAGLI M, 1989, PHYSICA D, V35, P335, DOI 10.1016/0167-2789(89)90074-2; Trevelyan PMJ, 2004, PHYS FLUIDS, V16, P3191, DOI 10.1063/1.1767834; CHANG HC, 1993, PHYSICA D, V63, P299, DOI 10.1016/0167-2789(93)90113-F; Maggs JE, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.185003; Slingo J, 2011, PHILOS T R SOC A, V369, P4751, DOI 10.1098/rsta.2011.0161; Ruyer-Quil C, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.046302; Tseluiko D, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.016322; GUCKENHEIMER J, 1982, NATURE, V298, P358, DOI 10.1038/298358a0; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; CHANG HC, 1995, J FLUID MECH, V294, P123, DOI 10.1017/S0022112095002837; Chian ACL, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.035203; CAZELLES B, 1992, NATURE, V355, P25, DOI 10.1038/355025b0; SIVASHINSKY GI, 1977, ACTA ASTRONAUT, V4, P1177, DOI 10.1016/0094-5765(77)90096-0; Wittenberg RW, 1999, CHAOS, V9, P452, DOI 10.1063/1.166419; Katul G, 2001, PHYS FLUIDS, V13, P241, DOI 10.1063/1.1324706; Schmuck M, 2015, IMA J APPL MATH, V80, P273, DOI 10.1093/imamat/hxt041; Tseluiko D, 2010, P EST ACAD SCI, V59, P139, DOI 10.3176/proc.2010.2.12; Bian CH, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.021906; Sato M, 1998, PHYS REV LETT, V80, P4233, DOI 10.1103/PhysRevLett.80.4233; Zunino L, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.046210; Rempel EL, 2003, PHYS LETT A, V319, P104, DOI 10.1016/j.physleta.2003.10.004; KAWAHARA T, 1983, PHYS REV LETT, V51, P381, DOI 10.1103/PhysRevLett.51.381; Gotoda H, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.026211; Gao JB, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.066204; Baek SJ, 2004, CHAOS, V14, P1042, DOI 10.1063/1.1788091; EI S, 1994, PHYS REV E, V50, P4672, DOI 10.1103/PhysRevE.50.4672; Misbah C, 1996, PHYS REV E, V53, pR4318; Aragon JL, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.026201; BABCHIN AJ, 1983, PHYS FLUIDS, V26, P3159, DOI 10.1063/1.864083; BALMFORTH NJ, 1995, ANNU REV FLUID MECH, V27, P335; Biagini F, 2008, PROBAB APPL SER, P1; COULLET P, 1985, PHYS REV LETT, V55, P2857, DOI 10.1103/PhysRevLett.55.2857; Duprat C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.234501; FRASER AM, 1986, PHYS REV A, V33, P1134, DOI 10.1103/PhysRevA.33.1134; HOMSY G. M., 1974, LECT APPL MATH, V15, P191; Kalliadasis S, 2012, APPL MATH SCI, V176, P1, DOI 10.1007/978-1-84882-367-9; Lauritsen KB, 1996, PHYS REV E, V54, P3577, DOI 10.1103/PhysRevE.54.3577; Malomed A, 1992, PHYS REV A, V45, P1009; MANDELBR.BB, 1968, SIAM REV, V10, P422, DOI 10.1137/1010093; Manneville P., 1985, LECT NOTES PHYS, V230; Nicoli M, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.045202; Patil DJ, 2001, PHYS REV LETT, V86, P5878, DOI 10.1103/PhysRevLett86.5878; Pradas M, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3572061; Pradas M, 2012, IMA J APPL MATH, V77, P408, DOI 10.1093/imamat/hxs028; Rosso OA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.154102; Sato M, 1995, EUROPHYS LETT, V32, P639, DOI 10.1209/0295-5075/32/8/004; Shen J, 2011, SPR SER COMPUT MATH, V41, P1, DOI 10.1007/978-3-540-71041-7; SUGIHARA G, 1990, NATURE, V344, P734, DOI 10.1038/344734a0; Takens F., 1981, LECT NOTES MATH, V898; Tseluiko D, 2010, PHYSICA D, V239, P2000, DOI 10.1016/j.physd.2010.07.011; Tseluiko D, 2014, IMA J APPL MATH, V79, P274, DOI 10.1093/imamat/hxs064	77	1	1	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0218-1274	1793-6551		INT J BIFURCAT CHAOS	Int. J. Bifurcation Chaos	MAY	2015	25	5							1530015	10.1142/S0218127415300153		18	Mathematics, Interdisciplinary Applications; Multidisciplinary Sciences	Mathematics; Science & Technology - Other Topics	CI8IE	WOS:000355015000002		
J	Yuan, HR; Deng, LF; Qi, YJ; Kobayashi, N; Hasatani, M				Yuan, Haoran; Deng, Lifang; Qi, Yujie; Kobayashi, Noriyuki; Hasatani, Masanobu			Morphology-dependent Performance of Nanostructured MnO2 as an Oxygen Reduction Catalyst in Microbial Fuel Cells	INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE			English	Article						Hydrothermal; Nanostructured manganese dioxide; Electrochemical oxygen-reduction activity; Cathode catalyst; Microbial fuel cell	MANGANESE-DIOXIDE; CATHODIC CATALYST; ELECTRICITY-GENERATION; NANOTUBES; OXIDE; SUPERCAPACITORS; MECHANISM; ELECTRODE	Different nanostructures (nanoflowers, nanorods and nanotubes) of manganese dioxide (MnO2) were successfully synthesized using hydrothermal methods with different dwell times and were demonstrated to be efficient and stable cathode catalysts for the oxygen reduction reaction (ORR). Subsequent examination of these nanostructures using field-emission scanning electron microscopy and transmission electron microscopy revealed a strong correlation between the dwell time and the resulting morphology of the nanostructures and confirmed the successful synthesis of nanotubes. The electrocatalytic activities of the different nanostructures were investigated using cyclic voltammetry and linear sweep voltammetry, and the results indicated that all of the MnO2 nanostructures can catalyze the ORR with different catalytic activities. The nanotubes appeared to possess the highest catalytic activity, with a more positive peak potential and a larger ORR peak current. Additionally, a maximum power density of 11.6 W/m(3) was produced by the microbial fuel cell (MFC) with the nanotube cathode, which was higher than that of the other nanostructures and comparable to that of Pt/C (14.1 W/m(3)). The results of this study demonstrate that nanotubes are ideal crystal structures for MnO2 and that they offer a good alternative to Pt/C for practical MFC applications.	[Yuan, Haoran; Deng, Lifang; Qi, Yujie] Chinese Acad Sci, Guangzhou Inst Energy Convers, Guangzhou 510640, Guangdong, Peoples R China; [Yuan, Haoran; Deng, Lifang; Qi, Yujie] Chinese Acad Sci, Key Lab Renewable Energy, Guangzhou 510640, Guangdong, Peoples R China; [Kobayashi, Noriyuki; Hasatani, Masanobu] Nagoya Univ, EcoTopia Sci Inst, Nagoya, Aichi 4648603, Japan	Yuan, HR (reprint author), Chinese Acad Sci, Guangzhou Inst Energy Convers, Guangzhou 510640, Guangdong, Peoples R China.	denglf@ms.giec.ac.cn			National 973 project of China [2011CB201501]; Projects of International Cooperation and Exchanges NSFC [51161140330]; Knowledge Innovation Program of the Chinese Academy of Sciences [NKSCX2-EW-G-1-5]; Program of Guangdong Province - Chinese Academy of sciences strategic cooperation [2010A090100035]	We gratefully acknowledge financial support from the National 973 project of China (2011CB201501), Projects of International Cooperation and Exchanges NSFC (51161140330), Knowledge Innovation Program of the Chinese Academy of Sciences (NKSCX2-EW-G-1-5), and The Program of Guangdong Province - Chinese Academy of sciences strategic cooperation (2010A090100035).	Liu XW, 2010, WATER RES, V44, P5298, DOI 10.1016/j.watres.2010.06.065; Antonopoulou G, 2010, BIOCHEM ENG J, V50, P10, DOI 10.1016/j.bej.2010.02.008; Lu M, 2012, CRIT REV ENV SCI TEC, V42, P2504, DOI 10.1080/10643389.2011.592744; Roche I, 2010, J APPL ELECTROCHEM, V40, P13, DOI 10.1007/s10800-009-9957-4; Logan BE, 2009, NAT REV MICROBIOL, V7, P375, DOI 10.1038/nrmicro2113; Li X, 2011, BIOCHEM ENG J, V54, P10, DOI 10.1016/j.bej.2011.01.001; Ahn Y, 2010, BIORESOURCE TECHNOL, V101, P469, DOI 10.1016/j.biortech.2009.07.039; Tang Q, 2003, J CRYST GROWTH, V259, P208, DOI 10.1016/S0022-0248(03)01590-2; Chang IS, 2005, BIOSENS BIOELECTRON, V20, P1856, DOI 10.1016/j.bios.2004.06.003; Wang X, 2003, CHEM-EUR J, V9, P300, DOI 10.1002/chem.200390024; Martin E, 2010, BIOCHEM ENG J, V51, P132, DOI 10.1016/j.bej.2010.06.006; Jang JK, 2004, PROCESS BIOCHEM, V39, P1007, DOI 10.1016/S0032-9592(03)00203-6; Zhang YP, 2011, J POWER SOURCES, V196, P9284, DOI 10.1016/j.jpowsour.2011.07.069; Chen YF, 2012, J POWER SOURCES, V201, P136, DOI 10.1016/j.jpowsour.2011.10.134; Chen YC, 2011, ELECTROCHIM ACTA, V56, P7124, DOI 10.1016/j.electacta.2011.05.090; Zheng DS, 2005, J PHYS CHEM B, V109, P16439, DOI 10.1021/jp0523701; Lu M, 2011, BIOSENS BIOELECTRON, V26, P4728, DOI 10.1016/j.bios.2011.05.036; Li X, 2010, J POWER SOURCES, V195, P2586, DOI 10.1016/j.jpowsour.2009.10.084; Zhang LX, 2009, BIOSENS BIOELECTRON, V24, P2825, DOI 10.1016/j.bios.2009.02.010; Truong TT, 2012, ACS NANO, V6, P8067, DOI 10.1021/nn302654p; Hou Y, 2010, NANO LETT, V10, P2727, DOI 10.1021/nl101723g; Subramanian V, 2006, J POWER SOURCES, V159, P361, DOI 10.1016/j.jpowsour.2006.04.012; Zhang X, 2013, ELECTROCHIM ACTA, V87, P637, DOI 10.1016/j.electacta.2012.10.022; Luo J, 2008, J PHYS CHEM C, V112, P12594, DOI 10.1021/jp8052967; Donne SW, 2010, J POWER SOURCES, V195, P367, DOI 10.1016/j.jpowsour.2009.06.103; Chen M, 2002, J MATER CHEM, V12, P748, DOI 10.1039/b105652m; Deng LF, 2010, CHINESE SCI BULL, V55, P99, DOI 10.1007/s11434-009-0563-y; Gnana kumar G., 2014, ACS SUS CHEM ENG, V53, P528; Gnana kumar G., 2013, IND ENG CHEM RES, V43, P461; Jia C. J., 2005, ANGEW CHEM, V117, P4402, DOI 10.1002/ange.200463038; Kalubarme R.S., 2011, NANOTECHNOLOGY, V22, P395; Mahmoud M, 2011, BIORESOURCE TECHNOL, V102, P10459, DOI 10.1016/j.biortech.2011.08.123; Xiao W., 2009, J PHYS CHEM C, V114, P1694; Yuan H. R., 2014, SCI WORLD, V2014, P1; Zhang X, 2010, J NANOSCI NANOTECHNO, V10, P898, DOI 10.1166/jnn.2010.1893	35	0	0	ESG	BELGRADE	BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA	1452-3981			INT J ELECTROCHEM SC	Int. J. Electrochem. Sci.	MAY	2015	10	5					3693	3706				14	Electrochemistry	Electrochemistry	CI5GK	WOS:000354782200001		
J	Marin, AV; Aguirre, MJ; Muena, JP; Dehaen, W; Maes, W; Ngo, TH; Ramirez, G; Arevalo, MC				Marin, A., V; Aguirre, M. J.; Muena, J. P.; Dehaen, W.; Maes, W.; Ngo, Thien H.; Ramirez, G.; Arevalo, M. C.			Electro-reduction of Oxygen to Water Mediated by Stable Glassy Carbon Electrodes Modified by Co(II)-porphyrins with Voluminous Meso-Substituent	INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE			English	Article						Co-porphyrins; electro-reduction of oxygen; modified electrodes; oxygen to water reduction; substitution pattern	COBALT PORPHYRINS; ELECTROCATALYTIC REDUCTION; IRON TETRAPHENYLPORPHYRIN; GRAPHITE-ELECTRODES; ELECTROPOLYMERIZATION; PHTHALOCYANINE; OXIDATION; DIOXYGEN; BEHAVIOR; ELECTROCHEMISTRY	Glassy carbon electrodes were modified by physisorption of two different Co(II)-porphyrins, specifically designed and synthesized to study the effect of the substitution pattern (and the resulting steric hindrance) on the electrocatalytic behavior for a characteristic inner-sphere reaction such as the reduction of oxygen. In spite of the change in morphology caused by a change in the relative positions of the meso substituents, they showed practically the same behavior toward the electro-reduction of O-2. In both cases, water was obtained as the main product. The modified electrodes were also active toward the electro-reduction of hydrogen peroxide. Both electrodes were found stable for more than a month upon exposure to air and the current for the electro-reduction remained practically the same.	[Marin, A., V] Univ Tarapaca, Fac Ingn Ind Inform & Sistemas, Arica, Chile; [Aguirre, M. J.; Muena, J. P.] Univ Santiago Chile, Fac Quim & Biol, Dept Quim Mat, Estn Cent, Santiago, Chile; [Dehaen, W.; Maes, W.; Ngo, Thien H.] Katholieke Univ Leuven, Dept Chem, Mol Design & Synth, B-3001 Leuven, Belgium; [Maes, W.] Hasselt Univ, Inst Mat Res IMO IMOMEC, DSOS, B-3590 Diepenbeek, Belgium; [Ngo, Thien H.] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton MANA, ICYS, Tsukuba, Ibaraki 3050044, Japan; [Ramirez, G.] Pontificia Univ Catolica Chile, Fac Quim, Dept Quim Inorgan, Santiago, Chile; [Arevalo, M. C.] Univ La Laguna, Fac Quim, Dept Quim Fis, Tenerife 38071, Spain	Marin, AV (reprint author), Univ Tarapaca, Fac Ingn Ind Inform & Sistemas, Av Gen Velasquez 1775, Arica, Chile.	maria.aguirre@usach.cl; carevalo@ull.es			CONICYT (Chile); Fondecyt [1120071, 1120049]; FWO (Fund for Scientific Research - Flanders); Ministerie voor Wetenschapsbeleid; IWT (Institute for the Promotion of Innovation through Science and Technology in Flanders); Alexander von Humboldt Foundation	A.M.V kindly acknowledges CONICYT (Chile) for a doctoral fellowship. M.J.A and J.P. Muena acknowledges Fondecyt (1120071), Mecesup and Dicyt projects. G.R. acknowledges Fondecyt project (1120049). W. Maes, T. H. Ngo and W. Dehaen thank the FWO (Fund for Scientific Research - Flanders), the KU Leuven and the Ministerie voor Wetenschapsbeleid for continuing financial support. T. H. Ngo further acknowledges the IWT (Institute for the Promotion of Innovation through Science and Technology in Flanders) and the Alexander von Humboldt Foundation for a doctoral and postdoctoral fellowship, respectively.	Peljo P, 2011, INT J HYDROGEN ENERG, V36, P10033, DOI 10.1016/j.ijhydene.2011.05.042; Song EH, 1998, LANGMUIR, V14, P4315, DOI 10.1021/la980084d; Jeong H, 2004, MICROCHEM J, V78, P181, DOI 10.1016/j.microc.2004.04.005; COLLMAN JP, 1980, J AM CHEM SOC, V102, P6027, DOI 10.1021/ja00539a009; SHI CN, 1990, INORG CHEM, V29, P4298, DOI 10.1021/ic00346a027; Choi A, 2008, ELECTROCHIM ACTA, V53, P2579, DOI 10.1016/j.electacta.2007.10.029; WOLBERG A, 1970, J AM CHEM SOC, V92, P2982, DOI 10.1021/ja00713a010; Chlistunoff J, 2014, J PHYS CHEM C, V118, P19139, DOI 10.1021/jp5044249; Anson FC, 1997, ACCOUNTS CHEM RES, V30, P437, DOI 10.1021/ar960264j; Li Y, 2012, CHEM-EUR J, V18, P7372, DOI 10.1002/chem.201200191; BONNETT R, 1965, J ORG CHEM, V30, P2791, DOI 10.1021/jo01019a070; Morozan A, 2011, CARBON, V49, P4839, DOI 10.1016/j.carbon.2011.07.004; Zhu SF, 2008, J AM CHEM SOC, V130, P5042, DOI 10.1021/ja7106838; COLLMAN JP, 1994, ANGEW CHEM INT EDIT, V33, P1537, DOI 10.1002/anie.199415371; Lokesh KS, 2012, MOLECULES, V17, P7824, DOI 10.3390/molecules17077824; Vengatesan S, 2012, KOREAN J CHEM ENG, V29, P621, DOI 10.1007/s11814-011-0225-z; Sun B, 2014, INORG CHEM, V53, P8600, DOI 10.1021/ic501210t; Blanco MJ, 2000, ORG LETT, V2, P3051, DOI 10.1021/ol006137b; Bruti EM, 1999, ELECTROANAL, V11, P565, DOI 10.1002/(SICI)1521-4109(199906)11:8<565::AID-ELAN565>3.0.CO;2-V; Cardoso WS, 2005, J ELECTROANAL CHEM, V583, P300, DOI 10.1016/j.jelechem.2005.06.015; Cheuquepan W, 2010, J CHIL CHEM SOC, V55, P253, DOI 10.4067/S0717-97072010000200024; Cornejo G, 2003, J CHIL CHEM SOC, V48, P49; Goya MC, 2011, INT J ELECTROCHEM SC, V6, P4984; Imahori H., 2000, P ELECTROCHEM SOC, P60; Isaacs M, 1998, ELECTROCHIM ACTA, V43, P1821, DOI 10.1016/S0013-4686(97)00314-9; Knoll J, 2009, INORG CHIM ACTA, V362, P2989, DOI 10.1016/j.ica.2009.01.028; Kozub BR, 2010, SENSOR ACTUAT B-CHEM, V147, P350, DOI 10.1016/j.snb.2010.02.062; Mazloum-Ardakani M, 2007, ELECTROANAL, V19, P2258, DOI 10.1002/elan.200704006; Paulus J., 2001, ELECTROANAL CHEM, V495, P134; Ramirez G, 2001, BOL SOC CHIL QUIM, V46, P247; Sarapuu A, 2010, ELECTROCHIM ACTA, V55, P6376, DOI 10.1016/j.electacta.2010.06.055; Sousa AL, 2008, TALANTA, V75, P333, DOI 10.1016/j.talanta.2007.10.016; TRUXILLO LA, 1975, ANAL CHEM, V47, P2260, DOI 10.1021/ac60363a052	33	1	1	ESG	BELGRADE	BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA	1452-3981			INT J ELECTROCHEM SC	Int. J. Electrochem. Sci.	MAY	2015	10	5					3949	3960				12	Electrochemistry	Electrochemistry	CI5GK	WOS:000354782200022		
J	Fukuda, I; Nishiumi, S; Mukai, R; Yoshida, K; Ashida, H				Fukuda, Itsuko; Nishiumi, Shin; Mukai, Rie; Yoshida, Ken-ichi; Ashida, Hitoshi			Catechins in tea suppress the activity of cytochrome P450 1A1 through the aryl hydrocarbon receptor activation pathway in rat livers	INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION			English	Article						Aryl hydrocarbon receptor; catechin; cytochrome P450 1As; tea	ACCELERATES DIOXIN EXCRETION; DRUG-METABOLIZING-ENZYMES; GREEN TEA; LIQUID-CHROMATOGRAPHY; ETHANOLIC EXTRACTS; OXIDATIVE STRESS; TRANSFORMATION; EXPRESSION; THEAFLAVINS; CELLS	Polycyclic aromatic hydrocarbons (PAHs) and halogenated aromatic hydrocarbons (HAHs) develop various adverse effects through activation of an aryl hydrocarbon receptor (AhR). The suppressive effects of brewed green tea and black tea on 3-methylcholanthrene (MC)-induced AhR activation and its downstream events were examined in the liver of rats. Ad-libitum drinking of green tea and black tea suppressed MC-induced AhR activation and elevation of ethoxyresorufin O-deethylase activity in the liver, whereas the teas themselves did not induce them. Tea showed a suppressive fashion on the expression of cytochrome P450 1A1 (CYP1A1). Tea suppressed the AhR activation induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) ex vivo. A part of catechins and theaflavins was present in plasma and liver as conjugated and intact forms. The results of this study suggested that active component(s) of tea are incorporated in the liver and suppress the activity of CYP1As through the AhR activation pathway.	[Fukuda, Itsuko] Kobe Univ, Grad Sch Agr Sci, Res Ctr Food Safety & Secur, Kobe, Hyogo 6578501, Japan; [Nishiumi, Shin; Mukai, Rie; Yoshida, Ken-ichi; Ashida, Hitoshi] Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Div Appl Chem Biosci, Kobe, Hyogo 6578501, Japan	Ashida, H (reprint author), Kobe Univ, Grad Sch Agr Sci, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	ashida@kobe-u.ac.jp			Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe), MEXT, Japan; Honjo International Scholarship Foundation, Japan	The authors declare no conflict of interest. This study was partially supported by the Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe), MEXT, Japan; and Honjo International Scholarship Foundation, Japan.	Nishiumi S, 2007, ARCH BIOCHEM BIOPHYS, V466, P267, DOI 10.1016/j.abb.2007.08.007; Natsume M, 2003, FREE RADICAL BIO MED, V34, P840, DOI 10.1016/S0891-5849(02)01434-X; Ashida H, 2000, FEBS LETT, V476, P213, DOI 10.1016/S0014-5793(00)01730-0; Han SG, 2012, TOXICOL APPL PHARM, V261, P181, DOI 10.1016/j.taap.2012.03.024; Palermo CM, 2003, CHEM RES TOXICOL, V16, P865, DOI 10.1021/tx025672c; Ciolino HP, 1999, BIOCHEM J, V340, P715, DOI 10.1042/0264-6021:3400715; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Morita K, 1999, J NUTR, V129, P1731; Palermo CM, 2005, BIOCHEMISTRY-US, V44, P5041, DOI 10.1021/bi047433p; Williams SN, 2000, CHEM-BIOL INTERACT, V128, P211, DOI 10.1016/S0009-2797(00)00204-0; SAFE SH, 1994, CRIT REV TOXICOL, V24, P87, DOI 10.3109/10408449409049308; Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693; BURKE MD, 1983, CHEM-BIOL INTERACT, V45, P243; Nakagawa K, 1997, BIOSCI BIOTECH BIOCH, V61, P1981; Maliakal PP, 2001, J PHARM PHARMACOL, V53, P1323, DOI 10.1211/0022357011777819; Lee MJ, 2000, ANAL BIOCHEM, V279, P164, DOI 10.1006/abio.2000.4487; Ciolino HP, 1999, MOL PHARMACOL, V56, P760; Morita K, 2001, ENVIRON HEALTH PERSP, V109, P289, DOI 10.2307/3434698; Vaidyanathan JB, 2003, J PHARMACOL EXP THER, V307, P745, DOI 10.1124/jpet.103.054296; Park YK, 2005, J AGR FOOD CHEM, V53, P10306, DOI 10.1021/jf058111a; Amakura Y, 2003, BIOL PHARM BULL, V26, P1754, DOI 10.1248/bpb.26.1754; Ciolino HP, 1999, BRIT J CANCER, V79, P1340, DOI 10.1038/sj.bjc.6690216; Donovan JL, 2001, J NUTR, V131, P1753; Amakura Y, 2008, PHYTOCHEMISTRY, V69, P3117, DOI 10.1016/j.phytochem.2007.07.022; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; Mulder TPJ, 2001, J CHROMATOGR B, V760, P271, DOI 10.1016/S0378-4347(01)00285-7; RUSHMORE TH, 1990, J BIOL CHEM, V265, P14648; Ciolino HP, 1998, BIOCHEM PHARMACOL, V56, P197, DOI 10.1016/S0006-2952(98)00143-9; Arif JM, 1997, MUTAT RES-FUND MOL M, V378, P31, DOI 10.1016/S0027-5107(97)00095-X; Ashida H, 2000, BIOFACTORS, V12, P201; BAILEY RG, 1990, J SCI FOOD AGR, V52, P509, DOI 10.1002/jsfa.2740520409; BIRNBAUM LS, 1985, ENVIRON HEALTH PERSP, V61, P11, DOI 10.2307/3430058; Catterall F, 2003, FOOD CHEM TOXICOL, V41, P1141, DOI 10.1016/S0278-6915(03)00073-5; Ciolino HP, 1998, CANCER RES, V58, P2754; Feng Q, 2002, J AGR FOOD CHEM, V50, P213, DOI 10.1021/jf010875c; Fukuda I, 2004, J AGR FOOD CHEM, V52, P2499, DOI 10.1021/jf030786v; Fukuda I, 2005, BIOSCI BIOTECH BIOCH, V69, P883, DOI 10.1271/bbb.69.883; Fukuda I, 2004, J IMMUNOL METHODS, V287, P187, DOI 10.1016/j.jim.2004.02.003; Fukuda I, 2007, BIOCHEM BIOPH RES CO, V359, P822, DOI 10.1016/j.bbrc.2007.05.199; Fukuda I, 2009, BIOSCI BIOTECH BIOCH, V73, P1206, DOI 10.1271/bbb.80868; Goto T, 1996, J CHROMATOGR A, V749, P295, DOI 10.1016/0021-9673(96)00456-6; Hashimoto T, 2002, BIOSCI BIOTECH BIOCH, V66, P1610, DOI 10.1271/bbb.66.1610; Hashimoto T, 2002, ENVIRON MOL MUTAGEN, V40, P175, DOI 10.1002/em.10104; JAISWAL AK, 1991, BIOCHEMISTRY-US, V30, P10647, DOI 10.1021/bi00108a007; Kinehara M, 2008, GENES GENET SYST, V83, P455, DOI 10.1266/ggs.83.455; Maliakal PP, 2001, J PHARM PHARMACOL, V53, P569, DOI 10.1211/0022357011775695; Newsome BJ, 2014, J NUTR BIOCHEM, V25, P126, DOI 10.1016/j.jnutbio.2013.10.003; Nishiumi S, 2006, FOOD CHEM TOXICOL, V44, P250, DOI 10.1016/j.fct.2005.07.007; Nishiumi Shin, 2006, Asian Pac J Cancer Prev, V7, P208; Park YK, 2004, BIOSCI BIOTECH BIOCH, V68, P935, DOI 10.1271/bbb.68.935; Safe SH, 1990, ANN REV TOXICOL, V21, P51	51	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0963-7486	1465-3478		INT J FOOD SCI NUTR	Int. J. Food Sci. Nutr.	MAY	2015	66	3					300	307		10.3109/09637486.2014.992007		8	Food Science & Technology; Nutrition & Dietetics	Food Science & Technology; Nutrition & Dietetics	CI7OA	WOS:000354952000010		
J	Ochiai, R; Sugiura, Y; Otsuka, K; Katsuragi, Y; Hashiguchi, T				Ochiai, Ryuji; Sugiura, Yoko; Otsuka, Kazuhiro; Katsuragi, Yoshihisa; Hashiguchi, Teruto			Coffee bean polyphenols ameliorate postprandial endothelial dysfunction in healthy male adults	INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION			English	Article						Chlorogenic acid; coffee; endothelial function; flow-mediated dilation; nitric oxide; polyphenol	TYPE-2 DIABETES-MELLITUS; CHLOROGENIC ACID; BLOOD-PRESSURE; LIPID-PEROXIDATION; RISK; CONSUMPTION; DRINKING; GLUCOSE; ATHEROSCLEROSIS; VASOREACTIVITY	To reveal the effect of coffee bean polyphenols (CBPs) on blood vessels, this study aimed to investigate the effect of CBPs on acute postprandial endothelial dysfunction. Thirteen healthy non-diabetic men (mean age, 44.9 +/- 1.4 years) consumed a test beverage (active: containing CBPs, placebo: no CBPs) before a 554-kcal test meal containing 14 g of protein, 30 g of fat and 58 g of carbohydrates. Then, a crossover analysis was performed to investigate the time-dependent changes in flow-mediated dilation (FMD) in the brachial artery. In the active group, the postprandial impairment of FMD was significantly improved, the two-hour postprandial nitric oxide metabolite levels were significantly increased and the six-hour postprandial urinary 8-epi-prostaglandin F2 alpha levels were significantly reduced compared to the placebo group. The test meal increased the levels of blood glucose, insulin and triglycerides in both groups with no significant intergroup differences. These findings indicate that CBPs intake ameliorates postprandial endothelial dysfunction in healthy men.	[Ochiai, Ryuji; Sugiura, Yoko; Otsuka, Kazuhiro; Katsuragi, Yoshihisa] Kao Corp, Hlth Care Food Res Labs, Tokyo 1318501, Japan; [Hashiguchi, Teruto] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Lab & Vasc Med, Kagoshima 890, Japan	Ochiai, R (reprint author), Kao Corp, Hlth Care Food Res Labs, Sumida Ku, 2-1-3 Bunka, Tokyo 1318501, Japan.	ochiai.ryuuji@kao.co.jp			Kao Corporation	This study was supported financially by Kao Corporation. Ryuji Ochiai, Yoko Sugiura, Kazuhiro Otsuka and Yoshihisa Katsuragi are Kao Corporation employees.	Ochiai R, 2014, NUTR RES, V34, P155, DOI 10.1016/j.nutres.2013.11.001; Meagher EA, 2000, FREE RADICAL BIO MED, V28, P1745, DOI 10.1016/S0891-5849(00)00232-X; Buscemi S, 2009, EUR J CLIN NUTR, V63, P1200, DOI 10.1038/ejcn.2009.51; van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X; Sakano N, 2009, J CLIN BIOCHEM NUTR, V44, P185, DOI 10.3164/jcbn.08-252; Morrow JD, 2005, ARTERIOSCL THROM VAS, V25, P279, DOI 10.1161/01.ATV.0000152605.64964.c0; Suzuki A, 2006, J HYPERTENS, V24, P1065, DOI 10.1097/01.hjh.0000226196.67052.c0; Ochiai R, 2004, HYPERTENS RES, V27, P731, DOI 10.1291/hypres.27.731; Matsui T, 2004, BIOL PHARM BULL, V27, P1797, DOI 10.1248/bpb.27.1797; Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D; Cavalot F, 2006, J CLIN ENDOCR METAB, V91, P813, DOI 10.1210/jc.2005-1005; Ranheim T, 2005, MOL NUTR FOOD RES, V49, P274, DOI 10.1002/mnfr.200400109; Ochiai R, 2009, HYPERTENS RES, V32, P969, DOI 10.1038/hr.2009.132; Fukushima Y, 2009, J AGR FOOD CHEM, V57, P1253, DOI 10.1021/jf802418j; Eskelinen MH, 2009, J ALZHEIMERS DIS, V16, P85, DOI 10.3233/JAD-2009-0920; Hernan MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277; Papamichael CM, 2005, CLIN SCI, V109, P55; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Kawano H, 1999, J AM COLL CARDIOL, V34, P146, DOI 10.1016/S0735-1097(99)00168-0; Jee SH, 1999, HYPERTENSION, V33, P647; Nakatani N, 2000, J AGR FOOD CHEM, V48, P5512, DOI 10.1021/jf000422s; Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019; Buscemi S, 2010, EUR J CLIN NUTR, V64, P483, DOI 10.1038/ejcn.2010.9; O'Keefe JH, 2008, J AM COLL CARDIOL, V51, P249, DOI 10.1016/j.jacc.2007.10.016; Stalmach A, 2010, ARCH BIOCHEM BIOPHYS, V501, P98, DOI 10.1016/j.abb.2010.03.005; HALLIWELL B, 1993, AM J CLIN NUTR, V57, P715; Hyson Dianne, 2003, Curr Atheroscler Rep, V5, P437, DOI 10.1007/s11883-003-0033-y; Mubarak A, 2012, J AGR FOOD CHEM, V60, P9130, DOI 10.1021/jf303440j; Teraoka M, 2012, J CLIN BIOCHEM NUTR, V51, P122, DOI 10.3164/jcbn.D-11-00030	29	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0963-7486	1465-3478		INT J FOOD SCI NUTR	Int. J. Food Sci. Nutr.	MAY	2015	66	3					350	354		10.3109/09637486.2015.1007453		5	Food Science & Technology; Nutrition & Dietetics	Food Science & Technology; Nutrition & Dietetics	CI7OA	WOS:000354952000017		
J	Yokote, K				Yokote, Koji			Weak addition invariance and axiomatization of the weighted Shapley value	INTERNATIONAL JOURNAL OF GAME THEORY			English	Article						Weak Addition Invariance; Shapley value; Weighted Shapley value; Axiomatization	DIFFERENCE	In this paper, we give a new axiomatization of the weighted Shapley value. We investigate the asymmetric property of the value by focusing on the invariance of payoff after the change in the worths of singleton coalitions. We show that if the worths change by the same amount, then the Shapley value is invariant. On the other hand, if the worths change with multiplying by a positive weight, then the weighted Shapley value with the positive weight is invariant. Based on the invariance, we formulate a new axiom, -Weak Addition Invariance. We prove that the weighted Shapley value is the unique solution function which satisfies -Weak Addition Invariance and Dummy Player Property. In the proof, we introduce a new basis of the set of all games. The basis has two properties. First, when we express a game by a linear combination of the basis, coefficients coincide with the weighted Shapley value. Second, the basis induces the null space of the weighted Shapley value. By generalizing the new axiomatization, we also axiomatize the family of weighted Shapley values.	Waseda Univ, Grad Sch Econ, Shinjuku Ku, Tokyo 1698050, Japan	Yokote, K (reprint author), Waseda Univ, Grad Sch Econ, Shinjuku Ku, 1-6-1 Nishi Waseda, Tokyo 1698050, Japan.	sidehand@toki.waseda.jp					van den Brink R, 2007, J ECON THEORY, V136, P767, DOI 10.1016/j.jet.2006.09.008; HART S, 1989, ECONOMETRICA, V57, P589, DOI 10.2307/1911054; Kamijo Y, 2012, EUR J OPER RES, V216, P638, DOI 10.1016/j.ejor.2011.08.011; CHUN Y, 1991, INT J GAME THEORY, V20, P183, DOI 10.1007/BF01240278; Beal S, 2012, 41530 MPRA; Derks J. J. M., 1999, INT GAME THEORY REV, V1, P301, DOI 10.1142/S0219198999000220; Harsanyi J. C., 1959, CONTRIBUTIONS THEORY, P325; KALAI E, 1987, INT J GAME THEORY, V16, P205, DOI 10.1007/BF01756292; Kamijo Y, 2010, INT J GAME THEORY, V39, P563, DOI 10.1007/s00182-009-0187-0; Shapley LS, 1953, THE SHAPLEY VALUE, P41; Sobolev AI, 1975, MATH METHODS SOCIAL, V6, P95; Sobolev AI, 1973, ADV GAME THEORY, P151; Yokote K, 2013, WASEDA EC WORKING PA, V13-001; Yokote K, 2013, E1304 I RES CONT POL; Yokote K, 2013, E1303 I RES CONT POL; Young H. P., 1985, International Journal of Game Theory, V14, DOI 10.1007/BF01769885	16	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0020-7276	1432-1270		INT J GAME THEORY	Int. J. Game Theory	MAY	2015	44	2					275	293		10.1007/s00182-014-0429-7		19	Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods; Statistics & Probability	Business & Economics; Mathematics; Mathematical Methods In Social Sciences	CI6RJ	WOS:000354888400002		
J	Baston, V; Kikuta, K				Baston, Vic; Kikuta, Kensaku			Search games on a network with travelling and search costs	INTERNATIONAL JOURNAL OF GAME THEORY			English	Article						Search game on a network; Traveling and search costs; Immobile hider	STARTING POINT; TREES	The authors analyse two-person zero-sum search games in which play takes place on a network and in discrete time. The hider first chooses a node and remains there for the duration of the game. The searcher then chooses a node and searches there. At each subsequent time instant the searcher moves from the node he occupies to an adjacent node and decides whether or not to search it. Play terminates when the searcher is at the node chosen by the hider and searches there. The searcher incurs costs in moving from one node to another and also when a node is searched. The searcher wants to minimize the costs of finding the hider and the hider wants to maximize them. The paper has two main strands. The first investigates these games on directed, not necessarily strongly connected, networks; previous work has tended to concentrate on undirected networks. The second complements previous work on undirected networks by obtaining results for the case when the search cost is the same for all nodes.	[Baston, Vic] Univ Southampton, Fac Math Studies, Southampton SO17 1BJ, Hants, England; [Kikuta, Kensaku] Univ Hyogo, Dept Business Adm, Nishi Ku, Kobe, Hyogo 6512197, Japan	Kikuta, K (reprint author), Univ Hyogo, Dept Business Adm, Nishi Ku, Gakuen Nishi 8-2-1, Kobe, Hyogo 6512197, Japan.	vic.baston@btinternet.com; kikuta@biz.u-hyogo.ac.jp			JSPS KAKENHI [23510177]	The authors are grateful to two anonymous reviewers and the Associate Editor for helpful comments and suggestions. This work was supported by JSPS KAKENHI Grant Number 23510177.	Alpern S, 2008, INT J GAME THEORY, V37, P281, DOI 10.1007/s00182-008-0116-7; Alpern S, 2013, MATH OPER RES, DOI [10.1287/moor.2013.0634, DOI 10.1287/M00R.2013.0634]; Alpern S, 2013, OPER RES, V61, P265, DOI 10.1287/opre.1120.1134; Alpern S, 2009, NETWORKS, V53, P392, DOI 10.1002/net.20314; Alpern S, 2010, SIAM J CONTROL OPTIM, V48, P5547, DOI 10.1137/090781115; Alpern S., 2003, KLUWER INT SERIES OP; Baston V, 2013, NETWORKS, V62, P72, DOI 10.1002/net.21504; Benavent E, 2009, NETWORKS, V54, P216, DOI 10.1002/net.20334; Corberan A, 2008, SIAM J DISCRETE MATH, V22, P606, DOI 10.1137/050640886; Dagan A, 2008, NETWORKS, V52, P156, DOI 10.1002/net.20241; Gal S, 2013, SEARCH GAMES REV SEA; Kikuta K, 2004, NAV RES LOG, V51, P977, DOI 10.1002/nav.20025; KIKUTA K, 1995, J OPER RES SOC JPN, V38, P70; KIKUTA K, 1994, NAV RES LOG, V41, P821, DOI 10.1002/1520-6750(199410)41:6<821::AID-NAV3220410610>3.0.CO;2-Y	14	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0020-7276	1432-1270		INT J GAME THEORY	Int. J. Game Theory	MAY	2015	44	2					347	365		10.1007/s00182-014-0432-z		19	Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods; Statistics & Probability	Business & Economics; Mathematics; Mathematical Methods In Social Sciences	CI6RJ	WOS:000354888400005		
J	Lapirattanakul, J; Nomura, R; Matsumoto-Nakano, M; Srisatjaluk, R; Ooshima, T; Nakano, K				Lapirattanakul, Jinthana; Nomura, Ryota; Matsumoto-Nakano, Michiyo; Srisatjaluk, Ratchapin; Ooshima, Takashi; Nakano, Kazuhiko			Variation of expression defects in cell surface 190-kDa protein antigen of Streptococcus mutans	INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY			English	Article						S. mutans; Serotype; Expression defect; Cell surface protein antigen; MLST	INFECTIVE ENDOCARDITIS; DENTAL-CARIES; ORAL-CAVITY; SEQUENCE; SEROTYPE; SORTASE; STRAINS; GENE; VIRULENCE; BACTERIA	Streptococcus mutans, which consists of four serotypes, c, e, f, and k, possesses a 190-kDa cell surface protein antigen (PA) for initial tooth adhesion. We used Western blot analysis to determine PA expression in 750 S. mutans isolates from 150 subjects and found a significantly higher prevalence of the isolates with PA expression defects in serotypes f and k compared to serotypes c and e. Moreover, the defect patterns could be classified into three types; no PA expression on whole bacterial cells and in their supernatant samples (Type N1), PA expression mainly seen in supernatant samples (Type N2), and only low expression of PA in the samples of whole bacterial cells (Type W). The underlying reasons for the defects were mutations in the gene encoding PA as well as in the transcriptional processing of this gene for Type N1, defects in the sortase gene for Type N2, and low mRNA expression of PA for Type W. Since cellular hydrophobicity and phagocytosis susceptibility of the PA-defective isolates were significantly lower than those of the normal expression isolates, the potential implication of such defective isolates in systemic diseases involving bacteremia other than dental caries was suggested. Additionally, multilocus sequence typing was utilized to characterize S. mutans clones that represented a proportion of isolates with PA defects of 65-100%. Therefore, we described the molecular basis for variation defects in PA expression of S. mutans. Furthermore, we also emphasized the strong association between PA expression defects and serotypes f and k as well as the clonal relationships among these isolates. (C) 2015 Elsevier GmbH. All rights reserved.	[Lapirattanakul, Jinthana; Srisatjaluk, Ratchapin] Mahidol Univ, Fac Dent, Bangkok 10400, Thailand; [Nomura, Ryota; Ooshima, Takashi; Nakano, Kazuhiko] Osaka Univ, Grad Sch Dent, Osaka 5650871, Japan; [Matsumoto-Nakano, Michiyo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008525, Japan	Lapirattanakul, J (reprint author), Mahidol Univ, Fac Dent, Dept Oral Microbiol, 6 Yothi St, Bangkok 10400, Thailand.	jinthana.lap@mahidol.ac.th			Thailand Research Fund, Office of the Higher Education Commission; Mahidol University [MRG5580025]; Japan Society for Promotion of Science [23390472, 24390461]	This study was supported by Thailand Research Fund, Office of the Higher Education Commission, and Mahidol University (MRG5580025), and a Grant-in-Aid for Scientific Research (B) 23390472 and 24390461 from the Japan Society for Promotion of Science.	Nakano K, 2004, J CLIN MICROBIOL, V42, P4925, DOI 10.1128/JCM.42.11.4925-4930.2004; Luan SL, 2005, J CLIN MICROBIOL, V43, P3727, DOI 10.1128/JCM.43.8.3727-3733.2005; Moreillon P, 2002, INFECT DIS CLIN N AM, V16, P297, DOI 10.1016/S0891-5520(01)00009-5; Nakano K, 2004, J CLIN MICROBIOL, V42, P198, DOI 10.1128/JCM.421.1.198-202.2004; Lapirattanakul J, 2011, J MED MICROBIOL, V60, P1677, DOI 10.1099/jmm.0.033415-0; Lapirattanakul J, 2008, CARIES RES, V42, P466, DOI 10.1159/000170588; OKAHASHI N, 1989, MOL MICROBIOL, V3, P673, DOI 10.1111/j.1365-2958.1989.tb00215.x; Feil EJ, 2001, P NATL ACAD SCI USA, V98, P182, DOI 10.1073/pnas.98.1.182; OOSHIMA T, 1983, JPN J MED SCI BIOL, V36, P219; ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x; Spirig T, 2011, MOL MICROBIOL, V82, P1044, DOI 10.1111/j.1365-2958.2011.07887.x; Nakano K, 2007, J CLIN MICROBIOL, V45, P2616, DOI 10.1128/JCM.02343-06; Nomura R, 2013, ARCH ORAL BIOL, V58, P1627, DOI 10.1016/j.archoralbio.2013.06.008; Nakano K, 2009, FUTURE MICROBIOL, V4, P891, DOI [10.2217/fmb.09.64, 10.2217/FMB.09.64]; Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Lapirattanakul J, 2013, ARCH ORAL BIOL, V58, P989, DOI 10.1016/j.archoralbio.2013.02.007; Banas JA, 2004, FRONT BIOSCI, V9, P1267, DOI 10.2741/1305; Nakano K, 2008, J DENT RES, V87, P964; Lee SF, 2003, INFECT IMMUN, V71, P676, DOI 10.1128/IAI.71.2.676-681.2003; HAMADA S, 1980, MICROBIOL REV, V44, P331; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Crowley PJ, 1999, INFECT IMMUN, V67, P1201; Ellstrom P., 2013, CLIN MICROBIOL INFEC; FORESTER H, 1983, J GEN MICROBIOL, V129, P2779; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; HOLBROOK WP, 1987, SCAND J DENT RES, V95, P37; Igarashi T, 2004, ORAL MICROBIOL IMMUN, V19, P210, DOI 10.1111/j.0902-0055.2004.00136.x; Igarashi T, 2003, ORAL MICROBIOL IMMUN, V18, P266, DOI 10.1034/j.1399-302X.2003.00076.x; LEE SF, 1989, INFECT IMMUN, V57, P3306; Lee SF, 2004, INFECT IMMUN, V72, P4314, DOI 10.1128/IAI.72.7.4314-4317.2004; Matsumoto-Nakano M, 2006, J BACTERIOL, V188, P8095, DOI 10.1128/JB.00908-06; Nakano K, 2006, MICROBES INFECT, V8, P114, DOI 10.1016/j.micinf.2005.06.005; Nakano K, 2007, J MED MICROBIOL, V56, P1413, DOI 10.1099/jmm.0.47335-0; Nomura R, 2007, J MED MICROBIOL, V56, P988, DOI 10.1099/jmm.0.47186-0; Old LA, 2008, FEMS MICROBIOL LETT, V287, P199, DOI 10.1111/j.1574-6968.2008.01312.x; Scheie A A, 1994, Adv Dent Res, V8, P246	36	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	1438-4221	1618-0607		INT J MED MICROBIOL	Int. J. Med. Microbiol.	MAY	2015	305	3					383	391		10.1016/j.ijmm.2015.03.001		9	Microbiology; Virology	Microbiology; Virology	CI2NI	WOS:000354583900013		
J	Tumurkhuu, G; Koide, N; Dagvadorj, J; Noman, ASM; Iftakhar-E-Khuda, I; Naiki, Y; Komatsu, T; Yoshida, T; Oda, M; Nagahama, M; Sakurai, J; Yokochi, T				Tumurkhuu, Gantsetseg; Koide, Naoki; Dagvadorj, Jargalsaikhan; Noman, Abu Shadat Mohammod; Iftakhar-E-Khuda, Imtiaz; Naiki, Yoshikazu; Komatsu, Takayuki; Yoshida, Tomoaki; Oda, Masataka; Nagahama, Masahiro; Sakurai, Jun; Yokochi, Takashi			The inhibition of lipopolysaccharide-induced tumor necrosis factor-alpha and nitric oxide production by Clostridium perfringens alpha-toxin and its relation to alpha-toxin-induced intracellular ceramide generation (vol 299, pg 554, 2009)	INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY			English	Correction									[Tumurkhuu, Gantsetseg; Koide, Naoki; Dagvadorj, Jargalsaikhan; Noman, Abu Shadat Mohammod; Iftakhar-E-Khuda, Imtiaz; Naiki, Yoshikazu; Komatsu, Takayuki; Yoshida, Tomoaki; Yokochi, Takashi] Aichi Med Univ, Sch Med, Dept Microbiol & Immunol, Nagakute, Aichi 4801195, Japan; [Oda, Masataka; Nagahama, Masahiro; Sakurai, Jun] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Microbiol, Tokushima, Japan	Yokochi, T (reprint author), Aichi Med Univ, Sch Med, Dept Microbiol & Immunol, Nagakute, Aichi 4801195, Japan.	yokochi@aichi-med-u.ac.jp					Tumurkhuu G, 2009, INT J MED MICROBIOL, V299, P554, DOI 10.1016/j.ijmm.2009.04.003	1	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	1438-4221	1618-0607		INT J MED MICROBIOL	Int. J. Med. Microbiol.	MAY	2015	305	3					433	433		10.1016/j.ijmm.2015.02.006		1	Microbiology; Virology	Microbiology; Virology	CI2NI	WOS:000354583900019		
J	Takahashi, N; Yoshizaki, T; Hiranaka, N; Kumano, O; Suzuki, T; Akanuma, M; Yui, T; Kanazawa, K; Yoshida, M; Naito, S; Fujiya, M; Kohgo, Y; Ieko, M				Takahashi, N.; Yoshizaki, T.; Hiranaka, N.; Kumano, O.; Suzuki, T.; Akanuma, M.; Yui, T.; Kanazawa, K.; Yoshida, M.; Naito, S.; Fujiya, M.; Kohgo, Y.; Ieko, M.			The production of coagulation factor VII by adipocytes is enhanced by tumor necrosis factor-alpha or isoproterenol	INTERNATIONAL JOURNAL OF OBESITY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; BODY-FAT DISTRIBUTION; WHITE ADIPOSE-TISSUE; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; PROCOAGULANT ACTIVITY; DIABETES-MELLITUS; BLOOD-COAGULATION; WEIGHT-LOSS; DB/DB MICE	BACKGROUND: A relationship has been reported between blood concentrations of coagulation factor VII (FVII) and obesity. In addition to its role in coagulation, FVII has been shown to inhibit insulin signals in adipocytes. However, the production of FVII by adipocytes remains unclear. OBJECTIVE: We herein investigated the production and secretion of FVII by adipocytes, especially in relation to obesity-related conditions including adipose inflammation and sympathetic nerve activation. METHODS: C57Bl/6J mice were fed a low- or high-fat diet and the expression of FVII messenger RNA (mRNA) was then examined in adipose tissue. 3T3-L1 cells were used as an adipocyte model for in vitro experiments in which these cells were treated with tumor necrosis factor-alpha (TNF-alpha) or isoproterenol. The expression and secretion of FVII were assessed by quantitative real-time PCR, Western blotting and enzyme-linked immunosorbent assays. RESULTS: The expression of FVII mRNA in the adipose tissue of mice fed with high-fat diet was significantly higher than that in mice fed with low-fat diet. Expression of the FVII gene and protein was induced during adipogenesis and maintained in mature adipocytes. The expression and secretion of FVII mRNA were increased in the culture medium of 3T3-L1 adipocytes treated with TNF-alpha, and these effects were blocked when these cells were exposed to inhibitors of mitogen-activated kinases or NF-kappa B activation. The beta-adrenoceptor agonist isoproterenol stimulated the secretion of FVII from mature adipocytes via the cyclic AMP/protein kinase A pathway. Blockade of secreted FVII with the anti-FVII antibody did not affect the phosphorylation of Akt in the isoproterenol-stimulated adipocytes. CONCLUSION: Obese adipose tissue produced FVII. The production and secretion of FVII by adipocytes was enhanced by TNF-alpha or isoproterenol via different mechanisms. These results indicate that FVII is an adipokine that plays an important role in the pathogenesis of obesity.	[Takahashi, N.; Hiranaka, N.; Kumano, O.; Suzuki, T.; Ieko, M.] Hlth Sci Univ Hokkaido, Sch Dent, Dept Internal Med, Ishikari, Hokkaido 0610023, Japan; [Takahashi, N.; Fujiya, M.; Kohgo, Y.] Asahikawa Med Univ, Dept Med, Div Gastroenterol & Hematol Oncol, Asahikawa, Hokkaido, Japan; [Yoshizaki, T.] Fukuyama Univ, Fac Life Sci & Biotechnol, Dept Biotechnol, Fukuyama, Hiroshima, Japan; [Kumano, O.; Suzuki, T.] Sysmex Corp, Hemostasis Prod Engn, Kobe, Hyogo, Japan; [Akanuma, M.; Yui, T.] Hlth Sci Univ Hokkaido, Sch Dent, Dept Fixed Prosthodont & Oral Implantol, Ishikari, Hokkaido 0610023, Japan; [Kanazawa, K.] Hlth Sci Univ Hokkaido, Sch Dent, Dept Dent Anesthesiol, Ishikari, Hokkaido 0610023, Japan; [Yoshida, M.; Naito, S.] Hlth Sci Univ Hokkaido, Dept Clin Lab, Ishikari, Hokkaido 0610023, Japan	Takahashi, N (reprint author), Hlth Sci Univ Hokkaido, Sch Dent, Dept Internal Med, Kanazawa 1757, Ishikari, Hokkaido 0610023, Japan.	ntkhs@hoku-iryo-u.ac.jp			JSPS KAKENHI [25460696, 23590684]	We thank the members of the Department of Biochemistry, School of Dentistry, Health Sciences University of Hokkaido for the use of laboratory equipment. This work was supported in part by JSPS KAKENHI Grant Numbers 25460696, 23590684 (to NT and MI).	Lau DCW, 2005, AM J PHYSIOL-HEART C, V288, pH2031, DOI 10.1152/ajpheart.01058.2005; Alvarez GE, 2002, CIRCULATION, V106, P2533, DOI 10.1161/01.CIR.0000041244.79165.25; Boden G, 2007, J CLIN ENDOCR METAB, V92, P4352, DOI 10.1210/jc.2007-0933; KARIO K, 1994, ARTERIOSCLER THROMB, V14, P265; Canale MP, 2013, INT J ENDOCRINOL, DOI 10.1155/2013/865965; Badeanlou L, 2011, NAT MED, V17, P1490, DOI 10.1038/nm.2461; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Carr ME, 2001, J DIABETES COMPLICAT, V15, P44, DOI 10.1016/S1056-8727(00)00132-X; Lambert GW, 2010, PHARMACOL THERAPEUT, V126, P159, DOI 10.1016/j.pharmthera.2010.02.002; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; FOLSOM AR, 1993, ARTERIOSCLER THROMB, V13, P162; Rao AK, 1999, DIABETES, V48, P1156, DOI 10.2337/diabetes.48.5.1156; Bartness TJ, 2010, MOL CELL ENDOCRINOL, V318, P34, DOI 10.1016/j.mce.2009.08.031; Lijnen HR, 2012, THROMB RES, V129, P74, DOI 10.1016/j.thromres.2011.05.023; Halleux CM, 1999, J CLIN ENDOCR METAB, V84, P4097, DOI 10.1210/jc.84.11.4097; Mihara M, 2010, ENDOCRINOLOGY, V151, P513, DOI 10.1210/en.2009-0661; Lorenzet R, 2012, THROMB RES, V129, P285, DOI 10.1016/j.thromres.2011.10.021; Skurk T, 2004, INT J OBESITY, V28, P1357, DOI 10.1038/sj.ijo.0802778; Tentolouris N, 2006, ANN NY ACAD SCI, V1083, P129, DOI 10.1196/annals.1367.010; Grassi G, 2004, J HYPERTENS, V22, P2363, DOI 10.1097/00004872-200412000-00019; Faber DR, 2009, OBES REV, V10, P554, DOI 10.1111/j.1467-789X.2009.00593.x; YOUNGSTROM TG, 1995, AM J PHYSIOL-REG I, V268, pR744; Bartness TJ, 2007, J LIPID RES, V48, P1655, DOI 10.1194/jlr.R700006-JLR200; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Ceriello A, 2000, DIABETES METAB RES, V16, P125, DOI 10.1002/(SICI)1520-7560(200003/04)16:2<125::AID-DMRR90>3.0.CO;2-4; CONNELLY JB, 1993, THROMB HAEMOSTASIS, V70, P250; Cronin KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040994; DALAKER K, 1986, SCAND J HAEMATOL, V36, P430; Foster MT, 2006, AM J PHYSIOL-REG I, V291, pR1630, DOI 10.1152/ajpregu.00197.2006; Godsland IF, 2005, J CLIN ENDOCR METAB, V90, P190, DOI 10.1210/jc.2004-1292; Gottschling-Zeller H, 2000, HORM METAB RES, V32, P509, DOI 10.1055/s-2007-978678; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670; Jackson AA, 2007, J BIOL CHEM, V282, P31156, DOI 10.1074/jbc.M704694200; Jimenez M, 2003, EUR J BIOCHEM, V270, P699, DOI 10.1046/j.1432-1033.2003.03422.x; Koizume S, 2009, MOL CANCER RES, V7, P1928, DOI 10.1158/1541-7786.MCR-09-0372; Kopp CW, 2003, OBES RES, V11, P950, DOI 10.1038/oby.2003.131; Krysiak R, 2010, DIABETES CARE, V33, P2266, DOI 10.2337/dc10-0272; Marckmann P, 1998, EUR J CLIN NUTR, V52, P75, DOI 10.1038/sj.ejcn.1600533; Mertens I, 2002, Obes Rev, V3, P85, DOI 10.1046/j.1467-789X.2002.00056.x; Monroe DM, 2007, J THROMB HAEMOST, V5, P1097, DOI 10.1111/j.1538-7836.2007.02435.x; Rosito GA, 2004, THROMB HAEMOSTASIS, V91, P683, DOI 10.1160/TH03-01-0014; Takahashi N, 2011, BIOCHEM BIOPH RES CO, V415, P200, DOI 10.1016/j.bbrc.2011.10.060; Wilcox JN, 2003, ARTERIOSCL THROM VAS, V23, P136, DOI 10.1161/01.ATV.0000043418.84185.3C	44	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0307-0565	1476-5497		INT J OBESITY	Int. J. Obes.	MAY	2015	39	5					747	754		10.1038/ijo.2014.208		8	Endocrinology & Metabolism; Nutrition & Dietetics	Endocrinology & Metabolism; Nutrition & Dietetics	CH5TJ	WOS:000354097900005		
J	Fujita, S; Kosaka, N; Mito, T; Hayashi, H; Morita, Y				Fujita, Shunichi; Kosaka, Nami; Mito, Takafumi; Hayashi, Hiroaki; Morita, Yoshitaka			Development of aseptic subcutaneous abscess after tocilizumab therapy in a patient with SAPHO syndrome complicated by amyloid A amyloidosis	INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES			English	Letter							ANTI-IL-6 RECEPTOR ANTIBODY; ULCERATIVE-COLITIS; RHEUMATOID-ARTHRITIS; DISEASE; SERUM		[Fujita, Shunichi; Kosaka, Nami; Mito, Takafumi; Morita, Yoshitaka] Kawasaki Med Univ, Dept Rheumatol, Okayama, Japan; [Hayashi, Hiroaki] Kawasaki Med Univ, Dept Dermatol, Okayama, Japan	Morita, Y (reprint author), Kawasaki Med Univ, Dept Rheumatol, Okayama, Japan.	morita@med.kawasaki-m.ac.jp					Nishimoto N, 2008, BLOOD, V112, P3959, DOI 10.1182/blood-2008-05-155846; Miyagawa I, 2014, MOD RHEUMATOL, V24, P405, DOI 10.3109/14397595.2013.844294; Bannai E, 2014, MOD RHEUMAT IN PRESS; Ben Abdelghani K, 2010, J RHEUMATOL, V37, P1699, DOI 10.3899/jrheum.091086; Hara H, 2000, J AM ACAD DERMATOL, V42, P363, DOI 10.1016/S0190-9622(00)90113-0; Kosaka N, 2013, INT J RHEUM DIS, V16, P486, DOI 10.1111/1756-185X.12123; Li KJ, 2006, DIGEST DIS SCI, V51, P401, DOI 10.1007/s10620-006-3144-9; Murata I, 1999, AM J GASTROENTEROL, V94, P844; Redondo-Pachon MD, 2013, RENAL FAILURE, V35, P547, DOI 10.3109/0886022X.2013.773913; Sakurai A, 2012, J VISUAL DERMATOL, V11, P1080	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1756-1841	1756-185X		INT J RHEUM DIS	Int. J. Rheum. Dis.	MAY	2015	18	4					476	479		10.1111/1756-185X.12525		4	Rheumatology	Rheumatology	CI9YS	WOS:000355127800015		
J	Yamamoto, T; Hoshi, M				Yamamoto, Toshiyuki; Hoshi, Michiko			The dramatic effect of dapsone on cutaneous bullous and pustular rheumatoid vasculitis on the sole	INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES			English	Letter							ARTHRITIS; MANIFESTATIONS		[Yamamoto, Toshiyuki] Fukushima Med Univ, Dept Dermatol, Fukushima, Japan; [Hoshi, Michiko] Hoshi Gen Hosp, Dept Dermatol, Fukushima, Japan	Yamamoto, T (reprint author), Fukushima Med Univ, Dept Dermatol, Fukushima, Japan.	toyamade@fmu.ac.jp					Zhu YI, 2001, J AM ACAD DERMATOL, V45, P420, DOI 10.1067/mjd.2001.114733; Sayah A, 2005, J AM ACAD DERMATOL, V53, P191, DOI 10.1016/j.jaad.2004.07.023; BERNARD P, 1988, J AM ACAD DERMATOL, V18, P140, DOI 10.1016/S0190-9622(88)80049-5; Chen KR, 2002, BRIT J DERMATOL, V147, P905, DOI 10.1046/j.1365-2133.2002.04933.x; COHEN MG, 1993, BRIT J RHEUMATOL, V32, P209; JORIZZO JL, 1983, J AM ACAD DERMATOL, V8, P439, DOI 10.1016/S0190-9622(83)70049-6; Kaye O, 1996, J RHEUMATOL, V23, P253; ORTONNE JP, 1983, ACTA DERM-VENEREOL, V63, P543; Yamamoto T, 2009, RHEUMATOL INT, V29, P979, DOI 10.1007/s00296-009-0881-z; Yamamoto T, 2013, J GENET SYNDR GENE T, V4, P8	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1756-1841	1756-185X		INT J RHEUM DIS	Int. J. Rheum. Dis.	MAY	2015	18	4					480	481		10.1111/1756-185X.12553		2	Rheumatology	Rheumatology	CI9YS	WOS:000355127800016		
J	Im, K				Im, Koonsam			Korean exchange rate and FTAs under the Roh Moo-hyun administration	INTERNATIONAL RELATIONS OF THE ASIA-PACIFIC			English	Article							FREE-TRADE AGREEMENTS; JAPAN; POLICY; REGIONALISM; LIBERALIZATION; DETERMINANTS; POLITICS; STRATEGY	The Korean government's engagement in FTAs since the late 1990s has been enthusiastic. As of 2012, the Korean government concluded FTAs with small trading partners such as Chile, Singapore, EFTA, ASEAN, India, Peru, and Turkey, and major counterparts such as the European Union (EU) and the United States as well. However, the degree of each of the Korean administrations' engagement in FTAs has shown discernible differences: While the Kim Dae-jung administration passively engaged in FTAs, the Roh Moo-hyun administration was proactive in that engagement. What explains the shift from the Kim administration's passive FTA policy to the Roh administration's comprehensive multi-track FTA policy? This article argues that the appreciation of the Korean won since 2001 made Korean exporters lose their price competitiveness in the global market, thereby forcing the Roh administration to offset Korean exporters' lost price competitiveness by formulating a comprehensive multi-track FTA policy, with huge side payments for politically sensitive import-competing sectors.	Tokyo Metropolitan Univ, Int Ctr, Hachioji, Tokyo, Japan	Im, K (reprint author), Tokyo Metropolitan Univ, Int Ctr, Hachioji, Tokyo, Japan.	i16hoursaday@gmail.com					Mansfield ED, 2003, INT ORGAN, V57, P829, DOI 10.1017/S0020818303574069; Sohn Y, 2011, INT RELAT ASIA-PAC, V11, P433, DOI 10.1093/irap/lcr009; GROSSMAN GM, 1995, AM ECON REV, V85, P667; [Anonymous], 2003, KOREA TIMES; [Anonymous], 2001, KOREA TIMES; [Anonymous], 2002, KOREA TIMES; Ravenhill J, 2010, REV INT POLIT ECON, V17, P178, DOI 10.1080/09692290903070887; [Anonymous], 2002, KOREA HERALD    0221; Mansfield ED, 1999, INT ORGAN, V53, P589, DOI 10.1162/002081899551002; [Anonymous], 2004, KOREA TIMES; [Anonymous], 2001, KOREA HERALD    0323; Baldwin R., 1993, 4465 NAT BUR EC RES; Choi BI, 2011, PAC REV, V24, P505, DOI 10.1080/09512748.2011.596562; Choi T., 2006, HAN KOOK KWA KOOK JE, V53, P87; Frieden Jeffry, 2001, CURRENCY GAME EXCHAN, P1; Frieden JA, 1994, REV INT POLIT ECON, V1, P81, DOI 10.1080/09692299408434269; Hiscox M. J., 2008, GLOBAL POLITICAL EC, P96; Hyun M., 2004, HANKOOK ILBO    0209; International Monetary Fund (IMF), 2006, 06382 IMF; Kim CW, 2011, ASIAN PERSPECT-SEOUL, V35, P471; Kim S., 2006, KOREA HERALD    1211; Klingner B., 2007, BACKGROUNDER; Koo M. G., 2008, S KOREAS FTAS MOVING; Lee HC, 2010, J CONTEMP ASIA, V40, P291, DOI 10.1080/00472331003600507; Lee HH, 2008, WORLD ECON, V31, P841, DOI 10.1111/j.1467-9701.2008.01105.x; Lee S, 2009, POLIT ECON ASIA PAC, P37, DOI 10.1007/978-3-540-79594-0_2; Lindberg L., 2012, INT NEGOTIATION, V17, P163; Manger M, 2005, REV INT POLIT ECON, V12, P804, DOI 10.1080/09692290500339800; Manyin M. E., 2004, CRS REP C; Milner H. V., 1997, INTEREST I INFORM DO; Ministry of Economy Trade and Industry (METI), 2013, 2013 WHIT PAP INT EC; Ministry of Foreign Affairs and Trade (MOFAT), 2006, KEY IN YEAR 2006; Moon SB, 2009, KOREA OBS, V40, P587; Myung J., 2010, TRADE FOCUS, V9, P1; Park SH, 2007, PAC AFF, V80, P259; Rhyu SY, 2011, POLIT ECON ASIA PAC, P71, DOI 10.1007/978-1-4419-6833-3_4; Sato K., 2013, RIETI DISCUSSION PAP; Solis M, 2010, REV INT POLIT ECON, V17, P209, DOI 10.1080/09692290902997908; Solis M, 2007, PAC AFF, V80, P229; Solis M, 2013, FOREIGN POLICY BROOK, V31, P1; The Yonhap News Agency, 2004, YONHAP NEWS AGE 0504; The Yonhap News Agency, 2004, YONHAP NEWS AGE 0804; Urata S, 2009, INT POLIT ECON SER, P27; Yoo C, 2002, KOREA HERALD    0205; Yoo C, 2002, KOREA HERALD    0510; Yoo C, 2002, KOREA HERALD    0322; Yoo C, 2002, KOREA HERALD    0319; Yoshimatsu H, 2010, ASIAN SURV, V50, P1058, DOI 10.1525/as.2010.50.6.1058; Yoshimatsu H, 2005, ASIAN SURV, V45, P258, DOI 10.1525/as.2005.45.2.258; Yoshimatsu H, 2012, ASIAN POLITICS POLIC, V4, P193; Yu Hyun-Seok, 2006, Korea Observer, V37, P643	51	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1470-482X	1470-4838		INT RELAT ASIA-PAC	Int. Relat. Asia-Pac.	MAY	2015	15	2					367	396		10.1093/irap/lcu022		30	International Relations	International Relations	CI4BM	WOS:000354691400006		
J	Kuroda, M; Shinke, T; Sakaguchi, K; Otake, H; Takaya, T; Hirota, Y; Sugiyama, D; Nakagawa, M; Hariki, H; Inoue, T; Osue, T; Taniguchi, Y; Iwasaki, M; Nishio, R; Kinutani, H; Konishi, A; Hiranuma, N; Takahashi, H; Terashita, D; Hirata, K				Kuroda, Masaru; Shinke, Toshiro; Sakaguchi, Kazuhiko; Otake, Hiromasa; Takaya, Tomofumi; Hirota, Yushi; Sugiyama, Daisuke; Nakagawa, Masayuki; Hariki, Hirotoshi; Inoue, Takumi; Osue, Tsuyoshi; Taniguchi, Yu; Iwasaki, Masamichi; Nishio, Ryo; Kinutani, Hiroto; Konishi, Akihide; Hiranuma, Noritoshi; Takahashi, Hachidai; Terashita, Daisuke; Hirata, Ken-ichi			Effect of Daily Glucose Fluctuation on Coronary Plaque Vulnerability in Patients Pre-Treated With Lipid-Lowering Therapy A Prospective Observational Study	JACC-CARDIOVASCULAR INTERVENTIONS			English	Article						continuous glucose monitoring; glucose fluctuation; mean amplitude of glycemic excursion; thin-cap fibroatheroma; virtual histology intravascular ultrasound	RADIOFREQUENCY DATA-ANALYSIS; INTRAVASCULAR ULTRASOUND; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; ASSOCIATION; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPOGLYCEMIA; PREVENTION; MEN	OBJECTIVES This study sought to investigate the effect of daily glucose fluctuation on coronary plaque properties in patients with coronary artery disease (CAD) pre-treated with lipid-lowering therapy. BACKGROUND There is growing evidence that glucose fluctuation, as a residual risk apart from dyslipidemia, is an important factor contributing to the development of CAD. METHODS This prospective study enrolled 70 consecutive CAD patients who were referred for percutaneous coronary intervention and whose low-density lipoprotein cholesterol level was < 120 mg/dl under statin treatment or < 100 mg/dl without statins. Daily glucose fluctuation was analyzed by measuring the mean amplitude of glycemic excursion (MAGE). The plaque properties in the culprit and nonculprit lesions were assessed by virtual histology intravascular ultrasound, and the volume percentage of necrotic core within the plaque (%NC) and the presence of thin-cap fibroatheroma were evaluated. RESULTS In total, 165 lesions were evaluated in 70 patients (40 diabetic and 30 nondiabetic patients). % NC was well correlated with MAGE (r = 0.490, p < 0.001). A linear mixed effect model showed that MAGE had the strongest effect on % NC (coefficient beta = 0.080 +/- 0.020 [standard error], p < 0.001). The generalized linear mixed effect model revealed that MAGE was the only independent predictor of the presence of thin-cap fibroatheroma (odds ratio: 1.037; 95% confidence interval: 1.010 to 1.065; p = 0.007). CONCLUSIONS Daily glucose fluctuation may have an effect on coronary plaque vulnerability in patients with CAD pre-treated with lipid-lowering therapy. Further investigations should address the rationale for the early detection and control of glucose fluctuation in the era of universal statin use for CAD patients. (C) 2015 by the American College of Cardiology Foundation.	[Kuroda, Masaru; Shinke, Toshiro; Otake, Hiromasa; Takaya, Tomofumi; Nakagawa, Masayuki; Hariki, Hirotoshi; Inoue, Takumi; Osue, Tsuyoshi; Taniguchi, Yu; Iwasaki, Masamichi; Nishio, Ryo; Kinutani, Hiroto; Konishi, Akihide; Hiranuma, Noritoshi; Takahashi, Hachidai; Terashita, Daisuke; Hirata, Ken-ichi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo 6500017, Japan; [Sakaguchi, Kazuhiko; Hirota, Yushi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet & Metab, Kobe, Hyogo 6500017, Japan; [Sugiyama, Daisuke] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan	Shinke, T (reprint author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	shinke@med.kobe-u.ac.jp		Takaya, Tomofumi/0000-0001-5775-8072	NIH T32; Gilead Sciences; Medtronic, Inc.	JACC: Cardiovascular Interventions CME Editor Olivia Hung, MD, PhD, has received research grant support from NIH T32, Gilead Sciences, and Medtronic, Inc.	Nair A, 2002, CIRCULATION, V106, P2200, DOI 10.1161/01.CIR.0000035654.18341.5E; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Garcia-Garcia HM, 2009, EUROINTERVENTION, V5, P177, DOI 10.4244/EIJV5I2A29; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920; Moore MP, 1998, HEART, V79, P459; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Hong YJ, 2009, JACC-CARDIOVASC IMAG, V2, P339, DOI 10.1016/j.jcmg.2008.10.017; Desouza CV, 2010, DIABETES CARE, V33, P1389, DOI 10.2337/dc09-2082; SERVICE FJ, 1970, DIABETES, V19, P644; Lowe LP, 1997, DIABETES CARE, V20, P163, DOI 10.2337/diacare.20.2.163; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Kojima S, 2011, INT J CARDIOL, V147, P371, DOI 10.1016/j.ijcard.2009.09.536; Ceriello A, 2000, DIABETES METAB RES, V16, P125, DOI 10.1002/(SICI)1520-7560(200003/04)16:2<125::AID-DMRR90>3.0.CO;2-4; Chen XM, 2010, DIABETES RES CLIN PR, V90, P95, DOI 10.1016/j.diabres.2010.05.004; DECODE Study Group, 1999, LANCET, V354, P617; Galassetti P, 2000, CLIN SCI, V99, P351, DOI 10.1042/CS20000022; Gibbons RJ, 1999, J AM COLL CARDIOL, V33, P2092, DOI 10.1016/S0735-1097(99)00150-3; Nair Anuja, 2007, EuroIntervention, V3, P113; Risso A, 2001, AM J PHYSIOL-ENDOC M, V281, pE924; Rodriguez-Granillo GA, 2005, J AM COLL CARDIOL, V46, P2038, DOI 10.1016/j.jacc.2005.07.064; Su G, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-19	24	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-8798	1876-7605		JACC-CARDIOVASC INTE	JACC-Cardiovasc. Interv.	MAY	2015	8	6					800	811		10.1016/j.jcin.2014.11.025		12	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CI5DX	WOS:000354774300014		
J	Ueda, Y; Matsuo, K; Nishimoto, Y; Sugihara, R; Hirata, A; Nemoto, T; Okada, M; Murakami, A; Kashiwase, K; Kodama, K				Ueda, Yasunori; Matsuo, Koshi; Nishimoto, Yuji; Sugihara, Ryuta; Hirata, Akio; Nemoto, Takayoshi; Okada, Masato; Murakami, Ayaka; Kashiwase, Kazunori; Kodama, Kazuhisa			In-Stent Yellow Plaque at 1 Year After Implantation Is Associated With Future Event of Very Late Stent Failure The DESNOTE Study (Detect the Event of Very late Stent Failure From the Drug-Eluting Stent Not Well Covered by Neointima Determined by Angioscopy)	JACC-CARDIOVASCULAR INTERVENTIONS			English	Article						coronary stent; intravascular imaging; late stent failure; lipid-rich plaque	CORONARY-ARTERY LESIONS; RANDOMIZED CONTROLLED-TRIAL; CLINICAL FOLLOW-UP; ENDEAVOR-II TRIAL; BARE-METAL STENT; IV TRIAL; SYSTEM; EVEROLIMUS; THROMBOSIS; EFFICACY	OBJECTIVES This study examined whether coronary angioscopy-verified in-stent yellow plaque at 1 year after drug-eluting stent (DES) implantation is associated with future event of very late stent failure (VLSF). BACKGROUND Atherosclerosis detected as yellow plaque by angioscopy has been associated with future events of acute coronary syndrome. Development of in-stent neoatherosclerosis is a probable mechanism of VLSF. METHODS This study included 360 consecutive patients who received successful angioscopic examination at 1 year after implantation of a DES. They were clinically followed up for VLSF defined as cardiac death, acute myocardial infarction or unstable angina, or need for revascularization associated with the stent site. RESULTS The follow-up interval was 1,558 +/- 890 days (4.3 +/- 2.4 years). The incidence of VLSF was significantly higher in the patients with yellow plaque than in those without (8.1% vs. 1.6%; log rank p = 0.02). Multivariable analysis revealed the presence of yellow plaque (hazard ratio [HR]: 5.38; p = 0.02) and absence of statin therapy (HR: 3.25; p = 0.02) as risks of VLSF. CONCLUSIONS In-stent atherosclerosis evaluated by yellow plaque at 1 year after the implantation of DES and the absence of statin therapy were risks of VLSF. The underlying mechanism of VLSF appeared to be the progression of atherosclerosis as demonstrated by the yellow plaque. (C) 2015 by the American College of Cardiology Foundation.	[Ueda, Yasunori; Matsuo, Koshi; Nishimoto, Yuji; Sugihara, Ryuta; Hirata, Akio; Nemoto, Takayoshi; Okada, Masato; Murakami, Ayaka; Kashiwase, Kazunori; Kodama, Kazuhisa] Osaka Police Hosp, Div Cardiovasc, Osaka 5430035, Japan	Ueda, Y (reprint author), Osaka Police Hosp, Div Cardiovasc, Tennoji Ku, 10-31 Kitayama Cho, Osaka 5430035, Japan.	yellowplaque@gmail.com					Kang SJ, 2011, CIRCULATION, V123, P2954, DOI 10.1161/CIRCULATIONAHA.110.988436; Nakazawa G, 2009, JACC-CARDIOVASC IMAG, V2, P625, DOI 10.1016/j.jcmg.2009.01.011; Eisenstein EL, 2009, JACC-CARDIOVASC INTE, V2, P1178, DOI 10.1016/j.jcin.2009.10.011; Weisz G, 2009, J AM COLL CARDIOL, V53, P2009, DOI 10.1016/j.jacc.2009.01.050; Kubo T, 2008, JACC-CARDIOVASC INTE, V1, P74, DOI 10.1016/j.jcin.2007.11.001; Fajadet J, 2010, EUROINTERVENTION, V6, P562, DOI 10.4244/EIJV6I5A95; Ellis SG, 2009, JACC-CARDIOVASC INTE, V2, P1248, DOI 10.1016/j.jcin.2009.10.003; Holmes DR, 2004, CIRCULATION, V109, P634, DOI 10.1161/01.CIR.0000112572.57794.22; Onuma Y, 2013, EUROINTERVENTION, V8, P1047, DOI 10.4244/EIJV8I9A161; Stone GW, 2008, JAMA-J AM MED ASSOC, V299, P1903, DOI 10.1001/jama.299.16.1903; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Hasegawa K, 2006, CATHETER CARDIO INTE, V68, P554, DOI 10.1002/ccd.20787; Natsuaki M, 2012, AM J CARDIOL, V109, P1387, DOI 10.1016/j.amjcard.2012.01.350; Fajadet J, 2006, CIRCULATION, V114, P798, DOI 10.1161/CIRCULATIONHA.105.591206; Ueda Y, 2004, AM HEART J, V148, P333, DOI 10.1016/j.ahj.2004.03.047; Ohtani T, 2006, J AM COLL CARDIOL, V47, P2194, DOI 10.1016/j.jacc.2006.01.064; Stone GW, 2004, CIRCULATION, V109, P1942, DOI 10.1161/01.CIR.0000127110.49192.72; Stone GW, 2009, CIRCULATION, V119, P680, DOI 10.1161/CIRCULATIONAHA.108.803528; Stone GW, 2011, J AM COLL CARDIOL, V58, P19, DOI 10.1016/j.jacc.2011.02.022; Liistro F, 2002, CIRCULATION, V105, P1883, DOI 10.1161/01.CIR.0000016042.69606.61; Kang SJ, 2013, JACC-CARDIOVASC IMAG, V6, P695, DOI 10.1016/j.jcmg.2013.02.006; Kandzari DE, 2011, JACC-CARDIOVASC INTE, V4, P543, DOI 10.1016/j.jcin.2010.12.014; Choi IJ, 2013, J INTERV CARDIOL, V26, P137, DOI 10.1111/joic.12001; Garg S, 2009, JACC-CARDIOVASC INTE, V2, P1190, DOI 10.1016/j.jcin.2009.10.002; Higo T, 2009, JACC-CARDIOVASC IMAG, V2, P616, DOI 10.1016/j.jcmg.2008.12.026; Leon MB, 2009, JACC-CARDIOVASC INTE, V2, P1208, DOI 10.1016/j.jcin.2009.10.008; Matsuo K, 2013, HEART ASIA, V5, P192; Matsuo K, 2012, J CARDIOL CASES, V5, pe12; Oyabu J, 2006, AM HEART J, V152, P1168, DOI 10.1016/j.ahj.2006.07.025; Ueda Y, 2001, J AM COLL CARDIOL, V38, P1916, DOI 10.1016/S0735-1097(01)01673-4; UEDA Y, 1994, J AM COLL CARDIOL, V23, P341; Yokoyama S, 2009, CIRC-CARDIOVASC INTE, V2, P205, DOI 10.1161/CIRCINTERVENTIONS.109.854679	33	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-8798	1876-7605		JACC-CARDIOVASC INTE	JACC-Cardiovasc. Interv.	MAY	2015	8	6					814	821		10.1016/j.jcin.2014.12.239		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CI5DX	WOS:000354774300016		
J	Goto, K; Takebayashi, H; Mukai, S; Yamane, H; Hagikura, A; Morimoto, Y; Kikuta, Y; Sato, K; Taniguchi, M; Hiramatsu, S; Haruta, S				Goto, Kenji; Takebayashi, Hideo; Mukai, Shogo; Yamane, Hiroki; Hagikura, Arata; Morimoto, Yoshimasa; Kikuta, Yuetsu; Sato, Katsumasa; Taniguchi, Masahito; Hiramatsu, Shigeki; Haruta, Seiichi			Acute Myocardial Infarction Caused by Left Main Coronary Artery Compression as a Result of a Mycotic Aneurysm of the Sinus of Valsalva	JACC-CARDIOVASCULAR INTERVENTIONS			English	Editorial Material						acute MI; patch repair; ruptured sinus of Valsalva aneurysm	UNRUPTURED ANEURYSM		[Goto, Kenji; Takebayashi, Hideo; Mukai, Shogo; Yamane, Hiroki; Hagikura, Arata; Morimoto, Yoshimasa; Kikuta, Yuetsu; Sato, Katsumasa; Taniguchi, Masahito; Hiramatsu, Shigeki; Haruta, Seiichi] Fukuyama Cardiovasc Hosp, Fukuyama, Hiroshima 7200804, Japan	Goto, K (reprint author), Fukuyama Cardiovasc Hosp, 2-39 Midorimachi, Fukuyama, Hiroshima 7200804, Japan.	kgoto0369@yahoo.co.jp					Lijoi A, 2002, TEX HEART I J, V29, P40; Hausinger P, 2014, HERZ, V39, P770, DOI 10.1007/s00059-013-3891-2; Ott DA., 2006, CARDIAC SURG ANN, V9, P165; Regueiro Abel Margarita, 2002, Rev Esp Cardiol, V55, P77	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-8798	1876-7605		JACC-CARDIOVASC INTE	JACC-Cardiovasc. Interv.	MAY	2015	8	6					E87	E89		10.1016/j.jcin.2014.12.241		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CI5DX	WOS:000354774300002		
J	Naganuma, T; Panoulas, VF; Latib, A; Kawamoto, H; Sato, K; Miyazaki, T; Colombo, A				Naganuma, Toru; Panoulas, Vasileios F.; Latib, Azeem; Kawamoto, Hiroyoshi; Sato, Katsumasa; Miyazaki, Tadashi; Colombo, Antonio			1-Year Follow-Up Optical Coherence Tomography of a "Hybrid" Neocarina After T-Stenting With Small Protrusion Technique Using a Bioresorbable Vascular Scaffold and a Metallic Stent	JACC-CARDIOVASCULAR INTERVENTIONS			English	Editorial Material						bioresorbable vascular; scaffold; coronary bifurcation; neocarina; optical coherence tomography; T-stenting with small protrusion technique			[Naganuma, Toru; Panoulas, Vasileios F.; Latib, Azeem; Kawamoto, Hiroyoshi; Sato, Katsumasa; Miyazaki, Tadashi; Colombo, Antonio] Ist Sci San Raffaele, Intervent Cardiol Unit, I-20132 Milan, Italy; [Naganuma, Toru; Panoulas, Vasileios F.; Latib, Azeem; Kawamoto, Hiroyoshi; Sato, Katsumasa; Miyazaki, Tadashi; Colombo, Antonio] EMO GVM Ctr Cuore Columbus, Intervent Cardiol Unit, I-20145 Milan, Italy; [Naganuma, Toru; Kawamoto, Hiroyoshi] New Tokyo Hosp, Intervent Cardiol Unit, Chiba, Japan; [Panoulas, Vasileios F.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England	Colombo, A (reprint author), EMO GVM Ctr Cuore Columbus, 48 Via M Buonarroti, I-20145 Milan, Italy.	info@emocolumbus.it					Naganuma T, 2013, JACC-CARDIOVASC INTE, V6, P554, DOI 10.1016/j.jcin.2013.01.137; Lassen JF, 2014, EUROINTERVENTION, V10, P545, DOI 10.4244/EIJV10I5A97	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-8798	1876-7605		JACC-CARDIOVASC INTE	JACC-Cardiovasc. Interv.	MAY	2015	8	6					E101	E103		10.1016/j.jcin.2015.01.025		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CI5DX	WOS:000354774300006		
J	Satogami, K; Ino, Y; Kubo, T; Shiono, Y; Nishiguchi, T; Matsuo, Y; Orii, M; Yamano, T; Yamaguchi, T; Hirata, K; Tanaka, A; Akasaka, T				Satogami, Keisuke; Ino, Yasushi; Kubo, Takashi; Shiono, Yasutsugu; Nishiguchi, Tsuyoshi; Matsuo, Yoshiki; Orii, Makoto; Yamano, Takashi; Yamaguchi, Tomoyuki; Hirata, Kumiko; Tanaka, Atsushi; Akasaka, Takashi			Successful Stenting With Optical Frequency Domain Imaging Guidance For Spontaneous Coronary Artery Dissection	JACC-CARDIOVASCULAR INTERVENTIONS			English	Editorial Material						acute coronary syndrome; optical coherence tomography; percutaneous coronary intervention; spontaneous coronary artery dissection			[Satogami, Keisuke; Ino, Yasushi; Kubo, Takashi; Shiono, Yasutsugu; Nishiguchi, Tsuyoshi; Matsuo, Yoshiki; Orii, Makoto; Yamano, Takashi; Yamaguchi, Tomoyuki; Hirata, Kumiko; Tanaka, Atsushi; Akasaka, Takashi] Wakayama Med Univ, Dept Cardiovasc Med, Wakayama 6418509, Japan	Ino, Y (reprint author), Wakayama Med Univ, Dept Cardiovasc Med, 811-1 Kimiidera, Wakayama 6418509, Japan.	yasushi470923@yahoo.co.jp					Alfonso F, 2012, JACC-CARDIOVASC INTE, V5, P1062, DOI 10.1016/j.jcin.2012.06.014; Alfonso F, 2012, J AM COLL CARDIOL, V59, P1073, DOI 10.1016/j.jacc.2011.08.082; Nishiguchi T, 2013, EUR HEART J ACU 0911	3	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-8798	1876-7605		JACC-CARDIOVASC INTE	JACC-Cardiovasc. Interv.	MAY	2015	8	6					E83	E85		10.1016/j.jcin.2014.12.247		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CI5DX	WOS:000354774300001		
J	Al-Attili, AZ; Kako, S; Husain, MK; Gardes, FY; Arimoto, H; Higashitarumizu, N; Iwamoto, S; Arakawa, Y; Ishikawa, Y; Saito, SNC				Al-Attili, Abdelrahman Z.; Kako, Satoshi; Husain, Muhammad K.; Gardes, Frederic Y.; Arimoto, Hideo; Higashitarumizu, Naoki; Iwamoto, Satoshi; Arakawa, Yasuhiko; Ishikawa, Yasuhiko; Saito, Shinichi			Spin-on doping of germanium-on-insulator wafers for monolithic light sources on silicon	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							EPITAXIAL LAYERS; N-TYPE; GE; SI; LASER; DIFFUSION; JUNCTIONS	High electron doping of germanium (Ge) is considered to be an important process to convert Ge into an optical gain material and realize a monolithic light source integrated on a silicon chip. Spin-on doping is a method that offers the potential to achieve high doping concentrations without affecting crystalline qualities over other methods such as ion implantation and in-situ doping during material growth. However, a standard spin-on doping recipe satisfying these requirements is not yet available. In this paper we examine spin-on doping of Ge-on-insulator (GOI) wafers. Several issues were identified during the spin-on doping process and specifically the adhesion between Ge and the oxide, surface oxidation during activation, and the stress created in the layers due to annealing. In order to mitigate these problems, Ge disks were first patterned by dry etching followed by spin-on doping. Even by using this method to reduce the stress, local peeling of Ge could still be identified by optical microscope imaging. Nevertheless, most of the Ge disks remained after the removal of the glass. According to the Raman data, we could not identify broadening of the lineshape which shows a good crystalline quality, while the stress is slightly relaxed. We also determined the linear increase of the photoluminescence intensity by increasing the optical pumping power for the doped sample, which implies a direct population and recombination at the gamma valley. (C) 2015 The Japan Society of Applied Physics	[Al-Attili, Abdelrahman Z.; Husain, Muhammad K.; Gardes, Frederic Y.; Arimoto, Hideo; Saito, Shinichi] Univ Southampton, Nano Res Grp, Fac Phys Sci & Engn, Southampton SO17 1BJ, Hants, England; [Kako, Satoshi; Iwamoto, Satoshi; Arakawa, Yasuhiko] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; [Higashitarumizu, Naoki; Ishikawa, Yasuhiko] Univ Tokyo, Dept Mat Engn, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan	Al-Attili, AZ (reprint author), Univ Southampton, Nano Res Grp, Fac Phys Sci & Engn, Southampton SO17 1BJ, Hants, England.	S.Saito@soton.ac.uk	Ishikawa, Yasuhiko/L-8874-2014; Gardes, Frederic/C-1619-2013	Gardes, Frederic/0000-0003-1400-3272	Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovation R&D on Science and Technology (FIRST Program)"; Project for Developing Innovation Systems; Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT) [KAKENHI 216860312]; Marie-Curie Carrier Integration Grant (CIG, FP7, EU) [PCIG13-GA-2013-618116]; EPSRC, U.K. [EP/M009416/1]; University of Southampton, Zepler Institute, Research Collaboration Stimulus Fund	Parts of the studies discussed here were supported by the Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovation R&D on Science and Technology (FIRST Program)", the Project for Developing Innovation Systems, and KAKENHI 216860312, the Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT). This work is also supported by Marie-Curie Carrier Integration Grant (CIG, PCIG13-GA-2013-618116, FP7, EU), Standard Grant (EP/M009416/1, EPSRC, U.K.), and University of Southampton, Zepler Institute, Research Collaboration Stimulus Fund.	Liu JF, 2012, SEMICOND SCI TECH, V27, DOI 10.1088/0268-1242/27/9/094006; Sun XC, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3170870; Roth JE, 2007, OPT EXPRESS, V15, P5851, DOI 10.1364/OE.15.005851; DENNARD RH, 1974, IEEE J SOLID-ST CIRC, VSC 9, P256, DOI 10.1109/JSSC.1974.1050511; Mashanovich GZ, 2011, OPT EXPRESS, V19, P7112, DOI 10.1364/OE.19.007112; Michel J, 2010, NAT PHOTONICS, V4, P527, DOI [10.1038/NPHOTON.2010.157, 10.1038/nphoton.2010.157]; ESAKI L, 1958, PHYS REV, V109, P603, DOI 10.1103/PhysRev.109.603; HALL RN, 1962, PHYS REV LETT, V9, P366, DOI 10.1103/PhysRevLett.9.366; Liu JF, 2012, THIN SOLID FILMS, V520, P3354, DOI 10.1016/j.tsf.2011.10.121; Camacho-Aguilera RE, 2012, OPT MATER EXPRESS, V2, P1462; Posthuma NE, 2007, IEEE T ELECTRON DEV, V54, P1210, DOI 10.1109/TED.2007.894610; Nam D, 2014, OPT LETT, V39, P6205, DOI 10.1364/OL.39.006205; Liu J, 2007, OPT EXPRESS, V15, P11272, DOI 10.1364/OE.15.011272; El Kurdi M, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3138155; Liu JF, 2010, OPT LETT, V35, P679, DOI 10.1364/OL.35.000679; Yu HY, 2013, CURR APPL PHYS, V13, P1060, DOI 10.1016/j.cap.2013.02.021; Camacho-Aguilera RE, 2012, OPT EXPRESS, V20, P11316, DOI 10.1364/OE.20.011316; CUTTRISS DB, 1961, AT&T TECH J, V40, P509; CHAPIN DM, 1954, J APPL PHYS, V25, P676, DOI 10.1063/1.1721711; El Kurdi M, 2010, J APPL PHYS, V107, DOI 10.1063/1.3279307; Hartmann JM, 2012, J CRYST GROWTH, V347, P37, DOI 10.1016/j.jcrysgro.2012.03.023; Bessette J. T., 2011, 8 IEEE INT C GROUP 4, P130; BUCHAL C, 1994, ANNU REV MATER SCI, V24, P125; Camacho-Aguilera R, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4802199; Cammilleri D, 2008, THIN SOLID FILMS, V517, P75, DOI 10.1016/j.tsf.2008.08.073; Carroll L, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.057402; Ishikawa Y, 2005, J APPL PHYS, V98, DOI 10.1063/1.1943507; Jamil M, 2011, IEEE ELECTR DEVICE L, V32, P1203, DOI 10.1109/LED.2011.2160142; Mathiot D., 1998, Materials Science in Semiconductor Processing, V1, DOI 10.1016/S1369-8001(98)00045-6; Parker MA, 2005, PHYS OPTOELECTRONICS; Peng CY, 2009, J APPL PHYS, V105, DOI 10.1063/1.3110184; Saito S, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3670053; Saito S., 2014, FRONT MAT, V1, P15; Sorianello V, 2014, PHYS STATUS SOLIDI C, V11, P57, DOI 10.1002/pssc.201300114; Wanlass F., 1963, 6 INT SOL STAT CIRC, P32; Xu X., 2014, C LAS EL CLEO	36	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							052101	10.7567/JJAP.54.052101		6	Physics, Applied	Physics	CI7XS	WOS:000354980300011		
J	Arimochi, M; Watanabe, T; Yoshida, H; Tange, T; Nomachi, I; Ikeda, M; Dai, P; He, W; Ji, L; Lu, SL; Yang, H; Uchida, S				Arimochi, Masayuki; Watanabe, Tomomasa; Yoshida, Hiroshi; Tange, Takashi; Nomachi, Ichiro; Ikeda, Masao; Dai, Pan; He, Wei; Ji, Lian; Lu, Shulong; Yang, Hui; Uchida, Shiro			III-V compound semiconductor multi-junction solar cells fabricated by room-temperature wafer-bonding technique	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							MOLECULAR-BEAM-EPITAXY; HIGH-EFFICIENCY; JUNCTION; GAAS; OPTIMIZATION; DIFFUSION	We have developed III-V compound semiconductor multi-junction solar cells by a room-temperature wafer-bonding technique to avoid the formation of dislocations and voids due to lattice mismatch and thermal damage during a conventional high-temperature wafer-bonding process. First, we separately grew an (Al) GaAs top cell on a GaAs substrate and an InGaAs bottom cell on an InP substrate by metal solid source molecular beam epitaxy. Thereafter, we successfully bonded these sub-cells by the room-temperature wafer-bonding technique and fabricated (Al) GaAs parallel to InGaAs wafer-bonded solar cells. To the best of our knowledge, the obtained GaAs parallel to InGaAs and AlGaAs parallel to InGaAs wafer-bonded solar cells exhibited the lowest electrical and optical losses ever reported. The AlGaAs parallel to InGaAs solar cells reached the maximum efficiency of 27.7% at 120 suns. These results suggest that the room-temperature wafer-bonding technique has high potential for achieving higher conversion efficiencies. (C) 2015 The Japan Society of Applied Physics	[Arimochi, Masayuki; Watanabe, Tomomasa; Yoshida, Hiroshi; Tange, Takashi; Nomachi, Ichiro; Uchida, Shiro] Sony Corp, Adv Mat Labs, Atsugi, Kanagawa 2430014, Japan; [Ikeda, Masao; Dai, Pan; He, Wei; Ji, Lian; Lu, Shulong; Yang, Hui] Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, Suzhou 215123, Jiangsu, Peoples R China	Arimochi, M (reprint author), Sony Corp, Adv Mat Labs, 4-14-1 Asahi Cho, Atsugi, Kanagawa 2430014, Japan.	Masayuki.Arimochi@jp.sony.com					AMANO C, 1987, APPL PHYS LETT, V51, P1998, DOI 10.1063/1.98272; AMANO C, 1985, J APPL PHYS, V58, P2780, DOI 10.1063/1.335871; AMANO C, 1987, APPL PHYS LETT, V51, P1075, DOI 10.1063/1.98744; McCambridge JD, 2011, PROG PHOTOVOLTAICS, V19, P352, DOI 10.1002/pip.1030; Geisz JF, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2753729; Derendorf K, 2013, IEEE J PHOTOVOLT, V3, P1423, DOI 10.1109/JPHOTOV.2013.2273097; HENRY CH, 1980, J APPL PHYS, V51, P4494, DOI 10.1063/1.328272; Mitchell B, 2011, PROG PHOTOVOLTAICS, V19, P61, DOI 10.1002/pip.988; Green MA, 2014, PROG PHOTOVOLTAICS, V22, P701, DOI 10.1002/pip.2525; Xiong KL, 2010, SOL ENERGY, V84, P1975, DOI 10.1016/j.solener.2010.10.011; Matsubara H, 1998, SOL ENERG MAT SOL C, V50, P177, DOI 10.1016/S0927-0248(97)00142-6; Mizuno H, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4766339; Tanabe K, 2006, APPL PHYS LETT, V89, DOI [10.1063/1.2347280, 10.1063/1.2348280]; Dimroth F, 2014, PROG PHOTOVOLTAICS, V22, P277, DOI 10.1002/pip.2475; Chiu PT, 2014, IEEE J PHOTOVOLT, V4, P493, DOI 10.1109/JPHOTOV.2013.2279336; Takamoto T, 1997, JPN J APPL PHYS 1, V36, P6215, DOI 10.1143/JJAP.36.6215; Guter W, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3148341; Kurtz S, 2008, PROG PHOTOVOLTAICS, V16, P537, DOI 10.1002/pip.830; Yamaguchi M, 2008, SOL ENERGY, V82, P173, DOI 10.1016/j.solener.2007.06.011; King RR, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2734507; Takamoto T, 1999, J APPL PHYS, V85, P1481, DOI 10.1063/1.369278; Yamaguchi M, 2005, SOL ENERGY, V79, P78, DOI 10.1016/j.solener.2004.09.018; Dai P., 2013, J SEMICOND, V34; Kojima N, 1998, SOL ENERG MAT SOL C, V50, P237, DOI 10.1016/S0927-0248(97)00153-0; Lu SL, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-576; Nakayama K, 2008, J APPL PHYS, V103, DOI 10.1063/1.2912717; Sameshima T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.052301; Shigekawa N, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.04ER05; Tanabe K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00349; Uchida S, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.112301; WATKINS SP, 1991, APPL PHYS LETT, V59, P2263, DOI 10.1063/1.106064; Yoon SF, 1999, JPN J APPL PHYS 1, V38, P981, DOI 10.1143/JJAP.38.981	32	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							056601	10.7567/JJAP.54.056601		4	Physics, Applied	Physics	CI7XS	WOS:000354980300044		
J	Banzai, K; Naka, S; Okada, H				Banzai, Kazuki; Naka, Shigeki; Okada, Hiroyuki			MoO3/Ag/MoO3 anode for organic light-emitting diodes and its carrier injection property	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ELECTROLUMINESCENT DEVICES; TRANSPARENT ELECTRODES; THIN-FILMS; CATHODE; ENERGY; LAYER; GRIDS; OXIDE	We report on the application of the dielectric/metal/dielectric (DMD) structure consisting of a molybdenum trioxide (MoO3)/silver (Ag)/MoO3 stack as the transparent electrode in organic light-emitting diodes (OLEDs). Bright emission similar to that of the indium-tin-oxide anode (ITO) device was obtained from the OLEDs with the DMD anode. Also, the barrier height at the interface of DMD/bis[N-(1-naphthyl)-N-phenyl] benzidine (alpha-NPD) is similar to that at the ITO/alpha-NPD interface. The DMD electrode is a promising anode for OLEDs. (C) 2015 The Japan Society of Applied Physics	[Banzai, Kazuki; Naka, Shigeki; Okada, Hiroyuki] Toyama Univ, Grad Sch Sci & Engn Res, Toyama 9308555, Japan; [Okada, Hiroyuki] Toyama Univ, Ctr Res & Dev Nat Sci, Toyama 9308555, Japan	Banzai, K (reprint author), Toyama Univ, Grad Sch Sci & Engn Res, Toyama 9308555, Japan.	nak@eng.u-toyama.ac.jp			Mazda Foundation	Part of this research work is supported by a research grant from The Mazda Foundation.	Sivaramakrishnan K, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3077184; Al-Kuhaili MF, 2002, THIN SOLID FILMS, V408, P188, DOI 10.1016/S0040-6090(02)00138-4; Zhang DH, 2006, NANO LETT, V6, P1880, DOI 10.1021/nl0608543; TANG CW, 1989, J APPL PHYS, V65, P3610, DOI 10.1063/1.343409; PARKER ID, 1994, J APPL PHYS, V75, P1656, DOI 10.1063/1.356350; FAN JCC, 1974, APPL PHYS LETT, V25, P693, DOI 10.1063/1.1655364; Miyashita T, 2005, JPN J APPL PHYS 1, V44, P3682, DOI 10.1143/JJAP.44.3682; ADACHI C, 1988, JPN J APPL PHYS 2, V27, pL269, DOI 10.1143/JJAP.27.L269; Hong K, 2011, J PHYS CHEM C, V115, P3453, DOI 10.1021/jp109943b; Tokito S, 1996, J PHYS D APPL PHYS, V29, P2750, DOI 10.1088/0022-3727/29/11/004; Bharathan J, 1998, APPL PHYS LETT, V72, P2660, DOI 10.1063/1.121090; Yook KS, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2955528; Matsushima T, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2825275; Tvingstedt K, 2007, ADV MATER, V19, P2893, DOI 10.1002/adma.200602561; GUSTAFSSON G, 1992, NATURE, V357, P477, DOI 10.1038/357477a0; Lim JW, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.115801; Kang MG, 2007, ADV MATER, V19, P1391, DOI 10.1002/adma.200700134; Wu JB, 2010, ACS NANO, V4, P43, DOI 10.1021/nn900728d; Naka S, 1997, SYNTHETIC MET, V91, P129, DOI 10.1016/S0379-6779(98)80072-6; Sam FLM, 2014, LASER PHOTONICS REV, V8, P172, DOI 10.1002/lpor.201300121; Jeon K, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-253; Koike K, 2008, J VAC SCI TECHNOL A, V26, P444, DOI 10.1116/1.2897315; Kumar A, 2008, OPT EXPRESS, V16, P16113, DOI 10.1364/OE.16.016113; Liu XJ, 2001, APPL SURF SCI, V183, P103, DOI 10.1016/S0169-4332(01)00570-0; Matsumura M, 1996, JPN J APPL PHYS 1, V35, P5735, DOI 10.1143/JJAP.35.5735; Moon DG, 2004, SYNTHETIC MET, V146, P63, DOI 10.1016/j.synthmet.2004.06.002; PRESLAND AE, 1972, SURF SCI, V29, P435, DOI 10.1016/0039-6028(72)90230-0; Ryu SY, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2835044; Shibasaki M., 2013, P 20 IDW, P915; Shimazaki N, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.041602; Takayama M, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.05DC15; TANG CW, 1987, APPL PHYS LETT, V51, P913, DOI 10.1063/1.98799; Tian BL, 2011, J APPL PHYS, V110, DOI 10.1063/1.3662194; Tsutsui T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.110001; Zhao JQ, 2000, SYNTHETIC MET, V114, P251, DOI 10.1016/S0379-6779(00)00237-X; Zou JY, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3394679	36	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							054101	10.7567/JJAP.54.054101		4	Physics, Applied	Physics	CI7XS	WOS:000354980300026		
J	Chen, YQ; Kawamura, Y; Hayashi, J; Sekine, C				Chen, Yuqi; Kawamura, Yukihiro; Hayashi, Junichi; Sekine, Chihiro			Thermoelectric properties of YbxCo4Sb12 prepared under high pressure	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SKUTTERUDITE-TYPE STRUCTURE; COSB3 SKUTTERUDITES; LATTICE	We report the thermoelectric properties of partially filled skutterudites YbxCo4Sb12 (0 <= x <= 0.8) synthesized under high pressure. The phase compositions and actual Yb filling ratios were characterized by X-ray diffraction and electron probe microanalysis (EPMA), respectively. The EPMA results show that the maximum actual Yb doping content can be increased to 0.29, the highest for any YbxCo4Sb12 reported so far. The lattice thermal conductivity is reduced by increasing the Yb filling fraction. The minimum value is 2.02 Wm(-1)K(-1) for Yb0.6Co4Sb12 at 300 K. The electrical conductivity and the Seebeck coefficient for Yb-doped samples exhibit the typical behavior of n-type filled skutterudites. The maximum ZT value is 0.1 for Yb0.2Co4Sb12 at room temperature. (C) 2015 The Japan Society of Applied Physics	[Chen, Yuqi; Kawamura, Yukihiro; Hayashi, Junichi; Sekine, Chihiro] Muroran Inst Technol, Muroran, Hokkaido 0508585, Japan	Chen, YQ (reprint author), Muroran Inst Technol, Muroran, Hokkaido 0508585, Japan.	sekine@mmm.muroran-it.ac.jp			Japan Society for the Promotion of Science [23340092]	This work was supported by a Grant-in-Aid for Scientific Research (B) (No. 23340092) from the Japan Society for the Promotion of Science. The authors gratefully acknowledge Dr. Patrick Heinrich (Vienna University of Technology, Austria) for his helpful discussions and assistance with language editing.	Yang J, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.115329; Sekine C, 2000, PHYS REV B, V62, P11581, DOI 10.1103/PhysRevB.62.11581; Zhao XY, 2006, APPL PHYS LETT, V89, DOI [10.1063/1.2345249, 10.1016/1.2345249]; SHARP JW, 1995, J APPL PHYS, V78, P1013, DOI 10.1063/1.360402; Nolas GS, 1996, J APPL PHYS, V79, P4002, DOI 10.1063/1.361828; Sales BC, 1997, PHYS REV B, V56, P15081, DOI 10.1103/PhysRevB.56.15081; Li H, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2936277; Shi X, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.185503; Nolas GS, 2000, APPL PHYS LETT, V77, P1855, DOI 10.1063/1.1311597; Nolas GS, 1999, ANNU REV MATER SCI, V29, P89, DOI 10.1146/annurev.matsci.29.1.89; Bauer E, 2000, EUR PHYS J B, V14, P483, DOI 10.1007/s100510051057; Dimitrov IK, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.174301; Liu HQ, 2012, J RARE EARTH, V30, P456, DOI 10.1016/S1002-0721(12)60072-6; Mei ZG, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.153202; Mi JL, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.064114; Mori H, 2005, MATER TRANS, V46, P1476, DOI 10.2320/matertrans.46.1476; Nagao J, 2002, J APPL PHYS, V92, P4135, DOI 10.1063/1.1503161; Park KH, 2013, J KOREAN PHYS SOC, V63, P1764, DOI 10.3938/jkps.63.1764; Park KH, 2014, J KOREAN PHYS SOC, V65, P491, DOI 10.3938/jkps.65.491; Sekine C, 1998, SOLID STATE COMMUN, V106, P441, DOI 10.1016/S0038-1098(98)00062-3; Sekine C, 2008, J PHYS SOC JPN, V77, P135, DOI 10.1143/JPSJS.77SA.135; Shirotani I, 2005, J PHYS-CONDENS MAT, V17, P7353, DOI 10.1088/0953-8984/17/46/019; Takizawa H, 1999, J ALLOY COMPD, V282, P79, DOI 10.1016/S0925-8388(98)00802-0; Tang GD, 2011, J ELECTRON MATER, V40, P611, DOI 10.1007/s11664-010-1477-9; Uher C, 2001, SEMICONDUCT SEMIMET, V69, P139	25	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							055501	10.7567/JJAP.54.055501		5	Physics, Applied	Physics	CI7XS	WOS:000354980300036		
J	Enpuku, K; Miyazaki, T; Morishita, M; Tsujita, Y; Matsuo, M; Bai, S; Sasayama, T; Yoshida, T				Enpuku, Keiji; Miyazaki, Takashi; Morishita, Manabu; Tsujita, Yuya; Matsuo, Masaaki; Bai, Shi; Sasayama, Teruyoshi; Yoshida, Takashi			Narrowband magnetic nanoparticle imaging using cooled pickup coil and gradient field	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							MRI; MPI; SYSTEM	Magnetic particle imaging (MPI) has been extensively studied for in-vivo biomedical diagnosis. We developed a narrowband MPI system utilizing third harmonic detection. The third harmonic signal from the magnetic nanoparticles (MNPs) was detected with a pickup coil cooled to 77 K, and its output was read out with a resonant circuit. The noise of the detection system was S-B(1/2) = 12 fT/Hz(1/2) at a signal frequency of 8.79 kHz. We also introduced the so-called gradient field with a field gradient of 0.3 T/m in order to improve the MPI spatial resolution. We first clarified the properties of MNPs, which provided the basis for MPI using the gradient field. Next, we measured the signal-field map generated from the MNPs when an excitation field with a root mean square value of 1.6 mT and frequency of 2.93 kHz was applied. Using a mathematical technique called singular value decomposition (SVD), we reconstructed an image of the MNP distribution from the measured map. We demonstrated the detection of MNP samples as small as 1 mu g at a distance of 50 mm. The spatial resolution of the reconstructed MNP distribution was approximately 10 mm. These results will indicate the feasibility of the system for the application to breast cancer detection. (C) 2015 The Japan Society of Applied Physics	[Enpuku, Keiji; Miyazaki, Takashi; Morishita, Manabu; Tsujita, Yuya; Matsuo, Masaaki; Bai, Shi; Sasayama, Teruyoshi; Yoshida, Takashi] Kyushu Univ, Dept Elect Engn, Fukuoka 8190395, Japan	Enpuku, K (reprint author), Kyushu Univ, Dept Elect Engn, Fukuoka 8190395, Japan.				Strategic Promotion of Innovative R&D, Japan Science and Technology Agency	This work was supported in part by the Strategic Promotion of Innovative R&D, Japan Science and Technology Agency.	Adolphi NL, 2012, CONTRAST MEDIA MOL I, V7, P308, DOI 10.1002/cmmi.499; Saritas EU, 2013, J MAGN RESON, V229, P116, DOI 10.1016/j.jmr.2012.11.029; Goodwill PW, 2012, ADV MATER, V24, P3870, DOI 10.1002/adma.201200221; Dhavalikar R, 2014, J APPL PHYS, V115, DOI 10.1063/1.4866680; Morishige T, 2014, IEEE T APPL SUPERCON, V24, DOI 10.1109/TASC.2014.2311433; Enpuku K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.103002; Bai S, 2014, IEEE T MAGN, V50, DOI 10.1109/TMAG.2014.2324556; Flynn ER, 2005, PHYS MED BIOL, V50, P1273, DOI 10.1088/0031-9155/50/6/016; Othman NB, 2012, IEEE T MAGN, V48, P3776, DOI 10.1109/TMAG.2012.2198440; Goodwill PW, 2011, IEEE T MED IMAGING, V30, P1581, DOI 10.1109/TMI.2011.2125982; Gleich B, 2005, NATURE, V435, P1214, DOI 10.1038/nature03808; Hong H, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4861916; Goodwill PW, 2009, IEEE T MED IMAGING, V28, P1231, DOI 10.1109/TMI.2009.2013849; Yoshida T, 2013, J APPL PHYS, V114, DOI 10.1063/1.4829484; Knopp T, 2010, IEEE T MED IMAGING, V29, P12, DOI 10.1109/TMI.2009.2021612; Rahmer J, 2012, IEEE T MED IMAGING, V31, P1289, DOI 10.1109/TMI.2012.2188639; Ludwig F, 2014, J MAGN MAGN MATER, V360, P169, DOI 10.1016/j.jmmm.2014.02.020; Borgert J, 2012, J CARDIOVASC COMPUT, V6, P149, DOI 10.1016/j.jcct.2012.04.007; Chieh JJ, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2012.2229778; Enpuku K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.087001; Hathaway HJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3050; Huang KW, 2012, INT J NANOMED, V7, P2987, DOI 10.2147/IJN.S30061; Magnelind PE, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/4/044031; Murase K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.067001; Vogel P, 2014, IEEE T MED IMAGING, V33, P1954, DOI 10.1109/TMI.2014.2327515	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							057002	10.7567/JJAP.54.057002		6	Physics, Applied	Physics	CI7XS	WOS:000354980300046		
J	Harii, K; Chudo, H; Ono, M; Matsuo, M; Ieda, J; Okayasu, S; Maekawa, S; Saitoh, E				Harii, Kazuya; Chudo, Hiroyuki; Ono, Masao; Matsuo, Mamoru; Ieda, Jun'ichi; Okayasu, Satoru; Maekawa, Sadamichi; Saitoh, Eiji			Line splitting by mechanical rotation in nuclear magnetic resonance	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							PHASE	Nuclear magnetic resonance (NMR) measurements for a nuclear spin 1/2 system in an external magnetic field and mechanical rotation in kHz range are reported. NMR signals are measured by the synchronous rotation of a sample and a detector coil under the condition that the rotation axis is perpendicular to the external field. NMR line splits into two despite the system having a single Zeeman level separation. We analytically show that the splitting originates in the nuclear spin motion under mechanical rotation, and is determined by only the angular velocity of the rotation without any material parameters. (C) 2015 The Japan Society of Applied Physics	[Harii, Kazuya; Chudo, Hiroyuki; Ono, Masao; Matsuo, Mamoru; Ieda, Jun'ichi; Okayasu, Satoru; Maekawa, Sadamichi; Saitoh, Eiji] Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan; [Harii, Kazuya; Chudo, Hiroyuki; Ono, Masao; Matsuo, Mamoru; Ieda, Jun'ichi; Okayasu, Satoru; Maekawa, Sadamichi; Saitoh, Eiji] Japan Sci & Technol Agcy, ERATO, Sendai, Miyagi 9808577, Japan; [Saitoh, Eiji] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Saitoh, Eiji] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan	Harii, K (reprint author), Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan.		Saitoh, Eiji/C-1004-2011		Ministry of Education, Culture, Sports, Science and Technology, Japan [26103005, 00633900, 25800209, 20463797, 24760722, 24244051, 26247063]	The authors thank H. Yasuoka for valuable discussions. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Nano Spin Conversion Science" (26103005) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This work was also supported by a Grant-in-Aid for Challenging Exploratory Research (00633900), Grants-in-Aid for Young Scientists B (25800209, 20463797, and 24760722), Grants-in-Aid for Scientific Research A (24244051 and 26247063) from the the Ministry of Education, Culture, Sports, Science and Technology, Japan.	ANDERSON WA, 1954, PHYS REV, V94, P497, DOI 10.1103/PhysRev.94.497; SIMON B, 1983, PHYS REV LETT, V51, P2167, DOI 10.1103/PhysRevLett.51.2167; Barnett SJ, 1935, REV MOD PHYS, V7, P0129, DOI 10.1103/RevModPhys.7.129; WILCZEK F, 1984, PHYS REV LETT, V52, P2111, DOI 10.1103/PhysRevLett.52.2111; Matsuo M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.076601; Chudo H, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.063004; HEHL FW, 1990, PHYS REV D, V42, P2045, DOI 10.1103/PhysRevD.42.2045; Barnett SJ, 1915, PHYS REV, V6, P239, DOI 10.1103/PhysRev.6.239; Sakellariou D, 2007, NATURE, V447, P694, DOI 10.1038/nature05897; Stone NJ, 2005, ATOM DATA NUCL DATA, V90, P75, DOI 10.1016/j.adt.2005.04.001; BERRY MV, 1984, P ROY SOC LOND A MAT, V392, P45, DOI 10.1098/rspa.1984.0023; BLOCH F, 1954, PHYS REV, V94, P496, DOI 10.1103/PhysRev.94.496.2; Einstein A., 1915, KNAW P 1, V18, P698; Griffiths D. J., 2004, INTRO QUANTUM MECH; KAPLAN JI, 1957, J CHEM PHYS, V27, P1426, DOI 10.1063/1.1744033; Matsuo M, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.180402; Slichter C.P., 1996, PRINCIPLES MAGNETIC; TYCKO R, 1987, PHYS REV LETT, V58, P2281, DOI 10.1103/PhysRevLett.58.2281; WILLIAMS GA, 1956, PHYS REV, V104, P278, DOI 10.1103/PhysRev.104.278; Zolfagharkhani G, 2008, NAT NANOTECHNOL, V3, P720, DOI 10.1038/nnano.2008.311	20	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							050302	10.7567/JJAP.54.050302		3	Physics, Applied	Physics	CI7XS	WOS:000354980300003		
J	Hishida, M; Ueno, H; Sekimoto, T; Terakawa, A				Hishida, Mitsuoki; Ueno, Hiroyuki; Sekimoto, Takeyuki; Terakawa, Akira			Use of microcrystallinity depth profiling in an actual tandem silicon solar cell by polishing to achieve high conversion efficiency	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SURFACE-MORPHOLOGY; THIN-FILMS; MICROSTRUCTURE; SUBSTRATE	In order to perform an accurate evaluation of the crystallinity (X-c) of hydrogenated microcrystalline silicon (mu c-Si:H), polishing was performed from the electrode layer side after measuring the current-voltage characteristics of thin-film silicon tandem solar cells. The angle of polishing was about 1.4 degrees, and the mu c-Si:H was exposed in the horizontal direction. The polishing could facilitate the measurement of X-c in the vertical direction of mu c-Si: H by Raman analysis, and it succeeded in revealing a variation of X-c in the depth direction of the solar cell, which even further clarified its characteristics of the solar cells. Additionally, an X-c-adjustment film was used to adjust the X-c profile of i-mu c-Si:H. It could control X-c in the depth direction of mu c-Si:H, and a high X-c was obtained, which did not decrease during the process of forming a thick film. As a result, the conversion efficiency was improved by 1.8% (0.21 points) compared with that under normal conditions. In this paper, we propose an index of the Xc profile of mu c-Si:H for obtaining high conversion efficiency. (C) 2015 The Japan Society of Applied Physics	[Hishida, Mitsuoki; Sekimoto, Takeyuki] Panasonic Corp, R&D Div, Kyoto 6190237, Japan; [Ueno, Hiroyuki] Eco Solut Co, SANYO Elect Co Ltd, Eco Solut Div, Panasonic Grp, Kaizuka, Osaka 5970094, Japan; [Terakawa, Akira] Panasonic Corp, Eco Solut Co, Kadoma, Osaka 5718686, Japan	Hishida, M (reprint author), Panasonic Corp, Automot & Ind Syst Co, Kyoto 6190237, Japan.	hishida.mitsuoki@jp.panasonic.com					Bailat J, 2002, J NON-CRYST SOLIDS, V299, P1219, DOI 10.1016/S0022-3093(01)01142-5; Nasuno Y, 2001, JPN J APPL PHYS 2, V40, pL303, DOI 10.1143/JJAP.40.L303; Dolbec R, 2002, THIN SOLID FILMS, V419, P230, DOI 10.1016/S0040-6090(02)00769-1; Konagai M, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.030001; HISHIKAWA Y, 1991, JPN J APPL PHYS 1, V30, P1008, DOI 10.1143/JJAP.30.1008; Droz C, 2004, SOL ENERG MAT SOL C, V81, P61, DOI 10.1016/j.solmat.2003.07.004; Matsui T, 2002, JPN J APPL PHYS 1, V41, P20, DOI 10.1143/JJAP.41.201; Smets AHM, 2008, J APPL PHYS, V104, DOI 10.1063/1.2961334; Smets AHM, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2837536; Terakawa A, 2013, SOL ENERG MAT SOL C, V119, P204, DOI 10.1016/j.solmat.2013.06.044; Boccard M, 2014, IEEE J PHOTOVOLT, V4, P1368, DOI 10.1109/JPHOTOV.2014.2357495; Keppner H, 1999, APPL PHYS A-MATER, V69, P169, DOI 10.1007/s003390050987; Hongsingthong A, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.051102; Bailat J., 2006, P 4 WORLD C PHOT EN; Choong G, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/23/235105; Cuony P, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3517492; Flikweert AJ, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/1/015101; Kanematsu D, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.076501; Kim S, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NB11; Krajangsang T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.051101; Kurokawa A, 2004, JPN J APPL PHYS 1, V43, P281, DOI 10.1143/JJAP.43.281; Meier J, 2001, SOL ENERG MAT SOL C, V66, P73, DOI 10.1016/S0927-0248(00)00160-4; Mirabella Jr F. M., 1993, INTERNAL REFLECTION, P255; Naruse Y., 2012, P 38 IEEE PHOT SCI E; Sasaki T., 2010, P 35 IEEE PHOT SPEC, P412; Sekimoto T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.095501; Shimizu T, 1999, JPN J APPL PHYS 2, V38, pL911, DOI 10.1143/JJAP.38.L911; Smets A H M, 2009, Proceedings of the 2009 34th IEEE Photovoltaic Specialists Conference (PVSC 2009), DOI 10.1109/PVSC.2009.5411182; Terakawa A., 2013, MRS P, V1536, P17; Terakawa Akira, 2011, Proceedings of the 26th European International Conference on Photovoltaic Solar Energy; Vallat-Sauvain E, 2005, THIN SOLID FILMS, V485, P77, DOI 10.1016/j.tsf.2005.03.017; Wen C, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-303; Xu L, 2011, J APPL PHYS, V110, DOI 10.1063/1.3638712; YAMAMOTO I, 1992, JPN J APPL PHYS 2, V31, pL1381; YAMASHIT.K, 1969, JPN J APPL PHYS, V8, P1505, DOI 10.1143/JJAP.8.1505; Yata S., 2012, 22 PHOT SCI ENG C, P4	36	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							052302	10.7567/JJAP.54.052302		5	Physics, Applied	Physics	CI7XS	WOS:000354980300016		
J	Nguyen, HD; Ono, T				Huy Duy Nguyen; Ono, Tomoya			Electron-transport properties of ethyne-bridged diphenyl zinc-porphyrin molecules	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							WIRES; CONDUCTANCE; RESISTANCE; JUNCTIONS; SYSTEMS	We investigate the electron-transport properties of ethyne-bridged diphenyl zinc-porphyrin molecules suspended between gold (111) electrodes by first-principles calculations within the framework of density functional theory. It is found that the conductance of a molecular junction in which phenyl and porphyrin rings are perpendicular is reduced by three orders of magnitude compared with that of a junction in which the phenyl and porphyrin rings are coplanar. In the coplanar configuration, electrons are transmitted through p states, which extend over the whole molecule. In the perpendicular configuration, the conductance is suppressed because of the reduction of electron hopping between p states of the phenyl ring and s states of the porphyrin ring. (C) 2015 The Japan Society of Applied Physics	[Huy Duy Nguyen] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Ono, Tomoya] Univ Tsukuba, Ctr Computat Sci, Tsukuba, Ibaraki 3058577, Japan; [Ono, Tomoya] JST PRESTO, Kawaguchi, Saitama 3320012, Japan	Nguyen, HD (reprint author), Vietnam Natl Univ, Hanoi Univ Sci, Fac Phys, 334 Nguyen Trai, Hanoi, Vietnam.	huy@cp.prec.eng.osaka-u.ac.jp	Ono, Tomoya/C-5077-2013		Computational Materials Science Initiative (CMSI); Japan Society for the Promotion of Science "Core to Core" Program; Ministry of Education, Culture, Sports, Science and Technology, Japan [22104007]	This research was partially supported by the Computational Materials Science Initiative (CMSI), the Japan Society for the Promotion of Science "Core to Core" Program, and a Grant-in-Aid for Scientific Research on Innovative Areas (Grant No. 22104007) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The numerical calculation was carried out using the computer facilities of the Institute for Solid State Physics at the University of Tokyo and Center for Computational Sciences at the University of Tsukuba. H.D.N. thanks Faculty of Physics, Hanoi University of Science, Vietnam National University, for providing the computer facilities during preparing and revising the manuscript.	Hakkinen H, 2012, NAT CHEM, V4, P443, DOI [10.1038/nchem.1352, 10.1038/NCHEM.1352]; Moresco F, 2001, PHYS REV LETT, V86, P672, DOI 10.1103/PhysRevLett.86.672; Emberly EG, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.188301; Di Ventra M, 2000, PHYS REV LETT, V84, P979, DOI 10.1103/PhysRevLett.84.979; An YP, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3615492; Ono T, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.205115; Xu BQ, 2003, SCIENCE, V301, P1221, DOI 10.1126/science.1087481; Banerjee P, 2010, ACS NANO, V4, P1019, DOI 10.1021/nn901148m; Ono T, 1999, PHYS REV LETT, V82, P5016, DOI 10.1103/PhysRevLett.82.5016; Nitzan A, 2003, SCIENCE, V300, P1384, DOI 10.1126/science.1081572; Ghosh AW, 2004, NANO LETT, V4, P565, DOI 10.1021/nl035109u; Sedghi G, 2008, J AM CHEM SOC, V130, P8582, DOI 10.1021/ja802281c; Tans SJ, 1997, NATURE, V386, P474, DOI 10.1038/386474a0; LIN VSY, 1994, SCIENCE, V264, P1105, DOI 10.1126/science.8178169; JOACHIM C, 1995, PHYS REV LETT, V74, P2102, DOI 10.1103/PhysRevLett.74.2102; TROULLIER N, 1991, PHYS REV B, V43, P1993, DOI 10.1103/PhysRevB.43.1993; BUTTIKER M, 1985, PHYS REV B, V31, P6207, DOI 10.1103/PhysRevB.31.6207; PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048; Madsen CB, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.073007; Li ZH, 2012, NANO LETT, V12, P2722, DOI 10.1021/nl2043216; Sedghi G, 2011, NAT NANOTECHNOL, V6, P517, DOI [10.1038/nnano.2011.111, 10.1038/NNANO.2011.111]; Winters MU, 2007, J PHYS CHEM C, V111, P7192, DOI 10.1021/jp0683519; Blchl P. E., 1994, PHYS REV B, VB50, P17953, DOI DOI 10.1103/PHYSREVB.50.17953; CHELIKOWSKY JR, 1994, PHYS REV LETT, V72, P1240, DOI 10.1103/PhysRevLett.72.1240; Fujimoto Y, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.195315; Hirose K., 2005, 1 PRINCIPLES CALCULA; Kobayashi K, 1999, COMP MATER SCI, V14, P72, DOI 10.1016/S0927-0256(98)00074-3; Kong LZ, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.235422; Madsen CB, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3149789; Ono T, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.085115; Orellana P, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.178302; Ramakrishna S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.103001; Sergueev N, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.073106; Xue YQ, 1999, PHYS REV B, V59, pR7852, DOI 10.1103/PhysRevB.59.R7852	34	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							055201	10.7567/JJAP.54.055201		4	Physics, Applied	Physics	CI7XS	WOS:000354980300033		
J	Imamura, M; Kobayashi, E; Sasaki, M				Imamura, Motoyasu; Kobayashi, Eiichi; Sasaki, Masahiro			Depth analysis on oxidation of Al/Si(111) thin film by X-ray photoelectron spectroscopy using synchrotron radiation	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							MEAN FREE PATHS; ENERGY-LOSS-SPECTROSCOPY; ALUMINUM-OXIDE FILMS; SINGLE-CRYSTAL FACES; CORE-LEVEL SHIFTS; OXYGEN-ADSORPTION; OXIDIZED ALUMINUM; AL(111) OXIDATION; INITIAL-STAGES; SURFACE EXAFS	An Al thin film deposited on a Si(111) substrate in an ultrahigh vacuum (UHV) chamber was oxidized by oxygen exposure of 4 and 100 L at room temperature. Then, X-ray photoelectron spectroscopy (XPS) using X-rays with various excitation energies using synchrotron radiation (SR) was carried out to evaluate the thickness of the very thin oxide. The obtained spectra showed Al 2p peaks assigned to the metal and the oxide. From their peak ratios obtained by the curve fitting of the spectra, the depth profile of oxygen composition was derived by considering the analysis depth of XPS on the basis of the effective attenuation length (EAL) of photoelectrons. By simulation using a single-layer model, the thicknesses of the oxide generated by oxygen exposure of 4 and 100 L were determined. The results suggest that the oxide layer generated by only a few langumuir of oxygen in the initial stage suppresses the diffusion of oxygen to the interface of the oxide and the metal. (C) 2015 The Japan Society of Applied Physics	[Imamura, Motoyasu; Kobayashi, Eiichi] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan; [Imamura, Motoyasu; Sasaki, Masahiro] Univ Tsukuba, Inst Appl Phys, Tsukuba, Ibaraki 3058573, Japan	Imamura, M (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan.	motoyasu@ni.aist.go.jp			Nanotechnology Material Metrology Project	This experiment using SR was performed under the approval of the Photon Factory Advisory Committee (Proposal 2003G268) of the High Energy Accelerator Research Organization. The research was supported by the Nanotechnology Material Metrology Project (FY2001-2007) managed by the New Energy and Industrial Technology Development Organization (NEDO).	Klein TM, 1999, APPL PHYS LETT, V75, P4001, DOI 10.1063/1.125519; Jeurgens LPH, 2000, APPL SURF SCI, V161, P139, DOI 10.1016/S0169-4332(00)00273-7; OLEFJORD I, 1990, SURF INTERFACE ANAL, V15, P681, DOI 10.1002/sia.740151108; Jeurgens LPH, 1999, APPL SURF SCI, V144-45, P11, DOI 10.1016/S0169-4332(98)00755-7; BRUNE H, 1993, J CHEM PHYS, V99, P2128, DOI 10.1063/1.465278; BERG C, 1993, PHYS REV B, V47, P13063, DOI 10.1103/PhysRevB.47.13063; MARTINSON CWB, 1979, SURF SCI, V80, P306, DOI 10.1016/0039-6028(79)90691-5; Copel M, 2001, APPL PHYS LETT, V78, P2670, DOI 10.1063/1.1367902; EALET B, 1994, THIN SOLID FILMS, V250, P92, DOI 10.1016/0040-6090(94)90171-6; Imamura M, 2000, J PHYS CHEM B, V104, P7348, DOI 10.1021/jp994148k; TANUMA S, 1993, SURF INTERFACE ANAL, V20, P77, DOI 10.1002/sia.740200112; TANUMA S, 1991, SURF INTERFACE ANAL, V17, P927, DOI 10.1002/sia.740171305; Schmid M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.046101; Alexander MR, 2002, SURF INTERFACE ANAL, V34, P485, DOI 10.1002/sia.1344; THOMAS PV, 1989, THIN SOLID FILMS, V170, P35, DOI 10.1016/0040-6090(89)90619-6; Reichel F, 2008, J APPL PHYS, V103, DOI 10.1063/1.2913505; SASAKI S, 1989, REV SCI INSTRUM, V60, P1859, DOI 10.1063/1.1140923; TANUMA S, 1994, SURF INTERFACE ANAL, V21, P165, DOI 10.1002/sia.740210302; Tanuma S, 2003, SURF INTERFACE ANAL, V35, P268, DOI 10.1002/sia.1526; Alexander MR, 2000, SURF INTERFACE ANAL, V29, P468, DOI 10.1002/1096-9918(200007)29:7<468::AID-SIA890>3.0.CO;2-V; STROHMEIER BR, 1990, SURF INTERFACE ANAL, V15, P51, DOI 10.1002/sia.740150109; Zhukov V, 1999, SURF SCI, V441, P240, DOI 10.1016/S0039-6028(99)00613-5; BACHRACH RZ, 1981, SURF SCI, V109, pL560; BARRIE A, 1973, CHEM PHYS LETT, V19, P109, DOI 10.1016/0009-2614(73)87074-5; BEDAIR SM, 1968, J APPL PHYS, V39, P4026, DOI 10.1063/1.1656896; BEDAIR SM, 1971, J APPL PHYS, V42, P3616, DOI 10.1063/1.1660777; Borg M, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.235418; Chang CL, 2009, J PHYS CHEM C, V113, P3502, DOI 10.1021/jp808424g; CLARK DT, 1973, NATURE-PHYS SCI, V244, P77; CROWELL JE, 1986, SURF SCI, V165, P37, DOI 10.1016/0039-6028(86)90663-1; Do T., 1999, SURF SCI, V433-435, P136; DONIACH S, 1970, J PHYS PART C SOLID, V3, P285, DOI 10.1088/0022-3719/3/2/010; ERSKINE JL, 1982, PHYS REV B, V25, P5547, DOI 10.1103/PhysRevB.25.5547; FLODSTROM SA, 1978, PHYS REV LETT, V40, P907, DOI 10.1103/PhysRevLett.40.907; FLODSTROM SA, 1976, PHYS REV LETT, V37, P1282, DOI 10.1103/PhysRevLett.37.1282; Fomin VM, 1998, NUCL INSTRUM METH B, V145, P545, DOI 10.1016/S0168-583X(98)00530-8; FUGGLE JC, 1977, PHYS REV B, V16, P750, DOI 10.1103/PhysRevB.16.750; HOFFMAN A, 1987, SURF SCI, V182, P56, DOI 10.1016/0039-6028(87)90088-4; JEPSEN DW, 1972, PHYS REV B, V6, P3684, DOI 10.1103/PhysRevB.6.3684; Jeurgens LPH, 2006, APPL SURF SCI, V253, P627, DOI 10.1016/j.apsusc.2005.12.147; Kobayashi K, 1996, JPN J APPL PHYS 1, V35, P5925, DOI 10.1143/JJAP.35.5925; Komrowski AJ, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.246103; Kravchuk T, 2004, SURF SCI, V562, P83, DOI 10.1016/j.susc.2004.05.116; MATSUBAYASHI N, 1992, REV SCI INSTRUM, V63, P1363, DOI 10.1063/1.1143071; MICHEL R, 1980, SURF SCI, V95, P309, DOI 10.1016/0039-6028(80)90144-2; NORMAN D, 1981, SURF SCI, V105, pL297, DOI 10.1016/0039-6028(81)90006-6; NYHOLM R, 1991, PHYS REV B, V44, P10987, DOI 10.1103/PhysRevB.44.10987; OCONNOR DJ, 1993, SURF SCI, V287, P438, DOI 10.1016/0039-6028(93)90819-6; Paparazzo E, 2001, VACUUM, V62, P47, DOI 10.1016/S0042-207X(01)00123-3; Pedersen K, 2003, THIN SOLID FILMS, V443, P78, DOI 10.1016/S0040-6090(03)00674-6; Popova I, 2000, J APPL PHYS, V87, P8143, DOI 10.1063/1.373509; Powell CJ, 2002, SURF INTERFACE ANAL, V33, P211, DOI 10.1002/sia.1204; Powell C.J., 2011, NIST ELECT EFFECTIVE; Reichel F, 2008, SURF INTERFACE ANAL, V40, P281, DOI 10.1002/sia.2705; Rotole JA, 1999, J VAC SCI TECHNOL A, V17, P1091, DOI 10.1116/1.581779; Schouborg J, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/26/265003; Shimada H, 1996, APPL SURF SCI, V100, P56, DOI 10.1016/0169-4332(96)00256-5; SHIMADA H, 1995, REV SCI INSTRUM, V66, P1780, DOI 10.1063/1.1145848; SHIRLEY DA, 1972, PHYS REV B, V5, P4709, DOI 10.1103/PhysRevB.5.4709; ENDRIZ JG, 1971, PHYS REV B, V4, P4159, DOI 10.1103/PhysRevB.4.4159; STRONG RL, 1982, PHYS REV B, V26, P3483, DOI 10.1103/PhysRevB.26.3483; TRIPATHI KC, 1973, NATURE-PHYS SCI, V241, P162; Trost J, 1998, J CHEM PHYS, V108, P1740, DOI 10.1063/1.475546; Zhukov V, 1999, J VAC SCI TECHNOL A, V17, P1727, DOI 10.1116/1.581881	64	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							055202	10.7567/JJAP.54.055202		5	Physics, Applied	Physics	CI7XS	WOS:000354980300034		
J	Iwata, M; Ando, K; Maeda, M; Ishibashi, Y				Iwata, Makoto; Ando, Kenichiro; Maeda, Masaki; Ishibashi, Yoshihiro			Temperature-field phase diagram under electric field along [111](c) direction in BaTiO3	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							TITANATE SINGLE-CRYSTALS; BARIUM-TITANATE; BEHAVIOR	The temperature-field phase diagram of BaTiO3 (BT) was studied under an electric field applied along the [111](c) direction in pseudocubic coordinates. The field coefficients in the transition temperatures, dTc/dE, were discussed on the basis of the Clausius-Clapeyron equation reduced from the Landau-Devonshire free energy. In the engineered domain configuration (EDC) under the electric field applied along the [111](c) direction in BT, at 25 degrees C, no field-induced transition from the tetragonal phase to the orthorhombic phase occurs below 20 kV/cm, indicating that all domains in EDC are composed of the tetragonal domains. (C) 2015 The Japan Society of Applied Physics	[Iwata, Makoto; Ando, Kenichiro; Maeda, Masaki] Nagoya Inst Technol, Grad Sch Engn, Dept Engn Phys Elect & Mech, Nagoya, Aichi 4668555, Japan; [Ishibashi, Yoshihiro] Nagoya Univ, Dept Appl Phys, Nagoya, Aichi 4648603, Japan	Iwata, M (reprint author), Nagoya Inst Technol, Grad Sch Engn, Dept Engn Phys Elect & Mech, Nagoya, Aichi 4668555, Japan.				Japan Society for the Promotion of Science [25400323]	The authors would like to thank NF Corporation for fabricating the DC bias probe for ZGA5900 used to measure the dielectric constant. This work was supported in part by a Grant-in-Aid for Scientific Research (C) (No. 25400323) from the Japan Society for the Promotion of Science to MI.	Wada S, 2005, J APPL PHYS, V98, DOI 10.1063/1.1957130; Park SE, 1997, J APPL PHYS, V82, P1804, DOI 10.1063/1.365983; Wang JJ, 2010, J APPL PHYS, V108, DOI 10.1063/1.3504194; WIEDER HH, 1955, PHYS REV, V99, P1161, DOI 10.1103/PhysRev.99.1161; Wada S, 1999, JPN J APPL PHYS 1, V38, P5505, DOI 10.1143/JJAP.38.5505; Park SE, 1999, J APPL PHYS, V86, P2746, DOI 10.1063/1.371120; BELL AJ, 1984, FERROELECTRICS, V59, P197; Iwata M, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.034703; FESENKO OE, 1981, FERROELECTRICS, V37, P729, DOI 10.1080/00150198108223535; MERZ WJ, 1949, PHYS REV, V76, P1221, DOI 10.1103/PhysRev.76.1221; Bell AJ, 2001, J APPL PHYS, V89, P3907, DOI 10.1063/1.1352682; Kutnjak Z, 2006, NATURE, V441, P956, DOI 10.1038/nature04854; Iwata M, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.038004; Wang YL, 2007, J APPL PHYS, V101, DOI 10.1063/1.2733744; Wada S, 2004, BRIT CERAM T, V103, P93, DOI 10.1179/096797804225012747; DEVONSHIRE AF, 1949, PHILOS MAG, V40, P1040; Iwata M, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.021502; JANOVEC V, 1975, CZECH J PHYS, V25, P1362, DOI 10.1007/BF01587561; Jona F., 1993, FERROELECTRIC CRYSTA, P108; Li Y L, 2005, J APPL PHYS, V98; Scott J. F., 2000, FERROELECTRIC MEMORI	21	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							051501	10.7567/JJAP.54.051501		4	Physics, Applied	Physics	CI7XS	WOS:000354980300010		
J	Jin, RG; Yagi, S; Hijikata, Y; Yaguchi, H				Jin, Ri Guo; Yagi, Shuhei; Hijikata, Yasuto; Yaguchi, Hiroyuki			Growth temperature dependence of the surface segregation of Er atoms in GaAs during molecular beam epitaxy	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							VAPOR-PHASE EPITAXY; INDIVIDUAL NITROGEN PAIRS; SINGLE-PHOTON EMISSION; DELTA-DOPED GAAS; INCORPORATION KINETICS; PHOTOLUMINESCENCE; ERBIUM; SI; GAP; INP	We have quantitatively studied the temperature dependence of the surface segregation of Er atoms in GaAs during molecular beam epitaxy using secondary ion mass spectroscopy. It was found that a significant number of Er atoms segregate to the growing surface at temperatures of 400 degrees C and above and that the segregation decay length is approximately 0.5 mu m at 500 degrees C, indicating that the incorporation ratio of Er atoms into GaAs is less than 10(-3). In contrast to the growth at higher temperatures, GaAs overlayer growth at a temperature as low as 300 degrees C is effective in suppressing the surface segregation of Er and obtaining delta-doped structures. (C) 2015 The Japan Society of Applied Physics	[Jin, Ri Guo; Yagi, Shuhei; Hijikata, Yasuto; Yaguchi, Hiroyuki] Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan	Jin, RG (reprint author), Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan.	kim@opt.ees.saitama-u.ac.jp	Yaguchi, Hiroyuki/B-3902-2012; Hijikata, Yasuto/B-3843-2012	Yaguchi, Hiroyuki/0000-0003-0621-3501; 	JSPS KAKENHI [24360004]	This study was partly supported by JSPS KAKENHI Grant Number 24360004.	Ikezawa M, 2007, JPN J APPL PHYS 2, V46, pL871, DOI 10.1143/JJAP.46.L871; MURAKI K, 1992, APPL PHYS LETT, V61, P557, DOI 10.1063/1.107835; Nutzel JF, 1996, PHYS REV B, V53, P13551, DOI 10.1103/PhysRevB.53.13551; BANTIEN F, 1987, J APPL PHYS, V61, P2803, DOI 10.1063/1.337870; Crook AM, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3565168; Endo Y, 2007, J CRYST GROWTH, V298, P73, DOI 10.1016/j.jcrysgro.2006.10.019; Endo Y, 2008, PHYSICA E, V40, P2110, DOI 10.1016/j.physe.2007.10.047; ENNEN H, 1987, J APPL PHYS, V61, P4877, DOI 10.1063/1.338353; FUKATSU S, 1991, APPL PHYS LETT, V59, P2103, DOI 10.1063/1.106412; Fujiwara Y, 1999, PHYSICA B, V273-4, P770, DOI 10.1016/S0921-4526(99)00645-6; Fujiwara Y, 1997, JPN J APPL PHYS 1, V36, P2587, DOI 10.1143/JJAP.36.2587; Fukushima T, 2010, PHYSICA E, V42, P2529, DOI 10.1016/j.physe.2009.12.011; HOBART KD, 1993, APPL PHYS LETT, V63, P1381, DOI 10.1063/1.109683; Jin RG, 2013, J CRYST GROWTH, V378, P85, DOI 10.1016/j.jcrysgro.2012.12.043; JOURDAN N, 1993, JPN J APPL PHYS 2, V32, pL1784; Koizumi A, 2003, APPL PHYS LETT, V83, P4521, DOI 10.1063/1.1630165; Maltez RL, 1999, J APPL PHYS, V85, P1105, DOI 10.1063/1.369236; MIYASHITA K, 1995, APPL PHYS LETT, V67, P235, DOI 10.1063/1.114678; Miyashita K, 1995, J CRYST GROWTH, V157, P333, DOI 10.1016/0022-0248(95)00415-7; NAKAGAWA K, 1991, J APPL PHYS, V69, P3058, DOI 10.1063/1.348566; POMRENKE GS, 1986, J APPL PHYS, V59, P601, DOI 10.1063/1.336619; Sakuma Y, 2008, J CRYST GROWTH, V310, P4790, DOI 10.1016/j.jcrysgro.2008.07.125; SERNA R, 1995, APPL PHYS LETT, V66, P1385, DOI 10.1063/1.113209; SMITH RS, 1987, APPL PHYS LETT, V50, P49, DOI 10.1063/1.98127; SUDIJONO J, 1993, SURF SCI, V280, P247, DOI 10.1016/0039-6028(93)90678-D; TAKAHEI K, 1989, J APPL PHYS, V65, P1257, DOI 10.1063/1.343019; Takamiya K, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.111201; UWAI K, 1987, APPL PHYS LETT, V51, P1010, DOI 10.1063/1.98814; Yaguchi H, 2011, PROC SPIE, V7945, DOI 10.1117/12.865770	29	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							051201	10.7567/JJAP.54.051201		4	Physics, Applied	Physics	CI7XS	WOS:000354980300009		
J	Kizuka, H; Yagi, T; Jia, JJ; Yamashita, Y; Nakamura, S; Taketoshi, N; Shigesato, Y				Kizuka, Hinako; Yagi, Takashi; Jia, Junjun; Yamashita, Yuichiro; Nakamura, Shinichi; Taketoshi, Naoyuki; Shigesato, Yuzo			Temperature dependence of thermal conductivity of VO2 thin films across metal-insulator transition	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							VANADIUM DIOXIDE; MOTT-HUBBARD; BAND THEORY; PEIERLS; OXIDES; VIEW	Thermal conductivity of a 300-nm-thick VO2 thin film and its temperature dependence across the metal-insulator phase transition (TMIT) were studied using a pulsed light heating thermoreflectance technique. The VO2 and Mo/VO2/Mo films with a VO2 thickness of 300nm were prepared on quartz glass substrates: the former was used for the characterization of electrical properties, and the latter was used for the thermal conductivity measurement. The VO2 films were deposited by reactive rf magnetron sputtering using a V2O3 target and an Ar-O-2 mixture gas at 645 K. The VO2 films consisted of single phase VO2 as confirmed by X-ray diffraction and electron beam diffraction. With increased temperature, the electrical resistivity of the VO2 film decreased abruptly from 6.3 x 10(-1) to 5.3 x 10(-4) Omega cm across the T-MIT of around 325-340 K. The thermal conductivity of the VO2 film increased from 3.6 to 5.4W m(-1) K-1 across the T-MIT. This discontinuity and temperature dependence of thermal conductivity can be explained by the phonon heat conduction and the Wiedemann-Franz law. (C) 2015 The Japan Society of Applied Physics	[Kizuka, Hinako; Jia, Junjun; Nakamura, Shinichi; Shigesato, Yuzo] Aoyama Gakuin Univ, Grad Sch Sci & Engn, Sagamihara, Kanagawa 2525258, Japan; [Yagi, Takashi; Yamashita, Yuichiro; Taketoshi, Naoyuki] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058563, Japan	Kizuka, H (reprint author), Aoyama Gakuin Univ, Grad Sch Sci & Engn, Sagamihara, Kanagawa 2525258, Japan.	t-yagi@aist.go.jp; yuzo@chem.aoyama.ac.jp					ALLEN PB, 1993, PHYS REV B, V48, P4359, DOI 10.1103/PhysRevB.48.4359; RICE TM, 1994, PHYS REV LETT, V73, P3042, DOI 10.1103/PhysRevLett.73.3042; Kato K, 2003, JPN J APPL PHYS 1, V42, P6523, DOI 10.1143/JJAP.42.6523; BERGLUND CN, 1969, PHYS REV, V185, P1022, DOI 10.1103/PhysRev.185.1022; ZYLBERSZTEJN A, 1975, PHYS REV B, V11, P4383, DOI 10.1103/PhysRevB.11.4383; Cavalleri A, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.161102; Muraoka Y, 2002, APPL PHYS LETT, V80, P583, DOI 10.1063/1.1446215; FULS EN, 1967, APPL PHYS LETT, V10, P199, DOI 10.1063/1.1754909; ANDERSSON G, 1956, ACTA CHEM SCAND, V10, P623, DOI 10.3891/acta.chem.scand.10-0623; Yang Z, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3590920; Oh DW, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3394016; Zhao Y, 2012, J APPL PHYS, V111, DOI 10.1063/1.3692391; MORIN FJ, 1959, PHYS REV LETT, V3, P34, DOI 10.1103/PhysRevLett.3.34; Cahill DG, 2004, REV SCI INSTRUM, V75, P5119, DOI 10.1063/1.1819431; WENTZCOVITCH RM, 1994, PHYS REV LETT, V72, P3389, DOI 10.1103/PhysRevLett.72.3389; KUCHARCZYK D, 1979, J APPL CRYSTALLOGR, V12, P370, DOI 10.1107/S0021889879012711; Baba T, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.05EB04; Chase Jr M. W., 1998, NIST JANAF THERMOCHE, V9, P1578; Chen CH, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3519361; Hada M, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.153401; Samsonov G. V., 1987, OXIDE HDB, V2nd, P19; Shigesato Y, 2000, JPN J APPL PHYS 1, V39, P6016, DOI 10.1143/JJAP.39.6016; Wu CZ, 2008, CHEM COMMUN, P3891, DOI 10.1039/b806009f; Ziman J. M., 1960, ELECTRONS PHONONS, P291; Ziman J. M., 1960, ELECT PHONONS, P364	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							053201	10.7567/JJAP.54.053201		5	Physics, Applied	Physics	CI7XS	WOS:000354980300024		
J	Koda, S; Takabayashi, Y; Kaneyasu, T; Iwasaki, Y				Koda, Shigeru; Takabayashi, Yuichi; Kaneyasu, Tatsuo; Iwasaki, Yoshitaka			Observation of edge radiation from a straight section of SAGA-LS storage ring	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article								Edge radiation generated by relativistic electrons passing between two bending magnets was investigated in a straight section of the SAGA-LS storage ring. Observations with correction of the closed orbit distortion (COD) and with large COD by single dipole kick were performed. Small but uncontrolled dipole kicks due to various magnets such as quadrupoles, sextupoles and steering magnets between the two bending magnets were considered to be non-negligible as a disturbance factor of the spatial distribution of the edge radiation. In addition, clear edge radiation was observed under the large COD due to a single dipole kick. The large COD was thought to generate a "pure" straight subsection, which contained no magnets and was clearly off-axis with respect to other subsections. Calculation based on this consideration showed good agreement with our observations. (C) 2015 The Japan Society of Applied Physics	[Koda, Shigeru; Takabayashi, Yuichi; Kaneyasu, Tatsuo; Iwasaki, Yoshitaka] Saga Light Source, Tosu, Saga 8410005, Japan; [Koda, Shigeru] Nagoya Univ, Synchrotron Radiat Res Ctr, Nagoya, Aichi 4638603, Japan	Koda, S (reprint author), Saga Light Source, Tosu, Saga 8410005, Japan.	koda@saga-ls.jp			JSPS KAKENHI [26390125]	This work was financially supported by JSPS KAKENHI Grant Number 26390125.	Ablett J., 2006, NSLS 2 CONCEPTUAL DE, P8; Bryant P. J., 2000, CERNPS2000036DR; Chubar O., 1998, P EPAC 98, P1177; Chubar O. V., 1995, Proceedings of the 1995 Particle Accelerator Conference (Cat. No.95CH35843), DOI 10.1109/PAC.1995.505564; CHUBAR OV, 1993, PROCEEDINGS OF THE 1993 PARTICLE ACCELERATOR CONFERENCE, VOLS 1-5, P2474, DOI 10.1109/PAC.1993.309360; Geloni G, 2009, NUCL INSTRUM METH A, V605, P409, DOI 10.1016/j.nima.2009.03.240; Koda S., 2010, P 2010 INT PART ACC, P2579; Korchuganov V. N., 2008, P RUPAC 08, P148; May T. E., 1999, Proceedings of the 1999 Particle Accelerator Conference (Cat. No.99CH36366), DOI 10.1109/PAC.1999.792702; Smolyakov N, 2000, NUCL INSTRUM METH A, V448, P73, DOI 10.1016/S0168-9002(99)00699-3; Smolyakov N. V., 2001, PACS2001. Proceedings of the 2001 Particle Accelerator Conference (Cat. No.01CH37268), DOI 10.1109/PAC.2001.987877	11	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							056401	10.7567/JJAP.54.056401		5	Physics, Applied	Physics	CI7XS	WOS:000354980300041		
J	Koshibae, W; Kaneko, Y; Iwasaki, J; Kawasaki, M; Tokura, Y; Nagaosa, N				Koshibae, Wataru; Kaneko, Yoshio; Iwasaki, Junichi; Kawasaki, Masashi; Tokura, Yoshinori; Nagaosa, Naoto			Memory functions of magnetic skyrmions	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							DOMAIN-WALL; WEAK FERROMAGNETISM; CHIRAL MAGNET; PHASE-DIAGRAM; SPIN; MNSI; DYNAMICS; MOTION; TEMPERATURE; SCATTERING	We study, by microsimulation on the chiral magnets, the elementary functions of magnetic skyrmions and the design principles of skyrmionic memory devices. The external stimuli, such as local heating, magnetic field, electric field and electric current, trigger the creation and annihilation of the skyrmion. These procedures, corresponding to the writing and erasing operations, are achieved typically within of the order of nano or pico seconds. We also examine the current driven motion of the skyrmions and find that the gyro-dynamics, which is induced by the topological nature of the skyrmion, leads to the variety of useful functions including the remarkable enhancement of the spin-transfer-torque effect. These features are shown to be advantageous for (a) high-density data-storage, (b) nonvolatile memory, and (c) ultra-low current and energy cost manipulation. (C) 2015 The Japan Society of Applied Physics	[Koshibae, Wataru; Kaneko, Yoshio; Kawasaki, Masashi; Tokura, Yoshinori; Nagaosa, Naoto] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan; [Iwasaki, Junichi; Kawasaki, Masashi; Tokura, Yoshinori; Nagaosa, Naoto] Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; [Iwasaki, Junichi; Kawasaki, Masashi; Tokura, Yoshinori; Nagaosa, Naoto] Univ Tokyo, Quantum Phase Elect Ctr, Bunkyo Ku, Tokyo 1138656, Japan	Koshibae, W (reprint author), RIKEN, Ctr Emergent Matter Sci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.		Kawasaki, Masashi/B-5826-2008; Tokura, Yoshinori/C-7352-2009; Iwasaki, Junichi/N-2970-2015; Nagaosa, Naoto/G-7057-2012	Iwasaki, Junichi/0000-0002-9937-6686; 	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [24360036, 24224009]; World-Leading Innovative R&D on Science and Technology; JSPS [2610547]	We are grateful to Y. Ogimoto and A. Toriumi for stimulating discussions. We also thank M. Ishida for technical assistances. This work was supported by Grants-in-Aid for Scientific Research (Nos. 24360036 and 24224009) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) and by the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program). J.I. was supported by a Grant-in-Aid for JSPS Fellows (No. 2610547).	Fujisaki Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.040001; Sampaio J, 2013, NAT NANOTECHNOL, V8, P839, DOI [10.1038/nnano.2013.210, 10.1038/nnano.2013.233, 10.1038/NNANO.2013.210]; DZYALOSHINSKY I, 1958, J PHYS CHEM SOLIDS, V4, P241, DOI 10.1016/0022-3697(58)90076-3; Garcia-Palacios JL, 1998, PHYS REV B, V58, P14937, DOI 10.1103/PhysRevB.58.14937; Yu XZ, 2011, NAT MATER, V10, P106, DOI 10.1038/nmat2916; Parkin SSP, 2008, SCIENCE, V320, P190, DOI 10.1126/science.1145799; Nagaosa N, 2013, NAT NANOTECHNOL, V8, P899, DOI [10.1038/nnano.2013.243, 10.1038/NNANO.2013.243]; Muhlbauer S, 2009, SCIENCE, V323, P915, DOI 10.1126/science.1166767; Ezawa M, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.100408; Wilhelm H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.127203; LEBECH B, 1989, J PHYS-CONDENS MAT, V1, P6105, DOI 10.1088/0953-8984/1/35/010; Fujisaki Y, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.100001; Seki S, 2012, SCIENCE, V336, P198, DOI 10.1126/science.1214143; Munzer W, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.041203; Pfleiderer C, 2004, NATURE, V427, P227, DOI 10.1038/nature02232; Iwasaki J, 2013, NAT NANOTECHNOL, V8, P742, DOI 10.1038/nnano.2013.176; Schulz T, 2012, NAT PHYS, V8, P301, DOI [10.1038/nphys2231, 10.1038/NPHYS2231]; Grigoriev SV, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.224424; Mochizuki M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.017601; Schutte C, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.174434; Heinze S, 2011, NAT PHYS, V7, P713, DOI [10.1038/nphys2045, 10.1038/NPHYS2045]; Yu XZ, 2010, NATURE, V465, P901, DOI 10.1038/nature09124; LEBECH B, 1995, J MAGN MAGN MATER, V140, P119, DOI 10.1016/0304-8853(94)01115-X; Shibata K, 2013, NAT NANOTECHNOL, V8, P723, DOI 10.1038/nnano.2013.174; Grigoriev SV, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.037204; Iwasaki J, 2014, NANO LETT, V14, P4432, DOI 10.1021/nl501379k; Berger L, 1996, PHYS REV B, V54, P9353, DOI 10.1103/PhysRevB.54.9353; Yamaguchi A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.077205; Jonietz F, 2010, SCIENCE, V330, P1648, DOI 10.1126/science.1195709; ISHIKAWA Y, 1984, J PHYS SOC JPN, V53, P2726, DOI 10.1143/JPSJ.53.2726; Janoschek M, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.134407; ISHIKAWA Y, 1976, SOLID STATE COMMUN, V19, P525, DOI 10.1016/0038-1098(76)90057-0; Neubauer A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.186602; Yi SD, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.054416; MORIYA T, 1960, PHYS REV, V120, P91, DOI 10.1103/PhysRev.120.91; Boniardi M., 2014, IEDM; Chilcazumi Soshin, 2009, INT SERIES MONOGRAPH, V2nd; Fert A, 2004, J MAGN MAGN MATER, V272, P1706, DOI 10.1016/j.jmmm.2003.12.1351; Ikegami K., 2014, IEDM, pS28; ISHIMOTO K, 1995, PHYSICA B, V213, P381, DOI 10.1016/0921-4526(95)00163-4; Iwasaki J, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.064412; Iwasaki J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2442; Kanazawa N, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.041122; Kim KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3011; Kitagawa E., 2012, IEDM; Kubota M, 2013, J APPL PHYS, V114, DOI 10.1063/1.4817285; Lam C. H., 2014, IEDM; Maekawa S., 2006, CONCEPTS SPIN ELECT; Malozemoff A. P., 1979, MAGNETIC DOMAIN WALL; Koshibae W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6148; Ono T, 1999, SCIENCE, V284, P468, DOI 10.1126/science.284.5413.468; Onose Y, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.224431; Slonczewski JC, 1996, J MAGN MAGN MATER, V159, pL1, DOI 10.1016/0304-8853(96)00062-5; Tomasello R, 2014, SCI REP-UK, V4, DOI 10.1038/srep06784; Uchida M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.184402; Yu XZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1990; Zahurak J., 2014, IEDM; Zhou Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5652	58	3	3	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							053001	10.7567/JJAP.54.053001		8	Physics, Applied	Physics	CI7XS	WOS:000354980300020		
J	Kozawa, T				Kozawa, Takahiro			Effects of diffusion constant of photodecomposable quencher on chemical gradient of chemically amplified extreme-ultraviolet resists	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ELECTRON-BEAM; LITHOGRAPHY; AMPLIFICATION	The photodecomposable quencher is an important resist technology used for the high-volume production of semiconductor devices. In this study, the effects of the diffusion constant of photodecomposable quenchers on the chemical gradient were investigated by calculating the chemical gradient of line-and-space patterns with an 11 nm half-pitch on the basis of the sensitization and reaction mechanisms of chemically amplified extreme-ultraviolet resists. It was found that the concentration of photodecomposable quencher and the chemical gradient can be markedly increased by decreasing the quencher diffusion constant relative to the acid diffusion constant. Because of the resolution requirement, we should consider the exclusion volume effect of resist units in the future resist design. From this viewpoint, it is attractive that the quenchers have two functions (not only the termination of catalytic reactions but also the capture of thermalized electrons). (C) 2015 The Japan Society of Applied Physics	Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan	Kozawa, T (reprint author), Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan.	kozawa@sanken.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [25246036]	This work was supported in part by a Grant-in-Aid for Scientific Research (Project No. 25246036) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT).	Yamamoto H, 2005, JPN J APPL PHYS 1, V44, P5836, DOI 10.1143/JJAP.44.5836; Kozawa T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.066504; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.126501; Natsuda K, 2007, JPN J APPL PHYS 1, V46, P7285, DOI 10.1143/JJAP.46.7285; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.076503; Kozawa T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.026502; Fukuyama T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.065004; KOZAWA T, 1992, JPN J APPL PHYS 1, V31, P4301, DOI 10.1143/JJAP.31.4301; Ito H, 2005, ADV POLYM SCI, V172, P37, DOI 10.1007/b97574; KINOSHITA H, 1989, J VAC SCI TECHNOL B, V7, P1648, DOI 10.1116/1.584507; Natsuda K, 2008, JPN J APPL PHYS, V47, P4932, DOI 10.1143/JJAP.47.4932; Kozawa T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.116505; Yamamoto H, 2004, JPN J APPL PHYS 2, V43, pL848, DOI 10.1143/JJAP.43.L848; Vogt BD, 2007, J VAC SCI TECHNOL B, V25, P175, DOI 10.1116/1.2429675; Thackeray J, 2013, J PHOTOPOLYM SCI TEC, V26, P605; Kozawa T, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.036501; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.030209; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.076505; Itani T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.010002; Kozawa T, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.016503; Kozawa T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.066508; Nalamasu O, 1998, J VAC SCI TECHNOL B, V16, P3716, DOI 10.1116/1.590396; Hirose R, 2007, JPN J APPL PHYS 2, V46, pL979, DOI 10.1143/JJAP.46.L979; Wurm S, 2007, JPN J APPL PHYS 1, V46, P6105, DOI 10.1143/JJAP.46.6105; Natsuda K, 2006, JPN J APPL PHYS 2, V45, pL1256, DOI 10.1143/JJAP.45.L1256; Kozawa T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.030001; ITO H, 1983, POLYM ENG SCI, V23, P1012, DOI 10.1002/pen.760231807; Kozawa T, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.016502; Van Steenwinckel D, 2008, J MICRO-NANOLITH MEM, V7, DOI 10.1117/1.2909204; Chen S. F., 2012, P SOC PHOTO-OPT INS, V8325; Funato S., 1995, J PHOTOPOLYM SCI TEC, V8, P543, DOI 10.2494/photopolymer.8.543; Gallatin G., 2005, P SOC PHOTO-OPT INS, V5754, P38; Hendrickx E, 2013, J PHOTOPOLYM SCI TEC, V26, P587; Itani T, 2011, J PHOTOPOLYM SCI TEC, V24, P111, DOI 10.2494/photopolymer.24.111; Jung B, 2011, PROC SPIE, V7972, DOI 10.1117/12.879288; Kaneyama K, 2011, PROC SPIE, V7969, DOI 10.1117/12.878429; Kozawa T, 2008, JPN J APPL PHYS, V47, P5404, DOI 10.1143/JJAP.47.5404; Kozawa T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.076504; Kozawa T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.06JC02; Kozawa T, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.074301; Kozawa T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.076501; Peeters R., 2014, EUV S; Wurm S., 2014, EUV S; Yen A., 2014, EUV S	44	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							056502	10.7567/JJAP.54.056502		5	Physics, Applied	Physics	CI7XS	WOS:000354980300043		
J	Matsuba, S; Hayakawa, T; Shizuma, T; Nishimori, N; Nagai, R; Sawamura, M; Angell, CT; Fujiwara, M; Hajima, R				Matsuba, Shunya; Hayakawa, Takehito; Shizuma, Toshiyuki; Nishimori, Nobuyuki; Nagai, Ryoji; Sawamura, Masaru; Angell, Christopher T.; Fujiwara, Mamoru; Hajima, Ryoichi			Diffraction of gamma-rays with energies of 1.17 and 1.33MeV by a flat Si crystal	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							NUCLEAR-RESONANCE FLUORESCENCE; LASER-COMPTON-SCATTERING; ASSAY	Diffraction of gamma-rays by a flat Si crystal has been demonstrated using a high flux 60Co source with an intensity of 2.3 TBq. The diffraction intensities of the gamma-rays with energies of 1.17 and 1.33MeV have been measured as a function of the rotation angle of the crystal. Three peaks corresponding to the Si(440) and Si(220) diffractions for 1.17MeV and the Si(440) diffraction for 1.33MeV have been measured. The heights and shapes of these three peaks are well reproduced by taking into account Bragg's law and the experimental geometry. (C) 2015 The Japan Society of Applied Physics	[Matsuba, Shunya; Hayakawa, Takehito; Shizuma, Toshiyuki; Nishimori, Nobuyuki; Nagai, Ryoji; Sawamura, Masaru; Angell, Christopher T.; Hajima, Ryoichi] Japan Atom Energy Agcy, Tokai, Ibaraki 3191112, Japan; [Fujiwara, Mamoru] Osaka Univ, Res Ctr Nucl Phys, Osaka 5670047, Japan	Matsuba, S (reprint author), Natl Inst Radiol Sci, Chiba 2638555, Japan.	matsuba@nirs.go.jp	Hayakawa, Takehito/K-8478-2015		Japan Society for the Promotion of Science [24340060]	We are grateful to S. Nishino, H. Yoshitomi, M. Kowatari and other members of Facility of Radiation Standards for their support of our experiments. This work has been supported in part by a Grant-in-Aid for Scientific Research (24340060) from the Japan Society for the Promotion of Science.	Albert F, 2011, PHYS REV SPEC TOP-AC, V14, DOI 10.1103/PhysRevSTAB.14.050703; Hajima R, 2014, EUR PHYS J-SPEC TOP, V223, P1229, DOI 10.1140/epjst/e2014-02177-y; Hajima R, 2008, J NUCL SCI TECHNOL, V45, P441, DOI 10.3327/jnst.45.441; Ohgaki H, 2000, NUCL INSTRUM METH A, V455, P54, DOI 10.1016/S0168-9002(00)00693-8; Litvinenko VN, 1997, PHYS REV LETT, V78, P4569, DOI 10.1103/PhysRevLett.78.4569; Miyamoto S, 2006, RADIAT MEAS, V41, pS179, DOI 10.1016/j.radmeas.2007.01.013; BERTSCHY M, 1995, NUCL INSTRUM METH B, V99, P286, DOI 10.1016/0168-583X(94)00614-8; Habs Dietrich, 2011, NUCL PHYS NEWS, V21, P23, DOI DOI 10.1080/10619127.2010.529741; Hayakawa T, 2010, NUCL INSTRUM METH A, V621, P695, DOI 10.1016/j.nima.2010.06.096; KAERTS E, 1987, NUCL INSTRUM METH A, V256, P323, DOI 10.1016/0168-9002(87)90225-7; Kessler EG, 2001, NUCL INSTRUM METH A, V457, P187, DOI 10.1016/S0168-9002(00)00753-1; Kikuzawa N, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.036502; Quiter BJ, 2011, NUCL INSTRUM METH B, V269, P1130, DOI 10.1016/j.nimb.2011.02.081; REIDY JJ, 1966, NUCL PHYS, V79, P193, DOI 10.1016/0029-5582(66)90402-0; Toyokawa H, 2002, REV SCI INSTRUM, V73, P3358, DOI 10.1063/1.1497502; Toyokawa H, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.100209; Zachariasen W., 1945, THEORY XRAY DIFFRACT	17	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							052203	10.7567/JJAP.54.052203		5	Physics, Applied	Physics	CI7XS	WOS:000354980300014		
J	Matsushima, N				Matsushima, Naoki			Polymer optical waveguide lens with large optical coupling tolerance by segmented waveguide structure	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SILICON PHOTONICS; LASER; FABRICATION	A polymer optical waveguide lens with large optical coupling tolerance has been developed. An extension in the tolerance for laser diode (LD) positional misalignment has been obtained by using segmented optical waveguides on the edge of the optical waveguide that can control the beam spot size of the propagated optical beam. The proposed structure is calculated based on an extension of about 40% with a 0.5 dB misalignment tolerance. The effect of the tolerance extension is also obtained when measuring the optical coupling characteristics of the prototype polymer optical waveguide, which is manufactured on the basis of simulation results. (C) 2015 The Japan Society of Applied Physics	Hitachi Ltd, Ctr Technol Innovat Prod Engn, Yokohama, Kanagawa 2440817, Japan	Matsushima, N (reprint author), Hitachi Ltd, Ctr Technol Innovat Prod Engn, Yokohama, Kanagawa 2440817, Japan.						Lee BG, 2010, IEEE J SEL TOP QUANT, V16, P6, DOI 10.1109/JSTQE.2009.2028437; CHUNG Y, 1990, IEEE J QUANTUM ELECT, V26, P1335, DOI 10.1109/3.59679; HADLEY GR, 1992, OPT LETT, V17, P1426, DOI 10.1364/OL.17.001426; Arakawa Y, 2013, IEEE COMMUN MAG, V51, P72, DOI 10.1109/MCOM.2013.6476868; Soref R, 2006, IEEE J SEL TOP QUANT, V12, P1678, DOI 10.1109/JSTQE.2006.883151; Benner A., 2012, OFC NFOEC2012 OSA; Carminati M., 2014, IEEE OIC, P59; Chujo N., 2013, OFC NFOEC2013; Gulden KH, 2001, TG IEEE GAL ARS, P53, DOI 10.1109/GAAS.2001.964345; Kogelnik H., 1964, MICROWAVE RES I S SE, V14, P333; Larsson A., 2012, IPRM INT C, P269; Maruyama K., 2014, IEEE CPMT S JAP, P59; Matsushima N., 2013, IEEE CPMT S JAP, P1; Okamoto, 1999, PLUS E, V21, P570; Okunuki Y., 2000, OFC C, V2, P287, DOI 10.1109/OFC.2000.868316; Park S, 2005, IEEE PHOTONIC TECH L, V17, P1444, DOI 10.1109/LPT.2005.848287; Park SW, 2004, IEEE PHOTONIC TECH L, V16, P732, DOI 10.1109/LPT.2004.823721; Pleros N, 2011, IEEE PHOTONICS J, V3, P296, DOI 10.1109/JPHOT.2011.2127470; SARUWATARI M, 1979, APPL OPTICS, V18, P1847, DOI 10.1364/AO.18.001847; Schow CL, 2012, IEEE PHOTONIC TECH L, V24, P824, DOI 10.1109/LPT.2012.2188830; Spuhler MM, 1998, J LIGHTWAVE TECHNOL, V16, P1680, DOI 10.1109/50.712252; Taira Y., 2014, IEEE CPMT S JAP, P63; Takenobu S., 2012, ECOC 38 EUR C, P1; WEISSMAN Z, 1995, J LIGHTWAVE TECHNOL, V13, P2053, DOI 10.1109/50.469728; Yokoyama K, 1998, J LIGHTWAVE TECHNOL, V16, P1456, DOI 10.1109/50.704611	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							052501	10.7567/JJAP.54.052501		5	Physics, Applied	Physics	CI7XS	WOS:000354980300019		
J	Miyoshi, T; Oshima, T; Noguchi, J				Miyoshi, Tomoyuki; Oshima, Takayuki; Noguchi, Junji			Technologies for suppressing charge-traps in novel p-channel Field-MOSFET with thick gate oxide	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							BIAS TEMPERATURE INSTABILITY; CMOS TECHNOLOGY; INTERFACES; FLUORINE; PLATFORM; DESIGN	High voltage laterally diffused MOS (LDMOS) FETs are widely used in analog applications. A Field-MOSFET with a thick gate oxide is one of the best ways of achieving a simpler design and smaller circuit footprint for high-voltage analog circuits. This paper focuses on an approach to improving the reliability of p-channel Field-MOSFETs. By introducing a fluorine implantation process and terminating fluorine at the LOCOS bird's beak, the gate oxide breakdown voltage could be raised to 350V at a high-slew rate and the negative bias temperature instability (NBTI) shift could be kept to within 15% over a product's lifetime. By controlling the amount of charge in the insulating layer through improving the interlayer dielectric (ILD) deposition processes, a higher BVDSS of 370V and 10-year tolerability of 300 V were obtained with an assisted reduced surface electric field (RESURF) effect. These techniques can supply an efficient solution for ensuring reliable high-performance applications. (C) 2015 The Japan Society of Applied Physics	[Miyoshi, Tomoyuki] Hitachi Ltd, Res & Dev Grp, Ctr Technol Innovat Elect, Hitachi, Ibaraki 3191292, Japan; [Oshima, Takayuki] Hitachi Automot Syst Ltd, Powertrain & Elect Control Syst Div, Hitachinaka, Ibaraki 3128503, Japan; [Noguchi, Junji] Hitachi Ltd, Informat & Telecommun Syst Co, Smart Informat Syst Div, Shinagawa Ku, Tokyo 1408572, Japan	Miyoshi, T (reprint author), Hitachi Ltd, Res & Dev Grp, Ctr Technol Innovat Elect, Hitachi, Ibaraki 3191292, Japan.	tomoyuki.miyoshi.pt@hitachi.com					WRIGHT PJ, 1989, IEEE T ELECTRON DEV, V36, P879, DOI 10.1109/16.299669; Ushio J, 2002, APPL PHYS LETT, V81, P1818, DOI 10.1063/1.1504872; Roggero R, 2013, PROC INT SYMP POWER, P361, DOI 10.1109/ISPSD.2013.6694422; Miyoshi T, 2014, IEEE T ELECTRON DEV, V61, P1451, DOI 10.1109/TED.2014.2309672; Sambi M, 2011, PROC INT SYMP POWER, P36, DOI 10.1109/ISPSD.2011.5890784; SAKURAI T, 1981, J APPL PHYS, V52, P2889, DOI 10.1063/1.329023; Schroder DK, 2003, J APPL PHYS, V94, P1, DOI 10.1063/1.1567461; CHEN IC, 1985, IEEE T ELECTRON DEV, V32, P413; Holke A, 2010, PROC INT SYMP POWER, P257; Hook TB, 2001, IEEE T ELECTRON DEV, V48, P1346, DOI 10.1109/16.930650; Mahapatra S, 2004, IEEE T ELECTRON DEV, V51, P1371, DOI 10.1109/TED.2004.833592; Miyoshi T, 2013, IEEE T ELECTRON DEV, V60, P354, DOI 10.1109/TED.2012.2227750; NICOLLIA.EH, 1965, APPL PHYS LETT, V7, P216, DOI 10.1063/1.1754385; Palumbo Vincenzo, 2008, Proceedings of the 20th International Symposium on Power Semiconductor Devices & ICs; Rudolf R, 2011, PROC INT SYMP POWER, P20, DOI 10.1109/ISPSD.2011.5890780; Satake H., 1997, P INT REL PHYS S, P156; Satake H., 1993, International Electron Devices Meeting 1993. Technical Digest (Cat. No.93CH3361-3), DOI 10.1109/IEDM.1993.347339; Shimamoto S, 2013, IEEE T ELECTRON DEV, V60, P360, DOI 10.1109/TED.2012.2228202; Tokumitsu S, 2010, PROC INT SYMP POWER, P253; Tomita H, 2011, PROC INT SYMP POWER, P28, DOI 10.1109/ISPSD.2011.5890782; Yang HN, 2013, PROC INT SYMP POWER, P357	21	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							054102	10.7567/JJAP.54.054102		7	Physics, Applied	Physics	CI7XS	WOS:000354980300027		
J	Murakami, R; Kurosawa, S; Shishido, T; Sugawara, T; Nomura, A; Yubuta, K; Suzuki, A; Shoji, Y; Ohashi, Y; Pejchal, J; Kamada, K; Yokota, Y; Yoshikawa, A				Murakami, Rikito; Kurosawa, Shunsuke; Shishido, Toetsu; Sugawara, Takamasa; Nomura, Akiko; Yubuta, Kunio; Suzuki, Akira; Shoji, Yasuhiro; Ohashi, Yuji; Pejchal, Jan; Kamada, Kei; Yokota, Yuui; Yoshikawa, Akira			Luminescence properties of Pr-doped (La, Gd)(2)Si2O7 grown by the floating zone method	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SINGLE-CRYSTAL; SCINTILLATION PROPERTIES; CE; LUTETIUM; LU2SI2O7-CE3+; PERFORMANCE; LU2SIO5; LPS; GSO	Scintillation properties of a Pr-doped gadolinium lanthanum pyrosilicate (Pr:La-GPS) crystal grown by the floating zone (FZ) method were investigated, because the Pr3+ 5d-4f transition is expected to show a shorter decay time than the Ce3+ 5d-4f transition. In both alpha-ray radioluminescence and photoluminescence spectra, the emission peak related to the Pr3+ 5d-4f transition was observed at around 350 nm. The photoluminescence decay time of Pr: La-GPS was found to be as short as similar to 23 ns, whereas Ce:La-GPS had a decay time of similar to 31 ns. (C) 2015 The Japan Society of Applied Physics	[Murakami, Rikito; Kurosawa, Shunsuke; Shishido, Toetsu; Sugawara, Takamasa; Nomura, Akiko; Yubuta, Kunio; Suzuki, Akira; Shoji, Yasuhiro; Ohashi, Yuji; Yoshikawa, Akira] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Kurosawa, Shunsuke; Shishido, Toetsu; Pejchal, Jan; Kamada, Kei; Yokota, Yuui; Yoshikawa, Akira] Tohoku Univ, New Ind Creat Hatchery Ctr NICHe, Sendai, Miyagi 9808579, Japan; [Shoji, Yasuhiro; Kamada, Kei; Yoshikawa, Akira] C&A Corp, Sendai, Miyagi 9808577, Japan; [Pejchal, Jan] Inst Phys AS CR, Prague 16200 6, Czech Republic	Murakami, R (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.	r_murakami@imr.tohoku.ac.jp; kurosawa@imr.tohoku.ac.jp			Japan Society for the Promotion of Science (JSPS) [14462961]; Development of Systems and Technology for Advanced Measurement and Analysis (SENTAN); Japan Science and Technology Agency (JST); Adaptable & Seamless Technology Transfer Program through Target-driven RD (A-STEP), JST; Association for the Progress of New Chemical Technology; Murata Science Foundation; Nippon Sheet Glass Foundation for Materials Science and Engineering; Tonen General Sekiyu Foundation	This work is partially supported by (i) Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (C) (S. Kurosawa, Grant Number 14462961), (ii) Development of Systems and Technology for Advanced Measurement and Analysis (SENTAN), Japan Science and Technology Agency (JST), (iii) Adaptable & Seamless Technology Transfer Program through Target-driven R&D (A-STEP), JST, (iv) the Association for the Progress of New Chemical Technology, (v) The Murata Science Foundation, (vi) Nippon Sheet Glass Foundation for Materials Science and Engineering, and (vii) Tonen General Sekiyu Foundation. In addition, we would like to thank the following persons for their support: Mr. Yoshihiro Nakamura of Institute of Multidisciplinary Research for Advanced Materials (IMRAM)/Tohoku University, Issei Narita of Cooperative Research and Development Center for Advanced Materials IMR/Tohoku University, and Mr. Hiroshi Uemura, Ms. Keiko Toguchi, Ms. Megumi Sasaki, Ms. Yuka Takeda, and Ms. Kuniko Kawaguchi of IMR/Tohoku University.	Pauwels D, 2000, IEEE T NUCL SCI, V47, P1787, DOI 10.1109/23.914446; Nikl M, 2005, CHEM PHYS LETT, V410, P218, DOI 10.1016/j.cplett.2005.04.115; Sidletskiy O, 2010, RADIAT MEAS, V45, P365, DOI 10.1016/j.radmeas.2009.12.022; TAKAGI K, 1983, APPL PHYS LETT, V42, P43, DOI 10.1063/1.93760; MELCHER CL, 1992, NUCL INSTRUM METH A, V314, P212, DOI 10.1016/0168-9002(92)90517-8; Ueda J, 2013, OPT MATER, V35, P1952, DOI 10.1016/j.optmat.2012.11.016; Dorenbos P, 2010, IEEE T NUCL SCI, V57, P1162, DOI 10.1109/TNS.2009.2031140; Cutler PA, 2009, IEEE T NUCL SCI, V56, P915, DOI 10.1109/TNS.2009.2016421; Gerasymov I, 2011, J CRYST GROWTH, V318, P805, DOI 10.1016/j.jcrysgro.2010.11.047; Balcerzyk M, 2000, IEEE T NUCL SCI, V47, P1319, DOI 10.1109/23.872971; VANEIJK CWE, 1994, IEEE T NUCL SCI, V41, P738, DOI 10.1109/23.322798; Pidol L, 2003, J PHYS-CONDENS MAT, V15, P2091, DOI 10.1088/0953-8984/15/12/326; Yoshikawa A, 2013, ACTA PHYS POL A, V124, P250; Duan CK, 2006, CURR APPL PHYS, V6, P348, DOI 10.1016/j.cap.2005.11.016; Ishibashi H, 1998, IEEE T NUCL SCI, V45, P518, DOI 10.1109/23.682439; Kawamura S, 2006, IEEE NUCL SCI CONF R, P1160, DOI 10.1109/NSSMIC.2006.356049; Kawamura S, 2007, NUCL INSTRUM METH A, V583, P356, DOI 10.1016/j.nima.2007.09.021; Kurosawa S, 2015, NUCL INSTRUM METH A, V772, P72, DOI 10.1016/j.nima.2014.10.008; Kurosawa S, 2014, J CRYST GROWTH, V393, P142, DOI 10.1016/j.jcrysgro.2013.12.038; Kurosawa S., NUCL INSTRUM A UNPUB; Kurosawa S., OPT MAT IN PRESS; Monteverde F, 2002, J EUR CERAM SOC, V22, P721, DOI 10.1016/S0955-2219(01)00338-7; Pidol L, 2004, IEEE T NUCL SCI, V51, P1084, DOI 10.1109/TNS.2004.829542; Suzuki A, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.102601; Tsubota Y., 2011, PROG NUCL SCI TECHNO, V1, P288; van der Kolk E, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.165120; van der Kolk E, 2003, APPL PHYS LETT, V83, P1740, DOI 10.1063/1.1603337	27	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							052401	10.7567/JJAP.54.052401		4	Physics, Applied	Physics	CI7XS	WOS:000354980300018		
J	Nakada, K; Irikawa, J; Miyajima, S; Konagai, M				Nakada, Kazuyoshi; Irikawa, Junpei; Miyajima, Shinsuke; Konagai, Makoto			Silicon heterojunction solar cells with high surface passivation quality realized using amorphous silicon oxide films with epitaxial phase	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							TIME SPECTROSCOPIC ELLIPSOMETRY; STEADY-STATE PHOTOCONDUCTANCE; LOW-TEMPERATURE GROWTH; MICROCRYSTALLINE SILICON; POLYCRYSTALLINE SILICON; CRYSTALLINE SILICON; HYDROGEN; PLASMA; PARAMETERS; DEPOSITION	The epitaxial growth of the i-layer of crystalline silicon heterojunction solar cells has been widely accepted as harmful to surface passivation. In our experiments, however, although a very rough epitaxial phase in the intrinsic a-Si1-xOx:H passivation layer was confirmed by transmission electron microscopy and spectroscopic ellipsometry, a high effective lifetime and an implied-V-OC of over 720mV were achieved with lifetime samples. The high passivation quality was confirmed by the obtained open circuit voltages of 728 and 721 mV for n- and p-type solar cells, respectively, with an a-Si1-xOx:H/p-mu c-Si1-xOx:H stack rear structure. These results indicate that, contrary to the common knowledge, high surface passivation quality can be achieved even when the epitaxial phase is present. (C) 2015 The Japan Society of Applied Physics	[Nakada, Kazuyoshi; Irikawa, Junpei; Miyajima, Shinsuke; Konagai, Makoto] Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1528552, Japan; [Konagai, Makoto] MEXT JST FUTURE PV Innovat Res, Meguro Ku, Tokyo 1528552, Japan	Nakada, K (reprint author), Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1528552, Japan.	nakada.k.aa@m.titech.ac.jp		Nakada, Kazuyoshi/0000-0002-2219-6345	MEXT Fukushima Top-level United Center for Renewable Energy Research-Photovoltaics Innovation (FUTURE-PV Innovation) Project; New Energy and Industrial Technology Development Organization (NEDO)	This study was partially supported by MEXT Fukushima Top-level United Center for Renewable Energy Research-Photovoltaics Innovation (FUTURE-PV Innovation) Project, and New Energy and Industrial Technology Development Organization (NEDO).	Yan YF, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2189670; Taguchi M, 2000, PROG PHOTOVOLTAICS, V8, P503, DOI 10.1002/1099-159X(200009/10)8:5<503::AID-PIP347>3.0.CO;2-G; Fujiwara H, 2007, J APPL PHYS, V101, DOI 10.1063/1.2559975; Sritharathikhun J, 2007, JPN J APPL PHYS 1, V46, P3296, DOI 10.1143/JJAP.46.3296; Gielis JJH, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.205329; HATALIS MK, 1988, J APPL PHYS, V63, P2260, DOI 10.1063/1.341065; Fujiwara H, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.115306; Olibet S, 2010, PHYS STATUS SOLIDI A, V207, P651, DOI 10.1002/pssa.200982845; Fujiwara H, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2790815; Descoeudres A, 2013, IEEE J PHOTOVOLT, V3, P83, DOI 10.1109/JPHOTOV.2012.2209407; Sinton RA, 1996, APPL PHYS LETT, V69, P2510, DOI 10.1063/1.117723; PANKOVE JI, 1979, APPL PHYS LETT, V34, P156, DOI 10.1063/1.90711; EAGLESHAM DJ, 1990, PHYS REV LETT, V65, P1227, DOI 10.1103/PhysRevLett.65.1227; Zhao JH, 1999, PROG PHOTOVOLTAICS, V7, P471, DOI 10.1002/(SICI)1099-159X(199911/12)7:6<471::AID-PIP298>3.0.CO;2-7; Miyajima S, 2008, J NON-CRYST SOLIDS, V354, P2350, DOI 10.1016/j.jnoncrysol.2007.09.085; Taguchi M, 2014, IEEE J PHOTOVOLT, V4, P96, DOI 10.1109/JPHOTOV.2013.2282737; Nasuno Y, 2002, APPL PHYS LETT, V81, P3155, DOI 10.1063/1.1514396; Fujiwara H, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1850612; TSAI CC, 1991, J NON-CRYST SOLIDS, V137, P673, DOI 10.1016/S0022-3093(05)80210-8; Irikawa J, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.092301; [Anonymous], 2005, P 31 IEEE PHOT SPEC; Fujiwara H, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2426900; IVERSON RB, 1987, J APPL PHYS, V62, P1675, DOI 10.1063/1.339591; Wang TH, 2006, THIN SOLID FILMS, V501, P284, DOI 10.1016/j.tsf.2005.07.196; De Wolf S, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2783972; Miyajima S, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3460917; Sritharathikhun J, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.101603; Collins RW, 2003, SOL ENERG MAT SOL C, V78, P143, DOI 10.1016/S0927-0248(02)00436-1; Cuevas A, 1997, PROG PHOTOVOLTAICS, V5, P79, DOI 10.1002/(SICI)1099-159X(199703/04)5:2<79::AID-PIP155>3.0.CO;2-J; Damon-Lacoste J, 2009, J APPL PHYS, V105, DOI 10.1063/1.3091283; De Wolf S., 2011, PHYS TECHNOLOGY AMOR; De Wolf S, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2432297; De Wolf S, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2164902; Einsele F, 2007, J APPL PHYS, V102, DOI 10.1063/1.2803749; Fujiwara H., 2007, SPECTROSCOPIC ELLIPS, P182; Fujiwara H., 2006, P IEEE 4 WORLD C PHO, P1443; Fujiwara H, 2002, JPN J APPL PHYS 1, V41, P2821, DOI 10.1143/JJAP.41.2821; GANGULY G, 1993, J NONCRYST SOLIDS, V164, P31, DOI 10.1016/0022-3093(93)90485-G; Hamma S, 1997, THIN SOLID FILMS, V296, P11, DOI 10.1016/S0040-6090(96)09386-8; Hamma S., J NONCRYST SOLIDS, V227-230, P852; Jellison J. G. E., 1996, APPL PHYS LETT, V69, P371; Jia HJ, 2006, JPN J APPL PHYS 1, V45, P666, DOI 10.1143/JJAP.45.666; Kinoshita T., 2011, Proceedings of the 26th European International Conference on Photovoltaic Solar Energy; Kondo M, 2000, J NON-CRYST SOLIDS, V266, P84, DOI 10.1016/S0022-3093(99)00744-9; Levi DH, 2006, J VAC SCI TECHNOL A, V24, P1676, DOI 10.1116/1.2167083; Limmanee A, 2008, JPN J APPL PHYS, V47, P8796, DOI 10.1143/JJAP.47.8796; Mueller T, 2010, J APPL PHYS, V107, DOI 10.1063/1.3264626; Nakada K., 2011, P 21 INT PHOT SCI EN; Nakada K., 2012, P 27 EUR PHOT SOL EN, P1616; Nakada K., 2013, P 23 INT PHOT SCI EN; Roca i Cabarrocas P., 1995, APPL PHYS LETT, V66, P3609, DOI 10.1063/1.113803; Scholz M, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3059560; Schulze TF, 2011, ENRGY PROCED, V8, P282, DOI 10.1016/j.egypro.2011.06.137; Schwarzkopf J, 2003, J APPL PHYS, V93, P5215, DOI 10.1063/1.1563059; Sritharathikhun J, 2008, JPN J APPL PHYS, V47, P8452, DOI 10.1143/JJAP.47.8452; Street R. A., 2005, HYDROGENATED AMORPHO, P20; Taguchi M., 2009, P 24 EUR PHOT SOL EN, P1690; Wang T. H., 2004, P 19 EPVSEC PAR, P1296; Yamaguchi Yumiko, 2011, Proceedings of the 26th European International Conference on Photovoltaic Solar Energy; Yang HJ, 2010, CURR APPL PHYS, V10, pS375, DOI 10.1016/j.cap.2010.02.055	60	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							052303	10.7567/JJAP.54.052303		9	Physics, Applied	Physics	CI7XS	WOS:000354980300017		
J	Nakai, K; Nagai, T; Noami, K; Futagi, T				Nakai, Katsuhiko; Nagai, Tetsuya; Noami, Kengo; Futagi, Toshiro			Characterization of defects in beta-Ga2O3 single crystals	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							OPTICAL-ABSORPTION; BAND-EDGE; GROWTH; PHOTOCONDUCTIVITY	We have investigated defects in beta-type gallium oxide (beta-Ga2O3)single crystals by X-ray topography, selective etching, and transmission electron microscopy. Two types of defects, namely, dislocations and nanopipes, were found. Dislocations are screw dislocations with Burgers vector parallel to [010]. The majority of them lie on ((2) over bar 01) and (001). Nanopipes are hollow pipes of 0.1 mu m diameter and of at least 15 mu m length elongated along [010]. No strain field was found around them. From the observation results, we have discussed the formation mechanisms of these defects. (C) 2015 The Japan Society of Applied Physics	[Nakai, Katsuhiko; Nagai, Tetsuya; Noami, Kengo; Futagi, Toshiro] Nippon Steel & Sumikin Technol, Futtsu, Chiba 2930011, Japan	Nakai, K (reprint author), Nippon Steel & Sumikin Technol, Futtsu, Chiba 2930011, Japan.	nakai-katsuhiko@nsst.jp					GELLER S, 1960, J CHEM PHYS, V33, P676, DOI 10.1063/1.1731237; Higashiwaki M, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4821858; Skowronski M, 2002, J APPL PHYS, V92, P4699, DOI 10.1063/1.1505994; FRANK FC, 1951, ACTA CRYSTALLOGR, V4, P497, DOI 10.1107/S0365110X51001690; Tomm Y, 2000, J CRYST GROWTH, V220, P510, DOI 10.1016/S0022-0248(00)00851-4; TAKAHASHI J, 1994, J CRYST GROWTH, V135, P61, DOI 10.1016/0022-0248(94)90726-9; Villora EG, 2004, J CRYST GROWTH, V270, P420, DOI 10.1016/j.jcrysgro.2004.06.027; CHASE AB, 1964, J AM CERAM SOC, V47, P470, DOI 10.1111/j.1151-2916.1964.tb14442.x; LABELLE HE, 1971, MATER RES BULL, V6, P571, DOI 10.1016/0025-5408(71)90006-7; Read Jr W. T., 1953, DISLOCATIONS CRYSTAL, P178; TIPPINS HH, 1965, PHYS REV, V140, pA316, DOI 10.1103/PhysRev.140.A316; Vasyltsiv VI, 1996, PHYS STATUS SOLIDI B, V195, P653, DOI 10.1002/pssb.2221950232	12	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							051103	10.7567/JJAP.54.051103		6	Physics, Applied	Physics	CI7XS	WOS:000354980300008		
J	Vu, ND; Fukushima, T; Sato, K; Katayama-Yoshida, H				Nguyen Dang Vu; Fukushima, Tetsuya; Sato, Kazunori; Katayama-Yoshida, Hiroshi			Computational materials design of LiZnAs-, LiZnP-, and LiZnN-based n-type magnetic semiconductors	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article								The computational materials design of n-type filled tetrahedral compound magnetic semiconductors is proposed on the basis of first-principles calculations within the density functional theory. Using the Korringa-Kohn-Rostoker coherent potential approximation, the electronic structures of electron-doped Li(Zn,Mn)As, Li(Zn,Mn)P, and Li(Zn,Mn)N are calculated. By estimating free energy, the phase diagrams of these systems are predicted. It is shown that these systems are phase-separated and favor spinodal decomposition when the electrons are not doped. By introducing Li interstitials as donor impurities, spinodal decomposition is strongly suppressed and Mn can be doped at a high concentration. Moreover, ferromagnetic interactions between Mn atoms are induced by electron doping. Thus, we can expect electron-mediated ferromagnetism in these systems with a reasonable Curie temperature. (C) 2015 The Japan Society of Applied Physics	[Nguyen Dang Vu; Fukushima, Tetsuya; Katayama-Yoshida, Hiroshi] Osaka Univ, Grad Sch Engn Sci, Dept Mat Engn Sci, Toyonaka, Osaka 5608531, Japan; [Sato, Kazunori] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Suita, Osaka 5650871, Japan	Vu, ND (reprint author), Osaka Univ, Grad Sch Engn Sci, Dept Mat Engn Sci, Toyonaka, Osaka 5608531, Japan.	vund@aquarius.mp.es.osaka-u.ac.jp			JSPS Core-to-Core Program: Advanced Research Networks	The authors acknowledge the financial support from JSPS Core-to-Core Program: Advanced Research Networks. We also acknowledge the stimulated discussion in the meeting of the Cooperative Research Project of the Research Institute of Electrical Communication, Tohoku University. K. Sato thanks Grant-in-Aid for Scientific Research on Innovative Areas "Materials Design through Computics: Complex Correlation and Non-Equilibrium Dynamics".	Achenbach V G, 1981, Z ANORG ALLG CHEM, V475, P9; Ohya S, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2713176; Fujii H, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.043003; Chen L, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3259821; Sato K, 2007, JPN J APPL PHYS 2, V46, pL1120, DOI 10.1143/JJAP.46.L1120; Wang M, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2992200; Sato K, 2010, REV MOD PHYS, V82, P1633, DOI 10.1103/RevModPhys.82.1633; Mack S, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2927481; Sato K, 2004, J PHYS-CONDENS MAT, V16, pS5491, DOI 10.1088/0953-8984/16/48/003; Bergqvist L, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.165201; Chiba D, 2008, J APPL PHYS, V103, DOI 10.1063/1.2837469; Deng Z, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1425; JUZA R, 1968, ANGEW CHEM INT EDIT, V7, P360, DOI 10.1002/anie.196803601; Masek J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.067202; Sato K, 2012, PHYSICA B, V407, P2950, DOI 10.1016/j.physb.2011.09.036	15	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							053002	10.7567/JJAP.54.053002		5	Physics, Applied	Physics	CI7XS	WOS:000354980300021		
J	Dich, NQ; Dinh, TX; Pham, PH; Dau, VT				Nguyen Quang Dich; Thien Xuan Dinh; Phuc Hong Pham; Van Thanh Dau			Study of valveless electromagnetic micropump by volume-of-fluid and OpenFOAM	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							PUMP; FLOW; PERFORMANCE; SIMULATION; ACTUATION; SYSTEMS; DESIGN; LIQUID	The paper reports the first study on the backpressure of a valveless electromagnetic micropump using the volume-of-fluid (VOF) technique and open-source code OpenFOAM. The micropump consists of a vibrating diaphragm and fluidic microchannel connected to inlet and outlet tubes. The imbalance in fluid resistance of the fluidic microchannel during a vibration cycle of the diaphragm creates backpressure in the pump, which in turn produces a difference in water level between the inlet and outlet tubes. In this study, VOF was used in a transient simulation to obtain this difference in water level and then the backpressure. The obtained backpressure showed a slight discrepancy with the experimental data. The discrepancy was probably due to the difference in the wall surface quality of the fluidic microchannel between the simulation model and experimental device. These results are useful for analytical and numerical research on these types of micropumps and can easily be applied in an open-source code simulator with almost zero cost. (C) 2015 The Japan Society of Applied Physics	[Nguyen Quang Dich] HUST, Inst Control Engn & Automat, Hanoi, Vietnam; [Thien Xuan Dinh] Ritsumeikan Univ, Grad Sch Sci & Engn, Kusatsu, Shiga 5258577, Japan; [Phuc Hong Pham] HUST, Vietnam Japan Int Inst Sci Technol, Hanoi, Vietnam; [Van Thanh Dau] Sumitomo Chem Co Ltd, Res Grp Environm Hlth, Takarazuka, Hyogo 6658555, Japan	Dich, NQ (reprint author), HUST, Inst Control Engn & Automat, Hanoi, Vietnam.				Vietnam National Foundation for Science and Technology Development (NAFOSTED) [107.01-2011.06]	This research is funded by Vietnam National Foundation for Science and Technology Development (NAFOSTED) under grant number 107.01-2011.06.	Ahmadian MT, 2006, J PHYS CONF SER, V34, P379, DOI 10.1088/1742-6596/34/1/062; An S., 2012, P SOL STAT SENS ACT, P14; Anik'ev I. I., 1977, SOV APPL MECH, V13, P918, DOI 10.1007/BF00884804; [Anonymous], SYR PUMP; Pan TR, 2005, J MICROMECH MICROENG, V15, P1021, DOI 10.1088/0960-1317/15/5/018; Lei KF, 2012, JALA-J LAB AUTOM, V17, P330, DOI 10.1177/2211068212454853; Li HY, 2013, INT J HEAT MASS TRAN, V57, P722, DOI 10.1016/j.ijheatrnasstransfer.2012.11.005; Arana LR, 2003, J MICROELECTROMECH S, V12, P600, DOI 10.1109/JMEMS.2003.817897; Pan LS, 2001, SENSOR ACTUAT A-PHYS, V93, P173, DOI 10.1016/S0924-4247(01)00638-0; Yang X, 2006, SENSOR ACTUAT A-PHYS, V130, P531, DOI 10.1016/j.sna.2005.12.021; Maillefer D, 2001, PROC IEEE MICR ELECT, P413; Yamahata C, 2005, MICROELECTRON ENG, V78-79, P132, DOI 10.1016/j.mee.2004.12.018; Dau VT, 2009, MICROSYST TECHNOL, V15, P1039, DOI 10.1007/s00542-009-0878-2; Tanaka K, 2008, JPN J APPL PHYS, V47, P8615, DOI 10.1143/JJAP.47.8615; Schabmueller CGJ, 2002, J MICROMECH MICROENG, V12, P420, DOI 10.1088/0960-1317/12/4/313; Araz MK, 2013, JALA-J LAB AUTOM, V18, P350, DOI 10.1177/2211068213491408; Jeong OC, 2006, PROC IEEE MICR ELECT, P782; Olsson A, 1997, J MICROELECTROMECH S, V6, P161, DOI 10.1109/84.585794; Takemura K, 2009, SENSOR ACTUAT A-PHYS, V149, P173, DOI 10.1016/j.sna.2008.12.004; Fan B, 2005, SMART MATER STRUCT, V14, P400, DOI 10.1088/0964-1726/14/2/014; Dinh TX, 2010, SENSOR ACTUAT B-CHEM, V150, P819, DOI 10.1016/j.snb.2010.08.0009; Kim JH, 2001, PROC IEEE MICR ELECT, P443; [Anonymous], GAS CYL; Yoo JC, 2007, SENSOR ACTUAT A-PHYS, V139, P216, DOI 10.1016/j.sna.2007.04.056; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; Chandika S, 2012, FLOW MEAS INSTRUM, V28, P28, DOI 10.1016/j.flowmeasinst.2012.06.003; Dau V. T., 2009, P IEEE SENSORS, P679; Dau VT, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/12/125016; Dau V. T., 2008, IEEE SENSORS, P666; Dau V.T., 2009, SOL STAT SENS ACT MI, P1170; Ducree J., 2004, MICROFLUIDICS ROADMA; Fujita J.-H., 2011, J BIOMED MICRODEVICE, V13, P123; Gupta N. K., 2012, P IEEE 25 INT C MEMS, P152; Kim H., 2014, J MICROELECTROMECH S, V24, P192; Kim L. Y., 2005, P MICR TOT AN SYST 2, P530; Lee CY, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/3/035044; Metz S, 2002, PROC IEEE MICR ELECT, P81; OLSSON A, 1995, SENSOR ACTUAT A-PHYS, V47, P549, DOI 10.1016/0924-4247(94)00960-P; Pan LS, 2003, J MICROMECH MICROENG, V13, P390, DOI 10.1088/0960-1317/13/3/307; Shen M, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/2/025031; Teymoori MM, 2005, SENSOR ACTUAT A-PHYS, V117, P222, DOI 10.1016/j.sna.2004.06.025; Timoshenko S. P., 1959, THEORY PLATE SHELLS, V2nd, p[58, 407]; Ullmann A, 2001, J FLUID ENG-T ASME, V123, P92, DOI 10.1115/1.1343459; Yamada M., 2005, P 9 INT C MIN SYST C, P326; Yokota S., 2014, MECH ENG REV, V1; Yoon JS, 2007, SENSOR ACTUAT A-PHYS, V135, P833, DOI 10.1016/j.sna.2006.08.017; Yu H., 2005, P 9 INT C MIN SYST C, P862	47	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							057201	10.7567/JJAP.54.057201		6	Physics, Applied	Physics	CI7XS	WOS:000354980300048		
J	Nishinaga, J; Kawaharazuka, A; Horikoshi, Y				Nishinaga, Jiro; Kawaharazuka, Atsushi; Horikoshi, Yoshiji			High absorption efficiency of AlGaAs/GaAs superlattice solar cells	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							QUANTUM-WELL; OPTICAL-ABSORPTION; BINDING-ENERGIES; EXCITON; TEMPERATURE	The effects of excitonic absorption on the solar cell efficiency have been investigated in solar cells with AlGaAs/GaAs superlattice absorption layers. Numerical calculations reveal that excitonic absorption considerably enhances the overall absorption coefficient. The excitonic absorption shows strong peaks at the absorption edge and in the energy region above the band gap. Absorption enhancement is also achieved in the AlGaAs/GaAs superlattice. The measured quantum efficiency spectra of superlattice solar cells at room temperature are reasonably well reproduced by simulations taking excitonic effects into account. The superlattice solar cells are confirmed to have a high absorbance and good temperature stability. The theoretical analysis of the experimental results confirms that the enhanced excitonic absorption in the superlattice absorption layers survives even at 100 degrees C, which is considered as the actual device temperature under realistic device operations. (C) 2015 The Japan Society of Applied Physics	[Nishinaga, Jiro] Waseda Univ, Waseda Inst Adv Study, Shinjuku Ku, Tokyo 1698555, Japan; [Nishinaga, Jiro; Kawaharazuka, Atsushi; Horikoshi, Yoshiji] JST, CREST, Kawaguchi, Saitama 3320012, Japan; [Nishinaga, Jiro] Nat Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Kawaharazuka, Atsushi; Horikoshi, Yoshiji] Waseda Univ, Sch Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan	Nishinaga, J (reprint author), Waseda Univ, Waseda Inst Adv Study, Shinjuku Ku, Tokyo 1698555, Japan.				Japan Society for the Promotion of Science (JSPS) [23360163, 25420298, 25420299]	This work is partly supported by Grants-in-Aid for Scientific Research (B) (23360163) and Scientific Research (C) (25420298, 25420299) from the Japan Society for the Promotion of Science (JSPS).	Ekins-Daukes NJ, 1999, APPL PHYS LETT, V75, P4195, DOI 10.1063/1.125580; Nozik AJ, 2002, PHYSICA E, V14, P115, DOI 10.1016/S1386-9477(02)00374-0; Shahrjerdi D, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3681397; DIGNAM MM, 1991, PHYS REV B, V43, P4097, DOI 10.1103/PhysRevB.43.4097; PAXMAN M, 1993, J APPL PHYS, V74, P614, DOI 10.1063/1.355275; STURGE MD, 1962, PHYS REV, V127, P768, DOI 10.1103/PhysRev.127.768; Barnham KWJ, 2002, PHYSICA E, V14, P27, DOI 10.1016/S1386-9477(02)00356-9; BASTARD G, 1982, PHYS REV B, V26, P1974, DOI 10.1103/PhysRevB.26.1974; Yamaguchi M, 2003, SOL ENERG MAT SOL C, V75, P261, DOI 10.1016/S0927-0248(02)00168-X; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; CHAN KS, 1987, J PHYS C SOLID STATE, V20, P791, DOI 10.1088/0022-3719/20/6/003; Fujii H, 2013, J APPL PHYS, V114, DOI 10.1063/1.4820396; GREENE RL, 1983, SOLID STATE COMMUN, V45, P831, DOI 10.1016/0038-1098(83)90810-4; GURIOLI M, 1993, PHYS REV B, V47, P15755, DOI 10.1103/PhysRevB.47.15755; IWAMURA H, 1984, JPN J APPL PHYS 2, V23, pL795, DOI 10.1143/JJAP.23.L795; Kawaharazuka A, 2011, J CRYST GROWTH, V323, P504, DOI 10.1016/j.jcrysgro.2010.12.051; Nishinaga J, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.052302; Nishinaga J, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.112302; Schaller RD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.186601; SCHNEIDER H, 1991, APPL PHYS LETT, V58, P1994, DOI 10.1063/1.105043; Sugiyama M, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/2/024001; Takahashi K, 2001, SOL ENERG MAT SOL C, V66, P517, DOI 10.1016/S0927-0248(00)00232-4; Wu PH, 2006, JPN J APPL PHYS 2, V45, pL647, DOI 10.1143/JJAP.45.L647; Wurfel P., 2009, PHYS SOLAR CELLS, V2nd, P182; YOUNG PM, 1993, J APPL PHYS, V74, P7369, DOI 10.1063/1.355005	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							052301	10.7567/JJAP.54.052301		6	Physics, Applied	Physics	CI7XS	WOS:000354980300015		
J	Nishinaga, T				Nishinaga, Tatau			Progress in art and science of crystal growth and its impacts on modern society	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Review							ENERGY ELECTRON-DIFFRACTION; MOLECULAR-BEAM EPITAXY; CHEMICAL-VAPOR-DEPOSITION; ARSENIC PRESSURE-DEPENDENCE; MICROPROBE-RHEED/SEM MBE; STRAINED-LAYER SUPERLATTICES; SURFACE-DIFFUSION LENGTH; LOW-DISLOCATION-DENSITY; REAL-TIME OBSERVATION; IN-SITU OBSERVATION	The impacts of the progress in the art and science of crystal growth on human life are reviewed. Even before the invention of the transistor, quartz and corundum crystals were used as crystal oscillators and jewel bearings, respectively. However, a major impact of crystal growth on society was experienced with the invention of the transistor, which required high-purity and perfect germanium crystals. Once the importance of crystal growth was clearly recognized, the science of crystal growth also extensively developed. The growth of single crystalline silicon allows us to produce integrated circuits, which are used in all the electronic devices in everyday use. The technological developments in the growth of compound semiconductors have also had a large impact on society through the inventions of the laser diode for optical communication and the p-n junction nitride light-emitting diode toward the realization of a less energy-intensive society. The latter invention was awarded the 2014 Nobel Prize in Physics. Finally, future aspects of crystal growth are discussed. (C) 2015 The Japan Society of Applied Physics	Univ Tokyo, Grad Sch Engn, Dept Elect Engn, Bunkyo Ku, Tokyo 1138656, Japan	Nishinaga, T (reprint author), Univ Tokyo, Grad Sch Engn, Dept Elect Engn, Bunkyo Ku, Tokyo 1138656, Japan.						Akasaka T, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3497017; Akasaka T, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.091002; Akasaki I, 2000, IPAP CONFERENCE SER, V1, P1; Akasaki I., J LUMIN, V48-49, P666; Sumiya H, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.090102; KIMOTO T, 1993, J APPL PHYS, V73, P726, DOI 10.1063/1.353329; Akasaka T, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.075602; AKASAKI I, 1989, J CRYST GROWTH, V98, P209, DOI 10.1016/0022-0248(89)90200-5; CHO AY, 1970, J APPL PHYS, V41, P2780, DOI 10.1063/1.1659315; MATTHEWS JW, 1976, THIN SOLID FILMS, V33, P253, DOI 10.1016/0040-6090(76)90085-7; Porowski S, 1996, J CRYST GROWTH, V166, P583, DOI 10.1016/0022-0248(96)00116-9; Dwilinski R, 2008, J CRYST GROWTH, V310, P3911, DOI 10.1016/j.jcrysgro.2008.06.036; Akasaki I, 2006, JPN J APPL PHYS 1, V45, P9001, DOI 10.1143/JJAP.45.9001; AKIYAMA M, 1984, JPN J APPL PHYS 2, V23, pL843, DOI 10.1143/JJAP.23.L843; Matsunami H, 1997, MAT SCI ENG R, V20, P125, DOI 10.1016/S0927-796X(97)00005-3; GOLDSTEIN L, 1985, APPL PHYS LETT, V47, P1099, DOI 10.1063/1.96342; NAKAMURA S, 1992, JPN J APPL PHYS 2, V31, pL139, DOI 10.1143/JJAP.31.L139; SHEN XQ, 1994, JPN J APPL PHYS 1, V33, P11, DOI 10.1143/JJAP.33.11; Meng YF, 2012, PHYS STATUS SOLIDI A, V209, P101, DOI 10.1002/pssa.201127417; THEUERER HC, 1961, J ELECTROCHEM SOC, V108, P649, DOI 10.1149/1.2428182; AMANO H, 1989, JPN J APPL PHYS 2, V28, pL2112; HARRIS JJ, 1981, SURF SCI, V103, pL90; AMANO H, 1986, APPL PHYS LETT, V48, P353, DOI 10.1063/1.96549; Usui A, 1997, JPN J APPL PHYS 2, V36, pL899, DOI 10.1143/JJAP.36.L899; Yano M, 2000, DIAM RELAT MATER, V9, P512, DOI 10.1016/S0925-9635(99)00308-8; ARAKAWA Y, 1982, APPL PHYS LETT, V40, P939, DOI 10.1063/1.92959; BOLLMANN W, 1972, SURF SCI, V31, P1, DOI 10.1016/0039-6028(72)90250-6; Buehler E., 2004, 50 YEARS PROGR CRYST, P105; Byrappa K., 2015, HDB CRYSTAL GROWTH, VII, P535; Byrappa K., 1994, HANDB CRYST GROWTH, VII, P465; Byrappa K., 2010, SPRINGER HDB CRYSTAL, P599, DOI 10.1007/978-3-540-74761-1_18; CABRERA N, 1956, PHILOS MAG, V1, P450, DOI 10.1080/14786435608238124; Chang YS, 1998, J CRYST GROWTH, V192, P18, DOI 10.1016/S0022-0248(98)00407-2; Chang YS, 1997, J CRYST GROWTH, V174, P630, DOI 10.1016/S0022-0248(97)00067-5; DANILEWSKY AN, 1990, J CRYST GROWTH, V99, P1281, DOI 10.1016/S0022-0248(08)80121-2; DANILEWSKY AN, 1989, J CRYST GROWTH, V97, P571, DOI 10.1016/0022-0248(89)90554-X; FISCHER R, 1984, ELECTRON LETT, V20, P945, DOI 10.1049/el:19840643; FUKUI T, 1991, APPL PHYS LETT, V58, P2018, DOI 10.1063/1.105026; HATA M, 1990, APPL PHYS LETT, V56, P2542, DOI 10.1063/1.102881; HATA M, 1990, J VAC SCI TECHNOL B, V8, P692, DOI 10.1116/1.584997; HOMMA Y, 1993, APPL PHYS LETT, V62, P3276, DOI 10.1063/1.109098; ICHIKAWA M, 1984, JPN J APPL PHYS 1, V23, P913, DOI 10.1143/JJAP.23.913; ISHIDA M, 1983, JPN J APPL PHYS 2, V22, pL438, DOI 10.1143/JJAP.22.L438; ISHIDA M, 1981, JPN J APPL PHYS, V20, pL541, DOI 10.1143/JJAP.20.L541; ISU T, 1988, JPN J APPL PHYS 2, V27, pL2259; ISU T, 1992, J CRYST GROWTH, V120, P45, DOI 10.1016/0022-0248(92)90362-M; ISU T, 1989, J VAC SCI TECHNOL B, V7, P714, DOI 10.1116/1.584631; KAPON E, 1989, PHYS REV LETT, V63, P430, DOI 10.1103/PhysRevLett.63.430; KAPON E, 1992, APPL PHYS LETT, V60, P477, DOI 10.1063/1.106641; KOIDE Y, 1988, JPN J APPL PHYS 1, V27, P1156, DOI 10.1143/JJAP.27.1156; Laudise R. A., 2004, 50 YEARS PROGR CRYST, P185; MANASEVI.HM, 1969, J ELECTROCHEM SOC, V116, P1725, DOI 10.1149/1.2411685; Nakamura S, 1997, JPN J APPL PHYS 2, V36, pL1568; Nassau K., 2004, 50 YEARS PROGR CRYST, P9; NEAVE JH, 1983, APPL PHYS A-MATER, V31, P1, DOI 10.1007/BF00617180; NEAVE JH, 1985, APPL PHYS LETT, V47, P100, DOI 10.1063/1.96281; NELSON H, 1963, RCA REV, V24, P603; NISHINAGA T, 1988, JPN J APPL PHYS 2, V27, pL12, DOI 10.1143/JJAP.27.L12; NISHINAGA T, 1989, JPN J APPL PHYS 1, V28, P836, DOI 10.1143/JJAP.28.836; NISHINAGA T, 1986, J CRYST GROWTH, V79, P806, DOI 10.1016/0022-0248(86)90558-0; Nishinaga T., 1989, MORPHOLOGY GROWTH UN, P139; Nishinaga T, 1997, THIN SOLID FILMS, V306, P187, DOI 10.1016/S0040-6090(97)00099-0; NISHINAGA T, 1994, APPL SURF SCI, V82-3, P141, DOI 10.1016/0169-4332(94)90210-0; NISHINAGA T, 1983, J CRYST GROWTH, V65, P607, DOI 10.1016/0022-0248(83)90111-2; Nishinaga T., 1986, Oyo Buturi, V55; Nishinaga T, 1996, J CRYST GROWTH, V163, P60, DOI 10.1016/0022-0248(95)01050-5; Nishinaga T, 2002, J CRYST GROWTH, V237, P1410, DOI 10.1016/S0022-0248(01)02227-8; NISHINAGA T, 1978, J CRYST GROWTH, V43, P85, DOI 10.1016/0022-0248(78)90372-X; Nishinaga T, 2013, CRYST RES TECHNOL, V48, P200, DOI 10.1002/crat.201200512; NISHINO S, 1980, J ELECTROCHEM SOC, V127, P2674, DOI 10.1149/1.2129570; OHNISHI S, 1978, JPN J APPL PHYS, V17, P773, DOI 10.1143/JJAP.17.773; Onda M, 2002, J CRYST GROWTH, V237, P2112, DOI 10.1016/S0022-0248(01)02269-2; OSAKA J, 1990, J CRYST GROWTH, V99, P120, DOI 10.1016/0022-0248(90)90496-8; Pfann W. G., 2004, 50 YEARS PROGR CRYST, P108; PFANN WG, 1952, T AM I MIN MET ENG, V194, P747; RANGANAT.S, 1966, ACTA CRYSTALLOGR, V21, P197, DOI 10.1107/S0365110X66002615; SAKAWA S, 1992, JPN J APPL PHYS 2, V31, pL359, DOI 10.1143/JJAP.31.L359; Sarukura N., 2015, HDB CRYSTAL GROWTH, VII, P131; Schenk HPD, 1999, J CRYST GROWTH, V200, P45, DOI 10.1016/S0022-0248(98)01245-7; SHEN XQ, 1993, JPN J APPL PHYS 2, V32, pL1117; SOGA T, 1985, J APPL PHYS, V57, P4578, DOI 10.1063/1.335363; TABUCHI M, 1990, J CRYST GROWTH, V99, P315, DOI 10.1016/0022-0248(90)90535-S; Takada K, 2002, JPN J APPL PHYS 2, V41, pL374, DOI 10.1143/JJAP.41.L374; TEAL GK, 1952, PHYS REV, V87, P190; TSAUR BY, 1982, APPL PHYS LETT, V41, P347, DOI 10.1063/1.93508; UJIIE Y, 1989, JPN J APPL PHYS 2, V28, pL337, DOI 10.1143/JJAP.28.L337; Walther H, 1937, REV SCI INSTRUM, V8, P406, DOI 10.1063/1.1752200; YAMADA K, 1989, APPL PHYS LETT, V55, P622, DOI 10.1063/1.101829; Yamane H, 1997, CHEM MATER, V9, P413, DOI 10.1021/cm960494s; Yamashiki A., 1997, CRYST RES TECHNOL, V32, P1048; Yan Z, 1999, J CRYST GROWTH, V203, P25, DOI 10.1016/S0022-0248(99)00050-0	91	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							050101	10.7567/JJAP.54.050101		12	Physics, Applied	Physics	CI7XS	WOS:000354980300001		
J	Ozao, A; Chiashi, S; Watanabe, S; Yamaguchi, G; Kato, H; Homma, Y				Ozao, Akihiko; Chiashi, Shohei; Watanabe, Satoshi; Yamaguchi, Genta; Kato, Hiroki; Homma, Yoshikazu			Gold deposition effects on photoluminescence and Raman scattering spectra of suspended single-walled carbon nanotubes	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ELECTRONIC-STRUCTURE; UNIAXIAL STRAIN; CHARGE-TRANSFER; BUNDLES	Gold (Au) deposition effects on suspended single-walled carbon nanotubes (SWCNTs) were investigated by photoluminescence (PL) and Raman scattering spectroscopies. Deposited Au atoms formed particles on the SWCNT surface. The PL intensity decreased with increasing Au coverage, while the enhancement of the G-band in Raman scattering spectra was observed owing to the surface-enhancement Raman scattering (SERS) effect. The changes in the optical transition energy obtained from the PL spectra and Raman shift of the G-band revealed that tensile strain, which reached 5 x 10(-3), occurred along the tube axis and was proportional to the Au coverage. The Au coverage dependence of the uniaxial strain can be understood in terms of the difference in the thermal expansion between SWCNT and Au. (C) 2015 The Japan Society of Applied Physics	[Ozao, Akihiko; Watanabe, Satoshi; Yamaguchi, Genta; Kato, Hiroki; Homma, Yoshikazu] Tokyo Univ Sci, Dept Phys, Shinjuku Ku, Tokyo 1628601, Japan; [Chiashi, Shohei; Homma, Yoshikazu] Tokyo Univ Sci, Res Inst Sci & Technol, Nanocarbon Res Div, Shinjuku Ku, Tokyo 1628601, Japan; [Chiashi, Shohei] Univ Tokyo, Dept Mech Engn, Bunkyo Ku, Tokyo 1138656, Japan	Ozao, A (reprint author), Tokyo Univ Sci, Dept Phys, Shinjuku Ku, Tokyo 1628601, Japan.	homma@rs.tus.ac.jp	Chiashi, Shohei/A-9172-2012		Scientific Research on Priority Areas "Carbon Nanotube NanoElectronics"	This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas "Carbon Nanotube NanoElectronics".	Alamusi Ning Hua, 2012, COMP MATER SCI, V54, P249; Lefebvre J, 2009, J PHYS CHEM C, V113, P7536, DOI 10.1021/jp810892z; Rao AM, 1997, NATURE, V388, P257; Nagatsu K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.157403; Corio P, 2000, PHYS REV B, V61, P13202, DOI 10.1103/PhysRevB.61.13202; Gao B, 2008, J PHYS CHEM C, V112, P20123, DOI 10.1021/jp809374j; Yang L, 2000, PHYS REV LETT, V85, P154, DOI 10.1103/PhysRevLett.85.154; Ohno Y, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.235427; Cao J, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.157601; Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Maruyama S, 2002, CHEM PHYS LETT, V360, P229, DOI 10.1016/S0009-2614(02)00838-2; Maki H, 2007, NANO LETT, V7, P890, DOI 10.1021/nl062680v; Minot ED, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.156401; Perebeinos V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.257402; Zhang Y, 2000, CHEM PHYS LETT, V331, P35, DOI 10.1016/S0009-2614(00)01162-3; Chiashi S, 2008, JPN J APPL PHYS, V47, P2010, DOI 10.1143/JJAP.47.2010; Gong C, 2010, J APPL PHYS, V108, DOI 10.1063/1.3524232; Huang MY, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.136803; Hall AR, 2007, NAT NANOTECHNOL, V2, P413, DOI 10.1038/nnano.2007.179; Zhang Y, 2000, APPL PHYS LETT, V77, P3015, DOI 10.1063/1.1324731; Lefebvre J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.167406; Homma Y, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/6/066502; Homma Y, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.157402; Lide D.L., 1994, CRC HDB CHEM PHYSICS, P12; IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0; Ma XD, 2014, ACS NANO, V8, P10613, DOI 10.1021/nn504138m; Voggu R, 2008, J PHYS CHEM C, V112, P13053, DOI 10.1021/jp805136e	27	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							055102	10.7567/JJAP.54.055102		4	Physics, Applied	Physics	CI7XS	WOS:000354980300032		
J	Sakuma, K; He, YL; Ueda, K; Asano, H				Sakuma, Keita; He, Yilun; Ueda, Kenji; Asano, Hidefumi			Deposition and reduction of infinite-layer Sr1-xLaxCuO2 films	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SUPERCONDUCTING THIN-FILMS; COMPOUND	Electron-doped infinite-layer (IL) Sr1-xLaxCuO2 thin films were grown on bare and lattice-matched Ba0.55Sr0.45TiO3-buffered LaAlO3(100) substrates by magnetron sputtering, and their structures and electrical properties were investigated systematically for various deposition and reduction conditions. The a- and c-axis-oriented films were obtained on LaAlO3 and LaAlO3//Ba0.55Sr0.45TiO3 substrates, respectively. For the c-axis-oriented films, short-time (<6min) reduction annealing in vacuum followed by deposition was effective for the removal of excess apical oxygen that was incorporated during deposition. The removal of excess apical oxygen was evidenced by the shortened c-axis and the appearance of superconductivity. However, subsequent annealing led to the elongation of the c-axis and loss of superconductivity. The a-axis-oriented films exhibited a similar behavior, although the time scale of such films for reduction annealing was significantly larger than that of the c-axis films. The implications of these results are discussed in terms of the oxygen sublattice in the IL compound. (C) 2015 The Japan Society of Applied Physics	[Sakuma, Keita; He, Yilun; Ueda, Kenji; Asano, Hidefumi] Nagoya Univ, Dept Crystalline Mat Sci, Nagoya, Aichi 4648603, Japan	Sakuma, K (reprint author), Nagoya Univ, Dept Crystalline Mat Sci, Nagoya, Aichi 4648603, Japan.	sakuma.keita@d.mbox.nagoya-u.ac.jp					ADACHI H, 1992, PHYSICA C, V196, P14, DOI 10.1016/0921-4534(92)90131-U; Akatsuka H, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2013.2255946; MCQUARRIE M, 1955, J AM CERAM SOC, V38, P444, DOI 10.1111/j.1151-2916.1955.tb14571.x; JORGENSEN JD, 1993, PHYS REV B, V47, P14654, DOI 10.1103/PhysRevB.47.14654; Krockenberger Y, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.043101; SUGII N, 1992, JPN J APPL PHYS 2, V31, pL1024; SMITH MG, 1991, NATURE, V351, P549, DOI 10.1038/351549a0; Karimoto S, 2001, APPL PHYS LETT, V79, P2767, DOI 10.1063/1.1410872; Gaojie X., 2001, J SUPERCOND, V14, P509, DOI 10.1023/A:1012291714331; IKEDA N, 1993, PHYSICA C, V210, P367, DOI 10.1016/0921-4534(93)90979-Z; Karimoto S, 2004, PHYSICA C, V412, P1349, DOI 10.1016/j.physc.2004.01.160; KORCZAK W, 1992, PHYSICA C, V193, P303, DOI 10.1016/0921-4534(92)90731-Q; Leca V, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2339840; Li ZZ, 2009, PHYSICA C, V469, P73, DOI 10.1016/j.physc.2008.11.006; SUGII N, 1993, J APPL PHYS, V74, P4047, DOI 10.1063/1.354448; TOKURA Y, 1989, NATURE, V337, P345, DOI 10.1038/337345a0	16	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							053101	10.7567/JJAP.54.053101		4	Physics, Applied	Physics	CI7XS	WOS:000354980300023		
J	Sato, S; Omura, Y				Sato, Shingo; Omura, Yasuhisa			Possible theoretical models for carrier diffusion coefficient of one-dimensional Si wire devices	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							P-N-JUNCTIONS; SILICON INVERSION-LAYERS; THERMOELECTRIC FIGURE; AUGER RECOMBINATION; MESOSCOPIC SYSTEMS; SURFACE-ROUGHNESS; TRANSPORT; ELECTRON; SEMICONDUCTORS; NANOWIRES	We use the semi-microscopic theory to elucidate the effective diffusion coefficient of carriers in one-dimensional Si wire devices. In the theoretical model, it is assumed that the primary spectrum of the diffusion process of majority and minority carriers rules the diffusion process; a statistical assessment of the diffusion coefficient is performed using quantum-mechanical analysis. Here the model assumes that the thermalization of carrier transport is ruled by the specific characteristic length. The theory reveals that the diffusion coefficient drastically decreases as the wire width enters the sub-10-nm range. Although it is suggested that the behavior of the diffusion coefficient of such Si wires is related to phonon scattering events in narrow wires, it is not so clear whether it is the dominant mechanism ruling the diffusion coefficient of Si wires. A quantitative prediction of carrier mobility in Si wires is also made on the basis of Einstein's relation, and the model's validity is examined. (C) 2015 The Japan Society of Applied Physics	[Sato, Shingo; Omura, Yasuhisa] Kansai Univ, Dept Elect Elect & Informat, Suita, Osaka 5648680, Japan	Sato, S (reprint author), Kansai Univ, Dept Elect Elect & Informat, Suita, Osaka 5648680, Japan.						NATORI K, 1994, J APPL PHYS, V76, P4879, DOI 10.1063/1.357263; HICKS LD, 1993, PHYS REV B, V47, P16631, DOI 10.1103/PhysRevB.47.16631; Moselund KE, 2010, IEEE T ELECTRON DEV, V57, P866, DOI 10.1109/TED.2010.2040939; Barbagiovanni EG, 2014, APPL PHYS REV, V1, DOI 10.1063/1.4835095; Martin P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.125503; Ishihara T, 2002, JPN J APPL PHYS 1, V41, P2353, DOI 10.1143/JJAP.41.2353; Hochbaum AI, 2008, NATURE, V451, P163, DOI 10.1038/nature06381; Boukai AI, 2008, NATURE, V451, P168, DOI 10.1038/nature06458; SAH CT, 1957, P IRE, V45, P1228, DOI 10.1109/JRPROC.1957.278528; HICKS LD, 1993, PHYS REV B, V47, P12727, DOI 10.1103/PhysRevB.47.12727; SHOCKLEY W, 1949, AT&T TECH J, V28, P435; Xiang CX, 2012, P NATL ACAD SCI USA, V109, P15622, DOI 10.1073/pnas.1118338109; FISCHETTI MV, 1993, PHYS REV B, V48, P2244, DOI 10.1103/PhysRevB.48.2244; Feng TL, 2014, J NANOMATER, DOI 10.1155/2014/206370; Gamiz F, 2003, J APPL PHYS, V94, P392, DOI 10.1063/1.1577227; SHOCKLEY W, 1952, PHYS REV, V87, P835, DOI 10.1103/PhysRev.87.835; Pop E, 2010, NANO RES, V3, P147, DOI 10.1007/s12274-010-1019-z; Balakrishnan V, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031102; Datta S. K., 1995, Flora and Fauna, V1, P1; Datta S., 1995, CAMBRIDGE STUDIES SE, V3, P39; Deleonibus S, 2009, ELECTRONIC DEVICE ARCHITECTURES FOR THE NANO-CMOS ERA: FROM ULITMATE CMOS SCALING TO BEYOND CMOS DEVICES, P1; Ferry D. K., 1995, TRANSPORT NANOSTRUCT, V1st; Freedman JP, 2013, SCI REP-UK, V3, DOI 10.1038/srep02963; Fujita S., 2011, IEEE INT M FUT EL DE, P62; GROVE AS, 1966, SOLID STATE ELECTRON, V9, P783, DOI 10.1016/0038-1101(66)90118-3; Henry A. S., 2008, J COMPUT THEOR NANOS, V5, P1, DOI DOI 10.1166/JCTN.2008.001A; Hess K., 2000, ADV THEORY SEMICONDU; Jeon SH, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.04CC26; Jin SH, 2007, J APPL PHYS, V102, DOI 10.1063/1.2802586; JUNG HK, 1995, JPN J APPL PHYS 1, V34, P3054, DOI 10.1143/JJAP.34.3054; Karamitaheri H., 2013, THESIS TU WIEN; Kato S, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-361; LAX M, 1960, REV MOD PHYS, V32, P25, DOI 10.1103/RevModPhys.32.25; LEE Y, 1992, SUPERLATTICE MICROST, V11, P137, DOI 10.1016/0749-6036(92)90237-Y; Mao K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.04CC08; Mao K., 2012, THESIS U TOKYO TOKYO; MCLENNAN MJ, 1991, PHYS REV B, V43, P13846, DOI 10.1103/PhysRevB.43.13846; Nehari K, 2006, SOLID STATE ELECTRON, V50, P716, DOI 10.1016/j.sse.2006.03.041; Niquet YM, 2012, J APPL PHYS, V112, DOI 10.1063/1.4759346; ODAGAKI T, 1983, PHYS REV B, V28, P2755, DOI 10.1103/PhysRevB.28.2755; ODAGAKI T, 1981, PHYS REV B, V24, P5284, DOI 10.1103/PhysRevB.24.5284; Omura Y, 2013, SOI LUBISTORS: LATERAL, UNIDIRECTIONAL, BIPOLAR-TYPE INSULATED-GATE TRANSISTORS, P1, DOI 10.1002/9781118487914; Ramayya EB, 2008, J COMPUT ELECTRON, V7, P319, DOI 10.1007/s10825-008-0195-5; Ramayya EB, 2008, J APPL PHYS, V104, DOI 10.1063/1.2977758; Sze S. M., 2002, SEMICONDUCTOR DEVICE; Tachi K., 2011, THESIS TOKYO I TECHN; TAKESHIMA M, 1982, PHYS REV B, V26, P3192, DOI 10.1103/PhysRevB.26.3192; TANAKA S, 1995, IEEE T ELECTRON DEV, V42, P1806, DOI 10.1109/16.464415; Uchida K, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P47, DOI 10.1109/IEDM.2002.1175776	49	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							054001	10.7567/JJAP.54.054001		7	Physics, Applied	Physics	CI7XS	WOS:000354980300025		
J	Seo, H; Suhara, T				Seo, Hiroshi; Suhara, Toshiaki			Polarization-selective directional coupler using Ti-indiffused MgO:LiNbO3 waveguide	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							LITHIUM-NIOBATE; LINBO3; GENERATION; DIFFUSION; SPLITTER; PHOTONS	Ti-indiffused MgO:LiNbO3 (MgO:LN) waveguides for telecom wavelength band confine extraordinary light much more strongly than ordinary light. We demonstrated a polarization-selective directional coupler utilizing this characteristic. The coupler was fabricated in a Z-cut MgO (5 mol %): LN crystal by thermal diffusion of Ti stripe at 1135 degrees C for 11 h in dry Ar followed by 1 h in dry O-2. We achieved the highest extinction ratio of 13 dB. (C) 2015 The Japan Society of Applied Physics	[Seo, Hiroshi; Suhara, Toshiaki] Osaka Univ, Grad Sch Engn, Div Elect Elect & Informat Engn, Suita, Osaka 5650871, Japan	Seo, H (reprint author), Osaka Univ, Grad Sch Engn, Div Elect Elect & Informat Engn, Suita, Osaka 5650871, Japan.				JSPS; Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program, MEXT	This work was supported by a Grant-in-Aid for Scientific Research from JSPS, and Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program, MEXT.	Zelmon DE, 1997, J OPT SOC AM B, V14, P3319, DOI 10.1364/JOSAB.14.003319; GERSON R, 1986, J APPL PHYS, V60, P3553, DOI 10.1063/1.337611; Herrmann H, 2013, OPT EXPRESS, V21, P27981, DOI 10.1364/OE.21.027981; Suhara T, 2009, LASER PHOTONICS REV, V3, P370, DOI 10.1002/lpor.200810054; BULMER CH, 1984, ELECTRON LETT, V20, P902, DOI 10.1049/el:19840613; Busacca AC, 2004, APPL PHYS LETT, V84, P4430, DOI 10.1063/1.1758776; Chen M, 2013, OPTIK, V124, P1974, DOI 10.1016/j.ijleo.2012.06.047; GOTO N, 1989, J LIGHTWAVE TECHNOL, V7, P1567, DOI 10.1109/50.39099; Gu DH, 2002, APPL OPTICS, V41, P74, DOI 10.1364/AO.41.000074; Ohmori Yutaka, 2014, Review of Laser Engineering, V42; Shin YW, 2012, OPT COMMUN, V285, P2061, DOI 10.1016/j.optcom.2011.12.066; Suhara T, 2007, IEEE PHOTONIC TECH L, V19, P1093, DOI 10.1109/LPT.2007.900060; VANDERTOL JJGM, 1991, J LIGHTWAVE TECHNOL, V9, P879, DOI 10.1109/50.85789; Zhang DL, 2010, J ELECTROCHEM SOC, V157, pD486, DOI 10.1149/1.3458861	14	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							058001	10.7567/JJAP.54.058001		3	Physics, Applied	Physics	CI7XS	WOS:000354980300049		
J	Sumi, T; Taniyama, Y; Takatsu, H; Juta, M; Kitamoto, A; Imade, M; Yoshimura, M; Isemura, M; Mori, Y				Sumi, Tomoaki; Taniyama, Yuuki; Takatsu, Hiroaki; Juta, Masami; Kitamoto, Akira; Imade, Mamoru; Yoshimura, Masashi; Isemura, Masashi; Mori, Yusuke			Growth of GaN layers using Ga2O vapor obtained from Ga and H2O vapor	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							LIGHT-EMITTING DIODES; PRESSURE SOLUTION GROWTH; FEED-SEED CONFIGURATION; BULK GAN; AMMONOTHERMAL GAN; CARBOTHERMAL REDUCTION; PHASE EPITAXY; LASER-DIODES; CRYSTALS; HVPE	In this study, we performed growth of GaN layers using Ga2O vapor synthesized from Ga and H2O vapor. In this process, we employed H2O vapor instead of HCl gas in hydride vapor phase epitaxy (HVPE) to synthesize Ga source gas. In the synthesis reaction of Ga2O, a Ga2O3 whisker formed and covered Ga, which impeded the synthesis reaction of Ga2O. The formation of the Ga2O3 whisker was suppressed in H-2 ambient at high temperatures. Then, we adopted this process to supply a group III precursor and obtained an epitaxial layer. X-ray diffraction (XRD) measurement revealed that the epitaxial layer was single-crystalline GaN. Growth rate increased linearly with Ga2O partial pressure and reached 104 mu m/h. (C) 2015 The Japan Society of Applied Physics	[Sumi, Tomoaki; Taniyama, Yuuki; Takatsu, Hiroaki; Juta, Masami; Kitamoto, Akira; Imade, Mamoru; Yoshimura, Masashi; Mori, Yusuke] Osaka Univ, Grad Sch Engn, Div Elect Elect & Informat Engn, Suita, Osaka 5650871, Japan; [Isemura, Masashi] Itochu Plast Inc, Shibuya Ku, Tokyo 1508525, Japan	Sumi, T (reprint author), Osaka Univ, Grad Sch Engn, Div Elect Elect & Informat Engn, Suita, Osaka 5650871, Japan.	sumi@cryst.eei.eng.osaka-u.ac.jp	Yoshimura, Masashi/N-7222-2013; Mori, Yusuke/C-3302-2014				Imade M, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.035503; Imade M, 2010, J CRYST GROWTH, V312, P676, DOI 10.1016/j.jcrysgro.2009.12.028; Nakamura S, 1998, SCIENCE, V281, P956, DOI 10.1126/science.281.5379.956; Nakamura S, 1996, JPN J APPL PHYS 2, V35, pL74, DOI 10.1143/JJAP.35.L74; Dwilinski R, 2008, J CRYST GROWTH, V310, P3911, DOI 10.1016/j.jcrysgro.2008.06.036; Geng HY, 2012, J CRYST GROWTH, V350, P44, DOI 10.1016/j.jcrysgro.2011.12.020; Pearton SJ, 1999, J APPL PHYS, V86, P1, DOI 10.1063/1.371145; Pimputkar S, 2014, J CRYST GROWTH, V403, P7, DOI 10.1016/j.jcrysgro.2014.06.017; Fujito K, 2009, J CRYST GROWTH, V311, P3011, DOI 10.1016/j.jcrysgro.2009.01.046; Jiang WK, 2014, J CRYST GROWTH, V403, P18, DOI 10.1016/j.jcrysgro.2014.06.002; Jain SC, 2000, J APPL PHYS, V87, P965, DOI 10.1063/1.371971; Han J, 1998, APPL PHYS LETT, V73, P1688, DOI 10.1063/1.122246; Imanishi M, 2013, PHYS STATUS SOLIDI C, V10, P400, DOI 10.1002/pssc.201200705; Sochacki T, 2014, J CRYST GROWTH, V394, P55, DOI 10.1016/j.jcrysgro.2014.02.020; BATTAT D, 1974, J CHEM SOC FARAD T 1, V70, P2280, DOI 10.1039/f19747002280; Bockowski M, 2011, PHYS STATUS SOLIDI A, V208, P1507, DOI 10.1002/pssa.201000981; Bockowski M, 2012, PHYS STATUS SOLIDI C, V9, P453, DOI 10.1002/pssc.201100366; Bu Y, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.035504; Bu Y, 2011, J CRYST GROWTH, V327, P89, DOI 10.1016/j.jcrysgro.2011.06.001; Bu Y, 2014, J CRYST GROWTH, V392, P1, DOI 10.1016/j.jcrysgro.2014.01.031; Garni B, 1996, APPL PHYS LETT, V68, P1380, DOI 10.1063/1.116086; Grzegory I, 2002, J CRYST GROWTH, V246, P177, DOI 10.1016/S0022-0248(02)01740-2; Imade M, 2012, J CRYST GROWTH, V350, P56, DOI 10.1016/j.jcrysgro.2011.12.022; Konishi Y, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.025503; Konkapaka P, 2006, J CRYST GROWTH, V289, P140, DOI 10.1016/j.jcrysgro.2005.11.005; Miura A, 2007, J CRYST GROWTH, V299, P22, DOI 10.1016/j.jcrysgro.2006.10.263; Miura A, 2008, J CRYST GROWTH, V310, P530, DOI 10.1016/j.jcrysgro.2007.11.068; NAKAMURA S, 1994, APPL PHYS LETT, V64, P1687, DOI 10.1063/1.111832; Richter E, 2010, PHYS STATUS SOLIDI C, V7, P28, DOI 10.1002/pssc.200982616; Yoshida T, 2011, PHYS STATUS SOLIDI C, V8, DOI 10.1002/pssc.201000953	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							051001	10.7567/JJAP.54.051001		4	Physics, Applied	Physics	CI7XS	WOS:000354980300004		
J	Uemukai, M; Terai, S; Suhara, T				Uemukai, Masahiro; Terai, Shohei; Suhara, Toshiaki			InGaAs ridge-waveguide distributed Bragg reflector laser with first-order grating fabricated by nanoimprint lithography	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							MONOLITHIC INTEGRATION	A distributed Bragg reflector (DBR) laser with a surface relief grating was fabricated by a simple process using room-temperature nanoimprint lithography. An imprint mold for first-order DBR gratings with a period of 151nm was formed using a silica plate. The grating pattern was imprinted on a nanoimprint layer and then transferred into an InGaAs quantum well waveguide by reactive ion etching. A single-mode lasing at a wavelength of 984.3nm with a side-mode suppression ratio of 30 dB and a maximum output power of 42mW were obtained under CW operation. (C) 2015 The Japan Society of Applied Physics	[Uemukai, Masahiro; Terai, Shohei; Suhara, Toshiaki] Osaka Univ, Grad Sch Engn, Dept Elect Elect & Informat Engn, Suita, Osaka 5650871, Japan	Uemukai, M (reprint author), Osaka Univ, Grad Sch Engn, Dept Elect Elect & Informat Engn, Suita, Osaka 5650871, Japan.	uemukai@eei.eng.osaka-u.ac.jp			JSPS KAKENHI [26390083]; MEXT Photonics Advanced Research Center Program (Osaka University)	This work was partly supported by JSPS KAKENHI Grant Number 26390083 and MEXT Photonics Advanced Research Center Program (Osaka University).	HOFSTETTER D, 1994, ELECTRON LETT, V30, P1858, DOI 10.1049/el:19941262; CHOU SY, 1995, APPL PHYS LETT, V67, P3114, DOI 10.1063/1.114851; Viheriala J, 2009, MICROELECTRON ENG, V86, P321, DOI 10.1016/j.mee.2008.10.010; Zhao JY, 2013, SEMICOND SCI TECH, V28, DOI 10.1088/0268-1242/28/5/055015; Kang Y, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.06GL13; Igaku Y, 2002, JPN J APPL PHYS 1, V41, P4198, DOI 10.1143/JJAP.41.4198; Nakarnatsu K, 2006, J VAC SCI TECHNOL B, V24, P195, DOI 10.1116/1.2151913; Nakamatsu K, 2006, JPN J APPL PHYS 2, V45, pL546, DOI 10.1143/JJAP.45.L546; Shimada N, 2001, IEEE J SEL TOP QUANT, V7, P350, DOI 10.1109/2944.954149; Telkkala J., 2010, CLEO OELS C; Uemukai M, 2004, JPN J APPL PHYS 1, V43, P5918, DOI 10.1143/JJAP.43.5918; Uemukai M, 1997, ELECTRON LETT, V33, P1464, DOI 10.1049/el:19970961; Uemukai M, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.020205; Yanagisawa M, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.06FH11; Yoshinaga H, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.08MB05; Zhao JY, 2013, SEMICOND SCI TECH, V28, DOI 10.1088/0268-1242/28/3/035001	16	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							058002	10.7567/JJAP.54.058002		3	Physics, Applied	Physics	CI7XS	WOS:000354980300050		
J	Wang, HF; Yamada, C; Homma, Y				Wang, Huafeng; Yamada, Chisato; Homma, Yoshikazu			Scanning electron microscopy imaging mechanisms of CVD-grown graphene on Cu substrate revealed by in situ observation	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							FILMS; COPPER	We performed in situ scanning electron microscopy (SEM) observation of the image contrast changes induced by vacuum heating of chemical-vapor-deposition-grown graphene on a Cu substrate. We demonstrated that the graphene on a pure Cu surface is invisible to SEM observation. Air exposure leads to the SEM contrast of graphene on Cu, which originates not only from uncovered Cu surface areas at the boundaries of graphene domains but also from graphene covered regions. This may be due to the adsorbed gases on the uncovered Cu surface and the formation of an intercalated gas layer between graphene and the Cu substrate. (C) 2015 The Japan Society of Applied Physics	[Wang, Huafeng; Yamada, Chisato; Homma, Yoshikazu] Tokyo Univ Sci, Dept Phys, Shinjuku Ku, Tokyo 1628601, Japan	Wang, HF (reprint author), Tokyo Univ Sci, Dept Phys, Shinjuku Ku, Tokyo 1628601, Japan.	wanghf@rs.tus.ac.jp; homma@rs.tus.ac.jp					Homma Y, 2004, APPL PHYS LETT, V84, P1750, DOI 10.1063/1.1667608; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Choubak S, 2013, J PHYS CHEM LETT, V4, P1100, DOI 10.1021/jz400400u; Li XS, 2010, NANO LETT, V10, P4328, DOI 10.1021/nl101629g; Ishigami M, 2007, NANO LETT, V7, P1643, DOI 10.1021/nl070613a; Larciprete R, 2012, ACS NANO, V6, P9551, DOI 10.1021/nn302729j; Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/nnano.2010.132, 10.1038/NNANO.2010.132]; Schriver M, 2013, ACS NANO, V7, P5763, DOI 10.1021/nn4014356; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Sutter P, 2010, J AM CHEM SOC, V132, P8175, DOI 10.1021/ja102398n; Kidambi PR, 2013, NANO LETT, V13, P4769, DOI 10.1021/nl4023572; Goldstein J., 2003, SCANNING ELECT MICRO; Hiura H, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.095101; Jia CC, 2012, SCI REP-UK, V2, DOI 10.1038/srep00707; Kochat V, 2011, J APPL PHYS, V110, DOI 10.1063/1.3608062; Reimer L, 1998, SCANNING ELECT MICRO; Walter AL, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.195443; Yang F, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/47/475705	18	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							050301	10.7567/JJAP.54.050301		4	Physics, Applied	Physics	CI7XS	WOS:000354980300002		
J	Yamaguchi, S; Suzuki, T; Inoue, K; Azumi, Y				Yamaguchi, Shigeo; Suzuki, Tadzunu; Inoue, Kazuhito; Azumi, Yoshitaka			DC-driven thermoelectric Peltier device for precise DNA amplification	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							POLYMERASE-CHAIN-REACTION; HAND-HELD DEVICE; THERMAL CYCLER; RAPID PCR; MICROSYSTEM; SYSTEM	Using a DC-driven Peltier device, we fabricated a DNA amplification system [polymerase chain reaction (PCR) system] with the aim of increasing its speed and precision. The Peltier device had a well block sandwiched by Bi2Se0.37Te2.36 as an N-type thermoelectric material and Bi0.59Sb1.30Te3 as a P-type material. The well block was directly controlled by the electric current, leading to a high thermal response. Using the Peltier device with the well block, we performed thermal cycles of a PCR, and we demonstrated that our PCR system produces a smaller amount of nonspecific products for the genome DNA (gDNA) of Arabidopsis thaliana, leading to a more precise DNA amplification system. (C) 2015 The Japan Society of Applied Physics	[Yamaguchi, Shigeo] Kanagawa Univ, Dept Elect Elect & Informat Engn, Yokohama, Kanagawa 2218686, Japan; [Suzuki, Tadzunu] Kanagawa Univ, Inst Engn Res, Yokohama, Kanagawa 2218686, Japan; [Inoue, Kazuhito; Azumi, Yoshitaka] Kanagawa Univ, Dept Biol Sci, Hiratsuka, Kanagawa 2591293, Japan	Yamaguchi, S (reprint author), Kanagawa Univ, Dept Elect Elect & Informat Engn, Yokohama, Kanagawa 2218686, Japan.	yamags18@kanagawa-u.ac.jp			JST A-STEP Grant for Exploratory Research	This study was partly supported by a JST A-STEP Grant for Exploratory Research.	Riffat SB, 2003, APPL THERM ENG, V23, P913, DOI 10.1016/S1359-4311(03)00012-7; Lagally ET, 2004, ANAL CHEM, V76, P3162, DOI 10.1021/ac035310p; Wheeler EK, 2011, ANALYST, V136, P3707, DOI 10.1039/c1an15365j; Khandurina J, 2000, ANAL CHEM, V72, P2995, DOI 10.1021/ac991471a; WILDING P, 1994, CLIN CHEM, V40, P1815; Belgrader P, 1998, J FORENSIC SCI, V43, P315; Yang JN, 2002, LAB CHIP, V2, P179, DOI 10.1039/b208405h; Liu P, 2007, ANAL CHEM, V79, P1881, DOI 10.1021/ac061961k; Lee TMH, 2003, LAB CHIP, V3, P100, DOI 10.1039/b300799e; Hashimoto M, 2004, LAB CHIP, V4, P638, DOI 10.1039/b406860b; Fuchiwaki Y, 2011, BIOSENS BIOELECTRON, V27, P88, DOI 10.1016/j.bios.2011.06.022; Lee TMH, 2006, ANAL CHIM ACTA, V556, P26, DOI 10.1016/j.aca.2005.05.075; Jenkins DM, 2011, BIOSENS BIOELECTRON, V30, P255, DOI 10.1016/j.bios.2011.09.020; Anzai T, 2009, J MICRO-NANOLITH MEM, V8, DOI 10.1117/1.3151998; Arakawa K, 2010, ECS TRANSACTIONS, V25, P75, DOI 10.1149/1.3334793; Innis M. A., 1999, PCR APPL; Kajikawa T., 2004, NETSUDEN HENKAN SHIS; McPherson MJ, 2006, PCR; Okuwaki Y, 2011, ADV MATER RES-SWITZ, V254, P128, DOI 10.4028/www.scientific.net/AMR.254.128; Park N, 2003, ANAL CHEM, V75, P6029, DOI 10.1021/ac0346959; Rowe D.M., 1995, CRC HDB THERMOELECTR; Suzuki T., 2011, SCI J KANAGAWA UNIV, V22, P83; Tsuchiya H, 2008, SENSOR ACTUAT B-CHEM, V130, P583, DOI 10.1016/j.snb.2007.10.014; Waters LC, 1998, ANAL CHEM, V70, P5172, DOI 10.1021/ac980447e; Wheeler EK, 2004, ANAL CHEM, V76, P4011, DOI 10.1021/ac034941g; Yamaguchi S, 2008, ELECTROCHEM SOLID ST, V11, pH103, DOI 10.1149/1.2839446; Zhao Z, 2003, SENSOR ACTUAT A-PHYS, V108, P162, DOI 10.1016/S0924-4247(03)00258-9	27	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							057001	10.7567/JJAP.54.057001		4	Physics, Applied	Physics	CI7XS	WOS:000354980300045		
J	Yamaura, D; Takeuchi, K; Lu, ZQ; Arai, Y; Ogino, T				Yamaura, Daichi; Takeuchi, Koji; Lu, Zhiqiang; Arai, Yuki; Ogino, Toshio			Height reversal of Si micro dot and well patterns during Si nanowire formation by Ag-assisted chemical etching	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ION BATTERY ANODES; FIELD-EFFECT TRANSISTORS; LONG CYCLE LIFE; SILICON NANOWIRES; LITHIUM; PERFORMANCE; ELECTRODES; GROWTH; FABRICATION	The Si nanowire (Si-NW) formation process has been studied to develop a new anode material for lithium ion batteries. Si-NWs were prepared by a combination of electroless metal deposition (EMD) of Ag and metal-assisted chemical etching (Mac etching) on Si substrates that have micro dot and well patterns with respect to their height. During the fabrication of Si-NWs, height reversal occurred in the micro dot and well patterns, and Si micro-and nano-hybrid systems were fabricated. We also observed structural changes of the Si micro-and nano-hybrid structures during the electrochemical charge/discharge process of lithium ions, and showed that this hybrid system is robust for the volume change accompanied with the lithiation/delithiation reaction. (C) 2015 The Japan Society of Applied Physics	[Yamaura, Daichi; Takeuchi, Koji; Lu, Zhiqiang; Arai, Yuki; Ogino, Toshio] Yokohama Natl Univ, Grad Sch Engn, Yokohama, Kanagawa 2408501, Japan; [Ogino, Toshio] CREST JST, Chiyoda Ku, Tokyo 1020076, Japan	Yamaura, D (reprint author), Yokohama Natl Univ, Grad Sch Engn, Yokohama, Kanagawa 2408501, Japan.						BOUKAMP BA, 1981, J ELECTROCHEM SOC, V128, P725, DOI 10.1149/1.2127495; Goldberger J, 2006, NANO LETT, V6, P973, DOI 10.1021/nl060166j; Peng KQ, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2929373; Cho JH, 2013, NANO LETT, V13, P5740, DOI 10.1021/nl4036498; Peng KQ, 2003, ADV FUNCT MATER, V13, P127, DOI 10.1002/adfm.200390018; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Shin HC, 2005, J POWER SOURCES, V139, P314, DOI 10.1016/j.jpowsour.2004.06.073; Ge MY, 2012, NANO LETT, V12, P2318, DOI 10.1021/nl300206e; Huang ZP, 2011, ADV MATER, V23, P285, DOI 10.1002/adma.201001784; Chan CK, 2008, NAT NANOTECHNOL, V3, P31, DOI 10.1038/nnano.2007.411; Mukherjee R, 2012, NANO ENERGY, V1, P518, DOI 10.1016/j.nanoen.2012.04.001; Li XL, 2012, CURR OPIN SOLID ST M, V16, P71, DOI 10.1016/j.cossms.2011.11.002; Abel PR, 2013, ACS NANO, V7, P2249, DOI 10.1021/nn3053632; Wachtler M, 2002, J POWER SOURCES, V105, P151, DOI 10.1016/S0378-7753(01)00934-X; Wu YY, 2001, J AM CHEM SOC, V123, P3165, DOI 10.1021/ja0059084; Song T, 2010, NANO LETT, V10, P1710, DOI 10.1021/nl100086e; Morales AM, 1998, SCIENCE, V279, P208, DOI 10.1126/science.279.5348.208; Wen ZS, 2013, J PHYS CHEM C, V117, P8604, DOI 10.1021/jp3096709; Hochbaum AI, 2009, NANO LETT, V9, P3550, DOI 10.1021/nl9017594; Yi R, 2013, ADV ENERGY MATER, V3, P295, DOI 10.1002/aenm.201200857; Chan CK, 2010, ACS NANO, V4, P1443, DOI 10.1021/nn901409q; Cui Y, 2003, NANO LETT, V3, P149, DOI 10.1021/nl025875l; Zhao Y, 2012, CHEM COMMUN, V48, P5079, DOI 10.1039/c2cc31476b; Yao Y, 2011, NANO LETT, V11, P2949, DOI 10.1021/nl201470j; Wu MY, 2013, NANO LETT, V13, P5397, DOI 10.1021/nl402953h; Chang JB, 2014, ADV MATER, V26, P758, DOI 10.1002/adma.201302757; Park MH, 2009, NANO LETT, V9, P3844, DOI 10.1021/nl902058c; Obrovac MN, 2004, ELECTROCHEM SOLID ST, V7, pA93, DOI 10.1149/1.1652421; Tsukamoto T, 2012, J ELECTROCHEM SOC, V159, pC155, DOI 10.1149/2.038204jes; Wu H, 2012, NAT NANOTECHNOL, V7, P309, DOI [10.1038/nnano.2012.35, 10.1038/NNANO.2012.35]	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAY	2015	54	5							055203	10.7567/JJAP.54.055203		5	Physics, Applied	Physics	CI7XS	WOS:000354980300035		
J	Yamashita, Y				Yamashita, Yoriko			Ovarian cancer: new developments in clear cell carcinoma and hopes for targeted therapy	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Review						ovarian clear cell carcinoma; PI3CA mutation; ARID1A mutation; MET amplification; targeted therapy	MALIGNANT-TRANSFORMATION; ATYPICAL ENDOMETRIOSIS; HISTOLOGICAL SUBTYPES; GYNECOLOGIC CANCERS; TUMOR-SUPPRESSOR; PIK3CA GENE; GROWTH; EXPRESSION; MUTATIONS; ARID1A	Until recently, ovarian clear cell carcinoma was recognized by its unique morphology and unfavorable patient outcome primarily due to tumor chemoresistance. Recently, specific molecular characteristics of ovarian clear cell carcinoma, such as PI3CA mutation, ARID1a mutation and MET amplification, have been elucidated. In addition, an association between endometriosis and the tumor has also been a focus of research in recent years. The aim of this review is to discuss the specificity and importance of molecular changes and various intriguing points that are not solved until today. Finally, future aspects, including hopes for the development of novel therapies, are discussed.	[Yamashita, Yoriko] Nagoya City Univ, Grad Sch Med Sci, Dept Expt Pathol & Tumor Biol, Nagoya, Aichi 4678601, Japan	Yamashita, Y (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Expt Pathol & Tumor Biol, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	k46581a@nucc.cc.nagoya-u.ac.jp	Yamashita, Yoriko/B-9810-2011		Japan Society for the Promotion of Science, Tokyo, Japan [26460423]	This study was supported by a Grant-in-Aid from the Japan Society for the Promotion of Science, Tokyo, Japan, for Scientific Research (no. 26460423). Funding to pay the Open Access publication charges for this article was also provided by the Grant-in-Aid from the Japan Society for the Promotion of Science, Tokyo, Japan, for Scientific Research (no. 26460423).	Anglesio MS, 2010, GYNECOL ONCOL, V121, P407; Gadducci A, 2014, GYNECOL ENDOCRINOL, V30, P612, DOI 10.3109/09513590.2014.926325; LAGRENADE A, 1988, HUM PATHOL, V19, P1080, DOI 10.1016/S0046-8177(88)80090-X; Fukunaga M, 1997, HISTOPATHOLOGY, V30, P249, DOI 10.1046/j.1365-2559.1997.d01-592.x; Sato N, 2000, CANCER RES, V60, P7052; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; Senthong A, 2014, INT J GYNECOL CANCER, V24, P36, DOI 10.1097/IGC.0000000000000021; Wiegand KC, 2011, J PATHOL, V224, P328, DOI 10.1002/path.2911; Jardim DLF, 2014, CLIN CANCER RES, V20, P6336, DOI 10.1158/1078-0432.CCR-14-1293; Levine DA, 2005, CLIN CANCER RES, V11, P2875, DOI 10.1158/1078-0432.CCR-04-2142; Kuo KT, 2009, AM J PATHOL, V174, P1597, DOI 10.2353/ajpath.2009.081000; Martini M, 2002, INT J CANCER, V102, P398, DOI 10.1002/ijc.10715; Sampson JA, 1925, ARCH SURG-CHICAGO, V10, P1; Yamamoto S, 2011, MODERN PATHOL, V24, P1146, DOI 10.1038/modpathol.2011.70; Uno S, 2010, NAT GENET, V42, P707, DOI 10.1038/ng.612; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kato N, 2006, MODERN PATHOL, V19, P83, DOI 10.1038/modpathol.3800492; Modesitt SC, 2002, OBSTET GYNECOL, V100, P788, DOI 10.1016/S0029-7844(02)02149-X; Ogawa S, 2000, GYNECOL ONCOL, V77, P298, DOI 10.1006/gyno.2000.5765; Yoshikawa H, 2000, GYNECOL OBSTET INVES, V50, P11, DOI 10.1159/000052873; Yamaguchi K, 2008, CLIN CANCER RES, V14, P32, DOI 10.1158/1078-0432.CCR-07-1614; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Cheng CW, 2011, J PATHOL, V224, P261, DOI 10.1002/path.2852; Oishi T, 2014, ONCOL REP, V32, P553, DOI 10.3892/or.2014.3268; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Hisamatsu T, 2013, MOL CANCER THER, V12, P1367, DOI 10.1158/1535-7163.MCT-12-1185; Toyokuni S, 2009, CANCER SCI, V100, P9, DOI 10.1111/j.1349-7006.2008.01001.x; Lee YY, 2011, GYNECOL ONCOL, V122, P541, DOI 10.1016/j.ygyno.2011.05.009; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Bartholomeusz C, 2012, MOL CANCER THER, V11, P360, DOI 10.1158/1535-7163.MCT-11-0400; BROOKS JJ, 1977, CANCER, V40, P3065, DOI 10.1002/1097-0142(197712)40:6<3065::AID-CNCR2820400645>3.0.CO;2-3; Eskander RN, 2014, EXPERT REV CLIN PHAR, V7, P847, DOI 10.1586/17512433.2014.968554; Graveel CR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009209; Guan B, 2014, J NATL CANC I, V106; HEAPS JM, 1990, OBSTET GYNECOL, V75, P1023; Khemapech N, 2012, ASIAN PAC J CANCER P, V13, P6357, DOI 10.7314/APJCP.2012.13.12.6357; Kobayashi H, 2012, FERTIL STERIL, V98, P415, DOI 10.1016/j.fertnstert.2012.04.047; Maeda D, 2009, MODERN PATHOL, V22, P824, DOI 10.1038/modpathol.2009.40; Nyiraneza C, 2010, FAM CANCER, V9, P383, DOI 10.1007/s10689-010-9321-1; Pather S, 2005, INT J GYNECOL CANCER, V15, P432, DOI 10.1111/j.1525-1438.2005.15305.x; Rahman MT, 2012, BRIT J CANCER, V107, P300, DOI 10.1038/bjc.2012.246; Ren F, 2012, ARCH GYNECOL OBSTET, V285, P215, DOI 10.1007/s00404-011-1922-x; Schmeler KM, 2008, CLIN TRANSL ONCOL, V10, P313, DOI 10.1007/s12094-008-0206-9; Shinjo K, 2014, INT J CANCER, V135, P308, DOI 10.1002/ijc.28692; Sung PL, 2014, GYNECOL ONCOL, V133, P147, DOI 10.1016/j.ygyno.2014.02.016; Suzuki S, 2011, CANCER SCI, V102, P1622, DOI 10.1111/j.1349-7006.2011.02003.x; Yamashita Y, 2014, MOD PATHOL; Yamashita Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057724; Zannoni GF, 2014, VIRCHOWS ARCH, V465, P193, DOI 10.1007/s00428-014-1599-1	49	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	MAY	2015	45	5					405	407		10.1093/jjco/hyu221		3	Oncology	Oncology	CI4NB	WOS:000354725500001		
J	Matsumoto, K; Onda, T; Yaegashi, N				Matsumoto, Koji; Onda, Takashi; Yaegashi, Nobuo			Pharmacotherapy for recurrent ovarian cancer: current status and future perspectives	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Review						chemo-gynecology; gynecol-med; molecular Dx	PEGYLATED LIPOSOMAL DOXORUBICIN; PHASE-III TRIAL; DOUBLE-BLIND; BEVACIZUMAB; THERAPY; CHEMOTHERAPY; CARBOPLATIN; COMBINATION; PROGRESSION; PACLITAXEL	Several 'lines of therapy' that utilize cytotoxic agents and are driven by platinum-free intervals are the current standard of care for patients with recurrent ovarian cancer. For patients with platinum-resistant disease, single agent chemotherapy (pegylated liposomal doxorubicin, topotecan, gemcitabine or weekly paclitaxel) is the standard of care. For patients with platinum-sensitive disease, combination chemotherapy (carboplatin plus paclitaxel, pegylated liposomal doxorubicin or gemcitabine) is the standard of care. In addition, antiangiogenic therapy using bevacizumab is an established option. Future directions could include 'lines of therapy' with biologic agents driven by specific biologic targets. Data from antiangiogenic agents (trebananib, pazopanib and cediranib), antifolate drugs (farletuzumab and vintafolide), poly(ADP-ribose) polymerase inhibitors (olaparib and veliparib), mTOR inhibitors (everolimus and temsirolimus) and immune editing agents (nivolumab) have been summarized in this review.	[Matsumoto, Koji] Hyogo Canc Ctr, Div Med Oncol, Akashi, Hyogo, Japan; [Onda, Takashi] Kitasato Univ, Div Gynecol & Obstet, Sagamihara, Kanagawa 228, Japan; [Yaegashi, Nobuo] Tohoku Univ, Div Gynecol & Obstet, Sendai, Miyagi 980, Japan	Matsumoto, K (reprint author), 13-70 Kitaoji Cho, Akashi, Hyogo 6738558, Japan.	kojmatsu@hp.pref.hyogo.jp			National Cancer Center Research and Development Funds [23-A-16, 23-A-17, 26-A-4]; Ministry of Health, Labor and Welfare of Japan [17S-1, 17S-5, 18-6, 20S-1, 20S-6]	The study was supported in part by the National Cancer Center Research and Development Funds (23-A-16, 23-A-17 and 26-A-4), the Grant-in-Aid for Clinical Cancer Research (17S-1, 17S-5, 18-6, 20S-1 and 20S-6) from the Ministry of Health, Labor and Welfare of Japan.	Aghajanian C, 2012, J CLIN ONCOL, V30, P2039, DOI 10.1200/JCO.2012.42.0505; Ledermann J, 2012, NEW ENGL J MED, V366, P1382, DOI 10.1056/NEJMoa1105535; Mutch DG, 2007, J CLIN ONCOL, V25, P2811, DOI 10.1200/JCO.2006.09.6735; Hanker LC, 2012, ANN ONCOL, V23, P2605, DOI 10.1093/annonc/mds203; Naumann RW, 2013, J CLIN ONCOL, V31, P4400, DOI 10.1200/JCO.2013.49.7685; Pujade-Lauraine E, 2010, J CLIN ONCOL, V28, P3323, DOI 10.1200/JCO.2009.25.7519; Pujade-Lauraine E, 2014, J CLIN ONCOL, V32, P1302, DOI 10.1200/JCO.2013.51.4489; MARKMAN M, 1991, J CLIN ONCOL, V9, P389; Poveda A, 2011, ANN ONCOL, V22, P39, DOI 10.1093/annonc/mdq352; Monk BJ, 2014, LANCET ONCOL, V15, P799, DOI 10.1016/S1470-2045(14)70244-X; Katsumata N, 2009, LANCET, V374, P1331, DOI 10.1016/S0140-6736(09)61157-0; von Minckwitz G, 2009, J CLIN ONCOL, V27, P1999, DOI 10.1200/JCO.2008.19.6618; Lortholary A, 2012, ANN ONCOL, V23, P346, DOI 10.1093/annonc/mdr149; Ranpura V, 2011, JAMA-J AM MED ASSOC, V305, P487, DOI 10.1001/jama.2011.51; Pfisterer J, 2006, J CLIN ONCOL, V24, P4699, DOI 10.1200/JCO.2006.06.0913; Parmar MKB, 2003, LANCET, V361, P2099; Monk BJ, 2010, J CLIN ONCOL, V28, P3107, DOI 10.1200/JCO.2009.25.4037; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; Kaufman B, 2014, J CLIN ONCOL; Meier W, 2009, GYNECOL ONCOL, V114, P199, DOI 10.1016/j.ygyno.2009.04.026; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Vergote I, 2009, EUR J CANCER, V45, P2324, DOI 10.1016/j.ejca.2009.05.016	23	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	MAY	2015	45	5					408	410		10.1093/jjco/hyv014		3	Oncology	Oncology	CI4NB	WOS:000354725500002		
J	Nakanishi, T; Aoki, D; Watanabe, Y; Ando, Y; Tomotsugu, N; Sato, Y; Saito, T				Nakanishi, Toru; Aoki, Daisuke; Watanabe, Yoh; Ando, Yuichi; Tomotsugu, Naoki; Sato, Yuji; Saito, Toshiaki			A Phase II clinical trial of pegylated liposomal doxorubicin and carboplatin in Japanese patients with platinum-sensitive recurrent ovarian, fallopian tube or primary peritoneal cancer	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						pegylated liposomal doxorubicin; carboplatin; ovarian cancer	PLD PLUS CARBOPLATIN; CHEMOTHERAPY; PACLITAXEL; GUIDELINES; EVALUATE; FORMULA; RE	Objective: This single-arm Phase II trial was designed to assess the safety and efficacy of pegylated liposomal doxorubicin and carboplatin combination chemotherapy in patients with platinum-sensitive recurrent ovarian cancer. Methods: Patients with a histological diagnosis of epithelial ovarian, fallopian tube or primary peritoneal carcinoma, who were relapse-free at least 6 months after completion of first-line platinum-based chemotherapy, and who had measurable disease and gave consent to participate in this study received infusions of pegylated liposomal doxorubicin (30 mg/m(2)) at 1 mg/min, followed by carboplatin (AUC 5 mg min/ml) over 30 min every 28 days. Results: Thirty-three of 35 enrolled patients were eligible for efficacy analysis. One patient (3.0%) achieved a complete response, while 16 (48.5%) achieved a partial response, with an overall objective response rate of 51.5% (95% confidence interval, 34.5-68.6%). Among the 22 patients who had evaluable CA125 levels at entry, responses were observed in 18 patients, with a response rate of 81.8% (95% confidence interval, 65.3-98.3%). The median progression-free survival and overall survival rates for all 35 patients were 10.7 months (95% confidence interval, 8.1-13.2 months) and 38.8 months (95% confidence interval, 31.0-46.7 months), respectively. The most frequent Grade 3-4 toxicities, regardless of cause, were neutropenia (82.9%), thrombocytopenia (51.4%), leukopenia (45.7%) and anemia (17.1%). Conclusions: The safety and efficacy of pegylated liposomal doxorubicin and carboplatin combination chemotherapy in patients with platinum-sensitive recurrent ovarian cancer were confirmed. Although there were concerns of severe hematological toxicity with this therapy, this potential complication was safely managed through adequate monitoring of bone marrow function.	[Nakanishi, Toru] Aichi Canc Ctr Hosp, Dept Gynecol, Nagoya, Aichi 4648681, Japan; [Aoki, Daisuke] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan; [Watanabe, Yoh] Kinki Univ, Fac Med, Dept Obstet & Gynecol, Osaka, Japan; [Ando, Yuichi] Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi, Japan; [Tomotsugu, Naoki; Sato, Yuji] Keio Univ, Sch Med, Ctr Clin Res, Tokyo, Japan; [Saito, Toshiaki] Kyushu Natl Canc Ctr, Gynecol Serv, Fukuoka, Japan	Nakanishi, T (reprint author), Aichi Canc Ctr Hosp, Dept Gynecol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	trnakans@aichi-cc.jp			Janssen Pharmaceutical K. K.	This study was supported by a grant from Janssen Pharmaceutical K. K.	Alberts DS, 2008, GYNECOL ONCOL, V108, P90, DOI 10.1016/j.ygyno.2007.08.075; Ando Y, 1997, BRIT J CANCER, V76, P1067, DOI 10.1038/bjc.1997.509; Weber B, 2009, ANTICANCER RES, V29, P4195; Pujade-Lauraine E, 2010, J CLIN ONCOL, V28, P3323, DOI 10.1200/JCO.2009.25.7519; Rustin GJS, 2004, J NATL CANCER I, V96, P487, DOI 10.1093/jnci/djh081; Vergote I, 2000, J NATL CANCER I, V92, P1534, DOI 10.1093/jnci/92.18.1534; CALVERT AH, 1989, J CLIN ONCOL, V7, P1748; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Bafaloukos D, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-3; Ferrero JM, 2007, ANN ONCOL, V18, P263, DOI 10.1093/annonc/mdl376; Hsiao SM, 2009, GYNECOL ONCOL, V112, P35, DOI 10.1016/j.ygyno.2008.09.033; JELLIFFE R W, 1972, Mathematical Biosciences, V14, P17, DOI 10.1016/0025-5564(72)90003-X; Power P, 2009, GYNECOL ONCOL, V114, P410, DOI 10.1016/j.ygyno.2009.04.037; Rapoport BL, 2009, INT J GYNECOL CANCER, V19, P1137, DOI 10.1111/IGC.0b013e3181a8b938	14	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	MAY	2015	45	5					422	426		10.1093/jjco/hyv016		5	Oncology	Oncology	CI4NB	WOS:000354725500005		
J	Shinohara, S; Kikuchi, M; Suehiro, A; Kishimoto, I; Harada, H; Hino, M; Ishihara, T				Shinohara, Shogo; Kikuchi, Masahiro; Suehiro, Atsushi; Kishimoto, Ippei; Harada, Hiroyuki; Hino, Megumu; Ishihara, Takashi			Characteristics and prognosis of patients with thyroglobulin-positive and radioactive iodine whole-body scan-negative differentiated thyroid carcinoma	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						thyroglobulin; radioiodine whole-body scan; thyroid differentiated carcinoma; survival analysis; sorafenib	ELEVATED SERUM THYROGLOBULIN; RADIOIODINE THERAPY; DOUBLING-TIME; CANCER; SURGERY; ABLATION; I-131	Objective: The prognosis of differentiated thyroid carcinoma is generally favorable. However, some patients have negative radioiodine whole-body scans and detectable serum thyroglobulin with biochemical radioiodine-refractory carcinoma and are candidates for treatment with a multikinase inhibitor, such as sorafenib. The purpose of this study is to investigate the characteristics and prognosis of differentiated thyroid carcinoma patients who are thyroglobulin positive and scan negative. Methods: We retrospectively classified 153 patients treated for 15 years by serum thyroglobulin level and radioiodine scan results and examined the relationship between clinical characteristics and prognosis. Results: Overall, 27% of the patients were classified as thyroglobulin positive/scan negative (positive/negative) while 61% were thyroglobulin negative/scan negative (double negative). Compared with double-negative patients, positive/negative patients were significantly older, predominantly male, had a higher pT and pN, stage, and had higher pre-operative thyroglobulin values. Positive/negative patients showed worse prognosis in terms of overall survival, disease-specific survival and disease-free survival than double-negative patients (10-year overall survival, 85 vs. 93%, P = 0.001; 10-year disease-specific survival, 94 vs. 100%, P = 0.03, 10-year disease-free survival, 77 vs. 93%, P < 0.001). Multivariate analysis revealed that positive/negative status was the only factor associated with disease-free survival, including age and TNM stage (hazard ratio: 6.37, 95% confidence interval: 1.22-33.3). However, the median duration of disease-free period for positive/negative patients was 14.2 years. Conclusions: Few patients among thyroglobulin-positive/scan-negative patients are candidates for sorafenib, despite the significant survival differences from double-negative patients.	[Shinohara, Shogo; Kikuchi, Masahiro; Suehiro, Atsushi; Kishimoto, Ippei; Harada, Hiroyuki] Kobe City Med Ctr Gen Hosp, Dept Otolaryngol Head & Neck Surg, Kobe, Hyogo 6500047, Japan; [Hino, Megumu] Kobe City Med Ctr Gen Hosp, Dept Radiol, Kobe, Hyogo 6500047, Japan; [Ishihara, Takashi] Kobe City Med Ctr Gen Hosp, Dept Endocrinol, Kobe, Hyogo 6500047, Japan	Shinohara, S (reprint author), Kobe City Med Ctr Gen Hosp, Dept Otolaryngol Head & Neck Surg, Chuo Ku, Minatojima Minamimachi 2-1-1, Kobe, Hyogo 6500047, Japan.	sinosino@kcho.jp			Kasahara Fund for promotion of cancer research	This study was financially supported by Kasahara Fund for promotion of cancer research.	Adedapo KS, 2011, HELL J NUCL MED, V14, P131; Alzahrani AS, 2005, J ENDOCRINOL INVEST, V28, P540; Brose MS, 2014, LANCET, V384, P319, DOI 10.1016/S0140-6736(14)60421-9; Castagna MG, 2011, EUR J ENDOCRINOL, V165, P441, DOI 10.1530/EJE-11-0466; Miyauchi A, 2011, THYROID, V21, P707, DOI 10.1089/thy.2010.0355; Pacini F, 2006, EUR J ENDOCRINOL, V154, P787, DOI 10.1530/eje.1.02158; Cooper DS, 2009, THYROID, V19, P1167, DOI DOI 10.1089/THY.2009.0110; Higashi T, 2012, ANN NUCL MED, V26, P99, DOI 10.1007/s12149-011-0553-4; Ito Y, 2014, ENDOCR J; Mazzaferri EL, 2002, J CLIN ENDOCR METAB, V87, P1490, DOI 10.1210/jc.87.4.1490; Miyauchi A, 2013, ENDOCR J, V60, P415; Saghari M, 2006, NUCL MED COMMUN, V27, P567, DOI 10.1097/00006231-200607000-00004; Shigematsu N, 2005, ENDOCR J, V52, P479, DOI 10.1507/endocrj.52.479; Zakani A, 2011, EUR REV MED PHARMACO, V15, P1215	14	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	MAY	2015	45	5					427	432		10.1093/jjco/hyv021		6	Oncology	Oncology	CI4NB	WOS:000354725500006		
J	Zenda, S; Ishi, S; Akimoto, T; Arahira, S; Motegi, A; Tahara, M; Hayashi, R; Asanuma, C				Zenda, Sadamoto; Ishi, Shinobu; Akimoto, Tetsuo; Arahira, Satoko; Motegi, Atsushi; Tahara, Makoto; Hayashi, Ryuichi; Asanuma, Chie			DeCoP, a Dermatitis Control Program using a moderately absorbent surgical pad for head and neck cancer patients receiving radiotherapy: a retrospective analysis	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						radiation oncology; H and N RadOncol; head and neck	LOCALLY ADVANCED HEAD; RADIATION-THERAPY; CHEMOTHERAPY; MANAGEMENT; SKIN	Objective: We evaluated the clinical characteristics of a Dermatitis Control Program based on a moderately absorbent surgical pad for head and neck cancer patients undergoing (chemo) radiotherapy. Methods: We retrospectively reviewed patients who underwent definitive radiotherapy or postoperative radiotherapy and were treated during radiotherapy with a Dermatitis Control Program using a moderately absorbent surgical pad from May 2011 through April 2012. The main protocol was the 'Dermatitis Control Program', a systematic program which consists of a three-step ladder. When radiation dermatitis reached Grade 2, the irradiated area was covered with a moderately absorbent surgical pad. All outpatients and their families were instructed on how to cover and moisten the irradiated area. Radiation dermatitis was evaluated by physicians or nurses at an outpatient clinic and reviewed from photographs. Results: A total of 116 head and neck cancer patients were treated by definitive or adjuvant (chemo) radiotherapy in our hospital from May 2011 through April 2012. Of these, 85 patients managed their dermatitis using a new device and they were reviewed. Fifty-five patients received chemoradiotherapy, of whom 22 received induction chemotherapy before chemoradiotherapy. Median radiation dose at the onset of Grade 2 dermatitis was 60.0 Gy (range 40-71.2 Gy). Median time to recover from the end of radiotherapy was 10.5 days (range 0-25 days). The rate of recovery from Grade 2 dermatitis within 2 weeks after the end of radiotherapy was 89.4%. The rate of Grade 3 dermatitis was 7.1, with 6.7% in radiotherapy and 7.3% in chemoradiotherapy. Conclusions: This study suggests that the DeCoP protocol with a moderately absorbent surgical pad might be useful for the treatment of radiation dermatitis in clinical practice.	[Zenda, Sadamoto; Ishi, Shinobu; Akimoto, Tetsuo; Arahira, Satoko; Asanuma, Chie] Natl Canc Ctr Hosp East, Div Radiat Oncol, Kashiwa, Chiba 2778577, Japan; [Tahara, Makoto] Natl Canc Ctr Hosp East, Head & Neck Med Oncol, Kashiwa, Chiba 2778577, Japan; [Hayashi, Ryuichi] Natl Canc Ctr Hosp East, Head & Neck Surg, Kashiwa, Chiba 2778577, Japan	Zenda, S (reprint author), Natl Canc Ctr Hosp East, Div Radiat Oncol, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	szenda@east.ncc.go.jp			Foundation for Promotion of Cancer Research	This study was supported by the Foundation for Promotion of Cancer Research.	Lohia S, 2014, JAMA OTOLARYNGOL, V140, P331, DOI 10.1001/jamaoto.2013.6777; Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; Evensen JF, 2001, ACTA ONCOL, V40, P751; Nutting CM, 2011, LANCET ONCOL, V12, P127, DOI 10.1016/S1470-2045(10)70290-4; Adelstein DJ, 2003, J CLIN ONCOL, V21, P92, DOI 10.1200/JCO.2003.01.008; Bolderston A, 2006, SUPPORT CARE CANCER, V14, P802, DOI 10.1007/s00520-006-0063-4; Seiwert TY, 2005, BRIT J CANCER, V92, P1341, DOI 10.1038/sj.bjc.6602510; Bernier J, 2005, HEAD NECK-J SCI SPEC, V27, P843, DOI 10.1002/hed.20279; Campbell I R, 1992, Clin Oncol (R Coll Radiol), V4, P78, DOI 10.1016/S0936-6555(05)80971-9; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; McQuestion Maurene, 2006, Semin Oncol Nurs, V22, P163, DOI 10.1016/j.soncn.2006.04.004; Spiotto MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094456; Zenda S, 2013, INT J CLIN ONCOL, V18, P350, DOI 10.1007/s10147-012-0385-9	14	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	MAY	2015	45	5					433	438		10.1093/jjco/hyv010		6	Oncology	Oncology	CI4NB	WOS:000354725500007		
J	Ioka, T; Okusaka, T; Ohkawa, S; Boku, N; Sawaki, A; Fujii, Y; Kamei, Y; Takahashi, S; Namazu, K; Umeyama, Y; Bycott, P; Furuse, J				Ioka, Tatsuya; Okusaka, Takuji; Ohkawa, Shinichi; Boku, Narikazu; Sawaki, Akira; Fujii, Yosuke; Kamei, Yoichi; Takahashi, Satori; Namazu, Katsushi; Umeyama, Yoshiko; Bycott, Paul; Furuse, Junji			Efficacy and safety of axitinib in combination with gemcitabine in advanced pancreatic cancer: subgroup analyses by region, including Japan, from the global randomized Phase III trial	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						axitinib; gemcitabine; Japanese; pancreatic cancer	ENDOTHELIAL GROWTH-FACTOR; RENAL-CELL CARCINOMA; PLUS PLACEBO; SURVIVAL; BEVACIZUMAB; EXPRESSION; SORAFENIB; S-1	Objective: Axitinib is a potent and selective inhibitor of vascular endothelial growth factor receptors 1-3. This analysis compared efficacy and safety of axitinib plus gemcitabine in patients with advanced pancreatic cancer from Japan, North America and the European Union, enrolled in a randomized Phase III study. Methods: Patients (n = 632), stratified by disease extent, were randomly assigned (1: 1) to receive axitinib/gemcitabine or placebo/gemcitabine. Axitinib was administered at a starting dose of 5 mg orally twice daily and gemcitabine at 1000 mg/m(2) once weekly for 3 weeks in 4 week cycles. Primary endpoint was overall survival. Results: Among Japanese patients, median overall survival was not estimable (95% confidence interval, 7.4 months-not estimable) with axitinib/gemcitabine (n = 58) and 9.9 months (95% confidence interval, 7.4-10.5) with placebo/gemcitabine (n = 56) (hazard ratio 1.093 [95% confidence interval, 0.525-2.274]). Median survival follow-up (range) was 5.1 months (0.02-12.3) with axitinib/gemcitabine vs. 5.4 months (1.8-10.5) with placebo/gemcitabine. Similarly, no difference was detected in overall survival between axitinib/gemcitabine and placebo/gemcitabine in patients from North America or the European Union. Common adverse events with axitinib/gemcitabine in Japanese patients were fatigue, anorexia, dysphonia, nausea and decreased platelet count. Axitinib safety profile was generally similar in patients from the three regions, although there were differences in incidence of some adverse events. An exploratory analysis did not show any correlation between axitinib/gemcitabine-related hypertension and overall survival. Conclusions: Axitinib/gemcitabine, while tolerated, did not provide survival benefit over gemcitabine alone in patients with advanced pancreatic cancer from Japan or other regions.	[Ioka, Tatsuya] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Hepatobiliary & Pancreat Oncol, Osaka 5378511, Japan; [Okusaka, Takuji] Natl Canc Ctr, Hepatobiliary & Pancreat Oncol Div, Tokyo, Japan; [Ohkawa, Shinichi] Kanagawa Canc Ctr, Dept Gastroenterol, Kanagawa, Japan; [Boku, Narikazu] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan; [Sawaki, Akira] Kawasaki Med Univ, Dept Clin Oncol, Okayama, Japan; [Fujii, Yosuke; Kamei, Yoichi; Takahashi, Satori; Namazu, Katsushi; Umeyama, Yoshiko] Pfizer Japan Inc, Tokyo, Japan; [Bycott, Paul] Pfizer Oncol, San Diego, CA USA; [Furuse, Junji] Kyorin Univ, Sch Med, Dept Med Oncol, Tokyo, Japan	Ioka, T (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Hepatobiliary & Pancreat Oncol, Higashinari Ku, 1-3-3 Nakamichi, Osaka 5378511, Japan.	ioka-ta@mc.pref.osaka.jp			Pfizer Inc.; Pfizer Japan Inc.	This work was funded by Pfizer Inc. Funding to pay the Open Access publication charges for this article was provided by Pfizer Japan Inc.	Ueno H, 2013, J CLIN ONCOL, V31, P1640, DOI 10.1200/JCO.2012.43.3680; Spano JP, 2008, LANCET, V371, P2101, DOI 10.1016/S0140-6736(08)60661-3; Ozaka M, 2012, CANCER CHEMOTH PHARM, V69, P1197, DOI 10.1007/s00280-012-1822-1; Rini BI, 2013, J CLIN PHARMACOL, V53, P491, DOI 10.1002/jcph.73; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Goncalves A, 2012, ANN ONCOL, V23, P2799, DOI 10.1093/annonc/mds135; Nakai Y, 2012, BRIT J CANCER, V106, P1934, DOI 10.1038/bjc.2012.183; Pithavala YK, 2010, CANCER CHEMOTH PHARM, V65, P563, DOI 10.1007/s00280-009-1065-y; Motzer RJ, 2013, LANCET ONCOL, V14, P552, DOI 10.1016/S1470-2045(13)70093-7; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Kindler HL, 2011, LANCET ONCOL, V12, P256, DOI 10.1016/S1470-2045(11)70004-3; Van Cutsem E, 2009, J CLIN ONCOL, V27, P2231, DOI 10.1200/JCO.2008.20.0238; Hu-Lowe DD, 2008, CLIN CANCER RES, V14, P7272, DOI 10.1158/1078-0432.CCR-08-0652; Kindler HL, 2010, J CLIN ONCOL, V28, P3617, DOI 10.1200/JCO.2010.28.1386; Ferlay J, 2012, IARC CANC BASE, V11; Itakura J, 1997, CLIN CANCER RES, V3, P1309; Kuwahara K, 2003, PANCREAS, V26, P344, DOI 10.1097/00006676-200305000-00006; National Comprehensive Cancer Network (NCCN), NCCN CLIN PRACT GUID; Seo Y, 2000, CANCER, V88, P2239, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2239::AID-CNCR6>3.0.CO;2-V; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208	20	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	MAY	2015	45	5					439	448		10.1093/jjco/hyv011		10	Oncology	Oncology	CI4NB	WOS:000354725500008		
J	Nakano, K; Motoi, N; Inagaki, L; Tomomatsu, J; Gokita, T; Ae, K; Tanizawa, T; Shimoji, T; Matsumoto, S; Takahashi, S				Nakano, Kenji; Motoi, Noriko; Inagaki, Lina; Tomomatsu, Junichi; Gokita, Tabu; Ae, Keisuke; Tanizawa, Taisuke; Shimoji, Takashi; Matsumoto, Seiichi; Takahashi, Shunji			Differences in the responses to pazopanib and the prognoses of soft tissue sarcomas by their histological eligibility for the PALETTE study	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						orthopedics/sarcoma-Med; chemotherapy; pazopanib; histological diagnoses; PALETTE study	PHASE-II TRIAL; EUROPEAN ORGANIZATION; INHIBITOR; CHEMOTHERAPY; ANGIOSARCOMA; CRIZOTINIB; TUMOR; EORTC; BONE	Objective: In Japan, pazopanib has been made available to soft tissue sarcoma patients, also to patients histologically diagnosed as ineligible for the international Phase 3 study (PALETTE). However, clinical evidence for the use of pazopanib in PALETTE-ineligible patients is currently insufficient. Methods: We retrospectively reviewed medical records of soft tissue sarcoma patients treated with pazopanib at our institute. By pathological review, the patients' eligibility for the PALETTE study was evaluated and the differences in their responses to pazopanib and incidences of adverse events were investigated. Results: From November 2012 to August 2014, a total of 47 patients received pazopanib, 38 (81%) of whom were histologically eligible for the PALETTE study, and 9 of whom (19%) were not. The median follow-up time was 7.5 months (range 1.4-20.3 months). An objective response was observed in both groups, but the patients' survival tended to be longer in the PALETTE-eligible patients; median progression-free survival was 4.5 months vs. 2.9 months (P = 0.15) and overall survival was 10.7 months vs. 7.8 months (P = 0.55), though these differences were not statistically significant. There were no significant differences in the incidence of adverse events by PALETTE eligibility, but dose skipping or dose reduction was more likely to be observed in PALETTE-ineligible patients. Conclusion: Pazopanib is tolerable to soft tissue sarcoma patients ineligible for the PALETTE study and some of them respond to pazopanib, but the prognoses of patients ineligible for the PALETTE study might be worse than those of PALETTE-eligible patients. The indication of pazopanib for soft tissue sarcoma patients with PALETTE-ineligible histologies should be decided carefully.	[Nakano, Kenji; Inagaki, Lina; Tomomatsu, Junichi; Takahashi, Shunji] Japanese Fdn Canc Res, Dept Med Oncol, Canc Inst Hosp, Tokyo, Japan; [Motoi, Noriko] Japanese Fdn Canc Res, Div Pathol, Inst Canc, Tokyo, Japan; [Gokita, Tabu; Ae, Keisuke; Tanizawa, Taisuke; Shimoji, Takashi; Matsumoto, Seiichi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Orthoped Surg, Tokyo, Japan	Takahashi, S (reprint author), Japanese Fdn Canc Res, Dept Med Oncol, Canc Inst Hosp, Ariake, Tokyo 1358550, Japan.	s.takahashi-chemotherapy@jfcr.or.jp					Sleijfer S, 2009, J CLIN ONCOL, V27, P3126, DOI 10.1200/JCO.2008.21.3223; Penel N, 2008, J CLIN ONCOL, V26, P5269, DOI 10.1200/JCO.2008.17.3146; van der Graaf WTA, 2012, LANCET, V379, P1879, DOI 10.1016/S0140-6736(12)60651-5; Sleijfer S, 2010, EUR J CANCER, V46, P72, DOI 10.1016/j.ejca.2009.09.022; Kasper B, 2014, ANN ONCOL, V25, P719, DOI 10.1093/annonc/mdt586; [Anonymous], 2014, INTERIM REPORT POSTM; Grier HE, 2003, NEW ENGL J MED, V348, P694, DOI 10.1056/NEJMoa020890; Dickson MA, 2013, J CLIN ONCOL, V31, P2024, DOI 10.1200/JCO.2012.46.5476; Butrynski JE, 2010, NEW ENGL J MED, V363, P1727, DOI 10.1056/NEJMoa1007056; Campos SM, 2014, GYNECOL ONCOL, V133, P537, DOI 10.1016/j.ygyno.2014.02.036; Tomita H, 2014, J AM ACAD DERMATOL, V70, pE19, DOI 10.1016/j.jaad.2013.08.055; Ganjoo KN, 2014, ANN ONCOL, V25, P236, DOI 10.1093/annonc/mdt484; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Blay JY, 2014, EUR J CANCER, V50, P1137, DOI 10.1016/j.ejca.2014.01.012; Schoffski P, 2011, LANCET ONCOL, V12, P1045, DOI 10.1016/S1470-2045(11)70230-3; Kattan MW, 2002, J CLIN ONCOL, V20, P791, DOI 10.1200/JCO.20.3.791; Blay JY, 2014, EUR J CANCER, V50, P679, DOI 10.1016/j.ejca.2013.11.011; ESMO/European Sarcoma Network Working Group, 2012, ANN ONCOL S7, V23, P92, DOI DOI 10.1093/ANNONC/MDS253; Fletcher Ch, 2013, WHO CLASSIFICATION T; Kimbara S, 2014, JPN J CLIN ONCOL, V44, P868, DOI 10.1093/jjco/hyu069; Raney R B, 2001, Sarcoma, V5, P9, DOI 10.1080/13577140120048890; Wilky BA, 2013, CURR OPIN ONCOL, V25, P373, DOI 10.1097/CCO.0b013e3283622d3a	22	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	MAY	2015	45	5					449	455		10.1093/jjco/hyv022		7	Oncology	Oncology	CI4NB	WOS:000354725500009		
J	Shimizu, K; Nakaya, N; Saito-Nakaya, K; Akechi, T; Ogawa, A; Fujisawa, D; Sone, T; Yoshiuchi, K; Goto, K; Iwasaki, M; Tsugane, S; Uchitomi, Y				Shimizu, Ken; Nakaya, Naoki; Saito-Nakaya, Kumi; Akechi, Tatsuo; Ogawa, Asao; Fujisawa, Daisuke; Sone, Toshimasa; Yoshiuchi, Kazuhiro; Goto, Koichi; Iwasaki, Motoki; Tsugane, Shoichiro; Uchitomi, Yosuke			Personality traits and coping styles explain anxiety in lung cancer patients to a greater extent than other factors	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						neoplasms; anxiety; adaptation; psychological; personality	QUALITY-OF-LIFE; PSYCHIATRIC-DISORDERS; BREAST-CANCER; PSYCHOLOGICAL DISTRESS; MAC SCALE; DEPRESSIVE SYMPTOMS; PREDICTIVE FACTORS; MENTAL ADJUSTMENT; DATABASE PROJECT; JAPANESE VERSION	Objective: Although various factors thought to be correlated with anxiety in cancer patients, relative importance of each factors were unknown. We tested our hypothesis that personality traits and coping styles explain anxiety in lung cancer patients to a greater extent than other factors. Methods: A total of 1334 consecutively recruited lung cancer patients were selected, and data on cancer-related variables, demographic characteristics, health behaviors, physical symptoms and psychological factors consisting of personality traits and coping styles were obtained. The participants were divided into groups with or without a significant anxiety using the Hospital Anxiety and Depression Scale-Anxiety, and a binary logistic regression analysis was used to identify factors correlated with significant anxiety using a multivariate model. Results: Among the recruited patients, 440 (33.0%) had significant anxiety. The binary logistic regression analysis revealed a coefficient of determination (overall R-2) of 39.0%, and the explanation for psychological factors was much higher (30.7%) than those for cancer-related variables (1.1%), demographic characteristics (2.1%), health behaviors (0.8%) and physical symptoms (4.3%). Four specific factors remained significant in a multivariate model. A neurotic personality trait, a coping style of helplessness/hopelessness, and a female sex were positively correlated with significant anxiety, while a coping style of fatalism was negatively correlated. Conclusions: Our hypothesis was supported, and anxiety was strongly linked with personality trait and coping style. As a clinical implication, the use of screening instruments to identify these factors and intervention for psychological crisis may be needed.	[Shimizu, Ken] Natl Canc Ctr, Psychooncol Div, Tokyo 1040045, Japan; [Nakaya, Naoki] Tohoku Univ, Tohoku Med Megabank Org, Div Personalized Prevent & Epidemiol, Dept Prevent Med & Epidemiol, Sendai, Miyagi 980, Japan; [Saito-Nakaya, Kumi] Tohoku Univ, Grad Sch Med, Dept Behav Med, Sendai, Miyagi 980, Japan; [Akechi, Tatsuo] Nagoya City Univ, Grad Sch Med Sci, Dept Psychiat & Cognitive Behav Med, Nagoya, Aichi, Japan; [Ogawa, Asao; Fujisawa, Daisuke] Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Psychooncol Div, Chiba, Japan; [Ogawa, Asao; Fujisawa, Daisuke] Natl Canc Ctr Hosp East, Psychooncol Div, Chiba, Japan; [Fujisawa, Daisuke] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Sone, Toshimasa] Tohoku Fukushi Univ, Dept Rehabil, Fac Hlth Sci, Sendai, Miyagi, Japan; [Yoshiuchi, Kazuhiro] Univ Tokyo, Grad Sch Sci, Dept Stress Sci & Psychosomat Med, Tokyo 113, Japan; [Goto, Koichi] Natl Canc Ctr Hosp East, Div Thorac Oncol, Chiba, Japan; [Iwasaki, Motoki] Natl Canc Ctr, Res Inst, Div Epidemiol, Res Ctr Canc Prevent & Screening, Tokyo 104, Japan; [Tsugane, Shoichiro] Natl Canc Ctr, Res Inst, Res Ctr Canc Prevent & Screening, Tokyo 104, Japan; [Uchitomi, Yosuke] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neuropsychiat, Okayama, Japan	Shimizu, K (reprint author), Natl Canc Ctr, Psychooncol Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	keshimiz@ncc.go.jp			Japanese Ministry of Health, Labor and Welfare [H22-033, H22-036]	This work was supported in part by a Grant-in-aid for Cancer Research, Clinical Cancer Research (H22-033) to K.S. and Third Term Comprehensive 10-year Strategy for Cancer Control (H22-036) to Y.U., from the Japanese Ministry of Health, Labor and Welfare.	Akechi T, 1998, SUPPORT CARE CANCER, V6, P281, DOI 10.1007/s005200050167; Akechi T, 2000, PSYCHO-ONCOL, V9, P395, DOI 10.1002/1099-1611(200009/10)9:5<395::AID-PON472>3.0.CO;2-O; ANDRYKOWSKI MA, 1990, PSYCHOSOM MED, V52, P458; Agarwal M, 2010, CANCER NURS, V33, P156, DOI 10.1097/NCC.0b013e3181bdef76; Kotov R, 2010, PSYCHOL BULL, V136, P768, DOI 10.1037/a0020327; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Bardwell WA, 2006, J CLIN ONCOL, V24, P2420, DOI 10.1200/JCO.2005.02.0081; DEROGATIS LR, 1983, JAMA-J AM MED ASSOC, V249, P751, DOI 10.1001/jama.249.6.751; Brown LF, 2010, PSYCHO-ONCOLOGY, V19, P734, DOI 10.1002/pon.1627; Kugaya A, 1998, JPN J CLIN ONCOL, V28, P333, DOI 10.1093/jjco/28.5.333; Lasheen W, 2010, SUPPORT CARE CANCER, V18, P265, DOI 10.1007/s00520-009-0772-6; Hopwood P, 2000, J CLIN ONCOL, V18, P893; Latini DM, 2007, J UROLOGY, V178, P826, DOI 10.1016/j.juro.2007.05.039; Uchitomi Y, 2001, CANCER, V92, P1926, DOI 10.1002/1097-0142(20011001)92:7<1926::AID-CNCR1711>3.0.CO;2-L; Smith EM, 2003, PALLIATIVE MED, V17, P509, DOI 10.1191/0269216303pm781oa; Kendler KS, 2011, PSYCHOL MED, V41, P2035, DOI 10.1017/S0033291711000225; Stark D, 2002, J CLIN ONCOL, V20, P3137, DOI 10.1200/JCO.2002.08.549; Teunissen SCCM, 2007, PALLIATIVE MED, V21, P341, DOI 10.1177/0269216307079067; Mitchell AJ, 2011, LANCET ONCOL, V12, P160, DOI 10.1016/S1470-2045(11)70002-X; Kissane DW, 2004, AUST NZ J PSYCHIAT, V38, P320, DOI 10.1080/j.1440-1614.2004.01358.x; Kangas M, 2005, J CONSULT CLIN PSYCH, V73, P763, DOI 10.1037/0022-006X.73.4.763; Greer JA, 2008, J PSYCHOSOM RES, V65, P549, DOI 10.1016/j.jpsychores.2008.03.005; Ewing G, 2004, J PAIN SYMPTOM MANAG, V27, P287, DOI 10.1016/j.jpainsymman.2003.12.012; Schnoll RA, 2002, PATIENT EDUC COUNS, V46, P137, DOI 10.1016/S0738-3991(01)00157-4; Jacobsen PB, 2008, CA-CANCER J CLIN, V58, P214, DOI 10.3322/CA.2008.0003; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Tanaka K, 2002, J PAIN SYMPTOM MANAG, V23, P490, DOI 10.1016/S0885-3924(02)00400-1; HOSOKAWA T, 1993, PSYCHOL REP, V72, P823; Miovic M, 2007, CANCER, V110, P1665, DOI 10.1002/cncr.22980; Osborne RH, 1999, PSYCHOL MED, V29, P1335, DOI 10.1017/S0033291799001142; Stark DPH, 2000, BRIT J CANCER, V83, P1261, DOI 10.1054/bjoc.2000.1405; RAZAVI D, 1990, BRIT J PSYCHIAT, V156, P79, DOI 10.1192/bjp.156.1.79; Lo C, 2010, J CLIN ONCOL, V28, P3084, DOI 10.1200/JCO.2009.26.9712; Shimizu K, 2012, ANN ONCOL, V23, P1973, DOI 10.1093/annonc/mds061; WATSON M, 1988, PSYCHOL MED, V18, P203; Akechi T, 2001, CANCER, V92, P2609, DOI 10.1002/1097-0142(20011115)92:10<2609::AID-CNCR1614>3.0.CO;2-K; Uchitomi Y, 2003, J CLIN ONCOL, V21, P69, DOI 10.1200/JCO.2003.12.139; Greer S, 2008, PSYCHO-ONCOL, V17, P170, DOI 10.1002/pon.1205; Bienvenu OJ, 2003, J PERS DISORD, V17, P139, DOI 10.1521/pedi.17.2.139.23991; Brandes Mina, 2006, Curr Psychiatry Rep, V8, P263, DOI 10.1007/s11920-006-0061-8; Brintzenhofe-Szoc KM, 2009, PSYCHOSOMATICS, V50, P383, DOI 10.1176/appi.psy.50.4.383; Eysenck H. J., 1975, MANUAL EYSENCK PERSO; Folkman S., 1984, STRESS APPRAISAL COP; Gonzalez BD, 2010, PSYCHO-ONCOLOGY, V21, P239; Hall A, 1999, EUR J CANCER, V35, P79, DOI 10.1016/S0959-8049(98)00308-6; House A, 2002, BRIT MED J, V325, P207, DOI 10.1136/bmj.325.7357.207; Hulbert-Williams N., 2011, PSYCHO-ONCOLOGY, V21, P857; Kudadjie-Gyamfi E, 2005, BREAST CANCER RES TR, V92, P35, DOI 10.1007/s10549-005-0154-9; Nakaya N, 2006, JPN J CLIN ONCOL, V36, P280, DOI 10.1093/jjco/hyl015; Okuyama T, 2001, J PAIN SYMPTOM MANAG, V22, P554, DOI 10.1016/S0885-3924(01)00305-0; Patrick Donald L, 2003, J Natl Cancer Inst, V95, P1110; Rolke HB, 2008, RESP MED, V102, P1460, DOI 10.1016/j.rmed.2008.04.002; Salvo N, 2012, CLIN ONCOL-UK, V24, P139, DOI 10.1016/j.clon.2011.05.003; STIEFEL F, 1994, SUPPORT CARE CANCER, V2, P233, DOI 10.1007/BF00365727; Traeger L, 2012, J CLIN ONCOL, V30, P1197, DOI 10.1200/JCO.2011.39.5632; Uchitomi Y, 2000, CANCER, V89, P1172, DOI 10.1002/1097-0142(20000901)89:5<1172::AID-CNCR27>3.0.CO;2-U; Vodermaier A, 2011, BRIT J CANCER, V105, P1814, DOI 10.1038/bjc.2011.503; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	58	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	MAY	2015	45	5					456	463		10.1093/jjco/hyv024		8	Oncology	Oncology	CI4NB	WOS:000354725500010		
J	Narukawa, T; Hara, T; Arai, E; Komiyama, M; Kawahara, T; Kanai, Y; Fujimoto, H				Narukawa, Tsukasa; Hara, Tomohiko; Arai, Eri; Komiyama, Motokiyo; Kawahara, Takashi; Kanai, Yae; Fujimoto, Hiroyuki			Tumour multifocality and grade predict intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma without a history of bladder cancer	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						urology; urologic-med; upper urinary tract urothelial carcinoma; ureteral cancer; renal pelvic cancer; intravesical recurrence	TRANSITIONAL-CELL CARCINOMA; RADICAL NEPHROURETERECTOMY; CUMULATIVE INCIDENCE; COMPETING RISK; MODEL; MULTICENTER; PREVENTION; LOCATION; IMPACT; TRIALS	Objective: Patients with upper urinary tract urothelial carcinoma (UUT-UC) without a history of bladder cancer have a different natural history of intravesical recurrence after nephroureterectomy compared with those with a history of bladder cancer. The aim of this study was to identify predictive factors for post-operative intravesical recurrence in patients with non-metastatic upper urinary tract-localized urothelial carcinoma without a history of bladder cancer and who were not taking medication during the perioperative period. Methods: This retrospective study included 133 patients who were treated between 1995 and 2012. Univariate and multivariate analyses were used to evaluate the clinical and pathological factors associated with the cumulative incidence of bladder cancer. Results: Of the 133 patients, 51 (38.3%) developed intravesical recurrence during a median follow-up of 71 months (range, 0.8-210.8). In the multivariate analysis, multifocality (P = 0.03) and high tumour grade (P = 0.007) were significantly associated with the cumulative incidence of bladder cancer. We constructed a prediction classification model on the basis of the total number of risk factors. The 2-year cumulative incidence rates were 5.6, 34.8 and 50.0% in individuals with no, one and two risk factors, respectively. There was a significant difference between patients with no risk factors and those with two risk factors (P = 0.01). Conclusions: Although this retrospective study had several limitations, tumour multifocality and tumour grade were found to be potential risk factors for intravesical recurrence in our cases.	[Narukawa, Tsukasa; Hara, Tomohiko; Komiyama, Motokiyo; Kawahara, Takashi; Fujimoto, Hiroyuki] Natl Canc Ctr, Div Urol, Tokyo 1040045, Japan; [Arai, Eri; Kanai, Yae] Natl Canc Ctr, Res Inst, Div Mol Pathol, Tokyo 104, Japan	Hara, T (reprint author), Natl Canc Ctr, Div Urol, Chuo Ku, Tsukiji 5-1-1, Tokyo 1040045, Japan.	tomohara-jua@umin.ac.jp			Ministry of Health and Welfare	This study was supported by grants from the Ministry of Health and Welfare for the Third-term Comprehensive 10-year Strategy for Cancer Control.	Abe T, 2010, BJU INT, V105, P1102, DOI 10.1111/j.1464-410X.2009.08836.x; O'Brien T, 2011, EUR UROL, V60, P703, DOI 10.1016/j.eururo.2011.05.064; Kobayashi Y, 2012, WORLD J UROL, V30, P271, DOI 10.1007/s00345-011-0731-y; Xylinas E, 2013, WORLD J UROL, V31, P61, DOI 10.1007/s00345-012-0957-3; Kim HT, 2007, CLIN CANCER RES, V13, P559, DOI 10.1158/1078-0432.CCR-06-1210; Xylinas E, 2014, EUR UROL, V65, P650, DOI 10.1016/j.eururo.2013.09.003; Zigeuner RE, 2006, BJU INT, V98, P1181, DOI 10.1111/j.1464-410X.2006.06519.x; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Luo HL, 2013, ANN SURG ONCOL, V20, P3121, DOI 10.1245/s10434-013-3000-z; Novara G, 2008, BJU INT, V101, P1368, DOI 10.1111/j.1464-410X.2008.07438.x; Koga F, 2001, UROL INT, V67, P135, DOI 10.1159/000050969; Pieras E, 2010, BJU INT, V106, P1319, DOI 10.1111/j.1464-410X.2010.09341.x; Chung SD, 2007, AM J KIDNEY DIS, V50, P743, DOI 10.1053/j.ajkd.2007.08.007; Hagiwara M, 2013, J UROLOGY, V189, P2062, DOI 10.1016/j.juro.2013.01.024; Ito A, 2013, J CLIN ONCOL, V31, P1422, DOI 10.1200/JCO.2012.45.2128; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Watanabe T, 2000, CANCER GENE THER, V7, P1575, DOI 10.1038/sj.cgt.7700261; Terakawa T, 2008, UROLOGY, V71, P123, DOI 10.1016/j.urology.2007.08.054; Azemar MD, 2011, UROL ONCOL-SEMIN ORI, V29, P130, DOI 10.1016/j.urolonc.2009.06.003; Chen MK, 2012, CHINESE MED J-PEKING, V125, P3821, DOI 10.3760/cma.j.issn.0366-6999.2012.21.014; Eble J, 2004, PATHOLOGY GENETICS T, V7; HARRIS AL, 1992, NEW ENGL J MED, V326, P759, DOI 10.1056/NEJM199203123261108; Hinotsu S, 1999, CANCER, V86, P1818, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1818::AID-CNCR25>3.0.CO;2-0; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Ku JH, 2011, UROL ONCOL-SEMIN ORI, V29, P383, DOI 10.1016/j.urolonc.2009.04.007; Papanicolaou GN., 1954, ATLAS EXFOLIATIVE CY, P13; Sobin LH, 2009, INT UNION CANC UICC; van der Poel HG, 2005, EUR UROL, V48, P438, DOI 10.1016/j.eururo.2005.03.009	30	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	MAY	2015	45	5					488	493		10.1093/jjco/hyv019		6	Oncology	Oncology	CI4NB	WOS:000354725500014		
J	Kataoka, K; Tsushima, T; Mizusawa, J; Hironaka, S; Tsubosa, Y; Kii, T; Shibuya, Y; Chin, K; Katayama, H; Kato, K; Fukuda, H; Kitagawa, Y				Kataoka, Kozo; Tsushima, Takahiro; Mizusawa, Junki; Hironaka, Shuichi; Tsubosa, Yasuhiro; Kii, Takayuki; Shibuya, Yuichi; Chin, Keisho; Katayama, Hiroshi; Kato, Ken; Fukuda, Haruhiko; Kitagawa, Yuko		Japan Esophageal Oncology Grp; Japan Clinical Oncology Grp	A randomized controlled Phase III trial comparing 2-weekly docetaxel combined with cisplatin plus fluorouracil (2-weekly DCF) with cisplatin plus fluorouracil (CF) in patients with metastatic or recurrent esophageal cancer: rationale, design and methods of Japan Clinical Oncology Group study JCOG1314 (MIRACLE study)	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						metastatic or recurrent esophageal cancer; 2-weekly DCF; Phase III	SQUAMOUS-CELL CARCINOMA; COMBINATION CHEMOTHERAPY; NECK-CANCER; 5-FLUOROURACIL; I/II; 5-FU; HEAD	Chemotherapy with cisplatin plus fluorouracil is the current standard treatment for metastatic or recurrent esophageal cancer. We have developed a 2-weekly docetaxel combined with CF regimen and conducted a Phase I/II trial for metastatic or recurrent esophageal cancer (JCOG0807). Promising efficacy and safety were shown in JCOG0807, and we have commenced a Phase III trial in September 2014 to confirm the superiority of 2-weekly DCF to CF for patients with metastatic or recurrent esophageal cancer. A total of 240 patients will be accrued from 41 Japanese institutions over a period of 4 years. The primary end point is overall survival. The secondary end points are progression-free survival, response rate and proportion of adverse events. This trial has been registered in the UMIN Clinical Trials Registry as UMIN000015107 (http://www.umin.ac.jp/ctr/index.htm).	[Kataoka, Kozo; Mizusawa, Junki; Katayama, Hiroshi; Fukuda, Haruhiko] Natl Canc Ctr, Ctr Res Adm & Support, JCOG Data Ctr, Operat Off, Tokyo 104, Japan; [Tsushima, Takahiro] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan; [Hironaka, Shuichi] Chiba Canc Ctr, Clin Trial Promot Dept, Chiba 2608717, Japan; [Tsubosa, Yasuhiro] Shizuoka Canc Ctr, Div Esophageal Surg, Shizuoka, Japan; [Kii, Takayuki] Osaka Med Coll, Canc Chemotherapy Ctr, Osaka, Japan; [Shibuya, Yuichi] Kochi Hlth Sci Ctr, Dept Gastroenterol Surg, Kochi, Japan; [Chin, Keisho] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan; [Kato, Ken] Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan; [Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan	Tsushima, T (reprint author), Shizuoka Canc Ctr, Div Gastrointestinal Oncol, 1007 Shimonagakubo, Nagaizumi, Shizuoka 4118777, Japan.	t.tsushima@scchr.jp			National Cancer Center Research and Development Fund [26-A-4]	This study is supported by the National Cancer Center Research and Development Fund (26-A-4).	Lorenzen S, 2009, ANN ONCOL, V20, P1667, DOI 10.1093/annonc/mdp069; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Overman MJ, 2010, CANCER-AM CANCER SOC, V116, P1446, DOI 10.1002/cncr.24925; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028; IIZUKA T, 1992, JPN J CLIN ONCOL, V22, P172; SCHOENFELD DA, 1982, BIOMETRICS, V38, P163, DOI 10.2307/2530299; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Yamasaki M, 2011, ONCOLOGY-BASEL, V80, P307, DOI 10.1159/000329806; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Osaka Y, 2011, ANTICANCER RES, V31, P633; Tebbutt NC, 2010, BRIT J CANCER, V102, P475, DOI 10.1038/sj.bjc.6605522; Ozawa S, 2012, ESOPHAGUS-TOKYO, V9, P75, DOI 10.1007/s10388-012-0327-7; Bleiberg H, 1997, EUR J CANCER, V33, P1216, DOI 10.1016/S0959-8049(97)00088-9; Rademaker-Lakhai JM, 2006, J CLIN ONCOL, V24, P918, DOI 10.1200/JCO.2006.10.077; Hayashi K, 2001, JPN J CLIN ONCOL, V31, P419, DOI 10.1093/jjco/hye090; Hironaka S, 2014, CANCER SCI, V105, P1189, DOI 10.1111/cas.12486; Iizuka T, 1991, JPN J CLIN ONCOL, V1991, P176; Japan Esophageal Society, 2009, ESOPHAGUS, V6, P1; Kato K, 2014, ESOPHAGUS-TOKYO, V11, P183, DOI 10.1007/s10388-014-0427-7; Rybak Leonard P, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P364, DOI 10.1097/MOO.0b013e3282eee452; Shah MA, 2010, J CLIN ONCOL, V28; Sobin LH, 2011, TNM CLASSIFICATION M; Takahashi H, 2010, J THORAC ONCOL, V5, P122, DOI 10.1097/JTO.0b013e3181c1ffd5; Tamura S, 2012, ANTICANCER RES, V32, P1403; Tsushima T, 2012, P 50 ANN M JAP SOC C	26	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	MAY	2015	45	5					494	498		10.1093/jjco/hyv012		5	Oncology	Oncology	CI4NB	WOS:000354725500015		
J	Hishida, T; Tsuboi, M; Shukuya, T; Takamochi, K; Sakurai, H; Yoh, K; Ohashi, Y; Kunitoh, H				Hishida, Tomoyuki; Tsuboi, Masahiro; Shukuya, Takehito; Takamochi, Kazuya; Sakurai, Hiroyuki; Yoh, Kiyotaka; Ohashi, Yasuo; Kunitoh, Hideo			Multicenter observational cohort study of post-operative treatment for completely resected non-small-cell lung cancer of pathological Stage I (T1 > 2 cm and T2 in TNM classification version 6)	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						non-small-cell lung cancer; early stage; post-operative adjuvant chemotherapy; randomized Phase III study; observational cohort study	ADJUVANT CHEMOTHERAPY; TEGAFUR-URACIL; ADENOCARCINOMA	Post-operative adjuvant chemotherapy has been considered an effective strategy to reduce cancer recurrence and improve survival for resected non-small-cell lung cancer. The Japan Clinical Oncology Group has completed patient accrual for a randomized Phase III study (JCOG0707), which compares the survival benefit of UFT and S-1 for completely resected pathological Stage I (T1 > 2 cm and T2 in TNM classification version 6) non-small-cell lung cancer. However, there is a growing concern that those who participated in clinical trials are highly selected patients and do not represent the 'real-world' population. This multicenter observational cohort study aims to analyze the backgrounds, pattern of care and outcomes of the patients who were excluded from the JCOG0707 study during the accrual period. The results of this cohort study will be useful for external validity of the results of clinical trial such as JCOG0707.	[Hishida, Tomoyuki; Tsuboi, Masahiro] Natl Canc Ctr Hosp East, Dept Thorac Surg, Chiba, Japan; [Shukuya, Takehito] Juntendo Univ, Sch Med, Dept Resp Med, Tokyo 113, Japan; [Takamochi, Kazuya] Juntendo Univ, Sch Med, Dept Gen Thorac Surg, Tokyo 113, Japan; [Sakurai, Hiroyuki] Natl Canc Ctr, Dept Thorac Surg, Tokyo, Japan; [Yoh, Kiyotaka] Natl Canc Ctr Hosp East, Dept Thorac Surg, Chiba, Japan; [Ohashi, Yasuo] Chuo Univ, Dept Integrated Sci & Engn Sustainable Soc, Tokyo 112, Japan; [Kunitoh, Hideo] Japanese Red Cross Med Ctr, Dept Chemotherapy, Tokyo, Japan	Hishida, T (reprint author), Natl Canc Ctr Hosp East, Dept Thorac Surg, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	thishida@nifty.com			Public Health Research Foundation; Taiho Pharmaceutical Co., Ltd.	This study is sponsored by the Comprehensive Support Project for Oncology Research (CSPOR) of Public Health Research Foundation. However, the funds for Study A are provided by Taiho Pharmaceutical Co., Ltd. according to a contract. The secretary for the CSPOR will perform the clerical work for the study but will not make decisions in association with planning, implementation, and publication of the study. Additionally, this study will be administered independent of the provider of the funds, and the provider of the funds will never be involved in the decision making for the planning, implementation, analysis and publication of the study. The decisions regarding the planning, implementation, and publication of the study will be made by the executive committee for the study.	Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Sawabata N, 2011, J THORAC ONCOL, V6, P1229, DOI 10.1097/JTO.0b013e318219aae2; Hamada C, 2009, J THORAC ONCOL, V4, P1511, DOI 10.1097/JTO.0b013e3181bbf1f2; Hamada C, 2005, J CLIN ONCOL, V23, P4999, DOI 10.1200/JCO.2005.09.017; Williams CD, 2014, CANCER-AM CANCER SOC, V120, P1939, DOI 10.1002/cncr.28679; Okada M, 2001, ANN THORAC SURG, V71, P956, DOI 10.1016/S0003-4975(00)02223-2; Kato H, 2004, NEW ENGL J MED, V350, P1713, DOI 10.1056/NEJMoa032792; Diasio RB, 2004, NEW ENGL J MED, V350, P1777, DOI 10.1056/NEJMe048035; Mohile SG, 2012, J GERIATR ONCOL, V3, P291, DOI 10.1016/j.jgo.2012.04.006; Shukuya T, 2010, MED ONCOL, V27, P932, DOI 10.1007/s12032-009-9309-6; Sobin LH, 2002, TNM CLASSIFICATION M; Younis T, 2008, J THORAC ONCOL, V3, P1272, DOI 10.1097/JTO.0b013e318189f562	12	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	MAY	2015	45	5					499	501		10.1093/jjco/hyv028		3	Oncology	Oncology	CI4NB	WOS:000354725500016		
J	Nishiwaki, S				Nishiwaki, Satoshi			Roles of volunteers and professionals in medical development-insights from the development of Allo-HSCT	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Letter							STEM-CELL TRANSPLANTATION; HEALTH-CARE		[Nishiwaki, Satoshi] Minist Hlth Labour & Welf, Off Transplantat Med, Hlth Serv Bur, Tokyo 1008916, Japan	Nishiwaki, S (reprint author), Minist Hlth Labour & Welf, Off Transplantat Med, Hlth Serv Bur, Chiyoda Ku, 1-2-2 Kasumigaseki, Tokyo 1008916, Japan.	n-3104@tf7.so-net.ne.jp					Gratwohl A, 2010, JAMA-J AM MED ASSOC, V303, P1617, DOI 10.1001/jama.2010.491; AuBuchon JP, 2014, TRANSFUSION, V54, P2077, DOI 10.1111/trf.12620; Epstein JS, 2013, TRANSFUSION, V53, P2265; Marcotte L, 2014, JAMA-J AM MED ASSOC, V312, P231, DOI 10.1001/jama.2014.6762; Nishiwaki S, 2015, JPN J CLIN ONCOL, V45, P311, DOI 10.1093/jjco/hyu225	5	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	MAY	2015	45	5					502	503		10.1093/jjco/hyv040		2	Oncology	Oncology	CI4NB	WOS:000354725500017		
J	Murakami, S; Manabe, S; Yamada, K				Murakami, Shuji; Manabe, Saki; Yamada, Kouzo			A case of lung adenocarcinoma with multiple cavitary metastases	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Editorial Material									[Murakami, Shuji; Manabe, Saki; Yamada, Kouzo] Kanagawa Canc Ctr Hosp, Dept Thorac Oncol, Kanagawa, Japan	Murakami, S (reprint author), Kanagawa Canc Ctr Hosp, Dept Thorac Oncol, Kanagawa, Japan.							0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	MAY	2015	45	5					504	505		10.1093/jjco/hyv047		2	Oncology	Oncology	CI4NB	WOS:000354725500018		
J	Machii, R; Saika, K				Machii, Ryoko; Saika, Kumiko			Morphological distribution of esophageal cancer from Cancer Incidence in Five Continents Vol. X	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Editorial Material									[Machii, Ryoko; Saika, Kumiko] Natl Canc Ctr, Div Screening Assessment & Management, Res Ctr Canc Prevent & Screening, Tokyo, Japan	Machii, R (reprint author), Natl Canc Ctr, Div Screening Assessment & Management, Res Ctr Canc Prevent & Screening, Tokyo, Japan.							0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	MAY	2015	45	5					506	507		10.1093/jjco/hyv061		2	Oncology	Oncology	CI4NB	WOS:000354725500019		
J	Mori, R; Aoyama, H				Mori, Ryota; Aoyama, Hisae			Improvement of Static Runway Assignment at Busy Airports Using Queueing Model	JOURNAL OF AIRCRAFT			English	Article							SCHEDULING AIRCRAFT LANDINGS; ALGORITHMS; CAPACITY	Congestion is a critical issue at most hub airports. This paper tackles this problem occurring at the airport with the most passengers in Japan: Tokyo International Airport. This airport has four intersecting runways, which interfere with each other and complicate the runway operation. To increase the efficiency, the runway operation is modeled by a queueing model, which calculates the average waiting time on each runway. A simple queueing model is applied and extended to describe the complicated runway operation, and several key parameters (e.g., takeoff and landing separations) are estimated via actual data. The accuracy of the model is also validated. Using the proposed models, the arrival traffic is optimized, and it is shown that about 100 min of waiting time can be saved by appropriate runway allocation on a sample day.	[Mori, Ryota; Aoyama, Hisae] Elect Nav Res Inst, Tokyo 1820012, Japan	Mori, R (reprint author), Air Traff Management Dept, 7-42-23 Jindaiji Higashimachi, Chofu, Tokyo 1820012, Japan.						Ernst AT, 1999, NETWORKS, V34, P229, DOI 10.1002/(SICI)1097-0037(199910)34:3<229::AID-NET8>3.0.CO;2-W; GALLIHER HP, 1958, OPER RES, V6, P264, DOI 10.1287/opre.6.2.264; Marianov V, 2003, COMPUT OPER RES, V30, P983, DOI 10.1016/S0305-0548(02)00052-7; Beasley JE, 2000, TRANSPORT SCI, V34, P180, DOI 10.1287/trsc.34.2.180.12302; Pinol H, 2006, EUR J OPER RES, V171, P439, DOI 10.1016/j.ejor.2004.09.040; Bencheikh G., 2011, INT J COMPUTER THEOR, V3, P224, DOI 10.7763/IJCTE.2011.V3.309; Bhat UN, 2008, STAT IND TECHNOL, P1, DOI 10.1007/978-0-8176-4725-4_1; Buzacott J. A., 1993, STOCHASTIC MODELS MA; Gilbo EP, 1997, IEEE T CONTR SYST T, V5, P490, DOI 10.1109/87.623035; Hebert JE, 1997, J AIRCRAFT, V34, P43, DOI 10.2514/2.2133; International Civil Aviation Organization, 2007, 4444 INT CIV AV ORG; Iovanella A., 2011, P SESAR INNOVATION D, P1; Janic M, 2007, TRANSPORT PLAN TECHN, V30, P501, DOI 10.1080/03081060701599995; Lasdon L. S., 1978, ACM Transactions on Mathematical Software, V4, DOI 10.1145/355769.355773; Moreau D. C., 2005, AIAA GUID NAV CONTR; Mori R., MATH PROBLE IN PRESS; Paul V. C., 1997, AUSTR J INTELLIGENT, V4, P206; RUE RC, 1985, TRANSPORT SCI, V19, P154, DOI 10.1287/trsc.19.2.154; Saraf A. P., 2006, P IEEE AER C IEEE PU; Wan Y., 2008, AIAA GUID NAV CONTR; Willemain T. R., 2004, 3804510 DSES RENN PO, P510; Yamada N., 2006, THESIS TOKYO I TECHN	22	0	0	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0021-8669	1533-3868		J AIRCRAFT	J. Aircr.	MAY-JUN	2015	52	3					819	826		10.2514/1.C032766		8	Engineering, Aerospace	Engineering	CI4VH	WOS:000354751400008		
J	Munday, PM; Taira, K; Suwa, T; Numata, D; Asai, K				Munday, Phillip M.; Taira, Kunihiko; Suwa, Tetsuya; Numata, Daiju; Asai, Keisuke			Nonlinear Lift on a Triangular Airfoil in Low-Reynolds-Number Compressible Flow	JOURNAL OF AIRCRAFT			English	Article							ROVER SURFACE OPERATIONS; AERODYNAMICS; VEHICLE; DESIGN	Numerical and experimental analyses of the aerodynamic performance of a triangular airfoil in low-Reynolds-number compressible flow are performed. This airfoil is one of the candidates for propeller blades on a possible future Martian air vehicle design. Based on past experimental studies conducted in the Mars Wind Tunnel at Tohoku University, this airfoil is known to exhibit nonlinear lift behavior. In the present study, direct numerical simulations of low-Reynolds-number compressible flow over a spanwise periodic triangular airfoil are conducted to identify the source of nonlinear lift. The numerical results reveal that the source of the nonlinear aerodynamic behavior is the lift enhancement provided by the large leading-edge vortex generated. For compressible low-Reynolds-number flow, the wake structure becomes elongated, causing the nonlinear lift enhancement to appear at higher angles of attack compared to the case of incompressible flow.	[Munday, Phillip M.; Taira, Kunihiko] Florida A&M Florida State Univ, Dept Mech Engn, Florida Ctr Adv Aeroprop, Coll Engn, Tallahassee, FL 32310 USA; [Suwa, Tetsuya; Numata, Daiju; Asai, Keisuke] Tohoku Univ, Dept Aerosp Engn, Sendai, Miyagi 9808579, Japan	Munday, PM (reprint author), Florida A&M Florida State Univ, Dept Mech Engn, Florida Ctr Adv Aeroprop, Coll Engn, Tallahassee, FL 32310 USA.	pmm06d@my.fsu.edu; ktaira@fsu.edu; suwa.tetsuya@aero.mech.tohoku.ac.jp; numata.daiju@aero.mech.tohoku.ac.jp; asai@aero.mech.tohoku.ac.jp		Taira, Kunihiko/0000-0002-3762-8075			Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; LISSAMAN PBS, 1983, ANNU REV FLUID MECH, V15, P223, DOI 10.1146/annurev.fl.15.010183.001255; Pines DJ, 2006, J AIRCRAFT, V43, P290, DOI 10.2514/1.4922; Conlisk AT, 1997, ANNU REV FLUID MECH, V29, P515, DOI 10.1146/annurev.fluid.29.1.515; Hoarau Y, 2003, J FLUID MECH, V496, P63, DOI 10.1017/S0022112003006530; DRELA M, 1992, J AIRCRAFT, V29, P1106, DOI 10.2514/3.46292; Mueller TJ, 2003, ANNU REV FLUID MECH, V35, P89, DOI 10.1146/annurev.fluid.35.101101.161102; Biesiadecki JJ, 2006, IEEE ROBOT AUTOM MAG, V13, P63, DOI 10.1109/MRA.2006.1638017; CARR LW, 1988, J AIRCRAFT, V25, P6, DOI 10.2514/3.45534; Anyoji M., 2009, 47 AIAA AER SCI M JA; Anyoji M., 2010, 48 AIAA AER SCI M JA; Anyoji M., 2011, THESIS TOHOKU U SEND; BRES G. A, 2012, 42 AIAA FLUID DYN C; Datta A, 2003, J AIRCRAFT, V40, P461, DOI 10.2514/2.3141; DICKINSON MH, 1993, J EXP BIOL, V174, P45; Fujita K., 2012, 50 AIAA AER SCI M JA; Khalighi Y., 2011, P ASME TURB EXP NEW; Khalighi Y., 2011, 17 AIAA CEAS AER C J; Kojima R, 2013, J AIRCRAFT, V50, P187, DOI 10.2514/1.C031849; Leger PC, 2005, IEEE SYS MAN CYBERN, P1815; Mueller T. J., 2001, FIXED FLAPPING WING, V195, P35; Nagai H., 2013, 51 AIAA AER SCI M JA; Niimi T, 2005, J THERMOPHYS HEAT TR, V19, P9, DOI 10.2514/1.5047; Okamoto M., 2005, THESIS NIHON U TOKYO; Ono T., 2010, P 14 INT S FLOW VIS; Owen T., 1977, Journal of Geophysical Research, V82, DOI 10.1029/JS082i028p04635; Sant Y. L., 2005, AEROSP SCI TECHNOL, V9, P285, DOI 10.1016/j.ast.2004.08.008; Seiff A., 1977, Journal of Geophysical Research, V82, DOI 10.1029/JS082i028p04364; SOBIECZKY H, 1984, ANNU REV FLUID MECH, V16, P337; Suwa T., 2012, 30 AIAA APPL AER C J; Tsuchiya T., 2013, 51 AIAA AER SCI M JA	31	1	1	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0021-8669	1533-3868		J AIRCRAFT	J. Aircr.	MAY-JUN	2015	52	3					924	931		10.2514/1.C032983		8	Engineering, Aerospace	Engineering	CI4VH	WOS:000354751400021		
J	Nagai, M; Aoyama, T; Ito, A; Tajino, J; Iijima, H; Yamaguchi, S; Zhang, XK; Kuroki, H				Nagai, Momoko; Aoyama, Tomoki; Ito, Akira; Tajino, Junichi; Iijima, Hirotaka; Yamaguchi, Shoki; Zhang, Xiangkai; Kuroki, Hiroshi			Alteration of cartilage surface collagen fibers differs locally after immobilization of knee joints in rats	JOURNAL OF ANATOMY			English	Article						cartilage; collagen fiber; immobilization; rat model; scanning electron microscopy	ARTICULAR-CARTILAGE; CONTRACTURE MODEL; YOUNG-RABBITS; REMOBILIZATION; MATRIX; OSTEOARTHRITIS; PROTEOGLYCAN; EXERCISE; MOTION; DEGENERATION	The purpose of this study was to examine the ultrastructural changes of surface cartilage collagen fibers, which differ by region and the length of the experimental period in an immobilization model of rat. Male Wistar rats were randomly divided into histological or macroscopic and ultrastructural assessment groups. The left knees of all the animals were surgically immobilized by external fixation for 1, 2, 4, 8 or 16weeks (n=5/time point). Sagittal histological sections of the medial mid-condylar region of the knee were obtained and assessed in four specific regions (contact and peripheral regions of the femur and tibia) and two zones (superficial and deep). To semi-quantify the staining intensity of the collagen fibers in the cartilage, picrosirius red staining was used. The cartilage surface changes of all the assessed regions were investigated by scanning electron microscopy (SEM). From histological and SEM observations, the fibrillation and irregular changes of the cartilage surface were more severe in the peripheral region than in the contact region. Interestingly, at 16weeks post-immobilization, we observed non-fibrous structures at both the contact and peripheral regions. The collagen fiber staining intensity decreased in the contact region compared with the peripheral region. In conclusion, the alteration of surface collagen fiber ultrastructure and collagen staining intensity differed by the specific cartilage regions after immobilization. These results demonstrate that the progressive degeneration of cartilage is region specific, and depends on the length of the immobilization period.	[Nagai, Momoko; Ito, Akira; Tajino, Junichi; Iijima, Hirotaka; Yamaguchi, Shoki; Zhang, Xiangkai; Kuroki, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Motor Funct Anal, Human Hlth Sci, Kyoto 6068507, Japan; [Aoyama, Tomoki] Kyoto Univ, Grad Sch Med, Dept Dev & Rehabil Motor Funct, Human Hlth Sci, Kyoto 6068507, Japan	Kuroki, H (reprint author), Kyoto Univ, Grad Sch Med, Dept Motor Funct Anal, Human Hlth Sci,Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	kuroki.hiroshi.6s@kyoto-u.ac.jp			JSPS KAKENHI [25242055, 25560258]	The authors thank Keiko Okamoto-Furuta and Haruyasu Kohda (Kyoto University, Kyoto) for their technical assistance. The authors thank Keiichiro Nishida (Okayama University, Okayama) for his knowledgeable advice. This study was supported in part by a JSPS KAKENHI Grant-in-Aid for Scientific Research (A) (no. 25242055) and a JSPS KAKENHI Grant-in-Aid for Challenging Exploratory Research (no. 25560258).	Ando A, 2009, TOHOKU J EXP MED, V217, P271; Schmitz N, 2010, OSTEOARTHR CARTILAGE, V18, pS113, DOI 10.1016/j.joca.2010.05.026; Ko FC, 2013, ARTHRITIS RHEUM-US, V65, P1569, DOI 10.1002/art.37906; CLARK JM, 1990, J ANAT, V171, P117; Jortikka MO, 1997, ANN RHEUM DIS, V56, P255, DOI 10.1136/ard.56.4.255; Hagiwara Y, 2009, J ORTHOP RES, V27, P236, DOI 10.1002/jor.20724; Julkunen P, 2010, J ANAT, V217, P262, DOI 10.1111/j.1469-7580.2010.01270.x; Kaab MJ, 2000, CELLS TISSUES ORGANS, V167, P106, DOI 10.1159/000016774; Nagase H, 2003, ARTHRITIS RES THER, V5, P94, DOI 10.1186/ar630; PALMOSKI MJ, 1980, ARTHRITIS RHEUM, V23, P325, DOI 10.1002/art.1780230310; Moger CJ, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3049478; Haapala J, 2001, ANN RHEUM DIS, V60, P55, DOI 10.1136/ard.60.1.55; Kaab MJ, 1998, J ORTHOPAED RES, V16, P743, DOI 10.1002/jor.1100160617; LEDINGHAM J, 1993, ANN RHEUM DIS, V52, P520, DOI 10.1136/ard.52.7.520; Ando A, 2011, TOHOKU J EXP MED, V224, P77, DOI 10.1620/tjem.224.77; BEHRENS F, 1989, J ORTHOPAED RES, V7, P335, DOI 10.1002/jor.1100070305; Williamson AK, 2001, J ORTHOPAED RES, V19, P1113, DOI 10.1016/S0736-0266(01)00052-3; OConnor KM, 1997, J BONE MINER RES, V12, P580, DOI 10.1359/jbmr.1997.12.4.580; Vanwanseele B, 2002, OSTEOARTHR CARTILAGE, V10, P408, DOI 10.1053/joca.2002.0529; [Anonymous], 1999, CLIN ORTHOPAEDICS; JURVELIN J, 1986, CLIN ORTHOP RELAT R, P246; SAH RLY, 1989, J ORTHOPAED RES, V7, P619, DOI 10.1002/jor.1100070502; BEESLEY JE, 1992, MATRIX, V12, P189; Clark JM, 1997, MICROSC RES TECHNIQ, V37, P299, DOI 10.1002/(SICI)1097-0029(19970515)37:4<299::AID-JEMT5>3.0.CO;2-G; ENNEKING WF, 1972, J BONE JOINT SURG AM, VA 54, P973; Haapala J, 1996, J RHEUMATOL, V23, P1586; Haapala J, 2000, INT J SPORTS MED, V21, P76; Hagiwara Y, 2010, CONNECT TISSUE RES, V51, P22, DOI 10.3109/03008200902859406; HELMINEN HJ, 1983, ACTA ANAT, V115, P327; Hong SP, 1996, ACTA ANAT, V157, P27; JOZSA L, 1987, INT ORTHOP, V11, P129; JURVELIN J, 1985, ACTA ANAT, V122, P62; JURVELIN J, 1983, ACTA ANAT, V116, P302; Leong DJ, 2010, MATRIX BIOL, V29, P420, DOI 10.1016/j.matbio.2010.02.004; MICHELSSON JE, 1984, SCAND J RHEUMATOL, V13, P273; Milentijevic D, 2003, J BIOMECH ENG-T ASME, V125, P594, DOI 10.1115/1.1610021; Moriyama H, 2008, OSTEOARTHR CARTILAGE, V16, P392, DOI 10.1016/j.joca.2007.07.002; Nagai M, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-224; SAAMANEN AM, 1987, CONNECT TISSUE RES, V16, P163, DOI 10.3109/03008208709002004; Schachar N S, 1999, J Orthop Sci, V4, P457, DOI 10.1007/s007760050130; Setton LA, 1997, OSTEOARTHR CARTILAGE, V5, P1, DOI 10.1016/S1063-4584(97)80027-1; SMITH RL, 2004, CLIN ORTHOP S, V427, pS89; TAMMI M, 1983, CONNECT TISSUE RES, V11, P45, DOI 10.3109/03008208309015010; TAMMI M, 1988, CONNECT TISSUE RES, V17, P199, DOI 10.3109/03008208809015030; Trudel G, 2003, J RHEUMATOL, V30, P2218; Trudel G, 2005, ARCH PHYS MED REHAB, V86, P90, DOI 10.1016/j.apmr.2004.01.029	46	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8782	1469-7580		J ANAT	J. Anat.	MAY	2015	226	5					447	457		10.1111/joa.12290		11	Anatomy & Morphology	Anatomy & Morphology	CI1VO	WOS:000354533300006		
J	Kohara, Y; Soeta, S; Izu, Y; Amasaki, H				Kohara, Yukihiro; Soeta, Satoshi; Izu, Yayoi; Amasaki, Hajime			Accumulation of type VI collagen in the primary osteon of the rat femur during postnatal development	JOURNAL OF ANATOMY			English	Article						intramembranous ossification; NG2; osteoblast; primary osteon; type VI collagen	CHONDROITIN SULFATE PROTEOGLYCAN; OSTEOBLAST-LIKE CELLS; NG2 PROTEOGLYCAN; EXTRACELLULAR-MATRIX; MELANOMA-CELLS; IN-VITRO; BONE; EXPRESSION; INTEGRIN; ADHESION	In rodents, the long bone diaphysis is expanded by forming primary osteons at the periosteal surface of the cortical bone. This ossification process is thought to be regulated by the microenvironment in the periosteum. Type VI collagen (Col VI), a component of the extracellular matrix (ECM) in the periosteum, is involved in osteoblast differentiation at early stages. In several cell types, Col VI interacts with NG2 on the cytoplasmic membrane to promote cell proliferation, spreading and motility. However, the detailed functions of Col VI and NG2 in the ossification process in the periosteum are still under investigation. In this study, to clarify the relationship between localization of Col VI and formation of the primary osteon, we examined the distribution of Col VI and osteoblast lineages expressing NG2 in the periosteum of rat femoral diaphysis during postnatal growing periods by immunohistochemistry. Primary osteons enclosing the osteonal cavity were clearly identified in the cortical bone from 2weeks old. The size of the osteonal cavities decreased from the outer to the inner region of the cortical bone. In addition, the osteonal cavities of newly formed primary osteons at the outermost region started to decrease in size after rats reached the age of 4weeks. Immunohistochemistry revealed concentrated localization of Col VI in the ECM in the osteonal cavity. Col VI-immunoreactive areas were reduced and they disappeared as the osteonal cavities became smaller from the outer to the inner region. In the osteonal cavities of the outer cortical regions, Runx2-immunoreactive spindle-shaped cells and mature osteoblasts were detected in Col VI-immunoreactive areas. The numbers of Runx2-immunoreactive cells were significantly higher in the osteonal cavities than in the osteogenic layers from 2 to 4weeks. Most of these Runx2-immunoreactive cells showed NG2-immunoreactivity. Furthermore, PCNA-immunoreactivity was detected in the Runx2-immunoreactive spindle cells in the osteonal cavities. These results indicate that Col VI provides a characteristic microenvironment in the osteonal cavity of the primary osteon, and that differentiation and proliferation of the osteoblast lineage occur in the Col VI-immunoreactive area. Interaction of Col VI and NG2 may be involved in the structural organization of the primary osteon by regulating osteoblast lineages.	[Kohara, Yukihiro; Soeta, Satoshi; Amasaki, Hajime] Nippon Vet & Life Sci Univ, Lab Vet Anat, Musashino, Tokyo 1808602, Japan; [Izu, Yayoi] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pharmacol, Tokyo, Japan	Soeta, S (reprint author), Nippon Vet & Life Sci Univ, Lab Vet Anat, 1-7-1 Kyonan Cho, Musashino, Tokyo 1808602, Japan.	s-soeta@nvlu.ac.jp					Amir LR, 2007, CELL TISSUE RES, V330, P35, DOI 10.1007/s00441-007-0448-9; Burg MA, 1996, J BIOL CHEM, V271, P26110; Tillet E, 1997, J BIOL CHEM, V272, P10769; Satomi-Kobayashi S, 2012, J BIOL CHEM, V287, P30336, DOI 10.1074/jbc.M111.329110; Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206; PFAFF M, 1993, EXP CELL RES, V206, P167, DOI 10.1006/excr.1993.1134; STALLCUP WB, 1990, J CELL BIOL, V111, P3177, DOI 10.1083/jcb.111.6.3177; Gattazzo F, 2014, BBA-GEN SUBJECTS, V1840, P2506, DOI 10.1016/j.bbagen.2014.01.010; DOANE KJ, 1992, EXP CELL RES, V200, P490, DOI 10.1016/0014-4827(92)90200-R; Ruhl M, 1999, J BIOL CHEM, V274, P34361, DOI 10.1074/jbc.274.48.34361; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Burg MA, 1998, J CELL PHYSIOL, V177, P299, DOI 10.1002/(SICI)1097-4652(199811)177:2<299::AID-JCP12>3.0.CO;2-5; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; Fukushi J, 2004, MOL BIOL CELL, V15, P3580, DOI 10.1091/mbc.E04-03-0236; Gara SK, 2008, J BIOL CHEM, V283, P10658, DOI 10.1074/jbc.M709540200; STOVER SM, 1992, J ANAT, V181, P455; Izu Y, 2012, TISSUE CELL, V44, P1, DOI 10.1016/j.tice.2011.08.002; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fukushi J, 2003, DEV DYNAM, V228, P143, DOI 10.1002/dvdy.10359; Mathews S, 2012, DIFFERENTIATION, V84, P185, DOI 10.1016/j.diff.2012.05.001; IIDA J, 1995, CANCER RES, V55, P2177; Atkinson JC, 1996, EXP CELL RES, V228, P283, DOI 10.1006/excr.1996.0328; Doane KJ, 1998, INVEST OPHTH VIS SCI, V39, P263; ALROY J, 1987, HISTOCHEMISTRY, V86, P603, DOI 10.1007/BF00489554; Nilsson SK, 1998, J HISTOCHEM CYTOCHEM, V46, P371; Yang JB, 2004, J CELL BIOL, V165, P881, DOI 10.1083/jcb.200403174; Tillet E, 2002, J CELL BIOCHEM, V86, P726, DOI 10.1002/jcb.10268; BASHEY RI, 1993, CARDIOVASC RES, V27, P1061, DOI 10.1093/cvr/27.6.1061; CARTER DH, 1991, J HISTOCHEM CYTOCHEM, V39, P599; Christensen SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033397; CURREY JD, 1984, PHILOS T ROY SOC B, V304, P509, DOI 10.1098/rstb.1984.0042; Currey JD, 1984, CALCIFIED TISSUE INT, V36, P118; Currey JD, 1984, CALCIFIED TISSUE INT, V36, P7; desMargerie E, 2004, J EXP BIOL, V207, P869; Enlow D. E., 1958, Texas Journal of Science, V10, P187; ENLOW DH, 1962, AM J ANAT, V110, P79, DOI 10.1002/aja.1001100202; ENLOW DH, 1962, AM J ANAT, V110, P269, DOI 10.1002/aja.1001100305; Everts V, 1998, J PERIODONTAL RES, V33, P118; Fan W, 2008, BONE, V42, P81, DOI 10.1016/j.bone.2007.08.048; Ham AW, 1987, HAMS HISTOLOGY, P280; Harumiya S, 2002, BIOSCI BIOTECH BIOCH, V66, P2743; Hu J, 2002, MUSCLE NERVE, V26, P696, DOI 10.1002/mus.10250; Ishibashi H, 1999, BBA-GEN SUBJECTS, V1472, P153, DOI 10.1016/S0304-4165(99)00115-4; Izu Y, 2010, MATRIX BIOL, V30, P53; Kodama N, 2009, BONE, V44, P699, DOI 10.1016/j.bone.2008.12.017; Maruyama Z, 2007, DEV DYNAM, V236, P1876, DOI 10.1002/dvdy.21187; Midwood KS, 2001, J PATHOL, V195, P631, DOI 10.1002/path.985; MULLIKEN JB, 1980, PLAST RECONSTR SURG, V65, P553, DOI 10.1097/00006534-198005000-00001; NISHIYAMA A, 1993, MOL BIOL CELL, V4, P1097; Ruhl M, 1999, EXP CELL RES, V250, P548, DOI 10.1006/excr.1999.4540; Schneider GB, 2011, J ORTHOP RES, V29, P1443, DOI 10.1002/jor.21382; Soeta S, 2000, J VET MED SCI, V62, P293, DOI 10.1292/jvms.62.293; TONNA EA, 1974, LAB INVEST, V31, P609; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; WAYNER EA, 1987, J CELL BIOL, V105, P1873, DOI 10.1083/jcb.105.4.1873; Weyand B, 2013, CELL BIOL INT, V37, P713, DOI 10.1002/cbin.10088	57	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8782	1469-7580		J ANAT	J. Anat.	MAY	2015	226	5					478	488		10.1111/joa.12296		11	Anatomy & Morphology	Anatomy & Morphology	CI1VO	WOS:000354533300008		
J	Take, A; Matsumoto, A; Omura, S; Takahashi, Y				Take, Akira; Matsumoto, Atsuko; Omura, Satoshi; Takahashi, Yoko			Streptomyces lactacystinicus sp nov and Streptomyces cyslabdanicus sp nov., producing lactacystin and cyslabdan, respectively	JOURNAL OF ANTIBIOTICS			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; DEOXYRIBONUCLEIC-ACID; MICROBIAL METABOLITE; NEUROBLASTOMA-CELLS; IMIPENEM ACTIVITY; SP K04-0144; FERMENTATION; CLASSIFICATION; DITERPENOIDS; ANTIBIOTICS	Actinomycete strains OM-6519(T) and K04-0144(T) produce the bioactive compounds lactacystin and cyslabdan, respectively. Here, the taxonomic positions of these two strains were determined. The morphological and chemical features of strains OM-6519(T) and K04-0144(T) indicated that they belonged to the genus Streptomyces. Strain OM-6519T showed the highest 16S rRNA gene sequence similarities with Streptomyces xanthocidicus NBRC 13469(T) (99.7%), Streptomyces chrysomallus subsp. fumigatus NBRC 15394(T) (99.6%) and Streptomyces aburaviensis NRRL B-2218(T) (99.5%). However, the DNA-DNA relatedness values between strain OM-6519(T) and the three related strains were below 70%. Strain K04-0144(T) showed the highest 16S rRNA gene sequence similarities with Streptomyces corchorusii NBRC 13032(T) (99.4%), Streptomyces olivaceoviridis NBRC 15394(T) (99.4%) and Streptomyces canarius NRRL B-2218(T) (99.3%). However, the DNA-DNA relatedness values between strain K04-0144(T) and the three related strains were also below 70%. Based on morphological, cultural and physiological characteristics and DNA-DNA relatedness data, strains OM-6519(T) and K04-0144(T) should be classified as new species of the genus Streptomyces, for which the names Streptomyces lactacystinicus sp. nov. and Streptomyces cyslabdanicus sp. nov. are proposed. The type strain of S. lactacystinicus is OM-6519(T) (= NBRC 110082(T), DSM 43136(T)). The type strain of S. cyslabdanicus is K04-0144(T) (= NBRC 110081(T), DSM 42135(T)).	[Take, Akira; Matsumoto, Atsuko; Takahashi, Yoko] Kitasato Univ, Grad Sch Infect Control Sci, Tokyo 1088641, Japan; [Matsumoto, Atsuko; Omura, Satoshi; Takahashi, Yoko] Kitasato Univ, Kitasato Inst Life Sci, Tokyo 1088641, Japan	Matsumoto, A (reprint author), Kitasato Univ, Kitasato Inst Life Sci, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	amatsu@lisci.kitasato-u.ac.jp					FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; OMURA S, 1991, J ANTIBIOT, V44, P117; MINNIKIN DE, 1977, INT J SYST BACTERIOL, V27, P104; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; BECKER B, 1965, APPL MICROBIOL, V13, P236; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; EZAKI T, 1989, INT J SYST BACTERIOL, V39, P224; OMURA S, 1979, J ANTIBIOT, V32, P255; PRIDHAM TG, 1948, J BACTERIOL, V56, P107; GORDON RE, 1974, INT J SYST BACTERIOL, V24, P54; WILLIAMS ST, 1983, J GEN MICROBIOL, V129, P1743; COLLINS MD, 1977, J GEN MICROBIOL, V100, P221; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Berdy J, 2012, J ANTIBIOT, V65, P385, DOI 10.1038/ja.2012.27; BURG RW, 1979, ANTIMICROB AGENTS CH, V15, P361; SAITO H, 1963, BIOCHIM BIOPHYS ACTA, V72, P619, DOI 10.1016/0926-6550(63)90386-4; OMURA S, 1991, J ANTIBIOT, V44, P113; Yuan L, 2009, HELV CHIM ACTA, V92, P1118, DOI 10.1002/hlca.200800424; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fukumoto A, 2008, J ANTIBIOT, V61, P7, DOI 10.1038/ja.2008.102; Fukumoto A, 2008, J ANTIBIOT, V61, P1, DOI 10.1038/ja.2008.101; Inahashi Y, 2010, INT J SYST EVOL MICR, V60, P2652, DOI 10.1099/ijs.0.016477-0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koyama N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048981; Nagamitsu T, 1996, J AM CHEM SOC, V118, P3584, DOI 10.1021/ja9541544; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sasser M, 1990, 101 MIDI INC; Sekiguchi M, 2001, J NAT PROD, V64, P1102, DOI 10.1021/np010097i; SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313; TAKAHASHI S, 1995, J ANTIBIOT, V48, P1015; TAMAOKA J, 1984, FEMS MICROBIOL LETT, V25, P125, DOI 10.1111/j.1574-6968.1984.tb01388.x; Taylor H. D., 1958, COLOR HARMONY MANUAL; Uchida R, 2010, J ANTIBIOT, V63, P151, DOI 10.1038/ja.2010.9; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463; Xu LH, 1996, APPL ENVIRON MICROB, V62, P244	37	1	1	JAPAN ANTIBIOTICS RESEARCH ASSOC	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	MAY	2015	68	5					322	327		10.1038/ja.2014.162		6	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	CJ0GC	WOS:000355152800005		
J	Cao, ZS; Yoshida, R; Kinashi, H; Arakawa, K				Cao, Zhisheng; Yoshida, Ryuhei; Kinashi, Haruyasu; Arakawa, Kenji			Blockage of the early step of lankacidin biosynthesis caused a large production of pentamycin, citreodiol and epi-citreodiol in Streptomyces rochei	JOURNAL OF ANTIBIOTICS			English	Article							LANKAMYCIN PRODUCTION; HETEROLOGOUS EXPRESSION; T-2636 ANTIBIOTICS; GENE CLUSTERS; IDENTIFICATION; ORGANIZATION; COELICOLOR; CELLULOSAE; RECEPTOR; COMPLEX	In our effort to find the key intermediates of lankacidin biosynthesis in Streptomyces rochei, three UV-active compounds were isolated from mutant FS18, a gene disruptant of lkcA encoding a non-ribosomal peptide synthetase (NRPS)-polyketide synthase (PKS) hybrid enzyme. Their structures were elucidated on the basis of spectroscopic data of NMR and MS. Two compounds of a higher mobile spot on silica gel TLC (R-f = 0.45 in CHCl3-MeOH = 20:1) were determined to be an epimeric mixture of citreodiol and epi-citreodiol at the C-6 position in the ratio of 2:1. In contrast, the compound of a lower mobile spot (R-f = similar to 0 in CHCl3-MeOH = 20: 1) was identical to a 28-membered polyene macrolide pentamycin. The yields of citreodiols and pentamycin in FS18 were 5- and 250-fold higher compared with the parent strain. Introduction of a second mutation of srrX, coding a biosynthetic gene of the signaling molecules SRBs, into mutant FS18 did not affect the production of three metabolites. Thus, their production was not regulated by the SRB signaling molecules in contrast to lankacidin or lankamycin.	[Cao, Zhisheng; Yoshida, Ryuhei; Kinashi, Haruyasu; Arakawa, Kenji] Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Hiroshima 7398530, Japan	Arakawa, K (reprint author), Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, 1-3-1 Kagamiyama, Hiroshima 7398530, Japan.	karakawa@hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Charitable Trust Araki Medical and Biochemical Research Memorial Fund	We thank Professor John C. Vederas (University of Alberta) for a kind gift of natural pentamycin. We thank Mrs. Tomoko Amimoto (Natural Science Center for Basic Research and Development, Hiroshima University) for the measurement of high-resolution mass spectra. This work was supported by a Grants-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), and a Charitable Trust Araki Medical and Biochemical Research Memorial Fund.	AHARONOWITZ Y, 1992, ANNU REV MICROBIOL, V46, P461, DOI 10.1146/annurev.mi.46.100192.002333; Auerbach T, 2010, P NATL ACAD SCI USA, V107, P1983, DOI 10.1073/pnas.0914100107; Arakawa K, 2007, MICROBIOL-SGM, V153, P1817, DOI 10.1099/mic.0.2006/002170-0; Belousoff MJ, 2011, P NATL ACAD SCI USA, V108, P2717, DOI 10.1073/pnas.1019406108; Yamamoto S, 2008, J BACTERIOL, V190, P1308, DOI 10.1128/JB.01383-07; Suzuki T, 2010, BIOSCI BIOTECH BIOCH, V74, P819, DOI 10.1271/bbb.90927; Takano E, 2005, MOL MICROBIOL, V56, P465, DOI 10.1111/j.1365-2958.2005.04543.x; Kawachi R, 2000, MOL MICROBIOL, V36, P302, DOI 10.1046/j.1365-2958.2000.01819.x; Sun YH, 2002, MICROBIOL-SGM, V148, P361; O'Rourke S, 2009, MOL MICROBIOL, V71, P763, DOI 10.1111/j.1365-2958.2008.06560.x; Tatsuno S, 2007, J ANTIBIOT, V60, P700; Ohnishi Y, 1999, MOL MICROBIOL, V34, P102, DOI 10.1046/j.1365-2958.1999.01579.x; Ikeda H, 2014, J IND MICROBIOL BIOT, V41, P233, DOI 10.1007/s10295-013-1327-x; BUTLER JD, 1987, P NATL ACAD SCI USA, V84, P556, DOI 10.1073/pnas.84.2.556; Komatsu M, 2013, ACS SYNTH BIOL, V2, P384, DOI 10.1021/sb3001003; KINASHI H, 1994, J ANTIBIOT, V47, P1447; Tatsuno S, 2009, BIOSCI BIOTECH BIOCH, V73, P2712, DOI 10.1271/bbb.90591; Nett M, 2009, NAT PROD REP, V26, P1362, DOI 10.1039/b817069j; Giovannini PP, 2011, ORG BIOMOL CHEM, V9, P8038, DOI 10.1039/c1ob05928a; Zhang H, 1997, J FERMENT BIOENG, V83, P217, DOI 10.1016/S0922-338X(97)80982-8; Olano C, 2008, METAB ENG, V10, P281, DOI 10.1016/j.ymben.2008.07.001; Mochizuki S, 2003, MOL MICROBIOL, V48, P1501, DOI 10.1046/j.1365-2958.2003.03523.x; Arakawa K, 2012, CHEMBIOCHEM, V13, P1447, DOI 10.1002/cbic.201200149; Arakawa K, 2005, CHEM BIOL, V12, P249, DOI 10.1016/j.chembiol.2005.01.009; Dickschat JS, 2011, CHEMBIOCHEM, V12, P2408, DOI 10.1002/cbic.201100474; Ghosh P, 2009, ORG LETT, V11, P4672, DOI 10.1021/ol901948d; HARADA S, 1969, TETRAHEDRON LETT, P2239; HARADA S, 1971, J ANTIBIOT, V24, P13; Ishikawa J, 1996, FEMS MICROBIOL LETT, V145, P113, DOI 10.1016/0378-1097(96)00397-7; Kieser T., 2000, PRACTICAL STREPTOMYC; LI Z, 1989, J ANTIBIOT, V42, P577; MATSUMOTO K, 1993, TETRAHEDRON LETT, V34, P4935, DOI 10.1016/S0040-4039(00)74050-0; NOGUCHI H, 1988, J AM CHEM SOC, V110, P2938, DOI 10.1021/ja00217a041; OISHI T, 1989, PURE APPL CHEM, V61, P427, DOI 10.1351/pac198961030427; SHIZURI Y, 1984, TETRAHEDRON LETT, V25, P4771, DOI 10.1016/S0040-4039(01)81515-X; Tytell A. A., 1954, ANTIBIOT ANNU, P716; UMEZAWA S, 1958, J ANTIBIOT, V11, P26; Wachtler V, 2006, TRENDS CELL BIOL, V16, P1, DOI 10.1016/j.tcb.2005.11.008; WHITFIELD GB, 1955, J AM CHEM SOC, V77, P4799, DOI 10.1021/ja01623a032; Xu LH, 2010, J BIOL CHEM, V285, P16844, DOI 10.1074/jbc.M109.092460; Yang YJ, 2011, BIOSCI BIOTECH BIOCH, V75, P1147, DOI 10.1271/bbb.110054	41	1	1	JAPAN ANTIBIOTICS RESEARCH ASSOC	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	MAY	2015	68	5					328	333		10.1038/ja.2014.160		6	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	CJ0GC	WOS:000355152800006		
J	Hoshino, S; Zhang, LH; Awakawa, T; Wakimoto, T; Onaka, H; Abe, I				Hoshino, Shotaro; Zhang, Lihan; Awakawa, Takayoshi; Wakimoto, Toshiyuki; Onaka, Hiroyasu; Abe, Ikuro			Arcyriaflavin E, a new cytotoxic indolocarbazole alkaloid isolated by combined-culture of mycolic acid-containing bacteria and Streptomyces cinnamoneus NBRC 13823	JOURNAL OF ANTIBIOTICS			English	Article							COMPLETE GENOME SEQUENCE		[Hoshino, Shotaro; Zhang, Lihan; Awakawa, Takayoshi; Wakimoto, Toshiyuki; Abe, Ikuro] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Onaka, Hiroyasu] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1130033, Japan	Abe, I (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Abe, Ikuro/E-4449-2010				Ohnishi Y, 2008, J BACTERIOL, V190, P4050, DOI 10.1128/JB.00204-08; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Igarashi Y, 2010, ORG LETT, V12, P3402, DOI 10.1021/ol1012982; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Watve MG, 2001, ARCH MICROBIOL, V176, P386, DOI 10.1007/s002030100345; Onaka H, 2011, APPL ENVIRON MICROB, V77, P400, DOI 10.1128/AEM.01337-10; KOJIRI K, 1991, J ANTIBIOT, V44, P723; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Reddy G. M., 2003, SYNTHESIS-STUTTGART, V4; Yassin AF, 1996, INT J SYST BACTERIOL, V46, P429	10	1	1	JAPAN ANTIBIOTICS RESEARCH ASSOC	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	MAY	2015	68	5					342	344		10.1038/ja.2014.147		3	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	CJ0GC	WOS:000355152800009		
J	Igarashi, Y; Ikeda, M; Miyanaga, S; Kasai, H; Shizuri, Y; Matsuura, N				Igarashi, Yasuhiro; Ikeda, Marumi; Miyanaga, Satoshi; Kasai, Hiroaki; Shizuri, Yoshikazu; Matsuura, Nobuyasu			Two butenolides with PPAR alpha agonistic activity from a marine-derived Streptomyces	JOURNAL OF ANTIBIOTICS			English	Article							FATTY-ACIDS; METABOLITES; BACTERIA; SEPARATION; DISCOVERY; VOLATILES; REAGENT; GAMMA		[Igarashi, Yasuhiro; Ikeda, Marumi; Miyanaga, Satoshi] Toyama Prefectural Univ, Biotechnol Res Ctr, Imizu, Toyama 9390398, Japan; [Igarashi, Yasuhiro; Ikeda, Marumi; Miyanaga, Satoshi] Toyama Prefectural Univ, Dept Biotechnol, Imizu, Toyama 9390398, Japan; [Kasai, Hiroaki; Shizuri, Yoshikazu] Kitasato Univ, Marine Biotechnol Kamaishi Lab, Kamaishi, Iwate, Japan; [Matsuura, Nobuyasu] Okayama Univ Sci, Fac Sci, Dept Life Sci, Okayama, Japan	Igarashi, Y (reprint author), Toyama Prefectural Univ, Biotechnol Res Ctr, 5180 Kurokawa, Imizu, Toyama 9390398, Japan.	yas@pu-toyama.ac.jp					Mukku VJRV, 2000, J NAT PROD, V63, P1570, DOI 10.1021/np0001676; Matsuhashi H, 2002, TETRAHEDRON, V58, P5619, DOI 10.1016/S0040-4020(02)00528-8; Akasaka K, 1997, TETRAHEDRON LETT, V38, P6853, DOI 10.1016/S0040-4039(97)01616-X; Citron CA, 2012, J NAT PROD, V75, P1765, DOI 10.1021/np300468h; Bhatnagar I, 2010, MAR DRUGS, V8, P2673, DOI 10.3390/md8102673; Jensen PR, 2005, ANTON LEEUW INT J G, V87, P43, DOI 10.1007/s10482-004-6540-1; Schulz S, 2010, MAR DRUGS, V8, P2976, DOI 10.3390/md8122976; Furumai T, 2002, J ANTIBIOT, V55, P128; Akasaka K, 1999, BIOSCI BIOTECH BIOCH, V63, P1209, DOI 10.1271/bbb.63.1209; Subramani R, 2012, MICROBIOL RES, V167, P571, DOI 10.1016/j.micres.2012.06.005; Azumi M, 2008, TETRAHEDRON, V64, P6420, DOI 10.1016/j.tet.2008.04.076; Cho KW, 2001, J NAT PROD, V64, P664, DOI 10.1021/np000599g; Dickschat JS, 2005, CHEM BIODIVERS, V2, P837, DOI 10.1002/cbdv.200590062; Furumai T, 2000, J ANTIBIOT, V53, P227; Harada N., 1983, CIRCULAR DICHRONIC S; Harada N., 2012, COMPREHENSIVE CHIROP, P115; KANEDA T, 1991, MICROBIOL REV, V55, P288; Kim Y, 2014, MAR DRUGS, V12, P4110, DOI 10.3390/md12074110; Kodera Y, 2000, J BIOL CHEM, V275, P33201, DOI 10.1074/jbc.C000517200; Murakami K, 1999, BIOCHEM BIOPH RES CO, V260, P609, DOI 10.1006/bbrc.1999.0951; Tyagi Sandeep, 2011, J Adv Pharm Technol Res, V2, P236, DOI 10.4103/2231-4040.90879	21	0	0	JAPAN ANTIBIOTICS RESEARCH ASSOC	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	MAY	2015	68	5					345	347		10.1038/ja.2014.151		3	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	CJ0GC	WOS:000355152800010		
J	Nakashima, T; Kamiya, Y; Yamaji, K; Iwatsuki, M; Sato, N; Takahashi, Y; Omura, S				Nakashima, Takuji; Kamiya, Yoshiyuki; Yamaji, Kenzaburo; Iwatsuki, Masato; Sato, Noriko; Takahashi, Yoko; Omura, Satoshi			New steroidal compounds from an actinomycete strain, Lechevalieria aerocolonigenes K10-0216	JOURNAL OF ANTIBIOTICS			English	Article							MANGROMICINS		[Nakashima, Takuji] Kitasato Univ, Res Org Infect Control Sci, Tokyo 1088641, Japan; [Kamiya, Yoshiyuki; Iwatsuki, Masato; Takahashi, Yoko] Kitasato Univ, Grad Sch Infect Control Sci, Tokyo 1088641, Japan; [Yamaji, Kenzaburo; Iwatsuki, Masato; Omura, Satoshi] Kitasato Univ, Kitasato Inst Life Sci, Tokyo 1088641, Japan; [Sato, Noriko] Kitasato Univ, Grad Sch Pharmaceut Sci, Tokyo 1088641, Japan	Nakashima, T (reprint author), Kitasato Univ, Res Org Infect Control Sci, Minato Ku, Tokyo 1088641, Japan.	takuji@lisci.kitasato-u.ac.jp; ytakaha@lisci.kitasato-u.ac.jp			Institute for Fermentation (IFO), Osaka, Japan	This study was supported by funds from the Institute for Fermentation (IFO), Osaka, Japan. We are grateful to Dr Kenichiro Nagai, School of Pharmacy, Kitasato University, for measurements of MS spectra.	Nakashima T, 2013, J ANTIBIOT, V66, P311, DOI 10.1038/ja.2013.17; Berdy J, 2005, J ANTIBIOT, V58, P1; Nakashima T, 2014, J ANTIBIOT, V67, P533, DOI 10.1038/ja.2014.34; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Berdy J, 2012, J ANTIBIOT, V65, P385, DOI 10.1038/ja.2012.27; Nakashima T, 2014, J ANTIBIOT, V67, P253, DOI 10.1038/ja.2013.129; Bérdy János, 2012, J Antibiot (Tokyo), V65, P441, DOI 10.1038/ja.2012.54	7	0	0	JAPAN ANTIBIOTICS RESEARCH ASSOC	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	MAY	2015	68	5					348	350		10.1038/ja.2014.152		3	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	CJ0GC	WOS:000355152800011		
J	Lin, JW; Nishiyama, M; Kuzuyama, T				Lin, Jianwen; Nishiyama, Makoto; Kuzuyama, Tomohisa			Identification of the biosynthetic gene cluster for the herbicide phosphonothrixin in Saccharothrix sp ST-888	JOURNAL OF ANTIBIOTICS			English	Editorial Material							NATURAL-PRODUCTS; STREPTOMYCES		[Lin, Jianwen; Nishiyama, Makoto; Kuzuyama, Tomohisa] Univ Tokyo, Biotechnol Res Ctr, Tokyo, Japan	Lin, JW (reprint author), Univ Tokyo, Biotechnol Res Ctr, Tokyo, Japan.	utkuz@mail.ecc.u-tokyo.ac.jp					TAKAHASHI E, 1995, J ANTIBIOT, V48, P1124; Metcalf WW, 2009, ANNU REV BIOCHEM, V78, P65, DOI 10.1146/annurev.biochem.78.091707.100215; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Komatsu M, 2013, ACS SYNTH BIOL, V2, P384, DOI 10.1021/sb3001003; Yu XM, 2013, P NATL ACAD SCI USA, V110, P20759, DOI 10.1073/pnas.1315107110; BOWMAN E, 1988, J AM CHEM SOC, V110, P5575, DOI 10.1021/ja00224a054; Isogai S, 2012, BIOORG MED CHEM LETT, V22, P5823, DOI 10.1016/j.bmcl.2012.07.084; Kim SY, 2012, ANTIMICROB AGENTS CH, V56, P4175, DOI 10.1128/AAC.06478-11; KIMURA T, 1995, J ANTIBIOT, V48, P1130; Nakamura K, 1997, TETRAHEDRON LETT, V38, P437, DOI 10.1016/S0040-4039(96)02319-2; Seto H, 1999, NAT PROD REP, V16, P589, DOI 10.1039/a809398i	11	1	1	JAPAN ANTIBIOTICS RESEARCH ASSOC	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	MAY	2015	68	5					357	359		10.1038/ja.2014.149		3	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	CJ0GC	WOS:000355152800014		
J	Harada, M; Takahashi, N; Hirata, T; Koga, K; Fujii, T; Osuga, Y				Harada, Miyuki; Takahashi, Nozomi; Hirata, Tetsuya; Koga, Kaori; Fujii, Tomoyuki; Osuga, Yutaka			Laparoscopic excision of ovarian endometrioma does not exert a qualitative effect on ovarian function: insights from in vitro fertilization and single embryo transfer cycles	JOURNAL OF ASSISTED REPRODUCTION AND GENETICS			English	Article						Laparoscopic excision; Ovarian endometrioma; Ovarian function; In vitro fertilization; Oocyte; Single embryo transfer	ANTIMULLERIAN HORMONE-LEVELS; PERIFOLLICULAR VASCULARITY; RESERVE; CYSTS; CYSTECTOMY; WOMEN; MECHANISMS; OOCYTES; DAMAGE	To evaluate whether laparoscopic excision of endometrioma exerts a qualitative effect on ovarian function. A retrospective analysis of oocytes retrieved in 25 cycles of 21 patients undergoing IVF treatment with controlled ovarian stimulation. The number of oocytes recovered from ovaries with a history of excision of endometrioma (E-Ov) were compared to those from contra-lateral healthy ovaries (H-Ov) as for the analysis of a quantitative effect of surgery. As for the analysis of a qualitative effect, 55 oocytes from E-Ov were compared to 128 oocytes from H-Ov in terms of normal fertilization rate and the rate of top-quality embryos per normally fertilized eggs. Furthermore, 10 embryos derived from oocytes recovered from E-Ov were compared to 24 embryos derived from oocytes from H-Ov in terms of clinical and on-going pregnancy rates per embryos in 34 single embryo transfer cycles. Mean number of oocytes recovered from E-Ov was significantly smaller than that from H-Ov (2.2 +/- 2.0 vs. 5.1 +/- 3.3, P = 0.009). There was no difference between oocytes from E-Ov and H-Ov as for normal fertilization rate (63.6 % vs. 69.5 %, P = 0.43) and the rate of top-quality embryos (40.0 % vs. 49.0 %, P = 0.34). Clinical and on-going pregnancy rates per embryos were also similar in embryos derived from oocytes recovered from E-Ov and H-Ov (40.0 % vs. 25.0 %, P = 0.39 and 20.0 % vs. 20.8 %, P = 0.96). The quality of oocytes recovered from the ovary with a history of laparoscopic excision of endometrioma is not inferior to the quality of oocytes from contra-lateral healthy ovary.	[Harada, Miyuki; Takahashi, Nozomi; Hirata, Tetsuya; Koga, Kaori; Fujii, Tomoyuki; Osuga, Yutaka] Univ Tokyo, Dept Obstet & Gynecol, Fac Med, Bunkyo Ku, Tokyo 1138655, Japan	Harada, M (reprint author), Univ Tokyo, Dept Obstet & Gynecol, Fac Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	haradam-tky@umin.ac.jp			Japan Society for the Promotion of Science	This work was supported by Grant-in-Aids for Scientific Research from Japan Society for the Promotion of Science.	Allegra A, 2014, J ASSIST REPROD GEN, V31, P1277, DOI 10.1007/s10815-014-0305-1; Muzii L, 2002, FERTIL STERIL, V77, P609, DOI 10.1016/S0015-0282(01)03203-4; Alborzi S, 2009, FERTIL STERIL, V92, P2004, DOI 10.1016/j.fertnstert.2008.09.014; Rustamov O, 2012, HUM REPROD, V27, P3085, DOI 10.1093/humrep/des260; Eskenazi B, 1997, OBSTET GYN CLIN N AM, V24, P235, DOI 10.1016/S0889-8545(05)70302-8; La Marca A, 2010, HUM REPROD UPDATE, V16, P113, DOI 10.1093/humupd/dmp036; Somigliana E, 2003, HUM REPROD, V18, P2450, DOI 10.1093/humrep/deg432; Celik HG, 2012, FERTIL STERIL, V97, P1472, DOI 10.1016/j.fertnstert.2012.03.027; Ragni G, 2005, AM J OBSTET GYNECOL, V193, P1908, DOI 10.1016/j.ajog.2005.05.056; Duru NK, 2007, J REPROD MED, V52, P805; Almog B, 2010, FERTIL STERIL, V94, P2340, DOI 10.1016/j.fertnstert.2010.01.055; Vercellini P, 2003, AM J OBSTET GYNECOL, V188, P606, DOI 10.1067/mob.2003.7; Raffi F, 2012, J CLIN ENDOCR METAB, V97, P3146, DOI 10.1210/jc.2012-1558; Gupta S, 2008, FERTIL STERIL, V90, P247, DOI 10.1016/j.fertnstert.2008.02.093; Wu MH, 2003, ULTRASOUND OBST GYN, V21, P480, DOI 10.1002/uog.113; Sugita A, 2013, FERTIL STERIL, V100, P516, DOI 10.1016/j.fertnstert.2013.03.032; Ho HY, 2002, J ASSIST REPROD GEN, V19, P507, DOI 10.1023/A:1020970417778; Bulletti C, 2010, J ASSIST REPROD GEN, V27, P441, DOI 10.1007/s10815-010-9436-1; Gardner DK, 1999, TOWARDS REPRODUCTIVE CERTAINTY, P378; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Lass A, 1999, HUM REPROD UPDATE, V5, P546, DOI 10.1093/humupd/5.5.546; Biacchiardi CP, 2011, REPROD BIOMED ONLINE, V23, P740, DOI 10.1016/j.rbmo.2011.07.014; Bhal PS, 1999, HUM REPROD, V14, P939, DOI 10.1093/humrep/14.4.939; Borini A, 2004, EUR J OBSTET GYN R B, V115, pS102, DOI 10.1016/j.ejogrb.2004.01.021; La Torre R, 1998, Clin Exp Obstet Gynecol, V25, P12; Ledger WL, 2014, FERTIL STERIL, V101, P339, DOI 10.1016/j.fertnstert.2013.11.017; Loh FH, 1999, FERTIL STERIL, V72, P316, DOI 10.1016/S0015-0282(99)00207-1; Norenstedt SN, 2001, J ASSIST REPROD GEN, V18, P644, DOI 10.1023/A:1013111200251; Somigliana E, 2006, ACTA OBSTET GYN SCAN, V85, P74, DOI 10.1080/00016340500334802; Veeck L, 1999, PREEMBRYO GRADING DE, P46	30	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1058-0468	1573-7330		J ASSIST REPROD GEN	J. Assist. Reprod. Genet.	MAY	2015	32	5					685	689		10.1007/s10815-015-0457-7		5	Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology	Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology	CI1EL	WOS:000354484900004		
J	Terao, C; Asai, K; Hashimoto, M; Yamazaki, T; Ohmura, K; Yamaguchi, A; Takahashi, K; Takei, N; Ishii, T; Kawaguchi, T; Tabara, Y; Takahashi, M; Nakayama, T; Kosugi, S; Sekine, A; Fujii, T; Yamada, R; Mimori, T; Matsuda, F; Bessho, K				Terao, Chikashi; Asai, Keita; Hashimoto, Motomu; Yamazaki, Toru; Ohmura, Koichiro; Yamaguchi, Akihiko; Takahashi, Katsu; Takei, Noriko; Ishii, Takanori; Kawaguchi, Takahisa; Tabara, Yasuharu; Takahashi, Meiko; Nakayama, Takeo; Kosugi, Shinji; Sekine, Akihiro; Fujii, Takao; Yamada, Ryo; Mimori, Tsuneyo; Matsuda, Fumihiko; Bessho, Kazuhisa		Nagahama Study Grp	Significant association of periodontal disease with anti-citrullinated peptide antibody in a Japanese healthy population - The Nagahama study	JOURNAL OF AUTOIMMUNITY			English	Article						Epidemiological study; Periodontal disease; ACPA; RF; Association study; Rheumatoid arthritis	RHEUMATOID-ARTHRITIS; PORPHYROMONAS-GINGIVALIS; AUTOIMMUNITY; ACCURACY; PROTEINS	Anti-citrullinated peptide antibody (ACPA) is a highly specific autoantibody to rheumatoid arthritis (RA). Recent studies have revealed that periodontal disease (PD) is closely associated with RA and production of ACPA in RA. Analyses of associations between PD and ACPA production in a healthy population may deepen our understandings. Here, we analyzed a total of 9554 adult healthy subjects. ACPA and IgM-rheumatoid factor (RF) was quantified and PD status was evaluated using the number of missing teeth (MT), the Community Periodontal Index (CPI) and Loss of Attachment (LA) for these subjects. PD status was analyzed for its association with the positivity and categorical levels of ACPA and RF conditioned for covariates which were shown to be associated with PD, ACPA or RF. As a result, all of MT. CPI and LA showed suggestive or significant associations with positivity (p = 0.024, 0.0042 and 0.037, respectively) and levels of ACPA (p <= 0.00031), but none of the PD parameters were associated with those of RF. These association patterns were also observed when we analyzed 6206 non-smokers of the participants. The significant associations between PD parameters and positivity and levels of ACPA in healthy population support the fundamental involvement of PD with ACPA production. (C) 2015 Elsevier Ltd. All rights reserved.	[Terao, Chikashi; Kawaguchi, Takahisa; Tabara, Yasuharu; Takahashi, Meiko; Yamada, Ryo; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto 6068507, Japan; [Terao, Chikashi; Ohmura, Koichiro; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto 6068507, Japan; [Hashimoto, Motomu; Fujii, Takao] Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Kyoto 6068507, Japan; [Takei, Noriko; Ishii, Takanori] Lion Fdn Dent Hlth, Tokyo 1300004, Japan; [Nakayama, Takeo] Kyoto Univ, Sch Publ Hlth, Dept Hlth Informat, Kyoto 6068501, Japan; [Kosugi, Shinji] Kyoto Univ, Sch Publ Hlth, Dept Med Eth & Med Genet, Kyoto 6068501, Japan; [Sekine, Akihiro] Kyoto Univ, Grad Sch Med, EBM Res Ctr, Kyoto 6068507, Japan	Terao, C (reprint author), Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto 6068507, Japan.	a0001101@kuhp.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan; Japan Society for the Promotion of Science; Takeda Science Foundation, Japan	This study was supported by a University Grants and a Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology in Japan; the Program for Enhancing Systematic Education in Graduate School from the Japan Society for the Promotion of Science; a research grant from the Takeda Science Foundation, Japan. None of the funding sources was related to design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	McGraw WT, 1999, INFECT IMMUN, V67, P3248; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; Sugiyama D, 2010, ANN RHEUM DIS, V69, P70, DOI 10.1136/ard.2008.096487; Kinloch AJ, 2011, ARTHRITIS RHEUM-US, V63, P3818, DOI 10.1002/art.30639; Pischon N, 2008, J PERIODONTOL, V79, P979, DOI 10.1902/jop.2008.070501 ; Eke PI, 2010, J DENT RES, V89, P1208, DOI 10.1177/0022034510377793; Pizzo G, 2010, EUR J INTERN MED, V21, P496, DOI 10.1016/j.ejim.2010.07.011; Klareskog L, 2006, ARTHRITIS RHEUM, V54, P38, DOI 10.1002/art.21575; Pitiphat W, 2003, J DENT RES, V82, P509; Nishimura K, 2007, ANN INTERN MED, V146, P797; Rosenstein ED, 2004, INFLAMMATION, V28, P311, DOI 10.1007/s10753-004-6641-z; Schellekens GA, 2000, ARTHRITIS RHEUM, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; Scher JU, 2012, ARTHRITIS RHEUM-US, V64, P3083, DOI 10.1002/art.34539; Kagamimori S, 2009, SOC SCI MED, V68, P2152, DOI 10.1016/j.socscimed.2009.03.030; de Pablo P, 2014, ANN RHEUM DIS, V73, P580, DOI 10.1136/annrheumdis-2012-202701; Dissick A, 2010, J PERIODONTOL, V81, P223, DOI 10.1902/jop.2009.090309; Atzeni F, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2420; Fukuda H, 2009, INT DENT J, V59, P96, DOI 10.1922/IDJ_2031Fukuda07; Lundberg K., 2012, ANN RHEUM DIS; Renaudineau Y, 2005, AUTOIMMUNITY, V38, P11, DOI 10.1080/08916930400022574; Santiago M.L., 2015, REUMATOL CLIN; Terao C., 2014, ARTHRITIS CARE RES H; Terao C., 2014, INFLAMM REGEN, V34, P71; Terao C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020457	24	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0896-8411	1095-9157		J AUTOIMMUN	J. Autoimmun.	MAY	2015	59						85	90		10.1016/j.jaut.2015.03.002		6	Immunology	Immunology	CI8SV	WOS:000355042900011		
J	Hamamatsu, Y; Watanabe, C; Umezaki, M				Hamamatsu, Yuri; Watanabe, Chiho; Umezaki, Masahiro			SECONDARY SEX RATIO AND MARRIAGE AFTER DISASTER: A REPLY TO O'DONNELL AND BEHIE	JOURNAL OF BIOSOCIAL SCIENCE			English	Editorial Material							EXPOSURE		[Hamamatsu, Yuri; Watanabe, Chiho; Umezaki, Masahiro] Univ Tokyo, Grad Sch Med, Dept Human Ecol, Tokyo 1138654, Japan	Hamamatsu, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Human Ecol, Tokyo 1138654, Japan.	yhama@humeco.m.u-tokyo.ac.jp					Alexopoulos EC, 2007, HUM REPROD, V22, P2999, DOI 10.1093/humrep/dem309; Torche F, 2012, HUM REPROD, V27, P558, DOI 10.1093/humrep/der390; Fukuda M, 1998, HUM REPROD, V13, P2321, DOI 10.1093/humrep/13.8.2321; Mocarelli P, 2000, LANCET, V355, P1858, DOI 10.1016/S0140-6736(00)02290-X; Hamamatsu Y, 2014, J BIOSOC SCI, V46, P830, DOI 10.1017/S0021932014000017; Hansen D, 1999, BRIT MED J, V319, P548; O'Donnell MH, 2015, J BIOSOC SCI, V47, P413, DOI 10.1017/S0021932014000285; Schoen R, 2005, POP STUD-J DEMOG, V59, P135, DOI 10.1080/00324720500099124; Statistics Bureau of Japan, 2011, IMP GREAT E JAP EART	9	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0021-9320	1469-7599		J BIOSOC SCI	J. Biosoc. Sci.	MAY	2015	47	3					417	420		10.1017/S0021932014000297		4	Demography; Public, Environmental & Occupational Health; Social Sciences, Biomedical	Demography; Public, Environmental & Occupational Health; Biomedical Social Sciences	CI7SW	WOS:000354966100010		
J	Kitagawa, N; Okada, H; Tanaka, M; Hashimoto, Y; Kimura, T; Tomiyasu, K; Nakano, K; Hasegawa, G; Nakamura, N; Fukui, M				Kitagawa, Noriyuki; Okada, Hiroshi; Tanaka, Muhei; Hashimoto, Yoshitaka; Kimura, Toshihiro; Tomiyasu, Kiichiro; Nakano, Koji; Hasegawa, Goji; Nakamura, Naoto; Fukui, Michiaki			High-sensitivity cardiac troponin T is associated with coronary artery calcification	JOURNAL OF CARDIOVASCULAR COMPUTED TOMOGRAPHY			English	Article						Cardiac troponin; Coronary calcium; Atherosclerosis	CHRONIC HEART-FAILURE; COMPUTED-TOMOGRAPHY; DISEASE; MORTALITY; ASSAY; RISK; POPULATION; ISCHEMIA; ADULTS; PLAQUE	Objective: Recent studies have suggested that high-sensitivity cardiac troponin T (hs-cTnT) may be useful for detecting subclinical atherosclerosis and assessing cardiovascular disease risk. The aim of this study was to investigate whether serum hs-cTnT is associated with the degree of coronary artery calcification. Methods: We measured serum hs-cTnT concentrations and performed multidetector row coronary CT in 215 consecutive, stable patients with clinical suspicion of coronary artery disease. Nonenhanced coronary CT was performed to determine the coronary calcium score, and contrast-enhanced coronary CT was performed to identify obstructive coronary artery disease. We then evaluated the relationship between serum hs-cTnT concentrations and the degree of coronary calcium or obstructive coronary artery disease using multiple regression analysis and logistic regression models. Results: Multiple regression analysis demonstrated that serum hs-cTnT concentrations and calcium score were independently associated after logarithmic transformation (beta = 0.348; P < .0001). Logistic regression analyses demonstrated that serum hs-cTnT concentration was associated with an increased odds of an Agatston score >10 (odds ratio, 1.250; 95% confidence interval [CI], 1.150-1.378), an Agatston Score >400 (odds ratio, 1.101; 95% CI, 1.054 -1.157), and obstructive coronary artery disease (odds ratio, 1.119; 95% CI, 1.066-1.185). Conclusion: Serum hs-cTnT is associated with coronary calcium in individuals with suspected coronary disease and may therefore be a marker to detect subclinical atherosclerosis. (C) 2015 Society of Cardiovascular Computed Tomography. All rights reserved.	[Kitagawa, Noriyuki; Okada, Hiroshi; Tanaka, Muhei; Hashimoto, Yoshitaka; Kimura, Toshihiro; Hasegawa, Goji; Nakamura, Naoto; Fukui, Michiaki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kamigyo Ku, Kyoto 6028566, Japan; [Tomiyasu, Kiichiro] Kyoto Yamashiro Gen Med Ctr, Dept Cardiol, Kizugawa, Kyoto 6190214, Japan; [Kimura, Toshihiro] Kyoto Yamashiro Gen Med Ctr, Dept Endocrinol & Metab, Kizugawa, Kyoto 6190214, Japan	Fukui, M (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	sayarinapm@hotmail.com		Hashimoto, Yoshitaka/0000-0002-8794-0550			AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827; Sabatine MS, 2009, EUR HEART J, V30, P162, DOI 10.1093/eurheartj/ehn504; Ndrepepa G, 2011, AM J CARDIOL, V108, P639, DOI 10.1016/j.amjcard.2011.04.012; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Lindahl B, 2000, NEW ENGL J MED, V343, P1139, DOI 10.1056/NEJM200010193431602; Masson S, 2012, CIRCULATION, V125, P280, DOI 10.1161/CIRCULATIONAHA.111.044149; Apple FS, 2005, CLIN CHEM, V51, P810, DOI 10.1373/clinchem.2004.046292; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; Agewall S, 2011, EUR HEART J, V32, P404, DOI 10.1093/eurheartj/ehq456; O'Rourke RA, 2000, J AM COLL CARDIOL, V36, P326, DOI 10.1016/S0735-1097(00)00831-7; Korosoglou G, 2011, HEART, V97, P823, DOI 10.1136/hrt.2010.193201; Latini R, 2007, CIRCULATION, V116, P1242, DOI 10.1161/CIRCULATIONAHA.106.655076; Leber AW, 2006, J AM COLL CARDIOL, V47, P672, DOI 10.1016/j.jacc.2005.10.058; Aviles RJ, 2002, NEW ENGL J MED, V346, P2047, DOI 10.1056/NEJMoa013456; Budoff MJ, 2006, CIRCULATION, V114, P1761, DOI 10.1161/CIRCULATIONAHA.106.178458; deFilippi CR, 2010, JAMA-J AM MED ASSOC, V304, P2494, DOI 10.1001/jama.2010.1708; Mant J, 2011, ANN INTERN MED, V155, P252, DOI [10.7326/0003-4819-155-4-201108160-00009, 10.1059/0003-4819-155-4-201108160-00009]; Rumberger JA, 1999, MAYO CLIN PROC, V74, P243; Mingels A, 2009, CLIN CHEM, V55, P101, DOI 10.1373/clinchem.2008.106427; Otsuka T, 2010, AM HEART J, V159, P972, DOI 10.1016/j.ahj.2010.02.036; Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Austen W G, 1975, Circulation, V51, P5; Donnelly R, 1998, LANCET, V351, P537, DOI 10.1016/S0140-6736(05)78549-4; Iso H, 2009, ATHEROSCLEROSIS, V207, P291, DOI 10.1016/j.atherosclerosis.2009.04.020; Kramer CK, 2013, BMJ-BRIT MED J, V346, P1654	25	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-5925			J CARDIOVASC COMPUT	J. Cardiovasc. Comput. Tomogr.	MAY-JUN	2015	9	3					209	214		10.1016/j.jcct.2015.01.015		6	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CI3SZ	WOS:000354669000006		
J	Tomizawa, N; Takahashi, M; Kaneko, M; Suzuki, K; Matsuoka, Y				Tomizawa, Nobuo; Takahashi, Masamichi; Kaneko, Masakazu; Suzuki, Kou; Matsuoka, Yujiro			Atresia of the right atrial ostium of the coronary sinus without persistent left superior vena cava	JOURNAL OF CARDIOVASCULAR COMPUTED TOMOGRAPHY			English	Article						Anomaly; Coronary sinus; Right atrial ostium		We present a case of atresia of the right atrial ostium of the coronary sinus., Recognizing this anomaly is important during catheter ablation or cardiac surgery, which could be noninvasively evaluated by multidetector CT. (C) 2015 Society of Cardiovascular Computed Tomography. All rights reserved.	[Tomizawa, Nobuo] New Tokyo Hosp, Dept Radiol, Matsudo, Chiba 2702232, Japan; [Tomizawa, Nobuo; Takahashi, Masamichi; Matsuoka, Yujiro] Tokyo Metropolitan Bokutoh Hosp, Dept Radiol, Tokyo, Japan; [Kaneko, Masakazu; Suzuki, Kou] Tokyo Metropolitan Bokutoh Hosp, Dept Cardiol, Tokyo, Japan	Tomizawa, N (reprint author), New Tokyo Hosp, Dept Radiol, 1271 Wanagaya, Matsudo, Chiba 2702232, Japan.	tomizawa-tky@umin.ac.jp					MANTINI E, 1966, CIRCULATION, V33, P317; Haissaguerre M, 2007, J CARDIOVASC ELECTR, V18, P378, DOI 10.1111/j.1540-8167.2007.00764.x; SOLORZANO J, 1978, ANN THORAC SURG, V25, P201; Yeo KK, 2010, CARDIOVASC REVASC ME, V11	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-5925			J CARDIOVASC COMPUT	J. Cardiovasc. Comput. Tomogr.	MAY-JUN	2015	9	3					227	229		10.1016/j.jcct.2014.12.005		3	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CI3SZ	WOS:000354669000009		
J	Abiko, H; Fujiwara, S; Ohashi, K; Hiatari, R; Mashiko, T; Sakamoto, N; Sato, M; Mizuno, K				Abiko, Hiyori; Fujiwara, Sachiko; Ohashi, Kazumasa; Hiatari, Ryuichi; Mashiko, Toshiya; Sakamoto, Naoya; Sato, Masaaki; Mizuno, Kensaku			Rho guanine nucleotide exchange factors involved in cyclic-stretch-induced reorientation of vascular endothelial cells	JOURNAL OF CELL SCIENCE			English	Article						Cyclic stretch; Endothelial cells; Mechanotransduction; Rho-GEF; Solo/ARHGEF40; VE-cadherin	SMALL GTPASES; SHEAR-STRESS; MECHANOTRANSDUCTION; FORCE; PHOSPHORYLATION; ACTIVATION; ORGANIZATION; PP125(FAK); EXPRESSION; MIGRATION	Cyclic stretch is an artificial model of mechanical force loading, which induces the reorientation of vascular endothelial cells and their stress fibers in a direction perpendicular to the stretch axis. Rho family GTPases are crucial for cyclic-stretch-induced endothelial cell reorientation; however, the mechanism underlying stretch-induced activation of Rho family GTPases is unknown. A screen of short hairpin RNAs targeting 63 Rho guanine nucleotide exchange factors (Rho-GEFs) revealed that at least 11 Rho-GEFs - Abr, alsin, ARHGEF10, Bcr, GEF-H1 (also known as ARHGEF2), LARG (also known as ARHGEF12), p190RhoGEF (also known as ARHGEF28), PLEKHG1, P-REX2, Solo (also known as ARHGEF40) and alpha-PIX (also known as ARHGEF6) - which specifically or broadly target RhoA, Rac1 and/or Cdc42, are involved in cyclic-stretch-induced perpendicular reorientation of endothelial cells. Overexpression of Solo induced RhoA activation and F-actin accumulation at cell-cell and cell-substrate adhesion sites. Knockdown of Solo suppressed cyclic-stretch- or tensile-force-induced RhoA activation. Moreover, knockdown of Solo significantly reduced cyclic-stretch-induced perpendicular reorientation of endothelial cells when cells were cultured at high density, but not when they were cultured at low density or pretreated with EGTA or VE-cadherin-targeting small interfering RNAs. These results suggest that Solo is involved in cell-cell-adhesion-mediated mechanical signal transduction during cyclic-stretch-induced endothelial cell reorientation.	[Abiko, Hiyori; Fujiwara, Sachiko; Ohashi, Kazumasa; Hiatari, Ryuichi; Mashiko, Toshiya; Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan; [Sakamoto, Naoya; Sato, Masaaki] Tohoku Univ, Grad Sch Biomed Engn, Dept Biomed Engn, Sendai, Miyagi 9808579, Japan	Ohashi, K (reprint author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan.	kohashi@biology.tohoku.ac.jp; kmizuno@biology.tohoku.ac.jp			Ministry of Education, Culture, Science, Sports and Technology of Japan [23112005, 25440076, 24370051, 24121702]; Mitsubishi Foundation	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Science, Sports and Technology of Japan [grant numbers 23112005 and 25440076 to K.O. and 24370051 and 24121702 to K.M.]; and the Mitsubishi Foundation (to K.M.).	Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Hayashi A, 2013, FEBS LETT, V587, P698, DOI 10.1016/j.febslet.2013.01.043; Lessey EC, 2012, BIOCHEMISTRY-US, V51, P7420, DOI 10.1021/bi300758e; DiPaolo BC, 2013, AM J PHYSIOL-LUNG C, V305, pL141, DOI 10.1152/ajplung.00298.2012; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Roca-Cusachs P, 2012, J CELL SCI, V125, P3025, DOI 10.1242/jcs.095794; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; Birukov KG, 2009, MICROVASC RES, V77, P46, DOI 10.1016/j.mvr.2008.09.006; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Ehrlicher AJ, 2011, NATURE, V478, P260, DOI 10.1038/nature10430; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; Tsuji T, 2010, MOL BIOL CELL, V21, P3590, DOI 10.1091/mbc.E10-02-0095; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Naruse K, 1998, ONCOGENE, V17, P455, DOI 10.1038/sj.onc.1201950; Cook DR, 2014, ONCOGENE, V33, P4021, DOI 10.1038/onc.2013.362; Lee CF, 2010, BIOCHEM BIOPH RES CO, V401, P344, DOI 10.1016/j.bbrc.2010.09.046; Huveneers S, 2013, J CELL SCI, V126, P403, DOI 10.1242/jcs.109447; DARTSCH PC, 1989, BASIC RES CARDIOL, V84, P268, DOI 10.1007/BF01907974; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Lecuit T, 2011, ANNU REV CELL DEV BI, V27, P157, DOI 10.1146/annurev-cellbio-100109-104027; Schwarz US, 2012, J CELL SCI, V125, P3051, DOI 10.1242/jcs.093716; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200462.9446.d7; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Franceschini N, 2013, AM J HUM GENET, V93, P545, DOI 10.1016/j.ajhg.2013.07.010; Goldyn AM, 2009, J CELL SCI, V122, P3644, DOI 10.1242/jcs.054866; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Curtis C, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-10; Daggett DF, 2004, CURR BIOL, V14, P1632, DOI 10.1016/j.cub.2004.08.024; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Liu WF, 2007, CIRC RES, V101, pE44, DOI 10.1161/CIRCRESAHA.107.158329; Matsushita T, 2010, HUM MOL GENET, V19, P1137, DOI 10.1093/hmg/ddp582; Nishita M, 2002, MOL CELL BIOL, V22, P774; Tse SW, 2005, GENE, V359, P63, DOI 10.1016/j.gene.2005.06.025; Ueki Y, 2010, Open Biomed Eng J, V4, P129, DOI 10.2174/1874120701004010129; Vallenius T, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130001; Yano Y, 1996, BIOCHEM BIOPH RES CO, V224, P508, DOI 10.1006/bbrc.1996.1057	45	2	2	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0021-9533	1477-9137		J CELL SCI	J. Cell Sci.	MAY 1	2015	128	9					1683	1695		10.1242/jcs.157503		13	Cell Biology	Cell Biology	CI6MI	WOS:000354873100005		
J	Inoue, J; Krueger, EW; Chen, J; Cao, H; Ninomiya, M; McNiven, MA				Inoue, Jun; Krueger, Eugene W.; Chen, Jing; Cao, Hong; Ninomiya, Masashi; McNiven, Mark A.			HBV secretion is regulated through the activation of endocytic and autophagic compartments mediated by Rab7 stimulation	JOURNAL OF CELL SCIENCE			English	Article						HBV; Rab7; MVB; Autophagosome; Tubule	HEPATITIS-B-VIRUS; HUMAN PRIMARY HEPATOCYTES; MULTIVESICULAR BODIES; LATE ENDOSOMES; PROTEIN RILP; E-ANTIGEN; REPLICATION; TRANSPORT; MATURATION; INFECTION	The cellular mechanisms by which hepatitis B virus (HBV) is assembled and exported are largely undefined. Recently, it has been suggested that these steps require the multivesicular body (MVB) and the autophagic machinery. However, the mechanisms by which HBV might regulate these compartments are unclear. In this study, we have found that by activating Rab7a, HBV alters its own secretion by inducing dramatic changes in the morphology of MVB and autophagic compartments. These changes are characterized by the formation of numerous tubules that are dependent upon the increase in Rab7 activity observed in the HBV-expressing HepG2.2.15 cells compared to HepG2 cells. Interestingly, transfection-based expression of the five individual viral proteins indicated that the precore protein, which is a precursor of HBeAg, was largely responsible for the increased Rab7 activity. Finally, small interfering RNA (siRNA)-mediated depletion of Rab7 significantly increased the secretion of virions, suggesting that reduced delivery of the virus to the lysosome facilitates viral secretion. These findings provide novel evidence indicating that HBV can regulate its own secretion through an activation of the endo-lysosomal and autophagic pathway mediated by Rab7 activation.	[Inoue, Jun; Krueger, Eugene W.; Chen, Jing; Cao, Hong; Ninomiya, Masashi; McNiven, Mark A.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Inoue, Jun; Krueger, Eugene W.; Chen, Jing; Cao, Hong; Ninomiya, Masashi; McNiven, Mark A.] Mayo Clin, Ctr Basic Res Digest Dis, Rochester, MN 55905 USA; [Inoue, Jun; Ninomiya, Masashi] Tohoku Univ, Div Gastroenterol, Grad Sch Med, Sendai, Miyagi 9808574, Japan	McNiven, MA (reprint author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	mcniven.mark@mayo.edu			Japan Society for the Promotion of Science; Mochida Memorial Foundation for Medical and Pharmaceutical Research; National Institute of Diabetes and Digestive and Kidney Diseases [DK44650]	This study was supported by the Japan Society for the Promotion of Science (to J.I.); the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to J.I.); and by the National Institute of Diabetes and Digestive and Kidney Diseases [grant number DK44650 to M.A.M.]. Deposited in PMC for release after 12 months.	Abdulkarim AS, 2003, J HEPATOL, V38, P76, DOI 10.1016/S0168-8278(02)00326-4; Lambert C, 2007, J VIROL, V81, P9050, DOI 10.1128/JVI.00479-07; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; van der Kant R, 2013, J CELL SCI, V126, P3462, DOI 10.1242/jcs.129270; Rijckborst V, 2011, ALIMENT PHARM THER, V33, P501, DOI 10.1111/j.1365-2036.2010.04555.x; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Bruss V, 2007, WORLD J GASTROENTERO, V13, P65; Huang HC, 2012, J VIROL, V86, P9443, DOI 10.1128/JVI.00873-12; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Prange R, 2012, MED MICROBIOL IMMUN, V201, P449, DOI 10.1007/s00430-012-0267-9; Li JH, 2011, J VIROL, V85, P6319, DOI 10.1128/JVI.02627-10; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Bucci C, 2000, MOL BIOL CELL, V11, P467; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Ozasa A, 2006, HEPATOLOGY, V44, P326, DOI 10.1002/hep.21249; McMahon BJ, 2005, SEMIN LIVER DIS, V25, P3, DOI 10.1055/s-2005-915644; Lang TL, 2011, J HEPATOL, V55, P762, DOI 10.1016/j.jhep.2010.12.042; Wieland SF, 2005, J VIROL, V79, P9369, DOI 10.1128/JVI.79.15.9369-9380.2005; Hyttinen JMT, 2013, BBA-MOL CELL RES, V1833, P503, DOI 10.1016/j.bbamcr.2012.11.018; Cooney JR, 2002, J NEUROSCI, V22, P2215; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Inoue J, 2011, J INFECT DIS, V204, P1017, DOI 10.1093/infdis/jir485; Milich D, 2003, HEPATOLOGY, V38, P1075, DOI 10.1053/jhep.2003.50453; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Aly HH, 2007, J HEPATOL, V46, P26, DOI 10.1016/j.jhep.2006.08.018; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Cortese K, 2013, MOL BIOL CELL, V24, P129, DOI 10.1091/mbc.E12-04-0282; Macovei A, 2013, J VIROL, V87, P6415, DOI 10.1128/JVI.00393-13; Watanabe T, 2007, P NATL ACAD SCI USA, V104, P10205, DOI 10.1073/pnas.070400104; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Sir D, 2010, P NATL ACAD SCI USA, V107, P4383, DOI 10.1073/pnas.0911373107; Tian YJ, 2011, J VIROL, V85, P13453, DOI 10.1128/JVI.06064-11; Chua PK, 2006, VIROLOGY, V354, P1, DOI 10.1016/j.virol.2006.07.018; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Fader CM, 2008, TRAFFIC, V9, P230, DOI 10.1111/j.1600-0854.2007.00677.x; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Wang TL, 2011, CELL SIGNAL, V23, P516, DOI 10.1016/j.cellsig.2010.09.012; EBLE BE, 1987, MOL CELL BIOL, V7, P3591; Gao WT, 2010, J BIOL CHEM, V285, P1371, DOI 10.1074/jbc.M109.054197; Garcia T, 2009, J VIROL, V83, P11152, DOI 10.1128/JVI.00905-09; Stieler JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091279; Schroeder B, 2012, MOL BIOL CELL, V23, P3602, DOI 10.1091/mbc.E11-08-0666; Schroeder B, 2010, EMBO J, V29, P3039, DOI 10.1038/emboj.2010.190; Schulze RJ, 2013, J CELL BIOL, V203, P315, DOI 10.1083/jcb.201306140; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049	47	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0021-9533	1477-9137		J CELL SCI	J. Cell Sci.	MAY 1	2015	128	9					1696	1706		10.1242/jcs.158097		11	Cell Biology	Cell Biology	CI6MI	WOS:000354873100006		
J	Mathuranyanon, R; Tsukamoto, T; Takeuchi, A; Ishiwata-Kimata, Y; Tsuchiya, Y; Kohno, K; Kimata, Y				Mathuranyanon, Rubwad; Tsukamoto, Tomoko; Takeuchi, Asumi; Ishiwata-Kimata, Yuki; Tsuchiya, Yuichi; Kohno, Kenji; Kimata, Yukio			Tight regulation of the unfolded protein sensor Ire1 by its intramolecularly antagonizing subdomain	JOURNAL OF CELL SCIENCE			English	Article						Unfolded protein response; Stress response; Endoplasmic reticulum; Intrinsically disordered region; Molecular chaperone; Misfolded protein	ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTOR; RESPONSE PATHWAY; STRESS-RESPONSE; YEAST; BIP; MECHANISM; KINASE; DEGRADATION; SUFFICIENT	Accumulation of unfolded proteins in the endoplasmic reticulum (ER) accompanies ER stress and causes the type-I transmembrane protein Ire1 (also known as ERN1) to trigger the unfolded protein response (UPR). When dimerized, the core stress-sensing region (CSSR) of Ire1 directly captures unfolded proteins and forms a high-order oligomer, leading to clustering and activation of Ire1. The CSSR is N-terminally flanked by an intrinsically disordered subdomain, which we previously named Subregion I, in Saccharomyces cerevisiae Ire1. In this study, we describe tight repression of Ire1 activity by Subregion I under conditions of no or weak stress. Weak hyperactivation of an Ire1 mutant lacking Subregion I slightly retarded growth of yeast cells cultured under unstressed conditions. Fungal Ire1 orthologs and the animal Ire1 family protein PERK (also known as EIF2AK3) carry N-terminal intrinsically disordered subdomains with a similar structure and function to that of Subregion I. Our observations presented here cumulatively indicate that Subregion I is captured by the CSSR as an unfolded protein substrate. This intramolecular subdomain interaction is likely to compromise self-association of the CSSR, explaining why Subregion I can suppress Ire1 activity when ER-accumulated unfolded proteins are not abundant.	[Mathuranyanon, Rubwad; Tsukamoto, Tomoko; Takeuchi, Asumi; Ishiwata-Kimata, Yuki; Tsuchiya, Yuichi; Kohno, Kenji; Kimata, Yukio] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara 6300192, Japan	Kimata, Y (reprint author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Ikoma, Nara 6300192, Japan.	kimata@bs.naist.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI [22657030, 24370081, 20380062, 24228002]	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI [grant numbers 22657030 and 24370081 to Y.K., and 20380062 and 24228002 to K.K.]. Deposited in PMC for immediate release.	MORI K, 1992, EMBO J, V11, P2583; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Bertolotti A, 2000, NAT CELL BIOL, V2, P326; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/nmeth.2413, 10.1038/NMETH.2413]; Ma YJ, 2010, CELL STRESS CHAPERON, V15, P281, DOI 10.1007/s12192-009-0142-9; Oikawa D, 2007, J CELL SCI, V120, P1681, DOI 10.1242/jcs.002808; Aragon T, 2009, NATURE, V457, P736, DOI 10.1038/nature07641; SIKORSKI RS, 1989, GENETICS, V122, P19; Rubio C, 2011, J CELL BIOL, V193, P171, DOI 10.1083/jcb.201007077; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Kimata Y, 2003, MOL BIOL CELL, V14, P2559, DOI 10.1091/mbc.E02-11-0708; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; Chawla A, 2011, J CELL BIOL, V193, P41, DOI 10.1083/jcb.201008071; Kimata Y, 2006, GENES CELLS, V11, P59, DOI 10.1111/j.1365-2443.2005.00921.x; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Harding HP, 1999, NATURE, V397, P271; Kimata Y, 2007, J CELL BIOL, V179, P75, DOI 10.1083/jcb.200704166; Kimata Y, 2011, CURR OPIN CELL BIOL, V23, P135, DOI 10.1016/j.ceb.2010.10.008; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Kimata Y, 2004, J CELL BIOL, V167, P445, DOI 10.1083/jcb.200405153; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Promlek T, 2011, MOL BIOL CELL, V22, P3520, DOI 10.1091/mbc.E11-04-0295; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Mori K, 2000, P NATL ACAD SCI USA, V97, P4660, DOI 10.1073/pnas.050010197; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Ishiwata-Kimata Y, 2013, GENES CELLS, V18, P288, DOI 10.1111/gtc.12035; Iwawaki T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013052; Oikawa D, 2005, BIOCHEM J, V391, P135, DOI 10.1042/BJ20050640; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Tsuru A, 2013, P NATL ACAD SCI USA, V110, P2864, DOI 10.1073/pnas.1212484110	36	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0021-9533	1477-9137		J CELL SCI	J. Cell Sci.	MAY 1	2015	128	9					1762	1772		10.1242/jcs.164111		11	Cell Biology	Cell Biology	CI6MI	WOS:000354873100011		
J	Kumar, R; Ghyselinck, N; Ishiguro, K; Watanabe, Y; Kouznetsova, A; Hoog, C; Strong, E; Schimenti, J; Daniel, K; Toth, A; de Massy, B				Kumar, Rajeev; Ghyselinck, Norbert; Ishiguro, Kei-ichiro; Watanabe, Yoshinori; Kouznetsova, Anna; Hoog, Christer; Strong, Edward; Schimenti, John; Daniel, Katrin; Toth, Attila; de Massy, Bernard			MEI4-a central player in the regulation of meiotic DNA double-strand break formation in the mouse	JOURNAL OF CELL SCIENCE			English	Article						Meiosis; Recombination; DNA double strand break; Synapsis	SISTER-CHROMATID COHESION; CHROMOSOME SYNAPSIS; SYNAPTONEMAL COMPLEX; SACCHAROMYCES-CEREVISIAE; RECOMBINATION PROTEINS; POSITIONAL CLONING; PROMOTES SYNAPSIS; CHIASMA FORMATION; AXIAL ELEMENTS; MEIOSIS	The formation of programmed DNA double-strand breaks (DSBs) at the beginning of meiotic prophase marks the initiation of meiotic recombination. Meiotic DSB formation is catalyzed by SPO11 and their repair takes place on meiotic chromosome axes. The evolutionarily conserved MEI4 protein is required for meiotic DSB formation and is localized on chromosome axes. Here, we show that HORMAD1, one of the meiotic chromosome axis components, is required for MEI4 localization. Importantly, the quantitative correlation between the level of axis-associated MEI4 and DSB formation suggests that axis-associated MEI4 could be a limiting factor for DSB formation. We also show that MEI1, REC8 and RAD21L are important for proper MEI4 localization. These findings on MEI4 dynamics during meiotic prophase suggest that the association of MEI4 to chromosome axes is required for DSB formation, and that the loss of this association upon DSB repair could contribute to turning off meiotic DSB formation.	[Kumar, Rajeev; de Massy, Bernard] CNRS, UPR 1142, Inst Human Genet, F-34396 Montpellier, France; [Ghyselinck, Norbert] INSERM, Inst Genet & Biol Mol & Cellulaire, CNRS UMR7104, Dept Funct Genom & Canc,U964, F-67404 Illkirch Graffenstaden, France; [Ishiguro, Kei-ichiro] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Bunkyo Ku, Tokyo 1130032, Japan; [Watanabe, Yoshinori; Kouznetsova, Anna; Hoog, Christer] Karolinska Inst, Dept Cell & Mol Biol CMB, S-17177 Stockholm, Sweden; [Strong, Edward; Schimenti, John] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA; [Daniel, Katrin; Toth, Attila] Tech Univ Dresden, Inst Physiol Chem, Fac Med, D-01307 Dresden, Germany	de Massy, B (reprint author), CNRS, UPR 1142, Inst Human Genet, 141 Rue Cardonille, F-34396 Montpellier, France.	bernard.de-massy@igh.cnrs.fr	GHYSELINCK, Norbert/I-6999-2015		Swedish Cancer Society; Swedish Research Council; Scientific Research on Innovative Areas; MEXT, Japan; Axa Research Fund; ANR; EDF; Deutsche Forschungsgemeinschaft [SPP1384: TO 421/4-1, TO 421/4-2, TO 421/5-1]; Fondation pour le Recherche Medicale; Association pour la Recherche contre le Cancer; Agence Nationale pour la Recherche [ANR-09-BLAN-0269-01]; Centre National pour la Recherche Scientifique (CNRS); European Research Council Executive Agency under the European Community's Seventh Framework Programme [322788]	C.H. and A.K. were funded by grants from the Swedish Cancer Society and the Swedish Research Council. K.I. is supported by a Grant-in-Aid for Scientific Research on Innovative Areas, Y.W. is supported by a Grant-in-Aid for Specially Promoted Research from MEXT, Japan. R.K. received financial support from ANR, EDF and a post-doctoral fellowship from the Axa Research Fund. K.D. and A.T. were funded by the Deutsche Forschungsgemeinschaft [grant numbers SPP1384: TO 421/4-1, TO 421/4-2, and Heisenberg Fellowship: TO 421/5-1]. B.d.M. was funded by grants from the Fondation pour le Recherche Medicale, Association pour la Recherche contre le Cancer, Agence Nationale pour la Recherche [grant number ANR-09-BLAN-0269-01], Centre National pour la Recherche Scientifique (CNRS) and the European Research Council Executive Agency under the European Community's Seventh Framework Programme (FP7/2007-2013) [grant number 322788]. Deposited in PMC for release after 6 months.	Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Henderson KA, 2006, CELL, V125, P1321, DOI 10.1016/j.cell.2006.04.039; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Zhang LR, 2011, P NATL ACAD SCI USA, V108, P20036, DOI 10.1073/pnas.1117937108; Kugou K, 2009, MOL BIOL CELL, V20, P3064, DOI 10.1091/mbc.E08-12-1223; Kim KP, 2010, CELL, V143, P924, DOI 10.1016/j.cell.2010.11.015; Herran Y, 2011, EMBO J, V30, P3091, DOI 10.1038/emboj.2011.222; Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI 10.1073/pnas.0807297105; Sommermeyer V, 2013, MOL CELL, V49, P43, DOI 10.1016/j.molcel.2012.11.008; Mets DG, 2009, CELL, V139, P73, DOI 10.1016/j.cell.2009.07.035; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; de Massy B, 2013, ANNU REV GENET, V47, P563, DOI 10.1146/annurev-genet-110711-155423; Murakami H, 2008, GENE DEV, V22, P286, DOI 10.1101/gad.1642308; Panizza S, 2011, CELL, V146, P372, DOI 10.1016/j.cell.2011.07.003; Thacker D, 2014, NATURE, V510, P241, DOI 10.1038/nature13120; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Ishiguro K, 2011, EMBO REP, V12, P267, DOI 10.1038/embor.2011.2; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Xu HL, 2005, DEV CELL, V8, P949, DOI 10.1016/j.devcel.2005.03.018; Kumar R, 2010, GENE DEV, V24, P1266, DOI 10.1101/gad.571710; Reinholdt LG, 2005, CHROMOSOMA, V114, P127, DOI 10.1007/s00412-005-0346-4; Morimoto A, 2012, J CELL BIOL, V198, P165, DOI 10.1083/jcb.201204085; Libby BJ, 2003, P NATL ACAD SCI USA, V100, P15706, DOI 10.1073/pnas.2432067100; Wood AJ, 2010, NAT REV GENET, V11, P391, DOI 10.1038/nrg2794; Acquaviva L, 2013, SCIENCE, V339, P215, DOI 10.1126/science.1225739; Novak I, 2008, J CELL BIOL, V180, P83, DOI 10.1083/jcb.200706136; Murakami H, 2014, CELL, V158, P861, DOI 10.1016/j.cell.2014.06.028; Daniel K, 2011, NAT CELL BIOL, V13, P599, DOI 10.1038/ncb2213; Borner GV, 2008, P NATL ACAD SCI USA, V105, P3327, DOI 10.1073/pnas.0711864105; Libby BJ, 2002, DEV BIOL, V242, P174, DOI 10.1006/dbio.2001.0535; Mark M, 2008, J CELL SCI, V121, P3233, DOI 10.1242/jcs.035071; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Haering CH, 2012, EXP CELL RES, V318, P1386, DOI 10.1016/j.yexcr.2012.03.016; Revenkova E, 2004, NAT CELL BIOL, V6, P555, DOI 10.1038/ncb1135; Bannister LA, 2004, GENESIS, V40, P184, DOI 10.1002/gene.20085; Biswas U, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003985; Bolcun-Filas E, 2007, J CELL BIOL, V176, P741, DOI 10.1083/jcb.200610027; Carballo JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003545; De Muyt A, 2007, EMBO J, V26, P4126, DOI 10.1038/sj.emboj.7601815; Eijpe M, 2003, J CELL BIOL, V160, P657, DOI 10.1083/jcb.200212080; Garcia V, 2015, NATURE, V520, P114, DOI 10.1038/nature13993; Hunter N, 2007, MOL GENETICS RECOMBI, V17, P381, DOI 10.1007/4735_2006_0215; Ishiguro K, 2014, GENE DEV, V28, P594, DOI 10.1101/gad.237313.113; Joyce EF, 2011, J CELL BIOL, V195, P359, DOI 10.1083/jcb.201104121; Keeney S, 2014, ANNU REV GENET, V48, P187, DOI 10.1146/annurev-genet-120213-092304; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Kogo H, 2012, GENES CELLS, V17, P439, DOI 10.1111/j.1365-2443.2012.01600.x; Kouznetsova A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028255; Kumar R, 2010, GENES-BASEL, V1, P521, DOI 10.3390/genes1030521; Lange J, 2011, NATURE, V479, P237, DOI 10.1038/nature10508; Li J, 2006, GENETICS, V173, P1969, DOI 10.1534/genetics.106.058768; Li X, 2007, PLOS GENET, V3, P1365, DOI 10.1371/journal.pgen.0030130; Llano E, 2012, J CELL BIOL, V197, P877, DOI 10.1083/jcb.201201100; Lorenz A, 2006, CHROMOSOMA, V115, P330, DOI 10.1007/s00412-006-0053-9; Maleki S, 2007, CHROMOSOMA, V116, P471, DOI 10.1007/s00412-007-0111-y; Miyoshi T, 2012, MOL CELL, V47, P722, DOI 10.1016/j.molcel.2012.06.023; Pelttari J, 2001, MOL CELL BIOL, V21, P5667, DOI 10.1128/MCB.21.16.5667-5677.2001; Roig I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001062; Rosu S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003674; Shin YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001190; Stamper EL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003679; Sun FY, 2008, CHROMOSOMA, V117, P471, DOI 10.1007/s00412-008-0167-3; Wojtasz L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000702	65	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0021-9533	1477-9137		J CELL SCI	J. Cell Sci.	MAY 1	2015	128	9					1800	1811		10.1242/jcs.165464		12	Cell Biology	Cell Biology	CI6MI	WOS:000354873100014		
J	Iwamoto, M; Koujin, T; Osakada, H; Mori, C; Kojidani, T; Matsuda, A; Asakawa, H; Hiraoka, Y; Haraguchi, T				Iwamoto, Masaaki; Koujin, Takako; Osakada, Hiroko; Mori, Chie; Kojidani, Tomoko; Matsuda, Atsushi; Asakawa, Haruhiko; Hiraoka, Yasushi; Haraguchi, Tokuko			Biased assembly of the nuclear pore complex is required for somatic and germline nuclear differentiation in Tetrahymena	JOURNAL OF CELL SCIENCE			English	Article						Ciliates; Live CLEM; Live cell imaging; Nuclear differentiation; Nuclear envelope; Nuclear pore complex	PROGRAMMED GENOME REARRANGEMENTS; DNA ELIMINATION; MACRONUCLEAR DEVELOPMENT; PARAMECIUM-CAUDATUM; SMALL RNAS; THERMOPHILA; PROTEIN; LOCALIZATION; EXCONJUGANTS; CONJUGATION	Ciliates have two functionally distinct nuclei, a somatic macronucleus (MAC) and a germline micronucleus (MIC) that develop from daughter nuclei of the last postzygotic division (PZD) during the sexual process of conjugation. Understanding this nuclear dimorphism is a central issue in ciliate biology. We show, by live-cell imaging of Tetrahymena, that biased assembly of the nuclear pore complex (NPC) occurs immediately after the last PZD, which generates anterior-posterior polarized nuclei: MAC-specific NPCs assemble in anterior presumptive MACs but not in posterior presumptive MICs. MAC-specific NPC assembly in the anterior nuclei occurs much earlier than transport of Twi1p, which is required for MAC genome rearrangement. Correlative light-electron microscopy shows that addition of new nuclear envelope (NE) precursors occurs through the formation of domains of redundant NE, where the outer double membrane contains the newly assembled NPCs. Nocodazole inhibition of the second PZD results in assembly of MAC-specific NPCs in the division-failed zygotic nuclei, leading to failure of MIC differentiation. Our findings demonstrate that NPC type switching has a crucial role in the establishment of nuclear differentiation in ciliates.	[Iwamoto, Masaaki; Koujin, Takako; Osakada, Hiroko; Mori, Chie; Kojidani, Tomoko; Matsuda, Atsushi; Asakawa, Haruhiko; Hiraoka, Yasushi; Haraguchi, Tokuko] Natl Inst Informat & Commun Technol NICT, Adv ICT Res Inst Kobe, Kobe, Hyogo 6512492, Japan; [Kojidani, Tomoko] Japan Womens Univ, Tokyo 1128681, Japan; [Matsuda, Atsushi; Asakawa, Haruhiko; Hiraoka, Yasushi; Haraguchi, Tokuko] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Hiraoka, Yasushi; Haraguchi, Tokuko] Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan	Haraguchi, T (reprint author), Natl Inst Informat & Commun Technol NICT, Adv ICT Res Inst Kobe, Kobe, Hyogo 6512492, Japan.	tokuko@nict.go.jp			Japan Science and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan [23128514, 24570227, 26440098, 26251037, 21370094, 23114724, 25116006, 26291007]	This work was supported by grants from Japan Science and Technology [to T.H]. and Ministry of Education, Culture, Sports, Science and Technology of Japan [grant number 23128514 and 24570227 to M.I., 26440098 to H.A., 26251037 to Y.H. and 21370094, 23114724, 25116006, 26291007 to T.H.]. Deposited in PMC for immediate release.	Iwamoto M, 2009, CURR BIOL, V19, P843, DOI 10.1016/j.cub.2009.03.055; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Malone CD, 2005, MOL CELL BIOL, V25, P9151, DOI 10.1128/MCB.25.20.9151-9164.2005; Boulanger J, 2009, MED IMAGE ANAL, V13, P132, DOI 10.1016/j.media.2008.06.017; Mochizuki K, 2004, CURR OPIN GENET DEV, V14, P181, DOI 10.1016/j.gde.2004.01.004; Chalker DL, 2008, BBA-MOL CELL RES, V1783, P2130, DOI 10.1016/j.bbamcr.2008.07.012; Haraguchi T, 2008, J CELL SCI, V121, P2540, DOI 10.1242/jcs.033597; Nikiforov MA, 1999, GENE DEV, V13, P2852, DOI 10.1101/gad.13.21.2852; Mochizuki K, 2012, DEV GROWTH DIFFER, V54, P108, DOI 10.1111/j.1440-169X.2011.01305.x; Aronica L, 2008, GENE DEV, V22, P2228, DOI 10.1101/gad.481908; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Kimura M, 2014, TRAFFIC, V15, P727, DOI 10.1111/tra.12174; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Asakawa H., 2012, CURRENT MICROSCOPY C, V1, P478; Cole E, 2012, METHOD CELL BIOL, V109, P177, DOI 10.1016/B978-0-12-385967-9.00007-4; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Gaertig J, 2000, J EUKARYOT MICROBIOL, V47, P590, DOI 10.1111/j.1550-7408.2000.tb00095.x; Goldfarb DS, 2009, CURR BIOL, V19, pR449, DOI 10.1016/j.cub.2009.04.023; GOROVSKY MA, 1969, J CELL BIOL, V42, P673, DOI 10.1083/jcb.42.3.673; KACZANOWSKI A, 1991, EXP CELL RES, V195, P330, DOI 10.1016/0014-4827(91)90381-4; Karrer KM, 2012, METHOD CELL BIOL, V109, P29, DOI 10.1016/B978-0-12-385967-9.00003-7; KLOBUTCHER LA, 1984, CELL, V36, P1045, DOI 10.1016/0092-8674(84)90054-0; Madireddi MT, 1996, CELL, V87, P75, DOI 10.1016/S0092-8674(00)81324-0; Malone CD, 2008, EUKARYOT CELL, V7, P1487, DOI 10.1128/EC.00193-08; MARTINDALE DW, 1982, EXP CELL RES, V140, P227, DOI 10.1016/0014-4827(82)90172-0; MIKAMI K, 1980, DEV BIOL, V80, P46, DOI 10.1016/0012-1606(80)90497-2; MIKAMI K, 1985, DEV GROWTH DIFFER, V27, P21; NANNEY DL, 1953, BIOL BULL, V105, P133, DOI 10.2307/1538562; Nikiforov MA, 2000, MOL CELL BIOL, V20, P4128, DOI 10.1128/MCB.20.11.4128-4134.2000; Orias E, 2011, RES MICROBIOL, V162, P578, DOI 10.1016/j.resmic.2011.05.001; Rahaman A, 2008, CURR BIOL, V18, P1227, DOI 10.1016/j.cub.2008.07.042; Sugioka K, 2011, CELL, V146, P941, DOI 10.1016/j.cell.2011.07.043; WHITE EM, 1989, J CELL BIOL, V109, P1983, DOI 10.1083/jcb.109.5.1983; YAO MC, 1984, CELL, V36, P433, DOI 10.1016/0092-8674(84)90236-8; Yao MC, 2007, J CELL SCI, V120, P1978, DOI 10.1242/jcs.006502	36	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0021-9533	1477-9137		J CELL SCI	J. Cell Sci.	MAY 1	2015	128	9					1812	1823		10.1242/jcs.167353		12	Cell Biology	Cell Biology	CI6MI	WOS:000354873100015		
J	Yan, Q; Kuriyama, K; Nishikawa, K; Tominaga, S; Tatsuta, H; Ando, T; Naka, H				Yan, Qi; Kuriyama, Kento; Nishikawa, Keisuke; Tominaga, Satoru; Tatsuta, Haruki; Ando, Tetsu; Naka, Hideshi			(Z)-13-Hexadecenyl Acetate: a Novel Moth Sex Pheromone Component from Herpetogramma submarginale (Lepidoptera: Crambidae)	JOURNAL OF CHEMICAL ECOLOGY			English	Article						Insect pheromone; Pyraloidea; Spilomelinini; Leaf roller; Prezygotic isolation	MASS-SPECTROMETRY	The sex pheromone of Herpetogramma submarginale (Swinhoe) was studied by gas chromatography (GC) with electroantennographic detection and GC coupled with mass spectrometry. Two pheromone candidates detected in the gland extracts of females were identified as (Z)-13-hexadecenyl acetate (Z13-16:OAc) and (E)-13-hexadecenyl acetate (E13-16:OAc) in a ratio of 87:13 by mass spectral analysis of the natural pheromone components and their dimethyldisulfide adducts. In field tests, Z13-16:OAc alone attracted H. submarginale males and caught significantly more males than live virgin females. Addition of E13-16:OAc did not enhance the attractiveness of Z13-16:OAc. Derivatives of Z13-16:OAc also were tested as potential pheromone components. Addition of (Z)-13-hexadecen-1-ol significantly reduced the number of males captured, and (Z)-13-hexadecenal had no effect on the attractiveness of the lure. These results suggest that the female-produced sex pheromone of H. submarginale is Z13-16:OAc. This hexadecenyl acetate is a novel moth sex pheromone component.	[Yan, Qi; Ando, Tetsu] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Koganei, Tokyo 1848588, Japan; [Kuriyama, Kento; Nishikawa, Keisuke; Tatsuta, Haruki] Univ Ryukyus, Fac Agr, Dept Ecol & Environm Sci, Entomol Lab, Nishihara, Okinawa 9030213, Japan; [Naka, Hideshi] Tottori Univ, Fac Agr, Appl Entomol Lab, Tottori, Tottori 6808553, Japan	Naka, H (reprint author), Tottori Univ, Fac Agr, Appl Entomol Lab, Koyama Minami 4-101, Tottori, Tottori 6808553, Japan.	chun@muses.tottori-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [KAKENHI] [25450071]	We thank Mr. Soki Kubota, Mses. Suzuka Yamanishi, Aguri Fujino, and students of the Lab. Applied Entomology in Faculty of Agriculture, Tottori University for help rearing H. submarginale larvae and adults. We also thank Dr. Takeshi Fujii in University of Tokyo, Prof. Masaaki Azuma, and Ms. Mariya Maruyama in Tottori University for supplying relevant information. This work was supported in part by a grant-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [KAKENHI, Grant-in-Aid for Scientific Research (C) No. 25450071].	Ando T., 2014, INTERNET DATABASE; Ando T, 2011, TRAC-TREND ANAL CHEM, V30, P990, DOI 10.1016/j.trac.2011.03.010; Liu WT, 2004, GENE, V342, P303, DOI 10.1016/j.gene.2004.08.017; BUSER HR, 1983, ANAL CHEM, V55, P818, DOI 10.1021/ac00257a003; Lassance JM, 2010, NATURE, V466, P486, DOI 10.1038/nature09058; Fujii T, 2011, P NATL ACAD SCI USA, V108, P7102, DOI 10.1073/pnas.1019519108; Baker TC, 2008, J CHEM ECOL, V34, P971, DOI 10.1007/s10886-008-9468-5; Gibb AR, 2007, J CHEM ECOL, V33, P839, DOI 10.1007/s10886-007-9259-4; JAIN SC, 1983, J ORG CHEM, V48, P2266, DOI 10.1021/jo00161a024; McElfresh JS, 2001, J CHEM ECOL, V27, P791, DOI 10.1023/A:1010310204552; R Development Core Team, 2014, R LANG ENV STAT COMP; Yamanaka A, 2013, STANDARD MOTHS JAP 4, VIV, P415	12	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0098-0331	1573-1561		J CHEM ECOL	J. Chem. Ecol.	MAY	2015	41	5					441	445		10.1007/s10886-015-0576-8		5	Biochemistry & Molecular Biology; Ecology	Biochemistry & Molecular Biology; Environmental Sciences & Ecology	CI4KE	WOS:000354716300002		
J	Takahashi, K; Yoshikawa, S; Kato, Y; Nishi, K				Takahashi, Koji; Yoshikawa, Shiro; Kato, Yoshihito; Nishi, Kazuhiko			Preface to the special issue for 4th Asian Conference on Mixing 2013 (ACOM4)	JOURNAL OF CHEMICAL ENGINEERING OF JAPAN			English	Editorial Material									[Takahashi, Koji] Yamagata Univ, Yamagata 990, Japan; [Yoshikawa, Shiro] Tokyo Inst Technol, Tokyo, Japan; [Kato, Yoshihito] Nagoya Inst Technol, Nagoya, Aichi, Japan; [Nishi, Kazuhiko] Yokohama Natl Univ, Yokohama, Kanagawa, Japan	Takahashi, K (reprint author), Yamagata Univ, Yamagata 990, Japan.							0	0	0	SOC CHEMICAL ENG JAPAN	BUNKYO KU TOKYO	KYORITSU BUILDING 4-16-19 KOHINATA, BUNKYO KU TOKYO, 112, JAPAN	0021-9592			J CHEM ENG JPN	J. Chem. Eng. Jpn.	MAY	2015	48	5					327	327				1	Engineering, Chemical	Engineering	CI7XV	WOS:000354981000001		
J	Wong, SD; Ibrahim, S; Zamzam, Z; Kato, Y; Sato, M				Wong, Siau Dhing; Ibrahim, Shaliza; Zamzam, Zauyah; Kato, Yoshikazu; Sato, Makoto			Effect of Impeller-To-Tank Geometry on Particles Distribution and Just-Suspension Speeds for a Range of Solids Loadings	JOURNAL OF CHEMICAL ENGINEERING OF JAPAN			English	Article; Proceedings Paper	4th Asian Conference on Mixing (ACOM)	SEP 10-13, 2013	Beijing, PEOPLES R CHINA	Beijing Univ Chem Technol, CCESDA Chem Engn Design Assoc		Impeller Geometry; Solid-Liquid; Flow Pattern; Just-Suspension; Solid Distribution	NEWTONIAN FLUIDS; STIRRED TANKS; PATTERN; REGIME; LIQUID	Particle distribution and just-suspension speeds have been studied for SATAKE SUPERMIX (R) HR100 and HS604 impellers in comparison to a 45 degrees pitched-blade turbine (4PBT) and propeller (3P) in a flat-base fully baffled cylindrical tank. The slurries were made up of 18.0 mu m, 75.3 mu m and 195.5 mu m diameter PMMA particles in water, with solids loading ranging from 5 to 40% by weight. Points of last suspension were either from the center, side, or annular region, and are directly related to the flow on the tank base, which could result from primary discharge or induced flow. Increasing impeller clearance from the base reduces the extent of flow for the 4PBT and 3P, such that at high clearances the main flow completely separates into two recirculating loops, with weaker secondary loops in the lower half of the tank. This led to the accumulation of particles at the tank center. By comparison, the HR100 generates a strong axial flow that was maintained at all clearances, thereby making it more advantageous in clearing particles at the tank center. N-js increased with increasing C/D, particularly at high clearances for the 4PBT and 3P, while the HR100 is relatively less affected by clearance. At C/D = 0.75 and 1.0, N-js for both the 4PBT and 3P are strongly affected by solids loading of 20 wt% and upwards. The HS604 has promising suspension performance in terms of stability with respect to changes in solids loading, and this is related to its discharge pattern that results from a very low clearance.	[Wong, Siau Dhing; Ibrahim, Shaliza] Univ Malaya, Dept Civil Engn, Kuala Lumpur 50603, Malaysia; [Zamzam, Zauyah; Kato, Yoshikazu; Sato, Makoto] SATAKE Chem Equipment MFG LTD, Mixing Technol Lab, Toda, Saitama 3350021, Japan	Ibrahim, S (reprint author), Univ Malaya, Dept Civil Engn, Kuala Lumpur 50603, Malaysia.	shaliza@um.edu.my	Engineering, Faculty /I-7935-2015; Ibrahim, Shaliza/A-5854-2010	Engineering, Faculty /0000-0002-4848-7052; 			RAO KSMSR, 1988, AICHE J, V34, P1332; KRESTA SM, 1993, CAN J CHEM ENG, V71, P42; Ibrahim S, 1996, CHEM ENG RES DES, V74, P679; Ayranci I, 2012, CHEM ENG SCI, V79, P163, DOI 10.1016/j.ces.2012.05.028; ZWIETERING TN, 1958, CHEM ENG SCI, V8, P244, DOI 10.1016/0009-2509(58)85031-9; Kumaresan T, 2006, CHEM ENG J, V115, P173, DOI 10.1016/j.cej.2005.10.002; Kasat GR, 2005, CAN J CHEM ENG, V83, P618; Ibrahim S., 2014, CHEM ENG RES DES, V94, P324; IBRAHIM S, 1995, CHEM ENG RES DES, V73, P485; Ibrahim S, 1999, CHEM ENG RES DES, V77, P721, DOI 10.1205/026387699526863; Nienow A. W., 1992, SUSPENSION SOLIDS, V2nd, P364; NIENOW AW, 1978, CHEM ENG J BIOCH ENG, V15, P13, DOI 10.1016/0300-9467(78)80033-1; Sharma RN, 2003, CHEM ENG SCI, V58, P2123, DOI 10.1016/S0009-2509(03)00023-X; Wu J, 2006, CHEM ENG PROCESS, V45, P625, DOI 10.1016/j.cep.2006.01.007	14	0	0	SOC CHEMICAL ENG JAPAN	BUNKYO KU TOKYO	KYORITSU BUILDING 4-16-19 KOHINATA, BUNKYO KU TOKYO, 112, JAPAN	0021-9592			J CHEM ENG JPN	J. Chem. Eng. Jpn.	MAY	2015	48	5					374	380				7	Engineering, Chemical	Engineering	CI7XV	WOS:000354981000008		
J	Fukuda, R; Ehara, M; Cammi, R				Fukuda, Ryoichi; Ehara, Masahiro; Cammi, Roberto			Modeling Molecular Systems at Extreme Pressure by an Extension of the Polarizable Continuum Model (PCM) Based on the Symmetry-Adapted Cluster-Configuration Interaction (SAC-CI) Method: Confined Electronic Excited States of Furan as a Test Case	JOURNAL OF CHEMICAL THEORY AND COMPUTATION			English	Article							REACTION FIELD TREATMENT; ANISOTROPIC DIELECTRICS; SOLVATOCHROMIC SHIFTS; EXCITATION-SPECTRA; CHARGE PENETRATION; NONPOLAR-SOLVENTS; IONIC-SOLUTIONS; VUV ABSORPTION; WAVE-FUNCTION; PYRROLE	Novel molecular photochemistry can be developed by combining high pressure and laser irradiation. For studying such high-pressure effects on the confined electronic ground and excited states, we extend the PCM (polarizable continuum model) SAC (symmetry-adapted cluster) and SAC-CI (SACconfiguration interaction) methods to the PCM-XP (extreme pressure) framework. By using the PCM-XP SAC/SAC-CI method, molecular systems in various electronic states can be confined by polarizable media in a smooth and flexible way. The PCM-XP SAC/SAC-CI method is applied to a furan (C(4)H4O) molecule in cyclohexane at high pressure (1-60 GPa). The relationship between the calculated free-energy and cavity volume can be approximately represented with the Murnaghan equation of state. The excitation energies of furan in cyclohexane show blueshifts with increasing pressure, and the extents of the blueshifts significantly depend on the character of the excitations. Particularly large confinement effects are found in the Rydberg states. The energy ordering of the lowest Rydberg and valence states alters under high-pressure. The pressure effects on the electronic structure may be classified into two contributions: a confinement of the molecular orbital and a suppression of the mixing between the valence and Rydberg configurations. The valence or Rydberg character in an excited state is, therefore, enhanced under high pressure.	[Fukuda, Ryoichi; Ehara, Masahiro] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448585, Japan; [Fukuda, Ryoichi; Ehara, Masahiro] Res Ctr Computat Sci, Okazaki, Aichi 4448585, Japan; [Fukuda, Ryoichi; Ehara, Masahiro] Kyoto Univ, ESICB, Kyoto 6158520, Japan; [Cammi, Roberto] Univ Parma, Dipartmento Chim, I-43100 Parma, Italy	Fukuda, R (reprint author), Natl Inst Nat Sci, Inst Mol Sci, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	fukuda@ims.ac.jp; roberto.cammi@unipr.it			Japan Society for the Promotion of Science (JSPS), Japan; Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education Culture, Sports, Science and Technology (MEXT), Japan; MEXT program "Elements Strategy Initiative to Form Core Research Center"	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS), Japan; Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education Culture, Sports, Science and Technology (MEXT), Japan, and the MEXT program "Elements Strategy Initiative to Form Core Research Center". We thank Gaussian Inc. for collaboration. The computations were partially performed at the Research Center for Computational Science, Okazaki, Japan.	THIERY MM, 1992, J CHEM PHYS, V96, P2633; [Anonymous], 1989, CHEM PHYS; Sorkhabi O, 1999, J CHEM PHYS, V111, P100, DOI 10.1063/1.479257; MIERTUS S, 1981, CHEM PHYS, V55, P117, DOI 10.1016/0301-0104(81)85090-2; Cances E, 1998, J MATH CHEM, V23, P309, DOI 10.1023/A:1019133611148; LONGUETHIGGINS HC, 1957, J CHEM PHYS, V27, P192, DOI 10.1063/1.1743666; Pagliai M, 2014, J PHYS CHEM A, V118, P5098, DOI 10.1021/jp504173k; Cances E, 2001, J CHEM PHYS, V114, P4744, DOI 10.1063/1.1349091; LESAR R, 1981, J PHYS CHEM-US, V85, P2798, DOI 10.1021/j150619a020; Pravica M, 2007, J PHYS CHEM B, V111, P4103, DOI 10.1021/jp070052b; Cammi R, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4757285; Nakano H, 1996, J CHEM PHYS, V104, P2312, DOI 10.1063/1.470926; Cances E, 1997, J CHEM PHYS, V107, P3032, DOI 10.1063/1.474659; VAIDYA SN, 1971, J CHEM PHYS, V55, P987, DOI 10.1063/1.1676268; Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009; Citroni M, 2002, SCIENCE, V295, P2058, DOI 10.1126/science.1068451; Sarsa A, 2011, J CHEM THEORY COMPUT, V7, P2786, DOI 10.1021/ct200284q; PALMER MH, 1995, CHEM PHYS, V192, P111, DOI 10.1016/0301-0104(94)00386-O; Chipman DM, 2000, J CHEM PHYS, V112, P5558, DOI 10.1063/1.481133; Fukuda R, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3562211; OOSHIKA Y, 1954, J PHYS SOC JPN, V9, P594, DOI 10.1143/JPSJ.9.594; Ceppatelli M, 2003, J CHEM PHYS, V118, P1499, DOI 10.1063/1.1527895; Renger T, 2008, P NATL ACAD SCI USA, V105, P13235, DOI 10.1073/pnas.0801025105; Cammi R, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3456540; SERRANOANDRES L, 1993, J AM CHEM SOC, V115, P6184, DOI 10.1021/ja00067a038; Bader RFW, 2009, ADV QUANTUM CHEM, V57, P285, DOI 10.1016/S0065-3276(09)00613-3; Bini R, 2004, ACCOUNTS CHEM RES, V37, P95, DOI 10.1021/ar030015c; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Borgoo A, 2009, PHYS CHEM CHEM PHYS, V11, P2862, DOI 10.1039/b820114e; Bottcher C. J. F., 1973, THEORY ELECT POLARIZ, V1; BROWN WB, 1958, J CHEM PHYS, V28, P522, DOI 10.1063/1.1744185; Cammi R, 2008, CHEM PHYS, V344, P135, DOI 10.1016/j.chemphys.2007.12.010; Mennucci B, 1997, J PHYS CHEM B, V101, P10506, DOI 10.1021/jp971959k; Ciabini L, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.085505; Frisch M J, 2010, GAUSSIAN 09 REVISION; Fukuda R, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2832867; Fukuda R, 2014, J COMPUT CHEM, V35, P2163, DOI 10.1002/jcc.23729; Fukuda R, 2013, J CHEM THEORY COMPUT, V9, P470, DOI 10.1021/ct300439r; Gimarc B. M., 1967, J CHEM PHYS, V47, P5110; Hay P. J., 1977, MODERN THEORETICAL C, V3, P1; King Jr H. E., 1968, PHYSICA B, V139, P168; LUDENA EV, 1979, J CHEM PHYS, V71, P2235; MARC G, 1985, ADV CHEM PHYS, V58, P209, DOI 10.1002/9780470142820.ch4; MCRAE EG, 1957, J PHYS CHEM-US, V61, P562, DOI 10.1021/j150551a012; Mumaghan F.D., 1944, P NATL ACAD SCI USA, V30, P244; NAKATSUJI H, 1981, INT J QUANTUM CHEM, V20, P1301, DOI 10.1002/qua.560200613; NAKATSUJI H, 1985, J CHEM PHYS, V83, P723, DOI 10.1063/1.449857; Palmer MH, 1998, CHEM PHYS, V238, P179, DOI 10.1016/S0301-0104(98)00285-7; Rossi AR, 2009, J PHYS CHEM A, V113, P1686, DOI 10.1021/jp807407c; Santoro M, 2003, J CHEM PHYS, V118, P8321, DOI 10.1063/1.1565997; SCOTT TW, 1981, J CHEM PHYS, V74, P3807, DOI 10.1063/1.441610; Wan J, 2000, J CHEM PHYS, V113, P7853, DOI 10.1063/1.1316034; Wortmann R, 1998, J CHEM PHYS, V108, P1001, DOI 10.1063/1.475462	53	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1549-9618	1549-9626		J CHEM THEORY COMPUT	J. Chem. Theory Comput.	MAY	2015	11	5					2063	2076		10.1021/ct5011517		14	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CI2LK	WOS:000354578900010		
J	Matsueda, S; Takaya, Y				Matsueda, Satoko; Takaya, Yuhei			The Global Influence of the Madden-Julian Oscillation on Extreme Temperature Events	JOURNAL OF CLIMATE			English	Article							WINTERTIME PRECIPITATION; NORTHERN WINTER; MJO; PREDICTABILITY; CIRCULATION; RAINFALL; IMPACT; VARIABILITY; PREDICTION; PROJECT	The authors investigated the influence of the Madden-Julian oscillation (MJO) on extreme warm and cold events, which may have large social and economic impacts. The frequencies of extreme temperature events were analyzed and compared between active and inactive MJO periods by using the 7-day running average of the 850-hPa temperature during the extended boreal winter (November-April). The results show that the frequency of extreme events is significantly modulated (i.e., increased by a factor of more than 2) by the MJO with a time lag over some areas in the extratropics as well as in the tropics. In the extratropics, the modulation of the frequency of the extreme events is roughly associated with midlatitude wave responses to tropical forcing and anomalous lower-level circulation due to the MJO. The relationship between the MJO and forecast skill of extreme temperature events was also investigated by using a suite of hindcasts made with the operational one-month ensemble prediction system of the Japan Meteorological Agency. Forecast skill of extreme events occurring after active MJO periods tend to be better over some areas, compared with after inactive MJO periods. These results suggest that a realistic representation of the MJO and of the atmospheric response to the MJO in forecast models is important for providing reliable early warning information about extreme events.	Japan Meteorol Agcy, Climate Predict Div, Tokyo 1008122, Japan; Japan Meteorol Agcy, Climate Res Dept, Meteorol Res Inst, Tsukuba, Ibaraki, Japan	Matsueda, S (reprint author), Japan Meteorol Agcy, Climate Predict Div, Chiyoda Ku, 1-3-4 Otemachi, Tokyo 1008122, Japan.	matsueda@met.kishou.go.jp			Climate Research Fund (C2) of the Meteorological Research Institute, Japan	The OLR data were provided by NOAA. We used a diagnostic package made available by the U.S. Climate Variability and Predictability Program (CLIVAR) MJO Working Group. This research was supported by the Climate Research Fund (C2) of the Meteorological Research Institute, Japan. We would thank Prof. Pedro L. Silva Dias and anonymous reviewers for their constructive comments to improve the manuscript.	Mori M, 2008, J METEOROL SOC JPN, V86, P213, DOI 10.2151/jmsj.86.213; Schreck CJ, 2013, MON WEATHER REV, V141, P3840, DOI 10.1175/MWR-D-13-00118.1; FERRANTI L, 1990, J ATMOS SCI, V47, P2177, DOI 10.1175/1520-0469(1990)047<2177:TEIAWT>2.0.CO;2; Carvalho LMV, 2004, J CLIMATE, V17, P88, DOI 10.1175/1520-0442(2004)017<0088:TSACZI>2.0.CO;2; Alaka GJ, 2012, J CLIMATE, V25, P3219, DOI 10.1175/JCLI-D-11-00232.1; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Wheeler MC, 2009, J CLIMATE, V22, P1482, DOI 10.1175/2008JCLI2595.1; HENDON HH, 1990, J ATMOS SCI, V47, P2909, DOI 10.1175/1520-0469(1990)047<2909:TIDOOT>2.0.CO;2; Ebita A, 2011, SOLA, V7, P149, DOI 10.2151/sola.2011-038; Zhou ST, 2012, CLIM DYNAM, V38, P1459, DOI 10.1007/s00382-011-1001-9; Lin H, 2009, MON WEATHER REV, V137, P2250, DOI 10.1175/2009MWR2831.1; Gottschalck J, 2010, B AM METEOROL SOC, V91, P1247, DOI 10.1175/2010BAMS2816.1; Paegle JN, 2000, MON WEATHER REV, V128, P837, DOI 10.1175/1520-0493(2000)128<0837:IMOSAS>2.0.CO;2; Reichler T, 2005, J CLIMATE, V18, P634, DOI 10.1175/JCLI-3295.1; Kobayashi S, 2015, J METEOROL SOC JPN, V93, P5, DOI 10.2151/jmsj.2015-001; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kiladis GN, 2014, MON WEATHER REV, V142, P1697, DOI 10.1175/MWR-D-13-00301.1; SARDESHMUKH PD, 1988, J ATMOS SCI, V45, P1228, DOI 10.1175/1520-0469(1988)045<1228:TGOGRF>2.0.CO;2; GRIMM AM, 1995, J ATMOS SCI, V52, P3538, DOI 10.1175/1520-0469(1995)052<3538:AOTIWI>2.0.CO;2; Ding RQ, 2010, MON WEATHER REV, V138, P1004, DOI 10.1175/2009MWR3082.1; JIN FF, 1995, J ATMOS SCI, V52, P307, DOI 10.1175/1520-0469(1995)052<0307:TDRTTH>2.0.CO;2; Liebmann B, 1996, B AM METEOROL SOC, V77, P1275; Waliser DE, 2003, B AM METEOROL SOC, V84, P33, DOI 10.1175/BAMS-84-1-33; Cassou C, 2008, NATURE, V455, P523, DOI 10.1038/nature07286; Pohl B, 2006, Q J ROY METEOR SOC, V132, P2521, DOI 10.1256/qj.05.104; Matthews AJ, 2004, Q J ROY METEOR SOC, V130, P1991, DOI 10.1256/qj.02.123; Seo KH, 2012, J ATMOS SCI, V69, P79, DOI 10.1175/2011JAS3686.1; Hong CC, 2009, J CLIMATE, V22, P3786, DOI 10.1175/2009JCLI2864.1; Zhang CD, 2005, REV GEOPHYS, V43, DOI 10.1029/2004RG000158; Jones C, 2011, MON WEATHER REV, V139, P332, DOI 10.1175/2010MWR3512.1; Wheeler MC, 2004, MON WEATHER REV, V132, P1917, DOI 10.1175/1520-0493(2004)132<1917:AARMMI>2.0.CO;2; Lin H, 2009, J CLIMATE, V22, P364, DOI 10.1175/2008JCLI2515.1; MADDEN RA, 1994, MON WEATHER REV, V122, P814, DOI 10.1175/1520-0493(1994)122<0814:OOTDTO>2.0.CO;2; Vitart F, 2010, Q J ROY METEOR SOC, V136, P842, DOI 10.1002/qj.623; Bechtold P., 2013, ECMWF NEWSLETTER, V134, P33; Efron B., 1994, INTRO BOOTSTRAP; Hirai M., 2014, CAS JSC WGNE RES ACT, V44, P9; Jeong JH, 2008, J CLIMATE, V21, P788, DOI 10.1175/2007JCLI1801.1; JMA, 2013, OUTL OP NUM WEATH PR; Jones C, 2004, MON WEATHER REV, V132, P1462, DOI 10.1175/1520-0493(2004)132<1462:TMOAII>2.0.CO;2; Lin H, 2010, MON WEATHER REV, V138, P3822, DOI 10.1175/2010MWR3363.1; Sato H., 2014, CAS JSC WGNE RES ACT, V44, P13	42	1	1	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	MAY	2015	28	10					4141	4151		10.1175/JCLI-D-14-00625.1		11	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CH9QE	WOS:000354370100014		
J	Otsu, M; Yamada, M; Nakajima, S; Kida, M; Maeyama, Y; Hatano, N; Toita, N; Takezaki, S; Okura, Y; Kobayashi, R; Matsumoto, Y; Tatsuzawa, O; Tsuchida, F; Kato, S; Kitagawa, M; Mineno, J; Hershfield, M; Bali, P; Candotti, F; Onodera, M; Kawamura, N; Sakiyama, Y; Ariga, T				Otsu, Makoto; Yamada, Masafumi; Nakajima, Satoru; Kida, Miyuki; Maeyama, Yoshihiro; Hatano, Norikazu; Toita, Nariaki; Takezaki, Shunichiro; Okura, Yuka; Kobayashi, Ryoji; Matsumoto, Yoshinori; Tatsuzawa, Osamu; Tsuchida, Fumiko; Kato, Shunichi; Kitagawa, Masanari; Mineno, Junichi; Hershfield, Michael S.; Bali, Pawan; Candotti, Fabio; Onodera, Masafumi; Kawamura, Nobuaki; Sakiyama, Yukio; Ariga, Tadashi			Outcomes in Two Japanese Adenosine Deaminase-Deficiency Patients Treated by Stem Cell Gene Therapy with No Cytoreductive Conditioning	JOURNAL OF CLINICAL IMMUNOLOGY			English	Article						Gene therapy; adenosine deaminase (ADA); severe combined immunodeficiency (SCID); primary immunodeficiency (PID); retroviral vector(s); hematopoietic stem cell(s)	SEVERE COMBINED IMMUNODEFICIENCY; CHRONIC GRANULOMATOUS-DISEASE; ENZYME-REPLACEMENT THERAPY; PERIPHERAL-BLOOD LYMPHOCYTES; WISKOTT-ALDRICH-SYNDROME; BONE-MARROW-CELLS; HEMATOPOIETIC STEM; RETROVIRAL VECTORS; ADA DEFICIENCY; T-LYMPHOCYTES	Objective We here describe treatment outcomes in two adenosine deaminase (ADA)-deficiency patients (pt) who received stem cell gene therapy (SCGT) with no cytoreductive conditioning. As this protocol has features distinct from those of other clinical trials, its results provide insights into SCGT for ADA deficiency. Patients and Methods Pt 1 was treated at age 4.7 years, whereas pt 2, who had previously received T-cell gene therapy, was treated at age 13 years. Bone marrow CD34(+) cells were harvested after enzyme replacement therapy (ERT) was withdrawn; following transduction of ADA cDNA by the gamma-retroviral vector GCsapM-ADA, they were administered intravenously. No cytoreductive conditioning, at present considered critical for therapeutic benefit, was given before cell infusion. Hematological/immunological reconstitution kinetics, levels of systemic detoxification, gene-marking levels, and proviral insertion sites in hematopoietic cells were assessed. Results Treatment was well tolerated, and no serious adverse events were observed. Engraftment of gene-modified repopulating cells was evidenced by the appearance and maintenance of peripheral lymphocytes expressing functional ADA. Systemic detoxification was moderately achieved, allowing temporary discontinuation of ERT for 6 and 10 years in pt 1 and pt 2, respectively. Recovery of immunity remained partial, with lymphocyte counts in pts 1 and 2, peaked at 408/mm(3) and 1248/mm(3), approximately 2 and 5 years after SCGT. Vector integration site analyses confirmed that hematopoiesis was reconstituted with a limited number of clones, some of which were shown to have myelo-lymphoid potential. Conclusions Outcomes in SCGT for ADA-SCID are described in the context of a unique protocol, which used neither ERT nor cytoreductive conditioning. Although proven safe, immune reconstitution was partial and temporary. Our results reiterate the importance of cytoreductive conditioning to ensure greater benefits from SCGT.	[Otsu, Makoto] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Tokyo, Japan; [Yamada, Masafumi; Hatano, Norikazu; Toita, Nariaki; Takezaki, Shunichiro; Okura, Yuka; Kobayashi, Ryoji; Matsumoto, Yoshinori; Kawamura, Nobuaki; Sakiyama, Yukio; Ariga, Tadashi] Hokkaido Univ, Grad Sch Med, Dept Pediat, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Otsu, Makoto; Nakajima, Satoru; Kida, Miyuki; Maeyama, Yoshihiro; Sakiyama, Yukio; Ariga, Tadashi] Hokkaido Univ, Grad Sch Med, Res Grp Human Gene Therapy, Sapporo, Hokkaido 0608638, Japan; [Tatsuzawa, Osamu; Onodera, Masafumi] Natl Ctr Child Hlth & Dev, Dept Human Genet, Tokyo, Japan; [Tsuchida, Fumiko; Kato, Shunichi] Tokai Univ, Sch Med, Dept Cell Transplantat & Regenerat Med, Hiratsuka, Kanagawa 25912, Japan; [Kitagawa, Masanari; Mineno, Junichi] Takara Bio, Shiga, Japan; [Hershfield, Michael S.; Bali, Pawan] Duke Univ, Sch Med, Dept Biochem, Durham, NC USA; [Candotti, Fabio] NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA	Ariga, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Pediat, Kita Ku, N-15,W-7, Sapporo, Hokkaido 0608638, Japan.	tada-ari@med.hokudai.ac.jp			Ministry of Health, Labor and Welfare	We would like to thank both patients and both families for their cooperation. We are also grateful to the doctors, nurses, and other co-medical staff members who have supported them and this study in many ways. We thank W. Jay Ramsey, Laura Tuschong, G. Jayashree Jagadeesh, and Linda Muul in the Clinical Gene Therapy Branch of the National Human Genome Research Institute, NIH, for the production of clinical-grade GCsapM-ADA supernatant. This work was supported by grants from the Ministry of Health, Labor and Welfare.	Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Gaspar HB, 2006, MOL THER, V14, P505, DOI 10.1016/j.ymthe.2006.06.007; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Gaspar HB, 2009, BLOOD, V114, P3524, DOI 10.1182/blood-2009-06-189209; Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Kang EM, 2010, BLOOD, V115, P783, DOI 10.1182/blood-2009-05-222760; Mukherjee S, 2013, GENE, V525, P174, DOI 10.1016/j.gene.2013.03.098; Onodera M, 1998, BLOOD, V91, P30; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Arredondo-Vega FX, 2002, BLOOD, V99, P1005, DOI 10.1182/blood.V99.3.1005; Dahlberg A, 2011, BLOOD, V117, P6083, DOI 10.1182/blood-2011-01-283606; BORDIGNON C, 1995, SCIENCE, V270, P470, DOI 10.1126/science.270.5235.470; Carbonaro DA, 2014, MOL THER, V22, P607, DOI 10.1038/mt.2013.265; Candotti F, 2012, BLOOD, V120, P3635, DOI 10.1182/blood-2012-02-400937; Kang HJ, 2011, MOL THER, V19, P2092, DOI 10.1038/mt.2011.166; Carbonaro DA, 2012, BLOOD, V120, P3677, DOI 10.1182/blood-2012-02-408591; Gaspar HB, 2012, BLOOD, V120, P3628, DOI 10.1182/blood-2012-08-446559; GIBLETT ER, 1972, LANCET, V2, P1067; Touzot F, 2014, EXPERT OPIN BIOL TH, V14, P789, DOI 10.1517/14712598.2014.895811; Onodera M, 1998, J VIROL, V72, P1769; KOHN DB, 1995, NAT MED, V1, P1017, DOI 10.1038/nm1095-1017; Walasek MA, 2012, ANN NY ACAD SCI, V1266, P138, DOI 10.1111/j.1749-6632.2012.06549.x; Boztug K, 2010, NEW ENGL J MED, V363, P1918, DOI 10.1056/NEJMoa1003548; Schmidt M, 2002, BLOOD, V100, P2737, DOI 10.1182/blood-2002-02-0407; Wada T, 2001, P NATL ACAD SCI USA, V98, P8697, DOI 10.1073/pnas.151260498; Hershfield MS, 1998, SEMIN HEMATOL, V35, P291; Chinen J, 2007, BLOOD, V110, P67, DOI 10.1182/blood-2006-11-058933; Ueda T, 2000, J CLIN INVEST, V105, P1013, DOI 10.1172/JCI8583; Hoogerbrugge PM, 1996, GENE THER, V3, P179; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Ariga T, 2001, BLOOD, V97, P2896, DOI 10.1182/blood.V97.9.2896; Bhattacharya D, 2006, J EXP MED, V203, P73, DOI 10.1084/jem.20051714; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; BORDIGNON C, 1993, HUM GENE THER, V4, P513, DOI 10.1089/hum.1993.4.4-513; Braun CJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007280; Chan B, 2005, CLIN IMMUNOL, V117, P133, DOI 10.1016/j.clim.2005.07.006; Engel BC, 2007, BLOOD, V109, P503, DOI 10.1182/blood-2006-06-031476; Gaspar HB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002715; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Haddad E, 1998, BLOOD, V91, P3646; HERSHFIELD MS, 1987, NEW ENGL J MED, V316, P589, DOI 10.1056/NEJM198703053161005; HOOGERBRUGGE PM, 1992, HUM GENE THER, V3, P553, DOI 10.1089/hum.1992.3.5-553; KATO S, 1990, BLOOD, V75, P806; Kawamura N, 1999, J IMMUNOL, V163, P2256; Kohn DB, 1998, NAT MED, V4, P775, DOI 10.1038/nm0798-775; Otsu M, 2002, HUM GENE THER, V13, P425, DOI 10.1089/10430340252792558; Rivat C, 2012, HUM GENE THER, V23, P668, DOI 10.1089/hum.2012.116	47	1	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0271-9142	1573-2592		J CLIN IMMUNOL	J. Clin. Immunol.	MAY	2015	35	4					384	398		10.1007/s10875-015-0157-1		15	Immunology	Immunology	CI5TW	WOS:000354823700010		
J	Rothe, T; Gruber, F; Uderhardt, S; Ipseiz, N; Rossner, S; Oskolkova, O; Bluml, S; Leitinger, N; Bicker, W; Bochkov, VN; Yamamoto, M; Steinkasserer, A; Schett, G; Zinser, E; Kronke, G				Rothe, Tobias; Gruber, Florian; Uderhardt, Stefan; Ipseiz, Natacha; Roessner, Susanne; Oskolkova, Olga; Blueml, Stephan; Leitinger, Norbert; Bicker, Wolfgang; Bochkov, Valery N.; Yamamoto, Masayuki; Steinkasserer, Alexander; Schett, Georg; Zinser, Elisabeth; Kroenke, Gerhard			12/15-lipoxygenase-mediated enzymatic lipid oxidation regulates DC maturation and function	JOURNAL OF CLINICAL INVESTIGATION			English	Article							E-DEFICIENT MICE; DENDRITIC CELLS; OXIDIZED PHOSPHOLIPIDS; AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; TISSUE-DAMAGE; BONE-MARROW; NRF2; INFLAMMATION; EXPRESSION	DCs are able to undergo rapid maturation, which subsequently allows them to initiate and orchestrate T cell-driven immune responses. DC maturation must be tightly controlled in order to avoid random T cell activation and development of autoimmunity. Here, we determined that 12/15-lipoxygenase-meditated (12/15-LO-mediated) enzymatic lipid oxidation regulates DC activation and fine-tunes consecutive T cell responses. Specifically, 12/15-LO activity determined the DC activation threshold via generation of phospholipid oxidation products that induced an antioxidative response dependent on the transcription factor NRF2. Deletion of the 12/15-LO-encoding gene or pharmacologic inhibition of 12/15-LO in murine or human DCs accelerated maturation and shifted the cytokine profile, thereby favoring the differentiation of Th17 cells. Exposure of 12/15-LO-deficient DCs to 12/15-LO-derived oxidized phospholipids attenuated both DC activation and the development of Th17 cells. Analysis of lymphatic tissues from 12/15-LO-deficient mice confirmed enhanced maturation of DCs as well as an increased differentiation of Th17 cells. Moreover, experimental autoimmune encephalomyelitis in mice lacking 12/15-LO resulted in an exacerbated Th17-driven autoimmune disease. Together, our data reveal that 12/15-LO controls maturation of DCs and implicate enzymatic lipid oxidation in shaping the adaptive immune response.	[Rothe, Tobias; Uderhardt, Stefan; Ipseiz, Natacha; Schett, Georg; Kroenke, Gerhard] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Internal Med 3, D-91054 Erlangen, Unk, Germany; [Rothe, Tobias; Uderhardt, Stefan; Ipseiz, Natacha; Schett, Georg; Kroenke, Gerhard] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Inst Clin Immunol, D-91054 Erlangen, Unk, Germany; [Rothe, Tobias; Uderhardt, Stefan; Ipseiz, Natacha; Kroenke, Gerhard] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Nikolaus Fiebiger Ctr Mol Med, D-91054 Erlangen, Unk, Germany; [Gruber, Florian] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Gruber, Florian] Med Univ Vienna, Christian Doppler Lab Biotechnol Skin Aging, Dept Dermatol, Vienna, Austria; [Roessner, Susanne; Steinkasserer, Alexander; Zinser, Elisabeth] Univ Hosp Erlangen, Dept Immune Modulat, Dept Dermatol, Erlangen, Germany; [Oskolkova, Olga; Bochkov, Valery N.] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Vienna, Austria; [Blueml, Stephan] Med Univ Vienna, Div Rheumatol, Internal Med 3, Vienna, Austria; [Leitinger, Norbert] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Bicker, Wolfgang] FTC Forens Toxicol Lab Ltd, Vienna, Austria; [Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sch Med, Sendai, Miyagi 980, Japan	Kronke, G (reprint author), Univ Erlangen Nurnberg, Glueckstr 4a, D-91054 Erlangen, Unk, Germany.	gerhard.kroenke@uk-erlangen.de			Else-Kroner Fresenius Stiftung; Deutsche Forschungsgemeinschaft [SCHE1583, KR3523, FG 661, SFB 643, SPP1468-IMMUNOBONE]; ELAN-Program of the University of Erlangen-Nuremberg; MASTERSWITCH project of the European Union; Interdisciplinary Centre for Clinical Research, Erlangen; Fonds zur Forderung wissenschaftlicher Forschung [P22267-B11]; NIH [R01 DK096076]	We thank Cornelia Stoll, Alexandra Klej, Lena Sandrock, and Ionela-Mariana Nagelreiter for excellent technical assistance. This study was supported by the Else-Kroner Fresenius Stiftung (to G. Kronke), the Deutsche Forschungsgemeinschaft (SCHE1583 to G. Schen; KR3523 to G. Kronke; FG 661 to G. Schett; SFB 643 to G. Schett, E. Zinser, and A. Steinkasserer; and SPP1468-IMMUNOBONE to G. Kronke and G. Schett), the ELAN-Program of the University of Erlangen-Nuremberg (to G. Kronke), the MASTERSWITCH project of the European Union (to G. Schett), the Interdisciplinary Centre for Clinical Research, Erlangen (to G. Kronke), the Fonds zur Forderung wissenschaftlicher Forschung (P22267-B11 to O.V. Oskolkova), and the NIH (R01 DK096076 to N. Leitinger).	Zhao L, 2002, J BIOL CHEM, V277, P35350, DOI 10.1074/jbc.M205738200; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Ivanov I, 2010, ARCH BIOCHEM BIOPHYS, V503, P161, DOI 10.1016/j.abb.2010.08.016; Rangasamy T, 2010, AM J RESP CELL MOL, V43, P276, DOI 10.1165/rcmb.2008-0438OC; Bluml S, 2005, J IMMUNOL, V175, P501; Williams MA, 2008, J IMMUNOL, V181, P4545; Uderhardt S, 2012, IMMUNITY, V36, P834, DOI 10.1016/j.immuni.2012.03.010; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Dobrian AD, 2011, PROG LIPID RES, V50, P115, DOI 10.1016/j.plipres.2010.10.005; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Bar-Or A, 2013, J NEUROL, V260, P2297, DOI 10.1007/s00415-013-6954-7; Uderhardt S, 2012, J MOL MED, V90, P1247, DOI 10.1007/s00109-012-0954-4; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Emerson MR, 2004, BRAIN RES, V1021, P140, DOI 10.1016/j.brainres.2004.06.045; Serhan CN, 2003, J IMMUNOL, V171, P6856; Asquith DL, 2010, ARTHRITIS RHEUM-US, V62, P472, DOI 10.1002/art.27205; Kronke G, 2003, J BIOL CHEM, V278, P51006, DOI 10.1074/jbc.M304103200; Johnson DA, 2010, TOXICOL SCI, V114, P237, DOI 10.1093/toxsci/kfp274; Kronke G, 2009, J IMMUNOL, V183, P3383, DOI 10.4049/jimmunol.0900327; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Angeli V, 2004, IMMUNITY, V21, P561, DOI 10.1016/j.immuni.2004.09.003; Ganguly D, 2013, NAT REV IMMUNOL, V13, P566, DOI 10.1038/nri3477; ZAL T, 1994, J EXP MED, V180, P2089, DOI 10.1084/jem.180.6.2089; Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715; Sheibanie AF, 2004, FASEB J, V18, P1318, DOI 10.1096/fj.03.1367fje; Kuhn H, 2005, MOL NUTR FOOD RES, V49, P1014, DOI 10.1002/mnfr.200500131; Pierson E, 2012, IMMUNOL REV, V248, P205, DOI 10.1111/j.1600-065X.2012.01126.x; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Yeang HXA, 2012, J BIOL CHEM, V287, P10556, DOI 10.1074/jbc.M111.322420; Cyrus T, 2001, CIRCULATION, V103, P2277; Middleton MK, 2006, J IMMUNOL, V176, P265; Al-Huseini LMA, 2013, J BIOL CHEM, V288, P22281, DOI 10.1074/jbc.M113.483420; Berliner JA, 2001, TRENDS CARDIOVAS MED, V11, P142, DOI 10.1016/S1050-1738(01)00098-6; Bluml S, 2009, BLOOD, V114, P5481, DOI 10.1182/blood-2008-11-191429; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Kuhn H, 2000, PROSTAG OTH LIPID M, V62, P255, DOI 10.1016/S0090-6980(00)00084-8; Morgan AH, 2009, J BIOL CHEM, V284, P21185, DOI 10.1074/jbc.M109.021634; Pareek TK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00201; Pfeiffer IA, 2013, IMMUNOBIOLOGY, V218, P1392, DOI 10.1016/j.imbio.2013.07.005; Shamshiev AT, 2007, J EXP MED, V204, P441, DOI 10.1084/jem.20061737; Spanbroek R, 2001, P NATL ACAD SCI USA, V98, P5152, DOI 10.1073/pnas.091076998; von Schlieffen E, 2009, ARTERIOSCL THROM VAS, V29, P356, DOI 10.1161/ATVBAHA.108.173799	44	0	0	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	MAY	2015	125	5					1944	1954		10.1172/JCI78490		11	Medicine, Research & Experimental	Research & Experimental Medicine	CH5JK	WOS:000354071700017		
J	Dobbelaere, S; Kiyota, K; Mairesse, J				Dobbelaere, Sabien; Kiyota, Kozo; Mairesse, Jacques			Product and labor market imperfections and scale economies: Micro-evidence on France, Japan and the Netherlands	JOURNAL OF COMPARATIVE ECONOMICS			English	Article						Rent sharing; Monopsony; Price-cost mark-ups; Production function; Panel data	PANEL-DATA MODELS; LEVEL PRODUCTION-FUNCTIONS; GMM ESTIMATION; MONOPSONISTIC COMPETITION; EXPORT STATUS; FIRM; OUTPUT; WAGES; PRICE; PROFITABILITY	Allowing for three labor market settings (perfect competition or right-to-manage bargaining, efficient bargaining and monopsony), this paper relies on two extensions of Hall's econometric framework for estimating simultaneously price-cost margins and scale economies. Using an unbalanced panel of 17653 firms over the period 1986-2001 in France, 8728 firms over the period 1994-2006 in Japan and 7828 firms over the period 1993-2008 in the Netherlands, we first apply two procedures to classify 30 comparable manufacturing industries in 6 distinct regimes that differ in terms of the type of competition prevailing in product and labor markets. For each of the predominant regimes in each country, we then investigate industry differences in the estimated product and labor market imperfections and scale economies. Consistent with differences in institutions and in the industrial relations system in the three countries, we find important regime differences across the three countries and also observe differences in the levels of product market imperfections and scale economies within regimes. Journal of Comparative Economics 43 (2) (2015) 290-322. VU University Amsterdam, De Boelelaan 1105, 1081 HV Amsterdam, The Netherlands; Tinbergen Institute (TIA), Gustav Mahlerplein 117, 1082 MS Amsterdam, The Netherlands; IZA, Schaumburg-Lippe-Strasse 5-9, 53113 Bonn, Germany; Keio Economic Observatory, Keio University, 2-15-45 Mita, Minato-ku 108-8345, Tokyo, Japan; RIETI, 1-3-1, Kasumigaseki, Chiyoda-ku, 100-8901 Tokyo, Japan; CREST (ParisTech-ENSAE), 15 Boulevard Gabriel Pen, 92245 Malakoff Cedex, France; UNU-MERIT (Maastricht University), Keizer Karelplein 19, 6211 TC Maastricht, The Netherlands; NBER, 1050 Massachusetts Ave., Cambridge, MA, USA. (C) 2014 Association for Comparative Economic Studies. Published by Elsevier Inc. All rights reserved.	[Dobbelaere, Sabien] Vrije Univ Amsterdam, NL-1081 HV Amsterdam, Netherlands; [Dobbelaere, Sabien] Tinbergen Inst TIA, NL-1082 MS Amsterdam, Netherlands; [Dobbelaere, Sabien] IZA, D-53113 Bonn, Germany; [Kiyota, Kozo] Keio Univ, Keio Econ Observ, Minato Ku, Tokyo 1088345, Japan; [Kiyota, Kozo] RIETI, Chiyoda Ku, Tokyo 1008901, Japan; [Mairesse, Jacques] CREST ParisTech ENSAE, F-92245 Malakoff, France; [Mairesse, Jacques] UNU MERIT Maastricht Univ, NL-6211 TC Maastricht, Netherlands; [Mairesse, Jacques] NBER, Cambridge, MA 02138 USA	Dobbelaere, S (reprint author), Vrije Univ Amsterdam, De Boelelaan 1105, NL-1081 HV Amsterdam, Netherlands.	sabien.dobbelaere@vu.nl; kiyota@sanken.keio.ac.jp; jacques.mairesse@ensae.fr			Japan Society for the Promotion of Science [A-22243023]	We are grateful to the Editor and an anonymous referee for helpful comments and suggestions. We also benefited from useful discussions with and comments by Christopher Baum, Bjorn Brugemann, Masahisa Fujita, Kyoji Fukao, Michihiro Kandori, Bas van der Klaauw, Jose Luis Moraga-Gonzalez, Masayuki Morikawa, Mark Schaffer, Ayumu Tanaka and other participants at various conferences and seminars. The analysis using the French firm-level data was conducted at "Centre de Recherche en Economie et Statistique" (CREST) and the one using the Japanese firm-level data at the Research Institute of Economy, Trade and Industry (RIETI). The authors would like to thank Statistics Netherlands for providing the Dutch data. Kiyota acknowledges financial support from the Japan Society for the Promotion of Science (Grant-in-aid A-22243023).	Ackerberg D. A., 2006, STRUCTURAL IDE UNPUB; Alan Manning, 2003, MONOPSONY MOTION IMP; Bowsher CG, 2002, ECON LETT, V77, P211, DOI 10.1016/S0165-1765(02)00130-1; Andersen TG, 1996, J BUS ECON STAT, V14, P328, DOI 10.2307/1392446; MCDONALD IM, 1981, AM ECON REV, V71, P896; Doraszelski U, 2013, REV ECON STUD, V80, P1338, DOI 10.1093/restud/rdt011; De Loecker J, 2011, ECONOMETRICA, V79, P1407, DOI 10.3982/ECTA7617; Syverson C, 2004, J POLIT ECON, V112, P1181, DOI 10.1086/424743; Konings J, 2001, INT J IND ORGAN, V19, P841, DOI 10.1016/S0167-7187(00)00096-5; Ackerberg D, 2007, HBK ECON, V2, P4171, DOI 10.1016/S1573-4412(07)06063-1; Burdett K, 1998, INT ECON REV, V39, P257, DOI 10.2307/2527292; Bhaskar V, 2002, J ECON PERSPECT, V16, P155, DOI 10.1257/0895330027300; Restuccia D, 2013, REV ECON DYNAM, V16, P1, DOI 10.1016/j.red.2012.11.003; Levinsohn J, 2003, REV ECON STUD, V70, P317, DOI 10.1111/1467-937X.00246; Klette TJ, 1996, J APPL ECONOM, V11, P343, DOI 10.1002/(SICI)1099-1255(199607)11:4<343::AID-JAE404>3.3.CO;2-W; Katayama H, 2009, INT J IND ORGAN, V27, P403, DOI 10.1016/j.ijindorg.2008.11.002; Foster L, 2008, AM ECON REV, V98, P394, DOI 10.1257/aer.98.1.394; Blundell R, 1998, J ECONOMETRICS, V87, P115, DOI 10.1016/S0304-4076(98)00009-8; Syverson C, 2011, J ECON LIT, V49, P326, DOI 10.1257/jel.49.2.326; HOLTZEAKIN D, 1988, ECONOMETRICA, V56, P1371, DOI 10.2307/1913103; Van Beveren I, 2012, J ECON SURV, V26, P98, DOI 10.1111/j.1467-6419.2010.00631.x; Hellerstein JK, 1999, J LABOR ECON, V17, P409, DOI 10.1086/209926; Wooldridge JM, 2009, ECON LETT, V104, P112, DOI 10.1016/j.econlet.2009.04.026; Eslava M, 2004, J DEV ECON, V75, P333, DOI 10.1016/j.jdeveco.2004.06.002; GRILICHES Z, 1986, J ECONOMETRICS, V31, P93, DOI 10.1016/0304-4076(86)90058-8; Boal WM, 1997, J ECON LIT, V35, P86; Windmeijer F, 2005, J ECONOMETRICS, V126, P25, DOI 10.1016/j.jeconom.2004.02.005; Fukao K, 2006, JPN ECON REV, V57, P195, DOI 10.1111/j.1468-5876.2006.00359.x; Van Biesebroeck J, 2007, J IND ECON, V55, P529, DOI 10.1111/j.1467-6451.2007.00322.x; Petrin A, 2013, REV ECON STAT, V95, P286, DOI 10.1162/REST_a_00238; ARELLANO M, 1995, J ECONOMETRICS, V68, P29, DOI 10.1016/0304-4076(94)01642-D; Arellano Manuel, 1991, REV EC STUDY, V58, P277; Baum C, 2006, INTRO MODERN ECONOME; Bellone F, 2014, EUR ECON REV, V70, P56, DOI 10.1016/j.euroecorev.2014.01.017; Bhaskar V, 1999, ECON J, V109, P190, DOI 10.1111/1468-0297.00427; Blundell R., 2000, ECONOMET REV, V19, P321, DOI DOI 10.1080/07474930008800475.ACCESSED; BOAL WM, 1995, RAND J ECON, V26, P519, DOI 10.2307/2556001; Bond S., 2007, HDB ECONOMETRICS A; Bond Stephen R., 2005, 200504 NUFF COLL EC; Booth AL, 2011, ECON REC, V87, P359, DOI 10.1111/j.1475-4932.2011.00728.x; Booth Alison, 2014, LABOUR EC SPECIAL IS; Boulhol H, 2011, BRIT J IND RELAT, V49, P331, DOI 10.1111/j.1467-8543.2009.00760.x; Bresnahan Timothy F., 1989, HDB IND ORG, V2; Cahuc P., 2004, LABOR EC; Crepon Bruno, 2005, ANN EC STAT, V79, P585; Del Gatto M, 2011, J ECON SURV, V25, P952, DOI 10.1111/j.1467-6419.2009.00620.x; Dobbelaere S, 2004, INT J IND ORGAN, V22, P1381, DOI 10.1016/j.ijindorg.2004.10.003; Dobbelaere S, 2013, J APPL ECONOMET, V28, P1, DOI 10.1002/jae.1256; Dunne Timothy, 1992, EMPIRICAL STUDIES IN; Eberhardt Markus, 2010, 513 U OXF DEP EC; Falch Torberg, 2001, LABOUR, V15, P343, DOI 10.1111/1467-9914.00168; Fukao K., 2007, 07E003 RIETI; Gandhi Amit, 2013, IDENTIFICATION UNPUB; Griliches Zvi, 1998, ECONOMETRIC SOC MONO; HALL RE, 1988, J POLIT ECON, V96, P921, DOI 10.1086/261570; Hsieh CT, 2009, Q J ECON, V124, P1403; Jaumandreu Jordi, 2006, 1247 MPRA; Kioyta Kozo, 2009, IND CORP CHANGE, V18, P381; Kiyota Kozo, 2010, 10E040 RIETI; Kleiman Mark A.R., 2008, OXFORD HDB PUBLIC PO; Koske Isabelle, 2014, OECD EC DEP WORKING; Levinsohn J., 2006, PRODUCTIVITY D UNPUB; Mairesse J, 2005, SCAND J ECON, V107, P651, DOI 10.1111/j.1467-9442.2005.00431.x; Mairesse Jacques, 1990, PANEL DATA LABOR MAR; Marschak J, 1944, ECONOMETRICA, V12, P143, DOI 10.2307/1905432; Melitz Marc, 2001, ESTIMATING FIR UNPUB; NELSON P, 1973, ECONOMETRICA, V41, P853, DOI 10.2307/1913810; NICKELL SJ, 1983, OXFORD ECON PAP, V35, P183; Noda T, 2013, J JPN INT ECON, V28, P91, DOI 10.1016/j.jjie.2013.01.003; Olley S., 1996, ECONOMETRICA, V64, P1263, DOI DOI 10.2307/2171831; Organisation for Economic Co-operation and Development, 2004, OECD EMPL OUTL; Ornaghi C, 2008, ECON LETT, V99, P168, DOI 10.1016/j.econlet.2007.06.020; Ornaghi C, 2006, J APPL ECONOM, V21, P879, DOI 10.1002/jae.887; Research and Statistics Department Ministry of Economy Trade and Industry (METH, 1994, KIG KATS KIH CHOUS H; Restuccia Diego, 2008, REV ECON DYNAM, V11, P707; Reynolds LG, 1946, Q J ECON, V60, P390, DOI 10.2307/1880679; Roodman, 2009, OXFORD B ECON STAT, V71, P135, DOI DOI 10.1111/J.1468-0084.2008.00542.X; SHEA J, 1993, J BUS ECON STAT, V11, P145, DOI 10.2307/1391366; Staiger DO, 2010, J LABOR ECON, V28, P211; SULLIVAN D, 1989, J LAW ECON, V32, pS135, DOI 10.1086/467192; Tokui Joji, 2008, 08E017 RIETI; Venn Danielle, 2009, 89 OECD SOC EMPL MIG; Verret Isabelle, 2006, COLLECTIVE EMP UNPUB; Wansbeek T, 2001, J ECONOMETRICS, V104, P259, DOI 10.1016/S0304-4076(01)00079-3; De Loecker J, 2012, AM ECON REV, V102, P2437, DOI 10.1257/aer.102.6.2437; Weimer D, 2005, POLICY ANAL CONCEPTS; Wolfl Anita, 2010, 799 OECD EC DEP; Wolfl Anita, 2009, 695 OECD EC DEP; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; Xiao ZG, 2010, STAT SINICA, V20, P1725	90	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0147-5967	1095-7227		J COMP ECON	J. Comp. Econ.	MAY	2015	43	2					290	322		10.1016/j.jce.2014.08.006		33	Economics	Business & Economics	CI8XY	WOS:000355056200004		
J	Miyazaki, A; Yonemaru, K; Hirata, A; Yanai, T; Sakai, H				Miyazaki, A.; Yonemaru, K.; Hirata, A.; Yanai, T.; Sakai, H.			Histopathological and Immunohistochemical Features of Atypical Epithelial Tumours of the Gland of the Third Eyelid in Seven Dogs	JOURNAL OF COMPARATIVE PATHOLOGY			English	Article						dog; epithelial tumour; third eyelid gland	BASAL-CELL ADENOCARCINOMA; SALIVARY-GLAND; MAMMARY-TUMORS	This report documents the histopathological and immunohistochemical features of atypical epithelial tumours of the gland of the third eyelid (GTE) in seven dogs. Cases 1 and 2 were diagnosed as myoepithelioma, comprising of compressive proliferations of interlacing bundles of neoplastic spindle cells expressing cytokeratin 14, p63, calponin and alpha-smooth muscle actin. Cases 3, 4 and 5 were diagnosed as complex carcinomas comprising of atypical glandular cells expressing cytokeratin 8/18, together with spindle-shaped or round neoplastic cells expressing cytokeratin 14, p63, calponin and alpha-smooth muscle actin. Cases 6 and 7 were diagnosed as basal cell adenocarcinomas (BCACs) comprising of a mixed proliferation of glandular and basal-type cells expressing cytokeratin 14 and p63. Therefore, in addition to glandular components, these tumours may include neoplastic cells with a myoepithelial or basal cell phenotype. Hence, there is diversity in the features of epithelial neoplasia of the GTE in dogs, similar to tumours in human salivary and lacrimal glands. (C) 2015 Elsevier Ltd. All rights reserved.	[Miyazaki, A.; Yonemaru, K.; Hirata, A.; Yanai, T.; Sakai, H.] Gifu Univ, Lab Vet Pathol, Gifu, Japan; [Yonemaru, K.; Hirata, A.; Sakai, H.] Gifu Univ, Comparat Canc Ctr, Gifu, Japan; [Hirata, A.] Gifu Univ, Div Anim Experimentat, Gifu, Japan	Sakai, H (reprint author), Gifu Univ, Lab Vet Pathol, 1-1 Yanagido, Gifu, Japan.	shiroki@gifu-u.ac.jp					Goldschmidt M, 2011, VET PATHOL, V48, P117, DOI 10.1177/0300985810393258; Bondoc A, 2014, J COMP PATHOL, V151, P186, DOI 10.1016/j.jcpa.2014.04.011; Dubielzig R.R., 2010, VET OCULAR PATHOLOGY, P143, DOI 10.1016/B978-0-7020-2797-0.00007-2; Ellis G, 2003, PATHOLOGY GENETICS H, P229; Goldschmidt M, 1998, HISTOLOGICAL CLASSIF, P28; Head KW, 2003, HIST CLASSIFICATION, P59; Jung MJ, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-171; Khalil M, 2000, OPHTHALMOLOGY, V107, P164, DOI 10.1016/S0161-6420(99)00007-X; Sozmen M, 2003, J VET MED A, V50, P399, DOI 10.1046/j.0931-184X.2003.00563.x; VOS JH, 1993, VET QUART, V15, P89; WILCOCK B, 1988, J AM VET MED ASSOC, V193, P1549; Wilcock B, 2002, HISTOLOGICAL CLASSIF, V9, P14; Yamagata K, 2006, PATHOL RES PRACT, V202, P475, DOI 10.1016/j.prp.2005.12.009	13	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9975	1532-3129		J COMP PATHOL	J. Comp. Pathol.	MAY	2015	152	4					299	303		10.1016/j.jcpa.2015.03.001		5	Pathology; Veterinary Sciences	Pathology; Veterinary Sciences	CI8XA	WOS:000355053800003		
J	Murotani, K; Nakai, M; Sato, M; Minamiguchi, H; Sonomura, T; Hosokawa, S; Nishioku, T				Murotani, Kazuhiro; Nakai, Motoki; Sato, Morio; Minamiguchi, Hiroki; Sonomura, Tetsuo; Hosokawa, Seiki; Nishioku, Tadayoshi			Change in Portal Vein Hemodynamics After Chemoembolization for Hepatocellular Carcinoma: Evaluation Through Multilevel Dynamic Multidetector Computed Tomography During Arterial Portography	JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY			English	Article						portal vein hemodynamics; transcatheter arterial chemoembolization; hepatocellular carcinoma; lipiodol; multilevel dynamic CT during arterial portography	HEPATIC ARTERIOGRAPHY; IMAGE QUALITY; HELICAL CT; EMBOLIZATION; LIVER; RESECTION; LIPIODOL; OIL	Objective: This study aimed to clarify the effect of embolization with lipiodol on portal vein hemodynamics. Methods: Time-density curves of the main portal vein on multilevel dynamic multidetector computed tomography during arterial portography were used to analyze peak computed tomography value (PV), time to PV (TPV), arrival time of contrast medium at the main portal vein (ATMPV), slope [(PV - 150) / (TPV - ATMPV)], and slope ratio (slope after embolization / slope before embolization). Results: In 20 patients with hepatoma, ATMPV and TPV were significantly prolonged and the time-density curve slope was significantly less after embolization. The difference in TPV increased (P = 0.02) and the slope ratio decreased with increasing embolized volume rate (P < 0.001). Strong correlation (R = -0.86) was found between the slope ratio and the embolized volume rate. Conclusions: Time-density curves revealed significant portal vein flow delay after embolization; the degree of which was correlated with the extent of the embolized volume.	[Murotani, Kazuhiro; Nakai, Motoki; Sato, Morio; Minamiguchi, Hiroki; Sonomura, Tetsuo; Hosokawa, Seiki; Nishioku, Tadayoshi] Wakayama Med Univ, Dept Radiol, Wakayama 6418510, Japan	Nakai, M (reprint author), Wakayama Med Univ, Dept Radiol, 811-1 Kimiidera, Wakayama 6418510, Japan.	morisato@wakayama-med.ac.jp					MATSUI O, 1985, J COMPUT ASSIST TOMO, V9, P19, DOI 10.1097/00004728-198501000-00004; Ueda K, 1998, RADIOLOGY, V206, P161; YAMADA R, 1983, RADIOLOGY, V148, P397; Camma C, 2002, RADIOLOGY, V224, P47, DOI 10.1148/radiol.2241011262; Murakami T, 1997, AM J ROENTGENOL, V169, P131; Rybicki FJ, 2008, INT J CARDIOVAS IMAG, V24, P535, DOI 10.1007/s10554-008-9308-2; Bronowicki JP, 1996, J HEPATOL, V24, P293, DOI 10.1016/S0168-8278(96)80007-9; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; May MS, 2014, ROFO-FORTSCHR RONTG, V186, P576, DOI 10.1055/s-0033-1356254; Bae T, 2003, RADIOLOGY, V227, P809; Hori M, 1998, ACTA RADIOL, V39, P144; KASUGAI H, 1989, GASTROENTEROLOGY, V97, P965; Kroft Lucia J M, 2010, Pediatr Radiol, V40, P294, DOI 10.1007/s00247-009-1436-x; Kropil P, 2014, ROFO-FORTSCHR RONTG, V186, P567, DOI 10.1055/s-0033-1356074; Lin DY, 1996, GASTROINTEST ENDOSC, V43, P132, DOI 10.1016/S0016-5107(06)80115-X; MATSUI O, 1987, RADIOLOGY, V165, P65; MIMURA H, 1986, WORLD J SURG, V10, P302; Miyayama S, 2012, JPN J RADIOL, V30, P263, DOI 10.1007/s11604-011-0043-6; NAGASUE N, 1983, ANN CHIR GYNAECOL FE, V72, P18; Nakai M, 2010, JPN J RADIOL, V28, P149, DOI 10.1007/s11604-009-0399-z; NAKAMURA H, 1988, RADIOLOGY, V167, P415; SATO M, 1993, CARDIOVASC INTER RAD, V16, P348, DOI 10.1007/BF02603139; SIRINEK KR, 1974, SURG GYNECOL OBSTET, V139, P573	23	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-8715	1532-3145		J COMPUT ASSIST TOMO	J. Comput. Assist. Tomogr.	MAY-JUN	2015	39	3					396	400				5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CI4KS	WOS:000354718100015		
J	Hiraka, T; Kanoto, M; Sugai, Y; Honma, T; Makino, N; Ueno, Y; Hosoya, T				Hiraka, Toshitada; Kanoto, Masafumi; Sugai, Yukio; Honma, Tsuguo; Makino, Naohiko; Ueno, Yoshiyuki; Hosoya, Takaaki			Computed Tomographic Findings of Enterohemorrhagic Escherichia coli O157 Infection: An Analysis of a 7-Case Regional Outbreak	JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY			English	Article						enterohemorrhagic E. coli (EHEC); O157; colitis; CT	FEATURES	Purpose: We experienced an outbreak of enterohemorrhagic Escherichia coli (EHEC) colitis. The purpose of this study was to reveal the computed tomographic (CT) findings on EHEC colitis. Methods: The subjects were 7 patients with EHEC colitis, which was caused by eating a contaminated Japanese rice cake. Contrast CT was performed on all patients. Two radiologists evaluated the CT findings (the thickness of colon wall, the range of thickened colon, and the existence of dirty fat signs around the colon, ascites, and swelling of lymph nodes), in accordance with our PACS system. Results: Wall swelling of the proximal colon from cecum to ascending colon was noted in all patients. Small intestine lesions were not noted in any cases. Conclusions: We should consider EHEC infection as part of a differential diagnosis when the findings of severe right colitis are seen without enteritis.	[Hiraka, Toshitada; Kanoto, Masafumi; Sugai, Yukio; Hosoya, Takaaki] Yamagata Univ, Fac Med, Dept Diagnost Radiol, Yamagata 9909585, Japan; [Honma, Tsuguo] Yamagata Prefectural Cent Hosp, Dept Diagnost Radiol, Yamagata, Japan; [Makino, Naohiko; Ueno, Yoshiyuki] Yamagata Univ, Fac Med, Dept Gastroenterol, Yamagata 990, Japan	Hiraka, T (reprint author), Yamagata Univ, Fac Med, Dept Diagnost Radiol, 2-2-2 Iida Nishi, Yamagata 9909585, Japan.	hirakatoshitada@gmail.com					Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Mead PS, 1998, LANCET, V352, P1207, DOI 10.1016/S0140-6736(98)01267-7; Bannas P, 2013, ROFO-FORTSCHR RONTG, V185, P434, DOI 10.1055/s-0032-1330520; CohenMB, 1996, LANCET, V43, P171; KELLY J, 1990, AM J SURG PATHOL, V14, P87, DOI 10.1097/00000478-199001000-00010; Miller FH, 2001, AM J ROENTGENOL, V177, P619; Morgan John, 2007, Emerg Radiol, V14, P187, DOI 10.1007/s10140-007-0585-1; Pocock G, 2013, HUMAN PHYSL, V4th, P619; Takashi S, 2008, DIGEST ENDOSC, V20, P123	9	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-8715	1532-3145		J COMPUT ASSIST TOMO	J. Comput. Assist. Tomogr.	MAY-JUN	2015	39	3					406	408				3	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CI4KS	WOS:000354718100017		
J	Mori, T; Ito, F; Matsushima, H; Takaoka, O; Koshiba, A; Tanaka, Y; Kusuki, I; Kitawaki, J				Mori, Taisuke; Ito, Fumitake; Matsushima, Hiroshi; Takaoka, Osamu; Koshiba, Akemi; Tanaka, Yukiko; Kusuki, Izumi; Kitawaki, Jo			Dienogest reduces HSD17 beta 1 expression and activity in endometriosis	JOURNAL OF ENDOCRINOLOGY			English	Article						17 beta-hydroxysteroid dehydrogenase 1; dienogest; endometriosis; ovarian endometrioma; spheroid culture	NECROSIS-FACTOR-ALPHA; PROSTAGLANDIN E-2 PRODUCTION; MESSENGER-RIBONUCLEIC-ACID; STROMAL CELLS; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE-2; EPITHELIAL-CELLS; AROMATASE EXPRESSION; SYNTHETIC PROGESTIN; SPHEROID CULTURE; 17-BETA-ESTRADIOL	Endometriosis is an estrogen-dependent disease. Abnormally biosynthesized estrogens in endometriotic tissues induce the growth of the lesion and worsen endometriosis-associated pelvic pain. Dienogest (DNG), a selective progesterone receptor agonist, is widely used to treat endometriosis and efficiently relieves the symptoms. However, its pharmacological action remains unknown. In this study, we elucidated the effect of DNG on enzymes involved in local estrogen metabolism in endometriosis. Surgically obtained specimens of 23 ovarian endometriomas (OE) and their homologous endometrium (EE), ten OE treated with DNG (OE w/D), and 19 normal endometria without endometriosis (NE) were analyzed. Spheroid cultures of stromal cells (SCs) were treated with DNG and progesterone. The expression of aromatase, 17 beta-hydroxysteroid dehydrogenase 1 (HSD17 beta 1), HSD17 beta 2, HSD17 beta 7, HSD17 beta 12, steroid sulfatase (STS), and estrogen sulfotransferase (EST) was evaluated by real-time quantitative PCR. The activity and protein level of HSD17 beta 1 were measured with an enzyme assay using radiolabeled estrogens and immunohistochemistry respectively. OESCs showed increased expression ofaromatase, HSD17 beta 1, STS, and EST, along with decreased HSD17 beta 2 expression, when compared with stromal cells from normal endometria without endometriosis (NESCs) (P<0.01) or stromal cells from homologous endometrium (EESCs) (P<0.01). In OESCs, DNG inhibited HSD17 beta 1 expression and enzyme activity at 10(-7) M (P<0.01). Results of immunohistochemical analysis displayed reduced HSD17 beta 1 staining intensity in OE w/D (P<0.05). In conclusion, DNG exerts comprehensive inhibition of abnormal estrogen production through inhibition of aromatase and HSD17 beta 1, contributing to a therapeutic effect of DNG on endometriosis.	[Mori, Taisuke; Ito, Fumitake; Matsushima, Hiroshi; Takaoka, Osamu; Koshiba, Akemi; Tanaka, Yukiko; Kusuki, Izumi; Kitawaki, Jo] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Obstet & Gynecol, Kamigyo Ku, Kyoto 6028566, Japan	Mori, T (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Obstet & Gynecol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	moriman@koto.kpu-m.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (Japan) [24592480, 23197849]	This work was supported in part by a Grant-in-Aid for Scientific Research 24592480 and 23197849 from the Ministry of Education, Culture, Sports, Science and Technology (Japan).	Moeller G, 2006, MOL CELL ENDOCRINOL, V248, P47, DOI 10.1016/j.mce.2005.11.031; Strowitzki T, 2010, HUM REPROD, V25, P633, DOI 10.1093/humrep/dep469; Smuc T, 2007, GYNECOL ENDOCRINOL, V23, P105, DOI 10.1080/09513590601152219; Fu L, 2008, FERTIL STERIL, V89, P1344, DOI 10.1016/j.fertnstert.2007.03.042; Okada H, 2001, MOL HUM REPROD, V7, P341, DOI 10.1093/molehr/7.4.341; Dassen H, 2007, HUM REPROD, V22, P3148, DOI 10.1093/humrep/dem310; Kitawaki J, 1997, BIOL REPROD, V57, P514, DOI 10.1095/biolreprod57.3.514; Yamanaka K, 2012, FERTIL STERIL, V97, P477, DOI 10.1016/j.fertnstert.2011.11.005; Horie S, 2005, FERTIL STERIL, V83, P1530, DOI 10.1016/j.fertnstert.2004.11.042; Vaheri A, 2009, EXP CELL RES, V315, P1633, DOI 10.1016/j.yexcr.2009.03.005; Sasagawa S, 2008, STEROIDS, V73, P222, DOI 10.1016/j.steroids.2007.10.003; Shimizu Y, 2009, MOL HUM REPROD, V15, P693, DOI 10.1093/molehr/gap042; Utsunomiya H, 2004, CLIN CANCER RES, V10, P5850, DOI 10.1158/1078-0432.CCR-04-0040; Day JM, 2008, ENDOCR-RELAT CANCER, V15, P665, DOI 10.1677/ERC-08-0042; Delvoux B, 2014, J CLIN ENDOCR METAB, V99, P276, DOI 10.1210/jc.2013-2851; Momoeda M, 2009, J OBSTET GYNAECOL RE, V35, P1069, DOI 10.1111/j.1447-0756.2009.01076.x; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Noble LS, 1996, J CLIN ENDOCR METAB, V81, P174, DOI 10.1210/jc.81.1.174; Harada T, 2009, FERTIL STERIL, V91, P675, DOI 10.1016/j.fertnstert.2007.12.080; Zeitoun K, 1998, J CLIN ENDOCR METAB, V83, P4474, DOI 10.1210/jc.83.12.4474; Petraglia F, 2012, ARCH GYNECOL OBSTET, V285, P167, DOI 10.1007/s00404-011-1941-7; Beranic N, 2012, J STEROID BIOCHEM, V132, P303, DOI 10.1016/j.jsbmb.2012.07.004; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Colette Sébastien, 2013, Fertil Steril, V100, P1642, DOI 10.1016/j.fertnstert.2013.08.003; Enzerink A, 2009, MOL IMMUNOL, V46, P1787, DOI 10.1016/j.molimm.2009.01.018; Kitawaki J, 2000, J CLIN ENDOCR METAB, V85, P3292, DOI 10.1210/jc.85.9.3292; Maeda N, 2014, EUR J OBSTET GYN R B, V177, P48, DOI 10.1016/j.ejogrb.2014.03.019; Matsuzaki S, 2006, FERTIL STERIL, V85, P308, DOI 10.1016/j.fertnstert.2005.08.017; McCormack PL, 2010, DRUGS, V70, P2073, DOI 10.2165/11206320-000000000-00000; Meriggiola MC, 2002, J CLIN ENDOCR METAB, V87, P2107, DOI 10.1210/jc.87.5.2107; Mita S, 2014, FERTIL STERIL, V101, P595, DOI 10.1016/j.fertnstert.2013.10.038; Mita S, 2011, FERTIL STERIL, V96, P1485, DOI 10.1016/j.fertnstert.2011.09.040; Poirier D, 2011, J STEROID BIOCHEM, V125, P83, DOI 10.1016/j.jsbmb.2010.12.007; Shimizu Y, 2011, STEROIDS, V76, P60, DOI 10.1016/j.steroids.2010.08.010	34	0	0	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	0022-0795	1479-6805		J ENDOCRINOL	J. Endocrinol.	MAY	2015	225	2					69	76		10.1530/JOE-15-0052		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CI6QX	WOS:000354887100004		
J	Otawa, M; Tanoue, R; Kido, H; Sawa, Y; Yamashita, J				Otawa, Masato; Tanoue, Ryuichiro; Kido, Hirofumi; Sawa, Yoshihiko; Yamashita, Junro			Intermittent Administration of Parathyroid Hormone Ameliorates Periapical Lesions in Mice	JOURNAL OF ENDODONTICS			English	Article						Lymphotoxin alpha; neutrophil infiltration; parathyroid hormone; periapical periodontitis	BONE LOSS; RANDOM MIGRATION; DEFICIENT MICE; PTH; PERIODONTITIS; RATS; REGENERATION; DESTRUCTION; LYMPHOCYTES; MECHANISMS	Introduction: Intermittent administration of parathy raid hormone (PTH) promotes oral osseous wound healing and protects against ligature-induced alveolar bone loss. However, its therapeutic value on periapical periodontitis is unknown. The goal of this study was to determine the effect of intermittent PTH administration on the progression of periapical periodontitis. Methods: Seven lymphotoxin alpha deficient mice received pulp exposures of mandibular first and second molars. Exposed pulp in the right mandible was covered with plaque-contaminated fibrin, whereas exposed pulp in the left mandible was left open. After 4 weeks, the perk apical tissues were examined to determine the effect of plaque-contaminated fibrin to induce periapical lesions. Fourteen mice received pulp exposure covered with plaque-contaminated fibrin. PTH (40 Ag/kg/d) was administered intermittently to half of the mice for 3 weeks beginning 1 week after pulp exposure. The remaining half received saline injections as the vehicle control. At sacrifice, mandibles and tibiae were harvested and processed for histologic examination. Evaluation of neutrophils and blood vessels was performed after staining with immunofluorescence, and periradicular bone was histomorphometrically analyzed. Results: The exposed pulp covered with plaque-contaminated fibrin resulted in significantly larger periapical lesions compared with the control. Intermittent PTH administration reduced the size of periapical lesions significantly. Significantly less neutrophil infiltration around the root apex was found in PTH-treated animals compared with the control. Conclusions: PTH treatment suppressed periapical inflammation by reducing neutrophil infiltration and protected against tissue destruction by periapical periodontitis.	[Otawa, Masato; Tanoue, Ryuichiro; Yamashita, Junro] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Div Prosthodont, Ann Arbor, MI 48109 USA; [Kido, Hirofumi] Fukuoka Dent Coll, Dept Oral Rehabil, Sect Oral Implantol, Fukuoka, Japan; [Sawa, Yoshihiko] Fukuoka Dent Coll, Dept Morphol Biol, Fukuoka, Japan; [Tanoue, Ryuichiro] Kurume Univ, Sch Med, Dent & Oral Med Ctr, Kurume, Fukuoka 830, Japan	Yamashita, J (reprint author), Univ Michigan, Sch Dent, 1011 North Univ Ave, Ann Arbor, MI 48109 USA.	yamashit@umich.edu			NIH/NIDCR [R01DE023538-01]	Supported by the NIH/NIDCR (grant no. R01DE023538-01) (J.Y.).	ALEXIEWICZ JM, 1991, AM J NEPHROL, V11, P102, DOI 10.1159/000168284; ALEXIEWICZ JM, 1990, J AM SOC NEPHROL, V1, P236; AlShwaimi E, 2013, J IMMUNOL, V191, P1785, DOI 10.4049/jimmunol.1202194; Kuroshima S, 2014, OSTEOPOROSIS INT, V25, P1141, DOI 10.1007/s00198-013-2570-8; Marton IJ, 2014, J ENDODONT, V40, P155, DOI 10.1016/j.joen.2013.10.036; AlShwaimi E, 2009, J ENDODONT, V35, P1229, DOI 10.1016/j.joen.2009.06.006; Hahn CL, 2007, J ENDODONT, V33, P773, DOI 10.1016/j.joen.2007.01.002; Kuroshima S, 2013, J DENT RES, V92, P553, DOI 10.1177/0022034513487558; Fukada SY, 2008, J DENT RES, V87, P1155; Nakajima A, 2002, J BONE MINER RES, V17, P2038, DOI 10.1359/jbmr.2002.17.11.2038; von Stechow D, 2003, J ENDODONT, V29, P252, DOI 10.1097/00004770-200304000-00005; Peichl P, 2011, J BONE JOINT SURG AM, V93A, P1583, DOI 10.2106/JBJS.J.01379; Bashutski JD, 2010, NEW ENGL J MED, V363, P2396, DOI 10.1056/NEJMoa1005361; Mounzer RH, 2010, BLOOD, V116, P2173, DOI 10.1182/blood-2009-12-256065; Barros SP, 2003, J DENT RES, V82, P791; BANKS TA, 1995, J IMMUNOL, V155, P1685; Abe T, 2013, J IMMUNOL METHODS, V394, P49, DOI 10.1016/j.jim.2013.05.002; Dobnig H, 1997, ENDOCRINOLOGY, V138, P4607, DOI 10.1210/en.138.11.4607; BAUMGARTNER JC, 1991, J ENDODONT, V17, P380; Chu FCS, 2005, J ENDODONT, V31, P424, DOI 10.1097/01.don.0000148149.27636.9c; DOHERTY CC, 1988, AM J NEPHROL, V8, P212, DOI 10.1159/000167585; Iida-Klein A, 2002, J BONE MINER RES, V17, P808, DOI 10.1359/jbmr.2002.17.5.808; Kaneko T, 1997, CLIN NEPHROL, V48, P353; KHAN F, 1979, J CLIN ENDOCR METAB, V48, P582; Kuroshima S, 2014, J PERIODONTOL, V85, P24, DOI 10.1902/jop.2013.130094; Kuroshima S, 2013, IMPLANT DENT, V22, P71, DOI 10.1097/ID.0b013e318278f94d; Matsuo T, 2003, J ENDODONT, V29, P194, DOI 10.1097/00004770-200303000-00008; McAbee J, 2012, J ENDODONT, V38, P1097, DOI 10.1016/j.joen.2012.04.016; PERRY HM, 1984, J BIOL CHEM, V259, P5531; Samadfam R, 2008, J BONE MINER RES, V23, P1257, DOI [10.1359/jbmr.080318, 10.1359/JBMR.080318]; Taichman N S, 1977, J Endod, V3, P292, DOI 10.1016/S0099-2399(77)80033-2; TUMA SN, 1981, J LAB CLIN MED, V97, P291; Wagner C, 2008, IMMUNOLOGY, V125, P503, DOI 10.1111/j.1365-2567.2008.02863.x; YAMAMOTO I, 1983, J CLIN INVEST, V71, P404, DOI 10.1172/JCI110784; Yamashita J, 2008, J BONE MINER RES, V23, P621, DOI 10.1359/JBMR.071211	35	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0099-2399	1878-3554		J ENDODONT	J. Endod.	MAY	2015	41	5					646	651		10.1016/j.joen.2014.12.008		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CI2SL	WOS:000354597200012		
J	Onoda, Y; Schieving, F; Anten, NPR				Onoda, Yusuke; Schieving, Feike; Anten, Niels P. R.			A novel method of measuring leaf epidermis and mesophyll stiffness shows the ubiquitous nature of the sandwich structure of leaf laminas in broad-leaved angiosperm species	JOURNAL OF EXPERIMENTAL BOTANY			English	Article						Biodiversity; biomechanics; cuticle; epidermis; evolution; leaf anatomy; mechanical design; mesophyll; sandwich structure; turgor pressure	HERBACEOUS PLANTS; TISSUE STRESSES; MECHANICAL-PROPERTIES; MAIZE LEAF; BIOMECHANICS; ORGANS; GROWTH; PERSPECTIVE; IRRADIANCE; SUNFLOWER	Leaf laminas are designed in sandwich structure, a very efficient structure used in e.g. airplane wing, which enables leaves to be thin, flat, ideal for photosynthesis but also mechanically stable.Plant leaves commonly exhibit a thin, flat structure that facilitates a high light interception per unit mass, but may increase risks of mechanical failure when subjected to gravity, wind and herbivory as well as other stresses. Leaf laminas are composed of thin epidermis layers and thicker intervening mesophyll layers, which resemble a composite material, i.e. sandwich structure, used in engineering constructions (e.g. airplane wings) where high bending stiffness with minimum weight is important. Yet, to what extent leaf laminas are mechanically designed and behave as a sandwich structure remains unclear. To resolve this issue, we developed and applied a novel method to estimate stiffness of epidermis- and mesophyll layers without separating the layers. Across a phylogenetically diverse range of 36 angiosperm species, the estimated Young's moduli (a measure of stiffness) of mesophyll layers were much lower than those of the epidermis layers, indicating that leaf laminas behaved similarly to efficient sandwich structures. The stiffness of epidermis layers was higher in evergreen species than in deciduous species, and strongly associated with cuticle thickness. The ubiquitous nature of sandwich structures in leaves across studied species suggests that the sandwich structure has evolutionary advantages as it enables leaves to be simultaneously thin and flat, efficiently capturing light and maintaining mechanical stability under various stresses.	[Onoda, Yusuke; Schieving, Feike; Anten, Niels P. R.] Univ Utrecht, Inst Environm Sci, Sect Plant Ecol & Biodivers, NL-3508 TB Utrecht, Netherlands; [Onoda, Yusuke] Kyoto Univ, Dept Agr, Kyoto 6068502, Japan; [Anten, Niels P. R.] Wageningen Univ, Ctr Crop Syst Anal, NL-6700 AK Wageningen, Netherlands	Onoda, Y (reprint author), Univ Utrecht, Inst Environm Sci, Sect Plant Ecol & Biodivers, POB 800-84, NL-3508 TB Utrecht, Netherlands.	yusuke.onoda@gmail.com	Onoda, Yusuke/L-7179-2015	Onoda, Yusuke/0000-0001-6245-2342	JSPS	We thank Andrew Allen, Tancrede Almeras, Heinjo During, Sean Gleason, Hidetoshi Kobayashi, Josh Madin, Bruno Moulia, Jack Putz, Marinus Werger, Mark Westoby and anonymous referees for discussion and comments on the manuscript, Yuko Yasumura for help with biomechanics measurement, and Betty Verduyn and Beatriz Cervantes for help with leaf anatomy analysis. This study was partly supported by Grant-in-Aid from JSPS for Young Research Fellows to YO.	Bargel H, 2006, FUNCT PLANT BIOL, V33, P893, DOI 10.1071/FP06139; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Brodribb TJ, 2007, PLANT PHYSIOL, V144, P1890, DOI 10.1104/pp.107.101352; Sack L, 2013, J EXP BOT, V64, P4053, DOI 10.1093/jxb/ert316; Terashima I, 2011, PLANT PHYSIOL, V155, P108, DOI 10.1104/pp.110.165472; Baskin TI, 2013, J EXP BOT, V64, P4697, DOI 10.1093/jxb/ert176; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; Niklas KJ, 1999, NEW PHYTOL, V143, P19, DOI 10.1046/j.1469-8137.1999.00441.x; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Onoda Y, 2011, ECOL LETT, V14, P301, DOI 10.1111/j.1461-0248.2010.01582.x; Kutschera U, 2007, J PLANT PHYSIOL, V164, P1395, DOI 10.1016/j.jplph.2007.08.002; Niklas KJ, 1997, AM J BOT, V84, P735, DOI 10.2307/2445809; Braybrook SA, 2010, PLANT CELL, V22, P1006, DOI 10.1105/tpc.110.073924; Hejnowicz Z, 1996, J EXP BOT, V47, P519, DOI 10.1093/jxb/47.4.519; Lee DW, 2000, AM J BOT, V87, P447, DOI 10.2307/2656588; Read J, 2006, AM J BOT, V93, P1546, DOI 10.3732/ajb.93.10.1546; Fournier M, 2013, J EXP BOT, V64, P4793, DOI 10.1093/jxb/ert279; Bremer B, 2009, BOT J LINN SOC, V161, P105; Blankenship R. E., 2014, MOL MECH PHOTOSYNTHE; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fung Y., 1993, BIOMECHANICS MECH PR; Gere JM, 1999, MECH MAT; GIBSON LJ, 1988, J MATER SCI, V23, P3041, DOI 10.1007/BF00551271; Givnish TJ., 1986, EC PLANT FORM FUNCTI, P525; Grubb P.J., 1986, P137; HEJNOWICZ Z, 1995, J EXP BOT, V46, P1045, DOI 10.1093/jxb/46.8.1045; HEJNOWICZ Z, 1995, J EXP BOT, V46, P1035, DOI 10.1093/jxb/46.8.1035; Kitajima K, 2010, NEW PHYTOL, V186, P708, DOI 10.1111/j.1469-8137.2010.03212.x; Kobayashi H, 2000, J SOC MATER SCI JPN, V49, P1318; Kobayashi H, 2002, ESDA 2002 6 BIENN C; Lambers H., 1998, PLANT PHYSL ECOLOGY; LUCAS PW, 1991, PHILOS T ROY SOC B, V334, P95, DOI 10.1098/rstb.1991.0099; MOULIA B, 1994, J MATER SCI, V29, P2359, DOI 10.1007/BF00363427; Moulia B, 2013, J EXP BOT, V64, P4617, DOI 10.1093/jxb/ert320; Moulia B, 1997, J MATER SCI, V32, P2771, DOI 10.1023/A:1018604012754; Niinemets U, 2002, PLANT BIOLOGY, V4, P523, DOI 10.1055/s-2002-34132; Niklas K. J., 1992, PLANT BIOMECHANICS E; NIKLAS KJ, 1991, AM J BOT, V78, P561, DOI 10.2307/2445265; Onoda Y, 2012, NEW PHYTOL, V196, P441, DOI 10.1111/j.1469-8137.2012.04263.x; Onoda Y, 2008, ANN BOT-LONDON, V101, P727, DOI 10.1093/aob/mcn013; Paradis E., 2012, ANAL PHYLOGENETICS E, P203; PARKHURST DF, 1977, J THEOR BIOL, V67, P471, DOI 10.1016/0022-5193(77)90050-9; Roderick ML, 1999, FUNCT ECOL, V13, P683, DOI 10.1046/j.1365-2435.1999.00368.x; Tadrist L, 2014, J THEOR BIOL, V341, P9, DOI 10.1016/j.jtbi.2013.09.025; Vandiver R, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/58004; VINCENT JFV, 1982, J MATER SCI, V17, P856, DOI 10.1007/BF00540384; VOGEL S, 1989, J EXP BOT, V40, P941, DOI 10.1093/jxb/40.8.941; Wiedemann P, 1998, BOT ACTA, V111, P28	50	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0957	1460-2431		J EXP BOT	J. Exp. Bot.	MAY	2015	66	9					2487	2499		10.1093/jxb/erv024		13	Plant Sciences	Plant Sciences	CI4SB	WOS:000354742200010		
J	Lu, Y; Sasaki, Y; Li, XW; Mori, IC; Matsuura, T; Hirayama, T; Sato, T; Yamaguchi, J				Lu, Yu; Sasaki, Yuki; Li, Xingwen; Mori, Izumi C.; Matsuura, Takakazu; Hirayama, Takashi; Sato, Takeo; Yamaguchi, Junji			ABI1 regulates carbon/nitrogen-nutrient signal transduction independent of ABA biosynthesis and canonical ABA signalling pathways in Arabidopsis	JOURNAL OF EXPERIMENTAL BOTANY			English	Article						Abscisic acid; C/N balance; FOX hunting system; nutrient signal; SnRK; sugar signal	2C PROTEIN PHOSPHATASES; ABSCISIC-ACID; GENE-EXPRESSION; INSENSITIVE MUTANTS; RESPONSE PATHWAYS; SUGAR; PLANTS; METABOLISM; KINASES; STRESS	ABI1 was identified as the corresponding gene of the C/N-nutrient response mutant cni2-D. This study provides a new insight into the cross-talk between C/N and ABA signalling under the control of ABI1.Plants are able to sense and mediate the balance between carbon (C) and nitrogen (N) nutrient availability to optimize metabolism and growth, described as the C/N response. To clarify the C/N signalling mechanism, C/N-insensitive plants were obtained from an Arabidopsis FOX hunting population, which over-expresses full-length cDNAs for individuals. The resulting cni2-D (carbon/nitrogen insensitive 2-dominant) plant was found to overcome the post-germination growth checkpoint and to expand green cotyledons in disrupted high C/low N stress conditions. The CNI2 gene encodes ABI1, a phosphatase type 2C protein, which negatively regulates abscisic acid (ABA) signal transduction. Over-expressors of ABI1 were found to be insensitive to disrupted C/N stress, whereas the loss-of function mutant abi1-2 was hypersensitive, suggesting that ABI1 plays an essential role in the plant C/N response. By contrast, the C/N-dependent growth phenotype observed in wild-type plants was not associated with endogenous ABA content. Accordingly, the ABA-insensitive mutant abi1-1, which could not bind to the ABA-ABA receptor complex, was not insensitive and restored normal sensitivity to high C/low N stress. The canonical ABA signalling mutants abi4 and abi5 were also sensitive to disrupted C/N stress. Further gene expression analysis demonstrated that several genes in the SnRK2s and SnRK1s pathways are transcriptionally affected by high C/low N stress in wild-type plants regardless of the lack of increased endogenous ABA contents, whereas the expression of these genes were significantly suppressed in ABI1 over-expressors. Taken together, these results suggest direct cross-talk between C/N and non-canonical ABA signalling pathways, regulated by ABI1, in plants.	[Lu, Yu; Sasaki, Yuki; Li, Xingwen; Sato, Takeo; Yamaguchi, Junji] Hokkaido Univ, Fac Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Lu, Yu; Sasaki, Yuki; Li, Xingwen; Sato, Takeo; Yamaguchi, Junji] Hokkaido Univ, Grad Sch Life Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Mori, Izumi C.; Matsuura, Takakazu; Hirayama, Takashi] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama 7100046, Japan	Yamaguchi, J (reprint author), Hokkaido Univ, Fac Sci, Kita Ku, N10-W8, Sapporo, Hokkaido 0600810, Japan.	jjyama@sci.hokudai.ac.jp	HIRAYAMA, Takashi/B-2496-2011	HIRAYAMA, Takashi/0000-0002-3868-2380	Japan Society for the Promotion of Science (JSPS) [2511250104, 2629218884, 2666004604, 24770035]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) as part of Joint Research Programme implemented at the Institute of Plant Science and Resources, Okayama University in Japan; Special Grant Programme for Young Foreign Scientists in Basic Science (Hokkaido University Faculty of Science); MEXT Honours Scholarship for Privately Financed International Students	We thank Drs Matsui and Ichikawa of the RIKEN Plant Science Center and RIKEN Bioresource Center for the Arabidopsis FOX lines and Arabidopsis cDNA. This work was supported by the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research Nos 2511250104, 2629218884, and 2666004604 to JY and 24770035 to TS. This work was also supported by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) as part of Joint Research Programme implemented at the Institute of Plant Science and Resources, Okayama University in Japan. LY was supported by a Special Grant Programme for Young Foreign Scientists in Basic Science (Hokkaido University Faculty of Science: 2014-2015) and MEXT Honours Scholarship for Privately Financed International Students (2014).	Acevedo-Hernandez GJ, 2005, PLANT J, V43, P506, DOI 10.1111/j.1365-313X.2005.02468.x; Stitt M, 2010, PLANT J, V61, P1067, DOI 10.1111/j.1365-313X.2010.04142.x; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Yang Y, 2011, PLANT PHYSIOL, V156, P873, DOI 10.1104/pp.111.175950; Saez A, 2006, PLANT PHYSIOL, V141, P1389, DOI 10.1104/pp.106.081018; Martin T, 2002, PLANT PHYSIOL, V128, P472, DOI 10.1104/pp.128.2.472; Arenas-Huertero F, 2000, GENE DEV, V14, P2085; Huijser C, 2000, PLANT J, V23, P577, DOI 10.1046/j.1365-313x.2000.00822.x; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Laby RJ, 2000, PLANT J, V23, P587, DOI 10.1046/j.1365-313x.2000.00833.x; Sato T, 2009, PLANT J, V60, P852, DOI 10.1111/j.1365-313X.2009.04006.x; Kiba T, 2011, J EXP BOT, V62, P1399, DOI 10.1093/jxb/erq410; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Ichikawa T, 2006, PLANT J, V48, P974, DOI 10.1111/j.1365-313X.2006.02924.x; Dekkers BJW, 2008, PLANT MOL BIOL, V67, P151, DOI 10.1007/s11103-008-9308-6; Coruzzi GM, 2001, CURR OPIN PLANT BIOL, V4, P247, DOI 10.1016/S1369-5266(00)00168-0; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Comparot S, 2003, J EXP BOT, V54, P595, DOI 10.1093/jxb/erg057; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; Jossier M, 2009, PLANT J, V59, P316, DOI 10.1111/j.1365-313X.2009.03871.x; Vlad F, 2009, PLANT CELL, V21, P3170, DOI 10.1105/tpc.109.069179; Santiago J, 2012, PLANT SCI, V182, P3, DOI 10.1016/j.plantsci.2010.11.014; Rook F, 2006, PLANT CELL ENVIRON, V29, P426, DOI 10.1111/j.1365-3040.2005.01477.x; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Baena-Gonzalez E, 2008, TRENDS PLANT SCI, V13, P474, DOI 10.1016/j.tplants.2008.06.006; Smeekens S, 2010, CURR OPIN PLANT BIOL, V13, P274, DOI 10.1016/j.pbi.2009.12.002; Leon P, 2003, TRENDS PLANT SCI, V8, P110, DOI 10.1016/S1360-1385(03)00011-6; Fujii H, 2011, P NATL ACAD SCI USA, V108, P1717, DOI 10.1073/pnas.1018367108; Krouk G, 2010, CURR OPIN PLANT BIOL, V13, P266, DOI 10.1016/j.pbi.2009.12.003; Signora L, 2001, PLANT J, V28, P655, DOI 10.1046/j.1365-313x.2001.01185.x; Palenchar PM, 2004, GENOME BIOL, V5; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Rodrigues A, 2013, PLANT CELL, V25, P3871, DOI 10.1105/tpc.113.114066; MEYER K, 1994, SCIENCE, V264, P1452, DOI 10.1126/science.8197457; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; Lunn JE, 2014, PLANT J, V79, P544, DOI 10.1111/tpj.12509; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Mizoguchi M, 2010, PLANT CELL PHYSIOL, V51, P842, DOI 10.1093/pcp/pcq041; FINKELSTEIN RR, 1994, PLANT J, V5, P765, DOI 10.1046/j.1365-313X.1994.5060765.x; Gutierrez RA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r7; Iehisa JCM, 2014, J PLANT PHYSIOL, V171, P25, DOI 10.1016/j.jplph.2013.10.001; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Oka M, 2012, J PLANT PHYSIOL, V169, P789, DOI 10.1016/j.jplph.2012.02.001; Rook F, 2003, J EXP BOT, V54, P495, DOI 10.1093/jxb/erg054; Sato T, 2011, PLANT J, V68, P137, DOI 10.1111/j.1365-313X.2011.04673.x	46	5	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0957	1460-2431		J EXP BOT	J. Exp. Bot.	MAY	2015	66	9					2763	2771		10.1093/jxb/erv086		9	Plant Sciences	Plant Sciences	CI4SB	WOS:000354742200030		
J	Sato, N; Araki, A; Ito, R; Ishigaki, K				Sato, Naho; Araki, Akiko; Ito, Ryuko; Ishigaki, Kazuko			Exploring the Beliefs of Japanese Mothers Caring for a Child With Disabilities	JOURNAL OF FAMILY NURSING			English	Article						beliefs; family; mothers; children with disabilities; Japan; Illness Beliefs Model	DEVELOPMENTAL-DISABILITIES; FAMILIES; PARENTS; STRESS; METAANALYSIS; MANAGEMENT; ILLNESS; HEALTH	The purpose of this study was to describe the beliefs of Japanese mothers caring for a child with disabilities to advance knowledge about beliefs of Japanese families experiencing illness. A semistructured interview was conducted with eight mothers who had a child with disabilities (physical, intellectual, and/or developmental). The interview invited their reflections about mutual thoughts of family members and family relationships in the context of daily life of caring for a child with disabilities. Data were qualitatively analyzed inductively and deductively and compared with the Common Tentative Framework of Japanese Family Beliefs developed from previous research. The analyses highlighted new understandings of the influence of Japanese cultural and societal beliefs on the family's experience of having a child with disabilities. Clinical implications are discussed and directions for future research suggested.	[Sato, Naho] Chiba Univ Grad Sch Nursing, Dept Adv Practice Nursing, Div Child Hlth Care Nursing, Chiba 2608672, Japan; [Araki, Akiko] Chiba Rehabil Ctr, Dept Nursing, Chiba, Japan; [Ito, Ryuko] Juntendo Univ, Fac Hlth Care & Nursing, Grad Sch Hlth Care & Nursing, Chiba, Japan; [Ishigaki, Kazuko] Ishikawa Prefectural Nursing Univ, Fac Nursing, Div Community Hlth Nursing, Kahoku, Ishikawa, Japan	Sato, N (reprint author), Chiba Univ Grad Sch Nursing, Chuo Ku, 1-8-1 Inohana, Chiba 2608672, Japan.	naho.sato@faculty.chiba-u.jp			Japan Society for the Promotion of Science (JSPS)	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Funding for this study was partially provided by the Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (JSPS).	Raina P, 2005, PEDIATRICS, V115, pE626, DOI 10.1542/peds.2004-1689; Lee J, 2013, RES DEV DISABIL, V34, P4255, DOI 10.1016/j.ridd.2013.09.008; Swallow V, 2012, HEALTH EXPECT, V15, P157, DOI 10.1111/j.1369-7625.2011.00674.x; Knafl KA, 2012, J FAM NURS, V18, P11, DOI 10.1177/1074840711427294; Rolland JS, 2006, CURR OPIN PEDIATR, V18, P527, DOI 10.1097/01.mop.0000245354.83454.68; Kyzar KB, 2012, RES PRACT PERS SEV D, V37, P31; Keller D, 2004, AM J ORTHOPSYCHIAT, V74, P337, DOI 10.1037/0002-9432.74.3.337; Wright LM, 2015, J FAM NURS, V21, P186, DOI 10.1177/1074840715575822; Aston M., 2014, J INTELL DISABIL RES, V18, P221, DOI [10.1177/1744629514538877, DOI 10.1177/1744629514538877]; Bell J. M., 2011, FAMILY NURSING ACTIO, P15; Berry J. G., 2013, LANDSCAPE MED CARE C; DROTAR D, 1975, PEDIATRICS, V56, P710; Dyches TT, 2012, RES DEV DISABIL, V33, P2213, DOI 10.1016/j.ridd.2012.06.015; Feudtner C, 2015, JAMA PEDIATR, V169, P39, DOI 10.1001/jamapediatrics.2014.2341; Ichihara M., 2007, J CHIBA ACAD NURSING, V13, P77; Ito I., 2010, J SCH NURSING CHIBA, V32, P63; Kazak AE, 2004, J PEDIATR PSYCHOL, V29, P531, DOI 10.1093/jpepsy/jsh055; Kimura M, 2013, QUAL HEALTH RES, V23, P1307, DOI 10.1177/1049732313504828; King GA, 2006, CHILD CARE HLTH DEV, V32, P353, DOI 10.1111/j.1365-2214.2006.00571.x; McConnell D., 2015, CURRENT DEV DISORDER, V2, P100, DOI [10.1007/s40474-015-0040-z, DOI 10.1007/S40474-015-0040-Z]; Ministry of Health Labour and Welfare, 2011, SEIK SHID NAD KANS C; Robinson C. A., 1995, J FAMILY NURSING, V1, P327, DOI [10.1177/107484079500100306, DOI 10.1177/107484079500100306]; Robinson C. A., 1998, J FAMILY NURSING, V4, P271, DOI [10.1177/107484079800400304, DOI 10.1177/107484079800400304]; Smith J, 2015, J PEDIATR NURS, V30, P143, DOI 10.1016/j.pedn.2014.10.014; Tanaka M., 2010, J ST LUKES SOC NURSI, V14, P29; Tanigawa R., 2009, COLLECTED PAPERS JAP, V39, P260; Vermaes IPR, 2012, J PEDIATR PSYCHOL, V37, P166, DOI 10.1093/jpepsy/jsr081; Wakimizu R, 2010, NURS HEALTH SCI, V12, P322, DOI 10.1111/j.1442-2018.2010.00533.x; Wakimizu R., 2014, J PSYCHOL ABNORMALIT, V3, P113, DOI [10.4172/2329-9525.1000113, DOI 10.4172/2329-9525.1000113]; Woodman AC, 2014, FAM RELAT, V63, P39, DOI 10.1111/fare.12049; Wright L. M., 2011, BELIEFS ILLNESS MODE; Wright L. M., 2002, BELIEFS HEART HEALIN; Wright L. M., 1996, BELIEFS HEART HEALIN; Wright L. M., 2013, NURSES FAMILIES GUID; Wright L.M., 2009, BELIEFS ILLNESS MODE	35	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1074-8407	1552-549X		J FAM NURS	J. Fam. Nurs.	MAY	2015	21	2			SI		232	260		10.1177/1074840715586551		29	Family Studies; Nursing	Family Studies; Nursing	CI6LU	WOS:000354871600004		
J	Yamaguchi, K; Komura, M; Yamaguchi, R; Imoto, S; Shimizu, E; Kasuya, S; Shibuya, T; Hatakeyama, S; Takahashi, N; Ikenoue, T; Hata, K; Tsurita, G; Shinozaki, M; Suzuki, Y; Sugano, S; Miyano, S; Furukawa, Y				Yamaguchi, Kiyoshi; Komura, Mitsuhiro; Yamaguchi, Rui; Imoto, Seiya; Shimizu, Eigo; Kasuya, Shinichi; Shibuya, Tetsuo; Hatakeyama, Seira; Takahashi, Norihiko; Ikenoue, Tsuneo; Hata, Keisuke; Tsurita, Giichiro; Shinozaki, Masaru; Suzuki, Yutaka; Sugano, Sumio; Miyano, Satoru; Furukawa, Yoichi			Detection of APC mosaicism by next-generation sequencing in an FAP patient	JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL ADENOMATOUS POLYPOSIS; MUTATIONS; RETINOBLASTOMA; CHALLENGES; EXOME; GENE	Familial adenomatous polyposis (FAP) of the colon is characterized by multiple polyps in the intestine and extra-colonic manifestations. Most FAP cases are caused by a germline mutation in the tumor-suppressor gene APC, but some cases of adenomatous polyposis result from germline mutations in MUTYH, POLD1 or POLE. Although sequence analysis of APC by the Sanger method is routinely performed for genetic testing, there remain cases whose mutations are not detected by the analysis. Next-generation sequencing has enabled us to analyze the comprehensive human genome, improving the chance of identifying disease causative variants. In this study, we conducted whole-genome sequencing of a sporadic FAP patient in which we did not find any pathogenic APC mutations by the conventional Sanger sequencing. Whole-genome sequencing and subsequent deep sequencing identified a mosaic mutation of c.3175G>T, p.E1059X in similar to 12% of his peripheral leukocytes. Additional deep sequencing of his buccal mucosa, hair follicles, non-cancerous mucosa of the stomach and colon disclosed that these tissues harbored the APC mutation at different frequencies. Our data implied that genetic analysis by next-generation sequencing is an effective strategy to identify genetic mosaicism in hereditary diseases.	[Yamaguchi, Kiyoshi; Hatakeyama, Seira; Takahashi, Norihiko; Ikenoue, Tsuneo; Furukawa, Yoichi] Univ Tokyo, Adv Clin Res Ctr, Inst Med Sci, Div Clin Genome Res, Tokyo 1088639, Japan; [Komura, Mitsuhiro; Imoto, Seiya; Shimizu, Eigo; Kasuya, Shinichi; Miyano, Satoru] Univ Tokyo, Ctr Human Genome, Inst Med Sci, Lab DNA Informat Anal, Tokyo 1088639, Japan; [Yamaguchi, Rui; Shibuya, Tetsuo; Miyano, Satoru] Univ Tokyo, Ctr Human Genome, Inst Med Sci, Lab Sequence Anal, Tokyo 1088639, Japan; [Hata, Keisuke; Tsurita, Giichiro; Shinozaki, Masaru] Univ Tokyo, Res Hosp, Inst Med Sci, Dept Surg, Tokyo 1088639, Japan; [Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Kashiwa, Chiba, Japan; [Sugano, Sumio] Univ Tokyo, Grad Sch Frontier Sci, Lab Funct Genom, Tokyo 1088639, Japan	Furukawa, Y (reprint author), Univ Tokyo, Adv Clin Res Ctr, Inst Med Sci, Div Clin Genome Res,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	furukawa@ims.u-tokyo.ac.jp			Japan Society for the Promotion of Science [26860206]; Center of Innovation (COI) program from the Japan Science and Technology Agency	We thank Kiyomi Imamura (The University of Tokyo) for technical help. This work was supported in part by the Grant-in-Aid for Young Scientists to K.Y. (#26860206) from the Japan Society for the Promotion of Science, and Center of Innovation (COI) program from the Japan Science and Technology Agency.	Pagnamenta AT, 2012, J HUM GENET, V57, P70, DOI 10.1038/jhg.2011.128; Biesecker LG, 2012, GENET MED, V14, P393, DOI 10.1038/gim.2011.78; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Mongin C, 2012, CLIN GENET, V81, P38, DOI 10.1111/j.1399-0004.2011.01676.x; IWAMA T, 1993, ANN SURG, V217, P101, DOI 10.1097/00000658-199302000-00002; Farrington SM, 1999, AM J HUM GENET, V64, P653, DOI 10.1086/302236; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; NAGASE H, 1992, CANCER RES, V52, P4055; Sippel KC, 1998, AM J HUM GENET, V62, P610, DOI 10.1086/301766; Rohlin A, 2009, HUM MUTAT, V30, P1012, DOI 10.1002/humu.20980; Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Taber KAJ, 2014, JAMA INTERN MED, V174, P275, DOI 10.1001/jamainternmed.2013.12048; Hes FJ, 2008, GUT, V57, P71, DOI 10.1136/gut.2006.117796; Verhoef S, 1999, AM J HUM GENET, V64, P1632, DOI 10.1086/302412; Aretz S, 2007, HUM MUTAT, V28, P985, DOI 10.1002/humu.20549; Knudsen Anne Lyster, 2003, Fam Cancer, V2, P43, DOI 10.1023/A:1023286520725; Kanter-Smoler G, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-10; Lohmann DR, 1999, HUM MUTAT, V14, P283, DOI 10.1002/(SICI)1098-1004(199910)14:4<283::AID-HUMU2>3.0.CO;2-J; Newton KF, 2012, CLIN GENET, V81, P521, DOI 10.1111/j.1399-0004.2011.01740.x; PARK JG, 1992, DIS COLON RECTUM, V35, P996, DOI 10.1007/BF02253505; Stoffel EM, 2014, CLIN GASTROENTEROL H, V12, P1059, DOI 10.1016/j.cgh.2013.08.015	22	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	MAY	2015	60	5					227	231		10.1038/jhg.2015.14		5	Genetics & Heredity	Genetics & Heredity	CI8IO	WOS:000355016200001		
J	Kubo, Y; Nishio, H; Saito, K				Kubo, Yuji; Nishio, Hisahide; Saito, Kayoko			A new method for SMN1 and hybrid SMN gene analysis in spinal muscular atrophy using long-range PCR followed by sequencing	JOURNAL OF HUMAN GENETICS			English	Article							MOTOR-NEURON GENE; COPY NUMBER; MOLECULAR ANALYSIS; MUTATIONS; SEVERITY; IDENTIFICATION; PHENOTYPE; DELETIONS; PROTEINS; DISEASE	Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder characterized by progressive loss of motor neurons in the spinal cord. Approximately 95% of SMA patients have a homozygous deletion of the survival motor neuron 1 (SMN1) gene, whereas 5% harbor compound heterozygous mutations such as an SMN1 deletion allele and an intragenic mutation in the other SMN1 allele. It is difficult to detect intragenic mutations in SMN1 because of the high degree of homology shared between SMN1 and SMN2. Current methods analyze a restricted region from exon 2a to exon 7 in SMN1. We propose a new, efficient long-range polymerase chain reaction (PCR) method for detecting intragenic mutations in SMN1 (exon 1-8) and hybrid SMN genes. We analyzed 20 unrelated SMA patients using SMN copy number analysis, and the new long-range PCR method followed by sequencing. We thus confirmed a novel mutation in SMN1 exon 1 (c.5C>T) in three patients with SMA type III who also had an SMN1 deletion allele. Moreover, we confirmed three hybrid SMN gene types in eight patients. We report a novel SMN1 mutation responsible for a relatively mild SMA phenotype and three hybrid SMN gene types in patients with SMA type III.	[Kubo, Yuji; Saito, Kayoko] Tokyo Womens Med Univ, Grad Sch Med, Branch Genet Med Adv Biomed Engn & Sci, Tokyo 1620054, Japan; [Kubo, Yuji; Saito, Kayoko] Tokyo Womens Med Univ, Global Ctr Excellence COE Program, Tokyo 1620054, Japan; [Kubo, Yuji; Saito, Kayoko] Tokyo Womens Med Univ, Inst Med Genet, Tokyo 1620054, Japan; [Kubo, Yuji] Toppan Printing Co Ltd, Tech Res Inst, Saitama, Japan; [Nishio, Hisahide] Kobe Univ, Grad Sch Med, Dept Community Med & Social Hlth Care, Kobe, Hyogo 657, Japan; [Nishio, Hisahide] Kobe Univ, Grad Sch Med, Dept Pediat, Kobe, Hyogo 657, Japan	Saito, K (reprint author), Tokyo Womens Med Univ, Inst Med Genet, Shinjuku Ku, 10-22 Kawada Cho, Tokyo 1620054, Japan.	saito.kayoko@twmu.ac.jp			Research Committee of Spinal Muscular Atrophy; Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports Science, and Technology (MEXT), Japan	We are grateful to the patients who agreed to participate in this study. We thank Drs T Yamamoto, S Morikawa, S Sawai, H Nakajima, T Oshita and T Kurashige for their valuable contributions to this study. This work was supported by Grants-in-Aid from the Research Committee of Spinal Muscular Atrophy, the Ministry of Health, Labour and Welfare of Japan (to KS). This work was also supported by the Global COE program, Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM) from the Ministry of Education, Culture, Sports Science, and Technology (MEXT), Japan (to YK and KS).	Harada Y, 2002, J NEUROL, V249, P1211, DOI 10.1007/s00415-002-0811-4; Alias L, 2009, HUM GENET, V125, P29, DOI 10.1007/s00439-008-0598-1; Burghes AHM, 1997, AM J HUM GENET, V61, P9, DOI 10.1086/513913; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Monani UR, 2003, J CELL BIOL, V160, P41, DOI 10.1083/jcb.200208079; Lunn MR, 2008, LANCET, V371, P2120, DOI 10.1016/S0140-6736(08)60921-6; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Parsons DW, 1998, AM J HUM GENET, V63, P1712, DOI 10.1086/302160; Ogino S, 2002, HUM GENET, V111, P477, DOI 10.1007/s00439-002-0828-x; Kolb SJ, 2011, ARCH NEUROL-CHICAGO, V68, P979, DOI 10.1001/archneurol.2011.74; Prior TW, 2009, AM J HUM GENET, V85, P408, DOI 10.1016/j.ajhg.2009.08.002; VANDERSTEEGE G, 1995, LANCET, V345, P985, DOI 10.1016/S0140-6736(95)90732-7; Clermont O, 2004, HUM MUTAT, V24, P417, DOI 10.1002/humu.20092; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Wirth B, 2000, HUM MUTAT, V15, P228, DOI 10.1002/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Prior TW, 2010, AM J MED GENET A, V152A, P1608, DOI 10.1002/ajmg.a.33474; Cusco I, 2001, HUM GENET, V108, P222, DOI 10.1007/s004390000452; Cusco I, 2006, J NEUROL, V253, P21, DOI 10.1007/s00415-005-0912-y; DiDonato CJ, 1997, ANN NEUROL, V41, P230, DOI 10.1002/ana.410410214; HAHNEN E, 1995, HUM MOL GENET, V4, P1927, DOI 10.1093/hmg/4.10.1927; Hahnen E, 1996, AM J HUM GENET, V59, P1057; Kotani T, 2007, J NEUROL, V254, P624, DOI 10.1007/s00415-006-0410-x; Pellizzoni L, 1999, P NATL ACAD SCI USA, V96, P11167, DOI 10.1073/pnas.96.20.11167; vanderSteege G, 1996, AM J HUM GENET, V59, P834; Yamamoto T, 2014, BRAIN DEV-JPN, V36, P914, DOI 10.1016/j.braindev.2013.11.009; Zapletalova E, 2007, NEUROMUSCULAR DISORD, V17, P476, DOI 10.1016/j.nmd.2007.03.003; Zerres K, 1999, Neuromuscul Disord, V9, P272, DOI 10.1016/S0960-8966(99)00016-4	30	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	MAY	2015	60	5					233	239		10.1038/jhg.2015.16		7	Genetics & Heredity	Genetics & Heredity	CI8IO	WOS:000355016200002		
J	Horibata, K; Kono, S; Ishigami, C; Zhang, X; Aizawa, M; Kako, Y; Ishii, T; Kosaki, R; Saijo, M; Tanaka, K				Horibata, Katsuyoshi; Kono, Sayaka; Ishigami, Chie; Zhang, Xue; Aizawa, Madoka; Kako, Yuko; Ishii, Takuma; Kosaki, Rika; Saijo, Masafumi; Tanaka, Kiyoji			Constructive rescue of TFIIH instability by an alternative isoform of XPD derived from a mutated XPD allele in mild but not severe XP-D/CS	JOURNAL OF HUMAN GENETICS			English	Article							PIGMENTOSUM GROUP-D; NUCLEOTIDE EXCISION-REPAIR; FACIO-SKELETAL SYNDROME; XERODERMA-PIGMENTOSUM; COCKAYNE-SYNDROME; DNA-REPAIR; CLINICAL-FEATURES; MOLECULAR-BASIS; COFS SYNDROME; 2 DECADES	Mutations in XPD cause xeroderma pigmentosum (XP), XP and Cockayne syndrome (CS) crossover syndrome (XP/CS), trichothiodystrophy and cerebro-oculo-facio-skeletal syndrome (COFS). COFS represents the most severe end of the CS spectrum. This study reports two Japanese patients, COFS-05-135 and COFS-Chiba1, who died at ages of <1 year and exhibited typical COFS manifestations caused by XPD mutations p.[I619del];[R666W]and p.[G47R];[I619del], respectively. Two other cases of severe XP-D/CS (XP group D/CS), XP1JI (p.[G47R];[0]) and XPCS1PV (p.[R666W];[0]), died at ages <2 years. On the other hand, two cases of mild XP-D/CS, XP1NE (p.[G47R];[L461V;V716_R730del]) and XPCS118LV (p.[L461V;V716_R730del];[R666W]), lived beyond 37 years of age. p. I619Del and p.[L461V;V716_R730del] are functionally null; therefore, despite the differences in clinical manifestations, the functional protein in all of these patients was either p. G47R or p. R666W. To resolve the discrepancies in these XPD genotype-phenotype relationships, the p.[L461V;V716_R730del] allele was analyzed and we found that p.[L461V;A717G] was expressed from the same allele as p.[L461V;V716_R730del] by authentic splicing. Additionally, p.[L461V;A717G] could partially rescue the loss of XPD function, resulting in the milder manifestations observed in XP1NE and XPCS118LV.	[Horibata, Katsuyoshi; Kono, Sayaka; Ishigami, Chie; Zhang, Xue; Saijo, Masafumi; Tanaka, Kiyoji] Osaka Univ, Grad Sch Frontier Biosci, Human Cell Biol Grp, Suita, Osaka, Japan; [Aizawa, Madoka; Kako, Yuko] Chiba Childrens Hosp, Div Neonatol, Midori Ku, Chiba, Japan; [Ishii, Takuma] Chiba Childrens Hosp, Div Clin Genet, Midori Ku, Chiba, Japan; [Ishii, Takuma] Kawaguchi Kogyo Gen Hosp, Dept Pediat, Kawaguchi, Saitama, Japan; [Kosaki, Rika] Natl Ctr Child Hlth & Dev, Div Med Genet, Setagaya Ku, Tokyo, Japan	Horibata, K (reprint author), Natl Inst Hlth Sci, Div Genet & Mutagenesis, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	horibata@nihs.go.jp; ktanaka@fbs.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan.	Andressoo JO, 2006, PLOS BIOL, V4, P1821, DOI 10.1371/journal.pbio.0040322; SCHAEFFER L, 1994, EMBO J, V13, P2388; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Fuss JO, 2011, DNA REPAIR, V10, P697, DOI 10.1016/j.dnarep.2011.04.028; Stefanini M, 2010, DNA REPAIR, V9, P2, DOI 10.1016/j.dnarep.2009.10.005; DiGiovanna JJ, 2012, J INVEST DERMATOL, V132, P785, DOI 10.1038/jid.2011.426; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; Coin F, 1998, NAT GENET, V20, P184, DOI 10.1038/2491; Egly JM, 2011, DNA REPAIR, V10, P714, DOI 10.1016/j.dnarep.2011.04.021; Taylor EM, 1997, P NATL ACAD SCI USA, V94, P8658, DOI 10.1073/pnas.94.16.8658; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Dubaele S, 2003, MOL CELL, V11, P1635, DOI 10.1016/S1097-2765(03)00182-5; BROUGHTON BC, 1995, AM J HUM GENET, V56, P167; FREDERICK GD, 1994, HUM MOL GENET, V3, P1783, DOI 10.1093/hmg/3.10.1783; Fujimoto M, 2005, J INVEST DERMATOL, V125, P86, DOI 10.1111/j.0022-202X.2005.23745.x; Graham JM, 2004, AM J MED GENET A, V128A, P235, DOI 10.1002/ajmg.a.30060; Graham JM, 2001, AM J HUM GENET, V69, P291, DOI 10.1086/321295; Hashimoto S, 2009, HUM MOL GENET, V18, pR224, DOI 10.1093/hmg/ddp390; Kobayashi T, 1997, HUM MUTAT, V9, P322, DOI 10.1002/(SICI)1098-1004(1997)9:4<322::AID-HUMU4>3.0.CO;2-7; Laugel V, 2008, J MED GENET, V45, P564, DOI 10.1136/jmg.2007.057141; PENA SDJ, 1974, CLIN GENET, V5, P285; TAKAYAMA K, 1995, CANCER RES, V55, P5656; Theron T, 2005, MOL CELL BIOL, V25, P8368, DOI 10.1128/MCB.25.18.8368-8378.2005	25	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	MAY	2015	60	5					259	265		10.1038/jhg.2015.18		7	Genetics & Heredity	Genetics & Heredity	CI8IO	WOS:000355016200005		
J	Fukai, R; Hiraki, Y; Yofune, H; Tsurusaki, Y; Nakashima, M; Saitsu, H; Tanaka, F; Miyake, N; Matsumoto, N				Fukai, Ryoko; Hiraki, Yoko; Yofune, Hiroko; Tsurusaki, Yoshinori; Nakashima, Mitsuko; Saitsu, Hirotomo; Tanaka, Fumiaki; Miyake, Noriko; Matsumoto, Naomichi			A case of autism spectrum disorder arising from a de novo missense mutation in POGZ	JOURNAL OF HUMAN GENETICS			English	Article							GENETICS; GENES	Autism spectrum disorder (ASD) is a clinically heterogeneous psychiatric disorder with various genetic backgrounds. Here, we report a novel mutation in the pogo transposable element-derived protein with zinc finger domain gene (POGZ) identified by triobased whole exome sequencing. To date, a total of seven de novo POGZ mutations in ASD have been reported. POGZ contains a total of five functional domains, and this study reports the first de novo missense mutation in the centromere protein B-like DNA-binding domain. POGZ is highly expressed in the human fetal brain and is involved in mitosis and the regulation of neuronal proliferation. Therefore its loss-of-function or pathogenic missense mutations are likely to be causative of ASD.	[Fukai, Ryoko; Tsurusaki, Yoshinori; Nakashima, Mitsuko; Saitsu, Hirotomo; Miyake, Noriko; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 2360004, Japan; [Fukai, Ryoko; Tanaka, Fumiaki] Yokohama City Univ, Grad Sch Med, Dept Neurol & Stroke Med, Yokohama, Kanagawa 2360004, Japan; [Hiraki, Yoko] Hiroshima Municipal Ctr Child Hlth & Dev, Hiroshima, Japan; [Yofune, Hiroko] Hiroshima City Hokubu Ctr Childrens Treatment & G, Hiroshima, Japan	Miyake, N (reprint author), Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanazawa Ku, Fukuura 3-9, Yokohama, Kanagawa 2360004, Japan.	nmiyake@yokohama-cu.ac.jp; naomat@yokohama-cu.ac.jp			Ministry of Health, Labour and Welfare of Japan; Japan Science and Technology Agency; Strategic Research Program for Brain Sciences; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Takeda Science Foundation; Hayashi Memorial Foundation for Female Natural Scientists	We thank the patient's family for participating in this work. This work was supported by research grants from the Ministry of Health, Labour and Welfare of Japan (HS, N Matsumoto, N Miyake), the fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems from the Japan Science and Technology Agency (N Matsumoto), the Strategic Research Program for Brain Sciences (N Matsumoto) and a Grant-in-Aid for Scientific Research on Innovative areas-(Transcription cycle)-from the Ministry of Education, Culture, Sports, Science and Technology of Japan (N Matsumoto), Grants-in-Aid for Scientific Research (A) and (B) from the Japan Society for the Promotion of Science (HS, N Miyake, N Matsumoto), the Takeda Science Foundation (N Matsumoto, N Miyake), the Yokohama Foundation for Advancement of Medical Science (N Miyake) and the Hayashi Memorial Foundation for Female Natural Scientists (N Miyake).	Xu LM, 2012, NUCLEIC ACIDS RES, V40, pD1016, DOI 10.1093/nar/gkr1145; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Gilissen C, 2014, NATURE, V511, P344, DOI 10.1038/nature13394; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nozawa RS, 2010, NAT CELL BIOL, V12, P719, DOI 10.1038/ncb2075; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Persico AM, 2013, BEHAV BRAIN RES, V251, P95, DOI 10.1016/j.bbr.2013.06.012; Elsabbagh M, 2012, AUTISM RES, V5, P160, DOI 10.1002/aur.239; Buxbaum JD, 2012, NEURON, V76, P1052, DOI 10.1016/j.neuron.2012.12.008; Enjoji M., 1961, PAEDIAT JPN, V4, P2, DOI 10.1111/j.1442-200X.1961.tb01032.x; Liu L, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-22; Ronemus M, 2014, NAT REV GENET, V15, P133, DOI 10.1038/nrg3585	20	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	MAY	2015	60	5					277	279		10.1038/jhg.2015.13		3	Genetics & Heredity	Genetics & Heredity	CI8IO	WOS:000355016200008		
J	Kasuga, K; Kikuchi, M; Tokutake, T; Nakaya, A; Tezuka, T; Tsukie, T; Hara, N; Miyashita, A; Kuwano, R; Ikeuchi, T				Kasuga, Kensaku; Kikuchi, Masataka; Tokutake, Takayoshi; Nakaya, Akihiro; Tezuka, Toshiyuki; Tsukie, Tamao; Hara, Norikazu; Miyashita, Akinori; Kuwano, Ryozo; Ikeuchi, Takeshi			Systematic review and meta-analysis of Japanese familial Alzheimer's disease and FTDP-17	JOURNAL OF HUMAN GENETICS			English	Review							DEMENTIA; MUTATION; ONSET; PARKINSONISM; SEIZURES; MAPT	Mutations in APP, PSEN1 and PSEN2 as the genetic causes of familial Alzheimer's disease (FAD) have been found in various ethnic populations. A substantial number of FAD pedigrees with mutations have been reported in the Japanese population; however, it remains unclear whether the genetic and clinical features of FAD in the Japanese population differ from those in other populations. To address this issue, we conducted a systematic review and meta-analysis of Japanese FAD and frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) by literature search. Using this analysis, we identified 39 different PSEN1 mutations in 140 patients, 5 APP mutations in 35 patients and 16 MAPT mutations in 84 patients. There was no PSEN2 mutation among Japanese patients. The age at onset in Japanese FAD patients with PSEN1 mutations was significantly younger than that in patients with APP mutations. Kaplan-Meier analysis revealed that patients with MAPT mutations showed a shorter survival than patients with PSEN1 or APP mutations. Patients with mutations in different genes exhibit characteristic clinical presentations, suggesting that mutations in causative genes may modify the clinical presentations. By collecting and cataloging genetic and clinical information on Japanese FAD and FTDP-17, we developed an original database designated as Japanese Familial Alzheimer's Disease Database, which is accessible at http://alzdb.bri. niigata-u.ac.jp/.	[Kasuga, Kensaku; Kikuchi, Masataka; Nakaya, Akihiro; Tsukie, Tamao; Hara, Norikazu; Miyashita, Akinori; Kuwano, Ryozo; Ikeuchi, Takeshi] Niigata Univ, Brain Res Inst, Dept Mol Genet, Niigata 9518585, Japan; [Kasuga, Kensaku] Niigata Univ, Ctr Transdisciplinary Res, Niigata 9518585, Japan; [Kikuchi, Masataka; Tsukie, Tamao] Res Assoc Biotechnol, Tokyo, Japan; [Tokutake, Takayoshi; Tezuka, Toshiyuki] Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 9518585, Japan; [Nakaya, Akihiro] Osaka Univ, Grad Sch Med, Dept Genome Informat, Osaka, Japan	Ikeuchi, T (reprint author), Niigata Univ, Brain Res Inst, Dept Mol Genet, 1-757 Asahimachi, Niigata 9518585, Japan.	ikeuchi@bri.niigata-u.ac.jp			Japan Society of Promotion of Science, Japan [26870209, 23591234, 20372469]; Ministry of Health, Labour and Welfare of Japan	This work is supported in part by Grants-in-Aid for scientific research from Japan Society of Promotion of Science, Japan (26870209 to KK, 23591234 and 20372469 to TI) and Grant-in-Aid from the Ministry of Health, Labour and Welfare of Japan. We are grateful to Dr Hasegawa and Ms Fukaumi for their technical assistance.	Vossel KA, 2013, JAMA NEUROL, V70, P1158, DOI 10.1001/jamaneurol.2013.136; Tabira T, 2002, J NEUROSCI RES, V70, P367, DOI 10.1002/jnr.10392; Cruts M, 2012, HUM MUTAT, V33, P1340, DOI 10.1002/humu.22117; Karch CM, 2014, NEURON, V83, P11, DOI 10.1016/j.neuron.2014.05.041; Noebels J, 2011, EPILEPSIA, V52, P39, DOI 10.1111/j.1528-1167.2010.02909.x; Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321; Ryman DC, 2014, NEUROLOGY, V83, P253, DOI 10.1212/WNL.0000000000000596; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Larner AJ, 2006, J NEUROL, V253, P139, DOI 10.1007/s00415-005-0019-5; Sperfeld AD, 1999, ANN NEUROL, V46, P708, DOI 10.1002/1531-8249(199911)46:5<708::AID-ANA5>3.0.CO;2-K; Guerreiro RJ, 2012, NEUROBIOL AGING, V33, P437, DOI 10.1016/j.neurobiolaging.2010.03.025; Foster NL, 1997, ANN NEUROL, V41, P706, DOI 10.1002/ana.410410606; Ikeuchi T, 2008, DEMENT GERIATR COGN, V26, P43, DOI 10.1159/000141483; Ogaki K, 2013, PARKINSONISM RELAT D, V19, P15, DOI 10.1016/j.parkreldis.2012.06.019; Rademakers R, 2003, HUM MUTAT, V22, P409, DOI 10.1002/humu.10269	15	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	MAY	2015	60	5					281	283		10.1038/jhg.2015.15		3	Genetics & Heredity	Genetics & Heredity	CI8IO	WOS:000355016200009		
J	Kwon, K; Shin, DS; Shin, BS; Park, HS; Lee, S; Jang, HG; Park, JS; Chung, MS				Kwon, Koojoo; Shin, Dong Sun; Shin, Byeong-Seok; Park, Hyung Seon; Lee, Sangho; Jang, Hae Gwon; Park, Jin Seo; Chung, Min Suk			Virtual Endoscopic and Laparoscopic Exploration of Stomach Wall Based on a Cadaver's Sectioned Images	JOURNAL OF KOREAN MEDICAL SCIENCE			English	Article						Visible Human Projects; Stomach; Imaging; Three-Dimensional; Endoscopy; Laparoscopy	VISIBLE KOREAN HUMAN; SURFACE MODELS; ANATOMY; SEGMENTATION; EDUCATION; BODY	We intended to determine that virtual endoscopy and laparoscopy of the stomach based on serially sectioned cadaver images is beneficial. Therefore, the outlines between the gastric wall and lumen were traced using the new female data of the Visible Korean to build a volume model. While the outlines were expanded at appropriate thicknesses, the stomach was observed endoscopically and laparoscopically in comparison with a chosen sectioned image. Four layers (mucosa, submucosa, muscular layer, and serosa) of the stomach were discernible by their proper colors in the sectioned images. All layers except the submucosa were identified in the endoscopic and laparoscopic views by using consistent colors. The stepwise expansion of the outlines revealed thickness of each layer as well as whether the thickness was uniform. Our ideas and the Visible Korean images could be a robust resource of virtual reality learning for medical students and clinicians.	[Kwon, Koojoo; Shin, Byeong-Seok] Inha Univ, Dept Comp Sci & Informat Technol, Inchon, South Korea; [Shin, Dong Sun] Osaka Univ, Grad Sch Med, Dept Orthopaed Biomat Sci, Osaka, Japan; [Park, Hyung Seon; Lee, Sangho] Korea Inst Sci & Technol, Taejon, South Korea; [Jang, Hae Gwon] Ajou Univ, Grad Sch Informat & Commun, Suwon 441749, South Korea; [Park, Jin Seo] Dongguk Univ, Coll Med, Dept Anat, Gyeongju, South Korea; [Chung, Min Suk] Ajou Univ, Sch Med, Dept Anat, Suwon 441749, South Korea	Chung, MS (reprint author), Ajou Univ, Sch Med, Dept Anat, 164 Worldcup Ro, Suwon 443380, South Korea.	dissect@ajou.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Education [2010-0009950]; Korea Institute of Science and Technology Information	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (grant number 2010-0009950). Raw data of the Visible Korean were acquired by the financial assistance from the Korea Institute of Science and Technology Information.	Shin DS, 2012, SURG RADIOL ANAT, V34, P235, DOI 10.1007/s00276-011-0870-2; Park JS, 2010, J KOREAN MED SCI, V25, P1710, DOI 10.3346/jkms.2010.25.12.1710; Park JS, 2005, IEEE T MED IMAGING, V24, P352, DOI 10.1109/TMI.2004.842454; Ackerman MJ, 1999, ACAD MED, V74, P667, DOI 10.1097/00001888-199906000-00012; Jastrow H, 2003, CLIN ANAT, V16, P44, DOI 10.1002/ca.10062; Shin DS, 2012, J KOREAN MED SCI, V27, P849, DOI 10.3346/jkms.2012.27.8.849; Park JS, 2006, CLIN ANAT, V19, P216, DOI 10.1002/ca.20275; Liu KJ, 2013, ANAT SCI INT, V88, P254, DOI 10.1007/s12565-013-0186-x; Heng PA, 2006, CLIN ANAT, V19, P232, DOI 10.1002/ca.20314; Pudney C, 1998, COMPUT VIS IMAGE UND, V72, P404, DOI 10.1006/cviu.1998.0680; Shin DS, 2009, CLIN ANAT, V22, P601, DOI 10.1002/ca.20823; Shin DS, 2011, ANAT SCI EDUC, V4, P327, DOI 10.1002/ase.249; Borgefors G, 1996, COMPUT VIS IMAGE UND, V64, P368, DOI 10.1006/cviu.1996.0065; Hadwiger M, 2006, REAL TIME VOLUME GRA, P163; Kruger J., 2003, IEEE VISUALIZATION, V287-92, P2003; Mescher AL, 2013, JUNQUEIRAS BASIC HIS, P303; Park JS, 2008, COMPUT METH PROG BIO, V92, P257, DOI 10.1016/j.cmpb.2008.07.007; Park JS, 2005, J DIGIT IMAGING, V18, P333, DOI 10.1007/s10278-005-6704-1; Shin DS, 2009, J KOREAN MED SCI, V24, P375, DOI 10.3346/jkms.2009.24.3.375; Shin DS, 2014, ANAT SCI INT, V89, P21, DOI 10.1007/s12565-013-0191-0	20	0	0	KOREAN ACAD MEDICAL SCIENCES	SEOUL	302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA	1011-8934	1598-6357		J KOREAN MED SCI	J. Korean Med. Sci.	MAY	2015	30	5					658	661		10.3346/jkms.2015.30.5.658		4	Medicine, General & Internal	General & Internal Medicine	CI7YB	WOS:000354981600022		
J	Choksi, N				Choksi, Nishaant			Surface Politics: Scaling Multiscriptality in an Indian Village Market	JOURNAL OF LINGUISTIC ANTHROPOLOGY			English	Article						script; scale; indigeneity; linguistic landscape; literacy	LANGUAGE; NORTH; IDEOLOGY; IDENTITY; NATION; CHOICE; SPACE	Linguistic anthropologists have used the concept of scale to describe how everyday interactions are linked to global flows and movements, particularly in the urban centers of Europe and North America. This article reconceptualizes the notion of scale by examining how residents in a small market village in eastern India order, in both hierarchical and nonhierarchical configurations, multiple graphic repertoires in dialogic engagement with the built environment. In the article, I suggest that script is an important semiotic modality through which indigenous and nonindigenous residents align notions of community, language, and territory according to different evaluative metrics, often in conflicting and antagonistic ways. These differential scalings of multiple scripts on the village's surfaces, and the disjunctures that exist between these scalings illuminate how dominant language hegemonies are perpetuated and, at the same time, contested by indigenous and minority language communities.	Univ Tokyo, Linguist, Tokyo 1138654, Japan	Choksi, N (reprint author), Univ Tokyo, Linguist, Tokyo 1138654, Japan.	nishaant@l.u-tokyo.ac.jp					Aggarwal Kailash, 1997, LANG PROBL LANG PLAN, V21, P35, DOI 10.1075/lplp.21.1.03agg; Ahmad R, 2008, J PRAGMATICS, V40, P1163, DOI 10.1016/j.pragma.2007.06.005; Angermeyer PS, 2005, LANG SOC, V34, P493, DOI 10.1017/S00474045050190; Silverstein M, 2003, LANG COMMUN, V23, P193, DOI 10.1016/S0271-5309(03)00013-2; Lempert M, 2012, ANTHROPOL EDUC QUART, V43, P138, DOI 10.1111/j.1548-1492.2012.01166.x; Bucholtz M, 2005, DISCOURSE STUD, V7, P585, DOI 10.1177/1461445605054407; Bender M, 2010, ETHNOHISTORY, V57, P175, DOI 10.1215/00141801-2009-059; Blommaert J, 2005, LANG COMMUN, V25, P197, DOI 10.1016/j.langcom.2005.05.002; Hill JH, 1998, AM ANTHROPOL, V100, P680, DOI 10.1525/aa.1998.100.3.680; Appadurai Arjun, 1996, MODERNITY LARGE CULT; Austin John L., 1962, DO THINGS WORDS; Blommaert J., 2014, TILBURG PAPERS CULTU, V89, P1; Blommaert Jan, 2010, SOCIOLINGUISTICS GLO; Blommaert J, 2013, CRIT LANG LIT STUD, V18, P1; Choksi Nishaant, 2015, PERFORMING IDENTITIE; Choksi Nishaant, 2010, TETRE SANTALI LIT J, V12, P5; Choksi Nishaant, 2014, INT J SOCIOL LANG, V2014, P47; Clifford J., 1988, PREDICAMENT CULTURE; Collins J., 2009, GLOBALIZATION LANGUA; Collins James, 1998, LANGUAGE IDEOLOGIES, P256; Collins James, 2003, LITERACY LITERACIES; Coupland Nikolas, 2010, INT J SOCIOL LANG, V205, P7; Das SN, 2012, J LINGUIST ANTHROPOL, V22, P220, DOI 10.1111/jola.12000; Das SN, 2008, J LINGUIST ANTHROPOL, V18, P1, DOI 10.1111/j.1548-1395.2008.00001.x; Daveluy M, 2009, J LINGUIST ANTHROPOL, V19, P78, DOI 10.1111/j.1548-1395.2009.01020.x; Goffman E., 1981, FORMS TALK; Gorter Durk, 2006, LINGUISTIC LANDSCAPE; Hansda Subodh, 2004, SANTALS WIN FREEDOM; Hembram Amineshwar, 2010, JOT KETIN MERE UNPUB; Hull MS, 2012, GOVERNMENT OF PAPER: THE MATERIALITY OF BUREAUCRACY IN URBAN PAKISTAN, P1; Ingold T, 2000, PERCEPTION ENV ESSAY; Irvine Judith T., 2013, ANN M AM ANTHR ASS C; Jaffe A, 1996, AM ETHNOL, V23, P816, DOI 10.1525/ae.1996.23.4.02a00080; Jaffe Alexandra, 2013, MULTILINGUALISM PERI; Jaffe Alexandra, 2000, J SOCIOLING, V4, P497, DOI DOI 10.1111/1467-9481.00127; Jaworski A., 2010, SEMIOTIC LANDSCAPES; Karlsson Bengt G., 2006, INDIGENEITY IN INDIA; King Christopher R, 1994, ONE LANGUAGE 2 SCRIP; Ladousa C, 2002, LANG SOC, V31, P213, DOI 10.1017/S0047404501020164; LaDousa C, 2005, AM ETHNOL, V32, P460, DOI 10.1525/ae.2005.32.3.460; Magner Thomas F., 2006, INT J SOCIOL LANG, V2006, P11; Meek B., 2010, WE ARE OUR LANGUAGE; Meek BA, 2010, CRIT ASIAN STUD, V42, P256, DOI 10.1080/14672715.2010.487407; Munda Ramdayal, 2003, JHARKHAND MOVEMENT I; Murmu Raghunath, LAKCHAR SEREN; Peter Backhaus, 2007, LINGUISTIC LANDSCAPE; Povinelli Elizabeth, 2011, EC ABANDONMENT SOCIA; Povinelli Elizabeth, 2002, CUNNING RECOGNITION; Rai Amrit, 1984, HOUSE DIVIDED ORIGIN; SCHIEFFELIN BB, 1994, AM ETHNOL, V21, P176, DOI 10.1525/ae.1994.21.1.02a00090; Scollon Ron, 2003, DISCOURSES PLACE LAN; Sebba M., 2009, WRITING SYSTEMS RES, V1, p[1, 35], DOI DOI 10.1093/WSR/WSP002; Sebba M., 2012, ORTHOGARPHY SOCIAL A, P1; Shah A, 2007, HIST COMPASS, V5, P1806, DOI 10.1111/j.1478-0542.2007.00471.x; Shohamy E., 2008, LINGUISTIC LANDSCAPE; Silverstein M, 1998, ANNU REV ANTHROPOL, V27, P401, DOI 10.1146/annurev.anthro.27.1.401; Singh Udaya Narayana, 2001, INT J SOCIOL LANG, V2001, P61, DOI 10.1515/ijsl.2001.036; Sundar Nandini, 2009, LEGAL GROUNDS NATURA; Tsing Anna Lowenhaupt, 1993, REALM DIAMOND QUEEN; Unseth Peter, 2008, INT J SOCIOL LANG, V192, P1; Webster AK, 2014, J ANTHROPOL RES, V70, P385, DOI 10.3998/jar.0521004.0070.303; Wyrod Christopher, 2008, INT J SOCIOL LANG, V2008, P27, DOI 10.1515/IJSL.2008.033; Yang Anand, 1998, BAZAAR INDIA MARKETS	63	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1055-1360	1548-1395		J LINGUIST ANTHROPOL	J. Linguist. Anthropol.	MAY	2015	25	1					1	24		10.1111/jola.12070		24	Anthropology; Linguistics; Language & Linguistics	Anthropology; Linguistics	CI4ND	WOS:000354725800001		
J	Inoue, J; Kanda, K; Fujita, T; Maenaka, K				Inoue, Jun-Ichi; Kanda, Kensuke; Fujita, Takayuki; Maenaka, Kazusuke			Thin-film piezoelectric bimorph actuators with increased thickness using double Pb[Zr,Ti]O-3 layers	JOURNAL OF MICROMECHANICS AND MICROENGINEERING			English	Article						PZT/PZT bimorph; thick-film; PZT; sputtering; MEMS	CONSTITUENT EQUATIONS; BENDING ACTUATORS; MEMS ACCELEROMETER; FABRICATION; CANTILEVER; DESIGN; SENSOR; ELECTRODES; DEPOSITION; DEVICES	We studied the effects of increasing the thickness of bimorph structures containing double layers of Pb(Zr,Ti)O-3 (PZT) thin films. Thick PZT films allow high-voltage application (e.g. in terms of coercive electric field and breakdown voltage) and large generative force, which are effective in microelectromechanical systems (MEMS) applications. Improvement of the deposition conditions and electrode structures facilitates the fabrication of the thin-film PZT/PZT bimorph structure. The PZT/PZT bimorph with a total thickness of 5.8 mu m, deposited using a radio-frequency (RF) magnetron sputtering system is much thicker than conventional bimorph structures. The characteristics of the two piezoelectric layers were similar to each other and revealed good electric and ferroelectric characteristics with a remanent polarization of 20 mu C cm(-2) and a coercive electric field of 50 kV cm(-1). PZT/PZT bimorph cantilevers were fabricated in order to evaluate their characteristics for actuator applications. The residual stress of the bimorph cantilever was reduced by an annealing process. The vibration test on the fabricated bimorph cantilevers during electrical voltage application revealed a twice as large displacement as compared with a single layer actuation, and the piezoelectric coefficient value d(31) was estimated to be -61 pm V-1, which is better than the value of conventional PZT/PZT bimorph cantilevers (-13 pm V-1). It was also shown that the influence of the temperature change is much less than that in unimorph structures with similar dimensions. The evaluated results demonstrate that the PZT/PZT bimorph structures are effective as MEMS devices.	[Inoue, Jun-Ichi; Kanda, Kensuke; Fujita, Takayuki; Maenaka, Kazusuke] Univ Hyogo, Grad Sch Engn, Himeji, Hyogo 6712280, Japan	Inoue, J (reprint author), Univ Hyogo, Grad Sch Engn, 2167 Shosha, Himeji, Hyogo 6712280, Japan.	kanda@eng.u-hyogo.ac.jp			Ministry of Education, Science, Sports and Culture [23760233, 26420204]	This research was partially supported by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Young Scientists (B), 23760233 and for Scientific Research (C) 26420204.	Kim YS, 2003, SENSOR ACTUAT A-PHYS, V103, P122, DOI 10.1016/S0924-4247(02)00311-4; Kobayashi T, 2005, JPN J APPL PHYS 1, V44, P7078, DOI 10.1143/JJAP.44.7078; Muralt P, 2009, PROCEDIA CHEM, V1, P1191, DOI 10.1016/j.proche.2009.07.297; Wang QM, 1998, FERROELECTRICS, V215, P187, DOI 10.1080/00150199808229562; Esashi M, 2005, J PHYS D APPL PHYS, V38, pR223, DOI 10.1088/0022-3727/38/13/R01; Wang QM, 1999, IEEE T ULTRASON FERR, V46, P638, DOI 10.1109/58.764850; Xu R, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/9/094007; Lee HC, 2007, SENSOR ACTUAT A-PHYS, V136, P282, DOI 10.1016/j.sna.2006.10.050; Colin M, 2013, J PHYS CONF SER, V476, DOI 10.1088/1742-6596/476/1/012133; Shibata T, 2004, SENSOR ACTUAT A-PHYS, V114, P398, DOI 10.1016/j.sna.2003.11.025; Kim H, 2005, SENSOR ACTUAT A-PHYS, V121, P162, DOI 10.1016/j.sna.2004.12.005; Yu HG, 2003, SENSOR ACTUAT A-PHYS, V107, P26, DOI 10.1016/S0924-4247(03)00271-1; Muralt P, 2000, IEEE T ULTRASON FERR, V47, P903, DOI 10.1109/58.852073; Ledermann N, 2003, SENSOR ACTUAT A-PHYS, V105, P162, DOI 10.1016/S0924-4247(03)00090-6; Yu JC, 2009, FERROELECTRICS, V383, P127, DOI 10.1080/00150190902888681; Ballas RG, 2006, SENSOR ACTUAT A-PHYS, V130, P91, DOI 10.1016/j.sna.2005.11.034; Che LF, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/1/015025; Cui Y, 2007, PHYS SCRIPTA, VT129, P209, DOI 10.1088/0031-8949/2007/T129/047; Hindrichsen CC, 2009, 2009 IEEE SENSORS, VOLS 1-3, P475, DOI 10.1109/ICSENS.2009.5398277; Inoue J, 2013, P IEEE INT S APPL FE, P260; Ishii T., 2005, KYOYUDENTAI DEVICE, P143; Jenkins DFL, 2001, J ELECTROCERAM, V7, P5, DOI 10.1023/A:1012256108078; Kanahara A, 2011, HAKUMAKUKOGAKU; Kanda K, 2009, P CHEM; Kanda K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.09LD12; Koh KH, 2009, PROCEDIA CHEM, V1, P1303, DOI 10.1016/j.proche.2009.07.325; Nagano T, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.021402; Nonomura Y, 2006, SENSOR ACTUAT A-PHYS, V132, P42, DOI 10.1016/j.sna.2006.06.002; Phan KL, 2008, SENSOR ACTUAT A-PHYS, V145, P109, DOI 10.1016/j.sna.2007.10.055; Rajaraman V, 2011, PROCEDIA ENGINEER, V25, DOI 10.1016/j.proeng.2011.12.161; Sakakibara T, 1994, P IEEE INT S MICR HU; SMITS JG, 1991, SENSOR ACTUAT A-PHYS, V28, P41, DOI 10.1016/0924-4247(91)80007-C; SMITS JG, 1991, IEEE T ULTRASON FERR, V38, P256, DOI 10.1109/58.79611; Trolier-McKinstry S, 2004, J ELECTROCERAM, V12, P7, DOI 10.1023/B:JECR.0000033998.72845.51; Tsai MH, 2010, PROCEDIA ENGINEER, V5, P1083, DOI 10.1016/j.proeng.2010.09.298; Tsaur J, 2002, JPN J APPL PHYS 1, V41, P4321, DOI 10.1143/JJAP.41.4321; Uchino K, 2010, ADV PIEZOELECTRIC MA, P369; Wang LP, 2003, J MICROELECTROMECH S, V12, P433, DOI 10.1109/JMEMS.2003.811749; Zou Q, 2008, J MICROELECTROMECH S, V17, P45, DOI 10.1109/JMEMS.2007.909100	39	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0960-1317	1361-6439		J MICROMECH MICROENG	J. Micromech. Microeng.	MAY	2015	25	5							055001	10.1088/0960-1317/25/5/055001		12	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Instruments & Instrumentation; Materials Science, Multidisciplinary; Mechanics	Engineering; Science & Technology - Other Topics; Instruments & Instrumentation; Materials Science; Mechanics	CI5MW	WOS:000354802200002		
J	Kusaka, Y; Nomura, K; Fukuda, N; Ushijima, H				Kusaka, Yasuyuki; Nomura, Ken-ichi; Fukuda, Nobuko; Ushijima, Hirobumi			Microcontact patterning of conductive silver lines by contact inking and its layer-transfer mechanisms	JOURNAL OF MICROMECHANICS AND MICROENGINEERING			English	Article						printed electronics; microcontact printing; conductive lines; adhesion; patterning	PRINTED ELECTRONICS; FRICTION; ADHESION; TRANSISTORS; NETWORKS; PDMS	We developed a contact inking technique for microcontact printing aiming at the fabrication of conductive silver-nanoparticle (Ag NP) lines with rectangular cross section and constant layer thickness, irrespective of pattern size and shape. In the proposed process, Ag NP ink was first coated on a blanket and then inking was carried out by a contact with a microcontact stamp. The ink transferred onto the top of the stamp was finally settled on a workpiece by pressing to complete the printing process. To achieve robust inking to the stamp, the peel strengths between the Ag NP layer and the blankets and between the Ag NP layer and the stamp were investigated using poly (dimethylsiloxane) (PDMS) materials with different surface energies. Interestingly, it was revealed that the transferability of Ag-NP from the blanket toward the stamp was not solely determined by the surface energy difference but also by the extent of solvent uptake by the PDMS blanket during inking. The solvent-containing PDMS significantly lowered its adhesion strength against adjacent ink layers and, as a consequence, the ink transfer was successfully achieved even if the ink passed from a higher to a lower energy surface. Furthermore, by the solvent-vapour annealing of contact-inked semi-dried patterns, arbitrarily iterated transfers between PDMS surfaces became possible. With the contact-inking process developed here, we demonstrate a finely defined printed structure of Ag NP conductive lines with widths of up to 1 mu m.	[Kusaka, Yasuyuki; Nomura, Ken-ichi; Fukuda, Nobuko; Ushijima, Hirobumi] Natl Inst Adv Ind Sci & Technol, Flexible Elect Res Ctr, Tsukuba, Ibaraki 3058565, Japan	Kusaka, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Flexible Elect Res Ctr, Tsukuba Cent 5,1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	y-kusaka@aist.go.jp			Japan Society for the Promotion of Science (JSPS) [26889075]	This research was financially supported partly by a Grant-in-Aid for Research Activity Start-up from the Japan Society for the Promotion of Science (JSPS) (Project No. 26889075). The authors gratefully acknowledge the technical assistance of M Fujita.	Cheng DF, 2012, J AM CHEM SOC, V134, P10191, DOI 10.1021/ja302903e; Lee TM, 2013, THIN SOLID FILMS, V548, P566, DOI 10.1016/j.tsf.2013.09.023; Keum CM, 2012, ORG ELECTRON, V13, P778, DOI 10.1016/j.orgel.2012.02.003; Leufgen M, 2004, APPL PHYS LETT, V84, P1582, DOI 10.1063/1.1652233; Kopola P, 2009, THIN SOLID FILMS, V517, P5757, DOI 10.1016/j.tsf.2009.03.209; Kang B, 2013, ACS APPL MATER INTER, V5, P2302, DOI 10.1021/am302796z; Kusaka Y, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/12/125019; Deganello D, 2010, THIN SOLID FILMS, V518, P6113, DOI 10.1016/j.tsf.2010.05.125; Nomura K, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/9/095021; Ghatak A, 2000, J PHYS CHEM B, V104, P4018, DOI 10.1021/jp9942973; Limpoco FT, 2007, LANGMUIR, V23, P12196, DOI 10.1021/la701272a; Lee JN, 2003, ANAL CHEM, V75, P6544, DOI 10.1021/ac0346712; Kusaka Y, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/3/035020; Nomura K, 2014, MICROELECTRON ENG, V123, P58, DOI 10.1016/j.mee.2014.05.009; Zhang Q, 2007, LANGMUIR, V23, P7562, DOI 10.1021/la0636681; Galliano A, 2003, J COLLOID INTERF SCI, V265, P372, DOI 10.1016/S0021-9797(03)00458-2; Choi N, 2012, MICROELECTRON ENG, V91, P93, DOI 10.1016/j.mee.2011.11.010; Pudas M, 2005, PROG ORG COAT, V54, P310, DOI 10.1016/j.porgcoat.2005.07.008; Lamberti A, 2012, APPL SURF SCI, V258, P9427, DOI 10.1016/j.apsusc.2011.12.117; Madaria AR, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/24/245201; Moonen PF, 2012, ADV MATER, V24, P5526, DOI 10.1002/adma.201202949; Libioulle L, 1999, LANGMUIR, V15, P300, DOI 10.1021/la980978y; Gates BD, 2005, CHEM REV, V105, P1171, DOI 10.1021/cr030076o; Lloyd JS, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/19/195602; Bai SE, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05HC05; Cen JL, 2014, LANGMUIR, V30, P13716, DOI 10.1021/la503180a; Chan BD, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/2/025010; Hines DR, 2008, J APPL PHYS, V104, DOI 10.1063/1.2959821; Hwang J H, 2013, J CONTROL SYST ENG, P67; Hyun WJ, 2015, ADV MATER, V27, P109, DOI 10.1002/adma.201404133; Kina O, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.01AB07; Kwak MK, 2010, J COLLOID INTERF SCI, V343, P301, DOI 10.1016/j.jcis.2009.11.003; OWEN MJ, 1981, J COATING TECHNOL, V53, P49	33	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0960-1317	1361-6439		J MICROMECH MICROENG	J. Micromech. Microeng.	MAY	2015	25	5							055022	10.1088/0960-1317/25/5/055022		9	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Instruments & Instrumentation; Materials Science, Multidisciplinary; Mechanics	Engineering; Science & Technology - Other Topics; Instruments & Instrumentation; Materials Science; Mechanics	CI5MW	WOS:000354802200023		
J	Li, Y; Gosalvez, MA; Pal, P; Sato, K; Xing, Y				Li, Yuan; Gosalvez, Miguel A.; Pal, Prem; Sato, Kazuo; Xing, Yan			Particle swarm optimization-based continuous cellular automaton for the simulation of deep reactive ion etching	JOURNAL OF MICROMECHANICS AND MICROENGINEERING			English	Article						particle swarm optimization; continuous cellular automaton; deep reactive ion etching; simulation; PSO-CCA method	RECTANGULAR TRENCHES; DEPOSITION; LAG; TRANSPORT; SILICON; MODEL	We combine the particle swarm optimization (PSO) method and the continuous cellular automaton (CCA) in order to simulate deep reactive ion etching (DRIE), also known as the Bosch process. By considering a generic growth/etch process, the proposed PSO-CCA method provides a general, integrated procedure to optimize the parameter values of any given theoretical model conceived to describe the corresponding experiments, which are simulated by the CCA method. To stress the flexibility of the PSO-CCA method, two different theoretical models of the DRIE process are used, namely, the ballistic transport and reaction (BTR) model, and the reactant concentration (RC) model. DRIE experiments are designed and conducted to compare the simulation results with the experiments on different machines and process conditions. Previously reported experimental data are also considered to further test the flexibility of the proposed method. The agreement between the simulations and experiments strongly indicates that the PSO-CCA method can be used to adjust the theoretical parameters by using a limited amount of experimental data. The proposed method has the potential to be applied on the modeling and optimization of other growth/ etch processes.	[Li, Yuan; Xing, Yan] Southeast Univ, Dept Mech Engn, Lab Micronano Med Devices, Nanjing, Jiangsu, Peoples R China; [Gosalvez, Miguel A.] Univ Basque Country, UPV EHU, Dept Mat Phys, San Sebastian 20018, Spain; [Gosalvez, Miguel A.] Ctr Mixto CSIC UPV EHU, Ctr Fis Mat, San Sebastian 20018, Spain; [Gosalvez, Miguel A.] Donostia Int Phys Ctr, San Sebastian 20018, Spain; [Pal, Prem] Indian Inst Technol, Dept Phys, MEMS & Micro Nano Syst Lab, Hyderabad, Andhra Pradesh, India; [Sato, Kazuo] Aichi Inst Technol, Dept Mech Engn, Aichi, Japan	Xing, Y (reprint author), Southeast Univ, Dept Mech Engn, Lab Micronano Med Devices, Nanjing, Jiangsu, Peoples R China.	xingyan@seu.edu.cn	DONOSTIA INTERNATIONAL PHYSICS CTR., DIPC/C-3171-2014; CSIC-UPV/EHU, CFM/F-4867-2012		National Natural Science Foundation of China [51375093]; Ramon y Cajal Fellowship Program by the Spanish Ministry of Science and Innovation	We are greatly thankful to Dr M Tilli, Okmetic Oy, Finland, for generously donating the {1 1 0} wafers used in the experiments (condition B). We also thank Dr J Ohara, Denso Corp., Japan, for experimental support and guidance. We acknowledge the financial support from the National Natural Science Foundation of China No. 51375093, and the Ramon y Cajal Fellowship Program by the Spanish Ministry of Science and Innovation.	Alam S, 2014, SWARM EVOL COMPUT, V17, P1, DOI 10.1016/j.swevo.2014.02.001; Ferrando N, 2011, COMPUT PHYS COMMUN, V182, P628, DOI 10.1016/j.cpc.2010.11.004; Panda S, 2008, APPL SOFT COMPUT, V8, P1418, DOI 10.1016/j.asoc.2007.10.009; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/ICNN.1995.488968; Weymouth GD, 2010, J COMPUT PHYS, V229, P2853, DOI 10.1016/j.jcp.2009.12.018; Mita Y, 2006, PROC IEEE MICR ELECT, P114; Shi Y, 2011, INFORM SCIENCES, V181, P4460, DOI 10.1016/j.ins.2010.05.025; Ranganathan N, 2011, IEEE T COMP PACK MAN, V1, P1497, DOI 10.1109/TCPMT.2011.2160395; Lai SL, 2006, J VAC SCI TECHNOL A, V24, P1283, DOI 10.1116/1.2172944; Ertl O, 2010, MICROELECTRON ENG, V87, P20, DOI 10.1016/j.mee.2009.05.011; Tan YY, 2006, J MICROMECH MICROENG, V16, P2570, DOI 10.1088/0960-1317/16/12/008; Encinas AH, 2007, ADV ENG SOFTW, V38, P372, DOI 10.1016/j.advengsoft.2006.09.002; Pilliod JE, 2004, J COMPUT PHYS, V199, P465, DOI 10.1016/j.jcp.2003.12.023; Cale TS, 2000, THIN SOLID FILMS, V365, P152, DOI 10.1016/S0040-6090(00)00756-2; CALE TS, 1990, J VAC SCI TECHNOL B, V8, P1242, DOI 10.1116/1.584901; CALE TS, 1990, J APPL PHYS, V68, P3645, DOI 10.1063/1.346328; Cale TS, 1998, COMP MATER SCI, V12, P333, DOI 10.1016/S0927-0256(98)00021-4; Chienliu Chang, 2005, Journal of Micromechanics and Microengineering, V15, DOI 10.1088/0960-1317/15/3/020; Ferrando N, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/2/025021; Gosalvez MA, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/6/065017; Hassan R., 2005, P 1 AIAA MULT DES OP, P18; Hauguth M, 2008, MICROELECTRON ENG, V85, P982, DOI 10.1016/j.mee.2008.01.019; Hong LS, 2000, THIN SOLID FILMS, V365, P176, DOI 10.1016/S0040-6090(99)01058-5; Ishchuk V, 2014, MICROSYST TECHNOL, V20, P1791, DOI 10.1007/s00542-013-1926-5; Knizikevicius R, 2003, VACUUM, V72, P53, DOI 10.1016/S0042-207X(03)00099-X; Li Y, 2013, P IEEE INT C TRANSD, P1087; Ma ZB, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/5/055028; Malik AM, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/12/125018; NAGEL K, 1992, J PHYS I, V2, P2221; Poli Riccardo, 2007, Swarm Intelligence, V1, DOI 10.1007/s11721-007-0002-0; Saraf I, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3579542; Shi Y, 1998, P IEEE INT C EV COMP, P69, DOI DOI 10.1109/ICEC.1998.699146; Sun G, 2007, PROGRESS OF INFORMATION TECHNOLOGY IN AGRICULTURE, P45; Volland BE, 2002, J VAC SCI TECHNOL B, V20, P3111, DOI 10.1116/1.1520572; Volland BE, 2003, MICROELECTRON ENG, V67-8, P338, DOI 10.1016/S0167-9317(03)00088-1; Wang Y, 2007, P 7 IEEE INT C NAN H, P1135, DOI DOI 10.1109/NANO.2007.4601383; Xing Y, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/12/436; Xing Y, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/1/015019; Xing Y, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/8/085020; ZHANG F, 2008, P IEEE C HPCC DAL CH, P891	40	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0960-1317	1361-6439		J MICROMECH MICROENG	J. Micromech. Microeng.	MAY	2015	25	5							055023	10.1088/0960-1317/25/5/055023		13	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Instruments & Instrumentation; Materials Science, Multidisciplinary; Mechanics	Engineering; Science & Technology - Other Topics; Instruments & Instrumentation; Materials Science; Mechanics	CI5MW	WOS:000354802200024		
J	Takeda, A; Koike, W; Hayashi, S; Imoto, S; Nakamura, H				Takeda, Akihiro; Koike, Wataru; Hayashi, Shotaro; Imoto, Sanae; Nakamura, Hiromi			Magnetic Resonance Imaging and 3-dimensional Computed Tomographic Angiography for Conservative Management of Proximal Interstitial Pregnancy by Hysteroscopic Resection After Transcatheter Arterial Chemoembolization	JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY			English	Article						Diagnostic imaging; Hysteroscopy; Interstitial pregnancy; Methotrexate; Single-port laparoscopy; Transcatheter arterial chemoembolization	DIAGNOSIS; GUIDANCE; SURGERY; REMOVAL	Ectopic pregnancy implanted in the interstitial portion of the fallopian tube is a rare potentially life-threatening disorder. A case of unruptured interstitial pregnancy with prominent neovascularization in a 37-year-old woman was precisely localized in the proximal interstitial portion of the fallopian tube with a dilated proximal tubal ostium by magnetic resonance imaging and 3-dimensional computed tomographic angiography. After devascularization by transcatheter arterial chemoembolization, hysteroscopic resection of the interstitial gestational products was performed with single-port laparoscopic assistance. Postoperatively, 3 rescue doses of systemic methotrexate were administered to accelerate the resolution of gestational products followed by uneventful recovery. The uterine wall structure around the interstitial portion was well preserved at the cesarean delivery in the subsequent spontaneous gestation. (C) 2015 AAGL. All rights reserved.	[Takeda, Akihiro; Hayashi, Shotaro; Imoto, Sanae; Nakamura, Hiromi] Gifu Prefectural Tajimi Hosp, Dept Obstet & Gynecol, Tajimi, Gifu 5078522, Japan; [Koike, Wataru] Gifu Prefectural Tajimi Hosp, Dept Diagnost Radiol, Tajimi, Gifu 5078522, Japan	Takeda, A (reprint author), Gifu Prefectural Tajimi Hosp, Dept Obstet & Gynecol, 5-161 Maebata Cho, Tajimi, Gifu 5078522, Japan.	gyendoscopy@gmail.com					Moawad NS, 2010, AM J OBSTET GYNECOL, V202, P15, DOI 10.1016/j.ajog.2009.07.054; Takeda A, 2010, EUR J OBSTET GYN R B, V152, P152, DOI 10.1016/j.ejogrb.2010.05.032; Takeda A, 2012, J MINIM INVAS GYN, V19, P647, DOI 10.1016/j.jmig.2012.03.024; Arleo EK, 2014, CLIN IMAG, V38, P763, DOI 10.1016/j.clinimag.2014.04.002; Cai ZH, 2009, J MINIM INVAS GYN, V16, P761, DOI 10.1016/j.jmig.2009.07.001; Cai ZH, 2012, ARCH GYNECOL OBSTET, V285, P727, DOI 10.1007/s00404-011-2060-1; Lin KQ, 2014, INT J GYNECOL OBSTET, V124, P256, DOI 10.1016/j.ijgo.2013.10.002; Nezhat CH, 2014, J MINIM INVAS GYN, V21, P1091, DOI 10.1016/j.jmig.2014.04.007; Sanz LE, 2002, OBSTET GYNECOL, V99, P941, DOI 10.1016/S0029-7844(02)01664-2	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1553-4650	1553-4669		J MINIM INVAS GYN	J. Mimim. Invasive Gynecol.	MAY-JUN	2015	22	4					658	662		10.1016/j.jmig.2015.01.004		5	Obstetrics & Gynecology	Obstetrics & Gynecology	CI8VJ	WOS:000355049500032		
J	Shigeta, N; Kobayashi, E; Sawada, K; Ueda, Y; Yoshino, K; Hori, Y; Kimura, T				Shigeta, Naoya; Kobayashi, Eiji; Sawada, Kenjiro; Ueda, Yutaka; Yoshino, Kiyoshi; Hori, Yumiko; Kimura, Tadashi			Laparoscopic Excisional Surgery for Growing Teratoma Syndrome of the Ovary: Case Report and Literature Review	JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY			English	Article						Growing teratoma syndrome; Laparoscopy; Ovarian; Peritonectomy	GERM-CELL TUMORS; OF-THE-LITERATURE; IMMATURE TERATOMA; MATURE TERATOMAS; CHEMOTHERAPY; RETROCONVERSION; SECONDARY; LAPAROTOMY; METASTASES; EXPERIENCE	Growing teratoma syndrome (GTS) is rare clinical phenomenon occurring as a sequelae of a malignant germ cell tumor. We present the case of a 20-year-old woman who developed GTS after undergoing fertility-sparing surgery and chemotherapy for, an immature teratoma. She underwent left salpingo-oophorectomy, right ovarian cystectomy, and disseminated tumor reduction during her primary surgery. The postsurgical histology report identified the tumor as an immature teratoma, grade 3, International Federation of Gynecology and Obstetrics (FIGO) stage IIIb. She subsequently received 3 cycles of chemotherapy consisting of bleomycin, etoposide, and cisplatin. At 17 months after the chemotherapy, follow-up computed tomography (CT) scan revealed an enlarged mass in her right paracolic gutter and a small peritoneal lesion in the pouch of Douglas. Her serum alpha-fetoprotein level was not elevated. These findings were compatible with GTS, but it was difficult to rule out a recurrent immature teratoma. Diagnostic exploratory laparoscopic surgery revealed the enlarged tumors that had been detected by the CT scan. Although there were multiple tumors in the pouch of Douglas, we were able to resect all of them laparoscopically. Histological diagnosis of the surgically resected specimens was of a mature teratoma, and so we concluded that this tumor was a GTS. Our experience suggests that laparoscopic surgery is an effective alternative diagnostic and therapeutic approach in cases suspicious of GTS where the disease is disseminated to the peritoneum. (C) 2015 AAGL. All rights reserved.	[Shigeta, Naoya; Kobayashi, Eiji; Sawada, Kenjiro; Ueda, Yutaka; Yoshino, Kiyoshi; Kimura, Tadashi] Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Suita, Osaka 5650871, Japan; [Hori, Yumiko] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka 5650871, Japan	Kobayashi, E (reprint author), Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ekobayashi@gyne.med.osaka-u.ac.jp					Amsalem H, 2004, GYNECOL ONCOL, V92, P357, DOI 10.1016/j.ygyno.2003.10.024; Yuen PM, 1997, AM J OBSTET GYNECOL, V177, P109, DOI 10.1016/S0002-9378(97)70447-2; Kikawa S, 2011, J OBSTET GYNAECOL RE, V37, P926, DOI 10.1111/j.1447-0756.2010.01439.x; Sengar AR, 2010, J GYNECOL ONCOL, V21, P129, DOI 10.3802/jgo.2010.21.2.129; Tangjitgamol S, 2006, INT J GYNECOL CANCER, V16, P384, DOI 10.1111/j.1525-1438.2006.00492.x; Andre F, 2000, EUR J CANCER, V36, P1389, DOI 10.1016/S0959-8049(00)00137-4; Zagame L, 2006, OBSTET GYNECOL, V108, P509, DOI 10.1097/01.AOG.0000231686.94924.41; Djordjevic B, 2007, AM J SURG PATHOL, V31, P1913, DOI 10.1097/PAS.0b013e318073cf44; WILLIAMS SD, 1994, GYNECOL ONCOL, V52, P287, DOI 10.1006/gyno.1994.1050; TONKIN KS, 1989, EUR J CANCER CLIN ON, V25, P1739, DOI 10.1016/0277-5379(89)90343-X; Kato N, 2013, PATHOL INT, V63, P607, DOI 10.1111/pin.12112; Kobayashi E, 2013, GYNECOL OBSTET INVES, V75, P250, DOI 10.1159/000349894; Tay SK, 2000, INT J GYNECOL CANCER, V10, P13, DOI 10.1046/j.1525-1438.2000.00010.x; ARONOWITZ J, 1983, GYNECOL ONCOL, V16, P414, DOI 10.1016/0090-8258(83)90170-1; CALDAS C, 1992, GYNECOL ONCOL, V47, P385, DOI 10.1016/0090-8258(92)90145-9; CASTEDO SMMJ, 1989, CANCER RES, V49, P672; DAVEY DD, 1987, CANCER, V59, P533, DOI 10.1002/1097-0142(19870201)59:3<533::AID-CNCR2820590329>3.0.CO;2-X; David Yehuda Ben, 2002, Gynecologic Oncology, V84, P464; Dewdney S, 2006, GYNECOL ONCOL, V100, P608, DOI 10.1016/j.ygyno.2005.09.007; DiSia PJ, 1997, OBSTET GYNECOL, V49, P1346; Geisler John P., 1994, Obstetrics and Gynecology, V84, P719; Hariprasad R, 2008, INT J CLIN ONCOL, V13, P83, DOI 10.1007/s10147-007-0693-7; Homs MY, 2013, CASE REP OBSTET GYNE, V2013; Inaoka T, 2003, EUR RADIOL, V13, P2115, DOI 10.1007/s00330-002-1733-3; Itani Y, 2002, J OBSTET GYNAECOL RE, V28, P166, DOI 10.1046/j.1341-8076.2002.00032.x; Jeong WK, 2013, WORLD J SURG, V37, P2683, DOI 10.1007/s00268-013-2165-8; JUMEAN HG, 1992, GYNECOL ONCOL, V46, P111, DOI 10.1016/0090-8258(92)90206-X; KATTAN J, 1993, GYNECOL ONCOL, V49, P395, DOI 10.1006/gyno.1993.1147; LENTINI JF, 1986, J COMPUT ASSIST TOMO, V10, P1060, DOI 10.1097/00004728-198611000-00037; Lorusso D, 2011, GYNECOL ONCOL CASE R, V8, P24; Matsushita H, 2010, GYNECOL OBSTET INVES, V69, P221, DOI 10.1159/000273205; MOLENAAR WM, 1986, CANCER, V58, P264, DOI 10.1002/1097-0142(19860715)58:2<264::AID-CNCR2820580211>3.0.CO;2-P; MOSKOVIC E, 1991, CLIN RADIOL, V43, P402, DOI 10.1016/S0009-9260(05)80570-7; Mrabti H, 2011, CASE REP MED, V2011; Nimkin K, 2004, PEDIATR RADIOL, V34, P259, DOI 10.1007/s00247-003-1045-z; Panda Ananya, 2014, J Clin Diagn Res, V8, P197, DOI 10.7860/JCDR/2014/7407.3837; Practice Committee of American Society for Reproductive Medicine in collaboration with Society of Reproductive S. Pathogenesis, 2013, FERTIL STERIL, V99, P1550; Shibata Kiyosumi, 2013, Case Rep Oncol, V6, P544, DOI 10.1159/000356563; Tzortzatos G, 2009, FERTIL STERIL, V91; Umekawa T, 2005, GYNECOL ONCOL, V99, P761, DOI 10.1016/j.ygyno.2005.07.029	40	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1553-4650	1553-4669		J MINIM INVAS GYN	J. Mimim. Invasive Gynecol.	MAY-JUN	2015	22	4					668	674		10.1016/j.jmig.2015.01.011		7	Obstetrics & Gynecology	Obstetrics & Gynecology	CI8VJ	WOS:000355049500034		
J	Takeda, A; Koike, W; Hayashi, S; Imoto, S; Nakamura, H				Takeda, Akihiro; Koike, Wataru; Hayashi, Shotaro; Imoto, Sanae; Nakamura, Hiromi			Cervico-Isthmic Pregnancy: Early Diagnostic Imaging and Successful Dual Therapy for Uterine-Sparing Treatment	JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY			English	Article						Cervico-isthmic pregnancy; Diagnostic imaging; First trimester; Hysteroscopy; Transcatheter arterial chemoembolization	CESAREAN SCAR; ECTOPIC PREGNANCY; TERM; MANAGEMENT; TRIMESTER; DELIVERY	Cervico-isthmic pregnancy is a rare and potentially life-threatening form of ectopic gestation in which the blastocyst implants in the uterine cervico-isthmus between the histological and anatomical internal os, followed by subsequent extension to the lower uterine segment. Early diagnosis may allow a conservative therapeutic approach that avoids catastrophic hemorrhage requiring hysterectomy. Here we report the case of a 43-year-old primigravida woman whose cervico-isthmic pregnancy complicated by massive hematometra was diagnosed at 6 weeks gestation by multimodal imaging and successfully treated by hysteroscopic resection, securing adequate hemostasis, after transcatheter arterial chemoembolization. (C) 2015 AAGL. All rights reserved.	[Takeda, Akihiro; Hayashi, Shotaro; Imoto, Sanae; Nakamura, Hiromi] Gifu Prefectural Tajimi Hosp, Dept Obstet & Gynecol, Tajimi, Gifu 5078522, Japan; [Koike, Wataru] Gifu Prefectural Tajimi Hosp, Dept Diagnost Radiol, Tajimi, Gifu 5078522, Japan	Takeda, A (reprint author), Gifu Prefectural Tajimi Hosp, Dept Obstet & Gynecol, 5-161 Maebata Cho, Tajimi, Gifu 5078522, Japan.	gyendoscopy@gmail.com					Takeda A, 2010, EUR J OBSTET GYN R B, V152, P152, DOI 10.1016/j.ejogrb.2010.05.032; Takeda A, 2010, FERTIL STERIL, V93, P1324, DOI 10.1016/j.fertnstert.2009.03.065; Avery DM, 2009, OBSTET GYNECOL SURV, V64, P335, DOI 10.1097/OGX.0b013e31819f95ff; Cetin M, 2010, J OBSTET GYNAECOL RE, V36, P1112, DOI 10.1111/j.1447-0756.2010.01256.x; DAVID MP, 1980, OBSTET GYNECOL, V56, P247; Honda T, 2005, J OBSTET GYNAECOL RE, V31, P332, DOI 10.1111/j.1447-0756.2005.00297.x; Huang Q, 2014, INT J GYNECOL OBSTET, V127, P144, DOI 10.1016/j.ijgo.2014.05.010; Itakura A, 2003, OBSTET GYNECOL, V101, P1149, DOI 10.1016/S0029-7844(02)02625-X; JELSEMA RD, 1992, OBSTET GYNECOL, V80, P517; Loureiro T, 2003, FETAL DIAGN THER, V18, P289, DOI 10.1159/000071985; Oyelese Y, 2003, J ULTRAS MED, V22, P981; Sakai A, 2013, J OBSTET GYNAECOL RE, V39, P371, DOI 10.1111/j.1447-0756.2012.01967.x; Sardo AD, 2013, REPROD BIOMED ONLINE, V26, P99, DOI 10.1016/j.rbmo.2012.10.005; Shahraki AD, 2014, J RES MED SCI, V19, P85; Strobelt N, 2001, ACTA OBSTET GYN SCAN, V80, P586, DOI 10.1034/j.1600-0412.2001.080006586.x; Takeda A, 2015, J MINIM INVASIVE GYN; Tinelli A, 2009, FERTIL STERIL, V92; Tsai SW, 2013, TAIWAN J OBSTET GYNE, V52, P505, DOI 10.1016/j.tjog.2013.10.009; Wendell-Smith CP, 1954, BJOG, V61, P87, DOI 10.1111/j.1471-0528.1954.tb07448.x	19	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1553-4650	1553-4669		J MINIM INVAS GYN	J. Mimim. Invasive Gynecol.	MAY-JUN	2015	22	4					678	683		10.1016/j.jmig.2015.01.019		6	Obstetrics & Gynecology	Obstetrics & Gynecology	CI8VJ	WOS:000355049500036		
J	Togami, S; Kobayashi, H; Haruyama, M; Orita, Y; Kamio, M; Douchi, T				Togami, Shinichi; Kobayashi, Hiroaki; Haruyama, Maki; Orita, Yuji; Kamio, Masaki; Douchi, Tsutomu			A Very Rare Case of Endometriosis Presenting With Massive Hemoperitoneum	JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY			English	Article						Acute abdomen; Endometriosis; Laparoscopy; Massive hemoperitoneum; Menstruation	CORPUS-LUTEUM HEMORRHAGE; CONSERVATIVE MANAGEMENT; SCAR ENDOMETRIOSIS; ANTICOAGULATION; THERAPY; PATIENT; DISEASE	Endometriosis is a cause of acute abdomen because of the leakage or rupture of endometriotic cyst and tubo-ovarian abscess. However, massive hemoperitoneum as a cause of acute abdomen with endometriosis is very rare. We herein present a case of a 48-year-old woman who was urgently referred to our clinic with colic, abdominal distension, and hypovolemic shock during menstruation. Ultrasonography revealed massive hemorrhagic ascites. Exploratory laparoscopy was urgently performed to achieve hemostasis. The volume of hemoperitoneum evacuated from the pelvis was 1,890 mL. Although the uterus and bilateral ovaries were normal, fresh bleeding was observed from endometriosis on the left cul-de-sac peritoneum, and hemostasis was successfully performed. The potential occurrence of hemorrhagic shock associated with endometriosis, depending on the implantation site, needs to be recognized. (C) 2015 AAGL. All rights reserved.	[Togami, Shinichi; Kobayashi, Hiroaki; Haruyama, Maki; Orita, Yuji; Kamio, Masaki; Douchi, Tsutomu] Kagoshima Univ, Fac Med, Dept Obstet & Gynecol, Kagoshima 8908520, Japan	Togami, S (reprint author), Kagoshima Univ, Fac Med, Dept Obstet & Gynecol, Sakuragaoka 8-35-1, Kagoshima 8908520, Japan.	togami@m3.kufm.kagoshima-u.ac.jp					Koninckx PR, 1998, HUM REPROD UPDATE, V4, P741, DOI 10.1093/humupd/4.5.741; Gupta A, 2015, ARCH GYNECOL OBSTET, V291, P427, DOI 10.1007/s00404-014-3394-2; HALME J, 1991, ANN NY ACAD SCI, V622, P266, DOI 10.1111/j.1749-6632.1991.tb37870.x; HILL JA, 1984, J REPROD MED, V29, P205; Ho WK, 2009, TAIWAN J OBSTET GYNE, V48, P108, DOI 10.1016/S1028-4559(09)60267-9; Hwang Becky J, 2012, Emerg Radiol, V19, P463, DOI 10.1007/s10140-012-1048-x; Khoo JJ, 2003, AUST NZ J OBSTET GYN, V43, P164, DOI 10.1046/j.0004-8666.2003.00028.x; Lin JN, 2010, J EMERG MED, V38, P30, DOI 10.1016/j.jemermed.2008.03.031; Lin YH, 2010, TAIWAN J OBSTET GYNE, V49, P359, DOI 10.1016/S1028-4559(10)60074-5; Luisi S, 2006, GYNECOL ENDOCRINOL, V22, P284, DOI 10.1080/09513590600777578; Morgan TL, 2013, AM J EMERG MED, V31, p272e1; Muneyyirci-Delale O, 1998, GYNECOL ONCOL, V69, P42, DOI 10.1006/gyno.1998.4953; Philip A, 2006, 18 FIGO WORLD C MOND, P66; Spinelli C, 2009, J PEDIATR ADOL GYNEC, V22, P163, DOI 10.1016/j.jpag.2008.07.013; Sun WC, 2013, J OBSTET GYNAECOL RE, V39, P399, DOI 10.1111/j.1447-0756.2012.01895.x; Terzic M, 2012, CLIN EXP OBSTET GYN, V39, P537; ULRICH U, 1994, J ENDOCRINOL INVEST, V17, P351; Yamakami LYS, 2011, LUPUS, V20, P523, DOI 10.1177/0961203310383300	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1553-4650	1553-4669		J MINIM INVAS GYN	J. Mimim. Invasive Gynecol.	MAY-JUN	2015	22	4					691	693		10.1016/j.jmig.2015.02.014		3	Obstetrics & Gynecology	Obstetrics & Gynecology	CI8VJ	WOS:000355049500039		
J	Abe, K				Abe, Keiko			Functional Food Science in Japan: Present State and Perspectives	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article									[Abe, Keiko] Univ Tokyo, Tokyo 1138654, Japan; [Abe, Keiko] KAST, Rossland, BC, Canada	Abe, K (reprint author), Univ Tokyo, Tokyo 1138654, Japan.							0	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S201	S201				1	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700081		
J	Akeda, Y				Akeda, Yukihiro			Food Safety and Infectious Diseases	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						food safety; foodborne disease; food hygiene; infectious disease		Food hygiene and a sufficient food supply are essential requirements to stay healthy. However, this can be hindered by foodborne infections, which are known to be prevalent throughout the world. The World Health Organization reports that, annually, diarrheal disease is responsible for the deaths of over 2 million people worldwide. The majority of these deaths occur in developing countries, following the ingestion of pathogen-contaminated food and water. In the developed world, outbreaks of foodborne diseases are also frequently documented, reflecting the global importance of following good food hygiene practices.	Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Akeda, Y (reprint author), Osaka Univ, Microbial Dis Res Inst, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	akeda@biken.osaka-u.ac.jp					World Health Organization, 2014, ADV FOOD SAF IN STRA	1	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S95	S95				1	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700039		
J	Amagase, H				Amagase, Harunobu			US Dietary Supplement Labeling Rules and the Possibility of Medical Cost Reduction	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						dietary supplements; health foods; US labeling system	BETA(3)-ADRENERGIC-RECEPTOR GENE	US dietary supplements classified as foods are regulated under the Dietary Supplement Health and Education Act (DSHEA) and other rules. After the DSHEA established in 1994, the supplement market grew by about 4 times and reached $32 billion as of 2012. One of the major reasons for this market expansion is that consumers can recognize functions of the supplements by the structure/function (S/F) claims. S/F claims must not be false or misleading, and must be based upon reliable scientific evidence, especially clinical studies. At the same time, disclaimers must be shown on the package, which are "These statements have not been evaluated by the Food and Drug Administration (FDA). These products are not intended to diagnose, treat, cure or prevent any disease." Both the FDA and Federal Trade Commission (FTC) are responsible for label claims and advertisement of dietary supplements. S/F claims are not medical claims, but these may have impact on people's mindset to be healthier. Recent research shows utilizing dietary supplements in 4 major areas with 10 popular ingredients could hypothetically reduce medical costs by over $50 billion in the US in the period of 2013-2020. Predicted fewer health problems and reduced medical cost information will further increase awareness of supplement usage and thus may raise quality of life. These may reduce the medical cost significantly, if the products are used appropriately with sufficient consumer education.	Amer Chamber Commerce Japan, Tokyo 1060041, Japan	Amagase, H (reprint author), Amer Chamber Commerce Japan, Tokyo 1060041, Japan.	Amagase@i.softbank.jp					YOSHIDA T, 1995, LANCET, V346, P1433, DOI 10.1016/S0140-6736(95)92452-3; Bailey RL, 2013, JAMA INTERN MED, V173, P355, DOI 10.1001/jamainternmed.2013.2299; US Government Accountability Office, 2013, GAO13244; WALSTON J, 1995, NEW ENGL J MED, V333, P343, DOI 10.1056/NEJM199508103330603; WIDEN E, 1995, NEW ENGL J MED, V333, P348, DOI 10.1056/NEJM199508103330604	5	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S136	S138				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700055		
J	Fukuoka, H				Fukuoka, Hideoki			DOHaD (Developmental Origins of Health and Disease) and Birth Cohort Research	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						DOHaD (developmental origins of health and disease); malnutrition in utero; epignentics; birth cohort study; lifestyle-related disease	ADULT LIFE; OBESITY; WEIGHT; SIZE; AGE	Epidemiological and animal experimental studies are disclosing that the malnutrition or overnutrition in utero would induce epigenetic changes of fetus, what is the origin of lifestyle-related disease in adult. Representative birth cohorts studies in DOHaD are explained.	Waseda Univ, Comprehens Res Fdn, Tokyo 1698555, Japan	Fukuoka, H (reprint author), Waseda Univ, Comprehens Res Fdn, Tokyo 1698555, Japan.	fukuoka-htp@aoni.waseda.jp					Eriksson J, 2001, INT J OBESITY, V25, P735, DOI 10.1038/sj.ijo.0801602; Gillman MW, 2004, J PEDIATR-US, V144, P240, DOI 10.1016/j.jpeds.2003.10.064; Roseboom TJ, 2001, MOL CELL ENDOCRINOL, V185, P93, DOI 10.1016/S0303-7207(01)00721-3; Wadhwa PD, 2005, PSYCHONEUROENDOCRINO, V30, P724, DOI 10.1016/j.psyneuen.2005.02.004; BARKER DJP, 1989, LANCET, V2, P577; Inskip HM, 2006, INT J EPIDEMIOL, V35, P42, DOI 10.1093/ije/dyi202; Taveras EM, 2009, PEDIATRICS, V123, P1177, DOI 10.1542/peds.2008-1149; Harvey NC, 2007, J CLIN ENDOCR METAB, V92, P523, DOI 10.1210/jc.2006-0456; Haugen G, 2005, CIRC RES, V96, P12, DOI 10.1161/01.RES.0000152391.45273.A2; Barker DJP, 2001, BRIT MED J, V323, P1273, DOI 10.1136/bmj.323.7324.1273; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Hanson MA, 2014, PHYSIOL REV, V94, P1027, DOI 10.1152/physrev.00029.2013; Drake AJ, 2007, CLIN SCI, V113, P219, DOI 10.1042/CS20070107; Entringer S, 2008, DEV PSYCHOBIOL, V50, P579, DOI 10.1002/dev.20316; Barker D, 1986, LANCET, V8489, P1077, DOI DOI 10.1016/S0140-6736(86)91340-1); Entringer S, 1995, AM J OBSTET GYNECOL, V498; Ruf M, 2011, TRANSL PSYCHIAT, V1, pe21; Wallace JG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004845	18	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S2	S4				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700002		
J	Ghosh, S; Kurpad, A; Tano-Debrah, K; Otoo, GE; Aaron, GA; Toride, Y; Uauy, R				Ghosh, Shibani; Kurpad, Anura; Tano-Debrah, Kwaku; Otoo, Gloria E.; Aaron, Grant A.; Toride, Yasuhiko; Uauy, Ricardo			Role of Protein and Amino Acids in Infant and Young Child Nutrition: Considerations for the Development and Delivery of High Quality Complementary Food Supplements	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						protein; amino acids; protein quality; complementary foods; infant and young child nutrition; KOKO Plus		Prevention of malnutrition in infants and children is multifaceted and requires the following: access to and intake of nutritious food starting at birth with exclusive breast-feeding for the first 6 mo of life, continued breastfeeding in combination with complementary foods from 6-24 mo of age, access to clean drinking water and sanitation, and access to preventive and curative health care (including prenatal). Nutrient-dense complementary foods can improve nutritional status and have long-term benefits; however, in a review of plant-based complementary foods in developing countries, most of them failed to meet many micronutrient requirements. There is need to provide other cost-effective alternatives to increase the quality of the diet during the complementary feeding stage of the lifecycle. This paper provides an overview of the development, testing, efficacy and effectiveness of the delivery of KOKO Plus on the growth and nutritional status of infants 6-24 mo of age.	[Ghosh, Shibani] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Ghosh, Shibani; Uauy, Ricardo] Nevin Scrimshaw Int Nutr Fdn, Boston, MA USA; [Kurpad, Anura] St Johns Med Coll, Bengaluru, India; [Tano-Debrah, Kwaku; Otoo, Gloria E.] Univ Ghana, Dept Nutr & Food Sci, Legon, Accra, Ghana; [Aaron, Grant A.] Global Alliance Improved Nutr, Geneva, Switzerland; [Toride, Yasuhiko] Ajinomoto Inc, Tokyo, Japan	Ghosh, S (reprint author), Tufts Univ, Friedman Sch Nutr Sci & Policy, 150 Harrison Ave, Boston, MA 02111 USA.	Shibani.ghosh@tufts.edup					Gibson RS, 1998, EUR J CLIN NUTR, V52, P764, DOI 10.1038/sj.ejcn.1600645; Briend A, 2003, J PEDIATR GASTR NUTR, V36, P12, DOI 10.1097/00005176-200301000-00006; de Pee S, 2009, FOOD NUTR BULL, V30, pS434; Lutter C.K., 2003, J NUTR, V133, P3011; Suri DJ, 2014, FOOD NUTR BULL, V35, P372; WHO, 2007, WHO TECH REP SER, V935, P1; [World Health Organization Pan American Health Organisation], 2003, GUID PRINC COMPL FEE	7	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S195	S196				2	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700078		
J	Goto, T; Takahashi, N; Kawada, T				Goto, Tsuyoshi; Takahashi, Nobuyuki; Kawada, Teruo			Food Components Modulate Obesity and Energy Metabolism via the Transcriptional Regulation of Lipid-Sensing Nuclear Receptors	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						obesity; food function; nuclear receptors; PPARs	FATTY-ACID REGULATION; PPAR-ALPHA; GENE-TRANSCRIPTION; FLAVONOIDS; ACTIVATION; HEPATOCYTES; RESVERATROL; ADIPONECTIN; BETA/DELTA; EXTRACT	Obesity is a major risk factor for chronic diseases such as diabetes, cardiovascular diseases, and hypertension. Many modern people have a tendency to overeat owing to stress and loosening of self-control. Moreover, energy expenditure varies greatly among individuals. Scientific reduction of obesity is important under these circumstances. Furthermore, recent research on molecular levels has clarified the differentiation of adipocytes, the level of subsequent fat accumulation, and the secretion of the biologically active adipokines by adipocytes. Adipose tissues and obesity have become the most important target for the prevention and treatment of many chronic diseases. We have identified various food-derived compounds modulating nuclear receptors, especially peroxisome proliferators-activated receptor(PPAR), in the regulation of energy metabolism and obesity. In this review, we discuss the PPARs that are most important in obesity and energy metabolism.	[Goto, Tsuyoshi; Takahashi, Nobuyuki; Kawada, Teruo] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Lab Mol Funct Food, Uji 6110011, Japan; [Goto, Tsuyoshi; Takahashi, Nobuyuki; Kawada, Teruo] Kyoto Univ, Ctr Promot Interdisciplinary Educ & Res, Res Unit Physiol Chem, Kyoto, Japan	Kawada, T (reprint author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Lab Mol Funct Food, Uji 6110011, Japan.	fat@kais.kyoto-u.ac.jp					Kim YI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031317; Inoue H, 2003, NEUROSCI LETT, V352, P203, DOI 10.1016/S0304-3940(03)01080-2; Goto T, 2005, BIOCHEM BIOPH RES CO, V337, P440, DOI 10.1016/j.bbrc.2005.09.077; Plaumann B, 1996, ONCOGENE, V13, P1605; Takahashi M, 2002, AM J PHYSIOL-GASTR L, V282, pG338; Liang YC, 2001, FEBS LETT, V496, P12, DOI 10.1016/S0014-5793(01)02393-6; Clarke SD, 2001, J NUTR, V131, P1129; Jump DB, 2005, J NUTR, V135, P2503; Harmon AW, 2001, AM J PHYSIOL-CELL PH, V280, pC807; Kim YI, 2011, MOL NUTR FOOD RES, V55, P585, DOI 10.1002/mnfr.201000264; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Takahashi N, 2009, BIOCHEM BIOPH RES CO, V390, P1372, DOI 10.1016/j.bbrc.2009.10.162; Liu L, 2008, PHYTOTHER RES, V22, P1400, DOI 10.1002/ptr.2504; Danesi F, 2009, BRIT J NUTR, V101, P1736, DOI 10.1017/S0007114508145871; Fang F, 2010, MOL NUTR FOOD RES, V54, P345, DOI 10.1002/mnfr.200900119; Kuroyanagi K, 2008, BIOCHEM BIOPH RES CO, V366, P219, DOI 10.1016/j.bbrc.2007.11.119; Nuclear Receptors Nomenclature Committee, 1999, CELL, V97, P161; Rosen ED, 2005, PROSTAG LEUKOTR ESS, V73, P31, DOI 10.1016/j.plefa.2005.04.004; Sasa M, 2009, J ATHEROSCLER THROMB, V16, P888; Silvia YMC, 1999, J LIPID RES, V40, P1426; Szapary Philippe O., 2001, Current Opinion in Pharmacology, V1, P113, DOI 10.1016/S1471-4892(01)00028-5; Takahashi N, 2011, MOL NUTR FOOD RES, V55, P1791, DOI 10.1002/mnfr.201100401; Tsukamoto T, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-46	23	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S128	S130				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700052		
J	Hashimoto, A; Kambe, T				Hashimoto, Ayako; Kambe, Taiho			Mg, Zn and Cu Transport Proteins: A Brief Overview from Physiological and Molecular Perspectives	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						mineral; zinc; copper; magnesium; transporters and channels	ZINC TRANSPORTERS; MENKES DISEASE; DIETARY ZINC; COPPER; TRPM6; ABSORPTION; MAGNESIUM; DEGRADATION; METABOLISM; GENE	Essential major and trace elements, including magnesium (Mg), zinc (Zn) and copper (Cu), are involved in numerous physiological processes. These elements are important components for maintaining proper protein structure and function. They are also used as catalytic cofactors for enzymes and as mediators in signaling cascades. Thus, systemic homeostasis of these metals is sophisticatedly regulated at a molecular level. A balance between absorption and excretion of these metals is critical, and transport proteins play a key role in this balance. In particular, transport proteins in intestinal epithelial cells are indispensable and ensure adequate metal absorption. Regulation of the expression and activity of these proteins is complicated. Thus, dysfunction of these proteins causes an imbalance in the systemic homeostasis of corresponding metals, and thus likely links to disease pathogenesis. In this review, we briefly describe the importance of mammalian metal transport proteins, including Mg channels, and Zn and Cu transporters, focusing on their roles in the absorption process in intestinal epithelial cells. Specifically, TRPM6 channels in Mg absorption, ZIP4 and ZnT1 transporters for Zn absorption, and CTR1 and ATP7A for Cu absorption are overviewed.	[Hashimoto, Ayako; Kambe, Taiho] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto 6068502, Japan	Kambe, T (reprint author), Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto 6068502, Japan.	kambel@kais.kyoto-u.ac.jp					Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Nose Y, 2006, CELL METAB, V4, P235, DOI 10.1016/j.cmet.2006.08.009; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; Langmade SJ, 2000, J BIOL CHEM, V275, P34803, DOI 10.1074/jbc.M007339200; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Schlingmann KP, 2007, BBA-MOL BASIS DIS, V1772, P813, DOI 10.1016/j.bbadis.2007.03.009; Wang YF, 2012, AM J PHYSIOL-GASTR L, V303, pG1236, DOI 10.1152/ajpgi.00339.2012; Kuo YM, 2006, J NUTR, V136, P21; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Wang XX, 2009, FASEB J, V23, P2650, DOI 10.1096/fj.08-126649; Nose Y, 2006, TRENDS BIOCHEM SCI, V31, P604, DOI 10.1016/j.tibs.2006.09.003; Fukada T, 2011, METALLOMICS, V3, P662, DOI 10.1039/c1mt00011j; Sahni J, 2013, MOL ASPECTS MED, V34, P620, DOI 10.1016/j.mam.2012.05.012; Groenestege WMT, 2006, J AM SOC NEPHROL, V17, P1035, DOI 10.1681/ASN.2005070700; Mao XQ, 2007, J BIOL CHEM, V282, P6992, DOI 10.1074/jbc.M610552200; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Geiser J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002766; Kambe T, 2014, CELL MOL LIFE SCI, V71, P3281, DOI 10.1007/s00018-014-1617-0; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Liuzzi JP, 2001, J NUTR, V131, P46; Mercer JFB, 1998, AM J CLIN NUTR, V67, p1022S; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Volpe S.L., 2013, ADV NUTR, V4, P378, DOI DOI 10.3945/AN.112.003483	26	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S116	S118				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700048		
J	Hashimoto, K				Hashimoto, Koshi			Epigenomic Regulation of Hepatic Lipid Metabolism and Its Clinical Application	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						DNA demethylation; PPAR alpha; FGF21			Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Preempt Med & Metab, Tokyo 1138510, Japan	Hashimoto, K (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Preempt Med & Metab, Tokyo 1138510, Japan.	khashimoto.mem@tmd.ac.jp						0	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S81	S81				1	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700033		
J	Hayashi, F; Takemi, Y				Hayashi, Fumi; Takemi, Yukari			Why Is Creating a Healthy Food Environment So Crucial to Making Improvements in Diet-Related NCDs?	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						non-communicable diseases; nutrition policy; food environment		Non-communicable diseases (NCDs) such as cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes are the leading cause of death worldwide. To decrease the global burden of NCDs and strengthen national efforts to combat NCDs, the World Health Organization (WHO) released the Global Action Plan for the Prevention and Control of NCDs 2013-2020. This plan provides established procedures and several policy options for member countries and other partners. Although many countries recognize that prevention of NCDs is an important health priority, their governments currently face a challenge: How do they adopt a multi-sectoral approach to promoting a healthy lifestyle among their populations? For this, all sectors of the food system (primary production, food processing, distribution, marketing, retail, catering, and food service) need to coordinate with each other for future governance. Since regulatory policy intervention areas for diet-related NCDs are widespread throughout the global food system, for future perspectives, comprehensive and coordinated approaches are needed for policy development and implementation across all levels of governments and food sectors in order to ensure sustainable policy action.	[Hayashi, Fumi] Chiba Prefectural Univ Hlth Sci, Chiba 2610014, Japan; [Takemi, Yukari] Kagawa Nutr Univ, Sakado, Saitama 3500288, Japan	Hayashi, F (reprint author), Chiba Prefectural Univ Hlth Sci, Chiba 2610014, Japan.	fumi.hayashi@cpuhs.ac.jp					Kelly B, 2014, HEALTH PROMOT INT, DOI [10.1093/heapro/dau055, DOI 10.1093/HEAPRO/DAU055]; Osawa E., 2014, Japanese Journal of Nutrition and Dietetics, V72, P147, DOI 10.5264/eiyogakuzashi.72.147; Ronit K, 2014, EUR J CLIN NUTR, V68, P753, DOI 10.1038/ejcn.2014.60; Savoie N, 2013, CAN J PUBLIC HEALTH, V104, pE359	4	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S36	S38				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700016		
J	Ikebe, K				Ikebe, Kazunori			Significance of Oral Function for Dietary Intakes in Old People	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						occlusal force; dietary intake; vegetable; elderly; multivariate analysis	TOOTH LOSS; MASTICATORY PERFORMANCE; OCCLUSAL FORCE; NUTRITIONAL-STATUS; SALIVARY FLOW; ASSOCIATION; ADULTS; TEETH; JAPANESE; NUTRIENTS	There is growing interest in the connection between oral health and systemic health. In recent years, oral health in particular is considered a predictor of circulatory mortality. Two major pathways may mediate this relationship, namely (1) the inflammatory effects of chronic periodontal infection on the circulatory system and (2) the effects of masticatory dysfunction on dietary behavior, nutrition and systemic diseases. Previous studies have shown that adults who are edentulous, or have fewer natural teeth are less likely to eat fruits, vegetables and meats. Because it can be easily assessed, the number of teeth has frequently been used as an indicator of oral health in investigations of food intake. However, the number of teeth alone presents a misleading picture. The role of prosthetic rehabilitation (i.e., dentures) on oral function must be taken into account as well. We investigated the association of occlusal force with food and nutrient intakes after adjusting for the number of teeth in independently living 70-y-old Japanese. After adjusting for socioeconomic status and the number of remaining teeth, decline of occlusal force was significantly associated with lower intakes of vegetables, vitamins A, C, and B6, folate, and dietary fiber (p for trend<0.05). It is concluded that occlusal force as a representative of oral function was significantly associated with intakes of vitamins and dietary fiber rather than number of remaining teeth.	Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, Osaka 5650871, Japan	Ikebe, K (reprint author), Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, Osaka 5650871, Japan.	ikebe@dent.osaka-u.ac.jp					Ikebe K, 2006, INT J PROSTHODONT, V19, P475; Inomata C, 2014, J DENT, V42, P556, DOI 10.1016/j.jdent.2014.02.015; Ikebe K, 2011, ARCH ORAL BIOL, V56, P991, DOI 10.1016/j.archoralbio.2011.03.019; Polzer I, 2012, CLIN ORAL INVEST, V16, P333, DOI 10.1007/s00784-011-0625-9; WILLETT WC, 1994, SCIENCE, V264, P532, DOI 10.1126/science.8160011; Sahyoun NR, 2003, J AM DIET ASSOC, V103, P61, DOI 10.1053/jada.2003.50003; Nowjack-Raymer RE, 2007, J DENT RES, V86, P1171; Ervin RB, 2012, GERODONTOLOGY, V29, pE693, DOI 10.1111/j.1741-2358.2011.00546.x; Hung HC, 2005, COMMUNITY DENT ORAL, V33, P167, DOI 10.1111/j.1600-0528.2005.00200.x; Ikebe K, 2012, J DENT, V40, P71, DOI 10.1016/j.jdent.2011.10.007; Wakai K, 2010, COMMUNITY DENT ORAL, V38, P43, DOI 10.1111/j.1600-0528.2009.00512.x	11	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S74	S75				2	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700030		
J	Inoue, M				Inoue, Makoto			Dysphagia Rehabilitation in Japan	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						dysphagia; pneumonia; elderly		In Japan, one of the most common causes of death in elderly people is aspiration pneumonia. Maintenance of oral hygiene and feeding functions are important elements, especially in patients with dysphagia caused by stroke, neurological diseases, and after operations on the head and neck cancer, as well as in the elderly to prevent aspiration pneumonia. It should also be noted that not only oral health care and physical therapy related to feeding functions but also dental treatment is included in the clinical management during interventions whenever needed. On the other hand, for the patients and/or elderly in need of assistance in maintaining a safe diet, it is recommended that a specialized team comprising physicians, dentists, and speech therapists in functional rehabilitation observes meal conditions of the subjects and evaluates such factors as meal contents, posture during meals, usage of dishes and cutlery, meal times, status of consciousness, perception, and motivation. First, I will present the clinical interventions to those patients, which include oral health care, dental treatment, physical therapy and meal assistance, as well as team approaches in those circumstances. In addition, clinical and basic research results will be introduced, which are expected to foster the understanding of physiology in chewing and swallowing. These results are also expected to develop the clinical technology to maintain or recover the feeding functions.	Niigata Univ, Grad Sch Med & Dent Sci, Div Dysphagia Rehabil, Niigata 9518514, Japan	Inoue, M (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Dysphagia Rehabil, Niigata 9518514, Japan.	inoue@dent.niigata-u.ac.jp					Palmer JB, 2000, AM FAM PHYSICIAN, V61, P2453; Yoneyama T, 1999, LANCET, V354, P515, DOI 10.1016/S0140-6736(05)75550-1; Ueda Koichiro, 2004, Gerodontology, V21, P108, DOI 10.1111/j.1741-2358.2004.00016.x	3	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S72	S73				2	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700029		
J	Ishaawa, M; Kusama, K; Shikanai, S				Ishaawa, Midori; Kusama, Kaoru; Shikanai, Saiko			Food and Nutritional Improvement Action of Communities in Japan: Lessons for the World	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						community-based food and nutrition actions; Healthy Japan 21 (second term); Shokuiku promotion; training for an empowerment-enabling environment; Sharing experience internationally		In Japan, the national health policy "Healthy Japan 21 (second term)" was introduced in 2013 to support prevention of lifestyle-related disease. Policy has also been recently revised on the promotion of nutrition education (shokuiku). Community-based food and nutrition actions were developed based on those policies and aimed to reinforce the linkages across the food chain, looking along its length "from field to food", including production, processing, preparation, eating and disposal. Local government is responsible for identifying the important food and nutritional problems, to devise and group effective actions on the basis of local health issues. The National Institute of Public Health (NIPH) is responsible for carrying out public health staff training on policy-based health issues. Training carried out by the NIPH, the Japan Dietetic Association and the Japan Public Health Association was designed to create an enabling environment for nutrition action. The community-based actions, including nutrition education and information, are carried out by several bodies, including local government, schools, facilities, volunteer groups, residents' associations, and commercial companies, to establish sustainable food systems promoting healthy diets. The community-empowering actions and effective cooperation are reported as good practice models in an annual white paper by the Cabinet Office. Japanese dieticians are expected to share their experiences of local nutrition improvement activities in Japan with international colleagues. Experience from elsewhere, including from Japanese dieticians working in developing countries, should also be applied on their return.	[Ishaawa, Midori] Natl Inst Publ Hlth, Wako, Saitama 3510197, Japan; [Kusama, Kaoru] Aomori Univ Hlth & Welf, Aomori 0308505, Japan; [Shikanai, Saiko] Jumonji Univ, Niza 3528510, Japan	Ishaawa, M (reprint author), Natl Inst Publ Hlth, 2-3-6 Minami, Wako, Saitama 3510197, Japan.	ishikawa@niph.go.jp					Cabinet office, 2014, SHOK PROM POL; Cabinet office, 2014, SHOK PROM POL FY 201; Ishikawa M, 2012, JPN J PUB HLTH, V59, P92; Ishikawa M, 2014, RES PROJECTS SUPPORT; Kusama K, 2011, J JPN DIETETIC ASS, V5404, P17; Ministry of Health Labour and Welfare, 2012, BAS DIR COMPR IMPL N; National Institute of Public Health, 2014, ED TRAIN SYST; Takemi Y, 2014, RES MONITORING POLIT	8	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S55	S57				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700023		
J	Ishida, H				Ishida, Hiromi			Role of School Meal Service in Nutrition	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						school meal service; food and nutrition education; nutrition teacher	CHILDREN	School meal service programs are essential for children's long-term nutrition and health promotion. The programs vary in content, depending on the economic condition, health condition and the food supply situation in each country. Children are encouraged to improve their nutrition, and choose healthy foods and learn good dietary habits through school meals and nutrition education. In Japan, the school lunch program started in 1889. The percentage of elementary schools serving school lunches had reached 99.2% in 2014, and the Nutrition Teacher system started in 2004. Nutrition teachers are to play the roles of teachers on food and nutrition education in addition to managers of foodservice operations in schools. Nutrition teachers are expected to have effects on school nutrition programs by providing meal service together with nutrition education. And so, significant effort is needed from both academia and the field to raise the related nutritional issues.	Kagawa Nutr Univ, Sakado, Saitama 3500288, Japan	Ishida, H (reprint author), Kagawa Nutr Univ, Sakado, Saitama 3500288, Japan.	ishida@eiyo.ac.jp					Yoon J, 2012, ASIA PAC J CLIN NUTR, V21, P128; Evans CEL, 2012, AM J CLIN NUTR, V96, P889, DOI 10.3945/ajcn.111.030270; [Anonymous], 2011, STUD COLL C DIET REF; Andersen R, 2014, BRIT J NUTR, V111, P1967, DOI 10.1017/S0007114514000634; Federation of Prefectural School Lunch Association of Japan, HIST SCH LUNCH SERV; Ministry of Education, 2014, NUMB NUTR TEACH; Ministry of Education Culture Sports Science and Tecnology, 2012 SCH LUNCH IMPL; Ministry of Education Culture Sports Science and Tecnology, 2013 SCH HLTH STAT; Ministry of Education Culture Sports Science and Tecnology, 2005, SCH HLTH STAT; Ministry of Education Culture Sports Science and Tecnology, 2013 SCH LUNCH IMPL; Nozue M, 2013, J NUTR SCI VITAMINOL, V59, P22, DOI 10.3177/jnsv.59.22; Nozue M., 2010, Japanese Journal of Nutrition and Dietetics, V68, P298, DOI 10.5264/eiyogakuzashi.68.298; School Food Trust, GUID INTR GOV FOOD B; Spence S, 2013, PLOS ONE, V8, P1; United States Department of Agriculture, NAT SCH LUNCH PROGR; United States Department of Agriculture, NUTR STAND NAT SCH L; Woodward-Lopez G, 2014, J ACAD NUTR DIET, V114, P1349, DOI 10.1016/j.jand.2014.05.002	17	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S20	S22				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700010		
J	Ishihara, J				Ishihara, Junko			Challenges in Dietary Exposure Assessment in Epidemiology: Research Trends	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						nutrition epidemiology; dietary assessment; food frequency questionnaire; 24-h dietary recall; biomarker	FOOD FREQUENCY QUESTIONNAIRE; CANCER; RECALL; BIOMARKERS; NUTRITION; PROTEIN; ENERGY	Although exposure assessment of the usual diet is an essential component of nutrition epidemiology, it remains one of the most challenging issues in the field. Dietary exposure is widely measured using Food Frequency Questionnaires (FFQs), which impose a low burden on respondents and are inexpensive in large-scale studies. FFQs have long satisfied the needs of epidemiological research, and have helped deliver the tremendous recent growth in knowledge of the diet-disease association. However, issues surrounding measurement errors with FFQs have attracted substantial research interest around the world. Attenuation of the diet-disease association due to measurement errors identified in Western populations has led to extended methodological investigations comparing the performance of FFQs with biomarkers. The need for better dietary assessment methods has increased. Dietary records or recall provide relatively accurate estimates of intake for specific days, and of the usual diet if collected on multiple days. Until recently, however, their use in large-scale studies was not feasible, mainly due to cost. One innovative tool which may overcome the limitations of dietary records or recall is computerized 24-h dietary recall systems. These systems have been demonstrated to provide high-quality dietary intake data among Western populations. Incorporation of such new technology into large-scale epidemiological studies would make multiple-day administration of 24-h recall feasible in terms of cost. Research efforts to improve dietary assessment among Japanese and Asian populations are still under development. The development of innovative methods for Japanese remains an urgent research challenge.	Sagami Womens Univ, Dept Nutr Sci, Minami Ku, Sagamihara, Kanagawa 2520383, Japan	Ishihara, J (reprint author), Sagami Womens Univ, Dept Nutr Sci, Minami Ku, 2-1-1 Bunkyo, Sagamihara, Kanagawa 2520383, Japan.	ishihara_junko@isc.sagami-wu.ac.jp					Bingham SA, 2003, LANCET, V362, P212, DOI 10.1016/S0140-6736(03)13913-X; Schatzkin A, 2003, INT J EPIDEMIOL, V32, P1054, DOI 10.1093/ije/dyg264; Subar AF, 2003, AM J EPIDEMIOL, V158, P1, DOI 10.1093/aje/kwg092; Wakai K, 2009, J EPIDEMIOL, V19, P1, DOI 10.2188/jea.JE20081007; Prentice RL, 2011, AM J EPIDEMIOL, V174, P591, DOI 10.1093/aje/kwr140; Subar AF, 2012, J ACAD NUTR DIET, V112, P1134, DOI 10.1016/j.jand.2012.04.016; Carroll RJ, 2012, AM J EPIDEMIOL, V175, P340, DOI 10.1093/aje/kwr317; Kipnis V, 2003, AM J EPIDEMIOL, V158, P14, DOI 10.1093/aje/kwg091; Day NE, 2001, INT J EPIDEMIOL, V30, P309, DOI 10.1093/ije/30.2.309; Crispim SP, 2014, BRIT J NUTR, V111, P506, DOI 10.1017/S0007114513002766; Schatzkin A, 2009, CANCER EPIDEM BIOMAR, V18, P1026, DOI 10.1158/1055-9965.EPI-08-1129; Willett W, 2013, NUTR EPIDEMIOLOGY	12	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S33	S35				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700015		
J	Ishimi, Y				Ishimi, Yoshiko			Osteoporosis and Lifestyle	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						osteoporosis; bone; nutrition; physical activity; lifestyle	POSTMENOPAUSAL JAPANESE WOMEN; BONE-MINERAL DENSITY; CONTROLLED TRIAL; METABOLISM; SUPPLEMENTATION; VITAMIN-K-2; ISOFLAVONE	Skeletal tissue is formed during the first two decades of life; then a constant bone mass is maintained until 40 y of age. In the case of women, the bone mass is rapidly reduced at menopause at around 50 y of age. After that, bone mass slowly decreases in both men and women who have passed the 70-y-old mark. The National Institute of Health Consensus Conference adopted the definition of osteoporosis as a skeletal disorder that is characterized by compromised bone strength leading to a predisposition for and an increased risk of fracture. Since osteoporotic fractures are the third-highest cause for becoming bedridden, the maintenance of healthy bones is an important factor in extending a person's healthy lifespan. Bone mass is influenced by many factors, such as nutrition, physical activity, smoking and alcohol intake, as well as by genetic factors. Thus, a healthy diet providing balanced nutrients including calcium, vitamin D, vitamin K and protein, regular physical activity, and not smoking help maintain bone health and delay or prevent osteoporosis. Some functional foods containing soy isoflavones, milk basic protein and n-3 fatty acid may help promote bone health.	Natl Inst Hlth & Nutr, Dept Food Funct & Labelling, Shinjyuku Ku, Tokyo 1628636, Japan	Ishimi, Y (reprint author), Natl Inst Hlth & Nutr, Dept Food Funct & Labelling, Shinjyuku Ku, 1-23-1 Toyama, Tokyo 1628636, Japan.	ishimi@nih.go.jp					Wu J, 2006, J BONE MINER RES, V21, P780, DOI 10.1359/JBMR.060208; Kruger MC, 1997, PROG LIPID RES, V36, P131, DOI 10.1016/S0163-7827(97)00007-6; Aoe S, 2001, BIOSCI BIOTECH BIOCH, V65, P913, DOI 10.1271/bbb.65.913; Okano T, 2008, J BIOL CHEM, V283, P11270, DOI 10.1074/jbc.M702971200; Moayyeri A, 2008, ANN EPIDEMIOL, V18, P827, DOI 10.1016/j.annepidem.2008.08.007; Tsugawa N, 2008, J BONE MINER METAB, V26, P79, DOI 10.1007/s00774-007-0790-8; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Booth SL, 2003, J NUTR, V133, P2565; Koitaya N, 2014, J BONE MINER METAB, V32, P142, DOI 10.1007/s00774-013-0472-7; Ministry of Health, 2015, DIET REF INT JAP; NIH Consensus Statement, 2000, OST PREV DIAGN THER, V17, P1; Orimo H., 2011, LIFE SCI, P64; Ozuru R, 2002, ENDOCR J, V49, P363, DOI 10.1507/endocrj.49.363; Rauh MJ, 2010, J ATHL TRAINING, V45, P243, DOI 10.4085/1062-6050-45.3.243; Taku K, 2010, ASIA PAC J CLIN NUTR, V19, P33; Wu Jian, 2000, Tairyoku Kagaku, V49, P543	16	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S139	S141				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700056		
J	Kambe, T; Fukue, K; Ishida, R; Miyazaki, S				Kambe, Taiho; Fukue, Kazuhisa; Ishida, Riko; Miyazaki, Shiho			Overview of Inherited Zinc Deficiency in Infants and Children	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						zinc deficiency; infants; children; acrodermatitis enteropathica; transient neonatal zinc deficiency	ACRODERMATITIS-ENTEROPATHICA; PUBLIC-HEALTH; TRANSPORTERS; MOUSE; MILK; GENE; SUPPLEMENTATION; IDENTIFICATION; DERMATITIS; MUTATION	Zinc nutrition is of special practical importance in infants and children. Poor zinc absorption causes zinc deficiency, which leads to a broad range of consequences such as alopecia, diarrhea, skin lesions, taste disorders, loss of appetite, impaired immune function and neuropsychiatric changes and growth retardation, thus potentially threatening life in infants and children. In addition to dietary zinc deficiency, inherited zinc deficiency, which rarely occurs, is found during the infant stage and early childhood. Recent molecular genetic studies have identified responsible genes for two inherited zinc deficiency disorders, acrodermatitis enteropathica (AE) and transient neonatal zinc deficiency (TNZD), clarifying the pathological mechanisms. Both of these zinc deficiencies are caused by mutations of zinc transporters, although the mechanisms are completely different. AE is an autosomal recessive disorder caused by mutations of the ZIP4 gene, consequently resulting in defective absorption of zinc in the small intestine. In contrast, TNZD is a disorder caused by mutations of the ZnT2 gene, which results in low zinc breast milk in the mother, consequently causing zinc deficiency in the breast-fed infant. In both cases, zinc deficiency symptoms are ameliorated by a daily oral zinc supplementation for the patients. Zinc is definitely one of the key factors for the healthy growth of infants and children, and thus zinc nutrition should receive much attention.	[Kambe, Taiho; Fukue, Kazuhisa; Ishida, Riko; Miyazaki, Shiho] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto 6068502, Japan	Kambe, T (reprint author), Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto 6068502, Japan.	kambe1@kais.kyoto-u.ac.jp					Ackland ML, 2006, GENES NUTR, V1, P41, DOI 10.1007/BF02829935; LONNERDAL B, 1982, AM J CLIN NUTR, V36, P1170; Moran VH, 2012, NUTRIENTS, V4, P841, DOI 10.3390/nu4080841; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Wardlaw T, 2010, LANCET, V375, P870, DOI 10.1016/S0140-6736(09)61798-0; Chowanadisai W, 2006, J BIOL CHEM, V281, P39699, DOI 10.1074/jbc.M605821200; Penny ME, 2013, ANN NUTR METAB, V62, P31, DOI 10.1159/000348263; Wang FD, 2004, HUM MOL GENET, V13, P563, DOI 10.1093/hmg/ddh049; Iglesia I, 2010, MATERN CHILD NUTR, V6, P84, DOI [10.1111/j.1740-8709.2010.00273.x, 10.1111/j.1/40-8/09.2010.00273.x]; Huang LP, 1997, NAT GENET, V17, P292, DOI 10.1038/ng1197-292; Fukada T, 2011, METALLOMICS, V3, P662, DOI 10.1039/c1mt00011j; Lasry I, 2012, J BIOL CHEM, V287, P29348, DOI 10.1074/jbc.M112.368159; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Maverakis E, 2007, J AM ACAD DERMATOL, V56, P116, DOI 10.1016/j.jaad.2006.08.015; Andrews GK, 2008, BIOCHEM SOC T, V36, P1242, DOI 10.1042/BST0361242; Barbarot S, 2010, PEDIATR DERMATOL, V27, P380, DOI 10.1111/j.1525-1470.2010.01174.x; Itsumura N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064045; Kambe T, 2014, CELL MOL LIFE SCI, V71, P3281, DOI 10.1007/s00018-014-1617-0; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Kawamura T, 2012, J CLIN INVEST, V122, P722, DOI 10.1172/JCI58618; Kienast A, 2007, EUR J PEDIATR, V166, P189, DOI 10.1007/s00431-006-0218-9	22	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S44	S46				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700019		
J	Kido, Y				Kido, Yasuhiro			The Issue of Nutrition in an Aging Society	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						long-term care insurance system; longevity; malnutrition; frailty; sarcopenia		Viewed from a global perspective, Japan is often considered a country where the progression towards a low birthrate and longevity has been prominent. In 2007, the ratio of the aged population reached 21.5%, propelling Japan into the classification of a super aging society. The long-term care insurance system in Japan was initiated in the year 2000, as a general long-term care service system for the whole society, covering the nutrition, medical care, and welfare fields. The goal of nutrition in an aged society is the extension of healthy life expectancy. The ratio of elderly citizens with malnutrition is high. Due to the loss of teeth, and a decrease in digestive and physical functions, there is often a decrease in appetite, and the inability to obtain enough nutrition for physical homeostasis is related to such conditions as frailty and the partial loss of physical functions due to sarcopenia, as well as a decrease in the quality of life (QOL). The elderly can easily fall into a state of protein and energy malnutrition (PEM), due to a variety of causes. Accordingly, it is important to adopt an appropriate approach that ensures a correct understanding of the causes of malnutrition and the special characteristics of malnutrition in the elderly.	Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto 6068522, Japan	Kido, Y (reprint author), Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto 6068522, Japan.	kido@kpu.ac.jp					Linda P., 2001, J GERONTOL A-BIOL, V5 6A, pM146	1	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S176	S177				2	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700070		
J	Kruger, MC; Tousen, Y; Katsumata, S; Tadaishi, M; Kasonga, AE; Deepak, V; Coetzee, M; Ishimi, Y				Kruger, M. C.; Tousen, Y.; Katsumata, S.; Tadaishi, M.; Kasonga, A. E.; Deepak, V.; Coetzee, M.; Ishimi, Y.			Effects of Soy Phytoestrogens and New Zealand Functional Foods on Bone Health	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						kiwifruit; omega 3 fats; osteoclasts; bone; soy phytoestrogens	N-3 FATTY-ACIDS; EQUOL PRODUCTION; MINERAL DENSITY; OVARIECTOMIZED MICE; ISOFLAVONES; METABOLISM; DAIDZEIN; WOMEN; OSTEOPOROSIS; SUPPLEMENTS	New Zealand is a rich source of food components that may have bioactivity on bone. Docosahexaenoic acid (DHA) from fish oil has been shown to maintain bone in ovariectomised (OVX) rats. Kiwifruit, a source of fibre and carotenoids, may also affect bone via a prebiotic as well as direct cell-based mechanisms. We aimed to 1) ascertain the effects of DHA on two cell models, including interactions with soy isoflavones; 2) and investigate the specific effects of carotenoids from kiwifruit as well as whole kiwifruit in cell-based and rodent models as well as in a human study. RAW 264.7 mouse monocytes or mouse bone marrow was used to generate osteoclasts (OC). Cells were exposed to the agents between 5 and 21 d and formation and activity of OC measured, including molecular markers. DHA inhibited OC formation in both cell models, including expression of cathepsin K, NFATc1 as well as actin ring formation. Combination with isoflavones enhanced these effects. In OVX rats and mice fed with kiwifruit for 8 wk, green kiwifruit reduced the rate of bone loss after OVX, and in mice it reduced C-telopeptide of Type 1 collagen (CTX) levels and RANKL expression while in menopausal women, green kiwifruit affected blood lipids and bone markers positively.	[Kruger, M. C.] Massey Univ, Sch Food & Nutr, Palmerston North, New Zealand; [Kruger, M. C.] Univ Pretoria, Fac Hlth Sci, Dept Human Nutr, ZA-0002 Pretoria, South Africa; [Tousen, Y.; Ishimi, Y.] Natl Inst Hlth & Nutr, Dept Food Funct & Labelling, Tokyo 1628636, Japan; [Katsumata, S.; Tadaishi, M.] Tokyo Univ Agr, Fac Appl Biosci, Dept Nutr Sci, Tokyo 1568502, Japan; [Kasonga, A. E.; Deepak, V.; Coetzee, M.] Univ Pretoria, Fac Hlth Sci, Dept Physiol, ZA-0002 Pretoria, South Africa	Kruger, MC (reprint author), Massey Univ, Sch Food & Nutr, Palmerston North, New Zealand.	m.c.kruger@massey.ac.nz					Beral V, 2005, LANCET, V365, P1543; Setchell KDR, 2002, J NUTR, V132, P3577; Boeyens JCA, 2014, NUTRIENTS, V6, P2584, DOI 10.3390/nu6072584; Rowland IR, 2000, NUTR CANCER, V36, P27, DOI 10.1207/S15327914NC3601_5; Benassayag C, 2002, J CHROMATOGR B, V777, P233, DOI 10.1016/S1570-0232(02)00340-9; Sahni S, 2009, OSTEOPOROSIS INT, V20, P1853, DOI 10.1007/s00198-009-0897-y; Sahni S, 2009, AM J CLIN NUTR, V89, P416, DOI 10.3945/ajcn.2008.26388; Tousen Y, 2011, MENOPAUSE, V18, P563, DOI 10.1097/gme.0b013e3181f85aa7; Kruger MC, 1997, PROG LIPID RES, V36, P131, DOI 10.1016/S0163-7827(97)00007-6; Tadaishi M, 2014, J CLIN BIOCHEM NUTR, V54, P109, DOI 10.3164/jcbn.13-94; Booth SL, 2009, ANNU REV NUTR, V29, P89, DOI 10.1146/annurev-nutr-080508-141217; Yamaguchi M, 1998, BIOCHEM PHARMACOL, V55, P71, DOI 10.1016/S0006-2952(97)00402-4; Atkinson C, 2005, EXP BIOL MED, V230, P155; Fujioka M, 2004, J NUTR, V134, P2623; Lee Yuan Kun, 2012, Microbial Ecology in Health and Disease, V23, P15, DOI 10.3402/mehd.v23i0.18572; Ohta A, 2002, J NUTR, V132, P2048; Salari P, 2008, MED SCI MONITOR, V14, pRA37; Taku K, 2010, ASIA PAC J CLIN NUTR, V19, P33; Tousen Y, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-127; Tousen Y, 2014, INT J FOOD SCI NUTR, V65, P360, DOI 10.3109/09637486.2013.858238; Tousen Y, 2012, J NUT SCI, V1, P1; Weiss LA, 2005, AM J CLIN NUTR, V81, P934; Wolber FM, 2013, ADV FOOD NUTR RES, V68	23	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S142	S144				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700057		
J	Ly, KR; Saito, S; Kusama, K				Ly, Koung Ry; Saito, Shino; Kusama, Kaoru			Cooperation between Japanese and Cambodian Dietitians in Setting up a Hospital Diet Management System	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						stunted; National Nutrition Strategy; dietitian; hospital diet; Cambodian eating habits		Cambodia faces a considerably high percentage of the stunted under 5 (Unicef, 2014). Despite the National Nutrition Strategy Launched by the Ministry of Health in cooperation with development partners, nutrition improvement projects have not always been effective. It is generally said these issues are addressed in many other developing nations, and the literature largely documented that successful nutrition programmes are community-based programmes because of their sustainability and the intensive communications between health workers and beneficiaries. Learning from the past experiences, the Foundation for International Development/Relief organized a project team with a Cambodian dietitian and an experienced Japanese dietitian to implement a hospital diet programme for children from April 2006 to March 2014 in the National Pediatric Hospital (NPH) in Cambodia. The project has two objectives: establishing a hospital diet management system, and developing the capacity of NPH staff. Hospital food menus were created paying particular attention to Cambodian culture, eating habits and accessibility to the ingredients for the purpose of continuous supply. We have also put emphasis on the communication between dietitians and family members of the children to let them understand the importance of a nutritious diet. After 8 y of project implementation, the hospital diet management system was established providing 7 types of menu with nutritious diets. The final evaluation of the project showed that NPH staff have the intention to continue hospital food supply with their acquired knowledge and capacity. In practice, a Cambodian dietitian currently takes the initiative for a continuous nutritional diet in NPH. The key to this success is the collaboration between Japanese dietitians with experience and Cambodian dietitians with knowledge of Cambodian eating habits. Taking our experience into account, it is highly recommended to educate Cambodian dietitians, as they are extremely scarce, and to increase the awareness of health care staff towards the importance of nutrition management.	[Ly, Koung Ry; Saito, Shino] Fdn Int Dev Relief, Khan Tuol Kork, Phnom Penh, Cambodia; [Kusama, Kaoru] Aomori Univ Hlth & Welf, Aomori 0308505, Japan	Ly, KR (reprint author), Fdn Int Dev Relief, 82F St 210,Sangkat Teuk La Ak 3, Khan Tuol Kork, Phnom Penh, Cambodia.	lykoungry@fidr.org.kh					[Anonymous], CAMB DEM HLTH SURV 2; Foundation for International Development/Relief, HOSP DIET ASS PROJ	2	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S58	S59				2	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700024		
J	Makanae, Y; Fujita, S				Makanae, Yuhei; Fujita, Satoshi			Role of Exercise and Nutrition in the Prevention of Sarcopenia	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						muscle protein synthesis; amino acids; exercise; sarcopenia	MUSCLE PROTEIN-SYNTHESIS; HUMAN SKELETAL-MUSCLE; ESSENTIAL AMINO-ACIDS; RESISTANCE EXERCISE; CARBOHYDRATE INGESTION; INSULIN-RESISTANCE; LEUCINE; STIMULATION; METABOLISM	The age-associated loss of skeletal muscle mass and strength (sarcopenia) has been shown to increase the risk of injury due to falls and incidence of metabolic complications including insulin resistance and diabetes, which subsequently becomes a significant factor to disability among the elderly population. Nutrient intake is the most important anabolic stimulus for skeletal muscle. Specifically, the amino acid leucine and meal-induced insulin both independently stimulate muscle protein synthesis. However, age-specific changes in muscle anabolic responses to leucine become apparent when sub-maximal amounts of amino acids are administered in older subjects. Furthermore, insulin resistance of muscle protein metabolism with aging has been demonstrated in healthy non-diabetic older subjects. Resistance exercise is another anabolic stimulus which increases myofibrillar muscle protein synthesis in both young and older individuals. The increased muscle anabolism is apparent within 2-3 h after a single bout of heavy resistance exercise and remains elevated up to 2 d following the exercise. The mTOR signaling pathway in skeletal muscle is associated with an increased rate of muscle protein synthesis during the early recovery phase following a bout of resistance exercise. Finally, recent evidence on the cumulative effect of resistance exercise in combination with nutritional supplement on muscle protein metabolism will be discussed to propose a possible preventative measure against sarcopenia.	[Makanae, Yuhei] Ritsumeikan Univ, Ritsumeikan Global Innovat Res Org, Kusatsu, Shiga, Japan; [Makanae, Yuhei; Fujita, Satoshi] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga, Japan	Makanae, Y (reprint author), Ritsumeikan Univ, Ritsumeikan Global Innovat Res Org, Kusatsu, Shiga, Japan.	safujita@fc.ritsumei.ac.jp					Ogasawara R, 2014, AM J PHYSIOL-ENDOC M, V306, pE1155, DOI 10.1152/ajpendo.00647.2013; Drummond MJ, 2009, J PHYSIOL-LONDON, V587, P1535, DOI 10.1113/jphysiol.2008.163816; Dreyer HC, 2008, AM J PHYSIOL-ENDOC M, V294, pE392, DOI 10.1152/ajpendo.00582.2007; Anthony TG, 2001, J NUTR, V131, P1171; Dreyer HC, 2006, J PHYSIOL-LONDON, V576, P613, DOI 10.1113/jphysiol.2006.113175; Rasmussen BB, 2006, FASEB J, V20, P768, DOI 10.1096/fj.05-4607fje; Fujita S, 2007, DIABETES, V56, P1615, DOI 10.2337/db06-1566; Drummond MJ, 2009, J APPL PHYSIOL, V106, P1374, DOI 10.1152/japplphysiol.91397.2008; Volpi E, 2003, AM J CLIN NUTR, V78, P250; MacDougall J D, 1995, Can J Appl Physiol, V20, P480; Fujita S, 2009, J APPL PHYSIOL, V106, P1730, DOI 10.1152/japplphysiol.90395.2008; Katsanos CS, 2006, AM J PHYSIOL-ENDOC M, V291, pE381, DOI 10.1152/ajpendo.00488.2005; Reitelseder S, 2011, AM J PHYSIOL-ENDOC M, V300, pE231, DOI 10.1152/ajpendo.00513.2010	13	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S125	S127				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700051		
J	Miyachi, M; Tripette, J; Kawakami, R; Murakami, H				Miyachi, Motohiko; Tripette, Julien; Kawakami, Ryoko; Murakami, Haruka			"+10 min of Physical Activity per Day": Japan Is Looking for Efficient but Feasible Recommendations for Its Population	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						physical activity; guideline; NCD; health promotion	PROSPECTIVE COHORT; ALL-CAUSE; METAANALYSIS; MORTALITY; RISK; CANCER; ASSOCIATION	Prospective cohort studies have shown that people with a larger amount of physical activity (PA) and exercise have lower risks of non-communicable diseases (NCDs). In Japan, the Ministry of Health, Labour and Welfare published in March 2013 the "Active-Guide," i.e. the Japanese official PA guidelines for health promotion. In this document, the most important message is "+10," standing for "add 10 min of MVPA per day" The establishment of the "+10" recommendation is supported by strong scientific evidence. Firstly, a meta-analysis including 26 cohort studies indicated that an increment of 10 min of moderate-to-vigorous PA per day can result in a 3.2% reduction of the average relative risk of NCDs, dementia, joint-musculoskeletal impairment, and mortality. Secondly, the National Health and Nutrition Survey (Japan, 2010) reported that 60.8% of the Japanese population is inclined to add the equivalent of 10 min of PA in their daily life. In line with these results, the "+10" recommendation is viewed as feasible and efficient for the Japanese population. To our knowledge, this implementation of an additional low-dose PA recommendation in a governmental health promotion policy is a world first. We hope that the Japanese PA policy will inspire other national and international public health agencies.	[Miyachi, Motohiko; Tripette, Julien; Kawakami, Ryoko; Murakami, Haruka] Natl Inst Hlth & Nutr, Dept Hlth Promot & Exercise, Tokyo 1628636, Japan; [Tripette, Julien] Ochanomizu Univ, Leading Grad Sch Promot Ctr, Tokyo 112, Japan; [Tripette, Julien] Ochanomizu Univ, Dept Life Sci, Tokyo 112, Japan	Miyachi, M (reprint author), Natl Inst Hlth & Nutr, Dept Hlth Promot & Exercise, Tokyo 1628636, Japan.	miyachi@nih.go.jp					Li J, 2012, INT J ENV RES PUB HE, V9, P391, DOI 10.3390/ijerph9020391; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Lee DC, 2014, J AM COLL CARDIOL, V64, P472, DOI 10.1016/j.jacc.2014.04.058; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; Zhong SL, 2014, EUR J EPIDEMIOL, V29, P391, DOI 10.1007/s10654-014-9916-1; Je Y, 2013, INT J CANCER, V133, P1905, DOI 10.1002/ijc.28208; Oguma Y, 2004, AM J PREV MED, V26, P407, DOI 10.1016/j.ampere.2004.02.007; Bassett DR, 2010, MED SCI SPORT EXER, V42, P1819, DOI 10.1249/MSS.0b013e3181dc2e54; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301; O'Rorke MA, 2010, INT J CANCER, V126, P2957, DOI 10.1002/ijc.24997; Blondell SJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-510; Ministry of Health Labour and Welfare, 2010, NAT HLTH NUTR SURV; Ministry of Health Labour and Welfare, 2013, JAP OFF PHYS ACT GUI; Ministry of Health Labour and Welfare, 2012, BAS DIR COMPR IMPL N, P1; Miyachi M, 2012, J PHYS FITNESS SPORT, V1, P467; SOROCK GS, 1988, J GERONTOL, V43, pM134; U.S. Department of Health Services, 2008, PHYS ACT GUID AM; World Health Organization, 2010, GLOB REC PHYS ACT HL	18	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S7	S9				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700004		
J	Miyazawa, T				Miyazawa, Teruo			Nutrition and Food for Longevity: For the Well-Being of All Preface	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Editorial Material									12th ACN2015, Yokohama, Kanagawa, Japan	Miyazawa, T (reprint author), 12th ACN2015, Yokohama, Kanagawa, Japan.							0	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S1	S1				1	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700001		
J	Mizumoto, K; Murakami, G; Oshidari, K; Trisnantor, L; Yoshiike, N				Mizumoto, Kaori; Murakami, Genki; Oshidari, Kenro; Trisnantor, Laksono; Yoshiike, Nobuo			Health Economics of Nutrition Intervention in Asia: Cost of Malnutrition	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						health economics; malnutrition; evaluation of interventions; developing countries		Asia has recorded the fastest economic growth in the world. However, some countries are still struggling with economic stagnation and poverty. Even in the emerging countries, there are economic disparities between urban and rural areas within a country. Reflecting the situations, nutritional issues in Asia came to be the antithetical situation of excess and insufficiency. The rate of overweight and obesity keeps increasing, especially in emerging countries. Meanwhile, underweight is still a critical problem in the region. Although the importance of nutrition is well recognized for social and economic development, it is difficult to identify the immediate outcome of nutrition interventions. Evidence-based decision-making is an important element of quality health care and efficiency and effectiveness are always key words. Along with enhanced attention to accountability and transparency of budget use in health services, attention to the economic evaluation of nutrition interventions has increased in recent years. In this symposium, we will review the current situation of nutritional issues and economic evaluation of nutrition interventions in Asia through experience of an international organization, the basis and trends for health care economics, and also efforts have been made in an Asian country. Discussion will be made about efficient and effective ways to evaluate projects/programmes for nutrition improvement.	[Mizumoto, Kaori] Fukuoka Womens Univ, Kita Ku, Fukuoka, Fukuoka 8138529, Japan; [Murakami, Genki] World Food Programme Reg Bur Asia, Bangkok 10330, Thailand; [Oshidari, Kenro] Univ Hosp Occupat & Environm Hlth, Yahata Nishi ku, Kitakyushu, Fukuoka 8078555, Japan; [Trisnantor, Laksono] Gadjah Mada Univ, Yogyakarta 55281, Daerah Istimewa, Indonesia; [Yoshiike, Nobuo] Aomori Univ Hlth & Welf, Aomori 0300947, Japan	Mizumoto, K (reprint author), Fukuoka Womens Univ, Kita Ku, 1-1-1 Kasumigaoka, Fukuoka, Fukuoka 8138529, Japan.	mizumoto@fwu.ac.jp					Hoddinott J, 2008, LANCET, V371, P411, DOI 10.1016/S0140-6736(08)60205-6; World Health Organization, 2009, GLOB HLTH RISKS MORT	2	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S47	S49				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700020		
J	Moritani, T; Akamatsu, Y				Moritani, Toshio; Akamatsu, Yasunori			Effect of Exericse and Nutrition upon Lifestyle-Related Disease and Cognitive Function	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						lifestyle-related disease; obesity; autonomic nervous system; brain-derived neurotrophic factor (BDNF)	ENERGY-EXPENDITURE; EXERCISE; OBESITY; HEALTH; ASSOCIATION; APPETITE; MUSCLE; BRAIN	Bray has proposed the "MONA LISA" hypothesis, an acronym for Most Obesities kNown Are Low In Sympathetic Activity indicating that obesity is associated with a relative or absolute reduction in the activity of the thermogenic component of the sympathetic nervous system. Our series of studies have suggested a potential reversibility in ANS activity regulating fat metabolism and appetite control by regular exercise training in middle aged individuals and obese children with depressed ANS activity. In other words habitual exercise plays a vital role in enhancing not only fat and glucose metabolism, but also ANS activities in the prevention of obesity and appetite control. There are growing expectations that too much sitting is a real and substantial risk to health. One of the intriguing findings from these accelerometer measurement studies is that breaks in sedentary time were shown to have beneficial associations with metabolic biomarkers, due possibly to challenging and enhancing autonomic nervous system that regulates body weight and appetite. Recent findings of brain-derived neurotrophic factors (BDNF) seem to have shed some light upon age-related neurodegenerative diseases and appear to influence energy metabolism, appetite and aspects of neuro-cognitive function. These data strongly suggest that a lack of exercise as characterized by a sedentary lifestyle and an unhealthy diet may lead to accelerated ageing, diseases of the body and brain, and an overall decline in the quality of life.	[Moritani, Toshio; Akamatsu, Yasunori] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan	Moritani, T (reprint author), Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan.	moritani.toshio.6e@kyoto-u.ac.jp					Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Brinkworth GD, 2009, ARCH INTERN MED, V169, P1873, DOI 10.1001/archinternmed.2009.329; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Wren AM, 2007, GASTROENTEROLOGY, V132, P2116, DOI 10.1053/j.gastro.2007.03.048; Jequier E, 1999, PHYSIOL REV, V79, P451; Seifert T, 2010, AM J PHYSIOL-REG I, V298, pR372, DOI 10.1152/ajpregu.00525.2009; Martins C, 2007, J ENDOCRINOL, V193, P251, DOI 10.1677/JOE-06-0030; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Crum AJ, 2011, HEALTH PSYCHOL, V30, P424, DOI 10.1037/a0023467; Yoneshiro T, 2011, OBESITY, V19, P13, DOI 10.1038/oby.2010.105; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; BRAY GA, 1991, J NUTR, V121, P1146; Hancox RJ, 2004, LANCET, V364, P257, DOI 10.1016/S0140-6736(04)16675-0; STUART CA, 1988, METABOLISM, V37, P802, DOI 10.1016/0026-0495(88)90018-2; Berggren JR, 2009, AM J PHYSIOL-ENDOC M, V294, pE726; Gomez-Pinilla F, 2011, PREV MED, V52, pS75, DOI 10.1016/j.ypmed.2011.01.023; Merchant AT, 2009, J AM DIET ASSOC, V109, P1165, DOI 10.1016/j.jada.2009.04.002; Moritani T, 2005, J ELECTROMYOGR KINES, V15, P240, DOI 10.1016/j.jelekin.2005.01.001; Shihara N, 1999, J CLIN ENDOCR METAB, V84, P1623, DOI 10.1210/jc.84.5.1623	21	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S122	S124				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700050		
J	Moriyama, T				Moriyama, Tatsuya			Diversity of Food Allergy	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						food allergy; food allergen; diversity of food allergy	EXERCISE-INDUCED ANAPHYLAXIS	Food allergy is defined as an immune system-mediated adverse reaction to food components. Food allergic reactions are mostly IgE mediated and also known as immediate type hypersensitivity (type I reaction). There are several characteristic clinical types of food allergy, such as Anaphylaxis, Food-dependent exercise-induced anaphylaxis (FDEIA), and Oral allergy syndrome (OAS). In addition, food allergy is also classified into two types (class 1 and class 2) based on the pathophysiological mechanism. In the class 2 food allergy, pollen allergy causes plant food allergy; therefore this type of allergy is sometimes called Pollen-food allergy syndrome (PFAS). The risk of food allergy (allergenicity) may vary with the treatment of the food allergens. The formation or status of the causative food affects its allergenicity. Class 1 food allergens are generally heat-, enzyme-, and low pH-resistant glycoproteins ranging in size from 10 to 70 kD. Class 1 food allergens induce allergic sensitization via the gastrointestinal tract and are responsible for systemic reactions. Class 2 food allergens are generally heat-labile, susceptible to digestion, and highly homologous with pollen allergens. Taken together, it may be important to consider the diversity of food allergy in order to fight against food allergy.	Kinki Univ, Fac Agr, Dept Appl Biol Chem, Lab Appl Cell Biol, Nara 6318505, Japan	Moriyama, T (reprint author), Kinki Univ, Fac Agr, Dept Appl Biol Chem, Lab Appl Cell Biol, 3327-204 Naka Machi, Nara 6318505, Japan.	tmoriyama@nara.kindai.ac.jp					Adachi A, 2009, CLIN EXP ALLERGY, V39, P167, DOI 10.1111/j.1365-2222.2008.03148.x; Kondo Yasuto, 2009, Allergology International, V58, P485, DOI 10.2332/allergolint.09-RAI-0136; Morita Eishin, 2009, Allergology International, V58, P493, DOI 10.2332/allergolint.09-RAI-0125; Beaudouin E, 2006, Eur Ann Allergy Clin Immunol, V38, P45; Coombs RRA, CLIN ASPECTS IMMUNOL, P575; Han Youngshin, 2012, Korean J Pediatr, V55, P153, DOI 10.3345/kjp.2012.55.5.153; Moriyama T, 2013, BIOSCI BIOTECH BIOCH, V77, P2371, DOI 10.1271/bbb.130487; Moriyama T, 2013, J NUTR SCI VITAMINOL, V59, P462, DOI 10.3177/jnsv.59.462	8	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S106	S108				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700044		
J	Murayama, N				Murayama, Nobuko			Effects of Socioeconomic Status on Nutrition in Asia and Future Nutrition Policy Studies	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						socioeconomic status; nutrition disparities; Asia; nutrition policy	NATIONAL-HEALTH; OBESITY; DIET; CONSUMPTION; PATTERNS; POVERTY; QUALITY; ADULTS	Evidence of health disparities has been reported around the world. One of the intermediate factors between socioeconomic status (SES) and health is nutrition. Many studies reported socioeconomically disadvantaged people had more risk of obesity and lifestyle-related diseases than others in western society. Micronutrient intake affected by SES, but little evidence indicates that SES affects either energy intake or the macronutrient composition of the diet in western countries. In contrast, there is not enough evidence of a consistent relationship between SES and nutrition in Asian countries at present. The present status of nutrition disparities in Asia is considered to vary by economic level of the country. For developing countries in Asia, India and Vietnam, SES associates with BMI positively in women. For relatively developed countries in Asia, Korea and Japan, SES associates with BMI negatively in women. Low SES groups consume more carbohydrate, and less protein and fat, so not only micronutrient but also macronutrient intake is affected by SES both in developing and in developed Asian countries. There are some studies on the pathway from SES to diet/nutrition. The association between low SES and obesity may be mediated, in part, by the low cost of energy-dense foods, concern about food price and dietary knowledge. Nutrition policy research is required to reduce nutrition disparities in Asia. We need a collaborative study of the impact of potential political options on diet and on health with other academic fields.	Univ Niigata Prefecture, Higashi Ku, Niigata, Niigata 9508680, Japan	Murayama, N (reprint author), Univ Niigata Prefecture, Higashi Ku, 471 Ebigase, Niigata, Niigata 9508680, Japan.	murayama@unii.ac.jp					Powell LM, 2009, MILBANK Q, V87, P229, DOI 10.1111/j.1468-0009.2009.00554.x; Thang NM, 2004, EUR J CLIN NUTR, V58, P145, DOI 10.1038/sj.ejcn.1601761; Darmon N, 2008, AM J CLIN NUTR, V87, P1107; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Tiffin R, 2012, P NUTR SOC, V71, P105, DOI 10.1017/S0029665111003284; Murakami K, 2009, NUTR RES, V29, P164, DOI 10.1016/j.nutres.2009.02.002; Monteiro C, 2004, INT J OBESITY, V28, P1181, DOI 10.1038/sj.ijo.0802716; Turrell G, 2006, PUBLIC HEALTH NUTR, V9, P375, DOI 10.1079/PHN2006850; Drewnowski A, 2005, AM J CLIN NUTR S, V82, p265S; Frank B, 2010, OBESITY EPIDEMIOLOGY, P317; Fukuda Y, 2012, BIOSCI TRENDS, V6, P176, DOI 10.5582/bst.2012.v6.4.176; Hong SA, 2012, NUTR RES PRACT, V6, P263, DOI 10.4162/nrp.2012.6.3.263; Kim Jihye, 2014, J Prev Med Public Health, V47, P94, DOI 10.3961/jpmph.2014.47.2.94; Lee JO, 2014, J KOREAN MED SCI, V29, P224, DOI 10.3346/jkms.2014.29.2.224; Murayama N, 2014, FOOD SYSTEM KENKYU F, V60, P77; Murayama N., 2015, EMPIRICAL RES SOCIOE; Okubo H, 2014, MATERN CHILD NUTR, V10, P213, DOI 10.1111/j.1740-8709.2012.00403.x; Park Sung Il, 2013, Korean J Fam Med, V34, P385, DOI 10.4082/kjfm.2013.34.6.385; Varadharajan KS, 2013, ASIA PAC J CLIN NUTR, V22, P326, DOI 10.6133/apjcn.2013.22.3.19	19	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S66	S68				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700027		
J	Nagao, K; Yanagita, T				Nagao, Koji; Yanagita, Teruyoshi			Functional Lipids in Metabolic Syndrome	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						functional lipids; metabolic syndrome; obese model animal; adiponectin	UNSATURATED FATTY-ACIDS; RATS	Metabolic syndrome is a cluster of metabolic disorders that contribute to increased cardiovascular morbidity and mortality. Although the pathogenesis of metabolic syndrome is complicated, dietary lipids have been recognized as contributory factors in the development and the prevention of cardiovascular risk clustering. We investigated the physiological functions and molecular actions of functional lipids, especially omega3-polyunsaturated fatty acid (PUFA)-containing lipids, in the development of metabolic syndrome using obese model animals. Feeding of omega3-PUFA-containing lipids, such as eicosapentaenoic acid, docosapentaenoic acid, docosahexaenoic acid, tetracosahexaenoic acid, and omega3-phosphatidylcholine, alleviated hepatic lipid accumulation through the suppression of lipogenic gene expression in the liver. Additionally, dietary omega3-PUFA-containing lipids increased serum adiponectin levels in obese animal models. Their molecular actions in the prevention and alleviation of metabolic syndrome could be attributed to the regulation of the activity or abundance of several transcriptional factors in the liver and adipose tissue. Dietary functional lipids would be useful to prevent or alleviate metabolic syndrome in obese animals. In particular, the function of omega3-containing lipids as dietary adiponectin inducers deserves attention with respect to alleviation of metabolic syndrome by dietary manipulation.	[Nagao, Koji] Saga Univ, Dept Appl Biochem & Food Sci, Saga, Japan; [Yanagita, Teruyoshi] Nishikyushu Univ, Dept Hlth & Nutr Sci, Kanzaki, Saga, Japan	Nagao, K (reprint author), Saga Univ, Dept Appl Biochem & Food Sci, Saga, Japan.	knagao@cc.saga-u.ac.jp					Nagao K, 2005, J BIOSCI BIOENG, V100, P152, DOI 10.1263/jbb.100.152; Gotoh N, 2009, J AGR FOOD CHEM, V57, P11047, DOI 10.1021/jf9026553; Nagao K, 2003, BIOCHEM BIOPH RES CO, V310, P562, DOI 10.1016/j.bbrc.2003.09.044; Nagao K, 2010, PHARMACOL RES, V61, P208, DOI 10.1016/j.phrs.2009.11.007; Nagao K, 2008, PROG LIPID RES, V47, P127, DOI 10.1016/j.plipres.2007.12.002; Nagao K, 2014, J OLEO SCI, V63, P979, DOI 10.5650/jos.ess14118; Shirouchi B, 2007, J AGR FOOD CHEM, V55, P7170, DOI 10.1021/jf071225x; Yoshinaga K, 2015, J NUTR BIOCHEM, V26, P57, DOI 10.1016/j.jnutbio.2014.09.004	8	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S159	S161				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700063		
J	Nakagawa, K; Kato, S; Miyazawa, T				Nakagawa, Kiyotaka; Kato, Shunji; Miyazawa, Teruo			Determination of Phosphatidylcholine Hydroperoxide (PCOOH) as a Marker of Membrane Lipid Peroxidation	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						phosphatidylcholine hydroperoxide; lipid peroxidation; food deterioration; oxidative diseases; mass spectrometry	RED-BLOOD-CELLS; MASS-SPECTROMETRY; ANTIOXIDANT CAPACITY; OXIDATIVE STRESS; HUMAN-PLASMA; OLEIC-ACID; INCREASES	Increasing evidence for phosphatidylcholine hydroperoxide (PCOOH) as a marker of oxidative food deterioration and oxidative diseases has revealed the need for a pure PCOOH standard and a reliable quantification method. Recently, we synthesized the PCOOH isomers 1-palmitoy1-2-(9-hydroperoxyoctadecadienoyl)-sn-glycero-3-phosphocholine, (16:0/9-HpODE PC) and 1-palmitoy1-2-(13-hydroperoxyoctadecadienoyl)-sn-glycero-3-phosphocholine (16:0/13-HpODE PC). Using these standards along with liquid chromatography-tandem mass spectrometry, a reliable quantification method was developed. This mini-review describes these analytical techniques, with a particular emphasis on clinical sample analysis.	[Nakagawa, Kiyotaka; Kato, Shunji; Miyazawa, Teruo] Tohoku Univ, Grad Sch Agr Sci, Food & Biodynam Chem Lab, Sendai, Miyagi 9818555, Japan; [Miyazawa, Teruo] Tohoku Univ, New Ind Creat Hatchery Ctr NICHe, Food & Biotechnol Innovat Project, Sendai, Miyagi 9808579, Japan	Nakagawa, K (reprint author), Tohoku Univ, Grad Sch Agr Sci, Food & Biodynam Chem Lab, Sendai, Miyagi 9818555, Japan.	nkgw@m.tohoku.ac.jp					Xu FG, 2009, RAPID COMMUN MASS SP, V23, P3243, DOI 10.1002/rcm.4246; Yoshida Y, 2013, J CLIN BIOCHEM NUTR, V52, P9, DOI 10.3164/jcbn.12-112; Donato P, 2012, MASS SPECTROM REV, V31, P523, DOI 10.1002/mas.20353; Tsuduki T, 2011, NUTRITION, V27, P334, DOI 10.1016/j.nut.2010.05.017; Hui SP, 2010, J CHROMATOGR B, V878, P1677, DOI 10.1016/j.jchromb.2010.04.011; Asai A, 2011, BIOCHEM BIOPH RES CO, V406, P273, DOI 10.1016/j.bbrc.2011.02.032; Asai A, 2009, J LIPID RES, V50, P957, DOI 10.1194/jlr.M800582-JLR200; Chien CT, 2004, ARTERIOSCL THROM VAS, V24, P1111, DOI 10.1161/01.ATV.0000127620.12310.89; Ibusuki D, 2008, J LIPID RES, V49, P2668, DOI 10.1194/jlr.D800034-JLR200; Kato S, 2014, J OLEO SCI, V63, P431, DOI 10.5650/jos.ess13225; Kato S, 2015, ANAL BIOCHEM, V471, P51, DOI 10.1016/j.ab.2014.10.017; Kiko T, 2012, J ALZHEIMERS DIS, V28, P593, DOI 10.3233/JAD-2011-111493; Kinoshita M, 2000, CLIN CHEM, V46, P822; MIYAZAWA T, 1995, LIPIDS, V30, P1001, DOI 10.1007/BF02536284; MIYAZAWA T, 1988, J BIOCHEM-TOKYO, V103, P744; Nagashima T, 2002, DIABETES RES CLIN PR, V56, P19, DOI 10.1016/S0168-8227(01)00353-9; Nakagawa K, 2011, BBA-GEN SUBJECTS, V1810, P1205, DOI 10.1016/j.bbagen.2011.08.018; Nakagawa K, 1999, J AGR FOOD CHEM, V47, P3967, DOI 10.1021/jf981195l; NAKAJIMA A, 1993, J PHOTOCH PHOTOBIO A, V74, P189, DOI 10.1016/1010-6030(93)80116-Q; PORTER NA, 1980, LIPIDS, V15, P163, DOI 10.1007/BF02540963; PORTER NA, 1990, CHEM RES TOXICOL, V3, P236, DOI 10.1021/tx00015a008; RIGAUDY J, 1953, CR HEBD ACAD SCI, V236, P2086; Sugawara T, 1999, J OIL CHEM SOC, V18, P1391; Yamanaka Y, 2008, MECH AGEING DEV, V129, P215, DOI 10.1016/j.mad.2007.12.008	24	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S78	S80				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700032		
J	Nakajima, M; Wang, Z; Chaudhry, O; Park, HJ; Juneja, LR				Nakajima, Mitsutoshi; Wang, Zheng; Chaudhry, Oasim; Park, Hyun Jin; Juneja, Lekh R.			Nano-Science-Engineering-Technology Applications to Food and Nutrition	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						food nanotechnology; emulsions; solid lipid nanoparticles; bioavailability; delivery system	BIOAVAILABILITY; NANOPARTICLES; DELIVERY; STABILITY; EMULSIONS; CHITOSAN; CURCUMIN	Nanoscale Science, Engineering and Technology are applied to Food and Nutrition. Various delivery systems include nanoemulsions, microemulsions, solid lipid nanoparticles, micelles, and liposomes. The nanoscale systems have advantages, such as higher bioavailabitity, and other physicochemical properties. The symposium will provide an overview of the formulation, characterization, and utilization of nanotechnology-based food and nutrition.	[Nakajima, Mitsutoshi; Wang, Zheng] Univ Tsukuba, Tsukuba, Ibaraki 305, Japan; [Chaudhry, Oasim] Food & Environm Res Agcy, London, England; [Park, Hyun Jin] Korea Univ, Seoul, South Korea; [Juneja, Lekh R.] Rohto Pharmaceut Co Ltd, Osaka, Japan	Nakajima, M (reprint author), Univ Tsukuba, Tsukuba, Ibaraki 305, Japan.	nakajima.m.fu@u.tsukuba.ac.jp	Park, Hyun Jin/I-4942-2015				Acosta E, 2009, CURR OPIN COLLOID IN, V14, P3, DOI 10.1016/j.cocis.2008.01.002; Chaudhry Q, 2010, RSC NANOSCI NANOTECH, P1, DOI 10.1039/9781847559883-00001; Vladisavljevic GT, 2013, ADV DRUG DELIVER REV, V65, P1626, DOI 10.1016/j.addr.2013.07.017; Haham M, 2012, FOOD FUNCT, V3, P737, DOI 10.1039/c2fo10249h; Shin GH, 2013, J AGR FOOD CHEM, V61, P11119, DOI 10.1021/jf4035404; Ichikawa S, 2005, BIOSCI BIOTECH BIOCH, V69, P1637, DOI 10.1271/bbb.69.1637; Sessa M, 2014, FOOD CHEM, V147, P42, DOI 10.1016/j.foodchem.2013.09.088; Arangoa MA, 2001, PHARMACEUT RES, V18, P1521, DOI 10.1023/A:1013018111829; Guzey D, 2006, ADV COLLOID INTERFAC, V128, P227, DOI 10.1016/j.cis.2006.11.021; Guri A, 2013, FOOD FUNCT, V4, P1410, DOI 10.1039/c3fo60180c; Akhtar M, 2014, FOOD HYDROCOLLOID, V34, P62, DOI 10.1016/j.foodhyd.2012.12.025; Joye IJ, 2014, TRENDS FOOD SCI TECH, V40, P168, DOI 10.1016/j.tifs.2014.08.006; Yi J, 2014, FOOD HYDROCOLLOID, V35, P19, DOI 10.1016/j.foodhyd.2013.07.025; Ezhilarasi PN, 2013, FOOD BIOPROCESS TECH, V6, P628, DOI 10.1007/s11947-012-0944-0; Patel AR, 2012, FOOD CHEM, V133, P423, DOI 10.1016/j.foodchem.2012.01.054; Chen Y, 2013, J FOOD BIOCHEM, V37, P144, DOI 10.1111/j.1745-4514.2011.00611.x; Sekhon Bhupinder S, 2010, Nanotechnol Sci Appl, V3, P1; Wang Z, 2012, FOOD SCI TECHNOL RES, V18, P149	18	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S180	S182				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700072		
J	Nishi, N				Nishi, Nobuo			Monitoring Obesity Trends in Health Japan 21	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						Health Japan 21; National Health and Nutrition Survey		Prevention of non-communicable diseases is more important than ever especially for the elderly to live a healthy life in the super-aged society of Japan. In 2000, the Ministry of Health, Labor and Welfare of Japan started Health Japan 21 as goal-oriented health promotion plan like Healthy People in the US and the Health of the Nation in the UK. Its second term started in 2013 with the aim of prolonging healthy life expectancy and reducing health inequalities. Improvement in both individuals' lifestyle and their social environment will help achieve the goal of the 2nd Health Japan 21. The National Health and Nutrition Survey (NHNS) is conducted every year to monitor the health and nutritional situation of the Japanese using a representative population. The NHNS data are useful for target setting and evaluation of the 2nd Health Japan 21, and the NHNS has shown an increasing trend of overweight (BMI >= 25) only for male adults in the most recent 10 y. In contrast, the dietary intake survey of the NHNS shows a decreasing trend of total energy intake both in male and female adults aged 69 y old or younger, and the trend for physical activity is not well known. Thus, we need further investigations on the causes of the obesity trend in Japan.	Natl Inst Hlth & Nutr, Ctr Int Collaborat & Partnership, Shinjuku Ku, Tokyo 1628636, Japan	Nishi, N (reprint author), Natl Inst Hlth & Nutr, Ctr Int Collaborat & Partnership, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628636, Japan.	nnishi@nih.go.jp					Funatogawa I, 2009, INT J EPIDEMIOL, V38, P83, DOI 10.1093/ije/dyn182; Cancer Control and Health Promotion Division Health Service Bureau Ministry of Health Labour and Welfare Japan, 2013, NAT HLTH NUTR SURV J; Nishi N., 2012, Journal of the National Institute of Public Health, V61, P399; Office of Nutrition Cancer Measures and Health Promotion Division Health Service Bureau Ministry of Health Labour and Welfare Japan, 2013, NAT HLTH NUTR SURV J; Working Group for the Evaluation of the Health, 2011, WORK GROUP EV HLTH J	5	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S17	S19				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700009		
J	Oda, H				Oda, Hiroaki			Chrononutrition	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						chrononutrition; meal timing; clock gene; liver clock; lipid metabolism	MAMMALS; CLOCK; MICE	Well-regulated eating habits are said to be important for health. A major breakthrough was the discovery of the negative regulatory feedback for transcription via the binding of Clock/Bmall to E-box, which forms the basis of biological clocks. Well-regulated eating habits normalize the liver clock gene, the rhythm of CYP7A1 gene, and blood cholesterol levels through insulin secretion. Moreover, well-regulated eating habits actively contribute to better lipid metabolism such as obesity, even if animals ingest a high-fat diet. From reported results so far, chrononutition has two important functions: 1) meal timing is important for our health, and 2) meal timing entrains our body clock.	Nagoya Univ, Lab Nutr Biochem, Nagoya, Aichi 4648601, Japan	Oda, H (reprint author), Nagoya Univ, Lab Nutr Biochem, Nagoya, Aichi 4648601, Japan.	hirooda@agr.nagoya-u.ac.jp					Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Iwanaga H, 2005, JPEN-PARENTER ENTER, V29, P157, DOI 10.1177/0148607105029003157; Kubo T, 2006, AM J EPIDEMIOL, V164, P549, DOI 10.1093/aje/kwj232; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Fukuzawa Y., 1971, COLLECTED WORKS YAKU; ICnutsson A., 2003, OCCUP MED, V53, P103; Kagawa Y, 2009, CHRONONUTRITION; Kohsake A, 2007, CELL METAB, V6, P411; Ministry of Health Labor and Welfare, 2007, NAT HLTH NUTR SURV; Oda H, 2012, ILSI, V110, P24; Oda H, 2005, HLTH NUTR; Tamura K., 2001, CHRONOTHERAPEUTICS; Wu T, 2008, GENE, V419, P27, DOI 10.1016/j.gene.2008.04.010; Yamajuku D, 2009, CIRC RES, V105, P545, DOI 10.1161/CIRCRESAHA.109.199034; Yamajuku D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00439	17	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S92	S94				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700038		
J	Rikimaru, T				Rikimaru, Toru			What Are the Current Situations and the Challenges of Maternal and Child Malnutrition in Asia?	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						malnutrition; undernutrition; Asia; SUN; MDGs		Changes in lifestyle have led to better nutrition or increasing the risk of NCDs in Asia, while there are still many children and reproductive-aged women (RAW) suffering undernutrition whose lives are at risk in the same region. The MDG of reducing the prevalence of underweight <5 children to half has been achieved already or nearly achieved in many Asian countries, whereas South Asian (SA) countries and several other countries (Cambodia, Laos, East Timor and Yemen) have difficulties in achieving the goal by 2015. In particular, East Timor and Yemen are in a critical situation with undernutrition. There is a strong concern about a rapid increase in overweight and obesity rates in West Asian (WA) and some Central Asian (CA) countries. Iron deficiency is one of the most important risk factors that threaten healthy life among RAW especially in SA, followed by Southeast Asia (SEA) and CA. The same issue is observed among children (1-4 y) in the same regions. Dietary risks (based on DALYS) increase with advancing age in most Asian regions whereas high Body Mass Index is the most important risk factor in WA and some CA countries. High priority should be placed on measures to tackle undernutrition and micronutrient deficiencies including iron deficiency in SA and some countries in SEA and WA; overweight and obesity in WA and CA; and dietary risks among RAW in most Asian regions.	JICA, Chiyoda Ku, Tokyo 1028012, Japan	Rikimaru, T (reprint author), JICA, Chiyoda Ku, 5-25 Niban Cho, Tokyo 1028012, Japan.	Rikimaru.Toru@jica.go.jp					de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; de Benoist B, 2008, WHO GLOBAL DATABASE; FAO WHO, 2014, 2 INT C NUTR NOV; Horton R, 2008, LANCET, V371, P179, DOI 10.1016/S0140-6736(07)61869-8; Institute for Health Metric and Evaluation, 2014, GLOB BURD DIS GBD; Lomborg Bjorn, 2014, SPEND 75 BILLION MAK; SUN Movement Secretariat, 2014, SUN MOV ANN PROGR RE; UNICEF, 2014, STAT WORLDS CHILD 20, P36; UNICEF WHO World Bank, LEV TRENDS CHILD MAL; United Nations, MILL DEV GOALS REP 2; World Health Organization, 2010, NUTR LANDSC INF SYST	11	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S63	S65				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700026		
J	Sato, R				Sato, Ryuichiro			Functions of Cholesterol Metabolites	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						cholesterol; SREBP; LXR; FXR; TGR5	ELEMENT-BINDING PROTEINS; BILE-ACIDS; RECEPTOR; MICE; ACTIVATION; STEROLS; INSIG-1; SREBP-1; LIVERS; CELLS	Cholesterol is a major component of membrane lipids. Thus, adjusting the membrane cholesterol composition is essential for maintaining cellular homeostasis. Cholesterol biosynthesis and uptake by LDL receptors are tightly regulated at the transcriptional level through negative feedback control, which is mediated by sterol regulatory element-binding proteins (SREBPs). In particular, SREBP-2 is activated in a cholesterol-dependent manner and, thus, is significantly involved in regulating the expression of those genes associated with cholesterol metabolism. Cholesterol metabolites such as oxysterols are involved in regulating sterol metabolism by binding to the nuclear receptor, liver X receptor (LXR). Cholesterol catabolites, i.e., bile acids, are agonists for another nuclear receptor, farnesoid X receptor (FXR), and a bile acid receptor, TGR5. Activated FXR regulates bile acid metabolism and TGR5 improves glucose metabolism through the actions of glucagon-like peptide-1 (GLP-1).	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan	Sato, R (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan.	aroysato@mail.ecc.u-tokyo.ac.jp					Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Pai JT, 1998, J BIOL CHEM, V273, P26138, DOI 10.1074/jbc.273.40.26138; Sato R, 2013, VITAM HORM, V91, P425, DOI 10.1016/B978-0-12-407766-9.00018-3; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.0139; Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978; Gonzalez FJ, 2012, COMPR PHYSIOL, V2, P2811, DOI 10.1002/cphy.c120007; SATO R, 1994, J BIOL CHEM, V269, P17267	15	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S151	S153				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700060		
J	Segawa, H; Shiozaki, Y; Kaneko, I; Miyamoto, KI				Segawa, Hiroko; Shiozaki, Yuji; Kaneko, Ichiro; Miyamoto, Ken-ichi			The Role of Sodium-Dependent Phosphate Transporter in Phosphate Homeostasis	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						phosphate; transporter; intestine; kidney	HEREDITARY HYPOPHOSPHATEMIC RICKETS; MUTATIONS; HYPERCALCIURIA; MICE; COTRANSPORTERS; METABOLISM	Inorganic phosphate (Pi) is an essential compound for several biologic functions. Pi levels outside the normal range, however, contribute to several pathological processes. Hypophosphatemia leads to bone abnormalities, such as rickets/osteomalacia. Hyperphosphatemia contributes to vascular calcification in patients with chronic kidney disease and hemodialysis patients and is independently associated with cardiac mortality. Pi homeostasis is regulated by the coordinated function of renal and intestinal sodium-dependent phosphate (NaPi) transporters with dietary Pi, parathyroid hormone, 1,25-dihydroxyvitamin D-3, and fibroblast growth factor 23. The type II NaPi transporter/SLC34 family, with three members identified to date, is mainly responsible for Pi homeostasis in the body. SLC34A1 and SCL34A3 are predominantly expressed in the kidney, whereas SLC34A2 is expressed in the small intestine. The role of each SLC34 in the body was recently established by studies of gene-targeted mice. Mutation of SLC34A1 causes Fanconi syndrome and mutation of SLC34A3 causes autosomal recessive hereditary hypophosphatemic rickets with hypercalciuria. SLC34A2 is thought to be a major intestinal NaPi transporter and mutation of SLC34A2 causes pulmonary alveolar microlithiasis. A detailed understanding of Pi regulation in the body is important toward maintaining health.	[Segawa, Hiroko; Shiozaki, Yuji; Kaneko, Ichiro; Miyamoto, Ken-ichi] Univ Tokushima, Sch Med, Inst Med Nutr, Dept Mol Nutr, Tokushima 7708503, Japan	Segawa, H (reprint author), Univ Tokushima, Sch Med, Inst Med Nutr, Dept Mol Nutr, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	segawa@tokushima-u.ac.jp					Bergwitz C, 2006, AM J HUM GENET, V78, P179, DOI 10.1086/499409; Lederer E, 2012, CLIN J AM SOC NEPHRO, V7, P1179, DOI 10.2215/CJN.09090911; Segawa H, 2009, J AM SOC NEPHROL, V20, P104, DOI 10.1681/ASN.2008020177; Berndt T, 2009, PHYSIOLOGY, V24, P17, DOI 10.1152/physiol.00034.2008; Segawa H, 2009, AM J PHYSIOL-RENAL, V297, pF671, DOI 10.1152/ajprenal.00156.2009; Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Sabbagh Y, 2011, ADV CHRONIC KIDNEY D, V18, P85, DOI 10.1053/j.ackd.2010.11.004; Dasgupta D, 2014, J AM SOC NEPHROL, V25, P2366, DOI 10.1681/ASN.2013101085; Haito-Sugino S, 2012, AM J PHYSIOL-CELL PH, V302, pC1316, DOI 10.1152/ajpcell.00314.2011; Huqun, 2007, Am J Respir Crit Care Med, V175, P263, DOI 10.1164/rccm.200609-1274OC; Magen D, 2010, NEW ENGL J MED, V362, P1102, DOI 10.1056/NEJMoa0905647; Marks J, 2013, CURR OPIN NEPHROL HY, V22, P481, DOI 10.1097/MNH.0b013e3283621310; Miyamoto KI, 2011, J PHARM SCI-US, V100, P3719, DOI 10.1002/jps.22614; Ohi A, 2011, AM J PHYSIOL-RENAL, V301, pF1105, DOI 10.1152/ajprenal.00663.2010	14	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S119	S121				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700049		
J	Seki, T; Hosono, T				Seki, Taiichiro; Hosono, Takashi			Prevention of Cardiovascular Diseases by Garlic-Derived Sulfur Compounds	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						life style-related diseases; food function; garlic	LOW-DENSITY-LIPOPROTEIN; DIALLYL TRISULFIDE; ORGANOSULFUR COMPOUNDS; PLATELET-AGGREGATION; HYDROGEN-SULFIDE; METAANALYSIS; JAPAN	Lifestyle-related diseases have complex pathogenesis which consists of several different steps. Basic causes of the diseases are attributed to unhealthy lifestyles in dietary habits, physical activity and suffering stress. The unhealthy lifestyles induce risk factors such as hypertension, dyslipidemia, obesity, and hyperglycemia. These risk factors all promote arteriosclerosis leading to serious vascular complications (i.e., thrombotic diseases), myocardial infarction and cerebral infarction. The total number of deaths from these thrombotic diseases almost equals that from cancer in our country. Cancer is also a typical lifestyle-related disease. Food has three different functions: the primary function is to provide enough nutrients to meet the metabolic requirements. The secondary function is the one relating to food preference. The third function is to control our body functions, which help reduction of the risk of diseases. Some of the compounds derived from food, especially phytochemicals in edible plants, vegetables and herbs, have potent functions to control our body functions and contribute to promoting our health. In this review article, we overview the lifestyle-related diseases and food functions involving prevention and amelioration of the diseases by food components especially from edible plants and vegetables. As an example, we will describe the food function of garlic and the prevention of lifestyle-related diseases by its components. Allyl sulfides are characteristic flavor compounds derived from garlic, and these organosulfur compounds are responsible for the food function of garlic.	[Seki, Taiichiro; Hosono, Takashi] Nihon Univ, Coll Bioresource Sci, Dept Chem & Life Sci, Fujisawa, Kanagawa 2520880, Japan	Seki, T (reprint author), Nihon Univ, Coll Bioresource Sci, Dept Chem & Life Sci, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	tseki@brs.nihon-u.ac.jp					Tsai CY, 2013, INT J CARDIOL, V168, P1286, DOI 10.1016/j.ijcard.2012.12.004; Huang CN, 2004, J AGR FOOD CHEM, V52, P3674, DOI 10.1021/jf0307292; Ariga T, 2006, BIOFACTORS, V26, P93; Liu LL, 2014, EUR J PHARMACOL, V725, P23, DOI [10.1016/j.ejphar.2014.01.010, 10.1010/j.ejphar.2014.01.010]; Benavides GA, 2007, P NATL ACAD SCI USA, V104, P17977, DOI 10.1073/pnas.0705710104; Lei YP, 2010, MOL NUTR FOOD RES, V54, pS42, DOI 10.1002/mnfr.200900278; Yun HM, 2014, PHARMACOL THERAPEUT, V142, P183, DOI 10.1016/j.pharmthera.2013.12.005; Predmore BL, 2012, AM J PHYSIOL-HEART C, V302, pH2410, DOI 10.1152/ajpheart.00044.2012; Reinhart KM, 2009, NUTR RES REV, V22, P39, DOI 10.1017/S0954422409350003; Ried K, 2013, NUTR REV, V71, P282, DOI 10.1111/nure.12012; APITZCASTRO R, 1986, THROMB RES, V42, P303, DOI 10.1016/0049-3848(86)90259-8; APITZCASTRO R, 1983, THROMB RES, V32, P155, DOI 10.1016/0049-3848(83)90027-0; APITZ-CASTRO R, 1986, Biochemical and Biophysical Research Communications, V141, P145, DOI 10.1016/S0006-291X(86)80346-1; Arai S, 2000, BIOFACTORS, V12, P13; ARIGA T, 1981, LANCET, V1, P150; Ariga T, 2000, BIOFACTORS, V13, P251; Wakai K, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-12	17	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S83	S85				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700035		
J	Shibata, K				Shibata, Katsumi			True Niacin Deficiency in Quinolinic Acid Phosphoribosyltransferase (QPRT) Knockout Mice	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						mice; niacin-deficient; pellagra; quinolinate phosphoribosyltrasnferase; tryptophan	PELLAGRA	Pyridine nucleotide coenzymes (PNCs) are involved in over 500 enzyme reactions. PNCs are biosynthesized from the amino acid L-tryptophan (L-Trp), as well as the vitamin niacin. Hence, "true" niacin-deficient animals cannot be "created" using nutritional techniques. We wanted to establish a truly niacin-deficient model animal using a protocol that did not involve manipulating dietary L-Trp. We generated mice that are missing the quinolinic acid phosphoribosyltransferase (QPRT) gene. QPRT activity was not detected in qprt(-/-) mice. The qprt(+/+), qprt(+/-) or qprt(-/-) mice (8 wk old) were fed a complete diet containing 30 mg nicotinic acid (NiA) and 2.3 g L-Trp/kg diet or an NiA-free diet containing 2.3 g L-Trp/kg diet for 23 d. When qprt(-/-) mice were fed a complete diet, food intake and body weight gain did not differ from those of the qprt(+/+) and the qprt(+/-) mice. On the other hand, in the qprt(-/-) mice fed the NiA-free diet, food intake and body weight were reduced to 60% (p<0.01) and 70% (p<0.05) of the corresponding values for the qprt(-/-) mice fed the complete diet at day 23, respectively. The nutritional levels of niacin such as blood and liver NAP concentrations were also lower in the qprt(-/-) mice than in the qprt(+/+) and the qprt(+/-) mice. Urinary excretion of quinolinic acid was greater in the qprt(-/-) mice than in the qprt(+/+) and the qprt(+/-) mice (p<0.01). These data suggest that we generated truly niacin-deficient mice.	Univ Shiga Prefecture, Sch Human Cultures, Dept Nutr, Hikone, Shiga 5228533, Japan	Shibata, K (reprint author), Univ Shiga Prefecture, Sch Human Cultures, Dept Nutr, 2500 Hassakacho, Hikone, Shiga 5228533, Japan.	kshibata@shc.usp.ac.jp					BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; Fukuwatari T, 2004, J NUTR SCI VITAMINOL, V50, P385; MILLER DF, 1978, AM J CLIN NUTR, V31, P558; NISHIZUKA Y, 1963, J BIOL CHEM, V238, P3369; Seal AJ, 2007, AM J CLIN NUTR, V85, P218; SHIBATA K, 1986, AGR BIOL CHEM TOKYO, V50, P2025; Terakata M, 2012, J NUTR, V142, P2148, DOI 10.3945/jn.112.167569; World Health Organization, 2002, PELL ITS PREV CONTR	8	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S145	S147				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700058		
J	Shimomura, Y; Kitaura, Y; Kadota, Y; Isbikawa, T; Kondo, Y; Xu, MJ; Ota, M; Morishita, Y; Bariuan, JV; Zhen, HM				Shimomura, Yoshiharu; Kitaura, Yasuyuki; Kadota, Yoshihiro; Isbikawa, Takuya; Kondo, Yusuke; Xu, Minjun; Ota, Miki; Morishita, Yukako; Bariuan, Jussiaea V.; Zhen, Hongmin			Novel Physiological Functions of Branched-Chain Amino Acids	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						branched-chain amino acid; protein and glucose metabolism; brain function	LIVER-DISEASE; MICE; NUTRIENTS; AUTOPHAGY; MUTATIONS; CIRRHOSIS; EXERCISE; RATS	Branched-chain amino acids (BCAAs) are essential amino acids for humans and are major building blocks of proteins. Recent studies indicate that BCAAs act not only as components of proteins, but also as nutrasignals. In this review, we summarize the findings of recent studies investigating the physiological functions of BCAAs in the regulation of protein and glucose metabolism and brain function.	[Shimomura, Yoshiharu; Kitaura, Yasuyuki; Kadota, Yoshihiro; Isbikawa, Takuya; Kondo, Yusuke; Xu, Minjun; Ota, Miki; Morishita, Yukako; Bariuan, Jussiaea V.; Zhen, Hongmin] Nagoya Univ, Grad Sch Bioagr Sci, Lab Nutr Biochem, Nagoya, Aichi 4648601, Japan	Shimomura, Y (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Lab Nutr Biochem, Nagoya, Aichi 4648601, Japan.	shimo@agr.nagoya-u.ac.jp					Novarino G, 2012, SCIENCE, V338, P394, DOI 10.1126/science.1224631; Joshi MA, 2006, BIOCHEM J, V400, P153, DOI 10.1042/BJ20060869; Kadota Y, 2012, JPEN-PARENTER ENTER, V36, P337, DOI 10.1177/0148607111414578; Garcia-Cazorla A, 2014, HUM MUTAT, V35, P470, DOI 10.1002/humu.22513; Nishitani S, 2004, BIOCHEM BIOPH RES CO, V313, P387, DOI 10.1016/j.bbrc.2003.11.023; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; Kimball SR, 2010, J BIOL CHEM, V285, P29027, DOI 10.1074/jbc.R110.137208; Kawaguchi T, 2011, HEPATOLOGY, V54, P1063, DOI 10.1002/hep.24412; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Doi M, 2007, AM J PHYSIOL-ENDOC M, V292, pE1683, DOI 10.1152/ajpendo.00609.2006; Nishitani S, 2005, AM J PHYSIOL-GASTR L, V288, pG1292, DOI 10.1152/ajpgi.00510.2003; Sako K, 2003, HEPATOL RES, V26, P327, DOI 10.1016/S1386-6346(03)00152-9; Shimomura Y, 2006, J NUTR, V136, p250S; WHO/FAO/UNU, 2007, WHO TECHN REP SER, V935, P135; Yudkoff M, 2005, J NUTR, V135, p1531S	16	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S112	S114				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700046		
J	Sudo, N				Sudo, Noriko			Roles of National and Local Governments and the Dietetic Association in Nutrition Assistance Response to Natural Disasters: Systems and Experiences in Japan and the USA	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						the Great East Japan Earthquake; nutrition assistance; natural disasters; United States Department of Agriculture		In the first half of this symposium, the disaster response system in Japan will be introduced. The ultimate aim of nutrition assistance is to keep people in disaster areas healthy. This is a task for the Ministry of Health, Labour and Welfare and the health departments of prefectural governments. Our first speaker, Dr. Yasuhiro Kanatani, National Institute of Public Health, will briefly overview the disaster response system in Japan and its related laws. He will also mention how the Ministry responded to the Great East Japan Earthquake. In the second presentation, I will play one chapter of DVD that we released in last September. In that chapter, Ms. Makiko Sawaguchi, a registered dietitian working for a public health center in the area affected by the Great East Japan Earthquake, talks about her experience in supporting disaster victims As an employee of Iwate Prefectural Government, she helped affected municipal governments and coordinated outside support. One type of outside support was registered dietitians dispatched by the Japan Dietetic Association (JDA). Dr. Nobuyo Tsuboyama-Kasaoka will report what those dietitians did in the affected areas. She will also explain the aim and training of the JDA-Disaster Assistance Team. Provision of food is essential in nutrition assistance. This is a task for the Ministry of Agriculture, Forestry and Fisheries. Our fourth speaker, Mr. Kunihiro Doi, analyzed the government procurement data and will discuss the limitations of government emergency food supplies and lessons learned from the Great East Japan Earthquake. As for the systems and experiences in the US, we invited Ms. Toni Abernathy from the Office of Emergency Management, Food and Nutrition Service (FNS), United States Department of Agriculture.	Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo 1128610, Japan	Sudo, N (reprint author), Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, 2-1-1 Otsuka, Tokyo 1128610, Japan.	sudo.noriko@ocha.ac.jp						0	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S13	S13				1	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700006		
J	Taketani, Y; Masuda, M; Yamanaka-Okumura, H; Tatsumi, S; Segawa, H; Miyamoto, K; Takeda, E; Yamamoto, H				Taketani, Yutaka; Masuda, Masashi; Yamanaka-Okumura, Hisami; Tatsumi, Sawako; Segawa, Hiroko; Miyamoto, Ken-ichi; Takeda, Eiji; Yamamoto, Hironori			Niacin and Chronic Kidney Disease	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						hyperphosphatemia; dyslipidemia; chronic kidney disease; cardiovascular disease; sodium-dependent phosphate transporter	NICOTINAMIDE; HYPERPHOSPHATEMIA; PHOSPHATE; RAT	Chronic kidney disease (CKD) is an increasing problem worldwide. The number of end-stage renal disease patients requiring treatment by dialysis is estimated to be increasing by 10,000 patients per year in Japan. Furthermore, an estimated 13 million people are living with CKD in Japan. Various complications are associated with CKD, including cardiovascular disease (CVD). More than one-third of CKD patients die from CVD. Thus, prevention of CVD is a primary concern for the treatment of CKD patients. CKD-mineral and bone disorder (CKD-MBD) is a serious complication that typically leads to CVD. Hyperphosphatemia is thought to be a central-risk factor for CKD-MBD. Therefore, managing hyperphosphatemia is crucial to prevent CKD-MBD and CVD. It is difficult to achieve the target serum phosphate level through dietary modifications alone in patients with hyperphosphatemia, because most foods contain phosphate. Thus, phosphate binders such as calcium carbonate are commonly prescribed to CKD patients with hyperphosphatemia, but these have undesirable side effects. Inhibition of intestinal phosphate transport activity has also been investigated as an alternative approach for controlling serum phosphate levels in CKD patients. Nicotinamide, which is the amide of niacin, can inhibit intestinal phosphate transport. Niacin and related compounds have also been developed as drugs for hyperlipidemia conditions, especially hypertriglyceridemia with low high-density lipoprotein. This type of dyslipidemia is frequently observed in CKD patients and is a modifiable risk factor for CVD. Thus, niacin and related compounds may have utility for the treatment of both hyperphosphatemia and dyslipidemia in CKD patients to prevent CVD.	[Taketani, Yutaka; Masuda, Masashi; Yamanaka-Okumura, Hisami; Takeda, Eiji; Yamamoto, Hironori] Univ Tokushima, Grad Sch, Dept Clin Nutr, Tokushima 7708503, Japan; [Tatsumi, Sawako; Segawa, Hiroko; Miyamoto, Ken-ichi] Univ Tokushima, Grad Sch, Dept Mol Nutr, Tokushima 7708503, Japan; [Yamamoto, Hironori] Jin Ai Univ, Echizen 9158586, Japan	Taketani, Y (reprint author), Univ Tokushima, Grad Sch, Dept Clin Nutr, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	taketani@tokushima-u.ac.jp					Katai K, 1999, NEPHROL DIAL TRANSPL, V14, P1195, DOI 10.1093/ndt/14.5.1195; KEMPSON SA, 1981, J CLIN INVEST, V67, P1347, DOI 10.1172/JCI110163; Shuto E, 2009, J AM SOC NEPHROL, V20, P1504, DOI 10.1681/ASN.2008101106; Takahashi Y, 2004, KIDNEY INT, V65, P1099, DOI 10.1111/j.1523-1755.2004.00482.x; Cho KH, 2010, BBA-GEN SUBJECTS, V1800, P6, DOI 10.1016/j.bbagen.2009.10.009; Kovesdy CP, 2013, NEPHRON CLIN PRACT, V123, P194, DOI 10.1159/000353593; Eto N, 2005, NEPHROL DIAL TRANSPL, V20, P1378, DOI 10.1093/ndt/gfh781; Nomura K, 2014, J AM SOC NEPHROL, V25, P761, DOI 10.1681/ASN.2013060569; Levin A, 2004, BLOOD PURIFICAT, V22, P21, DOI 10.1159/000074920; Rennick A, 2013, PHARMACOTHERAPY, V33, P683, DOI 10.1002/phar.1258; Shimoda K, 1998, Nihon Jinzo Gakkai Shi, V40, P1	11	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S173	S175				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700069		
J	Takimoto, H; Sarukura, N; Ishikawa-Takata, K				Takimoto, Hidemi; Sarukura, Nobuko; Ishikawa-Takata, Kazuko			How to Define Family Meals in "Shokuiku" (Food and Nutrition Education)	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						Shokuiku; family meals; children; parents; methodology	ADOLESCENCE; RISK	The Japanese government has set 11 targets to promote "Shokuiku." However, among the 11 targets, only two targets (frequency of shared family meals and the proportion of breakfast skipping in children and young men) are quantitative goals. The increase in children eating alone is often lamented in the popular media, but the methodology for identifying the status of family meals ("Kyoshoku"), or how the responses should be validated, is rarely discussed. In the current review, we attempt to clarify how a family meal and survey responses are defined, by searching literature published after 2009, using the following keywords: "family meals" or "shared meals," in the PubMed database for English. For literature published in Japanese, we searched the Igakuchuo-Zassi Database and Google Scholar for relevant studies. In the English literature, questions were likely to focus on whether a dinner or any meal was eaten together with family members living together, while Japanese literature was more focused on "breakfast or dinner" eaten together with family members. The response options varied across different studies, such as the number of family meals a week, or the number of days (per week) these family meals were eaten. We found it quite difficult to compare across the studies, as there is no standardized definition or response options for "family meals." Further studies are needed in order to develop a standardized method to assess the current status of "family meals."	[Takimoto, Hidemi; Sarukura, Nobuko; Ishikawa-Takata, Kazuko] Natl Inst Hlth & Nutr, Dept Nutr Educ, Tokyo 1628636, Japan	Takimoto, H (reprint author), Natl Inst Hlth & Nutr, Dept Nutr Educ, Tokyo 1628636, Japan.	thidemi@nih.go.jp					Ainuki T., 2011, Japanese Journal of Nutrition and Dietetics, V69, P304, DOI 10.5264/eiyogakuzashi.69.304; Goldfield GS, 2011, APPL PHYSIOL NUTR ME, V36, P539, DOI [10.1139/h11-049, 10.1139/H11-049]; Rollins BY, 2010, J AM DIET ASSOC, V110, P1335, DOI 10.1016/j.jada.2010.06.004; [Anonymous], 2012, SHOKUIKU PROMOTION P; Martin-Biggers J, 2014, ADV NUTR, V5, P235, DOI 10.3945/an.113.005116; Verzeletti C, 2010, EUR J PUBLIC HEALTH, V20, P312, DOI 10.1093/eurpub/ckp150; White J, 2010, J HEALTH PSYCHOL, V15, P526, DOI 10.1177/1359105309355337; Eto K, 2012, JJHEP, V20, P192; Granner ML, 2011, AM J HEALTH BEHAV, V35, P591; Haines Jess, 2010, Eat Disord, V18, P10, DOI 10.1080/10640260903439516; Hiramitsu Y, 2012, KOSEI SHIHYO, V59, P23; Lehto R, 2011, PUBLIC HEALTH NUTR, V14, P1245, DOI 10.1017/S1368980010003034; Nishida E, 2012, NAGASAKI KOKUSAI DAI, V12, P113; Ohki K., 2011, Japanese Journal of Nutrition and Dietetics, V69, P135, DOI 10.5264/eiyogakuzashi.69.135; Otaki H., 2012, Japanese Journal of Nutrition and Dietetics, V70, P28; Yi SY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-477	16	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S10	S12				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700005		
J	Terao, J				Terao, Junji			A Perspective of the Research on Food Factors in Human Health: A Return to the Mechanistic Approach	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						food factors; mechanistic approach; functional foods	OF-THE-ART; SCIENCE; JAPAN	Food is a mixture of several nutrients and non-nutrients. The functions of food in human health can be categorized as its primary function in nutrition, its secondary function in palatability and its tertiary function in bioregulation. Nutrients contribute mainly to the primary function, while many non-nutrients in foods and foodstuffs are strongly associated with the secondary and/or tertiary functions. Individual food ingredients and ingredients as a whole are the so-called food factors. Much interest has arisen in the tertiary function of food factors related to the prevention of lifestyle-related diseases and promoting health in an aging society. This is why many studies evaluating the tertiary functions of food factors are now in progress all over the world. This symposium aims to present cutting-edge knowledge from celebrated Asian professors on the molecular mechanisms for the tertiary functions of food factors, in particular, polyphenols in soybeans and green tea, and n-6 polyunsaturated fatty acids in fish. In this context, this article will briefly review recent trends in research on the tertiary function of food factors.	Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Food Sci, Tokushima 7708503, Japan	Terao, J (reprint author), Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Food Sci, Kuramoto 3-18-15, Tokushima 7708503, Japan.	terao@tokushima-u.ac.jp					Arai S, 2002, BIOSCI BIOTECH BIOCH, V66, P2017, DOI 10.1271/bbb.66.2017; Arai S, 1996, BIOSCI BIOTECH BIOCH, V60, P9; Arai S, 2008, CURR OPIN LIPIDOL, V19, P69, DOI 10.1097/MOL.0b013e3282f3f505; Murakami A, 2012, FOOD FUNCT, V3, P462, DOI 10.1039/c2fo10274a	4	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S98	S99				2	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700041		
J	Tsugawa, N				Tsugawa, Naoko			Cardiovascular Diseases and Fat Soluble Vitamins: Vitamin D and Vitamin K	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						vitamin D; vitamin K; cardiovascular disease; fat-soluble vitamins; mortality	MATRIX GLA-PROTEIN; SERUM 25-HYDROXYVITAMIN D; RENIN-ANGIOTENSIN SYSTEM; 1,25-DIHYDROXYVITAMIN D-3; INDEPENDENT ASSOCIATION; ARTERIAL STIFFNESS; ALL-CAUSE; RISK; MORTALITY; CALCIFICATION	Recently, the associations between insufficiency of fat soluble vitamins and cardiovascular diseases (CVDs) have been reported. Vitamin D affects the cardiovascular system via several pathways, such as suppression of parathyroid hormone, the renin- angiotensin-aldosterone system and vascular endothelial growth and the immune system. Cross-sectional and longitudinal studies have shown the association between the concentration of serum 25-hydroxyvitamin D (25OHD), which is a vitamin D metabolite indicating nutritional vitamin D status, and hypertension, myocardial infarction, heart failure and CVD mortality. On the other hand, the association between vitamin K status and CVDs, especially vascular calcification, has been also reported. Cross-sectional and cohort studies show that high vitamin K status is associated with reduced coronary artery calcification, CVDs and mortality risk. Epidemiological and basic studies indicate that vitamin K possesses a benefit in the prevention of the progression of coronary artery calcification via activation of matrix-gla protein (MGP). While these data in epidemiological and basic studies suggest the protective role of vitamin D and Kin CVDs, the benefits of supplementation of both vitamins have not been validated in randomized controlled trials. Further basic and interventional studies are needed to confirm the benefit of both vitamins in protection against CVDs.	[Tsugawa, Naoko] Kobe Pharmaceut Univ, Dept Hygien Sci, Kobe, Hyogo 6588558, Japan; [Tsugawa, Naoko] Osaka Shoin Womens Univ, Dept Publ Hlth, Higashiosaka, Osaka 5778550, Japan	Tsugawa, N (reprint author), Kobe Pharmaceut Univ, Dept Hygien Sci, Kobe, Hyogo 6588558, Japan.	tsugawa@kobepharma-u.ac.jp					Andrukhova O, 2014, MOL ENDOCRINOL, V28, P53, DOI 10.1210/me.2013-1252; Vardi M, 2013, J LIPID RES, V54, P2307, DOI 10.1194/jlr.R026641; Kim DH, 2008, AM J CARDIOL, V102, P1540, DOI 10.1016/j.amjcard.2008.06.067; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Tukaj S, 2012, ACTA BIOCHIM POL, V59, P395; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Tomaschitz A, 2010, CLIN CHIM ACTA, V411, P1354, DOI 10.1016/j.cca.2010.05.037; Takeda M, 2010, ARTERIOSCL THROM VAS, V30, P2495, DOI 10.1161/ATVBAHA.110.215459; Beulens JWJ, 2009, ATHEROSCLEROSIS, V203, P489, DOI 10.1016/j.atherosclerosis.2008.07.010; Yuan WH, 2007, J BIOL CHEM, V282, P29821, DOI 10.1074/jbc.M705495200; Forman JP, 2007, HYPERTENSION, V49, P1063, DOI 10.1161/HYPERTENSIONAHA.107.087288; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Mayer O, 2014, ATHEROSCLEROSIS, V235, P162, DOI 10.1016/j.atherosclerosis.2014.04.027; Ginde AA, 2009, J AM GERIATR SOC, V57, P1595, DOI 10.1111/j.1532-5415.2009.02359.x; Li YC, 2002, J CLIN INVEST, V110, P229, DOI 10.1172/JCI200215219; Delanaye P, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-145; Farhangi MA, 2013, J AM COLL NUTR, V32, P280, DOI 10.1080/07315724.2013.816616; Keyzer CA, 2014, AM J KIDNEY DIS; Khaw KT, 2014, AM J CLIN NUTR, V100, P1361, DOI 10.3945/ajcn.114.086413; Liew JY, 2014, NUTR METAB CARDIOVAS; Uemura H, 2014, BRIT J NUTR, V112, P1333, DOI 10.1017/S0007114514002153	22	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S170	S172				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700068		
J	Uauy, R; Kurpad, A; Tano-Debrah, K; Otoo, GE; Aaron, GA; Toride, Y; Ghosh, S				Uauy, Ricardo; Kurpad, Anura; Tano-Debrah, Kwaku; Otoo, Gloria E.; Aaron, Grant A.; Toride, Yasuhiko; Ghosh, Shibani			Role of Protein and Amino Acids in Infant and Young Child Nutrition: Protein and Amino Acid Needs and Relationship with Child Growth	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						protein; amino acids; protein quality; complementary foods; infant and young child nutrition	LYSINE REQUIREMENTS; BALANCE TECHNIQUE; ENERGY-INTAKE; EGG PROTEIN; MEN	Over a third of all deaths of children under the age of five are linked to undernutrition. At a 90% coverage level, a core group of ten interventions inclusive of infant and young child nutrition could save one million lives of children under 5 y of age (15% of all deaths) (Lancet 2013). The infant and young child nutrition package alone could save over 220,000 lives in children under 5 y of age. High quality proteins (e.g. milk) in complementary, supplementary and rehabilitation food products have been found to be effective for good growth. Individual amino acids such as lysine and arginine have been found to be factors linked to growth hormone release in young children via the somatotropic axis and high intakes are inversely associated with fat mass index in pre-pubertal lean girls. Protein intake in early life is positively associated with height and weight at 10 y of age. This paper will focus on examining the role of protein and amino acids in infant and young child nutrition by examining protein and amino acid needs in early life and the subsequent relationship with stunting.	[Uauy, Ricardo; Ghosh, Shibani] Nevin Scrimshaw Int Nutr Fdn, Boston, MA USA; [Kurpad, Anura] St Johns Med Coll, Bengaluru, India; [Tano-Debrah, Kwaku; Otoo, Gloria E.] Univ Ghana, Dept Nutr & Food Sci, Legon, Accra, Ghana; [Aaron, Grant A.] Global Alliance Improved Nutr, Geneva, Switzerland; [Toride, Yasuhiko] Ajinomoto Co Inc, Tokyo, Japan; [Ghosh, Shibani] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA	Uauy, R (reprint author), Univ Chile, INTA, El Libano 5524, Macul, Santiago De Chi, Chile.	druauy@gmail.com					Michaelsen KF, 2003, MONATSSCHR KINDERH, V151, pS78, DOI 10.1007/s00112-003-0805-z; Dewey KG, 1996, EUR J CLIN NUTR, V50, pS119; GARZA C, 1976, AM J CLIN NUTR, V29, P280; GARZA C, 1978, J NUTR, V108, P90; Ghosh S, 2010, 2 WORLD PUBL HLTH C; Ghosh S, 2012, BRIT J NUTR, V108, pS77, DOI 10.1017/S0007114512002577; Grillenberger M, 2003, J NUTR, V133, p3957S; KISHI K, 1978, J NUTR, V108, P658; Kurpad AV, 2001, AM J CLIN NUTR, V73, P900; Kurpad AV, 2003, AM J CLIN NUTR, V77, P101; Pellett Peter L., 1996, Food and Nutrition Bulletin, V17, P204; Pellett PL, 1991, EFFECTS DIFFERENT LE; SCRIMSHAW NS, 1959, AM J MED SCI, V237, P367; WHO, 2007, WHO TECH REP SER, V935, P1	14	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S192	S194				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700077		
J	Umegaki, K				Umegaki, Keizo			Positive and Negative Aspects of Food with Health Claims in Japan	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						health foods; health claims; consumer; safety; information	WARFARIN	Developments in food science and technology have accelerated the production and availability of health foods. Although consumers may acquire health benefits from some products, they may also suffer adverse health effects and economic losses. Unlike medicine, which is administered by health professionals, foods are chosen directly by the consumer and can be used at their own discretion. Food labeling plays a major role in providing consumers with proper information when choosing the desired products; however, the food labeling system is complex and inadequately understood by consumers. Moreover, there are some products that do not follow food labeling laws and contain ingredients that have not undergone proper effectiveness and safety evaluations. With the increasing popularity of health foods, it is becoming more important to ensure that they are effective and safely used. The biggest concern is that some consumers may mistake health foods for medicines that can cure or prevent diseases. The main reason that consumers are confused and misled is due to the vast amount of information that is available. This paper provides an overview of the following four approaches that we have taken in order to develop countermeasures against health foods being used improperly by consumers: (1) conducting a survey of actual health food use; (2) collecting data on adverse events suspected to be caused by health foods, and evaluating the causal relationship with methods suited to investigating health foods; (3) examining the safety of natural ingredients used in health foods; and (4) constructing an online database that compiles information on the safety and effectiveness of health foods and/or ingredients, and sharing such information with consumers and health professionals.	Natl Inst Hlth & Nutr, Informat Ctr, Shinjuku Ku, Tokyo 1628636, Japan	Umegaki, K (reprint author), Natl Inst Hlth & Nutr, Informat Ctr, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628636, Japan.	umegaki@nih.go.jp					Taki Y, 2012, PHYTOMEDICINE, V19, P177, DOI 10.1016/j.phymed.2011.06.020; Chiba T, 2014, NIPPON EIYO SHOKURYO, V67, P177; Ichimaru K, 2013, JPN J CLIN PHARM THE, V44, P405; Sato Y, 2013, ASIA PAC J CLIN NUTR, V22, P83, DOI 10.6133/apjcn.2013.22.1.08; Sato Yoko, 2014, Nihon Koshu Eisei Zasshi, V61, P321; Sato Y, 2009, J NUTR SCI VITAMINOL, V55, P317, DOI 10.3177/jnsv.55.317; Umegaki K, 2013, FOOD HYG SAFE SCI, V54, P282, DOI 10.3358/shokueishi.54.282; Yokotani K, 2012, J PHARM PHARMACOL, V64, P1793, DOI 10.1111/j.2042-7158.2012.01563.x	8	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S133	S135				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700054		
J	Watanabe, T; Terada, Y				Watanabe, Tatsuo; Terada, Yuko			Food Compounds Activating Thermosensitive TRP Channels in Asian Herbal and Medicinal Foods	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						thermosensitive TRP channels; TRPV1; TRPA1; Food compounds	HIGH-SUCROSE DIET; ADRENALINE SECRETION; CAPSAICIN RECEPTOR; PUNGENT COMPONENT; HIGH-FAT; AGONIST; MICE; CINNAMALDEHYDE; ACCUMULATION; PEPPER	There are several thermosensitive transient receptor potential (TRP) ion channels including capsaicin receptor, TRPV1. Food components activating TRPV1 inhibit body fat deposition through sympathetic nerve stimulation. TRPA1 is another pungency sensor for pungent compounds and is mainly coexpressed with TRPV1 in sensory nerve endings. Therefore, TRPA1 activation is expected to have an anti-obesity effect similar to TRPV1 activation. We have searched for agonists for TRPV1 and TRPA1 in vitro from Asian spices by the use of TRPV1- and TRPA1-expressing cells. Further, we performed food component addition tests to high-fat and high-sucrose diets in mice. We found capsiate, capsiconiate, capsainol from hot and sweet peppers, several piperine analogs from black pepper, gingeriols and shogaols from ginger, and sanshools and hydroxysanshools from sansho (Japanese pepper) to be TRPV1 agonists. We also identified several sulfides from garlic and durian, hydroxy fatty acids from royal jelly, miogadial and miogatrial from mioga (Zingiber mioga), piperine analogs from black pepper, and acetoxychavicol acetate (ACA) from galangal (Alpinia galanga) as TRPA1 agonists. Piperine addition to diets diminished visceral fats and increased the uncoupling protein 1 (UCP1) in interscapular brown adipose tissue (MAT), and black pepper extract showed stronger effects than piperine. Cinnamaldehyde and ACA as TRPA1 agonists inhibited fat deposition and increased UCP1. We found that several agonists of TRPV1 and TRPA1 and some agonists of TRPV1 and TRPA1 inhibit visceral fat deposition in mice. The effects of such compounds on humans remain to be clarified, but we expect that they will be helpful in the prevention of obesity.	[Watanabe, Tatsuo; Terada, Yuko] Univ Shizuoka, Sch Food & Nutr Sci, Suruga Ku, Shizuoka 4228526, Japan	Watanabe, T (reprint author), Univ Shizuoka, Sch Food & Nutr Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	watanbt@u-shizuoka-ken.ac.jp					Kawabata F, 2006, BIOSCI BIOTECH BIOCH, V70, P2824, DOI 10.1271/bbb.60206; Terada Y, 2014, FOOD CHEM, V157, P213, DOI 10.1016/j.foodchem.2014.02.031; Sugai E, 2005, BIOSCI BIOTECH BIOCH, V69, P1951, DOI 10.1271/bbb.69.1951; Iwai K, 2003, P JPN ACAD B-PHYS, V79, P207, DOI 10.2183/pjab.79B.207; Caterina MJ, 1997, NATURE, V389, P816; Iwasaki Y, 2011, BIOSCI BIOTECH BIOCH, V75, P904, DOI 10.1271/bbb.100850; Okumura Y, 2010, BIOSCI BIOTECH BIOCH, V74, P1545, DOI 10.1271/bbb.100117; Iwasaki Y, 2006, NUTR NEUROSCI, V9, P169, DOI 10.1080/10284150600955164; Okumura Y, 2010, BIOSCI BIOTECH BIOCH, V74, P1068, DOI 10.1271/bbb.90964; Iida T., 2003, Neuropharmacology, V44, P958, DOI 10.1016/S0028-3908(03)00100-X; Iwasaki Y, 2008, LIPIDS, V43, P471, DOI 10.1007/s11745-008-3182-5; Iwasaki Y, 2008, BIOSCI BIOTECH BIOCH, V72, P2608, DOI 10.1271/bbb.80289; Kobata K, 2008, PHYTOCHEMISTRY, V69, P1179, DOI 10.1016/j.phytochem.2007.11.017; Kobata K, 2006, BIOSCI BIOTECH BIOCH, V70, P1904, DOI 10.1271/bbb.60064; Koizumi K, 2009, BIOCHEM BIOPH RES CO, V382, P545, DOI 10.1016/j.bbrc.2009.03.066; Narukawa M, 2010, BIOSCI BIOTECH BIOCH, V74, P1694, DOI 10.1271/bbb.100133; Tamura Y, 2012, J NUTR SCI VITAMINOL, V58, P9	17	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S86	S88				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700036		
J	Watanabe, T				Watanabe, Tomoko			Food Composition Tables of Japan and the Nutrient Table/Database	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						food composition tables of Japan; nutrient table/database; INFOODS; nutrient table/database of East Asia		A global food composition database has been constructed by the United Nations Food and Agriculture Organization (FAO) based on food composition tables from every country in the world. To improve this database, the FAO has organized the International Network of Food Data Systems (INFOODS). The most recent version of the food composition table for Japan was published by the Ministry of Education, Culture, Sports, Science and Technology and is presented in three books: "Standard Tables of Food Composition Japan -2010-," "Fatty Acid Composition of Foods -2005-," and "Amino Acid Composition of Foods -2010-." The Standard Tables of Food Composition in Japan -2015- (Energy, General Components, Minerals, Vitamins, etc. Section; Fatty Acids Section; Amino Acids Section; Carbohydrates Section) will be published in 2015 and is expected to play an important role as one of the main tables of the East Asia food composition tables.	[Watanabe, Tomoko] Chiba Prefectural Univ Hlth Sci, Fac Healthcare Sci, Dept Nutr, Mihama Ku, Chiba 2610014, Japan; [Watanabe, Tomoko] Minist Educ Culture Sports Sci & Technol, Subdiv Resource Study Council Sci & Technol, Chiba 2610014, Japan	Watanabe, T (reprint author), Chiba Prefectural Univ Hlth Sci, Fac Healthcare Sci, Dept Nutr, Mihama Ku, 2-10-1 Wakaba, Chiba 2610014, Japan.	tomoko.watanabe@cpuhs.ac.jp					Garrow JS, 2000, HUMAN NUTR DIETETICS, V10th, P303; The Council for Science and Technology Ministry of Education Culture Sports Science and Technology, 2005, FATT AC COMP FOODS 2; The Council for Science and Technology Ministry of Education Culture Sports Science and Technology, 2010, STAND TABL FOOD COMP; The Council for Science and Technology Ministry of Education Culture Sports Science and Technology, 2010, AM AC COMP FOODS 201; The Council for Science and Technology Ministry of Education Culture Sports Science and Technology, 2004, AN MAN STAND TABL FO; Watanabe T., 2011, Japanese Journal of Nutrition and Dietetics, V69, P10, DOI 10.5264/eiyogakuzashi.69.214	6	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S25	S27				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700012		
J	Yamaguchi, R; Hwang, LS				Yamaguchi, Ryuji; Hwang, Lucy Sun			Food Safety Program in Asian Countries	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						food safety regulation; risk assessment; food standard harmonization; ASEAN; climate change		By using the ILSI network in Asia, we are holding a session focused on food safety programs in several Asian areas. In view of the external environment, it is expected to impact the global food system in the near future, including the rapid increase in food demand and in public health services due to population growth, as well as the threats to biosecurity and food safety due to the rapid globalization of the food trade. Facilitating effective information sharing holds promise for the activation of the food industry. At this session, Prof. Hwang shares the current situation of Food Safety and Sanitation Regulations in Taiwan. Dr. Liu provides a talk on the role of risk assessment in food regulatory control focused on aluminum-containing food additives in China. After the JECFA evaluation of aluminum-containing food additives in 2011, each country has carried out risk assessment based on dietary intake surveys. Ms. Chan reports on the activities of a working group on Food Standards Harmonization in ASEAN. She also explains that the ILSI Southeast Asia Region has actively supported the various ASEAN Working Groups in utilizing science to harmonize food standards. Prof. Park provides current research activities in Korea focused on the effect of climate change on food safety. Climate change is generally seen as having a negative impact on food security, particularly in developing countries. We use these four presentations as a springboard to vigorous discussion on issues related to Food Safety in Asia.	[Yamaguchi, Ryuji] Int Life Sci Inst Japan, Chiyoda Ku, Tokyo 1020083, Japan; [Hwang, Lucy Sun] Natl Taiwan Univ, Grad Inst Food Sci & Tech, Taipei, Taiwan	Yamaguchi, R (reprint author), Int Life Sci Inst Japan, Chiyoda Ku, 3-5-19 Kojimachi, Tokyo 1020083, Japan.	ryamaguchi@ilsijapan.org						0	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S53	S54				2	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700022		
J	Yamazaki, H; Fushiki, T				Yamazaki, Hanae; Fushiki, Tohru			The Japan Society for Innovative Cuisine: Exploring New Visions of Japanese Cuisine	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						Japanese cuisine; cooking; gastronomy; culinary experiments		Kyoto cuisine has a long history and its traditions have been practiced for hundreds of years. In Kyoto, a group of scientists and renowned chefs strives to better understand traditional Kyoto cuisine in order to foster culinary innovation within traditional Kyoto cuisine. We launched a research project in April 2009 using a specially equipped "laboratory-kitchen" located in Kyoto University. Chefs chose a variety of topics related to basic concepts and techniques for cooking. We conducted culinary experimentation, thorough analysis, and diligent discussion on each topic for approximately 6 mo. In the symposium, chefs will present the results of their experiments, discussing their techniques and bringing samples of final products.	[Yamazaki, Hanae] Ryukoku Univ, Fac Agr, Kyoto 6128577, Japan; [Fushiki, Tohru] Kyoto Univ, Grad Sch Agr, Kyoto 6068502, Japan; [Yamazaki, Hanae; Fushiki, Tohru] Japan Soc Lab Cuisine, Kyoto 6068502, Japan	Yamazaki, H (reprint author), Ryukoku Univ, Fac Agr, Kyoto 6128577, Japan.	h-yamazaki@agr.ryukoku.ac.jp						0	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S162	S163				2	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700064		
J	Yanagita, T; Miyazawa, T				Yanagita, Teruyoshi; Miyazawa, Teruo			Lipid Nutrition and Healthy Aging	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						metabolic syndrome; lipids; C/EBP beta; carotenoid; food factor	UNSATURATED FATTY-ACIDS; MICE	Bioactive food factors are considered to be critical for health promotion and play an important role in the prevention of lifestyle-related diseases. Metabolic syndrome, a typical common disease, is a cluster of metabolic disorders, such as abdominal obesity, the combination of hypertriglyceridemia and lower level of HDL, hypertension and diabetes mellitus, that contribute to increased cardiovascular morbidity and mortality. In addition, the incidence of metabolic syndrome and non-alcoholic fatty liver disease (NAFLD) is closely linked with the increase in inflammation and the disorders of lipid metabolism. The pathogenesis of metabolic syndrome and related diseases is complicated. However, food factors have been recognized as contributing factors in the development and prevention of these diseases. Provocative evidence profoundly supports the preventive role of dietary bioactive lipids, polyphenols and other food ingredients. Recent studies suggest the central role of nuclear transcription factors in the pathogenesis of obesity and NAFLD. The goal of the present symposium is to enhance our understanding of cellular and molecular effects of bioactive food factors against obesity related pathogenesis.	[Yanagita, Teruyoshi] Nishikyushu Univ, Kanzaki, Saga, Japan; Tohoku Univ, Grad Sch, Sendai, Miyagi 980, Japan	Yanagita, T (reprint author), Nishikyushu Univ, Kanzaki, Saga, Japan.	yanagitt@gmail.com					Rahman SM, 2012, J BIOL CHEM, V287, P34349, DOI 10.1074/jbc.M112.410613; Chandrika UG, 2006, J SCI FOOD AGR, V86, P54, DOI 10.1002/jsfa.2307; Huang YS, 2006, DIETARY FATS RISK CH; Nagao K, 2014, J OLEO SCI, V63, P979, DOI 10.5650/jos.ess14118; Rahman SM, 2013, BIOCHEM BIOPH RES CO, V430, P336, DOI 10.1016/j.bbrc.2012.11.027; Yoshinaga K, 2015, J NUTR BIOCHEM, V26, P57, DOI 10.1016/j.jnutbio.2014.09.004	6	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S157	S158				2	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700062		
J	Yasui, T				Yasui, Takeshi			Advances in Food Composition Tables of Japan -Amino Acid, Fatty Acid and Available Carbohydrate Tables-	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						amino acid composition; available carbohydrate composition; fatty acid composition; food composition tables; Japan		The new revised version of the Standard Tables of Food Composition in Japan (STFCJ 2015) will be published in 2015. The aim of the present paper is to share information on issues we have encountered during the revision. New analytical data on amino acid composition will be provided for approximately 230 foods, fatty acid composition for approximately 140 foods, and available carbohydrate (starch, glucose, fructose, sucrose, maltose, and lactose) composition for approximately 340 foods. These data will be published separately as three supplements to the STFCJ 2015: amino acid tables, fatty acid tables, and available carbohydrate tables. Available carbohydrate tables will also provide polyol (sorbitol and mannitol) and organic acid (acetic acid, lactic acid, citric acid, etc.) data. In the supplements, amino acid content will be adjusted for protein content calculated as reference nitrogen multiplied by a nitrogen to protein conversion factor, and fatty acid content adjusted for extractable lipid content, as in previous revisions. Available carbohydrate content, however, will be adjusted for water content. Values of protein content calculated as the sum of amino acid residues <PROTCAA>, lipid content expressed as triacylglycerol equivalents of fatty acids <FATNLEA>, and available carbohydrate content <CHOAVLM> will appear in the main tables of the STFCJ 2015. Protein, fat and available carbohydrate contents were significantly decreased when the preferred analytical methods of FAO were applied instead of the acceptable methods. Online publication of Japanese and English versions of these tables, reference materials, and a retrievable food composition database is planned.	Minist Educ Culture Sports Sci & Technol, Council Sci & Technol, Subdiv Resource Study, Expert Comm Food Components, Tokyo, Japan	Yasui, T (reprint author), Minist Educ Culture Sports Sci & Technol, Council Sci & Technol, Subdiv Resource Study, Expert Comm Food Components, Tokyo, Japan.	yas@affre.go.jp					FAO, 2003, 77 FAO; FAO/INFOODS, 2012, FAO INFOODS GUID CON; JFRL, 2010, REP CARB CONT STAND; STFCJ, 2004, AN MAN STAND TABL FO; STFCJ, 2010, STAND TABL FOOD COMP	5	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S28	S30				3	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700013		
J	Yasumoto, T				Yasumoto, Takeshi			Chemistry and Safegurding Marine Resources from Natural Contaminants	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article									Japan Food Res Labs, Tokyo, Japan	Yasumoto, T (reprint author), Japan Food Res Labs, Tokyo, Japan.							0	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S205	S205				1	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700085		
J	Yoshita, K				Yoshita, Katsushi			Selection of a Dietary Assessment Method in Accordance with an Objective and Evaluation of the Results	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						dietary assessment; selection of a dietary assessment method; evaluation; comprehensive evaluation		In recent years, many studies have used epidemiological techniques to investigate the relationships of daily energy and nutrition intake to food intake, and to disease onset and treatment or prevention. Therefore, dietary assessments are now being used in various situations. A range of dietary assessment methods exists, and each has advantages and disadvantages. However, there is no absolute and universally applicable dietary assessment method. The most appropriate method or a combination of methods must be selected in accordance with factors such as the objective of a study and the number of subjects. Moreover, it is necessary to interpret dietary assessment results multilaterally and to grasp dietary habits, elements of a daily lifestyle environment, and physical conditions that could influence the diet.	Osaka City Univ, Grad Sch Human Life Sci, Dept Food & Human Hlth Sci, Osaka 5588585, Japan	Yoshita, K (reprint author), Osaka City Univ, Grad Sch Human Life Sci, Dept Food & Human Hlth Sci, Osaka 5588585, Japan.	yoshita@life.osaka-cu.ac.jp					Barasi Mary, 2007, NUTR GLANCE, P8; Gibson Rosalind S., 2005, PRINCIPLES NUTR ASSE, P129; Japan Gas Association, 2008, DIET SURVEY MAN, V2008, P3; Lennernäs M., 1998, Scandinavian Journal of Nutrition/Näringsforskning, V42, P63; Smith S, 2014, J HUM NUTR DIET, DOI [http://dx.doi.org/10.1111/jhn.12278, DOI 10.1111/JHN.12278, 10.1111/jhn.12278]	5	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	MAY	2015	61			S			S31	S32				2	Nutrition & Dietetics	Nutrition & Dietetics	CI8KH	WOS:000355020700014		
J	Liu, ZL; Jenkinson, SF; Vermaas, T; Adachi, I; Wormald, MR; Hata, Y; Kurashima, Y; Kaji, A; Yu, CY; Kato, A; Fleet, GWJ				Liu, Zilei; Jenkinson, Sarah F.; Vermaas, Tom; Adachi, Isao; Wormald, Mark R.; Hata, Yukako; Kurashima, Yukiko; Kaji, Akira; Yu, Chu-Yi; Kato, Atsushi; Fleet, George W. J.			3-Fluoroazetidinecarboxylic Acids and trans,trans-3,4-Difluoroproline as Peptide Scaffolds: Inhibition of Pancreatic Cancer Cell Growth by a Fluoroazetidine Iminosugar	JOURNAL OF ORGANIC CHEMISTRY			English	Article							SUGAR AMINO-ACIDS; AZETIDINE-2-CARBOXYLIC ACID; FLUORINATED DERIVATIVES; AZETIDINE IMINOSUGARS; THERAPEUTIC AGENTS; ORGANIC FLUORINE; POTENT; DISCOVERY; PROTEIN; NMR	Reverse aldol opening tenders amides of 3-hydroxyazetidinecarboxylic acids (3-OH-Aze) unstable above pH 8. Axe, found in sugar beet, is mis-incorporated for proline in peptides in humans and is associated with multiple sclerosis and teratogenesis. Axe-containing peptides may be oxygenated by prolyl hydroxylases resulting in potential damage of the protein by a reverse aldol of the hydroxyazetidine; this, rather than changes in conformation; may account for the deleterious effects of Axe. This paper describes the synthesis of 3-fluoro-Aze amino acids as hydroxy-Aze analogues which are not susceptible to aldol cleavage. 4-(Azidomethyl)-3-fluoro-Aze and 3,4-difluoroproline are new peptide building blocks. trans,trans-2,4-dihydroxy-3-fluoroazetidine, an iminosugar, inhibits the growth of pancreatic cancer cells to a similar degree as gemcitabine.	[Liu, Zilei; Jenkinson, Sarah F.; Vermaas, Tom; Fleet, George W. J.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England; [Adachi, Isao; Kato, Atsushi] Toyama Univ, Dept Hosp Pharm, Toyama 9300194, Japan; [Wormald, Mark R.] Univ Oxford, Dept Biochem, Glycobiol Inst, Oxford OX1 3QU, England; [Hata, Yukako; Kurashima, Yukiko; Kaji, Akira] Hokuriku Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa 9201181, Japan; [Yu, Chu-Yi] Chinese Acad Sci, Inst Chem, CAS Key Lab Mol Recognit & Funct, Beijing 100190, Peoples R China; [Yu, Chu-Yi; Fleet, George W. J.] Jiangxi Normal Univ, Natl Engn Res Ctr Carbohydrate Synth, Nanchang 330022, Peoples R China	Kato, A (reprint author), Toyama Univ, Dept Hosp Pharm, Toyama 9300194, Japan.	kato@med.u-toyama.ac.jp; george.fleet@chem.ox.ac.uk	Wormald, Mark/G-2785-2011	Wormald, Mark/0000-0002-4853-2773	Leverhulme Trust; Japanese Society for the Promotion of Science (JSPS) [26460143]	This work was supported in part by the Leverhulme Trust (G.W.J.F.) and a Grant-in-Aid for Scientific Research (C) (No. 26460143) (A.K.) from the Japanese Society for the Promotion of Science (JSPS).	Alam MP, 2014, BIOORGAN MED CHEM, V22, P4935, DOI 10.1016/j.bmc.2014.06.040; ALBERT R, 1985, J CARBOHYD CHEM, V4, P513, DOI 10.1080/07328308508082673; Zukauskaite A, 2014, EUR J ORG CHEM, V2014, P2312, DOI 10.1002/ejoc.201301741; Ayers BJ, 2014, J ORG CHEM, V79, P3398, DOI 10.1021/jo500157p; Marsh ENG, 2014, ACS CHEM BIOL, V9, P1242, DOI 10.1021/cb500111u; NAKAJIMA T, 1969, SCIENCE, V164, P1400, DOI 10.1126/science.164.3886.1400; Tysoe C, 2014, CURR TOP MED CHEM, V14, P865; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Pizzonero M, 2014, J MED CHEM, V57, P10044, DOI 10.1021/jm5012885; Liang T, 2013, ANGEW CHEM INT EDIT, V52, P8214, DOI 10.1002/anie.201206566; Hagmann WK, 2008, J MED CHEM, V51, P4359, DOI 10.1021/jm800219f; Hickey ER, 2015, BIOORG MED CHEM LETT, V25, P575, DOI 10.1016/j.bmcl.2014.12.033; Rzasa RM, 2014, BIOORGAN MED CHEM, V22, P6570, DOI 10.1016/j.bmc.2014.10.013; Kato A, 2008, PHYTOCHEMISTRY, V69, P1261, DOI 10.1016/j.phytochem.2007.11.018; Anxionnat B, 2012, J ORG CHEM, V77, P6087, DOI 10.1021/jo300887u; Wang J, 2014, CHEM REV, V114, P2432, DOI 10.1021/cr4002879; Kim DW, 2006, J AM CHEM SOC, V128, P16394, DOI 10.1021/ja0646895; Martinez RF, 2014, TETRAHEDRON-ASYMMETR, V25, P373, DOI 10.1016/j.tetasy.2014.01.014; Rjabovs V, 2013, TETRAHEDRON, V69, P10693, DOI 10.1016/j.tet.2013.10.021; Nash RJ, 2011, FUTURE MED CHEM, V3, P1513, DOI [10.4155/fmc.11.117, 10.4155/FMC.11.117]; Powell NH, 2014, CHEM COMMUN, V50, P8797, DOI 10.1039/c4cc03507k; Loenarz C, 2014, P NATL ACAD SCI USA, V111, P4019, DOI 10.1073/pnas.1311750111; Chang DL, 2002, ORG LETT, V4, P1859, DOI 10.1021/ol025829s; D'hooghe M, 2010, EUR J ORG CHEM, P4920, DOI 10.1002/ejoc.201000486; Buer BC, 2012, PROTEIN SCI, V21, P453, DOI 10.1002/pro.2030; Andersen SM, 1997, CARBOHYD RES, V301, P155, DOI 10.1016/S0008-6215(97)00099-2; Sun YY, 2014, CHEM BIODIVERS, V11, P115, DOI 10.1002/cbdv.201300092; Parsy C, 2014, BIOORG MED CHEM LETT, V24, P4444, DOI 10.1016/j.bmcl.2014.08.002; Lenagh-Snow GMJ, 2011, ORG LETT, V13, P5834, DOI 10.1021/ol2024482; Li YX, 2015, ORG LETT, V17, P716, DOI 10.1021/ol503728e; Zhao J, 2015, J PHYS CHEM B, V119, P3387, DOI 10.1021/jp5115288; Awale S, 2006, CANCER RES, V66, P1751, DOI 10.1158/0008-5472.CAN-05-3143; Risseeuw M, 2013, AMINO ACIDS, V45, P613, DOI 10.1007/s00726-013-1521-1; Metkar SD, 2013, MED CHEM RES, V22, P5982, DOI 10.1007/s00044-013-0579-3; Lee JC, 2012, J ORG CHEM, V77, P3082, DOI 10.1021/jo202054g; Mahe O, 2013, J FLUORINE CHEM, V153, P57, DOI 10.1016/j.jfluchem.2013.05.019; Kiss L, 2014, CHEM REV, V114, P1116, DOI 10.1021/cr300454h; Phillips DP, 2014, J MED CHEM, V57, P3263, DOI 10.1021/jm401731q; CARMICHAEL J, 1987, CANCER RES, V47, P943; Martinek TA, 2012, CHEM SOC REV, V41, P687, DOI 10.1039/c1cs15097a; Asano N, 2003, MOL LIFE SCI, V13, p93R; Backer D. C., 1972, CARBOHYD RES, V24, P192; Baek SH, 2012, J FOOD COMPOS ANAL, V25, P137, DOI 10.1016/j.jfca.2011.09.005; Bessonov K, 2010, PHYTOCHEMISTRY, V71, P502, DOI 10.1016/j.phytochem.2009.12.010; Best D, 2010, TETRAHEDRON LETT, V51, P2222, DOI 10.1016/j.tetlet.2010.02.063; Buck K. W., 1966, CARBOHYD RES, V3, P137, DOI 10.1016/S0008-6215(00)82310-1; BUKU A, 1980, P NATL ACAD SCI USA, V77, P2370, DOI 10.1073/pnas.77.5.2370; Card P. J., 1984, CARBOHYDR CHEM, V4, P451; Chakraborty TK, 2007, J MED CHEM, V50, P5539, DOI 10.1021/jm070619c; Chakraborty TK, 2004, J CHEM SCI, V116, P187, DOI 10.1007/BF02708268; Chakraborty TK, 2011, J PHYS ORG CHEM, V24, P720, DOI 10.1002/poc.1818; Champagne PA, 2015, SYNTHESIS-STUTTGART, V47, P306, DOI 10.1055/s-0034-1379537; Claridge TDW, 2001, TETRAHEDRON LETT, V42, P4251, DOI 10.1016/S0040-4039(01)00661-X; Cohen S., 1964, CHEM IND, V43, P1802; Couty F, 2009, SYNLETT, P3053, DOI 10.1055/s-0029-1218299; Dasuri K, 2011, J NEUROSCI RES, V89, P1471, DOI 10.1002/jnr.22677; Drouillat B, 2014, J PEPT SCI, V20, pS189; Egli M., 2010, J AM CHEM SOC, V133, P16642; FOWDEN L, 1955, NATURE, V176, P347, DOI 10.1038/176347a0; Glawar AFG, 2013, CHEMMEDCHEM, V8, P658, DOI 10.1002/cmdc.201200541; Glawar AFG, 2012, CHEM-EUR J, V18, P9341, DOI 10.1002/chem.201200110; Hara R, 2014, BIOSCI BIOTECH BIOCH, V78, P1384, DOI 10.1080/09168451.2014.918490; Hodgson DM, 2015, ORG LETT, V17, P330, DOI 10.1021/ol503441d; Jasinski M, 2014, EUR J ORG CHEM, P442, DOI 10.1002/ejoc.201301406; Kaji A, 1997, ANTICANCER RES, V17, P3675; Kern N, 2014, ORG LETT, V16, P6104, DOI 10.1021/ol5029496; KOLLONIT.J, 1970, J AM CHEM SOC, V92, P7494, DOI 10.1021/ja00728a056; KOVAC P, 1987, CARBOHYD RES, V169, P23, DOI 10.1016/0008-6215(87)80239-2; Lenagh-Snow GMJ, 2012, ORG LETT, V14, P2142, DOI 10.1021/ol300669v; Lensen N, 2015, ORG LETT, V17, P342, DOI 10.1021/ol503448w; Li YX, 2011, ORG BIOMOL CHEM, V9, P3405, DOI 10.1039/c0ob01063d; Lo C, 2014, TETRAHEDRON LETT, V55, P535, DOI 10.1016/j.tetlet.2013.11.092; Manta S, 2009, EUR J MED CHEM, V44, P4764, DOI 10.1016/j.ejmech.2009.06.013; Mastihubova M, 2004, CARBOHYD RES, V339, P2101, DOI 10.1016/j.carres.2004.06.001; Pan SF, 2013, ACS MED CHEM LETT, V4, P333, DOI 10.1021/ml300396r; Prell E, 2009, BIOORG MED CHEM LETT, V19, P5673, DOI 10.1016/j.bmcl.2009.08.012; Rajulu GG, 2014, MED CHEM RES, V23, P2856, DOI 10.1007/s00044-013-0873-0; Reddy BVS, 2014, TETRAHEDRON LETT, V55, P49, DOI 10.1016/j.tetlet.2013.10.095; Rodgers K., 2014, J EXPTL NEOROLOGY, V253, P192; Rubenstein E, 2008, J NEUROPATH EXP NEUR, V67, P1035, DOI 10.1097/NEN.0b013e31818add4a; Rubenstein E, 2000, MEDICINE, V79, P80, DOI 10.1097/00005792-200003000-00002; Rubenstein E, 2009, PHYTOCHEMISTRY, V70, P100, DOI 10.1016/j.phytochem.2008.11.007; RUBENSTEIN E, 2013, NEURAL CIRCUIT DEV F, P539; Shibasaki T, 1999, TETRAHEDRON LETT, V40, P5227, DOI 10.1016/S0040-4039(99)00944-2; Smith M. D., 1998, J CHEM SOC CHEM COMM, P2041; Stankovic S., 2014, SYNLETT, P75; Takhi M, 2014, EUR J MED CHEM, V84, P382, DOI 10.1016/j.ejmech.2014.07.036; Verniest G., 2009, J ORG CHEM, V75, P2250; Vranova V, 2012, LISTY CUKROV REPAR, V128, P22; Weids AJ, 2014, J CELL SCI, V127, P1327, DOI 10.1242/jcs.144022	90	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0022-3263			J ORG CHEM	J. Org. Chem.	MAY 1	2015	80	9					4244	4258		10.1021/acs.joc.5b00463		15	Chemistry, Organic	Chemistry	CH4LI	WOS:000354004600003		
J	Arihara, R; Kakita, K; Suzuki, N; Nakamura, S; Hashimoto, S				Arihara, Ryoichi; Kakita, Kosuke; Suzuki, Noritoshi; Nakamura, Seiichi; Hashimoto, Shunichi			Glycosylation with 2-Acetamido-2-deoxyglycosyl Donors at a Low Temperature: Scope of the Non-Oxazoline Method	JOURNAL OF ORGANIC CHEMISTRY			English	Article							CATALYZED STEREOSELECTIVE GLYCOSYLATION; GLYCOPYRANOSYL DIETHYL PHOSPHITES; POT OLIGOSACCHARIDE SYNTHESIS; AMINE-PROTECTING GROUP; SOLID-PHASE SYNTHESIS; LEWIS-ACID CATALYST; STEREOCONTROLLED CONSTRUCTION; DIPHENYL PHOSPHATES; GLYCOSIDE SYNTHESIS; CHEMICAL GLYCOSYLATION	A direct construction of 1,2-trans-beta-linked 2-acetamido-2-deoxyglycosides was investigated. The 3,4,6-tri-O-benzyl- and 3,4,6-tri-O-acetyl-protected glycosyl diethyl phosphites and 4,6-O-benzylidene-protected galactosyl diethyl phosphite each reacted with a variety of acceptor alcohols in the presence of a stoichiometric amount of Tf2NH in CH2Cl2 at -78 degrees C to afford the corresponding beta-glycosides in good to high yields with complete stereoselectivity. Some experiments provided strong evidence that the corresponding oxazolinium ions are not responsible for the reaction. We demonstrated that glycosylations with the corresponding glycosyl imidate and thioglycoside also proceeded at a low temperature, indicating the possibility of these donors being attractive alternatives to the phosphite. A plausible reaction mechanism, which features glycosyl triflimide and contact ion pair as reactive intermediates, is proposed on the basis of the results obtained with 2-acetamido-2-deoxymannosyl donors.	[Arihara, Ryoichi; Kakita, Kosuke; Suzuki, Noritoshi; Nakamura, Seiichi; Hashimoto, Shunichi] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan	Nakamura, S (reprint author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	nakamura@phar.nagoya-cu.ac.jp; hsmt@pharm.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science	This research was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. We also acknowledge the Japan Society for the Promotion of Science for graduate fellowships to R.A., K.K., and N.S. We thank S. Oka and M. Kiuchi of the Center for Instrumental Analysis, Hokkaido University, for mass measurements and elemental analysis.	Adinolfi M, 2006, TETRAHEDRON LETT, V47, P2595, DOI 10.1016/j.tetlet.2006.02.034; Aly MRE, 1998, EUR J ORG CHEM, P2305; SCHMIDT RR, 1986, ANGEW CHEM INT EDIT, V25, P212, DOI 10.1002/anie.198602121; Imamura A, 2008, HETEROCYCLES, V76, P883; Crasto CF, 2004, TETRAHEDRON LETT, V45, P4891, DOI 10.1016/j.tetlet.2004.04.127; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; Zhu XM, 2009, ANGEW CHEM INT EDIT, V48, P1900, DOI 10.1002/anie.200802036; Krag J, 2010, CARBOHYD RES, V345, P872, DOI 10.1016/j.carres.2010.02.013; Mensah EA, 2010, J AM CHEM SOC, V132, P14288, DOI 10.1021/ja106682m; VEENEMAN GH, 1990, TETRAHEDRON LETT, V31, P1331, DOI 10.1016/S0040-4039(00)88799-7; Codee JDC, 2005, CHEM SOC REV, V34, P769, DOI 10.1039/b417138c; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Huang M, 2012, NAT CHEM, V4, P663, DOI [10.1038/nchem.1404, 10.1038/NCHEM.1404]; Arihara R, 2005, ANGEW CHEM INT EDIT, V44, P2245, DOI 10.1002/anie.200461988; Cai Y, 2005, ORG LETT, V7, P4021, DOI 10.1021/ol051523k; Mathieu B, 1997, TETRAHEDRON LETT, V38, P5497, DOI 10.1016/S0040-4039(97)01208-2; LEMIEUX RU, 1979, CAN J CHEM, V57, P1244, DOI 10.1139/v79-203; Wei GH, 2008, CARBOHYD RES, V343, P3096, DOI 10.1016/j.carres.2008.09.003; Jensen KJ, 1996, J AM CHEM SOC, V118, P3148, DOI 10.1021/ja953529i; Huang M, 2012, J AM CHEM SOC, V134, P14746, DOI 10.1021/ja307266n; BLATTER G, 1994, CARBOHYD RES, V260, P189, DOI 10.1016/0008-6215(94)84038-5; KISO M, 1985, CARBOHYD RES, V136, P309, DOI 10.1016/0008-6215(85)85205-8; Imamura A, 2003, TETRAHEDRON LETT, V44, P6725, DOI 10.1016/S0040-4039(03)01647-2; SCHMIDT RR, 1994, ADV CARBOHYD CHEM BI, V50, P21, DOI 10.1016/S0065-2318(08)60150-X; Yamago S, 2004, ANGEW CHEM INT EDIT, V43, P2145, DOI 10.1002/anie.200353552; Manabe S, 2006, J AM CHEM SOC, V128, P10666, DOI 10.1021/ja062531e; Zachara NE, 2002, CHEM REV, V102, P431, DOI 10.1021/cr000406u; Dullenkopf W, 1996, CARBOHYD RES, V296, P135, DOI 10.1016/S0008-6215(96)00237-6; Walvoort MTC, 2010, CARBOHYD RES, V345, P1252, DOI 10.1016/j.carres.2010.02.027; FOROPOULOS J, 1984, INORG CHEM, V23, P3720, DOI 10.1021/ic00191a011; BANOUB J, 1992, CHEM REV, V92, P1167, DOI 10.1021/cr00014a002; Zhang ZY, 1999, J AM CHEM SOC, V121, P734, DOI 10.1021/ja982232s; Comer FI, 2000, J BIOL CHEM, V275, P29179, DOI 10.1074/jbc.R000010200; Bongat AFG, 2007, CARBOHYD RES, V342, P374, DOI 10.1016/j.carres.2006.10.021; SIM MM, 1993, J AM CHEM SOC, V115, P2260, DOI 10.1021/ja00059a023; Imamura A, 2006, CHEM-EUR J, V12, P8862, DOI 10.1002/chem.200600832; Hasegawa A, 2003, ANGEW CHEM INT EDIT, V42, P5731, DOI 10.1002/anie.200352382; CASTROPALOMINO JC, 1995, TETRAHEDRON LETT, V36, P6871, DOI 10.1016/0040-4039(95)01406-8; Azumaya I, 2004, SYNLETT, P959, DOI 10.1055/s-2004-822885; Bohe L, 2015, CARBOHYD RES, V403, P48, DOI 10.1016/j.carres.2014.06.020; BORDWELL FG, 1988, ACCOUNTS CHEM RES, V21, P456, DOI 10.1021/ar00156a004; BOULLANGER P, 1990, CARBOHYD RES, V202, P151, DOI 10.1016/0008-6215(90)84077-8; BOVIN NV, 1981, CARBOHYD RES, V98, P25, DOI 10.1016/S0008-6215(00)87138-4; Bowers SG, 1998, J ORG CHEM, V63, P4570, DOI 10.1021/jo9808728; CASTROPALOMINO JC, 1995, TETRAHEDRON LETT, V36, P5343, DOI 10.1016/0040-4039(95)01027-F; Castro-Palomino JC, 2000, TETRAHEDRON LETT, V41, P629, DOI 10.1016/S0040-4039(99)02136-X; Cato D, 2005, J CARBOHYD CHEM, V24, P503, DOI 10.1081/CAR-200067091; Chen XT, 1998, J AM CHEM SOC, V120, P7760, DOI 10.1021/ja980724z; Cheng YP, 2002, TETRAHEDRON LETT, V43, P7721, DOI 10.1016/S0040-4039(02)01849-X; Crich D, 1997, J AM CHEM SOC, V119, P11217, DOI 10.1021/ja971239r; Crich D, 2011, J ORG CHEM, V76, P9193, DOI 10.1021/jo2017026; Crich D, 2010, ACCOUNTS CHEM RES, V43, P1144, DOI 10.1021/ar100035r; Debenham J, 1997, LIEBIGS ANN-RECL, P791; Debenham JS, 1996, BIOORGAN MED CHEM, V4, P1909, DOI 10.1016/S0968-0896(96)00173-3; DEBENHAM JS, 1995, J AM CHEM SOC, V117, P3302, DOI 10.1021/ja00116a047; Di Bussolo V, 2000, ANGEW CHEM INT EDIT, V39, P204, DOI 10.1002/(SICI)1521-3773(20000103)39:1<204::AID-ANIE204>3.0.CO;2-Z; Douglas NL, 1998, J CHEM SOC PERK T, V1, P51; Ellervik U, 1996, CARBOHYD RES, V280, P251, DOI 10.1016/0008-6215(95)00318-5; Elofsson M, 1997, TETRAHEDRON, V53, P369, DOI 10.1016/S0040-4020(96)00992-1; Fan GT, 2005, TETRAHEDRON, V61, P1855, DOI 10.1016/j.tet.2004.12.027; FERRARI B, 1980, CARBOHYD RES, V79, pC1, DOI 10.1016/S0008-6215(00)85142-3; FRASERREID B, 1991, J AM CHEM SOC, V113, P1434, DOI 10.1021/ja00004a066; FRASERREID B, 1992, SYNLETT, P927; FRIEDRICHBOCHNITSCHEK S, 1989, J ORG CHEM, V54, P751, DOI 10.1021/jo00265a007; Geiger J, 2007, J ORG CHEM, V72, P4367, DOI 10.1021/jo061670b; GRIFFITH DA, 1990, J AM CHEM SOC, V112, P5811, DOI 10.1021/ja00171a021; GRUNDLER G, 1984, LIEBIGS ANN CHEM, P1826; HASHIMOTO S, 1995, TETRAHEDRON LETT, V36, P2251, DOI 10.1016/0040-4039(95)00263-C; HASHIMOTO S, 1989, J CHEM SOC CHEM COMM, P685, DOI 10.1039/c39890000685; HASHIMOTO S, 1992, TETRAHEDRON LETT, V33, P3523, DOI 10.1016/S0040-4039(00)92679-0; Hosoya T, 2014, J ORG CHEM, V79, P7889, DOI 10.1021/jo501012s; IMOTO M, 1987, B CHEM SOC JPN, V60, P2205, DOI 10.1246/bcsj.60.2205; Ishihara K, 1996, SYNLETT, P1045; Jiao HL, 1999, ANGEW CHEM INT EDIT, V38, P346, DOI 10.1002/(SICI)1521-3773(19990201)38:3<346::AID-ANIE346>3.0.CO;2-L; Jona H, 2002, B CHEM SOC JPN, V75, P291, DOI 10.1246/bcsj.75.291; Kakita K, 2012, TETRAHEDRON, V68, P5005, DOI 10.1016/j.tet.2012.04.059; Karkkainen TS, 2008, CARBOHYD RES, V343, P1830, DOI 10.1016/j.carres.2008.03.034; KISO M, 1979, CARBOHYD RES, V72, pC12, DOI 10.1016/S0008-6215(00)83962-2; KISO M, 1979, CARBOHYD RES, V72, pC15, DOI 10.1016/S0008-6215(00)83963-4; Koeller KM, 2000, BIOORGAN MED CHEM, V8, P1017, DOI 10.1016/S0968-0896(00)00041-9; KONDO H, 1994, J ORG CHEM, V59, P864, DOI 10.1021/jo00083a032; KONDO H, 1992, J AM CHEM SOC, V114, P8748, DOI 10.1021/ja00048a085; Koshiba M, 2008, CHEM-ASIAN J, V3, P1664, DOI 10.1002/asia.200800173; Koto S, 1999, B CHEM SOC JPN, V72, P765, DOI 10.1246/bcsj.72.765; Kretzschmar G, 1998, TETRAHEDRON, V54, P6341, DOI 10.1016/S0040-4020(98)00294-4; Krylov E. N., 1997, RUSS J GEN CHEM+, V67, P1; Lemieux R. U., 1976, ACS SYM SER, V39, P90, DOI DOI 10.1021/BK-1977-0039.CH006; LEMIEUX RU, 1975, J AM CHEM SOC, V97, P4063, DOI 10.1021/ja00847a033; Lian GY, 2015, CARBOHYD RES, V403, P13, DOI 10.1016/j.carres.2014.06.009; Liu J, 2002, J AM CHEM SOC, V124, P9789, DOI 10.1021/ja026281n; LUBINEAU A, 1987, TETRAHEDRON LETT, V28, P5041, DOI 10.1016/S0040-4039(00)96690-5; Ludek O. R., 2010, CARBOHYD RES, V345, P2074; Manabe S, 2011, EUR J ORG CHEM, P497, DOI 10.1002/ejoc.201001278; Manabe S, 2013, J ORG CHEM, V78, P4568, DOI 10.1021/jo400282x; MARTIN TJ, 1993, GLYCOCONJUGATE J, V10, P16, DOI 10.1007/BF00731182; MARTIN TJ, 1992, TETRAHEDRON LETT, V33, P6123; Mathieu B, 2002, TETRAHEDRON, V58, P8219, DOI 10.1016/S0040-4020(02)00971-7; MATSUBARA K, 1993, CHEM LETT, P581, DOI 10.1246/cl.1993.581; Meinjohanns E., 1995, J CHEM SOC PERK T, P405; NAKAHARA Y, 1990, TETRAHEDRON LETT, V31, P6897, DOI 10.1016/S0040-4039(00)97201-0; Nakamura S., 2008, HDB CHEM GLYCOSYLATI, P223; OGAWA T, 1981, CARBOHYD RES, V93, pC6, DOI 10.1016/S0008-6215(00)80765-X; OLAH GA, 1971, J ORG CHEM, V36, P1374, DOI 10.1021/jo00809a013; Oscarson S., 2000, CARBOHYDRATES CHEM B, P93; Palmacci E. R., 2002, EUR J ORG CHEM, P595; PAULSEN H, 1989, LIEBIGS ANN CHEM, P751; Qian XP, 1997, CHEM COMMUN, P1059, DOI 10.1039/a700549k; Rollin P., 1977, J CHEM SOC PERK T, P2513; Ryan DA, 2008, J AM CHEM SOC, V130, P15228, DOI 10.1021/ja804589j; Sakamoto H, 2000, TETRAHEDRON LETT, V41, P7691, DOI 10.1016/S0040-4039(00)01343-5; Sasaki K, 2003, TETRAHEDRON LETT, V44, P5605, DOI 10.1016/S0040-4039(03)01376-5; Schmidt R. R., 1997, PREPARATIVE CARBOHYD, P283; Schmidt R. R., 2000, CARBOHYDRATES CHEM B, P5, DOI 10.1002/9783527618255.ch2; Schmidt RR, 2008, ACCOUNTS CHEM RES, V41, P1059, DOI 10.1021/ar7002495; Shimizu H, 1996, BIOSCI BIOTECH BIOCH, V60, P73; SZABO L, 1995, CARBOHYD RES, V274, P11, DOI 10.1016/0008-6215(95)00016-M; Tanaka H, 1999, CHEM COMMUN, P1259, DOI 10.1039/a902845e; Tseng PH, 2001, CHEM-EUR J, V7, P585, DOI 10.1002/1521-3765(20010202)7:3<585::AID-CHEM585>3.0.CO;2-6; Tsuda T, 2003, TETRAHEDRON LETT, V44, P6453, DOI 10.1016/S0040-4039(03)01557-0; Tsuda T, 2005, TETRAHEDRON, V61, P10719, DOI 10.1016/j.tet.2005.08.090; Tsuda T, 2003, HETEROCYCLES, V59, P509; Tsuda T, 2004, TETRAHEDRON, V60, P10711, DOI 10.1016/j.tet.2004.08.076; Vankayalapati H, 2002, SYNLETT, P16; van Well RM, 2005, J CARBOHYD CHEM, V24, P463, DOI 10.1081/CAR-200067028; Walvoort MTC, 2013, CHEM SCI, V4, P897, DOI 10.1039/c2sc21610h; Winterfeld GA, 2003, EUR J ORG CHEM, P1009; Winterfeld GA, 2001, ANGEW CHEM INT EDIT, V40, P2654, DOI 10.1002/1521-3773(20010716)40:14<2654::AID-ANIE2654>3.0.CO;2-L; Wittmann V, 2002, EUR J ORG CHEM, P1363; Xue WH, 2009, J ORG CHEM, V74, P5079, DOI 10.1021/jo900609s; Yamada T, 2006, ANGEW CHEM INT EDIT, V45, P7575, DOI 10.1002/anie.200602699; Yang Y, 2007, TETRAHEDRON LETT, V48, P4557, DOI 10.1016/j.tetlet.2007.04.150; Zhang Z. Y., 2000, CARBOHYDRATES CHEM B, V1, P117; Zhong W., 2008, HDB CHEM GLYCOSYLATI, P261, DOI DOI 10.1002/9783527621644.CH4A; Zhu X., 2008, HDB CHEM GLYCOSYLATI, P143; ZURABYAN SE, 1970, CARBOHYD RES, V15, P21, DOI 10.1016/S0008-6215(00)80289-X; ZURABYAN SE, 1969, CARBOHYD RES, V9, P215, DOI 10.1016/S0008-6215(00)82136-9	136	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0022-3263			J ORG CHEM	J. Org. Chem.	MAY 1	2015	80	9					4259	4277		10.1021/acs.joc.5b00138		19	Chemistry, Organic	Chemistry	CH4LI	WOS:000354004600004		
J	Arihara, R; Kakita, K; Yamada, K; Nakamura, S; Hashimoto, S				Arihara, Ryoichi; Kakita, Kosuke; Yamada, Kazuhiro; Nakamura, Seiichi; Hashimoto, Shunichi			Synthesis of the Tetrasaccharide Repeating Unit from Acinetobacter baumannii Serogroup O18 Capitalizing on Phosphorus-Containing Leaving Groups	JOURNAL OF ORGANIC CHEMISTRY			English	Article							STEREOSELECTIVE-SYNTHESIS; GLYCOSYL PHOSPHATES; DIPHENYL PHOSPHATES; GLYCOSIDATION; POLYSACCHARIDE; CONSTRUCTION; LINKAGES; DONORS; 2-AZIDO-2-DEOXY-BETA-D-MANNOSIDES; MONOALKYLATION	The first convergent synthesis of the tetrasaccharide repeating unit of the polymeric O antigen isolated from Acinetobacter baumannii serogroup O18 has been achieved: The ManNAc beta 1 -> 4Gal and GalNAc beta 1 -> 3Gal units were successfully obtained through beta-selective glycosylation with 2-azido-4,6-O-benzylidene-2-deoxymannosyl diphenyl phosphate and Tf2NH-promoted glycosylation with 2-acetamido-2-deoxygalactosyl diethyl phosphite, respectively. The disaccharide units could be coupled with the aid of TMSClO4 as an activator of the diphenyl phosphate leaving group, and global deprotection, completed the synthesis of the tetrasaccharide.	[Arihara, Ryoichi; Kakita, Kosuke; Yamada, Kazuhiro; Nakamura, Seiichi; Hashimoto, Shunichi] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan	Nakamura, S (reprint author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	nakamura@phar.nagoya-cu.ac.jp; hsmt@pharm.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science	This research was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. We also acknowledge the Japan Society for the Promotion of Science for graduate fellowships to R.A. and K.K. We thank S. Oka and M. Kiuchi of the Center for Instrumental Analysis, Hokkaido University, for mass measurements and elemental analysis.	Litjens REJN, 2005, CHEM-EUR J, V11, P1010, DOI 10.1002/chem.200400862; SABESAN S, 1992, CARBOHYD RES, V223, P169, DOI 10.1016/0008-6215(92)80015-S; Haseley S, 1997, CARBOHYD RES, V301, P187, DOI 10.1016/S0008-6215(97)00095-5; HE DY, 1993, CARBOHYD RES, V239, P267, DOI 10.1016/0008-6215(93)84222-R; Nakamura S, 2009, HETEROCYCLES, V77, P843, DOI 10.3987/COM-08-S(F)108; Caroff M, 2003, CARBOHYD RES, V338, P2431, DOI 10.1016/j.carres.2003.07.010; OIKAWA Y, 1982, TETRAHEDRON LETT, V23, P885, DOI 10.1016/S0040-4039(00)86974-9; ZHENG QY, 1995, TETRAHEDRON LETT, V36, P2001, DOI 10.1016/0040-4039(95)00212-U; Arihara R, 2005, ANGEW CHEM INT EDIT, V44, P2245, DOI 10.1002/anie.200461988; NAGASHIMA N, 1991, CHEM PHARM BULL, V39, P1972; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Wozniak LA, 1999, TETRAHEDRON LETT, V40, P2637; Ueda T, 2004, ORG LETT, V6, P1753, DOI 10.1021/ol049598w; HORITA K, 1986, TETRAHEDRON, V42, P3021, DOI 10.1016/S0040-4020(01)90593-9; Codee JDC, 2003, ORG LETT, V5, P1519, DOI 10.1021/ol034312t; Astronomo RD, 2010, NAT REV DRUG DISCOV, V9, P308, DOI 10.1038/nrd3012; Arihara R., 2015, J ORG CHEM, DOI 10.1021/acs.joc.5b00138; Codee JDC, 2004, TETRAHEDRON, V60, P1057, DOI 10.1016/j.tet.2003.11.084; Crich D, 2011, J ORG CHEM, V76, P9193, DOI 10.1021/jo2017026; Crich D, 2010, ACCOUNTS CHEM RES, V43, P1144, DOI 10.1021/ar100035r; van den Bos LJ, 2007, EUR J ORG CHEM, P116, DOI 10.1002/ejoc.200600759; Hashimoto S, 1997, TETRAHEDRON LETT, V38, P8969, DOI 10.1016/S0040-4039(97)10365-3; HASHIMOTO S, 1991, TETRAHEDRON LETT, V32, P1653, DOI 10.1016/S0040-4039(00)74296-1; HASHIMOTO S, 1989, J CHEM SOC CHEM COMM, P685, DOI 10.1039/c39890000685; Hashimoto S., 1995, TETRAHEDRON LETT, V36, P2251; HASHIMOTO S, 1992, TETRAHEDRON LETT, V33, P3523, DOI 10.1016/S0040-4039(00)92679-0; HEBERT N, 1990, J CHEM SOC CHEM COMM, P1497, DOI 10.1039/c39900001497; INAGE M, 1982, CHEM LETT, P1281, DOI 10.1246/cl.1982.1281; [Кабанов Д.С. Kabanov D.S.], 2010, [Биохимия, BIOCHEMISTRY (MOSCOW), Biokhimiya], V75, P469; Kakita K, 2012, TETRAHEDRON, V68, P5005, DOI 10.1016/j.tet.2012.04.059; KINZY W, 1985, LIEBIGS ANN CHEM, P1537; Koshiba M, 2008, CHEM-ASIAN J, V3, P1664, DOI 10.1002/asia.200800173; Koto S, 2003, B CHEM SOC JPN, V76, P1603, DOI 10.1246/bcsj.76.1603; Litjens REJN, 2005, EUR J ORG CHEM, P918, DOI 10.1002/ejoc.200400784; Litjens REJN, 2001, TETRAHEDRON LETT, V42, P8693, DOI 10.1016/S0040-4039(01)01880-9; Morelli L, 2011, EUR J ORG CHEM, P5723, DOI 10.1002/ejoc.201100296; NAGASHIMA N, 1987, CHEM LETT, P141, DOI 10.1246/cl.1987.141; Nakamura S., 2008, HDB CHEM GLYCOSYLATI, P223; NASHED MA, 1976, TETRAHEDRON LETT, P3503; NASHED MA, 1976, CARBOHYD RES, V51, P65, DOI 10.1016/S0008-6215(00)84036-7; Palmacci ER, 2002, EUR J ORG CHEM, P595; Vankayalapati H, 2002, SYNLETT, P16; Weintraub A, 2003, CARBOHYD RES, V338, P2539, DOI 10.1016/j.carres.2003.07.008; WESTERDUIN P, 1986, TETRAHEDRON LETT, V27, P1211, DOI 10.1016/S0040-4039(00)84219-7; Zhang Z. Y., 2000, CARBOHYDRATES CHEM B, V1, P117	45	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0022-3263			J ORG CHEM	J. Org. Chem.	MAY 1	2015	80	9					4278	4288		10.1021/acs.joc.5b00139		11	Chemistry, Organic	Chemistry	CH4LI	WOS:000354004600005		
J	Kato, A; Zhang, ZL; Wang, HY; Jia, YM; Yu, CY; Kinami, K; Hirokami, Y; Tsuji, Y; Adachi, I; Nash, RJ; Fleet, GWJ; Koseki, J; Nakagome, I; Hirono, S				Kato, Atsushi; Zhang, Zhao-Lan; Wang, Hong-Yao; Jia, Yue-Mei; Yu, Chu-Yi; Kinami, Kyoko; Hirokami, Yuki; Tsuji, Yutaro; Adachi, Isao; Nash, Robert J.; Fleet, George W. J.; Koseki, Jun; Nakagome, Izumi; Hirono, Shuichi			Design and Synthesis of Labystegines, Hybrid Iminosugars from LAB and Calystegine, as Inhibitors of Intestinal alpha-Glucosidases: Binding Conformation and Interaction for ntSI	JOURNAL OF ORGANIC CHEMISTRY			English	Article							POSTPRANDIAL BLOOD-GLUCOSE; BRANCHED PYRROLIDINE IMINOSUGARS; HUMAN MALTASE-GLUCOAMYLASE; SUCRASE-ISOMALTASE; CYCLIC NITRONES; GLYCOSIDASE INHIBITORS; SUBSTRATE-SPECIFICITY; RADICAMINE-B; BAY M-1099; EN-ROUTE	This paper identifies the required configuration and orientation of alpha-glucosidase inhibitors, miglitol, alpha-1-C-butyl-DNJ, and alpha-1-C-butyl-LAB for binding to ntSI (isomaltase). Molecular dynamics (MD) calculations suggested that the flexibility around the keyhole of ntSI is lower than that of ctSI (sucrase). Furthermore, a molecular-docking study revealed that a specific binding orientation with a CH-pi interaction (Trp370 and Phe648) is a requirement for achieving a strong affinity with ntSI. On the basis of these results, a new class of nortropane-type iminosugars, labystegines, hybrid iminosugars of LAB and calystegine, have been designed and synthesized efficiently from sugar-derived cyclic nitrones with intramolecular 1,3-dipolar cycloaddition or samarium iodide catalyzed reductive coupling reaction as the key step. Biological evaluation showed that our newly designed 3(S)-hydroxy labystegine (6a) inherited the selectivity against intestinal alpha-glucosidases from LAB, and its inhibition potency was 10 times better than that of miglitol. Labystegine, therefore, represents a promising new class of nortropane-type iminosugar for improving postprandial hyperglycemia.	[Kato, Atsushi; Kinami, Kyoko; Hirokami, Yuki; Tsuji, Yutaro; Adachi, Isao] Toyama Univ, Dept Hosp Pharm, Toyama 9300194, Japan; [Zhang, Zhao-Lan; Wang, Hong-Yao; Jia, Yue-Mei; Yu, Chu-Yi] Chinese Acad Sci, BNLMS, CAS Key Lab Mol Recognit & Funct, Inst Chem, Beijing 100190, Peoples R China; [Nash, Robert J.] Phytoquest Ltd, Inst Biol Environm & Rural Sci, Plas Gogerddan, Aberystwyth SY23 3EB, Ceredigion, Wales; [Fleet, George W. J.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England; [Fleet, George W. J.] Jiangxi Normal Univ, Natl Engn Res Ctr Carbohydrate Synth, Nanchang 330022, Peoples R China; [Koseki, Jun; Nakagome, Izumi; Hirono, Shuichi] Kitasato Univ, Sch Pharmaceut Sci, Tokyo 1088641, Japan	Kato, A (reprint author), Toyama Univ, Dept Hosp Pharm, Toyama 9300194, Japan.	kato@med.u-toyama.ac.jp; yucy@iccas.ac.cn; hironos@pharm.kitasato-u.ac.jp			Japanese Society for the Promotion of Science (JSPS) [26460143]; Leverhulme Trust; National Basic Research Program of China [2011CB808603, 2012CB822101]; National Natural Science Foundation of China [21272240]; National Science and Technology Major Projects for "Major New Drugs Innovation and Development" [2013ZX09508104]; Development Fund for Collaborative Innovation Center of Glycoscience of Shandong University; National Engineering Research Center for Carbohydrate Synthesis of Jiangxi Normal University	This work was supported in part by a Grant-in-Aid for Scientific Research (C) (No: 26460143) (A.K.) from the Japanese Society for the Promotion of Science (JSPS) and the Leverhulme Trust (G.W.J.F.). Financial support from the National Basic Research Program of China (Nos. 2011CB808603, 2012CB822101), the National Natural Science Foundation of China (No. 21272240), the National Science and Technology Major Projects for "Major New Drugs Innovation and Development" (2013ZX09508104), the Development Fund for Collaborative Innovation Center of Glycoscience of Shandong University, and National Engineering Research Center for Carbohydrate Synthesis of Jiangxi Normal University is gratefully acknowledged.	Delso I, 2011, J ORG CHEM, V76, P4139, DOI 10.1021/jo200315k; Masson G, 2002, ANGEW CHEM INT EDIT, V41, P1772, DOI 10.1002/1521-3773(20020517)41:10<1772::AID-ANIE1772>3.0.CO;2-Q; Sim L, 2008, J MOL BIOL, V375, P782, DOI 10.1016/j.jmb.2007.10.069; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Cicchi S, 2001, TETRAHEDRON LETT, V42, P6503, DOI 10.1016/S0040-4039(01)01222-9; Quezada-Calvillo R, 2008, J NUTR, V138, P685; Best D, 2010, TETRAHEDRON-ASYMMETR, V21, P311, DOI 10.1016/j.tetasy.2010.01.017; Bonora E, 2001, DIABETOLOGIA, V44, P2107, DOI 10.1007/s001250100020; ASANO N, 1995, EUR J BIOCHEM, V229, P369, DOI 10.1111/j.1432-1033.1995.tb20477.x; Nash RJ, 2011, FUTURE MED CHEM, V3, P1513, DOI [10.4155/fmc.11.117, 10.4155/FMC.11.117]; Kato A, 2012, J MED CHEM, V55, P10347, DOI 10.1021/jm301304e; Nichols BL, 1998, J BIOL CHEM, V273, P3076, DOI 10.1074/jbc.273.5.3076; Ren LM, 2011, PROTEIN CELL, V2, P827, DOI 10.1007/s13238-011-1105-3; Sim L, 2010, J BIOL CHEM, V285, P17763, DOI 10.1074/jbc.M109.078980; Ceriello A, 2005, DIABETES, V54, P1, DOI 10.2337/diabetes.54.1.1; Rossi EJ, 2006, FEBS J, V273, P2673, DOI 10.1111/j.1742-4658.2006.05283.x; Watson AA, 2001, PHYTOCHEMISTRY, V56, P265, DOI 10.1016/S0031-9422(00)00451-9; Ren LM, 2011, CARBOHYD RES, V346, P2688, DOI 10.1016/j.carres.2011.09.012; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Yu CY, 2006, ORG LETT, V8, P3021, DOI 10.1021/ol0609210; Rasmussen TS, 2011, BIOORG MED CHEM LETT, V21, P1519, DOI 10.1016/j.bmcl.2010.12.106; Best D, 2010, TETRAHEDRON LETT, V51, P4170, DOI 10.1016/j.tetlet.2010.05.131; Nichols BL, 2003, P NATL ACAD SCI USA, V100, P1432, DOI 10.1073/pnas.0237170100; Asano N, 1997, EUR J BIOCHEM, V248, P296, DOI 10.1111/j.1432-1033.1997.00296.x; Asano N., 2003, GLYCOBIOLOGY, V13, p93R; Ayers BJ, 2012, J ORG CHEM, V77, P7777, DOI 10.1021/jo301243s; Belmatoug N, 2011, J INHERIT METAB DIS, V34, P991, DOI 10.1007/s10545-011-9368-7; Bowers KJ, 2006, P ACM IEEE C SUP SC0; Chavarot-Kerlidou M., 2010, EUR J ORG CHEM, V75, P944; Cheng H. H., 2006, FEBS J, V273, P4082; CICCHI S, 1995, J ORG CHEM, V60, P4743, DOI 10.1021/jo00120a016; da Cruz FP, 2011, TETRAHEDRON LETT, V52, P219, DOI 10.1015/j.tetlet.2010.10.173; DUCROT PH, 1990, TETRAHEDRON LETT, V31, P3879, DOI 10.1016/S0040-4039(00)97494-X; GOLDMANN A, 1990, PHYTOCHEMISTRY, V29, P2125, DOI 10.1016/0031-9422(90)83019-W; Hu XG, 2010, SYNLETT, P982, DOI 10.1055/s-0029-1219540; Hu XG, 2010, ORG LETT, V12, P2562, DOI 10.1021/ol1007718; JOUBERT PH, 1986, EUR J CLIN PHARMACOL, V30, P253, DOI 10.1007/BF00614315; Kato A, 2014, BIOORGAN MED CHEM, V22, P2435, DOI 10.1016/j.bmc.2014.02.057; KENNEDY FP, 1987, CLIN PHARMACOL THER, V42, P455; KESSLER M, 1978, BIOCHIM BIOPHYS ACTA, V506, P136, DOI 10.1016/0005-2736(78)90440-6; Masson G, 2005, ORG BIOMOL CHEM, V3, P2067, DOI 10.1039/b503981a; Merino P, 2008, EUR J ORG CHEM, P2929, DOI 10.1002/ejoc.200800098; Misago M, 2000, BIOCHEM BIOPH RES CO, V269, P219, DOI 10.1006/bbrc.2000.2269; MOLYNEUX RJ, 1993, ARCH BIOCHEM BIOPHYS, V304, P81, DOI 10.1006/abbi.1993.1324; Rasmussen TS, 2010, ORG BIOMOL CHEM, V8, P433, DOI 10.1039/b918576c; SCHNACK C, 1986, EUR J CLIN PHARMACOL, V30, P417, DOI 10.1007/BF00607953; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; VANBEERS EH, 1995, CRIT REV BIOCHEM MOL, V30, P197, DOI 10.3109/10409239509085143; Wang WB, 2010, SYNLETT, P488, DOI 10.1055/s-0029-1219189; WILTZ O, 1990, SURGERY, V108, P269; WILTZ O, 1991, GASTROENTEROLOGY, V100, P1266; WINCHESTER B, 1992, GLYCOBIOLOGY, V2, P199, DOI 10.1093/glycob/2.3.199; WISSELAAR HA, 1989, CLIN CHIM ACTA, V182, P41, DOI 10.1016/0009-8981(89)90148-4; Zhang ZL, 2011, ORG BIOMOL CHEM, V9, P7713, DOI 10.1039/c1ob06244a	55	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0022-3263			J ORG CHEM	J. Org. Chem.	MAY 1	2015	80	9					4501	4515		10.1021/acs.joc.5b00342		15	Chemistry, Organic	Chemistry	CH4LI	WOS:000354004600028		
J	Katori, A; Azuma, E; Ishimura, H; Kuramochi, K; Tsubaki, K				Katori, Akane; Azuma, Eriko; Ishimura, Hina; Kuramochi, Kouji; Tsubaki, Kazunori			Fluorescent Dyes with Directly Connected Xanthone and Xanthene Units	JOURNAL OF ORGANIC CHEMISTRY			English	Article							ORTHOGONALLY ARRANGED CHROMOPHORES; SPECTROSCOPIC PROPERTIES; ENERGY-TRANSFER; DERIVATIVES; PROBES; FLUOROPHORES	Unexpected dimerization of a methoxymethyl-protected xanthone occurred upon treatment with an aryl lithium reagent generated from 2-bromo-1,3-dimethylbenzene and n-butyllithium. The hydrogen between two directing ethereal oxygen atoms was not abstracted, but that adjacent to the carbonyl group was removed to afford a dimeric compound containing two directly connected fluorescent xanthone and xanthene units. Starting from this discovery, three dimeric dyes were constructed, and their optical properties were examined. Although the two fluorescent units were orthogonal in each dye, efficient energy transfer was observed in dimeric dye 16 in three solvent systems. In contrast, solvent-dependent energy transfer was detected for another dimeric dye, 5. After close investigation, we found that the orientation factor (kappa) is the main factor influencing Forster resonance energy transfer in these dyes.	[Katori, Akane; Azuma, Eriko; Ishimura, Hina; Kuramochi, Kouji; Tsubaki, Kazunori] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Sakyo Ku, Kyoto 6068522, Japan	Tsubaki, K (reprint author), Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Sakyo Ku, Kyoto 6068522, Japan.	tsubaki@kpu.ac.jp			KAKENHI [22390003, 26293005, 15K14931]	The authors thank Prof. Akito Ishida (Kyoto Prefectural University) for useful suggestions and discussion. The authors also appreciate the assistance of Kyoko Ohmine (ICR, Kyoto University) with NMR analysis and Sakiko Akaji, Dr. Yasushi Nakata, and Ikuko Hamagami (Horiba, Ltd.) with measurements of the fluorescence lifetimes of dimeric dyes. This study was partly supported by a Grant-in-Aid for the Japan Society for the Promotion of Science (JSPS) Fellows (to E.A.) and KAKENHI (nos. 22390003, 26293005, and 15K14931). This study was carried out using the 600 MHz NMR spectrometer and Fourier transform ion cyclotron resonance mass spectrometer at the Joint Usage/Research Center, Kyoto University.	ABRAMS SR, 1987, J LABELLED COMPD RAD, V24, P941, DOI 10.1002/jlcr.2580240809; Langhals H, 2010, J AM CHEM SOC, V132, P16777, DOI 10.1021/ja101544x; Li JQ, 2009, ORG LETT, V11, P3008, DOI 10.1021/ol9010344; Du YN, 2012, ORG LETT, V14, P3052, DOI 10.1021/ol300985h; MARTIN MM, 1975, J LUMIN, V10, P381, DOI 10.1016/0022-2313(75)90003-4; Sebej P, 2013, J ORG CHEM, V78, P1833, DOI 10.1021/jo301455n; Wu LX, 2008, J ORG CHEM, V73, P8711, DOI 10.1021/jo800902j; Kobayashi H, 2010, CHEM REV, V110, P2620, DOI 10.1021/cr900263j; de Silva AP, 1997, CHEM REV, V97, P1515, DOI 10.1021/cr960386p; Loudet A, 2007, CHEM REV, V107, P4891, DOI 10.1021/cr078381n; [Anonymous], 2001, MERCK INDEX, P1065; Kamiya M, 2007, J AM CHEM SOC, V129, P3918, DOI 10.1021/ja067710a; Urano Y, 2005, J AM CHEM SOC, V127, P4888, DOI 10.1021/ja043919h; Michalet X, 2006, CHEM REV, V106, P1785, DOI 10.1021/cr0404343; Terai T, 2013, CHEM COMMUN, V49, P3101, DOI 10.1039/c3cc38810g; Mottram LF, 2006, ORG LETT, V8, P581, DOI 10.1021/ol052655g; Kikuchi K, 2010, CHEM SOC REV, V39, P2048, DOI 10.1039/b819316a; Azuma E, 2012, J ORG CHEM, V77, P3492, DOI 10.1021/jo300177b; Yang YJ, 2005, J ORG CHEM, V70, P6907, DOI 10.1021/jo051002a; Azuma E, 2013, TETRAHEDRON, V69, P1694, DOI 10.1016/j.tet.2012.12.035; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Kim SH, 2008, ORG LETT, V10, P4931, DOI 10.1021/ol801907b; Lakowicz J. R., 1999, PRINCIPLES FLUORESCE, P367; Langhals H, 2008, EUR J ORG CHEM, P4559, DOI 10.1002/ejoc.200800451; LEE LG, 1989, CYTOMETRY, V10, P151, DOI 10.1002/cyto.990100206; Mchedlov-Petrossyan NO, 2010, J PHYS CHEM B, V114, P4551, DOI 10.1021/jp909854s; Odrowaz-Sypniewski MR, 2009, TETRAHEDRON LETT, V50, P5981, DOI 10.1016/j.tetlet.2009.08.050; Rostron JP, 2005, NEW J CHEM, V29, P1241, DOI 10.1039/b507585h; Steinberg I. Z., 1971, ANNU REV BIOCHEM, V40, P93; Woydziak ZR, 2012, J ORG CHEM, V77, P473, DOI 10.1021/jo202062f; Yang YJ, 2008, P NATL ACAD SCI USA, V105, P8829, DOI 10.1073/pnas.0710341105; Yoshida N, 2003, CHEM-EUR J, V9, P58, DOI 10.1002/chem.200390004	32	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0022-3263			J ORG CHEM	J. Org. Chem.	MAY 1	2015	80	9					4603	4610		10.1021/acs.joc.5b00479		8	Chemistry, Organic	Chemistry	CH4LI	WOS:000354004600038		
J	Yamane, Y; Sugawara, K; Nakarnura, N; Hayase, S; Nokami, T; Itoh, T				Yamane, Yu; Sugawara, Kiyotaka; Nakarnura, Naoshi; Hayase, Shuichi; Nokami, Toshiki; Itoh, Toshiyuki			Development of n-Type Semiconductor Based on Cyclopentene- or Cyclohexene-Fused [C-60]-Fullerene Derivatives	JOURNAL OF ORGANIC CHEMISTRY			English	Article							POLYMER SOLAR-CELLS; BAYLIS-HILLMAN REACTION; ORGANOMETAL HALIDE PEROVSKITES; PHOTOINDUCED ELECTRON-TRANSFER; PHOTOVOLTAIC CELLS; STEREOSELECTIVE-SYNTHESIS; FULLERENE DERIVATIVES; PERFORMANCE; EFFICIENT; ACCEPTOR	Properties of cydopentene- or cyclohexene-fused [C-60]-fullerene derivatives as the acceptor in photovoltaic cells have been investigated by use of poly(3-hexylthiophene) (P3HT) as the model donor polymer. Several cyclopentene- or cyclohexene-fused [C-60]-fullerene derivatives show high power conversion efficiency (PCB). The highest PCE was obtained for 3',6'-dihydro-4'-phenoxycarbonyl-6'-methylbenzo[1,9][5,6] (C-60-I-h)fullerene (3.2%); this is superior to that of [C-60]-PCBM with the P3HT polymer under the same experimental conditions. PCE of the OPV devices with alkyl-substituted cydohexene-fused [C-60],fullerenes depended on the alkyl substituent on the cyclohexene ring; compounds with substituents of odd-number alkyl groups showed better PCE than those compounds possessing even-number alkyl groups.	[Yamane, Yu; Sugawara, Kiyotaka; Nakarnura, Naoshi; Hayase, Shuichi; Nokami, Toshiki; Itoh, Toshiyuki] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 6808552, Japan; [Nokami, Toshiki; Itoh, Toshiyuki] Tottori Univ, Ctr Res Green Sustainable Chem, Tottori 6808552, Japan	Itoh, T (reprint author), Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, 4-101 Koyama Minami, Tottori 6808552, Japan.	titoh@chem.tottori-u.ac.jp			GSC Center of Tottori University from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Tottori Prefecture	The present work was supported by a Grant-in-Aid for Scientific Research of the GSC Center of Tottori University from the Ministry of Education, Culture, Sports, Science and Technology of Japan and was also supported by a fund for Environmental Research from Tottori Prefecture. We are grateful to Professor Hideyuki Murata and Ryo Itou of Japan Advanced Institute of Science and Technology for measurement of OPV properties of fullerene derivatives.	Wong WY, 2007, NAT MATER, V6, P521, DOI 10.1038/nmat1909; Padinger F, 2003, ADV FUNCT MATER, V13, P85, DOI 10.1002/adfm.200390011; Wei Y, 2013, CHEM REV, V113, P6659, DOI 10.1021/cr300192h; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Matsuo Y, 2009, J AM CHEM SOC, V131, P16048, DOI 10.1021/ja9048702; Kazim S, 2014, ANGEW CHEM INT EDIT, V53, P2812, DOI 10.1002/anie.201308719; Bai Y, 2014, CHEM REV, V114, P10095, DOI 10.1021/cr400606n; Chen CP, 2008, J AM CHEM SOC, V130, P12828, DOI 10.1021/ja801877k; Matsuo Y, 2013, ADV MATER, V25, P6266, DOI 10.1002/adma.201302607; Bakulin AA, 2012, SCIENCE, V335, P1340, DOI 10.1126/science.1217745; Kim JY, 2007, SCIENCE, V317, P222, DOI 10.1126/science.1141711; Troshin PA, 2009, ADV FUNCT MATER, V19, P779, DOI 10.1002/adfm.200801189; SARICIFTCI NS, 1992, SCIENCE, V258, P1474, DOI 10.1126/science.258.5087.1474; Kooistra FB, 2007, ORG LETT, V9, P551, DOI 10.1021/ol062666p; Chan SH, 2008, MACROMOLECULES, V41, P5519, DOI 10.1021/ma800494k; Shi CJ, 2006, J AM CHEM SOC, V128, P8980, DOI 10.1021/ja061664x; Laulhe S, 2012, J MASS SPECTROM, V47, P676, DOI 10.1002/jms.2986; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Wienk MM, 2003, ANGEW CHEM INT EDIT, V42, P3371, DOI 10.1002/anie.200351647; Camaioni N, 2002, J MATER CHEM, V12, P2065, DOI 10.1039/b201338j; HUMMELEN JC, 1995, J ORG CHEM, V60, P532, DOI 10.1021/jo00108a012; Green MA, 2012, PROG PHOTOVOLTAICS, V20, P12, DOI 10.1002/pip.2163; Matsuo Y, 2008, J AM CHEM SOC, V130, P15429, DOI 10.1021/ja8041299; Matsumoto K, 2010, J MATER CHEM, V20, P9226, DOI 10.1039/c0jm01565b; Taylor PC, 2009, ADV MATER, V21, P2314, DOI 10.1002/adma.200803291; Gunes S, 2007, CHEM REV, V107, P1324, DOI 10.1021/cr050149z; Prato M, 1998, ACCOUNTS CHEM RES, V31, P519, DOI 10.1021/ar970210p; Chanthamath S, 2013, ANGEW CHEM INT EDIT, V52, P5818, DOI 10.1002/anie.201300468; Jeong Y, 2010, J ORG CHEM, V75, P4183, DOI 10.1021/jo100618d; Basavaiah D, 2010, CHEM REV, V110, P5447, DOI 10.1021/cr900291g; Kim JY, 2006, ADV MATER, V18, P572, DOI 10.1002/adma.200501825; Zhang Y, 2011, J AM CHEM SOC, V133, P8086, DOI 10.1021/ja201267t; Diederich F, 1999, ACCOUNTS CHEM RES, V32, P537, DOI 10.1021/ar970321o; Giovanni W. A., 2011, J BRAZIL CHEM SOC, V8, P1568; HOFFMANN HMR, 1991, CHEM BER, V124, P2475; Imahori H, 1997, ADV MATER, V9, P537, DOI 10.1002/adma.19970090704; Latorre A, 2014, TETRAHEDRON, V70, P97, DOI 10.1016/j.tet.2013.11.014; Martijn L., 2008, ADV MATER, V20, P2116; Yoshimura K, 2012, TETRAHEDRON, V68, P3605, DOI 10.1016/j.tet.2012.02.080; Renz JA, 2008, PHYS STATUS SOLIDI-R, V2, P263, DOI 10.1002/pssr.200802199; Schmidt Y, 2011, CHEM-EUR J, V17, P11780, DOI 10.1002/chem.201100843; Shi M, 2002, MOLECULES, V7, P721, DOI 10.3390/71000721; Yang HT, 2013, J ORG CHEM, V78, P1163, DOI 10.1021/jo3025797; Yoshimura K, 2013, CHEM LETT, V42, P1209, DOI 10.1246/cl.130506; Zhou ZG, 2005, CURR ORG CHEM, V9, P789, DOI 10.2174/1385272053764971	45	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0022-3263			J ORG CHEM	J. Org. Chem.	MAY 1	2015	80	9					4638	4649		10.1021/acs.joc.5b00530		12	Chemistry, Organic	Chemistry	CH4LI	WOS:000354004600042		
J	Morita, N; Kono, R; Fukui, K; Miyazawa, A; Masu, H; Azumaya, I; Ban, S; Hashimoto, Y; Okamoto, I; Tamura, O				Morita, Nobuyoshi; Kono, Rina; Fukui, Kenji; Miyazawa, Asuka; Masu, Hyuma; Azumaya, Isao; Ban, Shintaro; Hashimoto, Yoshimitsu; Okamoto, Iwao; Tamura, Osamu			BF3-Mediated cis-Selective Cycloaddition of O-Silyloxime with Alkenes	JOURNAL OF ORGANIC CHEMISTRY			English	Article							ASYMMETRIC 1,3-DIPOLAR CYCLOADDITION; N-DEMETHYLATIVE REARRANGEMENT; TRAFFICKING INHIBITOR HPA-12; OXIME OLEFIN CYCLOADDITIONS; INTRAMOLECULAR CYCLOADDITION; CERAMIDE-TRAFFICKING; TERT-BUTYLDIMETHYLSILYLOXIMES; INTERMOLECULAR CYCLOADDITION; ENANTIOSELECTIVE SYNTHESIS; TERMINAL ALKYNES	A C-amide-substituted O-silylated oxime, (E)-(tert-butyldimethylsiloxyimino)acetic acid N,N-dimethylamide (8b), on treatment with 2.2 equiv of BF3 center dot OEt2, in situ generated boracyclic nitrone-type intermediate BF3 center dot 14, which underwent cycloaddition with alkenes to give 3,5-cis-isoxazolidines as the Major products. The mechanism was strongly supported by isolation of the reaction intermediate 14 that was characterized by X-ray diffraction and its further reaction. This cycloaddition was successfully applied to the synthesis of syn-HPA-12 known as an inhibitor of CERT that mediates the transport of ceramide.	[Morita, Nobuyoshi; Kono, Rina; Fukui, Kenji; Miyazawa, Asuka; Ban, Shintaro; Hashimoto, Yoshimitsu; Okamoto, Iwao; Tamura, Osamu] Showa Pharmaceut Univ, Machida, Tokyo 1948543, Japan; [Masu, Hyuma; Azumaya, Isao] Tokushima Bunri Univ, Fac Pharmaceut Sci, Sanuki 7692193, Japan	Tamura, O (reprint author), Showa Pharmaceut Univ, Machida, Tokyo 1948543, Japan.	tamura@ac.shoyaku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Hoansha Foundation; MEXT; MEXT-Supported Program for the Strategic Research Foundation at Private Universities	This work was supported by Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT), a Special Grant generously provided by the Hoansha Foundation, a Grant-in Aid for Scientific Research from MEXT, and a MEXT-Supported Program for the Strategic Research Foundation at Private Universities.	Fassler R, 2002, ANGEW CHEM INT EDIT, V41, P3054, DOI 10.1002/1521-3773(20020816)41:16<3054::AID-ANIE3054>3.0.CO;2-B; Gioia C, 2009, J AM CHEM SOC, V131, P9614, DOI 10.1021/ja902458m; Gothelf KV, 1998, CHEM REV, V98, P863, DOI 10.1021/cr970324e; Frederickson M, 1997, TETRAHEDRON, V53, P403, DOI 10.1016/S0040-4020(96)01095-2; Tamura O, 2004, TETRAHEDRON, V60, P9997, DOI 10.1016/j.tet.2004.08.023; Karyakarte SD, 2012, J ORG CHEM, V77, P7755, DOI 10.1021/jo3013226; Brandi A, 2009, CHEM-EUR J, V15, P7808, DOI 10.1002/chem.200900707; Ritter T, 2005, ANGEW CHEM INT EDIT, V44, P936, DOI 10.1002/anie.200461934; Saied EM, 2014, CHEM-ASIAN J, V9, P2092, DOI 10.1002/asia.201402241; Saubern S, 2010, TETRAHEDRON, V66, P2761, DOI 10.1016/j.tet.2010.01.062; Duris A, 2011, ORG LETT, V13, P1642, DOI 10.1021/ol2001057; Yao CZ, 2014, ORG LETT, V16, P5824, DOI 10.1021/ol502956j; Najera C, 2009, ORG BIOMOL CHEM, V7, P4567, DOI 10.1039/b913066g; Nguyen TB, 2012, ORG PREP PROCED INT, V44, P1, DOI 10.1080/00304948.2012.643193; Nguyen TB, 2010, ORG PREP PROCED INT, V42, P387, DOI 10.1080/00304948.2010.513886; [Anonymous], 2005, OSTEUROPA, V7, P7; Snider JR, 2013, SYNTHESIS-STUTTGART, V45, P1899, DOI 10.1055/s-0033-1338495; Tamura O, 2004, J ORG CHEM, V69, P1475, DOI 10.1021/jo030257q; Burrell AJM, 2010, CURR ORG SYNTH, V7, P312; Morita N, 2008, J ORG CHEM, V73, P7164, DOI 10.1021/jo800878p; Bhattacharjee A, 2003, TETRAHEDRON, V59, P4623, DOI 10.1016/S0040-4020(03)00634-3; Chiacchio U, 2006, TETRAHEDRON, V62, P1171, DOI 10.1016/j.tet.2005.10.075; Chiacchio U, 2007, TETRAHEDRON, V63, P4190, DOI 10.1016/j.tet.2007.03.013; Confalone P. N., 1988, ORG REACTIONS, V36, P1; Doyle L, 2010, TETRAHEDRON, V66, P7041, DOI 10.1016/j.tet.2010.06.005; Dransfield PJ, 1999, J CHEM SOC PERK T 1, P3349, DOI 10.1039/a905706d; Falb E, 1999, J ORG CHEM, V64, P498, DOI 10.1021/jo9815094; Gao ZX, 2009, ORG LETT, V11, P3678, DOI 10.1021/ol901511x; Gerfaud T, 2012, ORG PROCESS RES DEV, V16, P687, DOI 10.1021/op300069n; Gothelf KV, 2000, CHEM COMMUN, P1449, DOI 10.1039/b004597g; Gottlieb L, 2000, SYNTHETIC COMMUN, V30, P2445, DOI 10.1080/00397910008087409; Heaney F, 1998, J CHEM SOC PERK T 1, P955, DOI 10.1039/a707078k; IIDA H, 1986, J AM CHEM SOC, V108, P4647, DOI 10.1021/ja00275a064; Karlsson S., 2001, ORG PREP PROCED INT, V33, P103; Koumbis AE, 2003, CURR ORG CHEM, V7, P585, DOI 10.2174/1385272033486783; Merino P., 2004, SCI SYNTHESIS, V27, P511; Mita N, 2002, ORG LETT, V4, P1111, DOI 10.1021/ol0200044; Moutel S, 1998, SYNLETT, P1333; MZENGEZA S, 1987, J AM CHEM SOC, V109, P276, DOI 10.1021/ja00235a044; Noguchi M, 2001, B CHEM SOC JPN, V74, P917, DOI 10.1246/bcsj.74.917; Partridge KM, 2008, J AM CHEM SOC, V130, P2920, DOI 10.1021/ja711335d; Revuelta J, 2007, SYNTHESIS-STUTTGART, P485; Sharma GVM, 1999, TETRAHEDRON-ASYMMETR, V10, P229, DOI 10.1016/S0957-4166(99)00008-7; Shibue T, 2010, CHEM-EUR J, V16, P11678, DOI 10.1002/chem.201000963; Shibue T, 2009, TETRAHEDRON LETT, V50, P3845, DOI 10.1016/j.tetlet.2009.04.046; Tamura O, 2007, SYNLETT, P658, DOI 10.1055/s-2007-967939; Tamura O, 2005, J ORG CHEM, V70, P10720, DOI 10.1021/jo051652e; Tamura O, 2002, CHEM COMMUN, P1128, DOI 10.1039/b201423h; Topic D, 2005, ORG LETT, V7, P5329, DOI 10.1021/ol52331s; TROVA MP, 2003, J BIOORG MED CHEM, V11, P2695; Ueno M, 2001, TETRAHEDRON LETT, V42, P7863, DOI 10.1016/S0040-4039(01)01658-6; Ueno M, 2013, ORG LETT, V15, P2869, DOI 10.1021/ol401101u; VASELLA A, 1982, HELV CHIM ACTA, V65, P1953, DOI 10.1002/hlca.19820650702; Xiao ZF, 2014, ORG LETT, V16, P6512, DOI 10.1021/ol503261h; Yasuda S, 2001, J BIOL CHEM, V276, P43994, DOI 10.1074/jbc.M104884200	55	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0022-3263			J ORG CHEM	J. Org. Chem.	MAY 1	2015	80	9					4797	4802		10.1021/acs.joc.5b00426		6	Chemistry, Organic	Chemistry	CH4LI	WOS:000354004600063		
J	Baba, M; Maeda, I; Morita, T; Hisanaga, T; Ishihara, T; Iwashita, T; Kaneishi, K; Kawagoe, S; Kuriyama, T; Maeda, T; Mori, I; Nakajima, N; Nishi, T; Sakurai, H; Shimoyama, S; Shinjo, T; Shirayama, H; Yamada, T; Ono, S; Ozawa, T; Yamamoto, R; Tsuneto, S				Baba, Mika; Maeda, Isseki; Morita, Tatsuya; Hisanaga, Takayuki; Ishihara, Tatsuhiko; Iwashita, Tomoyuki; Kaneishi, Keisuke; Kawagoe, Shohei; Kuriyama, Toshiyuki; Maeda, Takashi; Mori, Ichiro; Nakajima, Nobuhisa; Nishi, Tomohiro; Sakurai, Hiroki; Shimoyama, Satofumi; Shinjo, Takuya; Shirayama, Hiroto; Yamada, Takeshi; Ono, Shigeki; Ozawa, Taketoshi; Yamamoto, Ryo; Tsuneto, Satoru			Independent Validation of the Modified Prognosis Palliative Care Study Predictor Models in Three Palliative Care Settings	JOURNAL OF PAIN AND SYMPTOM MANAGEMENT			English	Article						Prognosis palliative care study predictor models; modified; prognostic score; palliative setting; validation study	ILL CANCER-PATIENTS; CONSULTATION SERVICE; SURVIVAL PREDICTION; SCORE; INDEX; PROGNOSTICATION; PAP	Context. Accurate prognostic information in palliative care settings is needed for patients to make decisions and set goals and priorities. The Prognosis Palliative Care Study (PiPS) predictor models were presented in 2011, but have not yet been fully validated by other research teams. Objectives. The primary aim of this study is to examine the accuracy and to validate the modified PiPS (using physician-proxy ratings of mental status instead of patient interviews) in three palliative care settings, namely palliative care units, hospital-based palliative care teams, and home-based palliative care services. Methods. This multicenter prospective cohort study was conducted in 58 palliative care services including 16 palliative care units, 19 hospital-based palliative care teams, and 23 home-based palliative care services in Japan from September 2012 through April 2014. Results. A total of 2426 subjects were recruited. For reasons including lack of followup and missing variables (primarily blood examination data), we obtained analyzable data from 2212 and 1257 patients for the modified PiPS-A and PiPS-B, respectively. In all palliative care settings, both the modified PiPS-A and PiPS-B identified three risk groups with different survival rates (P < 0.001). The absolute agreement ranged from 56% to 60% in the PiPS-A model and 60% to 62% in the PiPS-B model. Conclusion. The modified PiPS was successfully validated and can be useful in palliative care units, hospital-based palliative care teams, and home-based palliative care services. (C) 2015 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.	[Baba, Mika] Saito Yukoukai Hosp, Dept Palliat Care, Ibaraki, Osaka 5670085, Japan; [Maeda, Isseki] Osaka Univ, Grad Sch Med, Dept Palliat Med, Suita, Osaka, Japan; [Morita, Tatsuya] Seirei Mikatahara Gen Hosp, Palliat & Support Care Div, Hamamatsu, Shizuoka, Japan; [Hisanaga, Takayuki] Tsukuba Med Ctr Fdn, Tsukuba, Ibaraki, Japan; [Ishihara, Tatsuhiko] Okayama Saiseikai Gen Hosp, Palliat Care Dept, Okayama, Okayama, Japan; [Iwashita, Tomoyuki] Matsue City Hosp, Matsue, Shimane, Japan; [Kaneishi, Keisuke] JCHO Tokyo Shinjuku Med Ctr, Dept Palliat Care Unit, Shinjuku Ku, Tokyo, Japan; [Kawagoe, Shohei] Aozora Clin, Matsudo, Chiba, Japan; [Kuriyama, Toshiyuki] Wakayama Med Univ Hosp, Ctr Oncol, Dept Palliat Med, Wakayama, Japan; [Maeda, Takashi] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Palliat Care, Bunkyo Ku, Tokyo, Japan; [Mori, Ichiro] Gratia Hosp Hosp, Mino, Osaka, Japan; [Nakajima, Nobuhisa] Tohoku Univ, Grad Sch Med, Dept Palliat Med, Sendai, Miyagi 980, Japan; [Nishi, Tomohiro] Kawasaki Municipal Ida Hosp, Kawasaki Comprehens Care Ctr, Nakahara Ku, Kawasaki, Kanagawa, Japan; [Sakurai, Hiroki] St Lukes Int Hosp, Dept Palliat Care, Chuo Ku, Tokyo, Japan; [Shimoyama, Satofumi] Aichi Canc Ctr Hosp, Dept Palliat Care, Chikusa Ku, Nagoya, Aichi 464, Japan; [Shinjo, Takuya] Shinjo Clin, Kobe, Hyogo, Japan; [Shirayama, Hiroto] Iryouhoujinn Takumikai Osaka Kita Homecare Clin, Osaka, Osaka, Japan; [Yamada, Takeshi] Nippon Med Sch, Dept Gastrointestinal & Hepatobiliary Pancreat Su, Bunkyo Ku, Tokyo 113, Japan; [Ono, Shigeki] Shizuoka Canc Ctr Hosp, Div Palliat Med, Shizuoka, Japan; [Ozawa, Taketoshi] Megumi Zaitaku Clin, Yokohama, Kanagawa, Japan; [Yamamoto, Ryo] Saku Cent Hosp, Adv Care Ctr, Dept Palliat Med, Saku, Nagano, Japan; [Tsuneto, Satoru] Kyoto Univ, Grad Sch Med, Dept Multidisciplinary Canc Treatment, Sakyo Ku, Kyoto, Japan	Baba, M (reprint author), Saito Yukoukai Hosp, Dept Palliat Care, 7-2-18 Saito Asagi, Ibaraki, Osaka 5670085, Japan.	baba@saito-yukoukai-hp.jp			National Cancer Center Research and Development Fund [25-A-22]	This work was supported in part by the National Cancer Center Research and Development Fund (25-A-22). The authors declare no conflicts of interest.	Maltoni M, 2005, J CLIN ONCOL, V23, P6240, DOI 10.1200/JCO.2005.06.866; Naylor C, 2010, J PAIN SYMPTOM MANAG, V39, P69, DOI 10.1016/j.jpainsymman.2009.05.020; Glare P, 2001, J PAIN SYMPTOM MANAG, V22, P891, DOI 10.1016/S0885-3924(01)00341-4; Morita T, 1999, SUPPORT CARE CANCER, V7, P128, DOI 10.1007/s005200050242; Stone PC, 2007, ANN ONCOL, V18, P971, DOI 10.1093/annonc/md1343; Alshemmari S, 2012, J PALLIAT MED, V15, P200, DOI 10.1089/jpm.2011.0253; Tassinari D, 2008, SUPPORT CARE CANCER, V16, P359, DOI 10.1007/s00520-007-0302-3; Morita T, 1999, JPN J CLIN ONCOL, V29, P156, DOI 10.1093/jjco/29.3.156; Glare P, 2003, BRIT MED J, V327, P195, DOI 10.1136/bmj.327.7408.195; Pirovano M, 1999, J PAIN SYMPTOM MANAG, V17, P231, DOI 10.1016/S0885-3924(98)00145-6; Maltoni M, 1999, J PAIN SYMPTOM MANAG, V17, P240, DOI 10.1016/S0885-3924(98)00146-8; Stone CA, 2008, J PAIN SYMPTOM MANAG, V35, P617, DOI 10.1016/j.jpainsymman.2007.07.006; Lau F, 2007, J PALLIAT CARE, V23, P93; Glare PA, 2004, J CLIN ONCOL, V22, P4823, DOI 10.1200/JCO.2004.12.056; Glare P, 2010, OXFORD TXB PALLIATIV, V4th, P81; Gwilliam B, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4920; HODKINSON H M, 1972, Age and Ageing, V1, P233, DOI 10.1093/ageing/1.4.233; Kim ES, 2013, EUR GERIATR MED, V4, pS81; Kurashima AY, 2010, PEDIATR BLOOD CANCER, V55, P1167, DOI 10.1002/pbc.22644; Numico G, 2011, SUPPORT CARE CANCER, V19, P1823, DOI 10.1007/s00520-010-1024-5; Stone Paddy, 2012, BMJ Support Palliat Care, V2, P219, DOI 10.1136/bmjspcare-2012-000216; Tarumi Y, 2011, J PAIN SYMPTOM MANAG, V42, P419, DOI 10.1016/j.jpainsymman.2010.12.013; Yoong Jaclyn, 2010, J Pain Symptom Manage, V39, pe2, DOI 10.1016/j.jpainsymman.2009.08.001	23	4	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0885-3924	1873-6513		J PAIN SYMPTOM MANAG	J. Pain Symptom Manage.	MAY	2015	49	5					853	860		10.1016/j.jpainsymman.2014.10.010		8	Health Care Sciences & Services; Medicine, General & Internal; Clinical Neurology	Health Care Sciences & Services; General & Internal Medicine; Neurosciences & Neurology	CI5VI	WOS:000354827500012		
J	Miyashita, M; Wada, M; Morita, T; Ishida, M; Onishi, H; Sasaki, Y; Narabayashi, M; Wada, T; Matsubara, M; Takigawa, C; Shinjo, T; Suga, A; Inoue, S; Ikenaga, M; Kohara, H; Tsuneto, S; Shima, Y				Miyashita, Mitsunori; Wada, Makoto; Morita, Tatsuya; Ishida, Mayumi; Onishi, Hideki; Sasaki, Yasutsuna; Narabayashi, Masaru; Wada, Tomomi; Matsubara, Mei; Takigawa, Chizuko; Shinjo, Takuya; Suga, Akihiko; Inoue, Satoshi; Ikenaga, Masayuki; Kohara, Hiroyuki; Tsuneto, Satoru; Shima, Yasuo			Independent Validation of the Japanese Version of the EORTC QLQ-C15-PAL for Patients With Advanced Cancer	JOURNAL OF PAIN AND SYMPTOM MANAGEMENT			English	Article						Palliative care; quality of life; neoplasms; questionnaires; advanced cancer patients	QUALITY-OF-LIFE; EUROPEAN-ORGANIZATION; PALLIATIVE CARE; QUESTIONNAIRE; QLQ-C30; ONCOLOGY	Context. Although the psychometric properties of the Japanese version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 15-Palliative Care (EORTC QLQ-C15-PAL) have been examined previously, that study had several limitations, for example, small sample size. Objectives. To examine the validity and reliability, including test-retest reliability, of the Japanese version of EORTC QLQ-C15-PAL for cancer patients with metastasis or recurrence. Methods. A cross-sectional anonymous questionnaire was administered to cancer patients who were being treated on an oncology inpatient ward, in an oncology outpatient clinic, and in seven inpatient palliative units in Japan, from August 2007 to March 2008. Results. Data from a total of 312 cancer patients were analyzed. The proportion of missing values was less than 4% for all items. The factor structure was reproduced identically with the original EORTC QLQ-C15-PAL, English version. The correlation of subscales showed a reasonable matrix. Cronbach's alpha coefficients were 0.76 to 0.86, and intraclass correlation coefficients, which indicate test-retest reliability, ranged from 0.52 to 0.77. All subscales, especially physical functioning, fatigue, and pain, were significantly correlated with self-reported Eastern Cooperative Oncology Group performance status. Conclusion. The Japanese version of EORTC QLQ-C15-PAL has sufficient validity, acceptable reliability, and feasibility for patients with advanced cancer. (C) 2015 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.	[Miyashita, Mitsunori] Univ Tokyo, Grad Sch Med, Sch Hlth Sci, Dept Adult Nursing Palliat Care Nursing, Tokyo, Japan; [Miyashita, Mitsunori] Tohoku Univ, Grad Sch Med, Div Palliat Nursing, Hlth Sci, Sendai, Miyagi 9808575, Japan; [Wada, Makoto; Ishida, Mayumi; Onishi, Hideki; Wada, Tomomi; Matsubara, Mei] Saitama Med Univ, Int Med Ctr, Dept Psychooncol, Saitama, Japan; [Sasaki, Yasutsuna] Saitama Med Univ, Int Med Ctr, Dept Med Oncol, Saitama, Japan; [Narabayashi, Masaru] Saitama Med Univ, Int Med Ctr, Dept Palliat Med, Saitama, Japan; [Morita, Tatsuya] Seirei Mikatahara Hosp, Palliat Care Team, Dept Palliat & Support Care, Shizuoka, Japan; [Morita, Tatsuya] Seirei Mikatahara Hosp, Palliat Care Team, Seirei Hosp, Shizuoka, Japan; [Sasaki, Yasutsuna] Showa Univ, Sch Med, Dept Med, Div Med Oncol, Tokyo 142, Japan; [Wada, Tomomi] Osaka Natl Hosp, Dept Psychiat, Osaka, Japan; [Takigawa, Chizuko] Sapporo Med Ctr, KKR Dept Palliat Med, Sapporo, Hokkaido, Japan; [Shinjo, Takuya] Shinjo Clin, Kobe, Hyogo, Japan; [Suga, Akihiko] Shizuoka Prefectural Gen Hosp, Dept Palliat Med, Shizuoka, Japan; [Suga, Akihiko] Shizuoka Saiseikai Gen Hosp, Dept Palliat Med, Shizuoka, Japan; [Inoue, Satoshi] Seirei Mikatahara Hosp, Seirei Hosp, Dept Palliat Care, Shizuoka, Japan; [Ikenaga, Masayuki] Yodogawa Christians Hosp, Hosp, Osaka, Japan; [Ikenaga, Masayuki] Yodogawa Christians Hosp, Childrens Hosp Hosp, Osaka, Japan; [Kohara, Hiroyuki] Hiroshima Prefectural Hosp, Dept Palliat Care, Hiroshima, Japan; [Tsuneto, Satoru] Osaka Univ, Grad Sch Med, Dept Palliat Med, Osaka, Japan; [Shima, Yasuo] Tsukuba Med Ctr Hosp, Dept Palliat Med, Ibaraki, Japan	Miyashita, M (reprint author), Tohoku Univ, Grad Sch Med, Div Palliat Nursing, Hlth Sci,Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	miyasita-tky@umin.net			Health and Labor Sciences Research Grant [H19-ganrisho-ippan-004]	This research was supported by a Health and Labor Sciences Research Grant for third-term comprehensive control research for cancer (H19-ganrisho-ippan-004). The authors declare no conflicts of interest.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; CELLA DF, 1993, J CLIN ONCOL, V11, P570; Caissie A, 2012, SUPPORT CARE CANCER, V20, P841, DOI 10.1007/s00520-011-1160-6; Groenvold M, 2006, EUR J CANCER, V42, P55, DOI 10.1016/j.ejca.2005.06.022; Cramarossa G, 2013, SUPPORT CARE CANCER, V21, P1709, DOI 10.1007/s00520-013-1717-7; Sepulveda C, 2002, J PAIN SYMPTOM MANAG, V24, P91, DOI 10.1016/S0885-3924(02)00440-2; Luckett T, 2011, ANN ONCOL, V22, P2179, DOI 10.1093/annonc/mdq721; Kobayashi K, 1998, EUR J CANCER, V34, P810, DOI 10.1016/S0959-8049(97)00395-X; Cohen SR, 1997, PALLIATIVE MED, V11, P3; European Organization for Research and Treatment of Cancer Quality of Life Group, EORTC QLQ C15 PAL; Groenvold M, 2006, ADDENDUM EORTIC QLQ; Hermann K, 2012, BMC PALLIAT CARE, V11, DOI 10.1186/1472-684X-11-13; Koo K, 2012, SUPPORT CARE CANCER, V20, P2121, DOI 10.1007/s00520-011-1322-6; Lam K, 2013, J PALLIAT MED, V16, P402, DOI 10.1089/jpm.2012.0398; Miyazaki K, 2012, QUAL LIFE RES, V21, P335, DOI 10.1007/s11136-011-9939-y; Shin DW, 2011, J PAIN SYMPTOM MANAG, V41, P478, DOI 10.1016/j.jpainsymman.2010.05.009; Steinhauser Karen E, 2004, Palliat Support Care, V2, P3; Steinhauser Karen E, 2002, J Palliat Med, V5, P829, DOI 10.1089/10966210260499014; Steinmann D, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-283; Velikova G, 1999, EUR J CANCER, V35, P1571, DOI 10.1016/S0959-8049(99)00193-8; Yun YH, 2006, EUR J CANCER, V42, P2310, DOI 10.1016/j.ejca.2006.04.010	21	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0885-3924	1873-6513		J PAIN SYMPTOM MANAG	J. Pain Symptom Manage.	MAY	2015	49	5					953	959		10.1016/j.jpainsymman.2014.11.299		7	Health Care Sciences & Services; Medicine, General & Internal; Clinical Neurology	Health Care Sciences & Services; General & Internal Medicine; Neurosciences & Neurology	CI5VI	WOS:000354827500025		
J	Kamibeppu, K; Sato, I; Hoshi, Y				Kamibeppu, Kiyoko; Sato, Iori; Hoshi, Yasutaka			The Experience of Japanese Adolescents and Young Adults After Losing Siblings to Childhood Cancer: Three Types of Narratives	JOURNAL OF PEDIATRIC ONCOLOGY NURSING			English	Article						bereavement; childhood cancer; narrative method; sibling; transition	CHILDREN; ADJUSTMENT; FAMILY; IMPACT	The aim of this study was to describe Japanese adolescents' and young adults' experiences after losing siblings to childhood cancer. A conceptual framework of the transition and analysis based on narrative method were adopted from qualitative data from 6 Japanese adolescents and young adults who had lost their siblings to childhood cancer. It was revealed that the participants' psychological experience after the sibling's death was directed by their perceptions of their mothers' responses to bereavement. We also found that the psychological distance between participants and their mothers could be an important factor in enabling transition into mourning and in orienting the lost sibling in their mind. The stories obtained from these 6 participants were categorized into the following 3 types of narratives: Mother in another world and the sibling who became a god, Return of the loving mother and the sibling as savior, and The poor mother and the sibling who needs my help to carry on her legacy. This typology will serve as a framework for grief care and future research.	[Kamibeppu, Kiyoko; Sato, Iori; Hoshi, Yasutaka] Univ Tokyo, Grad Sch Med, Dept Family Nursing, Tokyo 1130033, Japan	Kamibeppu, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Family Nursing, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kkamibeppu-tky@umin.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology [16390635]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was partially supported by a Grant-in-Aid for Scientific Research (B) 16390635 from the Japanese Ministry of Education, Culture, Sports, Science, and Technology.	Alderfer MA, 2006, PEDIATR BLOOD CANCER, V47, P537, DOI 10.1002/pbc.20691; ANDERSON H, 1988, FAM PROCESS, V27, P371, DOI 10.1111/j.1545-5300.1988.00371.x; Spinetta JJ, 1999, MED PEDIATR ONCOL, V33, P395, DOI 10.1002/(SICI)1096-911X(199910)33:4<395::AID-MPO9>3.0.CO;2-S; Woodgate RL, 2006, CANCER NURS, V29, P406, DOI 10.1097/00002820-200609000-00010; Alderfer MA, 2010, PSYCHO-ONCOLOGY, V19, P789, DOI 10.1002/pon.1638; Houtzager BA, 1999, SUPPORT CARE CANCER, V7, P302, DOI 10.1007/s005200050268; Patterson JM, 2004, PSYCHO-ONCOL, V13, P390, DOI 10.1002/pon.761; Birenbaum L K, 1989, J Pediatr Oncol Nurs, V6, P86; BRUNER J, 1987, SOC RES, V54, P11; Chick N., 1986, NURSING RES METHODOL, P237; Doi T., 1992, SHINTEI HOUHO TO SHI; Elliott J, 2005, USING NARRATIVE SOCI; Elmberger E, 2000, Health Care Women Int, V21, P485; Erikson E. H., 1963, CHILDHOOD SOC; Flick U., 2002, INTRO QUALITATIVE RE; Freeman K, 2000, Oncol Nurs Forum, V27, P843; Gallo A. D., 2003, PRAXIS KINDERPSYCHOL, V52, P141; Goldie Peter, 2004, NARRATIVE RES HLTH I, P156, DOI 10.1002/9780470755167.ch10; Green A., 1986, PRIVATE MADNESS; Hearn L., 1924, THE STUDY OF JAPAN; Holloway I., 1996, QUALITATIVE RES NURS; Holloway I., 2007, NARRATIVE RES NURSIN; Martinson I. M., 1991, J ADOLESCENT RES, V6, P54, DOI 10.1177/074355489161005; MARTINSON IM, 1990, CANCER NURS, V13, P183, DOI 10.1097/00002820-199006000-00008; Mattingly Cheryl F., 1998, HEALING DRAMAS CLIN; McGrath Pam, 2005, Issues Compr Pediatr Nurs, V28, P97, DOI 10.1080/01460860590950881; Mita S., 1984, GENDAI NIHON NO SEIS; Murray J S, 1998, Issues Compr Pediatr Nurs, V21, P217, DOI 10.1080/014608698265429; Murray J S, 1999, J Pediatr Oncol Nurs, V16, P25; Namihira E., 1990, YAMAI TO SHI NO BUNK; Namihira E., 2004, NIHONJIN NO SHI NO K; Nolbris Margaretha, 2005, J Pediatr Oncol Nurs, V22, P227, DOI 10.1177/1043454205274722; Ozawa M., 2000, J JAPAN PEDIAT SOC, V104, P1197; Riessman C. K., 1998, NARRATIVE ANAL; Rosenthal G., 1993, NARRATIVE STUDY LIVE, V1, P59; Saiki-Craighill S, 2001, J Pediatr Oncol Nurs, V18, P268, DOI 10.1053/jpon.2001.28456; Saiki-Craighill S., 2002, JAPANESE J HLTH BEHA, V17, P161; Saito S., 2003, NARRATIVE BASED MED; SCHLOSSBERG NK, 1981, COUNS PSYCHOL, V9, P2, DOI 10.1177/001100008100900202; Takaishi K., 1997, HAHA WO SASAERU MUSU; Wengraf T., 2001, QUALITATIVE RES INTE; Wilkins Krista Lynn, 2006, J Pediatr Nurs, V21, P256, DOI 10.1016/j.pedn.2006.01.090; Wilkins Krista L, 2005, J Pediatr Oncol Nurs, V22, P305, DOI 10.1177/1043454205278035; Winnicott D., 1971, PLAYING REALITY; Yin LK, 2004, CANCER NURS, V27, P17, DOI 10.1097/00002820-200401000-00003	45	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1043-4542	1532-8457		J PEDIATR ONCOL NURS	J. Pediatr. Oncol. Nurs.	MAY-JUN	2015	32	3					165	177		10.1177/1043454214554013		13	Oncology; Nursing	Oncology; Nursing	CI6CE	WOS:000354845500005		
J	Eickaravarodome, C; Thounthong, P; Jirasereeamornkul, K; Higuchi, K				Eickaravarodome, Chainarin; Thounthong, Phatiphat; Jirasereeamornkul, Kamon; Higuchi, Kohji			Analysis and Design of a DC-Side Symmetrical Class-D ZCS Rectifier for the PFC of Lighting Applications	JOURNAL OF POWER ELECTRONICS			English	Article						Class-D ZCS rectifier; Electronic ballast; Lighting applications; Line harmonic; Power-factor correction; Power quality; Symmetrical circuit	HIGH-POWER-FACTOR; HALF-BRIDGE CONVERTER; ELECTRONIC BALLAST; COUPLED-INDUCTOR; FACTOR CORRECTOR; IMPLEMENTATION; LAMPS	This paper proposes the analysis and design of a DC-side symmetrical zero-current-switching (ZCS) Class-D current-source driven resonant rectifier to improve the low power-factor and high line current harmonic distortion of lighting applications. An analysis of the junction capacitance effect of Class-D ZCS rectifier diodes, which has a significant impact on line current harmonic distortion, is discussed in this paper. The design procedure is based on the principle of the symmetrical Class-D ZCS rectifier, which ensures more accurate results and provides a more systematic and feasible analysis methodology. Improvement in the power quality is achieved by using the output characteristics of the DC-side Class-D ZCS rectifier, which is inserted between the front-end bridge-rectifier and the bulk-filter capacitor. By using this symmetrical topology, the conduction angle of the bridge-rectifier diode current is increased and the low line harmonic distortion and power-factor near unity were naturally achieved. The peak and ripple values of the line current are also reduced, which allows for a reduced filter-inductor volume of the electromagnetic interference (EMI) filter. In addition, low-cost standard-recovery diodes can be employed as a bridge-rectifier. The validity of the theoretical analysis is confirmed by simulation and experimental results.	[Eickaravarodome, Chainarin] King Mongkuts Univ Technol North Bangkok, Dept Instrumentat & Elect Eng, Bangkok, Thailand; [Thounthong, Phatiphat] King Mongkuts Univ Technol North Bangkok, Dept Teacher Training Elect Eng, Bangkok, Thailand; [Jirasereeamornkul, Kamon] King Mongkuts Univ Technol North Bangkok, Dept Elect & Telecommun Engn, Bangkok, Thailand; [Higuchi, Kohji] Univ Electrocommun, Dept Mech Eng & Intelligent Syst, Chofu, Tokyo 182, Japan	Eickaravarodome, C (reprint author), KMUTNB, Bangkok, Thailand.	chainarine@kmutnb.ac.th			King Mongkut's University of Technology North Bangkok (KMUTNB), Thailand [KMUTNB-GEN-58-04]	The author would like to thank King Mongkut's University of Technology North Bangkok (KMUTNB), Thailand, for financially supporting this research under Contract No. KMUTNB-GEN-58-04.	Arias M, 2013, IEEE T POWER ELECTR, V28, P2539, DOI 10.1109/TPEL.2012.2213613; [Anonymous], 2005, 6100032 IEC; Vlatkovic V, 1996, IEEE T POWER ELECTR, V11, P199, DOI 10.1109/63.484433; Moon S, 2013, IEEE T POWER ELECTR, V28, P4051, DOI 10.1109/TPEL.2012.2229471; Arias M, 2013, IEEE T IND APPL, V49, P127, DOI 10.1109/TIA.2012.2227644; Cheng HL, 2013, IET POWER ELECTRON, V6, P1010, DOI 10.1049/iet-pel.2012.0691; Bhim S., 2014, IET POWER ELECTRON, V7, P946; Cheng CA, 2014, IEEE T POWER ELECTR, V29, P1966, DOI 10.1109/TPEL.2013.2266137; Cho YW, 2012, J POWER ELECTRON, V12, P699, DOI 10.6113/JPE.2012.12.5.699; da Silva MF, 2013, IEEE T IND ELECTRON, V60, P3081, DOI 10.1109/TIE.2012.2203774; Ekkaravarodome C, 2012, J POWER ELECTRON, V12, P429, DOI 10.6113/JPE.2012.12.3.429; Ekkaravarodome C, 2013, J POWER ELECTRON, V13, P626, DOI 10.6113/JPE.2013.13.4.626; Ekkaravarodome C, 2014, IEEE T POWER ELECTR, V29, P4938, DOI 10.1109/TPEL.2013.2284872; Ekkaravarodome C, 2014, IEEE T POWER ELECTR, V29, P5486, DOI 10.1109/TPEL.2013.2290105; Eldcaravarodome C., 2010, IEEE T IND ELECTRON, V57, P3405; Fanghua Zhang, 2013, IEEE Transactions on Power Electronics, V28, DOI 10.1109/TPEL.2012.2233498; Garcia J., 2013, IEEE T IND APPL, V49, P1149; Giezendanner F, 2014, IEEE T IND ELECTRON, V61, P2236, DOI 10.1109/TIE.2013.2274411; Jirasereeamornkul K, 2006, IEEE T CIRCUITS-I, V53, P139, DOI 10.1109/TCSI.2005.855039; Kazimierczuk M. K., 2011, RESONANT POWER CONVE; Kazimierczuk M. K., 1993, IEEE Transactions on Power Electronics, V8, DOI 10.1109/63.261008; Kazimierczuk M. K., 1991, IEEE T IND ELECTRON, V38, P334; KAZIMIERCZUK MK, 1993, IEEE T AERO ELEC SYS, V29, P88, DOI 10.1109/7.249115; Kuo I. H., 2014, IET POWER ELECTRON, V7, P105; Kwon JM, 2005, IEE P-ELECT POW APPL, V152, P748, DOI 10.1049/ip-epa:20055262; Lam JCW, 2014, IEEE T IND ELECTRON, V61, P4654, DOI 10.1109/TIE.2013.2288207; Lin RL, 2012, IEEE T IND ELECTRON, V59, P1789, DOI 10.1109/TIE.2011.2166230; Tao F., 2000, 15 ANN IEEE APPL POW, P603; Wang YJ, 2014, IEEE T POWER ELECTR, V29, P3065, DOI 10.1109/TPEL.2013.2273360; Wang YJ, 2010, J POWER ELECTRON, V10, P451	30	0	0	KOREAN INST POWER ELECTRONICS	SEOUL	RM 408, KOREA SCIENCE & TECHNOLOGY BLDG, 635-4, YEOKSAM-DONG, KANGNAM-GU, SEOUL, 135-703, SOUTH KOREA	1598-2092	2093-4718		J POWER ELECTRON	J. Power Electron.	MAY	2015	15	3					621	633		10.6113/JPE.2015.15.3.621		13	Engineering, Electrical & Electronic	Engineering	CI5WQ	WOS:000354830900005		
J	Kamal, AM; Komatsu, S				Kamal, Abu Hena Mostafa; Komatsu, Setsuko			Involvement of Reactive Oxygen Species and Mitochondria! Proteins in Biophoton Emission in Roots of Soybean Plants under Flooding Stress	JOURNAL OF PROTEOME RESEARCH			English	Article						biophoton emission; enzyme activity; flooding stress; mitochondria; proteomics	ULTRAWEAK PHOTON-EMISSION; ARABIDOPSIS-THALIANA; COMPLEX-II; LIPOAMIDE DEHYDROGENASE; PROTEOMIC ANALYSIS; FATTY-ACID; OXIDATIVE-METABOLISM; TARGETING SEQUENCES; ELECTRON-TRANSPORT; IDENTIFICATION	To understand the mechanism of biophotori emission, ROS and mitochondrial proteins were analyzed in soybean plants under flooding Stress. Enzyme activity and biophoton emission were increased in the flooding stress samples when assayed in reaction mixes specific for antioxidant enzymes and reactive oxygen species; although the level: of the hydroxyl radicals was increased at day 4 (2 days of flooding) compared to nonflooding at day 4, the emission of biophotons did not Change. Mitochondria were isolated and purified from the Toots of soybean plants grown under flooding stress by using a Percoll gradient, and proteins were analyzed by a gel-free proteomic technique. Out of the 98 mitochondrial proteins that significantly changed abundance under flooding stress, 47 increased and 51 decreased at day 4. The mitochondrial enzymes fumarase, glutathione-S-transferase, and aldehyde dehydrogenase increased at day 4 in protein abundance and enzyme activity. Enzyme activity and biophoton emission decreased at day 4 by the assay of lipoxygenase under stress. Aconitase, acyl CoA oxidase, succinate dehydrogenase, and NADH ubiquinone dehydrogenase were up-regulated at the transcription level. These results indicate that oxidation and peroxide scavenging might lead to biophoton emission and oxidative damage in the roots of soybean plants under flooding stress.	[Kamal, Abu Hena Mostafa; Komatsu, Setsuko] Natl Agr & Food Res Org, Natl Inst Crop Sci, Tsukuba, Ibaraki 3058518, Japan	Komatsu, S (reprint author), Natl Agr & Food Res Org, Natl Inst Crop Sci, Kannondai 2-1-18, Tsukuba, Ibaraki 3058518, Japan.	skomatsu@affrc.go.jp			JSPS KAKENHI [25.03515]	The authors would like to thank Dr. Yohei Nanjo at the National Institute of Crop Science and Dr. Takahiro Makino at the Graduate School for the Creation of New Photonics Industries, Japan, for useful discussions. The authors thank the Open Laboratory for the Development of Environmentally Sound Pest Control Technology Research at the National Agricultural Research Center, Japan, for providing the ultra-centrifuge facility. This work was supported by JSPS KAKENHI Grant No. 25.03515.	Nunes-Nesi A, 2007, PLANT J, V50, P1093, DOI 10.1111/j.1365-313X.2007.03115.x; Dixon DP, 2010, PHYTOCHEMISTRY, V71, P338, DOI 10.1016/j.phytochem.2009.12.012; HABIG WH, 1974, P NATL ACAD SCI USA, V71, P3879, DOI 10.1073/pnas.71.10.3879; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Kruft V, 2001, PLANT PHYSIOL, V127, P1694, DOI 10.1104/pp.127.4.1694; Hossain Z, 2014, METHODS MOL BIOL, V1072, P315, DOI 10.1007/978-1-62703-631-3_23; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Millar AH, 2001, METHOD CELL BIOL, V65, P53, DOI 10.1016/S0091-679X(01)65004-0; ABELES FB, 1986, ANNU REV PLANT PHYS, V37, P49, DOI 10.1146/annurev.pp.37.060186.000405; Komatsu S, 2013, J PROTEOME RES, V12, P4769, DOI 10.1021/pr4001898; Khan MN, 2014, J PROTEOME RES, V13, P5812, DOI 10.1021/pr5007476; Sutherland MW, 1997, FREE RADICAL RES, V27, P283, DOI 10.3109/10715769709065766; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Noctor G, 1998, J EXP BOT, V49, P1895, DOI 10.1093/jexbot/49.329.1895; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Scandalios JG, 2005, BRAZ J MED BIOL RES, V38, P995, DOI 10.1590/S0100-879X2005000700003; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; SIEDOW JN, 1995, PLANT CELL, V7, P821, DOI 10.1105/tpc.7.7.821; Leon G, 2007, PLANT PHYSIOL, V143, P1534, DOI 10.1104/pp.106.095158; Chia DW, 2000, PLANTA, V211, P743, DOI 10.1007/s004250000345; Foyer CH, 2011, J EXP BOT, V62, P1467, DOI 10.1093/jxb/erq453; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Heazlewood JL, 2003, PLANT PHYSIOL, V132, P230, DOI 10.1104/pp.102.018986; Sappl PG, 2004, PLANT MOL BIOL, V54, P205, DOI 10.1023/B:PLAN.0000028786.57439.b3; America AHP, 2008, PROTEOMICS, V8, P731, DOI 10.1002/pmic.200700694; Dixon DP, 2002, J BIOL CHEM, V277, P30859, DOI 10.1074/jbc.M202919200; Kieffer P, 2009, J PROTEOME RES, V8, P400, DOI 10.1021/pr800561r; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.213585100; Giege P, 2003, PLANT CELL, V15, P2140, DOI 10.1105/tpc.012500; Hossain Z, 2012, J PROTEOMICS, V75, P4151, DOI 10.1016/j.jprot.2012.05.037; Khatoon A, 2012, J PROTEOMICS, V75, P5706, DOI 10.1016/j.jprot.2012.07.031; Pereira GJG, 2002, PLANT SOIL, V239, P123, DOI 10.1023/A:1014951524286; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Gleason C, 2011, P NATL ACAD SCI USA, V108, P10768, DOI 10.1073/pnas.1016060108; Catoni E, 2003, FEBS LETT, V534, P87, DOI 10.1016/S0014-5793(02)03782-1; Sweetlove LJ, 2010, TRENDS PLANT SCI, V15, P462, DOI 10.1016/j.tplants.2010.05.006; Bartoli CG, 2000, PLANT PHYSIOL, V123, P335, DOI 10.1104/pp.123.1.335; Nikolau BJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P211, DOI 10.1016/S0003-9861(03)00156-5; HATANAKA A, 1993, PHYTOCHEMISTRY, V34, P1201, DOI 10.1016/0031-9422(91)80003-J; Kausar R, 2012, MOL BIOL REP, V39, P10573, DOI 10.1007/s11033-012-1945-9; ELSTNER EF, 1982, ANNU REV PLANT PHYS, V33, P73, DOI 10.1146/annurev.pp.33.060182.000445; MEHDY MC, 1994, PLANT PHYSIOL, V105, P467; Nakamura T, 2012, JARQ-JPN AGR RES Q, V46, P237; Laloi C, 2001, P NATL ACAD SCI USA, V98, P14144, DOI 10.1073/pnas.241340898; KATO M, 1987, CAN J BOT, V65, P729; Fuentes D, 2011, PLANT PHYSIOL, V157, P1114, DOI 10.1104/pp.111.183939; Moeder W, 2007, PLANT MOL BIOL, V63, P273, DOI 10.1007/s11103-006-9087-x; Falk KL, 2004, PHYTOCHEMISTRY, V65, P1073, DOI 10.1016/j.phytochem.2004.02.021; Millar AH, 2001, PLANT PHYSIOL, V127, P1711, DOI 10.1104/pp.127.4.1711; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Heazlewood JL, 2004, PLANT CELL, V16, P241, DOI 10.1105/tpc.016055; Millar AH, 2005, TRENDS PLANT SCI, V10, P36, DOI 10.1016/j.tplants.2004.12.002; Komatsu S, 2013, J PROTEOMICS, V79, P231, DOI 10.1016/j.jprot.2012.12.023; Howell KA, 2006, PLANT MOL BIOL, V60, P201, DOI 10.1007/s11103-005-3688-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; NAKANO Y, 1987, PLANT CELL PHYSIOL, V28, P131; Komatsu S, 2011, J PROTEOME RES, V10, P3993, DOI 10.1021/pr2001918; Vigueira PA, 2014, CELL REP, V7, P2042, DOI 10.1016/j.celrep.2014.05.017; ARSHAD M, 1990, BIOL FERT SOILS, V10, P29; Baque MA, 2010, IN VITRO CELL DEV-PL, V46, P71, DOI 10.1007/s11627-009-9261-3; Bennett M, 2005, MOL PLANT MICROBE IN, V18, P95, DOI 10.1094/MPMI-18-0095; Berridge MV, 1998, PROTOPLASMA, V205, P74, DOI 10.1007/BF01279296; Bisht S. S., 1989, INDIAN J AGR BIOCH, V2, P109; CADENAS E, 1984, PHOTOCHEM PHOTOBIOL, V40, P823, DOI 10.1111/j.1751-1097.1984.tb04657.x; Chen WH, 2014, PLANT CELL ENVIRON, V37, P684, DOI 10.1111/pce.12187; Choi CH, 2003, NATURE, V424, P965, DOI 10.1038/nature01899; DANSON MJ, 1988, BIOCHEM SOC T, V16, P87; Davis DG, 2001, ENVIRON EXP BOT, V46, P95, DOI 10.1016/S0098-8472(01)00081-8; Elo A, 2003, PLANT CELL, V15, P1619, DOI 10.1105/tpc.010009; Emanuelsson O, 2000, J MOL BIOL, V300, P1005; Falk KL, 1998, PLANT PHYSIOL, V117, P473, DOI 10.1104/pp.117.2.473; FORSMARK P, 1991, FEBS LETT, V285, P39, DOI 10.1016/0014-5793(91)80720-N; Greetham D, 2009, MOL CELL BIOL, V29, P3229, DOI 10.1128/MCB.01918-08; Guda C., 2004, NUCLEIC ACIDS RES, V32, P372; Gueguen V, 2000, J BIOL CHEM, V275, P5016, DOI 10.1074/jbc.275.7.5016; HALLIWELL B, 1987, ANAL BIOCHEM, V165, P215, DOI 10.1016/0003-2697(87)90222-3; HIDEG E, 1993, J PHOTOCH PHOTOBIO B, V18, P239, DOI 10.1016/1011-1344(93)80070-P; Hou WC, 2000, J EXP BOT, V51, P713, DOI 10.1093/jexbot/51.345.713; Huang SB, 2014, METHODS MOL BIOL, V1072, P499, DOI 10.1007/978-1-62703-631-3_34; JANA S, 1982, AQUAT BOT, V12, P345, DOI 10.1016/0304-3770(82)90026-2; JIANG ZY, 1991, LIPIDS, V26, P853, DOI 10.1007/BF02536169; Kamal AHM, 2015, J PROTEOMICS, V112, P1, DOI 10.1016/j.jprot.2014.08.014; Katz E, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-68; Keeling PJ, 1997, P NATL ACAD SCI USA, V94, P1270, DOI 10.1073/pnas.94.4.1270; KIMMERER TW, 1987, PLANT PHYSIOL, V84, P1210, DOI 10.1104/pp.84.4.1210; Kobayashi M, 2007, J EXP BOT, V58, P465, DOI 10.1093/jxb/erl215; Kobayashi M, 1997, PHOTOCHEM PHOTOBIOL, V65, P535, DOI 10.1111/j.1751-1097.1997.tb08600.x; Komatsu S, 2012, J PROTEOME RES, V11, P68, DOI 10.1021/pr2008863; Komatsu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065301; Komatsu S, 2014, BBA-PROTEINS PROTEOM, V1844, P1208, DOI 10.1016/j.bbapap.2014.04.002; Kwon HJ, 1998, PLANT CELL PHYSIOL, V39, P655; Luck H, 1963, METHOD ENZYMAT AN, P895; Lutziger I, 2000, FEBS LETT, V484, P12, DOI 10.1016/S0014-5793(00)02116-5; Makino T, 2005, Biophotonics: Optical Science and Engineering for the 21st Century, P205, DOI 10.1007/0-387-24996-6_16; Makino T, 1996, PHOTOCHEM PHOTOBIOL, V64, P953, DOI 10.1111/j.1751-1097.1996.tb01860.x; MATUDA S, 1982, J BIOCHEM-TOKYO, V91, P553; Nakazono M, 2000, PLANT PHYSIOL, V124, P587, DOI 10.1104/pp.124.2.587; Olsson JM, 1999, FEBS LETT, V448, P190, DOI 10.1016/S0014-5793(99)00363-4; PAYNE G, 1980, PLANT PHYSIOL, V65, P785, DOI 10.1104/pp.65.5.785; Peters K, 2012, PLANT MOL BIOL, V79, P273, DOI 10.1007/s11103-012-9911-4; Popova TN, 1998, BBA-BIOENERGETICS, V1364, P307, DOI 10.1016/S0005-2728(98)00008-5; Pracharoenwattana I, 2005, PLANT CELL, V17, P2037, DOI 10.1105/tpc.105.031856; Prasad A., 2011, PLOS ONE, V6, P1; Radotic K, 1998, GEN PHYSIOL BIOPHYS, V17, P289; Raven E L, 2000, Subcell Biochem, V35, P317; Rotte C, 2001, MOL BIOL EVOL, V18, P710; Salas JJ, 1999, J AM OIL CHEM SOC, V76, P1163, DOI 10.1007/s11746-999-0090-7; SCHWARTZ AL, 1992, P NATL ACAD SCI USA, V89, P5542, DOI 10.1073/pnas.89.12.5542; SLAWINSKA D, 1991, PHYSIOL CHEM PHYS M, V23, P247; Steinhauser D, 2012, TRENDS PLANT SCI, V17, P503, DOI 10.1016/j.tplants.2012.05.005; SUZUKI S, 1991, J PHOTOCH PHOTOBIO B, V9, P211, DOI 10.1016/1011-1344(91)80153-9; Tanz S. K., 2013, NUCLEIC ACIDS RES, V41, P1185; Vizcaino J. A., 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI DOI 10.1093/NAR/GKS1262(PUBMED; Wang LX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083141; Williams Jr CH, 1992, CHEM BIOCH FLAVOENZY, VIII, P121; Winston G.W., 1990, STRESS RESPONSES PLA, P57; Wu CH, 2007, J PLANT BIOL, V50, P636; Yan B, 1996, PLANT SOIL, V179, P261, DOI 10.1007/BF00009336	119	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	MAY	2015	14	5					2219	2236		10.1021/acs.jproteome.5b00007		18	Biochemical Research Methods	Biochemistry & Molecular Biology	CH4LJ	WOS:000354004700022		
J	Wang, WX; Matsubara, T; Takao, Y; Yasuda, K; Hayashi, R				Wang, W. X.; Matsubara, T.; Takao, Y.; Yasuda, K.; Hayashi, R.			Effects of curing conditions on the short time co-cure of CFRP-steel hybrid laminates	JOURNAL OF REINFORCED PLASTICS AND COMPOSITES			English	Article						CFRP-steel hybrid laminate; short time co-cure; curing conditions; ILSS; hot press	MECHANICAL-PROPERTIES; AUTOMOTIVE APPLICATIONS; BONDED JOINTS; COMPOSITES; PRESSURE; ADHESION; BEHAVIOR	In this paper, short time co-cure of CFRP-steel hybrid laminates using hot pressing and the effects of curing conditions on the interlaminar shear strength (ILSS) of the hybrid laminates are investigated experimentally to explore a cost-effective co-cure process of CFRP-steel hybrid laminates for automotive applications. A new kind of CFRP prepreg which can be cured in several minutes is used. Various curing conditions including those with and without surface treatment of metal layer, those with and without an adhesive film, three kinds of adhesive films, and three curing pressures are investigated. Short beam three-point bending tests for the hybrid laminates are conducted to evaluate the ILSS of the hybrid laminates. A cost-effective co-cure process is proposed based on the experimental results.	[Wang, W. X.; Matsubara, T.] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan; [Takao, Y.] Sojo Univ, Dept Engn, Kumamoto, Japan; [Yasuda, K.; Hayashi, R.] NHK Spring Co Ltd, Kanazawa Ku, Yokohama, Kanagawa, Japan	Wang, WX (reprint author), Kyushu Univ, Appl Mech Res Inst, Dept Aeronaut & Astronaut, Sch Engn, 6-1 Kasuga Koen, Kasuga, Fukuoka 8168580, Japan.	bungaku@riam.kyushu-u.ac.jp	Kyushu, RIAM/F-4018-2015				Baldan A, 2012, INT J ADHES ADHES, V38, P95, DOI 10.1016/j.ijadhadh.2012.04.007; Witik RA, 2011, COMPOS PART A-APPL S, V42, P1694, DOI 10.1016/j.compositesa.2011.07.024; TANG JM, 1987, J COMPOS MATER, V21, P421, DOI 10.1177/002199838702100502; [Anonymous], 1991, K7078 JIS; Friedrich K, 2013, APPL COMPOS MATER, V20, P107, DOI 10.1007/s10443-012-9258-7; LIN CT, 1991, COMPOSITES, V22, P135, DOI 10.1016/0010-4361(91)90672-4; Vogelesang LB, 2000, J MATER PROCESS TECH, V103, P1, DOI 10.1016/S0924-0136(00)00411-8; Anyfantis KN, 2013, COMPOS STRUCT, V96, P850, DOI 10.1016/j.compstruct.2012.08.060; BEARDMORE P, 1986, COMPOS SCI TECHNOL, V26, P251, DOI 10.1016/0266-3538(86)90002-3; Bouchet J, 2000, COMPOS SCI TECHNOL, V60, P1891, DOI 10.1016/S0266-3538(00)00058-0; Burianek DA, 2002, COMPOS SCI TECHNOL, V62, P607, DOI 10.1016/S0266-3538(02)00027-1; Corum JM, 2003, COMPOS SCI TECHNOL, V63, P755, DOI 10.1016/S0266-3538(02)00265-8; de Boer T., 2001, FIBRE METAL INTRO, P39; Department of energy (DOE) Vehicles Technology Office, LIGHTW MAT CARS TRUC; KULKARNI H, 1980, COMPOSITES, V11, P225, DOI 10.1016/0010-4361(80)90429-2; Lawcock GD, 1997, COMPOS SCI TECHNOL, V57, P1609; Lee KJ, 1997, J MACROMOL SCI PHY B, VB36, P475; Mengel R, 2007, INT J ADHES ADHES, V27, P568, DOI 10.1016/j.ijadhadh.2006.11.003; Miller JL, 1994, PRELIMINARY EVALUATI; Reyes G, 2009, COMPOS PART A-APPL S, V40, P176, DOI 10.1016/j.compositesa.2008.10.016; Shin KC, 2003, J COMPOS MATER, V37, P401, DOI 10.1106/002199803031040; Taketa I, 2008, COMPOS PART A-APPL S, V39, P1884, DOI 10.1016/j.compositesa.2008.09.012; Vlot A., 2001, FIBER METAL LAMINATE, P1; Wang WX, 2007, 2007REL031, P1; Wang WX, 2007, J SOC MAT SCI JPN, V56, P420, DOI 10.2472/jsms.56.420	25	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0731-6844	1530-7964		J REINF PLAST COMP	J. Reinf. Plast. Compos.	MAY	2015	34	10					819	829		10.1177/0731684415582281		11	Materials Science, Composites; Polymer Science	Materials Science; Polymer Science	CI6LX	WOS:000354871900005		
J	Ozaki, H; Saito, H; Nakada, M; Miyano, Y				Ozaki, Hiroaki; Saito, Hiroshi; Nakada, Masayuki; Miyano, Yasushi			Residual flexural strength after impact for textile carbon fiber reinforced polycarbonate laminates	JOURNAL OF REINFORCED PLASTICS AND COMPOSITES			English	Article						Carbon fiber reinforced polycarbonate; drop weight impact test; impact damage; residual flexural strength	COMPOSITES; BEHAVIOR; DAMAGE; FATIGUE	This study prepared textile carbon fiber reinforced polycarbonate laminates of three kinds molded with different conditions and carbon fiber reinforced epoxy laminates consisting of the same carbon fiber textile. Drop-weight impact tests were conducted for these four laminates with three levels of impact energies. The residual flexural strengths were measured after impact. Results show that the residual flexural strengths for all laminates decrease clearly with increasing impact energy. The flexural strengths of these laminates without impact damage have mutually different values. Furthermore, the laminates exhibit a decreasing ratio of residual flexural strength by impact damage with mutually differing values. The reasons were examined through observations conducted using ultrasonic flaw detection and digital microscope.	[Ozaki, Hiroaki] Tsudakoma Corp, Composite Machinery Dept, Haku San, Ishikawa 9240016, Japan; [Ozaki, Hiroaki] Kanazawa Inst Technol, Grad Sch, Nonoichi, Ishikawa, Japan; [Saito, Hiroshi; Nakada, Masayuki; Miyano, Yasushi] Kanazawa Inst Technol, Mat Syst Res Lab, Nonoichi, Ishikawa, Japan	Ozaki, H (reprint author), Tsudakoma Corp, Composite Machinery Dept, 500 Miyanagaichi Machi, Haku San, Ishikawa 9240016, Japan.	h-ozaki@tsudakoma.co.jp					Vieille B, 2013, COMPOS PART B-ENG, V45, P821, DOI 10.1016/j.compositesb.2012.07.047; Liu Q, 2014, COMPOS STRUCT, V111, P332, DOI 10.1016/j.compstruct.2014.01.018; Simeoli G, 2014, COMPOS PART B-ENG, V62, P88, DOI 10.1016/j.compositesb.2014.02.018; Reyes G, 2010, COMPOS STRUCT, V92, P523, DOI 10.1016/j.compstruct.2009.08.038; Yan H, 2010, COMPOS SCI TECHNOL, V70, P2128, DOI 10.1016/j.compscitech.2010.08.012; Vieille B, 2014, COMPOS STRUCT, V110, P207, DOI 10.1016/j.compstruct.2013.12.008; Koo JM, 2013, COMPOS STRUCT, V105, P58, DOI 10.1016/j.compstruct.2013.05.004; He YX, 2013, COMPOS PART B-ENG, V44, P533, DOI 10.1016/j.compositesb.2012.03.014; Ozaki H, 2014, J REINF PLAST COMP, V33, P1893, DOI 10.1177/0731684414549223; Saito H, 2009, COMPOS SCI TECHNOL, V69, P847, DOI 10.1016/j.compscitech.2008.03.025; Santiuste C, 2010, COMPOS STRUCT, V92, P25, DOI 10.1016/j.compstruct.2009.06.007; Suvarna R, 2014, COMPOS PART B-ENG, V66, P58, DOI 10.1016/j.compositesb.2014.04.028; Zhang ZY, 2007, COMPOS STRUCT, V81, P195, DOI 10.1016/j.compstruct.2006.08.019	13	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0731-6844	1530-7964		J REINF PLAST COMP	J. Reinf. Plast. Compos.	MAY	2015	34	10					830	838		10.1177/0731684415581072		9	Materials Science, Composites; Polymer Science	Materials Science; Polymer Science	CI6LX	WOS:000354871900006		
J	Gjestland, T; Nguyen, TL; Yano, T				Gjestland, Truls; Thu Lan Nguyen; Yano, Takashi			Community response to noise in Vietnam: Exposure-response relationships based on the community tolerance level	JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA			English	Article							AIRCRAFT NOISE; TRANSPORTATION NOISE; ANNOYANCE; PREVALENCE	Social surveys on noise annoyance have been conducted in five different cities in Vietnam. The surveys included both aircraft noise (three airports) and road traffic noise (five cities). The main objective for these studies was to establish dose-response functions that were representative for Vietnam. The results have been compared with results from similar surveys from other regions. Dose-response functions for aircraft noise in Vietnam showing the percentage of highly annoyed people versus the noise level are nearly identical to those presented in the European Noise Directive [European Commission (2002). http://ec.europa.eu/environment/noise/directive.htm]. For road traffic noise, however, the results indicate that people in Vietnam are more tolerant. The noise levels can be increased by 5-10 dB in order to have a response similar to the curve recommended by the European Commission. (C) 2015 Acoustical Society of America.	[Gjestland, Truls] SINTEF, N-7465 Trondheim, Norway; [Thu Lan Nguyen; Yano, Takashi] Kumamoto Univ Kurokami, Chuo Ku, Komamoto 8608555, Japan	Gjestland, T (reprint author), SINTEF, N-7465 Trondheim, Norway.	truls.gjestland@sintef.no					Fields JM, 2001, J SOUND VIB, V242, P641, DOI 10.1006/jsvi.2000.3384; Schomer P, 2012, J ACOUST SOC AM, V131, P2772, DOI 10.1121/1.3688762; Miedema HME, 1998, J ACOUST SOC AM, V104, P3432, DOI 10.1121/1.423927; FINEGOLD LS, 1994, NOISE CONTROL ENG, V42, P25, DOI 10.3397/1.2827857; Fidell S, 2011, J ACOUST SOC AM, V130, P791, DOI 10.1121/1.3605673; SCHULTZ TJ, 1978, J ACOUST SOC AM, V64, P377, DOI 10.1121/1.382013; European Commission, 2002, POS PAP DOS RESP REL; FIDELL S, 1985, J SOUND VIB, V103, P139, DOI 10.1016/0022-460X(85)90252-4; Fidell S, 2002, J ACOUST SOC AM, V111, P200, DOI 10.1121/1.1423927; Fidell S, 2004, NOISE CONTROL ENG J, V52, P56, DOI 10.3397/1.2839741; Gelderblom F., 2014, P INT NOIS 2014 MELB; Horonjeff R. D., 1997, CR97205813 NASA; Janssen SA, 2011, J ACOUST SOC AM, V129, P1953, DOI 10.1121/1.3533739; Nguyen T. L., 2012, P INT 2012 NEW YORK; Nguyen T. L., 2013, P M AC, V15; Nguyen TL, 2012, APPL ACOUST, V73, P952, DOI 10.1016/j.apacoust.2012.04.005; Nguyen TL, 2011, APPL ACOUST, V72, P814, DOI 10.1016/j.apacoust.2011.05.002; Shimoyama K., 2014, P INT 2014 MELB AUST; Stansfeld S., 2015, AIRCRAFT NO IN PRESS; Van Kempen E. E., 2005, 012005 MGO EVK; Yano T, 2004, J SOUND VIB, V277, P583, DOI 10.1016/j.jsv.2004.03.020	21	0	0	ACOUSTICAL SOC AMER AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0001-4966	1520-8524		J ACOUST SOC AM	J. Acoust. Soc. Am.	MAY	2015	137	5					2596	2601		10.1121/1.4919309		6	Acoustics; Audiology & Speech-Language Pathology	Acoustics; Audiology & Speech-Language Pathology	CI7RU	WOS:000354962900017		
J	Kanagawa, T				Kanagawa, Tetsuya			Two types of nonlinear wave equations for diffractive beams in bubbly liquids with nonuniform bubble number density	JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA			English	Article							DISPERSE 2-PHASE FLOW; GAS-BUBBLES; SHOCK PROPAGATION; ULTRASOUND; MIXTURES; ACOUSTICS; BEHAVIOR; FORCES	This paper theoretically treats the weakly nonlinear propagation of diffracted sound beams in nonuniform bubbly liquids. The spatial distribution of the number density of the bubbles, initially in a quiescent state, is assumed to be a slowly varying function of the spatial coordinates; the amplitude of variation is assumed to be small compared to the mean number density. A previous derivation method of nonlinear wave equations for plane progressive waves in uniform bubbly liquids [Kanagawa, Yano, Watanabe, and Fujikawa (2010). J. Fluid Sci. Technol. 5(3), 351-369] is extended to handle quasi-plane beams in weakly nonuniform bubbly liquids. The diffraction effect is incorporated by adding a relation that scales the circular sound source diameter to the wavelength into the original set of scaling relations composed of nondimensional physical parameters. A set of basic equations for bubbly flows is composed of the averaged equations of mass and momentum, the Keller equation for bubble wall, and supplementary equations. As a result, two types of evolution equations, a nonlinear Schrodinger equation including dissipation, diffraction, and nonuniform effects for high-frequency short-wavelength case, and a Khokhlov-Zabolotskaya-Kuznetsov equation including dispersion and nonuniform effects for low-frequency long-wavelength case, are derived from the basic set. (C) 2015 Acoustical Society of America.	Univ Tsukuba, Dept Engn Mech & Energy, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki 3058573, Japan	Kanagawa, T (reprint author), Univ Tsukuba, Dept Engn Mech & Energy, Grad Sch Syst & Informat Engn, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058573, Japan.	kanagawa@kz.tsukuba.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [245892, 26820040]	The author wishes to thank Dr. Ryu Egashira for his helpful comments and Junya Kawahara for fruitful discussions. The present work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant Nos. 245892 and 26820040).	Akhatov I, 1996, PHYS REV E, V54, P4990, DOI 10.1103/PhysRevE.54.4990; Akhatov I. Sh., 2001, ACOUST PHYS, V47, P178; Ando K, 2011, INT J MULTIPHAS FLOW, V37, P596, DOI 10.1016/j.ijmultiphaseflow.2011.03.007; Louisnard O, 2012, ULTRASON SONOCHEM, V19, P56, DOI 10.1016/j.ultsonch.2011.06.007; PROSPERETTI A, 1991, J FLUID MECH, V222, P587, DOI 10.1017/S0022112091001234; Bailey MR, 2003, ACOUST PHYS+, V49, P369, DOI 10.1134/1.1591291; COMMANDER KW, 1989, J ACOUST SOC AM, V85, P732, DOI 10.1121/1.397599; ZHANG DZ, 1994, J FLUID MECH, V267, P185, DOI 10.1017/S0022112094001151; WATANABE M, 1994, J FLUID MECH, V274, P349, DOI 10.1017/S0022112094002156; DREW DA, 1983, ANNU REV FLUID MECH, V15, P261, DOI 10.1146/annurev.fl.15.010183.001401; Blackstock D. T., 2000, FUNDAMENTALS PHYS AC, P440; Eames I, 2004, J FLUID MECH, V505, P349, DOI 10.1017/S0022112004008535; Egashira R, 2004, FLUID DYN RES, V34, P317, DOI 10.1016/j.fluiddyn.2004.02.004; Grandjean H, 2012, J FLUID MECH, V701, P304, DOI 10.1017/jfm.2012.159; Gumerov N. A., 1992, PMM-J APPL MATH MEC, V56, P50, DOI 10.1016/0021-8928(92)90096-Q; Hamilton M. F., 1998, NONLINEAR ACOUSTICS, P233; Jeffrey A., 1982, ASYMPTOTIC METHODS N; Kadomtsev B. B., 1970, Soviet Physics - Doklady, V15; Kanagawa Tetsuya, 2010, Journal of Fluid Science and Technology, V5, DOI 10.1299/jfst.5.351; Kanagawa Tetsuya, 2011, Journal of Fluid Science and Technology, V6, DOI 10.1299/jfst.6.838; Kanagawa Tetsuya, 2012, Journal of Fluid Science and Technology, V6, DOI 10.1299/jfst.6.279; KELLER JB, 1956, J APPL PHYS, V27, P1152, DOI 10.1063/1.1722221; Khismatullin DB, 2001, PHYS FLUIDS, V13, P3582, DOI 10.1063/1.1416502; ZABOLOTS.EA, 1969, SOV PHYS ACOUST+, V15, P35; Kudryashov NA, 2014, INT J NONLIN MECH, V63, P31, DOI 10.1016/j.ijnonlinmec.2014.03.011; Kudryashov NA, 2013, WAVE MOTION, V50, P351, DOI 10.1016/j.wavemoti.2012.10.001; KUZNETSO.VP, 1971, SOV PHYS ACOUST+, V16, P467; KUZNETSOV VV, 1978, J FLUID MECH, V85, P85, DOI 10.1017/S0022112078000543; Leroy V, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046605; Liang B, 2008, J ACOUST SOC AM, V124, P1419, DOI 10.1121/1.2957931; Nakoryakov V. E., 1993, WAVE PROPAGATION GAS; Nayfeh A H, 1973, PERTURBATION METHODS; Nigmatulin R.I., 1991, DYNAMICS MULTIPHASE, V2; PROSPERETTI A, 1984, INT J MULTIPHAS FLOW, V10, P425, DOI 10.1016/0301-9322(84)90054-5; van Wijngaarden L., 1972, ANNU REV FLUID MECH, V4, P369, DOI [DOI 10.1146/ANNUREV.FL.04.010172.002101, 10.1146/annurev.fl.04.010172.002101]; VANWIJNG.L, 1968, J FLUID MECH, V33, P465; Vanhille C, 2009, ULTRASON SONOCHEM, V16, P669, DOI 10.1016/j.ultsonch.2008.11.013; Whitham G.B., 1974, LINEAR NONLINEAR WAV; Yano T., 2006, J PHYS SOC JPN, V75, P104401; Yano T., 2013, SHOCK WAVE SCI TECHN, V6, P107; ZEMANEK J, 1971, J ACOUST SOC AM, V49, P181, DOI 10.1121/1.1912316	41	0	0	ACOUSTICAL SOC AMER AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0001-4966	1520-8524		J ACOUST SOC AM	J. Acoust. Soc. Am.	MAY	2015	137	5					2642	2654		10.1121/1.4916371		13	Acoustics; Audiology & Speech-Language Pathology	Acoustics; Audiology & Speech-Language Pathology	CI7RU	WOS:000354962900021		
J	Funabashi, M				Funabashi, Masatoshi			Invariance in vowel systems	JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA			English	Article							FEMALE	This study applies information geometry of normal distribution to model Japanese vowels on the basis of the first and second formants. The distribution of Kullback-Leibler (KL) divergence and its decomposed components were investigated to reveal the statistical invariance in the vowel system. The results suggest that although significant variability exists in individual KL divergence distributions, the population distribution tends to converge into a specific log-normal distribution. This distribution can be considered as an invariant distribution for the standard-Japanese speaking population. Furthermore, it was revealed that the mean and variance components of KL divergence are linearly related in the population distribution. The significance of these invariant features is discussed. (C) 2015 Acoustical Society of America.	Sony Comp Sci Labs Inc, Fundamental Res Lab, Tokyo 1410022, Japan	Funabashi, M (reprint author), Sony Comp Sci Labs Inc, Fundamental Res Lab, Tokyo 1410022, Japan.	masa_funabashi@csl.sony.co.jp			University of Tokyo; French government (Promotion Simone de Beauvoir)	The author thanks all of the Hippo Family Club members for bringing many insights through their daily activities. Akira Tamaki, Akiko Okada, Eiichiro Osawa, Hiroyasu Kawakami, Chizuru Funabashi, Makie Murao, and Yukiko Sakakibara have especially supported the data analysis. This study was partially supported by the long-term study abroad support program of the University of Tokyo and by the French government (Promotion Simone de Beauvoir).	Amari S.-I., 2000, TRANSLATIONS MATH MO, V191; Nielsen F, 2009, IEEE T INFORM THEORY, V55, P2882, DOI 10.1109/TIT.2009.2018176; Lee S, 1999, J ACOUST SOC AM, V105, P1455, DOI 10.1121/1.426686; Menard L, 2008, SPEECH COMMUN, V50, P14, DOI 10.1016/j.specom.2007.06.004; KLATT DH, 1990, J ACOUST SOC AM, V87, P820, DOI 10.1121/1.398894; Chiba T., 1958, VOWEL ITS NATURE STR, P236; Costa S. I. R., DISCRETE APPL MATH; Crow E. L., 1987, LOGNORMAL DISTRIBUTI; Furui S., 1989, DIGITAL SPEECH PROCE, P390; Gibson J. J., 1979, ECOLOGICAL APPROACH; Goldstein U. G., 1980, THESIS MIT; Gunawardana A., 2001, THESIS J HOPKINS U B; Hurford J. R., 2001, ORIGINS VOWEL SYSTEM; Labov W., 1992, LANGUAGES, V26, P16, DOI 10.3406/lgge.1992.1648; Minematsu N., 2006, SPEECH REC INTR VAR, P47; Mitzenmacher M., 2004, INTERNET MATH, V1, P226, DOI DOI 10.1080/15427951.2004.10129088; Saitou M., 1990, J ACOUST SOC JPN, V90, P3; Samuelsson Y., 2006, GENDER EFFECTS PHONE, P1; Simpson AP, 2002, J PHONETICS, V30, P417, DOI 10.1006/jpho.2002.0171; Simpson AP, 2001, J ACOUST SOC AM, V109, P2153, DOI 10.1121/1.1356020; Sonmez M. K., 2000, P IEEE INT C AC SPEE, V6, P3743; Takano S, 2000, AIP CONF PROC, V519, P785; Turner R. E., 2003, J ACOUST SOC JPN, V33, P585; Verdoolaege G., 2014, ENTROPY	24	0	0	ACOUSTICAL SOC AMER AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0001-4966	1520-8524		J ACOUST SOC AM	J. Acoust. Soc. Am.	MAY	2015	137	5					2892	2900		10.1121/1.4919360		9	Acoustics; Audiology & Speech-Language Pathology	Acoustics; Audiology & Speech-Language Pathology	CI7RU	WOS:000354962900041		
J	Kikuchi, T; Okajima, K; Cornelissen, G; Sasaki, J; Oinuma, S; Yamanaka, G; Okumiya, K; Matsubayashi, K; Yamanaka, T; Otsuka, K				Kikuchi, Tomoko; Okajima, Kiyotaka; Cornelissen, Germaine; Sasaki, Junko; Oinuma, Sachiko; Yamanaka, Gaku; Okumiya, Kiyohito; Matsubayashi, Kozo; Yamanaka, Takashi; Otsuka, Kuniaki			Community-Based Comprehensive Geriatric Assessment of Short- and Long-Term Predictors of Cognitive Decline in Elderly Adults	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Letter							CENTRAL AORTIC PRESSURE; BLOOD-PRESSURE; DEMENTIA; RISK; OLDER		[Kikuchi, Tomoko; Sasaki, Junko; Oinuma, Sachiko] Tokyo Womens Med Univ, Dept Home Med Care, Med Ctr East, Tokyo, Japan; [Kikuchi, Tomoko; Okajima, Kiyotaka] Higashi Omiya Gen Hosp, Dept Cardiovasc Internal Med, Saitama, Japan; [Okajima, Kiyotaka; Otsuka, Kuniaki] Tokyo Womens Med Univ, Dept Chron & Gerontol, Tokyo, Japan; [Cornelissen, Germaine] Univ Minnesota, Halberg Chronobiol Ctr, Minneapolis, MN USA; [Yamanaka, Gaku] Tokyo Womens Med Univ, Dept Med, Med Ctr East, Tokyo, Japan; [Okumiya, Kiyohito; Matsubayashi, Kozo] Kyoto Univ, Dept Field Med, Ctr Southeast Asian Studies, Kyoto, Japan; [Yamanaka, Takashi] Univ Tokyo, Fac Med, Ctr Home Care Med, Tokyo 113, Japan	Kikuchi, T (reprint author), Tokyo Womens Med Univ, Dept Home Med Care, Med Ctr East, Tokyo, Japan.						Hong CH, 2013, NEUROLOGY, V81, P528, DOI 10.1212/WNL.0b013e31829e701d; Takazawa K, 2007, HYPERTENS RES, V30, P219, DOI 10.1291/hypres.30.219; Williams B, 2006, CIRCULATION, V113, P1213, DOI 10.1161/CIRCULATIONAHA.105.595496; Li G, 2007, J AM GERIATR SOC, V55, P1161, DOI 10.1111/j.1532-5415.2007.01233.x; Verghese J, 2014, NEUROLOGY, V83, P718, DOI 10.1212/WNL.0000000000000717; Verghese J, 2013, J GERONTOL A-BIOL, V68, P412, DOI 10.1093/gerona/gls191; Camicioli R, 1998, NEUROLOGY, V50, P1496; Ninomiya T, 2011, HYPERTENSION, V58, P22, DOI 10.1161/HYPERTENSIONAHA.110.163055; Pase MP, 2013, PSYCHOL SCI, V24, P2173, DOI 10.1177/0956797613488602; Yamamoto N, 2009, J AM GERIATR SOC, V57, P1120, DOI 10.1111/j.1532-5415.2009.02283.x	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	MAY	2015	63	5					1031	1033		10.1111/jgs.13426		3	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CI4NH	WOS:000354726400028		
J	Iguchi, T; Hiraki, T; Gobara, H; Fujiwara, H; Matsui, Y; Toyooka, S; Nishizaki, K; Kanazawa, S				Iguchi, Toshihiro; Hiraki, Takao; Gobara, Hideo; Fujiwara, Hiroyasu; Matsui, Yusuke; Toyooka, Shinichi; Nishizaki, Kazunori; Kanazawa, Susumu			Radiofrequency Ablation of Lung Metastases from Adenoid Cystic Carcinoma of the Head and Neck: Retrospective Evaluation of Nine Patients	JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article							SINGLE-CENTER EXPERIENCE; LOCAL PROGRESSION; SALIVARY-GLANDS; PULMONARY METASTASES; PHASE-II; TUMORS; CANCER	Purpose: To retrospectively evaluate the outcomes of radiofrequency (RF) ablation of lung metastases from head and neck adenoid cystic carcinoma (ACC). Materials and Methods: Nine patients (two men and seven women; mean age, 61.6 y) with 45 lung metastases (mean diameter, 1.1 cm; range, 0.4-2.7 cm) from head and neck ACC underwent RF ablation in 30 sessions. Primary endpoints were technical success, technique effectiveness, and procedural complications. Secondary endpoints included overall survival (OS). Results: RF ablation was technically successful for all 45 metastases. The median tumor follow-up period was 37.1 months (range, 12.9-128.3 mo). Local progression occurred in six tumors, two of which were treated again and subsequently showed complete response. Major complications (pneumothorax requiring chest tube placement) occurred in five sessions (16.7%). The median patient follow-up period was 61.6 months (range, 20.5-134.5 mo). Two patients died of disease progression at 38.9 and 61.6 months after RF ablation, respectively, whereas the other seven remained alive at the end of the study. OS rates from the initial RF ablation were 100% at 3 years and 83.3% at 5 years (mean survival time, 106.4 mo). OS rates from the treatment of the primary site were 100% at 5 years and 62.5% at 10 years (mean survival time, 210.1 mo). Conclusions: Radiofrequency ablation is an acceptable and effective local treatment for lung metastases from head and neck ACC. However, further study is needed to evaluate its effect on patient survival.	[Iguchi, Toshihiro; Hiraki, Takao; Gobara, Hideo; Fujiwara, Hiroyasu; Matsui, Yusuke; Kanazawa, Susumu] Okayama Univ, Sch Med, Dept Radiol, Kita Ku, Okayama 7008558, Japan; [Toyooka, Shinichi] Okayama Univ, Sch Med, Dept Gen Thorac Surg, Kita Ku, Okayama 7008558, Japan; [Nishizaki, Kazunori] Okayama Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Kita Ku, Okayama 7008558, Japan	Iguchi, T (reprint author), Okayama Univ, Sch Med, Dept Radiol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	iguchi@ba2.so-net.ne.jp					Zhu JC, 2008, ANN SURG ONCOL, V15, P1765, DOI 10.1245/s10434-008-9848-7; SPIRO RH, 1974, AM J SURG, V128, P512, DOI 10.1016/0002-9610(74)90265-7; Lencioni R, 2008, LANCET ONCOL, V9, P621, DOI 10.1016/S1470-2045(08)70155-4; Hiraki T, 2011, ACTA MED OKAYAMA, V65, P287; Ko YH, 2007, JPN J CLIN ONCOL, V37, P805, DOI 10.1093/jjco/hym119; Sano Y, 2007, CANCER, V109, P1397, DOI 10.1002/cncr.22541; Simon CJ, 2007, RADIOLOGY, V243, P268, DOI 10.1148/radiol.2431060088; Yamakado K, 2009, ONCOL REP, V22, P885, DOI 10.3892/or_00000513; Argiris A, 2011, CANCER-AM CANCER SOC, V117, P3374, DOI 10.1002/cncr.25852; VERMORKEN JB, 1993, ANN ONCOL, V4, P785; Kashima M, 2011, AM J ROENTGENOL, V197, pW576, DOI 10.2214/AJR.11.6408; Soga N, 2009, BJU INT, V104, P790, DOI 10.1111/j.1464-410X.2009.08459.x; Okuma T, 2010, CARDIOVASC INTER RAD, V33, P787, DOI 10.1007/s00270-009-9770-9; Ellington CL, 2012, CANCER-AM CANCER SOC, V118, P4444, DOI 10.1002/cncr.27408; Hiraki T, 2006, CANCER, V107, P2873, DOI 10.1002/cncr.22333; Petre EN, 2013, CLIN COLORECTAL CANC, V12, P37, DOI [10.1016/j.clcc.2012.07.003, 10.1016/clcc.2012.07.003]; de Baere T, 2011, CARDIOVASC INTER RAD, V34, P241, DOI 10.1007/s00270-010-9860-8; Bobbio A, 2008, EUR J CARDIO-THORAC, V33, P790, DOI 10.1016/j.ejcts.2007.12.057; Hiraki T, 2010, EUR J RADIOL, V74, P136, DOI 10.1016/j.ejrad.2009.01.026; van Herpen CML, 2008, EUR J CANCER, V44, P2542, DOI 10.1016/j.ejca.2008.08.014; van der Wal JE, 2002, HEAD NECK-J SCI SPEC, V24, P779, DOI 10.1002/hed.10126; Bianchi B, 2008, ORAL ONCOL, V44, P1026, DOI 10.1016/j.oraloncology.2008.01.005; Caballero M, 2013, HEAD NECK-J SCI SPEC, V35, pE52, DOI 10.1002/hed.21870; Goldberg SN, 2009, J VASC INTERV RADIOL, V20, pS377, DOI 10.1016/j.jvir.2009.04.011; Hiraki T, 2008, J VASC INTERV RADIOL, V19, P706, DOI 10.1016/j.jvir.2007.12.441; Liu D, 1999, ANN SURG ONCOL, V6, P572, DOI 10.1007/s10434-999-0572-8; Locati LD, 2005, ORAL ONCOL, V41, P890, DOI 10.1016/j.oraloncology.2005.04.014; Pan CC, 2012, EUR J RADIOL, V81, pE473, DOI 10.1016/j.ejrad.2011.05.037; Tochio M, 2010, CARDIOVASC INTER RAD, V33, P657, DOI 10.1007/s00270-009-9730-4	29	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1051-0443	1535-7732		J VASC INTERV RADIOL	J. Vasc. Interv. Radiol.	MAY	2015	26	5					703	708		10.1016/j.jvir.2014.11.040		6	Radiology, Nuclear Medicine & Medical Imaging; Peripheral Vascular Disease	Radiology, Nuclear Medicine & Medical Imaging; Cardiovascular System & Cardiology	CI1KV	WOS:000354504000012		
J	Inami, T; Tanimoto, Y; Minami, N; Yamaguchi, M; Kasai, K				Inami, Toshihiro; Tanimoto, Yasuhiro; Minami, Naomi; Yamaguchi, Masaru; Kasai, Kazutaka			Color stability of laboratory glass-fiber-reinforced plastics for esthetic orthodontic wires	KOREAN JOURNAL OF ORTHODONTICS			English	Article						Esthetics; Wire; Color stability; Fiber-reinforced composite	SURFACE CHARACTERISTICS; MECHANICAL-PROPERTIES; IN-VITRO; ARCHWIRES; BRACKETS	Objective: In our previous study, glass-fiber-reinforced plastics (GFRPs) made from polycarbonate and glass fibers were prepared for esthetic orthodontic wires using pultrusian. These laboratory GFRP wires are more transparent than the commercially available nickel-titanium wire; however, an investigation of the color stability of GFRP during orthodontic treatment is needed. Accordingly, in the present study, the color stability of GFRP was assessed using colorimetiy. Methods: Preparation of GFRP esthetic round wires (diameter: 0.45 mm [0.018 inch]) using pultrusion was described previously. Here, to investigate how the diameter of fiber reinforcement affects color stability, GFRPs were prepared by incorporating either 13-mu m (GFRP-13) or 7-mu m glass (GFRP-7) fibers. The color changes of GFRPs after 24 h, and following 1, 2, and 4 weeks of coffee immersion at 37 degrees C, were measured by colorimetry. We evaluated the color stability of GFRPs by two evaluating units: the color difference (Delta E*) and National Bureau of Standards (NBS). Results: After immersion, both GFRPs showed almost no visible color change. According to the colorimetry measurements, the Delta E* values of GFRP-13 and GFRP-7 were 0.73-1.16, and 0.62-1.10, respectively, in accordance with NBS units, both GFRPs showed "slight" color changes. As a result, there were no significant differences in the Delta E* values or NBS units for GFRP-13 or GFRP-7. Moreover, for both GFRPs, no significant differences were observed in any of the immersion periods. Conclusions: Our findings suggest that the GFRPs will maintain high color stability during orthodontic treatment, and are an attractive prospect as esthetic orthodontic wires.	[Inami, Toshihiro; Minami, Naomi; Yamaguchi, Masaru; Kasai, Kazutaka] Nihon Univ, Sch Dent, Dept Orthodont, Matsudo, Chiba 2718587, Japan; [Tanimoto, Yasuhiro] Nihon Univ, Sch Dent Matsudo, Dept Dent Biomat, Matsudo, Chiba 2718587, Japan	Tanimoto, Y (reprint author), Nihon Univ, Sch Dent Matsudo, Dept Dent Biomat, 2-870-1 Sakaecho Nishi, Matsudo, Chiba 2718587, Japan.	tanimoto.yasuhiro@nihon-u.ac.jp			Nihon University; Japan Society for the Promotion of Science [24792155]	This work was supported in part by a Nihon University Multidisciplinary Research Grant for (2011) and by a Grant-in-Aid for Young Scientists (B) (No. 24792155) from the Japan Society for the Promotion of Science.	Joiner A, 2004, J DENT, V32, P3, DOI 10.1016/j.jdent.2003.10.013; da Silva DL, 2013, ANGLE ORTHOD, V83, P994, DOI 10.2319/111112-866.1; Douglas RD, 2007, J PROSTHET DENT, V97, P200, DOI 10.1016/j.prosdent.2007.02.012; Lee YK, 2008, EUR J ORTHODONT, V30, P205, DOI 10.1093/ejo/cjm122; Elayyan F, 2008, EUR J ORTHODONT, V30, P661, DOI 10.1093/ejo/cjn057; Faltermeier A, 2007, EUR J ORTHODONT, V29, P354, DOI 10.1093/ejo/cjm020; DIETSCHI D, 1994, DENT MATER, V10, P353, DOI 10.1016/0109-5641(94)90059-0; Ardeshna AP, 2011, AM J ORTHOD DENTOFAC, V139, P761, DOI 10.1016/j.ajodo.2009.07.028; Lee IB, 2010, DENT MATER, V26, P443, DOI 10.1016/j.dental.2010.01.003; Faltermeier J, 2012, EUR J ORTHODONT, V34, P427, DOI 10.1093/ejo/cjr031; da Silva DL, 2013, ANGLE ORTHOD, V83, P127, DOI 10.2319/121311-764.1; de Mendonca MR, 2011, RPG REV POSGARD, V18, P20; Eliades T., 2001, ORTHODONTIC MAT SCI, P143; Eliades T., 2012, ORTHODONTICS CURRENT, P1023; Erta E, 2006, DENT MATER J, V2, P371, DOI DOI 10.4012/DMJ.25.371; Filho Hibernon Lopes, 2013, Aust Orthod J, V29, P13; Fujihara K, 2004, COMPOS SCI TECHNOL, V64, P775, DOI 10.1016/j.compscitech.2003.09.012; Hamanaka I, 2014, ACTA ODONTOL SCAND, V72, P859, DOI 10.3109/00016357.2014.919662; Kim SH, 2009, EUR J ORTHODONT, V31, P556, DOI 10.1093/ejo/cjp030; Lee YK, 2008, AM J ORTHOD DENTOFAC, V133; Silva Andréia Viana Martins da, 2012, Dental Press J. Orthod., V17, P76, DOI 10.1590/S2176-94512012000500011; O'Brien WJ, 2008, DENT MAT THEIR SELEC; Scabell AL, 2013, J RES PRACTICE DENT, DOI [10.5171/2013.304484, DOI 10.5171/2013.304484]; Shiozawa M, 2015, CLIN ORAL INVEST, V19, P309, DOI 10.1007/s00784-014-1272-8; Tanimoto Y, 2015, J BIOMED MATER RES B, V103, P743, DOI 10.1002/jbm.b.33245; Yamanel K, 2010, J ESTHET RESTOR DENT, V22, P379, DOI 10.1111/j.1708-8240.2010.00370.x; Yu Bin, 2011, J Orthod, V38, P167, DOI 10.1179/14653121141434; Zegan G, 2012, ROM J MORPHOL EMBRYO, V53, P935	28	0	0	KOREAN ASSOC ORTHODONTISTS	SEOUL	603 TRAPALACE II, 1327 SEOCHO-DONG, SEOCHO-GU, SEOUL, 137-070, SOUTH KOREA	2234-7518	2005-372X		KOREAN J ORTHOD	Korean J. Orthod.	MAY	2015	45	3					130	135		10.4041/kjod.2015.45.3.130		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CI6YD	WOS:000354909200004		
J	Arai, C; Choi, JW; Nakaoka, K; Hamada, Y; Nakamura, Y				Arai, Chihiro; Choi, Jae Won; Nakaoka, Kazutoshi; Hamada, Yoshiki; Nakamura, Yoshiki			Management of open bite that developed during treatment for internal derangement and osteoarthritis of the temporomandibular joint	KOREAN JOURNAL OF ORTHODONTICS			English	Article						Temporomandibular joint; Internal derangement; Osteoarthritis; Mini-screw implant	IDIOPATHIC CONDYLAR RESORPTION; ORTHOGNATHIC SURGERY; CLOSED LOCK; ARTHROCENTESIS; DIAGNOSIS; STABILITY	This case report describes the orthodontic treatment performed for open bite caused by internal derangement (ID) and osteoarthritis (OA) of the temporomandibular joint (TMJ). A Japanese woman, aged 31 years and 11 months, referred to our department by an oral surgeon had an open bite with clockwise rotation of the mandible and degeneration of the condyle. The overbite was corrected through intrusion of the maxillary and mandibular molars using mini-screw implants to induce counterclockwise rotation of the mandible. Then, the mandibular second premolars were extracted and comprehensive orthodontic treatment was performed to establish a Class I molar relationship with distalization of the maxillary arch and to eliminate anterior crowding. Following treatment, her facial profile improved and a functional and stable occlusion was achieved without recurrence of the TMJ symptoms. These results suggest that orthodontic intrusion of the molars is one of the safer and less stressful alternatives for the management of open bite due to degeneration of the condyles caused by ID and OA of TMJ.	[Arai, Chihiro; Nakamura, Yoshiki] Tsurumi Univ, Dept Orthodont, Sch Dent Med, Yokohama, Kanagawa 2308501, Japan; [Nakaoka, Kazutoshi; Hamada, Yoshiki] Tsurumi Univ, Sch Dent Med, Dept Oral & Maxillofacial Surg, Yokohama, Kanagawa 2308501, Japan	Arai, C (reprint author), Tsurumi Univ, Dept Orthodont, Sch Dent Med, Tsurumi Ku, 2-1-3 Tsurumi, Yokohama, Kanagawa 2308501, Japan.	arai-chihiro@tsurumi-u.ac.jp					CRAWFORD JG, 1994, J ORAL MAXIL SURG, V52, P460, DOI 10.1016/0278-2391(94)90341-7; Arnett GW, 1996, AM J ORTHOD DENTOFAC, V110, P8, DOI 10.1016/S0889-5406(96)70081-1; DIMITROULIS G, 1995, BRIT J ORAL MAX SURG, V33, P23, DOI 10.1016/0266-4356(95)90081-0; Kuroda S, 2004, ANGLE ORTHOD, V74, P558; Arnett GW, 1996, AM J ORTHOD DENTOFAC, V110, P117, DOI 10.1016/S0889-5406(96)70099-9; Arnett GW, 1990, ORAL MAXILLOFAC SURG, V2, P699; Baek MS, 2010, AM J ORTHOD DENTOFAC, V138, P396, DOI 10.1016/j.ajodo.2010.05.006; Bailey LJ, 2000, CONT ORTHODONTICS, V3rd, P679; Bertram S, 2001, J AM DENT ASSOC, V132, P753; Dimitroulis G, 1998, BRIT MED J, V317, P190; Dimitroulis G, 2002, J ORAL MAXIL SURG, V60, P519, DOI 10.1053/joms.2002.31848; Huang YL, 1997, J ORAL MAXIL SURG, V55, P114, DOI 10.1016/S0278-2391(97)90222-6; Kondoh T, 2003, ORAL SURG ORAL MED O, V95, P544, DOI 10.1067/moe.2003.160; McNeill C, 1993, TEMPOROMANDIBULAR DI; MERKX MAW, 1994, J CRANIO MAXILL SURG, V22, P53, DOI 10.1016/S1010-5182(05)80297-5; Nitzan DW, 1991, J ORAL MAXILLOFAC SU, V49, P1168; NITZAN DW, 1991, J ORAL MAXIL SURG, V49, P1163, DOI 10.1016/0278-2391(91)90409-F; Paik Cheol-Ho, 2003, J Clin Orthod, V37, P423; Sugawara Junji, 2002, Int J Adult Orthodon Orthognath Surg, V17, P243; Wolford LM, 1999, AM J ORTHOD DENTOFAC, V116, P667, DOI 10.1016/S0889-5406(99)70203-9	20	0	0	KOREAN ASSOC ORTHODONTISTS	SEOUL	603 TRAPALACE II, 1327 SEOCHO-DONG, SEOCHO-GU, SEOUL, 137-070, SOUTH KOREA	2234-7518	2005-372X		KOREAN J ORTHOD	Korean J. Orthod.	MAY	2015	45	3					136	145		10.4041/kjod.2015.45.3.136		10	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CI6YD	WOS:000354909200005		
J	Mikuriya, Y; Tashiro, H; Kobayashi, T; Kuroda, S; Abe, T; Hashimoto, M; Ohdan, H				Mikuriya, Yoshihiro; Tashiro, Hirotaka; Kobayashi, Tsuyoshi; Kuroda, Shintaro; Abe, Tomoyuki; Hashimoto, Masakazu; Ohdan, Hideki			Clinicopathological features of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease	LANGENBECKS ARCHIVES OF SURGERY			English	Article						HCC; Non-alcohol fatty liver disease; Hepatectomy; Vascular invasion; Steatotic liver	HEPATITIS-C VIRUS; SURFACE-ANTIGEN; RISK-FACTORS; HEPATECTOMY; ANTIBODY; TRANSECTION; RECURRENCE; JAPAN	The incidence of hepatocellular carcinoma (HCC) in patients with nonalcoholic fatty liver disease (NAFLD) is increasing. However, the clinicopathological features of HCC in these patients are little known. Thus, we investigated the differences in the clinical and pathological characteristics of HCC between NAFLD patients and hepatitis-C virus (HCV) patients. Data from 21 HCC patients with NAFLD and 645 HCC patients with HCV who underwent curative hepatectomy were collected and analyzed. To overcome bias due to differences in the distribution of covariates between the two groups, propensity score matching was performed, and clinicopathological features and outcomes were compared. In propensity score analysis, the rate of microscopic vascular invasion was significantly higher in the NAFLD group than in the HCV group (65 vs. 30 %; P = 0.027). However, overall survival and disease-free survival did not differ between the two matched groups. NAFLD may have permissive microenvironment for HCC progression.	[Mikuriya, Yoshihiro; Tashiro, Hirotaka; Kobayashi, Tsuyoshi; Kuroda, Shintaro; Abe, Tomoyuki; Hashimoto, Masakazu; Ohdan, Hideki] Hiroshima Univ Hosp, Dept Gastroenterol & Transplant Surg, Hiroshima 7348551, Japan	Tashiro, H (reprint author), Hiroshima Univ Hosp, Dept Gastroenterol & Transplant Surg, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	htashiro@hiroshima-u.ac.jp					Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; White DL, 2012, CLIN GASTROENTEROL H, V10, P1342, DOI 10.1016/j.cgh.2012.10.001; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Kaibori M, 2012, AM J SURG, V204, P300, DOI 10.1016/j.amjsurg.2011.11.014; MAKUUCHI M, 1985, SURG GYNECOL OBSTET, V161, P346; Nagaoki Y, 2012, HEPATOL RES, V42, P368, DOI 10.1111/j.1872-034X.2011.00929.x; LAYER P, 1986, GASTROENTEROLOGY, V91, P41; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Reddy SK, 2012, HEPATOLOGY, V55, P1809, DOI 10.1002/hep.25536; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Ohki T, 2009, GUT, V58, P839, DOI 10.1136/gut.2008.164053; Koike Y, 2000, HEPATOLOGY, V32, P1216, DOI 10.1053/jhep.2000.20237; SHIRATORI Y, 1995, HEPATOLOGY, V22, P1027, DOI 10.1016/0270-9139(95)90605-3; MAKUUCHI M, 1993, SEMIN SURG ONCOL, V9, P298, DOI 10.1002/ssu.2980090404; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409; Nouso K, 2010, ALIMENT PHARM THER, V31, P407, DOI 10.1111/j.1365-2036.2009.04179.x; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Abe H, 2008, J GASTROENTEROL, V43, P967, DOI 10.1007/s00535-008-2264-8; Baffy G, 2012, J HEPATOL, V56, P1384, DOI 10.1016/j.jhep.2011.10.027; Itamoto T, 2003, BRIT J SURG, V90, P23, DOI 10.1002/bjs.4012; Kobayashi Akira, 2008, J Hepatobiliary Pancreat Surg, V15, P515, DOI 10.1007/s00534-007-1293-7; Li T, 2013, CANCER-AM CANCER SOC, V119, P126, DOI 10.1002/cncr.27697; Mikuriya Y, 2015, INT J CANCER, V136, pE3, DOI 10.1002/ijc.29096; Nanashima A, 2010, J SURG ONCOL, V101, P557, DOI 10.1002/jso.21534; Noguchi K, 2000, INT J MOL MED, V6, P661; Rubin DB, 1997, ANN INTERN MED, V127, P757; Wakai T, 2011, J GASTROINTEST SURG, V15, P1450, DOI 10.1007/s11605-011-1540-8; Yamamoto M, 2001, SURGERY, V130, P443, DOI 10.1067/msy.2001.116406; Zinsmelster AR, 2008, AM J GASTROENTEROL, V103, P262, DOI 10.1111/j.1572-0241.2007.01590.x	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1435-2443	1435-2451		LANGENBECK ARCH SURG	Langenbecks Arch. Surg.	MAY	2015	400	4					471	476		10.1007/s00423-015-1295-x		6	Surgery	Surgery	CI6TR	WOS:000354895600006		
J	Sho, M; Akahori, T; Tanaka, T; Kinoshita, S; Nagai, M; Nishiwada, S; Tamamoto, T; Nishiofuku, H; Ohbayashi, C; Hasegawa, M; Kichikawa, K; Nakajima, Y				Sho, Masayuki; Akahori, Takahiro; Tanaka, Toshihiro; Kinoshita, Shoichi; Nagai, Minako; Nishiwada, Satoshi; Tamamoto, Tetsuro; Nishiofuku, Hideyuki; Ohbayashi, Chiho; Hasegawa, Masatoshi; Kichikawa, Kimihiko; Nakajima, Yoshiyuki			Optimal indication of neoadjuvant chemoradiotherapy for pancreatic cancer	LANGENBECKS ARCHIVES OF SURGERY			English	Article						Pancreatic cancer; Prognosis; Preoperative therapy; Neoadjuvant chemoradiotherapy; Surgery	PREOPERATIVE CHEMORADIATION; ADENOCARCINOMA; FOLFIRINOX; GEMCITABINE; MORBIDITY	Much attention has been paid to preoperative treatment as a new strategy especially for borderline resectable pancreatic cancer (BRPC). The purpose of this study was to define the optimal indication of neoadjuvant chemoradiotherapy (NACRT) for pancreatic cancer. We analyzed consecutive 184 patients who had undergone pancreatic resection in Nara Medical University Hospital. Resectability status was classified by NCCN guidelines. Full-dose gemcitabine with concurrent radiation was used as NACRT. We evaluated 85 patients treated with NACRT in comparison with 99 patients without NACRT as control. The regimen of NACRT was well tolerated and feasible. The perioperative outcomes were almost comparable. The postoperative complications were significantly less frequent in NACRT group than non-NACRT group. The pathological effects on both resectable and borderline tumors were favorable in NACRT group compared to non-NACRT group. The overall survival of resectable pancreatic cancer was significantly better than that of BRPC regardless of whether the patients were treated with or without NACRT. The prognosis of the patients with NACRT in resectable tumors was significantly better than without, while there was no significant difference in BRPC. Furthermore, multivariate analysis of various factors in the patients with NACRT identified resectability status and completion of adjuvant chemotherapy as independent prognostic factors. NACRT did not improve the prognosis of the patients with BRPC, although it induced substantial pathological antitumor effect. In contrast, the prognosis of resectable pancreatic cancer treated with NACRT was favorable. Therefore, resectable pancreatic cancer may be good indication for multimodal treatment including NACRT.	[Sho, Masayuki; Akahori, Takahiro; Kinoshita, Shoichi; Nagai, Minako; Nishiwada, Satoshi; Nakajima, Yoshiyuki] Nara Med Univ, Dept Surg, Kashihara, Nara 6348522, Japan; [Tanaka, Toshihiro; Nishiofuku, Hideyuki; Kichikawa, Kimihiko] Nara Med Univ, Dept Radiol, Kashihara, Nara 6348522, Japan; [Tamamoto, Tetsuro; Hasegawa, Masatoshi] Nara Med Univ, Dept Radiat Oncol, Kashihara, Nara 6348522, Japan; [Ohbayashi, Chiho] Nara Med Univ, Dept Diagnost Pathol, Kashihara, Nara 6348522, Japan	Sho, M (reprint author), Nara Med Univ, Dept Surg, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	m-sho@naramed-u.ac.jp					Ueno H, 2013, J CLIN ONCOL, V31, P1640, DOI 10.1200/JCO.2012.43.3680; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Boone BA, 2013, J SURG ONCOL, V108, P236, DOI 10.1002/jso.23392; Takahashi H, 2011, SURGERY, V150, P547, DOI 10.1016/j.surg.2011.03.001; Ma JM, 2013, JNCI-J NATL CANCER I, V105, P1694, DOI 10.1093/jnci/djt292; Cheng TY, 2006, ANN SURG ONCOL, V13, P66, DOI 10.1245/ASO.2006.02.003; Valle JW, 2014, J CLIN ONCOL, V32, P504, DOI 10.1200/JCO.2013.50.7657; Araujo RLC, 2013, HPB, V15, P574, DOI 10.1111/hpb.12033; Ferrone CR, 2015, ANN SURG, V261, P12, DOI 10.1097/SLA.0000000000000867	10	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1435-2443	1435-2451		LANGENBECK ARCH SURG	Langenbecks Arch. Surg.	MAY	2015	400	4					477	485		10.1007/s00423-015-1304-0		9	Surgery	Surgery	CI6TR	WOS:000354895600007		
J	Okabayashi, T; Shima, Y; Iwata, J; Morita, S; Sumiyoshi, T; Kozuki, A; Saisaka, Y; Tokumaru, T; Iiyama, T; Noda, Y; Hata, Y; Matsumoto, M				Okabayashi, Takehiro; Shima, Yasuo; Iwata, Jun; Morita, Sojiro; Sumiyoshi, Tatsuaki; Kozuki, Akihito; Saisaka, Yuichi; Tokumaru, Teppei; Iiyama, Tatsuo; Noda, Yoshihiro; Hata, Yasuhiro; Matsumoto, Manabu			Reconsideration about the aggressive surgery for resectable pancreatic cancer: a focus on real pathological portosplenomesenteric venous invasion	LANGENBECKS ARCHIVES OF SURGERY			English	Article						Pancreas; Adenocarcinoma; Surgery; Borderline pancreatic cancer; Portal vein invasion	INTERNATIONAL STUDY-GROUP; PORTAL-VEIN RESECTION; DUCTAL ADENOCARCINOMA; SURGICAL RESECTION; ADJUVANT THERAPY; CLASSIFICATION; CHEMOTHERAPY; GEMCITABINE; DEFINITION; TRIAL	Some clinicians have argued that combining pancreatic and portomesenteric venous resection could improve the rates of long-term survival. However, whether resection of the portosplenomesenteric vein could provide an acceptable survival benefit to patients with pancreatic cancer involving the portosplenomesenteric system remains controversial. The purpose of this study was to determine the significance of pathological portosplenomesenteric venous invasion on survival in patients who underwent surgical management for pancreatic adenocarcinoma. Patients who underwent curative surgical treatment were divided into two subgroups: those with pathological invasion to the portosplenomesenteric vein (PV-positive group) and those without invasion (PV-negative group). Of 160 studied patients, the median overall survival was 48.0 months after pancreatic surgery in the PV-negative group and 18.0 months in the PV-positive group. The incidence of postoperative peritoneal dissemination was significantly lower in the PV-negative group than in the PV-positive group. Accordingly, patients in the PV-negative group showed a cumulative rate of pancreatic cancer recurrence at 2 years after pancreatic surgery of 54.4 %, while this rate was 89.4 % in the PV-positive group. Finally, an elevated presurgical serum CA19-9 level (> 700 IU/mL) was found to be significantly associated with a poor outcome after surgery in pancreatic cancer patients with pathological portosplenomesenteric venous invasion. Pancreatic cancer carries a high risk of recurrence even if surgical resection is technically possible. The current study suggested that portosplenomesenteric involvement and preoperative high serum CA19-9 are poor prognostic indications; however, the findings provided little insight into the role of neoadjuvant therapy in such patients.	[Okabayashi, Takehiro; Shima, Yasuo; Sumiyoshi, Tatsuaki; Kozuki, Akihito; Saisaka, Yuichi; Tokumaru, Teppei] Kochi Hlth Sci Ctr, Dept Surg Gastroenterol, Kochi, Kochi 7818555, Japan; [Iwata, Jun; Matsumoto, Manabu] Kochi Hlth Sci Ctr, Dept Diagnost Pathol, Kochi, Kochi 7818555, Japan; [Morita, Sojiro; Noda, Yoshihiro; Hata, Yasuhiro] Kochi Hlth Sci Ctr, Dept Radiol, Kochi, Kochi 7818555, Japan; [Iiyama, Tatsuo] Kochi Hlth Sci Ctr, Dept Biostat, Kochi, Kochi 7818555, Japan	Okabayashi, T (reprint author), Kochi Hlth Sci Ctr, Dept Surg Gastroenterol, 2125-1 Ike, Kochi, Kochi 7818555, Japan.	tokabaya@kochi-u.ac.jp			Kochi organization	This work was supported by the Kochi organization for medical reformation and renewal grants. Dr. Takehiro Okabayashi is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. TO wrote the manuscript and researched the data. TS, AK, YS, TT, and TI researched the data. YS, JI, SM, and MM reviewed/edited the manuscript. TS, MM, YN, and YH contributed to discussion and reviewed/edited the manuscript. YS researched the data and contributed to the discussion.	Mollberg N, 2011, ANN SURG, V254, P882, DOI 10.1097/SLA.0b013e31823ac299; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Hartwig W, 2011, ANN SURG, V254, P311, DOI 10.1097/SLA.0b013e31821fd334; Yamada S, 2013, PANCREAS, V42, P1004, DOI 10.1097/MPA.0b013e31827b2d7c; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Michalski CW, 2007, BRIT J SURG, V94, P265, DOI 10.1002/bjs.5716; Alvarez R, 2013, BRIT J CANCER, V109, P926, DOI 10.1038/bjc.2013.415; Siriwardana HPP, 2006, BRIT J SURG, V93, P662, DOI 10.1002/bjs.5368; Nakao A, 2012, ANN SURG, V255, P103, DOI 10.1097/SLA.0b013e318237872e; Bockhorn M, 2014, SURGERY, V155, P977, DOI 10.1016/j.surg.2014.02.001; Konstantinidis IT, 2013, ANN SURG, V257, P731, DOI 10.1097/SLA.0b013e318263da2f; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Wente MN, 2007, SURGERY, V142, P761, DOI 10.1016/j.surg.2007.05.005; Bachellier P, 2011, ANN SURG, V253, P173, DOI 10.1097/SLA.0b013e3181f193ba; Cascinu S, 2009, ANN ONCOL, V20, P37, DOI 10.1093/annonc/mdp123; Choti MA, 2004, NEW ENGL J MED, V350, P1249, DOI 10.1056/NEJMe048002; Ferrone CR, 2015, ANN SURG, V261, P12, DOI 10.1097/SLA.0000000000000867; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; La Torre M, 2014, GUT LIVER, V8, P102, DOI 10.5009/gnl.2014.8.1.102; Müller Sascha A, 2012, Recent Results Cancer Res, V196, P53, DOI 10.1007/978-3-642-31629-6_4; Okabayashi T, 2014, WORLD J SURG, V38, P2986, DOI 10.1007/s00268-014-2703-z; Ravikumar R, 2014, J AM COLL SURGEONS, V218, P401, DOI 10.1016/j.jamcollsurg.2013.11.017; Shibata C, 2001, WORLD J SURG, V25, P1002; Sohal DP, 2014, J NATL CANC IN PRESS	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1435-2443	1435-2451		LANGENBECK ARCH SURG	Langenbecks Arch. Surg.	MAY	2015	400	4					487	494		10.1007/s00423-015-1305-z		8	Surgery	Surgery	CI6TR	WOS:000354895600008		
J	Torimitsu, S; Makino, Y; Saitoh, H; Sakuma, A; Ishii, N; Hayakawa, M; Inokuchi, G; Motomura, A; Chiba, F; Hoshioka, Y; Iwase, H				Torimitsu, Suguru; Makino, Yohsuke; Saitoh, Hisako; Sakuma, Ayaka; Ishii, Namiko; Hayakawa, Mutsumi; Inokuchi, Go; Motomura, Ayumi; Chiba, Fumiko; Hoshioka, Yumi; Iwase, Hirotaro			Stature estimation in Japanese cadavers based on the second cervical vertebra measured using multidetector computed tomography	LEGAL MEDICINE			English	Article						Anthropometry; Japanese; Multidetector computed tomography; Axis; Regression analysis; Stature estimation	LONG BONES; AMERICAN WHITES; ADULT STATURE; LENGTH; DIMENSIONS; HEIGHT; SPINE; ANTHROPOMETRY; POPULATION; BLACKS	The purpose of this study was to assess correlations between measurements of the second cervical vertebra (C2) and stature using multidetector computed tomography (MDCT) images, and to develop regression equations for estimating stature in a Japanese population. Measurements were performed on 216 Japanese subjects (116 males and 100 females) who underwent postmortem CT between May 2011 and November 2013. Sagittal images through the center of the C2 were used for assessment. The length from the top of the dens to the anteroinferior point of the vertebral body (DA), the length from the anteroinferior point of the vertebral body to the posterior point of the spinous process (AS), and the length from the top of the dens to the posterior point of the spinous process (DS) were measured. The correlation between stature and each parameter (DA, AS, and DS) was assessed using Pearson product-moment correlation coefficients and regression analysis was performed for stature estimation. All measurements of the C2 were positively correlated with stature regardless of sex. The highest correlation was observed for the DA in all. cases, and the lowest correlation was observed for AS in all cases. However, the standard errors of estimate were large. Thus, our study concludes that the size of the C2 as measured with MDCT images may be useful for stature estimation only when better predictors, such as long bones, are unavailable. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Torimitsu, Suguru; Makino, Yohsuke; Saitoh, Hisako; Sakuma, Ayaka; Ishii, Namiko; Hayakawa, Mutsumi; Inokuchi, Go; Motomura, Ayumi; Chiba, Fumiko; Hoshioka, Yumi; Iwase, Hirotaro] Chiba Univ, Grad Sch Med, Dept Legal Med, Chuo Ku, Chiba 2608670, Japan	Torimitsu, S (reprint author), Chiba Univ, Grad Sch Med, Dept Legal Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	number60188@chiba-u.jp; ymakino-tky@umin.ac.jp; hms1466@faculty.chiba-u.jp; a.sakuma@chiba-u.jp; acua2807@chiba-u.jp; moo600@faculty.chiba-u.jp; goinokuchi@chiba-u.jp; tsunetoa@graduate.chiba-u.jp; chibafumico@chiba-u.jp; yhoshioka@chiba-u.jp; iwase@faculty.chiba-u.jp					Aalia S, 2008, INDIAN J DENT RES, V19, P150; GRAY JP, 1980, AM J PHYS ANTHROPOL, V53, P441, DOI 10.1002/ajpa.1330530314; JASON DR, 1995, J FORENSIC SCI, V40, P59; Krishan Kewal, 2007, Legal Medicine, V9, P128, DOI 10.1016/j.legalmed.2006.12.001; MUSGRAVE JH, 1978, AM J PHYS ANTHROPOL, V48, P113, DOI 10.1002/ajpa.1330480117; Nagesh K. R., 2006, Legal Medicine, V8, P269, DOI 10.1016/j.legalmed.2006.05.007; Johnell O, 1997, AM J EPIDEMIOL, V146, P287; TROTTER M, 1958, AM J PHYS ANTHROPOL, V16, P79, DOI 10.1002/ajpa.1330160106; TIBBETTS GL, 1981, J FORENSIC SCI, V26, P715; MEADOWS L, 1992, J FORENSIC SCI, V37, P147; HEDLUND LR, 1989, CALCIFIED TISSUE INT, V44, P168, DOI 10.1007/BF02556559; Menezes RG, 2011, J FORENSIC LEG MED, V18, P242, DOI 10.1016/j.jflm.2011.04.004; TERAZAWA K, 1990, MED SCI LAW, V30, P354; Trotter M, 1952, AM J PHYS ANTHROP-NE, V10, P463, DOI 10.1002/ajpa.1330100407; Scheuer L, 2002, CLIN ANAT, V15, P297, DOI 10.1002/ca.10028; Karakas HM, 2011, SKELETAL RADIOL, V40, P623, DOI 10.1007/s00256-010-0937-x; Case DT, 2007, J FORENSIC SCI, V52, P264, DOI 10.1111/j.1556-4029.2006.00365.x; Giroux CL, 2008, J FORENSIC SCI, V53, P65, DOI 10.1111/j.1556-4029.2007.00598.x; Pelin C, 2005, J FORENSIC SCI, V50, P294; Burke RM, 2005, THESIS U IDAHO; BYERS S, 1989, AM J PHYS ANTHROPOL, V79, P275, DOI 10.1002/ajpa.1330790303; Cunha E, 2006, FORENSIC ANTHROPOLOGY AND MEDICINE: COMPLEMENTARY SCIENCES FROM RECOVERY TO CAUSE OF DEATH, P39, DOI 10.1007/978-1-59745-099-7_3; DAVIES KM, 1989, J BONE MINER RES, V4, P341; De Mendonca MC, 2000, AM J PHYS ANTHROPOL, V112, P39, DOI 10.1002/(SICI)1096-8644(200005)112:1<39::AID-AJPA5>3.0.CO;2-#; Ferreira MT, 2012, THESIS U COIMBRA; GALLAGHER JC, 1988, BONE MINER, V4, P189; Gama I, 2014, INT J LEGAL MED; GILES E, 1991, J FORENSIC SCI, V36, P765; Giurazza F, 2012, FORENSIC SCI INT, V222, pe1; Hauser R, 2005, FORENSIC SCI INT, V147, P185, DOI 10.1016/j.forsciint.2004.09.070; ISCAN MY, 1988, YEARB PHYS ANTHROPOL, V31, P203; Mahakkanukrauh P, 2011, FORENSIC SCI INT, V210, pe1; Maijanen H, 2009, J FORENSIC SCI, V54, P746, DOI 10.1111/j.1556-4029.2009.01053.x; Malek AK, 1990, FORENSIC SCI INT, V46, P181; Marinho L, 2012, FORENSIC SCI INT, V220, P1; Radoinova D., 2002, Homo, V52, P221, DOI 10.1078/0018-442X-00030; Ruhli FJ, 2005, AM J HUM BIOL, V17, P460, DOI 10.1002/ajhb.20403; Sakuma A, 2010, J FORENSIC SCI, V55, P1624, DOI 10.1111/j.1556-4029.2010.01526.x; SCHAFFLER MB, 1992, SPINE, V17, P738, DOI 10.1097/00007632-199207000-00002; SHINTAKU K, 1990, Journal of UOEH, V12, P215; TELKKA A, 1950, ACTA ANAT, V9, P103; Terry RJ, 1940, AM J PHYS ANTHROPOL, V26, P433, DOI 10.1002/ajpa.1330260141; WARD RE, 1991, J CRAN GENET DEV BIO, V11, P156; Weinberg SM, 2005, AM J HUM BIOL, V17, P368, DOI 10.1002/ajhb.20129	44	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1344-6223			LEGAL MED-TOKYO	Leg. Med.	MAY	2015	17	3					145	149		10.1016/j.legalmed.2014.11.003		5	Medicine, Legal; Social Sciences, Biomedical	Legal Medicine; Biomedical Social Sciences	CI3SK	WOS:000354667500001		
J	Nozawa, H; Minakata, K; Yamagishi, I; Hasegawa, K; Wurita, A; Gonmori, K; Suzuki, O; Watanabe, K				Nozawa, Hideki; Minakata, Kayoko; Yamagishi, Itaru; Hasegawa, Koutaro; Wurita, Amin; Gonmori, Kunio; Suzuki, Osamu; Watanabe, Kanako			MALDI-TOF mass spectrometric determination of eight benzodiazepines with two of their metabolites in blood	LEGAL MEDICINE			English	Article						Benzodiazepines; MALDI-TOF mass spectrometry; alpha-Cyano-4-hydroxy cinnamic acid; Blood	WHOLE-BLOOD; MOLECULES; URINE	A rapid and sensitive method was developed for the determination of benzodiazepines and benzodiazepine-like substances (BZDs) by matrix-assisted laser desorption ionization (MALDI)-time-of-flight (TOF)-mass spectrometry (MS). In this method, alpha-cyano-4-hydroxy cinnamic acid was used as the matrix to assist the ionization of BZDs. Determination of 8 BZDs (with two of their metabolites) belonging to top 12 medical drugs detected in poisonous cases in Japan, was performed using diazepam-d(5) as the internal standard. The limit of detection of zolpidem was 0.07 ng/ml with its quantification range of 0.2-20 ng/ml in blood, in the best case, and the limit of detection of flunitrazepam was 2 ng/ml with its quantification range of 6-200 ng/ml in blood, in the worst case. The spectra of zopiclone in MALDI-MS and MS/MS were different from those in electrospray ionization MS and MS/MS. Present method provides a simple and high throughput method for the screening of these BZDs using only 20 mu l of blood. The developed method was successfully used for the determination of BZDs in biological fluids obtained from two victims. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Nozawa, Hideki; Minakata, Kayoko; Yamagishi, Itaru; Hasegawa, Koutaro; Wurita, Amin; Gonmori, Kunio; Suzuki, Osamu; Watanabe, Kanako] Hamamatsu Univ Sch Med, Dept Legal Med, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Nozawa, H (reprint author), Hamamatsu Univ Sch Med, Dept Legal Med, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	hnozawa@hama-med.ac.jp					Smink BE, 2004, J CHROMATOGR B, V811, P13, DOI 10.1016/j.jchromb.2004.03.079; Miki A, 2011, FORENSIC TOXICOL, V29, P111, DOI 10.1007/s11419-011-0109-2; Sauve EN, 2012, J CHROMATOGR B, V883, P177, DOI 10.1016/j.jchromb.2011.10.033; Bogusz MJ, 1998, J CHROMATOGR B, V713, P361, DOI 10.1016/S0378-4347(98)00207-2; Bugey A, 2006, J CHROMATOGR B, V832, P249, DOI 10.1016/j.jchromb.2006.01.009; Gonmori K, 2012, FORENSIC TOXICOL, V30, P179, DOI 10.1007/s11419-012-0145-6; Guo Z, 2002, ANAL CHEM, V74, P1637, DOI 10.1021/ac010979m; Hayashida M, 2009, LEG MED, V11, P5423; Ho YC, 2011, ANAL CHIM ACTA, V697, P1, DOI 10.1016/j.aca.2011.04.008; Ishida T, 2009, J CHROMATOGR B, V877, P2652, DOI 10.1016/j.jchromb.2009.05.008; Kudo K, 2010, FORENSIC TOXICOL, V28, P25, DOI 10.1007/s11419-009-0088-8; Minakata K, 2013, FORENSIC TOXICOL, V31, P138, DOI 10.1007/s11419-012-0157-2; Moosmann B, 2013, FORENSIC TOXICOL, V31, P263, DOI 10.1007/s11419-013-0187-4; Terada Masaru, 2003, Leg Med (Tokyo), V5 Suppl 1, pS96, DOI 10.1016/S1344-6223(02)00075-5	14	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1344-6223			LEGAL MED-TOKYO	Leg. Med.	MAY	2015	17	3					150	156		10.1016/j.legalmed.2014.12.004		7	Medicine, Legal; Social Sciences, Biomedical	Legal Medicine; Biomedical Social Sciences	CI3SK	WOS:000354667500002		
J	Kano, T; Oritani, S; Michiue, T; Ishikawa, T; Hishmat, AM; Sogawa, N; Inamori-Kawamoto, O; Maeda, H				Kano, Tetsuya; Oritani, Shigeki; Michiue, Tomomi; Ishikawa, Takaki; Hishmat, Asmaa Mohammed; Sogawa, Nozomi; Inamori-Kawamoto, Osamu; Maeda, Hitoshi			Postmortem CT morphometry with a proposal of novel parameters for sex discrimination of the mandible using Japanese adult data	LEGAL MEDICINE			English	Article						Forensic anthropology; Sex discrimination; Mandible; Skeletal development; Japanese	GONIAL EVERSION; RAMUS FLEXURE; POPULATION; DIMORPHISM; MODELS; AGE; SKELETONS; INDICATOR; SAMPLE; ANGLE	Major human sex differences in the mandible after adolescence include the overall size as well as the shape of the chin and mandibular angle; however, objective interpretation of discrimination accuracy is difficult for these morphological indicators. The present study investigated measurements of the mandible for sex discrimination using postmortem CT morphometry in forensic autopsy cases of Japanese subjects after adolescence (age >16 years; male, n = 116, and female, n = 106), including the proposal of novel parameters representing the overall mandibular size and shape. The distance between the gnathion and condylus (gn-cdl), and bigonial width (go-go), as well as the angle formed by bilateral gn-cdl lines (Agn-cdl), correlated with bicondylar breadth (cdl-cdl), independent of the body height, showing no significant sex difference. The distance from the gn to the cdl-cdl line (oblique length), the ratio of Agn-cdl to cdl-cdl, and the oblique triangular area formed by bilateral gn-cdl and cdl-cdl lines (Delta obl), which were proposed as indicators of chin protrusion, showed significant sex differences (p < 0.001). Overall sensitivity and specificity at respective discriminating points for sex estimation were 0.72 and 0.78 at 105.0 mm for the oblique length, 0.73 and 0.83 at 0.49 for the Agn-cdl to cdl-cdl ratio, and 0.82 and 0.78 at 643 mm(2) for Delta obl; the efficacy for females was greater in younger subjects. Although these parameters weakly depended on the body height (p < 0.0001), the correlations were insufficient for stature estimation. These findings suggest the efficacy of CT morphometry of the mandible for sex discrimination with quantitative assessment. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Kano, Tetsuya; Oritani, Shigeki; Michiue, Tomomi; Ishikawa, Takaki; Hishmat, Asmaa Mohammed; Sogawa, Nozomi; Inamori-Kawamoto, Osamu; Maeda, Hitoshi] Osaka City Univ, Sch Med, Dept Legal Med, Abeno Ku, Osaka 5458585, Japan; [Michiue, Tomomi; Ishikawa, Takaki; Sogawa, Nozomi; Inamori-Kawamoto, Osamu; Maeda, Hitoshi] Osaka City Univ, Sch Med, Medicolegal Consultat & Postmortem Invest Support, Dept Legal Med,Forens Autopsy Sect,Abeno Ku, Osaka 5458585, Japan; [Ishikawa, Takaki] Tottori Univ, Fac Med, Div Forens Med, Yonago, Tottori 6838503, Japan; [Hishmat, Asmaa Mohammed] Menia Univ, Fac Med, Dept Forens Med & Clin Toxicol, Al Minya 61111, Egypt	Michiue, T (reprint author), Osaka City Univ, Sch Med, Dept Legal Med, Abeno Ku, Asahi Machi 1-4-3, Osaka 5458585, Japan.	michi.leg@med.osaka-cu.ac.jp					Aitchisin J, 1963, DENT PRACT, V14, P52; Anderson D L, 1978, Ont Dent, V55, P9; Scheuer L, 2002, AM J PHYS ANTHROPOL, V119, P189, DOI 10.1002/ajpa.10098; Saini V, 2011, J FORENSIC SCI, V56, pS13, DOI 10.1111/j.1556-4029.2010.01599.x; Tardivo D, 2014, INT J LEGAL MED, V128, P161, DOI 10.1007/s00414-013-0863-2; Vexler A, 2008, STAT MED, V27, P280, DOI 10.1002/sim.3035; Mahfouz M, 2007, FORENSIC SCI INT, V173, P161, DOI 10.1016/j.forsciint.2007.02.024; Dayal MR, 2008, HOMO, V59, P209, DOI 10.1016/j.jchb.2007.01.001; Steyn M, 1998, FORENSIC SCI INT, V98, P9, DOI 10.1016/S0379-0738(98)00120-0; Decker SJ, 2011, J FORENSIC SCI, V56, P1107, DOI 10.1111/j.1556-4029.2011.01803.x; Ayoub F, 2009, J FORENSIC LEG MED, V16, P121, DOI 10.1016/j.jflm.2008.07.014; Biwasaka Hitoshi, 2009, Leg Med (Tokyo), V11 Suppl 1, pS260, DOI 10.1016/j.legalmed.2009.02.052; Chapman T, 2014, FORENSIC SCI INT, V234, P189; Chapman T, 2014, FORENSIC SCI INT, V234, pe1; Darmawan MF, 2015, LEGAL MED-TOKYO, V17, P71, DOI 10.1016/j.legalmed.2014.09.006; Del Vecchio Simona, 1993, Archiv fuer Kriminologie, V191, P37; Duric M, 2005, FORENSIC SCI INT, V147, P159, DOI 10.1016/j.forsciint.2004.09.111; Franklin D, 2008, FORENSIC SCI INT, V179, p[84, e1]; GILES E, 1964, AM J PHYS ANTHROPOL, V22, P129, DOI 10.1002/ajpa.1330220212; Giurazza F, 2012, FORENSIC SCI INT, V222; Giurazza F, 2012, FORENSIC SCI INT, V222, pe1; Giurazza F, 2013, LEGAL MED-TOKYO, V15, P202, DOI 10.1016/j.legalmed.2013.01.002; Hars B, 1984, Beitr Gerichtl Med, V42, P169; Hill CA, 2000, AM J PHYS ANTHROPOL, V111, P573, DOI 10.1002/(SICI)1096-8644(200004)111:4<573::AID-AJPA11>3.0.CO;2-I; Hishmat AM, 2014, LEGAL MED-TOKYO, V16, P114, DOI 10.1016/j.legalmed.2014.01.004; Hu KS, 2006, J FORENSIC SCI, V51, P1376, DOI 10.1111/j.1556-4029.2006.00270.x; Humphrey LT, 1998, AM J PHYS ANTHROPOL, V105, P57, DOI 10.1002/(SICI)1096-8644(199801)105:1<57::AID-AJPA6>3.0.CO;2-A; Joshi Nishitha, 2014, J Clin Med Res, V6, P399, DOI 10.14740/jocmr1905w; Kemkes-Grottenthaler A, 2002, HOMO, V53, P97, DOI 10.1078/0018-442X-00039; Kharoshah MAA, 2010, J FORENSIC LEG MED, V17, P213, DOI 10.1016/j.jflm.2010.02.005; Oettle AC, 2009, AM J PHYS ANTHROPOL, V139, P505, DOI 10.1002/ajpa.21009; Oettle AC, 2009, HOMO, V60, P29, DOI 10.1016/j.jchb.2007.01.003; POTSCHSCHNEIDER L, 1985, Z RECHTSMED, V94, P21; Sakurai T, 2012, FORENSIC SCI MED PAT, V8, P351, DOI 10.1007/s12024-012-9327-0; Schmeling Andreas, 2003, Leg Med (Tokyo), V5 Suppl 1, pS367, DOI 10.1016/S1344-6223(02)00134-7; SCHUTKOWSKI H, 1993, AM J PHYS ANTHROPOL, V90, P199, DOI 10.1002/ajpa.1330900206; Uysal S, 2005, J FORENSIC SCI, V50, P1310; WEIJS WA, 1986, AM J PHYS ANTHROPOL, V70, P423, DOI 10.1002/ajpa.1330700403; Zech WD, 2012, FORENSIC SCI INT, V221, P39, DOI 10.1016/j.forsciint.2012.03.022	39	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1344-6223			LEGAL MED-TOKYO	Leg. Med.	MAY	2015	17	3					167	171		10.1016/j.legalmed.2014.12.009		5	Medicine, Legal; Social Sciences, Biomedical	Legal Medicine; Biomedical Social Sciences	CI3SK	WOS:000354667500005		
J	Tominaga, M; Michiue, T; Inamori-Kawamoto, O; Hishmat, AM; Oritani, S; Takama, M; Ishikawa, T; Maeda, H				Tominaga, Mariko; Michiue, Tomomi; Inamori-Kawamoto, Osamu; Hishmat, Asmaa Mohammed; Oritani, Shigeki; Takama, Masashi; Ishikawa, Takaki; Maeda, Hitoshi			Efficacy of drug screening in forensic autopsy: Retrospective investigation of routine toxicological findings	LEGAL MEDICINE			English	Article						Forensic autopsy; Toxicological screening; Drug abuse; Illicit drug; Cause of death; Manner of death	GC-MS; ABUSE; BENZODIAZEPINES; SPECIMENS; SYSTEM; URINE; FLUID; HPLC	Toxicological analysis is indispensable in forensic autopsy laboratories, but often depends on the limitations of individual institutions. The present study reviewed routine drug screening data of forensic autopsy cases (n = 2996) during an 18.5-year period (January 1996-June 2014) at our institute to examine the efficacy of the procedures and findings in autopsy diagnosis and interpretation. Drug screening was performed using on-site immunoassay screening devices and gas chromatography/mass spectrometry (GC/MS) in all cases, followed by re-examination using GC/MS and liquid chromatography/tandem mass spectrometry (LC/MS/MS) at a cooperating institute in specific cases in the last 4 years. GC/MS detected drugs in 486 cases (16.2%), including amphetamines (n = 160), major tranquilizers (n = 72), minor tranquilizers (n = 294), antidepressants (n = 21), cold remedies (n = 77), and other drugs (n = 19). Among these cases, fatal intoxication (n = 123) involved amphetamines (n = 73), major tranquilizers (n = 37), minor tranquilizers (n = 86), antidepressants (n = 3), and cold remedies (n = 9); most cases involved self-administration, alleged suicide and accidental overdose, while homicide was not included. These drugs were also identified in other manners of death, including homicide (n = 40/372), suicide (n = 34/226), accidental falls (n = 27/129), and natural death (n = 72/514). In these cases, on-site immunoassay screening of drugs of abuse showed negative findings in 2440 cases (81.4% in all cases), while GC/MS detected other drugs in 218 cases (7.3% in all cases), including several antipsychotic drugs, acetaminophen and salicylic acid. Further analysis using LC/MS/MS detected low concentrations of benzodiazepines in 32 cases, and also anti-diabetic and hypertensive drugs in a case of fatal abuse. These observations indicate the efficacy of systematic routine toxicological analysis to investigate not only the cause of death but also the background of fatalities in forensic autopsy. The provision of extensive drug screening is needed for forensic and social risk management, considering the marked diversity of medical and illicit drugs. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Tominaga, Mariko; Michiue, Tomomi; Inamori-Kawamoto, Osamu; Hishmat, Asmaa Mohammed; Oritani, Shigeki; Takama, Masashi; Ishikawa, Takaki; Maeda, Hitoshi] Osaka City Univ, Sch Med, Dept Legal Med, Abeno Ku, Osaka 5458585, Japan; [Tominaga, Mariko; Michiue, Tomomi; Inamori-Kawamoto, Osamu; Ishikawa, Takaki; Maeda, Hitoshi] Osaka City Univ, Sch Med, Medicolegal Consultat & Postmortem Invest Support, Forens Autopsy Sect,Abeno Ku, Osaka 5458585, Japan; [Hishmat, Asmaa Mohammed] Menia Univ, Fac Med, Dept Forens Med & Clin Toxicol, Al Minya 61111, Egypt; [Ishikawa, Takaki] Tottori Univ, Fac Med, Div Legal Med, Yonago, Tottori 6838503, Japan	Tominaga, M (reprint author), Osaka City Univ, Sch Med, Dept Legal Med, Abeno Ku, Asahi Machi 1-4-3, Osaka 5458585, Japan.	mari1216@med.osaka-cu.ac.jp					Lapoint J, 2011, CLIN TOXICOL, V49, P760, DOI 10.3109/15563650.2011.609822; WU AHB, 1993, J ANAL TOXICOL, V17, P241; Ferner RE, 2008, BRIT J CLIN PHARMACO, V66, P430, DOI 10.1111/j.1365-2125.2008.03231.x; Tominaga M, 2013, J ANAL TOXICOL, V37, P423, DOI 10.1093/jat/bkt047; Jones AW, 2011, FORENSIC SCI INT, V206, P43, DOI 10.1016/j.forsciint.2010.06.015; Crouch DJ, 1998, J ANAL TOXICOL, V22, P493; Shinozuka T, 2006, FORENSIC SCI INT, V162, P108, DOI 10.1016/j.forsciint.2006.03.038; Buajordet I, 2001, J INTERN MED, V250, P327, DOI 10.1046/j.1365-2796.2001.00892.x; Kudo K, 2009, FORENSIC TOXICOL, V27, P21, DOI 10.1007/s11419-009-0066-1; Bjornaas MA, 2009, CLIN TOXICOL, V47, P116, DOI 10.1080/15563650701771981; Kolbrich EA, 2003, J ANAL TOXICOL, V27, P407; Ballentine Noel H, 2008, Crit Care Nurs Q, V31, P40, DOI 10.1097/01.CNQ.0000306395.86905.8b; Carson Henry J., 2008, Legal Medicine, V10, P92, DOI 10.1016/j.legalmed.2007.08.001; Davies EC, 2006, J CLIN PHARM THER, V31, P335, DOI 10.1111/j.1365-2710.2006.00744.x; Drummer OH, 2007, FORENSIC SCI INT, V165, P199, DOI 10.1016/j.forsciint.2006.05.020; George S, 2002, CLIN CHEM, V48, P1639; Harald S, 2006, FORENSIC SCI MED PAT, V2, P75; Kurisaki E, 2005, J ANAL TOXICOL, V29, P539; Moriya F, 1997, LEG MED, V51, P214; Papoutsis I, 2013, J CHROMATOGR B, P947; Saito T, 1997, J ANAL TOXICOL, V21, P584; SCHRAMM W, 1992, J ANAL TOXICOL, V16, P1; Suzuki O, 2006, SYSMEX J WEB, V7; Valentine JL, 1996, J ANAL TOXICOL, V20, P416; Wong R, 2013, AM CLIN LAB, V21, P21; Yoshida Manabu, 2006, Legal Medicine, V8, P172, DOI 10.1016/j.legalmed.2005.11.003; Zhu BL, 2000, FORENSIC SCI INT, V113, P443, DOI 10.1016/S0379-0738(00)00281-4	27	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1344-6223			LEGAL MED-TOKYO	Leg. Med.	MAY	2015	17	3					172	176		10.1016/j.legalmed.2015.01.001		5	Medicine, Legal; Social Sciences, Biomedical	Legal Medicine; Biomedical Social Sciences	CI3SK	WOS:000354667500006		
J	Nishijima, A; Shiotani, S; Hayakawa, H; Nishijima, H				Nishijima, Akio; Shiotani, Seiji; Hayakawa, Hideyuki; Nishijima, Haruo			Pseudo-Hirschsprung's disease with rectal hypoganglionosis: An autopsied case of circulatory failure due to severe constipation	LEGAL MEDICINE			English	Article						Pseudo-Hirschsprung's disease; Hypoganglionosis; Megacolon; Postmortem computed tomography; Autopsy; Adult		We report a 21-year-old female patient who suddenly died of circulatory failure due to pressure from megacolon allied with pseudo-Hirschsprung's disease. Since 3 years before her death, she had exhibited the feeling of abdominal distention, which was diagnosed as constipation. However, her constipation did not respond well to the prescribed oral administration of laxatives and enemas. She was found dead at home in the morning, lying on her back. An autopsy revealed a decreased number of ganglion cells in the rectum, suggesting hypoganglionosis. In cases of intractable chronic constipation, careful investigation of the cause of such symptoms is important. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Nishijima, Akio] Univ Tsukuba, Dept Plast & Reconstruct Surg, Tsukuba, Ibaraki, Japan; [Shiotani, Seiji] Tsukuba Med Ctr, Dept Radiol, Tsukuba, Ibaraki, Japan; [Hayakawa, Hideyuki] Tsukuba Med Examiners Off, Dept Forens Med, Tsukuba, Ibaraki, Japan; [Nishijima, Haruo] Aomori Prefectural Cent Hosp, Dept Neurol, Aomori, Aomori 0308553, Japan; [Nishijima, Haruo] Hirosaki Univ, Grad Sch Med, Inst Brain Sci, Dept Neurophysiol, Hirosaki, Aomori, Japan	Nishijima, H (reprint author), Aomori Prefectural Cent Hosp, Dept Neurol, 2-1-1 Higashi Tsukurimichi, Aomori, Aomori 0308553, Japan.	hnishijima-tky@umin.ac.jp		Nishijima, Haruo/0000-0002-1065-664X			TALLEY NJ, 1993, GASTROENTEROLOGY, V105, P781; BENTLEY J. F. R., 1966, ARCH DIS CHILDHOOD, V41, P143; Do MY, 2011, DIGEST DIS SCI, V56, P1818, DOI 10.1007/s10620-010-1522-9; Hayasaki T, 2002, JAEM, V22, P947; Ito T, 2008, INTERNAL MED, V47, P421, DOI 10.2169/internalmedicine.47.0275; Kubota M., 2006, JPN J PEDIAT SURG, V38, P666; Puri Prem, 2004, Semin Pediatr Surg, V13, P293, DOI 10.1053/j.sempedsurg.2004.10.017; RAVITCH MM, 1958, ANN SURG, V147, P781; Suzuki E, 2002, TOYOTA MED J, V12, P28; Takahashi A., 2006, JPN J PEDIAT SURG, V38, P672; Tomita R, 2006, JPN J PEDIAT SURG, V38, P778; Urushihara N, 2006, JPN J PEDIAT SURG, V38, P701	12	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1344-6223			LEGAL MED-TOKYO	Leg. Med.	MAY	2015	17	3					177	179		10.1016/j.legalmed.2014.11.005		3	Medicine, Legal; Social Sciences, Biomedical	Legal Medicine; Biomedical Social Sciences	CI3SK	WOS:000354667500007		
J	Oshima, T; Yoshikawa, H; Ohtani, M; Mimasaka, S				Oshima, Toru; Yoshikawa, Hiroshi; Ohtani, Maki; Mimasaka, Sohtaro			Three cases of suprachoroidal hemorrhage associated with chest compression or asphyxiation and detected using postmortem computed tomography	LEGAL MEDICINE			English	Article						Postmortem computed tomography; Suprachoroidal hemorrhage; Expulsive hemorrhage; Asphyxia; Chest compressions; Intrathoracic pressure	RETINAL-DETACHMENT; VALSALVA MANEUVER; ENDOSCOPY	We report 3 cases of suprachoroidal hemorrhage (SCH) found to be triggered by increased intrathoracic pressure and detected using postmortem computed tomography (PMCT). Case 1 was a man aged in his 50s who was found dead at a landslide site. The autopsy showed clogging of the upper respiratory tract with soil debris from the landslide. The cause of death was determined to be asphyxia. PMCT showed SCH in both eyes, which was believed to be caused by chest compression or choking on the soil debris from the landslide. Case 2 was a woman aged in her 60s who was found dead in the sea. The autopsy revealed injuries primarily to her chest. We concluded that the cause of death was drowning. PMCT showed SCH in her right eye that was believed to be caused by chest compression. Case 3 was a woman aged in her 80s who was buried in a snowdrift and potentially died from hypothermia. PMCT showed SCH in both eyes, which was considered to be from an increase in intrathoracic pressure that might have been caused by the burial in the snow. Histological findings showed serous retinal detachment associated with retinal pigment epithelium damage due to SCH, which indicated that she was alive for several hours after the onset of SCH. The increase in intrathoracic pressure caused by dyspnea or chest compression was considered responsible for the onset of SCH in all of the present cases. PMCT might assist with the differential diagnosis of traumatic asphyxiation by SCH. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Oshima, Toru; Ohtani, Maki; Mimasaka, Sohtaro] Akita Univ, Grad Sch Med, Dept Forens Sci, Akita, Akita 0108543, Japan; [Yoshikawa, Hiroshi] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka 8128582, Japan	Oshima, T (reprint author), Akita Univ, Grad Sch Med, Dept Forens Sci, 1-1-1 Hondo, Akita, Akita 0108543, Japan.	tooshima@med.akita-u.ac.jp; yossy@med.kyushu-u.ac.jp; mohtani@doc.med.akita-u.ac.jp; mimasaka@med.akita-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology - Japan [25860485]	This research was supported by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology - Japan (Grant #25860485).	Pollack AL, 2001, AM J OPHTHALMOL, V132, P383, DOI 10.1016/S0002-9394(01)01049-2; Obuchowska I, 2005, EUR J OPHTHALMOL, V15, P712; Hammam T, 2003, EYE, V17, P261, DOI 10.1038/sj.eye.6700298; Thali MJ, 2003, J FORENSIC SCI, V48, P386; Amberg R, 2001, FORENSIC SCI INT, V124, P157, DOI 10.1016/S0379-0738(01)00582-5; Poulsen K, 2007, FORENSIC SCI INT, V171, P190, DOI 10.1016/j.forsciint.2006.05.041; Rutty GN, 2008, J TRAUMA, V65, P493, DOI 10.1097/TA.0b013e31817de420; Arima Mitsuru, 2011, Jpn J Ophthalmol, V55, P312, DOI 10.1007/s10384-011-0015-5; Davis NL, 2006, AM J FOREN MED PATH, V27, P1, DOI 10.1097/01.paf.0000201102.03778.65; DiMaio V.J., 2001, FORENSIC PATHOLOGY; Dutton JJ, 2010, CHOROIDAL DETACHMENT, P172; Dutton JJ, 2010, MALIGNANT MELANOMA U, P286; Feretis E, 2006, EUR J OPHTHALMOL, V16, P835; GAUDRIC A, 1987, AM J OPHTHALMOL, V104, P364; Haridas Anjana, 2011, Digit J Ophthalmol, V17, P9, DOI 10.5693/djo.02.2011.02.002; NEGI A, 1984, ARCH OPHTHALMOL-CHIC, V102, P445; O'Donnell C, 2008, CLIN RADIOL, V63, P1189; Tsuji M, 2007, JPN J OPHTHALMOL, V51, P127, DOI 10.1007/s10384-006-0404-3; Tsujinaka Masatake, 2003, Leg Med (Tokyo), V5 Suppl 1, pS288, DOI 10.1016/S1344-6223(02)00152-9	19	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1344-6223			LEGAL MED-TOKYO	Leg. Med.	MAY	2015	17	3					188	191		10.1016/j.legalmed.2014.12.003		4	Medicine, Legal; Social Sciences, Biomedical	Legal Medicine; Biomedical Social Sciences	CI3SK	WOS:000354667500010		
J	Suzuki, H; Hasegawa, I; Hoshino, N; Fukunaga, T				Suzuki, Hideto; Hasegawa, Iwao; Hoshino, Norio; Fukunaga, Tatsushige			Two forensic autopsy cases of death due to upper gastrointestinal hemorrhage: A comparison of postmortem computed tomography and autopsy findings	LEGAL MEDICINE			English	Article						Gastrointestinal hemorrhage; Postmortem computed tomography; Forensic autopsy	PRIMARY AORTOENTERIC FISTULA; SUDDEN-DEATH; CT; ESOPHAGUS; ROUTINE; DENSITY	In this report, we describe two autopsy cases of death due to upper gastrointestinal hemorrhage (Case 1: gastric ulcer, Case 2: aortoduodenal fistula). Postmortem computed tomography (CT) images from both cases revealed pooling of gastric fluid, which contained high attenuation areas, although these images also mirrored the different sources of the gastrointestinal hemorrhage. Fluid collection was observed in the small intestine for both cases, although the high attenuation areas were only remarkable in Case 2. The autopsy in Case 1 revealed a peptic ulcer, with small vessels exposed on the surface of the ulcer. Melena was also observed throughout the intestine, although clotting was only observed inside the stomach. The autopsy in Case 2 revealed diffuse massive clotting from the stomach to the upper portion of the ileum, which was due to a primary aortoduodenal fistula. Given our autopsy findings, the extent of the high attenuation areas in the digestive tract during postmortem CT scanning may be correlated with the speed of the gastrointestinal hemorrhage before death. Carefully evaluating the radiodensity of the gastrointestinal contents during postmortem CT scanning may indicate the primary site of the hemorrhage before the autopsy, thereby facilitating the accurate identification of the cause of death during forensic autopsy. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Suzuki, Hideto; Hasegawa, Iwao; Hoshino, Norio; Fukunaga, Tatsushige] Tokyo Metropolitan Govt, Tokyo Med Examiners Off, Tokyo 1120012, Japan	Suzuki, H (reprint author), Tokyo Metropolitan Govt, Tokyo Med Examiners Off, Bunkyo Ku, 4-21-18 Otsuka, Tokyo 1120012, Japan.	hideto-@qk9.so-net.ne.jp					Ambepitiya SGH, 2010, FORENSIC SCI MED PAT, V6, P121, DOI 10.1007/s12024-009-9137-1; Saers SJF, 2005, BRIT J SURG, V92, P143, DOI 10.1002/bjs.4928; Kennedy DW, 2010, J VASC INTERV RADIOL, V21, P848, DOI 10.1016/j.jvir.2010.01.039; Lee SS, 2011, RADIOLOGY, V259, P739, DOI 10.1148/radiol.11101936; Leth PM, 2009, AM J FOREN MED PATH, V30, P219, DOI 10.1097/PAF.0b013e318187e0af; Poulsen K, 2007, FORENSIC SCI INT, V171, P190, DOI 10.1016/j.forsciint.2006.05.041; Buyck PJ, 2013, AM J NEURORADIOL, V34, P1568, DOI 10.3174/ajnr.A3469; Black DF, 2011, AM J NEURORADIOL, V32, P1354, DOI 10.3174/ajnr.A2504; Christoffersen RK, 2012, AM J FOREN MED PATH, V33, P186, DOI 10.1097/PAF.0b013e318221be16; Egan C, 2012, AM J FOREN MED PATH, V33, P270, DOI 10.1097/PAF.0b013e318252e5e7; Ihama Y, 2008, WORLD J GASTROENTERO, V14, P4701, DOI 10.3748/wjg.14.4701; NEW PFJ, 1976, RADIOLOGY, V121, P635; Ng CY, 2007, SCOT MED J, V52, P20; Ranasinghe W, 2011, ANN VASC SURG, V25; Rashid SNB, 2012, FORENSIC SCI MED PAT, V8, P430, DOI 10.1007/s12024-012-9332-3; Stein John, 2002, Cal J Emerg Med, V3, P70; Tsokos M, 2002, ARCH PATHOL LAB MED, V126, P1197; Vogel Y, 2010, INTERNIST, V51, P1053, DOI 10.1007/s00108-009-2551-3; Walker HK, 1990, CLIN METHODS HIST PH, P490; Yamazaki K, 2006, FORENSIC SCI INT, V162, P163, DOI 10.1016/j.forsciint.2006.06.020	20	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1344-6223			LEGAL MED-TOKYO	Leg. Med.	MAY	2015	17	3					198	200		10.1016/j.legalmed.2014.12.010		3	Medicine, Legal; Social Sciences, Biomedical	Legal Medicine; Biomedical Social Sciences	CI3SK	WOS:000354667500012		
J	Okuda, T; Takanari, H; Shiotani, S; Hayakawa, H; Ohno, Y; Fowler, DR				Okuda, Takahisa; Takanari, Hiroki; Shiotani, Seiji; Hayakawa, Hideyuki; Ohno, Youkichi; Fowler, David R.			Pericardial tear as a consequence of cardiopulmonary resuscitation (CPR) involving chest compression: A report of two postmortem cases of acute type A aortic dissection with hemopericardium	LEGAL MEDICINE			English	Article; Proceedings Paper	73rd Annual Meeting of the Japan-Radiological-Society	APR 10-13, 2014	Yokohama, JAPAN	Japan Radiol Soc		Postmortem computed tomography (PMCT); Aortic dissection; Cardiopulmonary resuscitation (CPR); Chest compression; Pericardial tear	SEVERE LEFT HEMOTHORAX; ASCENDING AORTA; ANEURYSM; RUPTURE; DEFECT; COMPLICATIONS; LACERATION; TAMPONADE; EFFUSION; HISTORY	We present two cases of a pericardial tear as a consequence of cardiopulmonary resuscitation involving chest compressions in fatal acute type A aortic dissection (AoD) with hemopericardium. For each case, postmortem computed tomography revealed a hematoma in the false lumen of the ascending aorta with a slight hemopericardium and a large left hemothorax, as well as focal pericardial dimpling and discontinuity around the left ventricle. At autopsy, we confirmed a convex lens-shape gaping pericardial tear at the left posterolateral site of the pericardium and a massive volume of bloody fluid in the left thoracic cavity. It has been hypothesized that the pericardium ruptured due to chest compressions during resuscitation in these cases of acute type A AoD with hemopericardium and that intrapericardial blood leakage through the pericardial tear resulted in a hemothorax. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Okuda, Takahisa; Fowler, David R.] Off Chief Med Examiner, Baltimore, MD 21223 USA; [Okuda, Takahisa] Nippon Med Sch, Dept Legal Med, Tokyo, Japan; [Okuda, Takahisa; Hayakawa, Hideyuki] Tsukuba Med Examiners Off, Tsukuba, Ibaraki, Japan; [Takanari, Hiroki] Oita Univ, Dept Pathophysiol, Sch Med, Oita 87011, Japan; [Shiotani, Seiji] Tsukuba Med Ctr, Dept Radiol, Tsukuba, Ibaraki, Japan	Okuda, T (reprint author), Off Chief Med Examiner, Baltimore, MD 21223 USA.	takahisa.okuda@gmail.com					Matsuda N, 2004, ANN THORAC SURG, V77, P1069, DOI 10.1016/S0003-4975(03)01218-9; Takahashi N, 2012, EUR RADIOL, V22, P152, DOI 10.1007/s00330-011-2248-6; Gatzoulis MA, 2000, ANN THORAC SURG, V69, P1209, DOI 10.1016/S0003-4975(99)01552-0; Neschis DG, 2008, NEW ENGL J MED, V359, P1708, DOI 10.1056/NEJMra0706159; Okuda T, 2013, FORENSIC SCI INT, V225, P3, DOI 10.1016/j.forsciint.2012.03.010; Nakajima M, 2004, ANN THORAC SURG, V77, P1066, DOI 10.1016/S0003-4975(03)01147-0; AGDAL N, 1973, ACTA MED SCAND, V194, P477; Filograna L, 2013, FORENSIC SCI INT, V228, pE76, DOI 10.1016/j.forsciint.2013.01.039; Furui M, 2012, INTERACT CARDIOV TH, V15, P912, DOI 10.1093/icvts/ivs328; JOHANSSON G, 1995, J VASC SURG, V21, P985, DOI 10.1016/S0741-5214(95)70227-X; HIRST AE, 1958, MEDICINE, V37, P217; Nisanoglu V, 2005, TEX HEART I J, V32, P241; Bennett KR, 2000, ANN THORAC SURG, V70, P993, DOI 10.1016/S0003-4975(00)01287-X; Bennett KR, 2000, ANN THORAC SURG, V70, P3; Buschmann CT, 2009, INTENS CARE MED, V35, P397, DOI 10.1007/s00134-008-1255-9; GANDELMAN G, 1994, CHEST, V106, P636, DOI 10.1378/chest.106.2.636; Hashimoto Yoshiaki, 2007, Legal Medicine, V9, P94, DOI 10.1016/j.legalmed.2006.11.008; Juvonen T, 1997, ANN THORAC SURG, V63, P1533, DOI 10.1016/S0003-4975(97)00414-1; Kan CB, 2010, ANN THORAC SURG, V89, P2030, DOI 10.1016/j.athoracsur.2009.10.013; Kaneko Toshihiro, 2010, Risk Manag Healthc Policy, V3, P13, DOI 10.2147/RMHP.S10260; Little S, 1999, CHEST, V116, P1478, DOI 10.1378/chest.116.5.1478; Machii M, 2000, RESUSCITATION, V43, P151, DOI 10.1016/S0300-9572(99)00137-9; NOFFSINGER AE, 1991, J FORENSIC SCI, V36, P1760; Shiotani Seiji, 2004, Radiat Med, V22, P405; Takada Aya, 2003, Leg Med (Tokyo), V5, P27, DOI 10.1016/S1344-6223(03)00002-6; Turk EE, 2004, J TRAUMA, V57, P301, DOI 10.1097/01.TA.0000074554.86172.0E; Tyson MD, 1931, AM J PATHOL, V7, P581	27	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1344-6223			LEGAL MED-TOKYO	Leg. Med.	MAY	2015	17	3					201	204		10.1016/j.legalmed.2014.12.001		4	Medicine, Legal; Social Sciences, Biomedical	Legal Medicine; Biomedical Social Sciences	CI3SK	WOS:000354667500013		
J	Ozeki, M; Kato, H; Tamaki, K				Ozeki, Munetaka; Kato, Hiroki; Tamaki, Keiji			Development of a novel miniplex DNA identification system for the Japanese population	LEGAL MEDICINE			English	Article						DNA typing; Japanese population; Kinship analysis; Short tandem repeat	CELL-LINES; PCR; REPAIR; LOCI	To aid DNA identification using 36 short tandem repeat (STR) loci for kinship analysis, likelihood ratio (LR) distributions were estimated using the allele frequency data evaluated for the Japanese population in our previous study. The results revealed that the LR tended to be higher when kinship analysis was performed using the 36 STR loci than when the analysis was performed using Identifier (R), the most commonly used commercial DNA typing kit in Japan, even when a sibship case was analyzed. However, a typing kit targeting 36 STR loci is not suitable for the analysis of damaged DNA. In this study, we developed a novel miniplex DNA identification system targeting 7 STR loci (D3S1744, D5S818, D8S1179, D10S2325, Penta D, Penta E, and vWA) that was optimized for use in combination with MiniFiler (TM) for the Japanese population. The combined matching probability of the MiniFiler plus miniplex system was 4.8 x 10(-19), which is lower than that of Identifier (4.3 x 10(-17)). All expected alleles were detected successfully on DNA isolated from HepG2 human hepatocarcinoma cells by the miniplex system, but no significant signal was observed from a DNA sample isolated from COS-7 African green monkey kidney cells. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Ozeki, Munetaka; Tamaki, Keiji] Kyoto Univ, Grad Sch Med, Dept Forens Med, Sakyo Ku, Kyoto 6068501, Japan; [Kato, Hiroki] Nagoya Univ, Grad Sch Med, Dept Gen Med Family & Community Med, Showa Ku, Nagoya, Aichi 4668560, Japan	Ozeki, M (reprint author), Kyoto Univ, Grad Sch Med, Dept Forens Med, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	ozeki@fp.med.kyoto-u.ac.jp			Japan Society for the Promotion of Science [24590854]	This work was supported by a Grant-in-Aid for Scientific Research (C) (Grant Number: 24590854 [M.O.]) provided by the Japan Society for the Promotion of Science. We thank Hiroyuki Osada (Ricoh Japan Co., Ltd.) for his assistance with the kinship analysis simulation.	Almeida JL, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-102; Hares DR, 2012, FORENSIC SCI INT-GEN, V6, pE52, DOI 10.1016/j.fsigen.2011.04.012; Ge JY, 2011, J FORENSIC SCI, V56, pS23, DOI 10.1111/j.1556-4029.2010.01631.x; Planz JV, 2012, FORENSIC SCI INT-GEN, V6, P594, DOI 10.1016/j.fsigen.2012.02.002; Takagi M, 1997, APPL ENVIRON MICROB, V63, P4504; O'Connor KL, 2012, FORENSIC SCI INT-GEN, V6, P840, DOI 10.1016/j.fsigen.2012.03.008; Boiteux S, 2004, DNA REPAIR, V3, P1, DOI 10.1016/j.dnarep.2003.10.002; Ozeki M, 2013, LEGAL MED-TOKYO, V15, P342, DOI 10.1016/j.legalmed.2013.08.006; Jobling MA, 2004, NAT REV GENET, V5, P739, DOI 10.1038/nrg1455; Fondevila M, 2008, FORENSIC SCI INT-GEN, V2, P212, DOI 10.1016/j.fsigen.2008.02.005; Ge Jianye, 2012, Investig Genet, V3, P1, DOI 10.1186/2041-2223-3-1; Kling D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043873; Tie J, 2013, MOL BIOL REP, V40, P1505, DOI 10.1007/s11033-012-2194-7; van Pelt JF, 2003, MOL CELL BIOCHEM, V243, P49, DOI 10.1023/A:1021653506123	14	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1344-6223			LEGAL MED-TOKYO	Leg. Med.	MAY	2015	17	3					205	209		10.1016/j.legalmed.2014.12.007		5	Medicine, Legal; Social Sciences, Biomedical	Legal Medicine; Biomedical Social Sciences	CI3SK	WOS:000354667500014		
J	Igoh, A; Tomotake, S; Doi, Y				Igoh, Akihisa; Tomotake, Sho; Doi, Yusuke			Detection of proline-rich proteins for the identification of saliva by enzyme-linked immunosorbent assay	LEGAL MEDICINE			English	Article						Enzyme-linked immunosorbent assay; Saliva identification; Proline-rich proteins; PRP HaeIII subfamily 1/2; Salivary PRP 2; Statherin	PROSTATE-SPECIFIC ANTIGEN; IMMUNOCHROMATOGRAPHIC STRIP TEST; TAMM-HORSFALL PROTEIN; FORENSIC IDENTIFICATION; DEVELOPMENTAL VALIDATION; STAINS; ELISA; URINE; HISTATINS; AMYLASE	Saliva is one of the most common body fluids found at a crime scene. Therefore, identifying saliva is important in forensic science. However, the current protein marker assays used to identify saliva are not sufficiently specific. Although proline-rich proteins (PRPs) are highly specific for saliva, their forensic potential has not yet been investigated. In this study, we developed enzyme-linked immunosorbent assays (ELISAs) to detect acidic salivary PRP HaeIII subfamily 1/2 (PRH1/2) and basic salivary PRP 2 (PRB2). The specificity, sensitivity, and efficiency of the ELISAs for PRH1/2 and PRB2 were compared with those of the ELISA for statherin (STATH), a known protein marker for saliva. The levels of PRH1/2 were significantly higher in saliva and saliva stains than in other body fluids (nasal secretions, urine, semen, vaginal fluid, blood, and sweat). PRB2 and STATH were detected in both nasal secretions and saliva. The PRH1/2 ELISA showed sensitivity similar to that of STATH ELISA. The detection rate of PRH1/2 ELISA was almost similar to that of STATH ELISA, followed by the ELISA for PRB2. The PRH1/2 ELISA had higher specificity for saliva than STATH ELISA. Therefore, the PRH1/2 ELISA has potential as a method to identify saliva for forensic investigation. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Igoh, Akihisa; Tomotake, Sho; Doi, Yusuke] Forens Sci Lab Okayama Prefectural Police HQ, Kita Ku, Okayama 7000816, Japan; [Doi, Yusuke] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Legal Med, Okayama 7008558, Japan	Igoh, A (reprint author), Forens Sci Lab Okayama Prefectural Police HQ, Kita Ku, 1-3-2 Tondacho, Okayama 7000816, Japan.	op-qphif108@pref.okayama.jp					Akutsu T, 2010, INT J LEGAL MED, V124, P493, DOI 10.1007/s00414-009-0391-2; Akutsu T, 2012, J FORENSIC SCI, V57, P1570, DOI 10.1111/j.1556-4029.2012.02174.x; Akutsu T, 2010, J FORENSIC SCI, V55, P742, DOI 10.1111/j.1556-4029.2010.01325.x; JOHNSON ED, 1993, J FORENSIC SCI, V38, P250; Oudhoff MJ, 2008, FASEB J, V22, P3805, DOI 10.1096/fj.08-112003; Sakurada K, 2012, LEGAL MED-TOKYO, V14, P201, DOI 10.1016/j.legalmed.2012.01.014; SCHENKELS LCPM, 1995, CRIT REV ORAL BIOL M, V6, P161; Sato I, 2002, FORENSIC SCI INT, V127, P71, DOI 10.1016/S0379-0738(02)00111-1; Old J, 2012, J FORENSIC SCI, V57, P489, DOI 10.1111/j.1556-4029.2011.01968.x; Old JB, 2009, J FORENSIC SCI, V54, P866, DOI 10.1111/j.1556-4029.2009.01055.x; Fabian TK, 2012, INT J MOL SCI, V13, P4295, DOI 10.3390/ijms13044295; Nakanishi H, 2009, FORENSIC SCI INT, V183, P20, DOI 10.1016/j.forsciint.2008.10.003; Fabian TK, 2008, SALIVA HLTH DIS CHEM, V1st, P1; ITOH Y, 1990, FORENSIC SCI INT, V47, P79, DOI 10.1016/0379-0738(90)90287-9; Levine M, 2011, INT J DENT, V2011; MAEDA N, 1985, J BIOL CHEM, V260, P1123; Pang BCM, 2008, J FORENSIC SCI, V53, P1117, DOI 10.1111/j.1556-4029.2008.00814.x; Quarino L, 2005, J FORENSIC SCI, V50, P873; SABATINI LM, 1989, BIOCHEM BIOPH RES CO, V160, P495, DOI 10.1016/0006-291X(89)92460-1; Sakurada K, 2013, JPN J FORENSIC SCI T, V18, P1; Sakurada K, 2011, LEGAL MED-TOKYO, V13, P309, DOI 10.1016/j.legalmed.2011.07.002; STOWELL LI, 1991, FORENSIC SCI INT, V50, P125, DOI 10.1016/0379-0738(91)90141-5; TSUTSUMI H, 1988, J FORENSIC SCI, V33, P237; WILLOTT GM, 1980, FORENSIC SCI INT, V15, P79, DOI 10.1016/0379-0738(80)90198-X; WILLOTT GM, 1974, J FORENSIC SCI SOC, V14, P341, DOI 10.1016/S0015-7368(74)70923-9	25	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1344-6223			LEGAL MED-TOKYO	Leg. Med.	MAY	2015	17	3					210	213		10.1016/j.legalmed.2014.12.011		4	Medicine, Legal; Social Sciences, Biomedical	Legal Medicine; Biomedical Social Sciences	CI3SK	WOS:000354667500015		
J	Nishibe, Y; Takahashi, K; Ichikawa, T; Hidaka, K; Kurogi, H; Segawa, K; Saito, H				Nishibe, Yuichiro; Takahashi, Kazutaka; Ichikawa, Tadafumi; Hidaka, Kiyotaka; Kurogi, Hiroaki; Segawa, Kyohei; Saito, Hiroaki			Degradation of discarded appendicularian houses by oncaeid copepods	LIMNOLOGY AND OCEANOGRAPHY			English	Article							ABANDONED LARVACEAN HOUSES; MARINE SNOW; VERTICAL-DISTRIBUTION; COMMUNITY STRUCTURE; MONTEREY BAY; RED-SEA; ZOOPLANKTON; MECHANISMS; CALIFORNIA; PARTICLES	We examined the degradation of discarded appendicularian houses due to feeding by oncaeid copepods in surface waters of the Kuroshio region. Vertical distributions of oncaeid copepods and discarded houses were investigated by optical sampling using a video plankton recorder (VPR). In situ VPR observations revealed that oncaeid copepods were commonly associated with discarded houses: the proportion of individuals attached to discarded houses reached saturated values of 25-39% at house concentrations above 2000 houses m(-3), suggesting that feeding by oncaeids was not limited by encounters at house concentrations typically observed in the upper 50 m. Laboratory observations confirmed that oncaeid copepods attached to the surface of discarded houses and ingested both house membranes and adhering particles. Individual feeding rates of the dominant Oncaea species, O. venusta and O. media, determined by measuring fecal pellet production and assimilation efficiency, varied from 0.13 mu g C ind.(-1) d(-1) to 1.3 mu g C ind.(-1) d(-1) (10-37% body C d(-1)). Our results indicate that the oncaeid copepod community consumed up to 10% of house biomass each day in the upper 100 m of the water column, and show that through their close trophic coupling with discarded appendicularian houses, the oncaeids contribute significantly to house degradation in surface waters.	[Nishibe, Yuichiro; Saito, Hiroaki] Fisheries Res Agcy, Tohoku Natl Fisheries Res Inst, Fisheries Management & Oceanog Div, Shiogama, Miyagi, Japan; [Takahashi, Kazutaka] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Bunkyo Ku, Tokyo, Japan; [Ichikawa, Tadafumi; Hidaka, Kiyotaka; Segawa, Kyohei] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Res Ctr Fisheries Oceanog & Marine Ecosyst, Yokohama, Kanagawa, Japan; [Kurogi, Hiroaki] Fisheries Res Agcy, Yokosuka Lab, Natl Res Inst Aquaculture, Yokosuka, Kanagawa, Japan	Nishibe, Y (reprint author), Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan.	ynishibe@aori.u-tokyo.ac.jp			Agriculture, Forestry and Fisheries Research Council's	We thank Y. Kajigaya and the other staff of the Yokosuka Laboratory, National Research Institute of Aquaculture, for their help in carrying out our experiments. We are grateful to the captain and crew of the R/V Shunyo-Maru, National Research Institute of Far Seas Fisheries, for their support at sea. We also thank the two anonymous reviewers who provided constructive comments on the manuscript. This study was supported by the Agriculture, Forestry and Fisheries Research Council's "Study for the prediction and control of population outbreak of marine life in relation to environmental change."	Alldredge A, 1998, DEEP-SEA RES PT I, V45, P529, DOI 10.1016/S0967-0637(97)00048-4; Alldredge A. L., 2005, RESPONSE MARINE ECOS, P309; ALLDREDG.AL, 1972, SCIENCE, V177, P885, DOI 10.1126/science.177.4052.885; Koski M, 2007, J PLANKTON RES, V29, P641, DOI 10.1093/plankt/fbm046; Kiorboe T, 2011, BIOL REV, V86, P311, DOI 10.1111/j.1469-185X.2010.00148.x; BOTTGERSCHNACK R, 1994, HYDROBIOLOGIA, V293, P271; Sano M, 2013, PROG OCEANOGR, V110, P11, DOI 10.1016/j.pocean.2013.01.004; Green EP, 1997, J PLANKTON RES, V19, P435, DOI 10.1093/plankt/19.4.435; Sato R, 2003, MAR ECOL PROG SER, V259, P163, DOI 10.3354/meps259163; Kiorboe T, 2000, LIMNOL OCEANOGR, V45, P479; FOWLER SW, 1986, PROG OCEANOGR, V16, P147, DOI 10.1016/0079-6611(86)90032-7; Wilson SE, 2008, DEEP-SEA RES PT II, V55, P1636, DOI 10.1016/j.dsr2.2008.04.019; Urban-Rich J, 1998, MAR ECOL PROG SER, V171, P199; Davis CS, 2005, LIMNOL OCEANOGR-METH, V3, P59; Bottger-Schnack R, 2004, HYDROBIOLOGIA, V513, P1, DOI 10.1023/B:hydr.0000018301.50664.3d; Koski M, 2005, LIMNOL OCEANOGR, V50, P1254; GONZALEZ HE, 1994, MAR ECOL PROG SER, V113, P233, DOI 10.3354/meps113233; ALLDREDGE AL, 1988, PROG OCEANOGR, V20, P41, DOI 10.1016/0079-6611(88)90053-5; CONOVER RJ, 1966, LIMNOL OCEANOGR, V11, P338; Bottger-Schnack R., 2001, B NAT HIST MUS LOND, V67, P25; BOTTGERSCHNACK R, 1990, MAR BIOL, V106, P473, DOI 10.1007/BF01344328; Hansen JLS, 1996, MAR ECOL PROG SER, V141, P205, DOI 10.3354/meps141205; Itoh Hiroshi, 2014, Plankton & Benthos Research, V9, P1; Kiorboe T, 2001, SCI MAR, V65, P57; Nakata Kaoru, 2001, Bulletin of the National Research Institute of Fisheries Science, V16, P75; Nishibe Y, 2009, J MAR BIOL ASSOC UK, V89, P491, DOI 10.1017/S0025315409003087; Ohtsuka S., 1991, B PLANKTON SOC JPN, P535; Ohtsuka Susumu, 1993, Journal of Oceanography, V49, P115, DOI 10.1007/BF02234012; Ohtsuka Susumu, 1996, Bulletin of Plankton Society of Japan, V43, P89; Paffenhofer GA, 2006, MAR ECOL PROG SER, V317, P187, DOI 10.3354/meps317187; Sato Riki, 1999, Plankton Biology and Ecology, V46, P162; STEINBERG DK, 1994, LIMNOL OCEANOGR, V39, P1606; Steinberg DK, 1997, MAR ECOL PROG SER, V147, P167, DOI 10.3354/meps147167; Wassmann P, 2000, PROG OCEANOGR, V46, P241, DOI 10.1016/S0079-6611(00)00021-5	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0024-3590	1939-5590		LIMNOL OCEANOGR	Limnol. Oceanogr.	MAY	2015	60	3					967	976		10.1002/lno.10061		10	Limnology; Oceanography	Marine & Freshwater Biology; Oceanography	CI1GA	WOS:000354490100019		
J	Saito, I; Azuma, K; Kakikawa, T; Oshima, N; Hanson, ME; Tershakovec, AM				Saito, Itori; Azuma, Kyoichi; Kakikawa, Taro; Oshima, Nobuyuki; Hanson, Mary E.; Tershakovec, Andrew M.			A randomized, double-blind, placebo-controlled study of the effect of ezetimibe on glucose metabolism in subjects with type 2 diabetes mellitus and hypercholesterolemia	LIPIDS IN HEALTH AND DISEASE			English	Article						Fasting plasma glucose; Glycoalbumin; HbA1c; Japanese; LDL-C	CHOLESTEROL ABSORPTION INHIBITOR; LIPID-ALTERING EFFICACY; INSULIN SENSITIVITY; JAPANESE PATIENTS; STATIN THERAPY; SAFETY; ATORVASTATIN; SIMVASTATIN; TRIAL; METAANALYSIS	Background: Recent evidence points to an increased incidence of new-onset diabetes and a negative impact on glucose parameters with statin use. This study examined the safety of ezetimibe vs placebo for change from baseline to week 24 in HbA1c (primary endpoint), glycoalbumin, and fasting plasma glucose (secondary endpoints) in Japanese subjects with type 2 diabetes and hypercholesterolemia. Methods: This was a randomized, double-blind, placebo-controlled, parallel-group, multi-site trial. Adults with type 2 diabetes and hypercholesterolemia whose LDL-C measured <140 mg/dl (subjects receiving lipid-lowering drugs) or <160 mg/dl (subjects not receiving lipid-lowering drugs) at the start of the screening phase, were randomized after a 5-week wash-out period to ezetimibe 10 mg or placebo (1:1) for 24 weeks. Changes in HbA1c, glycoalbumin and fasting plasma glucose from baseline to week 24 were evaluated. The non-inferiority margin was set at 0.5% for HbA1c. Results: Overall, 152 subjects were randomized (75 to ezetimibe and 77 to placebo). From baseline to 24 weeks, HbA1c significantly increased in both the ezetimibe and placebo groups (between-treatment difference 0.08 [95% CI: -0.07 to 0.23]). Ezetimibe was statistically non-inferior to placebo. At 24 weeks, the mean change from baseline in glycoalbumin levels (between-treatment differences 0.00 [95% CI: -0.47, 0.47]) and fasting plasma glucose (between-treatment differences -4.8 [95% CI: -12.1, 2.1]) were similar in both treatment groups. Conclusions: These results suggest that ezetimibe 10 mg does not result in dysregulation of glucose metabolism in Japanese patients with type 2 diabetes and hypercholesterolemia over 24 weeks of treatment.	[Saito, Itori; Azuma, Kyoichi; Kakikawa, Taro; Oshima, Nobuyuki] MSD KK, Japan Dev Clin Res, Chiyoda Ku, Tokyo 1028667, Japan; [Hanson, Mary E.; Tershakovec, Andrew M.] Merck & Co Inc, Kenilworth, NJ USA	Kakikawa, T (reprint author), MSD KK, Japan Dev Clin Res, Chiyoda Ku, Kitanomaru Sq,1-13-12 Kudan Kita, Tokyo 1028667, Japan.	taro.kakikawa@merck.com			MSD KK, Tokyo, Japan	This study was funded by MSD KK, Tokyo, Japan.	Bays HE, 2004, CLIN THER, V26, P1758, DOI 10.1016/j.clinthera.2004.11.016; Zaharan NL, 2013, BRIT J CLIN PHARMACO, V75, P1118, DOI 10.1111/j.1365-2125.2012.04403.x; Knopp RH, 2003, EUR HEART J, V24, P729, DOI 10.1016/S0195-668X(02)00807-2; Koh KK, 2010, J AM COLL CARDIOL, V55, P1209, DOI 10.1016/j.jacc.2009.10.053; Tamaki N, 2012, J ATHEROSCLER THROMB, V19, P532; Ballantyne CM, 2003, CIRCULATION, V107, P2409, DOI 10.1161/01.CIR.0000068312.21969.C8; Rajpathak SN, 2009, DIABETES CARE, V32, P1924, DOI 10.2337/dc09-0738; Blazing MA, 2014, AM HEART J, V168, P205, DOI 10.1016/j.ahj.2014.05.004; Davidson MH, 2002, J AM COLL CARDIOL, V40, P2125, DOI 10.1016/S0735-1097(02)02610-4; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Deushi M, 2007, FEBS LETT, V581, P5664, DOI 10.1016/j.febslet.2007.11.023; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Pandor A, 2009, J INTERN MED, V265, P568, DOI 10.1111/j.1365-2796.2008.02062.x; Ishikawa M, 2006, INTERNAL MED, V45, P51, DOI 10.2169/internalmedicine.45.1476; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; Lim S, 2014, ATHEROSCLEROSIS, V235, P644, DOI 10.1016/j.atherosclerosis.2014.06.001; ASSMANN G, 1988, AM HEART J, V116, P1713, DOI 10.1016/0002-8703(88)90220-7; Blazing M., 2014, AM HEART ASS SCI SES; Cannon CP, 2014, AM HEART ASS SCI SES; Dagli N, 2007, INFLAMMATION, V30, P230, DOI 10.1007/s10753-007-9041-3; Dujovne CA, 2002, AM J CARDIOL, V90, P1092, DOI 10.1016/S0002-9149(02)02798-4; Goldberg AC, 2004, MAYO CLIN PROC, V79, P620; Gonzalez-Ortiz M, 2006, CARDIOVASC DRUG THER, V20, P143, DOI 10.1007/s10557-006-7805-x; Hawes BE, 2007, MOL PHARMACOL, V71, P19, DOI 10.1124/mol.106.027896; Kerzner B, 2003, AM J CARDIOL, V91, P418, DOI 10.1016/S0002-9149(02)03236-8; Kikuchi K, 2012, J ATHEROSCLER THROMB, V19, P1093; Kishimoto Miyako, 2011, J Med Invest, V58, P86, DOI 10.2152/jmi.58.86; Labonte ED, 2008, AM J PHYSIOL-GASTR L, V295, pG776, DOI 10.1152/ajpgi.90275.2008; Melani L, 2003, EUR HEART J, V24, P717, DOI 10.1016/S0195-668X(02)00803-5; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Robinson JG, 2009, AM J CARDIOL, V103, P1694, DOI 10.1016/j.amjcard.2009.05.003; Toth PP, 2013, J CLIN LIPIDOL, V7, P277; Toth PP, 2014, J AM COLL CARDIOL, V63, pA1313; Tsunoda T, 2013, DIABETES RES CLIN PR, V100, P46, DOI 10.1016/j.diabres.2012.12.026; Uemura Y, 2012, J CARDIOL, V59, P50, DOI 10.1016/j.jjcc.2011.09.001; Yagi S, 2010, J ATHEROSCLER THROMB, V17, P173; Zhong Y, 2012, EXP DIABETES RES, DOI 10.1155/2012/420854	37	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1476-511X			LIPIDS HEALTH DIS	Lipids Health Dis.	MAY 1	2015	14								40	10.1186/s12944-015-0036-z		9	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	CI7CB	WOS:000354919400001		
J	Yamasaki, N				Yamasaki, N.			Hydrothermal dehydration of biomass by superheated steam	MATERIALS RESEARCH INNOVATIONS			English	Article						Hydrothermal; Exhaust steam; dehydration; active carbon; biomass	METHANOL	Hydrothermal systems (viz. aqueous solution systems with high temperature (100-374 degrees C) and pressure (0.1-22 MPa) are frequently acknowledged as multi-functional reaction media for various organic and inorganic reactions. This paper presents two typical uses of exhaust superheated steam for hydrothermal dehydration of bamboo and cedar leaves at moderate conditions (< 300 degrees C). The active carbon prepared by the dehydration of bamboo and cedar leaves was characterised by scanning electron microscope, Brunauer-Emmett-Teller (BET) method and adsorption behaviour of heavy metals (e.g. Pb and Cd). The results indicate that the as-prepared active carbon from bamboo had a higher absorption ability than the commercial activated carbon formed by heating biomass at 800 degrees C. Moreover, the as-prepared carbon from cedar leaves expressed a much better adsorption of Pb than the commercial carbon products. Therefore, this demonstrates great potential of disposed exhaust stream up to 300 degrees C in the uses of the hydration of the biomass to produce high-performance active carbon products.	Res Inst Aqua Sci & Technol, Kochi 7891201, Japan	Yamasaki, N (reprint author), Res Inst Aqua Sci & Technol, Kochi 7891201, Japan.	cucumber@mint.ocn.ne.jp					Yamasaki N, 2003, J CERAM SOC JPN, V111, P709, DOI 10.2109/jcersj.111.709; YAMASAKI N, 1980, ENVIRON SCI TECHNOL, V14, P550, DOI 10.1021/es60165a011; Ikeda H, 2004, KAGAKU KOGAKU RONBUN, V30, P211, DOI 10.1252/kakoronbunshu.30.211; KAMAKURA T, 2001, INT J HIGH PRESSURE, V20, P421; Li Z., 2009, J JPN SOC MAT CYCLES, V20, P361; Yamaguchi H., 1994, J JPN SOC WASTE MANA, V5, P193; Yamasaki N., 1988, J CHEM SOC JPN, P1909; Yamasaki N., 1982, J CHEM SOC JPN IND C, V2, P1147; Yamasaki N., 1983, J CHEM SOC JPN IND C, P595; Yamasaki N., 1985, CHEM SOC JPN, P141; Yamasaki N., 1992, J CERAM SOC JPN, P792; Yamasaki N., 1987, J MINER METALL I JPN, V103, P519; Yamasaki N., 1984, CHEM SOC JPN, P691; Yamasaki N., 1983, J CHEM SOC JPN IND C, P1008; Yamasaki N., 1991, J CERAM SOC JPN, P1565; Yamasaki Y, 1999, CHEM LETT, P83	16	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1432-8917	1433-075X		MATER RES INNOV	Mater. Res. Innov.	MAY	2015	19			2						10.1179/1432891715Z.0000000001382		5	Materials Science, Multidisciplinary	Materials Science	CI7QN	WOS:000354959200034		
J	Yu, CC; Chu, JP; Lee, CM; Diyatmika, W; Chang, MH; Jeng, JY; Yokoyama, Y				Yu, Chia-Chi; Chu, Jinn P.; Lee, Cheng-Min; Diyatmika, Wahyu; Chang, M. H.; Jeng, Jeng-Ywan; Yokoyama, Yoshihiko			Bending property enhancements of Zr55Cu30Al10Ni5 bulk metallic glass: Effects of various surface modifications	MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES MICROSTRUCTURE AND PROCESSING			English	Article						Bulk metallic glass; Thin film metallic glass; Scratch; Femtosecond laser patterning; Four-point bending; Shear bands	MACROSCOPIC TENSILE PLASTICITY; MECHANICAL-PROPERTIES; SHEAR BANDS; MATRIX COMPOSITES; AMORPHOUS-ALLOYS; RESIDUAL-STRESS; IMPROVEMENT; DUCTILITY; TOUGHNESS; PLATES	Effects of various surface modifications on four-point bending property improvements of Zr55Cu30Al10Ni5 bulk metallic glass (BMG) are systematically studied. Surface modifications investigated include thin-film metallic glass coating, artificial scratches and femtosecond laser patterning. After modifications, the negligible plastic strain of 3-mm-thick BMG is found to markedly enhance to similar to 9.2%, without sacrificing its extraordinary strength. Instead, bending yield and fracture strengths in the surface-modified samples are increased to similar to 2.8 GPa and similar to 4.0 GPa, respectively, corresponding to a rise of similar to 66% from those of as-cast samples. In addition, the samples with surface modifications exhibit distinct shear band morphologies. Relationships between the shear band offset, shear band spacing and plastic strain of bent BMG samples are established. Our experimental results demonstrate that BMG is able to survive plastic flow without abrupt fracture through proper designs of surface modifications, in which large numbers of shear bands are formed to distribute the strain effectively upon loading. (C) 2015 Elsevier B.V. All rights reserved.	[Yu, Chia-Chi; Chu, Jinn P.; Lee, Cheng-Min; Diyatmika, Wahyu] Natl Taiwan Univ Sci & Technol, Dept Mat Sci & Engn, Taipei 10607, Taiwan; [Chang, M. H.; Jeng, Jeng-Ywan] Natl Taiwan Univ Sci & Technol, Dept Mech Engn, Taipei 10607, Taiwan; [Yokoyama, Yoshihiko] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan	Chu, JP (reprint author), Natl Taiwan Univ Sci & Technol, Dept Mat Sci & Engn, Taipei 10607, Taiwan.	jpchu@mail.ntust.edu.tw			Ministry of Science and Technology [NSC 101-2221-E-011-048-MY3]	This work is financially supported by Ministry of Science and Technology (NSC 101-2221-E-011-048-MY3). Professor Peter K. Liaw of The University of Tennessee and Dr. Yanhui Liu of Yale University are thanked for their valuable suggestions. We are indebted to Professor Jason S.C. Jang of National Central University for the sputtering target, Professor Chun-Hway Hsueh of National Taiwan University for using the materials testing system, and Chia-Hao Chang for his assistance with experiments. ITRI Southern Region Campus in Taiwan is acknowledged for using the femtosecond laser facility.	Chu JP, 2012, THIN SOLID FILMS, V520, P5097, DOI 10.1016/j.tsf.2012.03.092; He Q, 2012, ACTA MATER, V60, P4940, DOI 10.1016/j.actamat.2012.05.028; Qiu SB, 2008, APPL SURF SCI, V255, P3454, DOI 10.1016/j.apsusc.2008.07.077; Greer AL, 2013, MAT SCI ENG R, V74, P71, DOI 10.1016/j.mser.2013.04.001; Ashby MF, 2006, SCRIPTA MATER, V54, P321, DOI 10.1016/j.scriptamat.2005.09.051; Xu YK, 2005, ACTA MATER, V53, P1857, DOI 10.1016/j.actamat.2004.12.036; Conner RD, 2004, ACTA MATER, V52, P2429, DOI 10.1016/j.actamat.2004.01.034; Cao QP, 2010, ACTA MATER, V58, P1276, DOI 10.1016/j.actamat.2009.10.032; Hays CC, 2000, PHYS REV LETT, V84, P2901, DOI 10.1103/PhysRevLett.84.2901; Zhang Y, 2006, NAT MATER, V5, P857, DOI 10.1038/nmat1758; Chen BQ, 2012, SCRIPTA MATER, V66, P1057, DOI 10.1016/j.scriptamat.2012.02.046; Jia HL, 2014, THIN SOLID FILMS, V561, P2, DOI 10.1016/j.tsf.2013.12.024; Chen W, 2011, MAT SCI ENG A-STRUCT, V528, P2988, DOI 10.1016/j.msea.2010.12.077; Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6; Scudino S, 2011, J ALLOY COMPD, V509, pS128, DOI 10.1016/j.jallcom.2011.01.022; Chu JP, 2012, ACTA MATER, V60, P3226, DOI 10.1016/j.actamat.2012.02.037; Chen BQ, 2010, J ALLOY COMPD, V504, pS45, DOI 10.1016/j.jallcom.2010.04.053; Zhao JX, 2010, ACTA MATER, V58, P5420, DOI 10.1016/j.actamat.2010.06.017; Gonzalez S, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4833017; Zheng Q, 2014, MAT SCI ENG A-STRUCT, V592, P64, DOI 10.1016/j.msea.2013.11.003; Ravichandran G, 2005, ACTA MATER, V53, P4087, DOI 10.1016/j.actamat.2005.05.011; Chen W, 2012, MAT SCI ENG A-STRUCT, V552, P199, DOI 10.1016/j.msea.2012.05.031; Packard CE, 2007, ACTA MATER, V55, P5348, DOI 10.1016/j.actamat.2007.05.054; Choi YC, 2009, SCRIPTA MATER, V61, P481, DOI 10.1016/j.scriptamat.2009.05.003; Hofmann DC, 2008, NATURE, V451, P1085, DOI 10.1038/nature06598; Nieh TG, 2012, PROG NAT SCI-MATER, V22, P355, DOI 10.1016/j.pnsc.2012.09.006; Schuh CA, 2003, ACTA MATER, V51, P87, DOI 10.1016/S1359-6454(02)00303-8; Conner RD, 1998, ACTA MATER, V46, P6089, DOI 10.1016/S1359-6454(98)00275-4; Liu ZQ, 2012, ACTA MATER, V60, P3128, DOI 10.1016/j.actamat.2012.02.017; Lee ML, 2004, ACTA MATER, V52, P4121, DOI 10.1016/j.actamat.2004.05.025; Schuh CA, 2007, ACTA MATER, V55, P4067, DOI 10.1016/j.actamat.2007.01.052; Conner RD, 2003, J APPL PHYS, V94, P904, DOI 10.1063/1.1582555; Park JM, 2012, INTERMETALLICS, V29, P70, DOI 10.1016/j.intermet.2012.05.003; Jang JSC, 2010, J ALLOY COMPD, V504, pS102, DOI 10.1016/j.jallcom.2010.03.030; Jang J.S.C., 2008, APPL PHYS LETT, V92; Lee MH, 2010, SCRIPTA MATER, V62, P678, DOI 10.1016/j.scriptamat.2010.01.024; Li C., UNPUB; Pan D.G., 2006, APPL PHYS LETT, V89; Qu RT, 2012, MAT SCI ENG A-STRUCT, V534, P365, DOI 10.1016/j.msea.2011.11.082; Qu RT, 2013, SCRIPTA MATER, V68, P845, DOI 10.1016/j.scriptamat.2013.02.005; Sarac B., 2013, NAT COMMUN, V4; Wu GJ, 2012, INTERMETALLICS, V24, P50, DOI 10.1016/j.intermet.2012.01.022; Yokoyama Y, 2001, MATER TRANS, V42, P623, DOI 10.2320/matertrans.42.623; Yokoyama Y, 2001, SCRIPTA MATER, V44, P1529, DOI 10.1016/S1359-6462(01)00723-0; Zhu Z, 2010, SCRIPTA MATER, V62, P278, DOI 10.1016/j.scriptamat.2009.11.018	45	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0921-5093	1873-4936		MAT SCI ENG A-STRUCT	Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.	MAY 1	2015	633						69	75		10.1016/j.msea.2015.03.016		7	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Science & Technology - Other Topics; Materials Science; Metallurgy & Metallurgical Engineering	CH2HB	WOS:000353845200011		
J	Okayasu, M; Takeuchi, S				Okayasu, Mitsuhiro; Takeuchi, Shuhei			Crystallization characteristics of cast aluminum alloys during a unidirectional solidification process	MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES MICROSTRUCTURE AND PROCESSING			English	Article						Aluminum alloy; Texture; Lattice; Microstructure; Tensile property	WIRES; GROWTH	The crystal orientation characteristics of cast Al-Si, Al-Cu and Al-Mg alloys produced by a unidirectional solidification process are examined. Two distinct crystal orientation patterns are observed: uniform and random formation. A uniform crystal orientation is created by columnar growth of alpha-Al dendrites in the alloys with low proportions of alloying element, e.g., the Al-Si alloy (with Si <12.6%) and the Al-Cu and Al-Mg alloys (with Cu and Mg < 2%). A uniformly organized crystal orientation with [100] direction is created by columnar growth of alpha-Al dendrites. With increasing proportion of alloying element (>2% Cu or Mg), the uniform crystal orientations collapse in the Al-Cu and Al-Mg alloys, owing to interruption of the columnar alpha-Al dendrite growth as a result of different dynamics of the alloying atoms and the creation of a core for the eutectic phases. For the hypo-eutectic Al-Si alloys, a uniform crystal orientation is obtained. In contrast, a random orientation can be detected in the hyper-eutectic Al-Si alloy (15% Si), which results from interruption of the growth of the alpha-Al dendrites due to precipitation of primary Si particles. There is no clear effect of crystal formation on ultimate tensile strength (UTS), whereas crystal orientation does influence the material ductility, with the alloys with a uniform crystal orientation being elongated beyond their UTS points and with necking occurring in the test specimens. In contrast, the alloys with a nonuniform crystal orientation are not elongated beyond their UTS points. (C) 2015 Elsevier B.V. All rights reserved.	[Okayasu, Mitsuhiro; Takeuchi, Shuhei] Ehime Univ, Dept Mat Sci & Engn, Matsuyama, Ehime 7908577, Japan	Okayasu, M (reprint author), Ehime Univ, Dept Mat Sci & Engn, 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	mitsuhiro.okayasu@utoronto.ca					Henry S, 1998, ACTA MATER, V46, P6431, DOI 10.1016/S1359-6454(98)00308-5; Bhardwaj D, 2010, MATER CHARACT, V61, P882, DOI 10.1016/j.matchar.2010.05.013; Okayasu M, 2012, MAT SCI ENG A-STRUCT, V543, P185, DOI 10.1016/j.msea.2012.02.073; Motoyasu G, 2001, METALL MATER TRANS A, V32, P585, DOI 10.1007/s11661-001-0075-0; Okayasu M, 2012, J MATER SCI, V47, P241, DOI 10.1007/s10853-011-5791-2; Cole C.S., 1995, MATER CHARACT, V35, P3; Fashu S, 2011, RUSS J NON-FERR MET+, V52, P254, DOI 10.3103/S1067821211030072; Miyamoto Y., 2014, P INT S SMART MAT ME, P31; Motoyasu G, 1999, J MATER SCI, V34, P3893, DOI 10.1023/A:1004674823296; Ohno A., 1987, SOLIDIFICATION, Vfirst, P113; Okayasu M, 2013, INT J CAST METAL RES, V26, P160, DOI 10.1179/1743133612Y.0000000049; Okayasu M, 2010, MAT SCI ENG A-STRUCT, V527, P3120, DOI 10.1016/j.msea.2010.01.071; Reinhart G, 2005, MAT SCI ENG A-STRUCT, V413, P384, DOI 10.1016/j.msea.2005.08.197; Sengupta S, 2002, J MATER SCI, V37, P1747, DOI 10.1023/A:1014969000741; Soda H, 1995, MATER SCI TECH SER, V11, P1174; Takeuchi S., 2015, J JPN SOC ENG, P85; Zhang Z.M., 2008, ACTA METALL SIN, V21, P275, DOI 10.1016/S1006-7191(08)60049-6	17	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0921-5093	1873-4936		MAT SCI ENG A-STRUCT	Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.	MAY 1	2015	633						112	120		10.1016/j.msea.2015.03.001		9	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Science & Technology - Other Topics; Materials Science; Metallurgy & Metallurgical Engineering	CH2HB	WOS:000353845200015		
J	Huang, XS; Suzuki, K; Chino, Y; Mabuchi, M				Huang, Xinsheng; Suzuki, Kazutaka; Chino, Yasumasa; Mabuchi, Mamoru			Influence of aluminum content on the texture and sheet formability of AM series magnesium alloys	MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES MICROSTRUCTURE AND PROCESSING			English	Article						Magnesium alloy; Aluminum content; Texture; Mechanical property; Formability	AL-ZN ALLOY; ENHANCED STRETCH FORMABILITY; ROLLED MG-3AL-1ZN ALLOY; ROOM-TEMPERATURE; MECHANICAL-PROPERTIES; STRAIN-RATE; TENSILE PROPERTIES; PURE MAGNESIUM; GRAIN-SIZE; 723 K	The fabrication of magnesium (Mg) alloy sheets with both high mechanical strength and superior cold formability was sought by optimizing the aluminum (Al) content of the alloy sheets. We investigated the influence of varying Al content from 3 wt% to 8 wt% on the texture, mechanical properties, and stretch formability of AM series Mg alloys, processed by high-temperature rolling. The ultimate tensile strength improved steadily from 247 MPa to 303 MPa with an increase in Al, due to solid solution strengthening. The basal texture intensity decreased with increasing Al content, reached a minimum value at 6 wt%Al, and then increased as more Al was added. The weakest basal texture led to the smallest Lankford value and the largest strain hardening exponent in the AM60 (6 wt% Al) alloy. The alloys with lower Al contents of 3-5 wt% exhibited a high fracture elongation of 27%, which continuously decreased to 23% as the Al content increased to 8 wa. The AM50 alloy exhibited excellent stretch formability with the largest Erichsen value of 9.1, while the AM30 and AM80 alloys showed much smaller Erichsen values of 5.6 and 6.0, respectively. This can be attributed to a good balance among the decreased r-value, increased n-value, and enhanced tensile ductility in the AM50 alloy, despite its basal texture being slightly stronger than that of the AM60 alloy. (C) 2015 Elsevier B.V. All rights reserved.	[Huang, Xinsheng; Suzuki, Kazutaka; Chino, Yasumasa] Natl Inst Adv Ind Sci & Technol, Mat Res Inst Sustainable Dev, Nagoya, Aichi 4638560, Japan; [Mabuchi, Mamoru] Kyoto Univ, Grad Sch Energy Sci, Kyoto 6068501, Japan	Huang, XS (reprint author), Natl Inst Adv Ind Sci & Technol, Mat Res Inst Sustainable Dev, Nagoya, Aichi 4638560, Japan.	huang-xs@aist.go.jp					Akyuz B, 2013, T NONFERR METAL SOC, V23, P2243, DOI 10.1016/S1003-6326(13)62724-7; Uematsu Y, 2009, MAT SCI ENG A-STRUCT, V517, P138, DOI 10.1016/j.msea.2009.03.066; Huang XS, 2008, MAT SCI ENG A-STRUCT, V488, P214, DOI 10.1016/j.msea.2007.11.029; Chino Y, 2010, MAT SCI ENG A-STRUCT, V528, P566, DOI 10.1016/j.msea.2010.09.081; Tahreen N, 2014, MAT SCI ENG A-STRUCT, V594, P235, DOI 10.1016/j.msea.2013.11.078; Park SH, 2013, MAT SCI ENG A-STRUCT, V578, P271, DOI 10.1016/j.msea.2013.04.084; Huang XS, 2009, SCRIPTA MATER, V61, P445, DOI 10.1016/j.scriptamat.2009.04.042; Suh BC, 2014, SCRIPTA MATER, V84-85, P1, DOI 10.1016/j.scriptamat.2014.04.017; Huang XS, 2010, SCRIPTA MATER, V63, P395, DOI 10.1016/j.scriptamat.2010.04.032; Biswas S, 2010, ACTA MATER, V58, P3247, DOI 10.1016/j.actamat.2010.01.051; Song WQ, 2009, MATER DESIGN, V30, P642, DOI 10.1016/j.matdes.2008.05.050; Mordike BL, 2001, MAT SCI ENG A-STRUCT, V302, P37, DOI 10.1016/S0921-5093(00)01351-4; Asgari H, 2014, MATER DESIGN, V61, P26, DOI 10.1016/j.matdes.2014.04.049; Huang XS, 2009, MAT SCI ENG A-STRUCT, V508, P226, DOI 10.1016/j.msea.2008.12.052; Huang XS, 2009, J ALLOY COMPD, V470, P263, DOI 10.1016/j.jallcom.2008.02.029; Wang QD, 2010, MAT SCI ENG A-STRUCT, V527, P2265, DOI 10.1016/j.msea.2009.11.065; Huang XS, 2009, SCRIPTA MATER, V60, P651, DOI 10.1016/j.scriptamat.2008.12.035; StJohn DH, 2005, METALL MATER TRANS A, V36A, P1669, DOI 10.1007/s11661-005-0030-6; Hantzsche K, 2010, SCRIPTA MATER, V63, P725, DOI 10.1016/j.scriptamat.2009.12.033; Li X, 2012, SCRIPTA MATER, V66, P159, DOI 10.1016/j.scriptamat.2011.10.028; Wu D, 2011, J ALLOY COMPD, V509, P2856, DOI 10.1016/j.jallcom.2010.11.141; Huang XS, 2008, J MATER RES, V23, P3029, DOI 10.1557/JMR.2008.0368; Chino Y, 2009, MAT SCI ENG A-STRUCT, V513-14, P394, DOI 10.1016/j.msea.2009.01.074; Huang XS, 2011, J ALLOY COMPD, V509, P7579, DOI 10.1016/j.jallcom.2011.04.132; Davies C, 2004, JOM-US, V56, P22, DOI 10.1007/s11837-004-0121-7; Kang DH, 2009, SCRIPTA MATER, V61, P768, DOI 10.1016/j.scriptamat.2009.06.026; Huang XS, 2014, MAT SCI ENG A-STRUCT, V611, P152, DOI 10.1016/j.msea.2014.05.083; Avedesian M.M., 1999, MAGNESIUM MAGNESIUM, P37; Baghni IM, 2003, T NONFERR METAL SOC, V13, P1253; Bohlen J, 2007, MAT SCI ENG A-STRUCT, V462, P302, DOI 10.1016/j.msea.2006.02.470; Caceres C.H., 2001, J LIGHT METALS, V1, P151, DOI 10.1016/S1471-5317(01)00008-6; Chino Y, 2011, J JPN I MET, V75, P35, DOI 10.2320/jinstmet.75.35; Chino Y, 2008, MATER TRANS, V49, P1710, DOI [10.2320/matertrans.MEP2008136, 10.2320/matertrans.MEP20081361]; Chino Y, 2009, ACTA MATER, V57, P1476, DOI 10.1016/j.actamat.2008.11.033; Chino Y, 2009, SCRIPTA MATER, V60, P447, DOI 10.1016/j.scriptamat.2008.11.029; Chino Y, 2010, MATER TRANS, V51, P818, DOI 10.2320/matertrans.M2009385; Couling S. L., 1959, T ASM, V51, P94; Dobron P, 2007, MAT SCI ENG A-STRUCT, V462, P307, DOI 10.1016/j.msea.2005.12.111; Furui M, 2011, MATER TRANS, V52, P285, DOI 10.2320/matertrans.MB201011; Hirai K, 2007, SCRIPTA MATER, V56, P237, DOI 10.1016/j.scriptamat.2006.09.037; Huang XS, 2012, J MATER SCI, V47, P4561, DOI 10.1007/s10853-012-6314-5; Huang XS, 2013, MAT SCI ENG A-STRUCT, V587, P150, DOI 10.1016/j.msea.2013.08.067; Huang XS, 2015, J ALLOY COMPD, V632, P94, DOI 10.1016/j.jallcom.2015.01.148; Humphreys F.J., 1995, RECYRSTALLIZATION RE, P145; Lunder O., 1993, SAE TECHNICAL PAPER, P117; Luo AA, 2012, SCRIPTA MATER, V66, P491, DOI 10.1016/j.scriptamat.2011.12.025; McDonald JC, 1940, T AM I MIN MET ENG, V137, P430; Song JM, 2006, SCRIPTA MATER, V54, P399, DOI 10.1016/j.scriptamat.2005.10.021; Suzuki K, 2013, MATER TRANS, V54, P392, DOI 10.2320/matertrans.M2012312; Takuda H, 2000, J MATER PROCESS TECH, V101, P281, DOI 10.1016/S0924-0136(00)00484-2; Uesugi T., 2004, J JAPAN I LIGHT META, V54, P82; Zarandi F, 2008, MAT SCI ENG A-STRUCT, V496, P159, DOI 10.1016/j.msea.2008.05.003	52	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0921-5093	1873-4936		MAT SCI ENG A-STRUCT	Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.	MAY 1	2015	633						144	153		10.1016/j.msea.2015.03.018		10	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Science & Technology - Other Topics; Materials Science; Metallurgy & Metallurgical Engineering	CH2HB	WOS:000353845200019		
J	Wakai, N; Sumida, I; Otani, Y; Suzuki, O; Seo, Y; Isohashi, F; Yoshioka, Y; Hasegawa, M; Ogawa, K				Wakai, Nobuhide; Sumida, Iori; Otani, Yuki; Suzuki, Osamu; Seo, Yuji; Isohashi, Fumiaki; Yoshioka, Yasuo; Hasegawa, Masatoshi; Ogawa, Kazuhiko			Optimization of leaf margins for lung stereotactic body radiotherapy using a flattening filter-free beam	MEDICAL PHYSICS			English	Article						stereotactic body radiotherapy; lung cancer; leaf margin; flattening filter-free beam	MV PHOTON BEAMS; RADIATION-THERAPY; LINEAR-ACCELERATOR; DOSIMETRIC FACTORS; CANCER NSCLC; PNEUMONITIS; RADIOSURGERY; VOLUME; DELIVERY; IMMOBILIZATION	Purpose: The authors sought to determine the optimal collimator leaf margins which minimize normal tissue dose while achieving high conformity and to evaluate differences between the use of a flattening filter-free (FFF) beam and a flattening-filtered (FF) beam. Methods: Sixteen lung cancer patients scheduled for stereotactic body radiotherapy underwent treatment planning for a 7 MV FFF and a 6 MV FF beams to the planning target volume (PTV) with a range of leaf margins (-3 to 3 mm). Forty grays per four fractions were prescribed as a PTV D95. For PTV, the heterogeneity index (HI), conformity index, modified gradient index (GI), defined as the 50% isodose volume divided by target volume, maximum dose (Dmax), and mean dose (Dmean) were calculated. Mean lung dose (MLD), V20 Gy, and V5 Gy for the lung (defined as the volumes of lung receiving at least 20 and 5 Gy), mean heart dose, and Dmax to the spinal cord were measured as doses to organs at risk (OARs). Paired t-tests were used for statistical analysis. Results: HI was inversely related to changes in leaf margin. Conformity index and modified GI initially decreased as leaf margin width increased. After reaching a minimum, the two values then increased as leaf margin increased ("V" shape). The optimal leaf margins for conformity index and modified GI were -1.1 +/- 0.3 mm (mean +/- 1 SD) and -0.2 +/- 0.9 mm, respectively, for 7 MV FFF compared to -1.0 +/- 0.4 and -0.3 +/- 0.9 mm, respectively, for 6 MV FF. Dmax and Dmean for 7 MV FFF were higher than those for 6 MV FF by 3.6% and 1.7%, respectively. There was a positive correlation between the ratios of HI, Dmax, and Dmean for 7 MV FFF to those for 6 MV FF and PTV size (R = 0.767, 0.809, and 0.643, respectively). The differences in MLD, V20 Gy, and V5 Gy for lung between FFF and FF beams were negligible. The optimal leaf margins for MLD, V20 Gy, and V5 Gy for lung were -0.9 +/- 0.6, -1.1 +/- 0.8, and -2.1 +/- 1.2 mm, respectively, for 7 MV FFF compared to -0.9 +/- 0.6, -1.1 +/- 0.8, and -2.2 +/- 1.3 mm, respectively, for 6 MV FF. With the heart inside the radiation field, the mean heart dose showed a V-shaped relationship with leaf margins. The optimal leaf margins were -1.0 +/- 0.6 mm for both beams. Dmax to the spinal cord showed no clear trend for changes in leaf margin. Conclusions: The differences in doses to OARs between FFF and FF beams were negligible. Conformity index, modified GI, MLD, lung V20 Gy, lung V5 Gy, and mean heart dose showed a V-shaped relationship with leaf margins. There were no significant differences in optimal leaf margins to minimize these parameters between both FFF and FF beams. The authors' results suggest that a leaf margin of -1 mm achieves high conformity and minimizes doses to OARs for both FFF and FF beams. (C) 2015 American Association of Physicists in Medicine.	[Wakai, Nobuhide; Sumida, Iori; Otani, Yuki; Suzuki, Osamu; Seo, Yuji; Isohashi, Fumiaki; Yoshioka, Yasuo; Ogawa, Kazuhiko] Osaka Univ, Grad Sch Med, Dept Radiat Oncol, Suita, Osaka 5650871, Japan; [Wakai, Nobuhide; Hasegawa, Masatoshi] Nara Med Univ, Dept Radiat Oncol, Kashihara, Nara 6348522, Japan	Wakai, N (reprint author), Osaka Univ, Grad Sch Med, Dept Radiat Oncol, Suita, Osaka 5650871, Japan.	wakai@naramed-u.ac.jp					Benedict SH, 2010, MED PHYS, V37, P4078, DOI 10.1118/1.3438081; Takeda A, 2012, BRIT J RADIOL, V85, P636, DOI 10.1259/bjr/71635286; Onimaru R, 2003, INT J RADIAT ONCOL, V56, P126, DOI 10.1016/S0630-3016(03)00095-6; Murray B, 2007, MED DOSIM, V32, P86, DOI 10.1016/j.meddos.2007.01.005; Graham MV, 1999, INT J RADIAT ONCOL, V45, P323, DOI 10.1016/S0360-3016(99)00183-2; SHAW E, 1993, INT J RADIAT ONCOL, V27, P1231; Guckenberger M, 2010, RADIOTHER ONCOL, V97, P65, DOI 10.1016/j.radonc.2010.04.027; Georg D, 2011, MED PHYS, V38, P1280, DOI 10.1118/1.3554643; Vassiliev ON, 2009, J APPL CLIN MED PHYS, V10, P14, DOI 10.1120/jacmp.v10i1.2880; Nagata Y, 2005, INT J RADIAT ONCOL, V63, P1427, DOI 10.1016/j.ijrobp.2005.05.034; Barriger RB, 2012, INT J RADIAT ONCOL, V82, P457, DOI 10.1016/j.ijrobp.2010.08.056; Siva S, 2014, J MED IMAG RADIAT ON, V58, P244, DOI 10.1111/1754-9485.12112; Xia TY, 2006, INT J RADIAT ONCOL, V66, P117, DOI 10.1016/j.ijrobp.2006.04.013; Hof H, 2007, CANCER, V110, P148, DOI 10.1002/cncr.22763; Claude L, 2004, RADIOTHER ONCOL, V71, P175, DOI 10.1016/j.radonc.2004.02.005; Kyas I, 2007, INT J RADIAT ONCOL, V67, P768, DOI 10.1016/j.ijrobp.2006.08.066; Cardinale RM, 1999, INT J RADIAT ONCOL, V45, P515, DOI 10.1016/S0360-3016(99)00203-5; Ding CX, 2013, MED PHYS, V40, DOI 10.1118/1.4798944; Hong LX, 2011, MED PHYS, V38, P1239, DOI 10.1118/1.3549764; Kim S, 2013, J APPL CLIN MED PHYS, V14, P79, DOI 10.1120/jacmp.v14i5.4283; Liu RG, 2006, INT J RADIAT ONCOL, V66, P906, DOI 10.1016/j.ijrobp.2006.05.014; Mesbahi A, 2007, APPL RADIAT ISOTOPES, V65, P1029, DOI 10.1016/j.apradiso.2007.04.023; Ohtakara K, 2011, J RADIAT RES, V52, P592, DOI 10.1269/jrr.11005; Ricardi U, 2009, ACTA ONCOL, V48, P571, DOI 10.1080/02841860802520821; Stathakis S, 2009, APPL RADIAT ISOTOPES, V67, P1629, DOI 10.1016/j.apradiso.2009.03.014; Tacke MB, 2008, MED PHYS, V35, P1634, DOI 10.1118/1.2889782; Timmerman RD, 2005, SEMIN RADIAT ONCOL, V15, P202, DOI 10.1016/j.semradonc.2005.01.006; Vassiliev ON, 2006, PHYS MED BIOL, V51, P1907, DOI 10.1088/0031-9155/51/7/019	28	0	0	AMER ASSOC PHYSICISTS MEDICINE AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0094-2405			MED PHYS	Med. Phys.	MAY	2015	42	5					2125	2131		10.1118/1.4916683		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CI5ER	WOS:000354776800004		
J	Zhang, XY; Homma, N; Ichiji, K; Takai, Y; Yoshizawa, M				Zhang, Xiaoyong; Homma, Noriyasu; Ichiji, Kei; Takai, Yoshihiro; Yoshizawa, Makoto			Tracking tumor boundary in MV-EPID images without implanted markers: A feasibility study	MEDICAL PHYSICS			English	Article						radiotherapy; markerless; EPID; level set method	LUNG-CANCER RADIOTHERAPY; STEREOTACTIC BODY RADIOTHERAPY; DEEP-INSPIRATION; FIDUCIAL MARKERS; ACTIVE CONTOURS; BREATH-HOLD; RADIATION-THERAPY; MOVING-OBJECTS; MOTION; RESPIRATION	Purpose: To develop a markerless tracking algorithm to track the tumor boundary in megavoltage (MV)-electronic portal imaging device (EPID) images for image-guided radiation therapy. Methods: A level set method (LSM)-based algorithm is developed to track tumor boundary in EPID image sequences. Given an EPID image sequence, an initial curve is manually specified in the first frame. Driven by a region-scalable energy fitting function, the initial curve automatically evolves toward the tumor boundary and stops on the desired boundary while the energy function reaches its minimum. For the subsequent frames, the tracking algorithm updates the initial curve by using the tracking result in the previous frame and reuses the LSM to detect the tumor boundary in the subsequent frame so that the tracking processing can be continued without user intervention. The tracking algorithm is tested on three image datasets, including a 4-D phantom EPID image sequence, four digitally deformable phantom image sequences with different noise levels, and four clinical EPID image sequences acquired in lung cancer treatment. The tracking accuracy is evaluated based on two metrics: centroid localization error (CLE) and volume overlap index (VOI) between the tracking result and the ground truth. Results: For the 4-D phantom image sequence, the CLE is 0.23 +/- 0.20 mm, and VOI is 95.6% +/- 0.2%. For the digital phantom image sequences, the total CLE and VOI are 0.11 +/- 0.08 mm and 96.7% +/- 0.7%, respectively. In addition, for the clinical EPID image sequences, the proposed algorithm achieves 0.32 +/- 0.77 mm in the CLE and 72.1% +/- 5.5% in the VOI. These results demonstrate the effectiveness of the authors' proposed method both in tumor localization and boundary tracking in EPID images. In addition, compared with two existing tracking algorithms, the proposed method achieves a higher accuracy in tumor localization. Conclusions: In this paper, the authors presented a feasibility study of tracking tumor boundary in EPID images by using a LSM-based algorithm. Experimental results conducted on phantom and clinical EPID images demonstrated the effectiveness of the tracking algorithm for visible tumor target. Compared with previous tracking methods, the authors' algorithm has the potential to improve the tracking accuracy in radiation therapy. In addition, real-time tumor boundary information within the irradiation field will be potentially useful for further applications, such as adaptive beam delivery, dose evaluation. (C) 2015 American Association of Physicists in Medicine.	[Zhang, Xiaoyong; Homma, Noriyasu] Tohoku Univ, Grad Sch Med, Dept Radiol Imaging & Informat, Sendai, Miyagi 9808579, Japan; [Ichiji, Kei] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi 9808579, Japan; [Takai, Yoshihiro] Hirosaki Univ, Grad Sch Med, Dept Radiol & Radiat Oncol, Hirosaki, Aomori 0368562, Japan; [Yoshizawa, Makoto] Tohoku Univ, Cybersci Ctr, Res Div Adv Informat Technol, Sendai, Miyagi 9808579, Japan	Zhang, XY (reprint author), Tohoku Univ, Grad Sch Med, Dept Radiol Imaging & Informat, Sendai, Miyagi 9808579, Japan.	xiaoyong@ieee.org; homma@ieee.org; ichiji@yoshizawa.ecei.tohoku.ac.jp; y-takai@cc.hirosaki-u.ac.jp; yoshizawa@yoshizawa.ecei.tohoku.ac.jp			JSPS KAKENHI [25293258]; Kayamori Foundation of Information Science Advancement [K24-XVII-389]	This work was supported by JSPS KAKENHI Grant No. 25293258 and Kayamori Foundation of Information Science Advancement No. K24-XVII-389.	Li CM, 2008, IEEE T IMAGE PROCESS, V17, P1940, DOI 10.1109/TIP.2008.2002304; MALLADI R, 1995, IEEE T PATTERN ANAL, V17, P158, DOI 10.1109/34.368173; Lewis JH, 2010, PHYS MED BIOL, V55, P2505, DOI 10.1088/0031-9155/55/9/006; Shirato H, 2003, INT J RADIAT ONCOL, V56, P240, DOI 10.1016/S0360-3016(03)00076-2; CASELLES V, 1993, NUMER MATH, V66, P1, DOI 10.1007/BF01385685; Berbeco RI, 2007, INT J RADIAT ONCOL, V69, P258, DOI 10.1016/j.ijrobp.2007.04.051; Stevens CW, 2001, INT J RADIAT ONCOL, V51, P62, DOI 10.1016/S0360-3016(01)01621-2; Harada T, 2002, CANCER, V95, P1720, DOI 10.1002/cncr.10856; Sawant A, 2008, MED PHYS, V35, P2050, DOI 10.1118/1.2905355; Keall PJ, 2001, PHYS MED BIOL, V46, P1, DOI 10.1088/0031-9155/46/1/301; Vedam SS, 2003, MED PHYS, V30, P505, DOI 10.1118/1.1558675; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Li RJ, 2010, MED PHYS, V37, P2822, DOI 10.1118/1.3426002; Berbeco RI, 2006, MED PHYS, V33, P4149, DOI 10.1118/1.2358197; Kothary N, 2009, J VASC INTERV RADIOL, V20, P235, DOI 10.1016/j.jvir.2008.09.026; Cui Y, 2007, PHYS MED BIOL, V52, P6229, DOI 10.1088/0031-9155/52/20/010; Remouchamps VM, 2003, INT J RADIAT ONCOL, V56, P704, DOI 10.1016/S0360-3016(03)00010-5; Mah D, 2000, INT J RADIAT ONCOL, V48, P1175, DOI 10.1016/S0360-3016(00)00747-1; Keall PJ, 2004, MED PHYS, V31, P3492, DOI 10.1118/1.1812608; Kubo HD, 1996, PHYS MED BIOL, V41, P83, DOI 10.1088/0031-9155/41/1/007; Bert C, 2005, MED PHYS, V32, P2753, DOI 10.1118/1.1984263; Li CM, 2010, IEEE T IMAGE PROCESS, V19, P3243, DOI 10.1109/TIP.2010.2069690; Hoisak JDP, 2004, INT J RADIAT ONCOL, V60, P1298, DOI 10.1016/j.ijrobp.2004.07.681; Li RJ, 2011, MED PHYS, V38, P2783, DOI 10.1118/1.3582693; Cui Y, 2007, PHYS MED BIOL, V52, P741, DOI 10.1088/0031-9155/52/3/015; Barnes EIA, 2001, INT J RADIAT ONCOL, V50, P1091, DOI 10.1016/S0360-3016(01)01592-9; OSHER S, 1988, J COMPUT PHYS, V79, P12, DOI 10.1016/0021-9991(88)90002-2; Keall PJ, 2006, MED PHYS, V33, P3874, DOI 10.1118/1.2349696; Seppenwoolde Y, 2002, INT J RADIAT ONCOL, V53, P822, DOI 10.1016/S0360-3016(02)02803-1; Lin T, 2009, PHYS MED BIOL, V54, P1555, DOI 10.1088/0031-9155/54/6/010; Arimura H, 2009, PHYS MED BIOL, V54, P665, DOI 10.1088/0031-9155/54/3/013; Berbeco RI, 2005, PHYS MED BIOL, V50, P4481, DOI 10.1088/0031-9155/50/19/004; Bryant JH, 2014, MED PHYS, V41, DOI 10.1118/1.4900603; ICRU, 1994, 50 ICRU; International Commission on Radiation Units and Measurements - ICRU, 1999, 50 ICRU; Li RJ, 2009, PHYS MED BIOL, V54, pN489, DOI 10.1088/0031-9155/54/20/N03; Meyer J, 2006, MED PHYS, V33, P1275, DOI 10.1118/1.2191009; Paragios N, 2000, IEEE T PATTERN ANAL, V22, P266, DOI 10.1109/34.841758; Richter A, 2010, INT J RADIAT ONCOL, V78, P618, DOI 10.1016/j.ijrobp.2009.11.028; Rottmann J, 2013, PHYS MED BIOL, V58, P4195, DOI 10.1088/0031-9155/58/12/4195; Rottmann J, 2013, MED PHYS, V40, DOI 10.1118/1.4818655; Rottmann J, 2010, PHYS MED BIOL, V55, P5585, DOI 10.1088/0031-9155/55/18/021; Tacke M, 2007, PHYS MED BIOL, V52, pN505, DOI 10.1088/0031-9155/52/22/N01; Xie YQ, 2013, PHYS MED BIOL, V58, P3615, DOI 10.1088/0031-9155/58/11/3615; Zhang XY, 2014, PHYS MED BIOL, V59, P4897, DOI 10.1088/0031-9155/59/17/4897	45	0	0	AMER ASSOC PHYSICISTS MEDICINE AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0094-2405			MED PHYS	Med. Phys.	MAY	2015	42	5					2510	2523		10.1118/1.4918578		14	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CI5ER	WOS:000354776800041		
J	Depeursinge, A; Yanagawa, M; Leung, AN; Rubin, DL				Depeursinge, Adrien; Yanagawa, Masahiro; Leung, Ann N.; Rubin, Daniel L.			Predicting adenocarcinoma recurrence using computational texture models of nodule components in lung CT (vol 42, pg 2054, 2015)	MEDICAL PHYSICS			English	Correction									[Depeursinge, Adrien; Yanagawa, Masahiro; Leung, Ann N.; Rubin, Daniel L.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; [Depeursinge, Adrien] Univ Appl Sci Western Switzerland HES SO, Business Informat Syst, CH-3960 Sierre, Switzerland; [Yanagawa, Masahiro] Osaka Univ, Grad Sch Med, Dept Radiol, Suita, Osaka 5650871, Japan	Depeursinge, A (reprint author), Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA.	adrien.depeursinge@hevs.ch					Depeursinge A, 2015, MED PHYS, V42, P2054, DOI 10.1118/1.4916088	1	0	0	AMER ASSOC PHYSICISTS MEDICINE AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0094-2405			MED PHYS	Med. Phys.	MAY	2015	42	5					2653	2653		10.1118/1.4918920		1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CI5ER	WOS:000354776800055		
J	Goto, A; Noda, M; Matsushita, Y; Goto, M; Kato, M; Isogawa, A; Takahashi, Y; Kurotani, K; Oba, S; Nanri, A; Mizoue, T; Yamagishi, K; Yatsuya, H; Saito, I; Kokubo, Y; Sawada, N; Inoue, M; Iso, H; Kadowaki, T; Tsugane, S				Goto, Atsushi; Noda, Mitsuhiko; Matsushita, Yumi; Goto, Maki; Kato, Masayuki; Isogawa, Akihiro; Takahashi, Yoshihiko; Kurotani, Kayo; Oba, Shino; Nanri, Akiko; Mizoue, Tetsuya; Yamagishi, Kazumasa; Yatsuya, Hiroshi; Saito, Isao; Kokubo, Yoshihiro; Sawada, Norie; Inoue, Manami; Iso, Hiroyasu; Kadowaki, Takashi; Tsugane, Shoichiro		JPHC Study Grp	Hemoglobin A(1c) Levels and the Risk of Cardiovascular Disease in People Without Known Diabetes A Population-Based Cohort Study in Japan	MEDICINE			English	Article							CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; GLYCATED HEMOGLOBIN; NONDIABETIC ADULTS; HBA(1C); ASSOCIATION; STROKE; JPHC; A1C; COMPLICATIONS	High hemoglobin A(1c) (HbA(1c)) levels are strongly associated with an increased risk of cardiovascular disease (CVD) in people with and without diabetes. However, information regarding the relationship between low HbA(1c) levels and the risk of CVD among people without known diabetes is limited. The aim of this large-scale, prospective, population-based cohort study was to clarify the association between HbA(1c) levels and CVD risk among people without known diabetes. We followed-up 10,980 men and 18,079 women (46-80 years old and free of CVD and cancer at baseline) in the Japan Public Health Center-based Prospective Study. Using Cox models, we estimated the hazard ratios for CVD risk with adjustments for age, sex, geographic areas, body mass index, smoking status, sports and physical exercise, alcohol intake, systolic blood pressure, non-high-density lipoprotein cholesterol, and high-density lipoprotein cholesterol. During the median follow-up of 9.4 years, 935 CVD events (770 strokes and 165 coronary heart diseases) occurred. We observed a nonlinear association between HbA(1c) levels and CVD risk in participants without known diabetes. Compared with HbA(1c) levels of 5.0 to 5.4% (31-36 mmol/mol), the hazard ratios for CVD in participants without known diabetes were 1.50 (95% confidence interval: 1.151.95), 1.01 (0.85-1.20), 1.04 (0.82-1.32), and 1.77 (1.32-2.38) for HbA(1c) levels of < 5.0% (< 31 mmol/mol), 5.5 to 5.9% (37-41 mmol/mol), 6.0 to 6.4% (42-47 mmol/mol), and >= 6.5% (>= 48 mmol/mol), respectively (P value for nonlinear trend: < 0.001). In addition, the hazard ratio for CVD was 1.81 (1.43-2.29) in patients with known diabetes compared with participants with HbA(1c) levels of 5.0 to 5.4% and without known diabetes. This nonlinear relation persisted after excluding people with kidney dysfunction, liver dysfunction, anemia, body mass index <18.5 kg/m(2), or early events within 3 years of followup (P value for nonlinear trend: < 0.01 for all tests). In conclusion, both low and high levels of HbA(1c) were associated with a higher risk of CVD in a Japanese general population without known diabetes.	[Goto, Atsushi; Noda, Mitsuhiko; Goto, Maki; Kato, Masayuki] Natl Ctr Global Hlth & Med, Dept Diabet Res, Diabet Res Ctr, Tokyo 1628655, Japan; [Goto, Atsushi] Tokyo Womens Med Univ, Dept Publ Hlth, Tokyo, Japan; [Matsushita, Yumi] Natl Ctr Global Hlth & Med, Dept Clin Res, Tokyo 1628655, Japan; [Kurotani, Kayo; Nanri, Akiko; Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Dept Epidemiol & Prevent, Tokyo 1628655, Japan; [Isogawa, Akihiro] Mitsui Mem Hosp, Dept Internal Med, Tokyo 101, Japan; [Takahashi, Yoshihiko] Iwate Med Univ, Sch Med, Div Diabet & Metab, Morioka, Iwate, Japan; [Oba, Shino] Natl Inst Publ Hlth, Dept Hlth Promot, Saitama, Japan; [Yamagishi, Kazumasa] Univ Tsukuba, Dept Publ Hlth Med, Fac Med, Ibaraki, Japan; [Yatsuya, Hiroshi] Fujita Hlth Univ, Dept Publ Hlth, Toyoake, Aichi, Japan; [Saito, Isao] Ehime Univ, Dept Basic Nursing & Hlth Sci, Grad Sch Med, Matsuyama, Ehime 790, Japan; [Kokubo, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Osaka, Japan; [Sawada, Norie; Tsugane, Shoichiro] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Grp, Tokyo 104, Japan; [Inoue, Manami] Univ Tokyo, Grad Sch Med, AXA Dept Hlth & Human Secur, Tokyo, Japan; [Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Diabet & Metab Dis, Tokyo, Japan; [Iso, Hiroyasu] Osaka Univ, Grad Sch Med, Publ Hlth, Dept Social & Environm Med, Osaka, Japan	Noda, M (reprint author), Natl Ctr Global Hlth & Med, Dept Diabet Res, Diabet Res Ctr, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	mnoda@hosp.ncgm.go.jp			Boehringer Ingelheim; Astra Zeneca K.K.; Mitsubishi-Tanabe Pharma Corp.; Kowa Pharmaceutical Co. Ltd.; Sanwa Kagaku Kenkyusho Co. Ltd.; Kyowa Hakko Kirin Co.; Sanofi K.K.; Mitsubishi Tanabe Pharma Corp.; Daiichi Sankyo company; Eli Lilly Japan K.K.; MSD K.K.; Novo Nordisk Pharma Ltd.; Kissei Pharmaceutical Co. Ltd.; Ono Pharmaceutical Co. Ltd.; Takeda Pharmaceutical Co. Ltd.; Astellas Pharma Inc.; Taisho Toyama Pharmaceutical Co. Ltd.; Meiji Seika Pharma Co. Ltd.; Kyowa Hakko Kirin Co. Ltd.; Merck/MSD; Takeda Pharmaceutical Company Limited; Hiroshima Prefectural Medical Association; AXA Research Fund; AXA Department of Health and Human Security, Graduate School of Medicine, The University of Tokyo	AG has received a lecture fee from Boehringer Ingelheim, outside of the submitted work. MN received grants from Astra Zeneca K.K., Mitsubishi-Tanabe Pharma Corp., Kowa Pharmaceutical Co. Ltd., Sanwa Kagaku Kenkyusho Co. Ltd., and Kyowa Hakko Kirin Co. Ltd. as well as lecture fees from Sanofi K.K., Mitsubishi Tanabe Pharma Corp., Daiichi Sankyo company, Eli Lilly Japan K.K., MSD K.K., Novo Nordisk Pharma Ltd., Kissei Pharmaceutical Co. Ltd., Ono Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Astellas Pharma Inc., Kowa Pharmaceutical Co. Ltd., Taisho Toyama Pharmaceutical Co. Ltd., Meiji Seika Pharma Co. Ltd., and Kyowa Hakko Kirin Co. Ltd., outside of the submitted work. HY has received lecture fees from Merck/MSD, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim, and Hiroshima Prefectural Medical Association, outside of the submitted work. MI is the beneficiary of a financial contribution from the AXA Research Fund as a chair holder on the AXA Department of Health and Human Security, Graduate School of Medicine, The University of Tokyo. The AXA Research Fund had no role in the study design, data collection, data analysis, data interpretation, writing of the report, or decision to publish the results. All other authors declare that they do not have any potential conflicts of interest to disclose.	Aggarwal V, 2012, DIABETES CARE, V35, P2055, DOI 10.2337/dc11-2531; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Kim AS, 2011, CIRCULATION, V124, P314, DOI 10.1161/CIRCULATIONAHA.111.018820; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Sakurai M, 2013, DIABETES CARE, V36, P3759, DOI 10.2337/dc12-2412; Nichols GA, 2013, J AM COLL CARDIOL, V62, P121, DOI 10.1016/j.jacc.2013.04.031; Khaw KT, 2004, ANN INTERN MED, V141, P413; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ford ES, 2010, J AM COLL CARDIOL, V55, P1310, DOI 10.1016/j.jacc.2009.10.060; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Stratton IM, 2000, BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Di Angelantonio E, 2014, JAMA-J AM MED ASSOC, V311, P1225, DOI 10.1001/jama.2014.1873; Zoungas S, 2012, DIABETOLOGIA, V55, P636, DOI 10.1007/s00125-011-2404-1; Sarwar N, 2010, LANCET, V375, P2215; Yamagishi K, 2013, EUR HEART J, V34, P1225, DOI 10.1093/eurheartj/eht043; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Carson AP, 2010, CIRC-CARDIOVASC QUAL, V3, P661, DOI 10.1161/CIRCOUTCOMES.110.957936; Santulli G, 2012, JAMA-J AM MED ASSOC, V307, P1137, DOI 10.1001/jama.2012.323; Christman AL, 2011, DIABETES CARE, V34, P2548, DOI 10.2337/dc11-0944; GBD 2013 Mortality and Causes of Death Collaborators, 2014, LANCET, V385, P117; Goto A, 2013, BMJ-BRIT MED J, V29, P347; Greenland S, 2008, MODERN EPIDEMIOLOGY, P652; Ikeda F, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-164; Lee M, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3564; Nishimura R, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-58; Noda M, 2010, ENDOCR J, V57, P629; Rutter MK, 2012, DIABETOLOGIA, V55, P2307, DOI 10.1007/s00125-012-2620-3; Saito I, 2011, ATHEROSCLEROSIS, V216, P187, DOI 10.1016/j.atherosclerosis.2011.01.021; Santulli G, 2013, JCVD, V1, P1; Santulli G, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001081; Tsugane S, 2014, JPN J CLIN ONCOL, V44, P777, DOI 10.1093/jjco/hyu096; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583; Walker A, 1981, STROKE S1, V12, P113; Watanabe S, 2001, J Epidemiol, V11, pS3	35	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	MAY	2015	94	17							e785	10.1097/MD.0000000000000785		10	Medicine, General & Internal	General & Internal Medicine	CH1RO	WOS:000353799300032		
J	Kobayashi, H; Kotake, K; Sugihara, K				Kobayashi, Hirotoshi; Kotake, Kenjiro; Sugihara, Kenichi		Japanese Soc Canc Colon Rectum	Impact of Adjuvant Chemotherapy in Patients With Curatively Resected Stage IV Colorectal Cancer	MEDICINE			English	Article							LIVER METASTASES; COLON-CANCER; RANDOMIZED-TRIAL; FOLINIC ACID; FLUOROURACIL; OXALIPLATIN; LEUCOVORIN; SURGERY; INFUSION; BENEFIT	The aim of this study was to investigate the impact of adjuvant chemotherapy on survival of patients who had curative resection for stage IV colorectal cancer. The efficacy of adjuvant chemotherapy after curative resection for stage IV colorectal cancer remains unclear. The database of 3695 patients with stage IV colorectal cancer between 1991 and 2007 collected from 16 member hospitals of the Japanese Society for Cancer of the Colon and Rectum was used for this investigation. The survivals of patients with and without adjuvant chemotherapy after curative resection for stage IV colorectal cancer were evaluated using a propensity score matching method. The data of 689 patients who underwent curative resection for both primary and synchronous metastatic tumors were extracted from the database and used for analysis in this study. The 5- year overall survival rates of the patients with and without adjuvant chemotherapy were 41.8% and 33.9%, respectively. A Cox proportional hazards model showed that adjuvant chemotherapy (P = 0.0042), regional lymph node metastasis (P < 0.0001), and peritoneal metastasis (P = 0.0006) were independent factors for overall survival. In the propensity scorematched cohort, patients with adjuvant chemotherapy had better overall survival than those without (P = 0.026). The present study demonstrated that adjuvant chemotherapy improved overall survival after curative resection for stage IV colorectal cancer. The efficacy of each chemotherapeutic regimen in the adjuvant setting for stage IV colorectal cancer should be clarified in the future.	[Kobayashi, Hirotoshi] Tokyo Med & Dent Univ, Ctr Minimally Invas Surg, Bunkyo Ku, Tokyo 1138519, Japan; [Kobayashi, Hirotoshi; Sugihara, Kenichi] Tokyo Med & Dent Univ, Dept Surg Oncol, Bunkyo Ku, Tokyo 1138519, Japan; [Kotake, Kenjiro] Tochigi Canc Ctr, Dept Surg, Utsunomiya, Tochigi, Japan	Kobayashi, H (reprint author), Tokyo Med & Dent Univ, Ctr Minimally Invas Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	h-kobayashi.srg2@tmd.ac.jp					AJCC, 2010, CANC STAGING MANUAL; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Mitry E, 2008, J CLIN ONCOL, V26, P4906, DOI 10.1200/JCO.2008.17.3781; Kotake K, 2003, DIS COLON RECTUM, V46, pS32, DOI 10.1097/01.DCR.0000083389.92214.AA; Kanemitsu Y, 2009, JPN J CLIN ONCOL, V39, P406, DOI 10.1093/jjco/hyp035; Kemeny MM, 2002, J CLIN ONCOL, V20, P1499, DOI 10.1200/JCO.20.6.1499; Perkins SM, 2000, PHARMACOEPIDEM DR S, V9, P93, DOI 10.1002/(SICI)1099-1557(200003/04)9:2&lt;93::AID-PDS474&gt;3.0.CO;2-I; Portier G, 2006, J CLIN ONCOL, V24, P4976, DOI 10.1200/JCO.2006.06.8353; Kobayashi H, 2013, INT J CLIN ONCOL, V18, P696, DOI 10.1007/s10147-012-0433-5; Kobayashi H, 2014, J GASTROENTEROL, V49, P646, DOI 10.1007/s00535-013-0820-3; [Anonymous], 2014, NCCN GUID VERSION3 2; WOLMARK N, 1993, J CLIN ONCOL, V11, P1879; Van Cutsem E, 2010, ANN ONCOL, V21, pv93, DOI 10.1093/annonc/mdq222; Lorenz M, 1998, ANN SURG, V228, P756, DOI 10.1097/00000658-199812000-00006; Hsu HC, 2013, ANTICANCER RES, V33, P3317; Moertel CG, 1990, NEW ENGL J MED, V322, P348; Muto Tetsuichiro, 2001, International Journal of Clinical Oncology, V6, P171, DOI 10.1007/PL00012102; Nozawa H, 2011, ONCOLOGY-BASEL, V80, P84, DOI 10.1159/000328761	19	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	MAY	2015	94	17							e696	10.1097/MD.0000000000000696		6	Medicine, General & Internal	General & Internal Medicine	CH1RO	WOS:000353799300006		
J	Manabe, N; Shimizu, T; Tanouchi, T; Fueki, K; Ino, M; Toda, N; Itoh, K; Shirakura, K				Manabe, Nodoka; Shimizu, Takachika; Tanouchi, Tetsu; Fueki, Keisuke; Ino, Masatake; Toda, Naofumi; Itoh, Kanako; Shirakura, Kenji			A Novel Skull Clamp Positioning System and Technique for Posterior Cervical Surgery Clinical Impact on Cervical Sagittal Alignment	MEDICINE			English	Article							TRANSARTICULAR SCREW FIXATION; SPINE; FUSION	A prospective radiographic study. The purpose of this study was to analyze whether a novel skull clamp positioning systemand technique is useful for obtaining good, quantitative cervical sagittal alignment during posterior cervical surgery. Different surgical procedures depend on cervical spine positioning. However, maneuver of the device and cervical position depends on the skill of the operator. This study included 21 male and 10 female patients with cervical spondylotic myelopathy and ossification of the posterior longitudinal ligament of the cervical spine, undergoing posterior cervical surgery using the novel skull clamppositioning system. The average patient agewas 68.6 years (range: 56-87 years). The novel systemhas a scale to adjust the neck positionandtoenableintendedcervical sagittalalignment. First, thepatient was placed on the operating table in the prone position with preplanned head-neck sagittal alignment (neutral position in general). The head was rotated sagittally, and the head was positioned in the military tuck position with the novel device that was used towiden the interlaminar space. After completing the decompression procedure, the head was rotated again back to the initial preplanned position. During this position change, the scale equippedwith the devicewas useful indeterminingaccurate positions. The C0-C1, C0-C2, C1-C2, C2-C7, andC0-C7 anglesweremeasuredonlateral radiographs taken pre-, intra-, and postoperatively. This novel system allowed us to obtain adequate, quantitative cervical sagittal alignment during posterior cervical surgery. There were no clinically significant differences observed between the pre-and postoperative angles for C1-C2 and C2-C7. Sagittal neck position was quantitatively changed during posterior cervical surgery using a novel skull clamp positioning system, enabling adequate final cervical sagittal alignment identical to the preplanned neck position.	[Manabe, Nodoka; Shimizu, Takachika; Tanouchi, Tetsu; Fueki, Keisuke; Ino, Masatake; Toda, Naofumi; Itoh, Kanako] Harunaso Hosp, Dept Orthopaed Surg, Gunma Spine Ctr, Takasaki, Gunma 3700871, Japan; [Shirakura, Kenji] Gunma Univ, Grad Sch Med, Dept Rehabil Med, Maebashi, Gunma 371, Japan	Manabe, N (reprint author), Harunaso Hosp, Dept Orthopaed Surg, Gunma Spine Ctr, 828-1 Kamitoyooka, Takasaki, Gunma 3700871, Japan.	nodokamanabe0817@me.com			Gunma Spine Center (Harunaso Hospital)	This study was supported by Gunma Spine Center (Harunaso Hospital).	Gluf WM, 2005, J NEUROSURG-SPINE, V2, P155, DOI 10.3171/spi.2005.2.2.0155; Haid RW, 2001, NEUROSURGERY, V49, P71, DOI 10.1097/00006123-200107000-00011; Iizuka H, 2001, SPINE, V26, P2220, DOI 10.1097/00007632-200110150-00013; Yoshida M, 2007, SPINE, V32, pE267, DOI 10.1097/01.brs.0000259977.69726.6f; Rao R, 2002, J BONE JOINT SURG AM, V84A, P1872; CHEN IH, 1994, J SPINAL DISORD, V7, P93; Ataka H, 2010, SPINE, V35, P971; CALLAHAN RA, 1981, CLIN ORTHOP RELAT R, P22; Chen CJ, 2003, RADIOLOGY, V227, P136, DOI 10.1148/radiol.2271020116; Fueki K, 2007, JSSR, V18, P368; KYOSHIMA K, 1987, NEUROSURGERY, V21, P591; Mesfin A, 2011, ORTHOPEDICS, V34, P597, DOI 10.3928/01477447-20110627-19; Ota M, 2011, SPINE, V36, P720; Shimizu T., 1991, OS NOW, V4, P168	14	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	MAY	2015	94	17							e695	10.1097/MD.0000000000000695		7	Medicine, General & Internal	General & Internal Medicine	CH1RO	WOS:000353799300005		
J	Terahara, K; Ishige, M; Ikeno, S; Okada, S; Kobayashi-Ishihara, M; Ato, M; Tsunetsugu-Yokota, Y				Terahara, Kazutaka; Ishige, Masayuki; Ikeno, Shota; Okada, Seiji; Kobayashi-Ishihara, Mie; Ato, Manabu; Tsunetsugu-Yokota, Yasuko			Humanized mice dually challenged with R5 and X4 HIV-1 show preferential R5 viremia and restricted X4 infection of CCR5(+)CD4(+) T cells	MICROBES AND INFECTION			English	Article						HIV; Humanized mice; CD4(+) T cells; CCR5	HUMAN-IMMUNODEFICIENCY-VIRUS; SYNCYTIUM-INDUCING PHENOTYPE; TYPE-1 INFECTION; SELECTIVE TRANSMISSION; BIOLOGICAL PHENOTYPE; DISEASE PROGRESSION; CORECEPTOR USAGE; RT-PCR; CCR5; CD4(+)	CCR5-tropic (R5) immunodeficiency virus type 1 (HIV-1) strains are highly transmissible during the early stage of infection in humans, whereas CXCR4-tropic (X4) strains are less transmissible. This study aimed to explore the basis for early phase R5 and X4 HIV-1 infection in vivo by using humanized mice dually challenged with R5 HIV-1(NLAD8-D) harboring DsRed and X4 HIV-1(NL-E) harboring EGFP. Whereas R5 HIV-1 replicated well, X4 HIV-1 caused only transient viremia with variable kinetics; however, this was distinct from the low level but persistent viremia observed in mice challenged with X4 HIV-1 alone. Flow cytometric analysis of HIV-1-infected cells revealed that X4 HIV-1 infection of CCR5(+)CD4(+) T cells was significantly suppressed in the presence of R5 HIV-1. X4 HIV-1 was more cytopathic than R5 HIV-1; however, this was not the cause of restricted X4 HIV-1 infection because there were no significant differences in the mortality rates of CCR5(+) and CCR5(-) cells within the X4 HIV-1-infected cell populations. Taken together, these results suggest that restricted infection of CCR5(+)CD4(+) T cells by X4 (occurring via a still-to-be-identified mechanism) might contribute to the preferential transmission of R5 HIV-1 during the early phase of infection. (C) 2015 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.	[Terahara, Kazutaka; Ishige, Masayuki; Ikeno, Shota; Kobayashi-Ishihara, Mie; Ato, Manabu; Tsunetsugu-Yokota, Yasuko] Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, Tokyo 1628640, Japan; [Ishige, Masayuki; Okada, Seiji] Kumamoto Univ, Ctr AIDS Res, Div Hematopoiesis, Kumamoto 8600811, Japan; [Ikeno, Shota] Tokyo Univ Agr & Technol, Waseda Univ Grad Sch Collaborat Educ Curriculum, Cooperat Major Adv Hlth Sci, Shinjuku Ku, Tokyo 1698555, Japan; [Kobayashi-Ishihara, Mie] Japan Fdn AIDS Prevent, Chiyoda Ku, Tokyo 1010061, Japan; [Tsunetsugu-Yokota, Yasuko] Tokyo Univ Technol, Sch Human Sci, Dept Med Technol, Ota Ku, Tokyo 1448535, Japan	Tsunetsugu-Yokota, Y (reprint author), Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	yyokota@nih.go.jp			Ministry of Education, Science, Sports and Culture of Japan; Ministry of Health, Labor and Welfare of Japan; Japan Foundation for AIDS Prevention	We thank Kaori Okano for technical support. This work was supported by Grants from the Ministry of Education, Science, Sports and Culture of Japan (KT), and the Ministry of Health, Labor and Welfare of Japan (YT-Y). MK-I received a research fellowship from the Japan Foundation for AIDS Prevention.	ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453; [Anonymous], 2010, J TRANSL MED, DOI DOI 10.1186/1479-5876-9-S1-S6; WOLINSKY SM, 1992, SCIENCE, V255, P1134, DOI 10.1126/science.1546316; Grivel JC, 1999, NAT MED, V5, P344; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; KOOT M, 1993, ANN INTERN MED, V118, P681; Keele BF, 2009, CURR OPIN HIV AIDS, V4, P352, DOI 10.1097/COH.0b013e32832d9fef; Sato K, 2011, EXP BIOL MED, V236, P977, DOI 10.1258/ebm.2011.010294; Thakor D, 2007, MOL THER, V15, P2124, DOI 10.1038/sj.mt.6300256; Picker LJ, 2006, CURR OPIN IMMUNOL, V18, P399, DOI 10.1016/j.coi.2006.05.001; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Okada S, 2008, INT J HEMATOL, V88, P476, DOI 10.1007/s12185-008-0215-z; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; RICHMAN DD, 1994, J INFECT DIS, V169, P968; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; CORNELISSEN M, 1995, J VIROL, V69, P1810; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Hoffmann B, 2006, J VIROL METHODS, V136, P200, DOI 10.1016/j.jviromet.2006.05.020; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; Goodenow MM, 2006, J LEUKOCYTE BIOL, V80, P965, DOI 10.1189/jlb.0306148; SCHUITEMAKER H, 1992, J VIROL, V66, P1354; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Berges BK, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-65; Cotton MF, 1997, PEDIATR RES, V42, P656, DOI 10.1203/00006450-199711000-00018; Cummins NW, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.77; Fevrier M, 2011, VIRUSES-BASEL, V3, P586, DOI 10.3390/v3050586; Harouse JM, 2003, P NATL ACAD SCI USA, V100, P10977, DOI 10.1073/pnas.1933268100; Ikeno S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00298; Yamamoto T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000279; PRATT RD, 1995, J INFECT DIS, V172, P851; ROOS MTL, 1992, J INFECT DIS, V165, P427; Roy AM, 2005, JAIDS-J ACQ IMM DEF, V40, P267, DOI 10.1097/01.qai.0000176593.14172.52; Sato Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013109; Schweighardt B, 2004, J VIROL, V78, P9164, DOI 10.1128/JVI.78.17.9164-9173.2004; Shimizu N, 1999, VIROLOGY, V259, P324, DOI 10.1006/viro.1999.9764; Terahara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053495; TSUNETSUGUYOKOTA Y, 1995, J VIROL, V69, P4544; VANTWOUT AB, 1994, J CLIN INVEST, V94, P2060, DOI 10.1172/JCI117560; Verrier F, 1999, AIDS RES HUM RETROV, V15, P731, DOI 10.1089/088922299310827; Wolinsky SM, 2004, VIROLOGY, V328, P19, DOI 10.1016/j.virol.2004.07.021; Zhou Y, 2008, J VIROL, V82, P9154, DOI 10.1128/JVI.00773-08	45	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1286-4579	1769-714X		MICROBES INFECT	Microbes Infect.	MAY	2015	17	5					378	386		10.1016/j.micinf.2015.02.002		9	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CI8QU	WOS:000355037600008		
J	Abe, H; Kamitani, S; Fukui-Miyazaki, A; Shinzawa, N; Nakamura, K; Horiguchi, Y				Abe, Hiroyuki; Kamitani, Shigeki; Fukui-Miyazaki, Aya; Shinzawa, Naoaki; Nakamura, Keiji; Horiguchi, Yasuhiko			Detection of genes expressed in Bordetella bronchiseptica colonizing rat trachea by in vivo expressed-tag immunoprecipitation method	MICROBIOLOGY AND IMMUNOLOGY			English	Article						Bordetella pathogenesis; gene regulation; in vivo induced gene	ADENYLATE-CYCLASE TOXIN; III SECRETION SYSTEM; RESPIRATORY-INFECTION; BACTERIAL GENES; PERTUSSIS; HOST; CONSTRUCTION; SELECTION; REGULON; VECTOR	Analyses of bacterial genes expressed in response to the host environment provide clues to understanding the host-pathogen interactions that lead to the establishment of infection. In this study, a novel method named In Vivo Expressed-Tag ImmunoPrecipitation (IVET-PI) was developed for detecting genes expressed in bacteria that are recovered in a small numbers from host tissues. IVET-IP was designed to overcome some drawbacks of previous similar methods. We applied IVET-IP to Bordetella bronchiseptica colonizing rat trachea and identified 173 genes that were expressed in the bacteria over the entire course of an infection. These gene products included two transcriptional factors that are involved in the expression of filamentous hemagglutinin, adenylate cyclase toxin, and major virulence factors for the bordetellae. We consider that this method might provide novel insight into the course of Bordetella infection.	[Abe, Hiroyuki; Kamitani, Shigeki; Fukui-Miyazaki, Aya; Shinzawa, Naoaki; Nakamura, Keiji; Horiguchi, Yasuhiko] Osaka Univ, Dept Mol Bacteriol, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Kamitani, Shigeki] Osaka Prefecture Univ, Grad Sch Comprehens Rehabil, Habikino, Osaka 5838555, Japan	Abe, H (reprint author), Osaka Univ, Dept Mol Bacteriol, Microbial Dis Res Inst, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	hirop@biken.osaka-u.ac.jp			Japan Society for the Promotion of Science	We thank A. Ullmann (Institut Pasteur, Paris, France), M. E. Kovach (Baldwin Wallace College, Berea, OH, USA), A. Abe (Kitasato University, Tokyo, Japan), K. Minamisawa (Tohoku University, Sendai, Japan) and P. A. Cotter (University of North Carolina, Chapel Hill, NC, USA) for providing pCACT3, pBBR1MCS-5, pABB-CRS2, pRK2013 and B. bronchiseptica RB50, respectively. We also thank Dr. K. Saito (Research Institute for Microbial Diseases, Osaka University, Osaka, Japan) for technical assistance with peptide mass fingerprinting. This work was supported by Grants-in-Aid for Scientific Research (B), for Scientific Research (C) and for Challenging Exploratory Research from the Japan Society for the Promotion of Science.	AKERLEY BJ, 1995, CELL, V80, P611, DOI 10.1016/0092-8674(95)90515-4; Valdivia RH, 1997, SCIENCE, V277, P2007, DOI 10.1126/science.277.5334.2007; Brickman TJ, 2011, J BACTERIOL, V193, P4798, DOI 10.1128/JB.05136-11; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; de Tejada GM, 1998, INFECT IMMUN, V66, P2762; STAINER DW, 1970, J GEN MICROBIOL, V63, P211; Cotter PA, 2003, TRENDS MICROBIOL, V11, P367, DOI 10.1016/S0966-842X(03)00156-2; Vojtova J, 2006, CURR OPIN MICROBIOL, V9, P69, DOI 10.1016/j.mib.2005.12.011; EHRMANN IE, 1992, FEBS LETT, V304, P51, DOI 10.1016/0014-5793(92)80587-7; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; BETSOU F, 1993, INFECT IMMUN, V61, P3583; Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598; SEBO P, 1995, INFECT IMMUN, V63, P3851; Croucher NJ, 2010, CURR OPIN MICROBIOL, V13, P619, DOI 10.1016/j.mib.2010.09.009; Merkel TJ, 1998, INFECT IMMUN, V66, P4367; deTejada GM, 1996, MOL MICROBIOL, V22, P895; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; CAMILLI A, 1994, P NATL ACAD SCI USA, V91, P2634, DOI 10.1073/pnas.91.7.2634; Cummings CA, 2004, J BACTERIOL, V186, P1484, DOI 10.1128/JB.186.5.1484-1492.2004; Hester SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047635; Kurushima J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038925; Kurushima J, 2012, MICROBIOL IMMUNOL, V56, P356, DOI 10.1111/j.1348-0421.2012.00442.x; MAHAN MJ, 1995, P NATL ACAD SCI USA, V92, P669, DOI 10.1073/pnas.92.3.669; MILLER VL, 1988, J BACTERIOL, V170, P2575; Nicholson TL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-220; Oliver DC, 2003, MOL MICROBIOL, V47, P1367, DOI 10.1046/j.1365-2958.2003.03377.x; Rediers H, 2005, MICROBIOL MOL BIOL R, V69, P217, DOI 10.1128/MMBR.69.2.217-261.2005	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	MAY	2015	59	5					249	261		10.1111/1348-0421.12247		13	Immunology; Microbiology	Immunology; Microbiology	CI5SG	WOS:000354818900001		
J	Diep, TT; Nguyen, NTN; Nguyen, TNC; An, HK; Nguyen, TQ; Nguyen, VH; Nguyen, TV; Nguyen, TNA; Izumiya, H; Ohnishi, M; Yamashiro, T; Nguyen, LTP				Tai The Diep; Nhi Thi Ngoc Nguyen; Thi Ngoc Cat Nguyen; Huy Khac An; Truong Quang Nguyen; Vu Hoang Nguyen; Thuong Van Nguyen; Thu Ngoc Anh Nguyen; Izumiya, Hidemasa; Ohnishi, Makoto; Yamashiro, Tetsu; Lan Thi Phuong Nguyen			Isolation of New Delhi metallo--lactamase 1-producing Vibrio cholerae non-O1, non-O139 strain carrying ctxA, st and hly genes in southern Vietnam	MICROBIOLOGY AND IMMUNOLOGY			English	Article						bla(NDM-1); NAG vibrio; Vibrio cholerae; virulent gene	HEAT-STABLE ENTEROTOXIN; MOLECULAR ANALYSIS; UNITED-STATES; NAG-ST; TOXIN; INDIA; CALCUTTA; DIARRHEA; O1; EPIDEMIOLOGY	Vibrio cholerae non-O1, non-O139 (VC_NAG) organisms are universally present in the aquatic environment and regarded as non-pathogenic bacteria. However, considering that they do occasionally induce gastroenteritis, a study of their virulence and antibiotic resistance genes is important. The presence of enteropathogenic genes, including ctxA, VC_NAG-specific heat-stable toxin gene (st), hemolysin (hly), and zona occludens toxin (zot) was determined by PCR in 100 VC_NAG strains isolated in southern Vietnam in 2010-2013 from 94 environmental and six human origins. These 100 VC_NAG strains were also tested phenotypically and genotypically for the presence of the New Delhi metallo--lactamase (NDM-1). Of the 100 VC_NAG strains tested, six were positive for ctxA; five from the environment and one of human origin. The st gene was detected in 17 isolates, 15 and two of which were of environmental and human origins, respectively. Gene hly was detected in 19 VC_NAG strains examined, two of which were isolated from humans and 17 from environments. The zot gene was not detected in any of the strains tested. Three VC_NAG strains of environmental origin were confirmed to produce NDM-1 and the bla(NDM-1) gene was detected in those strains by PCR. Of note, one of the three NDM-1-producing VC_NAG strains was confirmed to carry ctxA, st and hly genes concurrently. This is the first report of isolation of NDM-1-producing VC_NAG strains in Vietnam.	[Tai The Diep; Nhi Thi Ngoc Nguyen; Thi Ngoc Cat Nguyen; Huy Khac An; Truong Quang Nguyen; Vu Hoang Nguyen; Thuong Van Nguyen; Thu Ngoc Anh Nguyen; Lan Thi Phuong Nguyen] Pasteur Inst Ho Chi Minh City, Lab Bacteria Microbiol, Ho Chi Minh City, Vietnam; [Tai The Diep; Nhi Thi Ngoc Nguyen; Thi Ngoc Cat Nguyen; Huy Khac An; Truong Quang Nguyen; Vu Hoang Nguyen; Thuong Van Nguyen; Thu Ngoc Anh Nguyen; Lan Thi Phuong Nguyen] Pasteur Inst Ho Chi Minh City, Dept Immunol, Ho Chi Minh City, Vietnam; [Izumiya, Hidemasa; Ohnishi, Makoto] Natl Inst Infect Dis, Dept Bacteriol 1, Shinjuku Ku, Tokyo 1628640, Japan; [Yamashiro, Tetsu] Nagasaki Univ, Inst Trop Med, Ctr Infect Dis Res Asia & Africa, Nagasaki 8528523, Japan; [Yamashiro, Tetsu] Nagasaki Univ, Natl Inst Hyg & Epidemiol, Inst Trop Med, Vietnam Res Stn, Hanoi, Vietnam	Yamashiro, T (reprint author), Nagasaki Univ, Inst Trop Med, Ctr Infect Dis Res Asia & Africa, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	tyamashi@nagasaki-u.ac.jp			Japan Initiative for Global Research Network on Infectious Diseases	We are grateful to all the staff of the provincial preventive medicine centers for assisting with collection of samples. We are also grateful to the staff of the HIV unit, Department of Medical Analysis, Pasteur Institute of Ho Chi Minh City for supporting DNA analyses. This work was partially funded by a grant from the Japan Initiative for Global Research Network on Infectious Diseases.	Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Jiang S, 2003, APPL ENVIRON MICROB, V69, P7541, DOI 10.1128/AEM.69.12.7541-7544.2003; HOOD MA, 1982, APPL ENVIRON MICROB, V43, P578; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Sharma C, 1998, J CLIN MICROBIOL, V36, P756; Mandal J, 2012, EMERG INFECT DIS, V18, P1326, DOI 10.3201/eid1808.111686; Singh DV, 2001, APPL ENVIRON MICROB, V67, P910, DOI 10.1128/AEM.67.2.910-921.2001; RAMAMURTHY T, 1993, J MED MICROBIOL, V39, P310; Moellering RC, 2010, NEW ENGL J MED, V363, P2377, DOI 10.1056/NEJMp1011715; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Dalsgaard A, 1999, EPIDEMIOL INFECT, V122, P217, DOI 10.1017/S0950268899002137; Isozumi R, 2012, EMERG INFECT DIS, V18, P1383, DOI 10.3201/eid1808.111816; Dalsgaard A, 2001, J CLIN MICROBIOL, V39, P4086, DOI 10.1128/JCM.39.11.4086-4092.2001; Pfeifer Y, 2011, J ANTIMICROB CHEMOTH, V66, P1998, DOI 10.1093/jac/dkr256; MORRIS JG, 1990, EPIDEMIOL REV, V12, P179; Li MR, 2003, APPL ENVIRON MICROB, V69, P1728, DOI 10.1128/AEM.69.3.1728-1738.2003; ARITA M, 1986, INFECT IMMUN, V52, P45; BAGCHI K, 1993, J CLIN MICROBIOL, V31, P1315; BLAKE PA, 1980, NEW ENGL J MED, V302, P305, DOI 10.1056/NEJM198002073020601; Clinical and Laboratory Standards Institute (CLSI), 2013, M100S23 CLSI; Darley E, 2012, LANCET, V380, P1358, DOI 10.1016/S0140-6736(12)60911-8; DATTAROY K, 1986, APPL ENVIRON MICROB, V52, P875; Departmenf of Health and Human Services C. f. D. C. a. P, MOD HODG TEST CARB D; Guhathakurta B, 1999, FEMS MICROBIOL LETT, V179, P401, DOI 10.1016/S0378-1097(99)00441-3; HOGE CW, 1990, J CLIN MICROBIOL, V28, P1473; KAPER JB, 1986, J CLIN MICROBIOL, V23, P652; Binh MN, 2009, J CLIN MICROBIOL, V47, P1568, DOI 10.1128/JCM.02040-08; PAL A, 1992, APPL ENVIRON MICROB, V58, P2485; Sarkar A, 2011, INFECT DIS, P223, DOI 10.1007/978-1-60327-265-0_13; Walsh TR, 2010, INT J ANTIMICROB AG, V36, pS8, DOI 10.1016/S0924-8579(10)70004-2; WHO, 1993, WKLY EPIDEMIOL REC, V68, P149; ZINNAKA Y, 1972, JOHNS HOPKINS MED J, V131, P403	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	MAY	2015	59	5					262	267		10.1111/1348-0421.12248		6	Immunology; Microbiology	Immunology; Microbiology	CI5SG	WOS:000354818900002		
J	Imamura, D; Mizuno, T; Miyoshi, S; Shinoda, S				Imamura, Daisuke; Mizuno, Tamaki; Miyoshi, Shin-ichi; Shinoda, Sumio			Stepwise changes in viable but nonculturable Vibrio cholerae cells	MICROBIOLOGY AND IMMUNOLOGY			English	Article						resuscitation; viable but nonculturable; Vibrio cholerae	NON-CULTURABLE STATE; ESCHERICHIA-COLI; BACTERIA; RESUSCITATION; ENVIRONMENT; VULNIFICUS; SURVIVAL; TEMPERATURE; STARVATION	Many bacterial species are known to become viable but nonculturable (VBNC) under conditions that are unsuitable for growth. In this study, the requirements for resuscitation of VBNC-state Vibrio cholerae cells were found to change over time. Although VBNC cells could initially be converted to culturable by treatment with catalase or HT-29 cell extract, they subsequently entered a state that was not convertible to culturable by these factors. However, fluorescence microscopy revealed the presence of live cells in this state, from which VBNC cells were resuscitated by co-cultivation with HT-29 human colon adenocarcinoma cells. Ultimately, all cells entered a state from which they could not be resuscitated, even by co-cultivation with HT-29. These characteristic changes in VBNC-state cells were a common feature of strains in both V. cholerae O1 and O139 serogroups. Thus, the VBNC state of V. cholerae is not a single property but continues to change over time.	[Imamura, Daisuke; Mizuno, Tamaki; Shinoda, Sumio] Natl Inst Cholera & Enter Dis, Collaborat Res Ctr Okayama Univ Infect Dis India, Kolkata 700010, India; [Miyoshi, Shin-ichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008530, Japan	Imamura, D (reprint author), Natl Inst Cholera & Enter Dis, 1st Floor ID Hosp Campus,57 Dr SC Banerjee Rd, Kolkata 700010, India.	imadaisuke@gmail.com			Japan Initiative for Global Research Network on Infectious Diseases, Ministry of Education, Culture, Sports, Science and Technology in Japan; Osimo Foundation	This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases, Ministry of Education, Culture, Sports, Science and Technology in Japan and by the Osimo Foundation.	Oliver JD, 2005, J MICROBIOL, V43, P93; Desnues B, 2003, EMBO REP, V4, P400, DOI 10.1038/sj.embor.embor799; Cuny C, 2005, J BACTERIOL, V187, P2244, DOI 10.1128/JB.187.7.2244-2248.2005; Mizunoe Y, 2000, FEMS MICROBIOL LETT, V186, P115, DOI 10.1111/j.1574-6968.2000.tb09091.x; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; XU HS, 1982, MICROBIAL ECOL, V8, P313, DOI 10.1007/BF02010671; Stewart EJ, 2012, J BACTERIOL, V194, P4151, DOI 10.1128/JB.00345-12; Colwell RR, 1996, WORLD J MICROB BIOT, V12, P28, DOI 10.1007/BF00327795; Ayrapetyan M, 2014, APPL ENVIRON MICROB, V80, P2478, DOI 10.1128/AEM.00080-14; WOLF PW, 1992, FEMS MICROBIOL ECOL, V101, P33; Kong IS, 2004, FEMS MICROBIOL ECOL, V50, P133, DOI 10.1016/j.femsec.2004.06.004; Serpaggi V, 2012, FOOD MICROBIOL, V30, P438, DOI 10.1016/j.fm.2011.12.020; Mukamolova GV, 2003, ADV MICROB PHYSIOL, V47, P65, DOI 10.1016/S0065-2911(03)47002-1; Bogosian G, 2000, J BACTERIOL, V182, P5070, DOI 10.1128/JB.182.18.5070-5075.2000; Bunker Stephen T., 2004, Environmental Biosafety Research, V3, P83, DOI 10.1051/ebr:2004008; COLWELL RR, 1985, BIO-TECHNOL, V3, P817, DOI 10.1038/nbt0985-817; Ducret A, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-3; Fakruddin M., 2013, ISRN BIOTECHNOLOGY, V2013, P1; Gupte AR, 2003, APPL ENVIRON MICROB, V69, P6669, DOI 10.1128/AEM.69.11.6669-6675.2003; Li L, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00258; Lle M. M., 2007, ENVIRON MICROBIOL, V9, P2313; ROSZAK DB, 1987, MICROBIOL REV, V51, P365; Salma M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077600; Sardessai YN, 2005, CURR SCI INDIA, V89, P1650; Senoh M, 2014, MICROBIOLOGYOPEN, V3, P239, DOI 10.1002/mbo3.164; Senoh M, 2010, MICROBIOL IMMUNOL, V54, P502, DOI 10.1111/j.1348-0421.2010.00245.x; SHIRAI H, 1991, J CLIN MICROBIOL, V29, P2517	27	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	MAY	2015	59	5					305	310		10.1111/1348-0421.12246		6	Immunology; Microbiology	Immunology; Microbiology	CI5SG	WOS:000354818900007		
J	Miyamoto, S; Fukunaga, Y; Fujiki, M; Nakatni, F; Tanzawa, Y; Sakuraba, M				Miyamoto, Shimpei; Fukunaga, Yutaka; Fujiki, Masahide; Nakatni, Fumihiko; Tanzawa, Yoshikazu; Sakuraba, Minoru			Accompanying artery of sciatic nerve as recipient vessel for free-flap transfer: A computed tomographic angiography study and case reports	MICROSURGERY			English	Article							RECONSTRUCTION; SELECTION; KNEE	Suitable recipient vessels for free-flap transfer are hard to find in the posterior thigh. To investigate the versatility of accompanying artery of sciatic nerve as a recipient vessel in this region, we performed computed tomographic angiographic study of 20 consecutive healthy thighs in 10 patients. The presence and internal diameter of the accompanying artery were studied. The accompanying artery of the sciatic nerve was present in 11 thighs (55%) and the internal diameter of the artery at the mid-thigh level ranged from 2.1 to 3.2 mm. We used this artery as a recipient vessel for free flaps transferred to reconstruct extensive thigh defects in three patients with sarcomas. In all patients the flaps survived without vascular compromise. No sensory or motor dysfunction in the sciatic nerve distribution occurred in any patients. We believe that the accompanying artery of the sciatic nerve may be a recipient vessel for free-flap transfer in selected patients. (c) 2014 Wiley Periodicals, Inc. Microsurgery 35:284-289, 2015.	[Miyamoto, Shimpei; Fujiki, Masahide] Natl Canc Ctr, Div Plast & Reconstruct Surg, Tokyo 1040045, Japan; [Fukunaga, Yutaka; Sakuraba, Minoru] Natl Canc Ctr Hosp East, Div Plast & Reconstruct Surg, Kashiwa, Chiba, Japan; [Nakatni, Fumihiko; Tanzawa, Yoshikazu] Natl Canc Ctr, Div Orthoped Surg, Tokyo 1040045, Japan	Miyamoto, S (reprint author), Natl Canc Ctr, Div Plast & Reconstruct Surg, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	shimiyam@ncc.go.jp					Agur A., 1999, GRANTS ATLAS ANATOMY; Fang TL, 2013, ANN PLAS SURG, V71, P429, DOI 10.1097/SAP.0b013e31824e5e6e; Miyamoto S, 2008, PLAST RECONSTR SURG, V122, P449, DOI 10.1097/PRS.0b013e31817d62c5; Khouri RK, 1998, PLAST RECONSTR SURG, V102, P711, DOI 10.1097/00006534-199809030-00015; Chang LR, 2008, MICROSURG, V28, P157, DOI 10.1002/micr.20471; Gravvanis A, 2014, MICROSURG, V34, P169, DOI 10.1002/micr.22193; Hallock GG, 2008, J RECONSTR MICROSURG, V24, P131, DOI 10.1055/s-2008-1076083; Ishizawa A, 2013, FOLIA MORPHOL, V72, P41, DOI 10.5603/FM.2013.0007; Karmańska W, 1993, Folia Morphol (Warsz), V52, P209; Kawashima Tomokazu, 2010, Okajimas Folia Anatomica Japonica, V87, P141; Miyamoto Shimpei, 2014, Plast Reconstr Surg Glob Open, V2, pe127, DOI 10.1097/GOX.0000000000000080; Onoda S, 2012, J PLAST RECONSTR AES, V65, pE229, DOI 10.1016/j.bjps.2012.02.013; Park S, 2001, PLAST RECONSTR SURG, V107, P1177, DOI 10.1097/00006534-200104150-00012; Teunis T, 2013, MICROSURG, V33, P496, DOI 10.1002/micr.22119; Ugrenovic SZ, 2013, CLIN ANAT, V26, P875, DOI 10.1002/ca.22135; YAJIMA H, 1993, J BONE JOINT SURG BR, V75, P123	16	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0738-1085	1098-2752		MICROSURG	Microsurgery	MAY	2015	35	4					284	289		10.1002/micr.22324		6	Surgery	Surgery	CJ0BF	WOS:000355135900005		
J	Vargas, CR; Nguyen, JT; Ashitate, Y; Silvestre, J; Venugopal, V; Neacsu, F; Kettenring, F; Frangioni, JV; Gioux, S; Lee, BT				Vargas, Christina R.; Nguyen, John T.; Ashitate, Yoshitomo; Silvestre, Jason; Venugopal, Vivek; Neacsu, Florin; Kettenring, Frank; Frangioni, John V.; Gioux, Sylvain; Lee, Bernard T.			Near-infrared imaging for the assessment of anastomotic patency, thrombosis, and reperfusion in microsurgery: A pilot study in a porcine model	MICROSURGERY			English	Article							PERFORATOR FLAP DESIGN; QUANTITATIVE ASSESSMENT; BREAST RECONSTRUCTION; BLOOD-FLOW; RAT MODEL; FLUORESCENCE; PERFUSION; ANGIOGRAPHY; EXPERIENCE; SYSTEM	BackgroundAdvances in microsurgical techniques have increased the use of free tissue transfer. Methods of intraoperative flap perfusion assessment, however, still rely primarily on subjective evaluation of traditional clinical parameters. Anastomotic thrombosis, if not expeditiously identified and revised, can result in flap loss with significant associated morbidity. This study aims to evaluate the use of near-infrared (NIR) fluorescence imaging in the assessment of microsurgical anastomotic patency, thrombosis, and vascular revision. Materials and MethodsA model of pedicle thrombosis was created using bilateral abdominal flaps isolated on deep superior epigastric vascular pedicles in four Yorkshire pigs. Following flap elevation, microvascular arterial and venous anastomoses were performed unilaterally, preserving an intact contralateral control flap. Thrombosis was induced at the arterial anastomosis site using ferric chloride, and both flaps imaged using NIR fluorescence angiography. The thrombosed vascular segments were subsequently excised and new anastomoses performed to restore flow. Follow-up imaging of both flaps was then obtained to confirm patency using fluorescence imaging technology. ResultsPedicled abdominal flaps were created and successful anastomotic thrombosis was induced unilaterally in each pig. Fluorescence imaging technology identified large decreases in tissue perfusion of the thrombosed flap within 2 minutes. After successful revision anastomosis, NIR imaging demonstrated dramatic increase in flow to the reconstructed flap, but intensity did not return to pre-thrombosis levels. ConclusionsEarly identification of anastomotic thrombosis is important in successful free tissue transfer. Real-time, intraoperative evaluation of flap perfusion, anastomotic thrombosis, and successful revision can be performed using NIR fluorescence imaging. (c) 2015 Wiley Periodicals, Inc. Microsurgery 35:309-314, 2015.	[Vargas, Christina R.; Nguyen, John T.; Silvestre, Jason; Lee, Bernard T.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA; [Vargas, Christina R.; Nguyen, John T.; Silvestre, Jason; Lee, Bernard T.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Plast Surg, Boston, MA 02215 USA; [Ashitate, Yoshitomo] Hokkaido Univ, Grad Sch Med, Div Canc Diagnost & Therapeut, Sapporo, Hokkaido, Japan; [Venugopal, Vivek; Neacsu, Florin; Kettenring, Frank; Frangioni, John V.; Gioux, Sylvain] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Venugopal, Vivek; Neacsu, Florin; Kettenring, Frank; Frangioni, John V.; Gioux, Sylvain] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Hematol & Oncol, Boston, MA 02215 USA; [Frangioni, John V.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA; [Frangioni, John V.] Curadel LLC, Worcester, MA USA	Lee, BT (reprint author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, 110 Francis St Suite 5A, Boston, MA 02215 USA.	blee3@bidmc.harvard.edu			National Institutes of Health [R01-DE-2820, R01-CA-5296]	Grant sponsor: National Institutes of Health grants; Grant number: R01-DE-2820 and R01-CA-5296.	Al-Dam A, 2014, J CRANIO MAXILL SURG, V42, P1178, DOI 10.1016/j.jcms.2014.02.005; Lee BT, 2010, J RECONSTR MICROSURG, V26, P59, DOI 10.1055/s-0029-1244805; Gioux S, 2010, MOL IMAGING, V9, P237, DOI 10.2310/7290.2010.00034; Nguyen JT, 2013, J SURG RES, V184, P714, DOI 10.1016/j.jss.2013.04.039; Tanaka E, 2009, J THORAC CARDIOV SUR, V138, P133, DOI 10.1016/j.jtcvs.2008.09.082; Wei FC, 2001, PLAST RECONSTR SURG, V108, P1154, DOI 10.1097/00006534-200110000-00007; Nguyen JT, 2012, J SURG RES, V177, pE83, DOI 10.1016/j.jss.2012.04.015; Nguyen JT, 2012, J SURG RES, V178, pE43, DOI 10.1016/j.jss.2012.05.014; Zhu YL, 2013, MICROSURG, V33, P600, DOI 10.1002/micr.22177; Lee BT, 2010, PLAST RECONSTR SURG, V126, P1472, DOI 10.1097/PRS.0b013e3181f059c7; Matsui A, 2009, PLAST RECONSTR SURG, V124, P451, DOI 10.1097/PRS.0b013e3181adcf7d; Ashitate Y, 2013, ANN PLAS SURG, V70, P360, DOI 10.1097/SAP.0b013e318236babe; Fowler NM, 2014, CURR OPIN OTOLARYNGO, V22, P127, DOI 10.1097/MOO.0000000000000028; de Weerd L, 2006, ANN PLAS SURG, V57, P279, DOI 10.1097/01.sap.0000218579.17185.c9; Hallock GG, 2003, CLIN PLAST SURG, V30, P347, DOI 10.1016/S0094-1298(03)00036-1; Schlosser S, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3449598; Matsui A, 2009, PLAST RECONSTR SURG, V124, P1098, DOI 10.1097/PRS.0b013e3181b5a44c; KURZ KD, 1990, THROMB RES, V60, P269, DOI 10.1016/0049-3848(90)90106-M; Gioux S, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3614566; Disa JJ, 1999, PLAST RECONSTR SURG, V104, P97, DOI 10.1097/00006534-199907000-00013; Matsui A, 2009, ANN PLAS SURG, V63, P327, DOI 10.1097/SAP.0b013e318193493d; Chauhan AK, 2007, BLOOD, V109, P2424, DOI 10.1182/blood-2006-06-028241; Troyan SL, 2009, ANN SURG ONCOL, V16, P2943, DOI 10.1245/s10434-009-0594-2; Diaz JA, 2012, ARTERIOSCL THROM VAS, V32, P556, DOI 10.1161/ATVBAHA.111.244608; Ashitate Y, 2013, ANN PLAS SURG, V70, P149, DOI 10.1097/SAP.0b013e31822f9af7; ARNOLD F, 1995, BRIT J PLAST SURG, V48, P280, DOI 10.1016/0007-1226(95)90065-9; Ashitate Y, 2012, J VASC SURG, V56, P171, DOI 10.1016/j.jvs.2011.11.058; Blondeel PN, 1998, BRIT J PLAST SURG, V51, P202, DOI 10.1016/S0007-1226(98)80010-6; Boas DA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3285504; Detter C, 2007, CIRCULATION, V116, P1007, DOI 10.1161/CIRCULATIONAHA.106.655936; Edmunds MC, 2013, JOVE-J VIS EXP, V8, P76; Flaumenhaft R, 2007, CIRCULATION, V115, P84, DOI 10.1161/CIRCULATIONAHA.106.643908; HJORTDAL VE, 1994, PLAST RECONSTR SURG, V93, P375, DOI 10.1097/00006534-199402000-00024; Kakarala K, 2012, LARYNGOSCOPE, V122, P2160, DOI 10.1002/lary.23457; Matsui A, 2010, PLAST RECONSTR SURG, V126, P1517, DOI 10.1097/PRS.0b013e3181ef8ce7; Matsui A., 2009, PLASTIC RECONSTRUCTI, V123, P125; Mucke T, 2013, MICROSURG, V33, P287, DOI 10.1002/micr.22095; Schrey A, 2010, J PLAST RECONSTR AES, V63, P314, DOI 10.1016/j.bjps.2008.09.029; Wong AK, 2015, MICROSURG, V35, P6, DOI 10.1002/micr.22223	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0738-1085	1098-2752		MICROSURG	Microsurgery	MAY	2015	35	4					309	314		10.1002/micr.22376		6	Surgery	Surgery	CJ0BF	WOS:000355135900009		
J	Yamamoto, T; Yamamoto, N; Koshima, I				Yamamoto, Takumi; Yamamoto, Nana; Koshima, Isao			Sensate superficial inferior epigastric artery flap innervated by the iliohypogastric nerve for reconstruction of a finger soft tissue defect	MICROSURGERY			English	Article							FASCIOCUTANEOUS FLAPS; PERFORATOR FLAP; LOWER-EXTREMITY; VERSATILITY; COVERAGE; HEAD	In the era of perforator flaps, lower-abdominal/inguinal perforator flaps such as superficial circumflex iliac artery perforator (SCIP) flap and superficial inferior epigastric artery (SIEA) perforator flap are becoming popular with its longer vascular pedicle and usefulness in various reconstructions. SIEA flap's region is innervated by the T12 nerve and the iliohypogastric nerve (IHN), but no sensate SIEA flap has been reported so far. In this report, we present a case in which a sensate SIEA flap innervated by the IHN was used for reconstruction of a finger soft tissue defect. A 55-year-old male suffering from the volar skin necrosis of the right ring finger underwent the volar soft tissue reconstruction using a free sensate SIEA flap because of hypoplastic SCIA. The SIEA flap included the IHN anterior branch, and neuroraphy was performed between the IHN and the third common digital nerve in an end-to-side manner after vascular anastomoses. The reconstructed volar skin could sensate 14 weeks after the surgery. At postoperative 6 months, Semmes-Weinstein test and moving 2-point discrimination revealed 3.64 and 8 mm in the proximal portion of the SIEA flap where the IHN was supposed to innervate. The IHN may be included in a SIEA flap, and a sensate SIEA flap may be a useful option when a SCIP flap is not available. Further anatomical and clinical studies are required to clarify anatomy and clinical usefulness of the IHN. (c) 2014 Wiley Periodicals, Inc. Microsurgery 35:324-327, 2015.	[Yamamoto, Takumi; Koshima, Isao] Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, Tokyo 1138655, Japan; [Yamamoto, Takumi] Noda Hosp, Dept Plast Surg, Chiba, Japan; [Yamamoto, Nana] Toranomon Gen Hosp, Dept Plast Surg, Tokyo, Japan	Yamamoto, T (reprint author), Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tyamamoto-tky@umin.ac.jp					Klaassen Z, 2011, CLIN ANAT, V24, P454, DOI 10.1002/ca.21098; Koshima I, 2004, PLAST RECONSTR SURG, V113, P233, DOI 10.1097/01.PRS.0000095948.03605.20; Iida T, 2013, J PLAST RECONSTR AES, V66, P1596, DOI 10.1016/j.bjps.2013.03.031; Hong JP, 2013, ANN PLAS SURG, V71, P380, DOI 10.1097/SAP.0b013e3182503ac5; Dias RJS, 2004, ARQ NEURO-PSIQUIAT, V62, P895, DOI 10.1590/S0004-282X2004000500032; Iida T, 2013, J PLAST RECONSTR AES, V66, P1564, DOI 10.1016/j.bjps.2013.06.056; Kayalar M, 2014, MICROSURG, V34, P527, DOI 10.1002/micr.22267; Lin CT, 2013, MICROSURG, V33, P191, DOI 10.1002/micr.22064; Nasir S, 2010, ANN PLAS SURG, V65, P32, DOI 10.1097/SAP.0b013e3181bb4b24; Nasir S, 2008, ANN PLAS SURG, V61, P622, DOI 10.1097/SAP.0b013e31817433f8; Okada M, 2014, MICROSURG, V34, P454, DOI 10.1002/micr.22222; STEVENSON TR, 1984, ANN PLAS SURG, V12, P333, DOI 10.1097/00000637-198404000-00005	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0738-1085	1098-2752		MICROSURG	Microsurgery	MAY	2015	35	4					324	327		10.1002/micr.22360		4	Surgery	Surgery	CJ0BF	WOS:000355135900012		
J	Kato, M; Yamamoto, T				Kato, Motoi; Yamamoto, Takumi			Simple wire retractor for supermicrosurgical lymphaticovenular anastomosis	MICROSURGERY			English	Letter							LYMPHEDEMA		[Kato, Motoi; Yamamoto, Takumi] Univ Tokyo, Dept Plast & Reconstruct Surg, Tokyo, Japan	Kato, M (reprint author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1138655, Japan.	motoikato25@gmail.com					Yamamoto T, 2013, MICROSURG, V33, P130, DOI 10.1002/micr.22040; Yamamoto T, 2014, VASC ENDOVASC SURG, V48, P139, DOI 10.1177/1538574413510979; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1979, DOI 10.1097/PRS.0b013e31820cf5df; Yamamoto T, 2014, MICROSURG, V34, P23, DOI 10.1002/micr.22115; Yamamoto T, 2012, ANN PLAST SURG, V72, P67	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0738-1085	1098-2752		MICROSURG	Microsurgery	MAY	2015	35	4					335	336		10.1002/micr.22310		2	Surgery	Surgery	CJ0BF	WOS:000355135900015		
J	Choy, YS; Bhattacharya, K; Balasubramaniam, S; Fietz, M; Fu, A; Inwood, A; Jin, DK; Kim, OH; Kosuga, M; Kwun, YH; Lin, HY; Lin, SP; Mendelsohn, NJ; Okuyama, T; Samion, H; Tan, A; Tanaka, A; Thamkunanon, V; Thong, MK; Toh, TH; Yang, AD; McGill, J				Choy, Yew Sing; Bhattacharya, Kaustuv; Balasubramaniam, Shanti; Fietz, Michael; Fu, Antony; Inwood, Anita; Jin, Dong-Kyu; Kim, Ok-Hwa; Kosuga, Motomichi; Kwun, Young Hee; Lin, Hsiang-Yu; Lin, Shuan-Pei; Mendelsohn, Nancy J.; Okuyama, Torayuki; Samion, Hasri; Tan, Adeline; Tanaka, Akemi; Thamkunanon, Verasak; Thong, Meow-Keong; Toh, Teck-Hock; Yang, Albert D.; McGill, Jim			Identifying the need for a multidisciplinary approach for early recognition of mucopolysaccharidosis VI (MPS VI)	MOLECULAR GENETICS AND METABOLISM			English	Article						Mucopolysaccharidosis; MPS VI; Diagnosis; Asia; Pacific; Symptoms	MAROTEAUX-LAMY-SYNDROME; ENZYME REPLACEMENT THERAPY; DISEASE PROGRESSION; DIAGNOSTIC-TEST; GLYCOSAMINOGLYCAN	Mucopolysaccharidosis VI (MPS VI, Maroteaux Lamy syndrome) is caused by deficient activity of the enzyme, N-acetylgalactosamine-4-sulfatase, resulting in impaired degradation of the glycosaminoglycan dermatan sulfate. Patients experience a range of manifestations including joint contractures, short stature, dysostosis multiplex, coarse facial features, decreased pulmonary function, cardiac abnormalities, corneal clouding and shortened life span. Recently, clinicians from institutions in the Asia-Pacific region met to discuss the occurrence and implications of delayed diagnosis and misdiagnosis of MPS VI in the patients they have managed. Eighteen patients (44% female) were diagnosed. The most common sign presented by the patients was bone deformities in 11 patients (65%). Delays to diagnosis occurred due to the lack of or distance to diagnostic facilities for four patients (31%), alternative diagnoses for two patients (15%), and misleading symptoms experienced by two patients (15%). Several patients experienced manifestations that were subtler than would be expected and were subsequently overlooked. Several cases highlighted the unique challenges associated with diagnosing MPS VI from the perspective of different specialties and provide insights into how these patients initially present, which may help to elucidate strategies to improve the diagnosis of MPS VI. (C) 2015 Elsevier Inc. All rights reserved.	[Choy, Yew Sing] Prince Court Med Ctr, Kuala Lumpur 50450, Wilayah Perseku, Malaysia; [Bhattacharya, Kaustuv] Childrens Hosp Westmead, Genet Metab Disorders Serv, Sydney, NSW, Australia; [Balasubramaniam, Shanti] Princess Margaret Childrens Hosp, Subiaco, WA 6008, Australia; [Fietz, Michael] Womens & Childrens Hosp, SA Pathol, Adelaide, SA 5006, Australia; [Fu, Antony] Prince Wales Hosp, Sha Tin, Hong Kong, Peoples R China; [Inwood, Anita; McGill, Jim] Lady Cilento Childrens Hosp, Dept Metab Med, South Brisbane, Qld 4101, Australia; [Jin, Dong-Kyu; Kwun, Young Hee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea; [Kim, Ok-Hwa] Woorisoa Childrens Hosp, Dept Radiol, Seoul 152862, South Korea; [Kosuga, Motomichi; Okuyama, Torayuki] Natl Ctr Child Hlth & Dev, Setagaya Ku, Tokyo 1578535, Japan; [Lin, Hsiang-Yu; Lin, Shuan-Pei] Mackay Mem Hosp, Dept Pediat, Taipei 10449, Taiwan; [Mendelsohn, Nancy J.] Childrens Hosp & Clin Minnesota, Minneapolis, MN USA; [Samion, Hasri] Natl Heart Inst, Kuala Lumpur 50586, Wilayah Perseku, Malaysia; [Tan, Adeline] Ipoh Specialist Hosp, Ipoh, Perak, Malaysia; [Tanaka, Akemi] Osaka City Univ, Grad Sch Med, Abeno Ku, Osaka 5458585, Japan; [Thamkunanon, Verasak] Queen Sirikit Natl Inst Child Hlth, Bangkok 10400, Thailand; [Thong, Meow-Keong] Univ Malaya, Fac Med, Dept Paediat, Kuala Lumpur 50603, Malaysia; [Toh, Teck-Hock] Sibu Hosp, Dept Paediat, Sibu, Sarawak, Malaysia; [Toh, Teck-Hock] Sibu Hosp, Clin Res Ctr, Sibu, Sarawak, Malaysia; [Yang, Albert D.] Changhua Christian Hosp, Changhua 526, Changhua County, Taiwan	McGill, J (reprint author), Lady Cilento Childrens Hosp, Dept Metab Med, 501 Stanley St, South Brisbane, Qld 4101, Australia.				BioMarin Pharmaceutical Inc.	Judy Wiles provided medical writing with graphical assistance by Selma Tse, both of Facet Communications. Medical writing assistance was funded by BioMarin Pharmaceutical Inc.	Golda A, 2012, INT J CARDIOL, V158, P6, DOI 10.1016/j.ijcard.2011.06.097; Wood T, 2012, MOL GENET METAB, V106, P73, DOI 10.1016/j.ymgme.2012.02.005; Furujo M, 2011, MOL GENET METAB, V104, P597, DOI 10.1016/j.ymgme.2011.08.029; Lachman RS, 2014, SKELETAL RADIOL, V43, P359, DOI 10.1007/s00256-013-1797-y; WHITLEY CB, 1989, CLIN CHEM, V35, P374; McGill JJ, 2010, CLIN GENET, V77, P492, DOI 10.1111/j.1399-0004.2009.01324.x; Braunlin EA, 2011, J INHERIT METAB DIS, V34, P1183, DOI 10.1007/s10545-011-9359-8; FONG LV, 1987, CLIN CARDIOL, V10, P362; HAYFLICK S, 1992, J PEDIATR-US, V120, P269, DOI 10.1016/S0022-3476(05)80441-X; Jurecka A, 2013, AM J MED GENET A, V161A, P1291, DOI 10.1002/ajmg.a.35905; Mendelsohn Nancy J, 2013, JIMD Rep, V11, P125, DOI 10.1007/8904_2013_231; Neufeld EF, 2001, METABOLIC MOL BASES, VIII, P3421; Scarpa Maurizio, 2010, J Pediatr Rehabil Med, V3, P71, DOI 10.3233/PRM-2010-0104; Swiedler SJ, 2005, AM J MED GENET A, V134A, P144, DOI 10.1002/ajmg.a.30579; Thumler A, 2012, J INHERIT METAB DIS, V35, P1071, DOI 10.1007/s10545-012-9474-1; Valayannopoulos V, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-5; WHITLEY CB, 1989, CLIN CHEM, V35, P2074	17	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	MAY	2015	115	1					41	47		10.1016/j.ymgme.2015.03.005		7	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CI8OO	WOS:000355031800007		
J	Yen, NY; Jin, Q; Tsai, JC; Park, JJ				Yen, Neil Y.; Jin, Qun; Tsai, Joseph C.; Park, James J.			Intelligent state machine for social ad hoc data management and reuse	MULTIMEDIA TOOLS AND APPLICATIONS			English	Article						Intelligent state machine; Social contexts; User-generated data; Human-centered support; Information retrieval	PETRI-NET; NETWORKS	Recent advances in information technology have turned out World Wide Web to be the main platform for interactions where participants-users and corresponding events-are triggered. Although the participants vary in accordance with scenarios, a considerable size of data will be generated. This phenomenon indeed causes the complexity in information retrieval, management, and resuse, and meanwhile, turns down the value of this data. In this research, we attempt to achieve efficient management of user-generated data and its derivative contexts (i.e., social ad hoc data) for human supports. The correlations among data, contexts, and their hybridization are specifically concentrated. An intelligent state machine is proposed to outline the relations of data and contexts, and applied to further identify their usage scenarios. The performance and feasibility can be revealed by the experiments that were conducted on the data collected from open social networks (e.g., Facebook, Twitter, etc.) in the past few years with size around 500 users and 8,000,000 shared contents from them.	[Yen, Neil Y.; Tsai, Joseph C.] Univ Aizu, Scool Comp Sci & Engn, Aizu Wakamatsu, Japan; [Jin, Qun] China Jiliang Univ, Coll Informat Engn, Dept Comp Sci & Technol, Hangzhou, Zhejiang, Peoples R China; [Jin, Qun] Waseda Univ, Dept Human Informat & Cognit Sci, Fac Human Sci, Networked Informat Syst Lab, Tokyo, Japan; [Park, James J.] Seoul Natl Univ Sci & Technol, Dept Comp Sci & Engn, Seoul 139743, South Korea	Jin, Q (reprint author), China Jiliang Univ, Coll Informat Engn, Dept Comp Sci & Technol, 258 Xueyuan St, Hangzhou, Zhejiang, Peoples R China.	neilyyen@u-aizu.ac.jp; jin@acm.org; jctsai@u-aizu.ac.jp; parkjonghyuk1@hotmail.com			MSIP (Ministry of Science, ICT and Future Planning), Korea, under the ITRC (Information Technology Research Center) [NIPA-2014-H0301-14-4007]	This research was supported by the MSIP (Ministry of Science, ICT and Future Planning), Korea, under the ITRC (Information Technology Research Center) support program (NIPA-2014-H0301-14-4007) supervised by the NIPA(National IT Industry Promotion Agency).	Aarts F, 2010, LECT NOTES COMPUT SC, V6435, P188, DOI 10.1007/978-3-642-16573-3_14; Keogh E, 2003, DATA MIN KNOWL DISC, V7, P349, DOI 10.1023/A:1024988512476; Mitra S, 2002, IEEE T NEURAL NETWOR, V13, P3, DOI 10.1109/72.977258; Schadt EE, 2010, NAT REV GENET, V11, P647, DOI 10.1038/nrg2857; Karsai M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.025102; Steyvers M, 2005, COGNITIVE SCI, V29, P41, DOI 10.1207/s15516709cog2901_3; Fagni T, 2006, ACM T INFORM SYST, V24, P51, DOI 10.1145/1125857.1125859; Gaber MM, 2005, SIGMOD RECORD, V34, P18, DOI 10.1145/1083784.1083789; Cavalli A, 2003, INFORM SOFTWARE TECH, V45, P837, DOI 10.1016/S0950-5849(03)00063-6; Liu BD, 2002, IEEE T FUZZY SYST, V10, P445, DOI 10.1109/TFUZZ.2002.800692; Tay FEH, 2001, OMEGA-INT J MANAGE S, V29, P309, DOI 10.1016/S0305-0483(01)00026-3; Bose I, 2001, INFORM MANAGE-AMSTER, V39, P211, DOI 10.1016/S0378-7206(01)00091-X; Carpineto C, 2009, ACM COMPUT SURV, V41, DOI 10.1145/1541880.1541884; Chen Y., 2002, P 28 INT C VER LARG, P323; Cheng KT, 1996, ACM T DES AUTOMAT EL, V1, P57, DOI 10.1145/225871.225880; Culotta A, 2004, P CEAS 1; Erickson T., 2000, ACM Transactions on Computer-Human Interaction, V7, DOI 10.1145/344949.345004; Esling P, 2012, ACM COMPUT SURV, V45, DOI 10.1145/2379776.2379788; Faloutsos C, 2004, P ACM SIGKDD 2004; Folstad A, 2013, HUMAN CENTRIC COMPUT, V3, P18; Glynn Mangold W, 2009, BUS HORIZONS, V52, P357; Guralnik V., 1999, P 5 ACM SIGKDD INT C, P33, DOI 10.1145/312129.312190; Harada M, 2004, P JOINT C DIG LIB JC; Hoheisel A, 2007, WORKFLOWS E SCI, P190, DOI 10.1007/978-1-84628-757-2_13; Hong JE, 2000, INFORM SCIENCES, V130, P133, DOI 10.1016/S0020-0255(00)00090-6; Jensen Kurt, 2007, International Journal on Software Tools for Technology Transfer, V9, DOI 10.1007/s10009-007-0038-x; Joachims T., 2005, P 28 ANN INT ACM SIG, P154, DOI DOI 10.1145/1076034.1076063; KOZLOWSKI T, 1995, IEE P-COMPUT DIG T, V142, P263, DOI 10.1049/ip-cdt:19951886; Lee K, 2013, P 19 ACM SIGKDD INT, P1474; Li LX, 2008, IEEE T SYST MAN CY A, V38, P207, DOI 10.1109/TSMCA.2007.909559; Mandal SN, 2008, J THEOR APPL INF TEC, V4, P1131; Mika P, 2005, P ISWC2005; Milanovic N, 2004, IEEE INTERNET COMPUT, V8, P51, DOI 10.1109/MIC.2004.58; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Pais R, 2011, IEEE IND ELEC, P3776; Salimifard K, 2001, EUR J OPER RES, V134, P664, DOI 10.1016/S0377-2217(00)00292-7; Shtykh RY, 2011, HUMAN CENTRIC COMPUT, V1, P2; Thelwall M, 2001, J INFORM SCI, V27, P319; van der Aalst WMP, 2004, LECT NOTES COMPUT SC, V3080, P244; Yen NY, 2013, ACM T INTEL SYST TEC, V4, DOI [10.1145/2438653.2438665, 10.1145/2438653.2438668]; Zhang J, 2004, IEEE INTERNATIONAL CONFERENCE ON WEB SERVICES, PROCEEDINGS, P420	41	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1380-7501	1573-7721		MULTIMED TOOLS APPL	Multimed. Tools Appl.	MAY	2015	74	10					3521	3541		10.1007/s11042-014-1941-2		21	Computer Science, Information Systems; Computer Science, Software Engineering; Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CI1GY	WOS:000354493000019		
J	Fujita, K; Fukuda, M; Fukui, H; Horie, M; Endoh, S; Uchida, K; Shichiri, M; Morimoto, Y; Ogami, A; Iwahashi, H				Fujita, Katsuhide; Fukuda, Makiko; Fukui, Hiroko; Horie, Masanori; Endoh, Shigehisa; Uchida, Kunio; Shichiri, Mototada; Morimoto, Yasuo; Ogami, Akira; Iwahashi, Hitoshi			Intratracheal instillation of single-wall carbon nanotubes in the rat lung induces time-dependent changes in gene expression	NANOTOXICOLOGY			English	Article						Fiber toxicology; genomics; nanotoxicology; nanotubes	IN-VITRO TOXICITY; INHALATION TOXICITY; PULMONARY TOXICITY; EPITHELIAL-CELLS; HEME OXYGENASE-1; INJURY; RESPONSES; PROFILES; EXPOSURE; CULTURE	The use of carbon nanotubes in the industry has grown; however, little is known about their toxicological mechanism of action. Single-wall carbon nanotube (SWCNT) suspensions were administered by single intratracheal instillation in rats. Persistence of alveolar macrophage-containing granuloma was observed around the sites of SWCNT aggregation at 90 days post-instillation in 0.2-mg- or 0.4-mg-injected doses per rat. Meanwhile, gene expression profiling revealed that a large number of genes involved in the inflammatory response were markedly upregulated until 90 days or 180 days post-instillation. Subsequently, gene expression patterns were dramatically altered at 365 days post-instillation, and the number of upregulated genes involved in the inflammatory response was reduced. These results suggested that alveolar macrophage-containing granuloma reflected a characteristic of the histopathological transition period from the acute-phase to the subchronic-phase of inflammation, as well as pulmonary acute phase response persistence up to 90 or 180 days after intratracheal instillation in this experimental setting. The expression levels of the genes Ctsk, Gcgr, Gpnmb, Lilrb4, Marco, Mreg, Mt3, Padi1, Slc26a4, Spp1, Tnfsf4 and Trem2 were persistently upregulated in a dose-dependent manner until 365 days post-instillation. In addition, the expression levels of Atp6v0d2, Lpo, Mmp7, Mmp12 and Rnase9 were significantly upregulated until 754 days post-instillation. We propose that these persistently upregulated genes in the chronic-phase response following the acute-phase response act as potential biomarkers in lung tissue after SWCNT instillation. This study provides further insight into the time-dependent changes in genomic expression associated with the pulmonary toxicity of SWCNTs.	[Fujita, Katsuhide; Fukui, Hiroko] Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil, Tsukuba, Ibaraki, Japan; [Fujita, Katsuhide; Fukuda, Makiko; Endoh, Shigehisa] Technol Res Assoc Single Wall Carbon Nanotubes TA, Tsukuba, Ibaraki, Japan; [Horie, Masanori; Morimoto, Yasuo; Ogami, Akira] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Kitakyushu, Fukuoka 807, Japan; [Uchida, Kunio] AIST, Nanosyst Res Inst, Tsukuba, Ibaraki, Japan; [Shichiri, Mototada] AIST, Hlth Res Inst, Ikeda, Osaka, Japan; [Iwahashi, Hitoshi] Gifu Univ, Fac Appl Biol Sci, Gifu, Japan	Fujita, K (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil, Tsukuba, Ibaraki, Japan.	ka-fujita@aist.go.jp			New Energy and Industrial Technology Development Organization of Japan (NEDO) [P06041, P10024]	This research was funded by New Energy and Industrial Technology Development Organization of Japan (NEDO) grants "Evaluating risks associated with manufactured nanomaterials (P06041)" and "Innovative carbon nanotubes composite materials project toward achieving a low-carbon society (P10024)".	Sargent LM, 2012, MUTAT RES-GEN TOX EN, V745, P28, DOI 10.1016/j.mrgentox.2011.11.017; Chou CC, 2008, NANO LETT, V8, P437, DOI 10.1021/nl0723634; Morimoto Y, 2012, NANOTOXICOLOGY, V6, P587, DOI 10.3109/17435390.2011.594912; Treumann S, 2013, TOXICOL SCI, V134, P103, DOI 10.1093/toxsci/kft089; Ma-Hock L, 2009, TOXICOL SCI, V112, P468, DOI 10.1093/toxsci/kfp146; Shapiro SD, 1998, CURR OPIN CELL BIOL, V10, P602, DOI 10.1016/S0955-0674(98)80035-5; Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243; Stern ST, 2008, TOXICOL SCI, V101, P4, DOI 10.1093/toxsci/kfm169; Hirano S, 2010, TOXICOL APPL PHARM, V249, P8, DOI 10.1016/j.taap.2010.08.019; Fujita K, 2009, TOXICOLOGY, V258, P47, DOI 10.1016/j.tox.2009.01.005; Kobayashi N, 2011, INHAL TOXICOL, V23, P814, DOI 10.3109/08958378.2011.614968; Johnston HJ, 2010, NANOTOXICOLOGY, V4, P207, DOI 10.3109/17435390903569639; Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Pauluhn J, 2010, TOXICOL SCI, V113, P226, DOI 10.1093/toxsci/kfp247; Porter DW, 2013, NANOTOXICOLOGY, V7, P1179, DOI 10.3109/17435390.2012.719649; Haniu H, 2013, TOXICOL IN VITRO, V27, P1679, DOI 10.1016/j.tiv.2013.04.012; Davoren M, 2007, TOXICOL IN VITRO, V21, P438, DOI 10.1016/j.tiv.2006.10.007; Mitchell LA, 2007, TOXICOL SCI, V100, P203, DOI 10.1093/toxsci/kfm196; Takahashi F, 2001, AM J RESP CELL MOL, V24, P264; Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111; Fujita K, 2013, TOXICOL MECH METHOD, V23, P598, DOI 10.3109/15376516.2013.811568; Cavallo D, 2012, J APPL TOXICOL, V32, P454, DOI 10.1002/jat.2711; Fujita K, 2010, TOXICOLOGY, V274, P34, DOI 10.1016/j.tox.2010.05.004; Fujita K, 2009, ATMOSPHERIC BIOL ENV, P221; Guo NL, 2012, J TOXICOL ENV HEAL A, V75, P1129, DOI 10.1080/15287394.2012.699852; Liu J, 2008, BMC Res Notes, V1, P111, DOI 10.1186/1756-0500-1-111; Ma-Hock L, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-23; Morimoto Y, 2012, J NANO RES-SW, V18-19, P9, DOI 10.4028/www.scientific.net/JNanoR.18-19.9; Nagatomo H, 2007, INHAL TOXICOL, V19, P317, DOI 10.1080/08958370601144167; Nagatomo H, 2006, J OCCUP HEALTH, V48, P124, DOI 10.1539/joh.48.124; Urankar RN, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-38; Wu HP, 2009, J BONE MINER RES, V24, P871, DOI [10.1359/jbmr.081239, 10.1359/JBMR.081239]	33	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	1743-5390	1743-5404		NANOTOXICOLOGY	Nanotoxicology	MAY	2015	9	3					290	301		10.3109/17435390.2014.921737		12	Nanoscience & Nanotechnology; Toxicology	Science & Technology - Other Topics; Toxicology	CI7WI	WOS:000354975400003		
J	Ashihara, H				Ashihara, Hiroshi			Metabolism and Biological Function of Natural Products in Plants Preface	NATURAL PRODUCT COMMUNICATIONS			English	Editorial Material									Ochanomizu Univ, Tokyo 112, Japan	Ashihara, H (reprint author), Ochanomizu Univ, Tokyo 112, Japan.							0	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	MAY	2015	10	5										1	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CI3SQ	WOS:000354668100002		
J	Sato, K; Akai, S; Yoshimura, J				Sato, Ken-ichi; Akai, Shoji; Yoshimura, Juji			Stereocontrolled Total Synthesis of Tetrodotoxin from myo-Inositol and D-Glucose by Three Routes: Aspects for Constructing Complex Multi-Functionalized Cyclitols with Branched-Chain Structures	NATURAL PRODUCT COMMUNICATIONS			English	Article						Tetrodotoxin; Functionalized cyclitol; Branched-chain sugar; Henry reaction; Ferrier(II) reaction	OPTICALLY-ACTIVE TETRODOTOXIN; EFFICIENT TOTAL-SYNTHESIS; INTERMEDIATES POTENTIALLY USEFUL; PUFFER FISH TOXIN; LIQUID-CHROMATOGRAPHY; SECONDARY ALCOHOLS; TARICHA-GRANULOSA; UNNATURAL ANALOG; KEY COMPOUND; DERIVATIVES	This report describes the stereocontrolled total synthesis of the multi-functionalized cyclitol derivative, tetrodotoxin, containing eight asymmetric carbons and different types of branched-chains, from myo-inositol and D-glucose using three different methods. The tetrodotoxin derivatives possess a relatively small molecular weight but unique structural and chemical properties. Selection of the appropriate synthetic method may be useful not only for compounds related to TTX (including related derivatives), but also for other highly complex multi-functionalized cyclitols containing branched-chains.	[Sato, Ken-ichi; Akai, Shoji] Kanagawa Univ, Dept Mat & Life Chem, Fac Engn, Kanagawa Ku, Yokohama, Kanagawa 2218686, Japan; [Yoshimura, Juji] Iwaki Meisel Univ, Coll Sci & Engn, Dept Basic Sci, Iwaki, Fukushima 9708551, Japan	Sato, K (reprint author), Kanagawa Univ, Dept Mat & Life Chem, Fac Engn, Kanagawa Ku, 3-27-1 Rokkakubashi, Yokohama, Kanagawa 2218686, Japan.	satouk01@kanagawa-u.ac.jp			Ministry of Education, Science, Sports and Culture, Japan [01540460, 19750147]	The authors thank Dr T. Nakagawa, Professor Emeritus of Yokohama City University, Dr H. Hashimoto, Professor Emeritus of Tokyo Institute of Technology, and Dr M. Funabashi, Professor Emeritus of Ciba University, for helpful References discussions. The authors also thank Dr Y. Nakamura, Dr Y. Kajihara, Dr K. Suzuki, and Mr N. Sugita. This work was partially supported by "High-Tech Research Center Project" and "Science Frontier Project of Kanagawa University" and Grants-in-Aid for Scientific Research (No. 01540460, 19750147) from the Ministry of Education, Science, Sports and Culture, Japan.	Adachi M, 2013, J ORG CHEM, V78, P1699, DOI 10.1021/jo302773f; Akai S, 2010, B CHEM SOC JPN, V83, P279, DOI 10.1246/bcsj.20090194; Akai S, 1999, ANAL SCI, V15, P503, DOI 10.2116/analsci.15.503; GOTO T, 1965, TETRAHEDRON, V21, P2059, DOI 10.1016/S0040-4020(01)98344-9; Wu BQ, 1996, TOXICON, V34, P407, DOI 10.1016/0041-0101(95)00168-9; KODAMA M, 1985, MAR BIOL, V87, P199, DOI 10.1007/BF00539429; WOODWARD RB, 1964, J AM CHEM SOC, V86, P5030, DOI 10.1021/ja01076a076; Ballini R, 2004, TETRAHEDRON, V60, P1017, DOI 10.1016/j.tet.2003.11.016; DESS DB, 1991, J AM CHEM SOC, V113, P7277, DOI 10.1021/ja00019a027; Luzzio FA, 2001, TETRAHEDRON, V57, P915, DOI 10.1016/S0040-4020(00)00965-0; Taber DF, 2003, J ORG CHEM, V68, P7768, DOI 10.1021/jo0301189; DESS DB, 1983, J ORG CHEM, V48, P4155, DOI 10.1021/jo00170a070; MATSUMURA K, 1995, NATURE, V378, P563, DOI 10.1038/378563b0; YASUMOTO T, 1988, J AM CHEM SOC, V110, P2344, DOI 10.1021/ja00215a078; YotsuYamashita M, 1995, TETRAHEDRON LETT, V36, P9329, DOI 10.1016/0040-4039(95)02020-P; YASUMOTO T, 1985, AGR BIOL CHEM TOKYO, V49, P3077; TSUDA K, 1964, CHEM PHARM BULL, V12, P1357; Sato KI, 2008, J ORG CHEM, V73, P1234, DOI 10.1021/jo701655v; Ohyabu N, 2003, J AM CHEM SOC, V125, P8798, DOI 10.1021/ja0342998; YASUMOTO T, 1986, AGR BIOL CHEM TOKYO, V50, P793; Nakagawa T, 2006, ANAL BIOCHEM, V352, P142, DOI 10.1016/j.ab.2006.02.010; LEE HW, 1985, J ORG CHEM, V50, P4402, DOI 10.1021/jo00222a046; MOSHER HS, 1964, SCIENCE, V144, P1100, DOI 10.1126/science.144.3622.1100; Asai M, 2001, TETRAHEDRON, V57, P4543, DOI 10.1016/S0040-4020(01)00382-9; BAER HH, 1965, CAN J CHEMISTRY, V43, P3462, DOI 10.1139/v65-487; BALERNA M, 1981, BIOCHIM BIOPHYS ACTA, V644, P219, DOI 10.1016/0005-2736(81)90378-3; BAUDIN G, 1988, HELV CHIM ACTA, V71, P1367, DOI 10.1002/hlca.19880710548; BENDER SL, 1991, J AM CHEM SOC, V113, P9883, DOI 10.1021/ja00026a042; BERGERON RJ, 1987, J ORG CHEM, V52, P1700, DOI 10.1021/jo00385a010; BILLINGTON DC, 1987, CHEM COMMUN, P1011; BONTEMPS J, 1984, ANAL BIOCHEM, V139, P149, DOI 10.1016/0003-2697(84)90400-7; Burgey CS, 1996, J ORG CHEM, V61, P1609, DOI 10.1021/jo951747o; CHAN TH, 1970, TETRAHEDRON LETT, P1137; Chau J, 2011, MAR DRUGS, V9, P2046, DOI 10.3390/md9102046; ENDO A, 1988, TETRAHEDRON LETT, V29, P4127, DOI 10.1016/S0040-4039(00)80434-7; Fernandez-Gonzalez M, 2006, J ORG CHEM, V71, P6767, DOI 10.1021/jo060883y; FERRIER RJ, 1993, CHEM REV, V93, P2779, DOI 10.1021/cr00024a008; FUNABASHI M, 1980, J CHEM SOC PERK T 1, P14, DOI 10.1039/p19800000014; FUNABASHI M, 1976, B CHEM SOC JPN, V49, P788, DOI 10.1246/bcsj.49.788; Gravestock D, 2002, CHEM SOC REV, V31, P195; Hanessian S., 1983, ORGANIC CHEM SERIES, V3, P21; HUCHO F, 1995, ANGEW CHEM INT EDIT, V34, P39, DOI 10.1002/anie.199500391; INCH TD, 1972, CARBOHYD RES, V22, P91, DOI 10.1016/S0008-6215(00)85729-8; Itoh T, 2002, SYNLETT, P1323; KAO CY, 1986, ANN NY ACAD SCI, V479, P52, DOI 10.1111/j.1749-6632.1986.tb15561.x; KARTHA KPR, 1986, TETRAHEDRON LETT, V27, P3415, DOI 10.1016/S0040-4039(00)84810-8; KEANA JFW, 1983, J ORG CHEM, V48, P3627, DOI 10.1021/jo00169a002; KEANA JFW, 1983, J ORG CHEM, V48, P3621, DOI 10.1021/jo00169a001; Khora SS, 1989, TETRAHEDRON LETT, V30, P4393; KIM KS, 1993, TETRAHEDRON LETT, V34, P7195; KINOSHITA M, 1988, B CHEM SOC JPN, V61, P2147, DOI 10.1246/bcsj.61.2147; KISHI Y, 1972, J AM CHEM SOC, V94, P9219, DOI 10.1021/ja00781a039; KISHI Y, 1972, J AM CHEM SOC, V94, P9217, DOI 10.1021/ja00781a038; Kobayashi J, 1999, COMPREHENSIVE NATURA, P415; Koert U, 2004, ANGEW CHEM INT EDIT, V43, P5572, DOI 10.1002/anie.200461097; KOTAKI Y, 1993, J AM CHEM SOC, V115, P827, DOI 10.1021/ja00056a001; Luca LD, 1975, J ORG CHEM, V40, P2764; MATSUZAWA M, 1981, B CHEM SOC JPN, V54, P3505, DOI 10.1246/bcsj.54.3505; MCMURRY JE, 1974, J ORG CHEM, V39, P259, DOI 10.1021/jo00916a037; NARAHASH.T, 1974, PHYSIOL REV, V54, P813; NARAHASHI T, 1964, J GEN PHYSIOL, V47, P965, DOI 10.1085/jgp.47.5.965; Nishikawa T, 2004, ANGEW CHEM INT EDIT, V43, P4782, DOI 10.1002/anie.200460293; Nishikawa T, 2002, ORG LETT, V4, P2679, DOI 10.1021/ol026177a; Nishikawa T, 2013, CHEM REC, V13, P286, DOI 10.1002/tcr.201200025; Nishikawa T, 2004, CHEM-EUR J, V10, P452, DOI 10.1002/chem.200305111; Nishikawa T, 2010, B CHEM SOC JPN, V83, P66, DOI 10.1246/bcsj.20090223; NOGUCHI T, 1986, J BIOCHEM-TOKYO, V99, P311; Noheda P, 2007, Patent No. [EP 1785427 Al 20070516, 1785427, EP 1785427]; Noya B, 2000, J ORG CHEM, V65, P5960, DOI 10.1021/jo000325y; Ohtani Y, 2003, SYNLETT, P619; Otero JM, 2012, TETRAHEDRON, V68, P1612, DOI 10.1016/j.tet.2011.11.072; ROSENTHA.A, 1969, CAN J CHEMISTRY, V47, P4477, DOI 10.1139/v69-738; SAITO T, 1985, B JPN SOC SCI FISH, V51, P1175; Satake Y, 2010, SYNTHESIS-STUTTGART, P1992, DOI 10.1055/s-0029-1218747; Sato K, 1997, B CHEM SOC JPN, V70, P225, DOI 10.1246/bcsj.70.225; SATO K, 1991, CHEM LETT, P1559, DOI 10.1246/cl.1991.1559; SATO K, 1991, CHEM LETT, P17, DOI 10.1246/cl.1991.17; SATO K, 1994, CHEM LETT, P37, DOI 10.1246/cl.1994.37; Sato K, 2002, TETRAHEDRON LETT, V43, P3087, DOI 10.1016/S0040-4039(02)00302-7; SATO K, 1994, B CHEM SOC JPN, V67, P1633, DOI 10.1246/bcsj.67.1633; SATO K, 1991, CHEM LETT, P1469, DOI 10.1246/cl.1991.1469; Sato K, 2005, J ORG CHEM, V70, P7496, DOI 10.1021/jo050342t; SHIMIZU Y, 1983, CHEM PHARM BULL, V31, P3625; SHIMIZU Y, 1986, ANN NY ACAD SCI, V479, P24, DOI 10.1111/j.1749-6632.1986.tb15558.x; SZAREK WA, 1969, CAN J CHEMISTRY, V47, P4473, DOI 10.1139/v69-737; Tahara Y, 1911, BIOCHEM Z, V30, P255; Takahashi H, 2002, YAKUGAKU ZASSHI, V122, P755, DOI 10.1248/yakushi.122.755; Umezawa T, 2006, ORG LETT, V8, P4971, DOI 10.1021/ol062098d; Urabe D, 2006, CHEM-ASIAN J, V1, P125, DOI 10.1002/asia.200600038; Woodward R.B., 1964, PURE APPL CHEM, V9, P49, DOI 10.1351/pac196409010049; Yasumoto T., 1989, KAGAKU TO SEIBUTSU, V27, P401; SATO K, 1979, CARBOHYD RES, V73, P75, DOI 10.1016/S0008-6215(00)85476-2; YOSHIMURA J, 1977, CHEM LETT, P1327, DOI 10.1246/cl.1977.1327; YOSHIMURA J, 1976, B CHEM SOC JPN, V49, P1686, DOI 10.1246/bcsj.49.1686; YOSHIMURA J, 1979, B CHEM SOC JPN, V52, P2630, DOI 10.1246/bcsj.52.2630; SATO KI, 1978, B CHEM SOC JPN, V51, P2116, DOI 10.1246/bcsj.51.2116; Yoshimura J, 1980, ACS SYM SER, V125, P75, DOI 10.1021/bk-1980-0125.ch004; YOSHIMUR.J, 1972, B CHEM SOC JPN, V45, P1806, DOI 10.1246/bcsj.45.1806; YOTSU M, 1992, BIOSCI BIOTECH BIOCH, V56, P370; Yotsu-Yamashita M., 2001, J TOXICOL-TOXIN REV, V20, P50; Yotsu-Yamashita M, 2005, CHEM RES TOXICOL, V18, P865, DOI 10.1021/tx050015g	101	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	MAY	2015	10	5					691	702				12	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CI3SQ	WOS:000354668100003		
J	Deng, WW; Ashihara, H				Deng, Wei-Wei; Ashihara, Hiroshi			Occurrence and De novo Biosynthesis of Caffeine and Theanine in Seedlings of Tea (Camellia sinensis)	NATURAL PRODUCT COMMUNICATIONS			English	Article						Camellia sinensis; Tea; Caffeine; Theanine; Occurrence; Biosynthesis; N-15-metabolism	PURINE ALKALOIDS; PLANTS; METABOLISM; ASSIMILATION; LEAVES	Caffeine (1,3,7-trimethyl xanthine) and theanine (gamma-glutamyl-L-ethylamide) are the major nitrogen-containing secondary metabolites in tea leaves. The aim of the present study was to elucidate the relative concentration and amounts of these compounds and the de novo biosynthetic activity in different parts of tea seedlings grown for 27-, 106- and 205 days. The results indicated that caffeine and its biosynthetic activity occur only in leaves and stems, while theanine is distributed in all organs, including roots. The concentration of caffeine and theanine in leaves ranged from 0.3-1.1 mg N/g and 0.1-0.5 mg N/g fresh weight, respectively. A higher concentration of theanine was found in roots (0.5-1.1 mg N). The total amounts of theanine expressed as g N/seedling were 1.1-1.5 times higher than that of caffeine. The high biosynthetic activity of caffeine from NH4+ was found in young leaves during the first 106 days after germination. Theanine biosynthetic activity probably occurs in roots, since higher N-15 atom% excess was observed in roots during the first 27 days. Theanine may be synthesized mainly in roots and translocated to leaves. The de novo biosynthesis of caffeine and theanine in tea seedlings and their accumulation and translocation are discussed.	[Deng, Wei-Wei] Anhui Agr Univ, State Key Lab Tea Plant Biol & Utilizat, Hefei 230036, Anhui, Peoples R China; [Ashihara, Hiroshi] Ochanomizu Univ, Dept Biol, Fac Sci, Tokyo 1128610, Japan	Ashihara, H (reprint author), Ochanomizu Univ, Dept Biol, Fac Sci, Tokyo 1128610, Japan.	ashihara.hiroshi@ocha.ac.jp					Yang YY, 2013, RUSS J PLANT PHYSL+, V60, P91, DOI 10.1134/S1021443712060180; Ashihara H, 2013, ADV BOT RES, V68, P111, DOI 10.1016/B978-0-12-408061-4.00004-3; Ashihara H, 1999, ADV BOT RES, V30, P117; Ashihara H, 2004, FRONT BIOSCI, V9, P1864, DOI 10.2741/1367; Ashihara H, 1997, PHYSIOL PLANTARUM, V100, P909, DOI 10.1034/j.1399-3054.1997.1000417.x; Ashihara H, 1997, PLANT CELL PHYSIOL, V38, P413; ASHIHARA H, 1986, PHYSIOL PLANTARUM, V68, P275, DOI 10.1111/j.1399-3054.1986.tb01926.x; Ashihara H, 2015, NAT PROD COMMUN, V10, P803; Deng WW, 2009, Z NATURFORSCH C, V64, P387; Deng WW, 2008, PHYTOCHEM LETT, V1, P115, DOI 10.1016/j.phytol.2008.06.002; Ito E, 1999, J PLANT PHYSIOL, V154, P145; Konishi S, 1968, NIPPON DOJOUHIRYOUGA, V39, P439; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Oh K, 2008, PEDOSPHERE, V18, P222, DOI 10.1016/S1002-0160(08)60010-7; SUZUKI T, 1992, PHYTOCHEMISTRY, V31, P2575, DOI 10.1016/0031-9422(92)83590-U	15	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	MAY	2015	10	5					703	706				4	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CI3SQ	WOS:000354668100004		
J	Yin, YL; Katahira, R; Ashihara, H				Yin, Yuling; Katahira, Riko; Ashihara, Hiroshi			Metabolism of Purine Alkaloids and Xanthine in Leaves of Mate (Ilex paraguariensis)	NATURAL PRODUCT COMMUNICATIONS			English	Article						Ilex paraguariensis (mate); Caffeine; Theobromine; Theophylline; Methylxanthine; Xanthine	COFFEA-ARABICA; HIGHER-PLANTS; CAFFEINE; BIOSYNTHESIS; CATABOLISM; THEOBROMINE; 7-METHYLXANTHINE; METHYLXANTHINES; LEAF	Accumulation and metabolism of purine alkaloids in leaves of mate (Ilex paraguariensis) were investigated. In winter, leaves accumulated caffeine but not theobromine, indicating that caffeine is the end product of purine alkaloid synthesis in mate. To elucidate the purine alkaloid metabolism in mate leaves, the metabolic fate of [8-C-14]theobromine, [8-C-14]theophylline, [8-C-14]caffeine and [8-C-14] xanthine was investigated in the leaf disks of young and mature leaves. In young mate leaves, significant amounts of theobromine and theophylline were utilized for caffeine biosynthesis, but the conversion was not observed in mature leaves. A small amount of theophylline was converted to theobromine. Practically no caffeine catabolism was detected in mate leaves during a 24 h-incubation. Catabolism of theobromine and theophylline via 3-methylxanthine was observed mainly in mature leaves. Xanthine was catabolised extensively via ureides in both young and mature leaves, but limited amounts are also utilized for the synthesis of theobromine, theophylline and caffeine. Possible pathways for the metabolism of purine alkaloids in mate leaves are discussed.	[Yin, Yuling] Dalian Med Univ, Dept Biotechnol, Dalian 116044, Peoples R China; [Katahira, Riko] Kobe Shoin Womens Univ, Dept Lifestyle Studies, Kobe, Hyogo 6570015, Japan; [Ashihara, Hiroshi] Ochanomizu Univ, Dept Biol, Fac Sci, Tokyo 1128610, Japan	Ashihara, H (reprint author), Ochanomizu Univ, Dept Biol, Fac Sci, Tokyo 1128610, Japan.	ashihara.hiroshi@ocha.ac.jp					ALIKARIDIS F, 1987, J ETHNOPHARMACOL, V20, P121, DOI 10.1016/0378-8741(87)90084-5; Ashihara H, 2013, ADV BOT RES, V68, P111, DOI 10.1016/B978-0-12-408061-4.00004-3; Stasolla C, 2003, J PLANT PHYSIOL, V160, P1271, DOI 10.1078/0176-1617-01169; Reginatto FH, 1999, J BRAZIL CHEM SOC, V10, P443; Ashihara H, 2008, PHYTOCHEMISTRY, V69, P841, DOI 10.1016/j.phytochem.2007.10.029; Ashihara H, 1999, ADV BOT RES, V30, P117; Ashihara H, 2004, FRONT BIOSCI, V9, P1864, DOI 10.2741/1367; Koshiro Y, 2006, PLANT SCI, V171, P242, DOI 10.1016/j.plantsci.2006.03.017; CLIFFORD MN, 1990, FOOD CHEM, V35, P13, DOI 10.1016/0308-8146(90)90126-O; Ashihara Hiroshi, 2006, Brazilian Journal of Plant Physiology, V18, P1, DOI 10.1590/S1677-04202006000100001; Ashihara H, 2001, TRENDS PLANT SCI, V6, P407, DOI 10.1016/S1360-1385(01)02055-6; Ashihara H, 1996, PLANTA, V198, P334, DOI 10.1007/BF00620048; Ashihara H, 1997, PLANT CELL PHYSIOL, V38, P413; ASHIHARA H, 1993, PHYTOCHEMISTRY, V33, P1427, DOI 10.1016/0031-9422(93)85103-X; Ashihara H, 2011, METHYLXANTHINES HDB, P11; Cardozo EL, 2007, J FOOD COMPOS ANAL, V20, P553, DOI 10.1016/j.jfca.2007.04.007; Coelho GC, 2007, BIOCHEM SYST ECOL, V35, P75, DOI 10.1016/j.bse.2006.09.001; Coelho G. C., 2001, Revista Brasileira de Ciências Farmacêuticas, V37, P153; Deng WW, 2010, PLANT CELL PHYSIOL, V51, P2105, DOI 10.1093/pcp/pcq175; Ito E, 1997, BBA-GEN SUBJECTS, V1336, P323, DOI 10.1016/S0304-4165(97)00045-7; Kato M, 1996, PHYSIOL PLANTARUM, V98, P629, DOI 10.1034/j.1399-3054.1996.980325.x; Koyama Y, 2003, PLANT PHYSIOL BIOCH, V41, P977, DOI 10.1016/j.plaphy.2003.07.002; Marx F, 2003, PLANT FOOD HUM NUTR, V58, P1, DOI 10.1023/B:QUAL.0000041144.28025.fc; Mazzafera Paulo, 1994, Revista Brasileira de Fisiologia Vegetal, V6, P149; MAZZAFERA P, 1993, J AGR FOOD CHEM, V41, P1541, DOI 10.1021/jf00034a002; SUZUKI T, 1975, BIOCHEM J, V146, P87; Suzuki T, 1988, MOD METHOD PLANT, V8, P184; Yin YuLing, 2014, European Chemical Bulletin, V3, P925; Zrenner R, 2011, PLANT METABOLISM BIO, P135	29	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	MAY	2015	10	5					707	712				6	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CI3SQ	WOS:000354668100005		
J	Takahashi, K; Yoshida, K; Sakuta, M				Takahashi, Kana; Yoshida, Kazuko; Sakuta, Masaaki			Comparative Analysis of Two DOPA Dioxygenases from Phytolacca americana	NATURAL PRODUCT COMMUNICATIONS			English	Article						Betalains; Betalamic acid; Caryophyllales; DOPA dioxygenase; Phytolacca americana	PORTULACA-GRANDIFLORA; PLANT PIGMENTS; BIOSYNTHESIS; BETALAINS; ANTHOCYANINS; BETACYANINS; GENETICS	The comparative analysis of two Phytolacca americana DOPA dioxygenases (PaDOD1 and PaDOD2) that may be involved in betalain biosynthesis was carried out. The recombinant protein of PaDOD1 catalyzed the conversion of DOPA to betalamic acid, whereas DOD activity was not detected in PaDOD2 in vitro. The role of DOD genes is discussed in the evolutionary context using phylogenetic analysis, suggesting that DOD might have been duplicated early in evolution and that accumulation of base substitutions could have led to the different characteristics of DODs within the betalain-producing Caryophyllales.	[Takahashi, Kana; Yoshida, Kazuko; Sakuta, Masaaki] Ochanomizu Univ, Dept Biol Sci, Tokyo 1128610, Japan	Takahashi, K (reprint author), Ochanomizu Univ, Dept Biol Sci, Tokyo 1128610, Japan.	sakuta.masaaki@ocha.ac.jp					Steiner U, 1999, PLANTA, V208, P114, DOI 10.1007/s004250050541; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; JOY RW, 1995, PLANT PHYSIOL, V107, P1083, DOI 10.1104/pp.107.4.1083; Gandia-Herrero F, 2013, TRENDS PLANT SCI, V18, P334, DOI 10.1016/j.tplants.2013.01.003; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Hatlestad GJ, 2012, NAT GENET, V44, P816, DOI 10.1038/ng.2297; Strack D, 2003, PHYTOCHEMISTRY, V62, P247, DOI 10.1016/S0031-9422(02)00564-2; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Christinet L, 2004, PLANT PHYSIOL, V134, P265, DOI 10.1104/pp.103.031914; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sakuta M, 2014, PLANT BIOTECHNOL REP, V8, P37, DOI 10.1007/s11816-013-0294-z; Sakuta M, 2011, PLANT METABOLISM BIO, P343; Takahashi K, 2009, Z NATURFORSCH C, V64, P564; TREZZINI GF, 1991, PHYTOCHEMISTRY, V30, P1897, DOI 10.1016/0031-9422(91)85035-X; VONELBE JH, 1972, J FOOD SCI, V37, P932; Yamamoto K, 2001, PLANT CELL PHYSIOL, V42, P969, DOI 10.1093/pcp/pce125	17	1	1	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	MAY	2015	10	5					713	716				4	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CI3SQ	WOS:000354668100006		
J	Takahashi, K; Yoshida, K; Yura, K; Ashihara, H; Sakuta, M				Takahashi, Kana; Yoshida, Kazuko; Yura, Kei; Ashihara, Hiroshi; Sakuta, Masaaki			Biochemical Analysis of Phytolacca DOPA Dioxygenase	NATURAL PRODUCT COMMUNICATIONS			English	Article						Betalains; Betalamic acid; Caryophyllales; DOPA dioxygenase; Phytolacca americana	PORTULACA-GRANDIFLORA; AMANITA-MUSCARIA; PLANT PIGMENTS; BIOSYNTHESIS; BETALAINS; 4,5-DIOXYGENASE; ANTHOCYANINS	The biochemical analysis of Phytolacca americana DOPA dioxygenases (PaDOD1 and PaDOD2) was carried out. The recombinant protein of PaDOD1 catalyzed the conversion of DOPA to betalamic acid, whereas DOD activity was not detected in PaDOD2 in vitro. While the reported motif conserved in DODs from betalain-producing plants was found in PaDOD1, a single amino acid residue alteration was detected in PaDOD2. A mutated PaDOD1 protein with a change of 177 Asn to Gly showed reduced specific activity compared with PaDOD1, while DOPA dioxygenase activity was not observed for a mutated PaDOD2 protein which had its conserved motif replaced with that of PaDOD1. A three-dimensional (3D) structural model of PaDOD1 and PaDOD2 showed that the conserved motif in DODs was located in the N-terminal side of a loop, which was found close to the putative active site. The difference in stability of the loop may affect the enzymatic activity of PaDOD2.	[Takahashi, Kana; Yoshida, Kazuko; Yura, Kei; Ashihara, Hiroshi; Sakuta, Masaaki] Ochanomizu Univ, Dept Biol Sci, Tokyo 1128610, Japan	Takahashi, K (reprint author), Ochanomizu Univ, Dept Biol Sci, Tokyo 1128610, Japan.	sakuta.masaaki@ocha.ac.jp			Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	K.Y. was supported by Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.0.CO;2-7; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Christinet L, 2004, PLANT PHYSIOL, V134, P265, DOI 10.1104/pp.103.031914; Gandia-Herrero F, 2014, APPL MICROBIOL BIOT, V98, P1165, DOI 10.1007/s00253-013-4961-3; GIROD PA, 1991, PHYTOCHEMISTRY, V30, P169, DOI 10.1016/0031-9422(91)84119-D; Hinz UG, 1997, MOL GEN GENET, V256, P1; Mueller LA, 1997, PLANTA, V203, P260, DOI 10.1007/s004250050190; Mueller LA, 1997, PHYTOCHEMISTRY, V44, P567, DOI 10.1016/S0031-9422(96)00625-5; Sakuta M, 2014, PLANT BIOTECHNOL REP, V8, P37, DOI 10.1007/s11816-013-0294-z; Sakuta M, 2011, PLANT METABOLISM BIO, P343; Sasaki N, 2009, PLANT CELL PHYSIOL, V50, P1012, DOI 10.1093/pcp/pcp053; Takahashi K, 2009, Z NATURFORSCH C, V64, P564; Takahashi K, 2015, NAT PROD COMMUN, V10, P713	14	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	MAY	2015	10	5					717	719				3	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CI3SQ	WOS:000354668100007		
J	Wasano, N; Takemura, T; Ismil, R; Bakar, B; Fujii, Y				Wasano, Naoya; Takemura, Tomoko; Ismil, Raihan; Bakar, Baki; Fujii, Yoshiharu			Transcriptomic Evaluation of Plant Growth Inhibitory Activity of Goniothalamin from the Malaysian Medicinal Plant Goniothalamus andersonii	NATURAL PRODUCT COMMUNICATIONS			English	Article						Transcriptome; DNA microarray; Goniothalamin; Plant growth inhibitory; Heat shock proteins; Expansins; alpha,beta-Unsaturated carbonyl groups	HEAT-SHOCK PROTEINS	Goniothalamin produced by the Malaysian medicinal plant, Goniothalamus andersonii J. Sinclair, strongly inhibits plant growth. However, its mode of action has not been characterized at the gene expression level. We conducted DNA microarray assay to analyze the changes in early gene responses of Arabidopsis thaliana seedlings. After a 6-h exposure to goniothalamin, we observed an upregulation of genes highly associated with heat response, and 22 heat shock protein (AtHSP) genes were upregulated more than 50 fold. Together with these genes, we observed upregulation of the genes related to oxidative stress and protein folding. Also, the genes related to cell wall modification and cell growth, expansin (AtEXPA) genes, were significantly downregulated. The results suggested that goniothalamin induces oxidative stresses and inhibits the expression of cell wall-associated proteins resulting in growth inhibition of Arabidopsis seedlings.	[Wasano, Naoya; Fujii, Yoshiharu] Tokyo Univ Agr & Technol, Dept Int Environm Agr Sci, Fuchu, Tokyo 1838509, Japan; [Takemura, Tomoko; Ismil, Raihan] Natl Inst Agroenvironm Sci, Biodivers Div, Tsukuba, Ibaraki 3058604, Japan; [Bakar, Baki] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur 50603, Malaysia	Fujii, Y (reprint author), Tokyo Univ Agr & Technol, Dept Int Environm Agr Sci, 3-5-8 Saiwai Chou, Fuchu, Tokyo 1838509, Japan.	yfujii@cc.tuat.ac.jp			Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN), Tokyo, Japan; Ministry of Agriculture, Forestry and Fisheries of Japan [25029AB]	This research was supported by the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN), Tokyo, Japan. This research was also supported by the grant-in-aid for the research on Agriculture and Food Science (25029AB) from the Ministry of Agriculture, Forestry and Fisheries of Japan.	de Fatima A, 2005, BIOORGAN MED CHEM, V13, P2927, DOI 10.1016/j.bmc.2005.02.007; Timperio AM, 2008, J PROTEOMICS, V71, P391, DOI 10.1016/j.jprot.2008.07.005; Baerson SR, 2005, J BIOL CHEM, V280, P21867, DOI 10.1074/jbc.M500694200; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Chen WY, 2005, EUR J PHARMACOL, V522, P20, DOI 10.1016/j.ejphar.2005.08.047; Saunders RMK, 2003, BOT J LINN SOC, V142, P321, DOI 10.1046/j.1095-8339.2003.00177.x; Mirabella R, 2008, PLANT J, V53, P197, DOI 10.1111/j.1365-313X.2007.03323.x; Du Z., 2010, NUCLEIC ACIDS RES, V38, P64; Rudolph TK, 2014, SCI SIGNAL, V2, P1; Sharma Jha AB, 2012, J BOT, V2012, P1; Taiz L, 2002, PLANT PHYSIOL, VThird, P1; Takemura T, 2012, NAT PROD COMMUN, V7, P1197; Wasano N, 2014, J PESTIC SCI, V39, P85, DOI 10.1584/jpestics.D13-090; Wei Peng-Cheng, 2011, Plant Signal Behav, V6, P740	14	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	MAY	2015	10	5					725	727				3	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CI3SQ	WOS:000354668100009		
J	Kato-Noguchi, H; Kitajima, S				Kato-Noguchi, Hisashi; Kitajima, Shinya			Momilactone Sensitive Proteins in Arabidopsis thaliana	NATURAL PRODUCT COMMUNICATIONS			English	Article						Allelopathy; Growth inhibition; Metabolic inhibition; Momilactone; Stress protein	CONTROLLED TUMOR PROTEIN; RICE ORYZA-SATIVA; DEFENSE RESPONSES; ALLELOPATHY; GERMINATION; IDENTIFICATION; ACCUMULATION; RHIZOSPHERE; DORMANCY; RELEASE	The labdane-related diterpenoid, momilactone B has potent growth inhibitory activity and was demonstrated to play a particularly critical role in the allelopathy of rice (Oryza saliva L.). However, there is limited information available about the mode of action of momilactone B on the growth inhibition. The present research describes the effects of momilactone B on protein expression in the early development of Arabidopsis thaliana seedling, which was determined by two-dimensional electrophoresis and MALDI-TOFMS. Momilactone B inhibited the accumulation of subtilisin-like serine protease, amyrin synthase LUP2, beta-glucosidase and malate synthase at 1 h after the momilactone application. Those proteins are involved in the metabolic turnover and the production of intermediates needed for cell structures resulting in plant growth and development. Momilactone B also inhibited the breakdown of cruciferin 2, which is essential for seed germination and seedling growth to construct cell structures. Momilactone B induced the accumulation of translationally controlled tumor protein, glutathione S-transferase and 1-cysteine peroxiredoxin 1. These proteins are involved in stress responses and increased stress tolerance. In addition, glutathione S-transferase has the activity of herbicide detoxification and 1-cysteine peroxiredoxin 1 has inhibitory activity for seed germination under unfavorable conditions. The present research suggests that momilactone B may inhibit the seedling growth by the inhibition of the metabolic turnover and the production of intermediates for cell structures. In addition, momilactone induced proteins associated with plant defense responses.	[Kato-Noguchi, Hisashi; Kitajima, Shinya] Kagawa Univ, Dept Appl Biol Sci, Fac Agr, Miki, Kagawa 7610795, Japan	Kato-Noguchi, H (reprint author), Kagawa Univ, Dept Appl Biol Sci, Fac Agr, Miki, Kagawa 7610795, Japan.	hisashi@ag.kagawa-u.ac.jp			JSPS [22380016]	This research was supported by a JSPS Grant-in-Aid for Scientific Research (No. 22380016) to H.K-N.	Khanh TD, 2007, ANN APPL BIOL, V151, P325, DOI 10.1111/j.1744-7348.2007.00183.x; Kato-Noguchi H, 2013, J CHEM ECOL, V39, P175, DOI 10.1007/s10886-013-0236-9; Olofsdotter M, 1999, WEED RES, V39, P441, DOI 10.1046/j.1365-3180.1999.00159.x; Bommer UA, 2004, INT J BIOCHEM CELL B, V36, P379, DOI 10.1016/S1357-2725(03)00213-9; Halim VA, 2006, PLANT BIOLOGY, V8, P307, DOI 10.1055/s-2006-924025; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Kim YM, 2012, MOL CELLS, V33, P617, DOI 10.1007/s10059-012-0080-8; Carrera E, 2008, PLANT J, V53, P214, DOI 10.1111/j.1365-313X.2007.03331.x; Job C, 2005, PLANT PHYSIOL, V138, P790, DOI 10.1104/pp.105.062778; Hasegawa M, 2010, MOL PLANT MICROBE IN, V23, P1000, DOI 10.1094/MPMI-23-8-1000; Kato-Noguchi H, 2009, PLANT GROWTH REGUL, V59, P153, DOI 10.1007/s10725-009-9398-4; Haslekas C, 2003, PLANT PHYSIOL, V133, P1148, DOI 10.1104/pp.103.025916; Gruis DF, 2004, PLANT CELL, V16, P270, DOI 10.1105/tpc.016378; Kato-Noguchi H, 2013, WEED BIOL MANAG, V13, P19, DOI 10.1111/wbm.12005; Bi HH, 2007, J CHEM ECOL, V33, P1089, DOI 10.1007/s10886-007-9286-1; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Xu MM, 2012, NEW PHYTOL, V193, P570, DOI 10.1111/j.1469-8137.2011.04005.x; Rautengarten C, 2008, PLANT J, V54, P466, DOI 10.1111/j.1365-313X.2008.03437.x; Kato-Noguchi H, 2003, FUNCT PLANT BIOL, V30, P995, DOI 10.1071/FP03110; Fanucchi F, 2012, BBA-PROTEINS PROTEOM, V1824, P813, DOI 10.1016/j.bbapap.2012.03.015; Ohyama K, 2009, P NATL ACAD SCI USA, V106, P725, DOI 10.1073/pnas.0807675106; Gallardo K, 2002, PLANT PHYSIOL, V129, P823, DOI 10.1104/pp.002816; Berkowitz O, 2008, PLANT CELL, V20, P3430, DOI 10.1105/tpc.108.061010; FINKELSTEIN RR, 1985, PLANT PHYSIOL, V78, P630, DOI 10.1104/pp.78.3.630; Azmi M., 2000, Journal of Tropical Agriculture and Food Science, V28, P39; Bewley J. D., 1994, SEEDS PHYSL DEV GERM; Chen J, 2011, ZOOKEYS, P11, DOI 10.3897/zookeys.111.1284; Chen Y, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-33; Dalton BR, 1999, PRINCIPLES AND PRACTICES IN PLANT ECOLOGY, P57; Dilday R. H., 1989, P ARKANSAS ACAD SCI, V43, P21; Eastmond PJ, 2001, TRENDS PLANT SCI, V6, P72, DOI 10.1016/S1360-1385(00)01835-5; Jung R, 1998, PLANT CELL, V10, P343, DOI 10.1105/tpc.10.3.343; Kato-Noguchi H, 2010, J PLANT PHYSIOL, V167, P787, DOI 10.1016/j.jplph.2010.01.014; Kato-Noguchi H, 2008, ALLELOPATHY J, V22, P321; Kato-Noguchi H, 2007, J PLANT PHYSIOL, V164, P1548, DOI 10.1016/j.jplph.2006.12.008; Kato-Noguchi H, 2008, J PLANT PHYSIOL, V165, P691, DOI 10.1016/j.jplph.2007.07.018; Kato-Noguchi H, 2013, J RICE RES, V1, P108; Kato-Noguchi H, 2011, J PLANT PHYSIOL, V168, P1016, DOI 10.1016/j.jplph.2010.12.021; Kato-Noguchi H, 2001, BIOL PLANTARUM, V44, P635, DOI 10.1023/A:1013731828945; Kato-Noguchi H, 2012, J PLANT PHYSIOL, V169, P1471, DOI 10.1016/j.jplph.2012.05.022; Kato-Noguchi H, 2002, PHYSIOL PLANTARUM, V115, P401, DOI 10.1034/j.1399-3054.2002.1150310.x; Kim KU, 1999, KOREAN J WEED SCI, V19, P1; Kim Sangsoo, 2011, Genomics & Informatics, V9, P1; Kuroha T, 2009, PHYSIOL PLANTARUM, V137, P281, DOI 10.1111/j.1399-3054.2009.01281.x; MACKINTOSH C, 1994, PLANT J, V5, P137, DOI 10.1046/j.1365-313X.1994.5010137.x; Neuefeind T, 1997, BIOL CHEM, V378, P199; Rakwal R, 2001, PHYSIOL PLANTARUM, V111, P151, DOI 10.1034/j.1399-3054.2001.1110204.x; Rimando AM, 2003, RICE ORIGIN HIST TEC, P221; Rylott EL, 2001, BIOCHEM SOC T, V29, P283, DOI 10.1042/0300-5127:0290283; Shibuya M, 2009, PLANT PHYSIOL BIOCH, V47, P26, DOI 10.1016/j.plaphy.2008.09.007; Stacy RAP, 1999, PLANT J, V19, P1, DOI 10.1046/j.1365-313X.1999.00488.x; YAMADA A, 1993, BIOSCI BIOTECH BIOCH, V57, P405	53	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	MAY	2015	10	5					729	732				4	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CI3SQ	WOS:000354668100010		
J	Deng, WW; Sasamoto, H; Ashihara, H				Deng, Wei-Wei; Sasamoto, Hamako; Ashihara, Hiroshi			Effect of Caffeine on the Expression Pattern of Water-Soluble Proteins in Rice (Oryza sativa) Seedlings	NATURAL PRODUCT COMMUNICATIONS			English	Article						Allelopathy; Effect of caffeine; Protein expression; Rice seedling	POLYACRYLAMIDE-GELS; PURINE ALKALOIDS; PHASEOLUS-MUNGO; SEEDS; PLANTS; BIOSYNTHESIS; GERMINATION; ALLELOPATHY; METABOLISM; ENZYMES	It has been suggested that caffeine acts as an allelochemical which influences the germination and growth of plants. The effect of caffeine on the expression profiles of proteins was investigated in shoot-root axes of rice (Oryza sativa) seedlings. Two-dimensional difference gel electrophoresis combined with Matrix-Assisted Laser Desorption/Ionization Time of Flight/Time of Flight Mass Spectrometry was employed for the separation and identification of proteins. The results indicated that amounts of 51 protein spots were reduced and 14 were increased by treatment with 1 mM caffeine. Twelve rice seedling proteins were identified. Down-regulated proteins were beta-tubulin, sucrose synthase, glyceraldehyde-3-phosphate dehydrogenase, reversibly glycosylated polypeptide/alpha-1,4-glucan protein synthase and cytoplasmic malate dehydrogenase. In contrast, up-regulated proteins were alanyl-aminopeptidase, acetyl-CoA carboxylase, adenine phosphoribosyltransferase, NAD-malate dehydrogenase, ornithine carbamoyltransferase, glucose-6-phosphate isomerase and nuclear RNA binding protein. Possible alternation of metabolism caused by caffeine is discussed with the protein expression data.	[Deng, Wei-Wei] Anhui Agr Univ, Minist Educ, Key Lab Tea Biochem & Biotechnol, Hefei 230036, Anhui, Peoples R China; [Deng, Wei-Wei] Anhui Agr Univ, Minist Agr, Hefei 230036, Anhui, Peoples R China; [Sasamoto, Hamako] Yokohama Natl Univ, Fac Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan; [Ashihara, Hiroshi] Ochanomizu Univ, Dept Biol, Fac Sci, Tokyo 1128610, Japan	Ashihara, H (reprint author), Ochanomizu Univ, Dept Biol, Fac Sci, Tokyo 1128610, Japan.	ashihara.hiroshi@ocha.ac.jp					Stasolla C, 2003, J PLANT PHYSIOL, V160, P1271, DOI 10.1078/0176-1617-01169; Slocum RD, 2005, PLANT PHYSIOL BIOCH, V43, P729, DOI 10.1016/j.plaphy.2005.06.007; GIETL C, 1992, BIOCHIM BIOPHYS ACTA, V1100, P217, DOI 10.1016/0167-4838(92)90476-T; Ashihara H, 1999, ADV BOT RES, V30, P117; SUZUKI T, 1987, PLANT SOIL, V98, P131, DOI 10.1007/BF02381733; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; BEEVERS L, 1968, PHYTOCHEMISTRY, V7, P1837, DOI 10.1016/S0031-9422(00)86656-X; Shah K, 1998, ACTA PHYSIOL PLANT, V20, P189, DOI 10.1007/s11738-998-0013-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; ASHIHARA H, 1983, Z PFLANZENPHYSIOL, V113, P47; Baskin T, 2000, BIOCH MOL BIOL PLANT, P202; Carpita N, 2000, BIOCH MOL BIOL PLANT, P52; Dennis D. T., 2000, BIOCH MOL BIOL PLANT, P630; Jaganath IB, 2011, PLANT METABOLISM BIO, P293; KEENE JD, 1991, PROG NUCLEIC ACID RE, V41, P179; Rice EL, 1984, ALLELOPATHY; RIZVI SJH, 1981, AGR BIOL CHEM TOKYO, V45, P1255; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Siedow J. N., 2000, BIOCH MOL BIOL PLANT, P676; Somerville C, 2000, BIOCH MOL BIOL PLANT, P456; WALLER GR, 1989, BIOL PLANTARUM, V31, P418, DOI 10.1007/BF02876217	21	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	MAY	2015	10	5					733	736				4	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CI3SQ	WOS:000354668100011		
J	Deng, WW; Katahira, R; Ashihara, H				Deng, Wei-Wei; Katahira, Riko; Ashihara, Hiroshi			Short Term Effect of Caffeine on Purine, Pyrimidine and Pyridine Metabolism in Rice (Oryza sativa) Seedlings	NATURAL PRODUCT COMMUNICATIONS			English	Article						Oryza saliva; Rice; Allelopathy; Caffeine; Metabolism; Purine; Pyridine; Pyrimidine	TUBEROSUM L. TUBERS; COFFEA-ARABICA; CATHARANTHUS-ROSEUS; HIGHER-PLANTS; BIOSYNTHESIS; ALKALOIDS; SALVAGE; CATABOLISM; PROFILES; CELLS	As part of our studies on the physiological and ecological function of caffeine, we investigated the effect of exogenously supplied caffeine on purine, pyrimidine and pyridine metabolism in rice seedlings. We examined the effect of 1 mM caffeine on the in situ metabolism of C-14-labelled adenine, guanine, inosine, uridine, uracil, nicotinamide and nicotinic acid. The segments of 4-day-old dark-grown seedlings were incubated with these labelled compounds for 6 h. For purines, the incorporation of radioactivity from [8-C-14]adenine and [8-C-14]guanine into nucleotides was enhanced by caffeine; in contrast, incorporation into CO2 were reduced. The radioactivity in ureides (allantoin and allantoic acid) from [8-C-14]guanine and [8-C-14]inosine was increased by caffeine. For pyrimidines, caffeine enhanced the incorporation of radioactivity from [2-C-14]uridine into nucleotides, which was accompanied by a decrease in pyrimidine catabolism. Such difference was not found in the metabolism of [2-C-14]uracil. Caffeine did not influence the pyridine metabolism of [carbonyl-C-14]-nicotinamide and [2-C-14]nicotinic acid. The possible control steps of caffeine on nucleotide metabolism in rice are discussed.	[Deng, Wei-Wei] Anhui Agr Univ, Minist Educ, Key Lab Tea Biochem & Biotechnol, Hefei 230036, Anhui, Peoples R China; [Deng, Wei-Wei] Anhui Agr Univ, Minist Agr, Hefei 230036, Anhui, Peoples R China; [Katahira, Riko] Kobe Shoin Womens Univ, Dept Lifestyle Studies, Kobe, Hyogo 6570015, Japan; [Ashihara, Hiroshi] Ochanomizu Univ, Dept Biol, Fac Sci, Tokyo 1128610, Japan	Ashihara, H (reprint author), Ochanomizu Univ, Dept Biol, Fac Sci, Tokyo 1128610, Japan.	ashihara.hiroshi@ocha.ac.jp					Werner AK, 2011, TRENDS PLANT SCI, V16, P381, DOI 10.1016/j.tplants.2011.03.012; Zheng XQ, 2004, PLANT SCI, V166, P807, DOI 10.1016/j.plantsci.2003.11.024; Ashihara H, 2013, ADV BOT RES, V68, P111, DOI 10.1016/B978-0-12-408061-4.00004-3; Stasolla C, 2003, J PLANT PHYSIOL, V160, P1271, DOI 10.1078/0176-1617-01169; Katahira R, 2002, PLANTA, V215, P821, DOI 10.1007/s00425-002-0806-5; Ashihara H, 2012, J PLANT RES, V125, P781, DOI 10.1007/s10265-012-0490-x; Ashihara H, 2008, PHYTOCHEMISTRY, V69, P841, DOI 10.1016/j.phytochem.2007.10.029; Ashihara H, 1999, ADV BOT RES, V30, P117; Anaya AL, 2006, FRONT BIOSCI, V11, P2354, DOI 10.2741/1975; KANAMORIFUKUDA I, 1981, J EXP BOT, V32, P69, DOI 10.1093/jxb/32.1.69; Watanabe S, 2014, PLANT CELL ENVIRON, V37, P1022, DOI 10.1111/pce.12218; Ashihara H, 2004, FRONT BIOSCI, V9, P1864, DOI 10.2741/1367; Hollingsworth RG, 2002, NATURE, V417, P915, DOI 10.1038/417915a; FRIEDMAN J, 1983, J CHEM ECOL, V9, P1099, DOI 10.1007/BF00982214; Yin Y, 2007, J EXP BOT, V58, P1025, DOI 10.1093/jxb/erl264; SUZUKI T, 1987, PLANT SOIL, V98, P131, DOI 10.1007/BF02381733; Matsui A, 2007, PHYSIOL PLANTARUM, V131, P191, DOI 10.1111/j.1399-3054.2007.00959.x; Ashihara H, 2011, PLANT METABOLISM BIO, P163; CHOU CH, 1980, J CHEM ECOL, V6, P643, DOI 10.1007/BF00987675; Crozier A, 2012, TEAS COCOA COFFEE PL; Deng WW, 2010, PLANT CELL PHYSIOL, V51, P2105, DOI 10.1093/pcp/pcq175; FRIEDMAN J, 1985, TRENDS BIOCHEM SCI, V10, P47, DOI 10.1016/0968-0004(85)90224-5; Katahira R, 2006, PHYSIOL PLANTARUM, V127, P38, DOI 10.1111/j.1399-3054.2006.00658.x; Katahira R, 2006, PLANTA, V225, P115, DOI 10.1007/s00425-006-0334-9; Moffatt Barbara A, 2002, Arabidopsis Book, V1, pe0018, DOI 10.1199/tab.0018; Rice EL, 1984, ALLELOPATHY; RIZVI SJH, 1981, AGR BIOL CHEM TOKYO, V45, P1255; SHIMAZAKI A, 1982, ANN BOT-LONDON, V50, P531; SMYTH DA, 1992, J PLANT GROWTH REGUL, V11, P125, DOI 10.1007/BF00198025; Yin YuLing, 2014, European Chemical Bulletin, V3, P925; Zrenner R, 2011, PLANT METABOLISM BIO, P135	31	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	MAY	2015	10	5					737	741				5	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CI3SQ	WOS:000354668100012		
J	Maninang, JS; Okazaki, S; Fujii, Y				Maninang, John S.; Okazaki, Shin; Fujii, Yoshiharu			Cyanamide Phytotoxicity in Soybean (Glycine max) Seedlings involves Aldehyde Dehydrogenase Inhibition and Oxidative Stress	NATURAL PRODUCT COMMUNICATIONS			English	Article						Cyanamide; Soybean; Oxidative stress; Aldehyde dehydrogenase; Succinic-semialdehyde dehydrogenase	SUCCINIC-SEMIALDEHYDE DEHYDROGENASE; LIPID-PEROXIDATION; PLANTS; MITOCHONDRIA; EXPRESSION; PRODUCTS; PROTECTS; SHUNT	The phytotoxic effect of the allelochemical cyanamide has been well-documented yet the underlying mechanism for this phenomenon has not been fully characterized. Cognizant of the putative inhibitory effect of cyanamide on aldehyde dehydrogenases (ALDHs), we hereby show that the capacity of mitochondrial preparations from cyanamide-treated soybean seedlings to oxidize acetaldehyde and succinic-semialdehyde was dose-dependently reduced to at most 55% and 70%, respectively. Cyanamide-treated plants exhibited oxidative stress (i.e. increased lipid peroxidation and H2O2 accumulation) that was exacerbated upon exposure to UV-A - symptoms reminiscent of ALDH and succinic-semialdehyde dehydrogenase (SSADH) knock-out Arabidopsis mutants. We suggest that the inhibition of mitochondrial ALDH and SSADH may be a contributory mechanism to the burst in oxidative stress mediated by cyanamide.	[Maninang, John S.] Univ Tokyo, Coll Arts & Sci, Tokyo 1538902, Japan; [Maninang, John S.; Okazaki, Shin; Fujii, Yoshiharu] Tokyo Univ Agr & Technol, Dept Int Environm & Agr Sci, Fac Agr, Fuchu, Tokyo 1838509, Japan	Maninang, JS (reprint author), Univ Tokyo, Coll Arts & Sci, Tokyo 1538902, Japan.	maninang@gmail.com; yfujii@cc.tuat.ac.jp	OKAZAKI, Shin/G-1164-2013	OKAZAKI, Shin/0000-0002-6406-720X			Amberger A., 2013, International Journal of Plant Physiology and Biochemistry, V5, P1; Mano J, 2012, PLANT PHYSIOL BIOCH, V59, P90, DOI 10.1016/j.plaphy.2012.03.010; Kotchoni SO, 2006, PLANT CELL ENVIRON, V29, P1033, DOI 10.1111/j.1365-3040.2005.01458.x; NIR G, 1986, PLANT PHYSIOL, V81, P1140, DOI 10.1104/pp.81.4.1140; Shin JH, 2009, PLANT PHYSIOL, V149, P905, DOI 10.1104/pp.108.130716; Loreto F, 2001, PLANT PHYSIOL, V127, P1781, DOI 10.1104/pp.127.4.1781; Soltys D, 2011, PLANTA, V234, P609, DOI 10.1007/s00425-011-1429-5; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fait A, 2008, TRENDS PLANT SCI, V13, P14, DOI 10.1016/j.tplants.2007.10.005; Weir TL, 2004, CURR OPIN PLANT BIOL, V7, P472, DOI 10.1016/j.pbi.2004.05.007; Bouche N, 2003, P NATL ACAD SCI USA, V100, P6843, DOI 10.1073/pnas.1037532100; Asakawa C, 2001, CROP PROT, V20, P261; BRIEN JF, 1985, TRENDS PHARMACOL SCI, V6, P477, DOI 10.1016/0165-6147(85)90227-5; Busch KB, 1999, PLANT PHYSIOL, V121, P589, DOI 10.1104/pp.121.2.589; Kamo T, 2012, BIOSCI BIOTECH BIOCH, V76, P1416, DOI 10.1271/bbb.120262; Kamo T, 2003, J CHEM ECOL, V29, P275, DOI 10.1023/A:1022621709486; MITCHELL DY, 1991, HEPATOLOGY, V13, P728, DOI 10.1016/0270-9139(91)92572-P; MITCHELL DY, 1988, DRUG METAB DISPOS, V16, P37; Nguyen E, 2003, BBA-MOL BASIS DIS, V1637, P107, DOI 10.1016/S0925-4439(02)00220-X; PAYNE G, 1980, PLANT PHYSIOL, V65, P785, DOI 10.1104/pp.65.5.785; Soltys D, 2014, J PLANT PHYSIOL, V171, P565, DOI 10.1016/j.jplph.2014.01.004	21	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	MAY	2015	10	5					743	746				4	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CI3SQ	WOS:000354668100013		
J	Inoue, A; Mori, D; Minagawa, R; Fujii, Y; Sasamoto, H				Inoue, Aya; Mori, Daisuke; Minagawa, Reiko; Fujii, Yoshiharu; Sasamoto, Hamako			Allelopathy in a Leguminous Mangrove Plant, Derris indica: Protoplast Co-culture Bioassay and Rotenone Effect	NATURAL PRODUCT COMMUNICATIONS			English	Article						Allelopathy; Bioassay method; Suspension cultures; Derris indica; Leguminosae; Mangrove plant; Protoplast culture	TRIGONELLINE; CULTURES	To investigate allelopathic activity of a leguminous mangrove plant, Derris indica, the 'Protoplasts Co-culture Method' for bioassay of allelopathy was developed using suspension culture. A suspension culture was induced from immature seed and sub-cultured in Murashige and Skoog's (MS) basal medium containing 10 mu M each of 2,4-dichlorophenoxyacetic acid (2,4-D) and 6-benzyladenine (BA). The protoplasts were isolated using the separate wells method with 2% each of Cellulase RS, Driselase 20 and Macerozyme R10 in 0.4 M mannitol solution. Protoplast cultures of D. indica revealed that high concentrations of cytokinins, BA and thidiazuron, were effective for cell divisions. The co-cultures of D. indica protoplasts with recipient lettuce protoplasts using 96 multi-well culture plates were performed in MS basal medium containing 0.4 M mannitol solution and 1 mu M 2,4-D and 0.1 mu M BA. The protoplast density of D. indica used in co-culturing varied from 6 x 10(3) - 10(5) / mL. Very strong inhibitory allelopathic effects of D. indica protoplasts on lettuce protoplast growth were found. A similar strong inhibitory allelopathic activity of dried young leaves on lettuce seedling growth was also observed by using the sandwich method. Rotenone, which is a component of Derris root, dissolved in DMSO, was highly inhibitory on the growth of lettuce protoplasts in culture and this could be one of the causes of the strong allelopathic activity of D. indica.	[Inoue, Aya; Mori, Daisuke] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan; [Minagawa, Reiko] Tokyo Univ Agr, Tokyo 1568502, Japan; [Fujii, Yoshiharu] Tokyo Univ Agr & Technol, Tokyo 1838509, Japan; [Sasamoto, Hamako] Yokohama Natl Univ, Fac Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan; [Sasamoto, Hamako] Kanagawa Univ, Res Inst Integrated Sci, Hiratsuka, Kanagawa 2591293, Japan	Sasamoto, H (reprint author), Yokohama Natl Univ, Fac Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan.	sasamoto@ynu.ac.jp					Yin YL, 2011, NAT PROD COMMUN, V6, P1835; Sasamoto H, 2014, PHYTOCHEM LETT, V7, P38, DOI 10.1016/j.phytol.2013.09.008; Fujii Yoshiharu, 2003, Weed Biology and Management, V3, P233, DOI 10.1046/j.1444-6162.2003.00111.x; Fujii Yoshiharu, 2004, Weed Biology and Management, V4, P19, DOI 10.1111/j.1445-6664.2003.00113.x; Hasegawa A, 2014, J PLANT RES, V127, P755, DOI 10.1007/s10265-014-0651-1; Mori D, 2011, P 17 ANN M JAP MANGR, P7; Mori D, 2014, J PLANT STUDIES, V4, P1; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ogita S, 2014, Z NATURFORSCH C, V69, P124, DOI 10.5560/ZNC.2013-0137; Reigosa MJ, 2006, ALLELOPATHY PHYSL PR; Santisuk T., 1983, NAT HIST B SIAM SOC, V31, P63; Sasamoto H., 2013, Journal of Plant Studies, V2, P71; Sasamoto H, 2010, P 74 ANN M BOT SOC J, P181; Sasamoto H, 1997, PLANT BIOTECHNOL, V14, P101; Scott OT, 2008, BIOENERG RES, V1, P2; Tomlinson P. B., 1986, BOT MANGROVES	16	1	1	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	MAY	2015	10	5					747	750				4	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CI3SQ	WOS:000354668100014		
J	Sasamoto, H; Fujii, Y; Ashihara, H				Sasamoto, Hamako; Fujii, Yoshiharu; Ashihara, Hiroshi			Effect of Purine Alkaloids on the Proliferation of Lettuce Cells Derived from Protoplasts	NATURAL PRODUCT COMMUNICATIONS			English	Article						Purine alkaloid; Caffeine; Theobromine; Theophylline; Paraxanthine; Methylxanthine; Allelopathy; Chemical defense	CAFFEINE; PLANTS; METABOLISM; BIOSYNTHESIS; CATABOLISM	To investigate the ecological role of caffeine, theobromine, theophylline and paraxanthine, which are released from purine alkaloid forming plants, the effects of these purine alkaloids on the division and colony formation of lettuce cells were assessed at concentrations up to 1 mM. Five days after treatment with 500 mu M caffeine, theophylline and paraxanthine, division of isolated protoplasts was significantly inhibited. Thirteen days treatment with >250 mu M caffeine had a marked inhibitory effect on the colony formation of cells derived from the protoplasts. Other purine alkaloids also acted as inhibitors. The order of the inhibition was caffeine > theophylline > paraxanthine > theobromine. These observations suggest that a relatively low concentration of caffeine is toxic for proliferation of plant cells. In contrast, theobromine is a weak inhibitor of proliferation. Possible allelopathic roles of purine alkaloids in natural ecosystems are discussed.	[Sasamoto, Hamako] Kanagawa Univ, Res Inst Integrated Sci, Hiratsuka, Kanagawa 2591293, Japan; [Fujii, Yoshiharu] Tokyo Univ Agr & Technol, Dept Int Environm & Agr Sci, Tokyo 1838509, Japan; [Ashihara, Hiroshi] Ochanomizu Univ, Dept Biol, Tokyo 1128610, Japan	Ashihara, H (reprint author), Ochanomizu Univ, Dept Biol, Tokyo 1128610, Japan.	ashihara.hiroshi@ocha.ac.jp					Ashihara H, 2013, ADV BOT RES, V68, P111, DOI 10.1016/B978-0-12-408061-4.00004-3; Ashihara H, 2008, PHYTOCHEMISTRY, V69, P841, DOI 10.1016/j.phytochem.2007.10.029; Ashihara H, 1999, ADV BOT RES, V30, P117; Sasamoto H, 2014, PHYTOCHEM LETT, V7, P38, DOI 10.1016/j.phytol.2013.09.008; Anaya AL, 2006, FRONT BIOSCI, V11, P2354, DOI 10.2741/1975; Ashihara H, 2001, TRENDS PLANT SCI, V6, P407, DOI 10.1016/S1360-1385(01)02055-6; Ashihara H, 2011, PLANT METABOLISM BIO, P163; CHOU CH, 1980, J CHEM ECOL, V6, P643, DOI 10.1007/BF00987675; Ito E, 1997, BBA-GEN SUBJECTS, V1336, P323, DOI 10.1016/S0304-4165(97)00045-7; Kihlman B.A., 1977, CAFFEINE CHROMOSOMES; Mazzafera P, 2004, FRONT BIOSCI, V9, P1348, DOI 10.2741/1339; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; RIZVI SJH, 1981, AGR BIOL CHEM TOKYO, V45, P1255; Sano H, 2013, ADV BOT RES, V68, P273, DOI 10.1016/B978-0-12-408061-4.00010-9; Sasamoto H., 2013, Journal of Plant Studies, V2, P71; SUZUKI T, 1992, PHYTOCHEMISTRY, V31, P2575, DOI 10.1016/0031-9422(92)83590-U	16	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	MAY	2015	10	5					751	754				4	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CI3SQ	WOS:000354668100015		
J	Inoue, A; Ogita, S; Tsuchiya, S; Minagawa, R; Sasamoto, H				Inoue, Aya; Ogita, Shinjiro; Tsuchiya, Shinpei; Minagawa, Reiko; Sasamoto, Hamako			A Protocol for Axenic Liquid Cell Cultures of a Woody Leguminous Mangrove, Caesalpinia crista, and their Amino Acids Profiling	NATURAL PRODUCT COMMUNICATIONS			English	Article						Amino acids; Basal media; Callus culture; Mangrove plant; Plant growth regulators; Protoplast culture	SONNERATIA-ALBA; SUSPENSION-CULTURES; GROWTH; PLANT; MAINTENANCE; PROTOPLASTS; CASEOLARIS; SALTS	Callus induction, maintenance and protoplast cultures were achieved from immature seeds of a woody leguminous mangrove, Caesalpinia crista. Axenic cultures were possible during 1.5 months of pod storage in 0.1% benzalkonium chloride solution. Callus induction was achieved using 1 mL liquid medium in a 10 mL flat-bottomed culture tube. Protoplasts were isolated using Cellulase R10, Hemicellulase, and Driselase 20 in 0.6 M mannitol solution and sub-culturable calluses were obtained in 50 mu L liquid medium using a 96-microplate method. The optimal hormonal concentration was 10 mu M each of 2,4-dichlorophenoxyacetic acid and benzyladenine in liquid Murashige and Skoog's basal medium for both callus induction and maintenance, and protoplast cultures. Similarities and differences in amino acid profiles and culture conditions are discussed among woody mangrove species and non-mangrove leguminous species. Caesalpinia crista cultures were unique as they secreted a large amount of amino acids, including proline, into the liquid culture medium.	[Inoue, Aya; Tsuchiya, Shinpei] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan; [Ogita, Shinjiro] Toyama Prefectural Univ, Biotechnol Res Ctr, Imizu, Toyama 9390398, Japan; [Ogita, Shinjiro] Toyama Prefectural Univ, Dept Biotechnol, Imizu, Toyama 9390398, Japan; [Minagawa, Reiko] Tokyo Univ Agr, Tokyo 1568502, Japan; [Sasamoto, Hamako] Yokohama Natl Univ, Fac Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan; [Sasamoto, Hamako] Kanagawa Univ, Res Inst Integrated Sci, Hiratsuka, Kanagawa 2591293, Japan	Sasamoto, H (reprint author), Yokohama Natl Univ, Fac Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan.	sasamoto@ynu.ac.jp					Akatsu M, 1996, J PLANT PHYSIOL, V149, P133; Kalauni SK, 2006, BIOL PHARM BULL, V29, P1050, DOI 10.1248/bpb.29.1050; KAO KN, 1975, PLANTA, V126, P105, DOI 10.1007/BF00380613; Anguelova-Merhar VS, 2003, ANN BOT-LONDON, V92, P401, DOI 10.1093/aob/mcg154; CHOWDHRY CN, 1993, PLANT CELL TISS ORG, V32, P357, DOI 10.1007/BF00042300; Fukumoto T, 2004, PLANT BIOTECHNOL, V21, P177, DOI 10.5511/plantbiotechnology.21.177; Hasegawa A, 2011, MANGROVE SCI, V8, P11; Hasegawa A, 2013, PLANT BIOTECHNOL REP, V7, P205, DOI 10.1007/s11816-012-0251-2; Hasegawa A, 2014, J PLANT RES, V127, P755, DOI 10.1007/s10265-014-0651-1; Hayashi S, 2009, PLANT BIOTECHNOL, V26, P561, DOI 10.5511/plantbiotechnology.26.561; Inoue A, 2015, NAT PROD COMMUN, V10, P747; Kawana Y, 2008, B SOC SEA WATER SCI, V62, P207; Kawana Y, 2009, MANGROVE SCI, V6, P9; Kawana Y, 2007, PLANT BIOTECHNOL REP, V1, P219, DOI 10.1007/s11816-007-0035-2; KOTANIGUCHI H, 1987, J CHROMATOGR-BIOMED, V420, P141, DOI 10.1016/0378-4347(87)80164-0; Mimura T, 1997, J PLANT RES, V110, P25, DOI 10.1007/BF02506839; Mori D., 2015, Journal of Plant Studies, V4, P1; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; OBATASASAMOTO H, 1981, PLANT CELL PHYSIOL, V22, P827; Ogita S, 2004, J PLANT RES, V117, P457, DOI 10.1007/s10265-004-0180-4; Ogita S, 2001, IN VITRO CELL DEV-PL, V37, P268; Saenger P, 2002, MANGROVE ECOLOGY SIL, P247; Sasamoto H, 2014, P ANN M BOT SOC JAP, P238; Sasamoto H, 2001, PROGR BIOTECHNOL, V18, P279; Sasamoto H., 2013, Journal of Plant Studies, V2, P71; Sasamoto H, 1997, PLANT BIOTECHNOL, V14, P101; Spalding M., 2010, WORLD ATLAS MANGROVE; Tomlinson P. B., 1986, BOT MANGROVES; Tsuchiya S., 2013, American Journal of Plant Sciences, V4, P1366; Yamamoto R, 2009, MANGROVE SCI, V6, P1	30	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	MAY	2015	10	5					755	760				6	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CI3SQ	WOS:000354668100016		
J	Kobayashi, A; Kato-Noguchi, H				Kobayashi, Ai; Kato-Noguchi, Hisashi			Phytotoxic Substance with Allelopathic Activity in Brachiaria decumbens	NATURAL PRODUCT COMMUNICATIONS			English	Article						Allelopathy; Brachiaria decumbens; Invasive plant; Growth inhibitor; Phytotoxin	POPULATION; BRIZANTHA; PLANTS	The grass Brachiaria decumbens becomes naturalized and quickly dominant in non-native areas. It was hypothesized that phytotoxic substances of plants may contribute to the domination and invasion of the plants. However, no potent phytotoxic substance has been reported in B. decumbens. Therefore, we searched for phytotoxic substances with allelopathic activity in this species. An aqueous methanol extract of B. decumbens inhibited the growth of roots and shoots of cress (Lepidium sativum), lettuce (Lactuca saliva), timothy (Phleum pratense) and ryegrass (Lolium multiflorum) seedlings. The extract was then purified using chromatographic methods and a phytotoxic substance with allelopathic activity was isolated and identified by spectral analysis as (6R,9S)-3-oxo-alpha-ionol. These results suggest that this compound may contribute to the allelopathic effect caused by the B. decumbens extract and may be in part responsible for the invasion and domination of B. decumbens. Two other Brachiaria species, B. brizantha and a Brachiaria hybrid were also confirmed to contain (6R,9S)-3-oxo-alpha-ionol. Therefore, this compound may play an important role in the phytotoxicity of the Brachiaria species.	[Kobayashi, Ai; Kato-Noguchi, Hisashi] Kagawa Univ, Dept Appl Biol Sci, Fac Agr, Miki, Kagawa 7610795, Japan	Kato-Noguchi, H (reprint author), Kagawa Univ, Dept Appl Biol Sci, Fac Agr, Miki, Kagawa 7610795, Japan.	hisashi@ag.kagawa-u.ac.jp					Bonanomi G, 2006, NEW PHYTOL, V169, P571, DOI 10.1111/j.1469-8137.2005.01611.x; Mack RN, 1996, BIOL CONSERV, V78, P107, DOI 10.1016/0006-3207(96)00021-3; Klink CA, 1996, J TROP ECOL, V12, P139; Pivello VR, 1999, BIODIVERS CONSERV, V8, P1281, DOI 10.1023/A:1008933305857; Kato-Noguchi H, 2014, J PLANT PHYSIOL, V171, P525, DOI 10.1016/j.jplph.2013.11.010; Meiners SJ, 2012, PLANT ECOL, V213, P1861, DOI 10.1007/s11258-012-0121-6; Belz RG, 2007, PEST MANAG SCI, V63, P308, DOI 10.1002/ps.1320; Cappuccino N, 2006, BIOL LETTERS, V2, P189, DOI 10.1098/rsbl.2005.0433; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; PABST A, 1992, PHYTOCHEMISTRY, V31, P1649, DOI 10.1016/0031-9422(92)83121-E; THOMPSON JD, 1991, NEW PHYTOL, V117, P115, DOI 10.1111/j.1469-8137.1991.tb00951.x; D'Abrosca B, 2004, PHYTOCHEMISTRY, V65, P497, DOI 10.1016/j.phytochem.2003.11.018; Barbosa EG, 2008, BRAZ ARCH BIOL TECHN, V51, P825, DOI 10.1590/S1516-89132008000400021; Borghi E, 2008, PLANTA DANINHA, V26, P559, DOI 10.1590/S0100-83582008000300011; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P419; Chengxu W, 2011, PROCEDIA ENG, V18, P240; Lockwood Julie L., 2001, Biological Invasions, V3, P1, DOI 10.1023/A:1011412820174; Martins D., 2006, Planta Daninha, V24, P61, DOI 10.1590/S0100-83582006000100008; MCGREGOR JT, 1988, WEED SCI, V36, P747; Souza FAPS, 2010, PLANTA DANINHA, V28, P927, DOI [DOI 10.1590/S0100-83582010000500001, 10.1590/S0100-83582010000500001]; Souza L. S., 2006, Planta Daninha, V24, P657, DOI 10.1590/S0100-83582006000400006	21	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	MAY	2015	10	5					761	763				3	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CI3SQ	WOS:000354668100017		
J	Suwitchayanon, P; Pukclai, P; Ohno, O; Suenaga, K; Kato-Noguchi, H				Suwitchayanon, Prapaipit; Pukclai, Piyatida; Ohno, Osamu; Suenaga, Kiyotake; Kato-Noguchi, Hisashi			Isolation and Identification of an Allelopathic Substance from Hibiscus sabdariffa	NATURAL PRODUCT COMMUNICATIONS			English	Article						Hibiscus sabdariffa; Trimethyl allo-hydroxycitrate; Phytotoxic activity; Allelopathic substance	GIANT HOGWEED; HERACLEUM; GERMINATION; INVASION; SEEDS; FUROCOUMARINS; INHIBITORS; WEAPONS; SUCCESS; EUROPE	In this study, an allelopathic substance was isolated from an aqueous methanol extract of Hibiscus sabdariffa L. by column chromatography and reverse phase HPLC. The chemical structure of the substance was determined by H-1 NMR spectroscopy and mass spectrometry as trimethyl allo-hydroxycitrate. Trimethyl allo-hydroxycitrate inhibited the growth of cress hypocotyls and roots at concentrations greater than 10 mM. The concentrations required for 50% growth inhibition of the hypocotyls and roots of cress were 20.3 and 14.4 mM, respectively. The inhibitory activity of trimethyl allo-hydroxycitrate suggests that the substance may act as an allelopathic substance of H. sabdariffa.	[Suwitchayanon, Prapaipit; Pukclai, Piyatida; Kato-Noguchi, Hisashi] Kagawa Univ, Dept Appl Biol Sci, Fac Agr, Takamatsu, Kagawa 7610795, Japan; [Ohno, Osamu; Suenaga, Kiyotake] Keio Univ, Fac Sci & Technol, Dept Chem, Yokohama, Kanagawa 2238522, Japan	Kato-Noguchi, H (reprint author), Kagawa Univ, Dept Appl Biol Sci, Fac Agr, Takamatsu, Kagawa 7610795, Japan.	hisashi@ag.kagawa-u.ac.jp	Suenaga, Kiyotake/F-7632-2014		Ministry of Agriculture, Forestry and Fisheries of Japan [25029AB]; JSPS KAKENHI [26304024]; MEXT [120573]	We would like to thank Dr Shvetsov A and Kazantseva E (Main Botanical Garden named after N.V. Tsitsin RAS, Moscow) and Dr Taran A (Sakhalin Botanical Garden FEB RAS, Yuzhno-Sakhalinsk) for help with seed collection. This research was supported by the grant-in-aid for research on Agriculture and Food Science (25029AB) from the Ministry of Agriculture, Forestry and Fisheries of Japan. This work was also supported by JSPS KAKENHI Grant Number 26304024 and MEXT Scholarship Number 120573.	Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.1890/1540-9295(2004)002[0436:NWISAT]2.0.CO;2; SHIMOMURA H, 1982, PHYTOCHEMISTRY, V21, P2213, DOI 10.1016/0031-9422(82)85180-7; Razavi S. M., 2011, International Journal of Biological Chemistry, V5, P86, DOI 10.3923/ijbc.2011.86.90; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; BASKIN JM, 1967, PHYTOCHEMISTRY, V6, P1209, DOI 10.1016/S0031-9422(00)86083-5; Jahodova S, 2007, DIVERS DISTRIB, V13, P99, DOI [10.1111/j.1472-4642.2006.00305.x, 10.1111/j.1366-9516.2006.00305.x]; Balezentiene L, 2012, ALLELOPATHY J, V30, P197; Balezentiene L, 2013, EKOLOGIYA, V59, P123; Baskin CC, 1998, SEEDS, P1, DOI 10.1016/B978-012080260-9/50001-4; Blair AC, 2006, J CHEM ECOL, V32, P2327, DOI 10.1007/s10886-006-9168-y; Dragan T., 1999, Herba Polonica, V45, P12; FRIEDMAN J, 1983, J CHEM ECOL, V9, P1107, DOI 10.1007/BF00982215; FRIEDMAN J, 1982, J CHEM ECOL, V8, P55, DOI 10.1007/BF00984005; Fujii Y., 2005, Proceedings of the 4th World Congress on Allelopathy, "Establishing the Scientific Base", Wagga Wagga, New South Wales, Australia, 21-26 August 2005, P73; Fujii Yoshiharu, 2003, Weed Biology and Management, V3, P233, DOI 10.1046/j.1444-6162.2003.00111.x; Golisz A, 2007, WEED BIOL MANAG, V7, P164, DOI 10.1111/j.1445-6664.2007.00252.x; Hiradate S., 2006, Natural products for pest management, 226th ACS National Meeting, Anaheim, California, USA, 28 March-1 April 2004, P113; Holub J., 1997, FLORA CZECH REPUBLIC, P386; JUNTTILA O, 1976, PHYSIOL PLANTARUM, V36, P374, DOI 10.1111/j.1399-3054.1976.tb02259.x; Laman NA, 2009, GIANT HOGWEED ARE DA, P1; MARTIN JT, 1966, ANN APPL BIOL, V57, P501, DOI 10.1111/j.1744-7348.1966.tb03842.x; Mishyna MU, 2011, NEWS NATL ACAD SCI B, V3, P129; Moravcova Lenka, 2007, P157, DOI 10.1079/9781845932060.0157; Ni GY, 2012, ALLELOPATHY J, V29, P199; Nielsen C, 2005, GIANT HOGWEED BEST P, P1; Nikolaeva MG, 1985, REFERENCE BOOK DORMA, P1; Otte A, 1998, PHYTOCOENOLOGIA, V28, P205; Takemura T., 2013, American Journal of Plant Sciences, V4, P1095, DOI 10.4236/ajps.2013.45136; Takemura T, 2013, J TROP FOR SCI, V25, P268; Tkachenko KG, 1989, RASTITELNYE RESURY, V1, P52; WAWRZYNOWICZ T, 1989, CHROMATOGRAPHIA, V28, P161, DOI 10.1007/BF02319640; Wille W, 2013, SEED SCI RES, V23, P157, DOI 10.1017/S096025851300007X; Zobel A. M., 1995, Allelopathy Journal, V2, P9	33	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	MAY	2015	10	5					765	770				6	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CI3SQ	WOS:000354668100018		
J	Mishyna, M; Laman, N; Prokhorov, V; Maninang, JS; Fujii, Y				Mishyna, Maryia; Laman, Nikolai; Prokhorov, Valery; Maninang, John Solomon; Fujii, Yoshiharu			Identification of Octanal as Plant Growth Inhibitory Volatile Compound Released from Heracleum sosnowskyi Fruit	NATURAL PRODUCT COMMUNICATIONS			English	Article						Heracleum sosnowskyi; Cotton swab method; Octanal; Volatile chemicals; Allelopathy; HS-GC-MS	MANTEGAZZIANUM APIACEAE; SEED-GERMINATION; ROOT-GROWTH; RESIDUES	Heracleum sosnowskyi Manden of the Apiaceae family is a malignant invasive plant in Eastern Europe, Belarus and Russia. The species is known for its prolific seed production, which has been linked to the plant's invasive success. The fruit also has a strong aroma, but the contribution of the fruit's volatile constituent to out-compete neighboring plants has not been fully established. In this study, fruit volatiles of H. sosnowskyi and conspecifics (i.e. H. asperum, H. lescovii, H. dissectum, H. hirtum) were identified by headspace gas chromatography-mass spectrometry (HS-GC-MS). Octyl acetate, octanol, octanal, hexyl isobutyrate, and hexyl-2-methyl butyrate were found to be the principal volatiles. Using authentic standards, the growth-inhibitory property of the individual compounds was assayed by the novel Cotton swab method. Assay results with lettuce (Lactuca sativa) showed that octanal strongly inhibited seed germination and radicle elongation of seedlings. The results suggest that octanal may be the main contributor to the allelopathic activity of H. sosnowksyi fruits. Furthermore, the mixture of fruit volatiles from the invasive H. sosnowskyi more strongly delayed lettuce seedling elongation than the volatiles from fruits of the non-invasive H. asperum, H. lescovii, H. dissectum and H. hirtum. Thus, the present study is the first to demonstrate the possible involvement of fruit volatiles of Heracleum species in plant-plant interaction.	[Mishyna, Maryia; Maninang, John Solomon; Fujii, Yoshiharu] Tokyo Univ Agr & Technol, Dept Int Environm & Agr Sci, Fac Agr, Tokyo 1838509, Japan; [Mishyna, Maryia; Laman, Nikolai; Prokhorov, Valery] Natl Acad Sci Belarus, Inst Expt Bot, Lab Plant Growth & Dev, Minsk 220072, Byelarus; [Maninang, John Solomon] Univ Tokyo, Coll Arts & Sci, Tokyo 1538902, Japan	Mishyna, M (reprint author), Tokyo Univ Agr & Technol, Dept Int Environm & Agr Sci, Fac Agr, Tokyo 1838509, Japan.	maryia.mishyna@gmail.com; yfujii@cc.tuat.ac.jp			Ministry of Agriculture, Forestry and Fisheries of Japan [25029AB]; JSPS KAKENHI [26304024]; MEXT [120573]	We would like to thank Dr Shvetsov A and Kazantseva E (Main Botanical Garden named after N.V. Tsitsin RAS, Moscow) and Dr Taran A (Sakhalin Botanical Garden FEB RAS, Yuzhno-Sakhalinsk) for help with seed collection. This research was supported by the grant-in-aid for research on Agriculture and Food Science (25029AB) from the Ministry of Agriculture, Forestry and Fisheries of Japan. This work was also supported by JSPS KAKENHI Grant Number 26304024 and MEXT Scholarship Number 120573.	Abrahim D, 2000, J CHEM ECOL, V26, P611, DOI 10.1023/A:1005467903297; Acimovic MG, 2014, NOT BOT HORTI AGROBO, V42, P232; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.1890/1540-9295(2004)002[0436:NWISAT]2.0.CO;2; Barney JN, 2009, PLANT ECOL, V203, P195, DOI 10.1007/s11258-008-9529-4; Jakubska-Busse A, 2013, ARCH BIOL SCI, V65, P877, DOI 10.2298/ABS1303877J; SHIMOMURA H, 1982, PHYTOCHEMISTRY, V21, P2213, DOI 10.1016/0031-9422(82)85180-7; Zhang FJ, 2012, WEED SCI, V60, P205, DOI 10.1614/WS-D-11-00156.1; Balezentiene L, 2012, ALLELOPATHY J, V30, P197; Balezentiene L, 2014, ALLELOPATHY J, V33, P267; BRADOW JM, 1990, J CHEM ECOL, V16, P645, DOI 10.1007/BF01016477; BRADOW JM, 1991, J CHEM ECOL, V17, P2193, DOI 10.1007/BF00988001; Denisova GA, 1989, TERPENOID CONTAINING, P1; Fujii Y., 2005, Proceedings of the 4th World Congress on Allelopathy, "Establishing the Scientific Base", Wagga Wagga, New South Wales, Australia, 21-26 August 2005, P73; Fujii Y., 2005, Proceedings of the 4th World Congress on Allelopathy, "Establishing the Scientific Base", Wagga Wagga, New South Wales, Australia, 21-26 August 2005, P493; Golisz A, 2007, WEED BIOL MANAG, V7, P164, DOI 10.1111/j.1445-6664.2007.00252.x; Hiradate S., 2006, Natural products for pest management, 226th ACS National Meeting, Anaheim, California, USA, 28 March-1 April 2004, P113; Holub J., 1997, FLORA CZECH REPUBLIC, P386; JUNTTILA O, 1975, PHYSIOL PLANTARUM, V33, P22, DOI 10.1111/j.1399-3054.1975.tb03758.x; Kudinov MA, 1980, INTRO BORSHCHEVIKOV, P1; Laman NA, 2009, GIANT HOGWEED IS DAN, P1; Mandenova IP, 1950, CAUCASIAN SPECIES GE, P1; Mishyna M, 2014, P 7 WORLD C ALL, V77; Mishyna MU, 2011, NEWS NATL ACAD SCI B, V3, P129; Moravcova Lenka, 2007, P157, DOI 10.1079/9781845932060.0157; Pimenov MG, 1993, GENERA UMBELLIFERAE, P1; Sedzik D, 1966, Acta Pol Pharm, V23, P149; Tkachenko KG, 1989, RASTITELNYE RESURY, V1, P52; Tkachenko KG, 2010, TURCZANINOWIA, V13, P74	28	1	1	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	MAY	2015	10	5					771	774				4	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CI3SQ	WOS:000354668100019		
J	Mardani, H; Sekine, T; Azizi, M; Mishyna, M; Fujii, Y				Mardani, Hossein; Sekine, Takayuki; Azizi, Majid; Mishyna, Maryia; Fujii, Yoshiharu			Identification of Safranal as the Main Allelochemical from Saffron (Crocus sativus)	NATURAL PRODUCT COMMUNICATIONS			English	Article						Allelopathy; Safranal; Saffron; Dish Pack Method	IRAN; L.	Dried parts of 75 medicinal plant species collected from different regions in Iran were assayed by the Dish Pack Method for volatile allelopathic activity, using Lactuca sativa (lettuce) as the test plant. The highest (60%) inhibition was observed for saffron (stigma of Crocus sativus), followed by Dracocephalum kotschyi, Solanum nigrum and Artemisia aucheri. Safranal was identified as the main chemical by Headspace Gas Chromatography-Mass Spectrometry (HS-GC-MS) analyses of saffron. Moreover, the EC50 of safranal was evaluated as 1.2 mu g/L (ppb). This is the first report on allelopathic activity of safranal as a bioactive compound identified from saffron.	[Mardani, Hossein; Mishyna, Maryia; Fujii, Yoshiharu] Tokyo Univ Agr & Technol, Dept Int Environm & Agr Sci, Fac Agr, Tokyo 1838509, Japan; [Sekine, Takayuki] Miyagi Prefectural Agr & Hort Res Ctr, Natori, Miyagi 9811243, Japan; [Mardani, Hossein; Azizi, Majid] Ferdowsi Univ Mashhad, Dept Hort, Fac Agr, Mashhad 9177948974, Iran	Mardani, H (reprint author), Tokyo Univ Agr & Technol, Dept Int Environm & Agr Sci, Fac Agr, Tokyo 1838509, Japan.	hmardani26@yahoo.com; yfujii@cc.tuat.ac.jp			Ministry of Agriculture, Forestry and Fisheries of Japan [25029AB]; JSPS KAKENHI [26304024]	This research was supported by the grant-in-aid for research on Agriculture and Food Science (25029AB) from the Ministry of Agriculture, Forestry and Fisheries of Japan. This work was also supported by JSPS KAKENHI Grant Number 26304024.	Amini S, 2014, THEOR EXP PLANT PHYS, V26, P189, DOI 10.1007/s40626-014-0017-z; Farahmand SK, 2013, BIOGERONTOLOGY, V14, P63, DOI 10.1007/s10522-012-9409-0; Geromichalos GD, 2012, J AGR FOOD CHEM, V60, P6131, DOI 10.1021/jf300589c; Abdullaev FI, 2002, EXP BIOL MED, V227, P20; Fujii Yoshiharu, 2003, Weed Biology and Management, V3, P233, DOI 10.1046/j.1444-6162.2003.00111.x; Fujii Y, 2000, J WEED SCI TECHNOL S, V45, P80; Heshmati GA, 2007, INT J PLANT PROD, V1, P215; Ikawa M, 1992, J CHEM ECOL, V10, P1755; Jung K, 2010, ALLELOPATHY J, V26, P243; Khan AL, 2009, AFR J BIOTECHNOL, V8, P1024; Malaekeh-Nikouei B, 2013, PHYTOTHER RES, V27, P1868, DOI 10.1002/ptr.4945; Mishyna M, 2015, NAT PROD COMMUN, V10, P771; Rezaee R, 2013, IRAN J BASIC MED SCI, V16, P12; Takemura T, 2013, J TROP FOR SCI, V25, P268	14	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	MAY	2015	10	5					775	777				3	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CI3SQ	WOS:000354668100020		
J	Ogita, S; Lee, JB; Kurosaki, F; Kato, Y				Ogita, Shinjiro; Lee, Jung-Bum; Kurosaki, Fumiya; Kato, Yasuo			The Biosynthetic Activities of Primary and Secondary Metabolites in Suspension Cultures of Aquilaria microcarpa	NATURAL PRODUCT COMMUNICATIONS			English	Article						DPBA; GC-MS; LSM; Nile red; Suspension culture; Aquilaria microcarpa	TRANSCRIPTIONAL ACTIVATION; CELL-CULTURES; GENES; EXPRESSION; INDUCTION; SINENSIS; SYNTHASE; CLONING; GROWTH; CALLI	Two types of suspension-cultured Aquilaria microcarpa cells, friable and aggregated, were selectively generated. The biosynthetic activities of primary and secondary metabolites in target cells were detected using laser scanning microscopy (LSM) imaging with diphenylboric acid 2-amino ethyl ester (DPBA) and 9-diethylamino-5H-benzo[alpha]phenoxazine-5-one (Nile red) staining. Scanned friable cells produced weakly fluorescent images revealing low productivity of metabolites. On the other hand, scanning of aggregated cells produced clear fluorescent images depicting the accumulations of flavonoids and lipids. Furthermore, abundant deposition of an unknown resinous compound in extracellular portion of aggregated cells could be visualized. The resinous compound was white to whitish-gray in color and highly sedimented in the medium. Based on these observations, we focused our investigation of metabolite productivity on aggregated suspension cells. Some prominent extracellular compounds were detected in the used liquid medium, as well as in the resinous residue within the medium. The characteristics of these metabolites were investigated in detail via gas chromatography-mass spectrometry (GC-MS) analysis.	[Ogita, Shinjiro; Kato, Yasuo] Toyama Prefectural Univ, Biotechnol Res Ctr, Imizu, Toyama 9390398, Japan; [Ogita, Shinjiro; Kato, Yasuo] Toyama Prefectural Univ, Dept Biotechnol, Imizu, Toyama 9390398, Japan; [Lee, Jung-Bum; Kurosaki, Fumiya] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Sugitani, Toyama 9300194, Japan	Ogita, S (reprint author), Toyama Prefectural Univ, Biotechnol Res Ctr, Imizu, Toyama 9390398, Japan.	ogita@pu-toyama.ac.jp			Japan Society for the Promotion of Science [23590146]; Scholarship Foundation of Toyama First Bank	The author (SO) thanks Ms Mishizu Hayashi for her technical assistance. This study was supported in part by Grants-in-Aid for Scientific Research C (no. 23590146 to FK) from the Japan Society for the Promotion of Science. This study was also partially supported by a research grant to SO from the Scholarship Foundation of Toyama First Bank.	Buer CS, 2004, PLANT CELL, V16, P1191, DOI 10.1105/tpc.020313; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Qi SY, 2005, PLANT CELL TISS ORG, V83, P217, DOI 10.1007/s11240-005-5479-x; Compton J, PC15 TRAFFIC; He Meng-ling, 2005, J Zhejiang Univ Sci B, V6, P849, DOI 10.1631/jzus.2005.B0849; Jayaraman S, 2014, J FORESTRY RES, V25, P535, DOI 10.1007/s11676-014-0492-8; Kenmotsu Y, 2010, BIOL PHARM BULL, V33, P1911, DOI 10.1248/bpb.33.1911; Kenmotsu Y, 2013, PLANT MOL BIOL REP, V31, P539, DOI 10.1007/s11105-012-0529-0; Kenmotsu Y, 2011, J NAT MED-TOKYO, V65, P194, DOI 10.1007/s11418-010-0451-4; Lee JB, 2014, NAT PROD COMMUN, V9, P1231; Moitreyee Saikia M, 2012, INT J PLANT RES, V2, P188; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ng L. T., 1997, Journal of Tropical Forest Products, V2, P272; Ogita S, 2011, PLANT BIOTECHNOL-NAR, V28, P43, DOI 10.5511/plantbiotechnology.10.1101a; Okudera Y, 2009, PLANT BIOTECHNOL, V26, P307, DOI 10.5511/plantbiotechnology.26.307; Xu YH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-227	16	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	MAY	2015	10	5					779	782				4	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CI3SQ	WOS:000354668100021		
J	Ogita, S; Shichiken, M; Ito, C; Yamashita, T; Nomura, T; Kato, Y				Ogita, Shinjiro; Shichiken, Masahito; Ito, Chizuru; Yamashita, Toshiyuki; Nomura, Taiji; Kato, Yasuo			A Stepwise Protocol for Induction and Selection of Prominent Coniferous Cell Cultures for the Production of beta-Thujaplicin	NATURAL PRODUCT COMMUNICATIONS			English	Article						Callus; Conifer; Habituation; Hinokitiol; beta-Thujaplicin	BAMBOO SUSPENSION CELLS; CUPRESSUS-LUSITANICA; GROWTH; INTERMEDIATE; PLANTS	In order to demonstrate the potential of plant cell culture systems to produce a target natural bioactive compound, we proposed a stepwise protocol for beta-thujaplicin production as follows. 1. Induction phase: Characteristics of callus cultures originating from newly flushed shoots of 10 conifer species were evaluated on different basal media such as Murashige and Skoog (MS), Schenk and Hildebrandt (SH), and Lloyd and McCown's Woody Plant medium (WP) containing 10 mu M 2,4-dichlorophenoxyacetic acid (2,4-D) either alone or in combination with 1 mu M of N-6-benzyladenine (BA). The conifer species used were as follows: Chamaecyparis (C. obtusa Sieb. et Zucc. and C. pisifera Sieb. et Zucc.), Juniperus (J. chinensis L. 'Kaizuka', J. chinensis L. var. sargentii, and J. conferta Parlatore), Thuja (T. occidentalis L. and T. standishii (Gord.) Carr.), Thujopsis (T. dolabrata Sieb. et Zucc. and T. dolabrata Sieb. et Zucc. var. hondae), and Cryptomeria (C. japonica D. Don). We observed the phenotypes of each callus to determine the optimal conditions for callus induction and to infer biosynthetic activity of the calli over 4-8 weeks. 2. Habituation phase: Each of the cell cultures obtained was transferred to a modified MS medium containing 680 mg L-1 KH2PO4 and 10 mu M Picloram to select the habituated cells with synchronous growth pattern. The growth of each cell culture was highly improved in the habituation medium, except that of J. chinensis 'Kaizuka'. 3. Metabolite-production phase: The concentration of beta-thujaplicin (known as hinokitiol in Japan) in the shoots of donor trees and the habituated cell cultures was analyzed via high-performance liquid chromatography (HPLC). Histochemical characteristics of the cells were also observed using laser scanning microscopy (LSM) imaging. After the third step, we tested the biosynthetic activity of two habituated calli (C. obtusa and J. conferta) on a 0.3%, w/v, yeast extract (YE)-containing medium. We found significant improvement in beta-thujaplicin production in J. conferta callus (4600 mu g g DW-1), which was up to 20-fold higher than in the habituation phase.	[Ogita, Shinjiro; Shichiken, Masahito; Nomura, Taiji; Kato, Yasuo] Toyama Prefectural Univ, Biotechnol Res Ctr, Imizu, Toyama 9390398, Japan; [Ogita, Shinjiro; Shichiken, Masahito; Nomura, Taiji; Kato, Yasuo] Toyama Prefectural Univ, Dept Biotechnol, Imizu, Toyama 9390398, Japan; [Ito, Chizuru] Iwata Chem Co Ltd, Shizuoka 4380078, Japan; [Yamashita, Toshiyuki] Bot Gardens Toyama, Toyama 9392713, Japan	Ogita, S (reprint author), Toyama Prefectural Univ, Biotechnol Res Ctr, Imizu, Toyama 9390398, Japan.	ogita@pu-toyama.ac.jp			Iwata Chemical, Co. ltd.; Scholarship Foundation of Toyama First Bank	The authors are thankful to the Botanic Gardens of Toyama for kindly providing conifer materials. Author (SO) thanks Ms Mishizu Hayashi for her technical assistance. This study was supported in part by financial support from Iwata Chemical, Co. ltd. This study was also partially supported by a research grant to SO from the Scholarship Foundation of Toyama First Bank.	Abdullah AA, 1987, TREE PHYSIOL, V3, P123; Hartmann T, 2007, PHYTOCHEMISTRY, V68, P2831, DOI 10.1016/j.phytochem.2007.09.017; Buer CS, 2004, PLANT CELL, V16, P1191, DOI 10.1105/tpc.020313; Matkowski A, 2008, BIOTECHNOL ADV, V26, P548, DOI 10.1016/j.biotechadv.2008.07.001; SCHENK RU, 1972, CAN J BOTANY, V50, P199; Davies KM, 2014, CURR OPIN BIOTECH, V26, P133, DOI 10.1016/j.copbio.2013.12.010; Thomas TD, 2008, BIOTECHNOL ADV, V26, P618, DOI 10.1016/j.biotechadv.2008.08.003; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Fujii R, 1995, PLANT TISSUE CULT LE, V12, P55, DOI 10.5511/plantbiotechnology1984.12.55; Fujita K, 2014, J PLANT PHYSIOL, V171, P610, DOI 10.1016/j.jplph.2013.12.016; Higashi Y, 2009, J COSMET SCI, V60, P519; Itose R, 1997, PLANT BIOTECHNOL, V14, P163; Lloyd G, 1981, P INT PLANT PROP SOC, V30, P421; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nault N, 1987, WOOD SCI TECHNOL, V21, P311; Nomura T, 2013, PLANT BIOTECHNOL-NAR, V30, P447, DOI 10.5511/plantbiotechnology.13.0704a; Ogita S, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-40; Ogita S, 2004, PLANT MOL BIOL, V54, P931, DOI 10.1007/s11103-004-0393-x; Ogita S, 1999, J WOOD SCI, V45, P87, DOI 10.1007/BF01192323; Ogita S, 2011, PLANT BIOTECHNOL-NAR, V28, P43, DOI 10.5511/plantbiotechnology.10.1101a; Okabe T, 1989, FRAGRANCE J, V17, P74; Ro DK, 2011, PLANT METABOLISM BIO, P217; SAKAI K, 1994, MOKUZAI GAKKAISHI, V40, P1; Tomita M, 1998, PLANT BIOTECHNOLOGY, V15, P145; Yamada J, 2003, J WOOD SCI, V49, P5, DOI 10.1007/s100860300001; Yamaguchi T, 1990, J WOOD SCI, V45, P170	26	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	MAY	2015	10	5					783	787				5	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CI3SQ	WOS:000354668100022		
J	Nakayama, F; Mizuno, K; Kato, M				Nakayama, Fumiyo; Mizuno, Kouichi; Kato, Misako			Biosynthesis of Caffeine Underlying the Diversity of Motif B ' Methyltransferase	NATURAL PRODUCT COMMUNICATIONS			English	Article						Caffeine synthase; Motif B ' methyltransferase; Purine alkaloid; Theobromine synthase	ACID CARBOXYL METHYLTRANSFERASE; COFFEA-ARABICA L.; PURINE ALKALOIDS; TEA LEAVES; N-METHYLTRANSFERASES; CAMELLIA PLANTS; SYNTHASE GENE; SABATH FAMILY; ENZYME; 7-METHYLXANTHINE	Caffeine (1,3,7-trimethylxanthine) and theobromine (3,7-dimethylxanthine) are well-known purine alkaloids in Camellia, Coffea, Cola, Paullinia, Ilex, and Theobroma spp. The caffeine biosynthetic pathway depends on the substrate specificity of N-methyltransferases, which are members of the motif B' methyltransferase family. The caffeine biosynthetic pathways in purine alkaloid-containing plants might have evolved in parallel with one another, consistent with different catalytic properties of the enzymes involved in these pathways.	[Nakayama, Fumiyo; Kato, Misako] Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo 1128610, Japan; [Mizuno, Kouichi] Akita Prefectural Univ, Fac Bioresource Sci, Akita, Akita 0100195, Japan	Nakayama, F (reprint author), Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo 1128610, Japan.	kato.misako@ocha.ac.jp					McCarthy AA, 2007, PLANT PHYSIOL, V144, P879, DOI 10.1104/pp.106.094854; Mizuno K, 2003, FEBS LETT, V534, P75, DOI 10.1016/S0014-5793(02)03781-X; Zhao N, 2008, PLANT PHYSIOL, V146, P455, DOI 10.1104/pp.107.110049; Schimpl FC, 2014, PHYTOCHEMISTRY, V105, P25, DOI 10.1016/j.phytochem.2014.04.018; Kato M, 2004, FRONT BIOSCI, V9, P1833, DOI 10.2741/1364; Mizuno K, 2003, FEBS LETT, V547, P56, DOI 10.1016/S0014-5793(03)00670-7; Ashihara H, 1999, ADV BOT RES, V30, P117; Zubieta C, 2003, PLANT CELL, V15, P1704, DOI 10.1105/tpc.014548; Uefuji H, 2003, PLANT PHYSIOL, V132, P372, DOI 10.1104/pp.102.019679; NAGATA T, 1985, PHYTOCHEMISTRY, V24, P2271, DOI 10.1016/S0031-9422(00)83024-1; Varbanova M, 2007, PLANT CELL, V19, P32, DOI 10.1105/tpc.106.044602; Ogawa M, 2001, J BIOL CHEM, V276, P8213, DOI 10.1074/jbc.M009480200; Dudareva N, 2000, PLANT CELL, V12, P949, DOI 10.1105/tpc.12.6.949; Seo HS, 2001, P NATL ACAD SCI USA, V98, P4788, DOI 10.1073/pnas.081557298; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ross JR, 1999, ARCH BIOCHEM BIOPHYS, V367, P9, DOI 10.1006/abbi.1999.1255; Kato M, 2000, NATURE, V406, P956, DOI 10.1038/35023072; Joshi CP, 1998, PLANT MOL BIOL, V37, P663, DOI 10.1023/A:1006035210889; Ashihara H, 1998, J PLANT RES, V111, P599, DOI 10.1007/BF02507798; ASHIHARA H, 1987, PLANT CELL PHYSIOL, V28, P535; Chang H, 1984, CAMELLIAS, P1; D'Auria JC, 2003, RECENT ADV PHYTOCHEM, V37, P253; FUJIMORI N, 1991, PHYTOCHEMISTRY, V30, P2245, DOI 10.1016/0031-9422(91)83622-R; Ishida M, 2009, PLANTA, V229, P559, DOI 10.1007/s00425-008-0847-5; Kato M, 1999, PLANT PHYSIOL, V120, P579, DOI 10.1104/pp.120.2.579; Mizuno K, 2014, BIOCHEM BIOPH RES CO, V452, P1060, DOI 10.1016/j.bbrc.2014.09.043; SUZUKI T, 1976, PHYTOCHEMISTRY, V15, P1235, DOI 10.1016/0031-9422(76)85084-4; Yoneyama N, 2006, MOL GENET GENOMICS, V275, P125, DOI 10.1007/s00428-005-0070-z	28	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	MAY	2015	10	5					799	801				3	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CI3SQ	WOS:000354668100025		
J	Ashihara, H				Ashihara, Hiroshi			Occurrence, Biosynthesis and Metabolism of Theanine (gamma-Glutamyl-L-ethylamide) in Plants: A Comprehensive Review	NATURAL PRODUCT COMMUNICATIONS			English	Article						Biosynthesis; Degradation; Theanine; gamma-Glutamylethylamide; gamma-Glutamylmethylamide; Occurrence; Theanine synthetase	TEA CAMELLIA-SINENSIS; NITRATE REDUCTASE-ACTIVITY; AMINO-ACIDS CONTENTS; NITROGEN ASSIMILATION; TISSUE CULTURE; GENUS CAMELLIA; L-ALANINE; SEEDLINGS; CAFFEINE; LEAVES	Theanine (gamma-glutamyl-L-ethylamide) is the most abundant non-protein amino acid in tea leaves. In addition to Camellia sinensis, theanine occurs in several plants belonging to the Ericales. Biosynthesis of theanine from glutamic acid and ethylamine by theanine synthetase is present in all organs of tea seedlings, but roots are the major site of theanine biosynthesis in adult tea trees. Theanine is transported from roots to young leaves via the xylem sap. Theanine is hydrolysed to glutamic acid and ethylamine in leaves. Ethylamine produced from theanine is predominantly used for catechin biosynthesis. Concentration of ammonia and light intensity influence the biosynthesis and degradation of theanine, respectively. Biosynthesis, translocation and degradation of theanine and related enzymes and genes are reviewed.	Ochanomizu Univ, Dept Biol, Fac Sci, Bunkyo Ku, Tokyo 1128610, Japan	Ashihara, H (reprint author), Ochanomizu Univ, Dept Biol, Fac Sci, Bunkyo Ku, Tokyo 1128610, Japan.	ashihara.hiroshi@ocha.ac.jp					Vuong QV, 2011, J SCI FOOD AGR, V91, P1931, DOI 10.1002/jsfa.4373; Yang YY, 2013, RUSS J PLANT PHYSL+, V60, P91, DOI 10.1134/S1021443712060180; Feng L, 2014, FOOD CHEM, V155, P98, DOI 10.1016/j.foodchem.2014.01.044; Hachiya T, 2012, PLANT CELL PHYSIOL, V53, P577, DOI 10.1093/pcp/pcs012; Ashihara H, 2008, PHYTOCHEMISTRY, V69, P841, DOI 10.1016/j.phytochem.2007.10.029; MIFLIN BJ, 1976, PHYTOCHEMISTRY, V15, P873, DOI 10.1016/S0031-9422(00)84362-9; Ruan JY, 2007, J SCI FOOD AGR, V87, P1505, DOI 10.1002/jsfa.2875; Wu HL, 2013, PLANT MOL BIOL REP, V31, P524, DOI 10.1007/s11105-012-0519-2; Rana NK, 2008, BIOL PLANTARUM, V52, P361, DOI 10.1007/s10535-008-0075-7; Deng WW, 2012, PLANT PHYSIOL BIOCH, V56, P35, DOI 10.1016/j.plaphy.2012.04.003; GIVAN CV, 1979, PHYTOCHEMISTRY, V18, P375, DOI 10.1016/S0031-9422(00)81870-1; Yang ZY, 2012, FOOD CHEM, V135, P2268, DOI 10.1016/j.foodchem.2012.07.066; Bindal S, 2014, J AGR FOOD CHEM, V62, P9151, DOI 10.1021/jf5022913; Bowsher C, 2012, PLANT BIOCH; CASIMIR J, 1960, BIOCHIM BIOPHYS ACTA, V39, P462, DOI 10.1016/0006-3002(60)90199-2; Chu D, 1997, CHEM APPL GREEN TEA, P129; Coruzzi G. M., 2000, BIOCH MOL BIOL PLANT, P358; CROCOMO OJ, 1970, PHYTOCHEMISTRY, V9, P537, DOI 10.1016/S0031-9422(00)85685-X; Deng WW, 2009, Z NATURFORSCH C, V64, P387; Deng WW, 2008, PHYTOCHEM LETT, V1, P115, DOI 10.1016/j.phytol.2008.06.002; Deng WW, 2010, PLANT PHYSIOL BIOCH, V48, P70, DOI 10.1016/j.plaphy.2009.09.009; Deng WW, 2013, PLANT GROWTH REGUL, V71, P295, DOI 10.1007/s10725-013-9828-1; FELDHEIM W, 1986, J SCI FOOD AGR, V37, P527, DOI 10.1002/jsfa.2740370604; FURUYA T, 1990, PHYTOCHEMISTRY, V29, P2539, DOI 10.1016/0031-9422(90)85184-H; HAYATSU M, 1993, SOIL SCI PLANT NUTR, V39, P209; Ibarashl I, 1973, NATURE-NEW BIOL, V244, P150; Ishigaki K, 1978, B NATL RES I TEA, V14, P1; Kamiya S, 2010, CHIKYU KANKYO, V15, P161; KITO M, 1966, AGR BIOL CHEM TOKYO, V30, P623; KITO M, 1968, PHYTOCHEMISTRY, V7, P599, DOI 10.1016/S0031-9422(00)88234-5; Konishi S, 1969, NIPPON DOJO HIRYOGAK, V40, P107; Konishi S, 1991, TEA SCI, P21; KONISHI S, 1972, PLANT CELL PHYSIOL, V13, P695; Konishi S, 1968, NIPPON DOJOUHIRYOUGA, V39, P439; Konishi S, 1969, NIPPON DOJO HIRYOGAK, V40, P479; KONISHI S, 1966, PLANT CELL PHYSIOL, V7, P171; Konishi S, 1982, NIPPON DOJO HIRYOGAK, V53, P241; Li P, 2005, J CHROMATOGR B, V819, P81, DOI 10.1016/j.jchromb.2005.01.026; MATSUURA T, 1992, BIOSCI BIOTECH BIOCH, V56, P1179; MATSUURA T, 1990, AGR BIOL CHEM TOKYO, V54, P2283; Morita A, 1998, SOIL SCI PLANT NUTR, V44, P647; NAGATA T, 1985, JPN J BREED, V35, P1; NAGATA T, 1984, JPN J BREED, V34, P459; NAGATA T, 1986, JARQ-JPN AGR RES Q, V19, P276; Nakagawa M, 2009, THE HIST OF TEA; Oh K, 2008, PEDOSPHERE, V18, P222, DOI 10.1016/S1002-0160(08)60010-7; Okada Y, 2006, Japan Patent, Patent No. [JP 2006-254780A, 2006254780]; Okano K, 1997, JPN J CROP SCI, V66, P279; ORIHARA Y, 1990, PLANT CELL REP, V9, P65, DOI 10.1007/BF00231550; Rana NK, 2008, MOL BIOTECHNOL, V39, P49, DOI 10.1007/s12033-007-9027-2; Sakato Y, 1949, NIPPON NOGEIKAGAKU K, V23, P262; SASAOKA K, 1963, AGR BIOL CHEM TOKYO, V27, P467; SASAOKA K, 1962, AGR BIOL CHEM TOKYO, V26, P265; SASAOKA K, 1965, AGR BIOL CHEM TOKYO, V29, P984; SASAOKA K, 1964, AGR BIOL CHEM TOKYO, V28, P318; STEINER M, 1967, NATURWISSENSCHAFTEN, V54, P370; Suzuki M, 2013, FUNCTION SCI TEA, P98; TAKEO T, 1979, AGR BIOL CHEM TOKYO, V43, P2257; TAKEO T, 1980, AGR BIOL CHEM TOKYO, V44, P2007; TAKEO T, 1974, PHYTOCHEMISTRY, V13, P1401, DOI 10.1016/0031-9422(74)80299-2; TAKEO T, 1978, PHYTOCHEMISTRY, V17, P313, DOI 10.1016/S0031-9422(00)94173-6; TAKIHARAMATSUURA T, 1994, BIOSCI BIOTECH BIOCH, V58, P1519; TSUSHIDA T, 1984, AGR BIOL CHEM TOKYO, V48, P2861; TSUSHIDA T, 1985, AGR BIOL CHEM TOKYO, V49, P2913; Venkatesan S, 2005, J SCI FOOD AGR, V85, P513, DOI 10.1002/jsfa.1986; Venkatesan S, 2004, COMMUN SOIL SCI PLAN, V35, P1283, DOI 10.1081/css-120037546; Wan X., 2009, TEA TEA PRODUCTS CHE, P255; Yamaguchi S, 2000, J NUTR, V130, p921S; Zhang QF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112572	69	1	1	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	MAY	2015	10	5					803	810				8	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CI3SQ	WOS:000354668100026		
J	Kato-Noguchi, H				Kato-Noguchi, Hisashi			Involvement of Allelopathy in the Formation of Monospecific Colonies of Ferns	NATURAL PRODUCT COMMUNICATIONS			English	Article						Allelopathy; Biological activity; Domination; Fern; Monospecific colony	DICRANOPTERIS-LINEARIS DEBRIS; GLEICHENIA-JAPONICA; PTERIDIUM-AQUILINUM; COMMON WEEDS; PLANTS; GROWTH; IDENTIFICATION; RHIZOSPHERE; FLAVONOIDS; GLYCOSIDES	Some fern species often dominate plant communities by forming large monospecific colonies. However, the potential mechanism for this domination of the ferns remains obscure. Many plants secrete a wide range of compounds into the rhizosphere and change the chemical and physical properties of the rhizosphere soil. Through the secretion of compounds, such as allelopathic substances, plants inhibit the germination and growth of neighboring plants to compete more effectively for the resources. Ferns contain a variety of secondary metabolites and some of those compounds are released from the ferns into the rhizosphere soil, either as exudates from living ferns or by decomposition of fern residues in sufficient quantities to affect the germination and growth of neighboring plants as allelopathic substances. Therefore, allelopathic chemical interaction of the ferns with neighboring plants may play an important role in the formation of the monospecific colonies of the ferns.	Kagawa Univ, Dept Appl Biol Sci, Fac Agr, Miki, Kagawa 7610795, Japan	Kato-Noguchi, H (reprint author), Kagawa Univ, Dept Appl Biol Sci, Fac Agr, Miki, Kagawa 7610795, Japan.	hisashi@ag.kagawa-u.ac.jp					AKIHISA T, 1993, CHEM PHARM BULL, V41, P624; Palmer AG, 2004, ANNU REV PHYTOPATHOL, V42, P439, DOI 10.1146/annurev.phyto.41.052002.095701; Bonanomi G, 2006, NEW PHYTOL, V169, P571, DOI 10.1111/j.1469-8137.2005.01611.x; Mack RN, 1996, BIOL CONSERV, V78, P107, DOI 10.1016/0006-3207(96)00021-3; Kato-Noguchi H, 2013, J PLANT PHYSIOL, V170, P577, DOI 10.1016/j.jplph.2012.11.015; Callaway RM, 2002, TRENDS ECOL EVOL, V17, P104, DOI 10.1016/S0169-5347(01)02438-7; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Badri DV, 2009, PLANT CELL ENVIRON, V32, P666, DOI [10.1111/j.1365-3040.2008.01926.x, 10.1111/j.1365-3040.2009.01926.x]; Einhellig FA, 1996, AGRON J, V88, P886; Macias FA, 2007, PEST MANAG SCI, V63, P327, DOI 10.1002/ps.1342; Belz RG, 2007, PEST MANAG SCI, V63, P308, DOI 10.1002/ps.1320; Weston LA, 2013, J CHEM ECOL, V39, P283, DOI 10.1007/s10886-013-0248-5; Rivera-Barreno R, 2010, CLIN EXP PHARMACOL P, V37, P980, DOI 10.1111/j.1440-1681.2010.05424.x; Hawes MC, 2000, TRENDS PLANT SCI, V5, P128, DOI 10.1016/S1360-1385(00)01556-9; Cappuccino N, 2006, BIOL LETTERS, V2, P189, DOI 10.1098/rsbl.2005.0433; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; TANAKA F, 1990, SOIL SCI PLANT NUTR, V36, P97; THOMPSON JD, 1991, NEW PHYTOL, V117, P115, DOI 10.1111/j.1469-8137.1991.tb00951.x; Lopez JJ, 2008, LIFE SCI, V82, P977, DOI 10.1016/j.lfs.2008.03.009; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P419; Campos JMS, 2008, ALLELOPATHY J, V22, P143; Chengxu W, 2011, PROCEDIA ENG, V18, P240; Chong TV, 2011, ACTA HORTIC, V902, P377; Cooper-Driver GA, 1980, J TORREY BOT SOC, V107, P116; Davidonis GH, 1973, PLANTA, V11, P23; Einhellig FA, 1999, PRINCIPLES AND PRACTICES IN PLANT ECOLOGY, P479; GLIESSMAN S R, 1972, Madrono, V21, P299; GLIESSMAN SR, 1978, J CHEM ECOL, V4, P337, DOI 10.1007/BF00989342; GROSS D, 1994, J PLANT GROWTH REGUL, V13, P93, DOI 10.1007/BF00210953; Inderjit, 1996, BOT REV, V62, P186; Ismail BS, 2009, ALLELOPATHY J, V23, P277; Ismail BS, 2007, ALLELOPATHY J, V20, P287; Kato-Noguchi H, 2015, J PLANT PHYS INPRESS; Kato-Noguchi H, 2012, PLANT ECOL, V213, P1937, DOI 10.1007/s11258-012-0096-3; Lockwood Julie L., 2001, Biological Invasions, V3, P1, DOI 10.1023/A:1011412820174; McCully E., 1999, ANNU REV PLANT PHYS, V50, P695; Moral RD, 1971, ECOLOGY, V52, P1030, DOI 10.2307/1933809; MUNESADA K, 1992, PHYTOCHEMISTRY, V31, P1533, DOI 10.1016/0031-9422(92)83100-D; Olofsdotter M, 2002, J CHEM ECOL, V28, P229, DOI 10.1023/A:1013531306670; Peres MTL, 1998, PESQUI AGROPECU BRAS, V33, P131; Rice EL, 1984, ALLELOPATHY; Rimando AM, 2003, RICE ORIGIN HIST TEC, P221; Russell AE, 1998, J ECOL, V86, P765, DOI 10.1046/j.1365-2745.1998.8650765.x; SHIOJIMA K, 1995, CHEM PHARM BULL, V43, P5; SHIOJIMA K, 1994, CHEM PHARM BULL, V42, P377; STAR AE, 1980, B TORREY BOT CLUB, V107, P146, DOI 10.2307/2484219; Stewart RE, 1975, J CHEM ECOL, V1, P161, DOI 10.1007/BF00987865; Tang C., 1986, SCI ALLELOPATHY; Tet-Vun C, 2006, WEED BIOL MANAG, V6, P59, DOI 10.1111/j.1445-6664.2006.00203.x; Wang HH, 2011, ALLELOPATHY J, V27, P97; Wergeland-Krog OM, 2008, BLYTTIA, V66, P97; WHITEHEAD DC, 1964, NATURE, V202, P417, DOI 10.1038/202417a0	52	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	MAY	2015	10	5					811	814				4	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CI3SQ	WOS:000354668100027		
J	Ogita, S				Ogita, Shinjiro			Plant Cell, Tissue and Organ Culture: the Most Flexible Foundations for Plant Metabolic Engineering Applications	NATURAL PRODUCT COMMUNICATIONS			English	Article						Bioactive compound; Biosynthesis; IT; Metabolic engineering; Plant cell biology; PCTOC; PDCA-cycle	BAMBOO SUSPENSION CELLS; RICE; TRANSFORMATION; PROTOPLASTS; GROWTH; ROOTS; RED	Significant advances in plant cell, tissue and organ culture (PCTOC) have been made in the last five decades. PCTOC is now thought to be the underlying technique for understanding general or specific biological functions of the plant kingdom, and it is one of the most flexible foundations for morphological, physiological and molecular biological applications of plants. Furthermore, the recent advances in the field of information technology (IT) have enabled access to a large amount of information regarding all aspects of plant biology. For example, sequencing information is stored in mega repositories such as the National Center for Biotechnology Information (NCBI), which can be easily accessed by researchers worldwide. To date, the PCTOC and IT combination strategy for regulation of target plant metabolism and the utilization of bioactive plant metabolites for commercial purposes is essential. In this review, the advantages and the limitations of these methodologies, especially regarding the production of bioactive plant secondary metabolites and metabolic engineering in target plants are discussed mainly from the phenotypic view point.	[Ogita, Shinjiro] Toyama Prefectural Univ, Biotechnol Res Ctr, Imizu, Toyama 9390398, Japan; [Ogita, Shinjiro] Toyama Prefectural Univ, Dept Biotechnol, Imizu, Toyama 9390398, Japan; [Ogita, Shinjiro] Prefectural Univ Hiroshima, Fac Life & Environm Sci, Dept Life Sci, Shobara 7270023, Japan	Ogita, S (reprint author), Toyama Prefectural Univ, Biotechnol Res Ctr, Imizu, Toyama 9390398, Japan.	ogita@pu-hiroshima.ac.jp			Japan Society for the Promotion of Science [22580387, 25450519, 25450134]; New Technology Development Foundation	The author (SO) would like to express his deep appreciation to all the members of the Plant and Cell Engineering Laboratory of Toyama Prefectural University. The author also thanks Ms Mishizu Hayashi for her technical assistance. This study was supported in part by Grants-in-Aid for Scientific Research C (no. 22580387, 25450519, and 25450134 to SO), from the Japan Society for the Promotion of Science. This study was also partially supported by a plant research grant to SO from the New Technology Development Foundation (2013-2014).	Yang WN, 2013, CURR OPIN PLANT BIOL, V16, P180, DOI 10.1016/j.pbi.2013.03.005; Hartmann T, 2007, PHYTOCHEMISTRY, V68, P2831, DOI 10.1016/j.phytochem.2007.09.017; Buer CS, 2004, PLANT CELL, V16, P1191, DOI 10.1105/tpc.020313; Matkowski A, 2008, BIOTECHNOL ADV, V26, P548, DOI 10.1016/j.biotechadv.2008.07.001; BABA A, 1986, PLANT CELL PHYSIOL, V27, P463; NAGATA T, 1992, INT REV CYTOL, V132, P1; Miao YS, 2008, BIOTECHNOL GENET ENG, V25, P363; Li ZH, 2010, MOLECULES, V15, P8933, DOI 10.3390/molecules15128933; Davies KM, 2014, CURR OPIN BIOTECH, V26, P133, DOI 10.1016/j.copbio.2013.12.010; Benson EE, 2008, CRIT REV PLANT SCI, V27, P141, DOI 10.1080/07352680802202034; Xu JF, 2011, BIOTECHNOL ADV, V29, P278, DOI 10.1016/j.biotechadv.2011.01.002; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Anderson KI, 2006, CYTOM PART A, V69A, P920, DOI 10.1002/cyto.a.20323; Wilson SA, 2014, CURR OPIN BIOTECH, V29, P163, DOI 10.1016/j.copbio.2014.07.001; Ludwig-Muller J, 2014, BIOTECHNOL ADV, V32, P1168, DOI 10.1016/j.biotechadv.2014.03.007; Aoyagi H, 2011, BIOCHEM ENG J, V56, P1, DOI 10.1016/j.bej.2010.05.004; Bielecka M, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00805; Bystriakova N, 2004, BAMBOO BIODIVERSITY, P1; Carciofi M, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-36; Chang WC, 1991, BIOTECHNOLOGY AGR FO, V15, P221; Donnelly DJ, 1988, GLOSSARY PLANT TISSU, P1; Iannucci A, 2012, AGROCHIMICA, V56, P185; Lee LY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-24; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nagata Toshiyuki, 1999, Methods in Cell Science, V21, P123, DOI 10.1023/A:1009832822096; Nomura T, 2013, PLANT BIOTECHNOL-NAR, V30, P447, DOI 10.5511/plantbiotechnology.13.0704a; Ogita S, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-40; Ogita S, 2005, PLANT BIOTECHNOL, V22, P119, DOI 10.5511/plantbiotechnology.22.119; Ogita S, 2011, PLANT BIOTECHNOL-NAR, V28, P43, DOI 10.5511/plantbiotechnology.10.1101a; Ogita S, 2003, NATURE, V423, P823, DOI 10.1038/423823a; Ogita S, 2009, NAT PROD COMMUN, V4, P377; Ogita S, 2008, FLORICULTURE ORNAMEN, V5, P240; Stasolla C, 2010, APPL PLANT BIOTECHNO; STEWARD FC, 1958, AM J BOT, V45, P709, DOI 10.2307/2439729; Sugiyama M, 2015, J PLANT RES, V128, P349, DOI 10.1007/s10265-015-0706-y; VASIL IK, 1972, IN VITRO CELL DEV B, V8, P117; WENT F. W., 1928, REC TRAV BOT NEERL, V25, P1; Yang ZG, 2014, METABOLOMICS, V10, P543, DOI 10.1007/s11306-013-0619-5	38	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	MAY	2015	10	5					815	820				6	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CI3SQ	WOS:000354668100028		
J	Smith, SJ; Clarke, LE; Edmonds, JA; Kejun, J; Kriegler, E; Masui, T; Riahi, K; Shukla, PR; Tavoni, M; van Vuuren, DP; Weyant, JP				Smith, Steven J.; Clarke, Leon E.; Edmonds, James A.; Kejun, Jiang; Kriegler, Elmar; Masui, Toshihiko; Riahi, Keywan; Shukla, Priyadarshi R.; Tavoni, Massimo; van Vuuren, Detlef P.; Weyant, John P.			Long history of IAM comparisons	NATURE CLIMATE CHANGE			English	Letter							COSTS		[Smith, Steven J.; Clarke, Leon E.; Edmonds, James A.] Pacific NW Natl Lab, Joint Global Change Res Inst, College Pk, MD 20740 USA; [Kejun, Jiang] Energy Res Inst, Beijing 100038, Peoples R China; [Kriegler, Elmar] Potsdam Inst Climate Impact Res, D-14412 Potsdam, Germany; [Masui, Toshihiko] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Riahi, Keywan] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Shukla, Priyadarshi R.] Indian Inst Management, Ahmadabad 380015, Gujarat, India; [Tavoni, Massimo] Fdn Eni Enrico Mattei, I-20123 Milan, Italy; [van Vuuren, Detlef P.] PBL Netherlands Environm Assessment Agcy, NL-3720 AH Bilthoven, Netherlands; [van Vuuren, Detlef P.] Univ Utrecht, Fac Geosci, NL-3584 CS Utrecht, Netherlands; [Weyant, John P.] Stanford Univ, Dept Management Sci & Engn, Stanford, CA 94305 USA	Smith, SJ (reprint author), Pacific NW Natl Lab, Joint Global Change Res Inst, College Pk, MD 20740 USA.	ssmith@pnl.gov	van Vuuren, Detlef/A-4764-2009	van Vuuren, Detlef/0000-0003-0398-2831			Edenhofer O, 2010, ENERG J, V31, P11; [Anonymous], 2015, NATURE CLIM CHANGE, V5, P81; Calvin K, 2012, ENERG ECON, V34, pS251, DOI 10.1016/j.eneco.2012.09.003; [Anonymous], 1975, UND CLIM CHANG; Kriegler E, 2015, TECHNOL FORECAST SOC, V90, P24, DOI 10.1016/j.techfore.2013.09.021; GASKINS DW, 1993, AM ECON REV, V83, P318; Gates WL, 1999, B AM METEOROL SOC, V80, P29, DOI 10.1175/1520-0477(1999)080<0029:AOOTRO>2.0.CO;2; Luderer G, 2012, CLIMATIC CHANGE, V114, P9, DOI 10.1007/s10584-011-0105-x; Covey C, 2000, CLIM DYNAM, V16, P775, DOI 10.1007/s003820000081; Clarke L., 2014, CLIMATE CHANGE 2014; EMF Working Group, 1977, 1 EMF STANF U	11	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1758-678X	1758-6798		NAT CLIM CHANGE	Nat. Clim. Chang.	MAY	2015	5	5					391	391				1	Environmental Sciences; Environmental Studies; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	CI6SO	WOS:000354891900004		
J	Lin, YS; Medlyn, BE; Duursma, RA; Prentice, IC; Wang, H; Baig, S; Eamus, D; de Dios, VR; Mitchell, P; Ellsworth, DS; Op de Beeck, M; Wallin, G; Uddling, J; Tarvainen, L; Linderson, ML; Cernusak, LA; Nippert, JB; Ocheltree, T; Tissue, DT; Martin-St Paul, NK; Rogers, A; Warren, JM; De Angelis, P; Hikosaka, K; Han, QM; Onoda, Y; Gimeno, TE; Barton, CVM; Bennie, J; Bonal, D; Bosc, A; Low, M; Macinins-Ng, C; Rey, A; Rowland, L; Setterfield, SA; Tausz-Posch, S; Zaragoza-Castells, J; Broadmeadow, MSJ; Drake, JE; Freeman, M; Ghannoum, O; Hutley, LB; Kelly, JW; Kikuzawa, K; Kolari, P; Koyama, K; Limousin, JM; Meir, P; da Costa, ACL; Mikkelsen, TN; Salinas, N; Sun, W; Wingate, L				Lin, Yan-Shih; Medlyn, Belinda E.; Duursma, Remko A.; Prentice, I. Colin; Wang, Han; Baig, Sofia; Eamus, Derek; Resco de Dios, Victor; Mitchell, Patrick; Ellsworth, David S.; Op de Beeck, Maarten; Wallin, Goran; Uddling, Johan; Tarvainen, Lasse; Linderson, Maj-Lena; Cernusak, Lucas A.; Nippert, Jesse B.; Ocheltree, Troyw.; Tissue, David T.; Martin-St Paul, Nicolas K.; Rogers, Alistair; Warren, Je M.; De Angelis, Paolo; Hikosaka, Kouki; Han, Qingmin; Onoda, Yusuke; Gimeno, Teresa E.; Barton, Craig V. M.; Bennie, Jonathan; Bonal, Damien; Bosc, Alexandre; Loew, Markus; Macinins-Ng, Cate; Rey, Ana; Rowland, Lucy; Setterfield, Samantha A.; Tausz-Posch, Sabine; Zaragoza-Castells, Joana; Broadmeadow, Mark S. J.; Drake, John E.; Freeman, Michael; Ghannoum, Oula; Hutley, Lindsay B.; Kelly, Jeff W.; Kikuzawa, Kihachiro; Kolari, Pasi; Koyama, Kohei; Limousin, Jean-Marc; Meir, Patrick; Lola da Costa, Antonio C.; Mikkelsen, Teis N.; Salinas, Norma; Sun, Wei; Wingate, Lisa			Optimal stomatal behaviour around the world	NATURE CLIMATE CHANGE			English	Article							HYDRAULIC ARCHITECTURE; CLIMATE-CHANGE; PLANT; MODEL; TREES; PHOTOSYNTHESIS; ASSIMILATION; CONVERGENCE; CONDUCTANCE; ECOLOGY	Stomatal conductance (g(s)) is a key land-surface attribute as it links transpiration, the dominant component of global land evapotranspiration, and photosynthesis, the driving force of the global carbon cycle. Despite the pivotal role of g(s) in predictions of global water and carbon cycle changes, a global-scale database and an associated globally applicable model of g(s) that allow predictions of stomatal behaviour are lacking. Here, we present a database of globally distributed g(s) obtained in the field for a wide range of plant functional types (PFTs) and biomes. We find that stomatal behaviour differs among PFTs according to their marginal carbon cost of water use, as predicted by the theory underpinning the optimal stomatal model(1) and the leaf and wood economics spectrum(2,3). We also demonstrate a global relationship with climate. These findin g(s) provide a robust theoretical framework for understanding and predicting the behaviour of g(s) across biomes and across PFTs that can be applied to regional, continental and global-scale modelling of ecosystem productivity, energy balance and ecohydrological processes in a future changing climate.	[Lin, Yan-Shih; Medlyn, Belinda E.; Prentice, I. Colin; Wang, Han; Baig, Sofia; Kelly, Jeff W.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia; [Duursma, Remko A.; Ellsworth, David S.; Tissue, David T.; Gimeno, Teresa E.; Barton, Craig V. M.; Drake, John E.; Ghannoum, Oula] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 2751, Australia; [Prentice, I. Colin] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, AXA Chair Biosphere & Climate Impacts Grand Chall, Ascot SL5 7PY, Berks, England; [Prentice, I. Colin] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Grantham Inst Climate Change & Environm, Ascot SL5 7PY, Berks, England; [Eamus, Derek] Univ Technol Sydney, Sch Environm, Sydney, NSW 2007, Australia; [Resco de Dios, Victor] Univ Lleida, AGROTECNIO Ctr, Dept Crop & Forest Sci, Ramon y Cajal Programme, E-25198 Lleida, Spain; [Mitchell, Patrick] CSIRO Ecosyst Sci, Sandy Bay, Tas 7005, Australia; [Op de Beeck, Maarten] Univ Antwerp, Res Grp Plant & Vegetat Ecol, B-2610 Antwerp, Belgium; [Wallin, Goran; Uddling, Johan] Univ Gothenburg, Dept Biol & Environm Sci, S-40530 Gothenburg, Sweden; [Tarvainen, Lasse] Swedish Univ Agr Sci, Dept Forest Ecol & Management, S-90183 Umea, Sweden; [Linderson, Maj-Lena] Lund Univ, Dept Phys Geog & Ecosyst Sci, S-22362 Lund, Sweden; [Cernusak, Lucas A.] James Cook Univ, Cairns, Qld 4879, Australia; [Nippert, Jesse B.] Kansas State Univ, Div Biol, Manhattan, KS 66505 USA; [Ocheltree, Troyw.] Colorado State Univ, Dept Forest & Rangeland Stewardship, Ft Collins, CO 80523 USA; [Martin-St Paul, Nicolas K.] Univ Paris 11, Lab Ecol Systemat & Evolut, UMR8079, F-91405 Orsay, France; [Rogers, Alistair] Brookhaven Natl Lab, Environm & Climate Sci Dept, Upton, NY 11973 USA; [Warren, Je M.] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [De Angelis, Paolo] Univ Tuscia, Dept Innovat Biol Agrofood & Forest Syst, I-01100 Viterbo, Italy; [Hikosaka, Kouki] Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Han, Qingmin] FFPRI, Hokkaido Res Ctr, Sapporo, Hokkaido 0628516, Japan; [Onoda, Yusuke] Kyoto Univ, Grad Sch Agr, Div Environm Sci & Technol, Kyoto 6068502, Japan; [Bennie, Jonathan] Univ Exeter, Environm & Sustainabil Inst, Penryn TR10 9FE, England; [Bonal, Damien] INRA, F-54280 Nancy, Champenoux, France; [Bosc, Alexandre; Wingate, Lisa] INRA, F-33140 Villenave Dornon, France; [Bosc, Alexandre] Bordeaux Sci Agro, UMR ISPA 1391, F-33170 Gradignan, France; [Loew, Markus; Tausz-Posch, Sabine] Univ Melbourne, Fac Vet & Agr Sci, Creswick, Vic 3363, Australia; [Macinins-Ng, Cate] Univ Auckland, Sch Environm, Auckland 1142, New Zealand; [Rey, Ana] MNCN CSIC, Spanish Sci Council, Dept Biogeog & Global Change, Madrid 28006, Spain; [Rowland, Lucy; Zaragoza-Castells, Joana; Meir, Patrick] Univ Edinburgh, Sch Geosci, Edinburgh EH8 9XP, Midlothian, Scotland; [Setterfield, Samantha A.; Hutley, Lindsay B.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Casuarina, NT 0909, Australia; [Broadmeadow, Mark S. J.] Forestry Commiss England, Climate Change Forest Serv, Bristol BD16 1EJ, Avon, England; [Freeman, Michael] Swedish Univ Agr Sci, Dept Ecol, S-75007 Uppsala, Sweden; [Kikuzawa, Kihachiro; Koyama, Kohei] Ishikawa Prefectural Univ, Fac Bioresources & Environm Sci, Dept Environm Sci, Nonoichi, Ishikawa 9218836, Japan; [Kolari, Pasi] Univ Helsinki, Dept Phys, FI-00014 Helsinki, Finland; [Koyama, Kohei] Obihiro Univ Agr & Vet Med, Dept Life Sci & Agr, Obihiro, Hokkaido 0800834, Japan; Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Lola da Costa, Antonio C.] Fed Univ Para, BR-66075110 Belem, Para, Brazil; [Mikkelsen, Teis N.] Tech Univ Denmark, Dept Chem & Biochem Engn, Ctr Ecosyst & Environm Sustainabil, DK-4000 Roskilde, Denmark; [Salinas, Norma] PUCP, Secc Quim, Lima 15088, Peru; [Salinas, Norma] Univ Oxford, Sch Geog, Oxford OX1 3QY, England; [Sun, Wei] NE Normal Univ, Key Lab Vegetat Ecol, Inst Grassland Sci, Changchun 130024, Jilin, Peoples R China	Lin, YS (reprint author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia.	yanshihL@gmail.com	Rogers, Alistair/E-1177-2011; Wingate, Lisa/G-5575-2015; Hikosaka, Kouki/A-5415-2013; Mitchell, Patrick/D-7454-2011; Koyama, Kohei/J-4153-2015; Warren, Jeffrey/B-9375-2012; Drake, John/N-8490-2014; Salinas, Norma/K-8960-2015; Onoda, Yusuke/L-7179-2015; James Cook University, TESS/B-8171-2012; Tissue, David/H-6596-2015; Resco de Dios, Victor/G-5555-2014; De Angelis, Paolo/A-6863-2012	Duursma, Remko/0000-0002-8499-5580; Wingate, Lisa/0000-0003-1921-1556; Hikosaka, Kouki/0000-0003-1744-3775; Koyama, Kohei/0000-0001-6707-3130; Warren, Jeffrey/0000-0002-0680-4697; Drake, John/0000-0003-4274-4780; Salinas, Norma/0000-0001-9941-2109; Onoda, Yusuke/0000-0001-6245-2342; Medlyn, Belinda/0000-0001-5728-9827; Tissue, David/0000-0002-8497-2047; Resco de Dios, Victor/0000-0002-5721-1656; Bennie, Jonathan/0000-0003-4394-2041; De Angelis, Paolo/0000-0001-8310-8831	Australian Research Council (ARC MIA Discovery Project) [1433500-2012-14]; Next-Generation Ecosystem Experiments (NGEE-Arctic) project by the Office of Biological and Environmental Research in the Department of Energy, Office of Science; United States Department of Energy [DE-AC02-98CH10886]; Belgian Science Policy (OFFQ) [SD/AF/02]	This research was supported by the Australian Research Council (ARC MIA Discovery Project 1433500-2012-14). A.R. was financially supported in part by The Next-Generation Ecosystem Experiments (NGEE-Arctic) project, which is supported by the Office of Biological and Environmental Research in the Department of Energy, Office of Science, and through the United States Department of Energy contract No. DE-AC02-98CH10886 to Brookhaven National Laboratory. M.O.d.B. acknowledges that the Brassica data were obtained within a research project financed by the Belgian Science Policy (OFFQ, contract number SD/AF/02) and coordinated by K. Vandermeiren at the Open-Top Chamber research facilities of CODA-CERVA (Tervuren, Belgium).	Bucci SJ, 2004, TREE PHYSIOL, V24, P891; Bernacchi CJ, 2001, PLANT CELL ENVIRON, V24, P253, DOI 10.1046/j.1365-3040.2001.00668.x; Cao MK, 1998, NATURE, V393, P249, DOI 10.1038/30460; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Eamus D, 2000, TREE PHYSIOL, V20, P1219; Harrison SP, 2010, J VEG SCI, V21, P300, DOI 10.1111/j.1654-1103.2009.01144.x; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; SCHULZE ED, 1994, ANNU REV ECOL SYST, V25, P629, DOI 10.1146/annurev.es.25.110194.003213; Gotsch SG, 2010, OECOLOGIA, V163, P291, DOI 10.1007/s00442-009-1543-2; Gobron N, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006511; Sperry JS, 2008, PLANT CELL ENVIRON, V31, P632, DOI 10.1111/j.1365-3040.2007.01765.x; Prentice IC, 2014, ECOL LETT, V17, P82, DOI 10.1111/ele.12211; Gallego-Sala AV, 2010, CLIM RES, V45, P151, DOI 10.3354/cr00911; Choat B, 2012, NATURE, V491, P752, DOI 10.1038/nature11688; Hacke UG, 2001, OECOLOGIA, V126, P457, DOI 10.1007/s004420100628; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; LLOYD J, 1994, OECOLOGIA, V99, P201, DOI 10.1007/BF00627732; Meinzer FC, 2003, PLANT CELL ENVIRON, V26, P1147, DOI 10.1046/j.1365-3040.2003.01039.x; Ball JT, 1987, PROGR PHOTOSYNTHESIS; Breheny P., 2014, VISREG VISUALIZATION; Cowan I R, 1977, Symp Soc Exp Biol, V31, P471; Heroult A., 2013, PLANT CELL ENVIRON, V36, P262; Kowalczyk E. A., 2006, CSIRO ATMOSPHERE BIO; LEUNING R, 1995, PLANT CELL ENVIRON, V18, P339, DOI 10.1111/j.1365-3040.1995.tb00370.x; Medlyn BE, 2011, GLOBAL CHANGE BIOL, V17, P2134, DOI 10.1111/j.1365-2486.2010.02375.x; Oleson KW, 2010, TECHNICAL DESCRIPTIO; Pinheiro J, 2014, NLME LINEAR NONLINEA; R Core Team, 2014, R LANG ENV STAT COMP; Wright IJ, 2006, PHYSIOL PLANTARUM, V127, P445, DOI 10.1111/j.1399-3054.2006.00699.x; Zanne AE, 2009, DATA WORLDWIDE WOOD	32	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1758-678X	1758-6798		NAT CLIM CHANGE	Nat. Clim. Chang.	MAY	2015	5	5					459	464		10.1038/NCLIMATE2550		6	Environmental Sciences; Environmental Studies; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	CI6SO	WOS:000354891900025		
J	Kawai, K				Kawai, Kensuke			Epilepsy Surgery: Current Status and Ongoing Challenges	NEUROLOGIA MEDICO-CHIRURGICA			English	Review						epilepsy; epilepsy surgery; neuromodulation; intracranial electroencephalography	VAGUS NERVE-STIMULATION; HIGH-FREQUENCY OSCILLATIONS; TEMPORAL-LOBE EPILEPSY; HIGH-GAMMA ACTIVITY; EXTRATEMPORAL NONLESIONAL EPILEPSY; MULTIPLE HIPPOCAMPAL TRANSECTION; REFRACTORY PARTIAL EPILEPSY; FOCAL EPILEPSY; SURGICAL-TREATMENT; SUBPIAL TRANSECTION	This article reviews the current status of surgical treatment of epilepsy and introduces the ongoing challenges. Seizure outcome of resective surgery for focal seizures associated with focal lesions is satisfactory. Particularly for mesial temporal lobe epilepsy, surgical treatment should be considered from the earlier stage of the disease. Meanwhile, surgical outcome in nonlesional extratemporal lobe epilepsy is still to be improved using various approaches. Disconnective surgeries reduce surgical complications of extensive resections while achieving equivalent or better seizure outcomes. Multiple subpial transection is still being modified expecting a better outcome by transection to the vertical cortices along the sulci- and multi-directional transection from a single entry point. Hippocampal transection is expected to preserve memory function while interrupting the abnormal epileptic synchronization. Proper selection or combination of subdural and depth electrodes and a wide-band analysis of electroencephalography may improve the accurate localization of epileptogenic region. Patients for whom curative resective surgery is not indicated because of generalized or bilateral multiple nature of their epilepsies, neuromodulation therapies are options of treatment which palliate their seizures.	[Kawai, Kensuke] NTT Med Ctr Tokyo, Dept Neurosurg, Tokyo 1418625, Japan; [Kawai, Kensuke] NTT Med Ctr Tokyo, Epilepsy Ctr, Tokyo 1418625, Japan	Kawai, K (reprint author), NTT Med Ctr Tokyo, Dept Neurosurg, Shinagawa Ku, 5-9-22 Higashi Gotanda, Tokyo 1418625, Japan.	kenkawai-tky@umin.net					Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Fisher RS, 1999, NEUROLOGY, V53, P666; Patil AA, 2013, SEIZURE-EUR J EPILEP, V22, P731, DOI 10.1016/j.seizure.2013.05.014; Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056; Ansari SF, 2010, CHILD NERV SYST, V26, P945, DOI 10.1007/s00381-009-1056-7; Zagon A, 2000, EPILEPSIA, V41, P1382, DOI 10.1111/j.1528-1157.2000.tb00113.x; Wu CY, 2013, NEUROMODULATION, V16, P10, DOI 10.1111/j.1525-1403.2012.00501.x; Neligan A, 2013, EPILEPSIA, V54, pe62, DOI 10.1111/epi.12148; Delalande O, 2003, NEUROL MED-CHIR, V43, P61, DOI 10.2176/nmc.43.61; Tellez-Zenteno JF, 2010, EPILEPSY RES, V89, P310, DOI 10.1016/j.eplepsyres.2010.02.007; Kunii N, 2013, NEUROIMAGE, V65, P242, DOI 10.1016/j.neuroimage.2012.09.059; Worrell GA, 2008, BRAIN, V131, P928, DOI 10.1093/brain/awn006; Ansari SF, 2010, ACTA NEUROCHIR, V152, P1299, DOI 10.1007/s00701-010-0697-3; Umeoka SC, 2012, J NEUROSURG, V116, P513, DOI 10.3171/2011.10.JNS11261; ZABARA J, 1992, EPILEPSIA, V33, P1005, DOI 10.1111/j.1528-1157.1992.tb01751.x; MORRELL F, 1989, J NEUROSURG, V70, P231, DOI 10.3171/jns.1989.70.2.0231; Englot DJ, 2012, NEUROLOGY, V78, P1200, DOI 10.1212/WNL.0b013e318250d7ea; Zijlmans M, 2012, ANN NEUROL, V71, P169, DOI 10.1002/ana.22548; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Engel J, 2012, JAMA-J AM MED ASSOC, V307, P922, DOI 10.1001/jama.2012.220; Sugano H, 2014, EPILEPSIA, V55, P683, DOI 10.1111/epi.12547; Fauser S, 2004, BRAIN, V127, P2406, DOI 10.1093/brain/awh277; Elliott RE, 2011, EPILEPSY BEHAV, V20, P57, DOI 10.1016/j.yebeh.2010.10.017; GEORGE R, 1995, NEUROLOGY, V45, P224; Handforth A, 1998, NEUROLOGY, V51, P48; Uda T, 2013, J NEUROSURG, V119, P1098, DOI 10.3171/2013.6.JNS13244; Labiner DM, 2009, EPILEPSIA, V50, P434, DOI 10.1111/j.1528-1167.2008.01792.x; Elger G, 2000, EPILEPSY RES, V42, P203, DOI 10.1016/S0920-1211(00)00181-9; Bower MR, 2012, EPILEPSIA, V53, P807, DOI 10.1111/j.1528-1167.2012.03417.x; Shimizu H, 2006, J CLIN NEUROSCI, V13, P322, DOI 10.1016/j.jocn.2005.04.020; de Tisi J, 2011, LANCET, V378, P1388, DOI 10.1016/S0140-6736(11)60890-8; Kunii N, 2011, NEUROSURGERY, V69, P590, DOI 10.1227/NEU.0b013e3182181be1; Henry TR, 1999, NEUROLOGY, V52, P1166; Truccolo W, 2011, NAT NEUROSCI, V14, P635, DOI 10.1038/nn.2782; Haegelen C, 2013, EPILEPSIA, V54, P848, DOI 10.1111/epi.12075; Clark KB, 1999, NAT NEUROSCI, V2, P94; Southwell DG, 2012, NEUROSURGERY, V70, P1406, DOI 10.1227/NEU.0b013e3182500a4c; Di Lazzaro V, 2004, NEUROLOGY, V62, P2310; Engel J, 2003, NEUROLOGY, V60, P538; Ntsambi-Eba G, 2013, NEUROSURGERY, V72, P890, DOI 10.1227/NEU.0b013e31828ba750; Jacobs J, 2009, BRAIN, V132, P1022, DOI 10.1093/brain/awn351; Groves DA, 2005, NEUROSCI LETT, V379, P174, DOI 10.1016/j.neulet.2004.12.055; Ferroli P, 2006, NEUROL SCI, V26, P390, DOI 10.1007/s10072-006-0521-2; Noe K, 2013, JAMA NEUROL, V70, P1003, DOI 10.1001/jamaneurol.2013.209; Cho YJ, 2009, EPILEPSIA, V50, P1910, DOI 10.1111/j.1528-1167.2009.02177.x; Costa J, 2011, EPILEPSIA, V52, P1280, DOI 10.1111/j.1528-1167.2011.03047.x; Cukiert A, 2013, SEIZURE, V23, P6; Daniel RT, 2007, EPILEPSIA, V48, P1429, DOI 10.1111/j.1528-1167.2007.01095.x; De Ribaupierre S, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC/2008/25/9/E14; Desai A, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11325; Dorfer C, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.3.FOCUS1362; Kanazawa K, 2015, CLIN NEUROPHYSIOL, V126, P47, DOI 10.1016/j.clinph.2014.05.028; Kawai K, 2006, EPILEPSIA, V47, P12; Kawai K, 2014, BRAIN DEV-JPN, V36, P124, DOI 10.1016/j.braindev.2012.12.013; Kilgard MP, 2012, TRENDS NEUROSCI, V35, P715, DOI 10.1016/j.tins.2012.09.002; Kunii N, 2013, CLIN NEUROPHYSIOL, V124, P91, DOI 10.1016/j.clinph.2012.06.006; Kunii N, 2014, EPILEPSIA, V55, P1594, DOI 10.1111/epi.12764; Manta Stella, 2009, J Psychiatry Neurosci, V34, P272; Matsuo T, 2013, NEUROSURGERY S, V73; Mohamed AR, 2011, J NEUROSURG-PEDIATR, V7, P660, DOI 10.3171/2011.4.PEDS10454; SALINSKY MC, 1993, EPILEPSIA, V34, P299, DOI 10.1111/j.1528-1157.1993.tb02415.x; Sprengers M., 2014, COCHRANE DB SYST REV, V6; Usami K, 2013, BRAIN STIMUL, V6, P615, DOI 10.1016/j.brs.2012.09.007; Usami Kenichi, 2013, Conf Proc IEEE Eng Med Biol Soc, V2013, P5348, DOI 10.1109/EMBC.2013.6610757; Van Gompel JJ, 2012, ARCH NEUROL-CHICAGO, V69, P1476, DOI 10.1001/archneurol.2012.1200	66	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	MAY	2015	55	5					357	366		10.2176/nmc.ra.2014-0414		10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CI3QF	WOS:000354661800001		
J	Kanno, A; Mikuni, N				Kanno, Aya; Mikuni, Nobuhiro			Evaluation of Language Function under Awake Craniotomy	NEUROLOGIA MEDICO-CHIRURGICA			English	Review						awake surgery; language; electric stimulation; mapping; monitoring	LOW-GRADE GLIOMAS; SURGICAL REMOVAL; SURGERY; AREAS; ELECTROSTIMULATION; CONNECTIVITY; RESECTION; EPILEPSY; MOTOR	Awake craniotomy is the only established way to assess patients' language functions intraoperatively and to contribute to their preservation, if necessary. Recent guidelines have enabled the approach to be used widely, effectively, and safely. Non-invasive brain functional imaging techniques, including functional magnetic resonance imaging and diffusion tensor imaging, have been used preoperatively to identify brain functional regions corresponding to language, and their accuracy has increased year by year. In addition, the use of neuronavigation that incorporates this preoperative information has made it possible to identify the positional relationships between the lesion and functional regions involved in language, conduct functional brain mapping in the awake state with electrical stimulation, and intraoperatively assess nerve function in real time when resecting the lesion. This article outlines the history of awake craniotomy, the current state of pre- and intraoperative evaluation of language function, and the clinical usefulness of such functional evaluation. When evaluating patients' language functions during awake craniotomy, given the various intraoperative stresses involved, it is necessary to carefully select the tasks to be undertaken, quickly perform all examinations, and promptly evaluate the results. As language functions involve both input and output, they are strongly affected by patients' preoperative cognitive function, degree of intraoperative wakefulness and fatigue, the ability to produce verbal articulations and utterances, as well as perform synergic movement. Therefore, it is essential to appropriately assess the reproducibility of language function evaluation using awake craniotomy techniques.	[Kanno, Aya; Mikuni, Nobuhiro] Sapporo Med Univ, Sch Med, Dept Neurosurg, Sapporo, Hokkaido, Japan	Mikuni, N (reprint author), 291,S1 W17,Chuo Ku, Sapporo, Hokkaido 0608543, Japan.	mikunin@sapmed.ac.jp					Chang EF, 2011, J NEUROSURG, V114, P566, DOI 10.3171/2010.6.JNS091246; Soffietti R, 2010, EUR J NEUROL, V17, P1124, DOI 10.1111/j.1468-1331.2010.03151.x; Duffau H, 2007, NEUROPHYSIOL CLIN, V37, P373, DOI 10.1016/j.neucli.2007.09.003; Yamao Y, 2014, HUM BRAIN MAPP, V35, P4345, DOI 10.1002/hbm.22479; Mikuni N, 2010, NEUROL MED-CHIR, V50, P622; Matsumoto R, 2004, BRAIN, V127, P2316, DOI 10.1093/brain/awh246; Sanai N, 2008, NEW ENGL J MED, V358, P18, DOI 10.1056/NEJMoa067819; Nossek E, 2013, J NEUROSURG, V118, P243, DOI 10.3171/2012.10.JNS12511; Bello L, 2007, NEUROSURGERY, V60, P67, DOI 10.1227/01.NEU.0000249206.58601.DE; Hamberger MJ, 2007, NEUROPSYCHOL REV, V17, P477, DOI 10.1007/s11065-007-9046-6; Duffau H, 2008, NEUROPSYCHOLOGIA, V46, P927, DOI 10.1016/j.neuropsychologia.2007.10.025; Bello L, 2008, NEUROIMAGE, V39, P369, DOI 10.1016/j.neuroimage.2007.08.031; De Witt Hamer Philip C, 2012, J Clin Oncol, V30, P2559, DOI 10.1200/JCO.2011.38.4818; Kayama Takamasa, 2012, Neurol Med Chir (Tokyo), V52, P119; Kim YH, 2011, ACTA NEUROCHIR, V153, P1739, DOI 10.1007/s00701-011-1074-6; Kumabe T, 2013, NEUROL MED-CHIR, V53, P455; Luders HO, 1991, EPILEPSY SURG, V7, P51; Mikuni N, 2006, CLIN NEUROPHYSIOL, V117, P33, DOI 10.1016/j.clinph.2005.08.021; Papanicolaou AC, 2014, EPILEPSIA, V55, P629, DOI 10.1111/epi.12569; Suzuki K, 2014, JSM NEUROSURG SPINE, V2, P1040; Trinh VT, 2014, STEREOT FUNCT NEUROS, V92, P315, DOI 10.1159/000365224; Yang TF, 2014, CHILD NERV SYST, V30, P1559, DOI 10.1007/s00381-014-2436-1; Yoshimitsu K, 2011, NEUROL MED-CHIR, V51, P472	23	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	MAY	2015	55	5					367	373		10.2176/nmc.ra.2014-0395		7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CI3QF	WOS:000354661800002		
J	Kunieda, T; Yamao, Y; Kikuchi, T; Matsumoto, R				Kunieda, Takeharu; Yamao, Yukihiro; Kikuchi, Takayuki; Matsumoto, Riki			New Approach for Exploring Cerebral Functional Connectivity: Review of Cortico-cortical Evoked Potential	NEUROLOGIA MEDICO-CHIRURGICA			English	Review						cortico-cortical evoked potential; neural network; cortico-cortical; language function; motor function	PULSE ELECTRICAL-STIMULATION; SUPPLEMENTARY MOTOR AREA; TEMPORAL-LOBE EPILEPSY; IN-VIVO; HUMAN BRAIN; NEOCORTICAL EPILEPSY; GRANGER CAUSALITY; LANGUAGE SYSTEM; ICTAL ONSET; RESPONSES	There has been a paradigm shift in the understanding of brain function. The intrinsic architecture of neuronal connections forms a key component of the cortical organization in our brain. Many imaging studies, such as noninvasive magnetic resonance imaging (MM) studies, have now enabled visualization of the white matter fiber tracts interconnecting the functional cortical areas in the living brain. Although such a structural connectome is essential for understanding of cortical function, the anatomical information alone is not sufficient. Practically, few techniques allow the investigation of the excitatory and inhibitory mechanisms of the cortex in vivo in humans. Several attempts have been made to track neuronal connectivity by applying direct electrical stimuli to the brain in order to stimulate subdural and/or depth electrodes and record responses from the functionally connected cortex. In vivo single-pulse electrical stimulation (SPES) and/or cortico-cortical evoked potential (CCEP) were recently introduced to track various brain networks. This article reviews the concepts, significance, methods, mechanisms, limitations, and clinical applications of CCEP in the analysis of these dynamic connections.	[Kunieda, Takeharu; Yamao, Yukihiro; Kikuchi, Takayuki] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, Kyoto 6068507, Japan; [Matsumoto, Riki] Kyoto Univ, Grad Sch Med, Dept Epilepsy & Movement Disorders & Physiol, Kyoto, Kyoto 6068507, Japan	Kunieda, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Neurosurg, Sakyo Ku, 54 Shogoinkawahara Cho, Kyoto, Kyoto 6068507, Japan.	kuny@kuhp.kyoto-u.ac.jp		Matsumoto, Riki/0000-0003-3985-9210	Ministry of Education, Culture, Sports, Science and Technology of Japan [26282218, 24592159, 25861273]; GlaxoSmithKline K.K.; Nihon Kohden Corporation; Otsuka Pharmaceutical Co. Ltd.; UCB Japan Co. Ltd.	This work was funded by the Grants-in-Aid for Scientific Research (KAKENHI)(B) (C), and Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Contract grant number: 26282218, 24592159, 25861273.; Department of Epilepsy, Movement Disorders and Physiology, Kyoto University Graduate School of Medicine is an endowment department, supported with grants by GlaxoSmithKline K.K., Nihon Kohden Corporation, Otsuka Pharmaceutical Co. Ltd., and UCB Japan Co. Ltd.	Almashaikhi T, 2014, HUM BRAIN MAPP, V35, P5279, DOI 10.1002/hbm.22549; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Matsumoto R, 2007, BRAIN, V130, P181, DOI 10.1093/brain/awl257; Oya H, 2007, BIOSYSTEMS, V89, P198, DOI 10.1016/j.biosystems.2006.05.018; Enatsu R, 2015, CORTEX, V62, P20, DOI 10.1016/j.cortex.2014.06.018; Valentin A, 2002, BRAIN, V125, P1709, DOI 10.1093/brain/awf187; Enatsu R, 2012, CLIN NEUROPHYSIOL, V123, P252, DOI 10.1016/j.clinph.2011.06.030; Umeoka S, 2009, NEUROSURGERY, V64, P847, DOI 10.1227/01.NEU.0000344001.26669.92; Keller CJ, 2011, P NATL ACAD SCI USA, V108, P10308, DOI 10.1073/pnas.1019750108; Yamao Y, 2014, HUM BRAIN MAPP, V35, P4345, DOI 10.1002/hbm.22479; Enatsu R, 2014, J NEUROL NEUROSUR PS, V85, P44, DOI 10.1136/jnnp-2013-305604; Shibasaki H, 2012, CLIN NEUROPHYSIOL, V123, P229, DOI 10.1016/j.clinph.2011.07.042; Kikuchi T, 2012, CLIN NEUROPHYSIOL, V123, P324, DOI 10.1016/j.clinph.2011.06.011; Matsumoto R, 2012, HUM BRAIN MAPP, V33, P2856, DOI 10.1002/hbm.21407; Matsumoto R, 2004, BRAIN, V127, P2316, DOI 10.1093/brain/awh246; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Brugge JF, 2003, J NEUROPHYSIOL, V90, P3750, DOI 10.1152/jn.00500.2003; Raichle ME, 2009, J NEUROSCI, V29, P12729, DOI 10.1523/JNEUROSCI.4366-09.2009; Catani M, 2012, CORTEX, V48, P1262, DOI 10.1016/j.cortex.2012.07.001; David O, 2013, NEUROIMAGE, V80, P307, DOI 10.1016/j.neuroimage.2013.05.075; Boros K, 2008, EUR J NEUROSCI, V27, P1292, DOI 10.1111/j.1460-9568.2008.06090.x; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Iwasaki M, 2010, EPILEPTIC DISORD, V12, P292, DOI 10.1684/epd.2010.0334; Kiebel SJ, 2009, HUM BRAIN MAPP, V30, P1866, DOI 10.1002/hbm.20775; Matsumoto R, 2005, EPILEPSIA, V46, P1744, DOI 10.1111/j.1528-1167.2005.00284.x; Enatsu R, 2013, CORTEX, V49, P2080, DOI 10.1016/j.cortex.2012.08.026; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Valentin A, 2005, NEUROLOGY, V65, P426, DOI 10.1212/01.wnl.0000171340.73078.c1; Kubota Y, 2013, CLIN NEUROPHYSIOL, V124, P1547, DOI 10.1016/j.clinph.2013.01.024; Swann NC, 2012, NEUROIMAGE, V59, P2860, DOI 10.1016/j.neuroimage.2011.09.049; Lacruz ME, 2007, EUR J NEUROSCI, V26, P1357, DOI 10.1111/j.1460-9568.2007.05730.x; Ara Id K, 2014, CLIN NEUROPHYSIOL, V19, pS1388; Catani M, 2013, NEUROIMAGE, V80, P2, DOI 10.1016/j.neuroimage.2013.05.109; Conner CR, 2011, COMPUT BIOL MED, V41, P1100, DOI 10.1016/j.compbiomed.2011.07.008; Enatsu R, 2012, EPILEPSY RES, V101, P76, DOI 10.1016/j.eplepsyres.2012.03.004; Enatsu R, 2013, EPILEPSY RES, V103, P73, DOI 10.1016/j.eplepsyres.2012.07.008; Entz L, 2014, HUM BRAIN MAPP, V35, P5736, DOI 10.1002/hbm.22581; Friston Karl J, 2011, Brain Connect, V1, P13, DOI 10.1089/brain.2011.0008; Keller CJ, 2014, BIOL SCI, P369; Kolckinos V, 2013, SEIZURE, V22, P198; Macdonald David B, 2006, J Clin Monit Comput, V20, P347, DOI 10.1007/s10877-006-9033-0; Matsumoto R, 2007, TXB EPILEPSY SURG, P1049; Matsuzaki N, 2013, CLIN NEUROPHYSIOL, V124, P1290, DOI 10.1016/j.clinph.2013.02.007; Mori S, 2000, ANN NEUROL, V47, P412, DOI 10.1002/1531-8249(200003)47:3<412::AID-ANA28>3.0.CO;2-H; Mulcherjee P, 2008, AM J NEURORADIOL, V29, P632; Roland Per E, 2014, Front Syst Neurosci, V8, P19, DOI 10.3389/fnsys.2014.00019; Saito T, 2014, NEUROSURGERY, V121, P827; Terada K, 2012, HUM BRAIN MAPP, V33, P14, DOI 10.1002/hbm.21189; WILSON CL, 1990, EXP BRAIN RES, V82, P279; Wilson CL, 1998, EPILEPSY RES, V31, P211, DOI 10.1016/S0920-1211(98)00063-1; Zappoli R, 2003, INT J PSYCHOPHYSIOL, V48, P189, DOI 10.1016/S0167-8760(03)00054-0	52	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	MAY	2015	55	5					374	382		10.2176/nmc.ra.2014-0388		9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CI3QF	WOS:000354661800003		
J	Tamura, M; Muragaki, Y; Saito, T; Maruyama, T; Nitta, M; Tsuzuki, S; Iseki, H; Okada, Y				Tamura, Manabu; Muragaki, Yoshihiro; Saito, Taiichi; Maruyama, Takashi; Nitta, Masayuki; Tsuzuki, Shunsuke; Iseki, Hiroshi; Okada, Yoshikazu			Strategy of Surgical Resection for Glioma Based on Intraoperative Functional Mapping and Monitoring	NEUROLOGIA MEDICO-CHIRURGICA			English	Review						information-guided surgery; decision-making; functional mapping; awake craniotomy; false-positive	BRAIN-TUMOR RESECTION; MOTOR EVOKED-POTENTIALS; GRADE-II GLIOMAS; ELECTRICAL-STIMULATION; CLINICAL ARTICLE; AWAKE CRANIOTOMY; FIBER-TRACKING; GENERAL-ANESTHESIA; PYRAMIDAL TRACTS; PREDICTIVE-VALUE	A growing number of papers have pointed out the relationship between aggressive resection of gliomas and survival prognosis. For maximum resection, the current concept of surgical decision-making is in "information-guided surgery" using multimodal intraoperative information. With this, anatomical information from intraoperative magnetic resonance imaging (MM) and navigation, functional information from brain mapping and monitoring, and histopathological information must all be taken into account in the new perspective for innovative minimally invasive surgical treatment of glioma. Intraoperative neurofunctional information such as neurophysiological functional monitoring takes the most important part in the process to acquire objective visual data during tumor removal and to integrate these findings as digitized data for intraoperative surgical decision-making. Moreover, the analysis of qualitative data and threshold-setting for quantitative data raise difficult issues in the interpretation and processing of each data type, such as determination of motor evoked potential (MEP) decline, underestimation in tractography, and judgments of patient response for neurofunctional mapping and monitoring during awake craniotomy. Neurofunctional diagnosis of false-positives in these situations may affect the extent of resection, while false-negatives influence intra- and postoperative complication rates. Additionally, even though the various intraoperative visualized data from multiple sources contribute significantly to the reliability of surgical decisions when the information is integrated and provided, it is not uncommon for individual pieces of information to convey opposing suggestions. Such conflicting pieces of information facilitate higher-order decision-making that is dependent on the policies of the facility and the priorities of the patient, as well as the availability of the histopathological characteristics from resected tissue.	[Tamura, Manabu; Muragaki, Yoshihiro; Maruyama, Takashi; Nitta, Masayuki; Iseki, Hiroshi] Tokyo Womens Med Univ, Fac Adv Technosurg, Tokyo 1628666, Japan; [Tamura, Manabu; Muragaki, Yoshihiro; Saito, Taiichi; Maruyama, Takashi; Nitta, Masayuki; Tsuzuki, Shunsuke; Okada, Yoshikazu] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Dept Neurosurg, Tokyo 1628666, Japan	Muragaki, Y (reprint author), Tokyo Womens Med Univ, Dept Neurosurg, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	ymuragaki@twmu.ac.jp			Japan National Cancer Research and Development Fund; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency;  [12007086]	This article was supported in part by grants from the Japan National Cancer Research and Development Fund and Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, and Grant-in-Aid for Scientific Research (C) (No.12007086).	Brown T, 2013, J NEUROSURG ANESTH, V25, P240, DOI 10.1097/ANA.0b013e318290c230; Neuloh G, 2007, NEUROSURGERY, V61, P337, DOI [10.1227/01.neu.0000279227.50826.6c, 10.1227/01.NEU.0000119326.15032.00]; Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337; Matsumoto R, 2007, BRAIN, V130, P181, DOI 10.1093/brain/awl257; Mikuni N, 2007, J NEUROSURG, V106, P593, DOI 10.3171/jns.2007.106.4.593; Ando T, 2011, BRAIN TUMOR PATHOL, V28, P43, DOI 10.1007/s10014-010-0002-4; Soffietti R, 2010, EUR J NEUROL, V17, P1124, DOI 10.1111/j.1468-1331.2010.03151.x; Duffau H, 2007, NEUROPHYSIOL CLIN, V37, P373, DOI 10.1016/j.neucli.2007.09.003; Yamao Y, 2014, HUM BRAIN MAPP, V35, P4345, DOI 10.1002/hbm.22479; Nitta M, 2013, NEUROL MED-CHIR, V53, P447; Neuloh G, 2007, J NEUROSURG, V106, P582, DOI 10.3171/jns.2007.106.4.582; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; Desmurget M, 2007, BRAIN, V130, P898, DOI 10.1093/brain/awl300; Cedzich C, 1996, NEUROSURGERY, V38, P962, DOI 10.1097/00006123-199605000-00023; Hamer PCD, 2012, J CLIN ONCOL, V30, P2559, DOI 10.1200/JCO.2011.38.4818; Duffau H, 2006, J NEURO-ONCOL, V79, P77, DOI 10.1007/s11060-005-9109-6; Senft C, 2011, LANCET ONCOL, V12, P997, DOI 10.1016/S1470-2045(11)70196-6; Matsumoto R, 2004, BRAIN, V127, P2316, DOI 10.1093/brain/awh246; Trinh VT, 2013, NEUROSURGERY, V72, P160, DOI 10.1227/NEU.0b013e31827b9a11; Kinno R, 2014, BRAIN, V137, P1193, DOI 10.1093/brain/awu013; Prabhu SS, 2011, J NEUROSURG, V114, P719, DOI 10.3171/2010.9.JNS10481; Krieg SM, 2012, NEUROSURGERY, V70, P1060, DOI 10.1227/NEU.0b013e31823f5ade; Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280; Sanai N, 2008, NEW ENGL J MED, V358, P18, DOI 10.1056/NEJMoa067819; Ojemann JG, 1996, NEUROSURGERY, V39, P253, DOI 10.1097/00006123-199608000-00003; Chaichana KL, 2014, NEURO-ONCOLOGY, V16, P113, DOI 10.1093/neuonc/not137; Kinoshita M, 2005, NEUROIMAGE, V25, P424, DOI 10.1016/j.neuroimage.2004.07.076; Kamada K, 2009, J NEUROSURG, V111, P785, DOI 10.3171/2008.9.JNS08414; Kinno R, 2009, BRAIN LANG, V110, P71, DOI 10.1016/j.bandl.2009.05.001; Bello L, 2007, NEUROSURGERY, V60, P67, DOI 10.1227/01.NEU.0000249206.58601.DE; Kalkanis SN, 2014, J NEURO-ONCOL, V116, P477, DOI 10.1007/s11060-013-1326-9; Wick W, 2009, J CLIN ONCOL, V27, P5874, DOI 10.1200/JCO.2009.23.6497; Duffau H, 2002, J NEUROL NEUROSUR PS, V72, P511; Shioyama T, 2013, J NEUROSURG, V118, P1232, DOI 10.3171/2013.1.JNS12681; Sanai N, 2011, J NEUROSURG, V115, P3, DOI 10.3171/2011.2.JNS10998; Nimsky C, 2005, NEUROSURGERY, V56, P130, DOI 10.1227/01.NEU.0000144842.18771.30; Szelenyi A, 2010, NEUROSURGERY, V67, P302, DOI 10.1227/01.NEU.0000371973.46234.46; TANIGUCHI M, 1993, NEUROSURGERY, V32, P219; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Zhou HH, 2001, NEUROSURGERY, V48, P1075, DOI 10.1097/00006123-200105000-00021; Kubota Y, 2013, CLIN NEUROPHYSIOL, V124, P1547, DOI 10.1016/j.clinph.2013.01.024; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Kim SS, 2009, NEUROSURGERY, V64, P836, DOI 10.1227/01.NEU.0000342405.80881.81; Berger MS, 2007, NEUROSURGERY S, V61, P304; Berger MS, 2007, NEUROSURGERY, V61, P279, DOI 10.1227/01.NEU.0000255489.88321.18; Burgel U, 2009, CENT EUR NEUROSURG, V70, P27, DOI 10.1055/s-0028-1087212; Conner CR, 2011, COMPUT BIOL MED, V41, P1100, DOI 10.1016/j.compbiomed.2011.07.008; Duffau H, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.5.FOCUS0938; EBELING U, 1992, ACTA NEUROCHIR, V119, P23, DOI 10.1007/BF01541777; Enatsu R, 2013, EPILEPSY RES, V103, P73, DOI 10.1016/j.eplepsyres.2012.07.008; Fernandez-Miranda JC, 2012, NEUROSURGERY, V71, P430, DOI 10.1227/NEU.0b013e3182592faa; Gempt J, 2013, J NEUROSURG, V119, P829, DOI 10.3171/2013.5.JNS121981; Goldratt E. M., 1990, HAYSTACK SYNDROME SI; Grabowski MM, 2014, J NEUROSURG, V121, P1115, DOI 10.3171/2014.7.JNS132449; Grant GA, 2002, J NEUROSURG, V97, P709, DOI 10.3171/jns.2002.97.3.0709; Hayashi Y, 2014, WORLD NEUROSURG, V82, pe1; Hayashi Y, 2014, WORLD NEUROSURG, V82, P536; Iseki H, 2001, STEREOT FUNCT NEUROS, V76, P159, DOI 10.1159/000066714; Kamada K, 2014, JPN J NEUROSURG TOKY, V23, P862; Kanamori M, 2014, J NEUROSURG, V120, P1288, DOI 10.3171/2014.3.JNS131505; KATAYAMA Y, 1988, J NEUROL NEUROSUR PS, V51, P50, DOI 10.1136/jnnp.51.1.50; Kayama Takamasa, 2012, Neurol Med Chir (Tokyo), V52, P119; Kombos T, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.8.FOCUS09140; Kumabe T, 2005, J CLIN NEUROSCI, V12, P66, DOI 10.1016/j.jocn.2004.05.008; Maesawa S, 2010, WORLD NEUROSURG, V74, P153, DOI 10.1016/j.wneu.2010.03.022; Mikuni N, 2006, CLIN NEUROPHYSIOL, V117, P33, DOI 10.1016/j.clinph.2005.08.021; Mikuni N, 2010, NEUROL MED-CHIR, V50, P720; Muragaki Y, 2008, JPN J NEUROSURG TOKY, V17, P37; Muragaki Y, 2014, JPN J NEUROSURG TOKY, V23, P876; Muragaki Yoshihiro, 2011, Acta Neurochir Suppl, V109, P67, DOI 10.1007/978-3-211-99651-5_11; Ojemann JG, 1996, NEUROSURGERY, V39, P258; Ozawa N, 2009, NEUROL MED-CHIR, V49, P51; Ozawal N, 2008, MINIM INVAS NEUROSUR, V51, P63, DOI 10.1055/s-2007-1004557; Ozawa N, 2008, MINIM INVAS NEUROSUR, V51, P67, DOI 10.1055/s-2007-1004558; Prada Francesco, 2014, J Ultrasound, V17, P243, DOI 10.1007/s40477-014-0111-8; Romstock J, 2002, J NEUROL NEUROSUR PS, V72, P221, DOI 10.1136/jnnp.72.2.221; Saito T, 2014, J NEUROSURG, V121, P827, DOI 10.3171/2014.4.JNS131195; Saito T, 2014, NEUROL MED-CHIR, V54, P587, DOI 10.2176/nmc.cr.2013-0248; SS Kim, 2009, NEUROSURGERY, V64, P345; Thirumala P, 2013, J CLIN NEUROL, V9, P244, DOI 10.3988/jcn.2013.9.4.244; Yamamoto T, 2004, NEUROL MED CHIR TOKY, V44, P181; Yamamoto T, 2004, NEUROL MED-CHIR, V44, P170, DOI 10.2176/nmc.44.170; Yoshimitsu K, 2011, NEUROL MED-CHIR, V51, P472; Zhou HH, 2001, NEUROSURGERY, V48, P1080	84	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	MAY	2015	55	5					383	398		10.2176/nmc.ra.2014-0415		16	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CI3QF	WOS:000354661800004		
J	Sugano, H; Arai, H				Sugano, Hidenori; Arai, Hajime			Epilepsy Surgery for Pediatric Epilepsy: Optimal Timing of Surgical Intervention	NEUROLOGIA MEDICO-CHIRURGICA			English	Review						pediatric epilepsy; epilepsy surgery; surgical indication; seizure outcome; psychomotor development	VAGUS NERVE-STIMULATION; STURGE-WEBER SYNDROME; NEURONAL MIGRATION DISORDERS; POSITRON-EMISSION-TOMOGRAPHY; INTRACTABLE PARTIAL EPILEPSY; 1ST 3 YEARS; EXTRATEMPORAL EPILEPSY; REFRACTORY EPILEPSY; CORTICAL DYSPLASIA; CORPUS CALLOSOTOMY	Pediatric epilepsy has a wide variety of etiology and severity. A recent epidemiological study suggested that surgery might be indicated in as many as 5% of the pediatric epilepsy population. Now, we know that effective epilepsy surgery can result in seizure freedom and improvement of psychomotor development. Seizure control is the most effective way to improve patients neurologically and psychologically. In this review, we look over the recent evidence related to pediatric epilepsy surgery, and try to establish the optimal surgical timing for patients with intractable epilepsy. Appropriate surgical timing depends on the etiology and natural history of the epilepsy to be treated. The most common etiology of pediatric intractable epilepsy patients is malformation of cortical development (MCD) and early surgery is recommended for them. Patients operated on earlier than 12 months of age tended to improve their psychomotor development compared to those operated on later. Recent progress in neuroimaging and electrophysiological studies provide the possibility of very early diagnosis and comprehensive surgical management even at an age before 12 months. Epilepsy surgery is the only solution for patients with MCD or other congenital diseases associated with intractable epilepsy, therefore physicians should aim at an early and precise diagnosis and predicting the future damage, consider a surgical solution within an optimal timing.	[Sugano, Hidenori; Arai, Hajime] Juntendo Univ, Dept Neurosurg, Tokyo 1138421, Japan	Sugano, H (reprint author), Juntendo Univ, Dept Neurosurg, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	debo@juntendo.ac.jp					Loddenkemper T, 2007, PEDIATRICS, V119, P930, DOI 10.1542/peds.2006-2530; Shinnar S, 2001, EPILEPSY RES, V43, P261, DOI 10.1016/S0920-1211(00)00206-0; Piastra M, 2004, CHILD NERV SYST, V20, P453, DOI 10.1007/s00381-004-0957-8; PALMINI A, 1991, ANN NEUROL, V30, P741, DOI 10.1002/ana.410300602; Shimizu H, 2000, NEUROSURGERY, V47, P367, DOI 10.1097/00006123-200008000-00018; Basheer SN, 2007, EPILEPSIA, V48, P133, DOI 10.1111/j.1528-1167.2006.00909.x; Cossu M, 2008, EPILEPSIA, V49, P65, DOI 10.1111/j.1528-1167.2007.01207.x; Schramm J, 2001, NEUROSURGERY, V49, P891, DOI 10.1097/00006123-200110000-00021; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Maehara T, 2001, EPILEPSIA, V42, P67, DOI 10.1046/j.1528-1157.2001.081422.x; Wyllie E, 1998, ANN NEUROL, V44, P740, DOI 10.1002/ana.410440507; Levy ML, 2010, J NEUROSURG-PEDIATR, V5, P595, DOI 10.3171/2010.3.PEDS09153; Hakimi AS, 2008, EPILEPSY BEHAV, V13, P96, DOI 10.1016/j.yebeh.2008.02.003; Barba C, 2012, EPILEPSIA, V53, pE141, DOI 10.1111/j.1528-1167.2012.03524.x; King MA, 1998, LANCET, V352, P1007, DOI 10.1016/S0140-6736(98)03543-0; Alkadhi H, 2000, AM J NEURORADIOL, V21, P1423; Sugano H, 2014, EPILEPSIA, V55, P683, DOI 10.1111/epi.12547; Cross JH, 2006, EPILEPSIA, V47, P952, DOI 10.1111/j.1528-1167.2006.00569.x; Devlin AM, 2003, BRAIN, V126, P556, DOI 10.1093/brain/awg052; VarghaKhadem F, 1997, BRAIN, V120, P159, DOI 10.1093/brain/120.1.159; CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112; Carson BS, 1996, J NEUROSURG, V84, P903, DOI 10.3171/jns.1996.84.6.0903; Guerrini R, 2014, LANCET NEUROL, V13, P710, DOI 10.1016/S1474-4422(14)70040-7; Wyllie E, 2007, NEUROLOGY, V69, P389, DOI 10.1212/01.wnl.0000266386.55715.3f; Berg AT, 2000, PEDIATRICS, V106, P527, DOI 10.1542/peds.106.3.527; Elliott RE, 2011, J NEUROSURG-PEDIATR, V7, P491, DOI 10.3171/2011.2.PEDS10505; Calautti C, 2001, STROKE, V32, P2534, DOI 10.1161/hs1101.097401; Schevon CA, 2007, EPILEPSIA, V48, P539, DOI 10.1111/j.1528-1167.2006.00962.x; Gaillard WD, 2009, EPILEPSIA, V50, P2147, DOI 10.1111/j.1528-1167.2009.02075.x; Duchowny M, 1998, EPILEPSIA, V39, P737, DOI 10.1111/j.1528-1157.1998.tb01159.x; Centeno RS, 2006, CHILD NERV SYST, V22, P945, DOI 10.1007/s00381-006-0145-0; Chamoun RB, 2007, EPILEPSY BEHAV, V11, P384, DOI 10.1016/j.yebeh.2007.05.015; Cross JH, 2010, DEV MED CHILD NEUROL, V52, P111, DOI 10.1111/j.1469-8749.2009.03599.x; Daniel RT, 2007, EPILEPSIA, V48, P1429, DOI 10.1111/j.1528-1167.2007.01095.x; Delalande O, 1960, NEUROSURGERY S1, V60, pONS19; Delalande O, 2007, NEUROSURGERY S1, V60, pONS32; Depositario-Cabacar DT, 2008, CURR NEUROL NEUROSCI, V8, P123, DOI 10.1007/s11910-008-0020-3; Hall-Patch L, 2012, EPILEPSY BEHAV, V23, P442, DOI 10.1016/j.yebeh.2012.01.025; Harvey A Simon, 2008, Epilepsia, V49, P146, DOI 10.1111/j.1528-1167.2007.01421.x; HIRABAYASHI S, 1993, J NEUROL NEUROSUR PS, V56, P765, DOI 10.1136/jnnp.56.7.765; Morris GL, 2013, EPILEPSY CURR, V13, P297, DOI 10.5698/1535-7597-13.6.297; Muller RA, 1997, J CHILD NEUROL, V12, P431; PALMINI A, 1991, ANN NEUROL, V30, P750, DOI 10.1002/ana.410300603; Pataraia E, 2005, NEUROLOGY, V64, P481; Schramm J, 2001, NEUROSURGERY, V49, P900; Steinbok P, 2009, EPILEPSIA, V50, P1442, DOI 10.1111/j.1528-1167.2008.01992.x; Sugano H, 2009, CHILD NERV SYST, V25, P143, DOI 10.1007/s00381-008-0696-3; Sunaga S, 2009, SEIZURE-EUR J EPILEP, V18, P124, DOI 10.1016/j.seizure.2008.08.001; Yoshiura T, 1997, AM J NEURORADIOL, V18, P865; Zentner J, 1996, EPILEPSIA, V37, P1072, DOI 10.1111/j.1528-1157.1996.tb01027.x	50	2	2	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	MAY	2015	55	5					399	406		10.2176/nmc.ra.2014-0369		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CI3QF	WOS:000354661800005		
J	Yamamoto, T				Yamamoto, Takamichi			Vagus Nerve Stimulation Therapy: Indications, Programing, and Outcomes	NEUROLOGIA MEDICO-CHIRURGICA			English	Review						vagus nerve stimulation; medically refractory epilepsy; indications; programing; seizure reduction	TREATMENT-RESISTANT EPILEPSY; RANDOMIZED CONTROLLED-TRIAL; LENNOX-GASTAUT SYNDROME; QUALITY-OF-LIFE; REFRACTORY EPILEPSY; LONG-TERM; DEVICE PARAMETERS; SURGERY; SEIZURES; METAANALYSIS	Vagus nerve stimulation (VNS) provides palliation of seizure reduction for patients with medically refractory epilepsy. VNS is indicated for symptomatic localization-related epilepsy with multiple and bilateral independent foci, symptomatic generalized epilepsy with diffuse epileptogenic abnormalities, refractory idiopathic generalized epilepsy, failed intracranial epilepsy surgery, and other several reasons of contraindications to epilepsy surgery. Programing of the parameters is a principal part in VNS. Output current and duty cycle should be adjusted to higher settings particularly when a patient does not respond to the initial setting, since the pivotal randomized trials performed in the United States demonstrated high stimulation made better responses in seizure frequency. These trials revealed that a >= 50% seizure reduction occurred in 36.8% of patients at 1 year, in 43.2% at 2 years, and in 42.7% at 3 years in 440 patients. Safety of VNS was also confirmed because side effects including hoarseness, throat discomfort, cough, paresthesia, and headache improved progressively during the period of 3 years. The largest retrospective study with 436 patients demonstrated the mean seizure reduction of 55.8% in nearly 5 years, and also found 75.5% at 10 years in 65 consecutive patients. The intermediate analysis report of the Japan VNS Registry showed that 60% of 164 cases got a 50% seizure reduction in 12 months. In addition to seizure reduction, VNS has positive effects in mood and improves energy level, memory difficulties, social aspects, and fear of seizures. VNS is an effective and safe option for patients who are not suitable candidates for intracranial epilepsy surgery.	[Yamamoto, Takamichi] Seirei Hamamatsu Gen Hosp, Comprehens Epilepsy Ctr, Hamamatsu, Shizuoka 4308558, Japan	Yamamoto, T (reprint author), Seirei Hamamatsu Gen Hosp, Comprehens Epilepsy Ctr, Naka Ku, 2-12-12 Sumiyoshi, Hamamatsu, Shizuoka 4308558, Japan.	taka-yamamd@sis.seirei.or.jp					Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Bernstein AL, 2007, EPILEPSY BEHAV, V10, P134, DOI 10.1016/j.yebeh.2006.09.014; Lancman G, 2013, SEIZURE-EUR J EPILEP, V22, P3, DOI 10.1016/j.seizure.2012.09.014; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Tatum WO, 2009, EPILEPSY BEHAV, V15, P299, DOI 10.1016/j.yebeh.2009.04.002; Amar AP, 2004, NEUROSURGERY, V55, P1086, DOI 10.1227/01.NEU.0000141073.08427.76; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; Stefan H, 2012, EPILEPSIA, V53, pe115, DOI 10.1111/j.1528-1167.2012.03492.x; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; DeGiorgio CM, 2013, NEUROLOGY, V80, P786, DOI 10.1212/WNL.0b013e318285c11a; Elliott RE, 2011, EPILEPSY BEHAV, V20, P57, DOI 10.1016/j.yebeh.2010.10.017; GEORGE R, 1995, NEUROLOGY, V45, P224; Handforth A, 1998, NEUROLOGY, V51, P48; Elger G, 2000, EPILEPSY RES, V42, P203, DOI 10.1016/S0920-1211(00)00181-9; DeGiorgio C, 2005, NEUROLOGY, V65, P317, DOI 10.1212/01.wnl.0000168899.11598.00; Bunch S, 2007, ACTA NEUROL SCAND, V116, P217, DOI 10.1111/j.1600-0404.2007.00878.x; Boon P, 1999, ACTA NEUROCHIR, V141, P447, DOI 10.1007/s007010050324; DeGiorgio CM, 2000, EPILEPSIA, V41, P1195, DOI 10.1111/j.1528-1157.2000.tb00325.x; DeGiorgio CM, 2001, EPILEPSIA, V42, P1017, DOI 10.1046/j.1528-1157.2001.0420081017.x; Ben-Menachem E, 2002, LANCET NEUROL, V1, P477, DOI 10.1016/S1474-4422(02)00220-X; Jayakar P, 2014, EPILEPSIA, V55, P507, DOI 10.1111/epi.12544; Elliott RE, 2011, J NEUROSURG-PEDIATR, V7, P491, DOI 10.3171/2011.2.PEDS10505; AGNEW WF, 1990, EPILEPSIA, V31, pS27, DOI 10.1111/j.1528-1157.1990.tb05845.x; Elliott RE, 2011, EPILEPSY BEHAV, V20, P478, DOI 10.1016/j.yebeh.2010.12.042; Heck C, 2002, NEUROLOGY, V59, pS31; Theodore WH, 2004, LANCET NEUROL, V3, P111, DOI 10.1016/S1474-4422(03)00664-1; Tellez-Zenteno JF, 2005, BRAIN, V128, P1188, DOI 10.1093/brain/awh449; Bulteau C, 2013, BRAIN DEV-JPN, V35, P742, DOI 10.1016/j.braindev.2013.05.004; Cramer JA, 2001, EPILEPSY BEHAV, V2, P460, DOI 10.1006/ebeh.2001.0248; Douglass LM, 2014, EPILEPSIA, V55, P21, DOI 10.1111/epi.12742; Duchowny MS, 2007, EPILEPSY COMPREHENSI, P1751; Engel J, 2013, EPILEPSY CURR, V13, P198, DOI 10.5698/1535-7597-13.5.198; Engel Jr J, 2007, EPILEPSY COMPREHENSI, P1761; Ergene E, 2001, EPILEPSY BEHAV, V2, P284, DOI 10.1006/ebeh.2001.0173; Fisher RS, 1997, NEUROLOGY, V49, P293; Heck CN, 2014, EPILEPSIA, V55, P432, DOI 10.1111/epi.12534; Kawai K, 2014, VNS ADV EPILEPSY, V1, P1; Mathern GW, 2007, EPILEPSY COMPREHENSI, V2, P1771; Morris GL, 1999, NEUROLOGY, V53, P1731; Ng M, 2004, SEIZURE-EUR J EPILEP, V13, P176, DOI 10.1016/S1059-1311(03)00147-X; Schachter SC, 2007, EPILEPSY COMPREHENSI, V2, P1395; Valencia I, 2001, PEDIATR NEUROL, V25, P368, DOI 10.1016/S0887-8994(01)00319-8; Yamamoto T, 2014, NEUROLOGICAL MED, V80, P223	43	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	MAY	2015	55	5					407	415		10.2176/nmc.ra.2014-0405		9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CI3QF	WOS:000354661800006		
J	Sugiyama, K; Nozaki, T; Asakawa, T; Koizumi, S; Saitoh, O; Namba, H				Sugiyama, Kenji; Nozaki, Takao; Asakawa, Tetsuya; Koizumi, Shinichiro; Saitoh, Osamu; Namba, Hiroki			The Present Indication and Future of Deep Brain Stimulation	NEUROLOGIA MEDICO-CHIRURGICA			English	Review						deep brain stimulation; indications; future invention; ethics	HIGH-FREQUENCY STIMULATION; PARKINSONS-DISEASE; TOURETTE-SYNDROME; NUCLEUS; CIRCUITS; DEPRESSION; THALAMUS; NEURONS	The use of electrical stimulation to treat pain in human disease dates back to ancient Rome or Greece. Modern deep brain stimulation (DBS) was initially applied for pain treatment in the 1960s, and was later used to treat movement disorders in the 1990s. After recognition of DBS as a therapy for central nervous system (CNS) circuit disorders, DBS use showed drastic increase in terms of adaptability to disease and the patient's population. More than 100,000 patients have received DBS therapy worldwide. The established indications for DBS are Parkinson's disease, tremor, and dystonia, whereas global indications of DBS expanded to other neuronal diseases or disorders such as neuropathic pain, epilepsy, and tinnitus. DBS is also experimentally used to manage cognitive disorders and psychiatric diseases such as major depression, obsessive-compulsive disorder (OCD), Tourette's syndrome, and eating disorders. The importance of ethics and conflicts surrounding the regulation and freedom of choice associated with the application of DBS therapy for new diseases or disorders is increasing. These debates are centered on the use of DBS to treat new diseases and disorders as well as its potential to enhance ability in normal healthy individuals. Here we present three issues that need to be addressed in the future: (1) elucidation of the mechanisms of DBS, (2) development of new DBS methods, and (3) miniaturization of the DBS system. With the use of DBS, functional neurosurgery entered into the new era that man can manage and control the brain circuit to treat intractable neuronal diseases and disorders.	[Sugiyama, Kenji; Nozaki, Takao; Asakawa, Tetsuya; Koizumi, Shinichiro; Saitoh, Osamu; Namba, Hiroki] Hamamatsu Univ Sch Med, Dept Neurosurg, Hamamatsu, Shizuoka 4313192, Japan	Sugiyama, K (reprint author), Hamamatsu Univ Sch Med, Dept Neurosurg, Higashi Ku, 1-20-1 Handa Yama, Hamamatsu, Shizuoka 4313192, Japan.	kesugi@hama-med.ac.jp					Hashimoto T, 2003, J NEUROSCI, V23, P1916; Leone M, 2004, CEPHALALGIA, V24, P934, DOI 10.1111/j.1468-2982.2004.00742.x; BENABID AL, 1994, STEREOT FUNCT NEUROS, V62, P76, DOI 10.1159/000098600; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Martens HCF, 2011, CLIN NEUROPHYSIOL, V122, P558, DOI 10.1016/j.clinph.2010.07.026; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Lozano AM, 2013, NEURON, V77, P406, DOI 10.1016/j.neuron.2013.01.020; Little S, 2012, ANN NY ACAD SCI, V1265, P9, DOI 10.1111/j.1749-6632.2012.06650.x; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; Nuttin BJ, 2003, NEUROSURGERY, V52, P1263, DOI 10.1227/01.NEU.0000065465.49299.9A; Shen KZ, 2003, SYNAPSE, V50, P314, DOI 10.1002/syn.10274; HASSLER R, 1960, BRAIN, V83, P337, DOI 10.1093/brain/83.2.337; BENABID AL, 1987, APPL NEUROPHYSIOL, V50, P344; Hariz M, 2013, MOVEMENT DISORD, V28, P1784, DOI 10.1002/mds.25665; Vandewalle V, 1999, LANCET, V353, P724, DOI 10.1016/S0140-6736(98)05964-9; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Schlaepfer TE, 2013, BIOL PSYCHIAT, V73, P1204, DOI 10.1016/j.biopsych.2013.01.034; Dostrovsky JO, 2000, J NEUROPHYSIOL, V84, P570; Rosin B, 2011, NEURON, V72, P370, DOI 10.1016/j.neuron.2011.08.023; Shi YB, 2009, OTOLARYNG HEAD NECK, V141, P285, DOI 10.1016/j.otohns.2009.05.020; Laxton AW, 2010, ANN NEUROL, V68, P521, DOI 10.1002/ana.22089; Finger S, 1994, ORIGINS NEUROSCIENCE, P415; Hariz MI, 2010, NEUROSURG FOCUS, V29, pE1; Kaido T, 2011, NEUROMODULATION, V14, P123, DOI 10.1111/j.1525-1403.2010.00324.x; Nuttin B, 2014, J NEUROL NEUROSUR PS, V85, P1003, DOI 10.1136/jnnp-2013-306580; SANO K, 1975, CONFIN NEUROL, V37, P285; Sun Bomin, 2013, Surg Neurol Int, V4, pS164, DOI 10.4103/2152-7806.110668; Yamamoto T, 2003, ACT NEUR S, V87, P15	28	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	MAY	2015	55	5					416	421		10.2176/nmc.ra.2014-0394		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CI3QF	WOS:000354661800007		
J	Fukaya, C; Yamamoto, T				Fukaya, Chikashi; Yamamoto, Takamitsu			Deep Brain Stimulation for Parkinson's Disease: Recent Trends and Future Direction	NEUROLOGIA MEDICO-CHIRURGICA			English	Review						deep brain stimulation; Parkinson's disease; levodopa; CSTC loop	SUBTHALAMIC NUCLEUS STIMULATION; RANDOMIZED CONTROLLED-TRIAL; GLOBUS-PALLIDUS; BILATERAL STIMULATION; STEREOTACTIC SURGERY; MEDICAL THERAPY; ADVERSE EVENTS; RISK-FACTORS; HEART-RATE; FOLLOW-UP	To date, deep brain stimulation (DBS) has already been performed on more than 120,000 patients worldwide and in more than 7,000 patients in Japan. However, fundamental understanding of DBS effects on the pathological neural circuitry remains insufficient. Recent studies have specifically shown the importance of cortico-striato-thalamo-cortical (CSTC) loops, which were identified as functionally and anatomically discrete units. Three main circuits exist in the CSTC loops, namely, the motor, associative, and limbic circuits. From these theoretical backgrounds, it is determined that DBS sometimes influences not only motor functions but also the cognitive and affective functions of Parkinson's disease (PD) patients. The main targets of DBS for PD are subthalamic nucleus (STN) and globus pallidus interna (GPi). Ventralis intermedius (Vim)-DBS was found to be effective in improving tremor. However, Vim-DBS cannot sufficiently improve akinesia and rigidity. Therefore, Vim-DBS is seldom carried out for the treatment of PD. In this article, we review the present state of DBS, mainly STN-DBS and GPi-DBS, for PD. In the first part of the article, appropriate indications and practical effects established in previous studies are discussed. The findings of previous investigations on the complications caused by the surgical procedure and on the adverse events induced by DBS itself are reviewed. In the second part, we discuss target selection (GPi vs. STN) and the effect of DBS on nonmotor symptoms. In the final part, as issues that should be resolved, the suitable timing of surgery, symptoms unresponsive to DBS such as on-period axial symptoms, and the related postoperative programing of stimulation parameters, are discussed.	[Fukaya, Chikashi; Yamamoto, Takamitsu] Nihon Univ, Sch Med, Dept Neurol Surg, Div Appl Syst Neurosci, Tokyo 1738610, Japan	Fukaya, C (reprint author), Nihon Univ, Sch Med, Dept Neurol Surg, Div Appl Syst Neurosci, 30-1 Itabashi Ku, Tokyo 1738610, Japan.	fukaya.chikashi@nihon-u.ac.jp			Strategic Research Program for Brain Science (MEXT); MEXT; Ministry of Education, Culture, Sports, Science and Technology of Japan [C-24592175]	The work was supported by the Strategic Research Program for Brain Science (MEXT), MEXT-Supported Program for the Strategic Research Foundation at Private University, and a grant (C-24592175) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Obeso JA, 2001, NEW ENGL J MED, V345, P956; Videnovic A, 2008, MOVEMENT DISORD, V23, P343, DOI 10.1002/mds.21753; Brefel-Courbon C, 2005, MOVEMENT DISORD, V20, P1557, DOI 10.1002/mds.20629; Monaca C, 2004, J NEUROL, V251, P214, DOI 10.1007/s00415-004-0305-7; Lyons KE, 2004, NEUROLOGY, V63, P612; Anderson VC, 2005, ARCH NEUROL-CHICAGO, V62, P554, DOI 10.1001/archneur.62.4.554; Maurer C, 2003, BRAIN, V126, P1146, DOI 10.1093/brain/awg100; Appleby BS, 2007, MOVEMENT DISORD, V22, P1722, DOI 10.1002/mds.21551; BENABID AL, 1994, STEREOT FUNCT NEUROS, V62, P76, DOI 10.1159/000098600; Follett KA, 2010, NEW ENGL J MED, V362, P2077, DOI 10.1056/NEJMoa0907083; Weaver FM, 2012, NEUROLOGY, V79, P55, DOI 10.1212/WNL.0b013e31825dcdc1; Odekerken VJJ, 2013, LANCET NEUROL, V12, P37, DOI 10.1016/S1474-4422(12)70264-8; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Halbig TD, 2009, EUR J NEUROL, V16, P493, DOI 10.1111/j.1468-1331.2008.02509.x; Yamamoto T, 2005, NEUROPSYCHOL REHABIL, V15, P406, DOI 10.1080/09602010443000353; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Weaver FM, 2009, JAMA-J AM MED ASSOC, V301, P63, DOI 10.1001/jama.2008.929; Castrioto A, 2011, ARCH NEUROL-CHICAGO, V68, P1550, DOI 10.1001/archneurol.2011.182; Chan DTM, 2009, ASIAN J SURG, V32, P258, DOI 10.1016/S1015-9584(09)60404-8; Langevin JP, 2010, J PSYCHIATR RES, V44, P1241, DOI 10.1016/j.jpsychires.2010.04.022; Halpern CH, 2008, J NEUROSURG, V109, P625, DOI 10.3171/JNS/2008/109/10/0625; Stefani A, 2007, BRAIN, V130, P1596, DOI 10.1093/brain/aw1346; Djaldetti R, 2004, NEUROLOGY, V62, P2171; Witt K, 2004, ARCH NEUROL-CHICAGO, V61, P697, DOI 10.1001/archneur.61.5.697; Rodriguez-Oroz MC, 2005, BRAIN, V128, P2240, DOI 10.1093/brain/awh571; BENABID AL, 1987, APPL NEUROPHYSIOL, V50, P344; Binder DK, 2005, NEUROSURGERY, V56, P722, DOI 10.1227/01.NEU.0000156473.57196.7E; Zangaglia R, 2009, MOVEMENT DISORD, V24, P1621, DOI 10.1002/mds.22603; Weiss D, 2013, BRAIN, V136, P2098, DOI 10.1093/brain/awt122; Ben-Haim S, 2009, NEUROSURGERY, V64, P754, DOI 10.1227/01.NEU.0000339173.77240.34; Beric A, 2001, STEREOT FUNCT NEUROS, V77, P73, DOI 10.1159/000064600; Sillay KA, 2008, NEUROSURGERY, V62, P360, DOI [10.1227/01.neu.0000316002.03765.33, 10.1227/01.NEU.0000297020.60125.FC]; Sansur CA, 2007, J NEUROSURG, V107, P998, DOI 10.3171/JNS-07/11/0998; Okun MS, 2012, LANCET NEUROL, V11, P140, DOI 10.1016/S1474-4422(11)70308-8; Zibetti M, 2011, MOVEMENT DISORD, V26, P2327, DOI 10.1002/mds.23903; Kuhn J, 2007, J NEUROL NEUROSUR PS, V78, P1152, DOI 10.1136/jnnp.2006.113092; Williams A, 2010, LANCET NEUROL, V9, P581, DOI 10.1016/S1474-4422(10)70093-4; Moro E, 2010, MOVEMENT DISORD, V25, P578, DOI 10.1002/mds.22735; Okun MS, 2009, ANN NEUROL, V65, P586, DOI 10.1002/ana.21596; Moreau C, 2008, NEUROLOGY, V71, P80, DOI 10.1212/01.wnl.0000303972.16279.46; Stolze H, 2001, NEUROLOGY, V57, P144; Fasano A, 2010, BRAIN, V133, P2664, DOI 10.1093/brain/awq221; Schuepbach WMM, 2013, NEW ENGL J MED, V368, P610, DOI 10.1056/NEJMoa1205158; Mazzone P, 2005, NEUROREPORT, V16, P1877, DOI 10.1097/01.wnr.0000187629.38010.12; Gorgulho A, 2005, J NEUROSURG, V102, P888, DOI 10.3171/jns.2005.102.5.0888; Broetz D, 2007, MOVEMENT DISORD, V22, P853, DOI 10.1002/mds.21439; Laxton AW, 2010, ANN NEUROL, V68, P521, DOI 10.1002/ana.22089; GOTHAM AM, 1988, BRAIN, V111, P299, DOI 10.1093/brain/111.2.299; Kim HJ, 2008, J NEUROL, V255, P1889, DOI 10.1007/s00415-009-0908-0; Hershey T, 2004, NEUROLOGY, V62, P1110; Parsons TD, 2006, LANCET NEUROL, V5, P578, DOI 10.1016/S1474-4422(06)70475-6; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Elias WJ, 2009, J NEUROSURG, V110, P201, DOI 10.3171/2008.7.17625; Erola T, 2006, CLIN AUTON RES, V16, P286, DOI 10.1007/s10286-006-0354-3; Fukaya Chikashi, 2014, No Shinkei Geka, V42, P751; St George R J, 2010, Neurology, V75, P1292, DOI 10.1212/WNL.0b013e3181f61329; Hariz MI, 2010, NEUROSURG FOCUS, V29, pE1; Holmberg B, 2005, MOVEMENT DISORD, V20, P976, DOI 10.1002/mds.20492; Katayama Y, 2006, STEREOT FUNCT NEUROS, V84, P176, DOI 10.1159/000094957; Kaufmann H, 2002, NEUROLOGY, V59, P1657; Kleiner-Fisman G, 2006, MOVEMENT DISORD, V21, pS290, DOI 10.1002/mds.20962; Kopell BH, 2004, J CLIN NEUROPHYSIOL, V21, P51, DOI 10.1097/00004691-200401000-00007; Lapidus KA, 2013, WORLD NEUROSURG, V80; Moreau C, 2009, MOVEMENT DISORD, V24, P2164, DOI 10.1002/mds.22743; Oshima H, 2012, J NEUROSURG, V116, P99, DOI 10.3171/2011.7.JNS11158; Otalca T, 2010, NEUROMODULATION, V13, P10; Rezai AR, 2014, JPN J NEUROSURG TOKY, V23, P648; Seijo FJ, 2007, ACTA NEUROCHIR, V149, P867, DOI 10.1007/s00701-007-1267-1; SIEGFRIED J, 1987, PACE, V10, P271, DOI 10.1111/j.1540-8159.1987.tb05961.x; Xiaowu Hu, 2010, Parkinsonism Relat Disord, V16, P96, DOI 10.1016/j.parkreldis.2009.07.013	70	1	1	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	MAY	2015	55	5					422	431		10.2176/nmc.ra.2014-0446		10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CI3QF	WOS:000354661800008		
J	Toda, H; Goto, M; Iwasaki, K				Toda, Hiroki; Goto, Masanori; Iwasaki, Koichi			Patterns and Variations in Microvascular Decompression for Trigeminal Neuralgia	NEUROLOGIA MEDICO-CHIRURGICA			English	Review						trigeminal neuralgia; microvascular decompression; surgical nuances	HEMIFACIAL SPASM; TIC-DOULOUREUX; TECHNICAL NOTE; GLOSSOPHARYNGEAL NEURALGIA; PREOPERATIVE ASSESSMENT; CRANIAL NERVES; FOLLOW-UP; SURGERY; ARTERY; COMPRESSION	Microvascular decompression (MVD) is a highly effective surgical treatment for trigeminal neuralgia (TN). Although there is little prospective clinical evidence, accumulated observational studies have demonstrated the benefits of MVD for refractory TN. In the current surgical practice of MVD for TN, there have been recognized patterns and variations in surgical anatomy and various decompression techniques. Here we provide a stepwise description of surgical procedures and relevant anatomical characteristics, as well as procedural options.	[Toda, Hiroki; Goto, Masanori; Iwasaki, Koichi] Tazuke Kofukai Med Res Inst, Dept Neurosurg, Osaka, Osaka 5308480, Japan; [Toda, Hiroki; Goto, Masanori; Iwasaki, Koichi] Kitano Hosp, Osaka, Osaka, Japan	Toda, H (reprint author), Tazuke Kofukai Med Res Inst, Dept Neurosurg, Kita Ku, 2-4-20 Ohgimachi, Osaka, Osaka 5308480, Japan.	htoda-nsu@umin.ac.jp					Abdeen K, 2000, NEUROL RES, V22, P522; Amagasaki K, 2014, J NEUROSURG, V121, P940, DOI 10.3171/2014.6.JNS132292; Day JD, 1996, NEUROSURGERY, V38, P1079, DOI 10.1097/00006123-199606000-00003; Zakrzewska JM, 2005, NEUROSURGERY, V56, P1304, DOI 10.1227/01.NEU.0000159883.35957.E0; Zhang H, 2013, WORLD NEUROSURG, V79, P756, DOI 10.1016/j.wneu.2012.01.040; Ichikawa T, 2011, NEUROSURGERY, V68, P377, DOI 10.1227/NEU.0b013e318217141c; SHELDEN CH, 1955, J NEUROSURG, V12, P123, DOI 10.3171/jns.1955.12.2.0123; MEANEY JFM, 1994, AM J ROENTGENOL, V163, P1447; Kobata H, 1998, NEUROSURGERY, V43, P1351, DOI 10.1097/00006123-199812000-00052; Barker FG, 1996, NEW ENGL J MED, V334, P1077, DOI 10.1056/NEJM199604253341701; HAKANSON S, 1981, NEUROSURGERY, V9, P638; Cruccu G, 2008, EUR J NEUROL, V15, P1013, DOI 10.1111/j.1468-1331.2008.02185.x; MULLAN S, 1983, J NEUROSURG, V59, P1007, DOI 10.3171/jns.1983.59.6.1007; Yoshino N, 2003, RADIOLOGY, V228, P539, DOI 10.1148/radiol.2282020439; Antonini G, 2014, PAIN, V155, P1464, DOI 10.1016/j.pain.2014.04.020; Broggi G, 2000, J NEUROL NEUROSUR PS, V68, P59, DOI 10.1136/jnnp.68.1.59; Zakrzewska JM, 2012, CURR OPIN NEUROL, V25, P296, DOI 10.1097/WCO.0b013e328352c465; RAND RW, 1993, STEREOT FUNCT NEUROS, V61, P93, DOI 10.1159/000100663; SWEET WH, 1974, J NEUROSURG, V40, P143, DOI 10.3171/jns.1974.40.2.0143; TAARNHOJ P, 1952, J NEUROSURG, V9, P288, DOI 10.3171/jns.1952.9.3.0288; Kondo A, 1998, J NEUROSURG, V88, P221, DOI 10.3171/jns.1998.88.2.0221; Cohen-Gadol AA, 2011, CLIN NEUROL NEUROSUR, V113, P844, DOI 10.1016/j.clineuro.2011.06.003; Rhoton AL, 2000, NEUROSURGERY, V47, pS29, DOI 10.1097/00006123-200009001-00010; Kalkanis SN, 2003, NEUROSURGERY, V52, P1251, DOI 10.1227/01.NEU.0000065129.25359; JANNETTA PJ, 1967, J NEUROSURG, V26, P159, DOI 10.3171/jns.1967.26.1part2.0159; Sarsam Z, 2010, BRIT J NEUROSURG, V24, P18, DOI 10.3109/02688690903370289; Gronseth G, 2008, NEUROLOGY, V71, P1183, DOI 10.1212/01.wnl.0000326598.83183.04; Broggi M, 2013, ACTA NEUROCHIR, V155, P1709, DOI 10.1007/s00701-013-1824-8; Attabib N, 2007, J NEUROSURG, V106, P929, DOI 10.3171/jns.2007.106.5.929; McLaughlin MR, 1999, J NEUROSURG, V90, P1, DOI 10.3171/jns.1999.90.1.0001; Xia L, 2014, J CRANIOFAC SURG, V25, P1413, DOI 10.1097/SCS.0000000000000984; Sekula RF, 2011, J NEUROSURG, V114, P172, DOI 10.3171/2010.6.JNS10142; LANG J, 1991, ACTA NEUROCHIR, V111, P147, DOI 10.1007/BF01400505; Zheng XS, 2012, WORLD NEUROSURG, V77, P771, DOI 10.1016/j.wneu.2011.08.031; Masuoka J, 2011, NEUROSURG REV, V34, P373, DOI 10.1007/s10143-011-0310-0; Helbig GM, 2009, NEUROSURGERY, V65, P958, DOI 10.1227/01.NEU.0000351757.29658.C0; Linskey ME, 2008, J NEUROSURG, V109, P160, DOI 10.3171/JNS/2008/109/12/S25; Banczerowski P, 2014, J NEUROSURG, V121, P1492, DOI 10.3171/2014.8.JNS132445; Chavez GDRC, 2005, NEUROSURGERY, V56, P628, DOI 10.1227/01.NEU.0000154709.44776.50; CUSHING H, 1983, JAMA-J AM MED ASSOC, V250, P519, DOI 10.1001/jama.250.4.519; Dandy WE, 1932, ANN SURG, V96, P787, DOI 10.1097/00000658-193210000-00026; Dandy WE, 1934, AM J SURG, V24, P447, DOI 10.1016/S0002-9610(34)90403-7; Ebel H, 1996, ACTA NEUROCHIR, V138, P1300, DOI 10.1007/BF01411059; Gandolfi A, 2005, CLIN NEUROL NEUROSUR, V107, P439, DOI 10.1016/j.clineuro.2004.09.023; GARDNER WJ, 1959, JAMA-J AM MED ASSOC, V170, P1773; Greenberg MS, 2010, HDB NEUROSURGERY, V7, P559; Hamasaki T, 2009, NEUROSURGERY, V64, P241, DOI 10.1227/01.NEU.0000336763.90656.2B; Honda Kazuhiro, 2006, Magn Reson Med Sci, V5, P211, DOI 10.2463/mrms.5.211; Ishimori Takashi, 2003, Magn Reson Med Sci, V2, P145, DOI 10.2463/mrms.2.145; Jannetta P J, 1966, Bull Los Angeles Neurol Soc, V31, P93; Kirschner M, 1932, ZENTRABL CHIR, V59, P2841; Lopez BC, 2005, NEUROSURGERY, V56, P1311; LOVE JG, 1952, P STAFF M MAYO CLIN, V27, P257; Melvill RL, 1996, J NEUROSURG, V84, P127, DOI 10.3171/jns.1996.84.1.0127; MORITA A, 1989, J NEUROSURG, V70, P415, DOI 10.3171/jns.1989.70.3.0415; NAGATA K, 1986, J NEUROSURG, V65, P564, DOI 10.3171/jns.1986.65.4.0564; Ohta M, 2014, ACTA NEUROCHIR, V156, P565, DOI 10.1007/s00701-013-1941-4; Olivecrona H, 1947, ACTA PSYCH NEUROL SU, P268; Park CK, 2014, J KOREAN NEUROSURG S, V56, P278, DOI 10.3340/jkns.2014.56.3.278; PIATT JH, 1984, NEUROSURGERY, V15, P456, DOI 10.1097/00006123-198409000-00024; Premsagar IC, 1997, J NEUROSURG, V87, P454, DOI 10.3171/jns.1997.87.3.0454; Shenouda EF, 2007, NEUROSURGERY S1, V60, pONS69; Skrap M, 2010, NEUROSURGERY, V66, P88, DOI 10.1227/01.NEU.0000367556.35258.FA; Spiller WG, 1901, PHILA MED J, V8, P1039; Squintani G, 2015, EUR J PAIN, V19, P253, DOI 10.1002/ejp.543; STONE JL, 1993, J NEUROSURG, V79, P943, DOI 10.3171/jns.1993.79.6.0943; SUZUKI S, 1990, Neurologia Medico-Chirurgica, V30, P1020, DOI 10.2176/nmc.30.1020; SWEET WH, 1981, NEUROSURGERY, V9, P647; Takao T, 2008, NEUROSURGERY S1, V63, pONS139; Takao T, 2008, NEUROSURGERY S1, V63; Tamura Y, 2003, NEUROSURGERY, V52, P1217, DOI 10.1227/01.NEU.0000058023.55777.44; Tanrikulu L, 2007, J NEUROSURG, V107, P1137, DOI 10.3171/JNS-07/12/1137; Taptas N, 1911, PRESSE MED, V19, P798; TASHIRO H, 1991, J NEUROSURG, V75, P783, DOI 10.3171/jns.1991.75.5.0783; Teo C, 2006, NEUROSURGERY S2, V59; Teo C, 2006, NEUROSURGERY S2, V59; Tubbs RS, 2011, NEUROSURGERY, V69, pE1029, DOI 10.1227/NEU.0b013e318229997c; Yamakami I, 2000, NEUROL MED-CHIR, V40, P545, DOI 10.2176/nmc.40.545; Yuyama R, 1998, NEUROL SURG TOKYO, V26, P685; ZAKRZEWSKA JM, 1993, ACTA NEUROCHIR, V122, P225, DOI 10.1007/BF01405533; Zakrzewska JM, 2011, COCHRANE DB SYST REV, V9	81	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	MAY	2015	55	5					432	441		10.2176/nmc.ra.2014-0393		10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CI3QF	WOS:000354661800009		
J	Nakajima, R; Nakada, M; Miyashita, K; Kinoshita, M; Okita, H; Yahata, T; Hayashi, Y				Nakajima, Riho; Nakada, Mitsutoshi; Miyashita, Katsuyoshi; Kinoshita, Masashi; Okita, Hirokazu; Yahata, Tetsutaro; Hayashi, Yutaka			Intraoperative Motor Symptoms during Brain Tumor Resection in the Supplementary Motor Area (SMA) without Positive Mapping during Awake Surgery	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						awake surgery; glioma; motor symptom; supplementary motor area	LOW-GRADE GLIOMAS; SURGICAL RESECTION; ELECTRICAL-STIMULATION; SUBCORTICAL ELECTROSTIMULATION; POSTOPERATIVE DEFICITS; CORTICAL STIMULATION; FUNCTIONAL RECOVERY; BIMANUAL MOVEMENT; ELOQUENT BRAIN; FRONTAL-LOBE	Awake surgery could be a useful modality for lesions locating in close proximity to the eloquent areas including primary motor cortex and pyramidal tract. In case with supplementary motor area (SMA) lesion, we often encounter with intraoperative motor symptoms during awake surgery even in area without positive mapping. Although the usual recovery of the SMA syndrome has been well documented, rare cases with permanent deficits could be encountered in the clinical setting. It has been difficult to evaluate during surgery whether the intraoperative motor symptoms lead to postoperative permanent deficits. The purpose of this study was to demonstrate the intraoperative motor symptoms could be reversible, further to provide useful information for making decision to continue surgical procedure of tumor resection. Eight consecutive patients (from July 2012 to June 2014, six men and two women, aged 33-63 years) with neoplastic lesions around the SMA underwent an awake surgery. Using a retrospective analysis of intraoperative video records, intraoperative motor symptoms during tumor resection were investigated. In continuous functional monitoring during resection of SMA tumor under awake conditions, the following motor symptoms were observed during resection of the region without positive mapping: delayed motor weakness, delay of movement initiation, slowness of movement, difficulty in dual task response, and coordination disturbance. In seven patients hemiparesis observed immediately after surgery recovered to preoperative level within 6 weeks. During awake surgery for SMA tumors, the above-mentioned motor symptoms could occur in area without positive mapping and might be predictors for reversible SMA syndrome.	[Nakajima, Riho] Kanazawa Univ, Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9208641, Japan; [Nakada, Mitsutoshi; Miyashita, Katsuyoshi; Kinoshita, Masashi; Hayashi, Yutaka] Kanazawa Univ, Dept Neurosurg, Kanazawa, Ishikawa 9208641, Japan; [Okita, Hirokazu; Yahata, Tetsutaro] Kanazawa Univ Hosp, Dept Phys Med & Rehabil, Kanazawa, Ishikawa, Japan	Hayashi, Y (reprint author), Kanazawa Univ, Dept Neurosurg, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.	yuh@med.kanazawa-u.ac.jp					Zentner J, 1996, J NEUROSURG, V85, P542, DOI 10.3171/jns.1996.85.4.0542; HALSBAND U, 1993, BRAIN, V116, P243, DOI 10.1093/brain/116.1.243; Ulu MO, 2008, TURK NEUROSURG, V18, P286; Russell SM, 2003, NEUROSURGERY, V52, P506, DOI 10.1227/01.NEU.0000047670.56996.53; IKEDA A, 1992, BRAIN, V115, P1017, DOI 10.1093/brain/115.4.1017; Tankus A, 2009, J NEUROSURG, V110, P1304, DOI 10.3171/2008.10.JNS08466; Debaere F, 2001, NEUROIMAGE, V14, P947, DOI 10.1006/nimg.2001.0892; Schucht P, 2013, HUM BRAIN MAPP, V34, P3023, DOI 10.1002/hbm.22122; LUDERS HO, 1995, ADV NEUROL, V67, P115; ROSTOMILY RC, 1991, J NEUROSURG, V75, P62, DOI 10.3171/jns.1991.75.1.0062; Kikuchi T, 2012, CLIN NEUROPHYSIOL, V123, P324, DOI 10.1016/j.clinph.2011.06.011; Chacko AG, 2013, CLIN NEUROL NEUROSUR, V115, P329, DOI 10.1016/j.clineuro.2012.10.022; Ius T, 2011, NEUROIMAGE, V56, P992, DOI 10.1016/j.neuroimage.2011.03.022; Filevich E, 2012, CORTEX, V48, P1251, DOI 10.1016/j.cortex.2012.04.014; Mita A, 2009, NAT NEUROSCI, V12, P502, DOI 10.1038/nn.2272; Serrien DJ, 2002, NEUROSCI LETT, V328, P89, DOI 10.1016/S0304-3940(02)00499-8; Rech F, 2014, HUM BRAIN MAPP, V35, P3439, DOI 10.1002/hbm.22413; De Benedictis A, 2012, J NEUROSURG, V117, P1053, DOI 10.3171/2012.7.JNS12628; Byblow WD, 2007, J NEUROPHYSIOL, V98, P414, DOI 10.1152/jn.00325.2007; Ikeda A, 2000, BRAIN, V123, P1710, DOI 10.1093/brain/123.8.1710; Tate MC, 2011, J NEUROSURG, V114, P640, DOI 10.3171/2010.9.JNS10709; Duffau H, 2003, J NEUROSURG, V98, P764, DOI 10.3171/jns.2003.98.4.0764; Duffau H, 2003, J NEUROL NEUROSUR PS, V74, P901, DOI 10.1136/jnnp.74.7.901; Ikeda A, 1999, BRAIN, V122, P915, DOI 10.1093/brain/122.5.915; BELL KR, 1994, BRAIN RES, V655, P202, DOI 10.1016/0006-8993(94)91615-2; Cunningham DA, 2013, BRAIN RES, V1531, P25, DOI 10.1016/j.brainres.2013.07.050; Duffau H, 2001, STEREOT FUNCT NEUROS, V76, P74, DOI 10.1159/000056496; Fontaine D, 2002, NEUROSURGERY, V50, P297, DOI 10.1097/00006123-200202000-00011; Gabarros A, 2011, NEUROCIRUGIA, V22, P123; Hanakawa T, 2001, EXP BRAIN RES, V138, P403, DOI 10.1007/s002210100727; Johansen-Berg H, 2002, EXP BRAIN RES, V142, P13, DOI 10.1007/s00221-001-0905-8; Kasasbeh AS, 2012, NEUROSURGERY, V70, P1152, DOI 10.1227/NEU.0b013e31823f6001; Kim YH, 2013, J NEUROSURG, V119, P7, DOI 10.3171/2013.3.JNS121492; Kinoshita M, 2014, BRAIN STRUCT FUNCT; LIM SH, 1994, ELECTROEN CLIN NEURO, V91, P179, DOI 10.1016/0013-4694(94)90068-X; ORGOGOZO JM, 1979, SCIENCE, V206, P847, DOI 10.1126/science.493986; Peraud A, 2002, NEUROSURGERY, V50, P966, DOI 10.1097/00006123-200205000-00009; Sawner KA, 1970, MOVEMENT THERAPY HEM, P41; Shinoura N, 2009, J CLIN NEUROSCI, V16, P188, DOI 10.1016/j.jocn.2008.02.013; Szelenyi A, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.12.FOCUS09237; Ullen F, 2003, J NEUROPHYSIOL, V89, P1126, DOI 10.1152/jn.00775.2002; Vergani F., 2014, J NEUROL NEUROSURG P; Wilson TW, 2014, NEUROIMAGE, V85, P445, DOI 10.1016/j.neuroimage.2013.04.112	43	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	MAY	2015	55	5					442	450		10.2176/nmc.oa.2014-0343		9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CI3QF	WOS:000354661800010		
J	Moriwaki, M; Ishihama, K				Moriwaki, Masanao; Ishihama, Kiyoshi			Possibilities for gasketed plate heat exchangers	NUCLEAR ENGINEERING INTERNATIONAL			English	Article									[Moriwaki, Masanao; Ishihama, Kiyoshi] Hitachi GE Nucl Energy Ltd, Hitachi, Ibaraki, Japan	Moriwaki, M (reprint author), Hitachi GE Nucl Energy Ltd, Hitachi, Ibaraki, Japan.	masanao.moriwaki.ug@hitachi.com; kiyoshi.ishihama.zf@hitachi.com						0	0	0	WILMINGTON PUBL	SIDCUP	WILMINGTON HOUSE, MAIDSTONE RD, FOOTS CRAY, SIDCUP DA14 SHZ, KENT, ENGLAND	0029-5507			NUCL ENG INT	Nucl. Eng. Int.	MAY	2015	60	730					26	27				2	Nuclear Science & Technology	Nuclear Science & Technology	CI4XI	WOS:000354756800009		
J	Kim, J; Ishiguro, K; Nambu, A; Akiyoshi, B; Yokobayashi, S; Kagami, A; Ishiguro, T; Pendas, AM; Takeda, N; Sakakibara, Y; Kitajima, TS; Tanno, Y; Sakuno, T; Watanabe, Y				Kim, Jihye; Ishiguro, Kei-ichiro; Nambu, Aya; Akiyoshi, Bungo; Yokobayashi, Shihori; Kagami, Ayano; Ishiguro, Tadashi; Pendas, Alberto M.; Takeda, Naoki; Sakakibara, Yogo; Kitajima, Tomoya S.; Tanno, Yuji; Sakuno, Takeshi; Watanabe, Yoshinori			Meikin Is a Conserved Regulator of Meiosis I-Specific Kinetochore Function	OBSTETRICAL & GYNECOLOGICAL SURVEY			English	Editorial Material								The kinetochore is a multiprotein complex that connects centromeres to microtubules in meiosis and mitosis. It plays an essential role in chromosome segregation. During meiosis I, unlike in mitosis, sister kinetochores are captured by microtubules from the same spindle pole (mono-orientation) and protect centromeric cohesion mediated by cohesin protein at the onset of anaphase. These 2 kinetochore functions, mono-orientation and centromeric cohesion protection, are widely conserved among eukaryotic organisms. The mechanism for conservation is unknown. A meiotic factor has been identified in budding and fission yeasts that regulates kinetochore function during segregation. It has been postulated that a similar factor exists in eukaryotes, but this factor-which could be the master regulator of meiotic chromosome segregation-has not been identified. The investigators identified a meiosis-specific kinetochore factor in mouse germ cells that functions in meiosis I but not in meiosis II or mitosis. They named this factor MEIKIN (meiosis-specific kinetochore protein). MEIKIN is expressed and localized to kinetochores. Mono-orientation and cohesion protection are defective in knockout mice unable to express the MEIKIN gene. Both male and female Meikin knockout mice are infertile. MEIKIN plays an essential role in both mono-orientation and centromeric cohesion protection, partly by stabilizing the localization of shugoshin, a protein that protects centromeric cohesin in mousemeiosis1. In mice as well as yeast, MEIKEN also regulates the activity of Polo-like kinase PLK1, which appears to be required for both kinetochore mono-orientation and centromeric cohesion protection. MEIKIN enriches PLK1 to kinetochores during segregation. These data show that MEIKEN, a meiosis-specific kinetochore protein identified in mice, has striking biochemical and functional similarities to a regulatory factor in fission yeast. It appears to be the long-awaited master regulator of meiotic chromosome segregation conserved in living organisms from yeasts to humans. It is possible that MEIKIN dysfunction could be associated with age-associated chromosome segregation errors, a major cause of birth defects in humans.	[Kim, Jihye; Ishiguro, Kei-ichiro; Nambu, Aya; Akiyoshi, Bungo; Yokobayashi, Shihori; Kagami, Ayano; Ishiguro, Tadashi; Tanno, Yuji; Sakuno, Takeshi; Watanabe, Yoshinori] Univ Tokyo, Lab Chromosome Dynam, Inst Mol & Cellular Biosci, Tokyo, Japan; [Pendas, Alberto M.] Inst Biol Mol & Celular Canc CSIC USAL, Salamanca, Spain; [Takeda, Naoki] Kumamoto Univ, Ctr Anim Resources & Dev, Kumamoto, Japan; [Sakakibara, Yogo; Kitajima, Tomoya S.] RIKEN Ctr Dev Biol, Lab Chromosome Segregat, Kobe, Hyogo, Japan	Kim, J (reprint author), Univ Tokyo, Lab Chromosome Dynam, Inst Mol & Cellular Biosci, Tokyo, Japan.							0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0029-7828	1533-9866		OBSTET GYNECOL SURV	Obstet. Gynecol. Surv.	MAY	2015	70	5					326	327				3	Obstetrics & Gynecology	Obstetrics & Gynecology	CI4MZ	WOS:000354725300017		
J	Mori, AS; Fujii, S; Kitagawa, R; Koide, D				Mori, Akira S.; Fujii, Saori; Kitagawa, Ryo; Koide, Dai			Null model approaches to evaluating the relative role of different assembly processes in shaping ecological communities	OECOLOGIA			English	Article						Abundance; beta-diversity; Community assembly; Biogeographical gradient; Species abundance distributions	SPECIES ABUNDANCE DISTRIBUTIONS; TROPICAL TREE COMMUNITIES; BETA-DIVERSITY; ELEVATIONAL GRADIENTS; FUNCTIONAL DIVERSITY; STOCHASTIC-PROCESSES; TEMPORAL TURNOVER; TEMPERATE FOREST; NEUTRAL THEORY; DRIVERS	Various local processes simultaneously shape ecological assemblages. beta-diversity is a useful metric for inferring the underlying mechanisms of community assembly. However, beta-diversity is not independent of gamma-diversity, which may mask the local mechanisms that govern community processes across regions. Recent approaches that rely on an abundance-based null model could solve this sampling issue. However, if abundance varies widely across a region, the relative roles of deterministic and stochastic processes may be substantially misestimated. Furthermore, there is additional uncertainty as to whether null models used to correct.-dependence in beta-diversity should be independent of the observed patterns of species abundance distributions or whether the models should reflect these patterns. Here, we aim to test what null models with various constraints imply about the underlying processes shaping beta-diversity. First, we found that an abundance-driven sampling effect could substantially influence the calculation of gamma-corrected beta-diversity. Second, we found that the null models that preserve the species abundance patterns could better reflect empirical patterns of spatial organization of individuals. The different implications generated from different applications of the null model approach therefore suggest that there are still frontiers regarding how local processes that shape species assemblages should be quantified. Carefully exploring each facet within different assembly processes is important.	[Mori, Akira S.; Fujii, Saori; Kitagawa, Ryo; Koide, Dai] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan	Mori, AS (reprint author), Yokohama Natl Univ, Grad Sch Environm & Informat Sci, 79-7 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	akira.s.mori@gmail.com	Mori, Akira/A-6570-2013	Mori, Akira/0000-0002-8422-1198	Sumitomo Foundation; Japan Securities Scholarship Foundation; Global COE Program from Japan Society for the Promotion of Science (JSPS) [E03]; Graduate School of Environment and Information Science, Yokohama National University; JSPS	The authors acknowledge those who contributed to the collection of data for the data sets used here. We thank T. Shiono for his critical comments on the earlier draft. Our original data were collected through studies under the budgetary support of the Sumitomo Foundation, the Japan Securities Scholarship Foundation, the Global COE Program (E03) from the Japan Society for the Promotion of Science (JSPS), and the Graduate School of Environment and Information Science, Yokohama National University (Category B). The study was partly supported by a JSPS Grant-in-Aid for Young Scientists (Category A). We appreciate further constructive comments from D. Laughlin and the two reviewers. The experiments comply with the current laws of the country (Japan) in which the experiments were performed.	Aiba M, 2012, J ECOL, V100, P950, DOI 10.1111/j.1365-2745.2012.01959.x; Anderson M.J., 2010, ECOL LETT, V14, P19, DOI DOI 10.1111/J.1461-0248.2010.01552.X; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Mori AS, 2013, GLOBAL ECOL BIOGEOGR, V22, P878, DOI 10.1111/geb.12058; Weiher E, 2011, PHILOS T R SOC B, V366, P2403, DOI 10.1098/rstb.2011.0056; Carvalho JC, 2012, GLOBAL ECOL BIOGEOGR, V21, P760, DOI 10.1111/j.1466-8238.2011.00694.x; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063; Rodrigues JLM, 2013, P NATL ACAD SCI USA, V110, P988, DOI 10.1073/pnas.1220608110; Mori AS, 2015, OECOLOGIA, V177, P533, DOI 10.1007/s00442-014-3111-7; Alonso D, 2008, ECOL LETT, V11, P93, DOI 10.1111/j.1461-0248.2007.01127.x; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Caruso T, 2012, J ANIM ECOL, V81, P214, DOI 10.1111/j.1365-2656.2011.01886.x; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Kohyama T, 2009, J ECOL, V97, P463, DOI 10.1111/j.1365-2745.2009.01490.x; Qian H, 2013, GLOBAL ECOL BIOGEOGR, V22, P659, DOI 10.1111/geb.12020; Li L, 2009, OIKOS, V118, P495, DOI 10.1111/j.1600-0706.2009.16753.x; Frund J, 2013, ECOLOGY, V94, P2042, DOI 10.1890/12-1620.1; Ulrich W, 2010, ECOLOGY, V91, P3384, DOI 10.1890/09-2157.1; Rosindell J, 2012, TRENDS ECOL EVOL, V27, P203, DOI 10.1016/j.tree.2012.01.004; Gotzenberger L, 2012, BIOL REV, V87, P111, DOI 10.1111/j.1469-185X.2011.00187.x; Karp DS, 2012, ECOL LETT, V15, P963, DOI 10.1111/j.1461-0248.2012.01815.x; Swenson NG, 2012, ECOLOGY, V93, P490, DOI 10.1890/11-1180.1; Purschke O, 2013, J ECOL, V101, P857, DOI 10.1111/1365-2745.12098; Gotelli NJ, 2012, OIKOS, V121, P171, DOI 10.1111/j.1600-0706.2011.20301.x; KOHYAMA T, 1993, J ECOL, V81, P131, DOI 10.2307/2261230; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Caruso T, 2011, ISME J, V5, P1406, DOI 10.1038/ismej.2011.21; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Belote RT, 2008, ECOLOGY, V89, P183, DOI 10.1890/07-0270.1; Myers JA, 2013, ECOL LETT, V16, P151, DOI 10.1111/ele.12021; Fukami T, 2011, ECOL LETT, V14, P973, DOI 10.1111/j.1461-0248.2011.01663.x; Lindo Z, 2009, OECOLOGIA, V160, P817, DOI 10.1007/s00442-009-1348-3; Laliberte E, 2009, OECOLOGIA, V159, P377, DOI 10.1007/s00442-008-1214-8; Ricklefs RE, 2012, SCIENCE, V335, P464, DOI 10.1126/science.1215182; De Caceres M, 2012, GLOBAL ECOL BIOGEOGR, V21, P1191, DOI 10.1111/j.1466-8238.2012.00770.x; Baraloto C, 2012, J ECOL, V100, P690, DOI 10.1111/j.1365-2745.2012.01966.x; Hardy OJ, 2008, J ECOL, V96, P914, DOI 10.1111/j.1365-2745.2008.01421.x; Carstensen DW, 2013, ECOGRAPHY, V36, P1310, DOI 10.1111/j.1600-0587.2013.00329.x; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Stegen JC, 2013, GLOBAL ECOL BIOGEOGR, V22, P202, DOI 10.1111/j.1466-8238.2012.00780.x; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; Questad EJ, 2008, ECOL LETT, V11, P717, DOI 10.1111/j.1461-0248.2008.01186.x; Beck J, 2013, METHODS ECOL EVOL, V4, P370, DOI 10.1111/2041-210x.12023; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Shipley B, 2012, ECOLOGY, V93, P760, DOI 10.1890/11-0944.1; de Bello F, 2012, GLOBAL ECOL BIOGEOGR, V21, P312, DOI 10.1111/j.1466-8238.2011.00682.x; Hubbell S. P., 2001, UNIFIED NEUTRAL THEO; Motomura I., 1932, JAPAN J ZOOL, V44, P379; Preston MI, 2007, FOREST ECOL MANAG, V243, P156, DOI 10.1016/j.foreco.2007.03.002; Qian H, 2012, SCIENCE, V335, DOI 10.1126/science.1216450; Ranjard L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2431; Swenson JE, 2012, ECOLOGY, V93, pS112; Tuomisto H, 2012, SCIENCE, V335, DOI 10.1126/science.1216393; Wang ZH, 2009, P NATL ACAD SCI USA, V106, P13388, DOI 10.1073/pnas.0905030106; Yen JDL, 2013, OECOLOGIA, V171, P517, DOI 10.1007/s00442-012-2438-1	59	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0029-8549	1432-1939		OECOLOGIA	Oecologia	MAY	2015	178	1					261	273		10.1007/s00442-014-3170-9		13	Ecology	Environmental Sciences & Ecology	CI4MY	WOS:000354725200023		
J	Hirohashi, Y; Torigoe, T; Mariya, T; Kochin, V; Saito, T; Sato, N				Hirohashi, Yoshihiko; Torigoe, Toshihiko; Mariya, Tasuku; Kochin, Vitaly; Saito, Tsuyoshi; Sato, Noriyuki			HLA class I as a predictor of clinical prognosis and CTL infiltration as a predictor of chemosensitivity in ovarian cancer	ONCOIMMUNOLOGY			English	Article						CTL; HLA class I; ovarian cancer; platinum resistance	EXPRESSION; ASSOCIATION; CARCINOMA	Cytotoxic T lymphocytes (CTLs) recognize the human leukocyte antigen (HLA) class I and antigenic peptide complex, and they play a crucial role in cancer immunity. Our recent study revealed that HLA class I downregulation is related to poorer prognosis and a low level of intratumoral CTLs is associated with platinum resistance, indicating the significance of immunological surveillance.	[Hirohashi, Yoshihiko; Torigoe, Toshihiko; Mariya, Tasuku; Kochin, Vitaly; Sato, Noriyuki] Sapporo Med Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan; [Mariya, Tasuku; Saito, Tsuyoshi] Sapporo Med Univ, Sch Med, Dept Obstet & Gynecol, Sapporo, Hokkaido, Japan	Hirohashi, Y (reprint author), Sapporo Med Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan.	hirohash@sapmed.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; Sagawa Foundation for Promotion of Cancer Research; Suharakinennzaidann Co., Ltd.; Kobayashi Foundation for Cancer Research	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to Noriyuki Sato, Toshihiko Torigoe, and Yoshihiko Hirohashi), the program for developing the supporting system for upgrading education and research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to Noriyuki Sato), the Takeda Science Foundation (to Yoshihiko Hirohashi), the Sagawa Foundation for Promotion of Cancer Research (to Yoshihiko Hirohashi), Suharakinennzaidann Co., Ltd. (to Yoshihiko Hirohashi), and the Kobayashi Foundation for Cancer Research (to Yoshihiko Hirohashi).	Vitale M, 2005, CLIN CANCER RES, V11, P67; Rolland P, 2007, CLIN CANCER RES, V13, P3591, DOI 10.1158/1078-0432.CCR-06-2087; Han LY, 2008, CLIN CANCER RES, V14, P3372, DOI 10.1158/1078-0432.CCR-07-4433; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Aptsiauri N, 2007, INT REV CYTOL, V256, P139, DOI 10.1016/S0074-7696(07)56005-5; Aranda F, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26621; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; Mariya T, 2014, CANCER IMMUNOL RES, V2, P1220, DOI 10.1158/2326-6066.CIR-14-0101; Shehata M, 2009, BRIT J CANCER, V101, P1321, DOI 10.1038/sj.bjc.6605315; Zitvogel L, 2013, IMMUNITY, V39, P74, DOI 10.1016/j.immuni.2013.06.014	10	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	2162-402X			ONCOIMMUNOLOGY	OncoImmunology	MAY	2015	4	5							e1005507	10.1080/2162402X.2015.1005507		3	Oncology; Immunology	Oncology; Immunology	CI7ZG	WOS:000354985400018		
J	Sasada, T; Kibe, S; Akagi, Y; Itoh, K				Sasada, Tetsuro; Kibe, Shiro; Akagi, Yoshito; Itoh, Kyogo			Personalized peptide vaccination for advanced colorectal cancer	ONCOIMMUNOLOGY			English	Article						biomarker; colorectal cancer; IL-6; peptide vaccine; personalized vaccine		We have developed a novel approach in cancer immunotherapy, the personalized peptide vaccination (PPV), in which human leukocyte antigen (HLA)-matched peptides are selected on the basis of preexisting host immunity before vaccination. Recently, we demonstrated the feasibility of PPV in previously treated patients with advanced colorectal cancer, thus warranting further clinical development of this approach.	[Sasada, Tetsuro; Itoh, Kyogo] Kurume Univ, Canc Vaccine Ctr, Kurume, Fukuoka 830, Japan; [Sasada, Tetsuro] Kanagawa Canc Ctr, Res Inst, Canc Vaccine Ctr, Yokohama, Kanagawa 2410815, Japan; [Kibe, Shiro; Akagi, Yoshito] Kurume Univ, Dept Surg, Kurume, Fukuoka 830, Japan	Sasada, T (reprint author), Kurume Univ, Canc Vaccine Ctr, Kurume, Fukuoka 830, Japan.	tsasada@kcch.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This study was supported by funding to a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) of the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Komatsu N, 2012, CANCER-AM CANCER SOC, V118, P3208, DOI 10.1002/cncr.26636; Disis ML, 2011, CANCER IMMUNOL IMMUN, V60, P433, DOI 10.1007/s00262-010-0960-8; Hoos A, 2010, J NATL CANCER I, V102, P1388, DOI 10.1093/jnci/djq310; Noguchi M, 2010, CANCER IMMUNOL IMMUN, V59, P1001, DOI 10.1007/s00262-010-0822-4; Terasaki M, 2011, J CLIN ONCOL, V29, P337, DOI 10.1200/JCO.2010.29.7499; Noguchi M, 2013, CANCER IMMUNOL IMMUN, V62, P919, DOI 10.1007/s00262-012-1379-1; Sasada T, 2014, CURR MED CHEM, V21, P2332; Yoshitomi M, 2012, EXP THER MED, V3, P463, DOI 10.3892/etm.2011.424; Kibe S, 2014, CANCER IMMUNOL RES, V2, P1154, DOI 10.1158/2326-6066.CIR-14-0035	9	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	2162-402X			ONCOIMMUNOLOGY	OncoImmunology	MAY	2015	4	5							e1005512	10.1080/2162402X.2015.1005512		3	Oncology; Immunology	Oncology; Immunology	CI7ZG	WOS:000354985400021		
J	Murayama, H; Nagao, K; Ohmiya, H; Sawamura, M				Murayama, Hiroaki; Nagao, Kazunori; Ohmiya, Hirohisa; Sawamura, Masaya			Copper(I)-Catalyzed Intramolecular Hydroalkoxylation of Unactivated Alkenes	ORGANIC LETTERS			English	Article							SATURATED OXYGEN HETEROCYCLES; CARBOXYLIC-ACIDS; OLEFINS; LIGANDS; CARBOETHERIFICATION; CYCLIZATION; TRIFLATE; BEARING	A Cu(I)-Xantphos system catalyzed the intramolecular hydroalkoxylation of unactivated terminal alkenes, giving five- and six-membered ring ethers. This system is applicable to both primary and secondary alcohols. A reaction pathway involving the addition of the Cu-O bond across the C-C double bond is proposed. A chiral Cu(I) catalyst system based on the (R)-DTBM-SEGPHOS ligand promoted enantioselective reaction with moderate enantioselectivity.	[Murayama, Hiroaki; Nagao, Kazunori; Ohmiya, Hirohisa; Sawamura, Masaya] Hokkaido Univ, Dept Chem, Sapporo, Hokkaido 0600810, Japan	Ohmiya, H (reprint author), Hokkaido Univ, Dept Chem, Sapporo, Hokkaido 0600810, Japan.	ohmiya@sci.hokudai.ac.jp; sawamura@sci.hokudai.ac.jp	Ohmiya, Hirohisa/F-2764-2012; Sawamura, Masaya/G-1428-2012		JSPS; CREST, JST	This work was supported by Grants-in-Aid for Young Scientists (A) and Challenging Exploratory Research, JSPS to H.O, and CREST, JST, to M.S. K.N. thanks JSPS for scholarship support.	Adrio LA, 2009, TETRAHEDRON, V65, P10334, DOI 10.1016/j.tet.2009.10.055; Alali FQ, 1999, J NAT PROD, V62, P504, DOI 10.1021/np980406d; Dzudza A, 2009, ORG LETT, V11, P1523, DOI 10.1021/ol8029559; Stollenz M, 2012, ORGANOMETALLICS, V31, P7708, DOI 10.1021/om3007689; Ohmiya H, 2009, ORG LETT, V11, P2145, DOI 10.1021/ol9007712; Miller Y, 2012, J AM CHEM SOC, V134, P12149, DOI 10.1021/ja3034075; Bovino MT, 2014, ANGEW CHEM INT EDIT, V53, P6383, DOI 10.1002/anie.201402462; Komeyama K, 2007, TETRAHEDRON LETT, V48, P3259, DOI 10.1016/j.tetlet.2007.03.004; Lipshutz BH, 2003, J AM CHEM SOC, V125, P8779, DOI 10.1021/ja021391f; Yang CG, 2005, J AM CHEM SOC, V127, P6966, DOI 10.1021/ja050392f; Yang CG, 2005, ORG LETT, V7, P4553, DOI 10.1021/ol051065f; Saito T, 2001, ADV SYNTH CATAL, V343, P264, DOI 10.1002/1615-4169(20010330)343:3<264::AID-ADSC264>3.0.CO;2-T; SAWAMURA M, 1995, ORGANOMETALLICS, V14, P4549, DOI 10.1021/om00010a020; Qian H, 2004, J AM CHEM SOC, V126, P9536, DOI 10.1021/ja0477773; Kawai J, 2013, ANGEW CHEM INT EDIT, V52, P7177, DOI 10.1002/anie.201302027; Coulombel L, 2006, CHEM-EUR J, V12, P6356, DOI 10.1002/chem.200501478; Elliott MC, 2000, J CHEM SOC PERK T 1, P1291, DOI 10.1039/a903885j; Elliott MC, 2001, J CHEM SOC PERK T 1, P2303, DOI 10.1039/b09079290g; Ito Y, 2007, J ORGANOMET CHEM, V692, P691, DOI 10.1016/j.jorganchem.2006.05.060; Kamiya I, 2007, CHEM LETT, V36, P646, DOI 10.1246/cl.2007.646; Ohta T, 2007, J ORGANOMET CHEM, V692, P671, DOI 10.1016/j.jorganchem.2006.05.059; Olimiya H., 2010, SYNLETT, P2136; Patil N. T., 2012, TETRAHEDRON, V68, P8079	23	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1523-7060	1523-7052		ORG LETT	Org. Lett.	MAY 1	2015	17	9					2039	2041		10.1021/acs.orglett.5b00758		3	Chemistry, Organic	Chemistry	CH4LG	WOS:000354004400001		
J	Ferris, DP; McGonigal, PR; Witus, LS; Kawaji, T; Algaradah, MM; Alnajadah, AR; Nassar, MS; Stoddart, JF				Ferris, Daniel P.; McGonigal, Paul R.; Witus, Leah S.; Kawaji, Takatoshi; Algaradah, Mohammed M.; Alnajadah, Ahmed R.; Nassar, Majed S.; Stoddart, J. Fraser			Oxime Ligation on the Surface of Mesoporous Silica Nanoparticles	ORGANIC LETTERS			English	Article							DRUG-DELIVERY; CANCER-CELLS; MECHANIZED NANOPARTICLES; BIOMEDICAL APPLICATIONS; CONTROLLED-RELEASE; NANOVALVES; BIOCOMPATIBILITY; STABILITY; MOLECULES; FUNCTIONALIZATION	A versatile surface-functionalization strategy applicable to mesoporous silica nanoparticles, which could potentially serve as drug delivery Vehicles, is described that makes use of alkoxyamine tethers on the surface of the nanoparticles. A-Wide variety of carbonyl compounds can be attached readily to thee tethers under the mild conditions of oxime ether formation, simply by incubating the chemically modified mesoporous silica nanoparticles with aldehydes or ketones in water.,	[Ferris, Daniel P.; McGonigal, Paul R.; Witus, Leah S.; Kawaji, Takatoshi; Algaradah, Mohammed M.; Alnajadah, Ahmed R.; Nassar, Majed S.; Stoddart, J. Fraser] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Kawaji, Takatoshi] Wakayama Coll, Natl Inst Technol, Dept Mat Sci, Nada Ku, Wakayama 6440023, Japan; [Algaradah, Mohammed M.; Alnajadah, Ahmed R.; Nassar, Majed S.] King Abdulaziz City Sci & Technol, Joint Ctr Excellence Integrated Nanosyst, Riyadh 11442, Saudi Arabia	Stoddart, JF (reprint author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	stoddart@northwestern.edu	McGonigal, Paul/J-8291-2012	McGonigal, Paul/0000-0002-8538-7579	Joint Center of Excellence in Integrated Nanosystems (JCIN) at the King Abdulaziz City for Science and Technology (KACST) [34-939]; Northwestern University (NU); KACST; NU; National Science Foundation (NSF) [CHE-1308107]; International Institute for Nanotechnology (IN) at NU; National Institute of General Medical Sciences of the National Institutes of Health (NIH) [F32GM105403]	This research is part (project 34-939) of the Joint Center of Excellence in Integrated Nanosystems (JCIN) at the King Abdulaziz City for Science and Technology (KACST) and Northwestern University (NU). We thank both KACST and NU for their continued support. We thank Timothy W. Wang for his assistance with TGA measurements. P.R.M. thanks the National Science Foundation (NSF) for support under CHE-1308107. L.S.W. acknowledges support from the International Institute for Nanotechnology (IN) at NU as well as support from the National Institute of General Medical Sciences of the National Institutes of Health (NIH) under award no. F32GM105403. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Leung KCF, 2006, CHEM MATER, V18, P5919, DOI 10.1021/cm061682d; Lee JH, 2010, ADV DRUG DELIVER REV, V62, P592, DOI 10.1016/j.addr.2010.03.003; Vivero-Escoto JL, 2009, J AM CHEM SOC, V131, P3462, DOI 10.1021/ja900025f; Lu J, 2008, SMALL, V4, P421, DOI 10.1002/smll.200700903; Kalia J, 2008, ANGEW CHEM INT EDIT, V47, P7523, DOI 10.1002/anie.200802651; Dhar S, 2008, P NATL ACAD SCI USA, V105, P17356, DOI 10.1073/pnas.0809154105; Xu XY, 2015, TRENDS MOL MED, V21, P223, DOI 10.1016/j.molmed.2015.01.001; Nguyen TD, 2007, J AM CHEM SOC, V129, P626, DOI 10.1021/ja065485r; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Liu R, 2008, J AM CHEM SOC, V130, P14418, DOI 10.1021/ja8060886; Nguyen TD, 2006, ORG LETT, V8, P3363, DOI 10.1021/ol0612509; Stephanopoulos N, 2011, NAT CHEM BIOL, V7, P876, DOI [10.1038/nchembio.720, 10.1038/NCHEMBIO.720]; Mal NK, 2003, NATURE, V421, P350, DOI 10.1038/nature01362; Trewyn BG, 2007, ACCOUNTS CHEM RES, V40, P846, DOI 10.1021/ar600032u; Frasconi M, 2013, J AM CHEM SOC, V135, P11603, DOI 10.1021/ja405058y; Patel K, 2008, J AM CHEM SOC, V130, P2382, DOI 10.1021/ja0772086; Coti KK, 2009, NANOSCALE, V1, P16, DOI 10.1039/b9nr00162j; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; Chen Y, 2013, ADV MATER, V25, P3144, DOI 10.1002/adma.201205292; Huh S, 2003, CHEM MATER, V15, P4247, DOI 10.1021/cm0210041; Angelos S, 2008, ANGEW CHEM INT EDIT, V47, P2222, DOI 10.1002/anie.200705211; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Tang L, 2015, CHEM SCI, V6, P2182, DOI 10.1039/c5sc00063g; Klajn R, 2010, CHEM SOC REV, V39, P2203, DOI 10.1039/b920377j; Ferris DP, 2009, J AM CHEM SOC, V131, P1686, DOI 10.1021/ja807798g; Lu J, 2007, SMALL, V3, P1341, DOI 10.1002/smll.200700005; Li ZX, 2012, CHEM SOC REV, V41, P2590, DOI 10.1039/c1cs15246g; Tarn D, 2013, ACCOUNTS CHEM RES, V46, P792, DOI 10.1021/ar3000986; Wang C, 2012, ANGEW CHEM INT EDIT, V51, P5460, DOI 10.1002/anie.201107960; Xing H, 2012, CURR OPIN CHEM BIOL, V16, P429, DOI 10.1016/j.cbpa.2012.03.016; Alley SC, 2010, CURR OPIN CHEM BIOL, V14, P529, DOI 10.1016/j.cbpa.2010.06.170; Wang YC, 2011, NAT MATER, V10, P482, DOI 10.1038/nmat3060; Xue ZQ, 2010, CHEM COMMUN, V46, P1212, DOI 10.1039/b922222g; Climent E, 2009, J AM CHEM SOC, V131, P14075, DOI 10.1021/ja904456d; Valtchev V, 2013, CHEM REV, V113, P6734, DOI 10.1021/cr300439k; Sudimack J, 2000, ADV DRUG DELIVER REV, V41, P147, DOI 10.1016/S0169-409X(99)00062-9; Zhang Y, 2015, CHEM SOC REV, V44, P315, DOI 10.1039/c4cs00199k; Ferris DP, 2011, SMALL, V7, P1816, DOI 10.1002/smll.201002300; Asefa T, 2012, CHEM RES TOXICOL, V25, P2265, DOI 10.1021/tx300166u; Tang FQ, 2012, ADV MATER, V24, P1504, DOI 10.1002/adma.201104763; Kumar R, 2006, CHEM MATER, V18, P4319, DOI 10.1021/cm060598v; Saha S, 2007, ADV FUNCT MATER, V17, P685, DOI 10.1002/adfm.200600989; Godoy-Alcantar C, 2005, J PHYS ORG CHEM, V18, P979, DOI 10.1002/poc.941; Angelos S, 2007, J PHYS CHEM C, V111, P6589, DOI 10.1021/jp0707211; Biju V, 2014, CHEM SOC REV, V43, P744, DOI 10.1039/c3cs60273g; JENCKS WP, 1959, J AM CHEM SOC, V81, P475, DOI 10.1021/ja01511a053; Kay E. R., 2015, ANGEW CHEM INT EDIT, V54, P418; Khashab NM, 2009, CHEM COMMUN, P5371, DOI 10.1039/b910431c; Kwon EJ, 2010, BIOMATERIALS, V31, P2417, DOI 10.1016/j.biomaterials.2009.11.086; Li LL, 2012, ADV HEALTHC MATER, V1, P567, DOI 10.1002/adhm.201200116; Liu QL, 2014, NPG ASIA MATER, V6, DOI 10.1038/am.2014.12; Mignani S, 2015, BIOMACROMOLECULES, V16, P1, DOI 10.1021/bm501285t; Mozafari M. R., 2007, NANOMATERIALS NANOSY; Radu DR, 2004, J AM CHEM SOC, V126, P1640, DOI 10.1021/ja038222v; Rocca JD, 2011, ACCOUNTS CHEM RES, V44, P957, DOI DOI 10.1021/AR200028A); Tarasova O.A., 1999, RUSS J ORG CHEM+, V35, P1581; Witus Leah S, 2010, Curr Protoc Chem Biol, V2, P125, DOI 10.1002/9780470559277.ch100018	59	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1523-7060	1523-7052		ORG LETT	Org. Lett.	MAY 1	2015	17	9					2146	2149		10.1021/acs.orglett.5b00740		4	Chemistry, Organic	Chemistry	CH4LG	WOS:000354004400028		
J	Danjo, H; Hashimoto, Y; Kidena, Y; Nogamine, A; Katagiri, K; Kawahata, M; Miyazawa, T; Yamaguchi, K				Danjo, Hiroshi; Hashimoto, Yuhki; Kidena, Yuki; Nogamine, Ayumi; Katagiri, Kosuke; Kawahata, Masatoshi; Miyazawa, Toshifumi; Yamaguchi, Kentaro			Nestable Tetrakis(spiroborate) Nanocycles	ORGANIC LETTERS			English	Article							SHAPE-PERSISTENT MACROCYCLES; IN-RING COMPLEXES; STACKS; CYCLOBIS(PARAQUAT-PARA-PHENYLENE); ENCAPSULATION; RECEPTOR; SQUARES	Multicomponent construction of the tetrakis(spiroborate) anionic nanocycles was achieved by reacting bis(dihydroxynaphthalene)s with tetrahydroxyanthraquinone in the presence of boric acid in a self-organized manner. These nanocycles exhibited selective molecular recognition behavior toward cationic guests such as methyl viologen derivatives. Formation of a supramolecular ring@ring and a guest@ring@ring structure was observed by combining the anionic nanocycle and the vinylogous analog of cyclobis(paraquat-p-phenylene).	[Danjo, Hiroshi; Katagiri, Kosuke; Miyazawa, Toshifumi] Konan Univ, Dept Chem, Higashinada Ku, Kobe, Hyogo 6588501, Japan; [Danjo, Hiroshi; Katagiri, Kosuke; Miyazawa, Toshifumi] Konan Univ, Grad Sch Nat Sci, Higashinada Ku, Kobe, Hyogo 6588501, Japan; [Kawahata, Masatoshi; Yamaguchi, Kentaro] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Sanuki, Kagawa 7692193, Japan	Danjo, H (reprint author), Konan Univ, Dept Chem, Higashinada Ku, 8-9-1 Okamoto, Kobe, Hyogo 6588501, Japan.	danjo@konan-u.ac.jp			Hirao Taro Foundation of the Konan University Association for Academic Research	This work was supported by The Hirao Taro Foundation of the Konan University Association for Academic Research. We thank Drs. G. Ueno, N. Mizuno, and S. Baba (Japan Synchrotron Radiation Research Institute (JASRI)) for invaluable help in data collection in the X-ray analysis of 9. (TBA)<INF>2</INF>, [11@10].(PF<INF>6</INF>)<INF>4</INF>, 10@5b, and 11@10@5a. The synchrotron radiation experiment was performed at the BL26B2 and BL38B1 stations of SPring-8 with the approval of JASRI (Proposal Nos. 2014A1214 and 2014B1423).	Abrahams BF, 2008, INORG CHEM, V47, P9797, DOI 10.1021/ic800544j; Day AI, 2002, ANGEW CHEM INT EDIT, V41, P275, DOI 10.1002/1521-3773(20020118)41:2<275::AID-ANIE275>3.0.CO;2-M; Kawase T, 2004, ANGEW CHEM INT EDIT, V43, P1722, DOI 10.1002/anie.200353517; Forgan RS, 2012, CHEM-EUR J, V18, P202, DOI 10.1002/chem.201102919; Yamaguchi K, 2003, J MASS SPECTROM, V38, P473, DOI 10.1002/jms.488; Hoger S, 2004, CHEM-EUR J, V10, P1320, DOI 10.1002/chem.200305496; Abrahams BF, 2006, ANGEW CHEM INT EDIT, V45, P806, DOI 10.1002/anie.200503156; Klosterman JK, 2009, CHEM SOC REV, V38, P1714, DOI 10.1039/b901261n; Harris WR, 2007, J AM CHEM SOC, V129, P12263, DOI 10.1021/ja073788v; Loren JC, 2003, ANGEW CHEM INT EDIT, V42, P5702, DOI 10.1002/anie.200352562; Yamauchi Y, 2010, J AM CHEM SOC, V132, P960, DOI 10.1021/ja904063r; McCord DJ, 1998, J AM CHEM SOC, V120, P9763, DOI 10.1021/ja981201u; Iyoda M, 2011, ANGEW CHEM INT EDIT, V50, P10522, DOI 10.1002/anie.201006198; Barnes JC, 2013, J AM CHEM SOC, V135, P183, DOI 10.1021/ja307360n; Zhang W, 2006, ANGEW CHEM INT EDIT, V45, P4416, DOI 10.1002/anie.200503988; ASHTON PR, 1994, J CHEM SOC CHEM COMM, P177, DOI 10.1039/c39940000177; ASHTON PR, 1988, ANGEW CHEM INT EDIT, V27, P1550, DOI 10.1002/anie.198815501; Ono K, 2009, J AM CHEM SOC, V131, P2782, DOI 10.1021/ja8089894; Chiu SH, 2002, ANGEW CHEM INT EDIT, V41, P270, DOI 10.1002/1521-3773(20020118)41:2<270::AID-ANIE270>3.0.CO;2-5; Danjo H, 2009, J AM CHEM SOC, V131, P1638, DOI 10.1021/ja8071435; Danjo H, 2012, CHEM-ASIAN J, V7, P1529, DOI 10.1002/asia.201200162; Grave C, 2002, EUR J ORG CHEM, P3075; Kawase T, 2007, ANGEW CHEM INT EDIT, V46, P1086, DOI 10.1002/anie.200603707; Liu Y, 2007, TETRAHEDRON LETT, V48, P3871, DOI 10.1016/j.tetlet.2007.03.144; ODELL B, 1988, ANGEW CHEM INT EDIT, V27, P1547, DOI 10.1002/anie.198815471; Parac TN, 2000, ANGEW CHEM INT EDIT, V39, P1239, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1239::AID-ANIE1239>3.0.CO;2-1; Schalley CA, 2002, ANGEW CHEM INT EDIT, V41, P1513, DOI 10.1002/1521-3773(20020503)41:9<1513::AID-ANIE1513>3.0.CO;2-H	27	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1523-7060	1523-7052		ORG LETT	Org. Lett.	MAY 1	2015	17	9					2154	2157		10.1021/acs.orglett.5b00747		4	Chemistry, Organic	Chemistry	CH4LG	WOS:000354004400030		
J	Yamashita, T; Kuranaga, T; Inoue, M				Yamashita, Tomoya; Kuranaga, Takefumi; Inoue, Masayuki			Solid-Phase Total Synthesis of Bogorol A: Stereocontrolled Construction of Thermodynamically Unfavored (E)-2-Amino-2-butenamide	ORGANIC LETTERS			English	Article							TRACELESS STAUDINGER LIGATION; PEPTIDE-SYNTHESIS; STRUCTURAL PERMUTATION; ANTIMICROBIAL PEPTIDES; CHEMICAL CONSTRUCTION; STAPHYLOCOCCUS-AUREUS; NONRIBOSOMAL PEPTIDE; COUPLING REAGENT; CARBOXYLIC-ACIDS; NATURAL-PRODUCTS	Bogorol A [(E)-1], a potent antibiotic against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus spp., possesses a thermodynamically unfavored (E)-2-amino-2-butenamide within its linear dodecapeptide sequence. The highly efficient total synthesis of natural (E)-isomer (E)-1 and its artificial (Z)-isomer (Z)-1 by employing a full solid-phase strategy is reported. The (E)- and (Z)-2-amino-2-butenamide moieties were stereoselectively constructed by applying traceless Staudinger ligation on the resin. Interestingly, (E)- and (Z)-1 showed comparable antimicrobial activity (MIC = 4 mu g/mL).	[Yamashita, Tomoya; Kuranaga, Takefumi; Inoue, Masayuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Inoue, M (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.	inoue@mol.f.u-tokyo.ac.jp			JSPS	This research was financially supported by a Grant-in-Aid for Scientific Research (A) to M.I. and a Grant-in-Aid for Young Scientists (B) (JSPS) to T.K. We thank Prof. Kazuhisa Sekimizu, Dr. Jyunichiro Yasukawa, and Dr. Hiroshi Hamamoto (The University of Tokyo) for evaluation of antibacterial activity.	Coates A, 2002, NAT REV DRUG DISCOV, V1, P895, DOI 10.1038/nrd940; O'Connell KMG, 2013, ANGEW CHEM INT EDIT, V52, P10706, DOI 10.1002/anie.201209979; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; Saxon E, 2000, ORG LETT, V2, P2141, DOI 10.1021/ol006054v; Fernandez-Suarez M, 2007, NAT BIOTECHNOL, V25, P1483, DOI 10.1038/nbt1355; Hang HC, 2004, J AM CHEM SOC, V126, P6, DOI 10.1021/ja037692m; Nilsson BL, 2001, ORG LETT, V3, P9, DOI 10.1021/ol006739v; Bacsa B, 2008, J ORG CHEM, V73, P7532, DOI 10.1021/jo8013897; Sieber SA, 2005, CHEM REV, V105, P715, DOI 10.1021/cr0301191; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Appelbaum PC, 2006, CLIN MICROBIOL INFEC, V12, P16, DOI 10.1111/j.1469-0691.2006.01344.x; von Nussbaum F, 2006, ANGEW CHEM INT EDIT, V45, P5072, DOI 10.1002/anie.200600350; Shangguan N, 2008, J AM CHEM SOC, V130, P6281, DOI 10.1021/ja800067q; COSTE J, 1990, TETRAHEDRON LETT, V31, P205, DOI 10.1016/S0040-4039(00)94371-5; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Butler MS, 2011, J ANTIBIOT, V64, P413, DOI 10.1038/ja.2011.44; YU HM, 1992, J ORG CHEM, V57, P4781, DOI 10.1021/jo00044a001; McGrath NA, 2011, ACCOUNTS CHEM RES, V44, P752, DOI 10.1021/ar200081s; Nilsson BL, 2000, ORG LETT, V2, P1939, DOI 10.1021/ol0060174; Matsuzaki K, 2009, BBA-BIOMEMBRANES, V1788, P1687, DOI 10.1016/j.bbamem.2008.09.013; Kosal AD, 2012, CHEM-EUR J, V18, P14444, DOI 10.1002/chem.201201773; Lemieux GA, 2003, J AM CHEM SOC, V125, P4708, DOI 10.1021/ja029013y; HANSON RN, 1987, J ORG CHEM, V52, P3687, DOI 10.1021/jo00392a036; Inoue M, 2014, P JPN ACAD B-PHYS, V90, P56, DOI 10.2183/pjab.90.56; Kuranaga T, 2014, NAT PROD REP, V31, P514, DOI 10.1039/c3np70103d; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; Walsh CT, 2013, ANGEW CHEM INT EDIT, V52, P7098, DOI 10.1002/anie.201208344; Giuliani A, 2007, CENT EUR J BIOL, V2, P1, DOI 10.2478/s11535-007-0010-5; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Kosal AD, 2012, ANGEW CHEM INT EDIT, V51, P12036, DOI 10.1002/anie.201206533; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Barsby T, 2006, J ORG CHEM, V71, P6031, DOI 10.1021/jo060667p; Barsby T, 2001, ORG LETT, V3, P437, DOI 10.1021/ol006942q; Bonauer C, 2006, SYNTHESIS-STUTTGART, P1, DOI 10.1055/s-2005-921759; Chan W. C., 2000, FMOC SOLID PHASE PEP; DOURTOGLOU V, 1984, SYNTHESIS-STUTTGART, P572, DOI 10.1055/s-1984-30895; Editorial, 2013, NATURE, V495, P141; Hamphrey J. M., 1997, CHEM REV, V97, P2243; Itoh H, 2013, ACCOUNTS CHEM RES, V46, P1567, DOI 10.1021/ar300315p; Kuranaga T, 2013, J AM CHEM SOC, V135, P5467, DOI 10.1021/ja401457h; Liang SO, 2010, CHEM COMMUN, V46, P153, DOI 10.1039/b921000h; MIYAKE H, 1989, CHEM LETT, P981, DOI 10.1246/cl.1989.981; RAJASHANKAR KR, 1995, J AM CHEM SOC, V117, P11773, DOI 10.1021/ja00152a020; RICH DH, 1978, J AM CHEM SOC, V100, P2212, DOI 10.1021/ja00475a037; Sal H., 2003, SYNTHESIS-STUTTGART, P201; Siodlak D, 2010, J PEPT SCI, V16, P496, DOI 10.1002/psc.1267; Thormann M, 1998, THEOCHEM-J MOL STRUC, V431, P79; Ward DE, 1999, J ORG CHEM, V64, P1657, DOI 10.1021/jo982376p; Yamashita T, 2014, TETRAHEDRON, V70, P7746, DOI 10.1016/j.tet.2014.05.091	50	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1523-7060	1523-7052		ORG LETT	Org. Lett.	MAY 1	2015	17	9					2170	2173		10.1021/acs.orglett.5b00769		4	Chemistry, Organic	Chemistry	CH4LG	WOS:000354004400034		
J	Mochizuki, M; Tsuda, S; Tanimura, K; Nishiuchi, Y				Mochizuki, Masayoshi; Tsuda, Shugo; Tanimura, Kyoko; Nishiuchi, Yuji			Regioselective Formation of Multiple Disulfide Bonds with the Aid of Postsynthetic S-Tritylation	ORGANIC LETTERS			English	Article							PEPTIDE-SYNTHESIS; CYSTEINE; INHIBITOR; STABILITY; OXIDATION; HEPCIDIN; OXYMA	Disulfide bond formation performed in solution with the tert-butylthio, (StBu) group was accomplished using a free peptide-having only the sulfhydryl groups of Cys protected with the aid of postsynthetic S-tritylation. This facilitated removal of the StBu group with subsequent disulfide formation Without any difficulty. The strategy using the StBu group in combination with the widely used acetamidomethyl (Acm), 4-methylbenzyl/4-methoxybenzyl (Meb/Mob), and trityl (Trt) groups enables reliable and regioselective synthesis of multicystine peptides.	[Mochizuki, Masayoshi; Tsuda, Shugo; Tanimura, Kyoko; Nishiuchi, Yuji] Peptide Inst Inc, Osaka 5670085, Japan; [Nishiuchi, Yuji] Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan	Nishiuchi, Y (reprint author), GlyTech Inc, Shimogyo Ku, Kyoto 6008813, Japan.	yuji-nishiuchi@glytech.jp					AKAJI K, 1993, J AM CHEM SOC, V115, P11384, DOI 10.1021/ja00077a043; Sollod BL, 2005, PEPTIDES, V26, P131, DOI 10.1016/j.peptides.2004.07.016; Jad YE, 2014, ORG BIOMOL CHEM, V12, P8379, DOI 10.1039/c4ob01612b; Beld J, 2007, BIOCHEMISTRY-US, V46, P5382, DOI 10.1021/bi700124p; KAMBER B, 1980, HELV CHIM ACTA, V63, P899, DOI 10.1002/hlca.19800630418; West PJ, 2002, BIOCHEMISTRY-US, V41, P15388, DOI 10.1021/bi0265628; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Mochizuki M, 2014, ORG LETT, V16, P5740, DOI 10.1021/ol502773v; Postma TM, 2014, EUR J ORG CHEM, V2014, P3519, DOI 10.1002/ejoc.201402149; Cuthbertson A, 2003, ORG LETT, V5, P2955, DOI 10.1021/ol035105w; FRIEDMAN M, 1965, J AM CHEM SOC, V87, P3672, DOI 10.1021/ja01094a025; CREIGHTON TE, 1988, BIOESSAYS, V8, P57, DOI 10.1002/bies.950080204; Subiros-Funosas R, 2009, CHEM-EUR J, V15, P9394, DOI 10.1002/chem.200900614; OTAKA A, 1991, TETRAHEDRON LETT, V32, P1223, DOI 10.1016/S0040-4039(00)92050-1; GRAY WR, 1993, PROTEIN SCI, V2, P1732; Swaisgood HE, 2005, BIOTECHNOL ADV, V23, P71, DOI 10.1016/j.biotechadv.2004.09.004; Jordan JB, 2009, J BIOL CHEM, V284, P24155, DOI 10.1074/jbc.M109.017764; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Dekan Z, 2014, ANGEW CHEM INT EDIT, V53, P2931, DOI 10.1002/anie.201310103; Gongora-Benitez M., 2011, PEPT SCI, V96, P69; Hibino Hajime, 2014, J Pept Sci, V20, P30, DOI 10.1002/psc.2585; Kellenberger C, 1995, PEPTIDE RES, V8, P321; NISHIUCHI Y, 1982, FEBS LETT, V148, P260, DOI 10.1016/0014-5793(82)80820-X; Okumura M, 2012, FEBS J, V279, P2283, DOI 10.1111/j.1742-4658.2012.08596.x; Stathopoulos P, 2014, AMINO ACIDS, V46, P1367, DOI 10.1007/s00726-014-1696-0; SZABO I, 2007, PEPT SCI, V88, P20; Taichi M, 2009, TETRAHEDRON LETT, V50, P2377, DOI 10.1016/j.tetlet.2009.02.213; Tanimura K., 2011, 9 AUSTR PEPT C QUEEN; YANG Y, 1994, PROTEIN SCI, V3, P1267	29	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1523-7060	1523-7052		ORG LETT	Org. Lett.	MAY 1	2015	17	9					2202	2205		10.1021/acs.orglett.5b00786		4	Chemistry, Organic	Chemistry	CH4LG	WOS:000354004400042		
J	He, Q; Xie, F; Fu, GH; Quan, M; Shen, CR; Yang, GQ; Gridnev, ID; Zhang, WB				He, Qun; Xie, Fang; Fu, Guanghong; Quan, Mao; Shen, Chaoren; Yang, Guoqiang; Gridnev, Ilya D.; Zhang, Wanbin			Palladium-Catalyzed Asymmetric Addition of Arylboronic Acids to Nitrostyrenes	ORGANIC LETTERS			English	Article							ALPHA,BETA-UNSATURATED CARBONYL-COMPOUNDS; CONJUGATE ADDITION; ORGANOBORONIC ACIDS; MICHAEL ADDITION; PALLADIUM(II)-CATALYZED 1,4-ADDITION; ENANTIOSELECTIVE CONSTRUCTION; QUATERNARY STEREOCENTERS; ARYLGLYCINE DERIVATIVES; PERHYDROINDOLIC ACID; CONVENIENT SYNTHESIS	A palladium-catalyzed asymmetric addition. of arylboronic acids to nitrostyrene is reported. The catalytic system employing iPr-IsoQuinox as 4 chiral ligand in MeOH solvent under an air atmosphere provides the chiral diarylsubstituted pro ducts in high yield's with good enantioseletivities. A variety of functionalized nitrostyrenes can be used, and the method tolerates some variation The stereochemical outcome can be explained using a Stereochemical model.	[He, Qun; Xie, Fang; Fu, Guanghong; Quan, Mao; Shen, Chaoren; Yang, Guoqiang; Zhang, Wanbin] Shanghai Jiao Tong Univ, Sch Chem & Chem Engn, Shanghai 200240, Peoples R China; [Gridnev, Ilya D.] Tohoku Univ, Grad Sch Sci, Dept Chem, Aoba Ku, Sendai, Miyagi 9808578, Japan	Yang, GQ (reprint author), Shanghai Jiao Tong Univ, Sch Chem & Chem Engn, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	gqyang@sjtu.edu.cn; wanbin@sjtu.edu.cn	Zhang, Wanbin/I-1208-2013		National Nature Science Foundation of China [21302124, 21172144]; China Postdoctoral Science Foundation [2012M520882]; Nippon Chemical Industrial Co. Ltd.; Shanghai Jiao Tong University (SJTU); Campus Asia Program of Tohoku University	This work was partly supported by the National Nature Science Foundation of China (Nos. 21302124, 21172144), China Postdoctoral Science Foundation (No. 2012M520882), Nippon Chemical Industrial Co. Ltd., Shanghai Jiao Tong University (SJTU), and Campus Asia Program of Tohoku University. We thank Prof. Tsuneo Imamoto and Dr. Masashi Sugiya of Nippon Chemical Industrial Co., Ltd., for help discussions and the Instrumental Analysis Center of SJTU.	Alexakis A, 2002, EUR J ORG CHEM, P3221; An QJ, 2013, SYNTHESIS-STUTTGART, V45, P1612, DOI 10.1055/s-0033-1338839; Kikushima K, 2011, J AM CHEM SOC, V133, P6902, DOI 10.1021/ja200664x; Bentley KW, 2006, NAT PROD REP, V23, P444, DOI 10.1039/b509523a; Zhou F, 2009, ORG LETT, V11, P1405, DOI 10.1021/ol9001015; NEUMEYER JL, 1990, J MED CHEM, V33, P521, DOI 10.1021/jm00164a009; Christoffers J, 2007, SYNTHESIS-STUTTGART, P1279, DOI 10.1055/s-2007-966005; Dai HX, 2008, ADV SYNTH CATAL, V350, P249, DOI 10.1002/adsc.200700362; Yamamoto Y, 2008, PURE APPL CHEM, V80, P807, DOI 10.1351/pac200880050807; Tian P, 2012, ACS CATAL, V2, P95, DOI 10.1021/cs200562n; Holder JC, 2013, J AM CHEM SOC, V135, P14996, DOI 10.1021/ja401713g; Wang FJ, 2012, COORDIN CHEM REV, V256, P804, DOI 10.1016/j.ccr.2011.11.013; Sun YW, 2013, RSC ADV, V3, P3153, DOI 10.1039/c2ra22674j; Hayashi T, 2003, CHEM REV, V103, P2829, DOI 10.1021/cr020022z; Song J, 2007, ORG LETT, V9, P2947, DOI 10.1021/ol0711772; Mei TS, 2013, J AM CHEM SOC, V135, P6830, DOI 10.1021/ja402916z; Nishikata T, 2003, ANGEW CHEM INT EDIT, V42, P2768, DOI 10.1002/anie.200350888; Zhang H, 2010, TETRAHEDRON LETT, V51, P3119, DOI 10.1016/j.tetlet.2010.04.033; Xu Q, 2010, J ORG CHEM, V75, P3935, DOI [10.1021/jo1006224, 10.1021/jo.1006224]; [Anonymous], 2005, INOCELLIA, V2005, P7; Ma GN, 2009, ORG LETT, V11, P875, DOI 10.1021/ol802861s; Peng Q, 2012, J ORG CHEM, V77, P7487, DOI 10.1021/jo301319j; Edwards HJ, 2010, CHEM SOC REV, V39, P2093, DOI 10.1039/b919762c; Nishikata T, 2005, ORGANOMETALLICS, V24, P5025, DOI 10.1021/om050678t; Li Y, 2014, CHEM COMMUN, V50, P3771, DOI 10.1039/c3cc49431d; Holder JC, 2013, CHEM-EUR J, V19, P74, DOI 10.1002/chem.201203643; Thaler T, 2009, ANGEW CHEM INT EDIT, V48, P645, DOI 10.1002/anie.200804446; Miyaura N, 2008, B CHEM SOC JPN, V81, P1535, DOI 10.1246/bcsj.81.1535; Lu XY, 2005, J ORG CHEM, V70, P9651, DOI 10.1021/jo051561h; Liu Z, 2010, TETRAHEDRON, V66, P2619, DOI 10.1016/j.tet.2010.02.037; Gottumukkala AL, 2012, CHEM-EUR J, V18, P6907, DOI 10.1002/chem.201200694; Scott JD, 2002, CHEM REV, V102, P1669, DOI 10.1021/cr010212u; Wang ZQ, 2010, ANGEW CHEM INT EDIT, V49, P5780, DOI 10.1002/anie.201001883; Jerphagnon T, 2009, CHEM SOC REV, V38, P1039, DOI 10.1039/b816853a; Dai HX, 2007, ORG LETT, V9, P3077, DOI 10.1021/ol0711220; Fagnou K, 2003, CHEM REV, V103, P169, DOI 10.1021/cr020007u; Lan Y, 2011, J ORG CHEM, V76, P4905, DOI 10.1021/jo2002903; Lin SH, 2010, ORG LETT, V12, P2536, DOI 10.1021/ol100767u; Wang FJ, 2013, CHEM COMMUN, V49, P3360, DOI 10.1039/c3cc00295k; Lopez F, 2007, ACCOUNTS CHEM RES, V40, P179, DOI 10.1021/ar0501976; Alexakis A, 2008, CHEM REV, V108, P2796, DOI 10.1021/cr0683515; Nishikata T, 2007, ADV SYNTH CATAL, V349, P1759, DOI 10.1002/adsc.200600622; Mei TS, 2014, NATURE, V508, P340, DOI 10.1038/nature13231; Feng XQ, 2012, ASIAN J ORG CHEM, V1, P204, DOI 10.1002/ajoc.201200069; Nishikata T, 2004, ORGANOMETALLICS, V23, P4317, DOI 10.1021/om0498044; CALDERARI G, 1985, HELV CHIM ACTA, V68, P1592, DOI 10.1002/hlca.19850680611; Chen JY, 2012, J ORG CHEM, V77, P8541, DOI 10.1021/jo301423e; Dai HX, 2009, TETRAHEDRON LETT, V50, P3478, DOI 10.1016/j.tetlet.2009.03.005; Li YR, 2011, J NAT PROD, V74, P1444, DOI 10.1021/np2001896; Hayashi T, 2000, J AM CHEM SOC, V122, P10716, DOI 10.1021/ja002805c; Berner OM, 2002, EUR J ORG CHEM, P1877; Berthon-Gelloz G., 2011, BORONIC ACIDS, V1, P263; Dong HQ, 2015, ORG CHEM FRONT, V2, P73, DOI 10.1039/c4qo00245h; Duursma A, 2005, TETRAHEDRON-ASYMMETR, V16, P1901, DOI 10.1016/j.tetasy.2005.05.006; Duursma A., 2003, ORG LETT, V5, P311; Gordaliza M, 2004, TOXICON, V44, P441, DOI 10.1016/j.toxicon.2004.05.008; Gu P, 2013, ORGANOMETALLICS, V32, P7575, DOI 10.1021/om4010687; Gutnov A, 2008, EUR J ORG CHEM, P4547, DOI 10.1002/ejoc.200800541; Harutyunyan S. R., 2008, CHEM REV, V108, P2824; Holder J. C., 2014, TETRAHEDRON; Hoveyda A. H., 2000, GRIGNARD REAGENTS NE, P107; Huang KC, 2013, ORG LETT, V15, P5730, DOI 10.1021/ol4027599; Jiang CH, 2014, ANGEW CHEM INT EDIT, V53, P9936, DOI 10.1002/anie.201406147; Jumde VR, 2013, ADV SYNTH CATAL, V355, P3475, DOI 10.1002/adsc.201300619; Lang F, 2011, CHEM-EUR J, V17, P5242, DOI 10.1002/chem.201100135; Liu GX, 2006, J AM CHEM SOC, V128, P16504, DOI 10.1021/ja0672425; Mauduit M., 2014, COMPREHENSIVE ORGANI, V4, P189; Miyaura N, 2009, SYNLETT, P2039, DOI 10.1055/s-0029-1217555; Nishikata T, 2007, TETRAHEDRON LETT, V48, P4007, DOI 10.1016/j.tetlet.2007.04.038; Nishikata T, 2005, CHEM LETT, V34, P720, DOI 10.1246/cl.2005.720; Nishikata T, 2007, CHEM LETT, V36, P1442, DOI 10.1246/cl.2007.1442; Perlmutter P, 1992, CONJUGATE ADDITION R; Petri A, 2014, TETRAHEDRON LETT, V55, P267, DOI 10.1016/j.tetlet.2013.11.015; Phillipson J. D., 1985, CHEM BIOL ISOQUINOLI; Quan M, 2015, ORG CHEM FRONT, V2, P398, DOI 10.1039/c4qo00347k; SHAH JH, 1995, J MED CHEM, V38, P4284, DOI 10.1021/jm00021a018; Tao Z., 2008, CHEM-EUR J, V14, P3759; Tomioka K., 1999, COMPREHENSIVE ASYMME, V3, P1105; Tomioka K., 2004, COMPREHENSIVE ASYMME, P109; Wong J, 2014, ADV SYNTH CATAL, V356, P3391, DOI 10.1002/adsc.201400473; Xue F, 2012, J ORG CHEM, V77, P3071, DOI 10.1021/jo3003562; Yang GQ, 2013, ANGEW CHEM INT EDIT, V52, P7540, DOI 10.1002/anie.201302861; Yoshida K, 2005, MODERN RHODIUM-CATALYZED ORGANIC REACTIONS, P55, DOI 10.1002/3527604693.ch3; Zhao LN, 2012, ORG BIOMOL CHEM, V10, P2840, DOI 10.1039/c2ob00003b	84	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1523-7060	1523-7052		ORG LETT	Org. Lett.	MAY 1	2015	17	9					2250	2253		10.1021/acs.orglett.5b00863		4	Chemistry, Organic	Chemistry	CH4LG	WOS:000354004400054		
J	Kato, T; Sato, T; Kashiwagi, Y; Hosokawa, S				Kato, Takuya; Sato, Tomohiko; Kashiwagi, Yuki; Hosokawa, Seijiro			Synthetic Studies on Aculeximycin: Synthesis of C24-C40 Segment by Kobayashi Aldolization and Epoxide Rearrangements	ORGANIC LETTERS			English	Article							1ST TOTAL-SYNTHESIS; E,E-VINYLKETENE SILYL N,O-ACETAL; BIOACTIVE NATURAL-PRODUCTS; MUKAIYAMA ALDOL REACTION; FORMAL TOTAL-SYNTHESIS; STRUCTURAL ELUCIDATION; STREPTOSPORANGIUM-ALBIDUM; MACROLIDE ANTIBIOTICS; ALLYLIC ALCOHOLS; ACTINOPYRONE-A	Stereoselective synthesis of the C24-C40 segment of aculeximycin has been achieved by using the Kobayashi aldol reactions and epoxy-opening rearrangement reactions. The C33-C40 segment was synthesized by the Kobayashi aldol reaction followed by epoxidation and Jung rearrangement of epoxide 9, while the C25-C32 segment was constructed by the Kobayashi aldol reaction followed by epoxidation and the epoxy-opening rearrangement reaction of epoxide 13. These segments were connected by the aldol reaction and the sequential dehydration, reduction, and conversion of ethyl ester to ethyl ketone to give the C24-C40 segment 1. All stereogenic centers were constructed by substrate-controlled stereoselective reactions.	[Kato, Takuya; Sato, Tomohiko; Kashiwagi, Yuki; Hosokawa, Seijiro] Waseda Univ, Dept Appl Chem, Fac Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan	Hosokawa, S (reprint author), Waseda Univ, Dept Appl Chem, Fac Sci & Engn, Shinjuku Ku, 3-4-1 Ohkubo, Tokyo 1698555, Japan.	seijiro@waseda.jp			NOVARTIS Foundation (Japan) for the Promotion of Science; Kurata Memorial Hitachi Science and Technology Foundation; Naito Foundation; GCOE program "Center for Practical Chemical Wisdom"; Scientific Research on Innovative Areas of The Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [24102531]; Supporting Strategic Research Platform for Fusion Biotechnology based on Biology, Chemistry, and Informatics Project to Form the Strategic Research Platforms for Private University; MEXT, Japan	The authors are grateful for financial support from The NOVARTIS Foundation (Japan) for the Promotion of Science, The Kurata Memorial Hitachi Science and Technology Foundation; The Naito Foundation; GCOE program "Center for Practical Chemical Wisdom"; Scientific Research on Innovative Areas #24102531 of The Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; and The Supporting Strategic Research Platform for Fusion Biotechnology based on Biology, Chemistry, and Informatics Project to Form the Strategic Research Platforms for Private University and a matching fund subsidy from MEXT, Japan.	Hoecker J, 2013, ORG LETT, V15, P670, DOI 10.1021/ol303502a; Nakamura T, 2006, ORG LETT, V8, P677, DOI 10.1021/ol052871p; Tatsuta K, 2005, CHEM REV, V105, P4707, DOI 10.1021/cr040630+; MURATA H, 1995, J ANTIBIOT, V48, P850; Hosokawa S, 2009, TETRAHEDRON LETT, V50, P6701, DOI 10.1016/j.tetlet.2009.09.089; Mitton-Fry MJ, 2007, ANGEW CHEM INT EDIT, V46, P1066, DOI 10.1002/anie.200602601; Bull SD, 2006, ORG BIOMOL CHEM, V4, P2945, DOI 10.1039/b605244d; Rai AN, 2003, TETRAHEDRON LETT, V44, P2267, DOI 10.1016/S0040-4039(03)00282-X; Nicolaou KC, 2007, ANGEW CHEM INT EDIT, V46, P5896, DOI 10.1002/anie.200702243; Lipshutz BH, 2009, J AM CHEM SOC, V131, P1396, DOI 10.1021/ja809542r; Hosokawa S, 2010, TETRAHEDRON LETT, V51, P5532, DOI 10.1016/j.tetlet.2010.07.153; Jiang X, 2007, J AM CHEM SOC, V129, P6386, DOI 10.1021/ja0715142; Yamaoka M, 2009, TETRAHEDRON LETT, V50, P6764, DOI 10.1016/j.tetlet.2009.09.088; Takahashi Y, 2014, ORG LETT, V16, P4106, DOI 10.1021/ol501805j; Nakamura T, 2013, ORG LETT, V15, P3170, DOI 10.1021/ol401406m; OHTANI I, 1991, J AM CHEM SOC, V113, P4092, DOI 10.1021/ja00011a006; Doroh B, 2006, ORG LETT, V8, P903, DOI 10.1021/ol0530225; Fujita K, 2012, ANGEW CHEM, V124, P7383; Fujita K, 2012, ANGEW CHEM INT EDIT, V51, P7271, DOI 10.1002/anie.201203093; Fujiwara K, 2015, J ORG CHEM, V80, P114, DOI [10.1021/jo502198y, 10.1021/jo502198y1J]; HASAN I, 1980, TETRAHEDRON LETT, V21, P4229, DOI 10.1016/S0040-4039(00)92869-7; Hofle G., 2012, CHEM-EUR J, V8, P11362; Hosokawa S, 2006, TETRAHEDRON LETT, V47, P6183, DOI 10.1016/j.tetlet.2006.06.158; Hosokawa S, 2005, TETRAHEDRON LETT, V46, P333, DOI 10.1016/j.tetlet.2004.11.004; Hosokawa S, 2008, CHEM-ASIAN J, V3, P1415, DOI 10.1002/asia.200800109; Hosokawa S, 2008, MINI-REV ORG CHEM, V5, P1, DOI 10.2174/157019308783498197; Hosokawa S, 2006, TETRAHEDRON LETT, V47, P5415, DOI 10.1016/j.tetlet.2006.05.028; Hosokawa S, 2009, J SYN ORG CHEM JPN, V67, P24; IKEMOTO T, 1983, J ANTIBIOT, V36, P1093; IKEMOTO T, 1983, J ANTIBIOT, V36, P1097; Jung ME, 2009, ANGEW CHEM INT EDIT, V48, P8766, DOI 10.1002/anie.200904607; JUNG ME, 1993, J AM CHEM SOC, V115, P12208, DOI 10.1021/ja00078a087; Jung ME, 2010, ORG LETT, V12, P2872, DOI 10.1021/ol100985n; Jung ME, 2000, TETRAHEDRON LETT, V41, P9719, DOI 10.1016/S0040-4039(00)01726-3; Jurjens G, 2014, ORG LETT, V16, P3000, DOI 10.1021/ol5011278; Kanoh N, 2014, ORG LETT, V16, P5216, DOI 10.1021/ol502633j; Larsen BJ, 2013, ORG LETT, V15, P2998, DOI 10.1021/ol401186f; Matsui R, 2011, ANGEW CHEM INT EDIT, V50, P680, DOI 10.1002/anie.201006230; Meiries S, 2008, J ORG CHEM, V73, P5015, DOI 10.1021/jo800574g; Miyatake-Ondozabal H, 2015, ANGEW CHEM INT EDIT, V54, P1933, DOI 10.1002/anie.201409464; Miyoshi H, 1996, J BIOCHEM, V119, P274; Mukaeda Y, 2012, ORG LETT, V14, P5298, DOI 10.1021/ol3024677; MURATA H, 1989, J ANTIBIOT, V42, P691; MURATA H, 1995, J ANTIBIOT, V48, P838; MURATA H, 1989, J ANTIBIOT, V42, P701; Nagasawa T, 2013, ORG LETT, V15, P3002, DOI 10.1021/ol401214f; Paterson I, 2010, ORG LETT, V12, P3724, DOI 10.1021/ol101630p; Ramesh P, 2012, TETRAHEDRON, V68, P9289, DOI 10.1016/j.tet.2012.08.035; ROSSITER BE, 1979, TETRAHEDRON LETT, P4733; Schmauder A, 2008, TETRAHEDRON, V64, P6263, DOI 10.1016/j.tet.2008.04.109; Schmauder A, 2010, CHEM-EUR J, V16, P4328, DOI 10.1002/chem.200903500; Shirokawa SI, 2007, ORG LETT, V9, P849, DOI 10.1021/ol0630191; Shirokawa SI, 2004, J AM CHEM SOC, V126, P13604, DOI 10.1021/ja0465855; Takahashi Y., 2014, ORG LETT, V16, P1406; Tsukada H, 2013, ORG LETT, V15, P678, DOI 10.1021/ol303519y; Yamaoka M, 2010, TETRAHEDRON LETT, V51, P287, DOI 10.1016/j.tetlet.2009.10.140; Yamaoka M, 2009, TETRAHEDRON LETT, V50, P3849, DOI 10.1016/j.tetlet.2009.04.039	57	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1523-7060	1523-7052		ORG LETT	Org. Lett.	MAY 1	2015	17	9					2274	2277		10.1021/acs.orglett.5b00965		4	Chemistry, Organic	Chemistry	CH4LG	WOS:000354004400060		
J	Furukawa, K; Shibuya, M; Yamamoto, Y				Furukawa, Keisuke; Shibuya, Masatoshi; Yamamoto, Yoshihiko			Chemoselective Catalytic Oxidation of 1,2-Diols to alpha-Hydroxy Acids Controlled by TEMPO-ClO2 Charge-Transfer Complex	ORGANIC LETTERS			English	Article							HYDROLYTIC KINETIC RESOLUTION; 2,3-EPOXY ALCOHOLS; CARBOXYLIC-ACIDS; ASYMMETRIC EPOXIDATION; NITROXYL RADICALS; CHLORINE DIOXIDE; EPOXIDES; CLEAVAGE; DIOLS; ACTIVATION	Chemoselective catalytic oxidation from 1,2-diols to a-hydroxy acids in a cat. TEMPO/cat. NaOCl/NaClO2 system has been achieved. The use of a two-phase condition consisting of hydrophobic toluene and water suppresses the concomitant oxidative cleavage. A study of the mechanism suggests that the observed selectivity is derived from the precise solubility: control of diols and hydroxy acids as well as the active species Of TEMPO, Although the oxoammonium species TEMPO+Cl- is hydrophilic, the active species dissolves into the organic layer by the formation of the charge-transfer (CT) complex TEMPO-ClO2 under the reaction conditions.	[Furukawa, Keisuke; Shibuya, Masatoshi; Yamamoto, Yoshihiko] Nagoya Univ, Grad Sch Pharmaceut Sci, Dept Basic Med Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Shibuya, M (reprint author), Nagoya Univ, Grad Sch Pharmaceut Sci, Dept Basic Med Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	m-shibu@ps.nagoya-u.ac.jp			MEXT; JSPS [23689001]	We dedicate this work to the memory of Prof. Tsutomu Katsuki. This work was partially supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Advanced Molecular Transformations by Organocatalysts" and Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT and by a Grant-in-Aid for Young Scientists (A) (No. 23689001) from JSPS.	Epp JB, 1999, J ORG CHEM, V64, P293, DOI 10.1021/jo981316g; Zhao MZ, 1999, J ORG CHEM, V64, P2564, DOI 10.1021/jo982143y; MURAKAMI Y, 1982, B JPN SOC SCI FISH, V48, P69; Schaus SE, 2002, J AM CHEM SOC, V124, P1307, DOI 10.1021/ja016737l; Nicolaou KC, 2010, ORG LETT, V12, P1552, DOI 10.1021/ol100290a; Lee W, 2013, CHEM COMMUN, V49, P5231, DOI 10.1039/c3cc42365d; DESS DB, 1991, J AM CHEM SOC, V113, P7277, DOI 10.1021/ja00019a027; Testa ML, 2004, ADV SYNTH CATAL, V346, P655, DOI 10.1002/adsc.200303239; Kubota J, 2006, TETRAHEDRON, V62, P4769, DOI 10.1016/j.tet.2006.03.020; Uesugi S, 2014, ORG LETT, V16, P4408, DOI 10.1021/ol502264y; KOLB HC, 1994, CHEM REV, V94, P2483, DOI 10.1021/cr00032a009; Ganiev IM, 1999, TETRAHEDRON LETT, V40, P4737, DOI 10.1016/S0040-4039(99)00837-0; CARON M, 1985, J ORG CHEM, V50, P1557, DOI 10.1021/jo00209a047; HANSON RM, 1986, J ORG CHEM, V51, P1922, DOI 10.1021/jo00360a058; Bonet A, 2011, ANGEW CHEM INT EDIT, V50, P7158, DOI 10.1002/anie.201101941; Painter RM, 2010, ANGEW CHEM INT EDIT, V49, P9456, DOI 10.1002/anie.201004063; Ryabenkova Y, 2014, TETRAHEDRON, V70, P6055, DOI 10.1016/j.tet.2014.02.043; KATSUKI T, 1980, J AM CHEM SOC, V102, P5974, DOI 10.1021/ja00538a077; Groger H, 2001, ADV SYNTH CATAL, V343, P547, DOI 10.1002/1615-4169(200108)343:6/7<547::AID-ADSC547>3.0.CO;2-A; Shibuya M, 2012, ORG LETT, V14, P5006, DOI 10.1021/ol3021429; Shibuya M, 2006, J AM CHEM SOC, V128, P8412, DOI 10.1021/ja0620336; Wang C, 2014, J AM CHEM SOC, V136, P6888, DOI 10.1021/ja5029809; Gancitano P, 2005, ORG BIOMOL CHEM, V3, P2389, DOI 10.1039/b505949f; Wang Z, 2008, J ORG CHEM, V73, P2270, DOI 10.1021/jo702401t; Watanabe T, 2010, ORG LETT, V12, P1040, DOI 10.1021/ol1000389; Bataille C. J. R., 2011, CHEM SOC REV, V40, P114, DOI DOI 10.1039/B923880H; Chinthapally K, 2014, ORG BIOMOL CHEM, V12, P4305, DOI 10.1039/c4ob00601a; Dey S, 2007, ANGEW CHEM INT EDIT, V46, P7010, DOI 10.1002/anie.200701280; Ganiev IM, 2001, RUSS CHEM B+, V50, P614, DOI 10.1023/A:1011344324652; Gruner SAW, 2002, CHEM-EUR J, V8, P4366; Ikunaka M, 2002, TETRAHEDRON-ASYMMETR, V13, P1201, DOI 10.1016/S0957-4166(02)00257-4; Kuranaga T, 2013, J AM CHEM SOC, V135, P5467, DOI 10.1021/ja401457h; Ley SV, 2007, B CHEM SOC JPN, V80, P1451, DOI 10.1246/bcsj.80.1451; Liang SO, 2010, CHEM COMMUN, V46, P153, DOI 10.1039/b921000h; McKeage K, 2013, CLIN DRUG INVEST, V33, P71, DOI 10.1007/s40261-012-0046-9; Pubill-Ulldemolins C, 2012, CHEM-EUR J, V18, P1121, DOI 10.1002/chem.201102209; Schmidt AKC, 2011, ORG LETT, V13, P5788, DOI 10.1021/ol202354g; SCHRODER M, 1980, CHEM REV, V80, P187, DOI 10.1021/cr60324a003; Shibuya M, 2012, ORG LETT, V14, P5010, DOI 10.1021/ol3021435; Shibuya M, 2009, CHEM COMMUN, P1739, DOI 10.1039/b822944a; SUZUKI T, 1982, TETRAHEDRON LETT, V23, P3597, DOI 10.1016/S0040-4039(00)87680-7; Uchida K, 2012, ANGEW CHEM INT EDIT, V51, P12850, DOI 10.1002/anie.201207800; WILSON KE, 1992, J ORG CHEM, V57, P7151, DOI 10.1021/jo00052a032; WONG CH, 1985, J ORG CHEM, V50, P1992, DOI 10.1021/jo00211a046	44	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1523-7060	1523-7052		ORG LETT	Org. Lett.	MAY 1	2015	17	9					2282	2285		10.1021/acs.orglett.5b01003		4	Chemistry, Organic	Chemistry	CH4LG	WOS:000354004400062		
J	Ogasawara, M; Wada, S; Isshiki, E; Kamimura, T; Yanagisawa, A; Takahashi, T; Yoshida, K				Ogasawara, Masamichi; Wada, Shiro; Isshiki, Erika; Kamimura, Takumi; Yanagisawa, Akira; Takahashi, Tamotsu; Yoshida, Kazuhiro			Enantioselective Synthesis of Planar-Chiral Ferrocene-Fused 4-Pyridones and Their Application in Construction of Pyridine-Based Organocatalyst Library	ORGANIC LETTERS			English	Article							RING-CLOSING METATHESIS; NONENZYMATIC KINETIC RESOLUTION; ASYMMETRIC-SYNTHESIS; OLEFIN METATHESIS; NUCLEOPHILIC CATALYSIS; SECONDARY ALCOHOLS; AROMATIC-COMPOUNDS; 2-SUBSTITUTED FERROCENECARBOXALDEHYDES; BETA-LACTAMS; SEC-ALCOHOLS	A couple of planar-chiral ferrocene-fused 4-pyridone derivatives 2a and 2b were synthesized in enantiomerically pure form by scalable asymmetric transformations. Pyridones 2 are versatile precursors to various ferrocene-fused pyridine derivatives, which are useful nucleophilic asymmetric organocatalysts.	[Ogasawara, Masamichi; Isshiki, Erika; Takahashi, Tamotsu] Hokkaido Univ, Catalysis Res Ctr, Kita Ku, Sapporo, Hokkaido 0010021, Japan; [Ogasawara, Masamichi; Isshiki, Erika; Takahashi, Tamotsu] Hokkaido Univ, Grad Sch Life Sci, Kita Ku, Sapporo, Hokkaido 0010021, Japan; [Wada, Shiro; Kamimura, Takumi; Yanagisawa, Akira; Yoshida, Kazuhiro] Chiba Univ, Grad Sch Sci, Dept Chem, Inage Ku, Chiba 2638522, Japan	Ogasawara, M (reprint author), Hokkaido Univ, Catalysis Res Ctr, Kita Ku, Sapporo, Hokkaido 0010021, Japan.	ogasawar@cat.hokudai.ac.jp; ayanagi@faculty.chiba-u.jp; tamotsu@cat.hokudai.ac.jp; kyoshida@faculty.chiba-u.jp	Yoshida, Kazuhiro/B-7272-2011; Ogasawara, Masamichi/B-7727-2012		Cooperative Research Program from Catalysis Research Center, Hokkaido University [11A0002]; MEXT, Japan [24105502, 25810058]; Uehara Memorial Foundation; Naito Foundation; Chiba University	This work was supported by the Cooperative Research Program from Catalysis Research Center, Hokkaido University (Grant #11A0002), a Grant-in-Aid for Scientific Research on Innovative Areas "Advanced Molecular Transformations by Organocatalysts" (Grant #24105502) from MEXT, Japan, and a Grant-in-Aid for Young Scientists (B) (Grant #25810058) from MEXT, Japan. We also gratefully acknowledge financial support from the Uehara Memorial Foundation, the Naito Foundation, and the next generation training program in Chiba University.	DeLorbe JE, 2011, J AM CHEM SOC, V133, P6549, DOI 10.1021/ja201789v; Ogasawara M, 2010, J AM CHEM SOC, V132, P2136, DOI 10.1021/ja910348z; Vedejs E, 2005, ANGEW CHEM INT EDIT, V44, P3974, DOI 10.1002/anie.200460842; Naraku G, 2000, ENANTIOMER, V5, P135; Kawabata T, 1997, J AM CHEM SOC, V119, P3169, DOI 10.1021/ja963275g; Berlin JM, 2008, ANGEW CHEM INT EDIT, V47, P7048, DOI 10.1002/anie.200802439; Shaw SA, 2003, J AM CHEM SOC, V125, P13368, DOI 10.1021/ja037223k; Mroczek A, 2010, TETRAHEDRON-ASYMMETR, V21, P1921; Hodous BL, 2002, J AM CHEM SOC, V124, P10006, DOI 10.1021/ja027466x; Kim J, 2009, SCIENCE, V324, P238, DOI 10.1126/science.1170777; Pin F, 2011, TETRAHEDRON, V67, P5564, DOI 10.1016/j.tet.2011.05.120; Riant O, 1997, J ORG CHEM, V62, P6733, DOI 10.1021/jo970075u; Spivey AC, 2004, ANGEW CHEM INT EDIT, V43, P5436, DOI 10.1002/anie.200460373; Lee SY, 2012, J AM CHEM SOC, V134, P15149, DOI 10.1021/ja307425g; Garber SB, 2000, J AM CHEM SOC, V122, P8168, DOI 10.1021/ja001179g; RIANT O, 1993, J AM CHEM SOC, V115, P5835, DOI 10.1021/ja00066a066; van Otterlo WAL, 2009, CHEM REV, V109, P3743, DOI 10.1021/cr900178p; Dochnahl M, 2009, ANGEW CHEM INT EDIT, V48, P2391, DOI 10.1002/anie.200805805; Yoshida K, 2011, ORG LETT, V13, P4762, DOI 10.1021/ol201510u; Takahashi H, 2009, J ORG CHEM, V74, P3632, DOI 10.1021/jo900456g; Hoveyda AH, 2004, ORG BIOMOL CHEM, V2, P8, DOI 10.1039/b311496c; Kawabata T, 2007, J AM CHEM SOC, V129, P12890, DOI 10.1021/ja074882e; Wurz RP, 2007, CHEM REV, V107, P5570, DOI 10.1021/cr068370e; HIRAKI K, 1994, ORGANOMETALLICS, V13, P1878, DOI 10.1021/om00017a051; Vedejs E, 1996, J AM CHEM SOC, V118, P1809, DOI 10.1021/ja953631f; Verniest G, 2010, TETRAHEDRON, V66, P1496, DOI 10.1016/j.tet.2009.10.033; Francais A, 2010, ORG LETT, V12, P340, DOI 10.1021/ol902676t; Tao BT, 1999, J AM CHEM SOC, V121, P5091, DOI 10.1021/ja9906958; SCRIVEN EFV, 1983, CHEM SOC REV, V12, P129, DOI 10.1039/cs9831200129; Yamada S, 2005, TETRAHEDRON LETT, V46, P2239, DOI 10.1016/j.tetlet.2005.02.019; Yoshida K, 2009, ORG LETT, V11, P515, DOI 10.1021/ol8023117; Ogasawara M, 2006, ORGANOMETALLICS, V25, P5201, DOI 10.1021/om0608298; Mittal N, 2012, ORG LETT, V14, P3084, DOI 10.1021/ol301155b; Hodous BL, 2002, J AM CHEM SOC, V124, P1578, DOI 10.1021/ja012427r; Ruble JC, 1997, J AM CHEM SOC, V119, P1492, DOI 10.1021/ja963835b; Biscoe MR, 2008, J AM CHEM SOC, V130, P6686, DOI 10.1021/ja801137k; Ruble JC, 1996, J ORG CHEM, V61, P7230, DOI 10.1021/jo961433g; Wilson JE, 2004, ANGEW CHEM INT EDIT, V43, P6358, DOI 10.1002/anie.200460698; Arae S, 2015, ORGANOMETALLICS, V34, P1197, DOI 10.1021/om5011484; Bellemin-Laponnaz S, 2000, CHEM COMMUN, P1009, DOI 10.1039/b002041i; Berry D. J., 2001, ARKIVOC, Vi, P201; Chen YH, 2006, J AM CHEM SOC, V128, P4568, DOI 10.1021/ja061082f; Dai X, 2007, ANGEW CHEM INT EDIT, V46, P4367, DOI 10.1002/anie.200700697; Dálaigh Ciarán O, 2007, J Org Chem, V72, P7066; Donohoe TJ, 2006, ANGEW CHEM INT EDIT, V45, P2664, DOI 10.1002/anie.200503512; Fu GC, 2000, ACCOUNTS CHEM RES, V33, P412, DOI 10.1021/ar990077w; Fu GC, 2004, ACCOUNTS CHEM RES, V37, P542, DOI 10.1021/ar030051b; Furuta T., 2012, SCI SYNTHESIS ASYMME, V1, P497; Geisler F.M., 2006, SYNTHESIS-STUTTGART, P2201; Grondal C, 2003, SYNLETT, P1568, DOI 10.1055/s-2003-40867; Kagan H. B., 1988, TOP STEREOCHEM, V18, P249, DOI 10.1002/9780470147276.ch4; Korinek M, 2009, SYNTHESIS-STUTTGART, P1291, DOI 10.1055/s-0028-1088036; Kotsuki H, 2000, SYNLETT, P116; Mamane V, 2010, TETRAHEDRON-ASYMMETR, V21, P1019, DOI 10.1016/j.tetasy.2010.03.012; Marion N., 2010, CHIRAL FERROCENES AS, P307; Ogasawara M, 2002, J AM CHEM SOC, V124, P9068, DOI 10.1021/ja026401r; Ogasawara M, 2003, ORGANOMETALLICS, V22, P1174, DOI 10.1021/om021058k; Ogasawara M, 2002, J AM CHEM SOC, V124, P12626, DOI 10.1021/ja028166i; Ogasawara M, 2013, ORGANOMETALLICS, V32, P6593, DOI 10.1021/om400936b; Ogasawara M, 2013, CHEM-EUR J, V19, P4151, DOI 10.1002/chem.201300116; Ruble JC, 1998, J AM CHEM SOC, V120, P11532, DOI 10.1021/ja982890c; Schaefer C, 2005, ANGEW CHEM INT EDIT, V44, P4606, DOI 10.1002/anie.200501434; Spivey AC, 1998, TETRAHEDRON LETT, V39, P8919, DOI 10.1016/S0040-4039(98)01951-0; Spivey AC, 2004, TETRAHEDRON, V60, P4513, DOI 10.1016/j.tet.2004.01.098; TAMANO M, 1988, NIPPON KAGAKU KAISHI, P1977; Tandon R, 2013, EUR J ORG CHEM, V2013, P5423, DOI 10.1002/ejoc.201300486; Wiskur SL, 2005, J AM CHEM SOC, V127, P6176, DOI 10.1021/ja0506152; Wolfle H, 2006, J ORGANOMET CHEM, V691, P1197, DOI 10.1016/j.jorganchem.2005.11.051; Wurz RP, 2007, ADV SYNTH CATAL, V349, P2345, DOI 10.1002/adsc.200700219; Yoshida K, 2013, TRANSITION-METAL-MEDIATED AROMATIC RING CONSTRUCTION, P721; Yoshida K, 2008, CHEM-EUR J, V14, P8246, DOI 10.1002/chem.200800484; Yoshida K, 2005, J AM CHEM SOC, V127, P10470, DOI 10.1021/ja050853x	72	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1523-7060	1523-7052		ORG LETT	Org. Lett.	MAY 1	2015	17	9					2286	2289		10.1021/acs.orglett.5b01044		4	Chemistry, Organic	Chemistry	CH4LG	WOS:000354004400063		
J	Arai, YCP; Nishihara, M; Yamamoto, Y; Arakawa, M; Kondo, M; Suzuki, C; Kinoshita, A; Kambara, K; Ikemoto, T				Arai, Young-Chang P.; Nishihara, Makoto; Yamamoto, Yoshihiro; Arakawa, Maki; Kondo, Miki; Suzuki, Chiharu; Kinoshita, Akiko; Kambara, Kazuyo; Ikemoto, Tatsunori			Dorsal Root Ganglion Pulsed Radiofrequency for the Management of Intractable Vertebral Metastatic Pain: A Case Series	PAIN MEDICINE			English	Article						Metastatic Bone Pain; Pulsed Radiofrequency; Dorsal Root Ganglion Block	BONE METASTASES; RAT; SURVIVAL; PLEXUS; CANCER; RELIEF	ObjectiveMetastatic bone pain is characteristic of cancer pain and is a form of refractory cancer pain, as the pain includes not only nociceptive but also neuropathic pain. Although some drugs are effective in the management of painful bone metastases, pain while moving is one of the most refractory forms of pain. Although pulsed radiofrequency (RF) dramatically reduces neuropathic pain, chronic pain, and vertebral metastatic pain, the number of cases reported in these studies was very small (five or less). DesignCase report. SettingSingle pain center. PatientsFifteen patients suffering from intractable vertebral metastatic pain. InterventionsDorsal root ganglion (DRG) pulsed RF. Outcome MeasuresA numerical rating scale (NRS) of pain at rest and while moving. ResultsAlmost all patients experienced sound pain relief after the pulsed RF treatment. There were no severe side effects reported. ConclusionDRG pulsed RF procedure provided sound pain relief for patients with intractable vertebral metastatic pain. Metastatic bone pain is characteristic of cancer pain and is a form of refractory cancer pain, as the pain includes not only nociceptive but also neuropathic pain. Although some drugs are effective in the management of painful bone metastases, pain while moving is one of the most refractory forms of pain. DRG pulsed RF procedure provided sound pain relief for patients with intractable vertebral metastatic pain.	[Arai, Young-Chang P.; Nishihara, Makoto; Yamamoto, Yoshihiro; Arakawa, Maki; Kondo, Miki; Suzuki, Chiharu; Kinoshita, Akiko; Kambara, Kazuyo; Ikemoto, Tatsunori] Aichi Med Univ, Ctr Multidisciplinary Pain, Sch Med, Nagakute, Aichi 4801195, Japan	Arai, YCP (reprint author), Aichi Med Univ, Ctr Multidisciplinary Pain, Sch Med, 21 Karimata, Nagakute, Aichi 4801195, Japan.	arainon@aichi-med-u.ac.jp					Van Zundert J, 2005, ANESTHESIOLOGY, V102, P125, DOI 10.1097/00000542-200501000-00021; Vallejo R, 2013, PAIN PHYSICIAN, V16, pE601; Sandkuhler J, 1997, J NEUROSCI, V17, P6483; Wong GY, 2004, JAMA-J AM MED ASSOC, V291, P1092, DOI 10.1001/jama.291.9.1092; Zeldin A, 2008, PAIN PHYSICIAN, V11, P921; Hagiwara S, 2009, EUR J PAIN, V13, P249, DOI 10.1016/j.ejpain.2008.04.013; Cahana A, 2003, J PAIN, V4, P197, DOI 10.1016/S1526-5900(03)00554-6; Arai YCP, 2013, J ANESTH, V27, P298, DOI 10.1007/s00540-012-1501-8; HANKS GW, 1985, J ROY SOC MED, V78, P26; Munglani R, 1999, PAIN, V80, P437, DOI 10.1016/S0304-3959(98)00183-3; Nishihara M, 2013, PAIN PHYSICIAN, V16, pE547; Racz G B, 2006, Pain Pract, V6, P46, DOI 10.1111/j.1533-2500.2006.00058.x; Rhame EE, 2009, PAIN PHYSICIAN, V12, P633; Schneider G, 2012, BREAST CARE, V7, P113, DOI 10.1159/000338579; Selvaggi K, 2006, NAT CLIN PRACT ONCOL, V3, P458, DOI 10.1038/ncponc0561; vansBoxem K, 2008, PAIN PRACT, V8, P385	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1526-2375	1526-4637		PAIN MED	Pain Med.	MAY	2015	16	5					1007	1012		10.1111/pme.12629		6	Medicine, General & Internal	General & Internal Medicine	CI4SC	WOS:000354742300019		
J	Yasudo, H; Ando, T; Hiwatari, M; Oka, A				Yasudo, Hiroki; Ando, Tomoaki; Hiwatari, Mitsuteru; Oka, Akira			Suplatast Tosilate for Treating Cutaneous Mastocytosis	PEDIATRIC DERMATOLOGY			English	Article							SUPPRESSION	Pediatric cutaneous mastocytosis is a rare disease caused by mast cell hyperplasia. We report the case of an infant diagnosed as cutaneous mastocytosis and seasonal allergies. The wheals, flushing, and pruritus of the mastocytosis were unresponsive to combination therapy with an antihistamine, a mast cell stabilizer (sodium cromoglycate), and a leukotriene antagonist. Addition of suplatast tosilate as a treatment for the seasonal allergy also dramatically improved his cutaneous symptoms and signs. Further trials of suplatast tosilate in selected cases of cutaneous mastocytosis are warranted.	[Yasudo, Hiroki; Ando, Tomoaki; Hiwatari, Mitsuteru; Oka, Akira] Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo, Japan; [Ando, Tomoaki] RIKEN Ctr Integrat Med Sci, Lab Allerg Dis, Yokohama, Kanagawa, Japan	Yasudo, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Pediat, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan.	yasudo-tky@umin.ac.jp					Shahriar M, 2009, J IMMUNOL, V183, P2133, DOI 10.4049/jimmunol.0901058; Frieri M, 2013, PEDIAT ALLER IMM PUL, V26, P175, DOI 10.1089/ped.2013.0275; Furukido K, 2002, AM J RHINOL, V16, P329; Kimata H, 1999, ANN ALLERG ASTHMA IM, V82, P293, DOI 10.1016/S1081-1206(10)62611-7; Turner Paul J, 2012, Pediatr Dermatol, V29, P222, DOI 10.1111/j.1525-1470.2011.01576.x	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0736-8046	1525-1470		PEDIATR DERMATOL	Pediatr. Dermatol.	MAY-JUN	2015	32	3					E118	E119		10.1111/pde.12552		2	Dermatology; Pediatrics	Dermatology; Pediatrics	CI5ST	WOS:000354820500018		
J	Tagaya, M; Matsuda, M; Yakehiro, M; Izutani, H				Tagaya, M.; Matsuda, M.; Yakehiro, M.; Izutani, H.			Features of an alternative hemodialysis method using a hemoconcentrator during cardiopulmonary bypass surgeries	PERFUSION-UK			English	Article						cardiopulmonary bypass; extracorporeal circulation; electrolyte imbalance; hemoconcentrator; dialysis	OPEN-HEART-SURGERY; CARDIAC-SURGERY; ELECTROLYTE DISORDERS; POTASSIUM; ARREST; HYPERKALEMIA; OPERATIONS; PROSPECTS	Purpose: This study clarified the features of a hemoconcentrator-based, alternative hemodialysis (ALTHD) method that improves the speed of serum potassium (K+) concentration adjustments, compared with dilutional ultrafiltration (DUF), during cardiopulmonary bypasses. Methods: Standardized bovine blood was recirculated (300 ml/min) through an in vitro hemoconcentrator circuit; hematocrit, K+ and glucose levels were measured at 5-20 min after DUF or ALTHD. We evaluated DUF at dialysis speeds of 50-250 ml/min and ALTHD at speeds of 50-1000 ml/min. Results: ALTHD rapidly corrected K+ and glucose concentrations at speeds up to 800 ml/min. ALTHD took 8.9 min to reach a K+ level of 4.5 mmol/L, faster than DUF (12.8 min). The ALTHD efficiency curves plateaued at 600 ml/min. Conclusion: ALTHD allowed faster adjustment of electrolyte levels, with peak efficiency at 600 ml/min. ALTHD has possible clinical application if available for potential use during all cardiopulmonary bypass surgeries involving extracorporeal circulation.	[Tagaya, M.] Natl Hosp Org, Kure Med Ctr, Dept Med Engn, Hiroshima 7370023, Japan; [Tagaya, M.; Matsuda, M.] Chugoku Canc Ctr, Hiroshima 7370023, Japan; [Tagaya, M.] Ehime Univ Hosp, Clin Engn Ctr, Toon, Ehime, Japan; [Tagaya, M.; Yakehiro, M.] Hiroshima Int Univ, Div Physiol, Hiroshima, Japan; [Matsuda, M.] Natl Hosp Org, Kure Med Ctr, Dept Internal Med, Hiroshima 7370023, Japan; [Izutani, H.] Ehime Univ, Grad Sch Med, Dept Cardiovasc & Thorac Surg, Matsuyama, Ehime 790, Japan	Tagaya, M (reprint author), Natl Hosp Org, Kure Med Ctr, Dept Med Engn, 3-1 Aoyamachou, Hiroshima 7370023, Japan.	tagayam@kure-nh.go.jp					Toraman F, 2004, PERFUSION-UK, V19, P85, DOI 10.1191/0267659104pf723oa; El-Sherif N, 2011, CARDIOL J, V18, P233; CROSBIE WA, 1972, BRIT MED J, V4, P388; Nissinen J, 2009, PERFUSION-UK, V24, P297, DOI 10.1177/0267659109354656; Seghaye MC, 1996, J THORAC CARDIOV SUR, V112, P687, DOI 10.1016/S0022-5223(96)70053-3; KIRKLIN JK, 1991, ANN THORAC SURG, V51, P529; BETHUNE DW, 1978, LANCET, V2, P380; de Betue CTI, 2012, CRIT CARE, V16, DOI 10.1186/cc11658; Flameng WJ, 1996, ANN THORAC SURG, V61, P621, DOI 10.1016/0003-4975(95)00970-1; Fukumoto A, 2006, J CARDIAC SURG, V21, P553, DOI 10.1111/j.1540-8191.2006.00295.x; Fukumura Fumio, 2004, J Artif Organs, V7, P9, DOI 10.1007/s10047-003-0241-9; ILSON BE, 1992, NEPHRON, V61, P170, DOI 10.1159/000186866; Ivens D, 1996, J CARDIOTHOR VASC AN, V10, P258, DOI 10.1016/S1053-0770(96)80250-3; Khoo MSC, 2003, AM J KIDNEY DIS, V41, P1247, DOI 10.1016/S0272-6386(03)00369-X; KOPMAN EA, 1980, ANESTH ANALG, V59, P69; LIM M, 1983, LANCET, V1, P241; Miyahara Ken, 2004, Interact Cardiovasc Thorac Surg, V3, P148, DOI 10.1016/S1569-9293(03)00261-5; OHQVIST G, 1981, SCAND J THORAC CARD, V15, P251, DOI 10.3109/14017438109100582; Polderman KH, 2004, CRIT CARE, V8, pR459, DOI 10.1186/cc2973; Ramanathan T, 2008, J CARDIAC SURG, V23, P611, DOI 10.1111/j.1540-8191.2008.00680.x; Tagaya M, 2014, PERFUSION-UK, V29, P117, DOI 10.1177/0267659113502831; Verrier ED, 1998, ANN THORAC SURG, V66, pS17, DOI 10.1016/S0003-4975(98)00965-5; Verrier ED, 1998, ANN THORAC SURG, V66, pS25	23	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0267-6591	1477-111X		PERFUSION-UK	Perfusion-UK	MAY	2015	30	4					318	322		10.1177/0267659114547378		5	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CH4DE	WOS:000353981100010		
J	Sasakura, D; Nakayama, K; Sakamoto, T; Chikuma, T				Sasakura, D.; Nakayama, K.; Sakamoto, T.; Chikuma, T.			Strategic development of a multivariate calibration model for the uniformity testing of tablets by transmission NIR analysis	PHARMAZIE			English	Article							PHARMACEUTICAL-PREPARATION; REFLECTANCE SPECTROSCOPY; VALIDATION	The use of transmission near infrared spectroscopy (TNIRS) is of particular interest in the pharmaceutical industry. This is because TNIRS does not require sample preparation and can analyze several tens of tablet samples in an hour. It has the capability to measure all relevant information from a tablet, while still on the production line. However, TNIRS has a narrow spectrum range and overtone vibrations often overlap. To perform content uniformity testing in tablets by TNIRS, various properties in the tableting process need to be analyzed by a multivariate prediction model, such as a Partial Least Square Regression modeling. One issue is that typical approaches require several hundred reference samples to act as the basis of the method rather than a strategically designed method. This means that many batches are needed to prepare the reference samples; this requires time and is not cost effective. Our group investigated the concentration dependence of the calibration model with a strategic design. Consequently, we developed a more effective approach to the TNIRS calibration model than the existing methodology.	[Sasakura, D.; Chikuma, T.] Showa Pharmaceut Univ, Dept Analyt Chem Med, Machida, Tokyo 1948543, Japan; [Nakayama, K.] Towa Pharmaceut Co Ltd, Div Formulat Sci, Machida, Tokyo 1948543, Japan; [Sakamoto, T.] Natl Inst Hlth Sci, Div Drugs, Tokyo, Japan	Sasakura, D (reprint author), Showa Pharmaceut Univ, Dept Analyt Chem Med, 3-3165 Higashi Tamagawagakuen, Machida, Tokyo 1948543, Japan.	saru_dai@hotmail.com					Blanco M, 1997, APPL SPECTROSC, V51, P240, DOI 10.1366/0003702971939947; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Blanco M, 2000, FRESEN J ANAL CHEM, V368, P534, DOI 10.1007/s002160000506; Blanco M, 1999, ANALYST, V124, P1089, DOI 10.1039/a901774g; Broad NW, 2001, ANALYST, V126, P2207, DOI 10.1039/b106741a; Carlos PM, 2006, AAPS PHARMSCITECH, V7, pE206; Gottfries J, 1996, J PHARMACEUT BIOMED, V14, P1495, DOI 10.1016/0731-7085(96)01800-6; Kemper MS, 2002, AAPS PHARMSCI, V3, pE23; Romanach RJ, 2003, AM PHARM ANAL, V11, P1227; Sigrid P, 2013, ANAL CHIM ACTA, V761, P62; United States Pharmacopeial Convention, 2005, 28NF19 USP	11	0	0	GOVI-VERLAG  PHARMAZEUTISCHER VERLAG GMBH	ESCHBORN	PHARMAZEUTISCCARL MANNICH STR 26, D-65760 ESCHBORN, GERMANY	0031-7144			PHARMAZIE	Pharmazie	MAY	2015	70	5					289	295		10.1691/ph.2015.4161		7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CI8KI	WOS:000355020800003		
J	Furuishi, T; Ishigami, T; Endo, T; Nagase, H; Okada, M; Nishiyama, I; Jo, A; Terao, K; Ueda, H				Furuishi, T.; Ishigami, T.; Endo, T.; Nagase, H.; Okada, M.; Nishiyama, I.; Jo, A.; Terao, K.; Ueda, H.			Effect of gamma-cyclodextrin as a lyoprotectant for freeze-dried actinidin	PHARMAZIE			English	Article							HYDROXYPROPYL-BETA-CYCLODEXTRIN; PROTEIN PHARMACEUTICALS; TREHALOSE; LYOPHILIZATION; STABILIZATION; PRESERVATION; AGGREGATION; CHINENSIS; ANTIBODY; SUCROSE	Actinidin (ATD) is a cysteine protease found in kiwifruit. It is used to tenderize meat and to enhance the digestion of proteins in the small intestine. However, ATD is unstable during freeze-drying, which alters its bioactivity. It is well known that sugars have the ability to protect proteins from the stress of freeze-drying. In this study, we investigated the protective effect of various saccharides on the stability of ATD during freeze-drying. The ATD activities of the samples containing gamma-cyclodextrin (CyD) showed only a small decrease, and compared with trehalose and sucrose, gamma-CyD was a more effective stabilizer for AID. Secondary structural changes in freeze-dried AID were observed by circular dichroism spectroscopy and compared with the changes in stabilized samples. There was a close relationship between the alpha-helix content and the stabilization. The sugars stabilized the protein by suppressing the changes in the alpha-helix. Fourier transform infrared spectroscopy measurement showed that the amide I band of AID with gamma-CyD was shifted to a lower wavenumber compared with other sugars. Therefore, stronger hydrogen bonds may be formed between ATD and gamma-CyD than between ATD and other sugars. The suppression of changes in the protein secondary structure accompanying the formation of hydrogen bonding between the protein and the sugar also contributed to the protective effect of the sugars.	[Furuishi, T.; Ishigami, T.; Endo, T.; Nagase, H.] Hoshi Univ, Fac Pharmaceut Sci, Dept Phys Chem, Tokyo 1428501, Japan; [Okada, M.; Nishiyama, I.] Komazawa Womens Coll, Fac Human Hlth, Dept Hlth & Nutr Sci, Tokyo, Japan; [Jo, A.; Terao, K.] CycloChem Co Ltd, Kobe, Hyogo, Japan; [Ueda, H.] Nihon Pharmaceut Univ, Dept Pharmaceut Sci, Saitama, Japan	Furuishi, T (reprint author), Hoshi Univ, Fac Pharmaceut Sci, Dept Phys Chem, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan.	t-furuishi@hoshi.ac.jp			Strategic Research Foundation from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); MEXT in Japan [25870795]	This work was supported in part by a grant from the Strategic Research Foundation Grant-aided Project for Private Universities, matching fund subsidy from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) 2008-2012, and part of Grant-in-Aid for Young Scientists (B) 25870795 from MEXT 2013-2014 in Japan (to T.F.). Also, Mr. Mitsugu Kokubo and Ms. Yu Yasujima are acknowledged for their assistance in conducting the experiments.	Wang W, 2000, INT J PHARM, V203, P1, DOI 10.1016/S0378-5173(00)00423-3; Aachmann FL, 2012, J INCL PHENOM MACRO, V73, P349, DOI 10.1007/s10847-011-0071-y; Brewster ME, 2007, ADV DRUG DELIVER REV, V59, P645, DOI 10.1016/j.addr.2007.05.012; GREEN JL, 1989, J PHYS CHEM-US, V93, P2880, DOI 10.1021/j100345a006; Koushik KN, 2001, PHARM DEV TECHNOL, V6, P595, DOI 10.1081/PDT-120000297; CROWE JH, 1983, ARCH BIOCHEM BIOPHYS, V220, P477, DOI 10.1016/0003-9861(83)90438-1; Chang LQ, 2005, J PHARM SCI-US, V94, P1427, DOI 10.1002/jps.20364; CARPENTER JF, 1989, BIOCHEMISTRY-US, V28, P3916, DOI 10.1021/bi00435a044; Tavornvipas S, 2006, J PHARM SCI-US, V95, P2722, DOI 10.1002/jps.20715; Batta G, 1999, CARBOHYD RES, V320, P267, DOI 10.1016/S0008-6215(99)00183-4; Chang LQ, 2009, J PHARM SCI-US, V98, P2886, DOI 10.1002/jps.21825; PRESTRELSKI SJ, 1995, PHARMACEUT RES, V12, P1250, DOI 10.1023/A:1016296801447; Serno T, 2010, J PHARM SCI-US, V99, P1193, DOI 10.1002/jps.21931; BREWSTER ME, 1991, PHARMACEUT RES, V8, P792, DOI 10.1023/A:1015870521744; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Abdul-Fattah AM, 2007, J PHARM SCI-US, V96, P1886, DOI 10.1002/jps.20842; ARCUS AC, 1959, BIOCHIM BIOPHYS ACTA, V33, P242, DOI 10.1016/0006-3002(59)90522-0; BAKER EN, 1980, J MOL BIOL, V141, P441, DOI 10.1016/0022-2836(80)90255-7; Ballone P, 2000, J PHYS CHEM B, V104, P6313, DOI 10.1021/jp00143b; BROCKLEHURST K, 1981, BIOCHEM J, V197, P739; CROWE JH, 1990, CRYOBIOLOGY, V27, P219, DOI 10.1016/0011-2240(90)90023-W; HORSKY J, 1994, J INCLUS PHENOM MOL, V18, P291, DOI 10.1007/BF00708735; Iwai J, 2007, J PHARM SCI-US, V96, P3140, DOI 10.1002/jps.20847; Kaur L, 2010, J AGR FOOD CHEM, V58, P5074, DOI 10.1021/jf903835g; Khajehpour M, 2004, PROTEINS, V55, P275, DOI 10.1002/prot.20036; LEWIS DA, 1988, J FOOD BIOCHEM, V12, P147, DOI 10.1111/j.1745-4514.1988.tb00368.x; Nohno K, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/1/017107; PRAEKELT UM, 1988, PLANT MOL BIOL, V10, P193, DOI 10.1007/BF00027396; RESSING ME, 1992, PHARMACEUT RES, V9, P266, DOI 10.1023/A:1018905927544; Trinadha C, 1992, Carbohydr Res, V223, P99, DOI 10.1016/0008-6215(92)80009-P	30	0	0	GOVI-VERLAG  PHARMAZEUTISCHER VERLAG GMBH	ESCHBORN	PHARMAZEUTISCCARL MANNICH STR 26, D-65760 ESCHBORN, GERMANY	0031-7144			PHARMAZIE	Pharmazie	MAY	2015	70	5					296	299		10.1691/ph.2015.4145		4	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CI8KI	WOS:000355020800004		
J	Yasuda, T; Hayashi, K; Katsuno, S; Takeuchi, T; Kamiyama, S; Iwaya, M; Akasaki, I; Amano, H				Yasuda, Toshiki; Hayashi, Kento; Katsuno, Syouta; Takeuchi, Tetsuya; Kamiyama, Satoshi; Iwaya, Motoaki; Akasaki, Isamu; Amano, Hiroshi			Polarization dilution in a Ga-polar UV-LED to reduce the influence of polarization charges	PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE			English	Article						AlGaN; light-emitting diodes; polarization	CHEMICAL-VAPOR-DEPOSITION; HETEROSTRUCTURES	We investigated the influence of polarization charges in nitride-based semiconductors. The influence due to polarization charges was calculated excluding the influences of the band offset. We found that the polarization charges (1x10(13)cm(-2)) resulted in an energy spike of more than 100meV at the location of the charges, which is a similar value to the band offset. We then proposed the concept of polarization dilution to suppress the energy spike for better hole transport by using a graded Mg-doped AlGaN layer in UV-LEDs. Device simulation results indicate lower operating voltage and higher injection efficiency by using the polarization dilution. So far, our actual 350nm LED with the polarization dilution showed lower operating voltage. These results suggested such polarization-charge management is important in the design of the nitride semiconductors.	[Yasuda, Toshiki; Hayashi, Kento; Katsuno, Syouta; Takeuchi, Tetsuya; Kamiyama, Satoshi; Iwaya, Motoaki; Akasaki, Isamu] Meijo Univ, Fac Sci & Technol, Nagoya, Aichi 4688502, Japan; [Akasaki, Isamu; Amano, Hiroshi] Nagoya Univ, Akasaki Res Ctr, Nagoya, Aichi 4648062, Japan; [Amano, Hiroshi] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648062, Japan	Yasuda, T (reprint author), Meijo Univ, Fac Sci & Technol, Nagoya, Aichi 4688502, Japan.	143441506@ccalumni.meijo-u.ac.jp			MEXT [25000011, 26286045]; Nippon Sheet Glass Foundation for Materials Science and Engineering; Asahi Glass Foundation	This study was supported by MEXT-Grants-in-Aid for Scientific Research Specially Promoted Research (#25000011), Grant-in-Aid for Scientific Research (B) (#26286045), Nippon Sheet Glass Foundation for Materials Science and Engineering, and The Asahi Glass Foundation.	Amano H, 2009, P SOC PHOTO-OPT INS, V7216, DOI 10.1117/12.808381; Taniyasu Y, 2006, NATURE, V441, P325, DOI 10.1038/nature04760; Gotz W, 1996, APPL PHYS LETT, V68, P667; KHAN MA, 1991, APPL PHYS LETT, V58, P2408, DOI 10.1063/1.104886; Morita D, 2004, JPN J APPL PHYS 1, V43, P5945, DOI 10.1143/JJAP.43.5945; Hirayama H, 2009, PHYS STATUS SOLIDI A, V206, P1176, DOI 10.1002/pssa.200880961; Simon J, 2010, SCIENCE, V327, P60, DOI 10.1126/science.1183226; Takeuchi T, 1997, JPN J APPL PHYS 2, V36, pL382, DOI 10.1143/JJAP.36.L382; Verma J, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3656707; Bernardini F, 1997, PHYS REV B, V56, P10024; Jena D, 2002, APPL PHYS LETT, V81, P4395, DOI 10.1063/1.1526161; Shatalov M., 2011, APEX, V5; Yasuda T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.08JJ05	13	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-6300	1862-6319		PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Mat.	MAY	2015	212	5			SI		920	924		10.1002/pssa.201431730		5	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CI0DB	WOS:000354405000005		
J	Ohya, M; Naniwae, K; Kondo, T; Suzuki, A; Mori, M; Kitano, T; Usui, A; Kamiyama, S				Ohya, Masaki; Naniwae, Koichi; Kondo, Toshiyuki; Suzuki, Atsushi; Mori, Midori; Kitano, Tsukasa; Usui, Akane; Kamiyama, Satoshi			Improvement of vertical light extraction from GaN-based LEDs on moth-eye patterned sapphire substrates	PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE			English	Article						GaN; light emitting diodes; light extraction; patterning; sapphire; substrates	EMITTING-DIODES; OUTPUT POWER	A newly developed moth-eye patterned sapphire substrate (MPSS) technology increased light extraction efficiency (LEE) in the vertical direction in nitride-based blue light emitting diodes (LEDs). MPSS is characterized by a submicron-scale periodical structure that exerts the Bragg diffraction effect at the interface between gallium nitride (GaN) and sapphire. Through simulations and experiments, it was revealed that emphasis of the diffraction effect by optimizing the MPSS structure enhanced vertical emission from LEDs. As a result, resin-encapsulated, large-sized LEDs on MPSS with a large diffraction effect achieved a high LEE of 0.76 that was comparable to that of commercially available thin-film LEDs. Bird's-eye view of scanning electron microscope (SEM) image of MPSS.	[Ohya, Masaki; Naniwae, Koichi; Kondo, Toshiyuki; Suzuki, Atsushi; Mori, Midori; Kitano, Tsukasa; Usui, Akane; Kamiyama, Satoshi] Meijo Univ, EL Seed Corp, Tenpaku Ku, Nagoya, Aichi 4680073, Japan; [Kamiyama, Satoshi] Meijo Univ, Fac Sci & Technol, Tenpaku Ku, Nagoya, Aichi 4688502, Japan	Ohya, M (reprint author), Meijo Univ, EL Seed Corp, Tenpaku Ku, Innovative Sci & Technol Bldg 2F, Nagoya, Aichi 4680073, Japan.	masaki_ohya@elseed.com			New Energy and Industrial Technology Development Organization (NEDO) in Japan	The authors thank Prof. Akasaki, Prof. Takeuchi, and Prof. Iwaya for their support and encouragement. This work was supported by the New Energy and Industrial Technology Development Organization (NEDO) in Japan.	Tadatomo K, 2001, JPN J APPL PHYS 2, V40, pL583, DOI 10.1143/JJAP.40.L583; Li XH, 2013, J DISP TECHNOL, V9, P324, DOI 10.1109/JDT.2013.2246541; Wuu DS, 2005, IEEE PHOTONIC TECH L, V17, P288, DOI 10.1109/LPT.2004.839012; Wiesmann C, 2009, LASER PHOTONICS REV, V3, P262, DOI 10.1002/lpor.200810053; Li YF, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3579255; Wierer JJ, 2004, APPL PHYS LETT, V84, P3885, DOI 10.1063/1.1738934; Su YK, 2008, JPN J APPL PHYS, V47, P6706, DOI 10.1143/JJAP.47.6706; McGroddy K, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2978068; Chiu CH, 2009, OPT EXPRESS, V17, P21250, DOI 10.1364/OE.17.021250; Chan CH, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3173817; Kim H., 2012, P 16 INT C MET ORG V; Kondo T, 2014, PHYS STATUS SOLIDI C, V11, P771, DOI 10.1002/pssc.201300492; Kondo T, 2010, PROC SPIE, V7602, DOI 10.1117/12.841518; Lee YJ, 2007, J DISP TECHNOL, V3, P118, DOI 10.1109/JDT.2007.894380; Naniwae K, 2013, PROC SPIE, V8641, DOI 10.1117/12.2002755; Ohya M., 2014, 2 C LED ITS IND APPL, P23; Shinagawa T., 2010, PHYS STATUS SOLIDI C, V7, P2615; Tsai CM, 2009, IEEE J SEL TOP QUANT, V15, P1275, DOI 10.1109/JSTQE.2009.2012505	18	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-6300	1862-6319		PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Mat.	MAY	2015	212	5			SI		935	940		10.1002/pssa.201431725		6	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CI0DB	WOS:000354405000008		
J	Hayashi, H; Fukushima, D; Tomimatsu, D; Noma, T; Konno, Y; Kishino, K				Hayashi, Hiroaki; Fukushima, Daishi; Tomimatsu, Daisuke; Noma, Tomohiro; Konno, Yuta; Kishino, Katsumi			Flip-chip bonding and fabrication of well-ordered nanocolumn arrays on sputter-deposited AlN/Si (111) substrate	PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE			English	Article						AlN; flip-chip bonding; nanocolumns; silicon; sputter deposition; substrates	LIGHT-EMITTING-DIODES; MOLECULAR-BEAM EPITAXY; LASER LIFT-OFF; INTERMEDIATE LAYER; SI SUBSTRATE; GAN; GROWTH; SURFACE; GREEN	Employing a thin AlN film sputter-deposited on Si substrates, well-ordered GaN nanocolumn arrays were demonstrated by RF-plasma-assisted molecular-beam-epitaxy selective-area growth. Dislocation-free crystals were grown even on this cost-effective framework, which included high-density threading dislocations (>3x10(11)cm(-2)), by applying nanocolumn growth techniques. Single-peak PL spectra from integrated InGaN/GaN MQW were obtained in red region and the peak wavelength changed from 640 to 690nm with increasing nanocolumn diameter. This framework also contributes to a fabrication of vertical injection type flip-chip structure, even if a nanocolumn device. Damage-free wet-etching removal of Si substrates resulted in exposure of flip-chip well-ordered nanocolumns array. (a) TEM image of nanocolumns array on sputter-deposited thin AlN film/Si (111) substrate. (b) SEM image of flip-chip well-ordered nanocolumns array.	[Hayashi, Hiroaki; Fukushima, Daishi; Tomimatsu, Daisuke; Noma, Tomohiro; Konno, Yuta; Kishino, Katsumi] Sophia Univ, Chiyoda Ku, Tokyo 102, Japan; [Kishino, Katsumi] Sophia Nanotechnol Res Ctr, Chiyoda Ku, Tokyo, Japan	Hayashi, H (reprint author), Sophia Univ, Chiyoda Ku, 7-1 Kioi Cho, Tokyo 102, Japan.	h.hiroaki@sophia.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24000013]; New Energy and Industrial Technology Development Organization (NEDO)	This research was supported by a Grant-in-Aid for Specially Promoted Research (24000013) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and partly by the New Energy and Industrial Technology Development Organization (NEDO).	Kishino K, 2009, J CRYST GROWTH, V311, P2063, DOI 10.1016/j.jcrysgro.2008.11.056; Sekiguchi H, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.124002; Stach EA, 2000, APPL PHYS LETT, V77, P1819, DOI 10.1063/1.1309030; Huh C, 2003, J APPL PHYS, V93, P9383, DOI 10.1063/1.1571962; Ikeda N, 2010, P IEEE, V98, P1151, DOI 10.1109/JPROC.2009.2034397; Chu CF, 2003, JPN J APPL PHYS 2, V42, pL147, DOI 10.1143/JJAP.42.L147; Kishino K, 2008, ELECTRON LETT, V44, P819, DOI [10.1049/el:20081323, 10.1049/e1:20081323]; Funato M, 2006, JPN J APPL PHYS 2, V45, pL659, DOI 10.1143/JJAP.45.L659; Mukai T, 1999, JPN J APPL PHYS 1, V38, P3976, DOI 10.1143/JJAP.38.3976; Kawakami Y, 2010, J APPL PHYS, V107, DOI 10.1063/1.3280032; Dong YJ, 2009, NANO LETT, V9, P2183, DOI 10.1021/nl900858v; Kishino K, 2014, IEEE J QUANTUM ELECT, V50, P538, DOI 10.1109/JQE.2014.2325013; Han DS, 2006, IEEE PHOTONIC TECH L, V18, P1406, DOI 10.1109/LPT.2006.877565; Yoshizawa M, 1997, JPN J APPL PHYS 2, V36, pL459, DOI 10.1143/JJAP.36.L459; WATANABE A, 1993, J CRYST GROWTH, V128, P391, DOI 10.1016/0022-0248(93)90354-Y; Ramesh V, 2010, J APPL PHYS, V107, DOI 10.1063/1.3369434; Kishino K, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.012101; Chen WH, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2783134; Igawa Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.08JD09; Ishikawa H, 1999, JPN J APPL PHYS 2, V38, pL492, DOI 10.1143/JJAP.38.L492; Kawaguchi Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.08JC08; Sekiguchi H, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3443734; Vadivelu R, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.08JE18	23	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-6300	1862-6319		PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Mat.	MAY	2015	212	5			SI		992	996		10.1002/pssa.201431728		5	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CI0DB	WOS:000354405000016		
J	Kafar, A; Stanczyk, S; Wisniewski, P; Oto, T; Makarowa, I; Targowski, G; Suski, T; Perlin, P				Kafar, Anna; Stanczyk, Szymon; Wisniewski, Przemek; Oto, Takao; Makarowa, Irina; Targowski, Grzegorz; Suski, Tadek; Perlin, Piotr			Design and optimization of InGaN superluminescent diodes	PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE			English	Article						nitride semiconductors; superluminescent diodes; InGaN	OPTICAL COHERENCE TOMOGRAPHY; FACET; MODE	The design process of superluminescent diode has been discussed on the basis of nitride diodes with bend-waveguide geometry. The devices were fabricated by MOVPE technique on bulk GaN substrates and emitted light at the wavelength of around 420nm. The effectiveness of the cavity suppression design was confirmed by measurements of high-resolution emission spectra. Further optimization was carried out by appropriate selection of the angles of the waveguide bend and the chip length. Thus; we succeeded in fabrication of high optical power superluminescent diodes with slope efficiency fully comparable to that of laser diodes (greater than 0.9 W/A). Comparison of emission spectra of a superluminescent diode and a laser diode.	[Kafar, Anna; Stanczyk, Szymon; Suski, Tadek; Perlin, Piotr] Polish Acad Sci, Inst High Pressure Phys, PL-01142 Warsaw, Poland; [Wisniewski, Przemek; Makarowa, Irina; Targowski, Grzegorz; Perlin, Piotr] TopGaN Ltd, PL-01142 Warsaw, Poland; [Oto, Takao] Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6158510, Japan	Kafar, A (reprint author), Polish Acad Sci, Inst High Pressure Phys, Sokolowska 29-37, PL-01142 Warsaw, Poland.	ak@unipress.waw.pl			Wroclaw Research Centre EIT+ within the project "The Application of Nanotechnology in Advanced Materials" - NanoMat [POIG.01.01.02-02-002/08]; European Regional Development Fund (operational Programme Innovative Economy) [1.1.2]	The work was supported by Wroclaw Research Centre EIT+ within the project "The Application of Nanotechnology in Advanced Materials" - NanoMat (POIG.01.01.02-02-002/08) co-financed by the European Regional Development Fund (operational Programme Innovative Economy, 1.1.2).	Alphonse GA, 2002, P SOC PHOTO-OPT INS, V4648, P125, DOI 10.1117/12.462649; ALPHONSE GA, 1992, J LIGHTWAVE TECHNOL, V10, P215, DOI 10.1109/50.120577; Schmitt JM, 1999, IEEE J SEL TOP QUANT, V5, P1205, DOI 10.1109/2944.796348; Dwilinski R, 2008, J CRYST GROWTH, V310, P3911, DOI 10.1016/j.jcrysgro.2008.06.036; Tomlins PH, 2005, J PHYS D APPL PHYS, V38, P2519, DOI 10.1088/0022-3727/38/15/002; Ashley PR, 2002, P SOC PHOTO-OPT INS, V4648, P104, DOI 10.1117/12.462647; Feltin E, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3202786; Hardy MT, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.121004; Holc K, 2010, J APPL PHYS, V108, DOI 10.1063/1.3459876; Kafar A, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.092102; Kafar A, 2012, J APPL PHYS, V111, DOI 10.1063/1.4704147; Kopp F, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.082105; Kopp F., 2013, JPN J APPL PHYS, V52, p08JH; Kruglov R, 2012, IEEE PHOTONIC TECH L, V24, P167, DOI 10.1109/LPT.2011.2174631; KURBATOV LN, 1971, SOV PHYS SEMICOND+, V4, P1739; LEE TP, 1973, IEEE J QUANTUM ELECT, VQE 9, P820; MARCUSE D, 1989, J LIGHTWAVE TECHNOL, V7, P336, DOI 10.1109/50.17776; Niesten M, 2008, P SOC PHOTO-OPT INS, V7001, pE10, DOI 10.1117/12.783330; Ohno H., 2011, IEEE PHOT C, P505; Rossetti M, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.061002; Zeng C, 2014, CHINESE SCI BULL, V59, P1903, DOI 10.1007/s11434-014-0223-8	21	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-6300	1862-6319		PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Mat.	MAY	2015	212	5			SI		997	1004		10.1002/pssa.201431741		8	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CI0DB	WOS:000354405000017		
J	Kouno, T; Suzuki, S; Kishino, K; Sakai, M; Yamano, K; Yanagihara, A; Hara, K				Kouno, Tetsuya; Suzuki, Sho; Kishino, Katsumi; Sakai, Masaru; Yamano, Kouji; Yanagihara, Ai; Hara, Kazuhiko			Optical properties of arrays of hexagonal GaN microdisks acting as whispering-gallery-mode-type optical microcavities	PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE			English	Article						GaN; microdisks; optical microcavities; whispering-gallery modes		The optical properties of arrays of hexagonal GaN microdisks, which potentially act as whispering-gallery-mode-type optical microcavities, were investigated. The arrays were fabricated from a GaN film using a top-down process, and the side lengths and height of the hexagonal GaN microdisks were approximately 1.5 and 500nm, respectively. The microdisk arrays exhibited optically pumped lasing actions. The estimated lasing intensities which were obtained from one microdisk in the arrays were related to the period of the arrays. We discuss the optical properties of the microdisk arrays in view of experimental results and numerical analyses obtained using a two-dimensional finite-difference time-domain method.	[Kouno, Tetsuya; Suzuki, Sho; Hara, Kazuhiko] Shizuoka Univ, Dept Elect & Mat Sci, Hamamatsu, Shizuoka 4328011, Japan; [Kishino, Katsumi; Yamano, Kouji; Yanagihara, Ai] Sophia Univ, Dept Engn & Appl Sci, Chiyoda Ku, Tokyo 1028554, Japan; [Sakai, Masaru] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi 4008511, Japan	Kouno, T (reprint author), Shizuoka Univ, Dept Elect & Mat Sci, Hamamatsu, Shizuoka 4328011, Japan.	rtkouno@ipc.shizuoka.ac.jp			Program to Disseminate Tenure Tracking System, Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science [24000013]; Futaba Electronics Memorial Foundation	This study was supported by the Program to Disseminate Tenure Tracking System, Japan Science and Technology Agency (JST), a Grant-in-Aid for Specially Promoted Research (24000013) from Japan Society for the Promotion of Science, and Futaba Electronics Memorial Foundation.	Gargas DJ, 2010, ACS NANO, V4, P3270, DOI 10.1021/nn9018174; Armani DK, 2003, NATURE, V421, P925, DOI 10.1038/nature01371; Wang D, 2006, J APPL PHYS, V99, DOI 10.1063/1.2196148; Kouno T, 2011, IEEE J QUANTUM ELECT, V47, P1565, DOI 10.1109/JQE.2011.2175369; Ku JF, 2011, OPT LETT, V36, P2871, DOI 10.1364/OL.36.002871; Czekalla C, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2946660; Dai J, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3264080; Dai J, 2013, APL MATER, V1, DOI 10.1063/1.4820432; Francois A, 2013, OPT EXPRESS, V21, P22566, DOI 10.1364/OE.21.022566; Grundmann M, 2012, PHYS STATUS SOLIDI B, V249, P871, DOI 10.1002/pssb.201100159; Kosma K, 2013, OPT LETT, V38, P1301, DOI 10.1364/OL.38.001301; Kouno T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.072001; Kouno T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.068005; Liu JZ, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2952763; Tamboli AC, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3160550; Zhang YY, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4881183	16	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-6300	1862-6319		PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Mat.	MAY	2015	212	5			SI		1017	1020		10.1002/pssa.201431651		4	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CI0DB	WOS:000354405000020		
J	Ogita, T; Uetake, Y; Yamashita, Y; Kuramata, A; Yamakoshi, S; Ohkawa, K				Ogita, Taro; Uetake, Yusuke; Yamashita, Yoshihiro; Kuramata, Akito; Yamakoshi, Shigenobu; Ohkawa, Kazuhiro			InGaN photocatalysts on conductive Ga2O3 substrates	PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE			English	Article						Ga2O3; hydrogen; InGaN; photocatalysis; substrates	AQUEOUS WATER; HYDROGEN GAS; DECOMPOSITION; GENERATION; OXIDATION; GROWTH; VAPOR; H-2	We succeeded in hydrogen evolution using InGaN photocatalysts grown on conductive Ga2O3 substrates. These photocatalysts exhibited a conversion efficiency of 0.8% from incident light energy to stored H-2 chemical energy. Their quantum efficiency was determined to be more than 1% at 404nm by incident photon-to-current conversion efficiency (IPCE) measurement. We found that the wavelength response of the InGaN structure can be extended to the visible region. These results indicate that the conductive Ga2O3 substrates are suitable for the photocatalysts.	[Ogita, Taro; Uetake, Yusuke; Ohkawa, Kazuhiro] Tokyo Univ Sci, Dept Appl Phys, Tokyo 1258585, Japan; [Yamashita, Yoshihiro; Kuramata, Akito; Yamakoshi, Shigenobu] Tamura Corp, Sayama, Saitama 3501328, Japan	Ohkawa, K (reprint author), Tokyo Univ Sci, Dept Appl Phys, Tokyo 1258585, Japan.	ohkawa@rs.kagu.tus.ac.jp					Mori M, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.082301; DOMEN K, 1986, J CATAL, V102, P92, DOI 10.1016/0021-9517(86)90143-0; Hayashi T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.112601; Ohkawa K, 2012, J CRYST GROWTH, V343, P13, DOI 10.1016/j.jcrysgro.2011.12.075; Zou ZG, 2001, NATURE, V414, P625, DOI 10.1038/414625a; Higashiwaki M, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4821858; Aida H, 2008, JPN J APPL PHYS, V47, P8506, DOI 10.1143/JJAP.47.8506; Shimamura K, 2005, JPN J APPL PHYS 2, V44, pL7, DOI 10.1143/JJAP.44.L7; Wang DA, 2013, ANGEW CHEM INT EDIT, V52, P11252, DOI 10.1002/anie.201303693; Sato J, 2005, J AM CHEM SOC, V127, P4150, DOI 10.1021/ja042973v; Higashiwaki M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3674287; DOMEN K, 1980, J CHEM SOC CHEM COMM, P543, DOI 10.1039/c39800000543; Fujii K, 2005, JPN J APPL PHYS 1, V44, P7433, DOI 10.1143/JJAP.44.7433; Fujii K, 2005, JPN J APPL PHYS 2, V44, pL543, DOI 10.1143/JJAP.44.L543; Iwaki Y, 2008, PHYS STATUS SOLIDI C, V5, P2349, DOI 10.1002/pssc.200778536; Morishima Y., 2014, 5 INT S GROWTH 3 NIT; Ohkawa K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.08JH04; Oshima T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.011202; Villora EG, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2910770	19	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-6300	1862-6319		PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Mat.	MAY	2015	212	5			SI		1029	1032		10.1002/pssa.201431731		4	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CI0DB	WOS:000354405000022		
J	Sumiya, M; Honda, T; Sang, L; Nakano, Y; Watanabe, K; Hasegawa, F				Sumiya, Masatomo; Honda, Tohru; Sang, Liwen; Nakano, Yoshitaka; Watanabe, Kenji; Hasegawa, Fumio			Improvement of strained InGaN solar cell performance with a heavily doped n(+)-GaN substrate	PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE			English	Article						III-V semiconductors; InGaN; nitride semiconductors; piezoelectric effects; solar cells	MOLECULAR-BEAM EPITAXY; CARRIER LIFETIME; EFFICIENCY; POLARIZATION; NITRIDE; GROWTH; DISLOCATION; ALLOYS; INN; GAN	We simulated III-V nitride heterojunction solar cells with a Mg-doped GaN/intrinsic InGaN/Si-doped GaN structure. We investigated the threshold dislocation density, the carrier lifetime, and the strain in the InGaN active layer. The conversion efficiency was sensitive to carrier lifetime limited by Shockely-Read recombination rather than the dislocation density. The electric field induced by the piezoelectric effect in the InGaN layer on +c polarity GaN was opposite to that in the depletion region. The recombination of photo-generated carriers in the p-GaN/i-InGaN/ n-GaN solar cell structure took place dominantly at the i/n interface even at 0V, and the performance was remarkably degraded. It was found that this negative influence of the piezoelectric effect was reduced by a heavy doping of more than 3x10(19)cm(-3) into the n(+)-GaN layer at the interface.	[Sumiya, Masatomo; Sang, Liwen] Natl Inst Mat Sci, Wide Bandgap Mat Grp, Tsukuba, Ibaraki 3050044, Japan; [Honda, Tohru] Kogakuin Univ, Hachioji, Tokyo 1920015, Japan; [Nakano, Yoshitaka; Hasegawa, Fumio] Chubu Univ, Kasugai, Aichi 4878501, Japan; [Watanabe, Kenji] Natl Inst Mat Sci, Optoelect Mat Grp, Tsukuba, Ibaraki 3050044, Japan	Sumiya, M (reprint author), Natl Inst Mat Sci, Wide Bandgap Mat Grp, Tsukuba, Ibaraki 3050044, Japan.	SUMIYA.Masatomo@nims.go.jp	sang, liwen/B-3497-2012; WATANABE, Kenji/H-2825-2011	WATANABE, Kenji/0000-0003-3701-8119	Japan Science and Technology Agency; JST-ALCA; JST-PRESTO project	This work was supported by the Japan Science and Technology Agency (and JST-ALCA and JST-PRESTO project).	Wright AF, 1998, APPL PHYS LETT, V73, P2751, DOI 10.1063/1.122579; Young NG, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4873117; Im JS, 1997, APPL PHYS LETT, V70, P631, DOI 10.1063/1.118293; [Anonymous], [No title captured], Patent No. 5598818; Kuwahara Y, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.021001; AHRENKIEL RK, 1992, SOLID STATE ELECTRON, V35, P239, DOI 10.1016/0038-1101(92)90228-5; Wang HW, 2013, IEEE J PHOTOVOLT, V3, P985, DOI 10.1109/JPHOTOV.2013.2252953; Nanishi Y, 2003, JPN J APPL PHYS 1, V42, P2549, DOI 10.1143/JJAP.42.2549; Wu J, 2003, J APPL PHYS, V94, P6477, DOI 10.1063/1.1618353; GREEN MA, 1982, SOL CELLS, V7, P337, DOI 10.1016/0379-6787(82)90057-6; Wierer JJ, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3301262; Fabien CAM, 2014, SOL ENERG MAT SOL C, V130, P354, DOI 10.1016/j.solmat.2014.07.018; Li ZQ, 2011, PHYS STATUS SOLIDI A, V208, P928, DOI 10.1002/pssa.201026489; Gorge V, 2013, MATER SCI ENG B-ADV, V178, P142, DOI 10.1016/j.mseb.2012.10.033; Bulashevich KA, 2014, PHYS STATUS SOLIDI C, V11, P640, DOI 10.1002/pssc.201300389; Bulashevich KA, 2008, PHYS STATUS SOLIDI C, V5, P2066, DOI 10.1002/pssc.200778414; Chang JY, 2013, IEEE J QUANTUM ELECT, V49, P17, DOI 10.1109/JQE.2012.2225601; Chang JY, 2011, IEEE ELECTR DEVICE L, V32, P937, DOI 10.1109/LED.2011.2150195; Karpov SY, 2002, APPL PHYS LETT, V81, P4721, DOI 10.1063/1.1527225; Mahala P, 2013, PHYS STATUS SOLIDI A, V210, P2656, DOI 10.1002/pssa.201330030; Masui H., 2011, SEMICOND SCI TECH, V26; Matsuoka T., 1990, I PHYS C SER, V106, P141; Sang LW, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.08JF04; Sumiya M., DEFECTS INGAN UNPUB; Wang XQ, 2006, JPN J APPL PHYS 2, V45, pL730, DOI 10.1143/JJAP.45.L730	25	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-6300	1862-6319		PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Mat.	MAY	2015	212	5			SI		1033	1038		10.1002/pssa.201431732		6	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CI0DB	WOS:000354405000023		
J	Yatabe, Z; Asubar, JT; Sato, T; Hashizume, T				Yatabe, Zenji; Asubar, Joel T.; Sato, Taketomo; Hashizume, Tamotsu			Interface trap states in Al2O3/AlGaN/GaN structure induced by inductively coupled plasma etching of AlGaN surfaces	PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE			English	Article						Al2O3; AlGaN; dry etching; high electron mobility transistors; interface states; metal-insulator-semiconductor structures	SCHOTTKY CONTACTS; INDUCED DAMAGE; GAN	We have investigated the effects of the inductively coupled plasma (ICP) etching of AlGaN surface on the resulting interface properties of the Al2O3/AlGaN/GaN structures. The experimentally measured capacitance-voltage (C-V) characteristics were compared with those calculated taking into account the interface states density at the Al2O3/AlGaN interface. As a complementary method, photoassisted C-V method utilizing photons with energies less than the bandgap of GaN was also used to probe the interface state density located near AlGaN midgap. It was found that the ICP etching of the AlGaN surface significantly increased the interface state density at the Al2O3/AlGaN interface. It is likely that ICP etching induced the interface roughness, disorder of chemical bonds and formation of various type of defect complexes including nitrogen-vacancy-related defects at the AlGaN surface, leading to poor C-V curve due to higher interface state density at the Al2O3/AlGaN interface.	[Yatabe, Zenji; Asubar, Joel T.; Sato, Taketomo; Hashizume, Tamotsu] Hokkaido Univ, Grad Sch Informat & Sci Technol, Sapporo, Hokkaido 0608628, Japan; [Yatabe, Zenji; Asubar, Joel T.; Sato, Taketomo; Hashizume, Tamotsu] Hokkaido Univ, RCIQE, Sapporo, Hokkaido 0608628, Japan; [Yatabe, Zenji; Asubar, Joel T.; Hashizume, Tamotsu] Japan Sci & Technol Agcy JST, CREST, Tokyo 1020075, Japan	Yatabe, Z (reprint author), Hokkaido Univ, Grad Sch Informat & Sci Technol, Sapporo, Hokkaido 0608628, Japan.	hashi@rciqe.hokudai.ac.jp; hashi@rciqe.hokudai.ac.jp	Yatabe, Zenji/A-5506-2012	Yatabe, Zenji/0000-0003-2069-6677			Choi KJ, 2003, APPL PHYS LETT, V82, P1233, DOI 10.1063/1.1557316; Yang S, 2013, IEEE ELECTR DEVICE L, V34, P1497, DOI 10.1109/LED.2013.2286090; Herbecq N, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.034103; Hashizume T, 2004, APPL SURF SCI, V234, P387, DOI 10.1016/j.apsusc.2004.05.091; Van Hove M, 2013, IEEE T ELECTRON DEV, V60, P3071, DOI 10.1109/TED.2013.2274730; Fagerlind M, 2010, J APPL PHYS, V108, DOI 10.1063/1.3428442; Tapajna M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3694768; Huang S, 2013, IEEE ELECTR DEVICE L, V34, P193, DOI 10.1109/LED.2012.2229106; Ishida M, 2013, IEEE T ELECTRON DEV, V60, P3053, DOI 10.1109/TED.2013.2268577; Cheng CJ, 2011, PHYSICA B, V406, P3098, DOI 10.1016/j.physb.2011.05.014; Fang ZQ, 2003, APPL PHYS LETT, V82, P1562, DOI 10.1063/1.1560562; Hashizume T., 2012, P 9 INT C ADV SEM DE, P31; Hori Y, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.080201; Hughes B., 2013, P 1 IEEE WORKSH WID, P76; Kikkawa T., 2013, P 1 IEEE WORKSH WID, P11; Kuzmik J, 2002, SEMICOND SCI TECH, V17, pL76, DOI 10.1088/0268-1242/17/11/103; Mehari SS, 2014, IEEE T ELECTRON DEV, V61, P3558, DOI 10.1109/TED.2014.2346461; Miczek M, 2008, J APPL PHYS, V103, DOI 10.1063/1.2924334; Miczek M, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.04C092; Mizue C, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.021001; Mouffak Z, 2004, J APPL PHYS, V95, P727, DOI 10.1063/1.1632552; Tang K, 2009, J ELECTRON MATER, V38, P523, DOI 10.1007/s11664-008-0617-y; Wu Y.-F., 2013, P 1 IEEE WORKSH WID, P6; Yatabe Z, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.016502	24	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-6300	1862-6319		PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Mat.	MAY	2015	212	5			SI		1075	1080		10.1002/pssa.201431652		6	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CI0DB	WOS:000354405000029		
J	Takei, Y; Kamiya, M; Tsutsui, K; Saito, W; Kakushima, K; Wakabayashi, H; Kataoka, Y; Iwai, H				Takei, Yusuke; Kamiya, Masayuki; Tsutsui, Kazuo; Saito, Wataru; Kakushima, Kuniyuki; Wakabayashi, Hitoshi; Kataoka, Yoshinori; Iwai, Hiroshi			Reduction of contact resistance on AlGaN/GaN HEMT structures introducing uneven AlGaN layers	PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE			English	Article						AlGaN; contact resistance; GaN; high electron mobility transistors; ohmic contacts; thin films	HETEROSTRUCTURE	A new technique to reduce contact resistance on AlGaN/GaN HEMTs was proposed. This method introduced uneven AlGaN layer structures. 2D device simulations revealed a clear increase in two-dimensional electron gas (2DEG) concentration near the edge regions where the AlGaN layer thickness fluctuated. This fringing effect is useful because metal and high-density 2DEG can approach each other, overcoming an inherent tradeoff involving the AlGaN layer thickness. Experiments demonstrated the effectiveness of this technique, in which contact resistances obtained on some structures with uneven AlGaN layers were lower than the lowest limit for conventional flat AlGaN structures.	[Takei, Yusuke; Kamiya, Masayuki; Tsutsui, Kazuo; Kakushima, Kuniyuki; Wakabayashi, Hitoshi; Kataoka, Yoshinori; Iwai, Hiroshi] Tokyo Inst Technol, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Saito, Wataru] Toshiba Co Ltd, Saiwai Ku, Kawasaki, Kanagawa 2128583, Japan	Takei, Y (reprint author), Tokyo Inst Technol, Midori Ku, Nagatsuta 4259-J2-69, Yokohama, Kanagawa 2268502, Japan.	takei.y.ae@m.titech.ac.jp			JSPS [26105014]	This work was partially supported by JSPS Grant-in-Aid for Scientific Research on Innovative Areas: Grant Number 26105014.	Pengelly RS, 2012, IEEE T MICROW THEORY, V60, P1764, DOI 10.1109/TMTT.2012.2187535; Ikeda N, 2010, P IEEE, V98, P1151, DOI 10.1109/JPROC.2009.2034397; BERGER HH, 1972, SOLID STATE ELECTRON, V15, P145, DOI 10.1016/0038-1101(72)90048-2; Ibbetson JP, 2000, APPL PHYS LETT, V77, P250, DOI 10.1063/1.126940; Bakeroot B, 2014, J APPL PHYS, V116, DOI 10.1063/1.4896900; Dong ZH, 2012, MICROELECTRON RELIAB, V52, P434, DOI 10.1016/j.microrel.2011.09.021; Fontsere A, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3661167; Iucolano F, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4828839; Okamoto M., 2013, P 1 IEEE WORKSH WID, P3024; Takei Y, 2014, ECS TRANSACTIONS, V61, P265, DOI 10.1149/06104.0265ecst	10	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-6300	1862-6319		PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Mat.	MAY	2015	212	5			SI		1104	1109		10.1002/pssa.201431645		6	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CI0DB	WOS:000354405000034		
J	Ozaki, S; Makiyama, K; Ohki, T; Kamada, Y; Sato, M; Niida, Y; Okamoto, N; Masuda, S; Joshin, K				Ozaki, Shiro; Makiyama, Kozo; Ohki, Toshihiro; Kamada, Yoichi; Sato, Masaru; Niida, Yoshitaka; Okamoto, Naoya; Masuda, Satoshi; Joshin, Kazukiyo			Reduction in current collapse of AlGaN/GaN HEMTs using methyl silsesquioxane-based low-k insulator films	PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE			English	Article						current collapse; GaN; high electron mobility transistors; insulators; KAlGaN; thin films	GAN-HEMT; PASSIVATION; PERFORMANCE; AMPLIFIER; MOISTURE; MMICS; BCB	We have investigated the effect of moisture on current collapse of AlGaN/GaN high-electron mobility transistors (HEMTs) when using low dielectric constant (low-k) insulator films to reduce the parasitic capacitance of millimeter-wave amplifier monolithic microwave integrated circuits. We clarified that current collapse is caused by moisture uptake through the surface and the sidewall of low-k films. Moreover, the moisture resistance of conventional carbon-based low-k films, such as benzocyclobutene, are insufficient to suppress current collapse because of hydrophilic surface and highly hydrophilized sidewall by the contact hole etching. We proposed the use of methyl silsesquioxane (MSQ)-based low-k films to improve the moisture resistance because of methyl group's hydrophobic property. This is the first time that MSQ has been used in AlGaN/GaN HEMTs. After appling MSQ, the moisture resistance of low-k films at the surface and the sidewall improved, and current collapse due to humidification was successfully reduced. Our findings suggest that improving the moisture resistance with hydrophobic low-k films does play a key role in reducing current collapse of AlGaN/GaN HEMTs.	[Ozaki, Shiro; Makiyama, Kozo; Ohki, Toshihiro; Sato, Masaru; Niida, Yoshitaka; Okamoto, Naoya; Masuda, Satoshi; Joshin, Kazukiyo] Fujitsu Ltd, Atsugi, Kanagawa 2430197, Japan; [Ozaki, Shiro; Makiyama, Kozo; Ohki, Toshihiro; Kamada, Yoichi; Sato, Masaru; Niida, Yoshitaka; Okamoto, Naoya; Masuda, Satoshi; Joshin, Kazukiyo] Fujitsu Labs Ltd, Atsugi, Kanagawa 2430197, Japan	Ozaki, S (reprint author), Fujitsu Ltd, 10-1 Morinosato Wakamiya, Atsugi, Kanagawa 2430197, Japan.	ozaki.shirou@jp.fujitsu.com					Wang WK, 2004, IEEE ELECTR DEVICE L, V25, P763, DOI 10.1109/LED.2004.838322; Kikkawa T, 2005, JPN J APPL PHYS 1, V44, P4896, DOI 10.1143/JJAP.44.4896; Gao F, 2012, IEEE ELECTR DEVICE L, V33, P1378, DOI 10.1109/LED.2012.2206556; Chiu H.-C., 2004, IPRM, P382; Eaves D, 2010, ECS TRANSACTIONS, V28, P563, DOI 10.1149/1.3372609; Hasan M. T., 2013, CS MANTECH, P131; Kikkawa T, 2009, PHYS STATUS SOLIDI A, V206, P1135, DOI 10.1002/pssa.200880983; Koehler A. D., 2013, CS MANTECH, P135; Kurpas P., 2013, CS MANTECH, P415; Makiyama K., 2009, PHYS STATUS SOLIDI C, V6, P1012; Makiyama K, 2011, PHYS STATUS SOLIDI C, V8, DOI 10.1002/pssc.201001034; Masuda S., 2009, EUMIC, P1796; Micovic M., 2008, IEEE CSIC S OCT, P10; Oku T., 2014, CS MANTECH, P179; Pei Y, 2009, IEEE ELECTR DEVICE L, V30, P313, DOI 10.1109/LED.2009.2012444; Stewart E., 2012, CS MANTECH, P207; Sugitani S, 2003, IEEE T ADV PACKAGING, V26, P133, DOI 10.1109/TADVP.2003.817338; Yamada A, 2010, PHYS STATUS SOLIDI C, V7, DOI 10.1002/pssc.200983902	18	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-6300	1862-6319		PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Mat.	MAY	2015	212	5			SI		1153	1157		10.1002/pssa.201431665		5	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CI0DB	WOS:000354405000041		
J	Lisi, G; Morimoto, J				Lisi, Giuseppe; Morimoto, Jun			EEG Single-Trial Detection of Gait Speed Changes during Treadmill Walk	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; INDEPENDENT COMPONENT ANALYSIS; BRAIN-COMPUTER INTERFACES; SOURCE LOCALIZATION; VIRTUAL-REALITY; VOLUNTARY DRIVE; MOVEMENT; ARTIFACTS; PERFORMANCE; CHILDREN	In this study, we analyse the electroencephalography (EEG) signal associated with gait speed changes (i.e. acceleration or deceleration). For data acquisition, healthy subjects were asked to perform volitional speed changes between 0, 1, and 2 Km/h, during treadmill walk. Simultaneously, the treadmill controller modified the speed of the belt according to the subject's linear speed. A classifier is trained to distinguish between the EEG signal associated with constant speed gait and with gait speed changes, respectively. Results indicate that the classification performance is fair to good for the majority of the subjects, with accuracies always above chance level, in both batch and pseudo-online approaches. Feature visualisation and equivalent dipole localisation suggest that the information used by the classifier is associated with increased activity in parietal areas, where mu and beta rhythms are suppressed during gait speed changes. Specifically, the parietal cortex may be involved in motor planning and visuomotor transformations throughout the online gait adaptation, which is in agreement with previous research. The findings of this study may help to shed light on the cortical involvement in human gait control, and represent a step towards a BMI for applications in post-stroke gait rehabilitation.	[Lisi, Giuseppe; Morimoto, Jun] ATR Computat Neurosci Labs, Dept Brain Robot Interface, Kyoto, Japan	Lisi, G (reprint author), ATR Computat Neurosci Labs, Dept Brain Robot Interface, Kyoto, Japan.	glisi@atr.jp			MIC-SCOPE; Ministry of Internal Affairs and Communications entitled "Novel and innovative R&D making use of brain structures"; MEXT KAKENHI, ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan), Strategic International Cooperative Program, Japan Science and Technology Agency (JST) [23120004]; JSPS; MIZS: Japan-Slovenia research Cooperative Program	This study is the result of "Development of BMI Technologies for Clinical Application," carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan. Part of this research was supported by MIC-SCOPE and a contract with the Ministry of Internal Affairs and Communications entitled "Novel and innovative R&D making use of brain structures." This research was also partially supported by MEXT KAKENHI grant number 23120004, ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan), Strategic International Cooperative Program, Japan Science and Technology Agency (JST), and by JSPS and MIZS: Japan-Slovenia research Cooperative Program. The authors Giuseppe Lisi and Jun Morimoto are affiliated with the company ATR Computational Neuroscience Laboratories. ATR Computational Neuroscience Laboratories provided support in the form of salaries for authors GL and JM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Tombini M, 2009, NEUROIMAGE, V47, P1735, DOI 10.1016/j.neuroimage.2009.04.046; Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Cuffin BN, 2001, CLIN NEUROPHYSIOL, V112, P46, DOI 10.1016/S1388-2457(00)00488-0; Haase-Fielitz A, 2009, CRIT CARE MED, V37, P553, DOI 10.1097/CCM.0b013e318195846e; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Wagner J, 2012, NEUROIMAGE, V63, P1203, DOI 10.1016/j.neuroimage.2012.08.019; Haggard P, 2008, NAT REV NEUROSCI, V9, P934, DOI 10.1038/nrn2497; Hwang HJ, 2009, J NEUROSCI METH, V179, P150, DOI 10.1016/j.jneumeth.2009.01.015; Sipp AR, 2013, J NEUROPHYSIOL, V110, P2050, DOI 10.1152/jn.00744.2012; Krings T, 1999, CLIN NEUROPHYSIOL, V110, P106, DOI 10.1016/S0013-4694(98)00106-0; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Yamashita O, 2008, NEUROIMAGE, V42, P1414, DOI 10.1016/j.neuroimage.2008.05.050; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; Lotze M, 2003, BRAIN, V126, P866, DOI 10.1093/brain/awg079; Raiche G, 2013, METHODOLOGY-EUR, V9, P23, DOI 10.1027/1614-2241/a000051; Brutsch K, 2011, J REHABIL MED, V43, P493, DOI 10.2340/16501977-0802; SHIK ML, 1976, PHYSIOL REV, V56, P465; Joyce CA, 2004, PSYCHOPHYSIOLOGY, V41, P313, DOI 10.1046/j.1469-8986.2003.00141.x; Blankertz B, 2002, ADV NEUR IN, V14, P157; Grosse-Wentrup M, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056015; Gwin JT, 2010, J NEUROPHYSIOL, V103, P3526, DOI 10.1152/jn.00105.2010; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; Seeber M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00485; Mognon A, 2011, PSYCHOPHYSIOLOGY, V48, P229, DOI 10.1111/j.1469-8986.2010.01061.x; Acar ZA, 2013, BRAIN TOPOGR, V26, P378, DOI 10.1007/s10548-012-0274-6; Haefeli J, 2011, EUR J NEUROSCI, V33, P338, DOI 10.1111/j.1460-9568.2010.07494.x; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4&lt;238::AID-HBM6&gt;3.0.CO;2-4; Gwin JT, 2011, NEUROIMAGE, V54, P1289, DOI 10.1016/j.neuroimage.2010.08.066; Severens M, 2012, IEEE ENG MED BIO, P2764, DOI 10.1109/EMBC.2012.6346537; Petersen TH, 2012, J PHYSIOL-LONDON, V590, P2443, DOI 10.1113/jphysiol.2012.227397; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Schieppati M, 1999, J NEUROL NEUROSUR PS, V66, P313, DOI 10.1136/jnnp.66.3.313; Castermans T, 2014, NEUROSCI LETT, V561, P166, DOI 10.1016/j.neulet.2013.12.059; Kaelin-Lang A, 2005, J NEUROPHYSIOL, V93, P1099, DOI 10.1152/jn.00143.2004; Zimmerli L, 2013, ARCH PHYS MED REHAB, V94, P1737, DOI 10.1016/j.apmr.2013.01.029; Schuler T, 2011, NEUROREHABILITATION, V28, P401, DOI 10.3233/NRE-2011-0670; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; DAUBECHIES I, 1990, IEEE T INFORM THEORY, V36, P961, DOI 10.1109/18.57199; Presacco A, 2011, J NEUROPHYSIOL, V106, P1875, DOI 10.1152/jn.00104.2011; Wojcikiewicz W, 2011, INT CONF ACOUST SPEE, P577; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Muller-Putz GR, 2007, BRAIN RES, V1137, P84, DOI 10.1016/j.brainres.2006.12.052; Fatourechi M, 2007, CLIN NEUROPHYSIOL, V118, P480, DOI 10.1016/j.clinph.2006.10.019; Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; Wieser M, 2010, EXP BRAIN RES, V203, P181, DOI 10.1007/s00221-010-2223-5; Graimann B, 2006, PROG BRAIN RES, V159, P79, DOI 10.1016/S0079-6123(06)59006-5; Suzuki M, 2004, NEUROIMAGE, V23, P1020, DOI 10.1016/j.neuroimage.2004.07.002; Buneo CA, 2006, NEUROPSYCHOLOGIA, V44, P2594, DOI 10.1016/j.neuropsychologia.2005.10.011; Bertrand A, 2013, BIOMED CIRC SYST C, P258, DOI 10.1109/BioCAS.2013.6679688; Billinger M, 2013, TOWARDS PRACTICAL BR, P333, DOI 10.1007/978-3-642-29746-5; Blank A, 2013, I IEEE EMBS C NEUR E, P1159, DOI 10.1109/NER.2013.6696144; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P581, DOI [10.1109/MSP.2008.4408441, DOI 10.1109/MSP.2008.4408441]; Bolognini N, 2007, CURR BIOL, V17, P1890, DOI 10.1016/j.cub.2007.09.057; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Delorme A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030135; Dietz V., 2001, Neural Plasticity, V8, P83, DOI 10.1155/NP.2001.83; Dornhege G, 2007, TOWARD BRAIN COMPUTE; Faller J, 2014, PLOS ONE, V07, DOI 10.1371/journal.pone.0101168; Grandchamp R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00236; Jankovic J, 2007, PARKINSONS DISEASE A; Jiang N, 2014, CLINICAL NEUROPHYSIO; Jolliffe I., 2002, PRINCIPAL COMPONENT; Brutsch K, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-15; Koenraadt KLM, 2014, NEUROIMAGE, V85, P415, DOI 10.1016/j.neuroimage.2013.04.070; Lisi Giuseppe, 2014, Front Syst Neurosci, V8, P85, DOI 10.3389/fnsys.2014.00085; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Makeig S, 2004, PLOS BIOL, V2, P747, DOI 10.1371/journal.pbio.0020176; Min BK, 2008, NEUROSCI LETT, V438, P270, DOI 10.1016/j.neulet.2008.04.067; Miyakoshi Makoto, 2013, Conf Proc IEEE Eng Med Biol Soc, V2013, P3282, DOI 10.1109/EMBC.2013.6610242; Muralidharan A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00039; Perfetti B, 2011, J NEUROPHYSIOL, V105, P18, DOI 10.1152/jn.00778.2010; Petzschner FH, 2012, J NEUROSCI, V32, P4703, DOI 10.1523/JNEUROSCI.0566-12.2012; Quian Quiroga R, 2006, THE JOURNAL OF NEURO, V26, P3615; Scherg M., 1990, ADV AUDIOL, V6, P40; Schlögl Alois, 2005, J Neural Eng, V2, pL14, DOI 10.1088/1741-2560/2/4/L02; Tangermann M, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00055; Wagner J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00093; Wang D, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00151; Wang YJ, 2009, LECT NOTES ARTIF INT, V5638, P437; Widmann A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00233; Yuan H, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026001	85	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125479	10.1371/journal.pone.0125479		28	Multidisciplinary Sciences	Science & Technology - Other Topics	CH2XA	WOS:000353887100114		
J	Marotta, L; Micciche, S; Fujiwara, Y; Iyetomi, H; Aoyama, H; Gallegati, M; Mantegna, RN				Marotta, Luca; Micciche, Salvatore; Fujiwara, Yoshi; Iyetomi, Hiroshi; Aoyama, Hideaki; Gallegati, Mauro; Mantegna, Rosario N.			Bank-Firm Credit Network in Japan: An Analysis of a Bipartite Network	PLOS ONE			English	Article								We investigate the networked nature of the Japanese credit market. Our investigation is performed with tools of network science. In our investigation we perform community detection with an algorithm which is identifying communities composed of both banks and firms. We show that the communities obtained by directly working on the bipartite network carry information about the networked nature of the Japanese credit market. Our analysis is performed for each calendar year during the time period from 1980 to 2011. To investigate the time evolution of the networked structure of the credit market we introduce a new statistical method to track the time evolution of detected communities. We then characterize the time evolution of communities by detecting for each time evolving set of communities the overexpression of attributes of firms and banks. Specifically, we consider as attributes the economic sector and the geographical location of firms and the type of banks. In our 32-year-long analysis we detect a persistence of the over-expression of attributes of communities of banks and firms together with a slow dynamic of changes from some specific attributes to new ones. Our empirical observations show that the credit market in Japan is a networked market where the type of banks, geographical location of firms and banks, and economic sector of the firm play a role in shaping the credit relationships between banks and firms.	[Marotta, Luca; Micciche, Salvatore; Mantegna, Rosario N.] Univ Palermo, Dipartimento Fis & Chim, Palermo, Italy; [Fujiwara, Yoshi] Univ Hyogo, Grad Sch Simulat Studies, Kobe, Hyogo 6500044, Japan; [Iyetomi, Hiroshi] Niigata Univ, Dept Math, Niigata, Japan; [Aoyama, Hideaki] Kyoto Univ, Grad Sch Sci, Kyoto, Japan; [Gallegati, Mauro] Univ Politecn Marche, Dipartimento Sci Econ & Sociali, Ancona, Italy; [Mantegna, Rosario N.] Cent European Univ, Ctr Network Sci, Budapest, Hungary; [Mantegna, Rosario N.] Cent European Univ, Dept Econ, Budapest, Hungary	Mantegna, RN (reprint author), Univ Palermo, Dipartimento Fis & Chim, Palermo, Italy.	rn.mantegna@gmail.com	Micciche', Salvatore/B-6575-2008	Micciche', Salvatore/0000-0003-3779-592X	JSPS [24243027, 25282094, 25400393]; Program for Promoting Methodological Innovation in Humanities and Social Sciences by Cross-Disciplinary Fusing of the JSPS; European Community Seventh Framework Programme [255987 (FOC-II), 297149 (FOC-INCO)]; Zengin Foundation for Studies on Economics and Finance; Kyoto University; Program for Interaction-based Initiative Team Studies: SPIRITS, Program for Promoting the Enhancement of Research Universities, MEXT, Japan; EU; INET	LM, SM, MG, and RNM acknowledge support from the EU project CRISIS and the INET project "New tools in the credit network modeling with agents' heterogeneity." This work is partially supported by Grant-in-Aid for Scientific Research (KAKENHI) grant numbers 24243027, 25282094, and 25400393 by JSPS, the Program for Promoting Methodological Innovation in Humanities and Social Sciences by Cross-Disciplinary Fusing of the JSPS, by the European Community Seventh Framework Programme (FP7/2007-2013) under Socio-economic Sciences and Humanities, grant agreement no. 255987 (FOC-II) and 297149 (FOC-INCO), by Zengin Foundation for Studies on Economics and Finance, and by the Kyoto University Supporting Program for Interaction-based Initiative Team Studies: SPIRITS, as part of the Program for Promoting the Enhancement of Research Universities, MEXT, Japan.	Guimera R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036102; Larremore DB, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.012805; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Barber MJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066102; Bargigli L, 2012, ECONOMICS DISCUSSION; De Masi G, 2011, EVOLUTIONARY I EC RE, V7, P209, DOI 10.14441/eier.7.209; Easley D, 2010, NETWORKS CROWDS AND; Fujiwara Y, 2009, EC E J, V3, P7; MATSUURA Y, 2013, INTELLIGENT DECISION, V255, P399; Melamed D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097823; Murata T, 2009, COMP SCI ENG 2009 CS, V4, P50; Newman M.E., 2004, PHYS REV E, V69, P26113, DOI DOI 10.1103/PHYSREVE.69.026113; Rosvall M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008694; Suzuki K., 2009, P 2009 INT C COMP SC, V4, P312, DOI DOI 10.1109/CSE.2009.451; Tumminello M, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/01/P01019	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123079	10.1371/journal.pone.0123079		18	Multidisciplinary Sciences	Science & Technology - Other Topics	CH2XA	WOS:000353887100014		
J	Matsuda, S; Aoki, K; Kawamata, T; Kimotsuki, T; Kobayashi, T; Kuriki, H; Nakayama, T; Okugawa, S; Sugimura, Y; Tomita, M; Takahashi, Y				Matsuda, Shinichi; Aoki, Kotonari; Kawamata, Takuya; Kimotsuki, Tetsuji; Kobayashi, Takumi; Kuriki, Hiroshi; Nakayama, Terumi; Okugawa, Seigo; Sugimura, Yoshihiko; Tomita, Minami; Takahashi, Yoichiro			Bias in Spontaneous Reporting of Adverse Drug Reactions in Japan	PLOS ONE			English	Article							PHARMACOVIGILANCE DATABASE; NOTORIETY BIAS; ATTITUDES; PHARMACISTS; PORTUGAL	Background Attitudes of healthcare professionals regarding spontaneous reporting of adverse drug reactions (ADRs) in Japan are not well known, and Japan's unique system of surveillance, called early post-marketing phase vigilance (EPPV), may affect these reporting attitudes. Our objectives were to describe potential effects of EPPV and to test whether ADR seriousness, prominence, and frequency are related to changes in reporting over time. Methods A manufacturer's database of spontaneous ADR reports was used to extract data from individual case safety reports for 5 drugs subject to EPPV. The trend of reporting and the time lag between ADR onset and reporting to the manufacturer were examined. The following indices for ADRs occurring with each drug were calculated and analyzed to assess reporting trends: Serious: Non-serious ratio, High prominence: Low prominence ratio, and High frequency: Low frequency ratio. Results For all 5 drugs, the time lag between ADR onset and reporting to the manufacturer was shorter in the EPPV period than in the post-EPPV period. All drugs showed higher Serious: Non-serious ratios in the post-EPPV period. No specific patterns were observed for the High prominence: Low prominence ratio. The High frequency: Low frequency ratio for peginterferon alpha-2a and sevelamer hydrochloride decreased steadily throughout the study period. Conclusions Healthcare professionals may be more likely to report serious ADRs than to report non-serious ADRs, but the effect of event prominence on reporting trends is still unclear. Factors associated with ADR reporting attitude in Japan might be different from those in other countries because of EPPV and the involvement of medical representatives in the spontaneous reporting process. Pharmacovigilance specialists should therefore be cautious when comparing data between different time periods or different countries. Further studies are needed to elucidate the underlying mechanism of spontaneous ADR reporting in Japan.	[Matsuda, Shinichi; Aoki, Kotonari; Kawamata, Takuya; Kimotsuki, Tetsuji; Kobayashi, Takumi; Nakayama, Terumi; Okugawa, Seigo; Sugimura, Yoshihiko; Tomita, Minami; Takahashi, Yoichiro] Chugai Pharmaceut Co Ltd, Drug Safety Div, Tokyo, Japan; [Kuriki, Hiroshi] Chugai Pharmaceut Co Ltd, Clin Dev Div, Tokyo, Japan	Matsuda, S (reprint author), Chugai Pharmaceut Co Ltd, Drug Safety Div, Tokyo, Japan.	matsudasni@chugai-pharm.co.jp			Chugai Pharmaceutical Co. Ltd.	Chugai Pharmaceutical Co. Ltd. provided support in the form of salaries for authors SM, KA, T. Kawamata, T. Kimotsuki, T. Kobayashi, HK, TN, SO, YS, MT, and YT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Herdeiro MT, 2006, DRUG SAFETY, V29, P331, DOI 10.2165/00002018-200629040-00004; Brown EG, 1999, DRUG SAFETY, V20, P109, DOI 10.2165/00002018-199920020-00002; Irujo M, 2007, DRUG SAFETY, V30, P1073; Bate A, 1998, EUR J CLIN PHARMACOL, V54, P315, DOI 10.1007/s002280050466; Hazell L, 2006, DRUG SAFETY, V29, P385, DOI 10.2165/00002018-200629050-00003; Moulis G, 2012, BRIT J CLIN PHARMACO, V74, P201, DOI 10.1111/j.1365-2125.2012.04185.x; PETRI H, 1991, STAT MED, V10, P577, DOI 10.1002/sim.4780100409; Pariente A, 2007, DRUG SAFETY, V30, P891; Kimura T, 2011, PHARMACOEPIDEM DR S, V20, P1237, DOI 10.1002/pds.2244; Meyboom RHB, 1999, DRUG SAFETY, V21, P429, DOI 10.2165/00002018-199921060-00001; DuMouchel W, 1999, AM STAT, V53, P177, DOI 10.2307/2686093; Lopez-Gonzalez E, 2009, DRUG SAFETY, V32, P19, DOI 10.2165/00002018-200932010-00002; de Boissieu P, 2014, PHARMACOEPIDEM DR S, V23, P989, DOI 10.1002/pds.3622; Council for International Organizations of Medical Sciences (CIOMS), 2014, PRACT APPR RISK MIN, P11; Gavaza P, 2011, BRIT J CLIN PHARMACO, V72, P143, DOI 10.1111/j.1365-2125.2011.03944.x; Ghosh P, 2015, PHARM STAT, V14, P20, DOI 10.1002/pst.1657; Herdeiro MT, 2004, J EVAL CLIN PRACT, V10, P483, DOI 10.1111/j.1365-2753.2003.00456.x; Herdeiro MT, 2005, DRUG SAFETY, V28, P825, DOI 10.2165/00002018-200528090-00007; Inman WHW, 1996, BRIT J CLIN PHARMACO, V41, P434; Maeda R, 2014, JPN J PHARMACOEPIDEM, V19, P51; Weber JCP, 1984, ADV INFLAMMAT RES, V6, P1; Yamada T, 2013, PHARMACOEPIDEM DR S, V22, P468, DOI 10.1002/pds.3378	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0126413	10.1371/journal.pone.0126413		11	Multidisciplinary Sciences	Science & Technology - Other Topics	CH2XA	WOS:000353887100153		
J	Sadiq, MW; Uchida, Y; Hoshi, Y; Tachikawa, M; Terasaki, T; Hammarlund-Udenaes, M				Sadiq, Muhammad Waqas; Uchida, Yasuo; Hoshi, Yutaro; Tachikawa, Masanori; Terasaki, Tetsuya; Hammarlund-Udenaes, Margareta			Validation of a P-Glycoprotein (P-gp) Humanized Mouse Model by Integrating Selective Absolute Quantification of Human MDR1, Mouse Mdr1a and Mdr1b Protein Expressions with In Vivo Functional Analysis for Blood-Brain Barrier Transport	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CAPILLARY ENDOTHELIAL-CELLS; KNOCKOUT MICE; SPECIES-DIFFERENCES; ACTIVE UPTAKE; VITRO; PHARMACOKINETICS; OXYCODONE; PHARMACODYNAMICS; PROTEOMICS	It is essential to establish a useful validation method for newly generated humanized mouse models. The novel approach of combining our established species-specific protein quantification method combined with in vivo functional studies is evaluated to validate a humanized mouse model of P-gp/MDR1 efflux transporter. The P-gp substrates digoxin, verapamil and docetaxel were administered to male FVB Mdr1a/1b(+/+) (FVB WT), FVB Mdr1a/1b(-/-) (Mdr1a/1b(-/-)), C57BL/6 Mdr1a/1b(+/+) (C57BL/6 WT) and humanized C57BL (hMDR1) mice. Brain-to-plasma total concentration ratios (K-p) were measured. Quantitative targeted absolute proteomic (QTAP) analysis was used to selectively quantify the protein expression levels of hMDR1, Mdr1a and Mdr1b in the isolated brain capillaries. The protein expressions of other transporters, receptors and claudin-5 were also quantified. The K-p for digoxin, verapamil, and docetaxel were 20, 30 and 4 times higher in the Mdr1a/1b(-/-) mice than in the FVB WT controls, as expected. The K-p for digoxin, verapamil and docetaxel were 2, 16 and 2-times higher in the hMDR1 compared to the C57BL/6 WT mice. The hMDR1 mice had 63- and 9.1-fold lower expressions of the hMDR1 and Mdr1a proteins than the corresponding expression of Mdr1a in C57BL/6 WT mice, respectively. The protein expression levels of other molecules were almost consistent between C57BL/6 WT and hMDR1 mice. The P-gp function at the BBB in the hMDR1 mice was smaller than that in WT mice due to lower protein expression levels of hMDR1 and Mdr1a. The combination of QTAP and in vivo functional analyses was successfully applied to validate the humanized animal model and evaluates its suitability for further studies.	[Sadiq, Muhammad Waqas; Hammarlund-Udenaes, Margareta] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden; [Uchida, Yasuo; Hoshi, Yutaro; Tachikawa, Masanori; Terasaki, Tetsuya] Tohoku Univ, Grad Sch Pharmaceut Sci, Div Membrane Transport & Drug Targeting, Aoba Ku, Sendai, Miyagi 980, Japan	Sadiq, MW (reprint author), Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden.	waqas.sadiq@farmbio.uu.se			Higher Education Commission, Pakistan	Britt Jansson and Jessica Dunhall are acknowledged for technical support during in vivo experiments. Karolina Nilsson and Thao Bui are also acknowledged for their contribution. Higher Education Commission, Pakistan is gratefully acknowledged for the scholarship of Muhammad Waqas Sadiq.	JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Sasongko L, 2005, CLIN PHARMACOL THER, V77, P503, DOI 10.1016/j.clpt.2005.01.022; KEILHOFF G, 1993, NEUROREPORT, V5, P129, DOI 10.1097/00001756-199311180-00008; Scheer N, 2008, J CLIN INVEST, V118, P3228, DOI 10.1172/JCI35483; Uchida Y, 2011, J NEUROCHEM, V117, P333, DOI 10.1111/j.1471-4159.2011.07208.x; Lagas JS, 2009, MOL INTERV, V9, P136, DOI 10.1124/mi.9.3.7; Friden M, 2007, DRUG METAB DISPOS, V35, P1711, DOI 10.1124/dmd.107.015222; Syvanen S, 2009, DRUG METAB DISPOS, V37, P635, DOI 10.1124/dmd.108.024745; Bostrom E, 2005, J PHARM SCI-US, V94, P1060, DOI 10.1002/jps.20327; Schinkel AH, 1998, INT J CLIN PHARM TH, V36, P9; Friden M, 2011, DRUG METAB DISPOS, V39, P353, DOI 10.1124/dmd.110.035998; Kamiie J, 2008, PHARM RES, V25, P1469, DOI 10.1007/s11095-008-9532-4; Friden M, 2010, J CEREBR BLOOD F MET, V30, P150, DOI 10.1038/jcbfm.2009.200; Banker MJ, 2003, J PHARM SCI, V92, P967, DOI 10.1002/jps.10332; Sadiq MW, 2011, J PHARM SCI-US, V100, P3912, DOI 10.1002/jps.22567; Schinkel AH, 1999, ADV DRUG DELIVER REV, V36, P179, DOI 10.1016/S0169-409X(98)00085-4; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Friden M, 2009, DRUG METAB DISPOS, V37, P1226, DOI 10.1124/dmd.108.026377; Agarwal S, 2012, DRUG METAB DISPOS, V40, P1164, DOI 10.1124/dmd.112.044719; Katoh M, 2006, J PHARM SCI-US, V95, P2673, DOI 10.1002/jps.20686; CHOKSAKULNIMITR S, 1995, J CONTROL RELEASE, V34, P233, DOI 10.1016/0168-3659(95)00007-U; Kemper EM, 2004, EUR J CANCER, V40, P1269, DOI 10.1016/j.ejca.2004.01.024; Bostrom E, 2006, DRUG METAB DISPOS, V34, P1624, DOI 10.1124/dmd.106.009746; Chen CP, 2003, CURR DRUG METAB, V4, P272, DOI 10.2174/1389200033489415; Cutler L, 2006, J PHARM SCI-US, V95, P1944, DOI 10.1002/jps.20658; Hammarlund-Udenaes M, 2008, PHARM RES-DORDR, V25, P1737, DOI 10.1007/s11095-007-9502-2; Hendrikse NH, 1998, BRIT J PHARMACOL, V124, P1413, DOI 10.1038/sj.bjp.0701979; Hogan BLM, 1994, MANIPULATING MOUSE E, P253, DOI 10. 1007/ 978- 1- 60327- 019- 9_ 13 PMID: 19504073; HSU SIH, 1989, J BIOL CHEM, V264, P12053; Loryan Irena, 2013, Fluids Barriers CNS, V10, P6, DOI 10.1186/2045-8118-10-6; Sadiq MW, 2013, J PHARM SCI-US, V102, P3320, DOI 10.1002/jps.23492; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214; TSUJI A, 1992, LIFE SCI, V51, P1427, DOI 10.1016/0024-3205(92)90537-Y	34	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0118638	10.1371/journal.pone.0118638		21	Multidisciplinary Sciences	Science & Technology - Other Topics	CH2XA	WOS:000353887100001		
J	Shimizu, Y; Yoshimoto, J; Toki, S; Takamura, M; Yoshimura, S; Okamoto, Y; Yamawaki, S; Doya, K				Shimizu, Yu; Yoshimoto, Junichiro; Toki, Shigeru; Takamura, Masahiro; Yoshimura, Shinpei; Okamoto, Yasumasa; Yamawaki, Shigeto; Doya, Kenji			Toward Probabilistic Diagnosis and Understanding of Depression Based on Functional MRI Data Analysis with Logistic Group LASSO	PLOS ONE			English	Article							VERBAL FLUENCY; IMAGING BIOMARKERS; VECTOR MACHINE; CLASSIFICATION; DISORDER; DISEASE; BRAIN; FMRI; NETWORKS; PATTERN	Diagnosis of psychiatric disorders based on brain imaging data is highly desirable in clinical applications. However, a common problem in applying machine learning algorithms is that the number of imaging data dimensions often greatly exceeds the number of available training samples. Furthermore, interpretability of the learned classifier with respect to brain function and anatomy is an important, but non-trivial issue. We propose the use of logistic regression with a least absolute shrinkage and selection operator (LASSO) to capture the most critical input features. In particular, we consider application of group LASSO to select brain areas relevant to diagnosis. An additional advantage of LASSO is its probabilistic output, which allows evaluation of diagnosis certainty. To verify our approach, we obtained semantic and phonological verbal fluency fMRI data from 31 depression patients and 31 control subjects, and compared the performances of group LASSO (gLASSO), and sparse group LASSO (sgLASSO) to those of standard LASSO (sLASSO), Support Vector Machine (SVM), and Random Forest. Over 90% classification accuracy was achieved with gLASSO, sgLASSO, as well as SVM; however, in contrast to SVM, LASSO approaches allow for identification of the most discriminative weights and estimation of prediction reliability. Semantic task data revealed contributions to the classification from left precuneus, left precentral gyrus, left inferior frontal cortex (pars triangularis), and left cerebellum (c rus1). Weights for the phonological task indicated contributions from left inferior frontal operculum, left post central gyrus, left insula, left middle frontal cortex, bilateral middle temporal cortices, bilateral precuneus, left inferior frontal cortex (pars triangularis), and left precentral gyrus. The distribution of normalized odds ratios further showed, that predictions with absolute odds ratios higher than 0.2 could be regarded as certain.	[Shimizu, Yu; Yoshimoto, Junichiro; Doya, Kenji] Grad Univ, Okinawa Inst Sci & Technol, Neural Computat Unit, Okinawa, Japan; [Yoshimoto, Junichiro] Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara 6300101, Japan; [Toki, Shigeru; Takamura, Masahiro; Okamoto, Yasumasa; Yamawaki, Shigeto] Hiroshima Univ, Dept Psychiat & Neurosci, Hiroshima, Japan; [Yoshimura, Shinpei] Otemon Gakuin Univ, Fac Psychol, Ibaraki, Osaka, Japan	Shimizu, Y (reprint author), Grad Univ, Okinawa Inst Sci & Technol, Neural Computat Unit, Okinawa, Japan.	yu.shimizu@oist.jp	Shimizu, Yu/G-2906-2015; Yoshimoto, Junichiro/B-5884-2015	Shimizu, Yu/0000-0001-9324-014X; Yoshimoto, Junichiro/0000-0001-7995-0321			American Psychiatric Association [APA], 2000, DIAGN STAT MAN MENT; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Zhou JY, 2013, NEUROIMAGE, V78, P233, DOI 10.1016/j.neuroimage.2013.03.073; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Costafreda SG, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-18; Montague PR, 2012, TRENDS COGN SCI, V16, P72, DOI 10.1016/j.tics.2011.11.018; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Henry JD, 2005, J CLIN EXP NEUROPSYC, V27, P78, DOI 10.1080/138033990513654; Gilbert SJ, 2008, CURR BIOL, V18, pR110, DOI 10.1016/j.cub.2007.12.014; Fu CHY, 2008, BIOL PSYCHIAT, V63, P656, DOI 10.1016/j.biopsych.2007.08.020; Marquand AF, 2008, NEUROREPORT, V19, P1507, DOI 10.1097/WNR.0b013e328310425e; Fairhall SL, 2010, BIOL PSYCHOL, V85, P499, DOI 10.1016/j.biopsycho.2010.09.002; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Tipping ME, 2001, J MACH LEARN RES, V1, P211, DOI 10.1162/15324430152748236; Mwangi B, 2012, BRAIN, V135, P1508, DOI 10.1093/brain/aws084; Lorenzetti V, 2009, J AFFECT DISORDERS, V117, P1, DOI 10.1016/j.jad.2008.11.021; Nouretdinov I, 2011, NEUROIMAGE, V56, P809, DOI 10.1016/j.neuroimage.2010.05.023; Forbes EE, 2011, NEUROPSYCHOPHARMACOL, V36, P372, DOI 10.1038/npp.2010.164; Friedman J, 2010, J STAT SOFTW, V33, P1; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Krug A, 2010, NEUROIMAGE, V49, P1831, DOI 10.1016/j.neuroimage.2009.09.028; Bom de Araujo N, 2011, CLINICS SAO PAULO, V66; Carey LM, 2015, FRONT HUM NEUROSCI, V8, P1; Chris R, 2014, MRICRON NIFTI VIEWER; Ebmeier K, 2009, NEUROTOX RES, V10, P1; Fiot JB, 2014, NEUROIMAGE-CLIN, V4, P718, DOI 10.1016/j.nicl.2014.02.002; Fossati P, 2003, PSYCHIAT RES, V117, P17, DOI 10.1016/S0165-1781(02)00300-1; Friedman J., 2010, TECHNICAL REPORT; Friedman J., 2009, ELEMENTS STAT LEARNI; Gammerman A., 2008, STAT APPL GENET MOL, V7; Gooren T, 2013, ACTA NEUROPSYCHIATR, V25; Heath S, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-98; Kipli K, 2013, IJBBB, V3, P444, DOI [DOI 10.7763/IJBBB.2013.V3.252, 10.7763/IJBBB.2013.V3.252]; Kipli K, 2013, NEURORADIOLOGY, V55, P567, DOI 10.1007/s00234-013-1139-8; Liu J., 2009, SLEP SPARSE LEARNING; Liu MH, 2014, NEUROINFORMATICS, V12, P381, DOI 10.1007/s12021-013-9218-x; Lord A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041282; Milne AMB, 2012, J PSYCHIATR NEUROSCI, V37, P28, DOI 10.1503/jpn.110004; Norris N, 1995, AGING NEUROPSYCHO C, V2, DOI [10.1080/13825589508256598, DOI 10.1080/13825589508256598]; Tsao S, 2014, P SOC PHOTO-OPT INST; Vapnik VN, 1998, NATURE STAT LEARNING; Xin B, 2014, 28 AAAI C ART INT, P2163	45	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123524	10.1371/journal.pone.0123524		23	Multidisciplinary Sciences	Science & Technology - Other Topics	CH2XA	WOS:000353887100022		
J	Supindham, T; Chariyalertsak, S; Utaipat, U; Miura, T; Ruanpeng, D; Chotirosniramit, N; Kosashunhanan, N; Sugandhavesa, P; Saokhieo, P; Songsupa, R; Siriaunkgul, S; Wongthanee, A				Supindham, Taweewat; Chariyalertsak, Suwat; Utaipat, Utaiwan; Miura, Toshiyuki; Ruanpeng, Darin; Chotirosniramit, Nuntisa; Kosashunhanan, Natthapol; Sugandhavesa, Patcharaphan; Saokhieo, Pongpun; Songsupa, Radchanok; Siriaunkgul, Sumalee; Wongthanee, Antika			High Prevalence and Genotype Diversity of Anal HPV Infection among MSM in Northern Thailand	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; UNINFECTED MEN; RISK-FACTORS; SEX	Background HPV infection is common and may cause cancer among men who have sex with men (MSM). Anal HPV infection (HPV+) was found in 85% of HIV-positive (HIV+) and 59% of HIV-negative (HIV-) MSM in Bangkok, central Thailand. As little is known about HPV in this group in northern Thailand, we studied MSM subgroups comprised of gay men (GM), bisexual men (BM), and transgender women (TGW). Methods From July 2012 through January 2013, 85 (42.5% of 200) GM, 30 (15%) BM, and 85 (42.5%) TGW who practiced receptive anal intercourse were recruited after informed consent, followed by self-assisted computer interview, HIV testing, and anal swabs for HPV genotyping. Results Of 197 adequate specimens, the overall prevalence of any HPV was 157 (80%). Prevalence was 89% (76/85) in GM, 48% (14/29) in BM, and 81% (67/83) in TGW. The most common high-risk types were HPV16 (27% of 197), HPV58 (23%), and HPV51 (18%). Prevalence of high-risk types was 74% in 85 GM, 35% in 29 BM, and 71% in 83 TGW. Prevalence of any HPV type, or high-risk type, was 100% and 94%, respectively, among 48 HIV+ MSM, 70% and 54% among 120 HIV- MSM. Of the 197 specimens, 36% (70) had HPV types 16 and/or 18 in the bivalent vaccine, compared to 48% (95) with >= 1 of types 16/18/06/11 in the quadrivalent, 56% (111) for 16/18/31/33/45/52/58 in the 7-valent, and 64% (126) for 16/18/31/33/45/52/58/06/11 in the 9-valent. HIV+, GM, and TGW were independently associated with HPV infection. Conclusions We found higher rates of both any HPV and high-risk types than previous studies. Among the heretofore unstudied TGW, their equivalent HPV rates were comparable to GM. Current and investigational HPV vaccines could substantially protect GM, BM, and TGW from the serious consequences of HPV infection especially among HIV + MSM.	[Supindham, Taweewat; Chariyalertsak, Suwat; Utaipat, Utaiwan; Ruanpeng, Darin; Chotirosniramit, Nuntisa; Kosashunhanan, Natthapol; Sugandhavesa, Patcharaphan; Saokhieo, Pongpun; Songsupa, Radchanok; Wongthanee, Antika] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand; [Miura, Toshiyuki] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki 852, Japan; [Siriaunkgul, Sumalee] Chiang Mai Univ, Fac Med, Dept Pathol, Chiang Mai 50000, Thailand	Chariyalertsak, S (reprint author), Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand.	suwat@rihes.org			Ministry of Education, Culture, Sports, Science and Technology(MEXT) of Japan [23406032]; Thailand's Office of the Higher Education Commission	This study was supported by a Grant-inAid for Scientific Research (B) (23406032) to Dr. Toshiyuki Miura from the Ministry of Education, Culture, Sports, Science and Technology(MEXT) of Japan. It was also supported in part by the National Research University Project under Thailand's Office of the Higher Education Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Yu CT, 2013, AIDS BEHAV, V17, P1211, DOI 10.1007/s10461-012-0173-6; Hu YF, 2013, JAIDS-J ACQ IMM DEF, V64, P103, DOI 10.1097/QAI.0b013e31829b6298; Nyitray AG, 2011, J INFECT DIS, V203, P49, DOI 10.1093/infdis/jiq021; Allison MA, 2013, ACAD PEDIATR, V13, P466, DOI 10.1016/j.acap.2013.03.006; Palefsky JM, 1998, AIDS, V12, P495, DOI 10.1097/00002030-199805000-00011; Schwartz LM, 2013, J INFECT DIS, V208, P1768, DOI 10.1093/infdis/jit374; Dona MG, 2012, J CLIN VIROL, V54, P185, DOI 10.1016/j.jcv.2012.02.014; MEHTA CR, 1995, STAT MED, V14, P2143, DOI 10.1002/sim.4780141908; Nyitray AG, 2011, SEX TRANSM DIS, V38, P932, DOI 10.1097/OLQ.0b013e31822154f9; Chariyalertsak S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024295; Gaisa M, 2013, AIDS; Gao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015256; Guadamuz TE, 2011, AIDS BEHAV, V15, P650, DOI 10.1007/s10461-010-9850-5; Guimaraes MDC, 2011, JAIDS-J ACQ IMM DEF, V57, pS217, DOI 10.1097/QAI.0b013e31821e9994; Lau JT, 2013, ARCH SEX BEHAV; Phanuphak N, 2011, 18 C RETR OPP INF CR; Phanuphak N, 2013, JAIDS-J ACQ IMM DEF, V63, P472, DOI 10.1097/QAI.0b013e3182918a5a; Rahman M, 2013, VACCINE; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Senba M, 2006, J MED VIROL, V78, P1341, DOI 10.1002/jmv.20703; Tong W, 2013, HIV MED; Wiley DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079492; Winitdhama G, 2006, ESTIMATES MEN HAVING	23	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124499	10.1371/journal.pone.0124499		17	Multidisciplinary Sciences	Science & Technology - Other Topics	CH2XA	WOS:000353887100044		
J	Yamaguchi, Y; Li, ZQ; Zhu, XF; Liu, CC; Zhang, DW; Dou, XM				Yamaguchi, Yoshinori; Li, Zhenqing; Zhu, Xifang; Liu, Chenchen; Zhang, Dawei; Dou, Xiaoming			Polyethylene Oxide (PEO) and Polyethylene Glycol (PEG) Polymer Sieving Matrix for RNA Capillary Electrophoresis	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; POLY(ETHYLENE OXIDE); DNA SEPARATION; NUCLEIC-ACIDS; BEHAVIOR; DYNAMICS; TEMPERATURE; MORPHOLOGY; FRAGMENTS; SIZE	The selection of sieving polymer for RNA fragments separation by capillary electrophoresis is imperative. We investigated the separation of RNA fragments ranged from 100 to 10,000 nt in polyethylene glycol (PEG) and polyethylene oxide (PEO) solutions with different molecular weight and different concentration. We found that the separation performance of the small RNA fragments (<1000 nt) was improved with the increase of polymer concentration, whereas the separation performance for the large ones (>4000 nt) deteriorated in PEG/PEO solutions when the concentration was above 1.0%/0.6%, respectively. By double logarithmic plot of mobility and RNA fragment size, we revealed three migration regimes for RNA in PEG (300-500k) and PEO (4,000k). Moreover, we calculated the smallest resolvable nucleotide length (N-min) from the resolution length analysis.	[Li, Zhenqing; Liu, Chenchen; Zhang, Dawei] E China Univ Sci & Technol, Grad Sch Sci, IPBM, Shanghai 200237, Peoples R China; [Yamaguchi, Yoshinori; Dou, Xiaoming] Univ Shanghai Sci & Technol, Engn Res Ctr Opt Instrument & Syst, Shanghai Key Lab Modern Opt Syst, Minist Educ, Shanghai 200093, Peoples R China; [Yamaguchi, Yoshinori] Osaka Univ, Grad Sch Engn, Dept Appl Phys, Suita, Osaka 5650871, Japan; [Zhu, Xifang] Changzhou Inst Technol, Coll Photoelect Engn, Changzhou 213002, Peoples R China	Li, ZQ (reprint author), E China Univ Sci & Technol, Grad Sch Sci, IPBM, 130 Meilong Rd, Shanghai 200237, Peoples R China.	zhenqingli@163.com; xiaomingdou@yeah.net			JSPS, Japan [25600049]; National Natural Science Foundation of China [21205078, 61378060]; Research Fund for the Doctoral Program of Higher Education of China [20123120110002]; Innovation Fund Project for Graduate Student of Shanghai, China [JWCXSL1401]	This project was partly supported by Grant-in-Aid for Scientific Research (Houga) (No. 25600049 (Y.Y.)), JSPS, Japan. The authors also gratefully acknowledge support from National Natural Science Foundation of China (No. 21205078 and No. 61378060), Research Fund for the Doctoral Program of Higher Education of China (No. 20123120110002), and the Innovation Fund Project for Graduate Student of Shanghai (No. JWCXSL1401), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Yu ZQ, 2010, ANAL BIOCHEM, V397, P197, DOI 10.1016/j.ab.2009.10.030; Tinoco I, 2002, BIOPHYS CHEM, V101, P513, DOI 10.1016/S0301-4622(02)00177-1; Anderson GJ, 2011, ANAL CHEM, V83, P1350, DOI 10.1021/ac102671n; Heller C, 2001, ELECTROPHORESIS, V22, P629, DOI 10.1002/1522-2683(200102)22:4<629::AID-ELPS629>3.0.CO;2-S; Guttman A, 1996, NATURE, V380, P461, DOI 10.1038/380461a0; Balijepalli S, 1996, MACROMOLECULES, V29, P6601, DOI 10.1021/ma960678s; Kim Y, 1997, J CHROMATOGR A, V781, P315, DOI 10.1016/S0021-9673(97)00472-X; HJERTEN S, 1985, J CHROMATOGR, V347, P191, DOI 10.1016/S0021-9673(01)95485-8; Yu ZQ, 2013, J AM CHEM SOC, V135, P2883, DOI 10.1021/ja311090e; VIOVY JL, 1993, ELECTROPHORESIS, V14, P322, DOI 10.1002/elps.1150140155; Liu P, 2007, ANAL CHEM, V79, P1881, DOI 10.1021/ac061961k; BARRON AE, 1993, J CHROMATOGR A, V652, P3, DOI 10.1016/0021-9673(93)80639-P; Bernard Tinland AP, 1997, MACROMOLECULES, V30, P5763; BIEZE TWN, 1994, MACROMOLECULES, V27, P1355, DOI 10.1021/ma00084a013; Briscoe B, 1996, MACROMOLECULES, V29, P6208, DOI 10.1021/ma960667z; CHEN JH, 1995, J POLYM SCI POL PHYS, V33, P1851, DOI 10.1002/polb.1995.090331301; CHENG SZD, 1991, J POLYM SCI POL PHYS, V29, P311, DOI 10.1002/polb.1991.090290306; Kan CW, 2003, ELECTROPHORESIS, V24, P55, DOI 10.1002/elps.200390031; KARGER BL, 1989, NATURE, V339, P641, DOI 10.1038/339641a0; Kim YS, 1997, ELECTROPHORESIS, V18, P2901, DOI 10.1002/elps.1150181530; Li Q, 2010, ANAL CHEM, V82, P5260, DOI 10.1021/ac100669z; Li ZQ, 2014, ANALYST, V139, P6113, DOI 10.1039/c4an01649a; Li ZQ, 2010, ELECTROPHORESIS, V31, P3531, DOI 10.1002/elps.201000175; Li ZQ, 2014, ANAL METHODS-UK, V6, P2473, DOI 10.1039/c3ay41965g; Li ZQ, 2011, ANAL BIOANAL CHEM, V401, P1661, DOI 10.1007/s00216-011-5228-4; Li ZQ, 2014, J CHROMATOGR A, V1331, P100, DOI 10.1016/j.chroma.2014.01.021; Li ZQ, 2010, J SEP SCI, V33, P2811, DOI 10.1002/jssc.201000188; Li ZQ, 2012, J CHROMATOGR A, V1229, P274, DOI 10.1016/j.chroma.2012.01.056; Lines JA, 2014, BIOCHEM BIOPH RES CO, V443, P308, DOI 10.1016/j.bbrc.2013.11.095; Masubuchi Y, 1996, ELECTROPHORESIS, V17, P1065, DOI 10.1002/elps.1150170615; Merdas A, 1996, J PHYS CHEM-US, V100, P15180, DOI 10.1021/jp960628p; Mitchelson KR, 2004, CAPILLARY ELECTROPHO; OANA H, 1994, MACROMOLECULES, V27, P6061, DOI 10.1021/ma00099a019; SHI XL, 1995, ANAL CHEM, V67, P3219, DOI 10.1021/ac00114a018; Slater GW, 2000, ELECTROPHORESIS, V21, P3873, DOI 10.1002/1522-2683(200012)21:18<3873::AID-ELPS3873>3.3.CO;2-#; SLATER GW, 1993, ELECTROPHORESIS, V14, P1, DOI 10.1002/elps.1150140102; Slater GW, 2001, METH MOL B, V162, P27; Sumitomo K, 2009, ELECTROPHORESIS, V30, P1538, DOI 10.1002/elps.200800457; Sumitomo K, 2009, ELECTROPHORESIS, V30, P3607, DOI 10.1002/elps.200900255; Todorov TI, 2003, ANAL CHEM, V75, P1837, DOI 10.1021/ac026325a; Todorov TI, 2002, ELECTROPHORESIS, V23, P1033, DOI 10.1002/1522-2683(200204)23:7/8<1033::AID-ELPS1033>3.0.CO;2-7; Yamaguchi Y, 2004, ELECTROPHORESIS, V25, P999, DOI 10.1002/elps.200305783	42	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123406	10.1371/journal.pone.0123406		12	Multidisciplinary Sciences	Science & Technology - Other Topics	CH2XA	WOS:000353887100020		
J	Yamasaki, H; Funai, Y; Funao, T; Mori, T; Nishikawa, K				Yamasaki, Hiroyuki; Funai, Yusuke; Funao, Tomoharu; Mori, Takashi; Nishikawa, Kiyonobu			Effects of Tramadol on Substantia Gelatinosa Neurons in the Rat Spinal Cord: An In Vivo Patch-Clamp Analysis	PLOS ONE			English	Article							MU-OPIOID RECEPTOR; DORSAL-HORN; INHIBITORY TRANSMISSION; SYNAPTIC-TRANSMISSION; VENTROMEDIAL MEDULLA; XENOPUS OOCYTES; PAIN; METABOLITE; ACTIVATION; MECHANISMS	Tramadol is thought to modulate synaptic transmissions in the spinal dorsal horn mainly by activating mu-opioid receptors and by inhibiting the reuptake of monoamines in the CNS. However, the precise mode of modulation remains unclear. We used an in vivo patch clamp technique in urethane-anesthetized rats to determine the antinociceptive mechanism of tramadol. In vivo whole-cell recordings of spontaneous inhibitory postsynaptic currents (sIPSCs) and spontaneous excitatory postsynaptic currents (sEPSCs) were made from substantia gelatinosa (SG) neurons (lamina II) at holding potentials of 0 mV and -70 mV, respectively. The effects of intravenous administration (0.5, 5, 15 mg/kg) of tramadol were evaluated. The effects of superfusion of tramadol on the surface of the spinal cord and of a tramadol metabolite (M1) were further analyzed. Intravenous administration of tramadol at doses >5 mg/kg decreased the sEPSCs and increased the sIPSCs in SG neurons. These effects were not observed following naloxone pretreatment. Tramadol superfusion at a clinically relevant concentration (10 mu M) had no effect, but when administered at a very high concentration (100 mu M), tramadol decreased sEPSCs, produced outward currents, and enhanced sIPSCs. The effects of M1 (1, 5 mg/kg intravenously) on sEPSCs and sIPSCs were similar to those of tramadol at a corresponding dose (5, 15 mg/kg). The present study demonstrated that systemically administered tramadol indirectly inhibited glutamatergic transmission, and enhanced GABAergic and glycinergic transmissions in SG neurons. These effects were mediated primarily by the activation of mu-opioid receptors. M1 may play a key role in the antinociceptive mechanisms of tramadol.	[Yamasaki, Hiroyuki; Funai, Yusuke; Funao, Tomoharu; Mori, Takashi; Nishikawa, Kiyonobu] Osaka City Univ, Grad Sch Med, Dept Anesthesiol, Osaka 558, Japan	Mori, T (reprint author), Osaka City Univ, Grad Sch Med, Dept Anesthesiol, Osaka 558, Japan.	m1377033@med.osaka-cu.ac.jp			Japan Society for the Promotion of Science, Tokyo, Japan [24592355]	This study was supported in part by a grant-in-aid for scientific research (24592355) from the Japan Society for the Promotion of Science, Tokyo, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Kimura M, 2012, ANESTH ANALG, V115, P443, DOI [10.1213/ANE.0b013e31825683c3, 10.1213/AM3.0b013e31825683c3]; Sonohata M, 2004, J PHYSIOL-LONDON, V555, P515, DOI 10.1113/jphysiol.2003.054932; Yoshimura M, 2006, J PHARMACOL SCI, V101, P107, DOI 10.1254/jphys.CRJ06008X; RAFFA RB, 1992, J PHARMACOL EXP THER, V260, P275; CERVERO F, 1980, BRAIN, V103, P717, DOI 10.1093/brain/103.4.717; Grond S, 1999, BRIT J CLIN PHARMACO, V48, P254, DOI 10.1046/j.1365-2125.1999.00986.x; Klotz U, 2003, ARZNEIMITTEL-FORSCH, V53, P681; Kohno T, 1999, J PHYSIOL-LONDON, V518, P803, DOI 10.1111/j.1469-7793.1999.0803p.x; Gillen C, 2000, N-S ARCH PHARMACOL, V362, P116, DOI 10.1007/s002100000266; Baccei ML, 2004, J NEUROSCI, V24, P4749, DOI 10.1523/JNEUROSCI.5211-03.2004; Shiraishi M, 2002, BRIT J PHARMACOL, V136, P207, DOI 10.1038/sj.bjp.0704703; Baba H, 2000, ANESTHESIOLOGY, V92, P485, DOI 10.1097/00000542-200002000-00031; Codd EE, 2008, PAIN, V134, P254, DOI 10.1016/j.pain.2007.04.019; DRIESSEN B, 1992, BRIT J PHARMACOL, V105, P147; Funai Y, 2014, PAIN, V155, P617, DOI 10.1016/j.pain.2013.12.018; Furue H, 1999, J PHYSIOL-LONDON, V521, P529, DOI 10.1111/j.1469-7793.1999.00529.x; Furue H, 2004, NEUROSCI RES, V48, P361, DOI 10.1016/j.neures.2003.12.005; Giusti P, 1997, BRIT J PHARMACOL, V122, P302, DOI 10.1038/sj.bjp.0701374; Hama A, 2007, EUR J PHARMACOL, V559, P32, DOI 10.1016/j.ejphar.2006.11.047; Hara K, 2005, ANESTH ANALG, V100, P1400, DOI 10.1213/01.ANE.0000150961.24747.98; HENNIES HH, 1988, ARZNEIMITTEL-FORSCH, V38-2, P877; Hurley RW, 2003, NEUROSCIENCE, V118, P789, DOI 10.1016/S0306-4522(03)00041-1; Ide S, 2006, NEUROPHARMACOLOGY, V51, P651, DOI 10.1016/j.neuropharm.2006.05.008; Kaneko K, 2014, NEUROSCI LETT, V562, P28, DOI 10.1016/j.neulet.2014.01.007; Kato G, 2006, J NEUROSCI, V26, P1787, DOI 10.1523/JNEUROSCI.4856-05.2006; Katsuki R, 2006, BRIT J PHARMACOL, V149, P319, DOI 10.1038/sj.bjp.0706868; Kawamata T, 2003, BRAIN RES, V978, P250, DOI 10.1016/S0006-8993(03)02952-4; Koga A, 2005, BRIT J PHARMACOL, V145, P602, DOI 10.1038/sj.bjp.0706225; Narikawa K, 2000, J NEUROPHYSIOL, V84, P2171; Parasrampuria R, 2007, CHIRALITY, V19, P190, DOI 10.1002/chir.20360; Pinto M, 2008, J COMP NEUROL, V510, P175, DOI 10.1002/cne.21793; Yoshimura M, 1996, PROG BRAIN RES, V113, P443, DOI 10.1016/S0079-6123(08)61103-6	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125147	10.1371/journal.pone.0125147		16	Multidisciplinary Sciences	Science & Technology - Other Topics	CH2XA	WOS:000353887100082		
J	Onuma, R; Horiguchi, T				Onuma, Ryo; Horiguchi, Takeo			Kleptochloroplast Enlargement, Karyoklepty and the Distribution of the Cryptomonad Nucleus in Nusuttodinium (= Gymnodinium) aeruginosum (Dinophyceae)	PROTIST			English	Article						Cryptomonad nucleus; karyoklepty; kleptochloroplast; morphological transition; Nusuttodinium aeruginosum; ultrastructure	DINOFLAGELLATE AMYLAX-TRIACANTHA; CILIATE MESODINIUM-RUBRUM; NUCLEOMORPH DIVISION; AMPHIDINIUM-POECILOCHROUM; ANTARCTIC DINOFLAGELLATE; MARINE DINOFLAGELLATE; ACIDOTUM DINOPHYCEAE; PERIDINIUM-BALTICUM; MYRIONECTA-RUBRA; ULTRASTRUCTURE	The unarmoured freshwater dinoflagellate Nusuttodinium (= Gymnodinium) aeruginosum retains a cryptomonad-derived kleptochloroplast and nucleus, the former of which fills the bulk of its cell volume. The paucity of studies following morphological changes to the kleptochloroplast with time make it unclear how the kleptochloroplast enlarges and why the cell ultimately loses the cryptomonad nucleus. We observed, both at the light and electron microscope level, morphological changes to the kleptochloroplast incurred by the enlargement process under culture conditions. The distribution of the cryptomonad nucleus after host cell division was also investigated. The volume of the kleptochloroplast increased more than 20-fold, within 120 h of ingestion of the cryptomonad. Host cell division was not preceded by cryptomonad karyokinesis so that only one of the daughter cells inherited a cryptomonad nucleus. The fate of all daughter cells originating from a single cell through five generations was closely monitored, and this observation revealed that the cell that inherited the cryptomonad nucleus consistently possessed the largest kleptochloroplast for that generation. Therefore, this study suggests that some important cryptomonad nucleus division mechanism is lost during ingestion process, and that the cryptomonad nucleus carries important information for the enlargement of the kleptochloroplast. (C) 2015 Elsevier GmbH. All rights reserved.	[Onuma, Ryo] Hokkaido Univ, Grad Sch Sci, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan; [Horiguchi, Takeo] Hokkaido Univ, Fac Sci, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan	Horiguchi, T (reprint author), Hokkaido Univ, Fac Sci, Dept Nat Hist Sci, North 10,West 8, Sapporo, Hokkaido 0600810, Japan.	horig@mail.sci.hokudai.ac.jp	Horiguchi, Takeo/D-7612-2012		Japan Society for the Promotion of Science [24370034]	We thank Dr. Stuart D. Sym for reading the manuscript. This work was partly supported by the Grant-in-Aid by the Japan Society for the Promotion of Science (No. 24370034).	HIBBERD DJ, 1977, J MAR BIOL ASSOC UK, V57, P45; Park MG, 2006, AQUAT MICROB ECOL, V45, P101, DOI 10.3354/ame045101; Park MG, 2008, J PHYCOL, V44, P1154, DOI 10.1111/j.1529-8817.2008.00579.x; MORRALL S, 1982, J CELL SCI, V54, P311; Nowack ECM, 2010, PHILOS T R SOC B, V365, P699, DOI 10.1098/rstb.2009.0188; Yamaguchi H, 2011, PROTIST, V162, P650, DOI 10.1016/j.protis.2011.01.002; Park MG, 2013, J EUKARYOT MICROBIOL, V60, P363, DOI 10.1111/jeu.12041; Nagai S, 2008, J PHYCOL, V44, P909, DOI 10.1111/j.1529-8817.2008.00544.x; TIPPIT DH, 1976, J CELL SCI, V21, P273; Gast RJ, 2007, ENVIRON MICROBIOL, V9, P39, DOI 10.1111/j.1462-2920.2006.01109.x; Johnson MD, 2007, NATURE, V445, P426, DOI 10.1038/nature05496; TOMAS RN, 1973, J PHYCOL, V9, P304; Nishitani Goh, 2008, Plankton & Benthos Research, V3, P78, DOI 10.3800/pbr.3.78; Gustafson DE, 2000, NATURE, V405, P1049, DOI 10.1038/35016570; Johnson MD, 2011, PHOTOSYNTH RES, V107, P117, DOI 10.1007/s11120-010-9546-8; Keeling PJ, 2013, ANNU REV PLANT BIOL, V64, P583, DOI 10.1146/annurev-arplant-050312-120144; Lewitus AJ, 1999, J PHYCOL, V35, P303, DOI 10.1046/j.1529-8817.1999.3520303.x; Eriksen Niels T., 2002, Harmful Algae, V1, P191, DOI 10.1016/S1568-9883(02)00011-2; FARMER MA, 1990, PROTOPLASMA, V153, P178, DOI 10.1007/BF01354002; FIELDS SD, 1991, J PHYCOL, V27, P525, DOI 10.1111/j.0022-3646.1991.00525.x; Figueror RI, 2009, PROTIST, V160, P85; Horiguchi Takeo, 1992, Japanese Journal of Phycology, V40, P353; HORIGUCHI T, 2006, PALEONTOL RES, V10, P299; Imanian B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010711; Imanian B, 2014, GENOME BIOL EVOL, V6, P333, DOI 10.1093/gbe/evu014; JEFFREY SW, 1976, J PHYCOL, V12, P450, DOI 10.1111/j.0022-3646.1976.00450.x; Kim M, 2014, J EUKARYOT MICROBIOL, V61, P354, DOI 10.1111/jeu.12115; Koike K, 2008, PHYCOL RES, V56, P301, DOI 10.1111/j.1440-1835.2008.00512.x; LARSEN J, 1988, PHYCOLOGIA, V27, P366, DOI 10.2216/i0031-8884-27-3-366.1; Lindholm T., 1985, Advances in Aquatic Microbiology, V3, P1; MCKERRACHER L, 1982, CAN J BOT, V60, P2440; OAKLEY BR, 1976, PROTOPLASMA, V88, P241, DOI 10.1007/BF01283249; Okamoto N, 2006, PROTIST, V157, P401, DOI 10.1016/j.protis.2006.05.011; Onuma R, 2013, PROTIST, V164, P622, DOI 10.1016/j.protis.2013.06.003; Sato T, 2014, PROTIST, V165, P113, DOI 10.1016/j.protis.2014.01.003; SCHNEPF E, 1989, PLANT SYST EVOL, V164, P75, DOI 10.1007/BF00940431; SCHNEPF E, 1988, BOT ACTA, V101, P196; SCHNEPF E, 1992, EUR J PROTISTOL, V28, P3, DOI 10.1016/S0932-4739(11)80315-9; Sellers CG, 2014, J PHYCOL, V50, P1081, DOI 10.1111/jpy.12240; Shi Z, 1983, HAIYANG YU HUZHAO, V14, P161; Skovgaard A, 1998, AQUAT MICROB ECOL, V15, P293, DOI 10.3354/ame015293; Takano Y, 2014, PROTIST, V165, P759, DOI 10.1016/j.protis.2014.09.001; WILCOX LW, 1984, J PHYCOL, V20, P236, DOI 10.1111/j.0022-3646.1984.00236.x; Xia S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053820	44	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	1434-4610			PROTIST	Protist	MAY	2015	166	2					177	195		10.1016/j.protis.2015.01.004		19	Microbiology	Microbiology	CI8JJ	WOS:000355018300002		
J	Doyle, F; Mcgee, H; Conroy, R; Conradi, HJ; Meijer, A; Steeds, R; Sato, H; Stewart, DE; Parakh, K; Carney, R; Freedland, K; Anselmino, M; Pelletier, R; Bos, EH; de Jonge, P				Doyle, Frank; Mcgee, Hannah; Conroy, Ronn; Conradi, Henk Jan; Meijer, Anna; Steeds, Richard; Sato, Hiroshi; Stewart, Donna E.; Parakh, Kapil; Carney, Robert; Freedland, Kenneth; Anselmino, Matteo; Pelletier, Roxanne; Bos, Elisabeth H.; de Jonge, Peter			Systematic Review and Individual Patient Data Meta-Analysis of Sex Differences in Depression and Prognosis in Persons With Myocardial Infarction: A MINDMAPS Study	PSYCHOSOMATIC MEDICINE			English	Review						depression; myocardial infarction; gender differences; prognosis; individual patient data meta-analysis	CORONARY-HEART-DISEASE; GENDER-DIFFERENCES; CARDIOVASCULAR EVENTS; ARTERY-DISEASE; RISK-FACTORS; MORTALITY; SYMPTOMS; VULNERABILITIES; OUTCOMES; WOMEN	Objective: Using combined individual patient data from prospective studies, we explored sex differences in depression and prognosis post-myocardial infarction (MI) and determined whether disease indices could account for found differences. Methods: Individual patient data analysis of 10,175 MI patients who completed diagnostic interviews or depression questionnaires from 16 prospective studies from the MINDMAPS study was conducted. Multilevel logistic and Cox regression models were used to determine sex differences in prevalence of depression and sex-specific effects of depression on subsequent outcomes. Results: Combined interview and questionnaire data from observational studies showed that 36% (635/1760) of women and 29% (1575/5526) of men reported elevated levels of depression (age-adjusted odds ratio = 0.68, 95% confidence interval [CI] = 0.60-0.77). The risk for all-cause mortality associated with depression was higher in men (hazard ratio = 1.38, 95% CI = 1.30-1.47) than in women (hazard ratio = 1.22, 95% CI = 1.14-1.31; sex by depression interaction: p < .001). Low left ventricular ejection fraction (LVEF) was associated with higher depression scores in men only (sex by LVEF interaction: B = 0.294, 95% CI = 0.090-0.498), which attenuated the sex difference in the association between depression and prognosis. Conclusions: The prevalence of depression post-MI was higher in women than in men, but the association between depression and cardiac prognosis was worse for men. LVEF was associated with depression in men only and accounted for the increased risk of all-cause mortality in depressed men versus women, suggesting that depression in men post-MI may, in part, reflect cardiovascular disease severity.	[Doyle, Frank] Royal Coll Surgeons Ireland, Div Populat Hlth Sci Psychol, Dublin 2, Ireland; [Conroy, Ronn] Royal Coll Surgeons Ireland, Populat Hlth Sci Epidemiol & Publ Hlth Med, Dublin 2, Ireland; [Mcgee, Hannah] Royal Coll Surgeons Ireland, Fac Med & Hlth Sci, Dublin 2, Ireland; [Conradi, Henk Jan] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands; [Meijer, Anna; Bos, Elisabeth H.; de Jonge, Peter] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Steeds, Richard] Queen Elizabeth Hosp, Dept Cardiol, Birmingham B15 2TH, W Midlands, England; [Sato, Hiroshi] Kwansei Gakuin Univ, Sch Human Welf Studies, Nishinomiya, Hyogo, Japan; [Stewart, Donna E.] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada; [Parakh, Kapil] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Carney, Robert; Freedland, Kenneth] Washington Univ, Dept Psychiat, St Louis, MO USA; [Anselmino, Matteo] Univ Turin, Div Cardiol, Dept Med Sci, Turin, Italy; [Pelletier, Roxanne] McGill Univ, Ctr Hlth, Montreal, PQ, Canada	Doyle, F (reprint author), Royal Coll Surgeons Ireland, Div Populat Hlth Sci Psychol, 123 St Stephens Green, Dublin 2, Ireland.	fdoyle4@rcsi.ie	Doyle, Frank/C-2750-2012; Conroy, Ronan/C-6416-2008	Doyle, Frank/0000-0002-3785-7433; Conroy, Ronan/0000-0001-5983-8682	Dutch Medical Research Council [016.086.397]; University and Society Collaboration from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (Tokyo, Japan) [15590743]; Japan Arteriosclerosis Prevention Fund (Tokyo, Japan); Canadian Institute of Health Research on Gender, Mental Health and Violence; Canadian Institutes of Health Research	A. Meijer, H.J. Conradi, and P. de Jonge received support from the Dutch Medical Research Council through a Vidi grant (Grant No. 016.086.397). H. Sato was supported by a grant-in-aid for University and Society Collaboration (15590743) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (Tokyo, Japan) and by a research grant from the Japan Arteriosclerosis Prevention Fund (Tokyo, Japan). D.E. Stewart received a grant from the Canadian Institute of Health Research on Gender, Mental Health and Violence; has a membership on the Duloxetine and Pregnancy Registry Scientific Advisory Board of Eli Lilly Inc; and also received travel support from Ranbaxy Pharma for a psychiatric meeting in Thailand. R. Carney PhD (or a member of his family) owns stock in Pfizer Inc and Forest Laboratories. R. Pelletier PhD is funded by the Canadian Institutes of Health Research. F. Doyle, H. McGee, R. Conroy, E. H. Bos, A. Meijer, R. Steeds, K. Parakh, K. Freedland, M. Anselmino, R. Pelletier, H.J. Conradi, P. de Jonge have no conflicts of interest or disclosures. The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.	Freedland KE, 2003, PSYCHOSOM MED, V65, P119, DOI 10.1097/01.PSY.0000038938.67401.85; Meijer A, 2013, BRIT J PSYCHIAT, V203, P90, DOI 10.1192/bjp.bp.112.111195; Doyle F, 2011, PSYCHOL HEALTH, V26, P619, DOI 10.1080/08870441003624398; Kraemer HC, 2001, AM J PSYCHIAT, V158, P848, DOI 10.1176/appi.ajp.158.6.848; Ormel J, 2011, PSYCHOTHER PSYCHOSOM, V80, P264, DOI 10.1159/000323165; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Carney RM, 2001, CIRCULATION, V104, P2024, DOI 10.1161/hc4201.097834; Milcent C, 2007, CIRCULATION, V115, P833, DOI 10.1161/CIRCULATIONAHA.106.664979; Kaptein KI, 2006, PSYCHOSOM MED, V68, P662, DOI 10.1097/01.psy.0000233237.79085.57; Bush DE, 2001, AM J CARDIOL, V88, P337, DOI 10.1016/S0002-9149(01)01675-7; Stewart LA, 2002, EVAL HEALTH PROF, V25, P76, DOI 10.1177/0163278702025001006; Meijer A, 2011, GEN HOSP PSYCHIAT, V33, P203, DOI 10.1016/j.genhosppsych.2011.02.007; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Vaccarino V, 2014, PSYCHOSOM MED, V76, P171, DOI 10.1097/PSY.0000000000000045; Christenfeld NJS, 2004, PSYCHOSOM MED, V66, P868, DOI 10.1097/01.psy.0000140008.70959.41; Thombs BD, 2006, J GEN INTERN MED, V21, P30, DOI 10.1111/j.1525-1497.2005.00269x; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Doyle F, 2014, PSYCHOSOM MED, V76, P44, DOI 10.1097/PSY.0000000000000020; Poon S, 2012, AM HEART J, V163, P66, DOI 10.1016/j.ahj.2011.09.025; Shaw LJ, 2009, J AM COLL CARDIOL, V54, P1561, DOI 10.1016/j.jacc.2009.04.098; Vaccarino V, 2013, NAT REV CARDIOL, V10, P508, DOI 10.1038/nrcardio.2013.93; Van Melle JP, 2007, BRIT J PSYCHIAT, V190, P460, DOI 10.1192/bjp.bp.106.028647; Doyle F, 2011, GEN HOSP PSYCHIAT, V33, P224, DOI 10.1016/j.genhosppsych.2011.03.008; Carney RM, 2002, J PSYCHOSOM RES, V53, P897, DOI 10.1016/S0022-3999(02)00311-2; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Gulati M, 2012, CLIN CARDIOL, V35, P141, DOI 10.1002/clc.21966; Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818; Van de Velde S, 2010, SOC SCI MED, V71, P305, DOI 10.1016/j.socscimed.2010.03.035; SAUERBREI W, 1992, STAT MED, V11, P2093, DOI 10.1002/sim.4780111607; Centers for Disease Control and Prevention, 2010, MORB MORT WEEKL REP; Centers for Disease Control and Prevention (CDC), 2007, QUICKSTATS PREV CURR; Clark Cari Jo, 2012, Front Psychiatry, V3, P5, DOI 10.3389/fpsyt.2012.00005; Doyle F, 2007, HLTH PSYCHOL REV, V1, P137, DOI 10.1080/17437190802046322; Goldstein JM, 2011, J DEV ORIG HLTH DIS, V2, P353, DOI 10.1017/S2040174411000651; Kendler KS, 2009, ARCH GEN PSYCHIAT, V66, P857, DOI 10.1001/archgenpsychiatry.2009.94; Lehto S, 2000, SCAND CARDIOVASC J, V34, P580; Martens EJ, 2008, PSYCHOL MED, V38, P257, DOI 10.1017/S0033291707001377; Naqvi TZ, 2005, PSYCHOSOM MED, V67, pS15, DOI 10.1097/01.psy.0000164013.55453.05; Rieckmann N, 2006, PSYCHOTHER PSYCHOSOM, V75, P353, DOI 10.1159/000095441; Schepis T, 2006, J NUCL MED, V47, P1288; Smith CT, 2005, J EVAL CLIN PRACT, V11, P468, DOI 10.1111/j.1365-2753.2005.00559.x; Sorensen C, 2005, ACTA PSYCHIAT SCAND, V111, P116, DOI 10.1111/j.1600-0447.2004.00430.x; van Melle JP, 2005, EUR HEART J, V26, P2650, DOI 10.1093/eurheartj/ehi480	43	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0033-3174	1534-7796		PSYCHOSOM MED	Psychosom. Med.	MAY	2015	77	4					419	428		10.1097/PSY.0000000000000174		10	Psychiatry; Psychology; Psychology, Multidisciplinary	Psychiatry; Psychology	CI2CR	WOS:000354553000008		
J	Gamsjager, H; Morishita, M				Gamsjaeger, Heinz; Morishita, Masao			Thermodynamic properties of molybdate ion: reaction cycles and experiments	PURE AND APPLIED CHEMISTRY			English	Article						enthalpy; entropy; ISSP-16; molybdate ion; thermodynamics	STANDARD MOLAR ENTHALPIES; SOLUTION CALORIMETRY; LITHIUM MOLYBDATE; BARIUM MOLYBDATE; GIBBS ENERGY; THERMOCHEMISTRY; PRECIPITATION; BAMOO4(S); 298.15-K; HEATS	Standard molar quantities of molybdate ion entropy, S-m(o), enthalpy of formation, Delta H-f(m)o, and Gibbs energy of formation, Delta(f)G(m)(o), are key data for the thermodynamic properties of molybdenum compounds and complexes, which are at present investigated by an OECD NEA review project. The most reliable method to determine Delta H-f(m)o of molybdate ion and alkali molybdates directly consists in measuring calorimetrically the enthalpy of dissolution of crystallized molybdenum trioxide and anhydrous alkali molybdates in corresponding aqueous alkali metal hydroxide solutions. Solubility equilibria of sparingly soluble alkaline earth molybdates and silver molybdate lead to trustworthy data for Delta(f)G(m)(o) of molybdate ion. Thereby the Gibbs energies of the metal molybdates and the corresponding metal ions are combined with the Gibbs energies of dissolution. As reliable values are available for Delta(f)G(m)(o) of the relevant metal ions the problem reduces to select the best values of solubility constants and Delta(f)G(m)(o) of alkaline earth molybdates and silver molybdate. There are two independent possibilities to achieve the latter task. (1) Delta H-f(m)o for alkaline earth molybdates and silver molybdate have been determined by solution calorimetry. Entropy data of molybdenum have been compiled and evaluated recently. CODATA key values are available for S-m(o) of the other elements involved. Whereas S-m(o) (CaMoO4 cr) is well known since decades, low-temperature heat capacity measurements had to be performed recently, but now reliable values for S-m(o) of Ag2MoO4 (cr), BaMoO4 (cr) and SrMoO4(cr) are available. (2) Delta H-f(m)o (BaMoO4, cr), for example, can be obtained from high temperature equilibria also, but the result is less accurate than that of the first method. Once Gibbs energy of formation, Delta(f)G(m)(o), and enthalpy of formation, Delta H-f(m)o, of molybdate ion are known its standard entropy, S-m(o), can be calculated.	[Gamsjaeger, Heinz] Montanuniv, Lehrstuhl Phys Chem, A-8700 Leoben, Austria; [Morishita, Masao] Univ Hyogo, Dept Mat Sci & Chem, Kobe, Hyogo 6712280, Japan	Gamsjager, H (reprint author), Montanuniv, Lehrstuhl Phys Chem, A-8700 Leoben, Austria.	gamsjaeg@unileoben.ac.at					ARCHER DG, 1990, J PHYS CHEM REF DATA, V19, P371; Barany R., 1962, 6143 US DEP INT BUR, P11; Chase Jr M. W., 1998, J PHYS CHEM REF DATA; Cox J.D., 1989, CODATA KEY VALUES TH; CROUCHBAKER S, 1983, J CHEM THERMODYN, V15, P675, DOI 10.1016/0021-9614(83)90081-2; DASH S, 1993, J NUCL MATER, V207, P350, DOI 10.1016/0022-3115(93)90280-C; Dash S, 2013, J THERM ANAL CALORIM, V112, P193, DOI 10.1007/s10973-012-2850-0; DELLIEN I, 1976, CHEM REV, V76, P283, DOI 10.1021/cr60301a001; Gamsjager H., 2012, CHEM THERMODYN, V12, P55; Gamsjager H, 2013, PURE APPL CHEM, V85, P2059, DOI 10.1351/PAC-CON-13-01-04; GRAHAM RL, 1956, J AM CHEM SOC, V78, P4846, DOI 10.1021/ja01600a007; Koehler M. F., 1962, US DEP INT BUR MIN R, P13; Kubaschewski O., 1993, MAT THERMOCHEMISTRY, P363; Latimer W. M., 1952, OXIDATION STATES ELE, P392; Lemire R. J., 2013, CHEM THERMODYN, V13, P1082; Morishita M., 2015, MAT T JIM IN PRESS, V56; MULDROW CN, 1956, J AM CHEM SOC, V78, P5989, DOI 10.1021/ja01604a007; MULDROW CN, 1958, J PHYS CHEM-US, V62, P982, DOI 10.1021/j150566a024; OHARE PAG, 1974, J CHEM THERMODYN, V6, P425, DOI 10.1016/0021-9614(74)90003-2; OHARE PAG, 1973, J CHEM THERMODYN, V5, P851, DOI 10.1016/S0021-9614(73)80047-3; OHARE PAG, 1974, J CHEM THERMODYN, V6, P681, DOI 10.1016/0021-9614(74)90118-9; OHARE PAG, 1974, J CHEM THERMODYN, V6, P117, DOI 10.1016/0021-9614(74)90254-7; SHUKLA NK, 1993, J CHEM THERMODYN, V25, P429, DOI 10.1006/jcht.1993.1047; SHUKLA NK, 1992, J CHEM THERMODYN, V24, P897, DOI 10.1016/S0021-9614(05)80001-1; Singh Z, 1998, J ALLOY COMPD, V266, P77, DOI 10.1016/S0925-8388(97)00458-1; Singh Z, 1998, J ALLOY COMPD, V279, P287, DOI 10.1016/S0925-8388(98)00663-X; Suponitskii Yu. L., 1978, RUSS J PHYS CHEM, V52, p[1699, 2956]; TANGRI RP, 1992, THERMOCHIM ACTA, V198, P259, DOI 10.1016/0040-6031(92)85082-7; Wagman D. D., 1982, J PHYS CHEM REF DA S, V11; Weller W. W., 1963, 6147 US DEP INT BUR, P6	30	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0033-4545	1365-3075		PURE APPL CHEM	Pure Appl. Chem.	MAY	2015	87	5					461	476		10.1515/pac-2014-1105		16	Chemistry, Multidisciplinary	Chemistry	CI7PM	WOS:000354956300004		
J	Watanabe, R; Rahmanian, S; Nikjoo, H				Watanabe, Ritsuko; Rahmanian, Shirin; Nikjoo, Hooshang			Spectrum of Radiation-Induced Clustered Non-DSB Damage - A Monte Carlo Track Structure Modeling and Calculations	RADIATION RESEARCH			English	Article							DOUBLE-STRAND BREAKS; BASE-EXCISION-REPAIR; LOW-ENERGY ELECTRONS; OXIDATIVE DNA-DAMAGE; IONIZING-RADIATION; ESCHERICHIA-COLI; MAMMALIAN-CELLS; BIOLOGICAL CONSEQUENCES; MATHEMATICAL-MODEL; ALPHA-PARTICLES	The aim of this report is to present the spectrum of initial radiation-induced cellular DNA damage [with particular focus on non-double-strand break (DSB) damage] generated by computer simulations. The radiation types modeled in this study were monoenergetic electrons (100 eV-1.5 keV), ultrasoft X-ray photons C k, Al K and Ti K, as well as some selected ions including 3.2 MeV/u proton; 0.74 and 2.4 MeV/u helium ions; 29 MeV/u nitrogen ions and 950MeV/u iron ions. Monte Carlo track structure methods were used to simulate damage induction by these radiation types in a cell-mimetic condition from a single-track action. The simulations took into account the action of direct energy deposition events and the reaction of hydroxyl radicals on atomistic linear B-DNA segments of a few helical turns including the water of hydration. Our results permitted the following conclusions: a. The absolute levels of different types of damage [base damage, simple and complex single-strand breaks (SSBs) and DSBs] vary depending on the radiation type; b. Within each damage class, the relative proportions of simple and complex damage vary with radiation type, the latter being higher with high-LET radiations; c. Overall, for both low-and high-LET radiations, the ratios of the yields of base damage to SSBs are similar, being about 3.0 +/- 0.2; d. Base damage contributes more to the complexity of both SSBs and DSBs, than additional SSB damage and this is true for both low-and high-LET radiations; and e. The average SSB/DSB ratio for low-LET radiations is about 18, which is about 5 times higher than that for high-LET radiations. The hypothesis that clustered DNA damage is more difficult for cells to repair has gained currency among radiobiologists. However, as yet, there is no direct in vivo experimental method to validate the dependence of kinetics of DNA repair on DNA damage complexity (both DSB and non-DSB types). The data on the detailed spectrum of DNA damage presented here, in particular the non-DSB type, provide a good basis for testing mechanistic models of DNA repair kinetics such as base excision repair. (C) 2015 by Radiation Research Society	[Watanabe, Ritsuko] Japan Atom Energy Agcy, Res Grp Radiat Effect Anal, Tokai, Ibaraki 3191195, Japan; [Rahmanian, Shirin; Nikjoo, Hooshang] Karolinska Inst, Dept Oncol Pathol, Radiat Biophys Grp, SE-17176 Stockholm, Sweden	Nikjoo, H (reprint author), Karolinska Inst, Oncol Pathol, Box 260,P9-02, SE-17176 Stockholm, Sweden.	hooshang.nikjoo@ki.se			Swedish Radiation Safety Authority (SSM); Karolinska Institutet Medical University	The work of the Radiation Biophysics Group is supported by the Swedish Radiation Safety Authority (SSM) and Karolinska Institutet Medical University. We are grateful to Professor K. Sankaranarayanan for his valuable comments and suggestions.	Dobbs TA, 2008, DNA REPAIR, V7, P1372, DOI 10.1016/j.dnarep.2008.05.001; Shikazono N, 2006, NUCLEIC ACIDS RES, V34, P3722, DOI 10.1093/nar/gkl503; Bernhardt P, 2002, RADIAT PROT DOSIM, V99, P203; CHARLTON DE, 1988, INT J RADIAT BIOL, V53, P353, DOI 10.1080/09553008814552501; Wallace SS, 1998, RADIAT RES, V150, pS60, DOI 10.2307/3579809; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; Taleei R, 2013, MUTAT RES-GEN TOX EN, V756, P206, DOI 10.1016/j.mrgentox.2013.06.004; Tsao D, 2007, RADIAT RES, V168, P87, DOI 10.1667/RR0865.1; Sutherland BM, 2000, BIOCHEMISTRY-US, V39, P8026, DOI 10.1021/bi9927989; Uehara S, 2006, J RADIAT RES, V47, P69, DOI 10.1269/jrr.47.69; Pearson CG, 2004, NUCLEIC ACIDS RES, V32, P263, DOI 10.1093/nar/gkh150; RITTER MA, 1977, NATURE, V266, P653, DOI 10.1038/266653a0; Noguchi M, 2012, MUTAT RES-FUND MOL M, V732, P34, DOI 10.1016/j.mrfmmm.2011.12.009; Little JB, 2000, CARCINOGENESIS, V21, P397, DOI 10.1093/carcin/21.3.397; Nikjoo H, 2006, RADIAT MEAS, V41, P1052, DOI 10.1016/j.radmeas.2006.02.001; Cadet J, 2012, CANCER LETT, V327, P5, DOI 10.1016/j.canlet.2012.04.005; Taleei R, 2012, INT J RADIAT BIOL, V88, P948, DOI 10.3109/09553002.2012.695098; Kozmin SG, 2009, NUCLEIC ACIDS RES, V37, P1767, DOI 10.1093/nar/gkp010; Semenenko VA, 2004, RADIAT RES, V161, P451, DOI 10.1667/RR3140; Shikazono N, 2009, MUTAT RES-FUND MOL M, V669, P162, DOI 10.1016/j.mrfmmm.2009.06.004; Semenenko VA, 2006, PHYS MED BIOL, V51, P1693, DOI 10.1088/0031-9155/51/7/004; Nikjoo H, 2012, INT J RADIAT BIOL, V88, P87, DOI 10.3109/09553002.2011.640860; Nikjoo H, 1999, RADIAT ENVIRON BIOPH, V38, P31, DOI 10.1007/s004110050135; Nikjoo H, 1997, INT J RADIAT BIOL, V71, P467; Hada M, 2008, J RADIAT RES, V49, P203, DOI 10.1269/jrr.07123; Fromme JC, 2004, ADV PROTEIN CHEM, V69, P1; OTTOLENGHI A, 1995, RADIAT ENVIRON BIOPH, V34, P239, DOI 10.1007/BF01209749; UMRANIA Y, 1995, INT J RADIAT BIOL, V67, P145, DOI 10.1080/09553009514550181; Malyarchuk S, 2004, NUCLEIC ACIDS RES, V32, P5721, DOI 10.1093/nar/gkh911; Harrison L, 1999, J MOL BIOL, V290, P667, DOI 10.1006/jmbi.1999.2892; Friedland W, 2003, RADIAT RES, V159, P401, DOI 10.1667/0033-7587(2003)159[0401:SODDAP]2.0.CO;2; Holley WR, 1996, RADIAT RES, V145, P188, DOI 10.2307/3579174; Nikjoo H, 1996, ACTA ONCOL, V35, P849, DOI 10.3109/02841869609104036; Nikjoo H, 2001, RADIAT RES, V156, P577, DOI 10.1667/0033-7587(2001)156[0577:CAFDTS]2.0.CO;2; Kryston TB, 2011, MUTAT RES-FUND MOL M, V711, P193, DOI 10.1016/j.mrfmmm.2010.12.016; Gulston M, 2002, NUCLEIC ACIDS RES, V30, P3464, DOI 10.1093/nar/gkf467; Wallace SS, 2014, DNA REPAIR, V19, P14, DOI 10.1016/j.dnarep.2014.03.030; Watanabe R, 2002, INT J RADIAT BIOL, V78, P953, DOI 10.1080/0955300021000024270; Sage E, 2011, MUTAT RES-FUND MOL M, V711, P123, DOI 10.1016/j.mrfmmm.2010.12.010; Dizdaroglu M, 2005, MUTAT RES-FUND MOL M, V591, P45, DOI 10.1016/j.mrfmmm.2005.01.033; Friedland W, 2005, RADIAT PHYS CHEM, V72, P279, DOI 10.1016/j.radphyschem.2004.05.053; Belli M, 2000, INT J RADIAT BIOL, V76, P1095; CHARLTON DE, 1989, INT J RADIAT BIOL, V56, P1, DOI 10.1080/09553008914551141; CHATTERJEE A, 1985, RADIAT PROT DOSIM, V13, P137; Chaudhry MA, 1997, J BIOL CHEM, V272, P15650, DOI 10.1074/jbc.272.25.15650; CHAUDHRY MA, 1995, J MOL BIOL, V249, P914; Close DM, 2013, J PHYS CHEM A, V117, P12608, DOI 10.1021/jp4084844; CULLIS PM, 1989, FREE RADICAL RES COM, V6, P149, DOI 10.3109/10715768909073455; Cunniffe SMT, 2007, DNA REPAIR, V6, P1839, DOI 10.1016/j.dnarep.2007.07.003; Datta K, 2010, RADIAT RES, V175, P97; Dianov GL, 2001, BIOESSAYS, V23, P745, DOI 10.1002/bies.1104; Eot-Houllier G, 2007, NUCLEIC ACIDS RES, V35, P3355, DOI 10.1093/nar/gkm190; FRANKENBERGSCHWAGER M, 1990, INT J RADIAT BIOL, V58, P569, DOI 10.1080/09553009014551931; Harrison L, 2002, PATHOPHYSIOLOGY, V8, P149, DOI 10.1016/S0928-4680(01)00079-7; Höglund H, 2001, Radiat Res, V155, P818; Kellerer AM, 1975, DOSIMETRY IONIZING R; Lomax ME, 2005, RADIAT RES, V163, P79, DOI 10.1667/RR3284; Lomax ME, 2002, RADIAT PROT DOSIM, V99, P63; Nikjoo H., 2004, CHARGED PARTICLE PHO; Nikjoo H., 2012, INTERACTION RAD MATT; Nikjoo H, 2010, PHYS MED BIOL, V55, pR65, DOI 10.1088/0031-9155/55/10/R01; Pomplun E, 1996, ACTA ONCOL, V35, P857, DOI 10.3109/02841869609104037; Rahmanian S, 2014, DNA REPAIR, V22, P89, DOI 10.1016/j.dnarep.2014.07.011; ROOTS R, 1979, RADIAT RES, V78, P38, DOI 10.2307/3575005; Sutherland BM, 2002, J RADIAT RES, V43, pS149; Taleei R, 2013, RADIAT RES, V179, P540, DOI 10.1667/RR3124.1; Taleei R, 2013, RADIAT RES, V179, P530, DOI 10.1667/RR3123.1; Taleei R, 2014, MUTAT RES-GEN TOX EN, V761, P50, DOI 10.1016/j.mrgentox.2014.01.001; WALLACE SS, 1988, ENVIRON MOL MUTAGEN, V12, P431, DOI 10.1002/em.2860120411; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; Ward JF, 1991, EARLY EFFECTS RAD DN; Weinfeld M, 2001, RADIAT RES, V156, P584, DOI 10.1667/0033-7587(2001)156[0584:ROBERE]2.0.CO;2	72	1	1	RADIATION RESEARCH SOC	LAWRENCE	810 E TENTH STREET, LAWRENCE, KS 66044 USA	0033-7587	1938-5404		RADIAT RES	Radiat. Res.	MAY	2015	183	5					525	540		10.1667/RR13902.1		16	Biology; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	Life Sciences & Biomedicine - Other Topics; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	CI7VI	WOS:000354972500005		
J	Takagi, R; Nishida, K; Aoki, Y; Maeda, T; Masuda, K; Takeo, M; Obara, K; Shiomi, K; Sato, M; Saito, K				Takagi, Ryota; Nishida, Kiwamu; Aoki, Yosuke; Maeda, Takuto; Masuda, Komei; Takeo, Minoru; Obara, Kazushige; Shiomi, Katsuhiko; Sato, Minemori; Saito, Kazuo			A Single Bit Matters: Coherent Noise of Seismic Data Loggers	SEISMOLOGICAL RESEARCH LETTERS			English	Article							SURFACE-WAVE TOMOGRAPHY; CRUSTAL		[Takagi, Ryota; Nishida, Kiwamu; Aoki, Yosuke; Maeda, Takuto; Masuda, Komei; Takeo, Minoru; Obara, Kazushige] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan; [Shiomi, Katsuhiko] Natl Res Inst Earth Sci & Disaster Prevent, Tsukuba, Ibaraki 3050006, Japan; [Sato, Minemori] Hakusan Corp, Tokyo 1830044, Japan; [Saito, Kazuo] Keisokugiken Corp, Takanezawa Town, Tochigi 3291233, Japan	Takagi, R (reprint author), Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, 1-1 Yayoi 1, Tokyo 1130032, Japan.	yaoki@eri.u-tokyo.ac.jp		Maeda, Takuto/0000-0002-8861-4597			Aid K, 1957, B EARTHQ RES I TOKYO, V25, P415; Brenguier F, 2008, SCIENCE, V321, P1478, DOI 10.1126/science.1160943; Nishida K, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005395; Brenguier F, 2014, SCIENCE, V345, P80, DOI 10.1126/science.1254073; Nagaoka Y, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045289; Obara K, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1854197; Brenguier F, 2008, NAT GEOSCI, V1, P126, DOI 10.1038/ngeo104; Nishida K, 2009, SCIENCE, V326, P112, DOI 10.1126/science.1176389; Campillo M, 2003, SCIENCE, V299, P547, DOI 10.1126/science.1078551; Shapiro NM, 2005, SCIENCE, V307, P1615, DOI 10.1126/science.1108339; Haney MM, 2012, GEOPHYS J INT, V191, P189, DOI 10.1111/j.1365-246X.2012.05597.x; Lin FC, 2011, NAT GEOSCI, V4, P55, DOI 10.1038/NGEO1036; Maeda T, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008464; Nagaoka Y, 2012, EARTH PLANET SC LETT, V333, P1, DOI 10.1016/j.epsl.2012.03.034; Peterson J, 1993, 93322 US GEOL SURV, P93; Takagi R, 2014, J GEOPHYS RES-SOL EA, V119, P2005, DOI 10.1002/2013JB010824; van Wijk K, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047442	17	0	0	SEISMOLOGICAL SOC AMER	ALBANY	400 EVELYN AVE, SUITE 201, ALBANY, CA 94706-1375 USA	0895-0695			SEISMOL RES LETT	Seismol. Res. Lett.	MAY-JUN	2015	86	3					901	907		10.1785/0220150030		7	Geochemistry & Geophysics	Geochemistry & Geophysics	CI3RX	WOS:000354666200017		
J	Kanao, M; Shimizu, T; Imamura, T; Nakamura, M				Kanao, M.; Shimizu, T.; Imamura, T.; Nakamura, M.			Hinode SOT Plate Scale Reinvestigated by G-Band Images on the 2012 Transit of Venus	SOLAR PHYSICS			English	Article						Ephemeris; Hinode; Instrument calibration; Transit of Venus	SOLAR OPTICAL TELESCOPE; ATMOSPHERE; CALIBRATION; AKATSUKI; MISSION; EXPRESS; CLOUDS; SYSTEM	The Hinode Solar Optical Telescope (SOT) successfully observed the transit of Venus with an unprecedented high spatial resolution on 5 -aEuro parts per thousand 6 June 2012, providing images of the aureole refracted by the atmosphere of Venus and the dark Venus disk against the bright solar surface. The transit of Venus provided a unique opportunity for calibrating the plate scale of SOT images. With the examination of the radius of the dark Venus disk, we determined the plate scale of G-band 430.5 nm images with high accuracy: 0.05369 +/- 0.00005 arcsec pixel(-1). The radius was defined at the intensity level of the 0.5 transmittance and compared with the angular radius of Venus including the thickness of the atmosphere determined with the measurements of SPICAV onboard Venus Express. Thanks to the high spatial resolution, SOT images show that the dark Venus can be well represented by an ellipse. We observed 7.6 km difference in altitude between the equator and the polar regions.	[Kanao, M.; Shimizu, T.; Imamura, T.; Nakamura, M.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Shimizu, T.; Imamura, T.; Nakamura, M.] Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan	Kanao, M (reprint author), Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, 3-1-1 Yoshinodai, Sagamihara, Kanagawa 2525210, Japan.	miho@stp.isas.jaxa.jp; shimizu@solar.isas.jaxa.jp; imamura.takeshi@jaxa.jp; mnakamur@isas.jaxa.jp					Ignatiev NI, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003320; BELTON MJS, 1991, SCIENCE, V253, P1531, DOI 10.1126/science.253.5027.1531; MAROV MY, 1980, ICARUS, V44, P608, DOI 10.1016/0019-1035(80)90131-1; MAROV MY, 1978, ANNU REV ASTRON ASTR, V16, P141, DOI 10.1146/annurev.aa.16.090178.001041; Tsuneta S, 2008, SOL PHYS, V249, P167, DOI 10.1007/s11207-008-9174-z; Wilquet V, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003186; Wilquet V, 2012, ICARUS, V217, P875, DOI 10.1016/j.icarus.2011.11.002; Archinal BA, 2011, CELEST MECH DYN ASTR, V109, P101, DOI 10.1007/s10569-010-9320-4; Kosugi T, 2007, SOL PHYS, V243, P3, DOI 10.1007/s11207-007-9014-6; Belyaev DA, 2012, ICARUS, V217, P740, DOI 10.1016/j.icarus.2011.09.025; Drossart P, 2007, NATURE, V450, P641, DOI 10.1038/nature06140; Ichimoto K, 2008, SOL PHYS, V249, P233, DOI 10.1007/s11207-008-9169-9; Meftah M, 2014, SOL PHYS, V289, P1, DOI 10.1007/s11207-013-0347-z; Bertaux JL, 2007, PLANET SPACE SCI, V55, P1673, DOI 10.1016/j.pss.2007.01.016; FORD PG, 1992, J GEOPHYS RES-PLANET, V97, P13103; Shimizu T, 2008, SOL PHYS, V249, P221, DOI 10.1007/s11207-007-9053-z; Imamura T, 2011, EARTH PLANETS SPACE, V63, P493, DOI [10.5047/eps.2011.0.1.009, 10.5047/eps.2011.03.009]; Kawabata K., 1980, J GEOPHYS RES, V85, P8129, DOI DOI 10.1029/JA085IA13P08129; Knollenberg R.G., 1980, J GEOPHYS RES, V85, P8039, DOI 10.1029/JA085iA13p08039; Moroz V. I., 1982, Pis'ma v Astronomicheskie Zhurnal, V8; Nakamura M., 2012, EARTH PLANETS SPACE, V63, P443; Ogohara K, 2012, ICARUS, V217, P661, DOI 10.1016/j.icarus.2011.05.017; Pasachoff JM, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/4/112; Seiff A., 1985, ADV SPACE RES, V5, P3, DOI DOI 10.1016/0273-1177(85)90197-8; Shimizu T, 2007, PUBL ASTRON SOC JPN, V59, pS845; Shimizu T, 2007, ASTR SOC P, V369, P51; Soma M., 2012, COMMUNICATION; Tanga P., 2012, ICARUS, V217, P875; Titov D.V., 2008, NATURE, V7222, P620; TRAVIS LD, 1979, SCIENCE, V203, P781, DOI 10.1126/science.203.4382.781; Suematsu Y, 2008, SOL PHYS, V249, P197, DOI 10.1007/s11207-008-9129-4; Wulser JP, 1998, SOL PHYS, V180, P131, DOI 10.1023/A:1005058818887	32	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0038-0938	1573-093X		SOL PHYS	Sol. Phys.	MAY	2015	290	5					1491	1506		10.1007/s11207-015-0675-2		16	Astronomy & Astrophysics	Astronomy & Astrophysics	CI1GB	WOS:000354490200012		
J	Shin, J; Sakurai, T				Shin, J.; Sakurai, T.			Vignetting Effect in the Soft X-Ray Telescope Onboard Yohkoh: I. Numerical Simulation	SOLAR PHYSICS			English	Article						Numerical simulation; Vignetting effect; Yohkoh SXT	SOLAR-A MISSION	Using a numerical simulation method, we examine the vignetting effect in the Soft X-ray Telescope (SXT) onboard Yohkoh. The off-axis variation of the effective area in the field-of-view shows that the vignetting in SXT cannot be described properly with a one-dimensional axisymmetric model. Our model assumes a response function of the X-ray mirror that is symmetric about the optical center, and an effect of occultation due to other telescope structures that is symmetric about the geometrical center; the vignetting is the result of these two contributions. We found that a rotationally non-symmetric distribution of the SXT effective area is mostly due to the offset of the optical center from the geometrical center of the telescope. The deviation from rotational symmetry due to the offset is most noticeable at the outskirts of the field-of-view, which results in the dispersion of effective area when considered as a one-dimensional distribution. The model cannot completely describe the vignetting in SXT because the fitting errors are larger than the measurement errors. We ultimately need a fully two-dimensional model for the vignetting in SXT.	[Shin, J.] Kyung Hee Univ, Sch Space Res, Yongin 446701, Gyunggi, South Korea; [Sakurai, T.] Natl Astron Observ, Div Solar & Plasma Astrophys, Mitaka, Tokyo 1818588, Japan; [Sakurai, T.] Grad Univ Adv Studies, Dept Astron Sci, Mitaka, Tokyo 1818588, Japan	Shin, J (reprint author), Kyung Hee Univ, Sch Space Res, Yongin 446701, Gyunggi, South Korea.	junhosn@khu.ac.kr			WCU - Korean Ministry of Education, Science and Technology [R31-10016]	JS has been supported by the WCU grant (No. R31-10016) funded by the Korean Ministry of Education, Science and Technology. Yohkoh was a Japanese ISAS (presently ISAS/JAXA) mission, collaborating with NASA/US and PPARC (presently STFC)/UK, and its scientific operation was conducted by the international science team organized in ISAS. Yohkoh/SXT was prepared by the Lockheed Palo Alto Research Laboratories, the National Astronomical Observatory of Japan, and the University of Tokyo with the support of NASA and ISAS.	Pizzo VJ, 2005, SOL PHYS, V226, P283, DOI 10.1007/s11207-005-7417-9; OGAWARA Y, 1991, SOL PHYS, V136, P1, DOI 10.1007/BF00151692; Golub L, 2007, SOL PHYS, V243, P63, DOI 10.1007/s11207-007-0182-1; TSUNETA S, 1991, SOL PHYS, V136, P37, DOI 10.1007/BF00151694; Bentley R. D., 1999, YOHKOH ANAL GUIDE US; Fuller R. A., 1994, 37FLA94 SXT; Fuller R. A., 1994, 36FL94 SXT; LEMEN JR, 1989, P SOC PHOTO-OPT INS, V1160, P316; MARTENS PC, 1995, SOL PHYS, V157, P141, DOI 10.1007/BF00680614; Shin J, 2009, SOL PHYS, V254, P357, DOI 10.1007/s11207-008-9297-2; Shin J., 2013, SOLAR PHYS UNPUB; Shin J, 2009, ADV SPACE RES, V43, P101, DOI 10.1016/j.asr.2008.07.007	12	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0038-0938	1573-093X		SOL PHYS	Sol. Phys.	MAY	2015	290	5					1531	1546		10.1007/s11207-013-0292-x		16	Astronomy & Astrophysics	Astronomy & Astrophysics	CI1GB	WOS:000354490200014		
J	Sasaki, T; Sotome, I; Okadome, H				Sasaki, Tomoko; Sotome, Itaru; Okadome, Hiroshi			In vitro starch digestibility and in vivo glucose response of gelatinized potato starch in the presence of non-starch polysaccharides	STARCH-STARKE			English	Article						Glucose response; Non-starch polysaccharides; Potato starch; Starch digestibility; Xanthan gum	GLYCEMIC INDEX; DIETARY FIBER; RHEOLOGICAL PROPERTIES; AVAILABLE GLUCOSE; ALPHA-AMYLASE; GUAR GUM; VISCOSITY; HYDROLYSIS; FOODS; MICROSTRUCTURE	Blending non-starch polysaccharides with starch is expected to change the rate and extent of starch digestion and has a potential effect on glucose response. The objective of this study was to investigate the effects of four water-soluble non-starch polysaccharides: xanthan gum, guar gum, pectin, and konjac-glucomannan, on in vitro starch digestibility and in vivo glucose response of gelatinized potato starch. Gelatinized potato starch was digested rapidly, and the added polysaccharides significantly reduced the digestion of gelatinized potato starch even over a short reaction time. Postprandial blood glucose response in rats was reduced by the addition of polysaccharides to gelatinized potato starch. The effects on the blood glucose level after ingestion were dependent on the type of polysaccharide. The addition of xanthan gum significantly reduced the blood glucose levels at 30 min, whereas guar gum and pectin reduced the levels at 60 min. The interaction between gelatinized potato amylopectin and polysaccharides was investigated using a quartz crystal microbalance. Xanthan gum was found to be immobilized on the layer of gelatinized amylopectin, suggesting that interaction between starch and xanthan gum is one of the major factors in starch hydrolysis inhibition.	[Sasaki, Tomoko; Sotome, Itaru; Okadome, Hiroshi] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan	Sasaki, T (reprint author), Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan.	tomokos@affrc.go.jp					Englyst KN, 1999, AM J CLIN NUTR, V69, P448; Jenkins AL, 2008, CROAT MED J, V49, P772, DOI 10.3325/cmj.2008.49.722; Charoenrein S, 2011, CARBOHYD POLYM, V83, P291, DOI 10.1016/j.carbpol.2010.07.056; Brennan CS, 2005, MOL NUTR FOOD RES, V49, P560, DOI 10.1002/mnfr.200500025; Mandala IG, 2004, FOOD HYDROCOLLOID, V18, P191, DOI 10.1016/S0268-005X(03)00064-X; Chung HJ, 2008, FOOD RES INT, V41, P579, DOI 10.1016/j.foodres.2008.04.006; Bordoloi A, 2012, FOOD CHEM, V133, P1206, DOI 10.1016/j.foodchem.2012.01.063; Chaisawang M, 2006, FOOD HYDROCOLLOID, V20, P641, DOI 10.1016/j.foodhyd.2005.06.003; Goni I, 1997, NUTR RES, V17, P427, DOI 10.1016/S0271-5317(97)00010-9; Ou SY, 2001, J AGR FOOD CHEM, V49, P1026, DOI 10.1021/jf000574n; LECLERE CJ, 1994, AM J CLIN NUTR, V59, P914; JENKINS DJA, 1978, BRIT MED J, V1, P1392; Kim JM, 1999, POLYMER, V40, P3291, DOI 10.1016/S0032-3861(98)00557-6; Brennan CS, 1996, J CEREAL SCI, V24, P151, DOI 10.1006/jcrs.1996.0048; Englyst KN, 2003, BRIT J NUTR, V89, P329, DOI 10.1079/BJN2002786; Babic J, 2006, CZECH J FOOD SCI, V24, P275; Zhang GY, 2009, CRIT REV FOOD SCI, V49, P852, DOI 10.1080/10408390903372466; Eelderink C, 2012, AM J CLIN NUTR, V96, P1017, DOI 10.3945/ajcn.112.041947; BeMiller J. N., 2007, CARBOHYDRATE CHEM FO; BJORCK I, 1994, TRENDS FOOD SCI TECH, V5, P213, DOI 10.1016/0924-2244(94)90251-8; CAMERONSMITH D, 1994, BRIT J NUTR, V71, P563, DOI 10.1079/BJN19940163; Dimantov A, 2004, FOOD HYDROCOLLOID, V18, P29, DOI 10.1016/S0268-005X(03)00039-0; Ek KL, 2014, BRIT J NUTR, V111, P699, DOI 10.1017/S0007114513003048; ENGLYST HN, 1992, EUR J CLIN NUTR, V46, pS33; Hallfrisch J, 2000, J AM COLL NUTR, V19, p320S; Febek H., 2014, FOOD HYDROCOLLOID, V35, P718; Hoefler A. C., 2004, HYDROCOLLOIDS FUNCTI; JENKINS DJA, 1982, AM J CLIN NUTR, V35, P1339; Mahasukhonthachat K, 2010, J CEREAL SCI, V51, P392, DOI 10.1016/j.jcs.2010.02.008; Muhrbeck P, 1996, CARBOHYD POLYM, V31, P263, DOI 10.1016/S0144-8617(96)00030-6; Sanz-Penella JM, 2014, PLANT FOOD HUM NUTR, V69, P216, DOI 10.1007/s11130-014-0436-7; Sasaki T, 2008, J AGR FOOD CHEM, V56, P1091, DOI 10.1021/jf072424j; Sasaki T, 2012, FOOD CHEM, V133, P1420, DOI 10.1016/j.foodchem.2012.02.029; Sauerbrey G. Z., 1959, PHYSIK, V155, P206; SWINKELS JJM, 1985, STARKE, V37, P1, DOI 10.1002/star.19850370102; Yousria A. B., 1994, STARCH, V46, P134	36	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0038-9056	1521-379X		STARCH-STARKE	Starch-Starke	MAY	2015	67	5-6					415	423		10.1002/star.201400214		9	Food Science & Technology	Food Science & Technology	CH7KL	WOS:000354215000005		
J	Kawase, T; Sumida, S; Oida, T				Kawase, Tokuzo; Sumida, Sho; Oida, Tatsuo			Hybrid Biosurfactant: Syntheses of Hybrid Corynomycolic Acid and its Monolayer Formation	TENSIDE SURFACTANTS DETERGENTS			English	Article						Hybrid biosurfactant; corynomycolic acid; surface tension; surface pressure-area isotherm; monolayer	AIR-WATER-INTERFACE; GEMINI SURFACTANTS; HYDROCARBON CHAINS; FLUOROCARBON; BEHAVIOR	Corynomycolic acids have two hydrophilic heads (OH and COOH) and two hydrophobic tails on adjacent carbon atoms. In this work, hybrid type corynomycolic acids (syn- and anti-isomers) were synthesized via the following three steps: 1) crossed Claisen condensation of t-butyl tridecanoate with ethyl perfluorooctanoate, 2) reduction of C = O to OH, and 3) conversion of COO-t-Bu to COOH using CF3COOH. Both hydrophilic groups (OH and COOH) of hybrid corynomycolic acid would dissociate to -O- and -COO- at alkaline condition (pH = 12) while they remain unchanged at acidic condition (pH < 3). The effect of hybrid structure on the surfactant properties was investigated by the surface tension and surface pressure-area (pi-A) measurements. Hybrid type corynomycolic acid gave smaller cmc and gamma(cmc) than dialkyl type one due to fluoroalkyl chain. With respect to the stereochemistry, the anti-isomer attained a smaller gamma(cmc) value than the syn-isomer. In pi-A measurements, the monolayer of the syn-isomer showed a lower collapsing pressure (similar to 15 mN m(-1)) than that of the anti-isomer.	[Kawase, Tokuzo; Sumida, Sho; Oida, Tatsuo] Kyoto Inst Technol, Kyoto 6068585, Japan	Kawase, T (reprint author), Kyoto Inst Technol, Dept Chem & Mat Technol, Sakyo Ku, Hashigamicho 1, Kyoto 6068585, Japan.	kawase@kit.ac.jp					AGRAWAL ML, 1988, J COLLOID INTERF SCI, V121, P355, DOI 10.1016/0021-9797(88)90439-0; Aisaka Tsunetomo, 2007, J Oleo Sci, V56, P633; Andres JM, 2001, TETRAHEDRON, V57, P8521, DOI 10.1016/S0040-4020(01)00804-3; KAJIYAMA T, 1989, CHEM LETT, P1047, DOI 10.1246/cl.1989.1047; VISCONTINI M, 1952, HELV CHIM ACTA, V35, P2280, DOI 10.1002/hlca.19520350714; Ohno A, 2008, J FLUORINE CHEM, V129, P577, DOI 10.1016/j.jfluchem.2008.03.007; Mukherjee S, 2006, TRENDS BIOTECHNOL, V24, P509, DOI 10.1016/j.tibtech.2006.09.005; Abe M, 1997, LANGMUIR, V13, P2932, DOI 10.1021/la961023n; Aydogan N, 2003, LANGMUIR, V19, P10726, DOI 10.1021/la0351921; Oda R, 2000, LANGMUIR, V16, P9759, DOI 10.1021/la0008075; Kaganer VM, 1999, REV MOD PHYS, V71, P779, DOI 10.1103/RevModPhys.71.779; ANH NT, 1973, J AM CHEM SOC, V95, P6146; Kawase T, 2011, J OLEO SCI, V60, P61, DOI 10.5650/jos.60.61; Yoshimura T, 2006, LANGMUIR, V22, P4643, DOI 10.1021/la0534266; CHEN YL, 1986, LANGMUIR, V2, P349, DOI 10.1021/la00069a018; Asakawa T, 2013, J OLEO SCI, V62, P17, DOI 10.5650/jos.62.17; COOPER DG, 1981, J AM OIL CHEM SOC, V58, P77, DOI 10.1007/BF02666059; CRAM DJ, 1952, J AM CHEM SOC, V74, P5828, DOI 10.1021/ja01143a007; DIENG SY, 1995, COLLOID SURFACE A, V98, P43, DOI 10.1016/0927-7757(95)03103-K; Fujii T, 1999, COLLOID POLYM SCI, V277, P334, DOI 10.1007/s003960050389; Fujii T., 1995, J JPN OIL CHEM SOC, V44, P419, DOI 10.5650/jos1956.44.419; Guo W., 1992, J PHYS CHEM-US, V96, P6738, DOI 10.1021/j100195a038; Ito A, 1997, LANGMUIR, V13, P2935, DOI 10.1021/la9602426; KAJIYAMA T, 1992, B CHEM SOC JPN, V65, P864, DOI 10.1246/bcsj.65.864; Kawase T, 2015, TENSIDE SURFACT DET, V52, P20, DOI 10.3139/113.110344; Schorken U, 2009, EUR J LIPID SCI TECH, V111, P627, DOI 10.1002/ejlt.200900057; Peresypkin A, 2007, MENDELEEV COMMUN, V17, P82, DOI 10.1016/j.mencom.2007.03.009; Rosen M. J., 1998, J SURFACTANTS DETERG, V4, P547, DOI 10.1007/s11743-998-0057-8; Rosen M. J., 2012, SURFACTANTS INTERFAC, V4th, DOI [10.1002/9781118228920, DOI 10.1002/9781118228920]; Seimiya T, 2003, J COLLOID INTERF SCI, V266, P422, DOI 10.1016/S0021-9797(03)00715-X; YOSHINO N, 1995, LANGMUIR, V11, P466, DOI 10.1021/la00002a016	31	0	0	CARL HANSER VERLAG	MUNICH	KOLBERGERSTRASSE 22, POSTFACH 86 04 20, D-81679 MUNICH, GERMANY	0932-3414			TENSIDE SURFACT DET	Tenside Surfactants Deterg.	MAY	2015	52	3					219	229		10.3139/113.110369		11	Chemistry, Applied; Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CI0WG	WOS:000354459400008		
